Citrus Sinensis ID: 002774
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 882 | 2.2.26 [Sep-21-2011] | |||||||
| Q9LT96 | 946 | Probable leucine-rich rep | no | no | 0.975 | 0.909 | 0.571 | 0.0 | |
| C0LGU1 | 959 | Probable LRR receptor-lik | no | no | 0.887 | 0.816 | 0.365 | 1e-131 | |
| C0LGD7 | 953 | Probable LRR receptor-lik | no | no | 0.878 | 0.813 | 0.364 | 1e-128 | |
| Q9LFG1 | 937 | Putative leucine-rich rep | no | no | 0.877 | 0.826 | 0.362 | 1e-120 | |
| O49545 | 1003 | Leucine-rich repeat recep | no | no | 0.875 | 0.769 | 0.317 | 1e-89 | |
| Q9FN37 | 1036 | Phytosulfokine receptor 2 | no | no | 0.885 | 0.753 | 0.325 | 2e-87 | |
| Q9SGP2 | 996 | Receptor-like protein kin | no | no | 0.896 | 0.794 | 0.313 | 3e-86 | |
| Q9LV48 | 652 | Proline-rich receptor-lik | no | no | 0.329 | 0.446 | 0.474 | 1e-75 | |
| C0LGR3 | 1091 | Probable LRR receptor-lik | no | no | 0.876 | 0.708 | 0.291 | 3e-74 | |
| Q9CAL8 | 710 | Proline-rich receptor-lik | no | no | 0.334 | 0.415 | 0.455 | 1e-73 |
| >sp|Q9LT96|Y5977_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g49770 OS=Arabidopsis thaliana GN=At5g49770 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 917 bits (2371), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 504/882 (57%), Positives = 642/882 (72%), Gaps = 22/882 (2%)
Query: 3 LKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGS 62
LKG+L +I+ L+EL TLDL+ N +L GPLP IGNL+KL+ L L+GC+F+GPIPDSIG+
Sbjct: 80 LKGKLPTEISTLSELQTLDLTGNPELSGPLPANIGNLRKLTFLSLMGCAFNGPIPDSIGN 139
Query: 63 LQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNS-PGLDMLVRAK 121
L++L LSLN N FSG +P S+G LS LYW D+ DN+LEG++PVSDG S PGLDML++
Sbjct: 140 LEQLTRLSLNLNKFSGTIPASMGRLSKLYWFDIADNQLEGKLPVSDGASLPGLDMLLQTG 199
Query: 122 HFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSG 181
HFHFG N+LSG IPEKLF +M L+HVLFD N TG +P +LGLV++L V+R DRN LSG
Sbjct: 200 HFHFGNNKLSGEIPEKLFSSEMTLLHVLFDGNQFTGSIPESLGLVQNLTVLRLDRNRLSG 259
Query: 182 PVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSL 241
+PS+LNNLT++ +L+LS+NK TG++PNLT L+ L LD+SNN S VPSW + SL
Sbjct: 260 DIPSSLNNLTNLQELHLSDNKFTGSLPNLTSLTSLYTLDVSNNPLALSPVPSWIPFLNSL 319
Query: 242 TTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENL-LVNLQNNRISA 300
+TL +E+ L G +P LFS LQTV +K N +N TLDLGT+YS+ L V+L++N I+
Sbjct: 320 STLRLEDIQLDGPVPTSLFSPLQLQTVSLKHNLINTTLDLGTNYSKQLDFVDLRDNFITG 379
Query: 301 YTERGGAPAVNLTLIDNPICQELGTA-KGYCQLSQPISPYSTKQKNCLPAPCNANQSSSP 359
Y P VN+ L DN +CQ+ GYC QP S +ST K C C + +
Sbjct: 380 YKSPANNP-VNVMLADNQVCQDPANQLSGYCNAVQPNSTFSTLTK-C-GNHCGKGKEPNQ 436
Query: 360 NCQCAYPYTGTLVFRSLSFSDLGNTTYYEILEQSVTTSFQSTYKLPIDSISLSNPHKNNF 419
C C YP TG RS SFS N + + +S+ T F++ K P+DS+++ N +N
Sbjct: 437 GCHCVYPLTGVFTLRSPSFSGFSNNSNFLKFGESLMTFFKNG-KYPVDSVAMRNISENPT 495
Query: 420 EY-LELSIQFFPSGQESFNRTGVSSVGFVLSNQIYSPPPLFGPMFFNGDPYQYFAESGGS 478
+Y L +++ FPSG++ FN+T + S+ + Q Y PPP FGP F D Y+ F++ S
Sbjct: 496 DYHLLINLLIFPSGRDRFNQTEMDSINSAFTIQDYKPPPRFGPYIFVADQYKTFSDLEDS 555
Query: 479 HKSTSIGVIIGAAAAGCVVLLLLLLAGVYAYHQKRRAEKANEQ-NPFAHWDMNKSSGSIP 537
K+ S+ VIIG V+LLLL LAG+YA QK+RA++A +Q NPFA WD K+ P
Sbjct: 556 -KTVSMKVIIGVVVGVVVLLLLLALAGIYALRQKKRAQRATDQMNPFAKWDAGKNEMDAP 614
Query: 538 QLKGARCFSFEEVKKYTNNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQE 597
QL G + F+FEE+ K TNNFSDANDVG GGYG+VYKGTLPNGQ+IAIKRAQQGSMQG E
Sbjct: 615 QLMGTKAFTFEELSKCTNNFSDANDVGGGGYGQVYKGTLPNGQVIAIKRAQQGSMQGAFE 674
Query: 598 FKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLK 657
FK EIELLSRVHHKN+V LLGFCFD+ EQML+YE++PNGSL D LSGKNG++LDW RRLK
Sbjct: 675 FKTEIELLSRVHHKNVVKLLGFCFDQKEQMLVYEYIPNGSLRDGLSGKNGVKLDWTRRLK 734
Query: 658 IALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQ 717
IALG+ +GL+YLHELA+PPIIHRD+KS+NILLDE L AKVADFGLSK + D EK H+TTQ
Sbjct: 735 IALGSGKGLAYLHELADPPIIHRDVKSNNILLDEHLTAKVADFGLSKLVGDPEKAHVTTQ 794
Query: 718 VKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKE 777
VKGTMGYLDPEYYMT QLTEKSDVY FGV+MLELLTG+ PI+RG Y+V+E++ MDK +
Sbjct: 795 VKGTMGYLDPEYYMTNQLTEKSDVYGFGVVMLELLTGKSPIDRGSYVVKEVKKKMDKSRN 854
Query: 778 LYNLYELIDPT-IGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQAGLN 836
LY+L EL+D T I S LKGFEKYVD+AL+CV+ G +RPTMSEVV+++E+IL+ GLN
Sbjct: 855 LYDLQELLDTTIIQNSGNLKGFEKYVDVALQCVEPEGVNRPTMSEVVQELESILRLVGLN 914
Query: 837 PNAESASSSASYEDASKGNFHHPYCNEEGFDYGYSGGFPTSK 878
PNA+ SA+YE+AS PY + + Y+G FPT K
Sbjct: 915 PNAD----SATYEEASG----DPYGRDS---FEYTGVFPTPK 945
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|C0LGU1|Y5374_ARATH Probable LRR receptor-like serine/threonine-protein kinase At5g37450 OS=Arabidopsis thaliana GN=At5g37450 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 468 bits (1204), Expect = e-131, Method: Compositional matrix adjust.
Identities = 314/858 (36%), Positives = 476/858 (55%), Gaps = 75/858 (8%)
Query: 25 NKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSI 84
N +L G L +G L L+ L + +G IP +G+L L+ L L+ N +G +P +
Sbjct: 86 NMNLTGQLAPELGLLSNLTILNFMWNDLTGQIPPELGNLTHLIFLLLSGNQLTGSLPQEL 145
Query: 85 GNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMV 144
G+LSNL L + N++ G++P S N L + KHFH N ++G IP + V
Sbjct: 146 GSLSNLLILQIDYNEISGKLPTSLAN------LKKLKHFHMNNNSITGQIPPEYSTLTNV 199
Query: 145 LIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGP-VPSNLNNLTSVNDLYLSNNKL 203
L H L D+N LTG LP L + SL +++ D ++ G +PS+ ++ ++ L L N L
Sbjct: 200 L-HFLMDNNKLTGNLPPELAQMPSLRILQLDGSNFDGTEIPSSYGSIPNLVKLSLRNCNL 258
Query: 204 TGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIP 263
G +P+L+ VL YLD+S+N + FS+ ++TT+ + N L G IP++ +P
Sbjct: 259 EGPIPDLSKSLVLYYLDISSNKLTGEIPKNKFSA--NITTINLYNNLLSGSIPSNFSGLP 316
Query: 264 HLQTVVMKTNELNGTLDLG-----TSYSENLLVNLQNNRISAYTERGGAPAVNLT--LID 316
LQ + ++ N L+G + + E L+++L+NN S + P N+T L
Sbjct: 317 RLQRLQVQNNNLSGEIPVIWENRILKAEEKLILDLRNNMFSNVSSVLLNPPSNVTVKLYG 376
Query: 317 NPICQELGTAK--GYCQLS-----------QPISPYSTKQKNCLPAPCNANQS----SSP 359
NP+C + K C +S + IS K+++C P + N S
Sbjct: 377 NPVCANVNAGKLADLCGISTLEVESPATSSETISTGDCKRQSC---PVSENYDYVIGSPV 433
Query: 360 NCQCAYPYTGTLVFRSLSFSDLGNTTYYEILEQSVTTSFQ-STYKLPIDSISLSNPHKNN 418
C CA P L RS SFSD +L+ + + + Y++ ID+ + + +
Sbjct: 434 ACFCAAPLGIDLRLRSPSFSDFRPYKVSYMLDVASPKNLGINPYQISIDTFAWQSGPR-- 491
Query: 419 FEYLELSIQFFPSGQE---SFNRTGVSSVGFVLSNQIYSPPPLFGP---MFFNGDPYQ-- 470
L ++++ FP E FN T V + + + GP + N Y+
Sbjct: 492 ---LFMNMKIFPEYSELNSKFNSTEVQRIVDFFATFTLNTDDSLGPYEIISINTGAYKDV 548
Query: 471 --YFAESGGSHKSTSIGVIIGAAAAGCVV--LLLLLLAGVYAYHQKRRAEKANEQNPFAH 526
F + G S+G+IIGA A V+ L L+ +K R +++P
Sbjct: 549 TIIFPKKSGMSIGVSVGIIIGAIAFFLVLSSLALVFFIKRSKRKRKTREVDMEQEHPLPK 608
Query: 527 WDMNKSSGSIPQLKGARCFSFEEVKKYTNNFSDANDVGSGGYGKVYKGTLPNGQLIAIKR 586
MN S +KG ++F E+ T++FSD + +G GGYGKVYKG LP G ++A+KR
Sbjct: 609 PPMNMES-----VKG---YNFTELDSATSSFSDLSQIGRGGYGKVYKGHLPGGLVVAVKR 660
Query: 587 AQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKN 646
A+QGS+QG +EF EIELLSR+HH+NLVSLLG+C +GEQML+YE++PNGSL D+LS +
Sbjct: 661 AEQGSLQGQKEFFTEIELLSRLHHRNLVSLLGYCDQKGEQMLVYEYMPNGSLQDALSARF 720
Query: 647 GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSM 706
L RL+IALG+ARG+ YLH A+PPIIHRDIK SNILLD ++N KVADFG+SK +
Sbjct: 721 RQPLSLALRLRIALGSARGILYLHTEADPPIIHRDIKPSNILLDSKMNPKVADFGISKLI 780
Query: 707 S----DSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGK 762
+ ++DH+TT VKGT GY+DPEYY++ +LTEKSDVYS G++ LE+LTG RPI G+
Sbjct: 781 ALDGGGVQRDHVTTIVKGTPGYVDPEYYLSHRLTEKSDVYSLGIVFLEILTGMRPISHGR 840
Query: 763 YIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEV 822
IVRE+ D + +ID ++G + + +++++LA++C Q++ + RP M E+
Sbjct: 841 NIVREVNEACDAGM----MMSVIDRSMG-QYSEECVKRFMELAIRCCQDNPEARPWMLEI 895
Query: 823 VKDIENILQQAGLNPNAE 840
V+++ENI GL P E
Sbjct: 896 VRELENIY---GLIPKEE 910
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGD7|Y1684_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g06840 OS=Arabidopsis thaliana GN=At1g06840 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 461 bits (1186), Expect = e-128, Method: Compositional matrix adjust.
Identities = 314/861 (36%), Positives = 477/861 (55%), Gaps = 86/861 (9%)
Query: 27 DLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGN 86
+L G L +G L +L+ L + +G IP IG+++ L LL LN N +G +P +G
Sbjct: 94 NLSGNLSPELGRLSRLTILSFMWNKITGSIPKEIGNIKSLELLLLNGNLLNGNLPEELGF 153
Query: 87 LSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFR-PDMVL 145
L NL + + +N++ G +P S N L + KHFH N +SG IP +L P +V
Sbjct: 154 LPNLDRIQIDENRISGPLPKSFAN------LNKTKHFHMNNNSISGQIPPELGSLPSIV- 206
Query: 146 IHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGP-VPSNLNNLTSVNDLYLSNNKLT 204
H+L D+NNL+G LP L + L +++ D N G +P + N++ + + L N L
Sbjct: 207 -HILLDNNNLSGYLPPELSNMPRLLILQLDNNHFDGTTIPQSYGNMSKLLKMSLRNCSLQ 265
Query: 205 GAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPH 264
G +P+L+ + L YLD+S N + S +P+ S S+TT+ + N +L G IP + +P
Sbjct: 266 GPVPDLSSIPNLGYLDLSQNQLNGS-IPAGKLS-DSITTIDLSNNSLTGTIPTNFSGLPR 323
Query: 265 LQTVVMKTNELNGTL------DLGTSYSENLLVNLQNNRISAYTERGG-APAVNLTLIDN 317
LQ + + N L+G++ + + +E+++V+L+NN S + R P V + L N
Sbjct: 324 LQKLSLANNALSGSIPSRIWQERELNSTESIIVDLRNNGFSNISGRSDLRPNVTVWLQGN 383
Query: 318 PICQELGTAKGYCQ--LSQPISPYSTKQKNCLPAPCNANQSSSP----NCQCAYPYTGTL 371
P+C + G C + I+ ST + + C SP C CA P
Sbjct: 384 PLCSD-GNLLRLCGPITEEDINQGSTNSNTTICSDCPPPYEFSPEPLRRCFCAAPLLVGY 442
Query: 372 VFRSLSFSDLGNTTYYEILEQSVTTSFQ-STYKLPIDSISLSNPHKNNFEYLELSIQFFP 430
+S FSD Y EQ +T+ + Y+L +DS + L + ++FFP
Sbjct: 443 RLKSPGFSDF--VPYRSEFEQYITSGLSLNLYQLRLDSFQWQKGPR-----LRMYLKFFP 495
Query: 431 ------SGQESFNRTGVSSVGFVLSNQIYSPPPLFGP---MFFN-----GDPYQYFAESG 476
+ FNR+ V + + + LFGP M F D + + SG
Sbjct: 496 VFGSNANNSFIFNRSEVRRIRGMFTGWNIRDEDLFGPYELMNFTLLDVYRDVFPSASPSG 555
Query: 477 GSHKSTSIGVIIGAAAAG----CVVLLLLL---LAGVYAYHQKRRAEKANEQNPFAHWDM 529
S+ + + G+++G+ AA ++ L+++ + G A +++R+ KA+ +
Sbjct: 556 LSNGAVA-GIVLGSVAAAVTLTAIIALIIMRKRMRGYSAVARRKRSSKASLK-------- 606
Query: 530 NKSSGSIPQLKGARCFSFEEVKKYTNNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQ 589
++G + F++ E+ T+NF+ + +G GGYGKVYKGTL +G ++AIKRAQ+
Sbjct: 607 ---------IEGVKSFTYAELALATDNFNSSTQIGQGGYGKVYKGTLGSGTVVAIKRAQE 657
Query: 590 GSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIR 649
GS+QG +EF EIELLSR+HH+NLVSLLGFC + GEQML+YE++ NG+L D++S K
Sbjct: 658 GSLQGEKEFLTEIELLSRLHHRNLVSLLGFCDEEGEQMLVYEYMENGTLRDNISVKLKEP 717
Query: 650 LDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSK----- 704
LD+ RL+IALG+A+G+ YLH ANPPI HRDIK+SNILLD R AKVADFGLS+
Sbjct: 718 LDFAMRLRIALGSAKGILYLHTEANPPIFHRDIKASNILLDSRFTAKVADFGLSRLAPVP 777
Query: 705 SMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYI 764
M H++T VKGT GYLDPEY++T QLT+KSDVYS GV++LEL TG +PI GK I
Sbjct: 778 DMEGISPQHVSTVVKGTPGYLDPEYFLTHQLTDKSDVYSLGVVLLELFTGMQPITHGKNI 837
Query: 765 VREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVK 824
VREI + L + + + S + EK+ LAL+C +E D RP+M+EVV+
Sbjct: 838 VREINIAYESGSILSTVDKRMS-----SVPDECLEKFATLALRCCREETDARPSMAEVVR 892
Query: 825 DIENILQQAGLNPNAESASSS 845
++E I + L P + A ++
Sbjct: 893 ELEIIWE---LMPESHVAKTA 910
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LFG1|Y3359_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At3g53590 OS=Arabidopsis thaliana GN=At3g53590 PE=3 SV=2 | Back alignment and function description |
|---|
Score = 431 bits (1109), Expect = e-120, Method: Compositional matrix adjust.
Identities = 302/834 (36%), Positives = 439/834 (52%), Gaps = 60/834 (7%)
Query: 27 DLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGN 86
+L G L +G L L L ++ + +G IP IG + L LL LN N F+G +PP +GN
Sbjct: 90 NLSGELAPEVGQLLYLEILDVMWNNLTGRIPLEIGRISSLKLLLLNGNKFTGSLPPELGN 149
Query: 87 LSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFR-PDMVL 145
L NL L + +N + G +P S GN L KH H N +SG IP +L + P L
Sbjct: 150 LQNLNRLQVDENNITGSVPFSFGN------LRSIKHLHLNNNTISGEIPVELSKLPK--L 201
Query: 146 IHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSG-PVPSNLNNLTSVNDLYLSNNKLT 204
+H++ D+NNLTG LP L + SL +++ D N+ G +P + + + L L N L
Sbjct: 202 VHMILDNNNLTGTLPLELAQLPSLTILQLDNNNFEGSTIPEAYGHFSRLVKLSLRNCGLQ 261
Query: 205 GAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPH 264
G++P+L+ + LSYLD+S N + S S ++TT+ + +L G IP +
Sbjct: 262 GSIPDLSRIENLSYLDLSWNHLTGTIPESKLS--DNMTTIELSYNHLTGSIPQSFSDLNS 319
Query: 265 LQTVVMKTNELNGTLDL----GTSYSENLL--VNLQNNRISAYTERGGAPAVNLTLIDNP 318
LQ + ++ N L+G++ S+ N L +L NN A V L L NP
Sbjct: 320 LQLLSLENNSLSGSVPTEIWQDKSFENNKLQVYDLNNNFSDATGNLRTPDNVTLYLRGNP 379
Query: 319 ICQELGTAKGYCQLSQPISPYSTKQKNCLPAPCN------ANQSSSPN-CQCAYPYTGTL 371
IC+ Q + I + PC+ N SP C C P +
Sbjct: 380 ICKSTSIPM-VTQFFEYICGEKKQTSTNSNTPCSNVSCPFENVKVSPGICLCTAPLSIDY 438
Query: 372 VFRSLSFSDLGNTTYYEI-LEQSVTTSFQ-STYKLPIDSISLSNPHKNNFEYLELSIQFF 429
+S SF T Y E + +T+S Q T++L ID + N + YL+L
Sbjct: 439 RLKSPSFFFF--TPYIERQFREYITSSLQLETHQLAIDRLVDENRLRPRM-YLKL----V 491
Query: 430 PSGQESFNRTGVSSVGFVLSNQIYSPPPLFGPMFFNGDPYQ-----YFAESGGSHKSTSI 484
P G+ +FN++ V + + ++ FGP P Q A++ G +
Sbjct: 492 PKGRITFNKSEVIRIRDRFMSWSFNKTDFFGPYELLDFPLQGPYADLLAQTSGIRTIVWM 551
Query: 485 GVIIGAAAAGCVVLLLLLLAGVYAYHQKRRAEKANEQNPFAHWDMNKSSGSIPQLKGARC 544
++ G+ A V L + Y +KRR +++ ++KG +
Sbjct: 552 MIVAGSVVAATV----LSVTATLLYVRKRRENSHTLTKKRVFRTISR------EIKGVKK 601
Query: 545 FSFEEVKKYTNNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIEL 604
FSF E+ TN F + +G G YGKVYKG L N +AIKR ++ S+Q +EF EI+L
Sbjct: 602 FSFVELSDATNGFDSSTLIGRGSYGKVYKGILSNKTEVAIKRGEETSLQSEKEFLNEIDL 661
Query: 605 LSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAAR 664
LSR+HH+NLVSL+G+ D GEQML+YE++PNG++ D LS L + R +ALG+A+
Sbjct: 662 LSRLHHRNLVSLIGYSSDIGEQMLVYEYMPNGNVRDWLSANAADTLSFSMRSHVALGSAK 721
Query: 665 GLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSK-----SMSDSEKDHITTQVK 719
G+ YLH ANPP+IHRDIK+SNILLD +L+AKVADFGLS+ D E H++T V+
Sbjct: 722 GILYLHTEANPPVIHRDIKTSNILLDCQLHAKVADFGLSRLAPAFGEGDGEPAHVSTVVR 781
Query: 720 GTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELY 779
GT GYLDPEY+MTQQLT +SDVYSFGV++LELLTG P G +I+RE+RT E
Sbjct: 782 GTPGYLDPEYFMTQQLTVRSDVYSFGVVLLELLTGMHPFFEGTHIIREVRTA----NECG 837
Query: 780 NLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQA 833
+ + D +G + K +K +LAL C ++ + RP MS+VVK++E I Q
Sbjct: 838 TVLSVADSRMGQCSPDK-VKKLAELALWCCEDRPETRPPMSKVVKELEGICQSV 890
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49545|BAME1_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM1 OS=Arabidopsis thaliana GN=BAM1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 331 bits (849), Expect = 1e-89, Method: Compositional matrix adjust.
Identities = 289/910 (31%), Positives = 417/910 (45%), Gaps = 138/910 (15%)
Query: 12 TGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSL 71
+GL L LD+ NN +L G LP ++ NL +L +L L G F+G IP S GS + L++
Sbjct: 139 SGLVNLRVLDVYNN-NLTGDLPVSVTNLTQLRHLHLGGNYFAGKIPPSYGSWPVIEYLAV 197
Query: 72 NSNGFSGRVPPSIGNLSNLYWL-------------------------DLTDNKLEGEIPV 106
+ N G++PP IGNL+ L L D + L GEIP
Sbjct: 198 SGNELVGKIPPEIGNLTTLRELYIGYYNAFEDGLPPEIGNLSELVRFDGANCGLTGEIPP 257
Query: 107 SDGNSPGLDMLV------------------RAKHFHFGKNQLSGSIPEKLFRPDMVLIHV 148
G LD L K N +G IP + +
Sbjct: 258 EIGKLQKLDTLFLQVNVFSGPLTWELGTLSSLKSMDLSNNMFTGEIPASFAELKNLTLLN 317
Query: 149 LFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMP 208
LF N L GE+P +G + LEV++ N+ +G +P L +N + LS+NKLTG +P
Sbjct: 318 LF-RNKLHGEIPEFIGDLPELEVLQLWENNFTGSIPQKLGENGKLNLVDLSSNKLTGTLP 376
Query: 209 -NLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQT 267
N+ + L L N F +P +SLT + M L G IP LF +P L
Sbjct: 377 PNMCSGNKLETLITLGN-FLFGSIPDSLGKCESLTRIRMGENFLNGSIPKGLFGLPKLTQ 435
Query: 268 VVMKTNELNGTLDLGTSYSENL-LVNLQNNRISAYT--ERGGAPAVNLTLIDN-----PI 319
V ++ N L+G L + S NL ++L NN++S G V L+D PI
Sbjct: 436 VELQDNYLSGELPVAGGVSVNLGQISLSNNQLSGPLPPAIGNFTGVQKLLLDGNKFQGPI 495
Query: 320 CQELGTAKGYCQLSQPISPYSTKQKNCLPAPCNANQSSSPNCQCAYPYTGTLVFRSLSFS 379
E+G + QLS+ ++ P C+ L F LS +
Sbjct: 496 PSEVGKLQ---QLSKIDFSHNLFSGRIAP--------EISRCKL-------LTFVDLSRN 537
Query: 380 DLGNTTYYEILEQSVTTSFQSTYKLPIDSI-----SLSNPHKNNFEYLELSIQFFPSGQE 434
+L EI + + + SI S+ + +F Y LS +GQ
Sbjct: 538 ELSGEIPNEITAMKILNYLNLSRNHLVGSIPGSISSMQSLTSLDFSYNNLSGLVPGTGQF 597
Query: 435 S-FNRTGVSSVGFVLSNQIYSPPPLFGPMFFNGDPYQYFAESGGSHKSTSIGVIIGA--- 490
S FN T L N P L GP P + GG H+S S G + +
Sbjct: 598 SYFNYTSF------LGN-----PDLCGPYL---GPCKDGVAKGG-HQSHSKGPLSASMKL 642
Query: 491 ----AAAGCVVLLLLLLAGVYAYHQKRRAEKANEQNPFAHWDMNKSSGSIPQLKGARCFS 546
C + V A + R +KA+E + R +
Sbjct: 643 LLVLGLLVCSIAF-----AVVAIIKARSLKKASES------------------RAWRLTA 679
Query: 547 FEEVKKYTNNFSDA----NDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQE--FKM 600
F+ + ++ D+ N +G GG G VYKG +PNG L+A+KR S + F
Sbjct: 680 FQRLDFTCDDVLDSLKEDNIIGKGGAGIVYKGVMPNGDLVAVKRLAAMSRGSSHDHGFNA 739
Query: 601 EIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIAL 660
EI+ L R+ H+++V LLGFC + +L+YE++PNGSLG+ L GK G L W R KIAL
Sbjct: 740 EIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAL 799
Query: 661 GAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKG 720
AA+GL YLH +P I+HRD+KS+NILLD A VADFGL+K + DS + + G
Sbjct: 800 EAAKGLCYLHHDCSPLIVHRDVKSNNILLDSNFEAHVADFGLAKFLQDSGTSECMSAIAG 859
Query: 721 TMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIER---GKYIVREIRTVMDKKKE 777
+ GY+ PEY T ++ EKSDVYSFGV++LEL+TGR+P+ G IV+ +R + D K+
Sbjct: 860 SYGYIAPEYAYTLKVDEKSDVYSFGVVLLELVTGRKPVGEFGDGVDIVQWVRKMTDSNKD 919
Query: 778 LYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENI--LQQAGL 835
++ +++DP + S + +A+ CV+E +RPTM EVV+ + I L +
Sbjct: 920 --SVLKVLDPRLS-SIPIHEVTHVFYVAMLCVEEQAVERPTMREVVQILTEIPKLPPSKD 976
Query: 836 NPNAESASSS 845
P ESA S
Sbjct: 977 QPMTESAPES 986
|
Necessary for male gametophyte development, as well as ovule specification and function. Involved in cell-cell communication process required during early anther development, and regulating cell division and differentiation to organize cell layers. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry. May regulate the CLV1-dependent CLV3-mediated signaling in meristems maintenance. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FN37|PSKR2_ARATH Phytosulfokine receptor 2 OS=Arabidopsis thaliana GN=PSKR2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 324 bits (830), Expect = 2e-87, Method: Compositional matrix adjust.
Identities = 278/855 (32%), Positives = 407/855 (47%), Gaps = 74/855 (8%)
Query: 3 LKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGS 62
L GQL + + EL L LS N L G L + NL L +L++ FS IPD G+
Sbjct: 220 LTGQLPDYLYSIRELEQLSLSGNY-LSGELSKNLSNLSGLKSLLISENRFSDVIPDVFGN 278
Query: 63 LQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKH 122
L +L L ++SN FSGR PPS+ S L LDL +N L G I ++ L +L A
Sbjct: 279 LTQLEHLDVSSNKFSGRFPPSLSQCSKLRVLDLRNNSLSGSINLNFTGFTDLCVLDLA-- 336
Query: 123 FHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGP 182
SN+ +G LP +LG ++++ +N G
Sbjct: 337 -----------------------------SNHFSGPLPDSLGHCPKMKILSLAKNEFRGK 367
Query: 183 VPSNLNNLTSVNDLYLSNN---KLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQ 239
+P NL S+ L LSNN + M L LS L +S N F E+P+ +
Sbjct: 368 IPDTFKNLQSLLFLSLSNNSFVDFSETMNVLQHCRNLSTLILSKN-FIGEEIPNNVTGFD 426
Query: 240 SLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENLL-VNLQNNRI 298
+L L + N L+GQIP+ L + L+ + + N GT+ E+L ++ NN +
Sbjct: 427 NLAILALGNCGLRGQIPSWLLNCKKLEVLDLSWNHFYGTIPHWIGKMESLFYIDFSNNTL 486
Query: 299 SAYTERGGAPAVNLTLIDNPICQELGTAKGYCQLSQPISPYSTKQKNCLPAPCNANQSSS 358
+ GA V +T + N I + GTA S I Y + K+ P N
Sbjct: 487 T------GAIPVAITELKNLI-RLNGTASQMTD-SSGIPLYVKRNKSSNGLPYNQVSRFP 538
Query: 359 PNCQ--------CAYPYTGTLVFRSLSFSDLGNTTYYEILEQSVT---------TSFQST 401
P+ P G L + L DL + + S++ S+
Sbjct: 539 PSIYLNNNRLNGTILPEIGRL--KELHMLDLSRNNFTGTIPDSISGLDNLEVLDLSYNHL 596
Query: 402 Y-KLPIDSISLSNPHKNNFEYLELSIQFFPSGQESFNRTGVSSVGFV-LSNQIYSPPPLF 459
Y +P+ SL+ + + Y L+ PSG + ++ S G + L I SP +
Sbjct: 597 YGSIPLSFQSLTFLSRFSVAYNRLT-GAIPSGGQFYSFPHSSFEGNLGLCRAIDSPCDVL 655
Query: 460 GPMFFNGDPYQYFAESGGSHKSTSIGVIIGAAAAGCVVLLLLLLAGVYAYHQKRRAEKAN 519
N +GG +SI V+ + A G +LL ++L + R +
Sbjct: 656 MSNMLNPKGSSRRNNNGGKFGRSSIVVLTISLAIGITLLLSVILLRISRKDVDDRINDVD 715
Query: 520 EQN-PFAHWDMNKSSGSIPQLKGARCFSFEEVKKYTNNFSDANDVGSGGYGKVYKGTLPN 578
E+ + S + G + S EE+ K TNNFS AN +G GG+G VYK P+
Sbjct: 716 EETISGVSKALGPSKIVLFHSCGCKDLSVEELLKSTNNFSQANIIGCGGFGLVYKANFPD 775
Query: 579 GQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSL 638
G A+KR Q +EF+ E+E LSR HKNLVSL G+C +++LIY F+ NGSL
Sbjct: 776 GSKAAVKRLSGDCGQMEREFQAEVEALSRAEHKNLVSLQGYCKHGNDRLLIYSFMENGSL 835
Query: 639 GDSLSGK--NGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAK 696
L + + L W RLKIA GAARGL+YLH++ P +IHRD+KSSNILLDE+ A
Sbjct: 836 DYWLHERVDGNMTLIWDVRLKIAQGAARGLAYLHKVCEPNVIHRDVKSSNILLDEKFEAH 895
Query: 697 VADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRR 756
+ADFGL++ + + H+TT + GT+GY+ PEY + T + DVYSFGV++LEL+TGRR
Sbjct: 896 LADFGLARLLRPYDT-HVTTDLVGTLGYIPPEYSQSLIATCRGDVYSFGVVLLELVTGRR 954
Query: 757 PIE--RGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGD 814
P+E +GK + V K E ELID TI + + + +++A KC+
Sbjct: 955 PVEVCKGKSCRDLVSRVFQMKAEKRE-AELIDTTIRENVNERTVLEMLEIACKCIDHEPR 1013
Query: 815 DRPTMSEVVKDIENI 829
RP + EVV +E++
Sbjct: 1014 RRPLIEEVVTWLEDL 1028
|
Phytosulfokine receptor with a serine/threonine-protein kinase activity. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SGP2|HSL1_ARATH Receptor-like protein kinase HSL1 OS=Arabidopsis thaliana GN=HSL1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 320 bits (821), Expect = 3e-86, Method: Compositional matrix adjust.
Identities = 283/902 (31%), Positives = 436/902 (48%), Gaps = 111/902 (12%)
Query: 3 LKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGS 62
L G + + ++ L L+LS N +P GNL L + L C G IPDS+G
Sbjct: 168 LDGTIPPFLGNISTLKMLNLSYNPFSPSRIPPEFGNLTNLEVMWLTECHLVGQIPDSLGQ 227
Query: 63 LQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKH 122
L +LV L L N G +PPS+G L+N+ ++L +N L GEIP GN L +L +
Sbjct: 228 LSKLVDLDLALNDLVGHIPPSLGGLTNVVQIELYNNSLTGEIPPELGNLKSLRLLDAS-- 285
Query: 123 FHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGP 182
NQL+G IP++L R + +++ NNL GELPA++ L +L +R N L+G
Sbjct: 286 ----MNQLTGKIPDELCRVPLESLNLY--ENNLEGELPASIALSPNLYEIRIFGNRLTGG 339
Query: 183 VPSNLNNLTSVNDLYLSNNKLTGAMP-NLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSL 241
+P +L + + L +S N+ +G +P +L L L + +NSF + +P + +SL
Sbjct: 340 LPKDLGLNSPLRWLDVSENEFSGDLPADLCAKGELEELLIIHNSF-SGVIPESLADCRSL 398
Query: 242 TTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENL-LVNLQNNRISA 300
T + + G +P + +PH+ + + N +G + + NL L+ L NN +
Sbjct: 399 TRIRLAYNRFSGSVPTGFWGLPHVNLLELVNNSFSGEISKSIGGASNLSLLILSNNEFT- 457
Query: 301 YTERGGAPAVNLTLIDNPICQELGTAKGYCQLSQPISPYSTKQKNCLPAPCNANQSSSPN 360
G P +E+G+ QLS A N S P+
Sbjct: 458 ----GSLP------------EEIGSLDNLNQLS---------------ASGNKFSGSLPD 486
Query: 361 CQCAYPYTGTLVFRSLSFS---DLGNTTYYEILEQSVTTSFQSTYKLP--IDSISLSNPH 415
+ GTL FS G ++ ++ E ++ + + T K+P I S+S+ N
Sbjct: 487 SLMSLGELGTLDLHGNQFSGELTSGIKSWKKLNELNLADN-EFTGKIPDEIGSLSVLN-- 543
Query: 416 KNNFEYLELSIQFF----PSGQESFNRTGVSSVGFVLSNQIYSPPPLFGPMF---FNGDP 468
YL+LS F P +S ++ LS + PP L M+ F G+P
Sbjct: 544 -----YLDLSGNMFSGKIPVSLQSLKLNQLNLSYNRLSGDL--PPSLAKDMYKNSFIGNP 596
Query: 469 YQYFAESG--GSHKSTSIGVIIGAAAAGCVVLLLLLLAGVYAYHQKRRAEKANEQNPFAH 526
G GS + + V+ ++LLAGV ++ K R K +
Sbjct: 597 GLCGDIKGLCGSENEAKKRGYVWLLRSIFVLAAMVLLAGVAWFYFKYRTFKKARAMERSK 656
Query: 527 WDMNKSSGSIPQLKGARCFSFEEVKKYTNNFSDANDVGSGGYGKVYKGTLPNGQLIAIKR 586
W + S +L FS E+ + + + N +G+G GKVYK L NG+ +A+KR
Sbjct: 657 WTLM----SFHKLG----FSEHEILE---SLDEDNVIGAGASGKVYKVVLTNGETVAVKR 705
Query: 587 AQQGSMQ-------------GGQE--FKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYE 631
GS++ G Q+ F+ E+E L ++ HKN+V L C R ++L+YE
Sbjct: 706 LWTGSVKETGDCDPEKGYKPGVQDEAFEAEVETLGKIRHKNIVKLWCCCSTRDCKLLVYE 765
Query: 632 FVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDE 691
++PNGSLGD L G L W R KI L AA GLSYLH + PPI+HRDIKS+NIL+D
Sbjct: 766 YMPNGSLGDLLHSSKGGMLGWQTRFKIILDAAEGLSYLHHDSVPPIVHRDIKSNNILIDG 825
Query: 692 RLNAKVADFGLSKSMSDSEKDHITTQV-KGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLE 750
A+VADFG++K++ + K + V G+ GY+ PEY T ++ EKSD+YSFGV++LE
Sbjct: 826 DYGARVADFGVAKAVDLTGKAPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILE 885
Query: 751 LLTGRRPI--ERG-KYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALK 807
++T +RP+ E G K +V+ + + +D+K + +IDP + S + K +++ L
Sbjct: 886 IVTRKRPVDPELGEKDLVKWVCSTLDQK----GIEHVIDPKLD-SCFKEEISKILNVGLL 940
Query: 808 CVQESGDDRPTMSEVVKDIENILQQAGLNPNAESASSSASYEDASKGNFHHPYCNEEGFD 867
C +RP+M VVK +LQ+ G S D G PY NE+ D
Sbjct: 941 CTSPLPINRPSMRRVVK----MLQEIG----GGDEDSLHKIRDDKDGKL-TPYYNEDTSD 991
Query: 868 YG 869
G
Sbjct: 992 QG 993
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LV48|PERK1_ARATH Proline-rich receptor-like protein kinase PERK1 OS=Arabidopsis thaliana GN=PERK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 285 bits (729), Expect = 1e-75, Method: Compositional matrix adjust.
Identities = 141/297 (47%), Positives = 205/297 (69%), Gaps = 6/297 (2%)
Query: 545 FSFEEVKKYTNNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIEL 604
F++EE+ + TN FS+AN +G GG+G V+KG LP+G+ +A+K+ + GS QG +EF+ E+E+
Sbjct: 268 FTYEELSRATNGFSEANLLGQGGFGYVHKGILPSGKEVAVKQLKAGSGQGEREFQAEVEI 327
Query: 605 LSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAAR 664
+SRVHH++LVSL+G+C +++L+YEFVPN +L L GK ++W RLKIALG+A+
Sbjct: 328 ISRVHHRHLVSLIGYCMAGVQRLLVYEFVPNNNLEFHLHGKGRPTMEWSTRLKIALGSAK 387
Query: 665 GLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGY 724
GLSYLHE NP IIHRDIK+SNIL+D + AKVADFGL+K SD+ H++T+V GT GY
Sbjct: 388 GLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASDTNT-HVSTRVMGTFGY 446
Query: 725 LDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVRE-----IRTVMDKKKELY 779
L PEY + +LTEKSDV+SFGV++LEL+TGRRP++ V + R ++++ E
Sbjct: 447 LAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVDANNVYVDDSLVDWARPLLNRASEEG 506
Query: 780 NLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQAGLN 836
+ L D +G + + V A CV+ S RP MS++V+ +E + + LN
Sbjct: 507 DFEGLADSKMGNEYDREEMARMVACAAACVRHSARRRPRMSQIVRALEGNVSLSDLN 563
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGR3|Y4265_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g26540 OS=Arabidopsis thaliana GN=At4g26540 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 280 bits (717), Expect = 3e-74, Method: Compositional matrix adjust.
Identities = 261/894 (29%), Positives = 422/894 (47%), Gaps = 121/894 (13%)
Query: 3 LKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGS 62
L+G+L +I L L L+ L G LP +IGNLK++ + + SGPIPD IG
Sbjct: 202 LRGELPWEIGNCENLVMLGLAETS-LSGKLPASIGNLKRVQTIAIYTSLLSGPIPDEIGY 260
Query: 63 LQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKH 122
EL L L N SG +P +IG L L L L N L G+IP GN P L ++ +++
Sbjct: 261 CTELQNLYLYQNSISGSIPTTIGGLKKLQSLLLWQNNLVGKIPTELGNCPELWLIDFSEN 320
Query: 123 F-------HFGK-----------NQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLG 164
FGK NQ+SG+IPE+L L H+ D+N +TGE+P+ +
Sbjct: 321 LLTGTIPRSFGKLENLQELQLSVNQISGTIPEELTNCTK-LTHLEIDNNLITGEIPSLMS 379
Query: 165 LVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMP---------------- 208
++SL + +N L+G +P +L+ + + LS N L+G++P
Sbjct: 380 NLRSLTMFFAWQNKLTGNIPQSLSQCRELQAIDLSYNSLSGSIPKEIFGLRNLTKLLLLS 439
Query: 209 -NLTGL--------SVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADL 259
+L+G + L L ++ N A +PS ++++L + + L G IP +
Sbjct: 440 NDLSGFIPPDIGNCTNLYRLRLNGNRL-AGSIPSEIGNLKNLNFVDISENRLVGSIPPAI 498
Query: 260 FSIPHLQTVVMKTNELNGTLDLGTSYSENL-LVNLQNNRISAYTERGGAPAVNLT---LI 315
L+ + + TN L+G+L LGT+ ++L ++ +N +S+ G LT L
Sbjct: 499 SGCESLEFLDLHTNSLSGSL-LGTTLPKSLKFIDFSDNALSSTLPPGIGLLTELTKLNLA 557
Query: 316 DNPICQELGTAKGYCQLSQPISPYSTKQKNCLPAPCNA--NQSSSPNCQCAYPYTGTLVF 373
N + E+ C+ Q ++ +P + + S N C + G +
Sbjct: 558 KNRLSGEIPREISTCRSLQLLNLGENDFSGEIPDELGQIPSLAISLNLSCNR-FVGEIPS 616
Query: 374 RSLSFSDLGNTTYYEILEQSVTTSFQSTYKLPIDSISLSNPHKNNFEYLELSIQFF---P 430
R FSDL N ++ +T + L + +SL N N+F + FF P
Sbjct: 617 R---FSDLKNLGVLDVSHNQLTGNLNVLTDLQ-NLVSL-NISYNDFSGDLPNTPFFRRLP 671
Query: 431 SGQESFNRTGVSSVGFVLSNQIYSPPPLFGPMFFNGDPYQYFAESGGSHKSTSIGVIIGA 490
+ NR G +SN I + P DP + S+ + + I
Sbjct: 672 LSDLASNR------GLYISNAISTRP----------DPT--------TRNSSVVRLTILI 707
Query: 491 AAAGCVVLLLLLLAGVYAYHQKRRAEKANEQNPFAHWDMNKSSGSIPQLKGARCFSFEEV 550
VL+L+ VY + R A K W++ L FS +++
Sbjct: 708 LVVVTAVLVLM---AVYTLVRARAAGKQLLGEEIDSWEVT--------LYQKLDFSIDDI 756
Query: 551 KKYTNNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHH 610
K N + AN +G+G G VY+ T+P+G+ +A+K+ G F EI+ L + H
Sbjct: 757 VK---NLTSANVIGTGSSGVVYRITIPSGESLAVKKMWSKEESGA--FNSEIKTLGSIRH 811
Query: 611 KNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSL--SGKNGIRLDWIRRLKIALGAARGLSY 668
+N+V LLG+C +R ++L Y+++PNGSL L +GK G +DW R + LG A L+Y
Sbjct: 812 RNIVRLLGWCSNRNLKLLFYDYLPNGSLSSRLHGAGKGGC-VDWEARYDVVLGVAHALAY 870
Query: 669 LHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMS-------DSEKDHITTQVKGT 721
LH P IIH D+K+ N+LL +ADFGL++++S D K + G+
Sbjct: 871 LHHDCLPTIIHGDVKAMNVLLGPHFEPYLADFGLARTISGYPNTGIDLAKPTNRPPMAGS 930
Query: 722 MGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIER----GKYIVREIRTVMDKKKE 777
GY+ PE+ Q++TEKSDVYS+GV++LE+LTG+ P++ G ++V+ +R + +KK+
Sbjct: 931 YGYMAPEHASMQRITEKSDVYSYGVVLLEVLTGKHPLDPDLPGGAHLVKWVRDHLAEKKD 990
Query: 778 LYNLYELIDPTIGLST--TLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENI 829
L+DP + T + + + +A CV ++RP M +VV + I
Sbjct: 991 ---PSRLLDPRLDGRTDSIMHEMLQTLAVAFLCVSNKANERPLMKDVVAMLTEI 1041
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9CAL8|PEK13_ARATH Proline-rich receptor-like protein kinase PERK13 OS=Arabidopsis thaliana GN=PERK13 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 278 bits (712), Expect = 1e-73, Method: Compositional matrix adjust.
Identities = 139/305 (45%), Positives = 208/305 (68%), Gaps = 10/305 (3%)
Query: 533 SGSIPQL----KGARCFSFEEVKKYTNNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQ 588
SGS P G F++EE+ T FS N +G GG+G VYKG L +G+L+A+K+ +
Sbjct: 325 SGSAPDSAVMGSGQTHFTYEELTDITEGFSKHNILGEGGFGCVYKGKLNDGKLVAVKQLK 384
Query: 589 QGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGI 648
GS QG +EFK E+E++SRVHH++LVSL+G+C E++LIYE+VPN +L L GK
Sbjct: 385 VGSGQGDREFKAEVEIISRVHHRHLVSLVGYCIADSERLLIYEYVPNQTLEHHLHGKGRP 444
Query: 649 RLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSD 708
L+W RR++IA+G+A+GL+YLHE +P IIHRDIKS+NILLD+ A+VADFGL+K ++D
Sbjct: 445 VLEWARRVRIAIGSAKGLAYLHEDCHPKIIHRDIKSANILLDDEFEAQVADFGLAK-LND 503
Query: 709 SEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIER-----GKY 763
S + H++T+V GT GYL PEY + +LT++SDV+SFGV++LEL+TGR+P+++ +
Sbjct: 504 STQTHVSTRVMGTFGYLAPEYAQSGKLTDRSDVFSFGVVLLELITGRKPVDQYQPLGEES 563
Query: 764 IVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVV 823
+V R ++ K E + EL+D + + ++ A CV+ SG RP M +VV
Sbjct: 564 LVEWARPLLHKAIETGDFSELVDRRLEKHYVENEVFRMIETAAACVRHSGPKRPRMVQVV 623
Query: 824 KDIEN 828
+ +++
Sbjct: 624 RALDS 628
|
Regulates negatively root hairs elongation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 882 | ||||||
| 255556695 | 960 | Serine/threonine-protein kinase PBS1, pu | 0.995 | 0.914 | 0.708 | 0.0 | |
| 225465318 | 954 | PREDICTED: probable leucine-rich repeat | 0.993 | 0.918 | 0.671 | 0.0 | |
| 297739430 | 2030 | unnamed protein product [Vitis vinifera] | 0.978 | 0.425 | 0.676 | 0.0 | |
| 356520135 | 959 | PREDICTED: probable leucine-rich repeat | 0.995 | 0.915 | 0.648 | 0.0 | |
| 356532392 | 908 | PREDICTED: probable leucine-rich repeat | 0.944 | 0.917 | 0.641 | 0.0 | |
| 356558021 | 914 | PREDICTED: probable leucine-rich repeat | 0.975 | 0.940 | 0.632 | 0.0 | |
| 357448317 | 986 | Somatic embryogenesis receptor-like kina | 0.975 | 0.872 | 0.595 | 0.0 | |
| 225465316 | 944 | PREDICTED: probable leucine-rich repeat | 0.982 | 0.918 | 0.619 | 0.0 | |
| 449439783 | 966 | PREDICTED: probable leucine-rich repeat | 0.990 | 0.904 | 0.581 | 0.0 | |
| 356546069 | 931 | PREDICTED: probable leucine-rich repeat | 0.968 | 0.917 | 0.569 | 0.0 |
| >gi|255556695|ref|XP_002519381.1| Serine/threonine-protein kinase PBS1, putative [Ricinus communis] gi|223541448|gb|EEF42998.1| Serine/threonine-protein kinase PBS1, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1274 bits (3297), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 627/885 (70%), Positives = 756/885 (85%), Gaps = 7/885 (0%)
Query: 1 MGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSI 60
+G+ GQLSGDI+ L EL LDLS NK L G LP +IGNLKKL+NL+LVGC FSGPIP+SI
Sbjct: 80 IGITGQLSGDISNLQELQILDLSYNKGLEGTLPESIGNLKKLTNLILVGCGFSGPIPNSI 139
Query: 61 GSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRA 120
GSLQ+LV LSLNSNGFSG +PPSIGNL+ LYWLDL DNKLEG IPVS G +PGL+MLV
Sbjct: 140 GSLQQLVFLSLNSNGFSGGIPPSIGNLAKLYWLDLADNKLEGRIPVSTGTTPGLNMLVNT 199
Query: 121 KHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLS 180
KHFHFGKN+L G+IP +LFR DM L+HVLF+SNN TG +P+TLGLV+SLE+VRFDRNSL+
Sbjct: 200 KHFHFGKNRLGGTIPPELFRSDMTLLHVLFESNNFTGSIPSTLGLVQSLEIVRFDRNSLT 259
Query: 181 GPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQS 240
GPVPSNLNNLT V++L+LSNN+LTG+ PNLTG++ LSYLDMSNNSFDAS+ PSW S++QS
Sbjct: 260 GPVPSNLNNLTGVSELFLSNNQLTGSFPNLTGMNSLSYLDMSNNSFDASDFPSWMSTLQS 319
Query: 241 LTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENLLVNLQNNRISA 300
LTTLMMENT L+GQIPA+ FS+ HL TVV++ N+LNGTLD+GT++ + LL++++NN IS
Sbjct: 320 LTTLMMENTQLQGQIPAEFFSLSHLTTVVLRDNKLNGTLDVGTTHGDQLLIDMRNNEISG 379
Query: 301 YTERGGAPAVNLTLIDNPICQELGTAKGYCQLSQPISPYSTKQKNCLPAPCNANQSSSPN 360
YT+ G L++NPICQE G + YC + SPY T NC P CN+NQSSSPN
Sbjct: 380 YTQHGTGQTPVTILLNNPICQETGVKEAYCSVPPSDSPYVTPPNNCEPVQCNSNQSSSPN 439
Query: 361 CQCAYPYTGTLVFRSLSFSDLGNTTYYEILEQSVTTSFQSTYKLPIDSISLSNPHKNNFE 420
C CAYPY G LVFR+ SFSDL NTT + LEQ++ SF+S ++P+DS+SLSNP K++ +
Sbjct: 440 CNCAYPYKGLLVFRAPSFSDLENTTLFISLEQALMNSFRSN-EVPVDSVSLSNPRKDSSD 498
Query: 421 YLELSIQFFPSGQESFNRTGVSSVGFVLSNQIYSPPPLFGPMFFNGDPYQYFA-ESGGSH 479
YL+ ++ FP+G++ F+R +S +GFVLSNQ + PP +FGP +F DPY++FA ES S+
Sbjct: 499 YLDFDLEVFPTGKDHFSRIDISGLGFVLSNQTFKPPKVFGPFYFIADPYKFFAGESTESN 558
Query: 480 KSTSIGVIIGAAAAGCVVLLLLLLAGVYAYHQKRRAEKANEQN-PFAHWDMNKSSGS-IP 537
S++ G+IIGAAA G V++LLLLLAG+YAY QK+RA++A EQN PFAHWD +KS G+ +P
Sbjct: 559 NSSNTGIIIGAAAGGVVLVLLLLLAGLYAYRQKKRAQRAKEQNNPFAHWDSSKSHGADVP 618
Query: 538 QLKGARCFSFEEVKKYTNNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQE 597
QLKGARCFSFEE+KKYTNNFSDAND+GSGGYGKVY+G LPNGQL+AIKRAQQGS+QGG E
Sbjct: 619 QLKGARCFSFEELKKYTNNFSDANDIGSGGYGKVYRGILPNGQLVAIKRAQQGSLQGGLE 678
Query: 598 FKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLK 657
FK EIELLSRVHHKNLVSLLGFCF+RGEQML+YEFV NGSL DSLSGK+GIRLDW+RRLK
Sbjct: 679 FKTEIELLSRVHHKNLVSLLGFCFERGEQMLVYEFVANGSLSDSLSGKSGIRLDWVRRLK 738
Query: 658 IALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQ 717
+ALG+ARGL+Y+HELANPPIIHRD+KS+NILLDERLNAKVADFGLSK MSDSEK H+TTQ
Sbjct: 739 VALGSARGLAYMHELANPPIIHRDVKSTNILLDERLNAKVADFGLSKPMSDSEKGHVTTQ 798
Query: 718 VKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKE 777
VKGTMGYLDPEYYMTQQLTEKSDVYSFGV+MLELLTG+RPIERGKYIVRE++ MD+ K+
Sbjct: 799 VKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELLTGKRPIERGKYIVREVKLAMDRTKD 858
Query: 778 LYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQAGLNP 837
LYNL+EL+DP IGL TTLKG +K+VDLA+KCVQE G DRPTM +VVK+IENIL+ AG+NP
Sbjct: 859 LYNLHELLDPGIGLETTLKGLDKFVDLAMKCVQELGADRPTMGDVVKEIENILKLAGVNP 918
Query: 838 NAESASSSASYEDASKGNFHHPYCNEEGFDYGYSGGFPTSKIEPQ 882
NAESAS+SASYE+ASKG+ HHPY N++ F+ YSG FP SKI+PQ
Sbjct: 919 NAESASTSASYEEASKGSPHHPY-NKDAFE--YSGAFPPSKIDPQ 960
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225465318|ref|XP_002269453.1| PREDICTED: probable leucine-rich repeat receptor-like protein kinase At5g49770-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1186 bits (3068), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 596/887 (67%), Positives = 722/887 (81%), Gaps = 11/887 (1%)
Query: 1 MGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSI 60
MGLKG LSGD+ L+EL LDLS NK+L G +P +IG+LKKL+NL+LVGCSFSGPIPD+I
Sbjct: 74 MGLKGGLSGDLDQLSELQILDLSYNKNLTGNIPASIGSLKKLTNLILVGCSFSGPIPDTI 133
Query: 61 GSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRA 120
GSL ELV LSLNSN FSG +PPSIGNLS LYWLDL DN+L G IP+S+G++PGLD L
Sbjct: 134 GSLTELVFLSLNSNSFSGGIPPSIGNLSKLYWLDLADNQLTGTIPISNGSTPGLDKLTHT 193
Query: 121 KHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLS 180
KHFHFGKN+LSGSIP KLF +M+LIH+L +SN LTG +P+TLGL+K+LEVVR D NSLS
Sbjct: 194 KHFHFGKNRLSGSIPPKLFSSNMILIHLLLESNRLTGSIPSTLGLLKTLEVVRLDGNSLS 253
Query: 181 GPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQS 240
GPVPSNLNNLT V DL+LSNNKLTG +P+LTG++ L+Y+DMSNNSFD S VPSW S++QS
Sbjct: 254 GPVPSNLNNLTEVKDLFLSNNKLTGTVPDLTGMNSLNYMDMSNNSFDVSNVPSWLSTLQS 313
Query: 241 LTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENL-LVNLQNNRIS 299
LTTL MENTNLKG IPA LFS+P LQTV ++ N +NGTLD G YS L LV+LQ N I
Sbjct: 314 LTTLTMENTNLKGAIPASLFSLPQLQTVSLRNNIINGTLDFGAGYSSQLQLVDLQKNYIV 373
Query: 300 AYTERGGAPAVNLTLIDNPICQELGTAKGYCQLSQPISPYSTKQKNCLPAPCNANQSSSP 359
A+TER G V + L++NPIC E + YC SQP YST NC+P+ C+++Q SP
Sbjct: 374 AFTERAGH-DVEIILVENPICLEGPKNEKYCMTSQPDFSYSTPPNNCVPSVCSSDQIPSP 432
Query: 360 NCQCAYPYTGTLVFRSLSFSDLGNTTYYEILEQSVTTSFQSTYKLPIDSISLSNPHKNNF 419
NC CAYPY GTLVFR+ SFS+LGN++YY LEQ + SFQS +LP+DS+ L++ K++
Sbjct: 433 NCICAYPYMGTLVFRAPSFSNLGNSSYYISLEQRLMQSFQSQ-QLPVDSVFLADLMKDSN 491
Query: 420 EYLELSIQFFPSGQESFNRTGVSSVGFVLSNQIYSPPPLFGPMFFNGDPYQYFAESGGS- 478
YL++S++ FP G++ FNRTG+S VGF LSNQ + PP FGP +FNG+ YQYF E S
Sbjct: 492 NYLQVSLKVFPHGRDRFNRTGISMVGFALSNQTFKPPSTFGPFYFNGEQYQYFEEVSLSL 551
Query: 479 --HKSTSIGVIIGAAAAGCVVLLLLLLAGVYAYHQKRRAEKANEQ-NPFAHWDMNKSSGS 535
+KS++ G+IIGAA G +++LLLL AGVYA+ QKRRAE+A EQ NPFA+WD +K SG
Sbjct: 552 EPNKSSNTGIIIGAAVGGSLLVLLLLFAGVYAFRQKRRAERATEQSNPFANWDESKGSGG 611
Query: 536 IPQLKGARCFSFEEVKKYTNNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGG 595
IPQLKGAR F+FEE+KK TNNFSD NDVGSGGYGKVY+ TLP GQ++AIKRA+Q SMQGG
Sbjct: 612 IPQLKGARRFTFEEIKKCTNNFSDVNDVGSGGYGKVYRATLPTGQMVAIKRAKQESMQGG 671
Query: 596 QEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRR 655
EFK EIELLSRVHHKN+VSL+GFCF GEQ+LIYE+VPNGSL +SLSG++GIRLDW RR
Sbjct: 672 LEFKTEIELLSRVHHKNVVSLIGFCFQLGEQILIYEYVPNGSLKESLSGRSGIRLDWRRR 731
Query: 656 LKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHIT 715
LK+ALG+ARGL+YLHELA+PPIIHRDIKS+NILLDE LNAKV DFGL K ++DSEK H+T
Sbjct: 732 LKVALGSARGLAYLHELADPPIIHRDIKSNNILLDEHLNAKVGDFGLCKLLADSEKGHVT 791
Query: 716 TQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKK 775
TQVKGTMGY+DPEYYM+QQLTEKSDVYSFGVLMLEL++ R+PIERGKYIV+E++ MDK
Sbjct: 792 TQVKGTMGYMDPEYYMSQQLTEKSDVYSFGVLMLELISARKPIERGKYIVKEVKIAMDKT 851
Query: 776 KELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQAGL 835
K+LYNL L+DPT+G TTL GF K+VDLAL+CV+ESG DRPTM EVVK+IENI+Q AGL
Sbjct: 852 KDLYNLQGLLDPTLG--TTLGGFNKFVDLALRCVEESGADRPTMGEVVKEIENIMQLAGL 909
Query: 836 NPNAESASSSASYEDASKGNFHHPYCNEEGFDYGYSGGFPTSKIEPQ 882
NP ES+S+SASYE++S G HPY + FD S G+P S +EP+
Sbjct: 910 NPITESSSASASYEESSTGTSSHPYGSNSAFD--SSAGYPPSTVEPK 954
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297739430|emb|CBI29612.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1175 bits (3040), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 590/872 (67%), Positives = 713/872 (81%), Gaps = 9/872 (1%)
Query: 1 MGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSI 60
MGLKG LSGD+ L+EL LDLS NK+L G +P +IG+LKKL+NL+LVGCSFSGPIPD+I
Sbjct: 74 MGLKGGLSGDLDQLSELQILDLSYNKNLTGNIPASIGSLKKLTNLILVGCSFSGPIPDTI 133
Query: 61 GSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRA 120
GSL ELV LSLNSN FSG +PPSIGNLS LYWLDL DN+L G IP+S+G++PGLD L
Sbjct: 134 GSLTELVFLSLNSNSFSGGIPPSIGNLSKLYWLDLADNQLTGTIPISNGSTPGLDKLTHT 193
Query: 121 KHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLS 180
KHFHFGKN+LSGSIP KLF +M+LIH+L +SN LTG +P+TLGL+K+LEVVR D NSLS
Sbjct: 194 KHFHFGKNRLSGSIPPKLFSSNMILIHLLLESNRLTGSIPSTLGLLKTLEVVRLDGNSLS 253
Query: 181 GPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQS 240
GPVPSNLNNLT V DL+LSNNKLTG +P+LTG++ L+Y+DMSNNSFD S VPSW S++QS
Sbjct: 254 GPVPSNLNNLTEVKDLFLSNNKLTGTVPDLTGMNSLNYMDMSNNSFDVSNVPSWLSTLQS 313
Query: 241 LTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENL-LVNLQNNRIS 299
LTTL MENTNLKG IPA LFS+P LQTV ++ N +NGTLD G YS L LV+LQ N I
Sbjct: 314 LTTLTMENTNLKGAIPASLFSLPQLQTVSLRNNIINGTLDFGAGYSSQLQLVDLQKNYIV 373
Query: 300 AYTERGGAPAVNLTLIDNPICQELGTAKGYCQLSQPISPYSTKQKNCLPAPCNANQSSSP 359
A+TER G V + L++NPIC E + YC SQP YST NC+P+ C+++Q SP
Sbjct: 374 AFTERAGH-DVEIILVENPICLEGPKNEKYCMTSQPDFSYSTPPNNCVPSVCSSDQIPSP 432
Query: 360 NCQCAYPYTGTLVFRSLSFSDLGNTTYYEILEQSVTTSFQSTYKLPIDSISLSNPHKNNF 419
NC CAYPY GTLVFR+ SFS+LGN++YY LEQ + SFQS +LP+DS+ L++ K++
Sbjct: 433 NCICAYPYMGTLVFRAPSFSNLGNSSYYISLEQRLMQSFQSQ-QLPVDSVFLADLMKDSN 491
Query: 420 EYLELSIQFFPSGQESFNRTGVSSVGFVLSNQIYSPPPLFGPMFFNGDPYQYFAESGGS- 478
YL++S++ FP G++ FNRTG+S VGF LSNQ + PP FGP +FNG+ YQYF E S
Sbjct: 492 NYLQVSLKVFPHGRDRFNRTGISMVGFALSNQTFKPPSTFGPFYFNGEQYQYFEEVSLSL 551
Query: 479 --HKSTSIGVIIGAAAAGCVVLLLLLLAGVYAYHQKRRAEKANEQ-NPFAHWDMNKSSGS 535
+KS++ G+IIGAA G +++LLLL AGVYA+ QKRRAE+A EQ NPFA+WD +K SG
Sbjct: 552 EPNKSSNTGIIIGAAVGGSLLVLLLLFAGVYAFRQKRRAERATEQSNPFANWDESKGSGG 611
Query: 536 IPQLKGARCFSFEEVKKYTNNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGG 595
IPQLKGAR F+FEE+KK TNNFSD NDVGSGGYGKVY+ TLP GQ++AIKRA+Q SMQGG
Sbjct: 612 IPQLKGARRFTFEEIKKCTNNFSDVNDVGSGGYGKVYRATLPTGQMVAIKRAKQESMQGG 671
Query: 596 QEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRR 655
EFK EIELLSRVHHKN+VSL+GFCF GEQ+LIYE+VPNGSL +SLSG++GIRLDW RR
Sbjct: 672 LEFKTEIELLSRVHHKNVVSLIGFCFQLGEQILIYEYVPNGSLKESLSGRSGIRLDWRRR 731
Query: 656 LKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHIT 715
LK+ALG+ARGL+YLHELA+PPIIHRDIKS+NILLDE LNAKV DFGL K ++DSEK H+T
Sbjct: 732 LKVALGSARGLAYLHELADPPIIHRDIKSNNILLDEHLNAKVGDFGLCKLLADSEKGHVT 791
Query: 716 TQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKK 775
TQVKGTMGY+DPEYYM+QQLTEKSDVYSFGVLMLEL++ R+PIERGKYIV+E++ MDK
Sbjct: 792 TQVKGTMGYMDPEYYMSQQLTEKSDVYSFGVLMLELISARKPIERGKYIVKEVKIAMDKT 851
Query: 776 KELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQAGL 835
K+LYNL L+DPT+G TTL GF K+VDLAL+CV+ESG DRPTM EVVK+IENI+Q AGL
Sbjct: 852 KDLYNLQGLLDPTLG--TTLGGFNKFVDLALRCVEESGADRPTMGEVVKEIENIMQLAGL 909
Query: 836 NPNAESASSSASYEDASKGNFHHPYCNEEGFD 867
NP ES+S+SASYE++S G HPY + FD
Sbjct: 910 NPITESSSASASYEESSTGTSSHPYGSNSAFD 941
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356520135|ref|XP_003528720.1| PREDICTED: probable leucine-rich repeat receptor-like protein kinase At5g49770-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1145 bits (2963), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 577/890 (64%), Positives = 700/890 (78%), Gaps = 12/890 (1%)
Query: 2 GLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIG 61
GL GQLSGDI L+EL TLDLS NKDL GPLP +IG LKKL+ L+LVGCSF GPIPDSIG
Sbjct: 73 GLAGQLSGDIGSLSELETLDLSYNKDLTGPLPESIGELKKLATLILVGCSFKGPIPDSIG 132
Query: 62 SLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAK 121
++QEL+ LSLNSN FSG +P SIGNLS LYWLDL DN+L+G IPVS G+ GLD L AK
Sbjct: 133 NMQELLFLSLNSNSFSGPIPHSIGNLSKLYWLDLADNQLQGNIPVSSGDISGLDKLHHAK 192
Query: 122 HFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSG 181
HFH GKN LSGSIP +LF +M LIHVL +SN LT ++P TLGLV+SLEVVR D NSL+G
Sbjct: 193 HFHLGKNNLSGSIPPQLFSSEMALIHVLLESNQLTDKIPPTLGLVQSLEVVRLDGNSLNG 252
Query: 182 PVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSL 241
PVP N+NNLT V DLYLSNNKL+G++PNLTG++ LSYLDMSNNSF + P WFS+++SL
Sbjct: 253 PVPPNINNLTHVQDLYLSNNKLSGSLPNLTGMNALSYLDMSNNSFKPLDFPGWFSTLKSL 312
Query: 242 TTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENL-LVNLQNNRISA 300
TTL ME T L+GQ+P LF++ +LQ VV+K N++NGTLD+G+SYS L LV+ + N I +
Sbjct: 313 TTLKMERTQLQGQVPTSLFTLINLQIVVLKDNKINGTLDIGSSYSNQLRLVDFETNSIDS 372
Query: 301 YTERGGAPAVNLTLI--DNPICQELGTAKGYCQLSQPISPYSTKQKNCLPAPCNANQSSS 358
+ ++ P V + +I DNPICQE G + YC SQP YST NC P C++ Q S
Sbjct: 373 FEQKDEVPNVKIKIILKDNPICQENGELESYCSSSQPNVSYSTPLNNCQPGTCSSEQILS 432
Query: 359 PNCQCAYPYTGTLVFRSLSFSDLGNTTYYEILEQSVTTSFQSTYKLPIDSISLSNPHKNN 418
PNC CAYPY+GTL FRS F D N TYY +LE+ + SF+S + LP+DS+ LS+P K++
Sbjct: 433 PNCICAYPYSGTLTFRSPPFLDFDNKTYYSMLEEGLMNSFKSHF-LPVDSVLLSHPSKDS 491
Query: 419 FEYLELSIQFFPSGQESFNRTGVSSVGFVLSNQIYSPPPLFGPMFFNGDPYQYFAESG-- 476
+YLELS+Q FPSGQ FNRTG S+GF+LSNQ + PP +FGP +F GD Y++F SG
Sbjct: 492 TQYLELSLQVFPSGQNHFNRTGAFSIGFLLSNQTFKPPKVFGPFYFVGDKYEHFENSGLT 551
Query: 477 GSHKSTSIGVIIGAAAAGCVVLLLLLLAGVYAYHQKRRAEKA-NEQNPFAHWDMNKSSGS 535
S KS++IG+IIGAA G V+L+LLLLAG+YA+ QK+RAEKA + NPF WD S
Sbjct: 552 ESSKSSNIGIIIGAAVGGLVLLVLLLLAGLYAFRQKKRAEKAIGQSNPFRRWDTASSKSE 611
Query: 536 IPQLKGARCFSFEEVKKYTNNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGG 595
+PQL AR FSFEE+KKYT NFS N +GSGG+GKVYKG LPNGQ+IAIKRAQ+ SMQG
Sbjct: 612 VPQLTEARMFSFEELKKYTKNFSQVNGIGSGGFGKVYKGNLPNGQVIAIKRAQKESMQGK 671
Query: 596 QEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRR 655
EFK EIELLSRVHHKNLVSL+GFCF+ EQML+YE+V NGSL D+LSGK+GIRLDWIRR
Sbjct: 672 LEFKAEIELLSRVHHKNLVSLVGFCFEHEEQMLVYEYVQNGSLKDALSGKSGIRLDWIRR 731
Query: 656 LKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHIT 715
LKIALG ARGL+YLHEL NPPIIHRDIKS+NILLD+RLNAKV+DFGLSKSM DSEKDH+T
Sbjct: 732 LKIALGTARGLAYLHELVNPPIIHRDIKSNNILLDDRLNAKVSDFGLSKSMVDSEKDHVT 791
Query: 716 TQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKK 775
TQVKGTMGYLDPEYYM+QQLTEKSDVYSFGVLMLEL++ RRP+ERGKYIV+E+R +DK
Sbjct: 792 TQVKGTMGYLDPEYYMSQQLTEKSDVYSFGVLMLELISARRPLERGKYIVKEVRNALDKT 851
Query: 776 KELYNLYELIDPTIGLST---TLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 832
K Y L E+IDP IGL++ TL GF+K+VD+ + CV+ESG DRP MS+VV++IENIL+
Sbjct: 852 KGSYGLDEIIDPAIGLASTTLTLSGFDKFVDMTMTCVKESGSDRPKMSDVVREIENILKS 911
Query: 833 AGLNPNAESASSSASYEDASKGNFHHPYCNEEGFDYGYSGGFPTSKIEPQ 882
AG NP ES S S+SYE+ S+G+ HPY + + FD S G P K++P+
Sbjct: 912 AGANPTEESPSISSSYEEVSRGSSSHPYNSNDTFD--LSAGLPYPKVDPK 959
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356532392|ref|XP_003534757.1| PREDICTED: probable leucine-rich repeat receptor-like protein kinase At5g49770-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1087 bits (2812), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 539/840 (64%), Positives = 669/840 (79%), Gaps = 7/840 (0%)
Query: 1 MGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSI 60
M L GQL+ DI L+EL LDLS NK L GPLP IGNL+KL NL+++ C F+GPIP +I
Sbjct: 47 MDLSGQLTSDIGSLSELLILDLSYNKKLTGPLPNDIGNLRKLRNLLVINCGFTGPIPVTI 106
Query: 61 GSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRA 120
G+L+ LV LSLNSNGF+G +P +IGNLSN+YWLDL +N+LEG IP+S+G +PGLDM+
Sbjct: 107 GNLERLVFLSLNSNGFTGPIPAAIGNLSNIYWLDLAENQLEGPIPISNGTTPGLDMMHHT 166
Query: 121 KHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLS 180
KHFHFGKN+LSG+IP +LF P+M LIHVLF+SN TG +P+TLGLVK+LEVVRFD N LS
Sbjct: 167 KHFHFGKNKLSGNIPSQLFSPEMSLIHVLFESNRFTGSIPSTLGLVKTLEVVRFDDNVLS 226
Query: 181 GPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQS 240
GPVP N+NNLTSV +L+LSNN+L+G+ PNLTG++ LSYLDMSNNSFD S+ P W ++ +
Sbjct: 227 GPVPLNINNLTSVRELFLSNNRLSGSPPNLTGMNSLSYLDMSNNSFDQSDFPPWLPTLPA 286
Query: 241 LTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENL-LVNLQNNRIS 299
LTT+MMENT L+G+IP LFS+ LQTVV+K N+LNGTLD+GTS S NL L++LQ N I
Sbjct: 287 LTTIMMENTKLQGRIPVSLFSLQQLQTVVLKNNQLNGTLDIGTSISNNLDLLDLQINFIE 346
Query: 300 AYTERGGAPAVNLTLIDNPICQELGTAKGYCQLSQPISPYSTKQKNCLPAPCNANQSSSP 359
+ + V + L++NPICQE G + YC +++ YST NC+P PC+ +Q+ SP
Sbjct: 347 DFDPQIDVSKVEIILVNNPICQETGVPQTYCSITKSNDSYSTPPDNCVPVPCSLDQTLSP 406
Query: 360 NCQCAYPYTGTLVFRSLSFSDLGNTTYYEILEQSVTTSFQSTYKLPIDSISLSNPHKNNF 419
C+CAYPY GTLV R+ SFSDL N T + LE S+ SFQ +K P+DSISLSNP KN +
Sbjct: 407 ECKCAYPYEGTLVLRAPSFSDLENKTIFVTLESSLMESFQ-LHKKPVDSISLSNPRKNIY 465
Query: 420 EYLELSIQFFPSGQESFNRTGVSSVGFVLSNQIYSPPPLFGPMFFNGDPYQYFAESGG-- 477
+YLEL+++ FP GQ+ FNRTG+S +GF+LSNQ Y PPP+FGP +F D Y+ + ++ G
Sbjct: 466 QYLELTLKIFPLGQDRFNRTGISDIGFLLSNQTYKPPPMFGPYYFIADEYENYVDNSGPV 525
Query: 478 --SHKSTSIGVIIGAAAAGCVVLLLLLLAGVYAYHQKRRAEKAN-EQNPFAHWDMNKSSG 534
+ KS++ G+I GA G +L+L+LLA VYA QK++ +K+ NPF WD + S+
Sbjct: 526 TSNRKSSNTGIIAGAGGGGAALLVLVLLACVYAISQKKKTKKSTGNNNPFEQWDPHDSNS 585
Query: 535 SIPQLKGARCFSFEEVKKYTNNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQG 594
SIPQLKGAR FSFEE++ T NFS N++GSGGYGKVY+GTLPNGQLIA+KRAQ+ SMQG
Sbjct: 586 SIPQLKGARRFSFEEIQNCTKNFSQVNNIGSGGYGKVYRGTLPNGQLIAVKRAQKESMQG 645
Query: 595 GQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIR 654
G EFK EIELLSRVHHKNLVSL+GFCFD+GEQMLIYE+V NG+L D+LSGK+GIRLDWIR
Sbjct: 646 GLEFKTEIELLSRVHHKNLVSLVGFCFDQGEQMLIYEYVANGTLKDTLSGKSGIRLDWIR 705
Query: 655 RLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHI 714
RLKIALGAARGL YLHELANPPIIHRDIKS+NILLDERL AKV+DFGLSK + + K +I
Sbjct: 706 RLKIALGAARGLDYLHELANPPIIHRDIKSTNILLDERLIAKVSDFGLSKPLGEGAKGYI 765
Query: 715 TTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDK 774
TTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVL+LEL+T RRPIERGKYIV+ ++ +DK
Sbjct: 766 TTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLLLELITARRPIERGKYIVKVVKGAIDK 825
Query: 775 KKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQAG 834
K Y L E++DPTI L T L GFEK+VD+A++CV+ES DRPTM+ VVK+IEN+LQ AG
Sbjct: 826 TKGFYGLEEILDPTIDLGTALSGFEKFVDIAMQCVEESSFDRPTMNYVVKEIENMLQLAG 885
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356558021|ref|XP_003547307.1| PREDICTED: probable leucine-rich repeat receptor-like protein kinase At5g49770-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1070 bits (2766), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 549/868 (63%), Positives = 690/868 (79%), Gaps = 8/868 (0%)
Query: 3 LKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGS 62
L GQL+ DI L+EL LDLS NK L GPLP+ IGNL+KL NL+L+ C F+GPIP +IG+
Sbjct: 45 LSGQLTSDIGSLSELLILDLSYNKKLTGPLPSNIGNLRKLRNLLLINCGFTGPIPVTIGN 104
Query: 63 LQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKH 122
L+ LV LSLNSNGF+G +P +IGNLSN+YWLDL +N+LEG IP+S+G +PGLDM+ KH
Sbjct: 105 LERLVFLSLNSNGFTGTIPAAIGNLSNVYWLDLAENQLEGPIPISNGTTPGLDMMHHTKH 164
Query: 123 FHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGP 182
FHFGKN+LSG+IP +LF P+M LIHVLF+SN TG +P+TLGLVK+LEVVRFD+N LS P
Sbjct: 165 FHFGKNKLSGNIPSQLFSPEMSLIHVLFESNRFTGGIPSTLGLVKTLEVVRFDKNFLSEP 224
Query: 183 VPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLT 242
+P N+NNLTSV +L+LSNN+L+G++PNLTG++ LSYLDMSNNSFD S+ P W ++ +LT
Sbjct: 225 LPLNINNLTSVRELFLSNNRLSGSLPNLTGMNSLSYLDMSNNSFDQSDFPPWLPTLPALT 284
Query: 243 TLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENL-LVNLQNNRISAY 301
T+MME+T L+G+IP LFS+ LQTVV+K N+LNGTLD+GTS S L L++LQ N I +
Sbjct: 285 TIMMEDTKLQGRIPVSLFSLQQLQTVVLKKNQLNGTLDIGTSISNQLDLLDLQINFIEDF 344
Query: 302 TERGGAPAVNLTLIDNPICQELGTAKGYCQLSQPISPYSTKQKNCLPAPCNANQSSSPNC 361
+ V + L++NP CQE G + YC +++ YST NC+P PC+ +Q+ SP C
Sbjct: 345 DPQIDVSKVEIILVNNPYCQESGVPQPYCTITKSNDSYSTPPDNCVPVPCSLDQTLSPKC 404
Query: 362 QCAYPYTGTLVFRSLSFSDLGNTTYYEILEQSVTTSFQSTYKLPIDSISLSNPHKNNFEY 421
+CAYPYTGTL R+ SFSDL N T + LE S+ SFQ K P++S+SLSNP KN ++Y
Sbjct: 405 KCAYPYTGTLFLRAPSFSDLENETVFVTLEYSLMESFQLHMK-PVNSVSLSNPRKNIYQY 463
Query: 422 LELSIQFFPSGQESFNRTGVSSVGFVLSNQIYSPPPLFGPMFFNGDPYQYFAESGG---- 477
LEL+++ FP GQ FNRTGVS +GF+LSNQ Y PP +FGP +F D Y+++ ++ G
Sbjct: 464 LELTLKIFPFGQGRFNRTGVSGIGFLLSNQTYKPPAMFGPYYFIADEYEHYVDNSGLVPS 523
Query: 478 SHKSTSIGVIIGAAAAGCVVLLLLLLAGVYAYHQKRRAEK-ANEQNPFAHWDMNKSSGSI 536
S KS++ G+I GAA G +L+L++LA VYA +K++++K NPF WD + S+ SI
Sbjct: 524 SSKSSNTGIIAGAAGGGAALLVLVVLACVYAISRKKKSKKSTGNSNPFEQWDPHDSNSSI 583
Query: 537 PQLKGARCFSFEEVKKYTNNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQ 596
PQLKGAR FSFEE++ T NFS N++GSGGYGKVY+GTLPNGQLIA+KRAQ+ SMQGG
Sbjct: 584 PQLKGARRFSFEEIQNCTKNFSQVNNIGSGGYGKVYRGTLPNGQLIAVKRAQKESMQGGL 643
Query: 597 EFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRL 656
EFK EIELLSRVHHKNLVSL+GFCF++GEQMLIYE+V NG+L D+LSGK+GIRLDWIRRL
Sbjct: 644 EFKTEIELLSRVHHKNLVSLVGFCFEQGEQMLIYEYVANGTLKDTLSGKSGIRLDWIRRL 703
Query: 657 KIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITT 716
KIALGAARGL YLHELANPPIIHRDIKS+NILLDERLNAKV+DFGLSK + + K +ITT
Sbjct: 704 KIALGAARGLDYLHELANPPIIHRDIKSTNILLDERLNAKVSDFGLSKPLGEGAKGYITT 763
Query: 717 QVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKK 776
QVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLEL+T RRPIERGKYIV+ ++ +DK K
Sbjct: 764 QVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELVTARRPIERGKYIVKVVKDAIDKTK 823
Query: 777 ELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQAGLN 836
Y L E++DPTI L T L GFEK+VDLA++CV+ES DRPTM+ VVK+IEN+LQ AG +
Sbjct: 824 GFYGLEEILDPTIELGTALSGFEKFVDLAMQCVEESSSDRPTMNYVVKEIENMLQLAGSS 883
Query: 837 PN-AESASSSASYEDASKGNFHHPYCNE 863
P + SAS+S+SY +A+KG+ HPY NE
Sbjct: 884 PILSASASTSSSYNNATKGSSLHPYNNE 911
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357448317|ref|XP_003594434.1| Somatic embryogenesis receptor-like kinase [Medicago truncatula] gi|355483482|gb|AES64685.1| Somatic embryogenesis receptor-like kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 1046 bits (2705), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 538/904 (59%), Positives = 674/904 (74%), Gaps = 44/904 (4%)
Query: 1 MGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSI 60
M L GQLS +I L+EL L LS NKDL GPLP IGNLKKL+NL L+ C F+GPIPD+I
Sbjct: 75 MDLSGQLSSEIGSLSELQILVLSYNKDLTGPLPAEIGNLKKLTNLQLINCGFTGPIPDTI 134
Query: 61 GSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRA 120
G+LQ LV LSLNSN FSGR+PPSIGNLSN+ WLDL +N+LEG IPVS+G +PGLDML +
Sbjct: 135 GNLQRLVFLSLNSNRFSGRIPPSIGNLSNINWLDLAENQLEGPIPVSNGTTPGLDMLHKT 194
Query: 121 KHF--------------------------------HFGKNQLSGSIPEKLFRPDMVLIHV 148
KH HFGKN+LSG+IP +LF DM LIHV
Sbjct: 195 KHLYVMLTFFSFDNIYSNLLHINQTLHNKFPFFYSHFGKNKLSGNIPPQLFSSDMSLIHV 254
Query: 149 LFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMP 208
LF+SN TG +P+TLG V+ LEVVR D N LSGP+P N+NNLT+V +L +S N+L+G +P
Sbjct: 255 LFESNQFTGTIPSTLGFVQKLEVVRLDNNILSGPLPININNLTNVRELLVSKNRLSGPLP 314
Query: 209 NLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTV 268
+LTG++VLSYLD+SNNSFD S+ P W S++QSL T+MME+T L+G IP LFS+ L TV
Sbjct: 315 DLTGMNVLSYLDVSNNSFDRSDFPLWLSTLQSLKTIMMEDTQLQGPIPVSLFSLVQLHTV 374
Query: 269 VMKTNELNGTLDLGTSYSENL-LVNLQNNRISAYTERGGAPAVNLTLIDNPICQELGTAK 327
++K N LNGTLD+GT+ S+ L ++NLQ N I + + V + L++NP+CQE G +
Sbjct: 375 MLKNNNLNGTLDIGTAISDQLGVLNLQTNFIEDFDPQIDVSKVEIILVNNPVCQETGVKR 434
Query: 328 GYCQLSQPISPYSTKQKNCLPAPCNANQSSSPNCQCAYPYTGTLVFRSLSFSDLGNTTYY 387
YC +++ Y+T NC+P CN NQ SP C+CAYPYTGTL R+ SFSD+ N T +
Sbjct: 435 TYCSIAKNNDTYTTPLNNCVPVECNKNQILSPKCKCAYPYTGTLTLRAPSFSDVRNKTVF 494
Query: 388 EILEQSVTTSFQSTYKLPIDSISLSNPHKNNFEYLELSIQFFPSGQESFNRTGVSSVGFV 447
+LE ++ SF+ ++ P+DS+SLSNP KN ++YL+LS++ FPSGQ+SFNRTG+S +GF+
Sbjct: 495 AMLEFTLMESFR-LHEKPVDSVSLSNPRKNAYQYLDLSLEIFPSGQDSFNRTGISGIGFM 553
Query: 448 LSNQIYSPPP-LFGPMFFNGDPYQYFAESG------GSHKSTSIGVIIGAAAAGCVVLLL 500
LSNQ Y PP FGP +F D Y+++ S KS+ IG+I GAAA GCV++LL
Sbjct: 554 LSNQTYKPPAETFGPYYFIADKYEHYLNDSVIEGPVKSSKSSHIGIIAGAAAGGCVLVLL 613
Query: 501 LLLAGVYAYHQ-KRRAEKANEQNPFAHWDMNKSSGSIPQLKGARCFSFEEVKKYTNNFSD 559
LLLA VY + Q + A + N F W ++S+ SIPQLKGAR F+FEE++ YT F++
Sbjct: 614 LLLAVVYGFRQKNKAKRAAKKSNLFEQWGPDESNSSIPQLKGARRFTFEEIQNYTKKFAE 673
Query: 560 ANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGF 619
A+ VGSGGYGKVY+G L NGQLIA+KRAQ+ S+QGG EFK EIELLSRVHHKNLVSL+GF
Sbjct: 674 ASYVGSGGYGKVYRGALLNGQLIAVKRAQKESIQGGLEFKTEIELLSRVHHKNLVSLIGF 733
Query: 620 CFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIH 679
CF++GEQ+L+YE+V NG+L D+LSGK+GIRLDWIRRLKIALGA+RGL YLHE ANPPIIH
Sbjct: 734 CFEQGEQILVYEYVVNGTLTDALSGKSGIRLDWIRRLKIALGASRGLDYLHEHANPPIIH 793
Query: 680 RDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKS 739
RD+KS+NILLDERLNAKV+DFGLSK + D K +ITTQVKGTMGYLDPEYYMTQQLTEKS
Sbjct: 794 RDVKSTNILLDERLNAKVSDFGLSKPLGDGAKGYITTQVKGTMGYLDPEYYMTQQLTEKS 853
Query: 740 DVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFE 799
DVYSFGVLMLEL+T RRPIERGKYIV+ I+ MDK KELY L E+IDP I +L FE
Sbjct: 854 DVYSFGVLMLELITARRPIERGKYIVKVIKNAMDKTKELYGLKEIIDPVIDFKASLSSFE 913
Query: 800 KYVDLALKCVQESGDDRPTMSEVVKDIENILQQAGLNPNAESASSSASYEDASKGNFHHP 859
K++DLA+KCV++S RP+M+ K+IEN+L G NPNAESA SS+SY ++ GN HP
Sbjct: 914 KFIDLAMKCVEDSSSSRPSMNYAFKEIENMLMLTGTNPNAESAPSSSSYNES--GNSMHP 971
Query: 860 YCNE 863
Y NE
Sbjct: 972 YENE 975
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225465316|ref|XP_002269419.1| PREDICTED: probable leucine-rich repeat receptor-like protein kinase At5g49770-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1038 bits (2683), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 550/888 (61%), Positives = 692/888 (77%), Gaps = 21/888 (2%)
Query: 1 MGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSI 60
M LKG+LS D GL+EL LDLS NK L G +P +IG+LK L+NL+L+GCSFSG IPD+I
Sbjct: 72 MDLKGELSEDFQGLSELKILDLSYNKGLTGNIPASIGSLKSLTNLILMGCSFSGQIPDTI 131
Query: 61 GSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRA 120
GSL LV+LSLNSN FSG +PPSIGNL NL WLD+T+N++ G IP+S+G +PGLDML +
Sbjct: 132 GSLTNLVVLSLNSNSFSGVIPPSIGNLYNLNWLDITENQITGTIPISNGGTPGLDMLTQM 191
Query: 121 KHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLS 180
KHFHFGKN+LSG IP +LF M +IH+L D+N+LTG +P TLGL +LE++R DRN LS
Sbjct: 192 KHFHFGKNRLSGPIPPQLFSSKMTMIHLLLDNNHLTGSIPPTLGLATTLEIIRLDRNLLS 251
Query: 181 GPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQS 240
GPVPSNLNNLTS+ +L LSNN LTG +PNLTG++ LSYLDMS N+F+ S+ PSWFS++ S
Sbjct: 252 GPVPSNLNNLTSLTELLLSNNNLTGTVPNLTGMNHLSYLDMSQNNFEVSDFPSWFSTLLS 311
Query: 241 LTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENL-LVNLQNNRIS 299
LTTL ME T L G IP LFS+P LQTV ++ N++ GTL+ G++Y+ +L LV+LQ N IS
Sbjct: 312 LTTLTMEFTKLTGDIPVALFSLPQLQTVKLRNNQITGTLEFGSAYNSHLRLVDLQKNYIS 371
Query: 300 AYTERGGAPAVNLTLIDNPICQELGTAKGYCQLSQPISPYSTKQKN-CLPAPCNANQSSS 358
+ + G + L+ NP+CQ+ G K YC +QP S YST+ K+ C+ C+++
Sbjct: 372 EF-KPGLEYEFKIILVGNPMCQDEGNEK-YCTPAQPNSSYSTQPKHSCIIPFCSSDLILG 429
Query: 359 PNCQCAYPYTGTLVFRSLSFSDLGNTTYYEILEQSVTTSFQSTYKLPIDSISLSNPHKNN 418
PNC CAYPY GTLVFR+ SFS+ G+++ Y+ +EQ + F+S +LP+D++SLSN +
Sbjct: 430 PNCSCAYPYIGTLVFRAPSFSNSGDSSDYKSIEQFLMQLFRS-LQLPVDTVSLSNSTMVD 488
Query: 419 FEYLELSIQFFPSGQESFNRTGVSSVGFVLSNQIYSPPPLFGPMFFNGDPYQYFAE---S 475
+YL+++++ FP GQ+ FNRTG+ VGF LSNQ + F DPYQ+F E
Sbjct: 489 -DYLKVNLKVFPQGQDRFNRTGIFLVGFALSNQTSA-------FSFIADPYQHFEEVPSP 540
Query: 476 GGSHKSTSIGVIIGAAAAGCVVLLLLLLAGVYAYHQKRRAEKANEQ-NPFAHWDMNKSSG 534
G+ KS++ G+I+GA G + LLLL AGVYA+ QKRRAE+A +Q NPFA WD K SG
Sbjct: 541 PGAKKSSNTGIIVGATTGGSFLALLLLFAGVYAFSQKRRAERATKQSNPFAKWDQRKGSG 600
Query: 535 SIPQLKGARCFSFEEVKKYTNNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQG 594
IPQLKGAR F+FEE+KK TNNFS+AN+VGSGGYGKVY+G LP GQ++AIKRA+Q SMQG
Sbjct: 601 GIPQLKGARQFTFEEIKKCTNNFSEANNVGSGGYGKVYRGILPTGQMVAIKRAKQESMQG 660
Query: 595 GQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIR 654
G EFK E+ELLSRVHHKN+V L+GFCF+ GEQML+YEFVPNGSL +SLSGK+GIRLDW +
Sbjct: 661 GLEFKTELELLSRVHHKNVVGLVGFCFEHGEQMLVYEFVPNGSLKESLSGKSGIRLDWRK 720
Query: 655 RLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHI 714
RLK+AL +ARGL+YLHELA PPIIHRDIKS+NILLDERLNAKVADFGL K ++DSEK H+
Sbjct: 721 RLKVALCSARGLAYLHELAEPPIIHRDIKSNNILLDERLNAKVADFGLCKLLADSEKGHV 780
Query: 715 TTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDK 774
TTQVKGTMGYLDPEYYM+QQLTEKSDVYSFGVLMLEL++ R+PIERGKYIV+E++ MDK
Sbjct: 781 TTQVKGTMGYLDPEYYMSQQLTEKSDVYSFGVLMLELISARKPIERGKYIVKEVKIEMDK 840
Query: 775 KKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQAG 834
K+LYNL L+DPT+G TTL GF K+VDLAL+CV+ESG DRP M EVVK+IENI+Q AG
Sbjct: 841 TKDLYNLQGLLDPTLG--TTLGGFNKFVDLALRCVEESGADRPRMGEVVKEIENIMQLAG 898
Query: 835 LNPNAESASSSASYEDASKGNFHHPYCNEEGFDYGYSGGFPTSKIEPQ 882
LNP ES+S+SASYE++S G HPY N FD S G+ S ++P+
Sbjct: 899 LNPIIESSSASASYEESSTGTSSHPYGNNSAFD--NSVGYSPSTVQPK 944
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449439783|ref|XP_004137665.1| PREDICTED: probable leucine-rich repeat receptor-like protein kinase At5g49770-like [Cucumis sativus] gi|449497159|ref|XP_004160329.1| PREDICTED: probable leucine-rich repeat receptor-like protein kinase At5g49770-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1015 bits (2624), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 523/900 (58%), Positives = 668/900 (74%), Gaps = 26/900 (2%)
Query: 1 MGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSI 60
MGLKG+L GDI GLTEL +LDLS NKDL G + +G+L+ LS L+L GC FSG IP+ +
Sbjct: 75 MGLKGKLGGDIGGLTELKSLDLSFNKDLTGSISPALGDLQNLSILILAGCGFSGSIPEQL 134
Query: 61 GSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRA 120
G+L L L+LNSN F+G +PPS+G LSNLYWLDL DN+L G +PVS +PGLD+L++A
Sbjct: 135 GNLSNLSFLALNSNNFTGTIPPSLGKLSNLYWLDLADNQLTGSLPVSTSETPGLDLLLKA 194
Query: 121 KHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLS 180
KHFHF KNQLSGSI KLFR +MVLIH+LFD N +G +P TLGLVK+LEV+R DRNSL+
Sbjct: 195 KHFHFNKNQLSGSISPKLFRSEMVLIHILFDGNKFSGNIPPTLGLVKTLEVLRLDRNSLA 254
Query: 181 GPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQS 240
G VPSNLNNLT++N+L L+NNKLTG +PNLT +S L+Y+D+SNNSFD+SE P WFS++QS
Sbjct: 255 GTVPSNLNNLTNINELNLANNKLTGPLPNLTQMSSLNYVDLSNNSFDSSEAPEWFSNLQS 314
Query: 241 LTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENL-LVNLQNNRIS 299
LTTL++E +++G +P +FS+P +Q V +K N + T D+G SE L LV+LQNN IS
Sbjct: 315 LTTLIIEFGSMRGSVPQGVFSLPQIQQVKLKKNAFSDTFDMGDKVSEQLQLVDLQNNNIS 374
Query: 300 AYTERGGAPAVNLTLIDNPICQELGTAKG--YCQLS-QPISPYSTKQKNCLPAPCNANQS 356
+T G L LI NP+C T YCQ+ QP+ PYST +CL C+ ++
Sbjct: 375 HFT-LGSRYTKTLMLIGNPVCSTDVTLSNTNYCQVQDQPVKPYSTSLASCLSKSCSPDEK 433
Query: 357 SSP-NCQCAYPYTGTLVFRSLSFSDLGNTTYYEILEQSVTTSFQSTYKLPIDSISLSNPH 415
SP +C+C YP+ GTL FR+ SF DL N T + LE S+ L S+S+ NP
Sbjct: 434 LSPQSCECTYPFEGTLYFRAPSFRDLSNVTLFHSLEFSLWKKLD----LTPGSVSIQNPF 489
Query: 416 KNNFEYLELSIQFFPSGQESFNRTGVSSVGFVLSNQIYSPPPLFGPMFFNGDPYQYFAES 475
N +YL++ + FPS + FNR+ + +GF LSNQ Y PP FGP +F PY + +
Sbjct: 490 FNVDDYLQMQLALFPSDGKYFNRSEIQRIGFYLSNQTYKPPHEFGPFYFIASPYGFADTT 549
Query: 476 GGSHKSTSIGVIIGAAAAGCVVLLLLLL-AGVYAYHQKRRAEKA-NEQNPFAHWD-MNKS 532
G+ S S GVIIG A GC L+L L+ G+YA QK+RAEKA PFA W
Sbjct: 550 KGT--SISPGVIIGVAI-GCAFLVLGLIGVGIYAIWQKKRAEKAIGLSRPFASWAPSGND 606
Query: 533 SGSIPQLKGARCFSFEEVKKYTNNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSM 592
SG PQLKGAR FS++E+KK TNNFS +N+VGSGGYGKVY+G L +GQ +AIKRAQQGSM
Sbjct: 607 SGGAPQLKGARWFSYDELKKCTNNFSMSNEVGSGGYGKVYRGMLVDGQAVAIKRAQQGSM 666
Query: 593 QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDW 652
QGG EFK EIELLSRVHHKNL+ L+GFCF++GEQML+YEF+PNG+L DSLSGK+GI LDW
Sbjct: 667 QGGLEFKTEIELLSRVHHKNLLGLVGFCFEQGEQMLVYEFMPNGTLRDSLSGKSGINLDW 726
Query: 653 IRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKD 712
RRL+IALG+ARGL+YLHELANPPIIHRD+KS+NILLDE LNAKVADFGLSK +SD+EK
Sbjct: 727 KRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDEHLNAKVADFGLSKLVSDNEKG 786
Query: 713 HITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVM 772
H++TQVKGT+GYLDPEYYMTQQLTEKSDVYSFGV+MLELLTG+ PIE+GKY+VRE+R +M
Sbjct: 787 HVSTQVKGTLGYLDPEYYMTQQLTEKSDVYSFGVVMLELLTGKLPIEKGKYVVREVRMLM 846
Query: 773 DK-KKELYNLYELIDPTI-GLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENIL 830
+K ++E Y L +++D TI +TT+ G ++++LA++CV+ES DRPTMSE+VK IE+IL
Sbjct: 847 NKSEEEYYGLKQIMDVTILNNTTTIIGLGRFLELAMRCVEESAGDRPTMSEMVKAIESIL 906
Query: 831 QQAGLNPNAESASSSASYEDASKGNFHHPYCN----EEGFD---YGYSGGFP-TSKIEPQ 882
Q G+N N SASSSA+ AS+ HPY + ++ D + YSGG+ ++K+EP+
Sbjct: 907 QNDGINTNTTSASSSATDFGASRNAPRHPYNDPIPKKDAHDSNSFDYSGGYTLSTKVEPK 966
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356546069|ref|XP_003541454.1| PREDICTED: probable leucine-rich repeat receptor-like protein kinase At5g49770-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1013 bits (2618), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 505/886 (56%), Positives = 660/886 (74%), Gaps = 32/886 (3%)
Query: 1 MGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSI 60
+ L GQLS I L+EL TLDLS N L G +P IGNLKKL +L LVGC FSG IPDSI
Sbjct: 74 LNLGGQLSSAIQSLSELDTLDLSYNTGLTGTVPQEIGNLKKLKSLSLVGCGFSGRIPDSI 133
Query: 61 GSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGN-SPGLDMLVR 119
GSL++L L+LNSN FSG +P S+GNLSN+ WLDL +N+LEG IPVSD PGLD+L++
Sbjct: 134 GSLKQLTFLALNSNNFSGTIPRSLGNLSNVDWLDLAENQLEGTIPVSDDQGRPGLDLLLK 193
Query: 120 AKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSL 179
A HFH G N+L+G+IPEKLF +M+L HVLFD N L G +P +L V +LEVVRFD+N L
Sbjct: 194 AHHFHMGSNKLTGTIPEKLFNSNMILEHVLFDHNQLEGGIPRSLSTVSTLEVVRFDKNGL 253
Query: 180 SGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQ 239
+G VP+NLN L ++++YLS+N L G++P+ +G++ L+Y+D+S+N F+AS++PSW +++
Sbjct: 254 TGGVPANLNKLGKLSEIYLSHNSLNGSLPDFSGMNSLTYVDLSDNDFNASDIPSWVTTL- 312
Query: 240 SLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENLLVNLQNNRIS 299
P L TV++ N L G L+L S L+NL++N I+
Sbjct: 313 -----------------------PGLTTVILGQNRLGGALNLSRYSSSLQLMNLEDNEIT 349
Query: 300 AYTERGGAPAVNLTLIDNPICQELGTA-KGYCQLSQP-ISPYSTKQKNCLPAPCNANQSS 357
+P L L +NP+C+E G + + YC++ P S YST NCLP+PC ++Q S
Sbjct: 350 ELDPENNSPTFELRLANNPLCRESGASERSYCKVPVPNPSFYSTPTNNCLPSPCGSDQVS 409
Query: 358 SPNCQCAYPYTGTLVFRSLSFSDLGNTTYYEILEQSVTTSFQSTYKLPIDSISLSNPHKN 417
SPNC+CA+PY+G L+ R+LSFS+ N +YY LEQS+ +F++ +P+DS+SLSNP +N
Sbjct: 410 SPNCKCAFPYSGLLISRALSFSNFSNASYYRELEQSLMDTFRNQ-SIPVDSVSLSNPFRN 468
Query: 418 NFEYLELSIQFFPSGQESFNRTGVSSVGFVLSNQIYSPPPLFGPMFFNGDPYQYF-AESG 476
+ EL++ FPS + FN TGV ++ F+LSNQIY PP F P F G Y+Y+ E
Sbjct: 469 TIDNFELTLDVFPSQTDRFNTTGVLTIAFLLSNQIYKPPEFFSPYIFKGANYEYYGGEPK 528
Query: 477 GSHKSTSIGVIIGAAAAGCVVLLLLLLAGVYAYHQKRRAEKANEQNPFAHWDMNKSSGSI 536
GS S+ +GVI+GA A V ++L AG+YA QKRRA ++ E NPFA+W+ N +SG+
Sbjct: 529 GSKSSSHVGVIVGAVVAVVVFVVLAFFAGMYALRQKRRARRSAELNPFANWEQNTNSGTA 588
Query: 537 PQLKGARCFSFEEVKKYTNNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQ 596
PQLKGAR FSF++++KYT+NFS+ N +GSGGYGKVY+G LP+G+L+AIKRA + SMQG
Sbjct: 589 PQLKGARWFSFDDLRKYTSNFSETNTIGSGGYGKVYQGNLPSGELVAIKRAAKESMQGAV 648
Query: 597 EFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRL 656
EFK EIELLSRVHHKNLV L+GFCF++GEQML+YE +PNG+L DSLSGK+GI +DWIRRL
Sbjct: 649 EFKTEIELLSRVHHKNLVGLVGFCFEKGEQMLVYEHIPNGTLMDSLSGKSGIWMDWIRRL 708
Query: 657 KIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITT 716
K+ALGAARGL+YLHELA+PPIIHRDIKSSNILLD LNAKVADFGLSK + DSE+ H+TT
Sbjct: 709 KVALGAARGLAYLHELADPPIIHRDIKSSNILLDHHLNAKVADFGLSKLLVDSERGHVTT 768
Query: 717 QVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKK 776
QVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLEL T RRPIE+GKYIVRE+ VMD K
Sbjct: 769 QVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELATARRPIEQGKYIVREVMRVMDTSK 828
Query: 777 ELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQAGLN 836
+LYNL+ ++DPTI +T KG EK+V LA++CV+E +RPTM+EVVK+IE++++ GLN
Sbjct: 829 DLYNLHSILDPTIMKATRPKGLEKFVMLAMRCVKEYAAERPTMAEVVKEIESMIELVGLN 888
Query: 837 PNAESASSSASYEDASKGNFHHPYCNEEGFDYGYSGGFPTSKIEPQ 882
PN+ESA++S +Y +A GN HPY E D+ YSG FP++++EPQ
Sbjct: 889 PNSESATTSETYVEAGVGNAQHPYREE---DFSYSGIFPSTRVEPQ 931
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 882 | ||||||
| TAIR|locus:2157042 | 953 | AT5G49760 [Arabidopsis thalian | 0.990 | 0.917 | 0.573 | 7.1e-267 | |
| TAIR|locus:2156992 | 946 | AT5G49770 [Arabidopsis thalian | 0.975 | 0.909 | 0.538 | 2.6e-244 | |
| TAIR|locus:2019863 | 971 | AT1G79620 [Arabidopsis thalian | 0.990 | 0.900 | 0.520 | 2.6e-237 | |
| TAIR|locus:2157002 | 857 | AT5G49780 [Arabidopsis thalian | 0.401 | 0.413 | 0.622 | 5.6e-226 | |
| TAIR|locus:2181017 | 951 | AT5G01950 [Arabidopsis thalian | 0.894 | 0.829 | 0.360 | 4.5e-114 | |
| TAIR|locus:2084016 | 937 | AT3G53590 [Arabidopsis thalian | 0.880 | 0.829 | 0.349 | 4.9e-108 | |
| TAIR|locus:2157047 | 493 | AT5G49750 [Arabidopsis thalian | 0.385 | 0.689 | 0.524 | 8.1e-92 | |
| TAIR|locus:2139885 | 1013 | AT4G28650 [Arabidopsis thalian | 0.272 | 0.236 | 0.422 | 4.3e-86 | |
| UNIPROTKB|Q8RZV7 | 1294 | P0413C03.22 "Putative extra sp | 0.311 | 0.212 | 0.422 | 5e-85 | |
| TAIR|locus:2009630 | 953 | AT1G53420 [Arabidopsis thalian | 0.319 | 0.295 | 0.430 | 1.4e-82 |
| TAIR|locus:2157042 AT5G49760 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2567 (908.7 bits), Expect = 7.1e-267, P = 7.1e-267
Identities = 509/887 (57%), Positives = 630/887 (71%)
Query: 1 MGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSI 60
+ L+G+L DI+ L+EL LDLS N L GPLP IGNL KL NL+LVGCSFSG IP+SI
Sbjct: 75 LDLEGKLPADISFLSELRILDLSYNPKLSGPLPPNIGNLGKLRNLILVGCSFSGQIPESI 134
Query: 61 GSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNS-PGLDMLVR 119
G+L+EL+ LSLN N FSG +PPSIG LS LYW D+ DN++EGE+PVS+G S PGLDML++
Sbjct: 135 GTLKELIYLSLNLNKFSGTIPPSIGLLSKLYWFDIADNQIEGELPVSNGTSAPGLDMLLQ 194
Query: 120 AKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSL 179
KHFHFGKN+LSG+IP++LF +M LIHVLFD N TGE+P TL LVK+L V+R DRN L
Sbjct: 195 TKHFHFGKNKLSGNIPKELFSSNMSLIHVLFDGNQFTGEIPETLSLVKTLTVLRLDRNKL 254
Query: 180 SGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQ 239
G +PS LNNLT++N+LYL+NN+ TG +PNLT L+ L LD+SNN+ D S +PSW SS+
Sbjct: 255 IGDIPSYLNNLTNLNELYLANNRFTGTLPNLTSLTSLYTLDVSNNTLDFSPIPSWISSLP 314
Query: 240 SLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENL-LVNLQNNRI 298
SL+TL ME L G IP FS P LQTV++K N + +LD GT S L V+LQ N I
Sbjct: 315 SLSTLRMEGIQLNGPIPISFFSPPQLQTVILKRNSIVESLDFGTDVSSQLEFVDLQYNEI 374
Query: 299 SAYTERGGAPAVNLTLIDNPICQELGTAKGYCQLSQPISPYSTKQKNCLPAPCNANQSSS 358
+ Y + + L +NP+C E G YC Q + +ST NC +PC +S
Sbjct: 375 TDYKPSANK-VLQVILANNPVCLEAGNGPSYCSAIQHNTSFSTLPTNC--SPCEPGMEAS 431
Query: 359 PNCQCAYPYTGTLVFRSLSFSDLGNTTYYEILEQSVTTSFQSTYKLPIDSISLSNPHKNN 418
P C+CAYP+ GTL FRS SFS L N+T + IL++++ F+ + P+DS+ + N +N
Sbjct: 432 PTCRCAYPFMGTLYFRSPSFSGLFNSTNFSILQKAIADFFKK-FNYPVDSVGVRNIRENP 490
Query: 419 FEY-LELSIQFFPSGQESFNRTGVSSVGFVLSNQIYSPPPLFGPMFFNGDPYQYFAESGG 477
++ L + + FP G+ESFN+TG+S VGF SNQ Y PPP+FGP F D Y+ F++
Sbjct: 491 TDHQLLIDLLVFPLGRESFNQTGMSLVGFAFSNQTYKPPPIFGPYIFKADLYKQFSDVEV 550
Query: 478 SHKSTSXXXXXXXXXXXXXXXXXXXXXXXXXYHQKRRAEKANEQN-PFAHWDMNKSSGSI 536
S KS++ QK+RAE+A QN PFA WD +KSS
Sbjct: 551 SSKSSNKSILIGAVVGVVVLLLLLTIAGIYALRQKKRAERATGQNNPFAKWDTSKSSIDA 610
Query: 537 PQLKGARCFSFEEVKKYTNNFSDANDXXXXXXXXXXXXTLPNGQLIAIKRAQQGSMQGGQ 596
PQL GA+ F+FEE+KK T+NFS+AND LPNGQLIAIKRAQQGS+QGG
Sbjct: 611 PQLMGAKAFTFEELKKCTDNFSEANDVGGGGYGKVYRGILPNGQLIAIKRAQQGSLQGGL 670
Query: 597 EFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRL 656
EFK EIELLSRVHHKN+V LLGFCFDR EQML+YE++ NGSL DSLSGK+GIRLDW RRL
Sbjct: 671 EFKTEIELLSRVHHKNVVRLLGFCFDRNEQMLVYEYISNGSLKDSLSGKSGIRLDWTRRL 730
Query: 657 KIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITT 716
KIALG+ +GL+YLHELA+PPIIHRDIKS+NILLDE L AKVADFGLSK + D EK H+TT
Sbjct: 731 KIALGSGKGLAYLHELADPPIIHRDIKSNNILLDENLTAKVADFGLSKLVGDPEKTHVTT 790
Query: 717 QVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKK 776
QVKGTMGYLDPEYYMT QLTEKSDVY FGV++LELLTGR PIERGKY+VRE++T M+K +
Sbjct: 791 QVKGTMGYLDPEYYMTNQLTEKSDVYGFGVVLLELLTGRSPIERGKYVVREVKTKMNKSR 850
Query: 777 ELYNLYELIDPTIGLST-TLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQAGL 835
LY+L EL+D TI S+ LKGFEKYVDLAL+CV+E G +RP+M EVVK+IENI+Q AGL
Sbjct: 851 SLYDLQELLDTTIIASSGNLKGFEKYVDLALRCVEEEGVNRPSMGEVVKEIENIMQLAGL 910
Query: 836 NPNXXXXXXXXXXXXXXKGNFHHPYCNEEGFDYGYSGGFPTSKIEPQ 882
NPN KG+ PY +E + YSG FP SK+EPQ
Sbjct: 911 NPNSDSATSSRTYEDAIKGS-GDPYGSES---FQYSGNFPASKLEPQ 953
|
|
| TAIR|locus:2156992 AT5G49770 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2354 (833.7 bits), Expect = 2.6e-244, P = 2.6e-244
Identities = 475/882 (53%), Positives = 607/882 (68%)
Query: 3 LKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGS 62
LKG+L +I+ L+EL TLDL+ N +L GPLP IGNL+KL+ L L+GC+F+GPIPDSIG+
Sbjct: 80 LKGKLPTEISTLSELQTLDLTGNPELSGPLPANIGNLRKLTFLSLMGCAFNGPIPDSIGN 139
Query: 63 LQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNS-PGLDMLVRAK 121
L++L LSLN N FSG +P S+G LS LYW D+ DN+LEG++PVSDG S PGLDML++
Sbjct: 140 LEQLTRLSLNLNKFSGTIPASMGRLSKLYWFDIADNQLEGKLPVSDGASLPGLDMLLQTG 199
Query: 122 HFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSG 181
HFHFG N+LSG IPEKLF +M L+HVLFD N TG +P +LGLV++L V+R DRN LSG
Sbjct: 200 HFHFGNNKLSGEIPEKLFSSEMTLLHVLFDGNQFTGSIPESLGLVQNLTVLRLDRNRLSG 259
Query: 182 PVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSL 241
+PS+LNNLT++ +L+LS+NK TG++PNLT L+ L LD+SNN S VPSW + SL
Sbjct: 260 DIPSSLNNLTNLQELHLSDNKFTGSLPNLTSLTSLYTLDVSNNPLALSPVPSWIPFLNSL 319
Query: 242 TTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENL-LVNLQNNRISA 300
+TL +E+ L G +P LFS LQTV +K N +N TLDLGT+YS+ L V+L++N I+
Sbjct: 320 STLRLEDIQLDGPVPTSLFSPLQLQTVSLKHNLINTTLDLGTNYSKQLDFVDLRDNFITG 379
Query: 301 YTERGGAPAVNLTLIDNPICQE-LGTAKGYCQLSQPISPYSTKQKNCLPAPCNANQSSSP 359
Y P VN+ L DN +CQ+ GYC QP S +ST K C C + +
Sbjct: 380 YKSPANNP-VNVMLADNQVCQDPANQLSGYCNAVQPNSTFSTLTK-C-GNHCGKGKEPNQ 436
Query: 360 NCQCAYPYTGTLVFRSLSFSDLGNTTYYEILEQSVTTSFQSTYKLPIDSISLSNPHKNNF 419
C C YP TG RS SFS N + + +S+ T F++ K P+DS+++ N +N
Sbjct: 437 GCHCVYPLTGVFTLRSPSFSGFSNNSNFLKFGESLMTFFKNG-KYPVDSVAMRNISENPT 495
Query: 420 EY-LELSIQFFPSGQESFNRTGVSSVGFVLSNQIYSPPPLFGPMFFNGDPYQYFAESGGS 478
+Y L +++ FPSG++ FN+T + S+ + Q Y PPP FGP F D Y+ F++ S
Sbjct: 496 DYHLLINLLIFPSGRDRFNQTEMDSINSAFTIQDYKPPPRFGPYIFVADQYKTFSDLEDS 555
Query: 479 HKSTSXXXXXXXXXXXXXXXXXXXXXXXXXYHQKRRAEKANEQ-NPFAHWDMNKSSGSIP 537
K+ S QK+RA++A +Q NPFA WD K+ P
Sbjct: 556 -KTVSMKVIIGVVVGVVVLLLLLALAGIYALRQKKRAQRATDQMNPFAKWDAGKNEMDAP 614
Query: 538 QLKGARCFSFEEVKKYTNNFSDANDXXXXXXXXXXXXTLPNGQLIAIKRAQQGSMQGGQE 597
QL G + F+FEE+ K TNNFSDAND TLPNGQ+IAIKRAQQGSMQG E
Sbjct: 615 QLMGTKAFTFEELSKCTNNFSDANDVGGGGYGQVYKGTLPNGQVIAIKRAQQGSMQGAFE 674
Query: 598 FKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLK 657
FK EIELLSRVHHKN+V LLGFCFD+ EQML+YE++PNGSL D LSGKNG++LDW RRLK
Sbjct: 675 FKTEIELLSRVHHKNVVKLLGFCFDQKEQMLVYEYIPNGSLRDGLSGKNGVKLDWTRRLK 734
Query: 658 IALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQ 717
IALG+ +GL+YLHELA+PPIIHRD+KS+NILLDE L AKVADFGLSK + D EK H+TTQ
Sbjct: 735 IALGSGKGLAYLHELADPPIIHRDVKSNNILLDEHLTAKVADFGLSKLVGDPEKAHVTTQ 794
Query: 718 VKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKE 777
VKGTMGYLDPEYYMT QLTEKSDVY FGV+MLELLTG+ PI+RG Y+V+E++ MDK +
Sbjct: 795 VKGTMGYLDPEYYMTNQLTEKSDVYGFGVVMLELLTGKSPIDRGSYVVKEVKKKMDKSRN 854
Query: 778 LYNLYELIDPTI-GLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQAGLN 836
LY+L EL+D TI S LKGFEKYVD+AL+CV+ G +RPTMSEVV+++E+IL+ GLN
Sbjct: 855 LYDLQELLDTTIIQNSGNLKGFEKYVDVALQCVEPEGVNRPTMSEVVQELESILRLVGLN 914
Query: 837 PNXXXXXXXXXXXXXXKGNFHHPYCNEEGFDYGYSGGFPTSK 878
PN G+ PY + F+Y +G FPT K
Sbjct: 915 PNADSATYEEAS-----GD---PY-GRDSFEY--TGVFPTPK 945
|
|
| TAIR|locus:2019863 AT1G79620 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2288 (810.5 bits), Expect = 2.6e-237, P = 2.6e-237
Identities = 467/897 (52%), Positives = 609/897 (67%)
Query: 1 MGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSI 60
MGLKG+LSGDI L EL +LDLS N+ L G L + +G+L+KL+ L+L GC F+G IP+ +
Sbjct: 83 MGLKGRLSGDIGELAELRSLDLSFNRGLTGSLTSRLGDLQKLNILILAGCGFTGTIPNEL 142
Query: 61 GSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRA 120
G L++L L+LNSN F+G++P S+GNL+ +YWLDL DN+L G IP+S G+SPGLD+L++A
Sbjct: 143 GYLKDLSFLALNSNNFTGKIPASLGNLTKVYWLDLADNQLTGPIPISSGSSPGLDLLLKA 202
Query: 121 KHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLS 180
KHFHF KNQLSG+IP KLF +M+LIHVLFD N TG +P+TLGL+++LEV+R DRN+L+
Sbjct: 203 KHFHFNKNQLSGTIPPKLFSSEMILIHVLFDGNRFTGSIPSTLGLIQTLEVLRLDRNTLT 262
Query: 181 GPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQS 240
G VP NL+NLT++ +L L++NKL G++P+L+ + ++Y+D+SNNSFD SE P WFS++ S
Sbjct: 263 GKVPENLSNLTNIIELNLAHNKLVGSLPDLSDMKSMNYVDLSNNSFDPSESPLWFSTLPS 322
Query: 241 LTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENL-LVNLQNNRIS 299
LTTL+ME +L+G +P LF P LQ V +K N NGTL LG + L LV+LQ+N IS
Sbjct: 323 LTTLVMEYGSLQGPLPNKLFGFPQLQQVRLKKNAFNGTLSLGDTVGPELQLVDLQDNDIS 382
Query: 300 AYTERGGAPAVNLTLIDNPICQELGTAKGYCQLSQPISP--YSTKQKNCLPAPCNANQSS 357
+ T G L L NP+C + YCQ+ Q YST NC C +Q
Sbjct: 383 SVTLSSGYTNT-LILEGNPVCTTALSNTNYCQIQQQQVKRIYSTSLANCGGKSCPLDQKV 441
Query: 358 SP-NCQCAYPYTGTLVFRSLSFSDLGNTTYYEILEQSVTTSFQSTYKLPIDSISLSNPHK 416
SP +C+CAYPY GTL FR F DL N Y LE S+ T P S+SL NP
Sbjct: 442 SPQSCECAYPYEGTLYFRGPMFRDLSNVNTYHSLEMSLWVKLGLT---P-GSVSLQNPFF 497
Query: 417 NNFEYLELSIQFFPSGQESFNRTGVSSVGFVLSNQIYSPPPLFGPMFFNGDPYQYFAESG 476
NN +YL++ + FP + FNRT V +GF LSNQ Y PPPLFGP +F PY + A+
Sbjct: 498 NNDDYLQIQLALFPPMGKYFNRTEVQRIGFDLSNQTYKPPPLFGPYYFIASPYTFPADGN 557
Query: 477 GSHKSTSXXXXXXXXXXXXXXXXXXXXXXXXXYHQKRRAEKA-NEQNPFAHW-DMNKSSG 534
G H +S + QKRRAE+A PF W K SG
Sbjct: 558 G-HSLSSRMVTGIITGCSALVLCLVALGIYAMW-QKRRAEQAIGLSRPFVSWASSGKDSG 615
Query: 535 SIPQLKGARCFSFEEVKKYTNNFSDANDXXXXXXXXXXXXTLPNGQLIAIKRAQQGSMQG 594
PQLKGAR FS+EE+KK TNNFS +++ L +G ++AIKRAQQGS QG
Sbjct: 616 GAPQLKGARWFSYEELKKITNNFSVSSELGYGGYGKVYKGMLQDGHMVAIKRAQQGSTQG 675
Query: 595 GQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIR 654
G EFK EIELLSRVHHKNLV L+GFCF++GEQ+L+YE++ NGSL DSL+G++GI LDW R
Sbjct: 676 GLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQILVYEYMSNGSLKDSLTGRSGITLDWKR 735
Query: 655 RLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHI 714
RL++ALG+ARGL+YLHELA+PPIIHRD+KS+NILLDE L AKVADFGLSK +SD K H+
Sbjct: 736 RLRVALGSARGLAYLHELADPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDCTKGHV 795
Query: 715 TTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDK 774
+TQVKGT+GYLDPEYY TQ+LTEKSDVYSFGV+M+EL+T ++PIE+GKYIVREI+ VM+K
Sbjct: 796 STQVKGTLGYLDPEYYTTQKLTEKSDVYSFGVVMMELITAKQPIEKGKYIVREIKLVMNK 855
Query: 775 KKE-LYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQA 833
+ Y L + +D ++ TL +Y++LALKCV E+ D+RPTMSEVVK+IE I+Q +
Sbjct: 856 SDDDFYGLRDKMDRSLRDVGTLPELGRYMELALKCVDETADERPTMSEVVKEIEIIIQNS 915
Query: 834 GLNPNXXXXXXXXXXXXXXKGNFHHPYCNEEGFD------YGYSGGF--PTSKIEPQ 882
G + + K + +E D + YSGG+ PT KIEP+
Sbjct: 916 GASSSSSASASSSATDFGEKLLYGGTLKKKEARDGDGGGAFDYSGGYSVPT-KIEPK 971
|
|
| TAIR|locus:2157002 AT5G49780 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1149 (409.5 bits), Expect = 5.6e-226, Sum P(2) = 5.6e-226
Identities = 224/360 (62%), Positives = 271/360 (75%)
Query: 525 AHWDMNKSSGSIPQLKGARCFSFEEVKKYTNNFSDANDXXXXXXXXXXXXTLPNGQLIAI 584
A WD N++S PQL G + F+FEE++K NNFS AND LP+GQLIAI
Sbjct: 502 AKWDANQNSVDAPQLMGTKAFTFEEMRKCANNFSVANDVGGGGYGQVYKGILPSGQLIAI 561
Query: 585 KRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSG 644
KRAQ GS+QG EFK EIELLSRVHHKN+V LLGFCFDRGEQML+YE++PNGSL DSLSG
Sbjct: 562 KRAQPGSLQGALEFKTEIELLSRVHHKNVVKLLGFCFDRGEQMLVYEYIPNGSLRDSLSG 621
Query: 645 KNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSK 704
K+GIRLDW RRL+IALG+ +GL+YLHELA+PPIIHRD+KSSN+LLDE L AKVADFGLS+
Sbjct: 622 KSGIRLDWTRRLRIALGSGKGLAYLHELADPPIIHRDVKSSNVLLDESLTAKVADFGLSQ 681
Query: 705 SMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYI 764
+ D+EK ++T QVKGTMGYLDPEYYMT QLTEKSDVY FGV+MLELLTG+ PIE GKY+
Sbjct: 682 LVEDAEKANVTAQVKGTMGYLDPEYYMTNQLTEKSDVYGFGVMMLELLTGKIPIENGKYV 741
Query: 765 VREIRTVMDKKKELYNLYELIDPTIGLSTT--LKGFEKYVDLALKCVQESGDDRPTMSEV 822
V+E++ M+K K LY+L + +D TI ++ LKGFEKYVD+AL+CV G RP+M+EV
Sbjct: 742 VKEMKMKMNKSKNLYDLQDFLDTTISATSNRNLKGFEKYVDVALRCVDPEGVKRPSMNEV 801
Query: 823 VKDIENILQQAGLNPNXXXXXXXXXXXXXXKGNFHHPYCNEEGFDYGYSGGFPTSKIEPQ 882
VK+IENI+Q AGLNPN K + Y N + YS FPT+ +EPQ
Sbjct: 802 VKEIENIMQYAGLNPNVESYASSRTYDEASKES-GDLYGNNS---FEYSASFPTTNLEPQ 857
|
|
| TAIR|locus:2181017 AT5G01950 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1125 (401.1 bits), Expect = 4.5e-114, P = 4.5e-114
Identities = 306/849 (36%), Positives = 446/849 (52%)
Query: 17 LHTLDLS-NNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNG 75
LH +L N +L G L + L L L + + SG IP+ IG + LVLL LN N
Sbjct: 78 LHVRELLLMNMNLSGTLSPELQKLAHLEILDFMWNNISGSIPNEIGQISSLVLLLLNGNK 137
Query: 76 FSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIP 135
SG +P +G LSNL + +N + G IP S N L + KH HF N L+G IP
Sbjct: 138 LSGTLPSELGYLSNLNRFQIDENNITGPIPKSFSN------LKKVKHLHFNNNSLTGQIP 191
Query: 136 EKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGP-VPSNLNNLTSVN 194
+L + HVL D+N L+G LP L + +L++++ D N+ SG +P++ N +++
Sbjct: 192 VELSNLTNIF-HVLLDNNKLSGNLPPQLSALPNLQILQLDNNNFSGSDIPASYGNFSNIL 250
Query: 195 DLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQ 254
L L N L GA+P+ + + L YLD+S N S FS + +TT+ + N L G
Sbjct: 251 KLSLRNCSLKGALPDFSKIRHLKYLDLSWNELTGPIPSSNFS--KDVTTINLSNNILNGS 308
Query: 255 IPADLFSIPHLQTVVMKTNELNGTL--DLGTSYS----ENLLVNLQNNRISAYTERGGAP 308
IP +P LQ +++K N L+G++ L + S LL++L+NN +S + P
Sbjct: 309 IPQSFSDLPLLQMLLLKNNMLSGSVPDSLWKNISFPKKARLLLDLRNNSLSR-VQGDLTP 367
Query: 309 AVNLTL-ID-NPICQE--LGTAKGYCQLS--QPIS-PYSTKQK--NCLPAPCNANQ---- 355
N+TL +D N IC + A +C+ + IS P ++ +C P C
Sbjct: 368 PQNVTLRLDGNLICTNGSISNANLFCESKGKEWISLPNNSTNSALDCPPLACPTPDFYEY 427
Query: 356 -SSSP-NCQCAYPYTGTLVFRSLSFSDLGNTTYYEILEQSVTTSFQ-STYKLPIDSISLS 412
+SP C CA P +S SFS Y + + VT Q Y+L IDS
Sbjct: 428 SPASPLRCFCAAPLRIGYRLKSPSFSYF--PPYIDQFGEYVTDFLQMEPYQLWIDSYQWE 485
Query: 413 NPHKNNFEYLELSIQFFPSGQESFNRTGVSSVGFVLSNQIYSPPPLFGPM----FFNGDP 468
+ YL+L + + +FN + V + + ++ + LFGP F P
Sbjct: 486 KGPRLRM-YLKLFPKVNETYTRTFNESEVLRIRGIFASWRFPGSDLFGPYELLNFTLQGP 544
Query: 469 YQYFAESGGSHKSTSXXXXXXXXXXXXXXXXXXXXXXXXXYHQKRRAEKANEQNPFAHWD 528
Y Y K S RR K +
Sbjct: 545 YSY-VNFNSERKGVSWRRLAAITAGAVVTAVAISAVVAALL--LRRYSKHEREI-----S 596
Query: 529 MNKSSGSIPQLK-GARCFSFEEVKKYTNNFSDANDXXXXXXXXXXXXTLPNGQLIAIKRA 587
+SS L G R FSF+E+ + T++FS + L + + AIKRA
Sbjct: 597 RRRSSSKASLLNSGIRGFSFKELAEATDDFSSSTLVGRGGYGKVYRGVLSDNTVAAIKRA 656
Query: 588 QQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNG 647
+GS+QG +EF EIELLSR+HH+NLVSL+G+C + EQML+YEF+ NG+L D LS K
Sbjct: 657 DEGSLQGEKEFLNEIELLSRLHHRNLVSLIGYCDEESEQMLVYEFMSNGTLRDWLSAKGK 716
Query: 648 IRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSK--S 705
L + R+++ALGAA+G+ YLH ANPP+ HRDIK+SNILLD NAKVADFGLS+
Sbjct: 717 ESLSFGMRIRVALGAAKGILYLHTEANPPVFHRDIKASNILLDPNFNAKVADFGLSRLAP 776
Query: 706 MSDSEKD---HITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGK 762
+ + E+D H++T V+GT GYLDPEY++T +LT+KSDVYS GV+ LELLTG I GK
Sbjct: 777 VLEDEEDVPKHVSTVVRGTPGYLDPEYFLTHKLTDKSDVYSIGVVFLELLTGMHAISHGK 836
Query: 763 YIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEV 822
IVRE++T +++++ + LID + +++ EK+ LAL+C +S + RP M+EV
Sbjct: 837 NIVREVKTA--EQRDM--MVSLIDKRME-PWSMESVEKFAALALRCSHDSPEMRPGMAEV 891
Query: 823 VKDIENILQ 831
VK++E++LQ
Sbjct: 892 VKELESLLQ 900
|
|
| TAIR|locus:2084016 AT3G53590 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1068 (381.0 bits), Expect = 4.9e-108, P = 4.9e-108
Identities = 289/827 (34%), Positives = 419/827 (50%)
Query: 27 DLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGN 86
+L G L +G L L L ++ + +G IP IG + L LL LN N F+G +PP +GN
Sbjct: 90 NLSGELAPEVGQLLYLEILDVMWNNLTGRIPLEIGRISSLKLLLLNGNKFTGSLPPELGN 149
Query: 87 LSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLI 146
L NL L + +N + G +P S GN L KH H N +SG IP +L + L+
Sbjct: 150 LQNLNRLQVDENNITGSVPFSFGN------LRSIKHLHLNNNTISGEIPVELSKLPK-LV 202
Query: 147 HVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGP-VPSNLNNLTSVNDLYLSNNKLTG 205
H++ D+NNLTG LP L + SL +++ D N+ G +P + + + L L N L G
Sbjct: 203 HMILDNNNLTGTLPLELAQLPSLTILQLDNNNFEGSTIPEAYGHFSRLVKLSLRNCGLQG 262
Query: 206 AMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHL 265
++P+L+ + LSYLD+S N + S S ++TT+ + +L G IP + L
Sbjct: 263 SIPDLSRIENLSYLDLSWNHLTGTIPESKLSD--NMTTIELSYNHLTGSIPQSFSDLNSL 320
Query: 266 QTVVMKTNELNGTLDL----GTSYSENLL-VNLQNNRISAYTERGGAPA-VNLTLIDNPI 319
Q + ++ N L+G++ S+ N L V NN S T P V L L NPI
Sbjct: 321 QLLSLENNSLSGSVPTEIWQDKSFENNKLQVYDLNNNFSDATGNLRTPDNVTLYLRGNPI 380
Query: 320 CQELGTAKGYCQLSQPISPYSTKQKNCLPAPCN------ANQSSSPN-CQCAYPYTGTLV 372
C+ Q + I + PC+ N SP C C P +
Sbjct: 381 CKSTSIPM-VTQFFEYICGEKKQTSTNSNTPCSNVSCPFENVKVSPGICLCTAPLSIDYR 439
Query: 373 FRSLSFSDLGNTTYYEI-LEQSVTTSFQ-STYKLPIDSISLSNPHKNNFEYLELSIQFFP 430
+S SF T Y E + +T+S Q T++L ID + N + YL+L P
Sbjct: 440 LKSPSFFFF--TPYIERQFREYITSSLQLETHQLAIDRLVDENRLRPRM-YLKL----VP 492
Query: 431 SGQESFNRTGVSSVGFVLSNQIYSPPPLFGPMFFNGDPYQY-FAESGGSHKSTSXXXXXX 489
G+ +FN++ V + + ++ FGP P Q +A+
Sbjct: 493 KGRITFNKSEVIRIRDRFMSWSFNKTDFFGPYELLDFPLQGPYADLLAQTSGIRTIVWMM 552
Query: 490 XXXXXXXXXXXXXXXXXXXYHQKRRAEKANEQNPFAHWDMNKSSGSIPQLKGARCFSFEE 549
Y +KRR +++ ++KG + FSF E
Sbjct: 553 IVAGSVVAATVLSVTATLLYVRKRRENSHTLTKKRVFRTISR------EIKGVKKFSFVE 606
Query: 550 VKKYTNNFSDANDXXXXXXXXXXXXTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVH 609
+ TN F + L N +AIKR ++ S+Q +EF EI+LLSR+H
Sbjct: 607 LSDATNGFDSSTLIGRGSYGKVYKGILSNKTEVAIKRGEETSLQSEKEFLNEIDLLSRLH 666
Query: 610 HKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYL 669
H+NLVSL+G+ D GEQML+YE++PNG++ D LS L + R +ALG+A+G+ YL
Sbjct: 667 HRNLVSLIGYSSDIGEQMLVYEYMPNGNVRDWLSANAADTLSFSMRSHVALGSAKGILYL 726
Query: 670 HELANPPIIHRDIKSSNILLDERLNAKVADFGLSK-----SMSDSEKDHITTQVKGTMGY 724
H ANPP+IHRDIK+SNILLD +L+AKVADFGLS+ D E H++T V+GT GY
Sbjct: 727 HTEANPPVIHRDIKTSNILLDCQLHAKVADFGLSRLAPAFGEGDGEPAHVSTVVRGTPGY 786
Query: 725 LDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYEL 784
LDPEY+MTQQLT +SDVYSFGV++LELLTG P G +I+RE+RT E + +
Sbjct: 787 LDPEYFMTQQLTVRSDVYSFGVVLLELLTGMHPFFEGTHIIREVRTA----NECGTVLSV 842
Query: 785 IDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQ 831
D +G + K +K +LAL C ++ + RP MS+VVK++E I Q
Sbjct: 843 ADSRMGQCSPDK-VKKLAELALWCCEDRPETRPPMSKVVKELEGICQ 888
|
|
| TAIR|locus:2157047 AT5G49750 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 915 (327.2 bits), Expect = 8.1e-92, P = 8.1e-92
Identities = 180/343 (52%), Positives = 244/343 (71%)
Query: 3 LKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGS 62
L+G LS I L+EL LDLS N L GPLP+ IG+LKKL NL+LVGC SG IPDSIGS
Sbjct: 134 LEGTLSEYILALSELEILDLSFNIGLTGPLPSNIGDLKKLKNLILVGCGLSGQIPDSIGS 193
Query: 63 LQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDG-NSPGLDMLVRAK 121
L++++ LSLN N FSG +P SIG LS L W D+ +N++EGE+P+S+G +SPGLDML + +
Sbjct: 194 LEQIINLSLNLNKFSGTIPASIGRLSKLDWFDIAENQIEGELPISNGTSSPGLDMLTQTQ 253
Query: 122 HFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSG 181
HFHFGKN+LSG IPEKLF +M LIHVLF++N TG++P +L LV +L V+R D N LSG
Sbjct: 254 HFHFGKNKLSGHIPEKLFNSNMSLIHVLFNNNQFTGKIPESLSLVTTLLVLRLDTNRLSG 313
Query: 182 PVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSL 241
+P +LNNLTS+N L+L NNK TG++PNL L+ L +D+SNN+ + S VPSW S+++L
Sbjct: 314 DIPPSLNNLTSLNQLHLCNNKFTGSLPNLASLTDLDEIDVSNNTLEFSLVPSWIVSLRNL 373
Query: 242 TTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENL-LVNLQNNRISA 300
T++ ME L G +P FS+ LQ+V +K N +NGTLD GT+YS+ L LV+L+ N I+
Sbjct: 374 TSIRMEGIQLIGPVPISFFSLIRLQSVNLKRNWINGTLDFGTNYSKQLELVSLRYNNITG 433
Query: 301 YTERGGAPAVNLTLIDNPICQELGTAKGYCQLSQPISPYSTKQ 343
Y + + + L +NP+C E+G +C + S +ST Q
Sbjct: 434 YKQAANEH-IKVILANNPVCGEVGNKPSFCSAIKHSSSFSTLQ 475
|
|
| TAIR|locus:2139885 AT4G28650 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 493 (178.6 bits), Expect = 4.3e-86, Sum P(2) = 4.3e-86
Identities = 107/253 (42%), Positives = 164/253 (64%)
Query: 581 LIAIKRAQQGS--MQGGQ--EFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNG 636
++A+K+ + + ++ G +F E+ LL ++ H+N+V LLGF ++ M++YEF+ NG
Sbjct: 724 VLAVKKLWRSAADIEDGTTGDFVGEVNLLGKLRHRNIVRLLGFLYNDKNMMIVYEFMLNG 783
Query: 637 SLGDSLSGKNGI-RL--DWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERL 693
+LGD++ GKN RL DW+ R IALG A GL+YLH +PP+IHRDIKS+NILLD L
Sbjct: 784 NLGDAIHGKNAAGRLLVDWVSRYNIALGVAHGLAYLHHDCHPPVIHRDIKSNNILLDANL 843
Query: 694 NAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT 753
+A++ADFGL++ M+ K + V G+ GY+ PEY T ++ EK D+YS+GV++LELLT
Sbjct: 844 DARIADFGLARMMA--RKKETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSYGVVLLELLT 901
Query: 754 GRRPIER--GKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYV-DLALKCVQ 810
GRRP+E G+ V + V K ++ +L E +DP +G ++ V +AL C
Sbjct: 902 GRRPLEPEFGES-VDIVEWVRRKIRDNISLEEALDPNVGNCRYVQEEMLLVLQIALLCTT 960
Query: 811 ESGDDRPTMSEVV 823
+ DRP+M +V+
Sbjct: 961 KLPKDRPSMRDVI 973
|
|
| UNIPROTKB|Q8RZV7 P0413C03.22 "Putative extra sporogenous cells" [Oryza sativa Japonica Group (taxid:39947)] | Back alignment and assigned GO terms |
|---|
Score = 522 (188.8 bits), Expect = 5.0e-85, Sum P(2) = 5.0e-85
Identities = 122/289 (42%), Positives = 173/289 (59%)
Query: 548 EEVKKYTNNFSDANDXXXXXXXXXXXXTLPNGQLIAIKRAQQG-SMQGGQEFKMEIELLS 606
+++ K T NFS + LP G+ +AIKR G QG +EF E+E +
Sbjct: 993 DDILKATENFSKVHIIGDGGFGTVYKAALPEGRRVAIKRLHGGHQFQGDREFLAEMETIG 1052
Query: 607 RVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGK-NGIR-LDWIRRLKIALGAAR 664
+V H NLV LLG+C E+ LIYE++ NGSL L + + + L W RLKI LG+AR
Sbjct: 1053 KVKHPNLVPLLGYCVCGDERFLIYEYMENGSLEMWLRNRADALEALGWPDRLKICLGSAR 1112
Query: 665 GLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGY 724
GL++LH P IIHRD+KSSNILLDE +V+DFGL++ +S E H++T + GT GY
Sbjct: 1113 GLAFLHHGFVPHIIHRDMKSSNILLDENFEPRVSDFGLARIISACET-HVSTDIAGTFGY 1171
Query: 725 LDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRP-----IERGKYIVREIRTVMDKKKELY 779
+ PEY +T + T K DVYSFGV+MLELLTGR P ++ G +V +R ++ + K+
Sbjct: 1172 IPPEYGLTMKSTTKGDVYSFGVVMLELLTGRPPTGQEEVQGGGNLVGWVRWMIARGKQ-- 1229
Query: 780 NLYELIDPTIGLSTTLKG-FEKYVDLALKCVQESGDDRPTMSEVVKDIE 827
N EL DP + +S+ + + + +A C + RPTM EVVK ++
Sbjct: 1230 N--ELFDPCLPVSSVWREQMARVLAIARDCTADEPFKRPTMLEVVKGLK 1276
|
|
| TAIR|locus:2009630 AT1G53420 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 595 (214.5 bits), Expect = 1.4e-82, Sum P(2) = 1.4e-82
Identities = 123/286 (43%), Positives = 178/286 (62%)
Query: 545 FSFEEVKKYTNNFSDANDXXXXXXXXXXXXTLPNGQLIAIKRAQQGSMQGGQEFKMEIEL 604
FS ++K TNNF AN L +G +IA+K+ GS QG +EF EI +
Sbjct: 612 FSLRQIKIATNNFDSANRIGEGGFGPVYKGKLFDGTIIAVKQLSTGSKQGNREFLNEIGM 671
Query: 605 LSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSG--KNGIRLDWIRRLKIALGA 662
+S +HH NLV L G C + G+ +L+YEFV N SL +L G + +RLDW R KI +G
Sbjct: 672 ISALHHPNLVKLYGCCVEGGQLLLVYEFVENNSLARALFGPQETQLRLDWPTRRKICIGV 731
Query: 663 ARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTM 722
ARGL+YLHE + I+HRDIK++N+LLD++LN K++DFGL+K + + + HI+T++ GT
Sbjct: 732 ARGLAYLHEESRLKIVHRDIKATNVLLDKQLNPKISDFGLAK-LDEEDSTHISTRIAGTF 790
Query: 723 GYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGR-RPIERGKYIVREIRTVMDKKKELYNL 781
GY+ PEY M LT+K+DVYSFG++ LE++ GR IER K + ++ +E NL
Sbjct: 791 GYMAPEYAMRGHLTDKADVYSFGIVALEIVHGRSNKIERSKNNTFYLIDWVEVLREKNNL 850
Query: 782 YELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIE 827
EL+DP +G + + +A+ C +RP+MSEVVK +E
Sbjct: 851 LELVDPRLGSEYNREEAMTMIQIAIMCTSSEPCERPSMSEVVKMLE 896
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.10.2 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 882 | |||
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 9e-54 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 4e-53 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-50 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 5e-50 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-49 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 4e-49 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-46 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 6e-45 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-40 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-38 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-35 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-34 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-32 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 5e-32 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-31 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 7e-31 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 9e-31 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-29 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-29 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-29 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-29 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 4e-29 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 4e-29 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-28 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-28 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-28 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-28 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 4e-28 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 8e-28 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-27 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-27 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-27 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-27 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 8e-27 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-26 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-26 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-26 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-26 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 5e-26 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 6e-26 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-25 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-25 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-25 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 4e-25 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 4e-25 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 5e-25 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 8e-25 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-24 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-24 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-24 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-24 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-24 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 4e-24 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 4e-24 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 5e-24 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 6e-24 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 6e-24 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 8e-24 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-23 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 4e-23 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 4e-23 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 8e-23 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-22 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-22 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-22 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-22 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-22 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-22 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-22 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 3e-22 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 4e-22 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 4e-22 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 4e-22 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 5e-22 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-22 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 8e-22 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 8e-22 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-21 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-21 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-21 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-21 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 4e-21 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 4e-21 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 4e-21 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 5e-21 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 8e-21 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 9e-21 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-20 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-20 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-20 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-20 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-20 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-20 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-20 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 4e-20 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 4e-20 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 4e-20 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 9e-20 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 9e-20 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-19 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-19 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-19 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-19 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-19 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-19 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-19 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-19 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-19 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-19 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 4e-19 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 5e-19 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 5e-19 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 6e-19 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 9e-19 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-18 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-18 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-18 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-18 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-18 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-18 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-18 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-18 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-18 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 5e-18 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 9e-18 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-17 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-17 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-17 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-17 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-17 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 4e-17 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 4e-17 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 4e-17 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 5e-17 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 6e-17 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 6e-17 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 7e-17 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-16 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-16 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-16 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 3e-16 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 4e-16 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 4e-16 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 5e-16 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 5e-16 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 5e-16 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 7e-16 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 8e-16 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-15 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-15 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-15 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-15 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-15 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-15 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-15 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-15 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-15 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-15 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-15 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-15 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 4e-15 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-15 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 6e-15 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 6e-15 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 7e-15 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 9e-15 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 9e-15 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-14 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-14 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-14 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-14 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-14 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-14 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-14 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-14 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-14 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-14 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-14 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 4e-14 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 4e-14 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 5e-14 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 6e-14 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 6e-14 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 6e-14 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 7e-14 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 7e-14 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 8e-14 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 9e-14 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 9e-14 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-13 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-13 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-13 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-13 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-13 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-13 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 5e-13 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 5e-13 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 6e-13 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 7e-13 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-12 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-12 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-12 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-12 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-12 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-12 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-12 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-12 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-12 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-12 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-12 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 4e-12 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-12 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 4e-12 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 4e-12 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 5e-12 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 5e-12 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 5e-12 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 6e-12 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 7e-12 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 7e-12 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 8e-12 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 8e-12 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-11 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-11 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-11 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-11 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-11 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-11 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-11 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-11 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-11 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 5e-11 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 6e-11 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 6e-11 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 6e-11 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 9e-11 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 9e-11 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 9e-11 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-10 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-10 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-10 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-10 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-10 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-10 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-10 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-10 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-10 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-10 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-10 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-10 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 4e-10 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 4e-10 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 5e-10 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 5e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 6e-10 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 7e-10 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 8e-10 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-09 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-09 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-09 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-09 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-09 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-09 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-09 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-09 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-09 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 3e-09 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-09 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-09 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 4e-09 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 5e-09 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 5e-09 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 5e-09 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 6e-09 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 1e-08 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-08 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-08 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-08 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-08 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-08 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-08 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-08 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 3e-08 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-08 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 4e-08 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 5e-08 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 6e-08 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 6e-08 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 6e-08 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 6e-08 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 7e-08 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-07 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-07 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 4e-07 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-07 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 5e-07 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 6e-07 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 7e-07 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 8e-07 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-06 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 4e-06 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 4e-06 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 4e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 8e-06 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-05 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-05 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-05 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-05 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 3e-05 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 4e-05 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 6e-05 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 7e-05 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 8e-05 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 9e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 1e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-04 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 1e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 2e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 4e-04 | |
| PLN03210 | 1153 | PLN03210, PLN03210, Resistant to P | 5e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 0.001 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 0.001 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 0.002 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 187 bits (477), Expect = 9e-54
Identities = 87/271 (32%), Positives = 130/271 (47%), Gaps = 28/271 (10%)
Query: 564 GSGGYGKVYKGTL-----PNGQLIAIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLVSLL 617
G G +G+VYKGTL +A+K ++ + Q +EF E ++ ++ H N+V LL
Sbjct: 8 GEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKLL 67
Query: 618 GFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPI 677
G C + M++ E++P G L D L L L AL ARG+ YL
Sbjct: 68 GVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK---NF 124
Query: 678 IHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTE 737
IHRD+ + N L+ E L K++DFGLS+ + D + K + ++ PE + T
Sbjct: 125 IHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYK-VKGGKLPIRWMAPESLKEGKFTS 183
Query: 738 KSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLY-ELIDPTIGLSTTL 795
KSDV+SFGVL+ E+ T G P Y V++ K+ Y L P
Sbjct: 184 KSDVWSFGVLLWEIFTLGEEP-----YPGMSNAEVLEYLKKGYRLPKPPNCP-------- 230
Query: 796 KGFEKYVDLALKCVQESGDDRPTMSEVVKDI 826
+ L L+C E +DRPT SE+V+ +
Sbjct: 231 ---PELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 185 bits (472), Expect = 4e-53
Identities = 85/274 (31%), Positives = 131/274 (47%), Gaps = 35/274 (12%)
Query: 564 GSGGYGKVYKGTL-----PNGQLIAIKRAQQGSMQGG-QEFKMEIELLSRVHHKNLVSLL 617
G G +G+VYKG L +A+K ++ + + +EF E ++ ++ H N+V LL
Sbjct: 8 GEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKLL 67
Query: 618 GFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPI 677
G C + ++ E++ G L L KN +L L AL ARG+ YL
Sbjct: 68 GVCTEEEPLYIVMEYMEGGDLLSYLR-KNRPKLSLSDLLSFALQIARGMEYLESK---NF 123
Query: 678 IHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMG---YLDPEYYMTQQ 734
IHRD+ + N L+ E L K++DFGLS+ + D + + +G ++ PE +
Sbjct: 124 IHRDLAARNCLVGENLVVKISDFGLSRDLYDDD----YYRKRGGKLPIRWMAPESLKEGK 179
Query: 735 LTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLY-ELIDPTIGLS 792
T KSDV+SFGVL+ E+ T G +P Y V++ K Y L P
Sbjct: 180 FTSKSDVWSFGVLLWEIFTLGEQP-----YPGMSNEEVLEYLKNGYRLPQPPNCP----- 229
Query: 793 TTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDI 826
+ DL L+C E +DRPT SE+V+ +
Sbjct: 230 ------PELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 178 bits (453), Expect = 1e-50
Identities = 79/265 (29%), Positives = 125/265 (47%), Gaps = 22/265 (8%)
Query: 563 VGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQE-FKMEIELLSRVHHKNLVSLLGFC 620
+G G +GKVY G+L+AIK ++ ++ +E EI++L ++ H N+V L
Sbjct: 7 LGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDVF 66
Query: 621 FDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHR 680
D + L+ E+ G L D L + + D R L YLH I+HR
Sbjct: 67 EDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEAR--FYLRQILSALEYLHSK---GIVHR 121
Query: 681 DIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSD 740
D+K NILLDE + K+ADFGL++ + EK +TT V GT Y+ PE + + + D
Sbjct: 122 DLKPENILLDEDGHVKLADFGLARQLDPGEK--LTTFV-GTPEYMAPEVLLGKGYGKAVD 178
Query: 741 VYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEK 800
++S GV++ ELLTG+ P ++ + + K P +S K
Sbjct: 179 IWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPK------PPFPPPEWDISPEAK---- 228
Query: 801 YVDLALKCVQESGDDRPTMSEVVKD 825
DL K + + + R T E ++
Sbjct: 229 --DLIRKLLVKDPEKRLTAEEALQH 251
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 176 bits (450), Expect = 5e-50
Identities = 79/286 (27%), Positives = 127/286 (44%), Gaps = 47/286 (16%)
Query: 563 VGSGGYGKVYKGTL----PNGQLIAIKRAQQGSMQGGQ-EFKMEIELLSRVHHKNLVSLL 617
+G G +G+VYKG L +A+K ++ + + + +F E ++ ++ H N+V LL
Sbjct: 3 LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLL 62
Query: 618 GFCFDRGEQMLIYEFVPNGSL-------GDSLSGKNGIRLDWIRRLKIALGAARGLSYLH 670
G C + L+ E++ G L L L A+ A+G+ YL
Sbjct: 63 GVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA 122
Query: 671 ELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYY 730
+HRD+ + N L+ E L K++DFGLS+ + D + T K + ++ PE
Sbjct: 123 SK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESL 179
Query: 731 MTQQLTEKSDVYSFGVLMLELLT-GRRPIE--RGKYIVREIR--TVMDK----KKELYNL 781
T KSDV+SFGVL+ E+ T G P + ++ +R + K ELY
Sbjct: 180 KDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPDELY-- 237
Query: 782 YELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIE 827
+L L C Q +DRPT SE+V+ +E
Sbjct: 238 ---------------------ELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 173 bits (442), Expect = 2e-49
Identities = 71/193 (36%), Positives = 103/193 (53%), Gaps = 10/193 (5%)
Query: 563 VGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGG-QEFKMEIELLSRVHHKNLVSLLGFC 620
+G GG+G VY G+ +AIK ++ +E EIE+L +++H N+V L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 621 FDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHR 680
D L+ E+ GSL D L +N +L L+I L GL YLH IIHR
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLK-ENEGKLSEDEILRILLQILEGLEYLHSN---GIIHR 116
Query: 681 DIKSSNILLDER-LNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQ-LTEK 738
D+K NILLD K+ADFGLSK ++ + + + GT Y+ PE + + +EK
Sbjct: 117 DLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVGTPAYMAPEVLLGKGYYSEK 174
Query: 739 SDVYSFGVLMLEL 751
SD++S GV++ EL
Sbjct: 175 SDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 174 bits (443), Expect = 4e-49
Identities = 87/285 (30%), Positives = 136/285 (47%), Gaps = 56/285 (19%)
Query: 564 GSGGYGKVYKGTL-----PNGQLIAIKRAQQGSMQGG-QEFKMEIELLSRVHHKNLVSLL 617
G G +G+VYKGTL +A+K ++G+ + +EF E ++ ++ H N+V LL
Sbjct: 8 GEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRLL 67
Query: 618 GFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPI 677
G C ++ E++P G L D L K+G +L L++AL A+G+ YL
Sbjct: 68 GVCTQGEPLYIVTEYMPGGDLLDFLR-KHGEKLTLKDLLQMALQIAKGMEYLESK---NF 123
Query: 678 IHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLD-----PEYYMT 732
+HRD+ + N L+ E L K++DFGLS+ + + + K G L PE
Sbjct: 124 VHRDLAARNCLVTENLVVKISDFGLSRDIYEDD-----YYRKRGGGKLPIKWMAPESLKD 178
Query: 733 QQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELY----------NL 781
+ T KSDV+SFGVL+ E+ T G +P Y V++ ++ Y L
Sbjct: 179 GKFTSKSDVWSFGVLLWEIFTLGEQP-----YPGMSNEEVLELLEDGYRLPRPENCPDEL 233
Query: 782 YELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDI 826
YEL+ L+C +DRPT SE+V+D+
Sbjct: 234 YELM--------------------LQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 165 bits (421), Expect = 4e-46
Identities = 66/204 (32%), Positives = 101/204 (49%), Gaps = 18/204 (8%)
Query: 563 VGSGGYGKVYKGTLP-NGQLIAIK--RAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGF 619
+G G +G VY G+L+A+K S + + + EI +LS + H N+V G
Sbjct: 8 LGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGS 67
Query: 620 CFDRGEQML-IY-EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAAR----GLSYLHELA 673
D + L I+ E+V GSL L + IR+ R GL+YLH
Sbjct: 68 ERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKY------TRQILEGLAYLHSNG 121
Query: 674 NPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQ 733
I+HRDIK +NIL+D K+ADFG +K + D E T V+GT ++ PE +
Sbjct: 122 ---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGE 178
Query: 734 QLTEKSDVYSFGVLMLELLTGRRP 757
+ +D++S G ++E+ TG+ P
Sbjct: 179 EYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 162 bits (412), Expect = 6e-45
Identities = 90/272 (33%), Positives = 126/272 (46%), Gaps = 30/272 (11%)
Query: 563 VGSGGYGKVYKGTLPN-GQLIAIK--RAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGF 619
+GSG +G VYK G+++A+K + + + Q + EI +L R+ H N+V L+
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66
Query: 620 CFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIH 679
D+ L+ E+ G L D LS G L KIAL RGL YLH IIH
Sbjct: 67 FEDKDHLYLVMEYCEGGDLFDYLS--RGGPLSEDEAKKIALQILRGLEYLHSNG---IIH 121
Query: 680 RDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQL-TEK 738
RD+K NILLDE K+ADFGL+K + + T GT Y+ PE + K
Sbjct: 122 RDLKPENILLDENGVVKIADFGLAKKL--LKSSSSLTTFVGTPWYMAPEVLLGGNGYGPK 179
Query: 739 SDVYSFGVLMLELLTGRRP-----IERGKYIVREIRTVMDKKKELYNLYELIDPTIGLST 793
DV+S GV++ ELLTG+ P I ++R I + E S
Sbjct: 180 VDVWSLGVILYELLTGKPPFSGENILDQLQLIRRI---LGPPLEFD-----EPKWSSGSE 231
Query: 794 TLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825
K DL KC+ + RPT E+++
Sbjct: 232 EAK------DLIKKCLNKDPSKRPTAEEILQH 257
|
Length = 260 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 161 bits (408), Expect = 2e-40
Identities = 116/336 (34%), Positives = 179/336 (53%), Gaps = 19/336 (5%)
Query: 3 LKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNL-KKLSNLMLVGCSFSGPIPDSIG 61
+ G++S I L + T++LSNN+ L GP+P I L L L +F+G IP G
Sbjct: 81 ISGKISSAIFRLPYIQTINLSNNQ-LSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--G 137
Query: 62 SLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAK 121
S+ L L L++N SG +P IG+ S+L LDL N L G+IP S N L+ L A
Sbjct: 138 SIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLA- 196
Query: 122 HFHFGKNQLSGSIPEKLFR-PDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLS 180
NQL G IP +L + + I++ + NNL+GE+P +G + SL + N+L+
Sbjct: 197 -----SNQLVGQIPRELGQMKSLKWIYLGY--NNLSGEIPYEIGGLTSLNHLDLVYNNLT 249
Query: 181 GPVPSNLNNLTSVNDLYLSNNKLTGAMPN-LTGLSVLSYLDMSNNSFDASEVPSWFSSMQ 239
GP+PS+L NL ++ L+L NKL+G +P + L L LD+S+NS + E+P +Q
Sbjct: 250 GPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSL-SGEIPELVIQLQ 308
Query: 240 SLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENLLV-NLQNNRI 298
+L L + + N G+IP L S+P LQ + + +N+ +G + NL V +L N +
Sbjct: 309 NLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNL 368
Query: 299 SAYTERGGAPAVNLT---LIDNPICQELGTAKGYCQ 331
+ G + NL L N + E+ + G C+
Sbjct: 369 TGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACR 404
|
Length = 968 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 143 bits (363), Expect = 2e-38
Identities = 79/268 (29%), Positives = 122/268 (45%), Gaps = 25/268 (9%)
Query: 557 FSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVS 615
F +G GG+G+VYK G+ +AIK + S + ++ EI++L + H N+V
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 616 LLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLD--WIRRLKIALGAARGLSYLHELA 673
G + E ++ EF GSL D L N L I + +GL YLH
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQ-TLTESQIA--YVCKELLKGLEYLHSNG 118
Query: 674 NPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQ 733
IIHRDIK++NILL K+ DFGLS +SD++ + GT ++ PE +
Sbjct: 119 ---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV---GTPYWMAPEVINGK 172
Query: 734 QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLST 793
K+D++S G+ +EL G+ P + + + L N + S
Sbjct: 173 PYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEK-------WSD 225
Query: 794 TLKGFEKYVDLALKCVQESGDDRPTMSE 821
K F K KC+Q++ + RPT +
Sbjct: 226 EFKDFLK------KCLQKNPEKRPTAEQ 247
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 1e-35
Identities = 112/322 (34%), Positives = 157/322 (48%), Gaps = 34/322 (10%)
Query: 3 LKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGS 62
L G + + L L L L NK L GP+P +I +L+KL +L L S SG IP+ +
Sbjct: 248 LTGPIPSSLGNLKNLQYLFLYQNK-LSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQ 306
Query: 63 LQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKH 122
LQ L +L L SN F+G++P ++ +L L L L NK GEIP + G L +L
Sbjct: 307 LQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVL----- 361
Query: 123 FHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGP 182
N L+G IPE L + +LF SN+L GE+P +LG +SL VR NS SG
Sbjct: 362 -DLSTNNLTGEIPEGLCSSGNLFKLILF-SNSLEGEIPKSLGACRSLRRVRLQDNSFSGE 419
Query: 183 VPSNLNNLTSVNDLYLSNNKLTG-------AMPNLTGLSV-----------------LSY 218
+PS L V L +SNN L G MP+L LS+ L
Sbjct: 420 LPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLEN 479
Query: 219 LDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGT 278
LD+S N F + VP S+ L L + L G+IP +L S L ++ + N+L+G
Sbjct: 480 LDLSRNQFSGA-VPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQ 538
Query: 279 LDLGTSYSENL-LVNLQNNRIS 299
+ S L ++L N++S
Sbjct: 539 IPASFSEMPVLSQLDLSQNQLS 560
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 5e-34
Identities = 106/329 (32%), Positives = 163/329 (49%), Gaps = 36/329 (10%)
Query: 3 LKGQLSGDITGLTELHTLDLSNNK-----------------------DLRGPLPTTIGNL 39
L G++ +T LT L L L++N+ +L G +P IG L
Sbjct: 176 LVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGL 235
Query: 40 KKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNK 99
L++L LV + +GPIP S+G+L+ L L L N SG +PPSI +L L LDL+DN
Sbjct: 236 TSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNS 295
Query: 100 LEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGEL 159
L GEIP L++L H N +G IP L + + L+ SN +GE+
Sbjct: 296 LSGEIPELVIQLQNLEIL------HLFSNNFTGKIPVALTSLPRLQVLQLW-SNKFSGEI 348
Query: 160 PATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMP-NLTGLSVLSY 218
P LG +L V+ N+L+G +P L + ++ L L +N L G +P +L L
Sbjct: 349 PKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRR 408
Query: 219 LDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGT 278
+ + +NSF + E+PS F+ + + L + N NL+G+I + + +P LQ + + N+ G
Sbjct: 409 VRLQDNSF-SGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGG 467
Query: 279 L--DLGTSYSENLLVNLQNNRISAYTERG 305
L G+ ENL +L N+ S R
Sbjct: 468 LPDSFGSKRLENL--DLSRNQFSGAVPRK 494
|
Length = 968 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 67/209 (32%), Positives = 104/209 (49%), Gaps = 18/209 (8%)
Query: 556 NFSDANDVGSGGYGKVYKG-TLPNGQLIAIKRAQQGSMQGGQ--EFKMEIELLSRVHHKN 612
N+ + +G G +G VYKG L G +AIK+ ++ EI+LL + H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 613 LVSLLGFCFDRGEQMLIYEFVPNGSLGDSL--SGKNGIRL--DWIRRLKIALGAARGLSY 668
+V +G +I E+ NGSL + G L ++ ++ +GL+Y
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQV------LQGLAY 114
Query: 669 LHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPE 728
LHE +IHRDIK++NIL + K+ADFG++ ++D KD V GT ++ PE
Sbjct: 115 LHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD--DASVVGTPYWMAPE 169
Query: 729 YYMTQQLTEKSDVYSFGVLMLELLTGRRP 757
+ SD++S G ++ELLTG P
Sbjct: 170 VIEMSGASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 125 bits (317), Expect = 5e-32
Identities = 77/289 (26%), Positives = 130/289 (44%), Gaps = 33/289 (11%)
Query: 561 NDVGSGGYGKVYKGTLPN-----GQLIAIKRAQQGSMQGGQ---EFKMEIELLSRVHHKN 612
+G G +GKV G+ +A+K Q +F+ EIE+L + H+N
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLN--HSGEEQHRSDFEREIEILRTLDHEN 67
Query: 613 LVSLLGFCFDRGEQ--MLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLH 670
+V G C G + LI E++P+GSL D L ++ +++ R L + +G+ YL
Sbjct: 68 IVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQ-RHRDQINLKRLLLFSSQICKGMDYLG 126
Query: 671 ELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGT--MGYLDPE 728
IHRD+ + NIL++ K++DFGL+K + + KD+ + G + + PE
Sbjct: 127 SQR---YIHRDLAARNILVESEDLVKISDFGLAKVLPED-KDYYYVKEPGESPIFWYAPE 182
Query: 729 YYMTQQLTEKSDVYSFGVLMLELLTGRRP-------IERGKYIVREIRTVMDKKKELYNL 781
T + + SDV+SFGV + EL T P R I + V L
Sbjct: 183 CLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTR-------L 235
Query: 782 YELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENIL 830
EL+ L ++ DL C + DRP+ ++++ ++ +
Sbjct: 236 LELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 133 bits (335), Expect = 1e-31
Identities = 97/317 (30%), Positives = 158/317 (49%), Gaps = 29/317 (9%)
Query: 7 LSGDITG--LTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQ 64
+G I + L TLDLSNN L G +P IG+ L L L G G IP+S+ +L
Sbjct: 130 FTGSIPRGSIPNLETLDLSNNM-LSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLT 188
Query: 65 ELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGN-------------- 110
L L+L SN G++P +G + +L W+ L N L GEIP G
Sbjct: 189 SLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNL 248
Query: 111 ----SPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLV 166
L L ++ +N+LSG IP +F LI + N+L+GE+P + +
Sbjct: 249 TGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQK-LISLDLSDNSLSGEIPELVIQL 307
Query: 167 KSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMP-NLTGLSVLSYLDMSNNS 225
++LE++ N+ +G +P L +L + L L +NK +G +P NL + L+ LD+S N+
Sbjct: 308 QNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNN 367
Query: 226 FDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSY 285
E+P S +L L++ + +L+G+IP L + L+ V ++ N +G +L + +
Sbjct: 368 L-TGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSG--ELPSEF 424
Query: 286 SENLLVN---LQNNRIS 299
++ LV + NN +
Sbjct: 425 TKLPLVYFLDISNNNLQ 441
|
Length = 968 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 7e-31
Identities = 66/201 (32%), Positives = 104/201 (51%), Gaps = 15/201 (7%)
Query: 563 VGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFD 622
+G G +G V G GQ +A+K + S Q F E +++ + H NLV LLG
Sbjct: 14 IGKGEFGDVMLGDY-RGQKVAVKCLKDDS-TAAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 623 RGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDI 682
++ E++ GSL D L + + ++L AL G+ YL E +HRD+
Sbjct: 72 GNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEE---KNFVHRDL 128
Query: 683 KSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQ--VKGTMGYLDPEYYMTQQLTEKSD 740
+ N+L+ E L AKV+DFGL+K ++ + + + VK T PE ++ + KSD
Sbjct: 129 AARNVLVSEDLVAKVSDFGLAK---EASQGQDSGKLPVKWTA----PEALREKKFSTKSD 181
Query: 741 VYSFGVLMLELLT-GRRPIER 760
V+SFG+L+ E+ + GR P R
Sbjct: 182 VWSFGILLWEIYSFGRVPYPR 202
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 9e-31
Identities = 60/206 (29%), Positives = 98/206 (47%), Gaps = 22/206 (10%)
Query: 563 VGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQ--EFKMEIELLSRVHHKNLVSLLGF 619
+G G +GKVY +G+L +K +M + + E+++L +++H N++
Sbjct: 8 IGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYES 67
Query: 620 CFDRGEQMLIYEFVPNGSLGDSLSGKNGIR--------LDWIRRLKIALGAARGLSYLHE 671
++G+ ++ E+ G L + + LDW +++ L L YLH
Sbjct: 68 FEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWF--VQLCLA----LKYLHS 121
Query: 672 LANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYM 731
I+HRDIK NI L K+ DFG+SK +S + D T V GT YL PE
Sbjct: 122 -RK--ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV-DLAKTVV-GTPYYLSPELCQ 176
Query: 732 TQQLTEKSDVYSFGVLMLELLTGRRP 757
+ KSD++S G ++ EL T + P
Sbjct: 177 NKPYNYKSDIWSLGCVLYELCTLKHP 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 1e-29
Identities = 81/276 (29%), Positives = 118/276 (42%), Gaps = 21/276 (7%)
Query: 563 VGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQE---FKMEIELLSRV-HHKNLVSLLG 618
+G G +G+VY +L+A+K + +E F EI++L+ + H N+V L
Sbjct: 8 LGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYD 65
Query: 619 FCFDRGEQMLIYEFVPNGSLGDSL-SGKNGIRLDWIRRLKIALGAARGLSYLHELANPPI 677
F D G L+ E+V GSL D L L L I L YLH I
Sbjct: 66 FFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GI 122
Query: 678 IHRDIKSSNILLDERLN-AKVADFGLSKSMSD----SEKDHITTQVKGTMGYLDPEYYM- 731
IHRDIK NILLD K+ DFGL+K + D S + + GT GY+ PE +
Sbjct: 123 IHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLG 182
Query: 732 --TQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTI 789
+ SD++S G+ + ELLTG P E G+ + EL + +
Sbjct: 183 LSLAYASSSSDIWSLGITLYELLTGLPPFE-GEKNSSATSQTLKIILELP--TPSLASPL 239
Query: 790 GLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825
S + DL K + + +R + S +
Sbjct: 240 SPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275
|
Length = 384 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 81/274 (29%), Positives = 129/274 (47%), Gaps = 26/274 (9%)
Query: 561 NDVGSGGYGKVYKGTLPN-GQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGF 619
+ +G G YG+VY+G +A+K ++ +M+ +EF E ++ + H NLV LLG
Sbjct: 12 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGV 70
Query: 620 CFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIH 679
C +I EF+ G+L D L N ++ + L +A + + YL E N IH
Sbjct: 71 CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL-EKKN--FIH 127
Query: 680 RDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQ--VKGTMGYLDPEYYMTQQLTE 737
RD+ + N L+ E KVADFGLS+ M+ D T K + + PE + +
Sbjct: 128 RDLAARNCLVGENHLVKVADFGLSRLMTG---DTYTAHAGAKFPIKWTAPESLAYNKFSI 184
Query: 738 KSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLK 796
KSDV++FGVL+ E+ T G P +L +YEL++ +
Sbjct: 185 KSDVWAFGVLLWEIATYGMSPY---------------PGIDLSQVYELLEKGYRMERPEG 229
Query: 797 GFEKYVDLALKCVQESGDDRPTMSEVVKDIENIL 830
K +L C Q + DRP+ +E+ + E +
Sbjct: 230 CPPKVYELMRACWQWNPSDRPSFAEIHQAFETMF 263
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 61/196 (31%), Positives = 98/196 (50%), Gaps = 8/196 (4%)
Query: 564 GSGGYGKVYKGTL-PNGQLIAIKRAQ-QGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCF 621
G G G VYK P G++ A+K+ G + ++ E++ L +V G +
Sbjct: 10 GQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFY 69
Query: 622 DRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRD 681
GE ++ E++ GSL D L I + IA +GL YLH + IIHRD
Sbjct: 70 KEGEISIVLEYMDGGSLADLLKKVGKIPEPVLA--YIARQILKGLDYLHTKRH--IIHRD 125
Query: 682 IKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDV 741
IK SN+L++ + K+ADFG+SK + ++ T GT+ Y+ PE + + +D+
Sbjct: 126 IKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV--GTVTYMSPERIQGESYSYAADI 183
Query: 742 YSFGVLMLELLTGRRP 757
+S G+ +LE G+ P
Sbjct: 184 WSLGLTLLECALGKFP 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 3e-29
Identities = 74/266 (27%), Positives = 134/266 (50%), Gaps = 22/266 (8%)
Query: 562 DVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCF 621
++GSG +G V+ G + +AIK ++G+M ++F E +++ ++ H LV L G C
Sbjct: 11 EIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSE-EDFIEEAQVMMKLSHPKLVQLYGVCT 69
Query: 622 DRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRD 681
+R L++EF+ +G L D L + G + L + L G++YL +IHRD
Sbjct: 70 ERSPICLVFEFMEHGCLSDYLRAQRG-KFSQETLLGMCLDVCEGMAYLESSN---VIHRD 125
Query: 682 IKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDV 741
+ + N L+ E KV+DFG+++ + D + +T K + + PE + + + KSDV
Sbjct: 126 LAARNCLVGENQVVKVSDFGMTRFVLDDQYTS-STGTKFPVKWSSPEVFSFSKYSSKSDV 184
Query: 742 YSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEK 800
+SFGVLM E+ + G+ P E R+ + + + + L P + +
Sbjct: 185 WSFGVLMWEVFSEGKTPYEN--------RSNSEVVETINAGFRLYKPRLASQSVY----- 231
Query: 801 YVDLALKCVQESGDDRPTMSEVVKDI 826
+L C +E +DRP+ S ++ +
Sbjct: 232 --ELMQHCWKERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 4e-29
Identities = 65/198 (32%), Positives = 106/198 (53%), Gaps = 12/198 (6%)
Query: 564 GSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDR 623
G+G +G+V+ GT +A+K + G+M + F E +++ ++ H LV L C +
Sbjct: 15 GAGQFGEVWMGTWNGTTKVAVKTLKPGTMSP-EAFLQEAQIMKKLRHDKLVQLYAVCSEE 73
Query: 624 GEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIK 683
++ E++ GSL D L G +L + + +A A G++YL IHRD+
Sbjct: 74 EPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLA 130
Query: 684 SSNILLDERLNAKVADFGLSKSMSDSE---KDHITTQVKGTMGYLDPEYYMTQQLTEKSD 740
+ NIL+ E L K+ADFGL++ + D E ++ +K T PE + T KSD
Sbjct: 131 ARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTA----PEAANYGRFTIKSD 186
Query: 741 VYSFGVLMLELLT-GRRP 757
V+SFG+L+ E++T GR P
Sbjct: 187 VWSFGILLTEIVTYGRVP 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 4e-29
Identities = 64/205 (31%), Positives = 103/205 (50%), Gaps = 17/205 (8%)
Query: 563 VGSGGYGKVYKG-TLPNGQLIAIK--RAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGF 619
+G G +GKVY L G+L+A+K R Q + +E E+++L + H NLV G
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67
Query: 620 CFDRGEQMLIY-EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPII 678
R E++ I+ E+ G+L + L + IR + L GL+YLH I+
Sbjct: 68 EVHR-EKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQL--LEGLAYLHSHG---IV 121
Query: 679 HRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMG---YLDPEYYMTQQL 735
HRDIK +NI LD K+ DFG + + ++ + +V+ G Y+ PE +
Sbjct: 122 HRDIKPANIFLDHNGVIKLGDFGCAVKLKNN-TTTMGEEVQSLAGTPAYMAPEVITGGKG 180
Query: 736 TEK---SDVYSFGVLMLELLTGRRP 757
+D++S G ++LE+ TG+RP
Sbjct: 181 KGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 64/210 (30%), Positives = 107/210 (50%), Gaps = 17/210 (8%)
Query: 555 NNFSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFK---MEIELLSRVHH 610
++ ++G+G G V K P G+++A+K + + K E+++L + +
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINE--AIQKQILRELDILHKCNS 58
Query: 611 KNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSL-SGKNGIRLDWIRRLKIALGAARGLSYL 669
+V G ++ G+ + E++ GSL L + I + KIA+ +GL+YL
Sbjct: 59 PYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILG--KIAVAVLKGLTYL 116
Query: 670 HELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDS-EKDHITTQVKGTMGYLDPE 728
HE IIHRD+K SNIL++ R K+ DFG+S + +S K + GT Y+ PE
Sbjct: 117 HEKHK--IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFV-----GTSSYMAPE 169
Query: 729 YYMTQQLTEKSDVYSFGVLMLELLTGRRPI 758
+ KSD++S G+ ++EL TGR P
Sbjct: 170 RIQGNDYSVKSDIWSLGLSLIELATGRFPY 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 3e-28
Identities = 86/278 (30%), Positives = 132/278 (47%), Gaps = 35/278 (12%)
Query: 3 LKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGS 62
G++ ++ L LDLS N +L G +P + + L L+L S G IP S+G+
Sbjct: 344 FSGEIPKNLGKHNNLTVLDLSTN-NLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGA 402
Query: 63 LQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKH 122
+ L + L N FSG +P L +Y+LD+++N L+G I + P L ML A+
Sbjct: 403 CRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLAR- 461
Query: 123 FHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGP 182
N G LP + G K LE + RN SG
Sbjct: 462 ------------------------------NKFFGGLPDSFG-SKRLENLDLSRNQFSGA 490
Query: 183 VPSNLNNLTSVNDLYLSNNKLTGAMPN-LTGLSVLSYLDMSNNSFDASEVPSWFSSMQSL 241
VP L +L+ + L LS NKL+G +P+ L+ L LD+S+N + ++P+ FS M L
Sbjct: 491 VPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQL-SGQIPASFSEMPVL 549
Query: 242 TTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTL 279
+ L + L G+IP +L ++ L V + N L+G+L
Sbjct: 550 SQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSL 587
|
Length = 968 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 69/205 (33%), Positives = 110/205 (53%), Gaps = 8/205 (3%)
Query: 557 FSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSL 616
F+ +GSG +G+V++G N +AIK + + Q+F+ E++ L R+ HK+L+SL
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 617 LGFCFDRGEQM-LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANP 675
C GE + +I E + GSL L G L + +A A G++YL E
Sbjct: 68 FAVC-SVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEE---Q 123
Query: 676 PIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQL 735
IHRD+ + NIL+ E L KVADFGL++ + + ++++ K + PE
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV--YLSSDKKIPYKWTAPEAASHGTF 181
Query: 736 TEKSDVYSFGVLMLELLT-GRRPIE 759
+ KSDV+SFG+L+ E+ T G+ P
Sbjct: 182 STKSDVWSFGILLYEMFTYGQVPYP 206
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 3e-28
Identities = 79/280 (28%), Positives = 134/280 (47%), Gaps = 21/280 (7%)
Query: 563 VGSGGYGKV----YKGTLPN-GQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLL 617
+G G +G V Y N G+++A+K+ Q + + ++F+ EIE+L + H N+V
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 618 GFCFDRG--EQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANP 675
G C+ G L+ E++P GSL D L K+ RLD + L A +G+ YL
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYLQ-KHRERLDHRKLLLYASQICKGMEYLGSKR-- 128
Query: 676 PIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGT--MGYLDPEYYMTQ 733
+HRD+ + NIL++ K+ DFGL+K + +K++ + G + + PE
Sbjct: 129 -YVHRDLATRNILVESENRVKIGDFGLTKVLP-QDKEYYKVREPGESPIFWYAPESLTES 186
Query: 734 QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKE----LYNLYELIDPTI 789
+ + SDV+SFGV++ EL T ++ E +M K+ +Y+L EL+
Sbjct: 187 KFSVASDVWSFGVVLYELFT---YSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNG 243
Query: 790 GLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENI 829
L + + +C RP+ SE+ +E I
Sbjct: 244 RLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 4e-28
Identities = 78/282 (27%), Positives = 138/282 (48%), Gaps = 36/282 (12%)
Query: 561 NDVGSGGYGKVYKGT--LPNGQLI--AIKRAQQGSMQGG-QEFKMEIELLSRVHHKNLVS 615
++G G +G V KG + +G+ + A+K +Q + G +EF E +++++ H +V
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 616 LLGFCFDRGEQ-MLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELAN 674
L+G C +GE ML+ E P G L L + I + ++ L A A G++YL E +
Sbjct: 61 LIGVC--KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKEL--AHQVAMGMAYL-ESKH 115
Query: 675 PPIIHRDIKSSNILLDERLNAKVADFGLSKSM-SDSEKDHITTQVKGTMGYLDPE--YYM 731
+HRD+ + N+LL R AK++DFG+S+++ + S+ TT + + + PE Y
Sbjct: 116 --FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYG 173
Query: 732 TQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIG 790
+ KSDV+S+GV + E + G +P Y E++ + L + L P
Sbjct: 174 K--FSSKSDVWSYGVTLWEAFSYGAKP-----Y--GEMKGA-EVIAMLESGERLPRP--- 220
Query: 791 LSTTLKGFEKYV-DLALKCVQESGDDRPTMSEVVKDIENILQ 831
+ + + + L C + +DRPT SE+ +
Sbjct: 221 -----EECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDPE 257
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 8e-28
Identities = 83/284 (29%), Positives = 140/284 (49%), Gaps = 31/284 (10%)
Query: 559 DANDV------GSGGYGKVYKGTL--PNGQ--LIAIKRAQQGSMQGGQ-EFKMEIELLSR 607
D + V G G +G+V +G L P + +AIK + GS + +F E ++ +
Sbjct: 2 DPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQ 61
Query: 608 VHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLS 667
H N++ L G M+I E++ NGSL L +G + + + + G A G+
Sbjct: 62 FDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDG-KFTVGQLVGMLRGIASGMK 120
Query: 668 YLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDP 727
YL E+ +HRD+ + NIL++ L KV+DFGLS+ + DSE + T K + + P
Sbjct: 121 YLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAP 177
Query: 728 EYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELID 786
E ++ T SDV+SFG++M E+++ G RP Y + V+ ++ Y L +D
Sbjct: 178 EAIAYRKFTSASDVWSFGIVMWEVMSYGERP-----YWDMSNQDVIKAVEDGYRLPPPMD 232
Query: 787 PTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENIL 830
L L L C Q+ ++RPT S++V ++ ++
Sbjct: 233 CPSALY----------QLMLDCWQKDRNERPTFSQIVSTLDKMI 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 2e-27
Identities = 76/270 (28%), Positives = 127/270 (47%), Gaps = 30/270 (11%)
Query: 562 DVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCF 621
++GSG +G V+ G +AIK ++G+M +F E +++ ++ H NLV L G C
Sbjct: 11 ELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSE-DDFIEEAKVMMKLSHPNLVQLYGVCT 69
Query: 622 DRGEQMLIYEFVPNGSLGDSLSGKNGI-RLDWIRRLKIALGAARGLSYLHELANPPIIHR 680
+ ++ E++ NG L + L + G +W+ L + + YL IHR
Sbjct: 70 KQRPIFIVTEYMANGCLLNYLRERKGKLGTEWL--LDMCSDVCEAMEYLESNG---FIHR 124
Query: 681 DIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGT---MGYLDPEYYMTQQLTE 737
D+ + N L+ E KV+DFGL++ + D + T +GT + + PE + + +
Sbjct: 125 DLAARNCLVGEDNVVKVSDFGLARYVLDDQ----YTSSQGTKFPVKWAPPEVFDYSRFSS 180
Query: 738 KSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLK 796
KSDV+SFGVLM E+ + G+ P ER V++ Y LY L
Sbjct: 181 KSDVWSFGVLMWEVFSEGKMPYER-----FSNSEVVESVSAGYRLYR---------PKLA 226
Query: 797 GFEKYVDLALKCVQESGDDRPTMSEVVKDI 826
E Y + C E +DRP +++ +
Sbjct: 227 PTEVY-TIMYSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 71/205 (34%), Positives = 104/205 (50%), Gaps = 23/205 (11%)
Query: 563 VGSGGYGKVY----KGTLPNGQLIAIK--RAQQGSMQGGQEF-KMEIELLSRVHHKNLVS 615
+G G +GKV K T G+L A+K + ++ + E E +LSR++H +V
Sbjct: 1 LGKGSFGKVLLVRKKDT---GKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVK 57
Query: 616 LLGFCFDRGEQM-LIYEFVPNGSLGDSLSGKNGIRLDWIRRL--KIALGAARGLSYLHEL 672
L + F E++ L+ E+ P G L LS + + R +I L L YLH L
Sbjct: 58 LH-YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLA----LEYLHSL 112
Query: 673 ANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMT 732
II+RD+K NILLD + K+ DFGL+K +S E T GT YL PE +
Sbjct: 113 G---IIYRDLKPENILLDADGHIKLTDFGLAKELSS-EGSRTNTFC-GTPEYLAPEVLLG 167
Query: 733 QQLTEKSDVYSFGVLMLELLTGRRP 757
+ + D +S GVL+ E+LTG+ P
Sbjct: 168 KGYGKAVDWWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 3e-27
Identities = 83/281 (29%), Positives = 135/281 (48%), Gaps = 55/281 (19%)
Query: 564 GSGGYGKVYKGT-LPNGQLIAIKRA-----QQGSMQGGQEFKMEIELLSRVHHKNLVSLL 617
GSG +G VYKG +P G+ + I A ++ S + +E E +++ V H ++V LL
Sbjct: 16 GSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLL 75
Query: 618 GFCFDRGEQ-MLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGA----------ARGL 666
G C Q LI + +P G L LD++R K +G+ A+G+
Sbjct: 76 GICL--SSQVQLITQLMPLGCL-----------LDYVRNHKDNIGSQYLLNWCVQIAKGM 122
Query: 667 SYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLD 726
SYL E ++HRD+ + N+L+ + K+ DFGL+K + EK++ K + ++
Sbjct: 123 SYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMA 179
Query: 727 PEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELI 785
E + + T KSDV+S+GV + EL+T G +P E G EI +++K + L
Sbjct: 180 LESILHRIYTHKSDVWSYGVTVWELMTFGAKPYE-GIP-AVEIPDLLEKGERLPQ----- 232
Query: 786 DP---TIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVV 823
P TI + L +KC + RPT E++
Sbjct: 233 -PPICTIDVYMVL----------VKCWMIDAESRPTFKELI 262
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 76/257 (29%), Positives = 128/257 (49%), Gaps = 21/257 (8%)
Query: 563 VGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFD 622
+G+G +G+V++G N +A+K + G+M ++F E +++ ++ H L+ L C
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDP-KDFLAEAQIMKKLRHPKLIQLYAVCTL 72
Query: 623 RGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDI 682
++ E + GSL + L G G L + + +A A G++YL E N IHRD+
Sbjct: 73 EEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYL-EAQN--YIHRDL 129
Query: 683 KSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVY 742
+ N+L+ E KVADFGL++ + + + K + + PE + + + KSDV+
Sbjct: 130 AARNVLVGENNICKVADFGLARVIKEDIYEA-REGAKFPIKWTAPEAALYNRFSIKSDVW 188
Query: 743 SFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKY 801
SFG+L+ E++T GR P E+ +D+ Y + P G L
Sbjct: 189 SFGILLTEIVTYGRMPYP--GMTNAEVLQQVDQG------YRMPCPP-GCPKEL------ 233
Query: 802 VDLALKCVQESGDDRPT 818
D+ L C +E DDRPT
Sbjct: 234 YDIMLDCWKEDPDDRPT 250
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 8e-27
Identities = 70/239 (29%), Positives = 121/239 (50%), Gaps = 13/239 (5%)
Query: 556 NFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQGGQ--EFKMEIELLSRVHHKN 612
+F N +G G +G V+K + ++ A+K+ M + E E +L+++
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 613 LVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHEL 672
++ D+G+ ++ E+ NG L L + G L + + + GL++LH
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH-- 118
Query: 673 ANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMT 732
+ I+HRDIKS N+ LD N K+ D G++K +SD+ + + GT YL PE
Sbjct: 119 -SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN--TNFANTIVGTPYYLSPELCED 175
Query: 733 QQLTEKSDVYSFGVLMLELLTGRRPIE---RGKYIVREIRTVMDKKKELYN--LYELID 786
+ EKSDV++ GV++ E TG+ P + +G I++ IR V ++Y+ L +LID
Sbjct: 176 KPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLID 234
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 85/286 (29%), Positives = 132/286 (46%), Gaps = 46/286 (16%)
Query: 563 VGSGGYGKVYKGTL--PNGQLI--AIKRAQQ-GSMQGGQEFKMEIELLSRVHHKNLVSLL 617
+G G +G VY GTL +GQ I A+K + ++ ++F E ++ H N++SLL
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 618 GFCF-DRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRR----------LKIALGAARGL 666
G C G +++ ++ +G L ++IR + L A+G+
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDL-----------RNFIRSETHNPTVKDLIGFGLQVAKGM 111
Query: 667 SYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE--KDHITTQVKGTMGY 724
YL A+ +HRD+ + N +LDE KVADFGL++ + D E H T K + +
Sbjct: 112 EYL---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKW 168
Query: 725 LDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYEL 784
+ E TQ+ T KSDV+SFGVL+ EL+T RG ++ + D L L
Sbjct: 169 MALESLQTQKFTTKSDVWSFGVLLWELMT------RGAPPYPDVDS-FDITVYLLQGRRL 221
Query: 785 IDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENIL 830
+ P ++ L C + RPT SE+V IE I
Sbjct: 222 LQPEYCPDPLY-------EVMLSCWHPKPEMRPTFSELVSRIEQIF 260
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 64/210 (30%), Positives = 109/210 (51%), Gaps = 22/210 (10%)
Query: 563 VGSGGYGKVYKG-TLPNGQLIAIKRAQQGSMQGGQE----------FKMEIELLSRVHHK 611
+G G YG+VY + G+++A+K+ + + G+ + EIE L + H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 612 NLVSLLGFCFDRGEQML-IY-EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYL 669
N+V LGF + E+ L I+ E+VP GS+G L +R + GL+YL
Sbjct: 69 NIVQYLGF--ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQV--LEGLAYL 124
Query: 670 HELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEY 729
H + I+HRD+K+ N+L+D K++DFG+SK D + ++G++ ++ PE
Sbjct: 125 H---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEV 181
Query: 730 YMTQQ--LTEKSDVYSFGVLMLELLTGRRP 757
+ + K D++S G ++LE+ GRRP
Sbjct: 182 IHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 76/265 (28%), Positives = 121/265 (45%), Gaps = 24/265 (9%)
Query: 563 VGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGG-QEFKMEIELLSRVHHKNLVSLLGFC 620
+G G YG VYK GQ++AIK ++ QE EI +L + +V G
Sbjct: 11 LGEGSYGSVYKAIHKETGQVVAIK---VVPVEEDLQEIIKEISILKQCDSPYIVKYYGSY 67
Query: 621 FDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHR 680
F + ++ E+ GS+ D + N L I +GL YLH + IHR
Sbjct: 68 FKNTDLWIVMEYCGAGSVSDIMKITN-KTLTEEEIAAILYQTLKGLEYLH---SNKKIHR 123
Query: 681 DIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSD 740
DIK+ NILL+E AK+ADFG+S ++D+ V GT ++ PE K+D
Sbjct: 124 DIKAGNILLNEEGQAKLADFGVSGQLTDTMAK--RNTVIGTPFWMAPEVIQEIGYNNKAD 181
Query: 741 VYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEK 800
++S G+ +E+ G+ P + +R I M K P LS K +
Sbjct: 182 IWSLGITAIEMAEGKPPY-SDIHPMRAI--FMIPNK----------PPPTLSDPEKWSPE 228
Query: 801 YVDLALKCVQESGDDRPTMSEVVKD 825
+ D KC+ + ++RP+ ++++
Sbjct: 229 FNDFVKKCLVKDPEERPSAIQLLQH 253
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 63/213 (29%), Positives = 105/213 (49%), Gaps = 27/213 (12%)
Query: 563 VGSGGYGKVYKG-TLPNGQLIAIKRAQQGSMQGGQE-----FKMEIELLSRVHHKNLVSL 616
+G G YG+VYK G+L+A+K+ M+ +E EI+LL ++ H N+V L
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKI---RMENEKEGFPITAIREIKLLQKLRHPNIVRL 63
Query: 617 LGFCFD--RGEQMLIYEFVPNGSLGDSLSG---KNGIRLDWIRRLK-IALGAARGLSYLH 670
+G +++E++ + D L+G ++ ++K GL YLH
Sbjct: 64 KEIVTSKGKGSIYMVFEYMDH----D-LTGLLDSPEVKFT-ESQIKCYMKQLLEGLQYLH 117
Query: 671 ELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYY 730
I+HRDIK SNIL++ K+ADFGL++ + T +V T+ Y PE
Sbjct: 118 SNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRPPELL 173
Query: 731 M-TQQLTEKSDVYSFGVLMLELLTGRRPIERGK 762
+ + + D++S G ++ EL G +PI +G
Sbjct: 174 LGATRYGPEVDMWSVGCILAELFLG-KPIFQGS 205
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 5e-26
Identities = 64/222 (28%), Positives = 113/222 (50%), Gaps = 37/222 (16%)
Query: 563 VGSGGYGKVYKGTLPNGQ------LIAIKRAQQGSMQGGQE-FKMEIELLSRVHHKNLVS 615
+G G +GKV+ G + + L+A+K ++ + ++ F+ E ELL+ H+N+V
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 616 LLGFCFDRGEQMLIYEFVPNGSLGDSL--SGKNGIRLDWIRR----------LKIALGAA 663
G C + ++++E++ +G L L G + L L+IA+ A
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 664 RGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITT---QVKG 720
G+ Y LA+ +HRD+ + N L+ L K+ DFG+S +D TT +V G
Sbjct: 133 SGMVY---LASQHFVHRDLATRNCLVGYDLVVKIGDFGMS-------RDVYTTDYYRVGG 182
Query: 721 T----MGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRP 757
+ ++ PE M ++ T +SDV+SFGV++ E+ T G++P
Sbjct: 183 HTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 6e-26
Identities = 81/259 (31%), Positives = 130/259 (50%), Gaps = 26/259 (10%)
Query: 563 VGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFD 622
+G+G +G+V+ G +AIK +QGSM + F E L+ ++ H LV L
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSP-EAFLAEANLMKQLQHPRLVRLYAVV-T 71
Query: 623 RGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDI 682
+ +I E++ NGSL D L GI+L + + +A A G++++ E N IHRD+
Sbjct: 72 QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFI-ERKN--YIHRDL 128
Query: 683 KSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQ--VKGTMGYLDPEYYMTQQLTEKSD 740
+++NIL+ E L K+ADFGL++ + D+E T + K + + PE T KSD
Sbjct: 129 RAANILVSETLCCKIADFGLARLIEDNE---YTAREGAKFPIKWTAPEAINYGTFTIKSD 185
Query: 741 VYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFE 799
V+SFG+L+ E++T GR P T + + L Y + P E
Sbjct: 186 VWSFGILLTEIVTYGRIPYPG--------MTNPEVIQNLERGYRMPRPD-------NCPE 230
Query: 800 KYVDLALKCVQESGDDRPT 818
+ +L C +E ++RPT
Sbjct: 231 ELYELMRLCWKEKPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 79/269 (29%), Positives = 135/269 (50%), Gaps = 26/269 (9%)
Query: 562 DVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCF 621
++G+G +G V G +AIK ++GSM EF E +++ ++ H+ LV L G C
Sbjct: 11 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMKLSHEKLVQLYGVCT 69
Query: 622 DRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRD 681
+ ++ E++ NG L + L ++G R + L++ G++YL + IHRD
Sbjct: 70 KQRPIYIVTEYMSNGCLLNYLR-EHGKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRD 125
Query: 682 IKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQV--KGTMGYLDPEYYMTQQLTEKS 739
+ + N L+D++ KV+DFGLS+ + D D T+ V K + + PE + + + KS
Sbjct: 126 LAARNCLVDDQGCVKVSDFGLSRYVLD---DEYTSSVGSKFPVRWSPPEVLLYSKFSSKS 182
Query: 740 DVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGF 798
DV++FGVLM E+ + G+ P ER + E + + LY P +
Sbjct: 183 DVWAFGVLMWEVYSLGKMPYER--FNNSETVEKVSQGLRLYR------PHL-------AS 227
Query: 799 EKYVDLALKCVQESGDDRPTMSEVVKDIE 827
EK + C E ++RPT +++ IE
Sbjct: 228 EKVYAIMYSCWHEKAEERPTFQQLLSSIE 256
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 85/278 (30%), Positives = 131/278 (47%), Gaps = 47/278 (16%)
Query: 563 VGSGGYGKVYKG-TLPNGQLIAIKR-----AQQGSMQGGQEFKMEIELLSRVHHKNLVSL 616
+GSG +G VY+G L +G A+K Q + ++ + EI LLS++ H N+V
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 617 LGFCFDRGEQMLIY-EFVPNGSLGDSLSGKNG------IRLDWIRRLKIALGAARGLSYL 669
LG + + + I+ E VP GSL L K G IRL + R++ GL YL
Sbjct: 68 LGTERE-EDNLYIFLELVPGGSL-AKLLKKYGSFPEPVIRL-YTRQI------LLGLEYL 118
Query: 670 HELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEY 729
H + +HRDIK +NIL+D K+ADFG++K + KG+ ++ PE
Sbjct: 119 H---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQ---VVEFSFAKSFKGSPYWMAPEV 172
Query: 730 YM-TQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPT 788
+D++S G +LE+ TG+ P + + + + + KEL P
Sbjct: 173 IAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIG--RSKEL--------PP 222
Query: 789 I--GLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVK 824
I LS K D LKC+Q RPT +E+++
Sbjct: 223 IPDHLSDEAK------DFILKCLQRDPSLRPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 2e-25
Identities = 68/218 (31%), Positives = 118/218 (54%), Gaps = 25/218 (11%)
Query: 562 DVGSGGYGKVYKGTL--PNG----QLIAIKRAQQ-GSMQGGQEFKMEIELLSRVHHKNLV 614
++G G +GKVYKG L PN +AIK ++ + QEF+ E EL+S + H N+V
Sbjct: 12 ELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIV 71
Query: 615 SLLGFCFDRGEQMLIYEFVPNGSLGDSL------------SGKNGIR--LDWIRRLKIAL 660
LLG C +++E++ +G L + L SG ++ LD L IA+
Sbjct: 72 CLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAI 131
Query: 661 GAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKG 720
A G+ Y L++ +HRD+ + N L+ E L K++DFGLS+ + ++ + ++
Sbjct: 132 QIAAGMEY---LSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLL 188
Query: 721 TMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRP 757
+ ++ PE + + T +SD++SFGV++ E+ + G +P
Sbjct: 189 PVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 4e-25
Identities = 75/276 (27%), Positives = 123/276 (44%), Gaps = 33/276 (11%)
Query: 562 DVGSGGYGKVYKGTL--PNGQLI--AIKRAQQGSMQGG-QEFKMEIELLSRVHHKNLVSL 616
+G G +G V +G G++I A+K + + +F E ++ + H+NL+ L
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 617 LGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRL-KIALGAARGLSYLHELANP 675
G M++ E P GSL D L K+ + I L A+ A G+ YL
Sbjct: 62 YGVVLTH-PLMMVTELAPLGSLLDRLR-KDALGHFLISTLCDYAVQIANGMRYLES---K 116
Query: 676 PIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQ--VKGTMGYLDPEYYMTQ 733
IHRD+ + NILL K+ DFGL +++ +DH + +K + PE T+
Sbjct: 117 RFIHRDLAARNILLASDDKVKIGDFGLMRALPQ-NEDHYVMEEHLKVPFAWCAPESLRTR 175
Query: 734 QLTEKSDVYSFGVLMLELLT-GRRPIE--RGKYIVREIRTVMDKKKELYNLYELIDPTIG 790
+ SDV+ FGV + E+ T G P G I+++I DK+ E L P
Sbjct: 176 TFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI----DKEGER-----LERPE-- 224
Query: 791 LSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDI 826
+ ++ L+C + DRPT + + + +
Sbjct: 225 -----ACPQDIYNVMLQCWAHNPADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 4e-25
Identities = 66/197 (33%), Positives = 100/197 (50%), Gaps = 13/197 (6%)
Query: 563 VGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQG-GQEFKMEIELLSRVHHKNLVSLLGFCF 621
+G G +G VYKG L +A+K + ++F E E+L + H N+V L+G C
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV 62
Query: 622 DRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRD 681
+ ++ E VP GSL L K RL + L+++L AA G+ YL E N IHRD
Sbjct: 63 QKQPIYIVMELVPGGSLLTFLRKKKN-RLTVKKLLQMSLDAAAGMEYL-ESKN--CIHRD 118
Query: 682 IKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGT----MGYLDPEYYMTQQLTE 737
+ + N L+ E K++DFG MS E+ I T G + + PE + T
Sbjct: 119 LAARNCLVGENNVLKISDFG----MSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTS 174
Query: 738 KSDVYSFGVLMLELLTG 754
+SDV+S+G+L+ E +
Sbjct: 175 ESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 5e-25
Identities = 64/238 (26%), Positives = 100/238 (42%), Gaps = 31/238 (13%)
Query: 556 NFSDANDVGSGGYGKVYKGTL-PNGQLIAIK---RAQQGSMQGGQEFKMEIELLSRVHHK 611
+F +G G +GKV ++ A+K + + + E +L ++H
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 612 NLVSLLGFCFDRGEQM-LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAAR------ 664
LV+L + F E M L+ + + G L R +++K + +
Sbjct: 61 FLVNLW-YSFQDEENMYLVVDLLLGGDL----------RYHLSQKVKFSEEQVKFWICEI 109
Query: 665 --GLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTM 722
L YLH IIHRDIK NILLDE+ + + DF ++ ++ TT GT
Sbjct: 110 VLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL---TTSTSGTP 163
Query: 723 GYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIE-RGKYIVREIRTVMDKKKELY 779
GY+ PE Q + D +S GV E L G+RP + I +IR + LY
Sbjct: 164 GYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLY 221
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 8e-25
Identities = 78/258 (30%), Positives = 133/258 (51%), Gaps = 24/258 (9%)
Query: 563 VGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFD 622
+G G +G+V+ GT +AIK + G+M + F E +++ ++ H+ LV L +
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVSE 72
Query: 623 RGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDI 682
++ E++ GSL D L G+ G L + + +A A G++Y+ + +HRD+
Sbjct: 73 E-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDL 128
Query: 683 KSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQ-VKGTMGYLDPEYYMTQQLTEKSDV 741
+++NIL+ E L KVADFGL++ + D+E + Q K + + PE + + T KSDV
Sbjct: 129 RAANILVGENLVCKVADFGLARLIEDNE--YTARQGAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 742 YSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEK 800
+SFG+L+ EL T GR P Y R V+D+ + Y + + E
Sbjct: 187 WSFGILLTELTTKGRVP-----YPGMVNREVLDQVERGYR----------MPCPPECPES 231
Query: 801 YVDLALKCVQESGDDRPT 818
DL +C ++ ++RPT
Sbjct: 232 LHDLMCQCWRKEPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 77/275 (28%), Positives = 137/275 (49%), Gaps = 26/275 (9%)
Query: 563 VGSGGYGKVYKG--TLPNGQLI--AIKRAQQGSMQGGQ-EFKMEIELLSRVHHKNLVSLL 617
+G+G +G+V G LP + I AIK + G + + +F E ++ + H N++ L
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 618 GFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPI 677
G M++ E++ NGSL D+ K+ + I+ + + G A G+ YL ++
Sbjct: 72 GVVTKSKPVMIVTEYMENGSL-DAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMG---Y 127
Query: 678 IHRDIKSSNILLDERLNAKVADFGLSKSMSDS-EKDHITTQVKGTMGYLDPEYYMTQQLT 736
+HRD+ + NIL++ L KV+DFGLS+ + D E + T K + + PE ++ T
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFT 187
Query: 737 EKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTL 795
SDV+S+G++M E+++ G RP Y + V+ +E Y L +D L
Sbjct: 188 SASDVWSYGIVMWEVMSYGERP-----YWEMSNQDVIKAIEEGYRLPAPMDCPAALHQ-- 240
Query: 796 KGFEKYVDLALKCVQESGDDRPTMSEVVKDIENIL 830
L L C Q+ ++RP ++V ++ ++
Sbjct: 241 --------LMLDCWQKDRNERPKFEQIVSILDKLI 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 2e-24
Identities = 77/272 (28%), Positives = 127/272 (46%), Gaps = 29/272 (10%)
Query: 562 DVGSGGYGKVYKGTLPN-GQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFC 620
++G G +GKVYK G A K Q S + ++F +EI++LS H N+V L
Sbjct: 12 ELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAY 71
Query: 621 FDRGEQMLIYEFVPNGSLGD-SLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIH 679
F + ++ EF G+L L + G+ IR + L++LH + +IH
Sbjct: 72 FYENKLWILIEFCDGGALDSIMLELERGLTEPQIR--YVCRQMLEALNFLH---SHKVIH 126
Query: 680 RDIKSSNILLDERLNAKVADFGLS-KSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTE- 737
RD+K+ NILL + K+ADFG+S K+ S +K T + GT ++ PE + +
Sbjct: 127 RDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRD--TFI-GTPYWMAPEVVACETFKDN 183
Query: 738 ----KSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLST 793
K+D++S G+ ++EL P ++ + L + + PT L
Sbjct: 184 PYDYKADIWSLGITLIELAQMEPP-----------HHELNPMRVLLKILKSEPPT--LDQ 230
Query: 794 TLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825
K + D C+ + DDRPT +E++K
Sbjct: 231 PSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 2e-24
Identities = 84/295 (28%), Positives = 136/295 (46%), Gaps = 51/295 (17%)
Query: 563 VGSGGYGKVYKGTLPNGQL---IAIKRAQQ-GSMQGGQEFKMEIELLSRV-HHKNLVSLL 617
+G G +G+V K + L AIKR ++ S ++F E+E+L ++ HH N+++LL
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74
Query: 618 GFCFDRGEQMLIYEFVPNGSLGD--------------SLSGKNGIRLDWIRRLKIALGAA 663
G C RG L E+ P+G+L D +++ L + L A A
Sbjct: 75 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 134
Query: 664 RGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMG 723
RG+ YL + IHRD+ + NIL+ E AK+ADFGLS+ VK TMG
Sbjct: 135 RGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQE--------VYVKKTMG 183
Query: 724 YLDPEYYMTQQL-----TEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKE 777
L + + L T SDV+S+GVL+ E+++ G P
Sbjct: 184 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY---------------CGMT 228
Query: 778 LYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 832
LYE + L L ++ DL +C +E +RP+ ++++ + +L++
Sbjct: 229 CAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 283
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 79/278 (28%), Positives = 135/278 (48%), Gaps = 38/278 (13%)
Query: 563 VGSGGYGKVYKG-TLPNGQLIAIKRAQQGSMQGGQE---------FKMEIELLSRVHHKN 612
+GSG +G VY G +G+L+A+K+ + S+ + EI LL + H+N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 613 LVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRR-LKIALGAARGLSYLHE 671
+V LG D + E+VP GS+ L+ +R ++ L +GL+YLH
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQIL---KGLNYLH- 123
Query: 672 LANPPIIHRDIKSSNILLDERLNAKVADFGLSK-----SMSDSEKDHITTQVKGTMGYLD 726
N IIHRDIK +NIL+D + K++DFG+SK S+S ++G++ ++
Sbjct: 124 --NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGA-RPSLQGSVFWMA 180
Query: 727 PEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELID 786
PE T K+D++S G L++E+LTG+ P + + ++ + E
Sbjct: 181 PEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPD-----------CTQLQAIFKIGENAS 229
Query: 787 PTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVK 824
P I + + + +D K + + RPT +E++K
Sbjct: 230 PEIPSNIS----SEAIDFLEKTFEIDHNKRPTAAELLK 263
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 3e-24
Identities = 75/275 (27%), Positives = 133/275 (48%), Gaps = 26/275 (9%)
Query: 563 VGSGGYGKVYKGTLP----NGQLIAIKRAQQG-SMQGGQEFKMEIELLSRVHHKNLVSLL 617
+G+G +G+V++G L +AIK + G + + Q+F E ++ + H N++ L
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 618 GFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPI 677
G M+I E++ NG+L L +G + + + G A G+ YL ++
Sbjct: 73 GVVTKFKPAMIITEYMENGALDKYLRDHDG-EFSSYQLVGMLRGIAAGMKYLSDMN---Y 128
Query: 678 IHRDIKSSNILLDERLNAKVADFGLSKSMSDS-EKDHITTQVKGTMGYLDPEYYMTQQLT 736
+HRD+ + NIL++ L KV+DFGLS+ + D E + T+ K + + PE ++ T
Sbjct: 129 VHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFT 188
Query: 737 EKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTL 795
SDV+SFG++M E+++ G RP Y VM + + L +D +
Sbjct: 189 SASDVWSFGIVMWEVMSFGERP-----YWDMSNHEVMKAINDGFRLPAPMDCPSAVY--- 240
Query: 796 KGFEKYVDLALKCVQESGDDRPTMSEVVKDIENIL 830
L L+C Q+ RP ++V ++ +L
Sbjct: 241 -------QLMLQCWQQDRARRPRFVDIVNLLDKLL 268
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 69/214 (32%), Positives = 107/214 (50%), Gaps = 22/214 (10%)
Query: 563 VGSGGYGKVYKGTLPN-------GQLIAIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLV 614
+GSG +G+VY+GT + +A+K ++G+ Q +EF E L+S +H N+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 615 SLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIR-----LDWIRRLKIALGAARGLSYL 669
LLG C Q +I E + G L L R L L I L A+G YL
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 670 HELANPPIIHRDIKSSNILLDE-----RLNAKVADFGLSKSMSDSEKDHITTQVKGTMGY 724
++ IHRD+ + N L+ E K+ DFGL++ + S+ + + +
Sbjct: 123 EQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRW 179
Query: 725 LDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRP 757
+ PE + + T +SDV+SFGVLM E+LT G++P
Sbjct: 180 MAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 4e-24
Identities = 80/284 (28%), Positives = 112/284 (39%), Gaps = 45/284 (15%)
Query: 555 NNFSDANDVGSGGYGKVYKGTLPNGQLI----AIKRAQQGSMQGGQEFKMEIELLSRVHH 610
+ + +G G G V K L N +I I +Q ++ E+E+
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQ--KQILRELEINKSCKS 58
Query: 611 KNLVSLLGFCFDRGEQML--IYEFVPNGSLGDSLSG---KNGIRLDWIRRLKIALGAARG 665
+V G D + E+ GSL DS+ K G R+ KIA +G
Sbjct: 59 PYIVKYYGAFLDESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGRIGEKVLGKIAESVLKG 117
Query: 666 LSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYL 725
LSYLH IIHRDIK SNILL + K+ DFG+S + +S T GT Y+
Sbjct: 118 LSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT----GTSFYM 170
Query: 726 DPEYYMTQQLTEKSDVYSFGVLMLELLTGR-----------RPIERGKYIVREIRTVMDK 774
PE + + SDV+S G+ +LE+ R PIE YIV +
Sbjct: 171 APERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKD 230
Query: 775 KKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPT 818
+ I S K F K C+++ RPT
Sbjct: 231 EPGN---------GIKWSEEFKDFIKQ------CLEKDPTRRPT 259
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 102 bits (254), Expect = 5e-24
Identities = 77/258 (29%), Positives = 133/258 (51%), Gaps = 24/258 (9%)
Query: 563 VGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFD 622
+G+G +G+V+ GT +A+K + G+M + F E +++ ++ H LV L +
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSP-ESFLEEAQIMKKLRHDKLVQLYAVVSE 72
Query: 623 RGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDI 682
++ E++ GSL D L G L + +A A G++Y+ + IHRD+
Sbjct: 73 E-PIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDL 128
Query: 683 KSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQ-VKGTMGYLDPEYYMTQQLTEKSDV 741
+S+NIL+ + L K+ADFGL++ + D+E + Q K + + PE + + T KSDV
Sbjct: 129 RSANILVGDGLVCKIADFGLARLIEDNE--YTARQGAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 742 YSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEK 800
+SFG+L+ EL+T GR P Y R V+++ + Y + D I L
Sbjct: 187 WSFGILLTELVTKGRVP-----YPGMNNREVLEQVERGYRMPCPQDCPISLH-------- 233
Query: 801 YVDLALKCVQESGDDRPT 818
+L L+C ++ ++RPT
Sbjct: 234 --ELMLQCWKKDPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 6e-24
Identities = 76/267 (28%), Positives = 131/267 (49%), Gaps = 24/267 (8%)
Query: 562 DVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCF 621
++GSG +G V+ G +AIK +G+M ++F E +++ ++ H LV L G C
Sbjct: 11 ELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSE-EDFIEEAKVMMKLSHPKLVQLYGVCT 69
Query: 622 DRGEQMLIYEFVPNGSLGDSLSGKNG-IRLDWIRRLKIALGAARGLSYLHELANPPIIHR 680
+ ++ EF+ NG L + L + G + D + L + G+ YL E + IHR
Sbjct: 70 QQKPLYIVTEFMENGCLLNYLRQRQGKLSKDML--LSMCQDVCEGMEYL-ERNS--FIHR 124
Query: 681 DIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSD 740
D+ + N L+ KV+DFG+++ + D E ++ K + + PE + + + KSD
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS-SSGAKFPVKWSPPEVFNFSKYSSKSD 183
Query: 741 VYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFE 799
V+SFGVLM E+ T G+ P E K E+ ++ + LY P + T +
Sbjct: 184 VWSFGVLMWEVFTEGKMPFE--KKSNYEVVEMISRGFRLYR------PKLASMTVYE--- 232
Query: 800 KYVDLALKCVQESGDDRPTMSEVVKDI 826
+ C E + RPT +E+++ I
Sbjct: 233 ----VMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 6e-24
Identities = 83/287 (28%), Positives = 124/287 (43%), Gaps = 36/287 (12%)
Query: 552 KYTNNFSDAND---VGSGGYGKVYKG-TLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSR 607
+Y + + + +G G YG VY L IAIK + + Q EI L S
Sbjct: 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSY 61
Query: 608 VHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAAR--- 664
+ H+N+V LG + G + E VP GSL L K G D I +
Sbjct: 62 LKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKD--NEQTIIFYTKQILE 119
Query: 665 GLSYLHELANPPIIHRDIKSSNILLDERLNA-KVADFGLSKSMSDSEKDHITTQVKGTMG 723
GL YLH+ I+HRDIK N+L++ K++DFG SK ++ + T GT+
Sbjct: 120 GLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI--NPCTETFTGTLQ 174
Query: 724 YLDPEYYMTQQ--LTEKSDVYSFGVLMLELLTGRRP-IERGKYIVREIRTVMDKKKELYN 780
Y+ PE +D++S G ++E+ TG+ P IE G+ + M K
Sbjct: 175 YMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFK------ 228
Query: 781 LYELIDPTI--GLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825
I P I LS K F L+C + D R + ++++D
Sbjct: 229 ----IHPEIPESLSAEAKNF------ILRCFEPDPDKRASAHDLLQD 265
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 8e-24
Identities = 82/296 (27%), Positives = 141/296 (47%), Gaps = 40/296 (13%)
Query: 544 CFSFEEVKKYTNNFSDANDVGSGGYGKVYKGTLP----NGQLIAIKRAQQG-SMQGGQEF 598
C EEV +G+G +G+V +G L +AIK + G + + ++F
Sbjct: 5 CVKIEEV------------IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDF 52
Query: 599 KMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKI 658
E ++ + H N++ L G M+I EF+ NG+L DS +N + I+ + +
Sbjct: 53 LSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGAL-DSFLRQNDGQFTVIQLVGM 111
Query: 659 ALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQV 718
G A G+ YL E+ +HRD+ + NIL++ L KV+DFGLS+ + D D T
Sbjct: 112 LRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSS 168
Query: 719 KG---TMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDK 774
G + + PE ++ T SDV+S+G++M E+++ G RP Y + V++
Sbjct: 169 LGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP-----YWDMSNQDVINA 223
Query: 775 KKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENIL 830
++ Y L P + T L L L C Q+ + RP ++V ++ ++
Sbjct: 224 IEQDYRL----PPPMDCPTALH------QLMLDCWQKDRNARPKFGQIVSTLDKMI 269
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 79/272 (29%), Positives = 122/272 (44%), Gaps = 27/272 (9%)
Query: 563 VGSGGYGKVYKG-TLPNGQLIAIKRAQQGSMQGGQEFKM-EIELLSRVHHKNLVSLLGFC 620
+G G VY LPN + +AIKR Q + E++ +S+ +H N+V
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF 68
Query: 621 FDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIAL---GAARGLSYLHELANPPI 677
E L+ ++ GSL D + K+ + IA +GL YLH
Sbjct: 69 VVGDELWLVMPYLSGGSLLDIM--KSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ--- 123
Query: 678 IHRDIKSSNILLDERLNAKVADFGLSKSMSDS--EKDHITTQVKGTMGYLDPEYYMTQQ- 734
IHRDIK+ NILL E + K+ADFG+S S++D + GT ++ PE M Q
Sbjct: 124 IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPE-VMEQVH 182
Query: 735 -LTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLST 793
K+D++SFG+ +EL TG P KY ++ L + P++
Sbjct: 183 GYDFKADIWSFGITAIELATGAAPYS--KYPPMKV---------LMLTLQNDPPSLETGA 231
Query: 794 TLKGFEK-YVDLALKCVQESGDDRPTMSEVVK 824
K + K + + C+Q+ RPT E++K
Sbjct: 232 DYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 4e-23
Identities = 69/213 (32%), Positives = 115/213 (53%), Gaps = 15/213 (7%)
Query: 563 VGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFD 622
+G G +G V +G GQ +A+K + Q F E +++++HHKNLV LLG
Sbjct: 14 IGEGEFGAVLQGEY-TGQKVAVKNIKCDVT--AQAFLEETAVMTKLHHKNLVRLLGVILH 70
Query: 623 RGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDI 682
G ++ E + G+L + L + + I+ L+ +L A G+ YL + ++HRD+
Sbjct: 71 NG-LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDL 126
Query: 683 KSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVY 742
+ NIL+ E AKV+DFGL++ S D+ VK T PE ++ + KSDV+
Sbjct: 127 AARNILVSEDGVAKVSDFGLARVGSMG-VDNSKLPVKWTA----PEALKHKKFSSKSDVW 181
Query: 743 SFGVLMLELLT-GRRPIERGKYIVREIRTVMDK 774
S+GVL+ E+ + GR P K ++E++ ++K
Sbjct: 182 SYGVLLWEVFSYGRAPYP--KMSLKEVKECVEK 212
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 99.4 bits (247), Expect = 4e-23
Identities = 78/268 (29%), Positives = 137/268 (51%), Gaps = 24/268 (8%)
Query: 563 VGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFD 622
+G G +G+V+ GT +AIK + G+M + F E +++ ++ H LV L +
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMP-EAFLQEAQIMKKLRHDKLVPLYAVVSE 72
Query: 623 RGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDI 682
++ EF+ GSL D L +G L + + +A A G++Y+ + IHRD+
Sbjct: 73 E-PIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDL 128
Query: 683 KSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQ-VKGTMGYLDPEYYMTQQLTEKSDV 741
+++NIL+ + L K+ADFGL++ + D+E + Q K + + PE + + T KSDV
Sbjct: 129 RAANILVGDNLVCKIADFGLARLIEDNE--YTARQGAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 742 YSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEK 800
+SFG+L+ EL+T GR P + RE+ +++ Y + P G +L
Sbjct: 187 WSFGILLTELVTKGRVPYP--GMVNREVLEQVERG------YRMPCPQ-GCPESLH---- 233
Query: 801 YVDLALKCVQESGDDRPTMSEVVKDIEN 828
+L C ++ D+RPT + +E+
Sbjct: 234 --ELMKLCWKKDPDERPTFEYIQSFLED 259
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 99.2 bits (247), Expect = 8e-23
Identities = 68/207 (32%), Positives = 112/207 (54%), Gaps = 25/207 (12%)
Query: 562 DVGSGGYGKV----YKGTLPN-GQLIAIKRAQQGSMQGGQ---EFKMEIELLSRVHHKNL 613
D+G G +GKV Y N G+ +A+K + S GG + K EIE+L ++H+N+
Sbjct: 11 DLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENI 68
Query: 614 VSLLGFCFDRGEQ--MLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHE 671
V G C + G LI EF+P+GSL + L +N +++ ++LK A+ +G+ YL
Sbjct: 69 VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLP-RNKNKINLKQQLKYAVQICKGMDYL-- 125
Query: 672 LANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE-----KDHITTQVKGTMGYLD 726
+ +HRD+ + N+L++ K+ DFGL+K++ + KD + + V +
Sbjct: 126 -GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVF----WYA 180
Query: 727 PEYYMTQQLTEKSDVYSFGVLMLELLT 753
PE + + SDV+SFGV + ELLT
Sbjct: 181 PECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 1e-22
Identities = 74/257 (28%), Positives = 123/257 (47%), Gaps = 21/257 (8%)
Query: 563 VGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFD 622
+G+G +G+V+ G N +A+K + G+M Q F E L+ + H LV L
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSV-QAFLEEANLMKTLQHDKLVRLYAVVTK 72
Query: 623 RGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDI 682
+I E++ GSL D L G ++ + + + A G++Y+ E N IHRD+
Sbjct: 73 EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYI-ERKN--YIHRDL 129
Query: 683 KSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVY 742
+++N+L+ E L K+ADFGL++ + D+E K + + PE T KSDV+
Sbjct: 130 RAANVLVSESLMCKIADFGLARVIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVW 188
Query: 743 SFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKY 801
SFG+L+ E++T G+ P Y VM + Y + + + L +K
Sbjct: 189 SFGILLYEIVTYGKIP-----YPGMSNSDVMSALQRGYRMPRMENCPDELYDIMK----- 238
Query: 802 VDLALKCVQESGDDRPT 818
C +E ++RPT
Sbjct: 239 -----TCWKEKAEERPT 250
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 97.7 bits (243), Expect = 1e-22
Identities = 68/200 (34%), Positives = 104/200 (52%), Gaps = 13/200 (6%)
Query: 563 VGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCF- 621
+G G +G V G G +A+K + + Q F E +++++ H NLV LLG
Sbjct: 14 IGKGEFGDVMLGDY-RGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 622 DRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRD 681
++G ++ E++ GSL D L + L LK +L + YL AN +HRD
Sbjct: 71 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE--ANN-FVHRD 127
Query: 682 IKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDV 741
+ + N+L+ E AKV+DFGL+K S S +D VK T PE ++ + KSDV
Sbjct: 128 LAARNVLVSEDNVAKVSDFGLTKEAS-STQDTGKLPVKWTA----PEALREKKFSTKSDV 182
Query: 742 YSFGVLMLELLT-GRRPIER 760
+SFG+L+ E+ + GR P R
Sbjct: 183 WSFGILLWEIYSFGRVPYPR 202
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 98.1 bits (244), Expect = 1e-22
Identities = 68/274 (24%), Positives = 122/274 (44%), Gaps = 28/274 (10%)
Query: 561 NDVGSGGYGKVYKGTLPNGQLIAIKRA------QQGSMQGGQEFKMEIELLSRVHHKNLV 614
+G G YG VY G GQLIA+K+ + + ++ + E++LL + H N+V
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 615 SLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELAN 674
LG C D + EFVP GS+ L+ + G + + K G++YLH N
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILN-RFGPLPEPVFC-KYTKQILDGVAYLH---N 120
Query: 675 PPIIHRDIKSSNILLDERLNAKVADFGLSKSMS----DSEKDHITTQVKGTMGYLDPEYY 730
++HRDIK +N++L K+ DFG ++ ++ ++ + GT ++ PE
Sbjct: 121 NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVI 180
Query: 731 MTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIG 790
KSD++S G + E+ TG+ P+ MD+ ++ +
Sbjct: 181 NESGYGRKSDIWSIGCTVFEMATGKPPLAS-----------MDRLAAMFYIGAHRGLMPR 229
Query: 791 LSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVK 824
L + +D C+ +RP+ ++++
Sbjct: 230 LPDSFSA--AAIDFVTSCLTRDQHERPSALQLLR 261
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 2e-22
Identities = 73/203 (35%), Positives = 106/203 (52%), Gaps = 16/203 (7%)
Query: 564 GSGGYGKVYK-GTLPNGQLIAIKRAQQGSM-QGGQEFKM-EIELLSRVHHKNLVSLLGFC 620
G G YG VYK L + Q A+K GSM Q +E + EI +L+ V+H N++S
Sbjct: 9 GKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAF 68
Query: 621 FDRGEQMLIYEFVPNGSLGDSLS----GKNGIRLDWIRRLKIALGAARGLSYLHELANPP 676
D + ++ E+ P G L ++S + I I R+ I L RGL LHE
Sbjct: 69 LDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQL--LRGLQALHEQK--- 123
Query: 677 IIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLT 736
I+HRD+KS+NILL K+ D G+SK + K+ TQ+ GT Y+ PE + + +
Sbjct: 124 ILHRDLKSANILLVANDLVKIGDLGISKVLK---KNMAKTQI-GTPHYMAPEVWKGRPYS 179
Query: 737 EKSDVYSFGVLMLELLTGRRPIE 759
KSD++S G L+ E+ T P E
Sbjct: 180 YKSDIWSLGCLLYEMATFAPPFE 202
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 3e-22
Identities = 74/288 (25%), Positives = 134/288 (46%), Gaps = 58/288 (20%)
Query: 563 VGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGG------QEFKMEIELLSRVHHKNLVS 615
+G+G + Y+ + G L+A+K+ + + EI L++R++H +++
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 616 LLGFCFDRGEQMLIYEFVPNGSLGDSLSG----KNGIRLDWIRRLKIALGAARGLSYLHE 671
+LG + L E++ GS+ LS K + +++ +L RGLSYLHE
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQL------LRGLSYLHE 121
Query: 672 LANPPIIHRDIKSSNILLD---ERLNAKVADFGLSKSMSD--SEKDHITTQVKGTMGYLD 726
IIHRD+K +N+L+D +RL ++ADFG + ++ + Q+ GT+ ++
Sbjct: 122 ---NQIIHRDVKGANLLIDSTGQRL--RIADFGAAARLAAKGTGAGEFQGQLLGTIAFMA 176
Query: 727 PEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELI- 785
PE +Q DV+S G +++E+ T + P ++ N LI
Sbjct: 177 PEVLRGEQYGRSCDVWSVGCVIIEMATAKPPW---------------NAEKHSNHLALIF 221
Query: 786 -------DPTI--GLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVK 824
P+I LS L+ D+ L+C++ +DRP E++K
Sbjct: 222 KIASATTAPSIPEHLSPGLR------DVTLRCLELQPEDRPPSRELLK 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 3e-22
Identities = 63/218 (28%), Positives = 115/218 (52%), Gaps = 25/218 (11%)
Query: 562 DVGSGGYGKVYKGTL-----PNGQLIAIKRAQQ-GSMQGGQEFKMEIELLSRVHHKNLVS 615
++G +GK+YKG L + QL+AIK + + Q EF+ E L++ +HH N+V
Sbjct: 12 ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71
Query: 616 LLGFCFDRGEQMLIYEFVPNGSLGDSL------------SGKNGI---RLDWIRRLKIAL 660
LLG +++E++ G L + L S ++G LD L IA+
Sbjct: 72 LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131
Query: 661 GAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKG 720
A G+ YL ++ +H+D+ + NIL+ E+L+ K++D GLS+ + ++ + +
Sbjct: 132 QIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188
Query: 721 TMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRP 757
+ ++ PE M + + SD++SFGV++ E+ + G +P
Sbjct: 189 PIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 3e-22
Identities = 75/204 (36%), Positives = 111/204 (54%), Gaps = 15/204 (7%)
Query: 563 VGSGGYGKVY---KGTLPN-GQLIAIKRAQQGSMQ--GGQEFKMEIELLSRVHHKNLVSL 616
+G G +GKV+ K T P+ GQL A+K ++ +++ KME ++L+ V+H +V L
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL 63
Query: 617 LGFCFD-RGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANP 675
+ F G+ LI +F+ G L LS + + ++ L A L +LH L
Sbjct: 64 -HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAEL--ALALDHLHSLG-- 118
Query: 676 PIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQL 735
II+RD+K NILLDE + K+ DFGLSK D EK GT+ Y+ PE +
Sbjct: 119 -IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK--AYSFCGTVEYMAPEVVNRRGH 175
Query: 736 TEKSDVYSFGVLMLELLTGRRPIE 759
T+ +D +SFGVLM E+LTG P +
Sbjct: 176 TQSADWWSFGVLMFEMLTGSLPFQ 199
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 3e-22
Identities = 85/292 (29%), Positives = 136/292 (46%), Gaps = 39/292 (13%)
Query: 542 ARCFSFEEVKKYTNNFSDANDVGSGGYGKVYKGT-LPNGQLIAIKR---AQQGSMQGGQE 597
A FS ++ +K F+D ++G G +G VY + +++AIK+ + + S + Q+
Sbjct: 5 AELFSKDDPEKL---FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQD 61
Query: 598 FKMEIELLSRVHHKNLVSLLGFCFDRGEQM-LIYEFVPNGSLGDSLS-GKNGIRLDWIRR 655
E+ L ++ H N + G C+ R L+ E+ GS D L K ++ I
Sbjct: 62 IIKEVRFLQQLRHPNTIEYKG-CYLREHTAWLVMEYCL-GSASDILEVHKKPLQEVEIA- 118
Query: 656 LKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHIT 715
I GA +GL+YLH IHRDIK+ NILL E K+ADFG S S+ +
Sbjct: 119 -AICHGALQGLAYLHSHER---IHRDIKAGNILLTEPGTVKLADFG-SASLVSPANSFV- 172
Query: 716 TQVKGTMGYLDPEYYMTQ---QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVM 772
GT ++ PE + Q K DV+S G+ +EL + P+ M
Sbjct: 173 ----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN-----------M 217
Query: 773 DKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVK 824
+ LY++ + PT+ + F +VD C+Q+ DRP+ E++K
Sbjct: 218 NAMSALYHIAQNDSPTLSSNDWSDYFRNFVD---SCLQKIPQDRPSSEELLK 266
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 97.3 bits (243), Expect = 4e-22
Identities = 55/230 (23%), Positives = 94/230 (40%), Gaps = 36/230 (15%)
Query: 555 NNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRA------QQGSMQGGQEFKMEIELLSR 607
++F +G G + V + AIK ++ ++ K+E E+L+R
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVK---YVKIEKEVLTR 57
Query: 608 V-HHKNLVSLLGFCF-DRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARG 665
+ H ++ L + F D + E+ PNG L + + R A
Sbjct: 58 LNGHPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRF--YAAEILLA 114
Query: 666 LSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVK------ 719
L YLH IIHRD+K NILLD+ ++ K+ DFG +K + +
Sbjct: 115 LEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQ 171
Query: 720 ------------GTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRP 757
GT Y+ PE + + SD+++ G ++ ++LTG+ P
Sbjct: 172 IEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 96.5 bits (241), Expect = 4e-22
Identities = 59/207 (28%), Positives = 89/207 (42%), Gaps = 13/207 (6%)
Query: 563 VGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKM---EIELLSRVHHKNLVSLLG 618
+G G +G V K +G+++ K G+M +E + E+ +L + H N+V
Sbjct: 8 IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTE-KEKQQLVSEVNILRELKHPNIVRYYD 66
Query: 619 FCFDRGEQML-IY-EFVPNGSLGDSLS--GKNGIRLDWIRRLKIALGAARGLSYLH--EL 672
DR Q L I E+ G L + K ++ +I L H
Sbjct: 67 RIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSD 126
Query: 673 ANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMT 732
++HRD+K +NI LD N K+ DFGL+K + + T V GT Y+ PE
Sbjct: 127 PGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL-GHDSSFAKTYV-GTPYYMSPEQLNH 184
Query: 733 QQLTEKSDVYSFGVLMLELLTGRRPIE 759
EKSD++S G L+ EL P
Sbjct: 185 MSYDEKSDIWSLGCLIYELCALSPPFT 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 4e-22
Identities = 58/202 (28%), Positives = 95/202 (47%), Gaps = 20/202 (9%)
Query: 563 VGSGGYGKVYKG-TLPNGQLIAIKRAQQGSMQGGQEFKM-------EIELLSRVHHKNLV 614
VG G YG V K G+++AIK+ + ++ + E+++L ++ H+N+V
Sbjct: 9 VGEGAYGVVLKCRNKATGEIVAIKK-----FKESEDDEDVKKTALREVKVLRQLRHENIV 63
Query: 615 SLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELAN 674
+L +G L++E+V L + G+ D +R L + ++Y H
Sbjct: 64 NLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQL--LQAIAYCHSHN- 120
Query: 675 PPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQ 734
IIHRDIK NIL+ E K+ DFG ++++ +T V T Y PE +
Sbjct: 121 --IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYV-ATRWYRAPELLVGDT 177
Query: 735 LTEKS-DVYSFGVLMLELLTGR 755
K DV++ G +M ELL G
Sbjct: 178 NYGKPVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 5e-22
Identities = 60/216 (27%), Positives = 116/216 (53%), Gaps = 23/216 (10%)
Query: 562 DVGSGGYGKVY----KGTLPNGQ--LIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVS 615
++G G +GKV+ LP L+A+K ++ S Q+F+ E ELL+ + H+++V
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 616 LLGFCFDRGEQMLIYEFVPNGSLG--------DS--LSGKNGI---RLDWIRRLKIALGA 662
G C + ++++E++ +G L D+ L+G + +L + L IA
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 663 ARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTM 722
A G+ YL L +HRD+ + N L+ + L K+ DFG+S+ + ++ + + +
Sbjct: 132 ASGMVYLASLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 188
Query: 723 GYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRP 757
++ PE + ++ T +SD++SFGV++ E+ T G++P
Sbjct: 189 RWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 6e-22
Identities = 81/268 (30%), Positives = 133/268 (49%), Gaps = 23/268 (8%)
Query: 35 TIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLS-NLYWL 93
T N ++ ++ L G + SG I +I L + ++L++N SG +P I S +L +L
Sbjct: 64 TCNNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYL 123
Query: 94 DLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKL--FRPDMVLIHVLFD 151
+L++N G IP G+ P L+ L N LSG IP + F VL
Sbjct: 124 NLSNNNFTGSIP--RGSIPNLETL------DLSNNMLSGEIPNDIGSFSSLKVLD---LG 172
Query: 152 SNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPN-L 210
N L G++P +L + SLE + N L G +P L + S+ +YL N L+G +P +
Sbjct: 173 GNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEI 232
Query: 211 TGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVM 270
GL+ L++LD+ N+ +PS ++++L L + L G IP +FS+ L ++ +
Sbjct: 233 GGLTSLNHLDLVYNNL-TGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDL 291
Query: 271 KTNELNGTLDLGTSYSENLLVNLQNNRI 298
N L+G + L++ LQN I
Sbjct: 292 SDNSLSGEI-------PELVIQLQNLEI 312
|
Length = 968 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 96.1 bits (239), Expect = 8e-22
Identities = 65/201 (32%), Positives = 106/201 (52%), Gaps = 15/201 (7%)
Query: 562 DVGSGGYGKV--YKGTLPN---GQLIAIKRAQQGSMQGGQE-FKMEIELLSRVHHKNLVS 615
+G G +GKV Y N G+++A+K ++ Q +K EI +L ++H+N+V
Sbjct: 11 VLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVK 70
Query: 616 LLGFCFDRGEQ--MLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELA 673
G C ++G + LI E+VP GSL D L K+ + L + L A G++YLH
Sbjct: 71 YKGCCSEQGGKGLQLIMEYVPLGSLRDYLP-KHKLNLAQL--LLFAQQICEGMAYLH--- 124
Query: 674 NPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDH-ITTQVKGTMGYLDPEYYMT 732
+ IHRD+ + N+LLD K+ DFGL+K++ + + + + + + E
Sbjct: 125 SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKE 184
Query: 733 QQLTEKSDVYSFGVLMLELLT 753
+ + SDV+SFGV + ELLT
Sbjct: 185 NKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 96.1 bits (240), Expect = 8e-22
Identities = 60/207 (28%), Positives = 104/207 (50%), Gaps = 12/207 (5%)
Query: 554 TNNFSDANDVGSGGYGKVYKGT-LPNGQLIAIK--RAQQGSMQGGQEFKMEIELLSRVHH 610
+ + +G G G+VYK T G+ +AIK R ++ + + EI ++ H
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKEL---IINEILIMKDCKH 74
Query: 611 KNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLH 670
N+V E ++ E++ GSL D ++ +N +R++ + + +GL YLH
Sbjct: 75 PNIVDYYDSYLVGDELWVVMEYMDGGSLTDIIT-QNFVRMNEPQIAYVCREVLQGLEYLH 133
Query: 671 ELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYY 730
+ +IHRDIKS NILL + + K+ADFG + ++ EK + V GT ++ PE
Sbjct: 134 ---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLT-KEKSKRNSVV-GTPYWMAPEVI 188
Query: 731 MTQQLTEKSDVYSFGVLMLELLTGRRP 757
+ K D++S G++ +E+ G P
Sbjct: 189 KRKDYGPKVDIWSLGIMCIEMAEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 1e-21
Identities = 59/219 (26%), Positives = 110/219 (50%), Gaps = 28/219 (12%)
Query: 562 DVGSGGYGKVYKGTLPN------GQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVS 615
++G G +GKV+ N L+A+K + ++ ++F+ E ELL+ + H+++V
Sbjct: 12 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 71
Query: 616 LLGFCFDRGEQMLIYEFVPNGSL----------------GDSLSGKNGIRLDWIRRLKIA 659
G C D ++++E++ +G L G K + L + L IA
Sbjct: 72 FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLS--QMLHIA 129
Query: 660 LGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVK 719
A G+ YL A+ +HRD+ + N L+ L K+ DFG+S+ + ++ +
Sbjct: 130 SQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 186
Query: 720 GTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRP 757
+ ++ PE M ++ T +SDV+SFGV++ E+ T G++P
Sbjct: 187 LPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 1e-21
Identities = 71/215 (33%), Positives = 106/215 (49%), Gaps = 35/215 (16%)
Query: 563 VGSGGYGKVYKGTLPNGQL---IAIKRAQQ-GSMQGGQEFKMEIELLSRV-HHKNLVSLL 617
+G G +G+V K + L AIKR ++ S ++F E+E+L ++ HH N+++LL
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 618 GFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLD--WIRR------------LKIALGAA 663
G C RG L E+ P+G+L D L + D + L A A
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122
Query: 664 RGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMG 723
RG+ YL + IHRD+ + NIL+ E AK+ADFGLS+ VK TMG
Sbjct: 123 RGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQE--------VYVKKTMG 171
Query: 724 YLDPEYYMTQQL-----TEKSDVYSFGVLMLELLT 753
L + + L T SDV+S+GVL+ E+++
Sbjct: 172 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 2e-21
Identities = 59/214 (27%), Positives = 107/214 (50%), Gaps = 21/214 (9%)
Query: 562 DVGSGGYGKVYKGTLPN------GQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVS 615
++G G +GKV+ N L+A+K + S ++F E ELL+ + H+++V
Sbjct: 12 ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVK 71
Query: 616 LLGFCFDRGEQMLIYEFVPNGSLGDSL-----------SGKNGIRLDWIRRLKIALGAAR 664
G C + ++++E++ +G L L G L + L IA A
Sbjct: 72 FYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAA 131
Query: 665 GLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGY 724
G+ YL A+ +HRD+ + N L+ E L K+ DFG+S+ + ++ + + +
Sbjct: 132 GMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRW 188
Query: 725 LDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRP 757
+ PE M ++ T +SDV+S GV++ E+ T G++P
Sbjct: 189 MPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 95.0 bits (236), Expect = 3e-21
Identities = 74/298 (24%), Positives = 133/298 (44%), Gaps = 48/298 (16%)
Query: 563 VGSGGYGKVYKGT------LPNGQLIAIKRAQQGSMQGG-QEFKMEIELLSRVHHKNLVS 615
+G G +GKV K T +A+K ++ + ++ E LL +V+H +++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 616 LLGFCFDRGEQMLIYEFVPNGSLGDSLS-----GKNGIRLDWIRR--------------- 655
L G C G +LI E+ GSL L G + + D R
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 656 --LKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDH 713
+ A +RG+ YL E+ ++HRD+ + N+L+ E K++DFGLS+ + + +
Sbjct: 128 DLISFAWQISRGMQYLAEMK---LVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184
Query: 714 ITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVM 772
++ + + ++ E T +SDV+SFGVL+ E++T G P I E
Sbjct: 185 KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG---IAPE----- 236
Query: 773 DKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENIL 830
L+ L+ + E+ +L L C ++ D RPT +++ K++E ++
Sbjct: 237 -------RLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM 287
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.1 bits (235), Expect = 4e-21
Identities = 59/208 (28%), Positives = 99/208 (47%), Gaps = 20/208 (9%)
Query: 563 VGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKM----EIELLSRVHHKNLVSLL 617
+G G YG VYK G+++A+K+ + + + G EI LL + H N+V LL
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEG--IPSTALREISLLKELKHPNIVKLL 64
Query: 618 GFCFDRGEQMLIYEFVPN--GSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANP 675
+ L++E+ D G + + I+ + L RGL+Y H
Sbjct: 65 DVIHTERKLYLVFEYCDMDLKKYLDKRPGP--LSPNLIKSIMYQL--LRGLAYCHSHR-- 118
Query: 676 PIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQL 735
I+HRD+K NIL++ K+ADFGL+++ T +V T+ Y PE + +
Sbjct: 119 -ILHRDLKPQNILINRDGVLKLADFGLARAFG-IPLRTYTHEVV-TLWYRAPEILLGSKH 175
Query: 736 TEKS-DVYSFGVLMLELLTGRRPIERGK 762
+ D++S G + E++TG +P+ G
Sbjct: 176 YSTAVDIWSVGCIFAEMITG-KPLFPGD 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 4e-21
Identities = 80/289 (27%), Positives = 138/289 (47%), Gaps = 42/289 (14%)
Query: 563 VGSGGYGKVYKGTLPN-GQLIAIKRAQQGSMQGGQEFKM-------EIELLSRVHHKNLV 614
VG G YG V K GQ++AIK+ + ++ KM EI +L ++ H+NLV
Sbjct: 9 VGEGSYGMVMKCKHKETGQIVAIKKFLES-----EDDKMVKKIAMREIRMLKQLRHENLV 63
Query: 615 SLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELAN 674
+L+ + L++EFV + L D NG LD R K RG+ + H +
Sbjct: 64 NLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNG--LDESRVRKYLFQILRGIEFCH---S 118
Query: 675 PPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQ 734
IIHRDIK NIL+ + K+ DFG +++++ + + T T Y PE +
Sbjct: 119 HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY--TDYVATRWYRAPELLVGDT 176
Query: 735 LTEKS-DVYSFGVLMLELLTGR------RPIERGKYIVREIRTVMDKKKELYNLYEL--- 784
++ D+++ G L+ E+LTG I++ +I++ + ++ + +E++ L
Sbjct: 177 KYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAG 236
Query: 785 -----IDPTIGLSTTLKGFEKY----VDLALKCVQESGDDRPTMSEVVK 824
+ L K F K +DLA +C++ DDRP+ S+++
Sbjct: 237 MRLPEVKEIEPLE---KRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 94.8 bits (235), Expect = 4e-21
Identities = 85/301 (28%), Positives = 139/301 (46%), Gaps = 35/301 (11%)
Query: 533 SGSIPQLKGARCFSFEEVKKYTNNFSDANDVGSGGYGKVY-KGTLPNGQLIAIKRAQQGS 591
+GS+ + A F E+ +K F+D ++G G +G VY + +++AIK+
Sbjct: 6 AGSLKDPEIAELFFKEDPEKL---FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSG 62
Query: 592 MQGGQEFK---MEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGI 648
Q ++++ E++ L R+ H N + G L+ E+ GS D L
Sbjct: 63 KQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL-GSASDLLEVHKK- 120
Query: 649 RLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSD 708
L + I GA +GL+YLH + +IHRDIK+ NILL E K+ADFG S S++
Sbjct: 121 PLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFG-SASIAS 176
Query: 709 SEKDHITTQVKGTMGYLDPEYYMTQ---QLTEKSDVYSFGVLMLELLTGRRPIERGKYIV 765
+ GT ++ PE + Q K DV+S G+ +EL + P+
Sbjct: 177 PANSFV-----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN----- 226
Query: 766 REIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825
M+ LY++ + PT+ + F +VD C+Q+ DRPT E++K
Sbjct: 227 ------MNAMSALYHIAQNESPTLQSNEWSDYFRNFVD---SCLQKIPQDRPTSEELLKH 277
Query: 826 I 826
+
Sbjct: 278 M 278
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 5e-21
Identities = 68/215 (31%), Positives = 106/215 (49%), Gaps = 35/215 (16%)
Query: 563 VGSGGYGKVYKGTLP---NGQLIAIKRAQQ-GSMQGGQEFKMEIELLSRV-HHKNLVSLL 617
+G G +G+V + + AIK ++ S ++F E+E+L ++ HH N+++LL
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69
Query: 618 GFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWI--------------RRLKIALGAA 663
G C +RG + E+ P G+L D L + D + L+ A A
Sbjct: 70 GACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVA 129
Query: 664 RGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMG 723
G+ YL E IHRD+ + N+L+ E L +K+ADFGLS+ VK TMG
Sbjct: 130 TGMQYLSE---KQFIHRDLAARNVLVGENLASKIADFGLSRGEE--------VYVKKTMG 178
Query: 724 YLDPEYYMTQQL-----TEKSDVYSFGVLMLELLT 753
L + + L T KSDV+SFGVL+ E+++
Sbjct: 179 RLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 93.5 bits (233), Expect = 8e-21
Identities = 56/199 (28%), Positives = 96/199 (48%), Gaps = 14/199 (7%)
Query: 563 VGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKM--EIELLSRVHHKNLVSLLGF 619
+G G +G V+K G+ +A+K+ ++GG + EI+ L H +V LL
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 620 CFDRGEQM-LIYEFVPNGSLGDSL-SGKNGIRLDWIRRLKIALGAARGLSYLHELANPPI 677
F G L+ E++P L + L + + ++ L +G++Y+H I
Sbjct: 68 -FPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRML--LKGVAYMHANG---I 120
Query: 678 IHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPE-YYMTQQLT 736
+HRD+K +N+L+ K+ADFGL++ S+ E + QV T Y PE Y ++
Sbjct: 121 MHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV-ATRWYRAPELLYGARKYD 179
Query: 737 EKSDVYSFGVLMLELLTGR 755
D+++ G + ELL G
Sbjct: 180 PGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 9e-21
Identities = 81/276 (29%), Positives = 133/276 (48%), Gaps = 36/276 (13%)
Query: 562 DVGSGGYGKVYKGT-LPNGQLIAIKR--AQQGSMQGGQEFK---MEIELLSR-VHHKNLV 614
++G G YG V K +P G ++A+KR A S QE K M++++ R V V
Sbjct: 8 ELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNS----QEQKRLLMDLDISMRSVDCPYTV 63
Query: 615 SLLGFCFDRGEQMLIYEFVPNGSLGDSLSGK---NGIRLDWIRRLKIALGAARGLSYLHE 671
+ G F G+ + E V + SL D K G+ + KIA+ + L YLH
Sbjct: 64 TFYGALFREGDVWICME-VMDTSL-DKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS 121
Query: 672 LANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMG--YLDPEY 729
+IHRD+K SN+L++ K+ DFG+S + DS I K M ++PE
Sbjct: 122 --KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPEL 179
Query: 730 YMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTI 789
+ KSDV+S G+ M+EL TGR P + K ++++ V++ +P+
Sbjct: 180 NQ-KGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVE------------EPSP 226
Query: 790 GLSTTLKGF-EKYVDLALKCVQESGDDRPTMSEVVK 824
L + F ++ D KC++++ +RP E+++
Sbjct: 227 QLPA--EKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 1e-20
Identities = 77/216 (35%), Positives = 104/216 (48%), Gaps = 21/216 (9%)
Query: 2 GLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIG 61
G+L + T L ++ LD+SNN L+G + + ++ L L L F G +PDS G
Sbjct: 415 SFSGELPSEFTKLPLVYFLDISNNN-LQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFG 473
Query: 62 SLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIP---VSDGNSPGLDMLV 118
S + L L L+ N FSG VP +G+LS L L L++NKL GEIP S LD+
Sbjct: 474 S-KRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDL-- 530
Query: 119 RAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNS 178
NQLSG IP F VL + N L+GE+P LG V+SL V N
Sbjct: 531 -------SHNQLSGQIPAS-FSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNH 582
Query: 179 LSGPVPSN----LNNLTSV--NDLYLSNNKLTGAMP 208
L G +PS N ++V N + +G P
Sbjct: 583 LHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPP 618
|
Length = 968 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 1e-20
Identities = 70/268 (26%), Positives = 127/268 (47%), Gaps = 27/268 (10%)
Query: 563 VGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFD 622
+G+G +G+V+ T +A+K + GSM + F E ++ + H LV L
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSV-EAFLAEANVMKTLQHDKLVKLHAVV-T 71
Query: 623 RGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDI 682
+ +I EF+ GSL D L G + + + + A G++++ + IHRD+
Sbjct: 72 KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDL 128
Query: 683 KSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQ-VKGTMGYLDPEYYMTQQLTEKSDV 741
+++NIL+ L K+ADFGL++ + D+E + + K + + PE T KSDV
Sbjct: 129 RAANILVSASLVCKIADFGLARVIEDNE--YTAREGAKFPIKWTAPEAINFGSFTIKSDV 186
Query: 742 YSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEK 800
+SFG+L++E++T GR P G IR + + + E+
Sbjct: 187 WSFGILLMEIVTYGRIPYP-GMSNPEVIRALERGYR--------------MPRPENCPEE 231
Query: 801 YVDLALKCVQESGDDRPT---MSEVVKD 825
++ ++C + ++RPT + V+ D
Sbjct: 232 LYNIMMRCWKNRPEERPTFEYIQSVLDD 259
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 1e-20
Identities = 77/278 (27%), Positives = 137/278 (49%), Gaps = 47/278 (16%)
Query: 563 VGSGGYGKVYKGT-LPNGQLI----AIKRAQQG-SMQGGQEFKMEIELLSRVHHKNLVSL 616
+GSG +G VYKG +P G+ + AIK ++ S + +E E +++ V + ++ L
Sbjct: 15 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 74
Query: 617 LGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGA----------ARGL 666
LG C Q LI + +P G L LD++R K +G+ A+G+
Sbjct: 75 LGICLTSTVQ-LITQLMPFGCL-----------LDYVREHKDNIGSQYLLNWCVQIAKGM 122
Query: 667 SYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLD 726
+YL E ++HRD+ + N+L+ + K+ DFGL+K + EK++ K + ++
Sbjct: 123 NYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMA 179
Query: 727 PEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELI 785
E + + T +SDV+S+GV + EL+T G +P + EI ++++K + L
Sbjct: 180 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD--GIPASEISSILEKGERL------- 230
Query: 786 DPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVV 823
P + T + Y+ + +KC D RP E++
Sbjct: 231 -PQPPICT----IDVYM-IMVKCWMIDADSRPKFRELI 262
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 1e-20
Identities = 75/284 (26%), Positives = 137/284 (48%), Gaps = 47/284 (16%)
Query: 563 VGSGGYGKVYKGT-LPNGQLIAIKRA-----QQGSMQGGQEFKMEIELLSRVHHKNLVSL 616
+GSG +G VYKG +P+G+ + I A + S + +E E +++ V + L
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 617 LGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGA----------ARGL 666
LG C Q L+ + +P G L LD++R K +G+ A+G+
Sbjct: 75 LGICLTSTVQ-LVTQLMPYGCL-----------LDYVRENKDRIGSQDLLNWCVQIAKGM 122
Query: 667 SYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLD 726
SYL E+ ++HRD+ + N+L+ + K+ DFGL++ + E ++ K + ++
Sbjct: 123 SYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMA 179
Query: 727 PEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELI 785
E + ++ T +SDV+S+GV + EL+T G +P + REI +++K + L
Sbjct: 180 LESILHRRFTHQSDVWSYGVTVWELMTFGAKPYD--GIPAREIPDLLEKGERL------- 230
Query: 786 DPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENI 829
P + T + Y+ + +KC + RP E+V + +
Sbjct: 231 -PQPPICTI----DVYM-IMVKCWMIDSECRPRFRELVDEFSRM 268
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 1e-20
Identities = 76/287 (26%), Positives = 130/287 (45%), Gaps = 46/287 (16%)
Query: 563 VGSGGYGKVYKGTL------PNGQLIAIK-RAQQGSMQGGQEFKMEIELLSRVHHKNLVS 615
+G G +G+VY+G +A+K + S Q +F ME ++S+ +H+N+V
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 616 LLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRR-----------LKIALGAAR 664
L+G F+R + ++ E + G L K+ +R + R L A A+
Sbjct: 74 LIGVSFERLPRFILLELMAGGDL------KSFLRENRPRPERPSSLTMKDLLFCARDVAK 127
Query: 665 GLSYLHELANPPIIHRDIKSSNILLDER---LNAKVADFGLSKSMSDSEKDHITTQVKGT 721
G YL E IHRDI + N LL + AK+ADFG+++ + + +
Sbjct: 128 GCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLP 184
Query: 722 MGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYN 780
+ ++ PE ++ T K+DV+SFGVL+ E+ + G P Y R + VM E
Sbjct: 185 IKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMP-----YPGRTNQEVM----EFVT 235
Query: 781 LYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIE 827
+DP G + + C Q + +DRP + +++ I+
Sbjct: 236 GGGRLDPPKGCPGPVYR------IMTDCWQHTPEDRPNFATILERIQ 276
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 2e-20
Identities = 67/215 (31%), Positives = 101/215 (46%), Gaps = 42/215 (19%)
Query: 563 VGSGGYGKVYKG-TLPNGQLIAIKRAQQGSMQGGQEFKM---EIELLSRVHHKNLVSLLG 618
+GSG YG VYK + G+L+AIK ++ G +F++ EI +L H N+V+ G
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIK---VIKLEPGDDFEIIQQEISMLKECRHPNIVAYFG 67
Query: 619 FCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIAL---GAARGLSYLHELANP 675
R + ++ E+ GSL D G + L+IA +GL+YLHE
Sbjct: 68 SYLRRDKLWIVMEYCGGGSLQDIYQVTRGP----LSELQIAYVCRETLKGLAYLHETG-- 121
Query: 676 PIIHRDIKSSNILLDERLNAKVADFG----LSKSMSDSEKDHITT---------QVKGTM 722
IHRDIK +NILL E + K+ADFG L+ +++ K I T V+
Sbjct: 122 -KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA-KRKSFIGTPYWMAPEVAAVERKG 179
Query: 723 GYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRP 757
GY K D+++ G+ +EL + P
Sbjct: 180 GY-----------DGKCDIWALGITAIELAELQPP 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 2e-20
Identities = 49/159 (30%), Positives = 79/159 (49%), Gaps = 5/159 (3%)
Query: 601 EIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIAL 660
EI +LS + H N+++ D ++ E+ G+L D + + G + L
Sbjct: 49 EIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLF 108
Query: 661 GAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKG 720
+SY+H+ I+HRDIK+ NI L + K+ DFG+SK + SE T V G
Sbjct: 109 QIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILG-SEYSMAETVV-G 163
Query: 721 TMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIE 759
T Y+ PE + KSD+++ G ++ ELLT +R +
Sbjct: 164 TPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFD 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.2 bits (227), Expect = 4e-20
Identities = 68/213 (31%), Positives = 97/213 (45%), Gaps = 27/213 (12%)
Query: 563 VGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRV-HHKNLVSLLGFC 620
+G G YGKVYK GQL+AIK +E K E +L + +H N+ + G
Sbjct: 14 IGEGTYGKVYKARHKKTGQLVAIK-IMDIIEDEEEEIKEEYNILRKYSNHPNIATFYG-A 71
Query: 621 F-------DRGEQMLIYEFVPNGSLGD----SLSGKNGIRLDWIRRLKIALGAARGLSYL 669
F + + L+ E GS+ D ++ +WI I RGL+YL
Sbjct: 72 FIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAY--ILRETLRGLAYL 129
Query: 670 HELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPE- 728
HE +IHRDIK NILL + K+ DFG+S + DS T + GT ++ PE
Sbjct: 130 HE---NKVIHRDIKGQNILLTKNAEVKLVDFGVS-AQLDSTLGRRNTFI-GTPYWMAPEV 184
Query: 729 ----YYMTQQLTEKSDVYSFGVLMLELLTGRRP 757
+SDV+S G+ +EL G+ P
Sbjct: 185 IACDEQPDASYDARSDVWSLGITAIELADGKPP 217
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.2 bits (227), Expect = 4e-20
Identities = 64/206 (31%), Positives = 104/206 (50%), Gaps = 16/206 (7%)
Query: 563 VGSGGYGKVYKG-TLPNGQLIAIKRAQQGSMQGGQEFKM---EIELLSRVHHKNLVSLLG 618
+G G YG VYK G+++AIK+ + G K EI+LL ++H N++ LL
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIP-KTALREIKLLKELNHPNIIKLLD 65
Query: 619 FCFDRGEQMLIYEFVPNGSLGDSLSGKN-GIRLDWIRRLKIALGAARGLSYLHELANPPI 677
+G+ L++EF+ + L + + G+ I+ L +GL++ H I
Sbjct: 66 VFRHKGDLYLVFEFM-DTDLYKLIKDRQRGLPESLIKSYLYQL--LQGLAFCHS-HG--I 119
Query: 678 IHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMT-QQLT 736
+HRD+K N+L++ K+ADFGL++S S T V T Y PE + + +
Sbjct: 120 LHRDLKPENLLINTEGVLKLADFGLARSF-GSPVRPYTHYV-VTRWYRAPELLLGDKGYS 177
Query: 737 EKSDVYSFGVLMLELLTGRRPIERGK 762
D++S G + ELL+ RRP+ GK
Sbjct: 178 TPVDIWSVGCIFAELLS-RRPLFPGK 202
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 4e-20
Identities = 57/205 (27%), Positives = 98/205 (47%), Gaps = 18/205 (8%)
Query: 563 VGSGGYGKVYKGTLPNG------QLIAIKRAQQGSMQGGQ-EFKMEIELLSRVHHKNLVS 615
+G G +G+V+ L+ +K Q+ + Q EF+ E+++ ++ HKN+V
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72
Query: 616 LLGFCFDRGEQMLIYEFVPNGSLGDSL----SGKNGIR---LDWIRRLKIALGAARGLSY 668
LLG C + +I E+ G L L S ++ L +++ + A G+ +
Sbjct: 73 LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132
Query: 669 LHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPE 728
L+N +HRD+ + N L+ + KV+ LSK + +SE + + +L PE
Sbjct: 133 ---LSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKL-RNALIPLRWLAPE 188
Query: 729 YYMTQQLTEKSDVYSFGVLMLELLT 753
+ KSDV+SFGVLM E+ T
Sbjct: 189 AVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 90.7 bits (226), Expect = 9e-20
Identities = 65/214 (30%), Positives = 95/214 (44%), Gaps = 37/214 (17%)
Query: 563 VGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQE---FKM--EIELLSRVHHKNLVSL 616
+G G Y VYK G+++AIK+ + G + ++ F EI+LL + H N++ L
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGL 67
Query: 617 LG-FCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAA----------RG 665
L F L++EF+ D L I+ I L A RG
Sbjct: 68 LDVFGHKSNIN-LVFEFME----TD-LEK-------VIKDKSIVLTPADIKSYMLMTLRG 114
Query: 666 LSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYL 725
L YLH I+HRD+K +N+L+ K+ADFGL++S +T QV T Y
Sbjct: 115 LEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSP-NRKMTHQVV-TRWYR 169
Query: 726 DPEYYM-TQQLTEKSDVYSFGVLMLELLTGRRPI 758
PE + D++S G + ELL R P
Sbjct: 170 APELLFGARHYGVGVDMWSVGCIFAELLL-RVPF 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.0 bits (224), Expect = 9e-20
Identities = 79/282 (28%), Positives = 126/282 (44%), Gaps = 48/282 (17%)
Query: 557 FSDANDVGSGGYGKVYKGT-LPNGQLIAIKRA------------QQGSMQGGQEFKMEIE 603
F+ +G G +G+VYK Q++AIK QQ EI+
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQ-----------EIQ 51
Query: 604 LLSRVHHKNLVSLLGFCFDRGEQM-LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGA 662
LS+ + G F +G ++ +I E+ GS D L K G +LD I
Sbjct: 52 FLSQCRSPYITKYYG-SFLKGSKLWIIMEYCGGGSCLDLL--KPG-KLDETYIAFILREV 107
Query: 663 ARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTM 722
GL YLHE IHRDIK++NILL E + K+ADFG+S ++ + T GT
Sbjct: 108 LLGLEYLHEEGK---IHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV--GTP 162
Query: 723 GYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLY 782
++ PE EK+D++S G+ +EL G P + + + L+ +
Sbjct: 163 FWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPP-----------LSDLHPMRVLFLIP 211
Query: 783 ELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVK 824
+ P++ + K F+ +V L C+ + +RP+ E++K
Sbjct: 212 KNNPPSLEGNKFSKPFKDFVSL---CLNKDPKERPSAKELLK 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 1e-19
Identities = 75/281 (26%), Positives = 137/281 (48%), Gaps = 41/281 (14%)
Query: 563 VGSGGYGKVYKGT-LPNGQLIAIKRA-----QQGSMQGGQEFKMEIELLSRVHHKNLVSL 616
+GSG +G VYKG +P G+ + I A + + EF E +++ + H +LV L
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 617 LGFCFDRGEQMLIYEFVPNGSL-------GDSLSGKNGIRLDWIRRLKIALGAARGLSYL 669
LG C Q L+ + +P+G L D++ + + L+W ++ A+G+ YL
Sbjct: 75 LGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQ--LLLNWCVQI------AKGMMYL 125
Query: 670 HELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEY 729
E ++HRD+ + N+L+ + K+ DFGL++ + EK++ K + ++ E
Sbjct: 126 EERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALEC 182
Query: 730 YMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPT 788
++ T +SDV+S+GV + EL+T G +P + REI +++K + L P
Sbjct: 183 IHYRKFTHQSDVWSYGVTIWELMTFGGKPYD--GIPTREIPDLLEKGERL--------PQ 232
Query: 789 IGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENI 829
+ T + Y+ + +KC D RP E+ + +
Sbjct: 233 PPICT----IDVYM-VMVKCWMIDADSRPKFKELAAEFSRM 268
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 1e-19
Identities = 75/269 (27%), Positives = 125/269 (46%), Gaps = 28/269 (10%)
Query: 563 VGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQ-EFKMEIELLSRVHHKNLVSLLGFCF 621
+G G +G+V+KGTL + +A+K ++ Q + +F E +L + H N+V L+G C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 622 DRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRD 681
R ++ E VP G L K L + +K AL AA G++YL E N IHRD
Sbjct: 63 QRQPIYIVMELVPGGDFLSFLRKKKD-ELKTKQLVKFALDAAAGMAYL-ESKN--CIHRD 118
Query: 682 IKSSNILLDERLNAKVADFGLSKSMSD---SEKDHITTQVKGTMGYLDPEYYMTQQLTEK 738
+ + N L+ E K++DFG+S+ D S +K T PE + + +
Sbjct: 119 LAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTA----PEALNYGRYSSE 174
Query: 739 SDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKG 797
SDV+S+G+L+ E + G P T ++++ Y + P K
Sbjct: 175 SDVWSYGILLWETFSLGVCPYPG--------MTNQQAREQVEKGYRMSCPQ-------KC 219
Query: 798 FEKYVDLALKCVQESGDDRPTMSEVVKDI 826
+ + +C ++RP SE+ K++
Sbjct: 220 PDDVYKVMQRCWDYKPENRPKFSELQKEL 248
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 2e-19
Identities = 67/199 (33%), Positives = 105/199 (52%), Gaps = 12/199 (6%)
Query: 562 DVGSGGYGKVYK-GTLPNGQLIAIKRAQQGSMQGGQ-EFKMEIELLSRVHHKNLVSLLGF 619
D+G+G G V K +P G ++A K G+ + + E++++ +VS G
Sbjct: 12 DLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGA 71
Query: 620 CFDRGEQMLIYEFVPNGSLGDSLSGKNG-IRLDWIRRLKIALGAARGLSYLHELANPPII 678
+ + EF+ GSL D + K G I ++ + KIA+ GL+YL+ + I+
Sbjct: 72 FLNENNICMCMEFMDCGSL-DRIYKKGGPIPVEILG--KIAVAVVEGLTYLYNVHR--IM 126
Query: 679 HRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEK 738
HRDIK SNIL++ R K+ DFG+S + +S D T V GT Y+ PE + T K
Sbjct: 127 HRDIKPSNILVNSRGQIKLCDFGVSGELINSIAD---TFV-GTSTYMSPERIQGGKYTVK 182
Query: 739 SDVYSFGVLMLELLTGRRP 757
SDV+S G+ ++EL G+ P
Sbjct: 183 SDVWSLGISIIELALGKFP 201
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 2e-19
Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 14/211 (6%)
Query: 555 NNFSDANDVGSGGYGKVYKG-TLPNGQLIAIKRAQQGSMQGG-----QEFKMEIELLSRV 608
N+ +G G +G+VY + G+ +A+K+ + EI+LL +
Sbjct: 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL 61
Query: 609 HHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSY 668
H+ +V G D + E++P GS+ D L G + + R K G+ Y
Sbjct: 62 QHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLK-AYGALTETVTR-KYTRQILEGVEY 119
Query: 669 LHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHIT--TQVKGTMGYLD 726
LH + I+HRDIK +NIL D N K+ DFG SK + + T V GT ++
Sbjct: 120 LH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ-TICSSGTGMKSVTGTPYWMS 175
Query: 727 PEYYMTQQLTEKSDVYSFGVLMLELLTGRRP 757
PE + K+DV+S G ++E+LT + P
Sbjct: 176 PEVISGEGYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 3e-19
Identities = 85/346 (24%), Positives = 148/346 (42%), Gaps = 39/346 (11%)
Query: 496 VVLLLLLLAGVYAYHQKRR--AEKANEQNPFAHWDMNKSSGSIPQLKGARCFSFEEVKKY 553
L+L L + R E +N W++ K ++ + ++
Sbjct: 637 GAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQ-----FFDSKVSKSITINDILSS 691
Query: 554 TNNFSDANDVGSGGYGKVYKGTLPNG--QLIAIKRAQQGSMQGGQEFKMEIELLSRVHHK 611
+ N + G G YKG Q + + S+ EI + ++ H
Sbjct: 692 LK---EENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP-----SSEIADMGKLQHP 743
Query: 612 NLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHE 671
N+V L+G C LI+E++ +L + L L W RR KIA+G A+ L +LH
Sbjct: 744 NIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHC 798
Query: 672 LANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYM 731
+P ++ ++ I++D + + L + K I++ Y+ PE
Sbjct: 799 RCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISS------AYVAPETRE 851
Query: 732 TQQLTEKSDVYSFGVLMLELLTGRRP--IERGKY--IVREIRTVMDKKKELYNLYELIDP 787
T+ +TEKSD+Y FG++++ELLTG+ P E G + IV R +L IDP
Sbjct: 852 TKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSD----CHLDMWIDP 907
Query: 788 TIGLSTTLKGFE--KYVDLALKCVQESGDDRPTMSEVVKDIENILQ 831
+I ++ E + ++LAL C RP ++V+K +E+ +
Sbjct: 908 SIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953
|
Length = 968 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 3e-19
Identities = 73/293 (24%), Positives = 128/293 (43%), Gaps = 45/293 (15%)
Query: 563 VGSGGYGKVYKGTL------PNGQLIAIKRAQQGSMQGGQEFK---MEIELLSRV-HHKN 612
+G G +G+V K +A+K + + + ++ E+E++ + HKN
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATE--KDLSDLVSEMEMMKMIGKHKN 77
Query: 613 LVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDW--------IRRLK------I 658
+++LLG C G ++ E+ +G+L D L + L
Sbjct: 78 IINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSF 137
Query: 659 ALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQV 718
A ARG+ +L A+ IHRD+ + N+L+ E K+ADFGL++ + + TT
Sbjct: 138 AYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNG 194
Query: 719 KGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKE 777
+ + ++ PE + T +SDV+SFGVL+ E+ T G P Y + + KE
Sbjct: 195 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSP-----YPGIPVEELFKLLKE 249
Query: 778 LYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENIL 830
Y + + + L L C E RPT ++V+D++ +L
Sbjct: 250 GYRM----EKPQNCTQELYH------LMRDCWHEVPSQRPTFKQLVEDLDRML 292
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 3e-19
Identities = 64/232 (27%), Positives = 111/232 (47%), Gaps = 42/232 (18%)
Query: 555 NNFSDANDVGSGGYGKVYKGTLPN---GQ---LIAIKRAQQG-SMQGGQEFKMEIELLSR 607
NN D+G G +G+V++ P + ++A+K ++ S +F+ E L++
Sbjct: 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 64
Query: 608 VHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSL--------------------SGKNG 647
H N+V LLG C L++E++ G L + L G N
Sbjct: 65 FDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNP 124
Query: 648 IRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSM- 706
+ L +L IA A G++YL E +HRD+ + N L+ E + K+ADFGLS+++
Sbjct: 125 LPLSCTEQLCIAKQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 181
Query: 707 -SD----SEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT 753
+D SE D I + ++ PE + T +SDV+++GV++ E+ +
Sbjct: 182 SADYYKASENDAIPIR------WMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 3e-19
Identities = 72/225 (32%), Positives = 108/225 (48%), Gaps = 33/225 (14%)
Query: 557 FSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKM--EIELLSRV---HH 610
+ + ++G G YG VYK L G+ +A+K+ + + G EI LL ++ H
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60
Query: 611 KNLVSLLGFC----FDRGEQM-LIYEFVPNGSLGDSLSG--KNGIRLDWIRRLKIALGAA 663
N+V LL C DR ++ L++E V + L LS K G+ + I+ L L
Sbjct: 61 PNIVRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIKDLMRQL--L 117
Query: 664 RGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMG 723
RG+ +LH I+HRD+K NIL+ K+ADFGL++ S +T+ V T+
Sbjct: 118 RGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA--LTSVVV-TLW 171
Query: 724 YLDPE-----YYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKY 763
Y PE Y T D++S G + EL RRP+ RG
Sbjct: 172 YRAPEVLLQSSYAT-----PVDMWSVGCIFAELFR-RRPLFRGTS 210
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 3e-19
Identities = 79/277 (28%), Positives = 130/277 (46%), Gaps = 37/277 (13%)
Query: 563 VGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRV-HHKNLVSLLGFC 620
VG+G YG+VYKG + GQL AIK + +E K EI +L + HH+N+ + G
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIK-VMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 72
Query: 621 FDRG-----EQM-LIYEFVPNGSLGDSLSGKNG--IRLDWIRRLKIALGAARGLSYLHEL 672
+ +Q+ L+ EF GS+ D + G ++ +WI I RGLS+LH+
Sbjct: 73 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICREILRGLSHLHQ- 129
Query: 673 ANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMT 732
+IHRDIK N+LL E K+ DFG+S + + T GT ++ PE
Sbjct: 130 --HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT--FIGTPYWMAPEVIAC 185
Query: 733 QQLTE-----KSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDP 787
+ + KSD++S G+ +E+ G P+ M + L+ + P
Sbjct: 186 DENPDATYDFKSDLWSLGITAIEMAEGAPPL-----------CDMHPMRALFLIPRNPAP 234
Query: 788 TIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVK 824
+ K F+ +++ C+ ++ RPT +++K
Sbjct: 235 RLKSKKWSKKFQSFIE---SCLVKNHSQRPTTEQLMK 268
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 3e-19
Identities = 70/214 (32%), Positives = 103/214 (48%), Gaps = 28/214 (13%)
Query: 561 NDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKM------EIELLSRVHHKNL 613
N +GSG G VYK P G+L A+K + G E + EIE+L V+H N+
Sbjct: 80 NRIGSGAGGTVYKVIHRPTGRLYALK-----VIYGNHEDTVRRQICREIEILRDVNHPNV 134
Query: 614 VSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELA 673
V GE ++ EF+ GSL + D R++ G++YLH
Sbjct: 135 VKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVARQI------LSGIAYLHRRH 188
Query: 674 NPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQ 733
I+HRDIK SN+L++ N K+ADFG+S+ ++ + D + V GT+ Y+ PE T
Sbjct: 189 ---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQT-MDPCNSSV-GTIAYMSPERINTD 243
Query: 734 QLTEK-----SDVYSFGVLMLELLTGRRPIERGK 762
D++S GV +LE GR P G+
Sbjct: 244 LNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGR 277
|
Length = 353 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 4e-19
Identities = 67/208 (32%), Positives = 104/208 (50%), Gaps = 22/208 (10%)
Query: 563 VGSGGYGKVYKG-TLPNGQLIAIKRAQ--QGSMQGGQE---FKMEIELLSRVHHKNLVSL 616
+G G +G+VY + G+ +A K+ Q S + +E + EI+LL + H+ +V
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 617 LGFCFDRGEQML--IYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELAN 674
G DR E+ L E++P GS+ D L + R+ + G+SYLH +
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQI--LEGMSYLH---S 124
Query: 675 PPIIHRDIKSSNILLDERLNAKVADFGLSKS-----MSDSEKDHITTQVKGTMGYLDPEY 729
I+HRDIK +NIL D N K+ DFG SK MS + +T GT ++ PE
Sbjct: 125 NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVT----GTPYWMSPEV 180
Query: 730 YMTQQLTEKSDVYSFGVLMLELLTGRRP 757
+ K+DV+S G ++E+LT + P
Sbjct: 181 ISGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 5e-19
Identities = 69/211 (32%), Positives = 107/211 (50%), Gaps = 23/211 (10%)
Query: 563 VGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRV-HHKNLVSLLGFC 620
VG+G YG+VYKG + GQL AIK + +E K+EI +L + HH+N+ + G
Sbjct: 24 VGNGTYGQVYKGRHVKTGQLAAIK-VMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAF 82
Query: 621 FDRG-----EQM-LIYEFVPNGSLGDSLSGKNG--IRLDWIRRLKIALGAARGLSYLHEL 672
+ +Q+ L+ EF GS+ D + G ++ DWI I RGL++LH
Sbjct: 83 IKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY--ICREILRGLAHLHA- 139
Query: 673 ANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMT 732
+IHRDIK N+LL E K+ DFG+S + D T + GT ++ PE
Sbjct: 140 --HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL-DRTVGRRNTFI-GTPYWMAPEVIAC 195
Query: 733 QQLTE-----KSDVYSFGVLMLELLTGRRPI 758
+ + +SD++S G+ +E+ G P+
Sbjct: 196 DENPDATYDYRSDIWSLGITAIEMAEGAPPL 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 5e-19
Identities = 64/282 (22%), Positives = 121/282 (42%), Gaps = 34/282 (12%)
Query: 563 VGSGGYGKVYKGTLPN------GQLIAIKRAQQ-GSMQGGQEFKMEIELLSRVHHKNLVS 615
+G G +G VY+G +AIK + SM+ EF E ++ + ++V
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 616 LLGFCFDRGEQMLIYEFVPNGSLGDSLSGK--------NGIRLDWIRRLKIALGAARGLS 667
LLG +++ E + G L L + + +++A A G++
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 668 YLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDP 727
YL +HRD+ + N ++ E L K+ DFG+++ + +++ + + ++ P
Sbjct: 134 YLAAKK---FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190
Query: 728 EYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELID 786
E T KSDV+SFGV++ E+ T +P + G ++ V+D +D
Sbjct: 191 ESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQ-GLSNEEVLKFVIDGG--------HLD 241
Query: 787 PTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIEN 828
+K ++L C Q + RPT E+V +++
Sbjct: 242 LPENCP------DKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 6e-19
Identities = 55/201 (27%), Positives = 93/201 (46%), Gaps = 12/201 (5%)
Query: 563 VGSGGYGKVYKGT--LPNGQLI--AIKRAQQGSMQG-GQEFKMEIELLSRVHHKNLVSLL 617
+G G +G VY+G P + I A+K + + ++F E ++ + H ++V L+
Sbjct: 14 IGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLI 73
Query: 618 GFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPI 677
G + ++ E P G L L N LD + + + L+YL
Sbjct: 74 GVITEN-PVWIVMELAPLGELRSYLQ-VNKYSLDLASLILYSYQLSTALAYLESKR---F 128
Query: 678 IHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTE 737
+HRDI + N+L+ K+ DFGLS+ + D + K + ++ PE ++ T
Sbjct: 129 VHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASK-GKLPIKWMAPESINFRRFTS 187
Query: 738 KSDVYSFGVLMLELLT-GRRP 757
SDV+ FGV M E+L G +P
Sbjct: 188 ASDVWMFGVCMWEILMLGVKP 208
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 9e-19
Identities = 78/284 (27%), Positives = 125/284 (44%), Gaps = 33/284 (11%)
Query: 563 VGSGGYGKVYKGTL--PNG--QLIAIK--RAQQGSMQGGQEFKMEIELLSRVHHKNLVSL 616
+G G +G V +G L +G +A+K + + +EF E + H N++ L
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 617 LGFCFDRGEQ------MLIYEFVPNGSLGDSL----SGKNGIRLDWIRRLKIALGAARGL 666
+G CF+ M+I F+ +G L L G +L LK + A G+
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 667 SYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLD 726
YL +N IHRD+ + N +L E + VADFGLSK + + K + ++
Sbjct: 127 EYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIA 183
Query: 727 PEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELID 786
E + T KSDV++FGV M E+ T RG+ + + E+Y+ L
Sbjct: 184 IESLADRVYTSKSDVWAFGVTMWEIAT------RGQTPYPGV-----ENHEIYDY--LRH 230
Query: 787 PTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENIL 830
L ++ DL C + DRPT +++ + +ENIL
Sbjct: 231 GN-RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENIL 273
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 1e-18
Identities = 52/211 (24%), Positives = 101/211 (47%), Gaps = 13/211 (6%)
Query: 563 VGSGGYGKVYKGTLPN-GQLIAIKRAQQG--SMQGGQEFKM-EIELLSRVHHKNLVSLLG 618
+G GG+G+V + G++ A K+ + + G++ + E ++L +V + +VSL
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-A 59
Query: 619 FCFDRGEQM-LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPI 677
+ F+ + + L+ + G L + R + A GL +LH+ I
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR---I 116
Query: 678 IHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTE 737
++RD+K N+LLD+ N +++D GL+ + +K GT GY+ PE +
Sbjct: 117 VYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK---IKGRAGTPGYMAPEVLQGEVYDF 173
Query: 738 KSDVYSFGVLMLELLTGRRPI-ERGKYIVRE 767
D ++ G + E++ GR P +R + + +E
Sbjct: 174 SVDWFALGCTLYEMIAGRSPFRQRKEKVEKE 204
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 1e-18
Identities = 59/197 (29%), Positives = 98/197 (49%), Gaps = 25/197 (12%)
Query: 579 GQLIAIKRAQQGSMQGGQE---FKMEIELLSRVHHKNLVSLLGFCFDRGEQ-----MLIY 630
G +AIK + + + + F+ E L +R++H N+V+LL D GE ++
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALL----DSGEAPPGLLFAVF 58
Query: 631 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILL- 689
E+VP +L + L+ L ++ L L+ H N I+HRD+K NI++
Sbjct: 59 EYVPGRTLREVLAADGA--LPAGETGRLMLQVLDALACAH---NQGIVHRDLKPQNIMVS 113
Query: 690 --DERLNAKVADFGLSKSMSDSEKDHI-----TTQVKGTMGYLDPEYYMTQQLTEKSDVY 742
R +AKV DFG+ + + TT+V GT Y PE + +T SD+Y
Sbjct: 114 QTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLY 173
Query: 743 SFGVLMLELLTGRRPIE 759
++G++ LE LTG+R ++
Sbjct: 174 AWGLIFLECLTGQRVVQ 190
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 1e-18
Identities = 63/228 (27%), Positives = 103/228 (45%), Gaps = 50/228 (21%)
Query: 555 NNFSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFK---MEIELLSRVHH 610
N+ + ++GSG G+VYK G ++A+K+ ++ + +E K M+++++ + H
Sbjct: 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK--EENKRILMDLDVVLKSHD 72
Query: 611 -KNLVS----------------LLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWI 653
+V L+ C D+ + I +P LG
Sbjct: 73 CPYIVKCYGYFITDSDVFICMELMSTCLDKLLK-RIQGPIPEDILG-------------- 117
Query: 654 RRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDH 713
K+ + + L YL E +IHRD+K SNILLD N K+ DFG+S + DS K
Sbjct: 118 ---KMTVAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRLVDS-KAK 171
Query: 714 ITTQVKGTMGYLDPEYYMTQQLTEK----SDVYSFGVLMLELLTGRRP 757
T+ G Y+ PE K +DV+S G+ ++EL TG+ P
Sbjct: 172 --TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 1e-18
Identities = 73/276 (26%), Positives = 134/276 (48%), Gaps = 39/276 (14%)
Query: 562 DVGSGGYGKVYKG-TLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFC 620
++G G +GKVYK G L A K + S + +++ +EIE+L+ +H +V LLG
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78
Query: 621 FDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLK---IALGAARGLSYLHELANPPI 677
+ G+ ++ EF P G++ + I L+ R L I + + L L L + I
Sbjct: 79 YWDGKLWIMIEFCPGGAV-------DAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKI 131
Query: 678 IHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVK----GTMGYLDPEYYMTQ 733
IHRD+K+ N+LL + K+ADFG+S K+ T Q + GT ++ PE M +
Sbjct: 132 IHRDLKAGNVLLTLDGDIKLADFGVSA------KNVKTLQRRDSFIGTPYWMAPEVVMCE 185
Query: 734 QLTE-----KSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPT 788
+ + K+D++S G+ ++E+ IE + + +R ++ K +P
Sbjct: 186 TMKDTPYDYKADIWSLGITLIEMAQ----IEPPHHELNPMRVLLKIAKS--------EPP 233
Query: 789 IGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVK 824
LS K ++ D + + + RP+ +++++
Sbjct: 234 -TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 2e-18
Identities = 55/202 (27%), Positives = 90/202 (44%), Gaps = 22/202 (10%)
Query: 566 GGYGKVY----KGTLPNGQLIAIKRAQQGSMQGGQE---FKMEIELLSRVHHKNLVSLLG 618
G +G VY + T G AIK ++ M + K E ++ V+ L
Sbjct: 7 GAFGSVYLAKKRST---GDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63
Query: 619 FCFDRGEQM-LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPI 677
+ F + + L+ E++ G + G+ DW + + G+ LH+ I
Sbjct: 64 YSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAK--QYIAEVVLGVEDLHQRG---I 118
Query: 678 IHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTE 737
IHRDIK N+L+D+ + K+ DFGLS++ +++K GT YL PE + +
Sbjct: 119 IHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKK------FVGTPDYLAPETILGVGDDK 172
Query: 738 KSDVYSFGVLMLELLTGRRPIE 759
SD +S G ++ E L G P
Sbjct: 173 MSDWWSLGCVIFEFLFGYPPFH 194
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 2e-18
Identities = 67/241 (27%), Positives = 107/241 (44%), Gaps = 41/241 (17%)
Query: 555 NNFSDANDVGSGGYGKVYKGTLPN-GQLIAIKRAQQGSMQGGQEFK---MEIELLSRVHH 610
+ D ++G G +G V K G ++A+KR + S +E K M+++++ R
Sbjct: 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIR--STVDEKEQKRLLMDLDVVMRSSD 61
Query: 611 -KNLVSLLGFCFDRG------EQMLI-----YEFV---PNGSLGDSLSGKNGIRLDWIRR 655
+V G F G E M I Y++V + + + GK
Sbjct: 62 CPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGK---------- 111
Query: 656 LKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHIT 715
IA+ + L+YL E IIHRD+K SNILLD N K+ DFG+S + DS
Sbjct: 112 --IAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAK--- 164
Query: 716 TQVKGTMGYLDPEYYMTQQLTE---KSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVM 772
T+ G Y+ PE +SDV+S G+ + E+ TG+ P + + ++ V+
Sbjct: 165 TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVV 224
Query: 773 D 773
Sbjct: 225 K 225
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 3e-18
Identities = 75/275 (27%), Positives = 125/275 (45%), Gaps = 32/275 (11%)
Query: 557 FSDANDVGSGGYGKVYKGTLPN-GQLIAIKRAQQGSMQGGQEFK---MEIELLSRVHHKN 612
F +++G G +G VY T + +++A+K+ Q ++++ E++ L ++ H N
Sbjct: 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82
Query: 613 LVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHEL 672
+ G L+ E+ GS D L L + I GA +GL+YLH
Sbjct: 83 TIEYKGCYLKEHTAWLVMEYCL-GSASDLLEVHKK-PLQEVEIAAITHGALQGLAYLHSH 140
Query: 673 ANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMT 732
+IHRDIK+ NILL E K+ADFG S S S + GT ++ PE +
Sbjct: 141 N---MIHRDIKAGNILLTEPGQVKLADFG-SASKSSPANSFV-----GTPYWMAPEVILA 191
Query: 733 Q---QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTI 789
Q K DV+S G+ +EL + P+ M+ LY++ + PT+
Sbjct: 192 MDEGQYDGKVDVWSLGITCIELAERKPPLFN-----------MNAMSALYHIAQNDSPTL 240
Query: 790 GLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVK 824
+ F +VD C+Q+ +RP +E+++
Sbjct: 241 QSNEWTDSFRGFVDY---CLQKIPQERPASAELLR 272
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 3e-18
Identities = 66/224 (29%), Positives = 110/224 (49%), Gaps = 21/224 (9%)
Query: 542 ARCFSFEEVKKYTNNFSDANDVGSGGYGKVYKGT-LPNGQLI----AIKRAQ-QGSMQGG 595
AR E++K +GSG +G V+KG +P G I AIK Q + Q
Sbjct: 1 ARILKETELRK-------LKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTF 53
Query: 596 QEFKMEIELLSRVHHKNLVSLLGFCFDRGEQM-LIYEFVPNGSLGDSLSGKNGIRLDWIR 654
QE + + + H +V LLG C G + L+ + P GSL D + LD R
Sbjct: 54 QEITDHMLAMGSLDHAYIVRLLGIC--PGASLQLVTQLSPLGSLLDHVRQHRD-SLDPQR 110
Query: 655 RLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHI 714
L + A+G+ YL E ++HR++ + NILL ++ADFG++ + +K +
Sbjct: 111 LLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYF 167
Query: 715 TTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRP 757
++ K + ++ E + + T +SDV+S+GV + E+++ G P
Sbjct: 168 YSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEP 211
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 3e-18
Identities = 74/275 (26%), Positives = 123/275 (44%), Gaps = 32/275 (11%)
Query: 557 FSDANDVGSGGYGKVYKG-TLPNGQLIAIKRAQQGSMQGGQEFK---MEIELLSRVHHKN 612
FSD ++G G +G VY + N +++AIK+ Q ++++ E+ L ++ H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 613 LVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHEL 672
+ G L+ E+ GS D L L + + GA +GL+YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKK-PLQEVEIAAVTHGALQGLAYLH-- 132
Query: 673 ANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMT 732
+ +IHRD+K+ NILL E K+ DFG + M+ + GT ++ PE +
Sbjct: 133 -SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------NXFVGTPYWMAPEVILA 185
Query: 733 Q---QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTI 789
Q K DV+S G+ +EL + P+ M+ LY++ + P +
Sbjct: 186 MDEGQYDGKVDVWSLGITCIELAERKPPLFN-----------MNAMSALYHIAQNESPAL 234
Query: 790 GLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVK 824
+ F +VD C+Q+ DRPT ++K
Sbjct: 235 QSGHWSEYFRNFVD---SCLQKIPQDRPTSEVLLK 266
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 84.6 bits (210), Expect = 5e-18
Identities = 59/199 (29%), Positives = 93/199 (46%), Gaps = 12/199 (6%)
Query: 563 VGSGGYGKVYKGTL-PNGQLIAIKRAQQGSM-QGGQE--FKMEIELLSRVHHKNLVSLLG 618
+G GG+G+V + + A+K ++ + + GQ+ E E+L +H +V L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 619 FCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPII 678
D+ ++ E+ G L L G+ ++ R IA YLH II
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILR-DRGLFDEYTARFYIA-CVVLAFEYLHNRG---II 115
Query: 679 HRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEK 738
+RD+K N+LLD K+ DFG +K + +K T GT Y+ PE + +
Sbjct: 116 YRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQK---TWTFCGTPEYVAPEIILNKGYDFS 172
Query: 739 SDVYSFGVLMLELLTGRRP 757
D +S G+L+ ELLTGR P
Sbjct: 173 VDYWSLGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 9e-18
Identities = 57/202 (28%), Positives = 102/202 (50%), Gaps = 11/202 (5%)
Query: 563 VGSGGYGKVY--KGTLPNGQLIAIKRAQQGSM--QGGQEFKMEIELLSRVHHKNLVSLLG 618
+G G +GK+Y K + + IK M + + K E+ LL+++ H N+V+
Sbjct: 8 IGEGSFGKIYLAKAKSDSEHCV-IKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFA 66
Query: 619 FCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPII 678
+ G ++ E+ G L ++ + G+ + L + + GL ++H+ I+
Sbjct: 67 SFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK---IL 123
Query: 679 HRDIKSSNILLDER-LNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTE 737
HRDIKS NI L + + AK+ DFG+++ ++DS + + GT YL PE +
Sbjct: 124 HRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME--LAYTCVGTPYYLSPEICQNRPYNN 181
Query: 738 KSDVYSFGVLMLELLTGRRPIE 759
K+D++S G ++ EL T + P E
Sbjct: 182 KTDIWSLGCVLYELCTLKHPFE 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 1e-17
Identities = 70/224 (31%), Positives = 116/224 (51%), Gaps = 25/224 (11%)
Query: 551 KKYTNNFSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKM----EIELL 605
K+ + F +G G YG+VYK G+L+A+K+ + + + G F + EI++L
Sbjct: 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEG--FPITAIREIKIL 60
Query: 606 SRVHHKNLVSL----------LGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRR 655
+++H+N+V+L L F D+G L++E++ + +G SG D I+
Sbjct: 61 RQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKS 120
Query: 656 LKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHIT 715
L GL+Y H +HRDIK SNILL+ + K+ADFGL++ + E T
Sbjct: 121 FMKQL--LEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYT 175
Query: 716 TQVKGTMGYLDPEYYMTQQL-TEKSDVYSFGVLMLELLTGRRPI 758
+V T+ Y PE + ++ DV+S G ++ EL T ++PI
Sbjct: 176 NKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFT-KKPI 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 2e-17
Identities = 63/204 (30%), Positives = 100/204 (49%), Gaps = 14/204 (6%)
Query: 563 VGSGGYGKVYKG-TLPNGQLIAIKRAQ--QGSMQGGQE---FKMEIELLSRVHHKNLVSL 616
+G G +G+VY G+ +A+K+ Q S + +E + EI+LL + H+ +V
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 617 LGFCFDRGEQML--IYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELAN 674
G D E+ L E +P GS+ D L + + R+ + G+SYLH +
Sbjct: 70 YGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQI--LEGVSYLH---S 124
Query: 675 PPIIHRDIKSSNILLDERLNAKVADFGLSKSMSD-SEKDHITTQVKGTMGYLDPEYYMTQ 733
I+HRDIK +NIL D N K+ DFG SK + V GT ++ PE +
Sbjct: 125 NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGE 184
Query: 734 QLTEKSDVYSFGVLMLELLTGRRP 757
K+D++S G ++E+LT + P
Sbjct: 185 GYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 2e-17
Identities = 70/251 (27%), Positives = 118/251 (47%), Gaps = 44/251 (17%)
Query: 601 EIELLSRV-HHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDW---IRRL 656
E+E++ + HKN+++LLG C G +I E+ G+L + L + +++ I R+
Sbjct: 70 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARV 129
Query: 657 -----------KIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKS 705
ARG+ YL A+ IHRD+ + N+L+ E K+ADFGL++
Sbjct: 130 PDEQMTFKDLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARD 186
Query: 706 MSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT--GRR----PIE 759
+++ + TT + + ++ PE + T +SDV+SFGVLM E+ T G P+E
Sbjct: 187 VNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 246
Query: 760 RGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTM 819
+++E MDK N E Y+ + C RPT
Sbjct: 247 ELFKLLKEGHR-MDKPANCTN------------------ELYM-MMRDCWHAIPSHRPTF 286
Query: 820 SEVVKDIENIL 830
++V+D++ IL
Sbjct: 287 KQLVEDLDRIL 297
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 3e-17
Identities = 74/275 (26%), Positives = 126/275 (45%), Gaps = 35/275 (12%)
Query: 557 FSDANDVGSGGYGKVYKGTLPNGQ-LIAIKRAQQGSMQGG-QEFKMEIELLSRVHHKNLV 614
F+ +G G +G+V+KG Q ++AIK + ++ + EI +LS+ +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 615 SLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELAN 674
G + +I E++ GS D L LK L +GL YLH
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEIL---KGLDYLHSEKK 122
Query: 675 PPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVK-----GTMGYLDPEY 729
IHRDIK++N+LL E+ + K+ADFG++ ++D TQ+K GT ++ PE
Sbjct: 123 ---IHRDIKAANVLLSEQGDVKLADFGVAGQLTD-------TQIKRNTFVGTPFWMAPEV 172
Query: 730 YMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTI 789
K+D++S G+ +EL G P + M + L+ + + PT+
Sbjct: 173 IQQSAYDSKADIWSLGITAIELAKGEPP-----------NSDMHPMRVLFLIPKNNPPTL 221
Query: 790 GLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVK 824
+ K F++++D C+ + RPT E++K
Sbjct: 222 TGEFS-KPFKEFID---ACLNKDPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 3e-17
Identities = 54/158 (34%), Positives = 83/158 (52%), Gaps = 8/158 (5%)
Query: 601 EIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIAL 660
E+++L + +V G + GE + E + GSL D + K G R+ KI++
Sbjct: 49 ELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAG-RIPENILGKISI 106
Query: 661 GAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKG 720
RGL+YL E I+HRD+K SNIL++ R K+ DFG+S + DS + G
Sbjct: 107 AVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVG 160
Query: 721 TMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPI 758
T Y+ PE T +SD++S G+ ++E+ GR PI
Sbjct: 161 TRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPI 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 4e-17
Identities = 65/208 (31%), Positives = 102/208 (49%), Gaps = 22/208 (10%)
Query: 563 VGSGGYGKVYKG-TLPNGQLIAIKRA--QQGSMQGGQE---FKMEIELLSRVHHKNLVSL 616
+G G +G+VY G+ +A+K+ S + +E + EI+LL + H +V
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69
Query: 617 LGFCFDRGEQML--IYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELAN 674
G D E+ L E++P GS+ D L + + RR + +G+SYLH +
Sbjct: 70 YGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQI--LQGVSYLH---S 124
Query: 675 PPIIHRDIKSSNILLDERLNAKVADFGLSKS-----MSDSEKDHITTQVKGTMGYLDPEY 729
I+HRDIK +NIL D N K+ DFG SK MS + +T GT ++ PE
Sbjct: 125 NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVT----GTPYWMSPEV 180
Query: 730 YMTQQLTEKSDVYSFGVLMLELLTGRRP 757
+ K+DV+S ++E+LT + P
Sbjct: 181 ISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 81.9 bits (203), Expect = 4e-17
Identities = 64/213 (30%), Positives = 100/213 (46%), Gaps = 31/213 (14%)
Query: 563 VGSGGYGKVY----KGTLPNGQLIAIKRAQQGSMQGG---QEFKMEIELLSRVHHKNLVS 615
+ G YG+V+ K T G + AIK ++ M + E ++LS+ +V
Sbjct: 1 ISKGAYGRVFLAKKKST---GDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVK 57
Query: 616 LLGFCFDRGEQM-LIYEFVPNGSLGDSLSGKNGIRLDWIRRL--KIALGAARGLSYLHEL 672
L + F + + L+ E++P G L L + D R +I L L YLH
Sbjct: 58 LY-YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLA----LEYLHSN 112
Query: 673 ANPPIIHRDIKSSNILLDERLNAKVADFGLSK--------SMSDSEKDHITTQVKGTMGY 724
IIHRD+K NIL+D + K+ DFGLSK +++D EK+ ++ GT Y
Sbjct: 113 G---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKE--DKRIVGTPDY 167
Query: 725 LDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRP 757
+ PE + Q ++ D +S G ++ E L G P
Sbjct: 168 IAPEVILGQGHSKTVDWWSLGCILYEFLVGIPP 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 4e-17
Identities = 59/210 (28%), Positives = 108/210 (51%), Gaps = 17/210 (8%)
Query: 562 DVGSGGYGKVYKGT--LPNGQL-IAIKRAQQGSMQGGQEFKM-EIELLSRVHHKNLVSLL 617
++GSG +G V KG + Q+ +AIK + + + ++ M E E++ ++ + +V ++
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 618 GFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIAL---GAARGLSYLHELAN 674
G C + ML+ E G L LSGK D I + + G+ YL
Sbjct: 62 GVC-EAEALMLVMEMASGGPLNKFLSGKK----DEITVSNVVELMHQVSMGMKYLEG--- 113
Query: 675 PPIIHRDIKSSNILLDERLNAKVADFGLSKSM-SDSEKDHITTQVKGTMGYLDPEYYMTQ 733
+HRD+ + N+LL + AK++DFGLSK++ +D + K + + PE +
Sbjct: 114 KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFR 173
Query: 734 QLTEKSDVYSFGVLMLELLT-GRRPIERGK 762
+ + +SDV+S+G+ M E + G++P ++ K
Sbjct: 174 KFSSRSDVWSYGITMWEAFSYGQKPYKKMK 203
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 5e-17
Identities = 67/219 (30%), Positives = 105/219 (47%), Gaps = 26/219 (11%)
Query: 556 NFSDANDVGSGGYGKVYKG-TLPNGQLIAIKRAQQGSMQGGQEFK--MEIELLSRVHHKN 612
F N +G G YG VY+ +G+++A+K+ + + + G EI LL + H N
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPN 67
Query: 613 LVSLLGFCFDRGEQM----LIYEFVPN--GSLGDSLSGKNGIRLDWIRRLK-IALGAARG 665
+V L G+ + L+ E+ SL D++ ++K + L RG
Sbjct: 68 IVELKEVVV--GKHLDSIFLVMEYCEQDLASLLDNMPTPFSES-----QVKCLMLQLLRG 120
Query: 666 LSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYL 725
L YLHE IIHRD+K SN+LL ++ K+ADFGL+++ K V T+ Y
Sbjct: 121 LQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV--TLWYR 175
Query: 726 DPE--YYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGK 762
PE T T D+++ G ++ ELL +P+ GK
Sbjct: 176 APELLLGCTTY-TTAIDMWAVGCILAELLAH-KPLLPGK 212
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 6e-17
Identities = 60/203 (29%), Positives = 97/203 (47%), Gaps = 27/203 (13%)
Query: 563 VGSGGYGKVYKGT-LPNGQLIAIKRAQQG-SMQGGQEFKMEIELLSRVHHKNLVSLLGFC 620
+G G G VYK L +++A+K +++ ++ E+E+L + ++ G
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 621 FDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRL------KIALGAARGLSYLHELAN 674
F + EF+ GSL D R++ +IA+ +GL+YL L
Sbjct: 69 FVENRISICTEFMDGGSL------------DVYRKIPEHVLGRIAVAVVKGLTYLWSLK- 115
Query: 675 PPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQ 734
I+HRD+K SN+L++ R K+ DFG+S + +S I GT Y+ PE +Q
Sbjct: 116 --ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS----IAKTYVGTNAYMAPERISGEQ 169
Query: 735 LTEKSDVYSFGVLMLELLTGRRP 757
SDV+S G+ +EL GR P
Sbjct: 170 YGIHSDVWSLGISFMELALGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 6e-17
Identities = 56/201 (27%), Positives = 96/201 (47%), Gaps = 10/201 (4%)
Query: 563 VGSGGYGKVYKGTLPNGQ-LIAIKR--AQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGF 619
VG G +G V+ Q L+ IK+ +Q + + E ++L + H N++
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67
Query: 620 CFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIH 679
+ M++ E+ P G+L + + + LD L + L ++H I+H
Sbjct: 68 FLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH---TKLILH 124
Query: 680 RDIKSSNILLDERLN-AKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEK 738
RD+K+ NILLD+ K+ DFG+SK +S K V GT Y+ PE + +K
Sbjct: 125 RDLKTQNILLDKHKMVVKIGDFGISKILSSKSK---AYTVVGTPCYISPELCEGKPYNQK 181
Query: 739 SDVYSFGVLMLELLTGRRPIE 759
SD+++ G ++ EL + +R E
Sbjct: 182 SDIWALGCVLYELASLKRAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 81.8 bits (203), Expect = 7e-17
Identities = 58/209 (27%), Positives = 93/209 (44%), Gaps = 34/209 (16%)
Query: 563 VGSGGYGKV----YKGTLPNGQLIAIKRAQQGSMQGGQEFKM--------EIELLSRVHH 610
+G+G +G+V +K +G+ A+K + + K+ E +L + H
Sbjct: 9 LGTGSFGRVMLVRHK---GSGKYYALKI-----LSKAKIVKLKQVEHVLNEKRILQSIRH 60
Query: 611 KNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIR--RLKIALGAARGLSY 668
LV+L G D L+ E+VP G L L R ++ L L Y
Sbjct: 61 PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLA----LEY 116
Query: 669 LHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPE 728
LH L I++RD+K N+LLD K+ DFG +K + T + GT YL PE
Sbjct: 117 LHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-----TYTLCGTPEYLAPE 168
Query: 729 YYMTQQLTEKSDVYSFGVLMLELLTGRRP 757
+++ + D ++ G+L+ E+L G P
Sbjct: 169 IILSKGYGKAVDWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 1e-16
Identities = 60/206 (29%), Positives = 101/206 (49%), Gaps = 10/206 (4%)
Query: 555 NNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGG--QEFKMEIELLSRVHHKN 612
++F +++G+G G V K LI ++ ++ + E+++L +
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 613 LVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHEL 672
+V G + GE + E + GSL L I + + ++ IA+ RGL+YL E
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAV--LRGLAYLRE- 121
Query: 673 ANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMT 732
I+HRD+K SNIL++ R K+ DFG+S + DS + GT Y+ PE
Sbjct: 122 -KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQG 176
Query: 733 QQLTEKSDVYSFGVLMLELLTGRRPI 758
+ +SD++S G+ ++EL GR PI
Sbjct: 177 THYSVQSDIWSMGLSLVELAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 2e-16
Identities = 59/239 (24%), Positives = 103/239 (43%), Gaps = 53/239 (22%)
Query: 563 VGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKM---------EIELLSRVHHKN 612
+GSG YG V +G+ +AIK+ F + E+++L H N
Sbjct: 13 IGSGAYGVVCSAIDTRSGKKVAIKKI-------PHAFDVPTLAKRTLRELKILRHFKHDN 65
Query: 613 LVSLLGFCFDRGEQMLIYEFVPNGSLGDS---------------LSGKNGIRLDWIRRLK 657
++++ P G+ + + + IR
Sbjct: 66 IIAIRDI------------LRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFL 113
Query: 658 IALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHIT-- 715
L RGL Y+H AN +IHRD+K SN+L++E ++ DFG+++ +S S +H
Sbjct: 114 YQL--LRGLKYIHS-AN--VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFM 168
Query: 716 TQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMD 773
T+ T Y PE ++ + T D++S G + E+L GRR + GK V +++ ++
Sbjct: 169 TEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQLFPGKNYVHQLKLILS 226
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 3e-16
Identities = 66/211 (31%), Positives = 107/211 (50%), Gaps = 31/211 (14%)
Query: 563 VGSGGYGKVYK-----GTLPNGQLIAIKRAQQGSMQGGQE----FKMEIELLSRVHHKNL 613
+G GGYGKV++ G G++ A+K ++ ++ Q+ K E +L V H +
Sbjct: 4 LGKGGYGKVFQVRKVTGA-DTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 614 VSLLGFCFDRGEQM-LIYEFVPNGSLGDSLSGKNGIRLD-----WIRRLKIALGAARGLS 667
V L+ + F G ++ LI E++ G L L + GI ++ ++ + +AL
Sbjct: 63 VDLI-YAFQTGGKLYLILEYLSGGELFMHLE-REGIFMEDTACFYLSEISLALE------ 114
Query: 668 YLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSK-SMSDSEKDHITTQVKGTMGYLD 726
+LH+ II+RD+K NILLD + + K+ DFGL K S+ + H GT+ Y+
Sbjct: 115 HLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFC---GTIEYMA 168
Query: 727 PEYYMTQQLTEKSDVYSFGVLMLELLTGRRP 757
PE M + D +S G LM ++LTG P
Sbjct: 169 PEILMRSGHGKAVDWWSLGALMYDMLTGAPP 199
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 3e-16
Identities = 75/284 (26%), Positives = 119/284 (41%), Gaps = 34/284 (11%)
Query: 563 VGSGGYGKVYKGTLPNGQLI---AIKRAQQG--SMQGGQEFKMEIELLSRVHHKNLVSLL 617
+G G +G V +G L I A+K + + ++F E + H N++ L+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 618 GFCFDRGEQ------MLIYEFVPNGSLGD----SLSGKNGIRLDWIRRLKIALGAARGLS 667
G C E ++I F+ +G L S G L +K A G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 668 YLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDP 727
YL ++ IHRD+ + N +L+E +N VADFGLSK + + + K + ++
Sbjct: 127 YL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183
Query: 728 EYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELID 786
E + T KSDV+SFGV M E+ T G+ P Y E + D ++ L + D
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEIATRGQTP-----YPGVENSEIYDYLRQGNRLKQPPD 238
Query: 787 PTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENIL 830
GL L C + DRP+ + ++E L
Sbjct: 239 CLDGL----------YSLMSSCWLLNPKDRPSFETLRCELEKAL 272
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 4e-16
Identities = 58/206 (28%), Positives = 102/206 (49%), Gaps = 10/206 (4%)
Query: 555 NNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGG--QEFKMEIELLSRVHHKN 612
++F +++G+G G V+K + LI ++ ++ + E+++L +
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 613 LVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHEL 672
+V G + GE + E + GSL L I + ++ IA+ +GL+YL E
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV--IKGLTYLRE- 121
Query: 673 ANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMT 732
I+HRD+K SNIL++ R K+ DFG+S + DS + GT Y+ PE
Sbjct: 122 -KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQG 176
Query: 733 QQLTEKSDVYSFGVLMLELLTGRRPI 758
+ +SD++S G+ ++E+ GR PI
Sbjct: 177 THYSVQSDIWSMGLSLVEMAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 4e-16
Identities = 64/212 (30%), Positives = 112/212 (52%), Gaps = 21/212 (9%)
Query: 555 NNFSDANDVGSGGYGKVYKGT---LPNGQL---IAIKRAQQGSMQGGQEFKM-EIELLSR 607
NN S +G+G +GKV + T L +A+K + + +E M E++++S
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94
Query: 608 V-HHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGL 666
+ +H+N+V+LLG C G ++I E+ G L + L K L L + A+G+
Sbjct: 95 LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGM 154
Query: 667 SYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKS-MSDSEKDHITTQVKGT---- 721
++L A+ IHRD+ + N+LL K+ DFGL++ M+DS +++ VKG
Sbjct: 155 AFL---ASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDS--NYV---VKGNARLP 206
Query: 722 MGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT 753
+ ++ PE T +SDV+S+G+L+ E+ +
Sbjct: 207 VKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 5e-16
Identities = 75/282 (26%), Positives = 120/282 (42%), Gaps = 37/282 (13%)
Query: 554 TNNFSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSM---QGGQEFKMEIELLSRVH 609
NF +G G + VYK L +G+++A+K+ Q M + Q+ EI+LL ++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 610 HKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSG-KNGIRLDWIRRL-KIALGAARGLS 667
H N++ L + E ++ E G L + K RL R + K + L
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 668 YLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDP 727
++H I+HRDIK +N+ + K+ D GL + S S+ + V GT Y+ P
Sbjct: 121 HMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFS-SKTTAAHSLV-GTPYYMSP 175
Query: 728 EYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELID- 786
E KSD++S G L+ E+ + P DK LY+L + I+
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEMAALQSPFY------------GDKMN-LYSLCKKIEK 222
Query: 787 ------PTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEV 822
P S L+ DL +C+ + RP +S V
Sbjct: 223 CDYPPLPADHYSEELR------DLVSRCINPDPEKRPDISYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 5e-16
Identities = 67/252 (26%), Positives = 114/252 (45%), Gaps = 46/252 (18%)
Query: 601 EIELLSRV-HHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRR---- 655
E+E++ + HKN+++LLG C G +I E+ G+L + L + +++
Sbjct: 73 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQV 132
Query: 656 ----------LKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKS 705
+ A ARG+ YL A+ IHRD+ + N+L+ E K+ADFGL++
Sbjct: 133 PEEQLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARD 189
Query: 706 MSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT------GRRPIE 759
+ + TT + + ++ PE + T +SDV+SFGVL+ E+ T P+E
Sbjct: 190 IHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 249
Query: 760 RGKYIVREIRTVMDKKKELYN-LYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPT 818
+++E MDK N LY ++ C RPT
Sbjct: 250 ELFKLLKEGHR-MDKPSNCTNELYMMMR--------------------DCWHAVPSQRPT 288
Query: 819 MSEVVKDIENIL 830
++V+D++ IL
Sbjct: 289 FKQLVEDLDRIL 300
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 5e-16
Identities = 52/168 (30%), Positives = 87/168 (51%), Gaps = 18/168 (10%)
Query: 601 EIELLSRV-HHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDW---IRRL 656
E+EL+ + HKN+++LLG C G +I E+ G+L + L + D+ I ++
Sbjct: 67 EMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKV 126
Query: 657 -----------KIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKS 705
A ARG+ YL + IHRD+ + N+L+ E K+ADFGL++
Sbjct: 127 PEEQLSFKDLVSCAYQVARGMEYL---ESRRCIHRDLAARNVLVTEDNVMKIADFGLARG 183
Query: 706 MSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT 753
+ D + T+ + + ++ PE + T +SDV+SFG+LM E+ T
Sbjct: 184 VHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 7e-16
Identities = 73/226 (32%), Positives = 107/226 (47%), Gaps = 20/226 (8%)
Query: 547 FEEVKKYTNNFSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKMEIELL 605
E + T+ + +G G YGKVYK T +G L A+K S +E + E +L
Sbjct: 14 LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNIL 72
Query: 606 SRV-HHKNLVSLLGFCFDR-----GEQMLIYEFVPNGSLGDSLSG--KNGIRLDWIRRLK 657
+ +H N+V G + G+ L+ E GS+ + + G G RLD
Sbjct: 73 QSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISY 132
Query: 658 IALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQ 717
I GA GL +LH N IIHRD+K +NILL K+ DFG+S ++ S + T
Sbjct: 133 ILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLT-STRLRRNTS 188
Query: 718 VKGTMGYLDPEYYMTQQLTEKS-----DVYSFGVLMLELLTGRRPI 758
V GT ++ PE +Q + S DV+S G+ +EL G P+
Sbjct: 189 V-GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL 233
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 8e-16
Identities = 70/285 (24%), Positives = 126/285 (44%), Gaps = 45/285 (15%)
Query: 561 NDVGSGGYGKVYKGTLPNGQLIA---IKRAQQGSMQGGQ-EFKMEIELLSRVHHKNLVSL 616
+++G+G +GKV G G A +K + + Q F E++ ++H N++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 617 LGFCFDRGEQMLIYEFVPNGSLGDSL-SGKNGIRLDWIRRL--KIALGAARGLSYLHELA 673
LG C + +L+ EF P G L + L S + + + + ++A A GL +LH+
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD 120
Query: 674 NPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGT--MGYLDPEYY- 730
IH D+ N L L+ K+ D+GL ++ +D+ T+ + +L PE
Sbjct: 121 ---FIHSDLALRNCQLTADLSVKIGDYGL--ALEQYPEDYYITKDCHAVPLRWLAPELVE 175
Query: 731 ------MTQQLTEKSDVYSFGVLMLELLT-GRRP------IERGKYIVREIRTVMDKKKE 777
+ + T+KS+++S GV M EL T +P + K +VRE + K
Sbjct: 176 IRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPK--- 232
Query: 778 LYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEV 822
P + L + +++ ++ C + + RPT EV
Sbjct: 233 ---------PQLDLKYS----DRWYEVMQFCWLDP-ETRPTAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 1e-15
Identities = 55/194 (28%), Positives = 94/194 (48%), Gaps = 14/194 (7%)
Query: 563 VGSGGYGKVYKGTL-PNGQLIAIKRAQQG-SMQGGQEFKMEIELLSRVHHKNLVSLLGFC 620
+G G +G+V+ G L + +A+K ++ +F E +L + H N+V L+G C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 621 FDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHR 680
+ ++ E V G L + G RL +++ AA G+ YL + IHR
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFLRTE-GPRLKVKELIQMVENAAAGMEYLE---SKHCIHR 118
Query: 681 DIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGT----MGYLDPEYYMTQQLT 736
D+ + N L+ E+ K++DFG MS E+D + G + + PE + +
Sbjct: 119 DLAARNCLVTEKNVLKISDFG----MSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYS 174
Query: 737 EKSDVYSFGVLMLE 750
+SDV+SFG+L+ E
Sbjct: 175 SESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 1e-15
Identities = 71/236 (30%), Positives = 118/236 (50%), Gaps = 33/236 (13%)
Query: 545 FSF-EEVKKYTNNFSDANDVGSGGYGKVYKG-TLPNGQLIAIKRAQQGSMQGGQEFKM-- 600
F F +EV KY +G G +G+V+K Q++A+K+ + + G F +
Sbjct: 5 FPFCDEVSKY----EKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEG--FPITA 58
Query: 601 --EIELLSRVHHKNLVSLLGFCF--------DRGEQMLIYEFVPNGSLGDSLSGKN-GIR 649
EI++L + H+N+V+L+ C +G L++EF + L LS KN
Sbjct: 59 LREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFT 117
Query: 650 LDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDS 709
L I+++ L GL Y+H I+HRD+K++NIL+ + K+ADFGL+++ S S
Sbjct: 118 LSEIKKVMKML--LNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLS 172
Query: 710 EKDH---ITTQVKGTMGYLDPEYYM-TQQLTEKSDVYSFGVLMLELLTGRRPIERG 761
+ T +V T+ Y PE + + D++ G +M E+ T R PI +G
Sbjct: 173 KNSKPNRYTNRVV-TLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWT-RSPIMQG 226
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 2e-15
Identities = 68/214 (31%), Positives = 106/214 (49%), Gaps = 20/214 (9%)
Query: 556 NFSDANDVGSGGYGKVY---KGTLPN-GQLIAIKRAQQGSM----QGGQEFKMEIELLSR 607
NF +G+G YGKV+ K T + G+L A+K Q+ ++ + + + E +L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 608 VHHKNLVSLLGFCFDRGEQM-LIYEFVPNGSLGDSLSGKNGIRLDWIRRL--KIALGAAR 664
V + L + F ++ LI ++V G + L ++ D +R +I L
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILA--- 117
Query: 665 GLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGY 724
L +LH+L I++RDIK NILLD + + DFGLSK EK+ T GT+ Y
Sbjct: 118 -LEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKER-TYSFCGTIEY 172
Query: 725 LDPEYYMTQQLTEKS-DVYSFGVLMLELLTGRRP 757
+ PE + K+ D +S G+L+ ELLTG P
Sbjct: 173 MAPEIIRGKGGHGKAVDWWSLGILIFELLTGASP 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 2e-15
Identities = 64/246 (26%), Positives = 116/246 (47%), Gaps = 34/246 (13%)
Query: 601 EIELLSRV-HHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWI------ 653
E+E++ + HKN+++LLG C G ++ E+ G+L + L + +D+
Sbjct: 67 EMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKL 126
Query: 654 --------RRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKS 705
+ A ARG+ YL A+ IHRD+ + N+L+ E K+ADFGL++
Sbjct: 127 PEEQLTFKDLVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARD 183
Query: 706 MSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYI 764
+ + + TT + + ++ PE + T +SDV+SFGVL+ E+ T G P Y
Sbjct: 184 VHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSP-----YP 238
Query: 765 VREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVK 824
+ + KE + + + + T L ++ +C RPT ++V+
Sbjct: 239 GIPVEELFKLLKEGHRMDKPANCTHELYMIMR----------ECWHAVPSQRPTFKQLVE 288
Query: 825 DIENIL 830
D++ +L
Sbjct: 289 DLDRVL 294
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 2e-15
Identities = 65/213 (30%), Positives = 95/213 (44%), Gaps = 17/213 (7%)
Query: 556 NFSDANDVGSGGYGKVY----KGTLPNGQLIAIKRAQQGSM---QGGQEFKM-EIELLSR 607
NF +G+G YGKV+ G G+L A+K ++ ++ E E ++L
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 608 VHHKNLVSLLGFCFDRGEQM-LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGL 666
V + L + F ++ LI ++V G L L + +R + A L
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLA--L 118
Query: 667 SYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLD 726
+LH+L II+RDIK NILLD + + DFGLSK E++ GT+ Y+
Sbjct: 119 DHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEER-AYSFCGTIEYMA 174
Query: 727 PEYYMTQQLTEKS--DVYSFGVLMLELLTGRRP 757
PE D +S GVL ELLTG P
Sbjct: 175 PEVIRGGSGGHDKAVDWWSLGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 2e-15
Identities = 64/253 (25%), Positives = 115/253 (45%), Gaps = 20/253 (7%)
Query: 581 LIAIKRAQQGSMQGGQ-EFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLG 639
L+A+K + + + +F EI+++SR+ + N++ LLG C +I E++ NG L
Sbjct: 46 LVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLN 105
Query: 640 DSLSGK---------NGI-RLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILL 689
LS + N I + L +A+ A G+ YL L +HRD+ + N L+
Sbjct: 106 QFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCLV 162
Query: 690 DERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLML 749
K+ADFG+S+++ + I + + ++ E + + T SDV++FGV +
Sbjct: 163 GNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLW 222
Query: 750 ELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCV 809
E+ T + Y + V++ E + I LS T L ++C
Sbjct: 223 EMFT---LCKEQPYSLLSDEQVIENTGEFFRNQ---GRQIYLSQTPLCPSPVFKLMMRCW 276
Query: 810 QESGDDRPTMSEV 822
DRPT +++
Sbjct: 277 SRDIKDRPTFNKI 289
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 2e-15
Identities = 68/273 (24%), Positives = 123/273 (45%), Gaps = 38/273 (13%)
Query: 563 VGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGG-QEFKMEIELLSRVHH---KNLVSLL 617
+G G YG VY+G +P G+++A+K + + + E+ LLS++ N+
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 618 GFCFDRGEQM-LIYEFVPNGSLGDSLSGKNGIRLDWI----RRLKIALGAARGLSYLHEL 672
G + +G ++ +I E+ GS+ +L I +I R + +AL Y+H++
Sbjct: 69 G-SYLKGPRLWIIMEYAEGGSV-RTLMKAGPIAEKYISVIIREVLVAL------KYIHKV 120
Query: 673 ANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMT 732
+IHRDIK++NIL+ N K+ DFG++ ++ + T GT ++ PE
Sbjct: 121 ---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST--FVGTPYWMAPEVITE 175
Query: 733 -QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGL 791
+ K+D++S G+ + E+ TG P R + + K G
Sbjct: 176 GKYYDTKADIWSLGITIYEMATGNPPYS-DVDAFRAMMLIPKSKPPRLEDN-------GY 227
Query: 792 STTLKGFEKYVDLALKCVQESGDDRPTMSEVVK 824
S L+ F C+ E +R + E++K
Sbjct: 228 SKLLREFVAA------CLDEEPKERLSAEELLK 254
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 2e-15
Identities = 67/209 (32%), Positives = 91/209 (43%), Gaps = 31/209 (14%)
Query: 564 GSGGYGKV----YKGTLPNGQLIAIKRAQQGSMQGGQEF------KMEIELLSRVHHKNL 613
G G +GKV YK T G+L AIK ++G + E K E + H L
Sbjct: 8 GRGHFGKVLLAEYKKT---GELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFL 64
Query: 614 VSLLGFCFDRGEQM-LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAAR---GLSYL 669
V+L CF + + + E+ G L I D + AA GL YL
Sbjct: 65 VNLFA-CFQTEDHVCFVMEYAAGGDL------MMHIHTDVFSEPRAVFYAACVVLGLQYL 117
Query: 670 HELANPPIIHRDIKSSNILLDERLNAKVADFGLSKS-MSDSEKDHITTQVKGTMGYLDPE 728
HE I++RD+K N+LLD K+ADFGL K M ++ T+ GT +L PE
Sbjct: 118 HE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR---TSTFCGTPEFLAPE 171
Query: 729 YYMTQQLTEKSDVYSFGVLMLELLTGRRP 757
T D + GVL+ E+L G P
Sbjct: 172 VLTETSYTRAVDWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 2e-15
Identities = 62/266 (23%), Positives = 112/266 (42%), Gaps = 33/266 (12%)
Query: 571 VYKGTLPNGQLIAI---KRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQM 627
+YKG N + + I K+ +G + EI+ L R+ N++ + GF D + +
Sbjct: 36 IYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94
Query: 628 ----LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIK 683
LI E+ G L + L L + +L +A+ +GL L++ N P ++++
Sbjct: 95 PRLSLILEYCTRGYLREVLD--KEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLT 150
Query: 684 SSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMT--QQLTEKSDV 741
S + L+ E K+ GL K +S ++ M Y + + T K D+
Sbjct: 151 SVSFLVTENYKLKIICHGLEKILSSPPFKNVNF-----MVYFSYKMLNDIFSEYTIKDDI 205
Query: 742 YSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKY 801
YS GV++ E+ TG+ P E KE+Y+L +I+ L L +
Sbjct: 206 YSLGVVLWEIFTGKIPFENLTT------------KEIYDL--IINKNNSLKLPLDCPLEI 251
Query: 802 VDLALKCVQESGDDRPTMSEVVKDIE 827
+ C RP + E++ ++
Sbjct: 252 KCIVEACTSHDSIKRPNIKEILYNLS 277
|
Length = 283 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 3e-15
Identities = 51/201 (25%), Positives = 94/201 (46%), Gaps = 16/201 (7%)
Query: 566 GGYGKVYKGTL-----PNGQLIAIKR-AQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGF 619
G +G+++ G L + + +K S E LL + H+N++ +L
Sbjct: 17 GTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHV 76
Query: 620 C-FDRGEQMLIYEFVPNGSLGDSL------SGKNGIRLDWIRRLKIALGAARGLSYLHEL 672
C D ++Y ++ G+L L N L + + +A+ A G+SYLH+
Sbjct: 77 CIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR 136
Query: 673 ANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMT 732
+IH+DI + N ++DE L K+ D LS+ + + + + ++ E +
Sbjct: 137 G---VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVN 193
Query: 733 QQLTEKSDVYSFGVLMLELLT 753
++ + SDV+SFGVL+ EL+T
Sbjct: 194 KEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 3e-15
Identities = 63/232 (27%), Positives = 102/232 (43%), Gaps = 49/232 (21%)
Query: 556 NFSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQG-GQEFKMEIELLSRVHHKNL 613
+ + + +G G YG V T P G +AIK+ Q Q EI++L R H+N+
Sbjct: 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENI 65
Query: 614 VSLLGF-CFDRGEQM----LIYEFVPNGSLGDSLSGKNGIRLDWIRRLK----------- 657
+ +L E ++ E + D + +K
Sbjct: 66 IGILDIIRPPSFESFNDVYIVQELMET---------------DLYKLIKTQHLSNDHIQY 110
Query: 658 ----IALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDH 713
I G L Y+H AN ++HRD+K SN+LL+ + K+ DFGL++ +D E DH
Sbjct: 111 FLYQILRG----LKYIHS-AN--VLHRDLKPSNLLLNTNCDLKICDFGLARI-ADPEHDH 162
Query: 714 --ITTQVKGTMGYLDPEYYMTQQLTEKS-DVYSFGVLMLELLTGRRPIERGK 762
T+ T Y PE + + K+ D++S G ++ E+L+ RP+ GK
Sbjct: 163 TGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSN-RPLFPGK 213
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 3e-15
Identities = 59/212 (27%), Positives = 96/212 (45%), Gaps = 20/212 (9%)
Query: 563 VGSGGYGKVYKGTLP----NGQLIAIK--RAQQGSMQGGQEFKMEIELLSRVHHKNLVSL 616
+G G +G V + L + Q +A+K +A S +EF E + H N++ L
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66
Query: 617 LGFCFDRGEQ------MLIYEFVPNGSLGD----SLSGKNGIRLDWIRRLKIALGAARGL 666
+G + M+I F+ +G L S G+ L ++ + A G+
Sbjct: 67 IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGM 126
Query: 667 SYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLD 726
YL ++ IHRD+ + N +L+E + VADFGLSK + + K + +L
Sbjct: 127 EYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLA 183
Query: 727 PEYYMTQQLTEKSDVYSFGVLMLELLT-GRRP 757
E T SDV++FGV M E++T G+ P
Sbjct: 184 LESLADNVYTTHSDVWAFGVTMWEIMTRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 4e-15
Identities = 71/238 (29%), Positives = 111/238 (46%), Gaps = 30/238 (12%)
Query: 547 FEEVKKYTNNFSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQ---GSMQGGQEFKMEI 602
F V + TN + D VG G +G V GQ +AIK+ + + + ++ E+
Sbjct: 2 FGTVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYR-EL 60
Query: 603 ELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLK----- 657
+LL + H+N++SL E IY FV L G + RL R L+
Sbjct: 61 KLLKHLRHENIISLSDIFISPLED--IY-FV------TELLGTDLHRLLTSRPLEKQFIQ 111
Query: 658 -IALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITT 716
RGL Y+H ++HRD+K SNIL++E + K+ DFGL++ +D T
Sbjct: 112 YFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI-----QDPQMT 163
Query: 717 QVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMD 773
T Y PE +T Q+ + D++S G + E+L G +P+ GK V + + D
Sbjct: 164 GYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEG-KPLFPGKDHVNQFSIITD 220
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 5e-15
Identities = 38/105 (36%), Positives = 58/105 (55%), Gaps = 5/105 (4%)
Query: 24 NNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPS 83
+N+ LRG +P I L+ L ++ L G S G IP S+GS+ L +L L+ N F+G +P S
Sbjct: 426 DNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPES 485
Query: 84 IGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKN 128
+G L++L L+L N L G +P + G + F+F N
Sbjct: 486 LGQLTSLRILNLNGNSLSGRVPAALGGRL-----LHRASFNFTDN 525
|
Length = 623 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 6e-15
Identities = 75/277 (27%), Positives = 122/277 (44%), Gaps = 39/277 (14%)
Query: 557 FSDANDVGSGGYGKVYKGTLPNGQ-LIAIKRAQQGSMQGG-QEFKMEIELLSRVHHKNLV 614
F+ +G G +G+V+KG Q ++AIK + ++ + EI +LS+ +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 615 SLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELAN 674
G + +I E++ GS D L LD + I +GL YLH
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP---LDETQIATILREILKGLDYLHSEKK 122
Query: 675 PPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVK-----GTMGYLDPEY 729
IHRDIK++N+LL E K+ADFG++ ++D TQ+K GT ++ PE
Sbjct: 123 ---IHRDIKAANVLLSEHGEVKLADFGVAGQLTD-------TQIKRNTFVGTPFWMAPEV 172
Query: 730 YMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTI 789
K+D++S G+ +EL G P + + K L+ + + PT+
Sbjct: 173 IKQSAYDSKADIWSLGITAIELAKGEPP-----------HSELHPMKVLFLIPKNNPPTL 221
Query: 790 --GLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVK 824
S LK F + C+ + RPT E++K
Sbjct: 222 EGNYSKPLKEFVE------ACLNKEPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 6e-15
Identities = 58/223 (26%), Positives = 112/223 (50%), Gaps = 16/223 (7%)
Query: 563 VGSGGYGKVYKGTLPN-GQLIAIKRAQQGSMQ--GGQEFKM-EIELLSRVHHKNLVSLLG 618
+G GG+G+V + N G++ A K+ + ++ G++ + E E+L +V+ +V+L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNL-A 59
Query: 619 FCFDRGEQM-LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPI 677
+ F+ + L+ + G L + L+ R + + G+ +LH + I
Sbjct: 60 YAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD---I 116
Query: 678 IHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTE 737
++RD+K N+LLD++ N +++D GL+ + D + TQ GT GY+ PE + +
Sbjct: 117 VYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---ITQRAGTNGYMAPEILKEEPYSY 173
Query: 738 KSDVYSFGVLMLELLTGRRPIERGKYIVRE----IRTVMDKKK 776
D ++ G + E++ GR P + K V + RT+ D+ K
Sbjct: 174 PVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVK 216
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 7e-15
Identities = 62/230 (26%), Positives = 97/230 (42%), Gaps = 44/230 (19%)
Query: 563 VGSGGYGKVY----KGTLPNGQLIAIKRAQQGSM-QGGQE--FKMEIELLSRVHHKNLVS 615
+G G +G+V+ K T GQ+ A+K ++ M + Q + E ++L+ +V
Sbjct: 9 IGRGAFGEVWLVRDKDT---GQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVK 65
Query: 616 LLGFCF-DRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELAN 674
L + F D L+ E++P G L + L K+ + R L A L +H+L
Sbjct: 66 LY-YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLA--LDSVHKLG- 121
Query: 675 PPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKD---------------------- 712
IHRDIK NIL+D + K+ADFGL K M+ ++
Sbjct: 122 --FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRD 179
Query: 713 -----HITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRP 757
GT Y+ PE + D +S GV++ E+L G P
Sbjct: 180 HKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP 229
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 9e-15
Identities = 36/84 (42%), Positives = 55/84 (65%), Gaps = 1/84 (1%)
Query: 2 GLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIG 61
GL+G + DI+ L L +++LS N +RG +P ++G++ L L L SF+G IP+S+G
Sbjct: 429 GLRGFIPNDISKLRHLQSINLSGNS-IRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLG 487
Query: 62 SLQELVLLSLNSNGFSGRVPPSIG 85
L L +L+LN N SGRVP ++G
Sbjct: 488 QLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 9e-15
Identities = 53/208 (25%), Positives = 99/208 (47%), Gaps = 20/208 (9%)
Query: 563 VGSGGYGK-VYKGTLPNGQLIAIKRAQQGSMQGG--QEFKMEIELLSRVHHKNLVSLLGF 619
+G G +GK + + +G+ IK M +E + E+ +LS + H N+V
Sbjct: 8 IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQES 67
Query: 620 CFDRGEQMLIYEFVPNGSLGDSLSGKNGIR------LDWIRRLKIALGAARGLSYLHELA 673
+ G ++ ++ G L ++ + G+ LDW ++ +AL ++H+
Sbjct: 68 FEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLAL------KHVHDRK 121
Query: 674 NPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQ 733
I+HRDIKS NI L + K+ DFG+++ ++ + + + GT YL PE +
Sbjct: 122 ---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE--LARTCIGTPYYLSPEICENR 176
Query: 734 QLTEKSDVYSFGVLMLELLTGRRPIERG 761
KSD+++ G ++ E+ T + E G
Sbjct: 177 PYNNKSDIWALGCVLYEMCTLKHAFEAG 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 1e-14
Identities = 66/243 (27%), Positives = 110/243 (45%), Gaps = 31/243 (12%)
Query: 562 DVGSGGYGKVYKG---TLPNGQLIAIKRAQQGSMQGG--QEFKMEIELLSRVHHKNLVSL 616
++GSG +G V KG + + +A+K + + E E ++ ++ + +V +
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 617 LGFCFDRGEQ-MLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANP 675
+G C E ML+ E G L L + I L + G+ YL E
Sbjct: 62 IGIC--EAESWMLVMELAELGPLNKFLQKNKHVTEKNITEL--VHQVSMGMKYLEE---T 114
Query: 676 PIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDH-ITTQVKGTMGYLDPEYYMTQQ 734
+HRD+ + N+LL + AK++DFGLSK++ E + T K + + PE +
Sbjct: 115 NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYK 174
Query: 735 LTEKSDVYSFGVLMLELLT-GRRP------------IERGKYIVREIRTVMDKKKELYNL 781
+ KSDV+SFGVLM E + G++P IE G+ + E+Y+L
Sbjct: 175 FSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGE----RMECPQRCPPEMYDL 230
Query: 782 YEL 784
+L
Sbjct: 231 MKL 233
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 1e-14
Identities = 72/279 (25%), Positives = 130/279 (46%), Gaps = 45/279 (16%)
Query: 562 DVGSGGYGKVYKG-TLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFC 620
++G G +GKVYK G L A K S + +++ +EI++L+ H N+V LL
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 621 FDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLK------IALGAARGLSYLHELAN 674
+ ++ EF G++ + + L+ R L + L+YLHE
Sbjct: 72 YYENNLWILIEFCAGGAV-------DAVMLELERPLTEPQIRVVCKQTLEALNYLHE--- 121
Query: 675 PPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVK----GTMGYLDPEYY 730
IIHRD+K+ NIL + K+ADFG+S K+ T Q + GT ++ PE
Sbjct: 122 NKIIHRDLKAGNILFTLDGDIKLADFGVSA------KNTRTIQRRDSFIGTPYWMAPEVV 175
Query: 731 MTQQLTE-----KSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELI 785
M + + K+DV+S G+ ++E+ IE + + +R ++ K
Sbjct: 176 MCETSKDRPYDYKADVWSLGITLIEMAQ----IEPPHHELNPMRVLLKIAKS-------- 223
Query: 786 DPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVK 824
+P L+ + ++ D KC++++ D R T +++++
Sbjct: 224 EPPT-LAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 62/208 (29%), Positives = 100/208 (48%), Gaps = 20/208 (9%)
Query: 557 FSDANDVGSGGYGKVYKGTLPNG-QLIAIKRAQQGSMQGG-QEFKMEIELLSRVHHKNLV 614
F+ +G G +G+VYKG +++AIK + ++ + EI +LS+ +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 615 SLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELAN 674
G + +I E++ GS D L K G L+ I +GL YLH
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSALDLL--KPG-PLEETYIATILREILKGLDYLHSERK 122
Query: 675 PPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVK-----GTMGYLDPEY 729
IHRDIK++N+LL E+ + K+ADFG++ ++D TQ+K GT ++ PE
Sbjct: 123 ---IHRDIKAANVLLSEQGDVKLADFGVAGQLTD-------TQIKRNTFVGTPFWMAPEV 172
Query: 730 YMTQQLTEKSDVYSFGVLMLELLTGRRP 757
K+D++S G+ +EL G P
Sbjct: 173 IKQSAYDFKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 2e-14
Identities = 62/209 (29%), Positives = 98/209 (46%), Gaps = 15/209 (7%)
Query: 551 KKYTNNFSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKM-EIELLSRV 608
KKYT +G G G VY + GQ +AIK+ Q +E + EI ++
Sbjct: 19 KKYTR----FEKIGQGASGTVYTAIDVATGQEVAIKQMNL-QQQPKKELIINEILVMREN 73
Query: 609 HHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSY 668
H N+V+ L E ++ E++ GSL D ++ + +IA L
Sbjct: 74 KHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC------MDEGQIAAVCRECLQA 127
Query: 669 LHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPE 728
L L + +IHRDIKS NILL + K+ DFG ++ E+ +T V GT ++ PE
Sbjct: 128 LEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT-PEQSKRSTMV-GTPYWMAPE 185
Query: 729 YYMTQQLTEKSDVYSFGVLMLELLTGRRP 757
+ K D++S G++ +E++ G P
Sbjct: 186 VVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 2e-14
Identities = 43/121 (35%), Positives = 67/121 (55%), Gaps = 7/121 (5%)
Query: 669 LHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPE 728
+H + + +IHRDIKS+NILL K+ DFG SK + + D + GT Y+ PE
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPE 215
Query: 729 YYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPT 788
+ + ++K+D++S GVL+ ELLT +RP + + VM K L Y+ + P+
Sbjct: 216 IWRRKPYSKKADMFSLGVLLYELLTLKRPFDG-----ENMEEVM--HKTLAGRYDPLPPS 268
Query: 789 I 789
I
Sbjct: 269 I 269
|
Length = 496 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 2e-14
Identities = 60/263 (22%), Positives = 117/263 (44%), Gaps = 41/263 (15%)
Query: 581 LIAIKRAQQGSMQGGQ-EFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLG 639
L+A+K ++ + + + +F EI+++SR+ N++ LL C +I E++ NG L
Sbjct: 48 LVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLN 107
Query: 640 DSLS---------GKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLD 690
LS + + + + + +A A G+ YL L +HRD+ + N L+
Sbjct: 108 QFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNCLVG 164
Query: 691 ERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLE 750
+ K+ADFG+S+++ + I + + ++ E + + T SDV++FGV + E
Sbjct: 165 KNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWE 224
Query: 751 LLT-----------GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFE 799
+LT + IE R D+ +++Y + P +
Sbjct: 225 ILTLCKEQPYSQLSDEQVIENTGEFFR------DQGRQVYLPKPALCP-----------D 267
Query: 800 KYVDLALKCVQESGDDRPTMSEV 822
L L C + + +RP+ E+
Sbjct: 268 SLYKLMLSCWRRNAKERPSFQEI 290
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 66/226 (29%), Positives = 110/226 (48%), Gaps = 24/226 (10%)
Query: 562 DVGSGGYGKVYKG-TLPNG-QLIAIKRAQQGSMQGGQEFKM--EIELLSRVH---HKNLV 614
++G G YGKV+K L NG + +A+KR + + + G E+ +L + H N+V
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 615 SLLGFCF----DRGEQM-LIYEFVPNGSLGDSLSG--KNGIRLDWIRRLKIALGAARGLS 667
L C DR ++ L++E V + L L + G+ + I+ + L RGL
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQL--LRGLD 124
Query: 668 YLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDP 727
+LH + ++HRD+K NIL+ K+ADFGL++ S T V T+ Y P
Sbjct: 125 FLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM---ALTSVVVTLWYRAP 178
Query: 728 EYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMD 773
E + D++S G + E+ R+P+ RG V ++ ++D
Sbjct: 179 EVLLQSSYATPVDLWSVGCIFAEMFR-RKPLFRGSSDVDQLGKILD 223
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 2e-14
Identities = 65/231 (28%), Positives = 107/231 (46%), Gaps = 29/231 (12%)
Query: 539 LKGARCFSFEEVKKYT-NNFSDANDVGSGGYGKV----YKGTLPNGQLIAIK---RAQQG 590
+K A F+ + + ++F +G+G +G+V +KGT G+ AIK + +
Sbjct: 1 MKAAYMFTKPDTSSWKLSDFEMGETLGTGSFGRVRIAKHKGT---GEYYAIKCLKKREIL 57
Query: 591 SMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSL--SGK--N 646
M+ Q E +L + H +V+++ D + EFV G L L +G+ N
Sbjct: 58 KMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPN 117
Query: 647 GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSM 706
+ + L +A YLH II+RD+K N+LLD + + KV DFG +K +
Sbjct: 118 DVAKFYHAELVLAF------EYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKV 168
Query: 707 SDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRP 757
D T + GT YL PE ++ + D ++ GVL+ E + G P
Sbjct: 169 PDR-----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 2e-14
Identities = 63/209 (30%), Positives = 92/209 (44%), Gaps = 26/209 (12%)
Query: 563 VGSGGYGKV----YKGTLPNGQLIAIKR------AQQGSMQGGQEFKMEIELLSRVHHKN 612
+G G +GKV KGT +L A+K Q ++ K + L + H
Sbjct: 3 LGKGSFGKVLLAELKGT---DELYAVKVLKKDVILQDDDVECTMTEKRVLALAGK--HPF 57
Query: 613 LVSLLGFCFDRGEQM-LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHE 671
L L CF +++ + E+V G L + R D R A GL +LHE
Sbjct: 58 LTQLHS-CFQTKDRLFFVMEYVNGGDLMFHIQRSG--RFDEPRARFYAAEIVLGLQFLHE 114
Query: 672 LANPPIIHRDIKSSNILLDERLNAKVADFGLSK-SMSDSEKDHITTQVKGTMGYLDPEYY 730
II+RD+K N+LLD + K+ADFG+ K + T+ GT Y+ PE
Sbjct: 115 RG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT---TSTFCGTPDYIAPEIL 168
Query: 731 MTQQLTEKSDVYSFGVLMLELLTGRRPIE 759
Q D ++ GVL+ E+L G+ P E
Sbjct: 169 SYQPYGPAVDWWALGVLLYEMLAGQSPFE 197
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 3e-14
Identities = 62/203 (30%), Positives = 94/203 (46%), Gaps = 22/203 (10%)
Query: 563 VGSGGYGKVY----KGTLPNGQLIAIKRAQQGSMQGGQEFK---MEIELLSRVHHKNLVS 615
VG GGYG+V+ K T G+++A+KR ++ + E + E ++L+ + LV
Sbjct: 9 VGQGGYGQVFLAKKKDT---GEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVK 65
Query: 616 LLGFCFDRGEQM-LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELAN 674
LL + F E + L E+VP G L+ + D R + A + LHEL
Sbjct: 66 LL-YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEA--VDALHELG- 121
Query: 675 PPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQ 734
IHRD+K N L+D + K+ DFGLSK + V G+ Y+ PE +
Sbjct: 122 --YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-----YANSVVGSPDYMAPEVLRGKG 174
Query: 735 LTEKSDVYSFGVLMLELLTGRRP 757
D +S G ++ E L G P
Sbjct: 175 YDFTVDYWSLGCMLYEFLCGFPP 197
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.7 bits (182), Expect = 3e-14
Identities = 53/209 (25%), Positives = 92/209 (44%), Gaps = 35/209 (16%)
Query: 563 VGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKM--------EIELLSRV-HHKN 612
+G G +G VY G+L+AIK+ M+ ++F E++ L ++ H N
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKK-----MK--KKFYSWEECMNLREVKSLRKLNEHPN 59
Query: 613 LVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHEL 672
+V L + E ++E++ G+L + + G I +GL+++H+
Sbjct: 60 IVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH 118
Query: 673 ANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPE---- 728
HRD+K N+L+ K+ADFGL++ + + T V T Y PE
Sbjct: 119 G---FFHRDLKPENLLVSGPEVVKIADFGLAREI--RSRPPYTDYV-STRWYRAPEILLR 172
Query: 729 --YYMTQQLTEKSDVYSFGVLMLELLTGR 755
Y + D+++ G +M EL T R
Sbjct: 173 STSY-----SSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 4e-14
Identities = 68/260 (26%), Positives = 121/260 (46%), Gaps = 28/260 (10%)
Query: 551 KKYTNNFSDANDVGSGGYGKVYKGTLPN-GQLIAIKRAQQGSMQGGQEFKMEIELLSRVH 609
++Y ++F +G G G V T + G+ +A+K+ Q + E+ ++ H
Sbjct: 21 REYLDSFIK---IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYH 77
Query: 610 HKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYL 669
H+N+V + E ++ EF+ G+L D ++ R++ + + L R LSYL
Sbjct: 78 HENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHT---RMNEEQIATVCLSVLRALSYL 134
Query: 670 HELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEY 729
H N +IHRDIKS +ILL K++DFG +S + GT ++ PE
Sbjct: 135 H---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKR--KSLVGTPYWMAPEV 189
Query: 730 YMTQQLTEKSDVYSFGVLMLELLTGRRPI--ERGKYIVREIRTVMDKK-KELYNLYELID 786
+ D++S G++++E++ G P E +R IR + + K+ +
Sbjct: 190 ISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHK------ 243
Query: 787 PTIGLSTTLKGFEKYVDLAL 806
+S+ L+GF +DL L
Sbjct: 244 ----VSSVLRGF---LDLML 256
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 4e-14
Identities = 61/215 (28%), Positives = 105/215 (48%), Gaps = 27/215 (12%)
Query: 556 NFSDANDVGSGGYGKVYKG-TLPNGQLIAIKRAQQGSMQGGQEF---KMEIELLSRVHHK 611
+F +GSG YG VYK + G+L AIK + ++ G++F + EI ++ H
Sbjct: 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIK---LEPGEDFAVVQQEIIMMKDCKHS 66
Query: 612 NLVSLLGFCFDRGEQMLIYEFVPNGSLGD--SLSGKNGIRLDWIRRLKIALGAARGLSYL 669
N+V+ G R + + EF GSL D ++G + +IA + L L
Sbjct: 67 NIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGP-------LSESQIAYVSRETLQGL 119
Query: 670 HELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDS---EKDHITTQVKGTMGYLD 726
+ L + +HRDIK +NILL + + K+ADFG+S ++ + K I GT ++
Sbjct: 120 YYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI-----GTPYWMA 174
Query: 727 PEYYMTQQ---LTEKSDVYSFGVLMLELLTGRRPI 758
PE ++ + D+++ G+ +EL + P+
Sbjct: 175 PEVAAVERKGGYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 5e-14
Identities = 61/212 (28%), Positives = 103/212 (48%), Gaps = 26/212 (12%)
Query: 556 NFSDANDVGSGGYGKVYKG-TLPNGQLIAIKRAQ-QGSMQGGQEFKM-EIELLSRVHHKN 612
NF +G G YG VYK G+++A+K+ + +G + EI LL ++H N
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 613 LVSLLGFCFDRGEQMLIYEFVPNGSLG---DSLSGKNGIRLDWIRRLKIALGAARGLSYL 669
+V LL + L++EF+ + L D+ +GI L I+ L +GL++
Sbjct: 61 IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASP-LSGIPLPLIKSYLFQL--LQGLAFC 116
Query: 670 HELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPE- 728
H + ++HRD+K N+L++ K+ADFGL+++ + + V T+ Y PE
Sbjct: 117 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEI 171
Query: 729 -----YYMTQQLTEKSDVYSFGVLMLELLTGR 755
YY T D++S G + E++T R
Sbjct: 172 LLGCKYYST-----AVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 6e-14
Identities = 53/190 (27%), Positives = 94/190 (49%), Gaps = 21/190 (11%)
Query: 581 LIAIKRAQQGSMQGGQ-EFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLG 639
L+A+K + + + + +F E+++LSR+ N++ LLG C D +I E++ NG L
Sbjct: 48 LVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLN 107
Query: 640 DSLSGKN-----------------GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDI 682
LS + + + L +AL A G+ YL L +HRD+
Sbjct: 108 QFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVHRDL 164
Query: 683 KSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVY 742
+ N L+ E L K+ADFG+S+++ + I + + ++ E + + T SDV+
Sbjct: 165 ATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVW 224
Query: 743 SFGVLMLELL 752
+FGV + E+L
Sbjct: 225 AFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 6e-14
Identities = 71/231 (30%), Positives = 112/231 (48%), Gaps = 43/231 (18%)
Query: 563 VGSGGYGKVYKGTLP-NGQLIAIK---RAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLG 618
VGSG YG+V G+ +AIK R Q ++ + ++ E+ LL + H+N++ LL
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYR-ELRLLKHMDHENVIGLLD 81
Query: 619 FCFDRGEQM-------LIYEFVPNGSLGDSLSGKNGI----RL--DWIRRLKIALGAARG 665
F + L+ + G L N I +L D I+ L + RG
Sbjct: 82 -VFTPASSLEDFQDVYLVTHLM-----GADL---NNIVKCQKLSDDHIQFLVYQI--LRG 130
Query: 666 LSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYL 725
L Y+H A IIHRD+K SNI ++E K+ DFGL++ +D E +T V T Y
Sbjct: 131 LKYIHS-AG--IIHRDLKPSNIAVNEDCELKILDFGLAR-HTDDE---MTGYV-ATRWYR 182
Query: 726 DPE---YYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMD 773
PE +M + D++S G +M ELLTG + + G + +++ +M+
Sbjct: 183 APEIMLNWM--HYNQTVDIWSVGCIMAELLTG-KTLFPGSDHIDQLKRIMN 230
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 6e-14
Identities = 59/229 (25%), Positives = 104/229 (45%), Gaps = 46/229 (20%)
Query: 563 VGSGGYGKVYKG---TLPNGQLIAIKRAQQGSMQGGQEFKM----EIELLSRVHHKNLVS 615
+G G YG+VYK +G+ AIK+ + Q EI LL + H+N+VS
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQY-TGISQSACREIALLRELKHENVVS 66
Query: 616 LLGFCFDRGEQM--LIYEFVPNGSLGDSL------SGKNGIRLD--WIRRLKIALGAARG 665
L+ + ++ L++++ + D + + ++ L + G
Sbjct: 67 LVEVFLEHADKSVYLLFDYAEH----DLWQIIKFHRQAKRVSIPPSMVKSLLWQI--LNG 120
Query: 666 LSYLHELANPPIIHRDIKSSNILL----DERLNAKVADFGLS-------KSMSDSEKDHI 714
+ YLH +N ++HRD+K +NIL+ ER K+ D GL+ K ++D +
Sbjct: 121 VHYLH--SNW-VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDP--- 174
Query: 715 TTQVKGTMGYLDPEYYM-TQQLTEKSDVYSFGVLMLELLTGRRPIERGK 762
V T+ Y PE + + T+ D+++ G + ELLT PI +G+
Sbjct: 175 ---VVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-LEPIFKGR 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 7e-14
Identities = 76/291 (26%), Positives = 128/291 (43%), Gaps = 40/291 (13%)
Query: 555 NNFSDAND-------VGSGGYGKVYK-GTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLS 606
++F D +D +G G YGKV+K NG A+K +E + E +L
Sbjct: 11 DSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVK-ILDPIHDIDEEIEAEYNILK 69
Query: 607 RVH-HKNLVSLLGFCFDR----GEQM-LIYEFVPNGSLGDSLSG--KNGIRLDWIRRLKI 658
+ H N+V G + + G+Q+ L+ E GS+ D + G K G R++ I
Sbjct: 70 ALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYI 129
Query: 659 ALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQV 718
A GL +LH IHRD+K +NILL K+ DFG+S ++ + T+
Sbjct: 130 LHEALMGLQHLH---VNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV- 185
Query: 719 KGTMGYLDPEYYMTQQ-----LTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMD 773
GT ++ PE +Q + DV+S G+ +EL G P+ +
Sbjct: 186 -GTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLAD-----------LH 233
Query: 774 KKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVK 824
+ L+ + PT+ ++ D KC+ + + RPT+S++++
Sbjct: 234 PMRALFKIPRNPPPTLHQPELWSN--EFNDFIRKCLTKDYEKRPTVSDLLQ 282
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 7e-14
Identities = 59/217 (27%), Positives = 105/217 (48%), Gaps = 24/217 (11%)
Query: 556 NFSDANDVGSGGYGKVYKG-TLPNGQLIAIKRAQQGSMQGG--QEFKMEIELLSRVHHKN 612
+++ +G G YG VYKG GQ++A+K+ + S + G EI LL + H N
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPN 60
Query: 613 LVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHEL 672
+V L LI+EF+ S+ K LD + + + + A SYL+++
Sbjct: 61 IVCLQDVLMQESRLYLIFEFL-------SMDLKK--YLDSLPKGQ-YMDAELVKSYLYQI 110
Query: 673 ANP-------PIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYL 725
++HRD+K N+L+D + K+ADFGL+++ + + T T+ Y
Sbjct: 111 LQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR--VYTHEVVTLWYR 168
Query: 726 DPEYYM-TQQLTEKSDVYSFGVLMLELLTGRRPIERG 761
PE + + + + D++S G + E+ T ++P+ G
Sbjct: 169 APEVLLGSPRYSTPVDIWSIGTIFAEMAT-KKPLFHG 204
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 8e-14
Identities = 56/211 (26%), Positives = 104/211 (49%), Gaps = 13/211 (6%)
Query: 556 NFSDANDVGSGGYGKVYKG-TLPNGQLIAIKRAQQGSMQGGQEFKM-EIELLSRVHHKNL 613
NF +G G Y VYKG G+++A+K + +G + EI L+ + H+N+
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 614 VSLLGFCFDRGEQMLIYEFVPNG--SLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHE 671
V L + ML++E++ D+ + + + ++ L +G+++ HE
Sbjct: 61 VRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQL--LKGIAFCHE 118
Query: 672 LANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYM 731
++HRD+K N+L+++R K+ADFGL+++ V T+ Y P+ +
Sbjct: 119 ---NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV--TLWYRAPDVLL 173
Query: 732 TQQLTEKS-DVYSFGVLMLELLTGRRPIERG 761
+ S D++S G +M E++TG RP+ G
Sbjct: 174 GSRTYSTSIDIWSVGCIMAEMITG-RPLFPG 203
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 9e-14
Identities = 62/214 (28%), Positives = 103/214 (48%), Gaps = 39/214 (18%)
Query: 563 VGSGGYGKVYKG-TLPNGQLIAIKRAQQGSMQGGQEFKM---EIELLSRVHHKNLVSLLG 618
VGSG YG VYK L G+L A+K + ++ G +F + EI ++ H N+V+ G
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIK---LEPGDDFSLIQQEIFMVKECKHCNIVAYFG 73
Query: 619 FCFDRGEQMLIYEFVPNGSLGD--SLSGKNGIRLDWIRRLKIAL---GAARGLSYLHELA 673
R + + E+ GSL D ++G + L+IA +GL+YLH
Sbjct: 74 SYLSREKLWICMEYCGGGSLQDIYHVTGP-------LSELQIAYVCRETLQGLAYLHSKG 126
Query: 674 NPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQ 733
+HRDIK +NILL + + K+ADFG++ IT + ++ Y+M
Sbjct: 127 K---MHRDIKGANILLTDNGDVKLADFGVAAK--------ITATIAKRKSFIGTPYWMAP 175
Query: 734 QLT--EKS-------DVYSFGVLMLELLTGRRPI 758
++ EK+ D+++ G+ +EL + P+
Sbjct: 176 EVAAVEKNGGYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 9e-14
Identities = 54/208 (25%), Positives = 98/208 (47%), Gaps = 12/208 (5%)
Query: 551 KKYTNNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVH 609
+ Y +NF +G G G V T+ +G+L+A+K+ Q + E+ ++
Sbjct: 19 RTYLDNFIK---IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQ 75
Query: 610 HKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYL 669
H+N+V + E ++ EF+ G+L D ++ R++ + + L + LS L
Sbjct: 76 HENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLKALSVL 132
Query: 670 HELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEY 729
H +IHRDIKS +ILL K++DFG +S + GT ++ PE
Sbjct: 133 HAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR--KSLVGTPYWMAPEL 187
Query: 730 YMTQQLTEKSDVYSFGVLMLELLTGRRP 757
+ D++S G++++E++ G P
Sbjct: 188 ISRLPYGPEVDIWSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 54/220 (24%), Positives = 108/220 (49%), Gaps = 29/220 (13%)
Query: 562 DVGSGGYGKVYKGTL------PNGQLIAIKRAQ---QGSMQGGQEFKMEIELLSRVHHKN 612
++G +GKVYKG L Q +AIK + +G ++ +EFK E + SR+ H N
Sbjct: 12 ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLR--EEFKHEAMMRSRLQHPN 69
Query: 613 LVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKN--------------GIRLDWIRRLKI 658
+V LLG +I+ + + L + L ++ L+ + I
Sbjct: 70 IVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHI 129
Query: 659 ALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQV 718
A G+ + L++ ++H+D+ + N+L+ ++LN K++D GL + + ++ +
Sbjct: 130 VTQIAAGMEF---LSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNS 186
Query: 719 KGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRP 757
+ ++ PE M + + SD++S+GV++ E+ + G +P
Sbjct: 187 LLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 1e-13
Identities = 69/211 (32%), Positives = 103/211 (48%), Gaps = 25/211 (11%)
Query: 561 NDVGSGGYGKVYKGT-LPNGQLIAIK--RAQQGSMQGGQEFKMEIELLSRVHHKNLVSLL 617
+++G G YG VYK P G +A+K R + + Q ME+++L + +V
Sbjct: 7 DELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQ-IIMELDILHKAVSPYIVDFY 65
Query: 618 GFCFDRGEQMLIYEFVPNGSLGDSLSG----KNGIRLDWIRRLKIALGAARGLSYLHELA 673
G F G + E++ GSL D L GI D +RR I +GL +L E
Sbjct: 66 GAFFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRR--ITYAVVKGLKFLKEEH 122
Query: 674 NPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDS-EKDHITTQVKGTMGYLDPEYY-- 730
N IIHRD+K +N+L++ K+ DFG+S ++ S K +I G Y+ PE
Sbjct: 123 N--IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI-----GCQSYMAPERIKS 175
Query: 731 --MTQQLTE--KSDVYSFGVLMLELLTGRRP 757
Q T +SDV+S G+ +LE+ GR P
Sbjct: 176 GGPNQNPTYTVQSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 1e-13
Identities = 65/210 (30%), Positives = 100/210 (47%), Gaps = 23/210 (10%)
Query: 562 DVGSGGYGKVYKGTLPN-GQLIAIKRAQQGSMQGGQEFKM--EIELLSRVH---HKNLVS 615
++G G YG VYK P+ G +A+K + + + G E+ LL R+ H N+V
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 616 LLGFC----FDRGEQM-LIYEFVPNGSLGDSLSG--KNGIRLDWIRRLKIALGAARGLSY 668
L+ C DR ++ L++E V + L L G+ + I+ L RGL +
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQF--LRGLDF 123
Query: 669 LHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPE 728
LH AN I+HRD+K NIL+ K+ADFGL++ S T V T+ Y PE
Sbjct: 124 LH--ANC-IVHRDLKPENILVTSGGQVKLADFGLARIYS---CQMALTPVVVTLWYRAPE 177
Query: 729 YYMTQQLTEKSDVYSFGVLMLELLTGRRPI 758
+ D++S G + E+ R+P+
Sbjct: 178 VLLQSTYATPVDMWSVGCIFAEMFR-RKPL 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 71.7 bits (175), Expect = 2e-13
Identities = 58/208 (27%), Positives = 99/208 (47%), Gaps = 13/208 (6%)
Query: 551 KKYTNNFSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVH 609
KKYT +G G G V+ + GQ +AIK+ + EI ++ +
Sbjct: 19 KKYTR----YEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELK 74
Query: 610 HKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYL 669
+ N+V+ L E ++ E++ GSL D ++ +D + + + L +L
Sbjct: 75 NPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETC---MDEAQIAAVCRECLQALEFL 131
Query: 670 HELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEY 729
H AN +IHRDIKS N+LL + K+ DFG ++ E+ +T V GT ++ PE
Sbjct: 132 H--ANQ-VIHRDIKSDNVLLGMDGSVKLTDFGFCAQIT-PEQSKRSTMV-GTPYWMAPEV 186
Query: 730 YMTQQLTEKSDVYSFGVLMLELLTGRRP 757
+ K D++S G++ +E++ G P
Sbjct: 187 VTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 72.2 bits (178), Expect = 2e-13
Identities = 43/105 (40%), Positives = 64/105 (60%), Gaps = 9/105 (8%)
Query: 664 RGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSM--SDSEKDHITTQVKGT 721
RGL YLH AN +IHRD+K SNIL++ + K+ DFGL++ + + EK +T V T
Sbjct: 114 RGLKYLHS-AN--VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVV-T 169
Query: 722 MGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGK-YI 764
Y PE ++ + T+ D++S G + ELLT R+P+ G+ YI
Sbjct: 170 RWYRAPELLLSSSRYTKAIDIWSVGCIFAELLT-RKPLFPGRDYI 213
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 3e-13
Identities = 55/206 (26%), Positives = 97/206 (47%), Gaps = 15/206 (7%)
Query: 563 VGSGGYGKVYKGTLPN-GQLIAIKRAQ-QGSMQGGQEFKM-EIELLSRVHHKNLVSLLGF 619
+G G YG V+K +++A+KR + +G + EI LL + HKN+V L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 620 CFDRGEQMLIYEFVPNG--SLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPI 677
+ L++E+ DS +G I + ++ L +GL++ H +
Sbjct: 68 LHSDKKLTLVFEYCDQDLKKYFDSCNGD--IDPEIVKSFMFQL--LKGLAFCHS---HNV 120
Query: 678 IHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTE 737
+HRD+K N+L+++ K+ADFGL+++ + + V T+ Y P+ +L
Sbjct: 121 LHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV--TLWYRPPDVLFGAKLYS 178
Query: 738 KS-DVYSFGVLMLELLTGRRPIERGK 762
S D++S G + EL RP+ G
Sbjct: 179 TSIDMWSAGCIFAELANAGRPLFPGN 204
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 5e-13
Identities = 58/203 (28%), Positives = 93/203 (45%), Gaps = 22/203 (10%)
Query: 563 VGSGGYGKVYKGT-LPNGQLIAIKRAQQG---SMQGGQEFKMEIELLSRVHHKNLVSLLG 618
VG+G +G+V+ + A+K ++ Q E +L V H ++ L
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFW 68
Query: 619 FCFDRGEQMLIYEFVPNGSLGDSL--SGK--NGIRLDWIRRLKIALGAARGLSYLHELAN 674
D+ ++ E+VP G L L SG+ N L + + AL YLH
Sbjct: 69 TEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCAL------EYLHSKE- 121
Query: 675 PPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQ 734
I++RD+K NILLD+ + K+ DFG +K + D T + GT YL PE ++
Sbjct: 122 --IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR-----TWTLCGTPEYLAPEVIQSKG 174
Query: 735 LTEKSDVYSFGVLMLELLTGRRP 757
+ D ++ G+L+ E+L G P
Sbjct: 175 HNKAVDWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 5e-13
Identities = 63/201 (31%), Positives = 93/201 (46%), Gaps = 14/201 (6%)
Query: 563 VGSGGYGKVYKGTLP-NGQLIAIKRAQQGS--MQGGQEFKM-EIELLSRVHHKNLVSLLG 618
+G G +GKV+ L Q AIK ++ M E M E +LS ++ L
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62
Query: 619 FCFDRGEQML-IYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPI 677
F E + + E++ G L + + + D R A GL +LH I
Sbjct: 63 CTFQTKENLFFVMEYLNGGDLMFHIQSCH--KFDLPRATFYAAEIICGLQFLHSKG---I 117
Query: 678 IHRDIKSSNILLDERLNAKVADFGLSK-SMSDSEKDHITTQVKGTMGYLDPEYYMTQQLT 736
++RD+K NILLD + K+ADFG+ K +M K T GT Y+ PE + Q+
Sbjct: 118 VYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK---TCTFCGTPDYIAPEILLGQKYN 174
Query: 737 EKSDVYSFGVLMLELLTGRRP 757
D +SFGVL+ E+L G+ P
Sbjct: 175 TSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 6e-13
Identities = 61/203 (30%), Positives = 94/203 (46%), Gaps = 14/203 (6%)
Query: 563 VGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM--QGGQEFKM-EIELLSRVHHKNLVSLLG 618
+G G +GKV L +G+L A+K ++ + E M E +LS + ++ L
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 619 FCFDRGEQML-IYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPI 677
CF +++ + EFV G L + + R D R A L +LH+ I
Sbjct: 63 CCFQTPDRLFFVMEFVNGGDLMFHI--QKSRRFDEARARFYAAEITSALMFLHDKG---I 117
Query: 678 IHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQV-KGTMGYLDPEYYMTQQLT 736
I+RD+K N+LLD + K+ADFG+ K + + TT GT Y+ PE
Sbjct: 118 IYRDLKLDNVLLDHEGHCKLADFGMCK---EGIFNGKTTSTFCGTPDYIAPEILQEMLYG 174
Query: 737 EKSDVYSFGVLMLELLTGRRPIE 759
D ++ GVL+ E+L G P E
Sbjct: 175 PSVDWWAMGVLLYEMLCGHAPFE 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 7e-13
Identities = 57/211 (27%), Positives = 99/211 (46%), Gaps = 33/211 (15%)
Query: 563 VGSGGYGKVYKG-TLPNGQLIAIKRAQQGSMQGG--QEFKMEIELLSRVHHKNLVSLLGF 619
+G G YG VYK G+++A+K+ + + G EI LL ++H N+V LL
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66
Query: 620 CFDRGEQMLIYEF-----------VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSY 668
+ L++EF P L L +L +G++Y
Sbjct: 67 VHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQL------------LQGIAY 114
Query: 669 LHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPE 728
H + ++HRD+K N+L+D K+ADFGL+++ + + T +V T+ Y PE
Sbjct: 115 CH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTY-THEVV-TLWYRAPE 169
Query: 729 YYM-TQQLTEKSDVYSFGVLMLELLTGRRPI 758
+ ++Q + D++S G + E++ RRP+
Sbjct: 170 ILLGSRQYSTPVDIWSIGCIFAEMVN-RRPL 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 1e-12
Identities = 62/225 (27%), Positives = 107/225 (47%), Gaps = 37/225 (16%)
Query: 564 GSGGYGKVYKG-TLPNGQLIAIKRAQQGSMQGGQEFKM----EIELLSRVHHKNLVSLLG 618
G G +G+VYK + G+++A+K+ + + G F + EI++L ++ H N+V L+
Sbjct: 17 GEGTFGEVYKARQIKTGRVVALKKILMHNEKDG--FPITALREIKILKKLKHPNVVPLID 74
Query: 619 FCFDRGEQML-----IYEFVP------NGSLGDSLSGKNGIRLDWIRRLKIALGAARGLS 667
+R ++ +Y P +G L + ++L + L G++
Sbjct: 75 MAVERPDKSKRKRGSVYMVTPYMDHDLSGLLEN-----PSVKLTESQIKCYMLQLLEGIN 129
Query: 668 YLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDS---------EKDHITTQV 718
YLHE I+HRDIK++NIL+D + K+ADFGL++ T +
Sbjct: 130 YLHE---NHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNL 186
Query: 719 KGTMGYLDPEYYM-TQQLTEKSDVYSFGVLMLELLTGRRPIERGK 762
T Y PE + ++ T D++ G + E+ T RRPI +GK
Sbjct: 187 VVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFT-RRPILQGK 230
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 1e-12
Identities = 54/170 (31%), Positives = 86/170 (50%), Gaps = 22/170 (12%)
Query: 669 LHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPE 728
L E+ + ++HRD+KS+NI L K+ DFG SK SDS + + GT YL PE
Sbjct: 182 LDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPE 241
Query: 729 YYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDP- 787
+ ++ ++K+D++S GV++ ELLT RP + REI ++ LY Y DP
Sbjct: 242 LWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ--REIM-----QQVLYGKY---DPF 291
Query: 788 TIGLSTTLKGFEKYVDLALKCVQESGDDRPTM-----SEVVKDIENILQQ 832
+S+ +K L + ++ RPT +E +K + N+ Q
Sbjct: 292 PCPVSSGMKA------LLDPLLSKNPALRPTTQQLLHTEFLKYVANLFQD 335
|
Length = 478 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 1e-12
Identities = 64/201 (31%), Positives = 94/201 (46%), Gaps = 15/201 (7%)
Query: 563 VGSGGYGKVY----KGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLG 618
+G G +GKV + T L I++A S E +L++V+ +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPL-K 59
Query: 619 FCFDRGEQM-LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPI 677
F F E++ L+ F+ G L L + L R L A L LH+ +
Sbjct: 60 FSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCA--LENLHKFN---V 114
Query: 678 IHRDIKSSNILLDERLNAKVADFGLSK-SMSDSEKDHITTQVKGTMGYLDPEYYMTQQLT 736
I+RD+K NILLD + + + DFGL K +M D +K T GT YL PE + T
Sbjct: 115 IYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDK---TNTFCGTPEYLAPELLLGHGYT 171
Query: 737 EKSDVYSFGVLMLELLTGRRP 757
+ D ++ GVL+ E+LTG P
Sbjct: 172 KAVDWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 1e-12
Identities = 51/206 (24%), Positives = 92/206 (44%), Gaps = 15/206 (7%)
Query: 556 NFSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLV 614
+ +G G G V T G+ +A+K+ Q + E+ ++ H N+V
Sbjct: 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIV 79
Query: 615 SLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELAN 674
+ E ++ EF+ G+L D ++ R++ + + L + LS+LH
Sbjct: 80 EMYSSYLVGDELWVVMEFLEGGALTDIVTH---TRMNEEQIATVCLAVLKALSFLH---A 133
Query: 675 PPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVK---GTMGYLDPEYYM 731
+IHRDIKS +ILL K++DFG +S + K GT ++ PE
Sbjct: 134 QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE-----VPRRKSLVGTPYWMAPEVIS 188
Query: 732 TQQLTEKSDVYSFGVLMLELLTGRRP 757
+ D++S G++++E++ G P
Sbjct: 189 RLPYGTEVDIWSLGIMVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 68.8 bits (169), Expect = 1e-12
Identities = 62/221 (28%), Positives = 112/221 (50%), Gaps = 30/221 (13%)
Query: 556 NFSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKM----EIELLSRVHH 610
+ N + G YG VY+ G+++A+K+ + + G F + EI +L ++ H
Sbjct: 6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEG--FPITSLREINILLKLQH 63
Query: 611 KNLVSL----LGFCFDRGEQMLIY---EFVPNGSLGDSLS-GKNGIRLDWIRRLKIALGA 662
N+V++ +G D+ IY E+V + L + K ++ L + L
Sbjct: 64 PNIVTVKEVVVGSNLDK-----IYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQL-- 115
Query: 663 ARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTM 722
G+++LH+ I+HRD+K+SN+LL+ R K+ DFGL++ K + TQ+ T+
Sbjct: 116 LSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPY--TQLVVTL 170
Query: 723 GYLDPEYYM-TQQLTEKSDVYSFGVLMLELLTGRRPIERGK 762
Y PE + ++ + D++S G + ELLT ++P+ GK
Sbjct: 171 WYRAPELLLGAKEYSTAIDMWSVGCIFAELLT-KKPLFPGK 210
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 2e-12
Identities = 54/201 (26%), Positives = 99/201 (49%), Gaps = 11/201 (5%)
Query: 563 VGSGGYGKVYKG--TLPNGQ--LIAIKRAQQGSMQGGQE-FKMEIELLSRVHHKNLVSLL 617
+G+G +G++ +G LP+ + +AI + G + F E L + H N+V L
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72
Query: 618 GFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPI 677
G M++ E++ NG+L DS K+ +L + + + G A G+ YL E+
Sbjct: 73 GVITRGNTMMIVTEYMSNGAL-DSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMG---Y 128
Query: 678 IHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTE 737
+H+ + + +L++ L K++ F + SE + T K + + PE +
Sbjct: 129 VHKGLAAHKVLVNSDLVCKISGFRRLQE-DKSEAIYTTMSGKSPVLWAAPEAIQYHHFSS 187
Query: 738 KSDVYSFGVLMLELLT-GRRP 757
SDV+SFG++M E+++ G RP
Sbjct: 188 ASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 62/214 (28%), Positives = 101/214 (47%), Gaps = 19/214 (8%)
Query: 556 NFSDANDVGSGGYGKVY----KGTLPNGQLIAIKRAQQGSM----QGGQEFKMEIELLSR 607
NF +G+G YGKV+ +G+L A+K ++ ++ + + + E ++L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 608 VHHKNLVSLLGFCFDRGEQM-LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGA-ARG 665
+ + L + F ++ LI +++ G L LS + + + ++I G
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKE---QEVQIYSGEIVLA 117
Query: 666 LSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYL 725
L +LH+L II+RDIK NILLD + + DFGLSK + E + GT+ Y+
Sbjct: 118 LEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVER-AYSFCGTIEYM 173
Query: 726 DPEYYMTQQLTEKS--DVYSFGVLMLELLTGRRP 757
P+ D +S GVLM ELLTG P
Sbjct: 174 APDIVRGGDGGHDKAVDWWSMGVLMYELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 56/211 (26%), Positives = 109/211 (51%), Gaps = 13/211 (6%)
Query: 563 VGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQGGQEFKM---EIELLSRVHHKNLVSLLG 618
+G GG+G+V + G++ A K+ ++ ++ + M E ++L +V+ + +VSL
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSL-A 66
Query: 619 FCFDRGEQM-LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPI 677
+ ++ + + L+ + G L + + R + A GL LH+ I
Sbjct: 67 YAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQ---ERI 123
Query: 678 IHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTE 737
++RD+K NILLD+ + +++D GL+ + + + I +V GT+GY+ PE ++ T
Sbjct: 124 VYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRV-GTVGYMAPEVVKNERYTF 180
Query: 738 KSDVYSFGVLMLELLTGRRPI-ERGKYIVRE 767
D ++ G L+ E++ G+ P +R K I RE
Sbjct: 181 SPDWWALGCLLYEMIAGQSPFQQRKKKIKRE 211
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 60/213 (28%), Positives = 107/213 (50%), Gaps = 13/213 (6%)
Query: 563 VGSGGYGKVYKG-TLPNGQLIAIKRAQQGSMQGGQEFKM-EIELLSRVHHKNLVSLLGFC 620
+G G Y V+KG + L+A+K + +G + E+ LL + H N+V+L
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72
Query: 621 FDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIAL-GAARGLSYLHELANPPIIH 679
L++E++ + L L N L + +KI + RGLSY H+ I+H
Sbjct: 73 HTERCLTLVFEYLDS-DLKQYLD--NCGNLMSMHNVKIFMFQLLRGLSYCHKRK---ILH 126
Query: 680 RDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYM-TQQLTEK 738
RD+K N+L++E+ K+ADFGL+++ S K + V T+ Y P+ + + + +
Sbjct: 127 RDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLGSTEYSTP 184
Query: 739 SDVYSFGVLMLELLTGRRPIERGKYIVREIRTV 771
D++ G ++ E+ TG RP+ G + E+ +
Sbjct: 185 IDMWGVGCILYEMATG-RPMFPGSTVKEELHLI 216
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 70/280 (25%), Positives = 118/280 (42%), Gaps = 37/280 (13%)
Query: 556 NFSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSM---QGGQEFKMEIELLSRVHHK 611
NF +G G + +VY+ T L + + +A+K+ Q M + Q+ EI+LL +++H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 612 NLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSG-KNGIRLDWIRRL-KIALGAARGLSYL 669
N++ L + E ++ E G L + K RL R + K + + ++
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122
Query: 670 HELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEY 729
H + ++HRDIK +N+ + K+ D GL + S K + GT Y+ PE
Sbjct: 123 H---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVGTPYYMSPER 177
Query: 730 YMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELID--- 786
KSD++S G L+ E+ + P K L++L + I+
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAALQSPF-------------YGDKMNLFSLCQKIEQCD 224
Query: 787 ----PTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEV 822
PT S EK +L C+ D RP + V
Sbjct: 225 YPPLPTEHYS------EKLRELVSMCIYPDPDQRPDIGYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 2e-12
Identities = 58/208 (27%), Positives = 97/208 (46%), Gaps = 13/208 (6%)
Query: 551 KKYTNNFSDANDVGSGGYGKVYKG-TLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVH 609
KKYT +G G G VY + GQ +AIK+ + EI ++
Sbjct: 19 KKYTR----FEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENK 74
Query: 610 HKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYL 669
+ N+V+ L E ++ E++ GSL D ++ +D + + + L +L
Sbjct: 75 NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC---MDEGQIAAVCRECLQALDFL 131
Query: 670 HELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEY 729
H + +IHRDIKS NILL + K+ DFG ++ E+ +T V GT ++ PE
Sbjct: 132 H---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT-PEQSKRSTMV-GTPYWMAPEV 186
Query: 730 YMTQQLTEKSDVYSFGVLMLELLTGRRP 757
+ K D++S G++ +E++ G P
Sbjct: 187 VTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 4e-12
Identities = 60/200 (30%), Positives = 93/200 (46%), Gaps = 12/200 (6%)
Query: 563 VGSGGYGKVYKGTLP-NGQLIAIKRAQQGS--MQGGQEFKM-EIELLSRVHHKNLVSLLG 618
+G G +GKV L G+ A+K ++ + E M E +L+ ++ L
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62
Query: 619 FCFDRGEQML-IYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPI 677
F E + + EF+ G L + K R D R A GL +LH + I
Sbjct: 63 CTFQTKEHLFFVMEFLNGGDLMFHIQDKG--RFDLYRATFYAAEIVCGLQFLH---SKGI 117
Query: 678 IHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTE 737
I+RD+K N++LD + K+ADFG+ K + D+ + GT Y+ PE + T
Sbjct: 118 IYRDLKLDNVMLDRDGHIKIADFGMCKE--NVFGDNRASTFCGTPDYIAPEILQGLKYTF 175
Query: 738 KSDVYSFGVLMLELLTGRRP 757
D +SFGVL+ E+L G+ P
Sbjct: 176 SVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 4e-12
Identities = 54/208 (25%), Positives = 95/208 (45%), Gaps = 13/208 (6%)
Query: 551 KKYTNNFSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVH 609
KKYT +G G G VY + GQ +AI++ + EI ++
Sbjct: 20 KKYTR----FEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENK 75
Query: 610 HKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYL 669
+ N+V+ L E ++ E++ GSL D ++ +D + + + L +L
Sbjct: 76 NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC---MDEGQIAAVCRECLQALEFL 132
Query: 670 HELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEY 729
H + +IHRDIKS NILL + K+ DFG ++ + + + GT ++ PE
Sbjct: 133 H---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEV 187
Query: 730 YMTQQLTEKSDVYSFGVLMLELLTGRRP 757
+ K D++S G++ +E++ G P
Sbjct: 188 VTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 4e-12
Identities = 61/240 (25%), Positives = 104/240 (43%), Gaps = 41/240 (17%)
Query: 546 SFEEVKKYT--NNFSDANDVGSGGYGKVYKG-TLPNGQLIAIKR------------AQQG 590
SF ++Y +G G YGKV K G+++AIK+ +Q
Sbjct: 3 SFSISERYIQKGAH-----LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQL 57
Query: 591 SMQGGQEFKM--EIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGI 648
G F E+++++ + H+N++ L+ + L+ + + L + K I
Sbjct: 58 VGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDRK--I 114
Query: 649 RLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKS--- 705
RL + I L GL+ LH +HRD+ +NI ++ + K+ADFGL++
Sbjct: 115 RLTESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGY 171
Query: 706 --MSDSEKDHITTQVKG-------TMGYLDPEYYM-TQQLTEKSDVYSFGVLMLELLTGR 755
SD+ T Q + T+ Y PE M ++ D++S G + ELLTG+
Sbjct: 172 PPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 4e-12
Identities = 54/209 (25%), Positives = 104/209 (49%), Gaps = 12/209 (5%)
Query: 563 VGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQGGQEFKM---EIELLSRVHHKNLVSLLG 618
+G GG+G+V + G++ A K+ ++ ++ + M E +L +V+ + +VSL
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL-A 66
Query: 619 FCFDRGEQM-LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPI 677
+ ++ + + L+ + G L + D R + A GL L I
Sbjct: 67 YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQR---ERI 123
Query: 678 IHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTE 737
++RD+K NILLD+R + +++D GL+ + + E + +V GT+GY+ PE ++ T
Sbjct: 124 VYRDLKPENILLDDRGHIRISDLGLAVQIPEGET--VRGRV-GTVGYMAPEVINNEKYTF 180
Query: 738 KSDVYSFGVLMLELLTGRRPIERGKYIVR 766
D + G L+ E++ G+ P + K V+
Sbjct: 181 SPDWWGLGCLIYEMIQGQSPFRKRKERVK 209
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 5e-12
Identities = 56/206 (27%), Positives = 100/206 (48%), Gaps = 16/206 (7%)
Query: 555 NNFSDANDVGSGGYGKVYKG-TLPNGQLIAIK--RAQQGSMQGGQEFKM--EIELLSRVH 609
+++ +G G Y VYKG + NG+L+A+K R Q+ + G F E LL +
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQE---EEGTPFTAIREASLLKGLK 61
Query: 610 HKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYL 669
H N+V L + L++E+V G+ + ++ L RGLSY+
Sbjct: 62 HANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQL--LRGLSYI 119
Query: 670 HELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEY 729
H+ I+HRD+K N+L+ + K+ADFGL++ + S H + T+ Y P+
Sbjct: 120 HQRY---ILHRDLKPQNLLISDTGELKLADFGLAR--AKSVPSHTYSNEVVTLWYRPPDV 174
Query: 730 YM-TQQLTEKSDVYSFGVLMLELLTG 754
+ + + + D++ G + +E++ G
Sbjct: 175 LLGSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 5e-12
Identities = 37/93 (39%), Positives = 54/93 (58%), Gaps = 5/93 (5%)
Query: 665 GLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGY 724
GL +LH+ II+RD+K N+LLD+ + K+ADFG+ K + E + GT Y
Sbjct: 108 GLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG--KASTFCGTPDY 162
Query: 725 LDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRP 757
+ PE Q+ E D +SFGVL+ E+L G+ P
Sbjct: 163 IAPEILKGQKYNESVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 5e-12
Identities = 54/208 (25%), Positives = 97/208 (46%), Gaps = 19/208 (9%)
Query: 563 VGSGGYGKVYKGTL-PNGQLIAIKRAQQGSM---QGGQEFKMEIELLSRVHHKNLVSLLG 618
+G GG+G+V + G+L A K+ + + +G + +E +L++VH + +VSL
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSL-A 59
Query: 619 FCFDRGEQMLIYEFVPNGSLGD------SLSGKNGIRLDWIRRLKIALGAARGLSYLHEL 672
+ F + + + NG GD ++ +N R GL +LH+
Sbjct: 60 YAFQTKTDLCLVMTIMNG--GDLRYHIYNVDEENP-GFPEPRACFYTAQIISGLEHLHQ- 115
Query: 673 ANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMT 732
II+RD+K N+LLD N +++D GL+ + D + T GT G++ PE
Sbjct: 116 --RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TKGYAGTPGFMAPELLQG 171
Query: 733 QQLTEKSDVYSFGVLMLELLTGRRPIER 760
++ D ++ GV + E++ R P
Sbjct: 172 EEYDFSVDYFALGVTLYEMIAARGPFRA 199
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 6e-12
Identities = 42/110 (38%), Positives = 64/110 (58%), Gaps = 7/110 (6%)
Query: 664 RGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMG 723
RGL Y+H AN ++HRD+K SN+LL+ + K+ DFGL++ + SEK T+ T
Sbjct: 119 RGLKYIHS-AN--VLHRDLKPSNLLLNANCDLKICDFGLAR--TTSEKGDFMTEYVVTRW 173
Query: 724 YLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVM 772
Y PE + + T DV+S G + ELL GR+P+ GK V +++ +
Sbjct: 174 YRAPELLLNCSEYTTAIDVWSVGCIFAELL-GRKPLFPGKDYVHQLKLIT 222
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 7e-12
Identities = 56/207 (27%), Positives = 93/207 (44%), Gaps = 22/207 (10%)
Query: 563 VGSGGYGKVYKGTLPNG--QLIAIKRAQQGSMQGGQEFK----------MEIELL-SRVH 609
+GSG +G VYK N L+A+K + G++ + E+ ++ ++
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 610 HKNLVSLLGFCFDRGEQMLIYEFVPNGSLGD---SLSGKNGIRLDWIRRLKIALGAARGL 666
H N+V + ++ + + LG+ SL K R R I + L
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQ-RFTEERIWNIFVQMVLAL 126
Query: 667 SYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLD 726
YLH+ I+HRD+ +NI+L E + DFGL+K K T V GT+ Y
Sbjct: 127 RYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESK---LTSVVGTILYSC 181
Query: 727 PEYYMTQQLTEKSDVYSFGVLMLELLT 753
PE + EK+DV++FG ++ ++ T
Sbjct: 182 PEIVKNEPYGEKADVWAFGCILYQMCT 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 7e-12
Identities = 66/227 (29%), Positives = 107/227 (47%), Gaps = 25/227 (11%)
Query: 557 FSDANDVGSGGYGKV-YKGTLPNGQLIAIK---RAQQGSMQGGQEFKMEIELLSRVHHKN 612
+ D VGSG YG V G +AIK R Q + + ++ E+ LL + H+N
Sbjct: 17 YRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYR-ELRLLKHMKHEN 75
Query: 613 LVSLLG-FCFDRG-----EQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGL 666
++ LL F D + L+ F+ LG + + +L R + +GL
Sbjct: 76 VIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKHE---KLSEDRIQFLVYQMLKGL 131
Query: 667 SYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLD 726
Y+H IIHRD+K N+ ++E K+ DFGL++ +DSE T T Y
Sbjct: 132 KYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQ-TDSE----MTGYVVTRWYRA 183
Query: 727 PEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVM 772
PE + T+ D++S G +M E+LTG +P+ +G + ++ +M
Sbjct: 184 PEVILNWMHYTQTVDIWSVGCIMAEMLTG-KPLFKGHDHLDQLMEIM 229
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 8e-12
Identities = 74/287 (25%), Positives = 130/287 (45%), Gaps = 38/287 (13%)
Query: 563 VGSGGYGKVYK-GTLPNGQLIAIKRAQQGSMQGGQEFKM---EIELLSRVHHKNLVSLLG 618
+G G YG V+K GQ++AIK+ + S K+ EI +L ++ H NLV+L+
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVE-SEDDPVIKKIALREIRMLKQLKHPNLVNLIE 67
Query: 619 FCFDRGEQM-LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPI 677
F R ++ L++E+ + L + G+ I+ KI + +++ H+
Sbjct: 68 -VFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIK--KIIWQTLQAVNFCHKHN---C 121
Query: 678 IHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQ-QLT 736
IHRD+K NIL+ ++ K+ DFG ++ ++ D+ T T Y PE + Q
Sbjct: 122 IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDY--TDYVATRWYRAPELLVGDTQYG 179
Query: 737 EKSDVYSFGVLMLELLTGRRPIERGK------YIVREIRTVMD---------KKKELYNL 781
DV++ G + ELLTG +P+ GK Y++R +T+ D + +
Sbjct: 180 PPVDVWAIGCVFAELLTG-QPLWPGKSDVDQLYLIR--KTLGDLIPRHQQIFSTNQFFKG 236
Query: 782 YELIDPTIGLSTTLKGFEKYVDLAL----KCVQESGDDRPTMSEVVK 824
+ +P K F AL C+Q +R + E+++
Sbjct: 237 LSIPEPETREPLESK-FPNISSPALSFLKGCLQMDPTERLSCEELLE 282
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 8e-12
Identities = 60/206 (29%), Positives = 100/206 (48%), Gaps = 31/206 (15%)
Query: 563 VGSGGYGKVYKGTL----PNGQLIAIKRA--QQGSMQGGQEFKMEIELLSRVHHKNLVSL 616
VG G YG+V +L +G+ IK+ + S + + + E +LLS++ H N+V+
Sbjct: 8 VGKGSYGEV---SLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAY 64
Query: 617 LGFCFDRGEQMLIY---EFVPNGSLGDSLSGKNGIRL------DWIRRLKIALGAARGLS 667
GE L+Y F G L L + G L +W ++ +AL
Sbjct: 65 RESW--EGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMAL------Q 116
Query: 668 YLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDP 727
YLHE I+HRD+K+ N+ L KV D G+++ + +++ D +T + GT Y+ P
Sbjct: 117 YLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVL-ENQCDMASTLI-GTPYYMSP 171
Query: 728 EYYMTQQLTEKSDVYSFGVLMLELLT 753
E + + KSDV++ G + E+ T
Sbjct: 172 ELFSNKPYNYKSDVWALGCCVYEMAT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-11
Identities = 58/212 (27%), Positives = 104/212 (49%), Gaps = 13/212 (6%)
Query: 561 NDVGSGGYGKVYKG-TLPNGQLIAIKRAQQGSMQGGQEFKM-EIELLSRVHHKNLVSLLG 618
+ +G G Y VYKG + L+A+K + +G + E+ LL + H N+V+L
Sbjct: 12 DKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 619 FCFDRGEQMLIYEFVPNGSLGDSLSG-KNGIRLDWIRRLKIALGAARGLSYLHELANPPI 677
L++E++ + L L N I + ++ L RGL+Y H +
Sbjct: 72 IIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLFLFQL--LRGLNYCHR---RKV 125
Query: 678 IHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYM-TQQLT 736
+HRD+K N+L++ER K+ADFGL+++ S K + V T+ Y P+ + + +
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV--TLWYRPPDILLGSTDYS 183
Query: 737 EKSDVYSFGVLMLELLTGRRPIERGKYIVREI 768
+ D++ G + E+ TG RP+ G + ++
Sbjct: 184 TQIDMWGVGCIFYEMSTG-RPLFPGSTVEEQL 214
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 66.0 bits (162), Expect = 1e-11
Identities = 49/169 (28%), Positives = 71/169 (42%), Gaps = 21/169 (12%)
Query: 601 EIELLSRVH-----HKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRR 655
IE + VH + N + L +LI +++ +G L D L K +L
Sbjct: 56 AIEPM--VHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLL--KKEGKLSEAEV 111
Query: 656 LKIALGAARGLSYLHELANPPIIHRDIKSSNILLDE-RLNAKVADFGLSKSM-SDSEKDH 713
KI L+ LH IIH DIK N+L D + + D+GL K + + S D
Sbjct: 112 KKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYD- 167
Query: 714 ITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGK 762
GT+ Y PE D ++ GVL ELLTG+ P + +
Sbjct: 168 ------GTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDE 210
|
Length = 267 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 66.8 bits (164), Expect = 1e-11
Identities = 58/209 (27%), Positives = 105/209 (50%), Gaps = 29/209 (13%)
Query: 563 VGSGGYGKVYKGT-LPNGQLIAIKR---AQQGSMQGGQEFKMEIELLSRV-HHKNLVSLL 617
+G G YG V+K +++A+K+ A + + + F+ EI L + H N+V LL
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFR-EIMFLQELGDHPNIVKLL 73
Query: 618 GFCFDRGEQM----LIYEFVPNGSLGDS-LSG--KNGIRLDWIRRLKIALGAARGLSYLH 670
+ E L++E++ ++ L + I D + + I + L Y+H
Sbjct: 74 NVI--KAENDKDIYLVFEYM------ETDLHAVIRANILED-VHKRYIMYQLLKALKYIH 124
Query: 671 ELANPPIIHRDIKSSNILLDERLNAKVADFGLSKS---MSDSEKDHITTQVKGTMGYLDP 727
N +IHRD+K SNILL+ K+ADFGL++S + ++ ++ + T T Y P
Sbjct: 125 S-GN--VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAP 181
Query: 728 EYYM-TQQLTEKSDVYSFGVLMLELLTGR 755
E + + + T+ D++S G ++ E+L G+
Sbjct: 182 EILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 1e-11
Identities = 37/93 (39%), Positives = 51/93 (54%), Gaps = 5/93 (5%)
Query: 664 RGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMG 723
RGL YLH A I+HRDIK N+L++ K+ DFGL++ E H+T +V T
Sbjct: 114 RGLKYLHS-AG--ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV-TQY 169
Query: 724 YLDPEYYM-TQQLTEKSDVYSFGVLMLELLTGR 755
Y PE M ++ T D++S G + ELL R
Sbjct: 170 YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 58/225 (25%), Positives = 112/225 (49%), Gaps = 14/225 (6%)
Query: 563 VGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQGGQEFKM---EIELLSRVHHKNLVSLLG 618
+G GG+G+V + G++ A KR ++ ++ + M E ++L +V+ + +V+L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNL-A 66
Query: 619 FCFDRGEQM-LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPI 677
+ ++ + + L+ + G L + + R L A GL LH
Sbjct: 67 YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHR---ENT 123
Query: 678 IHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTE 737
++RD+K NILLD+ + +++D GL+ + E + I +V GT+GY+ PE Q+ T
Sbjct: 124 VYRDLKPENILLDDYGHIRISDLGLAVKI--PEGESIRGRV-GTVGYMAPEVLNNQRYTL 180
Query: 738 KSDVYSFGVLMLELLTGRRPIERGKYIVR--EIRTVMDKKKELYN 780
D + G L+ E++ G+ P K V+ E+ + + +E+Y+
Sbjct: 181 SPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYS 225
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 60/230 (26%), Positives = 108/230 (46%), Gaps = 24/230 (10%)
Query: 562 DVGSGGYGKVYKGTL-------PNGQLIAIKRAQQ-GSMQGGQEFKMEIELLSRVHHKNL 613
++G G +G VY+G P + +AIK + SM+ EF E ++ + ++
Sbjct: 13 ELGQGSFGMVYEGIAKGVVKDEPETR-VAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 71
Query: 614 VSLLGFCFDRGEQMLIYEFVPNG-------SLGDSLSGKNGIRLDWIRRL-KIALGAARG 665
V LLG ++I E + G SL + ++++ ++A A G
Sbjct: 72 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADG 131
Query: 666 LSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMG-- 723
++YL+ AN +HRD+ + N ++ E K+ DFG+++ + E D+ KG +
Sbjct: 132 MAYLN--ANK-FVHRDLAARNCMVAEDFTVKIGDFGMTRDI--YETDYYRKGGKGLLPVR 186
Query: 724 YLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMD 773
++ PE T SDV+SFGV++ E+ T +G + +R VM+
Sbjct: 187 WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVME 236
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 46/174 (26%), Positives = 83/174 (47%), Gaps = 17/174 (9%)
Query: 596 QEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNG------IR 649
++ + E LL+++ H N+V+ G ++ E+ G L + + G
Sbjct: 43 EDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTI 102
Query: 650 LDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDS 709
L W ++ + G+ ++HE ++HRDIKS NI L + K+ DFG ++ ++ S
Sbjct: 103 LQWFVQMCL------GVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLT-S 152
Query: 710 EKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKY 763
+ T V GT Y+ PE + KSD++S G ++ EL T + P + +
Sbjct: 153 PGAYACTYV-GTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 3e-11
Identities = 60/218 (27%), Positives = 98/218 (44%), Gaps = 40/218 (18%)
Query: 557 FSDANDVGSGGYGKVYKG-TLPNGQLIAIK---RAQQGSMQGGQEFKMEIELLSRVHHKN 612
+ + + VGSG YG V G +A+K R Q + + ++ E+ LL + H+N
Sbjct: 19 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHEN 77
Query: 613 LVSLLGFCFDRGEQMLIYEFVPNGSLGDS-----LSGKNGIRLDWIRRLK---------I 658
++ LL F P SL + ++ G L+ I + + +
Sbjct: 78 VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 125
Query: 659 ALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQV 718
RGL Y+H + IIHRD+K SN+ ++E K+ DFGL++ D ++ T+
Sbjct: 126 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR- 181
Query: 719 KGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGR 755
Y PE + + D++S G +M ELLTGR
Sbjct: 182 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 4e-11
Identities = 54/209 (25%), Positives = 95/209 (45%), Gaps = 26/209 (12%)
Query: 563 VGSGGYGKVYKG-TLPNGQLIAIKRAQQGSMQGG--QEFKMEIELLSRVHHKN-LVSLLG 618
+G G YGKVYK G+L+A+K+ + + G EI LL + +V LL
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLL- 67
Query: 619 FCFDRGEQ-------MLIYEFVPNG--SLGDSLSGKNGIRLD--WIRRLKIALGAARGLS 667
+ E+ L++E++ + DS G L I+ L +G++
Sbjct: 68 -DVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQL--LKGVA 124
Query: 668 YLHELANPPIIHRDIKSSNILLDERLNA-KVADFGLSKSMSDSEKDHITTQVKGTMGYLD 726
+ H+ ++HRD+K N+L+D++ K+AD GL ++ S K + V T+ Y
Sbjct: 125 HCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV--TLWYRA 179
Query: 727 PEYYM-TQQLTEKSDVYSFGVLMLELLTG 754
PE + + + D++S G + E+
Sbjct: 180 PEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 5e-11
Identities = 53/208 (25%), Positives = 94/208 (45%), Gaps = 11/208 (5%)
Query: 556 NFSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSM---QGGQEFKMEIELLSRVHHK 611
NF +G G + +VY+ T L +G +A+K+ Q + + + EI+LL +++H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 612 NLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSG-KNGIRLDWIRRL-KIALGAARGLSYL 669
N++ + E ++ E G L + K RL + + K + L ++
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122
Query: 670 HELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEY 729
H + ++HRDIK +N+ + K+ D GL + S K + GT Y+ PE
Sbjct: 123 H---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVGTPYYMSPER 177
Query: 730 YMTQQLTEKSDVYSFGVLMLELLTGRRP 757
KSD++S G L+ E+ + P
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 6e-11
Identities = 57/213 (26%), Positives = 105/213 (49%), Gaps = 13/213 (6%)
Query: 563 VGSGGYGKVYKG-TLPNGQLIAIKRAQQGSMQGGQEFKM-EIELLSRVHHKNLVSLLGFC 620
+G G Y V+KG + L+A+K + +G + E+ LL + H N+V+L
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV 73
Query: 621 FDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIAL-GAARGLSYLHELANPPIIH 679
L++E++ + L + I + +KI L RGL+Y H ++H
Sbjct: 74 HTDKSLTLVFEYL-DKDLKQYMDDCGNIMS--MHNVKIFLYQILRGLAYCHRRK---VLH 127
Query: 680 RDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYM-TQQLTEK 738
RD+K N+L++ER K+ADFGL+++ S K + V T+ Y P+ + + + + +
Sbjct: 128 RDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLGSSEYSTQ 185
Query: 739 SDVYSFGVLMLELLTGRRPIERGKYIVREIRTV 771
D++ G + E+ +G RP+ G + E+ +
Sbjct: 186 IDMWGVGCIFFEMASG-RPLFPGSTVEDELHLI 217
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 6e-11
Identities = 61/201 (30%), Positives = 90/201 (44%), Gaps = 14/201 (6%)
Query: 563 VGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQGGQEFKMEIE----LLSRVHHKNLVSLL 617
+G G +GKV +G+ A+K Q+ ++ +E K + LL V H LV L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL- 61
Query: 618 GFCFDRGEQM-LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPP 676
+ F +++ + ++V G L L + R A A L YLH L
Sbjct: 62 HYSFQTADKLYFVLDYVNGGELFFHLQRER--SFPEPRARFYAAEIASALGYLHSLN--- 116
Query: 677 IIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLT 736
II+RD+K NILLD + + + DFGL K + K T+ GT YL PE Q
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK--TTSTFCGTPEYLAPEVLRKQPYD 174
Query: 737 EKSDVYSFGVLMLELLTGRRP 757
D + G ++ E+L G P
Sbjct: 175 RTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 6e-11
Identities = 59/222 (26%), Positives = 103/222 (46%), Gaps = 14/222 (6%)
Query: 555 NNFSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFK----MEIELLSRVH 609
N F VG G YG V K +++AIK+ + + +E K E+++L +
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDS--EENEEVKETTLRELKMLRTLK 58
Query: 610 HKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYL 669
+N+V L RG+ L++E+V L NG+ + +R L A +
Sbjct: 59 QENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKA-----I 113
Query: 670 HELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEY 729
H I+HRDIK N+L+ K+ DFG ++++S+ + T V T Y PE
Sbjct: 114 HWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYV-ATRWYRSPEL 172
Query: 730 YMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTV 771
+ + D++S G ++ EL G +P+ G+ + ++ T+
Sbjct: 173 LLGAPYGKAVDMWSVGCILGELSDG-QPLFPGESEIDQLFTI 213
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 9e-11
Identities = 55/203 (27%), Positives = 90/203 (44%), Gaps = 26/203 (12%)
Query: 563 VGSGGYGKVY----KGTLPNGQLIAIKRAQQGSMQGGQEFK--MEIELLSRVHHKNLVSL 616
+G G +G VY K + +L +K G + + + E +LLS++ H +V
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKF 67
Query: 617 LGFCFDRGEQMLIYEFVPNGSLGDSLS--GKNGIRL------DWIRRLKIALGAARGLSY 668
+R +I E+ L L G L +W +L + G+ Y
Sbjct: 68 HASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLL------GVHY 121
Query: 669 LHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPE 728
+H+ I+HRD+K+ NI L L K+ DFG+S+ + S + T GT Y+ PE
Sbjct: 122 MHQRR---ILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCD--LATTFTGTPYYMSPE 175
Query: 729 YYMTQQLTEKSDVYSFGVLMLEL 751
Q KSD++S G ++ E+
Sbjct: 176 ALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 9e-11
Identities = 80/344 (23%), Positives = 139/344 (40%), Gaps = 96/344 (27%)
Query: 563 VGSGGYGKVYKGTL------PNGQLIAIKRAQQGSMQGGQEFKM-EIELLSRV-HHKNLV 614
+G G +GKV + + + + +A+K ++G+ + M E+++L + HH N+V
Sbjct: 15 LGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVV 74
Query: 615 SLLGFCFDR-GEQMLIYE-----------------FVPN------GSLGDSLSGKNGIRL 650
+LLG C G M+I E F P GK RL
Sbjct: 75 NLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQ-RL 133
Query: 651 D------------WI--RRLKIA-----------------------LGAARGLSYLHELA 673
D +I + L ARG+ +L A
Sbjct: 134 DSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFL---A 190
Query: 674 NPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITT-QVKGTMGYLDPEYYMT 732
+ IHRD+ + NILL E K+ DFGL++ + + D++ + + ++ PE
Sbjct: 191 SRKCIHRDLAARNILLSENNVVKICDFGLARDIY-KDPDYVRKGDARLPLKWMAPESIFD 249
Query: 733 QQLTEKSDVYSFGVLMLELLT-GRRP---IERGKYIVREIRTVMDKKKELYNLYELIDPT 788
+ T +SDV+SFGVL+ E+ + G P ++ + R ++ + Y E+
Sbjct: 250 KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEI---- 305
Query: 789 IGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 832
+ L C + +DRPT SE+V+ + ++LQ+
Sbjct: 306 -------------YSIMLDCWHNNPEDRPTFSELVEILGDLLQE 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 9e-11
Identities = 53/188 (28%), Positives = 92/188 (48%), Gaps = 14/188 (7%)
Query: 581 LIAIKRAQQGSMQGG-QEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLG 639
L+A+K + + ++F E+++LSR+ N+ LLG C +I E++ NG L
Sbjct: 48 LVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLN 107
Query: 640 ---------DSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLD 690
S N L + L +A A G+ YL L +HRD+ + N L+
Sbjct: 108 QFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRNCLVG 164
Query: 691 ERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLE 750
+ K+ADFG+S+++ S+ + + + ++ E + + T KSDV++FGV + E
Sbjct: 165 KNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWE 224
Query: 751 LLT-GRRP 757
+LT R
Sbjct: 225 ILTLCREQ 232
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 1e-10
Identities = 77/348 (22%), Positives = 132/348 (37%), Gaps = 100/348 (28%)
Query: 563 VGSGGYGKVYKGT------LPNGQLIAIKRAQQGSMQGGQEFKM-EIELLSRV-HHKNLV 614
+G G +G+V + + +A+K ++G+ M E+++L + HH N+V
Sbjct: 15 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 74
Query: 615 SLLGFCFDRGEQMLIY------------------EFVP----NGSLGDSLSGKNGIRLDW 652
+LLG C G +++ EFVP + SG I D
Sbjct: 75 NLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDL 134
Query: 653 IRRLK--------------------------------------------IALGAARGLSY 668
RRL + A+G+ +
Sbjct: 135 KRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEF 194
Query: 669 LHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITT-QVKGTMGYLDP 727
L A+ IHRD+ + NILL E K+ DFGL++ + + D++ + + ++ P
Sbjct: 195 L---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIY-KDPDYVRKGDARLPLKWMAP 250
Query: 728 EYYMTQQLTEKSDVYSFGVLMLELLT-GRRP---IERGKYIVREIRTVMDKKKELYNLYE 783
E + T +SDV+SFGVL+ E+ + G P ++ + R ++ + Y E
Sbjct: 251 ETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPE 310
Query: 784 LIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQ 831
+ L C RPT SE+V+ + N+LQ
Sbjct: 311 MYQTM-----------------LDCWHGEPSQRPTFSELVEHLGNLLQ 341
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 48/181 (26%), Positives = 85/181 (46%), Gaps = 10/181 (5%)
Query: 578 NGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGS 637
+G+ +A+K Q + E+ ++ H+N+V + E ++ EF+ G+
Sbjct: 45 SGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104
Query: 638 LGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKV 697
L D +S RL+ + + + L YLH +IHRDIKS +ILL K+
Sbjct: 105 LTDIVSQ---TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKL 158
Query: 698 ADFGLSKSMS-DSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRR 756
+DFG +S D K + GT ++ PE + D++S G++++E++ G
Sbjct: 159 SDFGFCAQISKDVPK---RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEP 215
Query: 757 P 757
P
Sbjct: 216 P 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 1e-10
Identities = 57/235 (24%), Positives = 103/235 (43%), Gaps = 18/235 (7%)
Query: 555 NNFSDANDVGSGGYGKVY----KGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHH 610
+F + VG G +G+V K T + +K++ + + F+ E ++LS +
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 611 KNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIA-LGAARGLSYL 669
+ L D+ L+ E+ P G L L+ + + + +A L A + +
Sbjct: 61 PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLA--IHSV 118
Query: 670 HELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEY 729
H++ +HRDIK N+L+D + K+ADFG + + + K + GT Y+ PE
Sbjct: 119 HQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARL-TANKMVNSKLPVGTPDYIAPEV 174
Query: 730 YMTQQLTEKS------DVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKEL 778
T K D +S GV+ E++ GR P G + +M+ ++ L
Sbjct: 175 LTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGT-SAKTYNNIMNFQRFL 228
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 53/196 (27%), Positives = 93/196 (47%), Gaps = 10/196 (5%)
Query: 563 VGSGGYGKVYKG-TLPNGQLIAIKRAQQGSMQGGQEFKM-EIELLSRVHHKNLVSLLGFC 620
+G G Y VYKG + NGQL+A+K + +G + E LL + H N+V L
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDII 72
Query: 621 FDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHR 680
+ ++E++ + G+ +R L RGL+Y+H I+HR
Sbjct: 73 HTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQL--LRGLAYIH---GQHILHR 127
Query: 681 DIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYM-TQQLTEKS 739
D+K N+L+ K+ADFGL+++ S + + + V T+ Y P+ + +
Sbjct: 128 DLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPDVLLGATDYSSAL 185
Query: 740 DVYSFGVLMLELLTGR 755
D++ G + +E+L G+
Sbjct: 186 DIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 1e-10
Identities = 57/205 (27%), Positives = 91/205 (44%), Gaps = 18/205 (8%)
Query: 563 VGSGGYGKVY----KGTLPNGQLIAIKRAQQGSMQGGQEFK---MEIELLSRVHHKNLVS 615
+G G +GKV KGT ++ AIK ++ + + E +L+ ++
Sbjct: 3 LGKGSFGKVMLAELKGT---DEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLT 59
Query: 616 LLGFCFDRGEQML-IYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELAN 674
L CF +++ + E+V G L + + + D R A L +LH
Sbjct: 60 ALHCCFQTKDRLFFVMEYVNGGDLMFQI--QRSRKFDEPRSRFYAAEVTLALMFLHRHG- 116
Query: 675 PPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQ 734
+I+RD+K NILLD + K+ADFG+ K TT GT Y+ PE +
Sbjct: 117 --VIYRDLKLDNILLDAEGHCKLADFGMCK--EGILNGVTTTTFCGTPDYIAPEILQELE 172
Query: 735 LTEKSDVYSFGVLMLELLTGRRPIE 759
D ++ GVLM E++ G+ P E
Sbjct: 173 YGPSVDWWALGVLMYEMMAGQPPFE 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 62/201 (30%), Positives = 99/201 (49%), Gaps = 22/201 (10%)
Query: 564 GSGGYGKVYKG-TLPNGQLIAIK--RAQQGSMQGGQEFKM--EIELLSRVHHKNLVSLLG 618
G G Y VYKG + GQL+A+K R + + G F E LL + H N+V+L
Sbjct: 14 GEGSYATVYKGRSKLTGQLVALKEIRLEH---EEGAPFTAIREASLLKDLKHANIVTLHD 70
Query: 619 FCFDRGEQMLIYEFVPNGSLGDSLSG-KNGIRLDWIRRLKIALGAARGLSYLHELANPPI 677
+ L++E++ + L + G+ + +R L RGL+Y H+ +
Sbjct: 71 IIHTKKTLTLVFEYL-DTDLKQYMDDCGGGLSMHNVRLFLFQL--LRGLAYCHQRR---V 124
Query: 678 IHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTE 737
+HRD+K N+L+ ER K+ADFGL+++ S K + V T+ Y P+ + TE
Sbjct: 125 LHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV--TLWYRPPDVLLGS--TE 180
Query: 738 KS---DVYSFGVLMLELLTGR 755
S D++ G + E+ TGR
Sbjct: 181 YSTSLDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 38/98 (38%), Positives = 57/98 (58%), Gaps = 7/98 (7%)
Query: 663 ARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQV-KGT 721
A GL +LH II+RD+K N++LD + K+ADFG+ K ++ D +TT+ GT
Sbjct: 111 AIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK---ENMWDGVTTKTFCGT 164
Query: 722 MGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIE 759
Y+ PE Q + D ++FGVL+ E+L G+ P E
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-10
Identities = 62/234 (26%), Positives = 108/234 (46%), Gaps = 36/234 (15%)
Query: 563 VGSGGYGKVYKGTLPNGQLIAIKRAQQ-GSMQGGQEFKM-----------EIELLSRVHH 610
+G G +G+V QL+ K +Q+ +M+ +F+M E ++++ +
Sbjct: 51 IGRGAFGEV--------QLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 102
Query: 611 KNLVSLLGFCFDRGEQML--IYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSY 668
+V L FC + ++ L + E++P G L + +S + + W + + A L
Sbjct: 103 PWVVQL--FCAFQDDKYLYMVMEYMPGGDLVNLMSNYD-VPEKWAKFYTAEVVLA--LDA 157
Query: 669 LHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPE 728
+H + +IHRD+K N+LLD+ + K+ADFG M ++ T V GT Y+ PE
Sbjct: 158 IHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV-GTPDYISPE 213
Query: 729 YYMTQ----QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKEL 778
+Q + D +S GV + E+L G P +V +MD K L
Sbjct: 214 VLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF-YADSLVGTYSKIMDHKNSL 266
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 2e-10
Identities = 56/211 (26%), Positives = 107/211 (50%), Gaps = 13/211 (6%)
Query: 563 VGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQGGQEFKM---EIELLSRVHHKNLVSLLG 618
+G GG+G+V + G++ A K+ ++ ++ + M E ++L +V+ + +VSL
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL-A 66
Query: 619 FCFDRGEQM-LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPI 677
+ ++ + + L+ + G L + D R + A GL LH I
Sbjct: 67 YAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH---RERI 123
Query: 678 IHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTE 737
++RD+K NILLD+ + +++D GL+ + + E I +V GT+GY+ PE ++ T
Sbjct: 124 VYRDLKPENILLDDYGHIRISDLGLAVEIPEGET--IRGRV-GTVGYMAPEVVKNERYTF 180
Query: 738 KSDVYSFGVLMLELLTGRRPI-ERGKYIVRE 767
D + G L+ E++ G+ P +R + + RE
Sbjct: 181 SPDWWGLGCLIYEMIEGKSPFRQRKEKVKRE 211
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 3e-10
Identities = 58/208 (27%), Positives = 105/208 (50%), Gaps = 17/208 (8%)
Query: 563 VGSGGYGKVYKGTLPN-GQLIAIK--RAQQGSMQGGQEFKM-EIELLSRVHHKN--LVSL 616
+G GG+G+VY + G++ A+K ++ M+ G+ + E +LS V + +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 617 LGFCFDRGEQM-LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANP 675
+ + F +++ I + + G L LS ++G+ + R A GL ++H N
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHLS-QHGVFSEKEMRF-YATEIILGLEHMH---NR 116
Query: 676 PIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQL 735
+++RD+K +NILLDE + +++D GL+ S +K H + GT GY+ PE
Sbjct: 117 FVVYRDLKPANILLDEHGHVRISDLGLACDFS-KKKPHASV---GTHGYMAPEVLQKGTA 172
Query: 736 TEKS-DVYSFGVLMLELLTGRRPIERGK 762
+ S D +S G ++ +LL G P + K
Sbjct: 173 YDSSADWFSLGCMLFKLLRGHSPFRQHK 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 3e-10
Identities = 35/98 (35%), Positives = 54/98 (55%), Gaps = 7/98 (7%)
Query: 663 ARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSK-SMSDSEKDHITTQVKGT 721
A GL +LH + II+RD+K N++LD + K+ADFG+ K ++ T GT
Sbjct: 111 AIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG---GKTTRTFCGT 164
Query: 722 MGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIE 759
Y+ PE Q + D ++FGVL+ E+L G+ P +
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 3e-10
Identities = 39/109 (35%), Positives = 64/109 (58%), Gaps = 9/109 (8%)
Query: 664 RGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKD---HITTQVKG 720
GL Y+H AN ++HRD+K N+L++ K+ DFGL++ S++ + +T V
Sbjct: 116 CGLKYIHS-AN--VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYV-A 171
Query: 721 TMGYLDPEYYMTQQLTEKS-DVYSFGVLMLELLTGRRPIERGKYIVREI 768
T Y PE ++ Q K+ DV+S G ++ ELL GR+P+ +GK V ++
Sbjct: 172 TRWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPVFKGKDYVDQL 219
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 4e-10
Identities = 47/159 (29%), Positives = 69/159 (43%), Gaps = 20/159 (12%)
Query: 628 LIYEFVPNGSLGDSLSGKNGIRLDWIR----RLKIALGAARGLSYLHELANPPIIHRDIK 683
++ E++P G L +L I W R + +AL A + + IHRD+K
Sbjct: 120 MVMEYMPGGDLV-NLMSNYDIPEKWARFYTAEVVLALDAIHSMGF---------IHRDVK 169
Query: 684 SSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQ----QLTEKS 739
N+LLD+ + K+ADFG M + T V GT Y+ PE +Q +
Sbjct: 170 PDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGREC 228
Query: 740 DVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKEL 778
D +S GV + E+L G P V +MD K L
Sbjct: 229 DWWSVGVFLYEMLVGDTPFYADSL-VGTYSKIMDHKNSL 266
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 4e-10
Identities = 59/230 (25%), Positives = 101/230 (43%), Gaps = 41/230 (17%)
Query: 563 VGSGGYGKVYKG-TLPNGQLIAIK---RAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLG 618
VGSG YG V Q +A+K R Q + + ++ E+ LL + H+N++ LL
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYR-ELRLLKHMKHENVIGLLD 81
Query: 619 FCFDRGEQMLIYEFVPNGSLGD--------SLSGKNGIRLDWIRRLK------IALGAAR 664
F P S+ + +L G + + ++L + R
Sbjct: 82 V------------FTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLR 129
Query: 665 GLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGY 724
GL Y+H IIHRD+K SN+ ++E ++ DFGL++ D ++ T+ Y
Sbjct: 130 GLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATR-----WY 181
Query: 725 LDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMD 773
PE + + D++S G +M ELL G+ YI +++ +M+
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYI-DQLKRIME 230
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 5e-10
Identities = 60/243 (24%), Positives = 100/243 (41%), Gaps = 61/243 (25%)
Query: 563 VGSGGYGKV----YKGTLPNGQLIAIKRAQQGSM-QGGQ--EFKMEIELLSRVHHKNLVS 615
+G G +G+V K T G + A+K+ ++ M + Q + E ++L+ + +V
Sbjct: 9 IGRGAFGEVRLVQKKDT---GHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVK 65
Query: 616 LLGFCF-DRGEQMLIYEFVPNGSLGDSLSGKNGIRLD----WIRRLKIALGAARGLSYLH 670
L + F D LI E++P G + L K+ + +I +A+ + L Y
Sbjct: 66 LY-YSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGY-- 122
Query: 671 ELANPPIIHRDIKSSNILLDERLNAKVADFGLS---KSMSDSEKDHITTQVK-------- 719
IHRDIK N+LLD + + K++DFGL K +E I +
Sbjct: 123 -------IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFI 175
Query: 720 -------------------------GTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTG 754
GT Y+ PE ++ ++ D +S GV+M E+L G
Sbjct: 176 SKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235
Query: 755 RRP 757
P
Sbjct: 236 YPP 238
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 5e-10
Identities = 62/204 (30%), Positives = 92/204 (45%), Gaps = 20/204 (9%)
Query: 563 VGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQGGQEFKMEIE----LLSRVHHKNLVSLL 617
+G G +GKV +G+ A+K Q+ + +E K + LL V H LV L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL- 61
Query: 618 GFCFDRGEQM-LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPP 676
+ F E++ + +FV G L L + R + +A L YLH +
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASA--LGYLHSIN--- 116
Query: 677 IIHRDIKSSNILLDERLNAKVADFGLSK---SMSDSEKDHITTQVKGTMGYLDPEYYMTQ 733
I++RD+K NILLD + + + DFGL K + SD+ TT GT YL PE Q
Sbjct: 117 IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT-----TTTFCGTPEYLAPEVIRKQ 171
Query: 734 QLTEKSDVYSFGVLMLELLTGRRP 757
D + G ++ E+L G P
Sbjct: 172 PYDNTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 6e-10
Identities = 32/96 (33%), Positives = 51/96 (53%), Gaps = 7/96 (7%)
Query: 69 LSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKN 128
L L++ G G +P I L +L ++L+ N + G IP S G+ L++L N
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVL------DLSYN 476
Query: 129 QLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLG 164
+GSIPE L + + I + + N+L+G +PA LG
Sbjct: 477 SFNGSIPESLGQLTSLRI-LNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 7e-10
Identities = 58/209 (27%), Positives = 101/209 (48%), Gaps = 26/209 (12%)
Query: 563 VGSGGYGKVY----KGTLPNGQLIAIKRAQQGSMQGGQEFK---MEIELLSRVHHKNLVS 615
+G G +GKV KGT +L AIK ++ + + + +E +L+ ++
Sbjct: 8 LGKGSFGKVMLAERKGT---DELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLT 64
Query: 616 LLGFCFDRGEQM-LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAAR---GLSYLHE 671
L CF +++ + E+V G L + ++ + + AA GL +LH
Sbjct: 65 QLHSCFQTVDRLYFVMEYVNGGDLMYHIQ-----QVGKFKEPQAVFYAAEISVGLFFLHR 119
Query: 672 LANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQV-KGTMGYLDPEYY 730
II+RD+K N++LD + K+ADFG+ K + D +TT+ GT Y+ PE
Sbjct: 120 RG---IIYRDLKLDNVMLDSEGHIKIADFGMCK---EHMVDGVTTRTFCGTPDYIAPEII 173
Query: 731 MTQQLTEKSDVYSFGVLMLELLTGRRPIE 759
Q + D +++GVL+ E+L G+ P +
Sbjct: 174 AYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 8e-10
Identities = 63/233 (27%), Positives = 96/233 (41%), Gaps = 43/233 (18%)
Query: 545 FSFEEVKKYT----NNFSDANDVGSGGYGKVYKGT-LPNGQLIAIK---RAQQGSMQGGQ 596
F EEV K ++ VGSG YG V G+ +AIK R Q + +
Sbjct: 1 FYREEVNKTVWELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKR 60
Query: 597 EFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGD-------------SLS 643
++ E+ LL + H+N++ LL D F S + L
Sbjct: 61 AYR-ELTLLKHMQHENVIGLL----DV--------FTSAVSGDEFQDFYLVMPYMQTDLQ 107
Query: 644 GKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLS 703
G L + + GL Y+H IIHRD+K N+ ++E K+ DFGL+
Sbjct: 108 KIMGHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLA 164
Query: 704 KSMSDSEKDHITTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGR 755
+ +D+E T T Y PE + + D++S G +M E+LTG+
Sbjct: 165 RH-ADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 1e-09
Identities = 57/204 (27%), Positives = 89/204 (43%), Gaps = 21/204 (10%)
Query: 563 VGSGGYGKVY----KGTLPNGQLIAIKRAQQGSMQGGQEFK---MEIELLSRVHHKNLVS 615
+G G +GKV K T G+ A+K ++ + E E +L H L +
Sbjct: 3 LGKGTFGKVILVREKAT---GKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTA 59
Query: 616 LLGFCFDRGEQM-LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELAN 674
L + F +++ + E+ G L LS + D R + +A L YLH
Sbjct: 60 L-KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSA--LGYLHSCD- 115
Query: 675 PPIIHRDIKSSNILLDERLNAKVADFGLSKS-MSDSEKDHITTQVKGTMGYLDPEYYMTQ 733
+++RD+K N++LD+ + K+ DFGL K +SD GT YL PE
Sbjct: 116 --VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGAT---MKTFCGTPEYLAPEVLEDN 170
Query: 734 QLTEKSDVYSFGVLMLELLTGRRP 757
D + GV+M E++ GR P
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 53/202 (26%), Positives = 92/202 (45%), Gaps = 12/202 (5%)
Query: 563 VGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQGGQEF---KMEIELLSRVHHKNLVSLLG 618
+G G Y KV L N Q+ A+K ++ + ++ + E + + + L
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 619 FCFDRGEQM-LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPI 677
CF ++ L+ E+V G L + + + + R + A L++LHE I
Sbjct: 63 SCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIA--LNFLHERG---I 117
Query: 678 IHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTE 737
I+RD+K N+LLD + K+ D+G+ K T+ GT Y+ PE ++
Sbjct: 118 IYRDLKLDNVLLDADGHIKLTDYGMCKE--GLGPGDTTSTFCGTPNYIAPEILRGEEYGF 175
Query: 738 KSDVYSFGVLMLELLTGRRPIE 759
D ++ GVLM E++ GR P +
Sbjct: 176 SVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 1e-09
Identities = 59/225 (26%), Positives = 101/225 (44%), Gaps = 32/225 (14%)
Query: 555 NNFSDANDVGSGGYGKVY----KGTLPNGQLIAIKRAQQGSM----QGGQEFKMEIELLS 606
+F + +G YG VY K T Q A+K+ + ++ Q Q F +E ++L+
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETR---QRFAMKKINKQNLILRNQIQQVF-VERDILT 56
Query: 607 RVHHKNLVSLLGFCFDRGEQM-LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARG 665
+ +VS+ F+ + ++ E+V G L + +D + R+ A
Sbjct: 57 FAENPFVVSMFC-SFETKRHLCMVMEYVEGGDCATLLKNIGALPVD-MARMYFA-ETVLA 113
Query: 666 LSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSK-------------SMSDSEKD 712
L YLH N I+HRD+K N+L+ + K+ DFGLSK + ++
Sbjct: 114 LEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170
Query: 713 HITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRP 757
+ QV GT Y+ PE + Q + D ++ G+++ E L G P
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 58/208 (27%), Positives = 105/208 (50%), Gaps = 17/208 (8%)
Query: 563 VGSGGYGKVYKGTLPN-GQLIAIK--RAQQGSMQGGQEFKM-EIELLSRVHHKN--LVSL 616
+G GG+G+VY + G++ A+K ++ M+ G+ + E +LS V + +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 617 LGFCFDRGEQM-LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANP 675
+ + F +++ I + + G L LS ++G+ + R A GL ++H N
Sbjct: 62 MSYAFHTPDKLSFILDLMNGGDLHYHLS-QHGVFSEAEMRF-YAAEIILGLEHMH---NR 116
Query: 676 PIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQL 735
+++RD+K +NILLDE + +++D GL+ S +K H + GT GY+ PE
Sbjct: 117 FVVYRDLKPANILLDEHGHVRISDLGLACDFS-KKKPHASV---GTHGYMAPEVLQKGVA 172
Query: 736 TEKS-DVYSFGVLMLELLTGRRPIERGK 762
+ S D +S G ++ +LL G P + K
Sbjct: 173 YDSSADWFSLGCMLFKLLRGHSPFRQHK 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 54/202 (26%), Positives = 91/202 (45%), Gaps = 19/202 (9%)
Query: 563 VGSGGYGKVYKGT-LPNGQLIAIK--RAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGF 619
+G G YG VYK + IA+K R +Q EI LL + H N+V L
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69
Query: 620 CFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIA----LGAARGLSYLHELANP 675
L++E+ L L D+ + ++ RG++Y H +
Sbjct: 70 VHSEKRLYLVFEY-----LDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH---SH 121
Query: 676 PIIHRDIKSSNILLDERLNA-KVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYM-TQ 733
++HRD+K N+L+D R NA K+ADFGL+++ + V T+ Y PE + ++
Sbjct: 122 RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV--TLWYRAPEILLGSR 179
Query: 734 QLTEKSDVYSFGVLMLELLTGR 755
+ D++S G + E++ +
Sbjct: 180 HYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.3 bits (148), Expect = 2e-09
Identities = 61/245 (24%), Positives = 107/245 (43%), Gaps = 49/245 (20%)
Query: 555 NNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQG------SMQGGQE-----FKMEIE 603
N + +G+G +G+V+ L+ KR Q+ S +G +E +E+
Sbjct: 13 NEYEVIKKIGNGRFGEVF--------LVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVN 64
Query: 604 LLSRVHHKNLVSLLGFCFDRGEQML--IYEFVPNGSLGDSLSG--KNGIRLDWIRRLKIA 659
++ + HKN+V + ++ Q L + EF G L ++ K +++ + I
Sbjct: 65 VMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDIT 124
Query: 660 LGAARGLSYLHELANPP----IIHRDIKSSNILL-----------------DERLNAKVA 698
L+Y H L + P ++HRD+K NI L + R AK+
Sbjct: 125 RQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIG 184
Query: 699 DFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYM--TQQLTEKSDVYSFGVLMLELLTGRR 756
DFGLSK++ H GT Y PE + T+ +KSD+++ G ++ EL +G+
Sbjct: 185 DFGLSKNIGIESMAH---SCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKT 241
Query: 757 PIERG 761
P +
Sbjct: 242 PFHKA 246
|
Length = 1021 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 58/201 (28%), Positives = 89/201 (44%), Gaps = 14/201 (6%)
Query: 563 VGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQGGQEFKMEIE----LLSRVHHKNLVSLL 617
+G G +GKV +G A+K Q+ ++ +E + LL + H LV L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL- 61
Query: 618 GFCFDRGEQM-LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPP 676
+ F E++ + ++V G L L + R + +A G YLH L
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIG--YLHSLN--- 116
Query: 677 IIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLT 736
II+RD+K NILLD + + + DFGL K E + T+ GT YL PE +
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFCGTPEYLAPEVLRKEPYD 174
Query: 737 EKSDVYSFGVLMLELLTGRRP 757
D + G ++ E+L G P
Sbjct: 175 RTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-09
Identities = 53/175 (30%), Positives = 87/175 (49%), Gaps = 26/175 (14%)
Query: 663 ARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGT- 721
ARG+ +L A+ IHRD+ + NILL E K+ DFGL++ + + D++ KG+
Sbjct: 184 ARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIY-KDPDYVR---KGSA 236
Query: 722 ---MGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKE 777
+ ++ PE + T +SDV+SFGVL+ E+ + G P Y +I ++
Sbjct: 237 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASP-----YPGVQINEEFCQR-- 289
Query: 778 LYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 832
L D T + E Y + L C Q +RPT S +V+ + ++LQ+
Sbjct: 290 ------LKDGTRMRAPENATPEIY-RIMLACWQGDPKERPTFSALVEILGDLLQE 337
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 3e-09
Identities = 61/240 (25%), Positives = 106/240 (44%), Gaps = 28/240 (11%)
Query: 526 HWDMNKSSGSIPQLKGARCFSFEEVKKYTNNFSDANDVGSGGYGKVYKGTLPNGQL--IA 583
K S S + K +E+ F+ +G+G +G+V T N +A
Sbjct: 8 QLHKKKDSDSTKEPKRKNKMKYED-------FNFIRTLGTGSFGRVILATYKNEDFPPVA 60
Query: 584 IKRAQQGSMQGGQEFK---MEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGD 640
IKR ++ + ++ E ++L+ ++H V+L G D L+ EFV G
Sbjct: 61 IKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFT 120
Query: 641 SLSGKNGIRLDWIRRLKIALG---AARGLSYLHELANPPIIHRDIKSSNILLDERLNAKV 697
L +N +R +G AA+ + L + I++RD+K N+LLD+ K+
Sbjct: 121 FLR-RN-------KRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKM 172
Query: 698 ADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRP 757
DFG +K + D T + GT Y+ PE + + +D ++ G+ + E+L G P
Sbjct: 173 TDFGFAKVV-----DTRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPP 227
|
Length = 340 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 3e-09
Identities = 61/247 (24%), Positives = 104/247 (42%), Gaps = 56/247 (22%)
Query: 555 NNFSDANDVGSGGYGKVY----KGTLPNGQLIAIKRAQQGSMQGGQE---FKMEIELLSR 607
++F +G G +G+V K T G + A+K ++ M ++ + E ++L
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDT---GHIYAMKILRKADMLEKEQVAHIRAERDILVE 57
Query: 608 VHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLD----WIRRLKIALGAA 663
+V + D+ LI EF+P G + L K+ + + +I +A+ A
Sbjct: 58 ADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDA- 116
Query: 664 RGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSM----------------- 706
+H+L IHRDIK N+LLD + + K++DFGL +
Sbjct: 117 -----IHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPP 168
Query: 707 SDSEKDHITTQVK----------------GTMGYLDPEYYMTQQLTEKSDVYSFGVLMLE 750
SD ++ ++ K GT Y+ PE +M + D +S GV+M E
Sbjct: 169 SDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYE 228
Query: 751 LLTGRRP 757
+L G P
Sbjct: 229 MLIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 3e-09
Identities = 58/212 (27%), Positives = 90/212 (42%), Gaps = 40/212 (18%)
Query: 563 VGSGGYGKV---YKGTLPNGQLIAIKRAQ---QGSMQGGQEFKMEIELLSRVHHKNLVSL 616
+GSG G V Y GQ +AIK+ Q + ++ E+ L+ V+HKN++ L
Sbjct: 24 IGSGAQGIVCAAYDTVT--GQNVAIKKLSRPFQNVTHAKRAYR-ELVLMKLVNHKNIIGL 80
Query: 617 LGFCFDRGEQMLIYEFVPNGSLGD-------------SLSGKNGIRLDWIRRLKIALGAA 663
L F P SL + +L + LD R +
Sbjct: 81 LNV------------FTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQML 128
Query: 664 RGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMG 723
G+ +LH + IIHRD+K SNI++ K+ DFGL+++ S + T T
Sbjct: 129 CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVVTRY 182
Query: 724 YLDPEYYMTQQLTEKSDVYSFGVLMLELLTGR 755
Y PE + E D++S G +M E++ G
Sbjct: 183 YRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.8 bits (143), Expect = 3e-09
Identities = 64/254 (25%), Positives = 98/254 (38%), Gaps = 59/254 (23%)
Query: 564 GSGGYGKVY----KGTLPNGQLIAIKRAQQGSMQGGQEFK---MEIELLSRVHHKNLVSL 616
G G G+V+ KGT G+L A+K + M + K E E+L+ + H L +L
Sbjct: 10 GKGDVGRVFLVRLKGT---GKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTL 66
Query: 617 LGFCFDRGEQM-LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAAR--------GLS 667
F + L+ ++ P G L L + G + L AR L
Sbjct: 67 YA-SFQTETYLCLVMDYCPGGELFRLLQRQPG------KCLSEE--VARFYAAEVLLALE 117
Query: 668 YLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSM---------------SDSEKD 712
YLH L I++RD+K NILL E + ++DF LSK S +
Sbjct: 118 YLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVN 174
Query: 713 HITTQVK------------GTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIER 760
I ++ GT Y+ PE D ++ G+L+ E+L G P +
Sbjct: 175 SIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPF-K 233
Query: 761 GKYIVREIRTVMDK 774
G ++ K
Sbjct: 234 GSNRDETFSNILKK 247
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 4e-09
Identities = 34/93 (36%), Positives = 51/93 (54%), Gaps = 6/93 (6%)
Query: 666 LSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYL 725
L +LH+ I++RD+K NILLD + + DFGLSK ++ + T GT YL
Sbjct: 109 LEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTEYL 163
Query: 726 DPEYYMTQQ-LTEKSDVYSFGVLMLELLTGRRP 757
PE + ++ T+ D +S GVL+ E+ G P
Sbjct: 164 APEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSP 196
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 5e-09
Identities = 70/278 (25%), Positives = 126/278 (45%), Gaps = 33/278 (11%)
Query: 562 DVGSGGYGKVYKGTLPNG----QLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLL 617
++G+G +GKV G + +G Q++ + S+Q +F E + + H NL+ L
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 618 GFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRL---DWIRRLKIALGAARGLSYLHELAN 674
G C + +L+ EF P G L L L D ++A A GL +LH+
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK--- 118
Query: 675 PPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITT--QVKGTMGYLDPEY--- 729
IH D+ N LL L K+ D+GLS + ++D+ T Q+ + ++ PE
Sbjct: 119 NNFIHSDLALRNCLLTADLTVKIGDYGLSH--NKYKEDYYVTPDQLWVPLRWIAPELVDE 176
Query: 730 ----YMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYEL 784
+ T++S+V+S GV + EL G +P ++ T ++++L +L
Sbjct: 177 VHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRH--LSDEQVLTYTVREQQL----KL 230
Query: 785 IDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEV 822
P + L + +++ ++ C + + RP+ EV
Sbjct: 231 PKPRLKLPLS----DRWYEVMQFCWLQP-EQRPSAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 58.6 bits (141), Expect = 5e-09
Identities = 62/236 (26%), Positives = 104/236 (44%), Gaps = 22/236 (9%)
Query: 546 SFEEVKKYTNNFSDANDVGSGGYGKV---YKGTLP-NGQLIAIKRAQQGSMQGGQEFKME 601
+F +K+Y N +GSG G V Y L N + + R Q + ++ E
Sbjct: 12 TFTVLKRYQN----LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-E 66
Query: 602 IELLSRVHHKNLVSLLG-FCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIAL 660
+ L+ V+HKN++SLL F + + ++ + +L + LD R +
Sbjct: 67 LVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLY 126
Query: 661 GAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKG 720
G+ +LH IIHRD+K SNI++ K+ DFGL+++ S + T
Sbjct: 127 QMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVV 180
Query: 721 TMGYLDPEYYMTQQLTEKSDVYSFGVLMLE------LLTGRRPIERGKYIVREIRT 770
T Y PE + E D++S G +M E L GR I++ ++ ++ T
Sbjct: 181 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGT 236
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 5e-09
Identities = 51/202 (25%), Positives = 86/202 (42%), Gaps = 12/202 (5%)
Query: 563 VGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQE----FKMEIELLSRVHHKNLVSLLG 618
+G G Y KV L + I + + + E + E + + + + L
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 619 FCFDRGEQML-IYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPI 677
CF ++ + E+V G L + + + + R + A L+YLHE I
Sbjct: 63 SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA--LNYLHERG---I 117
Query: 678 IHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTE 737
I+RD+K N+LLD + K+ D+G+ K T+ GT Y+ PE +
Sbjct: 118 IYRDLKLDNVLLDSEGHIKLTDYGMCKE--GLRPGDTTSTFCGTPNYIAPEILRGEDYGF 175
Query: 738 KSDVYSFGVLMLELLTGRRPIE 759
D ++ GVLM E++ GR P +
Sbjct: 176 SVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 6e-09
Identities = 66/256 (25%), Positives = 100/256 (39%), Gaps = 62/256 (24%)
Query: 555 NNFSDANDVGSGGYGKV-YKGTLPNGQLIAIKRAQQGSMQGGQEF---KMEIELLSRVHH 610
+F +G G +G+V G++ A+K + M + K E ++L+
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60
Query: 611 KNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDW----IRRLKIALGAARGL 666
+VSL D LI EF+P G L L I+ D + R +A +
Sbjct: 61 PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTML-----IKYDTFSEDVTRFYMA-ECVLAI 114
Query: 667 SYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSK---------------------- 704
+H+L IHRDIK NIL+D + K++DFGLS
Sbjct: 115 EAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKN 171
Query: 705 -------------SMSDSEKDHITTQVK----------GTMGYLDPEYYMTQQLTEKSDV 741
+++ S KD I T K GT Y+ PE ++ Q ++ D
Sbjct: 172 RIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDW 231
Query: 742 YSFGVLMLELLTGRRP 757
+S G +M E L G P
Sbjct: 232 WSLGAIMFECLIGWPP 247
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 1e-08
Identities = 71/224 (31%), Positives = 99/224 (44%), Gaps = 26/224 (11%)
Query: 7 LSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQEL 66
L ++ L L L S L + NL L +L L I + L L
Sbjct: 62 LPSSLSRLLSLDLLSPSGISSL--DGSENLLNLLPLPSLDLNLNRLRSNI-SELLELTNL 118
Query: 67 VLLSLNSNGFSGRVPPSIGNL-SNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHF 125
L L++N + +PP IG L SNL LDL+DNK+E +P N P L L
Sbjct: 119 TSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLD------L 170
Query: 126 GKNQLS-----GSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLS 180
N LS S L D+ S N +LP + L+ +LE + NS+
Sbjct: 171 SFNDLSDLPKLLSNLSNLNNLDL--------SGNKISDLPPEIELLSALEELDLSNNSII 222
Query: 181 GPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNN 224
+ S+L+NL +++ L LSNNKL ++ LS L LD+SNN
Sbjct: 223 -ELLSSLSNLKNLSGLELSNNKLEDLPESIGNLSNLETLDLSNN 265
|
Length = 394 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 1e-08
Identities = 60/246 (24%), Positives = 103/246 (41%), Gaps = 56/246 (22%)
Query: 556 NFSDANDVGSGGYGKVY----KGTLPNGQLIAIKRAQQGSMQGGQE---FKMEIELLSRV 608
+F +G G +G+V K T G + A+K ++ M ++ + E ++L
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDT---GHVYAMKILRKADMLEKEQVGHIRAERDILVEA 58
Query: 609 HHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLD----WIRRLKIALGAAR 664
+V + D+ LI EF+P G + L K+ + + +I +A+ +
Sbjct: 59 DSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDS-- 116
Query: 665 GLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSM-----------------S 707
+H+L IHRDIK N+LLD + + K++DFGL + S
Sbjct: 117 ----IHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPS 169
Query: 708 DSEKDHITTQVK----------------GTMGYLDPEYYMTQQLTEKSDVYSFGVLMLEL 751
D ++ ++ K GT Y+ PE +M + D +S GV+M E+
Sbjct: 170 DFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEM 229
Query: 752 LTGRRP 757
L G P
Sbjct: 230 LIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 1e-08
Identities = 51/211 (24%), Positives = 95/211 (45%), Gaps = 30/211 (14%)
Query: 562 DVGSGGYGKVYKGTL---PNGQLIAIKRAQ-QGSMQGGQEFKMEIELLSRVHHKNLVSLL 617
++G+G +GKV + + +K + S + EF + + + H N++ L
Sbjct: 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61
Query: 618 GFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRR-------LKIALGAARGLSYLH 670
G C + +L++E+ G L LS + W RR ++A A G++++H
Sbjct: 62 GQCVEAIPYLLVFEYCELGDLKSYLSQE-----QWHRRNSQLLLLQRMACEIAAGVTHMH 116
Query: 671 ELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVK--GTMGYLDPE 728
+ +H D+ N L L KV D+G+ S ++D+I T+ + +L PE
Sbjct: 117 KHN---FLHSDLALRNCFLTSDLTVKVGDYGI--GPSRYKEDYIETEDDKCVPLRWLAPE 171
Query: 729 Y-------YMTQQLTEKSDVYSFGVLMLELL 752
+T + T+ S+V++ GV + EL
Sbjct: 172 LVGEFHGGLITAEQTKPSNVWALGVTLWELF 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 58/201 (28%), Positives = 90/201 (44%), Gaps = 14/201 (6%)
Query: 563 VGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKMEIE----LLSRVHHKNLVSLL 617
+G G +GKV + A+K Q+ ++ +E K + LL V H LV L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL- 61
Query: 618 GFCFDRGEQM-LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPP 676
F F +++ + +++ G L L + R + +A L YLH L
Sbjct: 62 HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASA--LGYLHSLN--- 116
Query: 677 IIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLT 736
I++RD+K NILLD + + + DFGL K + E + T+ GT YL PE Q
Sbjct: 117 IVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNGTTSTFCGTPEYLAPEVLHKQPYD 174
Query: 737 EKSDVYSFGVLMLELLTGRRP 757
D + G ++ E+L G P
Sbjct: 175 RTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 1e-08
Identities = 32/94 (34%), Positives = 49/94 (52%), Gaps = 5/94 (5%)
Query: 666 LSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYL 725
L++LHE II+RD+K N+LLD + K+ D+G+ K T+ GT Y+
Sbjct: 109 LNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCK--EGIRPGDTTSTFCGTPNYI 163
Query: 726 DPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIE 759
PE + D ++ GVLM E++ GR P +
Sbjct: 164 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-08
Identities = 61/215 (28%), Positives = 99/215 (46%), Gaps = 15/215 (6%)
Query: 11 ITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLS 70
+ LT L +LDL NN +P IG LK + + + +P + +L L L
Sbjct: 112 LLELTNLTSLDLDNNNITD--IPPLIGLLKSNLKELDLSDNKIESLPSPLRNLPNLKNLD 169
Query: 71 LNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQL 130
L+ N S +P + NLSNL LDL+ NK+ ++P L+ L N +
Sbjct: 170 LSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELD------LSNNSI 221
Query: 131 SGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNL 190
+ L + L SNN +LP ++G + +LE + N +S S+L +L
Sbjct: 222 I-ELLSSLSNLKNLSG--LELSNNKLEDLPESIGNLSNLETLDLSNNQISSI--SSLGSL 276
Query: 191 TSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNS 225
T++ +L LS N L+ A+P + L +L L ++
Sbjct: 277 TNLRELDLSGNSLSNALPLIALLLLLLELLLNLLL 311
|
Length = 394 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 55/210 (26%), Positives = 88/210 (41%), Gaps = 36/210 (17%)
Query: 564 GSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQ---------GGQEFKMEIELLSRVHHKNL 613
G G + +YKG L L + Q+ S+ F L+S++ HK+L
Sbjct: 4 GQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHL 63
Query: 614 VSLLGFCFDRGEQMLIYEFVPNGSLGDSL-SGKNGIRLDWIRRLKIALGAARGLSYLHEL 672
V L G C M + E+V G L L KN + L W +L +A A L YL +
Sbjct: 64 VKLYGVCVRDENIM-VEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYLEDK 120
Query: 673 ANPPIIHRDIKSSNILLDE-------RLNAKVADFGLSKSMSDSEK--DHITTQVKGTMG 723
++H ++ NIL+ K++D G+ ++ E+ + I
Sbjct: 121 K---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERIP-------- 169
Query: 724 YLDPEYYMTQQ--LTEKSDVYSFGVLMLEL 751
++ PE Q LT +D +SFG +LE+
Sbjct: 170 WIAPECIRNGQASLTIAADKWSFGTTLLEI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 3e-08
Identities = 34/105 (32%), Positives = 49/105 (46%), Gaps = 9/105 (8%)
Query: 654 RRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDH 713
RRL L A L+YLH IIHRD+K+ NI LDE NA + DFG + +
Sbjct: 192 RRL---LEA---LAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTP 242
Query: 714 ITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPI 758
GT+ PE K+D++S G+++ E+ +
Sbjct: 243 QCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 3e-08
Identities = 46/192 (23%), Positives = 85/192 (44%), Gaps = 21/192 (10%)
Query: 565 SGGYGKVYKGTLPNGQ--LIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFD 622
G G+V+ T P GQ + +K Q+G+ +E LL V+H +++ +
Sbjct: 76 PGSEGRVFVATKP-GQPDPVVLKIGQKGTTL------IEAMLLQNVNHPSVIRMKDTLVS 128
Query: 623 RGEQMLIYEFVP--NGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHR 680
++ +P + L L+ ++ L + L I GL YLH IIHR
Sbjct: 129 GAITCMV---LPHYSSDLYTYLTKRSR-PLPIDQALIIEKQILEGLRYLHAQR---IIHR 181
Query: 681 DIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSD 740
D+K+ NI +++ + D G ++ + + GT+ PE + K+D
Sbjct: 182 DVKTENIFINDVDQVCIGDLGAAQFPVVAPAFL---GLAGTVETNAPEVLARDKYNSKAD 238
Query: 741 VYSFGVLMLELL 752
++S G+++ E+L
Sbjct: 239 IWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 3e-08
Identities = 37/113 (32%), Positives = 58/113 (51%), Gaps = 7/113 (6%)
Query: 664 RGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSK-SMSDSEKDHITTQVKGTM 722
R L Y+H AN + HRD+K NIL + K+ DFGL++ + +D+ T T
Sbjct: 114 RALKYIHT-AN--VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170
Query: 723 GYLDPEY--YMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMD 773
Y PE + T D++S G + E+LTG +P+ GK +V ++ + D
Sbjct: 171 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG-KPLFPGKNVVHQLDLITD 222
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 55.9 bits (134), Expect = 4e-08
Identities = 58/201 (28%), Positives = 91/201 (45%), Gaps = 15/201 (7%)
Query: 563 VGSGGYGKV-YKGTLPNGQLIAIKRAQQGSMQGGQEFK---MEIELLSRVHHKNLVSLLG 618
+G G +GKV +G+ A+K ++ + E E +L H L SL
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL-K 61
Query: 619 FCFDRGEQM-LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPI 677
+ F +++ + E+V G L LS + D R + +A L YLH + I
Sbjct: 62 YSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSA--LDYLH---SGKI 116
Query: 678 IHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQV-KGTMGYLDPEYYMTQQLT 736
++RD+K N++LD+ + K+ DFGL K + D T + GT YL PE
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCK---EGITDAATMKTFCGTPEYLAPEVLEDNDYG 173
Query: 737 EKSDVYSFGVLMLELLTGRRP 757
D + GV+M E++ GR P
Sbjct: 174 RAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 5e-08
Identities = 62/228 (27%), Positives = 96/228 (42%), Gaps = 44/228 (19%)
Query: 546 SFEEVKKYTNNFSDANDVGSGGYGKV---YKGTLPNGQLIAIK---RAQQGSMQGGQEFK 599
+F +K+Y +GSG G V + L G +A+K R Q + ++
Sbjct: 16 TFTVLKRY----QQLKPIGSGAQGIVCAAFDTVL--GINVAVKKLSRPFQNQTHAKRAYR 69
Query: 600 MEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGD-------------SLSGKN 646
E+ LL V+HKN++SLL F P SL + +L
Sbjct: 70 -ELVLLKCVNHKNIISLLNV------------FTPQKSLEEFQDVYLVMELMDANLCQVI 116
Query: 647 GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSM 706
+ LD R + G+ +LH IIHRD+K SNI++ K+ DFGL+++
Sbjct: 117 HMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 173
Query: 707 SDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTG 754
+ + T T Y PE + E D++S G +M EL+ G
Sbjct: 174 C---TNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 6e-08
Identities = 51/209 (24%), Positives = 97/209 (46%), Gaps = 22/209 (10%)
Query: 562 DVGSGGYGKVYKGT---LPNGQL---IAIKRAQQ-GSMQGGQEFKMEIELLSRVHHKNLV 614
++G G +G VY+G + G+ +A+K + S++ EF E ++ ++V
Sbjct: 13 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 72
Query: 615 SLLGFCFDRGEQMLIYEFVPNGSLGDSL------SGKNGIRLDWIRRLKIALGA--ARGL 666
LLG +++ E + +G L L + N R + I + A A G+
Sbjct: 73 RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132
Query: 667 SYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTM--GY 724
+YL+ +HRD+ + N ++ K+ DFG+++ + E D+ KG + +
Sbjct: 133 AYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDI--YETDYYRKGGKGLLPVRW 187
Query: 725 LDPEYYMTQQLTEKSDVYSFGVLMLELLT 753
+ PE T SD++SFGV++ E+ +
Sbjct: 188 MAPESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 54.6 bits (132), Expect = 6e-08
Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 45/211 (21%)
Query: 564 GSGGYGKVYKG-TLPNGQLIAIKRAQQ--GSMQGGQEFKMEIELLSRV-HHKNLVSLLGF 619
G G + +V K + G+ AIK ++ S++ + EI+ L R+ H N++ L+
Sbjct: 8 GEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLR-EIQALRRLSPHPNILRLIEV 66
Query: 620 CFDR--GEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHEL----- 672
FDR G L++E + + +L + I+ K L R SY+++L
Sbjct: 67 LFDRKTGRLALVFELM-DMNL-----------YELIKGRKRPLPEKRVKSYMYQLLKSLD 114
Query: 673 ---ANPPIIHRDIKSSNILL-DERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPE 728
N I HRDIK NIL+ D+ L K+ADFG + + T+ T Y PE
Sbjct: 115 HMHRNG-IFHRDIKPENILIKDDIL--KLADFGSCRGIYSK---PPYTEYISTRWYRAPE 168
Query: 729 ------YYMTQQLTEKSDVYSFGVLMLELLT 753
YY K D+++ G + E+L+
Sbjct: 169 CLLTDGYY-----GPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 6e-08
Identities = 33/114 (28%), Positives = 65/114 (57%), Gaps = 9/114 (7%)
Query: 664 RGLSYLHELANPPIIHRDIKSSNILLD-ERLNAKVADFGLSKSMSDSEKDH--ITTQVKG 720
RGL Y+H AN ++HRD+K +N+ ++ E L K+ DFGL++ + D H ++
Sbjct: 125 RGLKYIHS-AN--VLHRDLKPANVFINTEDLVLKIGDFGLARIV-DPHYSHKGYLSEGLV 180
Query: 721 TMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMD 773
T Y P ++ T+ D+++ G + E+LTG +P+ G + + +++ +++
Sbjct: 181 TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG-KPLFAGAHELEQMQLILE 233
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 6e-08
Identities = 51/211 (24%), Positives = 78/211 (36%), Gaps = 29/211 (13%)
Query: 564 GSGGYGKVYKGTLPNGQLIAIKRA--QQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCF 621
+ K P L+A+K+ S + + + EI ++ H N++ + F
Sbjct: 11 EDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYV-TSF 68
Query: 622 -DRGEQMLIYEFVPNGSLGDSLSG--KNGIRLDWIRRLKIAL---GAARGLSYLHELANP 675
E ++ + GS D L G+ L IA L Y+H
Sbjct: 69 IVDSELYVVSPLMAYGSCEDLLKTHFPEGLP-----ELAIAFILKDVLNALDYIHSKG-- 121
Query: 676 PIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDH-----ITTQVKGTMGYLDPEYY 730
IHR +K+S+ILL ++ S SM K + +L PE
Sbjct: 122 -FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPE-- 178
Query: 731 MTQQ----LTEKSDVYSFGVLMLELLTGRRP 757
+ QQ EKSD+YS G+ EL G P
Sbjct: 179 VLQQNLQGYNEKSDIYSVGITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 7e-08
Identities = 59/217 (27%), Positives = 96/217 (44%), Gaps = 20/217 (9%)
Query: 546 SFEEVKKYTNNFSDANDVGSGGYGKV---YKGTLPNGQLIAIK---RAQQGSMQGGQEFK 599
+F +K+Y N +GSG G V Y L +AIK R Q + ++
Sbjct: 19 TFTVLKRYQN----LKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR 72
Query: 600 MEIELLSRVHHKNLVSLLG-FCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKI 658
E+ L+ V+HKN++ LL F + + ++ + +L + LD R +
Sbjct: 73 -ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL 131
Query: 659 ALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQV 718
G+ +LH IIHRD+K SNI++ K+ DFGL+++ S + T
Sbjct: 132 LYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPY 185
Query: 719 KGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGR 755
T Y PE + E D++S G +M E++ G
Sbjct: 186 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 1e-07
Identities = 34/94 (36%), Positives = 49/94 (52%), Gaps = 6/94 (6%)
Query: 665 GLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQV-KGTMG 723
L YLH N +++RD+K N++LD+ + K+ DFGL K + KD T + GT
Sbjct: 107 ALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDGATMKTFCGTPE 161
Query: 724 YLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRP 757
YL PE D + GV+M E++ GR P
Sbjct: 162 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 1e-07
Identities = 45/155 (29%), Positives = 71/155 (45%), Gaps = 12/155 (7%)
Query: 628 LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNI 687
++ E++P G L + +S + + W R + A L +H + IHRD+K N+
Sbjct: 120 MVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEVVLA--LDAIHSMG---FIHRDVKPDNM 173
Query: 688 LLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQ----QLTEKSDVYS 743
LLD+ + K+ADFG M+ T V GT Y+ PE +Q + D +S
Sbjct: 174 LLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWS 232
Query: 744 FGVLMLELLTGRRPIERGKYIVREIRTVMDKKKEL 778
GV + E+L G P +V +M+ K L
Sbjct: 233 VGVFLYEMLVGDTPF-YADSLVGTYSKIMNHKNSL 266
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 1e-07
Identities = 36/108 (33%), Positives = 61/108 (56%), Gaps = 14/108 (12%)
Query: 656 LKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKS-MSDSEKDHI 714
L+ + A+G+ +L A+ IHRD+ + N+LL + AK+ DFGL++ M+DS
Sbjct: 215 LRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDS----- 266
Query: 715 TTQVKGT----MGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRP 757
VKG + ++ PE T +SDV+S+G+L+ E+ + G+ P
Sbjct: 267 NYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-07
Identities = 49/190 (25%), Positives = 83/190 (43%), Gaps = 26/190 (13%)
Query: 646 NGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKS 705
+ + LD L + A+G+S+L A+ IHRD+ + NILL K+ DFGL++
Sbjct: 207 DELALDTEDLLSFSYQVAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARD 263
Query: 706 MSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYI 764
+ + + + + ++ PE T +SDV+S+G+L+ E+ + G P
Sbjct: 264 IRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPG---- 319
Query: 765 VREIRTVMDKKKELYNL----YELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMS 820
M + Y + Y ++ P S E Y D+ C RPT
Sbjct: 320 -------MPVDSKFYKMIKEGYRMLSPECAPS------EMY-DIMKSCWDADPLKRPTFK 365
Query: 821 EVVKDIENIL 830
++V+ IE L
Sbjct: 366 QIVQLIEQQL 375
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 4e-07
Identities = 69/303 (22%), Positives = 128/303 (42%), Gaps = 87/303 (28%)
Query: 563 VGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEI-------------------- 602
+G G + K++KG R + G G+ K E+
Sbjct: 3 LGQGTFTKIFKG----------IRREVGD--YGELHKTEVLLKVLDKSHRNYSESFFEAA 50
Query: 603 ELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLS-GKNGIRLDWIRRLKIALG 661
++S++ HK+LV G C E +++ E+V GSL L KN I + W L
Sbjct: 51 SMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW------KLE 104
Query: 662 AARGLSY-LHELANPPIIHRDIKSSNILLDERLNA--------KVADFGLSKSMSDSEKD 712
A+ L++ LH L + + H ++ + N+LL + K++D G+S ++ K+
Sbjct: 105 VAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITV--LPKE 162
Query: 713 HITTQVKGTMGYLDPEYYM-TQQLTEKSDVYSFGVLMLELLTG-RRPIERGKYIVREIRT 770
+ ++ ++ PE Q L+ +D +SFG + E+ +G +P+ +
Sbjct: 163 ILLERIP----WVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPL-----------S 207
Query: 771 VMDKKKELYNLYE----LIDPTIGLSTTLKGFEKYVDLAL---KCVQESGDDRPTMSEVV 823
+D +K+L YE L P K+ +LA +C+ D RP+ ++
Sbjct: 208 ALDSQKKL-QFYEDRHQLPAP------------KWTELANLINQCMDYEPDFRPSFRAII 254
Query: 824 KDI 826
+D+
Sbjct: 255 RDL 257
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 5e-07
Identities = 24/60 (40%), Positives = 37/60 (61%)
Query: 153 NNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTG 212
N++ G +P +LG + SLEV+ NS +G +P +L LTS+ L L+ N L+G +P G
Sbjct: 452 NSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 5e-07
Identities = 56/203 (27%), Positives = 88/203 (43%), Gaps = 19/203 (9%)
Query: 563 VGSGGYGKVY----KGTLPNGQLIAIKRAQQGSMQGGQEFK---MEIELLSRVHHKNLVS 615
+G G +GKV K T G+ A+K ++ + E E +L H L +
Sbjct: 3 LGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 59
Query: 616 LLGFCFDRGEQM-LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELAN 674
L + F +++ + E+ G L LS + + R + +A L YLH +
Sbjct: 60 L-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSA--LEYLH---S 113
Query: 675 PPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQ 734
+++RDIK N++LD+ + K+ DFGL K T GT YL PE
Sbjct: 114 RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYLAPEVLEDND 171
Query: 735 LTEKSDVYSFGVLMLELLTGRRP 757
D + GV+M E++ GR P
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 6e-07
Identities = 47/178 (26%), Positives = 84/178 (47%), Gaps = 36/178 (20%)
Query: 663 ARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKS-MSDSEKDHITTQVKGT 721
A G+ +L A+ +HRD+ + N+L+ E K+ DFGL++ M DS ++I+ KG+
Sbjct: 249 ANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDS--NYIS---KGS 300
Query: 722 ----MGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKK 776
+ ++ PE T SDV+SFG+L+ E+ T G P + +
Sbjct: 301 TFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPE-----------LPMNE 349
Query: 777 ELYNL----YELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENIL 830
+ YN Y + P ++ ++ KC +E + RP S++V + ++L
Sbjct: 350 QFYNAIKRGYRMAKPA-------HASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 7e-07
Identities = 38/145 (26%), Positives = 63/145 (43%), Gaps = 12/145 (8%)
Query: 612 NLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHE 671
N+V L + L+ + G L +S I + ++R AA + L
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRW-----AAEMVVALDA 100
Query: 672 LANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDS-EKDHITTQVKGTMGYLDPEYY 730
L I+ RD+ +NILLD+R + ++ F + DS + + + Y PE
Sbjct: 101 LHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM------YCAPEVG 154
Query: 731 MTQQLTEKSDVYSFGVLMLELLTGR 755
+ TE D +S G ++ ELLTG+
Sbjct: 155 GISEETEACDWWSLGAILFELLTGK 179
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 8e-07
Identities = 30/114 (26%), Positives = 50/114 (43%), Gaps = 19/114 (16%)
Query: 665 GLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVK----- 719
+ Y+H ++HRD+K NILL + D+G + E+D + V
Sbjct: 125 TIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNIC 181
Query: 720 -----------GTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGK 762
GT Y+ PE + +E +D+Y+ GV++ ++LT P R K
Sbjct: 182 YSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKK 235
|
Length = 932 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 2e-06
Identities = 55/202 (27%), Positives = 87/202 (43%), Gaps = 50/202 (24%)
Query: 599 KMEIELLSRVHHKNLVSLLGFCF-DRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLK 657
K E ++L+ ++ +V L + F D+ + +++P G + SL + GI + + R
Sbjct: 49 KAERDILAEADNEWVVKLY-YSFQDKDNLYFVMDYIPGGDMM-SLLIRLGIFEEDLARFY 106
Query: 658 IA-LGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGL---------SK--- 704
IA L A + +H++ IHRDIK NIL+D + K+ DFGL SK
Sbjct: 107 IAELTCA--IESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQ 161
Query: 705 --------SMSDSE------------------KDHITTQVK---GTMGYLDPEYYMTQQL 735
SM SE + H GT Y+ PE +
Sbjct: 162 KGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGY 221
Query: 736 TEKSDVYSFGVLMLELLTGRRP 757
T+ D +S GV++ E+L G+ P
Sbjct: 222 TQLCDWWSVGVILYEMLVGQPP 243
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 4e-06
Identities = 53/227 (23%), Positives = 107/227 (47%), Gaps = 37/227 (16%)
Query: 561 NDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGF 619
N +G+G +G VY+ + + +AIK+ +Q Q E+ ++ ++H N++ L +
Sbjct: 72 NIIGNGSFGVVYEAICIDTSEKVAIKKV----LQDPQYKNRELLIMKNLNHINIIFLKDY 127
Query: 620 ----CFDRGEQML----IYEFVPNGSLGDSLS--GKNGIRLDWIRRLKIALGAARGLSYL 669
CF + E+ + + EF+P ++ + +N L + R L+Y+
Sbjct: 128 YYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYI 186
Query: 670 HELANPPIIHRDIKSSNILLDERLNA-KVADFGLSKSMSDSEKDHITTQVKGTMGYLDPE 728
H + I HRD+K N+L+D + K+ DFG +K++ ++ ++ Y+
Sbjct: 187 H---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQR---------SVSYICSR 234
Query: 729 YYMTQQL-------TEKSDVYSFGVLMLELLTGRRPIERGKYIVREI 768
+Y +L T D++S G ++ E++ G PI G+ V ++
Sbjct: 235 FYRAPELMLGATNYTTHIDLWSLGCIIAEMILG-YPIFSGQSSVDQL 280
|
Length = 440 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 4e-06
Identities = 53/196 (27%), Positives = 92/196 (46%), Gaps = 31/196 (15%)
Query: 604 LLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNG-IRLDWIRRLKIALGA 662
L+S+V H +L + G C E +++ EFV +G L L + G + + W ++ +A
Sbjct: 69 LMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--KITVAQQL 126
Query: 663 ARGLSYLHELANPPIIHRDIKSSNILLDERLNA-------KVADFGLS-KSMSDSEK-DH 713
A LSYL + ++H ++ + NILL A K++D G+S ++S E+ +
Sbjct: 127 ASALSYLE---DKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSREERVER 183
Query: 714 ITTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLEL-------LTGRRPIERGKYIV 765
I ++ PE L+ +D +SFG +LE+ L R P E+ ++
Sbjct: 184 IP--------WIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFYE 235
Query: 766 REIRTVMDKKKELYNL 781
++ R KEL L
Sbjct: 236 KKHRLPEPSCKELATL 251
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 4e-06
Identities = 30/94 (31%), Positives = 44/94 (46%), Gaps = 6/94 (6%)
Query: 669 LHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPE 728
+H + +HRDIK N+LLD + ++ADFG M+ + V GT Y+ PE
Sbjct: 115 IHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAV-GTPDYISPE 173
Query: 729 YYMTQQ-----LTEKSDVYSFGVLMLELLTGRRP 757
+ + D +S GV M E+L G P
Sbjct: 174 ILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 8e-06
Identities = 58/231 (25%), Positives = 98/231 (42%), Gaps = 27/231 (11%)
Query: 563 VGSGGYGKVYKGTLPNG-QLIAIKRAQQGSMQGGQE---FKMEIELLSRVHHKNLVSLLG 618
+G G +G+V L N ++ A+K + M E F+ E ++L ++ + +L
Sbjct: 9 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHY 68
Query: 619 FCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLD------WIRRLKIALGAARGLSYLHEL 672
D L+ ++ G L LS K RL ++ + IA+ + L Y
Sbjct: 69 AFQDENNLYLVMDYYVGGDLLTLLS-KFEDRLPEDMARFYLAEMVIAIDSVHQLHY---- 123
Query: 673 ANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMT 732
+HRDIK NIL+D + ++ADFG + + + V GT Y+ PE
Sbjct: 124 -----VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYISPEILQA 177
Query: 733 QQ-----LTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKEL 778
+ + D +S GV M E+L G P + +V +M+ K+
Sbjct: 178 MEDGKGKYGPECDWWSLGVCMYEMLYGETPF-YAESLVETYGKIMNHKERF 227
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 1e-05
Identities = 29/92 (31%), Positives = 49/92 (53%), Gaps = 8/92 (8%)
Query: 172 VRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMP----NLTGLSVLSYLDMSNNSFD 227
+ D L G +P++++ L + + LS N + G +P ++T L V LD+S NSF+
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEV---LDLSYNSFN 479
Query: 228 ASEVPSWFSSMQSLTTLMMENTNLKGQIPADL 259
S +P + SL L + +L G++PA L
Sbjct: 480 GS-IPESLGQLTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 62/218 (28%), Positives = 96/218 (44%), Gaps = 33/218 (15%)
Query: 563 VGSGGYGKVYKGTLPNGQL---IAIKRAQQG--SMQGGQEFKMEIELLSRVHHKNLVSL- 616
VG G YG VYK +G+ A+K+ + SM +E I LL + H N++SL
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACRE----IALLRELKHPNVISLQ 64
Query: 617 ----------LGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGL 666
+ FD E L + + + S + K ++L + G+
Sbjct: 65 KVFLSHADRKVWLLFDYAEHDLWHIIKFHRA---SKANKKPVQLPRGMVKSLLYQILDGI 121
Query: 667 SYLHELANPPIIHRDIKSSNILL----DERLNAKVADFGLSKSMSDSEKDHITTQ-VKGT 721
YLH AN ++HRD+K +NIL+ ER K+AD G ++ + K V T
Sbjct: 122 HYLH--ANW-VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVT 178
Query: 722 MGYLDPEYYM-TQQLTEKSDVYSFGVLMLELLTGRRPI 758
Y PE + + T+ D+++ G + ELLT PI
Sbjct: 179 FWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS-EPI 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 37/128 (28%), Positives = 61/128 (47%), Gaps = 11/128 (8%)
Query: 630 YEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILL 689
Y+ + + + LS L + L ARG+ +L A+ +HRD+ + N+LL
Sbjct: 214 YKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFL---ASKNCVHRDLAARNVLL 270
Query: 690 DERLNAKVADFGLSKS-MSDS---EKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFG 745
+ K+ DFGL++ M DS K VK ++ PE T SDV+S+G
Sbjct: 271 AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVK----WMAPESIFDNLYTTLSDVWSYG 326
Query: 746 VLMLELLT 753
+L+ E+ +
Sbjct: 327 ILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 56/250 (22%), Positives = 100/250 (40%), Gaps = 54/250 (21%)
Query: 557 FSDANDVGSGGYGKV-YKGTLPNGQLIAIKRAQQGSMQGGQEF---KMEIELLSRVHHKN 612
F +G G +G+V + L A+K ++ + + K E ++L+ ++
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62
Query: 613 LVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHEL 672
+V L D+ + +++P G + SL + + + + R IA + +H++
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMM-SLLIRMEVFPEVLARFYIA-ELTLAIESVHKM 120
Query: 673 ANPPIIHRDIKSSNILLDERLNAKVADFGL--------------------SKSMSDSE-- 710
IHRDIK NIL+D + K+ DFGL SM S+
Sbjct: 121 G---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLW 177
Query: 711 --------------------KDH---ITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVL 747
K H + + GT Y+ PE + + T+ D +S GV+
Sbjct: 178 DDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI 237
Query: 748 MLELLTGRRP 757
+ E+L G+ P
Sbjct: 238 LFEMLVGQPP 247
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 2e-05
Identities = 29/87 (33%), Positives = 43/87 (49%), Gaps = 10/87 (11%)
Query: 678 IHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTE 737
+HRDIK N+LLD+ + ++ADFG + V GT Y+ PE + Q + +
Sbjct: 124 VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAV-GTPDYISPE--ILQAMED 180
Query: 738 -------KSDVYSFGVLMLELLTGRRP 757
+ D +S GV M E+L G P
Sbjct: 181 GKGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 3e-05
Identities = 61/218 (27%), Positives = 96/218 (44%), Gaps = 33/218 (15%)
Query: 563 VGSGGYGKVYKGTLPNGQ---LIAIKRAQQG--SMQGGQEFKMEIELLSRVHHKNLVSL- 616
VG G YG VYK +G+ A+K+ + SM +E I LL + H N+++L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACRE----IALLRELKHPNVIALQ 64
Query: 617 ----------LGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGL 666
+ FD E L + + + S + K ++L + G+
Sbjct: 65 KVFLSHSDRKVWLLFDYAEHDLWHIIKFHRA---SKANKKPMQLPRSMVKSLLYQILDGI 121
Query: 667 SYLHELANPPIIHRDIKSSNILL----DERLNAKVADFGLSKSMSDSEKDHITTQ-VKGT 721
YLH AN ++HRD+K +NIL+ ER K+AD G ++ + K V T
Sbjct: 122 HYLH--ANW-VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVT 178
Query: 722 MGYLDPEYYM-TQQLTEKSDVYSFGVLMLELLTGRRPI 758
Y PE + + T+ D+++ G + ELLT PI
Sbjct: 179 FWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS-EPI 215
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 4e-05
Identities = 61/222 (27%), Positives = 90/222 (40%), Gaps = 17/222 (7%)
Query: 6 QLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQE 65
L + L L LDLS N LP + NL L+NL L G S +P I L
Sbjct: 154 SLPSPLRNLPNLKNLDLSFNDLSD--LPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSA 210
Query: 66 LVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHF 125
L L L++N + S+ NL NL L+L++NKLE ++P S GN L+ L
Sbjct: 211 LEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETL------DL 262
Query: 126 GKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPAT-LGLVKSLEVVRFDRNSLSGPVP 184
NQ+S SI L + N+L+ LP L L+ ++ + +
Sbjct: 263 SNNQIS-SISS--LGSLTNLRELDLSGNSLSNALPLIALLLLLLELLLNLLLTLKALELK 319
Query: 185 SNLNNLTSVND--LYLSNNKLTGAMPNLTGLSVLSYLDMSNN 224
N L + S+ + + +L L L +N
Sbjct: 320 LNSILLNNNILSNGETSSPEALSILESLNNLWTLDNALDESN 361
|
Length = 394 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 6e-05
Identities = 58/259 (22%), Positives = 107/259 (41%), Gaps = 41/259 (15%)
Query: 549 EVKKYTNNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRV 608
++ T V S GK P + + KR + GS Q + EI L R+
Sbjct: 168 ALRASTEEAEARRGVNSTNQGK------PKCERLIAKRVKAGSRAAIQ-LENEILALGRL 220
Query: 609 HHKNLVSL--------LGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIAL 660
+H+N++ + + + +Y F+ + + K+ L R + L
Sbjct: 221 NHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAF----DWKDRPLLKQTRAIMKQL 276
Query: 661 GAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKG 720
A + Y+H + +IHRDIK NI L+ + DFG + + E++ G
Sbjct: 277 LCA--VEYIH---DKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPF-EKEREAFDYGWVG 330
Query: 721 TMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT---------GRRPIERGKYIVREIRTV 771
T+ PE E +D++S G+++L++L+ G +P GK +++ I ++
Sbjct: 331 TVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKP---GKQLLKIIDSL 387
Query: 772 MDKKKEL----YNLYELID 786
+E L++ ID
Sbjct: 388 SVCDEEFPDPPCKLFDYID 406
|
Length = 501 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 7e-05
Identities = 38/137 (27%), Positives = 56/137 (40%), Gaps = 31/137 (22%)
Query: 621 FDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWI------------------RRLKIALGA 662
F +G Q L+++F + +LGD+L GK G + R + + G
Sbjct: 255 FTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDINVIKGV 314
Query: 663 AR----GLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQV 718
R GL LH + I+HRDIK N+L+ K+ DFG + M
Sbjct: 315 MRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTG------INF 365
Query: 719 KGTMGYLDPEYYMTQQL 735
G LDP Y ++L
Sbjct: 366 NPLYGMLDPRYSPPEEL 382
|
Length = 507 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 8e-05
Identities = 26/84 (30%), Positives = 47/84 (55%), Gaps = 2/84 (2%)
Query: 151 DSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNL 210
D+ L G +P + ++ L+ + NS+ G +P +L ++TS+ L LS N G++P
Sbjct: 426 DNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPES 485
Query: 211 TG-LSVLSYLDMSNNSFDASEVPS 233
G L+ L L+++ NS + VP+
Sbjct: 486 LGQLTSLRILNLNGNSL-SGRVPA 508
|
Length = 623 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 9e-05
Identities = 28/100 (28%), Positives = 43/100 (43%), Gaps = 4/100 (4%)
Query: 656 LKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHIT 715
L I R + YLH IIHRDIK+ NI ++ + + DFG + D +
Sbjct: 185 LAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYY 241
Query: 716 TQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGR 755
GT+ PE D++S G+++ E+ T
Sbjct: 242 GWA-GTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 40.6 bits (96), Expect = 1e-04
Identities = 18/60 (30%), Positives = 27/60 (45%), Gaps = 1/60 (1%)
Query: 168 SLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPN-LTGLSVLSYLDMSNNSF 226
+L+ + N L+ L ++ L LS N LT P +GL L LD+S N+
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-04
Identities = 50/205 (24%), Positives = 82/205 (40%), Gaps = 52/205 (25%)
Query: 599 KMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKI 658
K E ++L+ ++ +V L D+ + +++P G + SL + GI + + R I
Sbjct: 49 KAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMM-SLLIRMGIFPEDLARFYI 107
Query: 659 A-LGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGL--------------- 702
A L A + +H++ IHRDIK NIL+D + K+ DFGL
Sbjct: 108 AELTCA--VESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQS 162
Query: 703 -----------SKSMSDSEKDHITTQVK-------------------GTMGYLDPEYYMT 732
S D ++K GT Y+ PE +
Sbjct: 163 GDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR 222
Query: 733 QQLTEKSDVYSFGVLMLELLTGRRP 757
T+ D +S GV++ E+L G+ P
Sbjct: 223 TGYTQLCDWWSVGVILYEMLVGQPP 247
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 63/286 (22%), Positives = 122/286 (42%), Gaps = 56/286 (19%)
Query: 556 NFSDANDVGSGGYGKVYKGTL----PNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHK 611
N+ D ++ Y K K L P+ + I++ + SM + +V HK
Sbjct: 17 NYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASM------------MRQVSHK 64
Query: 612 NLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHE 671
++V L G C E +++ EFV G L D + L + K+A A LSYL +
Sbjct: 65 HIVLLYGVCVRDVENIMVEEFVEFGPL-DLFMHRKSDVLTTPWKFKVAKQLASALSYLED 123
Query: 672 LANPPIIHRDIKSSNILL-DERLNA------KVADFGLSKSMSDSEK--DHITTQVKGTM 722
++H ++ + NILL E ++ K++D G+ ++ ++ + I
Sbjct: 124 ---KDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVERIP------- 173
Query: 723 GYLDPEYYM-TQQLTEKSDVYSFGVLMLEL-LTGRRPIERGKYIVREIRTVMDKKKELYN 780
++ PE ++ L+ +D +SFG + E+ G P++ +T+ +K++
Sbjct: 174 -WIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKD--------KTLAEKERFYEG 224
Query: 781 LYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDI 826
L+ P+ ++ DL C+ + RP +++DI
Sbjct: 225 QCMLVTPSC---------KELADLMTHCMNYDPNQRPFFRAIMRDI 261
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 40/112 (35%), Positives = 57/112 (50%), Gaps = 16/112 (14%)
Query: 658 IALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMS---DSEKDHI 714
I GA RGL+YLH+ IHR+IK+S+IL+ + V+ GLS S + +K +
Sbjct: 106 ILFGALRGLNYLHQNG---YIHRNIKASHILISG--DGLVSLSGLSHLYSLVRNGQKAKV 160
Query: 715 TTQV----KGTMGYLDPEYYMTQQL---TEKSDVYSFGVLMLELLTGRRPIE 759
+ +L PE + Q L KSD+YS G+ EL TGR P +
Sbjct: 161 VYDFPQFSTSVLPWLSPEL-LRQDLYGYNVKSDIYSVGITACELATGRVPFQ 211
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 4e-04
Identities = 37/133 (27%), Positives = 59/133 (44%), Gaps = 10/133 (7%)
Query: 647 GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSM 706
G RL + ++ A + LS + + IIHRDIK+ N+L++ + + DFG +
Sbjct: 251 GARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFA 310
Query: 707 SDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLE-------LLTGRRPIE 759
S + GT+ PE T D++S G+++ E L + R E
Sbjct: 311 RGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDE 370
Query: 760 RGKY---IVREIR 769
R Y I+R IR
Sbjct: 371 RRPYDAQILRIIR 383
|
Length = 461 |
| >gnl|CDD|215633 PLN03210, PLN03210, Resistant to P | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 5e-04
Identities = 74/274 (27%), Positives = 108/274 (39%), Gaps = 58/274 (21%)
Query: 6 QLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQE 65
+L I L +L LD+S ++L LPT I NLK L L L GCS PD ++
Sbjct: 672 ELPSSIQYLNKLEDLDMSRCENLEI-LPTGI-NLKSLYRLNLSGCSRLKSFPDISTNISW 729
Query: 66 LVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHF 125
L L F PS L NL L L + K E +P + ML
Sbjct: 730 LDLDETAIEEF-----PSNLRLENLDELILCEMKSEKLWERVQPLTPLMTML-------- 776
Query: 126 GKNQLSGSIPEKLFRPDMVLIHVLFDSNNLT-GELPATLGLVKSLEVVRFD--RNSLSGP 182
L R LF S+ + ELP+++ + LE + + N + P
Sbjct: 777 ---------SPSLTR--------LFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLP 819
Query: 183 VPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVL-SYLDMSNNSFD-------ASEVPSW 234
NL +L S+ +L+G S L ++ D+S N D EVP W
Sbjct: 820 TGINLESLESL---------------DLSGCSRLRTFPDISTNISDLNLSRTGIEEVPWW 864
Query: 235 FSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTV 268
+L+ L M N ++ ++ + HL+TV
Sbjct: 865 IEKFSNLSFLDMNGCNNLQRVSLNISKLKHLETV 898
|
syringae 6; Provisional. Length = 1153 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 0.001
Identities = 20/43 (46%), Positives = 25/43 (58%), Gaps = 3/43 (6%)
Query: 662 AARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSK 704
A L YLH IIHRD+K N+L+ + K+ DFGLSK
Sbjct: 113 VALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.001
Identities = 50/198 (25%), Positives = 85/198 (42%), Gaps = 24/198 (12%)
Query: 577 PNGQLIAIKRAQQGSMQGGQEFKMEIEL-LSRV-HHKNLVSLLGFCFDRGEQMLIYEFVP 634
P G+ + ++R + ++ EL +S++ +H N+V E ++ F+
Sbjct: 23 PTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 82
Query: 635 NGSLGDSLSGKNGIRLDWIRRLKIA---LGAARGLSYLHELANPPIIHRDIKSSNILLDE 691
GS D + +D + L IA G + L Y+H + +HR +K+S+IL+
Sbjct: 83 YGSAKDLICTH---FMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILIS- 135
Query: 692 RLNAKVADFGLSKSMS--------DSEKDHITTQVKGTMGYLDPEYYMT--QQLTEKSDV 741
++ KV GL ++S D VK + +L PE Q KSD+
Sbjct: 136 -VDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVK-VLPWLSPEVLQQNLQGYDAKSDI 193
Query: 742 YSFGVLMLELLTGRRPIE 759
YS G+ EL G P +
Sbjct: 194 YSVGITACELANGHVPFK 211
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 0.002
Identities = 25/88 (28%), Positives = 43/88 (48%), Gaps = 2/88 (2%)
Query: 193 VNDLYLSNNKLTGAMPN-LTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNL 251
++ L L N L G +PN ++ L L +++S NS +P S+ SL L + +
Sbjct: 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRG-NIPPSLGSITSLEVLDLSYNSF 478
Query: 252 KGQIPADLFSIPHLQTVVMKTNELNGTL 279
G IP L + L+ + + N L+G +
Sbjct: 479 NGSIPESLGQLTSLRILNLNGNSLSGRV 506
|
Length = 623 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 882 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.98 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.98 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.98 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.98 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.98 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.98 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.94 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.93 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.92 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.92 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.92 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.91 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.91 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.89 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.89 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.89 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.86 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.86 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.86 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.86 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.85 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.84 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.84 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.84 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.83 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.83 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.82 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.82 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.82 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.81 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.8 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.8 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.79 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.78 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.77 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.75 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.74 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.72 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.71 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.7 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.7 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.7 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.69 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.69 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.68 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.68 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.67 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.66 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.65 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.6 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.6 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.53 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.53 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.44 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.41 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.4 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.37 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.36 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.36 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.32 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.3 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.3 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.29 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.24 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.22 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.18 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.17 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.16 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.16 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.14 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.14 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.12 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.11 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.07 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.07 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.05 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 98.98 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 98.97 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.96 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.92 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.92 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.87 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.8 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.79 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.74 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.72 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.7 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.69 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.65 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.62 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.58 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.58 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.5 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.5 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.41 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.38 | |
| COG5238 | 388 | RNA1 Ran GTPase-activating protein (RanGAP) involv | 98.37 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.35 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-75 Score=736.54 Aligned_cols=701 Identities=29% Similarity=0.453 Sum_probs=422.1
Q ss_pred cccCccccCCCCCCEEeccCCCCCccCCCccccCCCCCcEEEeeCCcCCccccccccCCCCCCEEEccCCcCCCCCCcCc
Q 002774 5 GQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSI 84 (882)
Q Consensus 5 ~~l~~~~~~l~~L~~L~L~~n~~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~ 84 (882)
+.+|..|.++++|++|+|++|+ +.+.+|..|+++++|++|+|++|.+++.+|..+.++++|++|+|++|++.+.+|..+
T Consensus 226 ~~~p~~l~~l~~L~~L~L~~n~-l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~ 304 (968)
T PLN00113 226 GEIPYEIGGLTSLNHLDLVYNN-LTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELV 304 (968)
T ss_pred CcCChhHhcCCCCCEEECcCce-eccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhH
Confidence 3344444444444444444443 333444444444444444444444444444444444444444444444444444444
Q ss_pred cCCCCCcEeeccCceeeeecCCCCCCCchhh------------------hhhcccceeccCCeeeecCCccccCCcccce
Q 002774 85 GNLSNLYWLDLTDNKLEGEIPVSDGNSPGLD------------------MLVRAKHFHFGKNQLSGSIPEKLFRPDMVLI 146 (882)
Q Consensus 85 ~~l~~L~~L~Ls~N~i~~~~p~~~~~~~~l~------------------~L~~L~~L~L~~N~l~~~ip~~~f~~~~~L~ 146 (882)
.++++|++|++++|.+++.+|..+..++.|+ .+++|+.|++++|++++.+|..+ ..+.+|+
T Consensus 305 ~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~-~~~~~L~ 383 (968)
T PLN00113 305 IQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGL-CSSGNLF 383 (968)
T ss_pred cCCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhH-hCcCCCC
Confidence 4444444444444444444443333322221 12345555555555554554432 2345566
Q ss_pred eeeccCCcccccCCccccCCCCCCEEEccCCCCCCCCCccCCCCCCCCEEEccCCcccccCCC-CCCCCCCCEEECcCCC
Q 002774 147 HVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPN-LTGLSVLSYLDMSNNS 225 (882)
Q Consensus 147 ~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~-~~~l~~L~~L~Ls~N~ 225 (882)
.|++++|++.+.+|..+..+++|+.|++++|.+++..|..|.++++|+.|+|++|.+++.++. +..+++|+.|+|++|+
T Consensus 384 ~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~ 463 (968)
T PLN00113 384 KLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNK 463 (968)
T ss_pred EEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCce
Confidence 666666666666777777888888888888888888888888888888888888888877664 6677788888888887
Q ss_pred CCCCCCCccccCCCCCCEEECcCCcccccCCccCCCCCCCCEEEccCCccceecCCC-CcccccccccccCCccccccCC
Q 002774 226 FDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLG-TSYSENLLVNLQNNRISAYTER 304 (882)
Q Consensus 226 l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~-~~~~~L~~L~L~~N~i~~~~~~ 304 (882)
+.+ .+|..+ .+++|+.|+|++|++++.+|..+..+++|+.|+|++|++.+.++.. ..+.+|+.|+|++|.+++..+.
T Consensus 464 ~~~-~~p~~~-~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 541 (968)
T PLN00113 464 FFG-GLPDSF-GSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPA 541 (968)
T ss_pred eee-ecCccc-ccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCCh
Confidence 764 455543 4567777777777777777777777777777777777777755544 3467777777777777777777
Q ss_pred CCCCccceEEecCccccccCCccccccccCCCCCCCCCCCCccCCcCCCCCCCCCCCeeeEeeeeEEEEeecccccCCCC
Q 002774 305 GGAPAVNLTLIDNPICQELGTAKGYCQLSQPISPYSTKQKNCLPAPCNANQSSSPNCQCAYPYTGTLVFRSLSFSDLGNT 384 (882)
Q Consensus 305 ~~~~~~~L~~l~~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (882)
.|..+++|+.||...|.-.... +........-....-..+... +..|..+. +..+..
T Consensus 542 ~~~~l~~L~~L~Ls~N~l~~~~----------p~~l~~l~~L~~l~ls~N~l~-----~~~p~~~~-------~~~~~~- 598 (968)
T PLN00113 542 SFSEMPVLSQLDLSQNQLSGEI----------PKNLGNVESLVQVNISHNHLH-----GSLPSTGA-------FLAINA- 598 (968)
T ss_pred hHhCcccCCEEECCCCcccccC----------ChhHhcCcccCEEeccCCcce-----eeCCCcch-------hcccCh-
Confidence 7777777777776554432211 110000000000000000000 00010000 000000
Q ss_pred hhHHHHHHHHHHHhcccceeeeeeEEecCCCCCCccceEEEEEeecCCccccccccccccceeeeccccCCCCCCCCccc
Q 002774 385 TYYEILEQSVTTSFQSTYKLPIDSISLSNPHKNNFEYLELSIQFFPSGQESFNRTGVSSVGFVLSNQIYSPPPLFGPMFF 464 (882)
Q Consensus 385 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 464 (882)
.++. .|+ ..
T Consensus 599 ----------------------~~~~-~n~------------------------------------------------~l 607 (968)
T PLN00113 599 ----------------------SAVA-GNI------------------------------------------------DL 607 (968)
T ss_pred ----------------------hhhc-CCc------------------------------------------------cc
Confidence 0000 000 00
Q ss_pred CCCCCcc-cccCCCCCccceeeeehhHHHHHHHHHHHHHHHHHHHhhhhhhhhhhccCCCCcccccCCCCCCCCCCCCCc
Q 002774 465 NGDPYQY-FAESGGSHKSTSIGVIIGAAAAGCVVLLLLLLAGVYAYHQKRRAEKANEQNPFAHWDMNKSSGSIPQLKGAR 543 (882)
Q Consensus 465 ~~~~~~~-~~~~~~~~~~~~~~iii~~~~~~~~~ll~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 543 (882)
|+.+... .+.+....++...+++|+++++++++++++++ +++++++|++.+..........|..... ......
T Consensus 608 c~~~~~~~~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~ 681 (968)
T PLN00113 608 CGGDTTSGLPPCKRVRKTPSWWFYITCTLGAFLVLALVAF-GFVFIRGRNNLELKRVENEDGTWELQFF-----DSKVSK 681 (968)
T ss_pred cCCccccCCCCCccccccceeeeehhHHHHHHHHHHHHHH-HHHHHHhhhccccccccccccccccccc-----ccccch
Confidence 1000000 00011111222334444444443333333332 2333332222111111111111211100 001112
Q ss_pred ccCHHHHHHHHcCCCCCCeeeccCcEEEEEEEe-cCCcEEEEEEcccCCcccHHHHHHHHHHHHhccCCCeeeEEEEEEe
Q 002774 544 CFSFEEVKKYTNNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFD 622 (882)
Q Consensus 544 ~~~~~e~~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~ 622 (882)
.++++++ ...|...++||+|+||+||+|+. .++..||||+++..... ..+|++.+++++|||||+++|+|.+
T Consensus 682 ~~~~~~~---~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~ 754 (968)
T PLN00113 682 SITINDI---LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRS 754 (968)
T ss_pred hhhHHHH---HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEc
Confidence 2344443 34678889999999999999996 57899999998754322 2346889999999999999999999
Q ss_pred CCceEEEEEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeeccc
Q 002774 623 RGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGL 702 (882)
Q Consensus 623 ~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGl 702 (882)
++..++||||+++|+|.++++ .++|.++.+++.|+|+||+|||+.+.++|+||||||+||+++.++.+++. ||.
T Consensus 755 ~~~~~lv~Ey~~~g~L~~~l~-----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~ 828 (968)
T PLN00113 755 EKGAYLIHEYIEGKNLSEVLR-----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSL 828 (968)
T ss_pred CCCCEEEEeCCCCCcHHHHHh-----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecc
Confidence 999999999999999999995 37899999999999999999997766679999999999999999988876 666
Q ss_pred ccccCCCCCceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCC----chHHHHHHHHHHhhhhh
Q 002774 703 SKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERG----KYIVREIRTVMDKKKEL 778 (882)
Q Consensus 703 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~----~~~~~~~~~~~~~~~~~ 778 (882)
+...... ....+|+.|||||++.+..++.++|||||||++|||+||+.||+.. ....++.+......
T Consensus 829 ~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--- 899 (968)
T PLN00113 829 PGLLCTD------TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDC--- 899 (968)
T ss_pred ccccccC------CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCcc---
Confidence 5433211 1235789999999999999999999999999999999999998532 22333333222111
Q ss_pred hhhhhccCCcCCC--CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 002774 779 YNLYELIDPTIGL--STTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 832 (882)
Q Consensus 779 ~~~~~~~d~~l~~--~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~ 832 (882)
.....+|+.+.. ....++..++.+++.+||+.||++||+|+|+++.|+++.+.
T Consensus 900 -~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~ 954 (968)
T PLN00113 900 -HLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS 954 (968)
T ss_pred -chhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence 123445555433 23445667889999999999999999999999999988654
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-53 Score=466.10 Aligned_cols=285 Identities=53% Similarity=0.910 Sum_probs=248.3
Q ss_pred CCcccCHHHHHHHHcCCCCCCeeeccCcEEEEEEEecCCcEEEEEEcccCCcccHHHHHHHHHHHHhccCCCeeeEEEEE
Q 002774 541 GARCFSFEEVKKYTNNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFC 620 (882)
Q Consensus 541 ~~~~~~~~e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~ 620 (882)
..+.|+++|++.+|++|+..++||+|+||.||+|.+.+|+.||||++........++|..|++++.+++|||+|+++|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 56789999999999999999999999999999999999999999988765443146699999999999999999999999
Q ss_pred EeCC-ceEEEEEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEee
Q 002774 621 FDRG-EQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVAD 699 (882)
Q Consensus 621 ~~~~-~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~D 699 (882)
.+.+ +.+||||||++|+|.++|+......++|.+|++||.++|+||+|||+.+.++||||||||+|||+|+++++||+|
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD 220 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD 220 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence 9999 499999999999999999986543789999999999999999999999989999999999999999999999999
Q ss_pred cccccccCCCCCceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCC-----chHHHHHHHHHHh
Q 002774 700 FGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERG-----KYIVREIRTVMDK 774 (882)
Q Consensus 700 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~-----~~~~~~~~~~~~~ 774 (882)
||+|+...... ....+...||.+|+|||++..+..+.|+|||||||+|+|++||++|.+.. ..+.+|....+..
T Consensus 221 FGLa~~~~~~~-~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~ 299 (361)
T KOG1187|consen 221 FGLAKLGPEGD-TSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEE 299 (361)
T ss_pred ccCcccCCccc-cceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHC
Confidence 99997654311 11111117999999999999999999999999999999999999988732 2356676555555
Q ss_pred hhhhhhhhhccCCcCC-CCCCH-HHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 002774 775 KKELYNLYELIDPTIG-LSTTL-KGFEKYVDLALKCVQESGDDRPTMSEVVKDIENIL 830 (882)
Q Consensus 775 ~~~~~~~~~~~d~~l~-~~~~~-~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~ 830 (882)
. .+.+++||.+. ..+.. ++..++..++.+|++.+|.+||+|.||++.|+.+.
T Consensus 300 ~----~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 300 G----KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred c----chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 4 47899999987 55553 68888999999999999999999999999986553
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-47 Score=414.61 Aligned_cols=258 Identities=36% Similarity=0.555 Sum_probs=215.6
Q ss_pred CCeeeccCcEEEEEEEecCCcEEEEEEcccCCccc--HHHHHHHHHHHHhccCCCeeeEEEEEEeCC-ceEEEEEeecCC
Q 002774 560 ANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQG--GQEFKMEIELLSRVHHKNLVSLLGFCFDRG-EQMLIYEFVPNG 636 (882)
Q Consensus 560 ~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-~~~lV~e~~~~g 636 (882)
.+.||+|+||+||+|.|.....||||++....... .++|.+|+.+|.+++|||||+++|+|.+.. ..++|||||++|
T Consensus 46 ~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~G 125 (362)
T KOG0192|consen 46 EEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGG 125 (362)
T ss_pred hhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCC
Confidence 45599999999999999754559999998654333 458999999999999999999999999887 799999999999
Q ss_pred CcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCC-ceeEeecccccccCCCCCceee
Q 002774 637 SLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERL-NAKVADFGLSKSMSDSEKDHIT 715 (882)
Q Consensus 637 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~-~~kl~DfGla~~~~~~~~~~~~ 715 (882)
+|.++++......+++..+++||.|||+||.|||+.+. ||||||||+|||++.++ ++||+|||+++...... ...
T Consensus 126 sL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~--~~~ 201 (362)
T KOG0192|consen 126 SLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK--TSM 201 (362)
T ss_pred cHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc--ccc
Confidence 99999987545589999999999999999999999764 99999999999999997 99999999998765432 223
Q ss_pred eeeeccCCCCCHHHHh--hCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCCCCC
Q 002774 716 TQVKGTMGYLDPEYYM--TQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLST 793 (882)
Q Consensus 716 ~~~~gt~~y~aPE~~~--~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 793 (882)
+...||+.|||||++. ...|+.|+||||||+++|||+||+.||..... ......+..... .|.+
T Consensus 202 ~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-~~~~~~v~~~~~---------Rp~~---- 267 (362)
T KOG0192|consen 202 TSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-VQVASAVVVGGL---------RPPI---- 267 (362)
T ss_pred cCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-HHHHHHHHhcCC---------CCCC----
Confidence 3467999999999999 56999999999999999999999999987655 333222222211 1111
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHcCC
Q 002774 794 TLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQAGL 835 (882)
Q Consensus 794 ~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~~~ 835 (882)
+..++..+..++.+||+.||..||++.+++..|+.+......
T Consensus 268 p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~ 309 (362)
T KOG0192|consen 268 PKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS 309 (362)
T ss_pred CccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence 222557899999999999999999999999999999876554
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-48 Score=426.98 Aligned_cols=410 Identities=23% Similarity=0.384 Sum_probs=292.7
Q ss_pred eeeeEEecCCCCCCccceEEEEEeecCCccccccccc--cccceeeeccccCCCCCCCCcccCC---CCCcccc-----c
Q 002774 405 PIDSISLSNPHKNNFEYLELSIQFFPSGQESFNRTGV--SSVGFVLSNQIYSPPPLFGPMFFNG---DPYQYFA-----E 474 (882)
Q Consensus 405 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~-----~ 474 (882)
....++|..|...|+..+++++.++++...+.+-+-. ....-.+.+........|...+.+. +++.... .
T Consensus 457 ~sitlsW~~p~~png~ildYEvky~ek~~~e~~~~~~~t~~~~~ti~gL~p~t~YvfqVRarT~aG~G~~S~~~~fqT~~ 536 (996)
T KOG0196|consen 457 DSITLSWSEPDQPNGVILDYEVKYYEKDEDERSYSTLKTKTTTATITGLKPGTVYVFQVRARTAAGYGPYSGKHEFQTLP 536 (996)
T ss_pred CceEEecCCCCCCCCcceeEEEEEeeccccccceeEEecccceEEeeccCCCcEEEEEEEEecccCCCCCCCceeeeecC
Confidence 3456889999999999999999999997654444333 3334556666655566666554442 2222111 0
Q ss_pred C-CCCCccceeeeehhHHHHHHHHHHHHHHHHHHHhhhhh--hhhhhcc-CCCCcccccCCCCCCCC-CCCCCcccCHHH
Q 002774 475 S-GGSHKSTSIGVIIGAAAAGCVVLLLLLLAGVYAYHQKR--RAEKANE-QNPFAHWDMNKSSGSIP-QLKGARCFSFEE 549 (882)
Q Consensus 475 ~-~~~~~~~~~~iii~~~~~~~~~ll~l~~~~~~~~~~~~--~~~~~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~~e 549 (882)
. .....+..+.+|+|+++++++++++++++.+.+.++|+ ...+..+ ..+...+-... ...+ ...-...++|+|
T Consensus 537 ~~~~~~~~~~l~~i~g~~~~~v~~lll~~vv~~~~~~~r~~~~~~~~~~~~t~~~~~~~~~--~~~pG~k~YiDP~TYED 614 (996)
T KOG0196|consen 537 SESSSQSGEQLPLIIGSILAGVVFLLLAAVVVVAIVCSRKRCGYSRAEQEYTEKLQHYSNG--EQLPGTKTYIDPHTYED 614 (996)
T ss_pred cccccccccchhhHHHHHHHHHHHHHHHHHHHHhheeecccccchhcccCCChhHhhhhcC--CCCCCceeecCCccccC
Confidence 1 11122234556777777666665544444444433333 1111110 01100000000 0000 001122344554
Q ss_pred HHHHHcC---------CCCCCeeeccCcEEEEEEEec----CCcEEEEEEcccCCcc-cHHHHHHHHHHHHhccCCCeee
Q 002774 550 VKKYTNN---------FSDANDVGSGGYGKVYKGTLP----NGQLIAIKRAQQGSMQ-GGQEFKMEIELLSRVHHKNLVS 615 (882)
Q Consensus 550 ~~~~~~~---------~~~~~~lG~G~fg~Vy~~~~~----~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~ 615 (882)
-.++... ..+.++||.|.||+||+|+++ ....||||.+|.+..+ .+.+|..|+.||.+.+||||++
T Consensus 615 PnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIr 694 (996)
T KOG0196|consen 615 PNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIR 694 (996)
T ss_pred ccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEE
Confidence 3333322 245679999999999999975 2458999999987554 4578999999999999999999
Q ss_pred EEEEEEeCCceEEEEEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCce
Q 002774 616 LLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNA 695 (882)
Q Consensus 616 l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~ 695 (882)
+.|+.......+||+|||+||+|..+|+.+.+ .+++.+...|.++||.||.||-+.+ +|||||.++|||++.+..+
T Consensus 695 LEGVVTks~PvMIiTEyMENGsLDsFLR~~DG-qftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvC 770 (996)
T KOG0196|consen 695 LEGVVTKSKPVMIITEYMENGSLDSFLRQNDG-QFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVC 770 (996)
T ss_pred EEEEEecCceeEEEhhhhhCCcHHHHHhhcCC-ceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEE
Confidence 99999999999999999999999999998765 5999999999999999999999999 9999999999999999999
Q ss_pred eEeecccccccCCCC-CceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHHH
Q 002774 696 KVADFGLSKSMSDSE-KDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMD 773 (882)
Q Consensus 696 kl~DfGla~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~t-g~~P~~~~~~~~~~~~~~~~ 773 (882)
||+|||++|.+.++. ....+....-+++|.|||.+..+++|.+|||||||+|+||.++ |.+||.+..+. +++.
T Consensus 771 KVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQ-----dVIk 845 (996)
T KOG0196|consen 771 KVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ-----DVIK 845 (996)
T ss_pred EeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchH-----HHHH
Confidence 999999999886544 2222223344689999999999999999999999999999998 99999764431 2222
Q ss_pred hhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHcCC
Q 002774 774 KKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQAGL 835 (882)
Q Consensus 774 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~~~ 835 (882)
. +....+...+++++..+.+||+.||++|-.+||++.||+..|.+++++-..
T Consensus 846 a----------Ie~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~S 897 (996)
T KOG0196|consen 846 A----------IEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNS 897 (996)
T ss_pred H----------HHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchh
Confidence 2 223344555667889999999999999999999999999999999877543
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-47 Score=413.12 Aligned_cols=254 Identities=31% Similarity=0.524 Sum_probs=217.8
Q ss_pred CCCeeeccCcEEEEEEEecCCcEEEEEEcccCCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEeecCCCc
Q 002774 559 DANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSL 638 (882)
Q Consensus 559 ~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 638 (882)
..+.||+|.||+||.|.|+....||+|.++..... .++|.+|+++|++|+|+|||+++|+|..++..+||||||+.|+|
T Consensus 210 l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~-~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsL 288 (468)
T KOG0197|consen 210 LIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMS-PEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSL 288 (468)
T ss_pred HHHHhcCCccceEEEEEEcCCCcccceEEeccccC-hhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcH
Confidence 35679999999999999987789999999876443 47899999999999999999999999999999999999999999
Q ss_pred ccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCceeeeee
Q 002774 639 GDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQV 718 (882)
Q Consensus 639 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 718 (882)
.++|+...+..+...+.+.++.|||+||+||++++ +|||||.++||||+++..+||+|||||+...++. .......
T Consensus 289 l~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~-Y~~~~~~ 364 (468)
T KOG0197|consen 289 LDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDE-YTASEGG 364 (468)
T ss_pred HHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCc-eeecCCC
Confidence 99999866778999999999999999999999998 9999999999999999999999999999554433 3334444
Q ss_pred eccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCCCCCCHHH
Q 002774 719 KGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKG 797 (882)
Q Consensus 719 ~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 797 (882)
.-++.|.|||.+..+.++.|||||||||+||||+| |+.||.... ..+.+ +.++...+...+..+
T Consensus 365 kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ms-n~ev~--------------~~le~GyRlp~P~~C 429 (468)
T KOG0197|consen 365 KFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMS-NEEVL--------------ELLERGYRLPRPEGC 429 (468)
T ss_pred CCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCC-HHHHH--------------HHHhccCcCCCCCCC
Confidence 56789999999999999999999999999999999 777875432 22222 222333344556668
Q ss_pred HHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 002774 798 FEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 832 (882)
Q Consensus 798 ~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~ 832 (882)
+..++++|..||+.+|++|||++.+...++++...
T Consensus 430 P~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 430 PDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred CHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 89999999999999999999999999998888543
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-46 Score=385.51 Aligned_cols=246 Identities=30% Similarity=0.465 Sum_probs=208.8
Q ss_pred CCCCeeeccCcEEEEEEEec-CCcEEEEEEcccC-CcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCc-eEEEEEeec
Q 002774 558 SDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQG-SMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGE-QMLIYEFVP 634 (882)
Q Consensus 558 ~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~-~~lV~e~~~ 634 (882)
...+.||+|..|+|||++++ +++.+|+|.+... .....+++.+|++++++.+||+||+++|+|+.++. ..++||||+
T Consensus 82 e~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMD 161 (364)
T KOG0581|consen 82 ERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMD 161 (364)
T ss_pred hhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcC
Confidence 44688999999999999975 6899999999543 33345789999999999999999999999999994 999999999
Q ss_pred CCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhh-cCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCce
Q 002774 635 NGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHE-LANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDH 713 (882)
Q Consensus 635 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 713 (882)
+|||.+++...+ ++++...-+|+.+|++||.|||+ ++ ||||||||+|||++..|++||||||.++.+...
T Consensus 162 gGSLd~~~k~~g--~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS---- 232 (364)
T KOG0581|consen 162 GGSLDDILKRVG--RIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS---- 232 (364)
T ss_pred CCCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhhh----
Confidence 999999998654 68899999999999999999996 66 999999999999999999999999999987654
Q ss_pred eeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCC----chHHHHHHHHHHhhhhhhhhhhccCCcC
Q 002774 714 ITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERG----KYIVREIRTVMDKKKELYNLYELIDPTI 789 (882)
Q Consensus 714 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~----~~~~~~~~~~~~~~~~~~~~~~~~d~~l 789 (882)
....++||..|||||.+.+..|+.++||||||++++|+++|+.||... ....+.+..+..+ ..|.+
T Consensus 233 ~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~----------ppP~l 302 (364)
T KOG0581|consen 233 IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDE----------PPPRL 302 (364)
T ss_pred hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcC----------CCCCC
Confidence 345678999999999999999999999999999999999999999764 2222332222221 12333
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 790 GLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 790 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
+.. ....+|.+++..|+++||.+||+++|++++
T Consensus 303 P~~---~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 303 PEG---EFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred Ccc---cCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 322 355789999999999999999999999986
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-46 Score=418.59 Aligned_cols=262 Identities=28% Similarity=0.499 Sum_probs=223.1
Q ss_pred HcCCCCCCeeeccCcEEEEEEEec------CCcEEEEEEcccCCcc-cHHHHHHHHHHHHhccCCCeeeEEEEEEeCCce
Q 002774 554 TNNFSDANDVGSGGYGKVYKGTLP------NGQLIAIKRAQQGSMQ-GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQ 626 (882)
Q Consensus 554 ~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 626 (882)
+.+....+.||+|+||+||+|+.. +...||||.++..... ..++|++|+++++.++|||||+++|.|.+++..
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~ 564 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL 564 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence 345556788999999999999853 3568999999987665 668999999999999999999999999999999
Q ss_pred EEEEEeecCCCcccccCCCC--------Cc----cccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCc
Q 002774 627 MLIYEFVPNGSLGDSLSGKN--------GI----RLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLN 694 (882)
Q Consensus 627 ~lV~e~~~~gsL~~~l~~~~--------~~----~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~ 694 (882)
++|+|||..|||.++|+... +. +++..+.+.||.|||.||+||-++. +|||||..+|+||.++..
T Consensus 565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~ 641 (774)
T KOG1026|consen 565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLV 641 (774)
T ss_pred EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceE
Confidence 99999999999999997532 12 3889999999999999999999888 999999999999999999
Q ss_pred eeEeecccccccCCCCCceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHHH
Q 002774 695 AKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMD 773 (882)
Q Consensus 695 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~t-g~~P~~~~~~~~~~~~~~~~ 773 (882)
+||+|||++|.....+.........-+++|||||.++.++||.+||||||||+|||+++ |+.||.+-.+. ++-..+.
T Consensus 642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~--EVIe~i~ 719 (774)
T KOG1026|consen 642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ--EVIECIR 719 (774)
T ss_pred EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchH--HHHHHHH
Confidence 99999999998887776665555567899999999999999999999999999999999 99998754331 1211122
Q ss_pred hhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHc
Q 002774 774 KKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQA 833 (882)
Q Consensus 774 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~ 833 (882)
.++ + ...+..++.++++||..||+..|.+||+++||-..|+...+..
T Consensus 720 ~g~------------l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s 766 (774)
T KOG1026|consen 720 AGQ------------L-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQAS 766 (774)
T ss_pred cCC------------c-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence 211 1 3455667899999999999999999999999999999886543
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-44 Score=369.96 Aligned_cols=249 Identities=28% Similarity=0.443 Sum_probs=199.1
Q ss_pred HcCCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCC--cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEE
Q 002774 554 TNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS--MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIY 630 (882)
Q Consensus 554 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 630 (882)
..+|...+.||+|+||+||+|+++ ++..||||.+.+.. ....+.+..|+.+|+.++|||||++++++.+++..||||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 346777888999999999999964 68999999997653 333456788999999999999999999999999999999
Q ss_pred EeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCC------CceeEeeccccc
Q 002774 631 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDER------LNAKVADFGLSK 704 (882)
Q Consensus 631 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~------~~~kl~DfGla~ 704 (882)
|||.+|+|.++++.++ .+++.....++.|+|.||++||+.+ ||||||||.||||+.. -.+||+|||+||
T Consensus 89 EyC~gGDLs~yi~~~~--~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR 163 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRG--RLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR 163 (429)
T ss_pred EeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence 9999999999999876 6899999999999999999999999 9999999999999765 468999999999
Q ss_pred ccCCCCCceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhc
Q 002774 705 SMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYEL 784 (882)
Q Consensus 705 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 784 (882)
.+.+.. .....+|++-|||||+++.++|+.|+|+||.|+|+|+|++|+.||... +..+... ..+....
T Consensus 164 ~L~~~~---~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~-t~~eL~~-~~~k~~~------- 231 (429)
T KOG0595|consen 164 FLQPGS---MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAE-TPKELLL-YIKKGNE------- 231 (429)
T ss_pred hCCchh---HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcccc-CHHHHHH-HHhcccc-------
Confidence 987543 344578999999999999999999999999999999999999999643 2223222 1111111
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 002774 785 IDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVV 823 (882)
Q Consensus 785 ~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl 823 (882)
+-|.+. ........+++...++.+|.+|-++.+-.
T Consensus 232 ~~~~~~----~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~ 266 (429)
T KOG0595|consen 232 IVPVLP----AELSNPLRELLISLLQRNPKDRISFEDFF 266 (429)
T ss_pred ccCchh----hhccCchhhhhhHHHhcCccccCchHHhh
Confidence 111110 11112234666777777777776665544
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=386.32 Aligned_cols=248 Identities=27% Similarity=0.447 Sum_probs=211.0
Q ss_pred cCCCCCCeeeccCcEEEEEEEe-cCCcEEEEEEcccCC---cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEE
Q 002774 555 NNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGS---MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIY 630 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 630 (882)
..|...+.||+|+|+.||+++. ..|+.||+|++.+.. ....+.+.+|+++.+.|+|||||+++++|++.+..|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 4688889999999999999996 789999999997643 233467889999999999999999999999999999999
Q ss_pred EeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCC
Q 002774 631 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE 710 (882)
Q Consensus 631 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~ 710 (882)
|+|++++|.++++.+ .++++.++..++.||+.||.|||+++ |+|||||..|+|+++++++||+|||||..+..++
T Consensus 98 ELC~~~sL~el~Krr--k~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~ 172 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRR--KPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG 172 (592)
T ss_pred EecCCccHHHHHHhc--CCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCcc
Confidence 999999999999854 47999999999999999999999999 9999999999999999999999999999887543
Q ss_pred CceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCC
Q 002774 711 KDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIG 790 (882)
Q Consensus 711 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 790 (882)
. ...+.+|||.|.|||++.....+..+||||+|||+|-|+.|++||+... ..+....+... +..-|.
T Consensus 173 E--rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~-vkety~~Ik~~--------~Y~~P~-- 239 (592)
T KOG0575|consen 173 E--RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT-VKETYNKIKLN--------EYSMPS-- 239 (592)
T ss_pred c--ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch-HHHHHHHHHhc--------Cccccc--
Confidence 2 3456899999999999999999999999999999999999999997532 22222222111 111111
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 791 LSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 791 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
....+..+||.++|+++|.+|||+.+|+.+
T Consensus 240 -----~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 240 -----HLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred -----ccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 123567899999999999999999999976
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=374.98 Aligned_cols=254 Identities=24% Similarity=0.367 Sum_probs=205.0
Q ss_pred HHcCCCCCCeeeccCcEEEEEEE-ecCCcEEEEEEcccCCcc-------cHHHHHHHHHHHHhccCCCeeeEEEEEEeCC
Q 002774 553 YTNNFSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQ-------GGQEFKMEIELLSRVHHKNLVSLLGFCFDRG 624 (882)
Q Consensus 553 ~~~~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~ 624 (882)
..+.|...+.||+|+||.|-+|. .++|+.||||++.+.... ......+|+++|++++|||||++++++...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 34567778999999999999997 458999999999764221 1234579999999999999999999999999
Q ss_pred ceEEEEEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCC---CceeEeecc
Q 002774 625 EQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDER---LNAKVADFG 701 (882)
Q Consensus 625 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~---~~~kl~DfG 701 (882)
..|||||||+||+|.+.+-.++ .+.+..-.-++.|++.|+.|||+.| |+||||||+|||+..+ ..+||+|||
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk--~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDFG 324 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANK--YLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDFG 324 (475)
T ss_pred ceEEEEEEecCccHHHHHHhcc--ccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecccc
Confidence 9999999999999999997765 4566666789999999999999999 9999999999999765 779999999
Q ss_pred cccccCCCCCceeeeeeeccCCCCCHHHHhhCC---CCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhh
Q 002774 702 LSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQ---LTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKEL 778 (882)
Q Consensus 702 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~ 778 (882)
+|+..+.. ..+.+.+||+.|.|||++.+.. +..++|+||+||+||-+++|..||.+..........+......
T Consensus 325 lAK~~g~~---sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~- 400 (475)
T KOG0615|consen 325 LAKVSGEG---SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYA- 400 (475)
T ss_pred hhhccccc---eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCccc-
Confidence 99987533 3466789999999999998654 3348899999999999999999997543322222222221110
Q ss_pred hhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 779 YNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 779 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
. ....+.+..++..++|.+||..||++|||+.|++++
T Consensus 401 --f--------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 401 --F--------GPLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred --c--------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 0 011233445788999999999999999999999986
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-45 Score=358.96 Aligned_cols=258 Identities=25% Similarity=0.395 Sum_probs=207.8
Q ss_pred cCCCCCCeeeccCcEEEEEEE-ecCCcEEEEEEcccCCc--ccHHHHHHHHHHHHhccCCCeeeEEE-EEEeCCc-eEEE
Q 002774 555 NNFSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSM--QGGQEFKMEIELLSRVHHKNLVSLLG-FCFDRGE-QMLI 629 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~-~~~~~~~-~~lV 629 (882)
.+|.+.++||+|+||+|||++ ..+|..||.|.++-+.. ...++...|+.+|++|+|||||++++ .+.++.+ .+||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 346677889999999999998 56899999999885433 34467889999999999999999998 3444444 8999
Q ss_pred EEeecCCCcccccCC--CCCccccHHHHHHHHHHHHHHHhhhhhcCC-CCeeecCCCCCceEEcCCCceeEeeccccccc
Q 002774 630 YEFVPNGSLGDSLSG--KNGIRLDWIRRLKIALGAARGLSYLHELAN-PPIIHRDIKSSNILLDERLNAKVADFGLSKSM 706 (882)
Q Consensus 630 ~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~-~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~ 706 (882)
|||+..|+|...++. ..+..+++..++++..|+++||.++|..-. ..|+||||||.||+++.+|.+||+|||+++.+
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 999999999998864 335679999999999999999999998331 23999999999999999999999999999988
Q ss_pred CCCCCceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccC
Q 002774 707 SDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELID 786 (882)
Q Consensus 707 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 786 (882)
.... ......+|||.||+||.+.+..|+.||||||+||++|||+.-++||.+. +..+....+ ....
T Consensus 179 ~s~~--tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~-n~~~L~~KI-~qgd---------- 244 (375)
T KOG0591|consen 179 SSKT--TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD-NLLSLCKKI-EQGD---------- 244 (375)
T ss_pred cchh--HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc-cHHHHHHHH-HcCC----------
Confidence 6543 2344578999999999999999999999999999999999999999765 333322222 1111
Q ss_pred CcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 002774 787 PTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIEN 828 (882)
Q Consensus 787 ~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~ 828 (882)
.+.-.......++..+|..|+..||+.||+...++..+..
T Consensus 245 --~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 245 --YPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred --CCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 1111123456789999999999999999997666666554
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-43 Score=408.79 Aligned_cols=261 Identities=31% Similarity=0.512 Sum_probs=219.5
Q ss_pred CCCCCCeeeccCcEEEEEEEecC--Cc----EEEEEEcccC-CcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEE
Q 002774 556 NFSDANDVGSGGYGKVYKGTLPN--GQ----LIAIKRAQQG-SMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQML 628 (882)
Q Consensus 556 ~~~~~~~lG~G~fg~Vy~~~~~~--g~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 628 (882)
.....+.||+|+||.||+|.+.+ |. .||||.+++. +.++..+|.+|..+|++++|||||+++|.|.+.+..++
T Consensus 693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i 772 (1025)
T KOG1095|consen 693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLI 772 (1025)
T ss_pred heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEE
Confidence 34456789999999999999643 43 4899999875 44556789999999999999999999999999999999
Q ss_pred EEEeecCCCcccccCCCC-----CccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccc
Q 002774 629 IYEFVPNGSLGDSLSGKN-----GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLS 703 (882)
Q Consensus 629 V~e~~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla 703 (882)
++|||++|+|..+|++.. ...++..+.+.++.|||+|+.||++.+ +|||||.++|+||++...+||+|||+|
T Consensus 773 ~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFGlA 849 (1025)
T KOG1095|consen 773 LLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFGLA 849 (1025)
T ss_pred EehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccchh
Confidence 999999999999998752 346889999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHhhhhhhhhh
Q 002774 704 KSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLY 782 (882)
Q Consensus 704 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 782 (882)
+.+.+.+.........-+.+|||||.+..+.++.|+|||||||++||++| |..||....+. +.+..++...
T Consensus 850 rDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~-~v~~~~~~gg------- 921 (1025)
T KOG1095|consen 850 RDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNF-EVLLDVLEGG------- 921 (1025)
T ss_pred HhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchH-HHHHHHHhCC-------
Confidence 97766655444333345679999999999999999999999999999999 88888654432 2222222222
Q ss_pred hccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHcC
Q 002774 783 ELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQAG 834 (882)
Q Consensus 783 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~~ 834 (882)
+...+..++..++++|..||+.+|++||++..+++.+..+.+...
T Consensus 922 -------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~ 966 (1025)
T KOG1095|consen 922 -------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAAL 966 (1025)
T ss_pred -------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhc
Confidence 234555678899999999999999999999999999999887654
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=350.63 Aligned_cols=263 Identities=25% Similarity=0.342 Sum_probs=204.5
Q ss_pred cCCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCCc--ccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEE
Q 002774 555 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM--QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYE 631 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e 631 (882)
+.|....++|+|+||+|||++.+ +|+.||||++..... .-.+-..+|+++|++++|+|+|.++++|......+||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 35667788999999999999965 699999999975432 223556789999999999999999999999999999999
Q ss_pred eecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCC
Q 002774 632 FVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEK 711 (882)
Q Consensus 632 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 711 (882)
|++..-|.+.-+... .++.....+++.|+++|+.|+|+++ +|||||||+||||+.++.+||||||+|+.+...
T Consensus 82 ~~dhTvL~eLe~~p~--G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p-- 154 (396)
T KOG0593|consen 82 YCDHTVLHELERYPN--GVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAP-- 154 (396)
T ss_pred ecchHHHHHHHhccC--CCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCC--
Confidence 998755554443333 4778889999999999999999999 999999999999999999999999999988742
Q ss_pred ceeeeeeeccCCCCCHHHHhh-CCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhh-h---------
Q 002774 712 DHITTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELY-N--------- 780 (882)
Q Consensus 712 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~-~--------- 780 (882)
....+..+.|.+|+|||.+.+ .+|...+||||.||++.||++|.+-| .++...+++..+...-..+. +
T Consensus 155 gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~-PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~ 233 (396)
T KOG0593|consen 155 GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLW-PGRSDIDQLYLIRKTLGNLIPRHQSIFSSNP 233 (396)
T ss_pred cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCC-CCcchHHHHHHHHHHHcccCHHHHHHhccCC
Confidence 234566789999999999987 78999999999999999999998555 45544454443333211111 0
Q ss_pred ------hhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 781 ------LYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 781 ------~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
+.+.-+++.-.....+...-+.++++.|++.||++|++-+|++.+
T Consensus 234 ~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 234 FFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred ceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 111111111111122223467899999999999999999999854
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=368.56 Aligned_cols=265 Identities=24% Similarity=0.417 Sum_probs=222.5
Q ss_pred HcCCCCCCeeeccCcEEEEEEEecCCcEEEEEEcccCCcccH-HHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEe
Q 002774 554 TNNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGG-QEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEF 632 (882)
Q Consensus 554 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~-~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 632 (882)
.......++||+|.||+|..+....+.+||||.++..+.... ++|.+|+++|.+++|||||+++|+|..++..++|+||
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY 616 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY 616 (807)
T ss_pred hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence 455667889999999999999998889999999998766554 8999999999999999999999999999999999999
Q ss_pred ecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCc
Q 002774 633 VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKD 712 (882)
Q Consensus 633 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 712 (882)
|++|+|.+++..+...........+|+.|||.||+||.+.. +|||||.++|+|+|.++++||+|||++|-+..++..
T Consensus 617 mEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy 693 (807)
T KOG1094|consen 617 MENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYY 693 (807)
T ss_pred HhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCCce
Confidence 99999999998775444566778889999999999999998 999999999999999999999999999988888877
Q ss_pred eeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHh--CCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCC
Q 002774 713 HITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT--GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIG 790 (882)
Q Consensus 713 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~t--g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 790 (882)
.+....+-+++|||+|.+.-++++.+||||+||+++||+++ .+.||....+. .++++... +...-.....
T Consensus 694 ~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e-----~vven~~~---~~~~~~~~~~ 765 (807)
T KOG1094|consen 694 RVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE-----QVVENAGE---FFRDQGRQVV 765 (807)
T ss_pred eeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH-----HHHHhhhh---hcCCCCccee
Confidence 77777888999999999999999999999999999999876 78898643221 11222111 1111111112
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 002774 791 LSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENI 829 (882)
Q Consensus 791 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 829 (882)
...+..++..+++++.+||..|-++||+++++...|.+.
T Consensus 766 l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 766 LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 234455678899999999999999999999999887654
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=358.34 Aligned_cols=249 Identities=26% Similarity=0.370 Sum_probs=206.6
Q ss_pred HcCCCCCCeeeccCcEEEEEEEe-cCCcEEEEEEcccCCcc---cHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEE
Q 002774 554 TNNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQ---GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLI 629 (882)
Q Consensus 554 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 629 (882)
.++|...++||+|+||+||.++. ++++.+|+|++++.... +.+...+|..+|.+++||.||+++..|++.+..|||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 45789999999999999999985 46899999999876443 335678899999999999999999999999999999
Q ss_pred EEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCC
Q 002774 630 YEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDS 709 (882)
Q Consensus 630 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~ 709 (882)
+||+.||.|...|..++ .+++..+..++..|+.||.|||+.+ ||||||||+|||+|++|+++|+|||+++..-..
T Consensus 104 ld~~~GGeLf~hL~~eg--~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~ 178 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQREG--RFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD 178 (357)
T ss_pred EeccCCccHHHHHHhcC--CcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcccC
Confidence 99999999999998765 6888889999999999999999999 999999999999999999999999999854332
Q ss_pred CCceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcC
Q 002774 710 EKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTI 789 (882)
Q Consensus 710 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 789 (882)
+ ..+..++||+.|||||++.+..|+..+|.||+|+++|||++|.+||.... .......+..... .
T Consensus 179 ~--~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~-~~~~~~~I~~~k~-------~----- 243 (357)
T KOG0598|consen 179 G--DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAED-VKKMYDKILKGKL-------P----- 243 (357)
T ss_pred C--CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCcc-HHHHHHHHhcCcC-------C-----
Confidence 2 23455899999999999999999999999999999999999999996543 3333333332220 0
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCCCCCC----CHHHHHH
Q 002774 790 GLSTTLKGFEKYVDLALKCVQESGDDRP----TMSEVVK 824 (882)
Q Consensus 790 ~~~~~~~~~~~l~~li~~cl~~dp~~RP----s~~evl~ 824 (882)
..+.....+..+++.+++..||++|. ++.++-+
T Consensus 244 --~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~ 280 (357)
T KOG0598|consen 244 --LPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKR 280 (357)
T ss_pred --CCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhc
Confidence 00111225678999999999999995 5555544
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=364.30 Aligned_cols=264 Identities=23% Similarity=0.348 Sum_probs=212.6
Q ss_pred HHcCCCCCCeeeccCcEEEEEEEe-cCCcEEEEEEcccCCcccHH-HHHHHHHHHHhcc-CCCeeeEEEEEEeCC-ceEE
Q 002774 553 YTNNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQGGQ-EFKMEIELLSRVH-HKNLVSLLGFCFDRG-EQML 628 (882)
Q Consensus 553 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~-~~~~E~~~l~~l~-H~niv~l~~~~~~~~-~~~l 628 (882)
..++|...++||.|+||.||+|+. .+|+.||||++++.-....+ .=.+|++.|+++. |||||++.+.+.+.+ ..++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 345677889999999999999984 57999999999875433222 2357999999998 999999999999988 9999
Q ss_pred EEEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCC
Q 002774 629 IYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSD 708 (882)
Q Consensus 629 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~ 708 (882)
|||||+ .+|.++++++ +..+++..+..|+.||++||+|+|.+| +.|||+||+|||+..+..+||+|||+||.+..
T Consensus 88 VfE~Md-~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~S 162 (538)
T KOG0661|consen 88 VFEFMD-CNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVRS 162 (538)
T ss_pred eHHhhh-hhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccccccccccc
Confidence 999994 6999999988 678999999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCceeeeeeeccCCCCCHHHHh-hCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhh--------hhh
Q 002774 709 SEKDHITTQVKGTMGYLDPEYYM-TQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKK--------ELY 779 (882)
Q Consensus 709 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~--------~~~ 779 (882)
.. ..+..+.|.+|+|||++. .+-|+.+.||||+|||++|+.+-+ |...|.+..+++.++.+-.. ...
T Consensus 163 kp---PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLr-PLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~ 238 (538)
T KOG0661|consen 163 KP---PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLR-PLFPGASEIDQIYKICEVLGTPDKDSWPEGY 238 (538)
T ss_pred CC---CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhc-ccCCCCcHHHHHHHHHHHhCCCccccchhHH
Confidence 43 355678999999999987 577999999999999999999965 55567677776666554111 111
Q ss_pred hhhhccCCcCC---C----CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 780 NLYELIDPTIG---L----STTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 780 ~~~~~~d~~l~---~----~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
.+...+.-.++ . ..-.....++.+++.+|+++||++|||++|++++
T Consensus 239 ~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 239 NLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 12222221111 0 0111244788999999999999999999999986
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=363.00 Aligned_cols=252 Identities=26% Similarity=0.340 Sum_probs=210.8
Q ss_pred HHcCCCCCCeeeccCcEEEEEEEe-cCCcEEEEEEcccCCc---ccHHHHHHHHHHHHhc-cCCCeeeEEEEEEeCCceE
Q 002774 553 YTNNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSM---QGGQEFKMEIELLSRV-HHKNLVSLLGFCFDRGEQM 627 (882)
Q Consensus 553 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~ 627 (882)
...+|...+.||+|+|++|++|+. ..++.||||++.+.-. ...+-+..|-++|.+| .||.|++|+..|.++...|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 345778889999999999999985 4689999999976422 2234577899999999 8999999999999999999
Q ss_pred EEEEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccC
Q 002774 628 LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMS 707 (882)
Q Consensus 628 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~ 707 (882)
+|+||+++|+|.++|+..+ .+++.....++.+|+.||+|||++| ||||||||+|||+|+||++||+|||.|+.+.
T Consensus 151 FvLe~A~nGdll~~i~K~G--sfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l~ 225 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIKKYG--SFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKILS 225 (604)
T ss_pred EEEEecCCCcHHHHHHHhC--cchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccCC
Confidence 9999999999999998765 6888889999999999999999999 9999999999999999999999999999886
Q ss_pred CCCCc---------ee--eeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhh
Q 002774 708 DSEKD---------HI--TTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKK 776 (882)
Q Consensus 708 ~~~~~---------~~--~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~ 776 (882)
+.... .. ...++||..|.+||++..+..+..+|+|+|||+||.|+.|++||...... -.++.++.-..
T Consensus 226 ~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney-liFqkI~~l~y 304 (604)
T KOG0592|consen 226 PSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY-LIFQKIQALDY 304 (604)
T ss_pred hhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH-HHHHHHHHhcc
Confidence 54322 11 14588999999999999999999999999999999999999999765432 22333332111
Q ss_pred hhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 777 ELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 777 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
.++...++.+.+|+.+.|..||.+|+|.+||.++
T Consensus 305 ---------------~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 305 ---------------EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred ---------------cCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 1122233678899999999999999999999875
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=372.39 Aligned_cols=267 Identities=27% Similarity=0.448 Sum_probs=214.3
Q ss_pred HHHHHHHcCCCCCCeeeccCcEEEEEEEecCCcEEEEEEcccCCccc--HHHHHHHHHHHHhccCCCeeeEEEEEEeCCc
Q 002774 548 EEVKKYTNNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQG--GQEFKMEIELLSRVHHKNLVSLLGFCFDRGE 625 (882)
Q Consensus 548 ~e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 625 (882)
+++....+.+.....||+|+||+||+|.|.. .||||+++...... .+.|+.|+.++++-||.||+-|.|||..++.
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~ 462 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL 462 (678)
T ss_pred cccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence 4444455566778899999999999999853 69999998765543 4789999999999999999999999988777
Q ss_pred eEEEEEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccc
Q 002774 626 QMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKS 705 (882)
Q Consensus 626 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~ 705 (882)
.||+.+|++-+|+.++|... ..++..+.+.||.|||+||.|||.++ |||||||..||++.+++.|||+|||++..
T Consensus 463 -AIiTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLatv 537 (678)
T KOG0193|consen 463 -AIITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLATV 537 (678)
T ss_pred -eeeehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccceee
Confidence 99999999999999999764 57999999999999999999999999 99999999999999999999999999975
Q ss_pred cCCCCCceeeeeeeccCCCCCHHHHhh---CCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhh
Q 002774 706 MSDSEKDHITTQVKGTMGYLDPEYYMT---QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLY 782 (882)
Q Consensus 706 ~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 782 (882)
-.............|...|||||+++. ..|++.+||||||+|+|||+||..||. ... .+++.-.+..+.
T Consensus 538 k~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~~-~dqIifmVGrG~------ 609 (678)
T KOG0193|consen 538 KTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQN-RDQIIFMVGRGY------ 609 (678)
T ss_pred eeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-CCC-hhheEEEecccc------
Confidence 433222222233458889999999984 468999999999999999999999997 222 221111111110
Q ss_pred hccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 002774 783 ELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 832 (882)
Q Consensus 783 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~ 832 (882)
-..|.. .....+.+++.+|+..||..++++||.+.+|+..|+.++..
T Consensus 610 l~pd~s---~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 610 LMPDLS---KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred cCccch---hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 001111 12234567899999999999999999999999999988764
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=360.39 Aligned_cols=263 Identities=26% Similarity=0.412 Sum_probs=209.2
Q ss_pred cCCCCCCeeeccCcEEEEEEE-ecCCcEEEEEEcccCCcc--cHHHHHHHHHHHHhccCCCeeeEEEEEEeC--CceEEE
Q 002774 555 NNFSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQ--GGQEFKMEIELLSRVHHKNLVSLLGFCFDR--GEQMLI 629 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lV 629 (882)
+.|..+++||+|+||.||||+ ..+|+.||+|+++..... ......+|+.+|++|+||||+++.+...+. +..|||
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 345666789999999999998 568999999999865433 235567899999999999999999999887 689999
Q ss_pred EEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCC
Q 002774 630 YEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDS 709 (882)
Q Consensus 630 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~ 709 (882)
+|||++ ||.-++... ...+++.++..++.|++.||+|||..| |+|||||.+|||||.+|.+||+|||||+++...
T Consensus 197 FeYMdh-DL~GLl~~p-~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~ 271 (560)
T KOG0600|consen 197 FEYMDH-DLSGLLSSP-GVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYTPS 271 (560)
T ss_pred Eecccc-hhhhhhcCC-CcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeeccCC
Confidence 999976 777777653 457999999999999999999999999 999999999999999999999999999988765
Q ss_pred CCceeeeeeeccCCCCCHHHHhh-CCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhh-hhhhhhh----
Q 002774 710 EKDHITTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKK-ELYNLYE---- 783 (882)
Q Consensus 710 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~-~~~~~~~---- 783 (882)
... ..+..+-|.+|+|||.+.+ ..|+.++|+||.||||.||++|++. ..+.+.++++..+++--. .-...+.
T Consensus 272 ~~~-~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI-~~G~tEveQl~kIfklcGSP~e~~W~~~kL 349 (560)
T KOG0600|consen 272 GSA-PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPI-LQGRTEVEQLHKIFKLCGSPTEDYWPVSKL 349 (560)
T ss_pred CCc-ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCC-cCCccHHHHHHHHHHHhCCCChhccccccC
Confidence 543 3566778999999999986 5799999999999999999998755 467777777766664211 0001111
Q ss_pred ----ccCCcCCCCCCH-----HHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002774 784 ----LIDPTIGLSTTL-----KGFEKYVDLALKCVQESGDDRPTMSEVVK 824 (882)
Q Consensus 784 ----~~d~~l~~~~~~-----~~~~~l~~li~~cl~~dp~~RPs~~evl~ 824 (882)
.+.|...-.... .......+|+..+|..||++|.|+.++++
T Consensus 350 P~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 350 PHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred CcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 111111100001 11255789999999999999999999985
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=332.07 Aligned_cols=262 Identities=26% Similarity=0.397 Sum_probs=212.6
Q ss_pred CCCCCCeeeccCcEEEEEEE-ecCCcEEEEEEcccCCcccH--HHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEe
Q 002774 556 NFSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGG--QEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEF 632 (882)
Q Consensus 556 ~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~~--~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 632 (882)
+|...++||+|.||.||+|+ ..+|+.||||+++.....+. ....+|++.|+.++|+||+.+++++...+..-||+||
T Consensus 3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEf 82 (318)
T KOG0659|consen 3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEF 82 (318)
T ss_pred hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEe
Confidence 56677889999999999998 46799999999987654432 4567899999999999999999999999999999999
Q ss_pred ecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCc
Q 002774 633 VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKD 712 (882)
Q Consensus 633 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 712 (882)
|+ .+|...++.+. ..++..++..++.++.+|++|||.+. |+||||||.|+|++.+|.+||+|||+|+.+......
T Consensus 83 m~-tdLe~vIkd~~-i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~ 157 (318)
T KOG0659|consen 83 MP-TDLEVVIKDKN-IILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI 157 (318)
T ss_pred cc-ccHHHHhcccc-cccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence 96 48988888654 57899999999999999999999999 999999999999999999999999999998765543
Q ss_pred eeeeeeeccCCCCCHHHHhh-CCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhh--------hhhhhhh
Q 002774 713 HITTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKK--------ELYNLYE 783 (882)
Q Consensus 713 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~--------~~~~~~~ 783 (882)
.+..+-|.+|+|||.+.+ +.|+..+||||.|||+.||+-| .||..|.+..+++..++..-. ++..+.+
T Consensus 158 --~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr-~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpd 234 (318)
T KOG0659|consen 158 --QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLR-VPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPD 234 (318)
T ss_pred --cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHcc-CCCCCCCchHHHHHHHHHHcCCCCcccCcccccccc
Confidence 333478999999999985 5799999999999999999975 577777777777766654211 1111111
Q ss_pred c-----cCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 784 L-----IDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 784 ~-----~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
. ..+......-..+..+..+++.+|+..||.+|++++|++++
T Consensus 235 Y~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 235 YVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred HHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 1 11111111223344677999999999999999999999985
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=368.31 Aligned_cols=250 Identities=26% Similarity=0.411 Sum_probs=214.4
Q ss_pred cCCCCCCeeeccCcEEEEEEE-ecCCcEEEEEEcccCCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEee
Q 002774 555 NNFSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFV 633 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 633 (882)
..|....+||+|+.|.||.|. ..+++.||||++........+-+.+|+.+|+..+|+|||.+++.+...++.|+|||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 356667889999999999997 4578999999998766666667889999999999999999999999999999999999
Q ss_pred cCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCce
Q 002774 634 PNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDH 713 (882)
Q Consensus 634 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 713 (882)
++|+|.|.+... .+++.++..|+.+++.||+|||..| |+|||||.+|||++.+|.+||+|||++..+.....
T Consensus 353 ~ggsLTDvVt~~---~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-- 424 (550)
T KOG0578|consen 353 EGGSLTDVVTKT---RMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-- 424 (550)
T ss_pred CCCchhhhhhcc---cccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC--
Confidence 999999999765 4899999999999999999999999 99999999999999999999999999998876543
Q ss_pred eeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCCCCC
Q 002774 714 ITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLST 793 (882)
Q Consensus 714 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 793 (882)
.....+||+.|||||++....|.+|+||||||++++||+.|++||-....+..... + ...-.|. ...
T Consensus 425 KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyL-I----------a~ng~P~--lk~ 491 (550)
T KOG0578|consen 425 KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-I----------ATNGTPK--LKN 491 (550)
T ss_pred ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHH-H----------hhcCCCC--cCC
Confidence 34457899999999999999999999999999999999999999976444332222 1 1111222 233
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 794 TLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 794 ~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
.......|.+++.+||+.|+++|+++.|+|++
T Consensus 492 ~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 492 PEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred ccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 44456789999999999999999999999985
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=350.64 Aligned_cols=258 Identities=28% Similarity=0.427 Sum_probs=202.3
Q ss_pred CCCCeeeccCcEEEEEEEecCCcEEEEEEcccCCcccHHHHHHHHHHHHhc--cCCCeeeEEEEEEeCC----ceEEEEE
Q 002774 558 SDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRV--HHKNLVSLLGFCFDRG----EQMLIYE 631 (882)
Q Consensus 558 ~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~H~niv~l~~~~~~~~----~~~lV~e 631 (882)
...+.||+|.||.||||++. ++.||||++.. ++.+.|+.|-+|.+.. +|+||++|+++-.... +++||+|
T Consensus 213 ~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~ 288 (534)
T KOG3653|consen 213 QLLELIGRGRFGCVWKAQLD-NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTE 288 (534)
T ss_pred hhHHHhhcCccceeehhhcc-CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEee
Confidence 34567999999999999995 58999999964 4456788888888764 8999999999876555 8899999
Q ss_pred eecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhc------CCCCeeecCCCCCceEEcCCCceeEeecccccc
Q 002774 632 FVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHEL------ANPPIIHRDIKSSNILLDERLNAKVADFGLSKS 705 (882)
Q Consensus 632 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~------~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~ 705 (882)
|.+.|+|.++|..+ .++|....+|+..+++||+|||+. .+|+|+|||||++||||.+|+++.|+|||+|..
T Consensus 289 fh~kGsL~dyL~~n---tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~ 365 (534)
T KOG3653|consen 289 FHPKGSLCDYLKAN---TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALR 365 (534)
T ss_pred eccCCcHHHHHHhc---cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEE
Confidence 99999999999876 599999999999999999999974 468899999999999999999999999999999
Q ss_pred cCCCCCceeeeeeeccCCCCCHHHHhhCC------CCchhHHHHHHHHHHHHHhCCCCCCC----------------Cch
Q 002774 706 MSDSEKDHITTQVKGTMGYLDPEYYMTQQ------LTEKSDVYSFGVLMLELLTGRRPIER----------------GKY 763 (882)
Q Consensus 706 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~sDv~S~Gvll~el~tg~~P~~~----------------~~~ 763 (882)
+.+.......-..+||.+|||||++.+.. .-.+.||||+|.|||||++...-+.. ...
T Consensus 366 ~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt 445 (534)
T KOG3653|consen 366 LEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPT 445 (534)
T ss_pred ecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCC
Confidence 88766555555578999999999997542 22368999999999999986543321 011
Q ss_pred HHHHHHHHHHhhhhhhhhhhccCCcCCCC-CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHH
Q 002774 764 IVREIRTVMDKKKELYNLYELIDPTIGLS-TTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQ 831 (882)
Q Consensus 764 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~ 831 (882)
+.+....++.+ ...|.++.. ..-..+..+.+.+..||..||+.|.|+.=|-+.+.++..
T Consensus 446 ~e~mq~~VV~k---------K~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~ 505 (534)
T KOG3653|consen 446 LEEMQELVVRK---------KQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMM 505 (534)
T ss_pred HHHHHHHHHhh---------ccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhc
Confidence 11111112221 122222211 111345778999999999999999999999988888753
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=351.03 Aligned_cols=262 Identities=25% Similarity=0.381 Sum_probs=212.1
Q ss_pred cCCCCCCeeeccCcEEEEEEEe-cCCcEEEEEEcccCCccc-HHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEe
Q 002774 555 NNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQG-GQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEF 632 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 632 (882)
.+|...++||.|.-++||+|+. ..++.||||++.-+.... .+.+.+|+..|+.++||||++++..|..+...|+||.|
T Consensus 26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpf 105 (516)
T KOG0582|consen 26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPF 105 (516)
T ss_pred cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehh
Confidence 4678889999999999999984 567999999998654443 47899999999999999999999999999999999999
Q ss_pred ecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCc
Q 002774 633 VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKD 712 (882)
Q Consensus 633 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 712 (882)
|.+||+.++++..-...+++..+..|.+++++||.|||++| .||||||+.||||+.+|.+||+|||.+..+.+....
T Consensus 106 Ma~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R 182 (516)
T KOG0582|consen 106 MAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDR 182 (516)
T ss_pred hcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccCce
Confidence 99999999998766566999999999999999999999999 999999999999999999999999988766554421
Q ss_pred ee-e-eeeeccCCCCCHHHHhh--CCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCc
Q 002774 713 HI-T-TQVKGTMGYLDPEYYMT--QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPT 788 (882)
Q Consensus 713 ~~-~-~~~~gt~~y~aPE~~~~--~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 788 (882)
.+ . ..+.||+.|||||+++. ..|+.|+||||||++..||.+|..||..-......+.......... .-..
T Consensus 183 ~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~------~t~~ 256 (516)
T KOG0582|consen 183 QVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTL------LTSG 256 (516)
T ss_pred eeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCc------cccc
Confidence 11 1 44689999999999764 4799999999999999999999999975443332222221111100 0001
Q ss_pred CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 789 IGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 789 l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
+..+........|.+++..|+++||.+|||+++++++
T Consensus 257 ~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 257 LDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred CChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 1112222334678999999999999999999999964
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=357.70 Aligned_cols=256 Identities=30% Similarity=0.463 Sum_probs=204.9
Q ss_pred CCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCC--ceEEEEEe
Q 002774 556 NFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRG--EQMLIYEF 632 (882)
Q Consensus 556 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~--~~~lV~e~ 632 (882)
+|...+.||+|+||+||++... +|+..|||.+........+.+.+|+.+|.+++|||||+++|...... .+++.|||
T Consensus 18 ~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy 97 (313)
T KOG0198|consen 18 NWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEY 97 (313)
T ss_pred hhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeec
Confidence 4667789999999999999965 48999999987653333567899999999999999999999855554 58999999
Q ss_pred ecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcC-CCceeEeecccccccCC-CC
Q 002774 633 VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDE-RLNAKVADFGLSKSMSD-SE 710 (882)
Q Consensus 633 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~-~~~~kl~DfGla~~~~~-~~ 710 (882)
+++|+|.+++...++ .+++..+.+++.||++||+|||++| ||||||||+|||++. ++.+||+|||+++.... ..
T Consensus 98 ~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~ 173 (313)
T KOG0198|consen 98 APGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGT 173 (313)
T ss_pred cCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccccccc
Confidence 999999999998776 7999999999999999999999999 999999999999999 79999999999987653 11
Q ss_pred CceeeeeeeccCCCCCHHHHhhC-CCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcC
Q 002774 711 KDHITTQVKGTMGYLDPEYYMTQ-QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTI 789 (882)
Q Consensus 711 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 789 (882)
.........||+.|||||++..+ ....++||||+||++.||+||+.||........++..+.... .-|.+
T Consensus 174 ~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~---------~~P~i 244 (313)
T KOG0198|consen 174 KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRED---------SLPEI 244 (313)
T ss_pred cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccC---------CCCCC
Confidence 12223457899999999999964 334599999999999999999999965311111111111111 11222
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 002774 790 GLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIEN 828 (882)
Q Consensus 790 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~ 828 (882)
+ .....+..+++.+|++.||++||||++++++...
T Consensus 245 p----~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~ 279 (313)
T KOG0198|consen 245 P----DSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFL 279 (313)
T ss_pred C----cccCHHHHHHHHHHhhcCcccCcCHHHHhhChhh
Confidence 1 1233678899999999999999999999987543
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=369.35 Aligned_cols=262 Identities=26% Similarity=0.433 Sum_probs=205.9
Q ss_pred HcCCCCCCeeeccCcEEEEEEEe------cCCcEEEEEEcccCCc-ccHHHHHHHHHHHHhc-cCCCeeeEEEEEEeCC-
Q 002774 554 TNNFSDANDVGSGGYGKVYKGTL------PNGQLIAIKRAQQGSM-QGGQEFKMEIELLSRV-HHKNLVSLLGFCFDRG- 624 (882)
Q Consensus 554 ~~~~~~~~~lG~G~fg~Vy~~~~------~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~- 624 (882)
.++|...++||+|+||.||+|.+ .+++.||||+++.... ...+.+.+|++++.++ +||||++++++|...+
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 45688889999999999999974 2357899999975432 2335688999999999 8999999999987644
Q ss_pred ceEEEEEeecCCCcccccCCCC----------------------------------------------------------
Q 002774 625 EQMLIYEFVPNGSLGDSLSGKN---------------------------------------------------------- 646 (882)
Q Consensus 625 ~~~lV~e~~~~gsL~~~l~~~~---------------------------------------------------------- 646 (882)
..++||||+++|+|.+++....
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 5789999999999988876421
Q ss_pred --CccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCceeeeeeeccCCC
Q 002774 647 --GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGY 724 (882)
Q Consensus 647 --~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y 724 (882)
..++++..+..++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++...............++..|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 124778889999999999999999988 999999999999999999999999999866433222222233467889
Q ss_pred CCHHHHhhCCCCchhHHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCCCCCCHHHHHHHHH
Q 002774 725 LDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVD 803 (882)
Q Consensus 725 ~aPE~~~~~~~~~~sDv~S~Gvll~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~ 803 (882)
+|||++.+..++.++|||||||++|||++ |..||........ ....+.... .+.. .......+.+
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~-~~~~~~~~~---------~~~~----~~~~~~~l~~ 308 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE-FCQRLKDGT---------RMRA----PENATPEIYR 308 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH-HHHHHhcCC---------CCCC----CCCCCHHHHH
Confidence 99999999999999999999999999997 9999865332211 111111111 0011 1123467889
Q ss_pred HHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 002774 804 LALKCVQESGDDRPTMSEVVKDIENILQQ 832 (882)
Q Consensus 804 li~~cl~~dp~~RPs~~evl~~L~~~~~~ 832 (882)
++.+||+.||++|||+.|+++.|++++++
T Consensus 309 li~~cl~~dp~~RPs~~el~~~l~~~~~~ 337 (338)
T cd05102 309 IMLACWQGDPKERPTFSALVEILGDLLQE 337 (338)
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 99999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-42 Score=363.87 Aligned_cols=249 Identities=28% Similarity=0.484 Sum_probs=210.3
Q ss_pred ccCHHHHHHHHcCCCCCCeeeccCcEEEEEEEecCCcEEEEEEcccCCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeC
Q 002774 544 CFSFEEVKKYTNNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDR 623 (882)
Q Consensus 544 ~~~~~e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~ 623 (882)
.+.|+++ ..++-||+|+.|.||+|++. ++.||||+++.-. ..+++-|++|+|+||+.|.|+|...
T Consensus 120 eiPFe~I-------sELeWlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqs 184 (904)
T KOG4721|consen 120 EIPFEEI-------SELEWLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQS 184 (904)
T ss_pred cCCHHHh-------hhhhhhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCC
Confidence 3556665 34678999999999999986 6789999986421 3478899999999999999999999
Q ss_pred CceEEEEEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccc
Q 002774 624 GEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLS 703 (882)
Q Consensus 624 ~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla 703 (882)
..++||||||+.|-|...|+... .+.......|..+||.||.|||.+. |||||||.-||||..+..+||+|||.+
T Consensus 185 PcyCIiMEfCa~GqL~~VLka~~--~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS 259 (904)
T KOG4721|consen 185 PCYCIIMEFCAQGQLYEVLKAGR--PITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTS 259 (904)
T ss_pred ceeEEeeeccccccHHHHHhccC--ccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccch
Confidence 99999999999999999998765 6788888999999999999999988 999999999999999999999999999
Q ss_pred cccCCCCCceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhh
Q 002774 704 KSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYE 783 (882)
Q Consensus 704 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 783 (882)
+...+. .....++||..|||||++.....++|+||||||||||||+||.-||.+-.... . ++.
T Consensus 260 ~e~~~~---STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA----I----------IwG 322 (904)
T KOG4721|consen 260 KELSDK---STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA----I----------IWG 322 (904)
T ss_pred Hhhhhh---hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe----e----------EEe
Confidence 877554 23456889999999999999999999999999999999999999996432110 0 222
Q ss_pred ccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 002774 784 LIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENI 829 (882)
Q Consensus 784 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 829 (882)
+-.-.+....+..+++-|.-|+++||+..|..||++.+++.+|+-.
T Consensus 323 VGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa 368 (904)
T KOG4721|consen 323 VGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA 368 (904)
T ss_pred ccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence 2222344445566778899999999999999999999999998753
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=366.79 Aligned_cols=259 Identities=30% Similarity=0.471 Sum_probs=210.6
Q ss_pred CCCCCCeeeccCcEEEEEEEecC--C--cE-EEEEEcccCC---cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceE
Q 002774 556 NFSDANDVGSGGYGKVYKGTLPN--G--QL-IAIKRAQQGS---MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQM 627 (882)
Q Consensus 556 ~~~~~~~lG~G~fg~Vy~~~~~~--g--~~-vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 627 (882)
+....++||+|+||+||+|++.. + .. ||||..+... ....++|.+|+++|++++|||||+++|++..+...+
T Consensus 158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ 237 (474)
T KOG0194|consen 158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLM 237 (474)
T ss_pred CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccE
Confidence 33445899999999999998643 2 23 8999998532 334578999999999999999999999999999999
Q ss_pred EEEEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccC
Q 002774 628 LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMS 707 (882)
Q Consensus 628 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~ 707 (882)
+|||+|+||+|.++|+.... .++..++..++.++|+||+|||+.+ ++||||.++|+|++.++.+||+|||+++.-.
T Consensus 238 ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~~~~ 313 (474)
T KOG0194|consen 238 LVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSRAGS 313 (474)
T ss_pred EEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccccccCCc
Confidence 99999999999999987654 6899999999999999999999998 9999999999999999999999999987543
Q ss_pred CCCCceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHhhhhhhhhhhccC
Q 002774 708 DSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELID 786 (882)
Q Consensus 708 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 786 (882)
..........-+.+|+|||.+..+.|+.++|||||||++||+++ |..||.+-... +....+.....
T Consensus 314 --~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~-~v~~kI~~~~~---------- 380 (474)
T KOG0194|consen 314 --QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY-EVKAKIVKNGY---------- 380 (474)
T ss_pred --ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH-HHHHHHHhcCc----------
Confidence 11111112246789999999999999999999999999999999 88898654432 22222212111
Q ss_pred CcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHcC
Q 002774 787 PTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQAG 834 (882)
Q Consensus 787 ~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~~ 834 (882)
+...+...+.++..++.+||..+|++||+|.++.+.++.+.....
T Consensus 381 ---r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 381 ---RMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred ---cCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 112222445778899999999999999999999999999876654
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=356.26 Aligned_cols=247 Identities=26% Similarity=0.433 Sum_probs=210.7
Q ss_pred cCCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCCc--ccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEE
Q 002774 555 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM--QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYE 631 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e 631 (882)
++|.+.+.||+|+||.||||+.+ +.+.||+|.+.+... .+.+.+.+|+++++.++|||||.++++|+...+.++|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 46778889999999999999854 689999999876433 234668899999999999999999999999999999999
Q ss_pred eecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCC
Q 002774 632 FVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEK 711 (882)
Q Consensus 632 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 711 (882)
|+.+ +|..++...+ .+++..+..++.+++.||.|||+.+ |+|||+||.|||++..+.+|+||||+|+.+.. .
T Consensus 82 ~a~g-~L~~il~~d~--~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~--~ 153 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDG--KLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMST--N 153 (808)
T ss_pred hhhh-hHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhccc--C
Confidence 9976 9999997655 6899999999999999999999998 99999999999999999999999999998754 3
Q ss_pred ceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCCC
Q 002774 712 DHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGL 791 (882)
Q Consensus 712 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 791 (882)
..+.+.+.||+-|||||+..++.|+..+|+||+||++||+++|++||... .+.+.++.+..+ |..
T Consensus 154 t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~-si~~Lv~~I~~d------------~v~-- 218 (808)
T KOG0597|consen 154 TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR-SITQLVKSILKD------------PVK-- 218 (808)
T ss_pred ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH-HHHHHHHHHhcC------------CCC--
Confidence 45677889999999999999999999999999999999999999999532 222333322221 111
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 792 STTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 792 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
.+......+..+++..+.+||..|.+..+++.+
T Consensus 219 -~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 219 -PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred -CcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 122445789999999999999999999999865
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=347.85 Aligned_cols=259 Identities=21% Similarity=0.335 Sum_probs=207.7
Q ss_pred CcccCHHHHHHHHcCCCCCCeeeccCcEEEEEEEecCCcEEEEEEcccCCccc---HHHHHHHHHHHHhccCCCeeeEEE
Q 002774 542 ARCFSFEEVKKYTNNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQG---GQEFKMEIELLSRVHHKNLVSLLG 618 (882)
Q Consensus 542 ~~~~~~~e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~H~niv~l~~ 618 (882)
.+.++.+++ +......||+|++|.||+|.+ +|+.||||+++...... .+.|.+|+++|++++|||||+++|
T Consensus 12 ~~~i~~~~i-----~~~~~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g 85 (283)
T PHA02988 12 IKCIESDDI-----DKYTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYG 85 (283)
T ss_pred ceecCHHHc-----CCCCCeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEee
Confidence 445566665 223346799999999999998 68999999998654333 356789999999999999999999
Q ss_pred EEEe----CCceEEEEEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhc-CCCCeeecCCCCCceEEcCCC
Q 002774 619 FCFD----RGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHEL-ANPPIIHRDIKSSNILLDERL 693 (882)
Q Consensus 619 ~~~~----~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivHrDlk~~NIll~~~~ 693 (882)
++.+ ....++||||+++|+|.+++.... .+++....+++.+++.||+|||+. + ++||||||+||++++++
T Consensus 86 ~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~ 160 (283)
T PHA02988 86 FIIDIVDDLPRLSLILEYCTRGYLREVLDKEK--DLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENY 160 (283)
T ss_pred eEEecccCCCceEEEEEeCCCCcHHHHHhhCC--CCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCC
Confidence 9877 346789999999999999997654 688999999999999999999984 6 88999999999999999
Q ss_pred ceeEeecccccccCCCCCceeeeeeeccCCCCCHHHHhh--CCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHH
Q 002774 694 NAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMT--QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTV 771 (882)
Q Consensus 694 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~ 771 (882)
.+||+|||+++.+.... ....|+..|+|||++.+ ..++.++|||||||++|||++|+.||..... .+....+
T Consensus 161 ~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~-~~~~~~i 234 (283)
T PHA02988 161 KLKIICHGLEKILSSPP-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT-KEIYDLI 234 (283)
T ss_pred cEEEcccchHhhhcccc-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH-HHHHHHH
Confidence 99999999998664322 12357899999999976 6899999999999999999999999975432 2222222
Q ss_pred HHhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 002774 772 MDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENIL 830 (882)
Q Consensus 772 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~ 830 (882)
..... .+. .+...+..+.+++.+||+.||++|||++|+++.|+.+-
T Consensus 235 ~~~~~---------~~~----~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 235 INKNN---------SLK----LPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred HhcCC---------CCC----CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 11111 111 11124567899999999999999999999999998763
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=357.59 Aligned_cols=261 Identities=29% Similarity=0.451 Sum_probs=222.4
Q ss_pred HHcCCCCCCeeeccCcEEEEEEEecC-CcEEEEEEcccCCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEE
Q 002774 553 YTNNFSDANDVGSGGYGKVYKGTLPN-GQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYE 631 (882)
Q Consensus 553 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e 631 (882)
-+.+.....+||-|.||.||.|.|+. .-.||||.++.+.+ ...+|..|..+|+.++|||+|+++|+|..+..+|||+|
T Consensus 265 eRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM-eveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTE 343 (1157)
T KOG4278|consen 265 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITE 343 (1157)
T ss_pred cchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcch-hHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEe
Confidence 34456677899999999999999864 56899999987544 45889999999999999999999999999999999999
Q ss_pred eecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCC
Q 002774 632 FVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEK 711 (882)
Q Consensus 632 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 711 (882)
||.+|+|.+||+..++..++....+.||.||+.||+||...+ +|||||.++|+|+.++..+||+|||+++.+..+..
T Consensus 344 fM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTY 420 (1157)
T KOG4278|consen 344 FMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTY 420 (1157)
T ss_pred cccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhcCCce
Confidence 999999999999988878888999999999999999999988 99999999999999999999999999999865443
Q ss_pred ceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCC
Q 002774 712 DHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIG 790 (882)
Q Consensus 712 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 790 (882)
+ ......-++.|.|||.+....++.|+|||+|||+|||+.| |..||.+ .++ .+ +++.+....+
T Consensus 421 T-AHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPG-idl-Sq-------------VY~LLEkgyR 484 (1157)
T KOG4278|consen 421 T-AHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPG-IDL-SQ-------------VYGLLEKGYR 484 (1157)
T ss_pred e-cccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCC-ccH-HH-------------HHHHHhcccc
Confidence 2 2223345789999999999999999999999999999999 7778743 222 12 2333344445
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHc
Q 002774 791 LSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQA 833 (882)
Q Consensus 791 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~ 833 (882)
...+..|+..+++||+.||++.|.+||+++|+-+.++.+++..
T Consensus 485 M~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~s 527 (1157)
T KOG4278|consen 485 MDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSS 527 (1157)
T ss_pred ccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhccc
Confidence 5666778899999999999999999999999999888765443
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=347.58 Aligned_cols=262 Identities=26% Similarity=0.426 Sum_probs=202.2
Q ss_pred cCCCCCCeeeccCcEEEEEEEecC-----------------CcEEEEEEcccCCcc-cHHHHHHHHHHHHhccCCCeeeE
Q 002774 555 NNFSDANDVGSGGYGKVYKGTLPN-----------------GQLIAIKRAQQGSMQ-GGQEFKMEIELLSRVHHKNLVSL 616 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~~~~~~-----------------g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l 616 (882)
++|...++||+|+||.||+|++.+ +..||+|.++..... ...+|.+|++++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 467888999999999999997532 347999998764332 34578999999999999999999
Q ss_pred EEEEEeCCceEEEEEeecCCCcccccCCCC-----------------CccccHHHHHHHHHHHHHHHhhhhhcCCCCeee
Q 002774 617 LGFCFDRGEQMLIYEFVPNGSLGDSLSGKN-----------------GIRLDWIRRLKIALGAARGLSYLHELANPPIIH 679 (882)
Q Consensus 617 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~-----------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH 679 (882)
++++.+.+..++||||+++|+|.+++.... ...+++..+.+++.|++.||+|||+.+ |+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence 999999999999999999999998875321 124688899999999999999999998 999
Q ss_pred cCCCCCceEEcCCCceeEeecccccccCCCCCceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHh--CCCC
Q 002774 680 RDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT--GRRP 757 (882)
Q Consensus 680 rDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~t--g~~P 757 (882)
|||||+|||+++++.+||+|||+++.+.............++..|||||++..+.++.++|||||||++|||++ +..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 99999999999999999999999987654433222333456789999999998999999999999999999987 5567
Q ss_pred CCCCchHHHHHHHHHHhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 002774 758 IERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIE 827 (882)
Q Consensus 758 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~ 827 (882)
|...... +........... ............++..+.+++.+||+.||++|||+.||.+.|+
T Consensus 242 ~~~~~~~-~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 242 YGELTDE-QVIENAGEFFRD-------QGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCcCCHH-HHHHHHHHHhhh-------ccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 7543221 111111110000 0000000111223467899999999999999999999988775
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=346.14 Aligned_cols=248 Identities=27% Similarity=0.422 Sum_probs=209.8
Q ss_pred CCCCCCeeeccCcEEEEEEEe-cCCcEEEEEEcccCCccc-HHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEee
Q 002774 556 NFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQG-GQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFV 633 (882)
Q Consensus 556 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 633 (882)
.|+..+.||+|+||.||||.. ..++.||+|++......+ ..++++|+.++..++|+||.+++|.+..+...+++||||
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~ 93 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC 93 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence 456678899999999999985 468999999998665444 367899999999999999999999999999999999999
Q ss_pred cCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCce
Q 002774 634 PNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDH 713 (882)
Q Consensus 634 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 713 (882)
.+|++.+.++... .+++....-|++++..|+.|||.++ .+|||||+.|||+..+|.+|++|||++..+.....
T Consensus 94 ~gGsv~~lL~~~~--~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~-- 166 (467)
T KOG0201|consen 94 GGGSVLDLLKSGN--ILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK-- 166 (467)
T ss_pred cCcchhhhhccCC--CCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhh--
Confidence 9999999998654 3477777788999999999999999 99999999999999999999999999988765433
Q ss_pred eeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCCCCC
Q 002774 714 ITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLST 793 (882)
Q Consensus 714 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 793 (882)
....++||+.|||||++....|+.|+||||||++.+||++|.+|+..-.. .+.++.+...-.|.+..
T Consensus 167 rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hP-----------mrvlflIpk~~PP~L~~-- 233 (467)
T KOG0201|consen 167 RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHP-----------MRVLFLIPKSAPPRLDG-- 233 (467)
T ss_pred ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCc-----------ceEEEeccCCCCCcccc--
Confidence 23568899999999999988999999999999999999999999864221 22222233344455544
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 794 TLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 794 ~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
.....|.+++..|+.+||+.||++.+++++
T Consensus 234 --~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 234 --DFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred --ccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 334668899999999999999999999975
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=352.85 Aligned_cols=251 Identities=27% Similarity=0.388 Sum_probs=206.6
Q ss_pred HHcCCCCCCeeeccCcEEEEEEEe-cCCcEEEEEEcccC----Cc-ccHHHHHHHHHHHHhcc-CCCeeeEEEEEEeCCc
Q 002774 553 YTNNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQG----SM-QGGQEFKMEIELLSRVH-HKNLVSLLGFCFDRGE 625 (882)
Q Consensus 553 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~ 625 (882)
....|...+.||+|+||+|+.|.. .+++.||+|.+... .. ...+.+.+|+.++++++ ||||++++.++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 356788899999999999999975 47899999977653 11 22356778999999998 9999999999999999
Q ss_pred eEEEEEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCC-CceeEeeccccc
Q 002774 626 QMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDER-LNAKVADFGLSK 704 (882)
Q Consensus 626 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~-~~~kl~DfGla~ 704 (882)
.++||||+.+|+|.+++...+ ++.+....+++.|++.|++|||+.| |+||||||+|||+|.+ +++||+|||++.
T Consensus 95 ~~ivmEy~~gGdL~~~i~~~g--~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s~ 169 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVNKG--RLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLSA 169 (370)
T ss_pred EEEEEEecCCccHHHHHHHcC--CCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEecccccc
Confidence 999999999999999998744 6888999999999999999999999 9999999999999999 999999999999
Q ss_pred ccCCCCCceeeeeeeccCCCCCHHHHhhCC-CC-chhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhh
Q 002774 705 SMSDSEKDHITTQVKGTMGYLDPEYYMTQQ-LT-EKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLY 782 (882)
Q Consensus 705 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 782 (882)
... .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|..||++.. .......+....- .+.
T Consensus 170 ~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~-~~~l~~ki~~~~~---~~p 243 (370)
T KOG0583|consen 170 ISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN-VPNLYRKIRKGEF---KIP 243 (370)
T ss_pred ccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc-HHHHHHHHhcCCc---cCC
Confidence 874 1223345678999999999999877 86 78999999999999999999998733 2222222111110 011
Q ss_pred hccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 783 ELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 783 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
. .+ . ..++..++.+|++.||.+|+++.+++++
T Consensus 244 ~----~~------~-S~~~~~Li~~mL~~~P~~R~t~~~i~~h 275 (370)
T KOG0583|consen 244 S----YL------L-SPEARSLIEKMLVPDPSTRITLLEILEH 275 (370)
T ss_pred C----Cc------C-CHHHHHHHHHHcCCCcccCCCHHHHhhC
Confidence 1 11 0 3678899999999999999999999944
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=321.82 Aligned_cols=236 Identities=28% Similarity=0.386 Sum_probs=201.0
Q ss_pred cCCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCCcccH---HHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEE
Q 002774 555 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQGG---QEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIY 630 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~---~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 630 (882)
++|...+.||.|+||+|..++.+ +|..+|+|++++...-.. +....|-.+|+.+.||.++++.+.+.+.+..||||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 45777899999999999999965 688999999987644333 44567999999999999999999999999999999
Q ss_pred EeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCC
Q 002774 631 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE 710 (882)
Q Consensus 631 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~ 710 (882)
||+++|-|..+++..+ ++++..+..+|.+|+.||+|||+.+ |++||+||+|||+|.+|.+||+|||.|+....
T Consensus 124 eyv~GGElFS~Lrk~~--rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~-- 196 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKSG--RFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSG-- 196 (355)
T ss_pred eccCCccHHHHHHhcC--CCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecC--
Confidence 9999999999998765 6899999999999999999999999 99999999999999999999999999998743
Q ss_pred CceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCC
Q 002774 711 KDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIG 790 (882)
Q Consensus 711 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 790 (882)
.+-..+||+.|+|||.+....+..++|.|||||++|||+.|.+||...... .....++... +
T Consensus 197 ---rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~-~iY~KI~~~~-------------v- 258 (355)
T KOG0616|consen 197 ---RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPI-QIYEKILEGK-------------V- 258 (355)
T ss_pred ---cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChH-HHHHHHHhCc-------------c-
Confidence 245689999999999999999999999999999999999999999765542 2222222211 1
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCC
Q 002774 791 LSTTLKGFEKYVDLALKCVQESGDDR 816 (882)
Q Consensus 791 ~~~~~~~~~~l~~li~~cl~~dp~~R 816 (882)
.++.....++.+|+.+.++.|-.+|
T Consensus 259 -~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 259 -KFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred -cCCcccCHHHHHHHHHHHhhhhHhh
Confidence 1122233678899999999999999
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=361.03 Aligned_cols=258 Identities=26% Similarity=0.439 Sum_probs=203.9
Q ss_pred cCCCCCCeeeccCcEEEEEEEe------cCCcEEEEEEcccCC-cccHHHHHHHHHHHHhc-cCCCeeeEEEEEEeCCce
Q 002774 555 NNFSDANDVGSGGYGKVYKGTL------PNGQLIAIKRAQQGS-MQGGQEFKMEIELLSRV-HHKNLVSLLGFCFDRGEQ 626 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~~~~------~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~ 626 (882)
++|+..+.||+|+||+||+|++ .++..||||+++... ....+.+.+|+++++.+ +||||++++++|.+++..
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~ 114 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPT 114 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcc
Confidence 4577889999999999999974 245689999997543 23346788999999999 899999999999999999
Q ss_pred EEEEEeecCCCcccccCCCC------------------------------------------------------------
Q 002774 627 MLIYEFVPNGSLGDSLSGKN------------------------------------------------------------ 646 (882)
Q Consensus 627 ~lV~e~~~~gsL~~~l~~~~------------------------------------------------------------ 646 (882)
++||||+++|+|.++++...
T Consensus 115 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (375)
T cd05104 115 LVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSY 194 (375)
T ss_pred eeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccccee
Confidence 99999999999988875421
Q ss_pred -------------CccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCce
Q 002774 647 -------------GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDH 713 (882)
Q Consensus 647 -------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 713 (882)
...+++..+.+++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++.........
T Consensus 195 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 271 (375)
T cd05104 195 IDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV 271 (375)
T ss_pred cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCccccc
Confidence 124788899999999999999999988 9999999999999999999999999998765433222
Q ss_pred eeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCCCC
Q 002774 714 ITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLS 792 (882)
Q Consensus 714 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 792 (882)
......++..|+|||++.+..++.++|||||||++|||++ |..||........... .+.... ....+
T Consensus 272 ~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~-~~~~~~------~~~~~----- 339 (375)
T cd05104 272 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYK-MIKEGY------RMLSP----- 339 (375)
T ss_pred ccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHH-HHHhCc------cCCCC-----
Confidence 2222345678999999999999999999999999999998 8888864332221111 111110 00001
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 002774 793 TTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENI 829 (882)
Q Consensus 793 ~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 829 (882)
...+.++.+++.+||+.||++||++.|+++.|++.
T Consensus 340 --~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 340 --ECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred --CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 11236789999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=342.10 Aligned_cols=255 Identities=24% Similarity=0.359 Sum_probs=204.6
Q ss_pred HHcCCCCCCeeeccCcEEEEEEEe-cCCcEEEEEEcccCCccc---HHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEE
Q 002774 553 YTNNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQG---GQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQML 628 (882)
Q Consensus 553 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 628 (882)
..++|..+.+||+|+||+||.|+. .+|..+|+|++++..... .+.+..|-.+|...++|.||+++..|.+.+..||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 356899999999999999999985 469999999999865543 3567889999999999999999999999999999
Q ss_pred EEEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCC
Q 002774 629 IYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSD 708 (882)
Q Consensus 629 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~ 708 (882)
||||+|||++..+|...+ .+++......+.+++.|++-+|+.| +|||||||+|+|||..|++||+||||+.-+..
T Consensus 219 iMEylPGGD~mTLL~~~~--~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~ 293 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRKD--TLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDK 293 (550)
T ss_pred EEEecCCccHHHHHHhcC--cCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhhh
Confidence 999999999999998765 6788888889999999999999999 99999999999999999999999999853321
Q ss_pred ----------------------CCCc----eee-------------------eeeeccCCCCCHHHHhhCCCCchhHHHH
Q 002774 709 ----------------------SEKD----HIT-------------------TQVKGTMGYLDPEYYMTQQLTEKSDVYS 743 (882)
Q Consensus 709 ----------------------~~~~----~~~-------------------~~~~gt~~y~aPE~~~~~~~~~~sDv~S 743 (882)
.+.. ... -..+|||.|||||++.+..|+..+|.||
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWS 373 (550)
T KOG0605|consen 294 KHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWS 373 (550)
T ss_pred hhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHH
Confidence 0000 000 1246999999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCC---HH
Q 002774 744 FGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPT---MS 820 (882)
Q Consensus 744 ~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs---~~ 820 (882)
+|||+|||+.|.+||..... .+..+.++..... +..........+..+||.+|+. ||++|.. ++
T Consensus 374 LG~ImyEmLvGyPPF~s~tp-~~T~rkI~nwr~~-----------l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~ 440 (550)
T KOG0605|consen 374 LGCIMYEMLVGYPPFCSETP-QETYRKIVNWRET-----------LKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAE 440 (550)
T ss_pred HHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhhh-----------ccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHH
Confidence 99999999999999975433 3333333332221 1111111223678899999999 9999965 66
Q ss_pred HHHHH
Q 002774 821 EVVKD 825 (882)
Q Consensus 821 evl~~ 825 (882)
||-++
T Consensus 441 EIK~H 445 (550)
T KOG0605|consen 441 EIKKH 445 (550)
T ss_pred HHhcC
Confidence 66543
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=341.68 Aligned_cols=249 Identities=35% Similarity=0.578 Sum_probs=197.3
Q ss_pred CCeeeccCcEEEEEEEec-----CCcEEEEEEcccCCcc-cHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEee
Q 002774 560 ANDVGSGGYGKVYKGTLP-----NGQLIAIKRAQQGSMQ-GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFV 633 (882)
Q Consensus 560 ~~~lG~G~fg~Vy~~~~~-----~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 633 (882)
.+.||.|+||.||+|.+. .+..|+||.++..... ..+.|.+|++.+++++||||++++|+|...+..++||||+
T Consensus 4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~ 83 (259)
T PF07714_consen 4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC 83 (259)
T ss_dssp EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence 467999999999999976 2578999999764333 3578999999999999999999999999888899999999
Q ss_pred cCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCce
Q 002774 634 PNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDH 713 (882)
Q Consensus 634 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 713 (882)
++|+|.++++......+++.++.+|+.|||+||+|||+.+ ++|+||+++||++++++.+||+|||+++.........
T Consensus 84 ~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~ 160 (259)
T PF07714_consen 84 PGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYK 160 (259)
T ss_dssp TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEE
T ss_pred cccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccc
Confidence 9999999998875567999999999999999999999988 9999999999999999999999999998774333322
Q ss_pred eeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCCCC
Q 002774 714 ITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLS 792 (882)
Q Consensus 714 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 792 (882)
..........|+|||.+....++.++||||||+++|||++ |+.||... ...+..... ..... ..
T Consensus 161 ~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~-~~~~~~~~~-~~~~~-------------~~ 225 (259)
T PF07714_consen 161 NDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY-DNEEIIEKL-KQGQR-------------LP 225 (259)
T ss_dssp ESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS-CHHHHHHHH-HTTEE-------------TT
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccc-ccccccccc-ccccc-------------ce
Confidence 2333457789999999999999999999999999999999 67887654 222222222 21110 00
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 002774 793 TTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDI 826 (882)
Q Consensus 793 ~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L 826 (882)
.....+..+.+++.+||+.+|++||+++++++.|
T Consensus 226 ~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 226 IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred eccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 1112346789999999999999999999999875
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=359.91 Aligned_cols=259 Identities=25% Similarity=0.416 Sum_probs=204.4
Q ss_pred cCCCCCCeeeccCcEEEEEEEec------CCcEEEEEEcccCCcc-cHHHHHHHHHHHHhc-cCCCeeeEEEEEEeCCce
Q 002774 555 NNFSDANDVGSGGYGKVYKGTLP------NGQLIAIKRAQQGSMQ-GGQEFKMEIELLSRV-HHKNLVSLLGFCFDRGEQ 626 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~ 626 (882)
++|...+.||+|+||.||+|+.. ++..||||+++..... ....+.+|+++++.+ +|+|||+++++|.+.+..
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~ 117 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPV 117 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence 46788899999999999999742 3458999999754332 235688999999999 899999999999999999
Q ss_pred EEEEEeecCCCcccccCCCC------------------------------------------------------------
Q 002774 627 MLIYEFVPNGSLGDSLSGKN------------------------------------------------------------ 646 (882)
Q Consensus 627 ~lV~e~~~~gsL~~~l~~~~------------------------------------------------------------ 646 (882)
++||||+++|+|.++++...
T Consensus 118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (374)
T cd05106 118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS 197 (374)
T ss_pred EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence 99999999999988774321
Q ss_pred --------CccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCceeeeee
Q 002774 647 --------GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQV 718 (882)
Q Consensus 647 --------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 718 (882)
..++++.++.+++.|+++||+|||+.+ |+||||||+||++++++.+||+|||+++..............
T Consensus 198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~ 274 (374)
T cd05106 198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNA 274 (374)
T ss_pred cchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCC
Confidence 124788899999999999999999988 999999999999999999999999999876443322222223
Q ss_pred eccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCCCCCCHHH
Q 002774 719 KGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKG 797 (882)
Q Consensus 719 ~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 797 (882)
.++..|||||++....++.++|||||||++|||++ |+.||........ ........ ..+.. ....
T Consensus 275 ~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~-~~~~~~~~---------~~~~~----~~~~ 340 (374)
T cd05106 275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK-FYKMVKRG---------YQMSR----PDFA 340 (374)
T ss_pred CCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH-HHHHHHcc---------cCccC----CCCC
Confidence 45678999999999999999999999999999997 9999864322111 11111110 00000 1112
Q ss_pred HHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 002774 798 FEKYVDLALKCVQESGDDRPTMSEVVKDIENIL 830 (882)
Q Consensus 798 ~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~ 830 (882)
+.++.+++.+||+.||++||++.++++.|++++
T Consensus 341 ~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 341 PPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 367899999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=344.81 Aligned_cols=249 Identities=24% Similarity=0.353 Sum_probs=201.9
Q ss_pred CCCCCeeeccCcEEEEEEEe-cCCcEEEEEEcccCCc---ccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEe
Q 002774 557 FSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSM---QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEF 632 (882)
Q Consensus 557 ~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 632 (882)
|+..+.||+|+||+||+|.. .+|+.||||.+..... .....+.+|++++++++|+||+++++++.+++..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 66788999999999999986 5789999999865322 2234578899999999999999999999999999999999
Q ss_pred ecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCc
Q 002774 633 VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKD 712 (882)
Q Consensus 633 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 712 (882)
+++|+|.+++.......+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~-- 156 (285)
T cd05631 82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE-- 156 (285)
T ss_pred cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC--
Confidence 99999988876544446899999999999999999999998 9999999999999999999999999998754322
Q ss_pred eeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHH--HHHHHHHHhhhhhhhhhhccCCcCC
Q 002774 713 HITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIV--REIRTVMDKKKELYNLYELIDPTIG 790 (882)
Q Consensus 713 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~--~~~~~~~~~~~~~~~~~~~~d~~l~ 790 (882)
......||..|+|||++.+..++.++|||||||++|||++|+.||....... +.+...... + .
T Consensus 157 -~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~------------~--~ 221 (285)
T cd05631 157 -TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKE------------D--Q 221 (285)
T ss_pred -eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhc------------c--c
Confidence 1234568999999999999999999999999999999999999997543211 111111100 0 0
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 002774 791 LSTTLKGFEKYVDLALKCVQESGDDRPT-----MSEVVKD 825 (882)
Q Consensus 791 ~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~evl~~ 825 (882)
.........++.+++.+||+.||++||+ +++++++
T Consensus 222 ~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 222 EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 0111223467889999999999999997 7888865
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=359.12 Aligned_cols=256 Identities=29% Similarity=0.455 Sum_probs=217.8
Q ss_pred CCCCeeeccCcEEEEEEEe-cCC----cEEEEEEcccC-CcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEE
Q 002774 558 SDANDVGSGGYGKVYKGTL-PNG----QLIAIKRAQQG-SMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYE 631 (882)
Q Consensus 558 ~~~~~lG~G~fg~Vy~~~~-~~g----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e 631 (882)
...++||+|+||+||||.| ..| -+||+|++... ..+..+++.+|+-+|.+++|||+++++|+|.... ..||++
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq 777 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ 777 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence 4568999999999999986 344 37899988754 3445688999999999999999999999998766 789999
Q ss_pred eecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCC
Q 002774 632 FVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEK 711 (882)
Q Consensus 632 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 711 (882)
|||.|+|.++++.++ ..+-....+.|..|||+||.|||++. +|||||.++||||.+-..+||.|||+|+.+...+.
T Consensus 778 ~mP~G~LlDyvr~hr-~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ 853 (1177)
T KOG1025|consen 778 LMPLGCLLDYVREHR-DNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK 853 (1177)
T ss_pred hcccchHHHHHHHhh-ccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence 999999999998754 36778889999999999999999888 99999999999999999999999999999988776
Q ss_pred ceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCC
Q 002774 712 DHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIG 790 (882)
Q Consensus 712 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 790 (882)
........-.+.|||-|.+..+.|+.++|||||||.+||++| |..|++... .+++.+.++... +
T Consensus 854 ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~--~~eI~dlle~ge-------------R 918 (1177)
T KOG1025|consen 854 EYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIP--AEEIPDLLEKGE-------------R 918 (1177)
T ss_pred cccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCC--HHHhhHHHhccc-------------c
Confidence 666666667889999999999999999999999999999999 999986532 344444444333 2
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHc
Q 002774 791 LSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQA 833 (882)
Q Consensus 791 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~ 833 (882)
...+.-+..+++.++.+||..|++.||+++++...+.++.+..
T Consensus 919 LsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardp 961 (1177)
T KOG1025|consen 919 LSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDP 961 (1177)
T ss_pred CCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCc
Confidence 3344456688999999999999999999999999988876543
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=334.03 Aligned_cols=270 Identities=23% Similarity=0.366 Sum_probs=211.7
Q ss_pred HHHHHHHHcCCCCCCeeeccCcEEEEEEEecCCcEEEEEEcccCCcccHHHHHHHHHHHHh--ccCCCeeeEEEEEEeCC
Q 002774 547 FEEVKKYTNNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSR--VHHKNLVSLLGFCFDRG 624 (882)
Q Consensus 547 ~~e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~~~~~~~~ 624 (882)
+--.+....+....+.||+|.||+||+|.|+ |+.||||++.. .+++.+.+|.++.+. |+|+||+.|++.-..+.
T Consensus 203 lLVQRTiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~s---rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~ 278 (513)
T KOG2052|consen 203 LLVQRTIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSS---RDERSWFRETEIYQTVMLRHENILGFIAADNKDN 278 (513)
T ss_pred hHhHHhhhheeEEEEEecCccccceeecccc-CCceEEEEecc---cchhhhhhHHHHHHHHHhccchhhhhhhccccCC
Confidence 3344555667788899999999999999996 88999999964 345678889888886 49999999998765433
Q ss_pred ----ceEEEEEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhh-----cCCCCeeecCCCCCceEEcCCCce
Q 002774 625 ----EQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHE-----LANPPIIHRDIKSSNILLDERLNA 695 (882)
Q Consensus 625 ----~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-----~~~~~ivHrDlk~~NIll~~~~~~ 695 (882)
.+|||++|.++|||.|+|... .++....++++..+|.||+|||. .|+|.|.|||||+.|||+..++.+
T Consensus 279 gs~TQLwLvTdYHe~GSL~DyL~r~---tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C 355 (513)
T KOG2052|consen 279 GSWTQLWLVTDYHEHGSLYDYLNRN---TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC 355 (513)
T ss_pred CceEEEEEeeecccCCcHHHHHhhc---cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcE
Confidence 579999999999999999874 68999999999999999999994 588999999999999999999999
Q ss_pred eEeecccccccCCCCC--ceeeeeeeccCCCCCHHHHhhCC----C--CchhHHHHHHHHHHHHHhC----------CCC
Q 002774 696 KVADFGLSKSMSDSEK--DHITTQVKGTMGYLDPEYYMTQQ----L--TEKSDVYSFGVLMLELLTG----------RRP 757 (882)
Q Consensus 696 kl~DfGla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~----~--~~~sDv~S~Gvll~el~tg----------~~P 757 (882)
.|+|+|||........ +......+||.+|||||++.... + -..+||||||.|+||++.. +.|
T Consensus 356 ~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~P 435 (513)
T KOG2052|consen 356 CIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLP 435 (513)
T ss_pred EEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCC
Confidence 9999999987654422 12234568999999999997532 1 2368999999999999862 345
Q ss_pred CCC---CchHHHHHHHHHHhhhhhhhhhhccCCcCCC-CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHH
Q 002774 758 IER---GKYIVREIRTVMDKKKELYNLYELIDPTIGL-STTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQ 831 (882)
Q Consensus 758 ~~~---~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~-~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~ 831 (882)
|.+ .+...+++++++-. +.+.|.++. ....+....+.++|+.||..+|..|-|+-.+-+.|.++.+
T Consensus 436 yyd~Vp~DPs~eeMrkVVCv--------~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 436 YYDVVPSDPSFEEMRKVVCV--------QKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred cccCCCCCCCHHHHhcceee--------cccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 542 22223333333322 223333332 2445677889999999999999999999999999988853
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=323.70 Aligned_cols=262 Identities=24% Similarity=0.324 Sum_probs=205.1
Q ss_pred CCCCCCeeeccCcEEEEEEEe-cCCcEEEEEEcccCCcccH--HHHHHHHHHHHhccCCCeeeEEEEEEeC--CceEEEE
Q 002774 556 NFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQGG--QEFKMEIELLSRVHHKNLVSLLGFCFDR--GEQMLIY 630 (882)
Q Consensus 556 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~--~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lV~ 630 (882)
.|...++|++|+||.||+|+. ++++.||+|+++....... -.-.+|+.+|.+.+|||||.+..+.... +..|+||
T Consensus 77 efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VM 156 (419)
T KOG0663|consen 77 EFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVM 156 (419)
T ss_pred HHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeH
Confidence 356678999999999999985 4789999999987543332 2357899999999999999999987653 5789999
Q ss_pred EeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCC
Q 002774 631 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE 710 (882)
Q Consensus 631 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~ 710 (882)
|||++ +|...+..-. .++...+...++.|+++|++|||... |+|||||++|+|++..|.+||+|||+||.++..-
T Consensus 157 e~~Eh-DLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~ 231 (419)
T KOG0663|consen 157 EYVEH-DLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL 231 (419)
T ss_pred HHHHh-hHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcCCc
Confidence 99986 7877776543 57899999999999999999999999 9999999999999999999999999999997664
Q ss_pred CceeeeeeeccCCCCCHHHHhh-CCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhh-hhhhhhccC--
Q 002774 711 KDHITTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKE-LYNLYELID-- 786 (882)
Q Consensus 711 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~-~~~~~~~~d-- 786 (882)
. ..+..+-|.+|+|||.+.+ ..|+...|+||+|||+.||+++++ ...|....+++..++..... ...++.-++
T Consensus 232 k--~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kP-lf~G~sE~dQl~~If~llGtPte~iwpg~~~l 308 (419)
T KOG0663|consen 232 K--PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKP-LFPGKSEIDQLDKIFKLLGTPSEAIWPGYSEL 308 (419)
T ss_pred c--cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCC-CCCCCchHHHHHHHHHHhCCCccccCCCcccc
Confidence 3 3566788999999999986 579999999999999999999764 44566666666655542211 000110000
Q ss_pred --------Cc-----CCCCCCHH-HHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 787 --------PT-----IGLSTTLK-GFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 787 --------~~-----l~~~~~~~-~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
+. ++..+... ..+.-++|+..++..||.+|.|+.|.+++
T Consensus 309 p~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 309 PAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred chhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 00 00001111 12556899999999999999999999986
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=350.12 Aligned_cols=248 Identities=28% Similarity=0.362 Sum_probs=210.0
Q ss_pred CCCCCCeeeccCcEEEEEEEe-cCCcEEEEEEcccCCc---ccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEE
Q 002774 556 NFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSM---QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYE 631 (882)
Q Consensus 556 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e 631 (882)
-|...+-||.|+-|.|-.|++ .+|+.+|||++.+... .....+.+|+.+|+.+.||||++++++|++..++|+|.|
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE 92 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE 92 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence 356678899999999999985 5899999999977522 223568899999999999999999999999999999999
Q ss_pred eecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCC
Q 002774 632 FVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEK 711 (882)
Q Consensus 632 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 711 (882)
|+++|-|.+++..++ ++++.+..+++.||+.|+.|+|..+ |+|||+||+|+|+|..+++||+|||+|..-.++
T Consensus 93 yv~gGELFdylv~kG--~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g-- 165 (786)
T KOG0588|consen 93 YVPGGELFDYLVRKG--PLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPG-- 165 (786)
T ss_pred ecCCchhHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCC--
Confidence 999999999998776 6889999999999999999999999 999999999999999999999999999865433
Q ss_pred ceeeeeeeccCCCCCHHHHhhCCCC-chhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCC
Q 002774 712 DHITTQVKGTMGYLDPEYYMTQQLT-EKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIG 790 (882)
Q Consensus 712 ~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 790 (882)
..-.+.+|.+.|.|||++++..|. .++||||+|||||.|+||+.||++ +++...+.++....- ++
T Consensus 166 -klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD-dNir~LLlKV~~G~f------~M------ 231 (786)
T KOG0588|consen 166 -KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD-DNIRVLLLKVQRGVF------EM------ 231 (786)
T ss_pred -ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC-ccHHHHHHHHHcCcc------cC------
Confidence 334567899999999999999986 689999999999999999999974 444444444433221 11
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 002774 791 LSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIE 827 (882)
Q Consensus 791 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~ 827 (882)
+.....+..+|+.+|+..||.+|.|++||+++-.
T Consensus 232 ---Ps~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~ 265 (786)
T KOG0588|consen 232 ---PSNISSEAQDLLRRMLDVDPSTRITTEEILKHPF 265 (786)
T ss_pred ---CCcCCHHHHHHHHHHhccCccccccHHHHhhCch
Confidence 1122367789999999999999999999999744
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=348.83 Aligned_cols=242 Identities=25% Similarity=0.361 Sum_probs=202.6
Q ss_pred HcCCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCCccc---HHHHHHHHHHHHhc-cCCCeeeEEEEEEeCCceEE
Q 002774 554 TNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQG---GQEFKMEIELLSRV-HHKNLVSLLGFCFDRGEQML 628 (882)
Q Consensus 554 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~---~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~l 628 (882)
.++|...++||+|+||+|++|..+ +++.+|||++++...-. .+..+.|.+++... +||.++.+++++.+.++.|+
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f 446 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF 446 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence 467889999999999999999975 68899999999875533 35567788888877 59999999999999999999
Q ss_pred EEEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCC
Q 002774 629 IYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSD 708 (882)
Q Consensus 629 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~ 708 (882)
||||+.||++..+.+.. .+++.++..+|..|+.||+|||+++ ||+||||.+|||+|.+|.+||+|||+++.--.
T Consensus 447 vmey~~Ggdm~~~~~~~---~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~ 520 (694)
T KOG0694|consen 447 VMEYVAGGDLMHHIHTD---VFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG 520 (694)
T ss_pred EEEecCCCcEEEEEecc---cccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccccccCC
Confidence 99999999966666543 5999999999999999999999999 99999999999999999999999999986432
Q ss_pred CCCceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCc
Q 002774 709 SEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPT 788 (882)
Q Consensus 709 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 788 (882)
....+.+++||+.|||||++.+..|+.++|.|||||+||||+.|+.||.+. +..+....++.. |+.
T Consensus 521 --~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gd-dEee~FdsI~~d-----------~~~ 586 (694)
T KOG0694|consen 521 --QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGD-DEEEVFDSIVND-----------EVR 586 (694)
T ss_pred --CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCC-CHHHHHHHHhcC-----------CCC
Confidence 234567799999999999999999999999999999999999999999643 333333322221 111
Q ss_pred CCCCCCHHHHHHHHHHHHHhhccCCCCCCCH
Q 002774 789 IGLSTTLKGFEKYVDLALKCVQESGDDRPTM 819 (882)
Q Consensus 789 l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~ 819 (882)
++.-...+.++++++++.++|++|.-+
T Consensus 587 ----yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 587 ----YPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred ----CCCcccHHHHHHHHHHhccCcccccCC
Confidence 122234778999999999999999865
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=342.55 Aligned_cols=259 Identities=25% Similarity=0.423 Sum_probs=217.7
Q ss_pred cCCCCCCeeeccCcEEEEEEEecC---C--cEEEEEEcccCC-cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEE
Q 002774 555 NNFSDANDVGSGGYGKVYKGTLPN---G--QLIAIKRAQQGS-MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQML 628 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~~~~~~---g--~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 628 (882)
+.....+.||+|-||.||+|.+.+ | -.||||..+... ..+.+.|.+|..+|++++|||||+++|.|.+ ...|+
T Consensus 389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wi 467 (974)
T KOG4257|consen 389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWI 467 (974)
T ss_pred hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeE
Confidence 344556789999999999999643 3 368999998743 3456789999999999999999999999965 47899
Q ss_pred EEEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCC
Q 002774 629 IYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSD 708 (882)
Q Consensus 629 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~ 708 (882)
|||.++-|.|.++|+.++ ..++......++.||..||+|||+.. +|||||.++|||+...--+|++|||++|.+.+
T Consensus 468 vmEL~~~GELr~yLq~nk-~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed 543 (974)
T KOG4257|consen 468 VMELAPLGELREYLQQNK-DSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYLED 543 (974)
T ss_pred EEecccchhHHHHHHhcc-ccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhccc
Confidence 999999999999998764 47888899999999999999999988 99999999999999999999999999999877
Q ss_pred CCCceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCC
Q 002774 709 SEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDP 787 (882)
Q Consensus 709 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 787 (882)
......+ ...-++.|||||.+..++++.+||||.|||.+||++. |.+||..-++. . ..-.+..
T Consensus 544 ~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNs-----------D----VI~~iEn 607 (974)
T KOG4257|consen 544 DAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNS-----------D----VIGHIEN 607 (974)
T ss_pred cchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccccc-----------c----eEEEecC
Confidence 6654433 4556789999999999999999999999999999998 99999753321 0 1122233
Q ss_pred cCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHcC
Q 002774 788 TIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQAG 834 (882)
Q Consensus 788 ~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~~ 834 (882)
.-+...+..++..++.++.+||+.+|.+||.+.|+...|..+++...
T Consensus 608 GeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qeek 654 (974)
T KOG4257|consen 608 GERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEEK 654 (974)
T ss_pred CCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHhh
Confidence 33455667788999999999999999999999999999999887543
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=331.68 Aligned_cols=259 Identities=26% Similarity=0.387 Sum_probs=203.2
Q ss_pred HHHHcCCCCCCeeeccCcEEEEEEEe-cCCcEEEEEEcccCCcc--------------cHHHHHHHHHHHHhccCCCeee
Q 002774 551 KKYTNNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQ--------------GGQEFKMEIELLSRVHHKNLVS 615 (882)
Q Consensus 551 ~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~--------------~~~~~~~E~~~l~~l~H~niv~ 615 (882)
....++|...+.||+|.||.|-+|+. .+++.||||++.+.... ..+...+|+.+|++++|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 34467899999999999999999985 47999999998653211 1246889999999999999999
Q ss_pred EEEEEEeC--CceEEEEEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCC
Q 002774 616 LLGFCFDR--GEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERL 693 (882)
Q Consensus 616 l~~~~~~~--~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~ 693 (882)
++.+..+. +..|||+|||..|.+...=... ..++..++++++.++..||+|||.+| ||||||||+|+||+++|
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~--~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g 247 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWCPPDK--PELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDG 247 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccCCCCc--ccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCC
Confidence 99998774 5789999999988775433222 13899999999999999999999999 99999999999999999
Q ss_pred ceeEeecccccccCCCC---CceeeeeeeccCCCCCHHHHhhCC----CCchhHHHHHHHHHHHHHhCCCCCCCCchHHH
Q 002774 694 NAKVADFGLSKSMSDSE---KDHITTQVKGTMGYLDPEYYMTQQ----LTEKSDVYSFGVLMLELLTGRRPIERGKYIVR 766 (882)
Q Consensus 694 ~~kl~DfGla~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~ 766 (882)
++||+|||.+....... .+.......||+.|||||...++. .+.+.||||+||+||.|+.|+.||.+. ...+
T Consensus 248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~-~~~~ 326 (576)
T KOG0585|consen 248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDD-FELE 326 (576)
T ss_pred cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccc-hHHH
Confidence 99999999998663221 111123367999999999998743 356789999999999999999999643 2222
Q ss_pred HHHHHHHhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 002774 767 EIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIEN 828 (882)
Q Consensus 767 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~ 828 (882)
...++. ...+......+..+++.+||++||++||+.|.+..+|..+.+.
T Consensus 327 l~~KIv-------------n~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwv 375 (576)
T KOG0585|consen 327 LFDKIV-------------NDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWV 375 (576)
T ss_pred HHHHHh-------------cCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheeccee
Confidence 222222 2222222222345788999999999999999999999987654
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=327.50 Aligned_cols=265 Identities=23% Similarity=0.356 Sum_probs=207.3
Q ss_pred HcCCCCCCeeeccCcEEEEEEEe-cCCcEEEEEEcc--cCCcccHHHHHHHHHHHHhccCCCeeeEEEEEEe-----CCc
Q 002774 554 TNNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQ--QGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFD-----RGE 625 (882)
Q Consensus 554 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-----~~~ 625 (882)
...|...+.||+|+||.|++|.. .+|+.||||++. .......++-.+|+++|+.++|+||+.+++.+.. -..
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 34556678899999999999985 478999999987 3344556778899999999999999999998765 346
Q ss_pred eEEEEEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccc
Q 002774 626 QMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKS 705 (882)
Q Consensus 626 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~ 705 (882)
.|+|+|+| ..+|...++.+. .++......++.|+++||.|+|+.+ |+|||+||+|+|++.+...||+|||+||.
T Consensus 101 vYiV~elM-etDL~~iik~~~--~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR~ 174 (359)
T KOG0660|consen 101 VYLVFELM-ETDLHQIIKSQQ--DLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLARY 174 (359)
T ss_pred eEEehhHH-hhHHHHHHHcCc--cccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccceee
Confidence 79999999 669999998654 5888899999999999999999999 99999999999999999999999999998
Q ss_pred cCCCCCceeeeeeeccCCCCCHHHHh-hCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhh-------
Q 002774 706 MSDSEKDHITTQVKGTMGYLDPEYYM-TQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKE------- 777 (882)
Q Consensus 706 ~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~------- 777 (882)
..........+..+.|.+|.|||.+. ...|+.+.||||.|||+.||++|+.-| .|.+..+++..++.-...
T Consensus 175 ~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplF-pG~d~v~Ql~lI~~~lGtP~~e~l~ 253 (359)
T KOG0660|consen 175 LDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLF-PGKDYVHQLQLILELLGTPSEEDLQ 253 (359)
T ss_pred ccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCC-CCCchHHHHHHHHHhcCCCCHHHHH
Confidence 86543334456778999999999987 468999999999999999999988655 455555555444431110
Q ss_pred ------hhhhhhccCCcCCCC---CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 778 ------LYNLYELIDPTIGLS---TTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 778 ------~~~~~~~~d~~l~~~---~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
..+......+..+.. .-.......++|+.+||..||.+|+|++|++++
T Consensus 254 ~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 254 KIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 000111111111110 011223678899999999999999999999986
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=339.17 Aligned_cols=256 Identities=28% Similarity=0.501 Sum_probs=206.3
Q ss_pred cCCCCCCeeeccCcEEEEEEEecC------CcEEEEEEcccCCc-ccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceE
Q 002774 555 NNFSDANDVGSGGYGKVYKGTLPN------GQLIAIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQM 627 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~~~~~~------g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 627 (882)
++|+..+.||+|+||.||+|.... ...||+|.++.... .....|.+|++++++++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 357788999999999999998642 25799999875432 23456899999999999999999999999999999
Q ss_pred EEEEeecCCCcccccCCCCC--------------ccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCC
Q 002774 628 LIYEFVPNGSLGDSLSGKNG--------------IRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERL 693 (882)
Q Consensus 628 lV~e~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~ 693 (882)
++|||+++|+|.+++..... ..+++..+..++.|++.||+|||+.+ ++||||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 99999999999998864321 35788999999999999999999998 99999999999999999
Q ss_pred ceeEeecccccccCCCCCceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHH
Q 002774 694 NAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVM 772 (882)
Q Consensus 694 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~t-g~~P~~~~~~~~~~~~~~~ 772 (882)
.+||+|||+++...............+++.|+|||++....++.++|||||||++|||++ |..||..... .+.... +
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~-~~~~~~-i 239 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN-QEVIEM-I 239 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH-HHHHHH-H
Confidence 999999999986644333223334457889999999998999999999999999999998 9999864322 111111 1
Q ss_pred HhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 002774 773 DKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIEN 828 (882)
Q Consensus 773 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~ 828 (882)
.... ........+.++.+++.+||+.||.+||+++||++.|+.
T Consensus 240 ~~~~-------------~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 240 RSRQ-------------LLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HcCC-------------cCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 1110 011122345789999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=335.87 Aligned_cols=255 Identities=22% Similarity=0.362 Sum_probs=203.9
Q ss_pred cCCCCCCeeeccCcEEEEEEEec----CCcEEEEEEcccCCc-ccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEE
Q 002774 555 NNFSDANDVGSGGYGKVYKGTLP----NGQLIAIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLI 629 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~~~~~----~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 629 (882)
.+|...+.||+|+||.||+|.+. .+..||+|.++.... .....|.+|+.++++++||||+++++++..++..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 45778899999999999999753 357899999986533 2335788999999999999999999999999999999
Q ss_pred EEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCC
Q 002774 630 YEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDS 709 (882)
Q Consensus 630 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~ 709 (882)
|||+++|+|.+++.... ..+++.+++.++.|++.||+|||+.+ ++||||||+||+++.++.+|++|||.+......
T Consensus 85 ~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~ 160 (266)
T cd05064 85 TEYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE 160 (266)
T ss_pred EEeCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence 99999999999987543 36899999999999999999999988 999999999999999999999999987654222
Q ss_pred CCceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCc
Q 002774 710 EKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPT 788 (882)
Q Consensus 710 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 788 (882)
.. .......++..|+|||.+.+..++.++|||||||++||+++ |..||...... +.... +.... .+
T Consensus 161 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~-~~~~~-~~~~~---------~~- 227 (266)
T cd05064 161 AI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ-DVIKA-VEDGF---------RL- 227 (266)
T ss_pred ch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH-HHHHH-HHCCC---------CC-
Confidence 11 11112335678999999999999999999999999999875 99998654321 11111 11110 00
Q ss_pred CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 002774 789 IGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENI 829 (882)
Q Consensus 789 l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 829 (882)
......+..+.+++.+||+.+|++||+++++++.|+++
T Consensus 228 ---~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 228 ---PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred ---CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 11122446789999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=344.05 Aligned_cols=259 Identities=27% Similarity=0.466 Sum_probs=206.0
Q ss_pred cCCCCCCeeeccCcEEEEEEEec-CCc----EEEEEEcccCC-cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEE
Q 002774 555 NNFSDANDVGSGGYGKVYKGTLP-NGQ----LIAIKRAQQGS-MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQML 628 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 628 (882)
.+|+..+.||+|+||+||+|++. +|+ .||||+++... ....+++.+|+.+++.++||||++++|+|... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 46888999999999999999863 343 48999987543 23456788999999999999999999999764 5789
Q ss_pred EEEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCC
Q 002774 629 IYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSD 708 (882)
Q Consensus 629 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~ 708 (882)
|+||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++.+..
T Consensus 86 v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 161 (316)
T cd05108 86 ITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 161 (316)
T ss_pred eeecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccccccccC
Confidence 999999999999987643 35788899999999999999999998 99999999999999999999999999987754
Q ss_pred CCCceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCC
Q 002774 709 SEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDP 787 (882)
Q Consensus 709 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 787 (882)
...........++..|+|||++....++.++|||||||++|||++ |..||...... ...........
T Consensus 162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~--~~~~~~~~~~~---------- 229 (316)
T cd05108 162 DEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EISSILEKGER---------- 229 (316)
T ss_pred CCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHhCCCC----------
Confidence 433222222335678999999999999999999999999999998 99998643221 11122211110
Q ss_pred cCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHc
Q 002774 788 TIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQA 833 (882)
Q Consensus 788 ~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~ 833 (882)
......+..++.+++.+||+.+|.+||++.+++..+..+.+..
T Consensus 230 ---~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 230 ---LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred ---CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 0001122357889999999999999999999999999886543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=352.59 Aligned_cols=260 Identities=23% Similarity=0.390 Sum_probs=205.3
Q ss_pred HcCCCCCCeeeccCcEEEEEEEec------CCcEEEEEEcccCCc-ccHHHHHHHHHHHHhcc-CCCeeeEEEEEEeCCc
Q 002774 554 TNNFSDANDVGSGGYGKVYKGTLP------NGQLIAIKRAQQGSM-QGGQEFKMEIELLSRVH-HKNLVSLLGFCFDRGE 625 (882)
Q Consensus 554 ~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~ 625 (882)
.++|...++||+|+||.||+|+.. .+..||||+++.... ...+.+.+|+++++++. |||||+++++|.+.+.
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 457788899999999999999852 234799999975433 23467899999999996 9999999999999999
Q ss_pred eEEEEEeecCCCcccccCCCC-----------------------------------------------------------
Q 002774 626 QMLIYEFVPNGSLGDSLSGKN----------------------------------------------------------- 646 (882)
Q Consensus 626 ~~lV~e~~~~gsL~~~l~~~~----------------------------------------------------------- 646 (882)
.++||||+++|+|.++++...
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 999999999999988765321
Q ss_pred -----------------------------------CccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcC
Q 002774 647 -----------------------------------GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDE 691 (882)
Q Consensus 647 -----------------------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~ 691 (882)
...+++..+..++.|+++||+|||+.+ |+||||||+||++++
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEeC
Confidence 124778888999999999999999988 999999999999999
Q ss_pred CCceeEeecccccccCCCCCceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHh-CCCCCCCCchHHHHHHH
Q 002774 692 RLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRT 770 (882)
Q Consensus 692 ~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~t-g~~P~~~~~~~~~~~~~ 770 (882)
++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||........ ...
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~-~~~ 351 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST-FYN 351 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH-HHH
Confidence 99999999999987644332222223456788999999999899999999999999999997 8899864321111 111
Q ss_pred HHHhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 002774 771 VMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENIL 830 (882)
Q Consensus 771 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~ 830 (882)
..... . ........+.++.+++.+||+.||++||++.++.+.|+++.
T Consensus 352 ~~~~~---------~----~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 352 KIKSG---------Y----RMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred HHhcC---------C----CCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 11110 0 01111233467899999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=333.75 Aligned_cols=254 Identities=26% Similarity=0.456 Sum_probs=207.7
Q ss_pred cCCCCCCeeeccCcEEEEEEEecCCcEEEEEEcccCCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEeec
Q 002774 555 NNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVP 634 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 634 (882)
++|+..++||+|+||.||+|...+++.||+|.+..... ..+.+.+|+.+++.++|+||+++++++.+.+..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA 84 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence 46788899999999999999988888999999875432 34688999999999999999999999999999999999999
Q ss_pred CCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCcee
Q 002774 635 NGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHI 714 (882)
Q Consensus 635 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 714 (882)
+|+|.++++......+++.++..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||+++....... ..
T Consensus 85 ~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-~~ 160 (261)
T cd05072 85 KGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY-TA 160 (261)
T ss_pred CCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCce-ec
Confidence 999999997655557889999999999999999999988 99999999999999999999999999987644321 11
Q ss_pred eeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCCCCC
Q 002774 715 TTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLST 793 (882)
Q Consensus 715 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 793 (882)
.....++..|+|||++....++.++|||||||++|||+| |..||...... ..... +... ... ..
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~-~~~~~-~~~~---------~~~----~~ 225 (261)
T cd05072 161 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS-DVMSA-LQRG---------YRM----PR 225 (261)
T ss_pred cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH-HHHHH-HHcC---------CCC----CC
Confidence 222346678999999998889999999999999999998 88898643221 11111 1111 000 01
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 002774 794 TLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIEN 828 (882)
Q Consensus 794 ~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~ 828 (882)
....+.++.+++.+||+.+|++||+++++.+.|++
T Consensus 226 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 226 MENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred CCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 11234678899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=341.36 Aligned_cols=245 Identities=25% Similarity=0.324 Sum_probs=201.7
Q ss_pred cCCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCCc---ccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEE
Q 002774 555 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM---QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIY 630 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 630 (882)
++|...+.||+|+||+||+|+.. +++.||+|++..... ...+.+.+|++++++++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36788899999999999999965 689999999864321 23456888999999999999999999999999999999
Q ss_pred EeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCC
Q 002774 631 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE 710 (882)
Q Consensus 631 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~ 710 (882)
||+++|+|.+++.... .+++.....++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 81 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~ 155 (291)
T cd05612 81 EYVPGGELFSYLRNSG--RFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT 155 (291)
T ss_pred eCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCCc
Confidence 9999999999987654 5888899999999999999999998 9999999999999999999999999998764321
Q ss_pred CceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCC
Q 002774 711 KDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIG 790 (882)
Q Consensus 711 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 790 (882)
....||+.|+|||.+.+..++.++|||||||++|||++|+.||..... ......+..... ..
T Consensus 156 -----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~-~~~~~~i~~~~~-----------~~- 217 (291)
T cd05612 156 -----WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP-FGIYEKILAGKL-----------EF- 217 (291)
T ss_pred -----ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhCCc-----------CC-
Confidence 234689999999999988999999999999999999999999975432 222222211110 01
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 002774 791 LSTTLKGFEKYVDLALKCVQESGDDRPT-----MSEVVKD 825 (882)
Q Consensus 791 ~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~evl~~ 825 (882)
+......+.+++.+||+.||.+||+ ++|++++
T Consensus 218 ---~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 218 ---PRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred ---CccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 1112356889999999999999995 8888865
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=346.28 Aligned_cols=242 Identities=21% Similarity=0.274 Sum_probs=197.6
Q ss_pred CeeeccCcEEEEEEEe-cCCcEEEEEEcccCCc---ccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEeecCC
Q 002774 561 NDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSM---QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNG 636 (882)
Q Consensus 561 ~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 636 (882)
+.||+|+||.||+|+. .+|+.||||+++.... .....+.+|++++++++||||+++++++..++..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999986 4789999999875322 22346778999999999999999999999999999999999999
Q ss_pred CcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCceeee
Q 002774 637 SLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITT 716 (882)
Q Consensus 637 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 716 (882)
+|.+++.... .+++.++..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++...... ....
T Consensus 81 ~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~--~~~~ 153 (323)
T cd05571 81 ELFFHLSRER--VFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG--ATMK 153 (323)
T ss_pred cHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC--Cccc
Confidence 9998887543 6889999999999999999999998 9999999999999999999999999997543221 1233
Q ss_pred eeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCCCCCCHH
Q 002774 717 QVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLK 796 (882)
Q Consensus 717 ~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 796 (882)
...||+.|+|||.+.+..++.++|||||||++|||++|+.||...... ......... +... +..
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~-~~~~~~~~~-----------~~~~----p~~ 217 (323)
T cd05571 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-KLFELILME-----------EIRF----PRT 217 (323)
T ss_pred ceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH-HHHHHHHcC-----------CCCC----CCC
Confidence 467999999999999999999999999999999999999999654321 111111110 0111 112
Q ss_pred HHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 002774 797 GFEKYVDLALKCVQESGDDRP-----TMSEVVKD 825 (882)
Q Consensus 797 ~~~~l~~li~~cl~~dp~~RP-----s~~evl~~ 825 (882)
...++.+++.+||+.||++|| ++.+++++
T Consensus 218 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 218 LSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred CCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 336788999999999999999 79999865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=334.77 Aligned_cols=256 Identities=29% Similarity=0.468 Sum_probs=212.6
Q ss_pred HHcCCCCCCeeeccCcEEEEEEEecCCcEEEEEEcccCCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEe
Q 002774 553 YTNNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEF 632 (882)
Q Consensus 553 ~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 632 (882)
...+|...++||+|+||+||+|...+++.+|+|.++.........+.+|+.+++.++|+||+++++++.+.+..++||||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 34567888999999999999999888999999999876655567899999999999999999999999999999999999
Q ss_pred ecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCc
Q 002774 633 VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKD 712 (882)
Q Consensus 633 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 712 (882)
+++|+|.++++......+++.++..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||.+........
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~- 159 (261)
T cd05148 84 MEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY- 159 (261)
T ss_pred cccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCccc-
Confidence 99999999998766667899999999999999999999988 99999999999999999999999999987643321
Q ss_pred eeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCCC
Q 002774 713 HITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGL 791 (882)
Q Consensus 713 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 791 (882)
......++..|+|||.+....++.++||||||+++|+|++ |+.||.... ..+......... ..
T Consensus 160 -~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~-~~~~~~~~~~~~--------------~~ 223 (261)
T cd05148 160 -LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN-NHEVYDQITAGY--------------RM 223 (261)
T ss_pred -cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC-HHHHHHHHHhCC--------------cC
Confidence 1223346778999999998899999999999999999998 888886433 122222211110 01
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 002774 792 STTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIEN 828 (882)
Q Consensus 792 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~ 828 (882)
......+..+.+++.+||+.||.+|||++++++.|+.
T Consensus 224 ~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 224 PCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 1112234678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=347.24 Aligned_cols=249 Identities=27% Similarity=0.449 Sum_probs=213.0
Q ss_pred CCCeeeccCcEEEEEEEec--CCc--EEEEEEcccCCcc-cHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEee
Q 002774 559 DANDVGSGGYGKVYKGTLP--NGQ--LIAIKRAQQGSMQ-GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFV 633 (882)
Q Consensus 559 ~~~~lG~G~fg~Vy~~~~~--~g~--~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 633 (882)
..+.||+|+||.|++|.|. .|+ .||||.++..... ...+|.+|+.+|-+|+|||+++++|.+.+ ....+|||++
T Consensus 114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELa 192 (1039)
T KOG0199|consen 114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELA 192 (1039)
T ss_pred HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhc
Confidence 3567999999999999985 344 5899999877655 56889999999999999999999999987 6788999999
Q ss_pred cCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCce
Q 002774 634 PNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDH 713 (882)
Q Consensus 634 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 713 (882)
+.|+|.+.|+......+-......++.|||.||+||..++ +|||||.++|+|+-....+||+|||+.|.+...+..+
T Consensus 193 plGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Y 269 (1039)
T KOG0199|consen 193 PLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMY 269 (1039)
T ss_pred ccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCCcce
Confidence 9999999999855567888889999999999999999988 9999999999999999999999999999988766544
Q ss_pred eee-eeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCCC
Q 002774 714 ITT-QVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGL 791 (882)
Q Consensus 714 ~~~-~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 791 (882)
+.. ...-.+.|+|||.+..+.++.++|||+|||++|||+| |+.||.+-.- .+ +.+.+|...+.
T Consensus 270 vm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g-~q--------------IL~~iD~~erL 334 (1039)
T KOG0199|consen 270 VMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG-IQ--------------ILKNIDAGERL 334 (1039)
T ss_pred EecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH-HH--------------HHHhccccccC
Confidence 332 3445778999999999999999999999999999999 8888864321 11 33445555556
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 002774 792 STTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDI 826 (882)
Q Consensus 792 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L 826 (882)
..+..+.+++++++++||..+|.+|||+..+.+++
T Consensus 335 pRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 335 PRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred CCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 66777889999999999999999999999998654
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=330.86 Aligned_cols=251 Identities=28% Similarity=0.491 Sum_probs=203.6
Q ss_pred cCCCCCCeeeccCcEEEEEEEecCCcEEEEEEcccCCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEeec
Q 002774 555 NNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVP 634 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 634 (882)
++|...+.||+|+||.||+|++.++..+|+|.++.... ..+++.+|++++++++||||+++++++.+.+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAM-SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCc-cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 35777889999999999999998888999999875433 34678899999999999999999999999999999999999
Q ss_pred CCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCcee
Q 002774 635 NGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHI 714 (882)
Q Consensus 635 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 714 (882)
+|+|.++++.... .+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||.++....... ..
T Consensus 83 ~~~L~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~-~~ 157 (256)
T cd05114 83 NGCLLNYLRQRQG-KLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY-TS 157 (256)
T ss_pred CCcHHHHHHhCcc-CCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCce-ec
Confidence 9999998875432 5889999999999999999999998 99999999999999999999999999986543221 11
Q ss_pred eeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCCCCC
Q 002774 715 TTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLST 793 (882)
Q Consensus 715 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 793 (882)
.....++..|+|||.+....++.++||||||+++|||++ |+.||..... .+....+.... ....+.
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~-~~~~~~i~~~~-------~~~~~~----- 224 (256)
T cd05114 158 SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN-YEVVEMISRGF-------RLYRPK----- 224 (256)
T ss_pred cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH-HHHHHHHHCCC-------CCCCCC-----
Confidence 122345678999999988889999999999999999999 8888864432 22222211110 001111
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 002774 794 TLKGFEKYVDLALKCVQESGDDRPTMSEVVKDI 826 (882)
Q Consensus 794 ~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L 826 (882)
.....+.+++.+||+.+|++||+++|+++.|
T Consensus 225 --~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 225 --LASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred --CCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 1235789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=345.63 Aligned_cols=261 Identities=27% Similarity=0.464 Sum_probs=204.6
Q ss_pred cCCCCCCeeeccCcEEEEEEEec------CCcEEEEEEcccCCcc-cHHHHHHHHHHHHhc-cCCCeeeEEEEEEeC-Cc
Q 002774 555 NNFSDANDVGSGGYGKVYKGTLP------NGQLIAIKRAQQGSMQ-GGQEFKMEIELLSRV-HHKNLVSLLGFCFDR-GE 625 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~-~~ 625 (882)
++|...+.||+|+||.||+|... +++.||+|+++..... ..+.+.+|+.++.++ +|+||++++++|... ..
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~ 86 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP 86 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence 46788899999999999999642 3578999998754322 235677899999999 799999999988754 56
Q ss_pred eEEEEEeecCCCcccccCCCC-----------------------------------------------------------
Q 002774 626 QMLIYEFVPNGSLGDSLSGKN----------------------------------------------------------- 646 (882)
Q Consensus 626 ~~lV~e~~~~gsL~~~l~~~~----------------------------------------------------------- 646 (882)
.++||||+++|+|.+++....
T Consensus 87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (337)
T cd05054 87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY 166 (337)
T ss_pred EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence 789999999999988875321
Q ss_pred CccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCceeeeeeeccCCCCC
Q 002774 647 GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLD 726 (882)
Q Consensus 647 ~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a 726 (882)
..+++|..+..++.||+.||+|||+.+ |+||||||+||++++++.+||+|||+++.+.............++..|+|
T Consensus 167 ~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 243 (337)
T cd05054 167 KEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 243 (337)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence 126789999999999999999999988 99999999999999999999999999987644332222223456778999
Q ss_pred HHHHhhCCCCchhHHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHH
Q 002774 727 PEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLA 805 (882)
Q Consensus 727 PE~~~~~~~~~~sDv~S~Gvll~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li 805 (882)
||++.+..++.++|||||||++|||++ |..||...... +.....+.... .+ ..+.....++.+++
T Consensus 244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~-~~~~~~~~~~~---------~~----~~~~~~~~~~~~l~ 309 (337)
T cd05054 244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQID-EEFCRRLKEGT---------RM----RAPEYATPEIYSIM 309 (337)
T ss_pred cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCcc-HHHHHHHhccC---------CC----CCCccCCHHHHHHH
Confidence 999999999999999999999999998 99998642211 11111111110 00 01112336789999
Q ss_pred HHhhccCCCCCCCHHHHHHHHHHHHHH
Q 002774 806 LKCVQESGDDRPTMSEVVKDIENILQQ 832 (882)
Q Consensus 806 ~~cl~~dp~~RPs~~evl~~L~~~~~~ 832 (882)
.+||+.+|++||++.|++++|+++++.
T Consensus 310 ~~cl~~~p~~RPs~~ell~~l~~~~~~ 336 (337)
T cd05054 310 LDCWHNNPEDRPTFSELVEILGDLLQE 336 (337)
T ss_pred HHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=331.14 Aligned_cols=254 Identities=28% Similarity=0.422 Sum_probs=206.9
Q ss_pred CCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEeec
Q 002774 556 NFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVP 634 (882)
Q Consensus 556 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 634 (882)
+|...+.||+|+||.||+|.+. .++.||+|+++.. ....+++.+|++++++++|+||+++++++..++..++||||++
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (263)
T cd05052 7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT 85 (263)
T ss_pred HeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCC
Confidence 4677889999999999999865 5889999998754 3334678999999999999999999999999999999999999
Q ss_pred CCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCcee
Q 002774 635 NGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHI 714 (882)
Q Consensus 635 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 714 (882)
+++|.+++.......+++..++.++.|+++||+|||+.+ ++||||||+||++++++.+||+|||+++....... ..
T Consensus 86 ~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~-~~ 161 (263)
T cd05052 86 YGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-TA 161 (263)
T ss_pred CCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCcccccccccee-ec
Confidence 999999987655556899999999999999999999988 99999999999999999999999999987654321 11
Q ss_pred eeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCCCCC
Q 002774 715 TTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLST 793 (882)
Q Consensus 715 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 793 (882)
.....++..|+|||++.+..++.++|||||||++|||++ |..||.... ..+....... ...+ ..
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~-~~~~~~~~~~----------~~~~----~~ 226 (263)
T cd05052 162 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEK----------GYRM----ER 226 (263)
T ss_pred cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC-HHHHHHHHHC----------CCCC----CC
Confidence 112234668999999999999999999999999999998 888886432 2222111111 0011 11
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 002774 794 TLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENI 829 (882)
Q Consensus 794 ~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 829 (882)
....+.++.+++.+||+.+|++||++.++++.|+.+
T Consensus 227 ~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 227 PEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 122346789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=346.45 Aligned_cols=245 Identities=25% Similarity=0.345 Sum_probs=201.5
Q ss_pred cCCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCC---cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEE
Q 002774 555 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS---MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIY 630 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 630 (882)
++|...+.||+|+||+||+|+.. +++.||||+++... ....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 46788899999999999999975 68999999987532 223356889999999999999999999999999999999
Q ss_pred EeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCC
Q 002774 631 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE 710 (882)
Q Consensus 631 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~ 710 (882)
||+++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 98 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 172 (329)
T PTZ00263 98 EFVVGGELFTHLRKAG--RFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT 172 (329)
T ss_pred cCCCCChHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCCc
Confidence 9999999999987654 5788888899999999999999998 9999999999999999999999999998764322
Q ss_pred CceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCC
Q 002774 711 KDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIG 790 (882)
Q Consensus 711 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 790 (882)
....||+.|+|||++.+..++.++|||||||++|||++|..||...... .....+... ...
T Consensus 173 -----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-~~~~~i~~~-------------~~~ 233 (329)
T PTZ00263 173 -----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF-RIYEKILAG-------------RLK 233 (329)
T ss_pred -----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH-HHHHHHhcC-------------CcC
Confidence 2356999999999999999999999999999999999999999754322 111111111 000
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 002774 791 LSTTLKGFEKYVDLALKCVQESGDDRPT-----MSEVVKD 825 (882)
Q Consensus 791 ~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~evl~~ 825 (882)
.+.....++.+++.+||+.||.+||+ +++++++
T Consensus 234 --~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 234 --FPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred --CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 01112356789999999999999997 6888765
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=335.79 Aligned_cols=260 Identities=25% Similarity=0.457 Sum_probs=208.9
Q ss_pred cCCCCCCeeeccCcEEEEEEEe------cCCcEEEEEEcccCCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEE
Q 002774 555 NNFSDANDVGSGGYGKVYKGTL------PNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQML 628 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 628 (882)
++|...+.||+|+||+||++.. .++..+|+|.+........+.+.+|++++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 4678889999999999999974 2346799999886655555779999999999999999999999999999999
Q ss_pred EEEeecCCCcccccCCCC-----------CccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeE
Q 002774 629 IYEFVPNGSLGDSLSGKN-----------GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKV 697 (882)
Q Consensus 629 V~e~~~~gsL~~~l~~~~-----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl 697 (882)
||||+++++|.+++.... ...+++.+++.++.|++.||+|||+.+ ++||||||+||++++++.+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEe
Confidence 999999999998886432 235899999999999999999999998 999999999999999999999
Q ss_pred eecccccccCCCCCceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHhhh
Q 002774 698 ADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKK 776 (882)
Q Consensus 698 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~t-g~~P~~~~~~~~~~~~~~~~~~~ 776 (882)
+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||..... .+....+.. ..
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~-~~~~~~i~~-~~ 239 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN-NEVIECITQ-GR 239 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHHc-CC
Confidence 99999986643322222223345778999999998899999999999999999999 8888864332 111111111 10
Q ss_pred hhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 002774 777 ELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 832 (882)
Q Consensus 777 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~ 832 (882)
.+.. ....+.++.+++.+||+.+|.+|||+.|+++.|+++.+.
T Consensus 240 ---------~~~~----~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 240 ---------VLQR----PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred ---------cCCC----CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 0001 111235789999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=306.85 Aligned_cols=252 Identities=28% Similarity=0.387 Sum_probs=212.0
Q ss_pred HcCCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCCc---ccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEE
Q 002774 554 TNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM---QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLI 629 (882)
Q Consensus 554 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 629 (882)
.++|...+.||+|.||.||.|+.+ ++-.||+|++.+... .-..++.+|+++-..|+||||+++++++.+....||+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 356888999999999999999964 688999999876432 2346789999999999999999999999999999999
Q ss_pred EEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCC
Q 002774 630 YEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDS 709 (882)
Q Consensus 630 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~ 709 (882)
+||.++|.+...|+.....++++.....+..|+|.|+.|+|..+ |+||||||+|+|++.++..|++|||.+..-..
T Consensus 101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~- 176 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS- 176 (281)
T ss_pred EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecCC-
Confidence 99999999999999777778999999999999999999999988 99999999999999999999999999876542
Q ss_pred CCceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcC
Q 002774 710 EKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTI 789 (882)
Q Consensus 710 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 789 (882)
......+||..|.+||...+..++..+|+|++|++.||++.|.+||+... ..+..+.+.. . +.-+|
T Consensus 177 ---~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~-~~etYkrI~k-~-------~~~~p-- 242 (281)
T KOG0580|consen 177 ---NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS-HSETYKRIRK-V-------DLKFP-- 242 (281)
T ss_pred ---CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh-hHHHHHHHHH-c-------cccCC--
Confidence 22345789999999999999999999999999999999999999997543 1122221111 1 11111
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 002774 790 GLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIEN 828 (882)
Q Consensus 790 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~ 828 (882)
........++|.+|+..+|.+|.+..|++++-+-
T Consensus 243 -----~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI 276 (281)
T KOG0580|consen 243 -----STISGGAADLISRLLVKNPIERLALTEVMDHPWI 276 (281)
T ss_pred -----cccChhHHHHHHHHhccCccccccHHHHhhhHHH
Confidence 2233667899999999999999999999988653
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=331.17 Aligned_cols=256 Identities=30% Similarity=0.497 Sum_probs=207.1
Q ss_pred cCCCCCCeeeccCcEEEEEEEecC----CcEEEEEEcccCCcc-cHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEE
Q 002774 555 NNFSDANDVGSGGYGKVYKGTLPN----GQLIAIKRAQQGSMQ-GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLI 629 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~~~~~~----g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 629 (882)
++|...+.||+|+||+||+|++.. ...||||.++..... ...+|.+|+.++++++||||+++++++.+.+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 568889999999999999998742 458999998754332 346788999999999999999999999999999999
Q ss_pred EEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCC
Q 002774 630 YEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDS 709 (882)
Q Consensus 630 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~ 709 (882)
|||+++++|.+++..... .+++..+.+++.|++.|++|||+.+ |+||||||+||++++++.++|+|||+++.....
T Consensus 84 ~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 84 TEYMENGSLDKFLRENDG-KFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred EEcCCCCCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence 999999999999876432 6899999999999999999999988 999999999999999999999999999987532
Q ss_pred CCceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCc
Q 002774 710 EKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPT 788 (882)
Q Consensus 710 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 788 (882)
..........++..|+|||.+....++.++||||||+++|||++ |..||...... +.... ..... ..+
T Consensus 160 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~-~~~~~-~~~~~--------~~~- 228 (266)
T cd05033 160 EATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ-DVIKA-VEDGY--------RLP- 228 (266)
T ss_pred ccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH-HHHHH-HHcCC--------CCC-
Confidence 22222222345678999999998999999999999999999998 99998643321 11111 11100 001
Q ss_pred CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 002774 789 IGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENI 829 (882)
Q Consensus 789 l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 829 (882)
.....+..+.+++.+||+.+|++||++.|+++.|.++
T Consensus 229 ----~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 229 ----PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred ----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1112346789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=335.57 Aligned_cols=256 Identities=27% Similarity=0.474 Sum_probs=203.7
Q ss_pred cCCCCCCeeeccCcEEEEEEEe-----cCCcEEEEEEcccCCc-ccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEE
Q 002774 555 NNFSDANDVGSGGYGKVYKGTL-----PNGQLIAIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQML 628 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~~~~-----~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 628 (882)
.+|+..+.||+|+||+||+|++ .++..||+|.++.... ....++.+|++++++++||||+++++++..++..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 3567788999999999999984 2467899999975433 233678899999999999999999999999999999
Q ss_pred EEEeecCCCcccccCCCC---------------CccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCC
Q 002774 629 IYEFVPNGSLGDSLSGKN---------------GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERL 693 (882)
Q Consensus 629 V~e~~~~gsL~~~l~~~~---------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~ 693 (882)
||||+++++|.+++.... ...+++.+...++.|++.||+|||+.+ ++||||||+||++++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 999999999999874221 234788999999999999999999998 99999999999999999
Q ss_pred ceeEeecccccccCCCCCceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHH
Q 002774 694 NAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVM 772 (882)
Q Consensus 694 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~t-g~~P~~~~~~~~~~~~~~~ 772 (882)
.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||..... .. +....
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~-~~-~~~~~ 239 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN-QE-VIEMV 239 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH-HH-HHHHH
Confidence 999999999987654333222333446778999999988889999999999999999999 8888864322 11 11111
Q ss_pred HhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 002774 773 DKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIEN 828 (882)
Q Consensus 773 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~ 828 (882)
.... ........+.++.+++.+||+.||.+||++.++++.|..
T Consensus 240 ~~~~-------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 240 RKRQ-------------LLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HcCC-------------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 1111 000111234678899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=342.06 Aligned_cols=264 Identities=25% Similarity=0.393 Sum_probs=205.0
Q ss_pred HcCCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCCc-ccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEE
Q 002774 554 TNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYE 631 (882)
Q Consensus 554 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e 631 (882)
.++|+..+.||+|+||.||+++.. +|..||+|.+..... ...+.+.+|++++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 357888999999999999999965 688999999875432 234578999999999999999999999999999999999
Q ss_pred eecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCC
Q 002774 632 FVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEK 711 (882)
Q Consensus 632 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 711 (882)
|+++|+|.+++.... .+++..+..++.|++.||.|||+.+ .|+||||||+||+++.++.+||+|||+++......
T Consensus 84 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 158 (331)
T cd06649 84 HMDGGSLDQVLKEAK--RIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 158 (331)
T ss_pred cCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccccc-
Confidence 999999999987644 5788899999999999999999742 29999999999999999999999999998664322
Q ss_pred ceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhh-----hh--------
Q 002774 712 DHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKK-----EL-------- 778 (882)
Q Consensus 712 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~-----~~-------- 778 (882)
.....||..|+|||++.+..++.++|||||||++|||++|+.||...... + +........ ..
T Consensus 159 ---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~-~-~~~~~~~~~~~~~~~~~~~~~~~~ 233 (331)
T cd06649 159 ---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAK-E-LEAIFGRPVVDGEEGEPHSISPRP 233 (331)
T ss_pred ---cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH-H-HHHHhcccccccccCCccccCccc
Confidence 23346899999999999989999999999999999999999999643321 1 111111000 00
Q ss_pred --------------------hhhhhcc-CCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 002774 779 --------------------YNLYELI-DPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIE 827 (882)
Q Consensus 779 --------------------~~~~~~~-d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~ 827 (882)
......+ ..............++.+++.+||+.||++|||+.|++++-.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~ 303 (331)
T cd06649 234 RPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTF 303 (331)
T ss_pred ccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChH
Confidence 0000000 000000001123467899999999999999999999998743
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=330.97 Aligned_cols=255 Identities=28% Similarity=0.486 Sum_probs=207.9
Q ss_pred HcCCCCCCeeeccCcEEEEEEEecCCcEEEEEEcccCCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEee
Q 002774 554 TNNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFV 633 (882)
Q Consensus 554 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 633 (882)
.++|+..+.||+|+||.||+|...+++.||||.++.... ..+++.+|++++++++|+||+++++++...+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM-DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc-cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 456888899999999999999987788999999876443 3567899999999999999999999999999999999999
Q ss_pred cCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCce
Q 002774 634 PNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDH 713 (882)
Q Consensus 634 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 713 (882)
++++|.+++.......+++..+..++.|++.|+.|||+.+ |+||||||+||++++++.+||+|||+++........
T Consensus 84 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~- 159 (261)
T cd05068 84 KYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE- 159 (261)
T ss_pred cCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCccc-
Confidence 9999999997655557899999999999999999999988 999999999999999999999999999877532211
Q ss_pred eeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCCCC
Q 002774 714 ITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLS 792 (882)
Q Consensus 714 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 792 (882)
.......+..|+|||++....++.++||||||+++|||++ |+.||..... ....... .... . ..
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-~~~~~~~-~~~~---------~----~~ 224 (261)
T cd05068 160 AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN-AEVLQQV-DQGY---------R----MP 224 (261)
T ss_pred ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH-HHHHHHH-HcCC---------C----CC
Confidence 1111223457999999998899999999999999999999 8888864322 1111111 1100 0 01
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 002774 793 TTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIEN 828 (882)
Q Consensus 793 ~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~ 828 (882)
.....+..+.+++.+||+.+|++||++.++++.|+.
T Consensus 225 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 225 CPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred CCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 111234678999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=336.08 Aligned_cols=259 Identities=25% Similarity=0.461 Sum_probs=209.5
Q ss_pred CCCCCCeeeccCcEEEEEEEec------CCcEEEEEEcccCCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEE
Q 002774 556 NFSDANDVGSGGYGKVYKGTLP------NGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLI 629 (882)
Q Consensus 556 ~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 629 (882)
+|...+.||+|+||.||+|+.. ++..+|+|.++.......+.+.+|++++++++|+||+++++++...+..++|
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (291)
T cd05094 6 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMV 85 (291)
T ss_pred HeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEE
Confidence 4677789999999999999742 3567999998876655567899999999999999999999999999999999
Q ss_pred EEeecCCCcccccCCCC--------------CccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCce
Q 002774 630 YEFVPNGSLGDSLSGKN--------------GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNA 695 (882)
Q Consensus 630 ~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~ 695 (882)
|||+++++|.+++.... ...+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+
T Consensus 86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~~ 162 (291)
T cd05094 86 FEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLLV 162 (291)
T ss_pred EecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcE
Confidence 99999999999886432 234889999999999999999999998 9999999999999999999
Q ss_pred eEeecccccccCCCCCceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHh
Q 002774 696 KVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDK 774 (882)
Q Consensus 696 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~t-g~~P~~~~~~~~~~~~~~~~~ 774 (882)
+|+|||+++...............++..|+|||++.+..++.++|||||||++|||+| |..||...... ..... ...
T Consensus 163 ~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~-~~~~~-~~~ 240 (291)
T cd05094 163 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT-EVIEC-ITQ 240 (291)
T ss_pred EECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHH-HhC
Confidence 9999999986654332222233456788999999999999999999999999999999 99998654321 11111 111
Q ss_pred hhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 002774 775 KKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 832 (882)
Q Consensus 775 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~ 832 (882)
.. . +. .....+..+.+++.+||+.+|++||++.++++.|+++...
T Consensus 241 ~~--------~-~~----~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 241 GR--------V-LE----RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred CC--------C-CC----CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 10 0 00 1112346788999999999999999999999999998543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=335.41 Aligned_cols=255 Identities=24% Similarity=0.474 Sum_probs=205.5
Q ss_pred cCCCCCCeeeccCcEEEEEEEecC------CcEEEEEEcccCCcc-cHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceE
Q 002774 555 NNFSDANDVGSGGYGKVYKGTLPN------GQLIAIKRAQQGSMQ-GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQM 627 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~~~~~~------g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 627 (882)
++|...+.||+|+||.||+|+..+ ++.||||.++..... ..+.+.+|+++++.++|+||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 457778899999999999998633 478999999765443 3468999999999999999999999999999999
Q ss_pred EEEEeecCCCcccccCCCC------------CccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCce
Q 002774 628 LIYEFVPNGSLGDSLSGKN------------GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNA 695 (882)
Q Consensus 628 lV~e~~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~ 695 (882)
+||||+++++|.+++...+ ...+++.++..++.|++.|++|||+.+ ++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeE
Confidence 9999999999999886532 235788999999999999999999998 9999999999999999999
Q ss_pred eEeecccccccCCCCCceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHh
Q 002774 696 KVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDK 774 (882)
Q Consensus 696 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~t-g~~P~~~~~~~~~~~~~~~~~ 774 (882)
||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||...... +...... .
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~-~~~~~~~-~ 239 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE-EVIECIT-Q 239 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH-HHHHHHH-c
Confidence 9999999986543322222223346788999999999999999999999999999999 99998644321 1111111 1
Q ss_pred hhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 002774 775 KKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIE 827 (882)
Q Consensus 775 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~ 827 (882)
.. . + ......+..+.+++.+||+.||++||++.|+++.|+
T Consensus 240 ~~--------~-~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 240 GR--------L-L----QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred CC--------c-C----CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 00 0 0 011123467899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=357.07 Aligned_cols=251 Identities=22% Similarity=0.284 Sum_probs=203.9
Q ss_pred CCCCCeeeccCcEEEEEEEec-C-CcEEEEEEcccCCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEeec
Q 002774 557 FSDANDVGSGGYGKVYKGTLP-N-GQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVP 634 (882)
Q Consensus 557 ~~~~~~lG~G~fg~Vy~~~~~-~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 634 (882)
|...+.||+|+||.||+|... + ++.||+|.+..........+.+|+.+++.++|||||++++++..++..++||||++
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~ 148 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS 148 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence 778899999999999999753 3 67889998765544445667889999999999999999999999999999999999
Q ss_pred CCCcccccCCC--CCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCc
Q 002774 635 NGSLGDSLSGK--NGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKD 712 (882)
Q Consensus 635 ~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 712 (882)
+|+|.++++.. ...++++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+......
T Consensus 149 gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 225 (478)
T PTZ00267 149 GGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL 225 (478)
T ss_pred CCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCcccc
Confidence 99999877542 2346889999999999999999999988 999999999999999999999999999876543332
Q ss_pred eeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCCCC
Q 002774 713 HITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLS 792 (882)
Q Consensus 713 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 792 (882)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+........ ..++
T Consensus 226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~-~~~~~~~~~~---------~~~~----- 290 (478)
T PTZ00267 226 DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ-REIMQQVLYG---------KYDP----- 290 (478)
T ss_pred ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhC---------CCCC-----
Confidence 233456799999999999999999999999999999999999999965332 2222221111 0111
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 793 TTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 793 ~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
.+.....++.+++.+||+.||++||++.+++.+
T Consensus 291 ~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 291 FPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred CCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 111233678999999999999999999999753
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=335.76 Aligned_cols=264 Identities=21% Similarity=0.271 Sum_probs=201.7
Q ss_pred cCCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCCc--ccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEE
Q 002774 555 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM--QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYE 631 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e 631 (882)
++|...+.||+|+||+||+|+.. +++.||||+++.... ...+.+.+|+++++.++||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 36888899999999999999975 688999999875422 234567889999999999999999999999999999999
Q ss_pred eecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCC
Q 002774 632 FVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEK 711 (882)
Q Consensus 632 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 711 (882)
|++++.+..+.... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 155 (287)
T cd07848 81 YVEKNMLELLEEMP--NGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN 155 (287)
T ss_pred cCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCccccccccc
Confidence 99988776554332 35888899999999999999999988 99999999999999999999999999987643322
Q ss_pred ceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhh-----hh------h
Q 002774 712 DHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKE-----LY------N 780 (882)
Q Consensus 712 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~-----~~------~ 780 (882)
.......|++.|+|||++.+..++.++|||||||++|||++|+.||.......... ........ .. .
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07848 156 -ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLF-TIQKVLGPLPAEQMKLFYSNPR 233 (287)
T ss_pred -ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHH-HHHHhhCCCCHHHHHhhhccch
Confidence 12234568999999999998899999999999999999999999997543322211 11100000 00 0
Q ss_pred hhhccCCcCCCCC------CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 781 LYELIDPTIGLST------TLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 781 ~~~~~d~~l~~~~------~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
......+...... .......+.+++.+||+.||++|||++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000000000000 01123568999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=326.26 Aligned_cols=258 Identities=27% Similarity=0.388 Sum_probs=198.9
Q ss_pred CCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCc-----eEEE
Q 002774 556 NFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGE-----QMLI 629 (882)
Q Consensus 556 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~-----~~lV 629 (882)
.|...+++|.|+||.||+|+.. +++.||||+...... --.+|+.+|+.++|||||+++-++....+ ..+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 4566789999999999999964 579999999875433 22469999999999999999999876432 3589
Q ss_pred EEeecCCCcccccCC--CCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCC-CceeEeeccccccc
Q 002774 630 YEFVPNGSLGDSLSG--KNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDER-LNAKVADFGLSKSM 706 (882)
Q Consensus 630 ~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~-~~~kl~DfGla~~~ 706 (882)
|||||. +|.+.++. ..+.+++...+.-++.|+.+||+|||+.+ |+||||||.|+|+|.+ |.+||||||.|+.+
T Consensus 101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 999986 88887763 12346777788889999999999999988 9999999999999976 99999999999998
Q ss_pred CCCCCceeeeeeeccCCCCCHHHHhh-CCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhh-----hhhh
Q 002774 707 SDSEKDHITTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKK-----ELYN 780 (882)
Q Consensus 707 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~-----~~~~ 780 (882)
..++.. .....|..|+|||.+.+ ..|+.+.||||.|||+.||+-|++-| .|++..+++..+++-.. ++..
T Consensus 177 ~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plF-pG~s~~dQL~eIik~lG~Pt~e~I~~ 252 (364)
T KOG0658|consen 177 VKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLF-PGDSSVDQLVEIIKVLGTPTREDIKS 252 (364)
T ss_pred ccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCccc-CCCCHHHHHHHHHHHhCCCCHHHHhh
Confidence 776653 34567899999999986 47999999999999999999988655 45666665555443111 1000
Q ss_pred h----hhccCCcCCCC-----CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 781 L----YELIDPTIGLS-----TTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 781 ~----~~~~d~~l~~~-----~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
+ .+.-.|.+... .......+..+++.++++.+|.+|.++.|++.+
T Consensus 253 mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 253 MNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred cCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 0 01111222111 122334788999999999999999999999865
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=334.36 Aligned_cols=263 Identities=22% Similarity=0.330 Sum_probs=200.2
Q ss_pred cCCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCCc-ccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEe
Q 002774 555 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEF 632 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 632 (882)
++|...++||+|+||+||+|+.. +++.||+|+++.... .....+.+|++++++++||||+++++++.+++..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 46888899999999999999864 689999999875432 2335678899999999999999999999999999999999
Q ss_pred ecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCc
Q 002774 633 VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKD 712 (882)
Q Consensus 633 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 712 (882)
++ |+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.......
T Consensus 85 ~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~- 158 (288)
T cd07871 85 LD-SDLKQYLDNCG-NLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK- 158 (288)
T ss_pred CC-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCCc-
Confidence 97 58888876443 35788899999999999999999998 99999999999999999999999999976543221
Q ss_pred eeeeeeeccCCCCCHHHHhh-CCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhh----h-------hhh
Q 002774 713 HITTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKK----E-------LYN 780 (882)
Q Consensus 713 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~----~-------~~~ 780 (882)
......+++.|+|||.+.+ ..++.++||||+||++|||+||+.||..... .+.+........ . ...
T Consensus 159 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07871 159 -TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTV-KEELHLIFRLLGTPTEETWPGITSNEE 236 (288)
T ss_pred -cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCChHHhhccccchh
Confidence 1233468999999999875 5689999999999999999999999964432 222222211100 0 000
Q ss_pred hhhccCCcCCCCC----CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 781 LYELIDPTIGLST----TLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 781 ~~~~~d~~l~~~~----~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
......+...... ......++.+++.+|++.||.+|||++|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 237 FRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred hhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0011111110000 01123567899999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=335.69 Aligned_cols=265 Identities=24% Similarity=0.347 Sum_probs=201.8
Q ss_pred HcCCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCCc-ccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEE
Q 002774 554 TNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYE 631 (882)
Q Consensus 554 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e 631 (882)
.++|...+.||+|+||+||+|+.. +++.||||+++.... .....+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 367889999999999999999965 689999999875432 223467789999999999999999999999999999999
Q ss_pred eecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCC
Q 002774 632 FVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEK 711 (882)
Q Consensus 632 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 711 (882)
|++ ++|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++......
T Consensus 84 ~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~- 157 (303)
T cd07869 84 YVH-TDLCQYMDKHP-GGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS- 157 (303)
T ss_pred CCC-cCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC-
Confidence 995 67777775432 35788889999999999999999998 9999999999999999999999999997543322
Q ss_pred ceeeeeeeccCCCCCHHHHhh-CCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhh-----hhhhh--h
Q 002774 712 DHITTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKE-----LYNLY--E 783 (882)
Q Consensus 712 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~-----~~~~~--~ 783 (882)
.......||+.|+|||.+.+ ..++.++||||+||++|||++|..||.......+........... ..... .
T Consensus 158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T cd07869 158 -HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLP 236 (303)
T ss_pred -ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcc
Confidence 12233568999999999875 458899999999999999999999998655544433332221100 00000 0
Q ss_pred ccCCc-CCC--CCC-------HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 784 LIDPT-IGL--STT-------LKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 784 ~~d~~-l~~--~~~-------~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
..++. ... ... ......+.+++.+|++.||.+|||++|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h 288 (303)
T cd07869 237 HFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH 288 (303)
T ss_pred ccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence 00000 000 000 0012467899999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=344.81 Aligned_cols=252 Identities=24% Similarity=0.356 Sum_probs=204.2
Q ss_pred CCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCC---cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEE
Q 002774 556 NFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS---MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYE 631 (882)
Q Consensus 556 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e 631 (882)
+|...+.||+|+||.||+|+.. +++.||||+++... ....+.+.+|++++..++||||+++++++.+++..++|||
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 81 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAME 81 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEe
Confidence 6888899999999999999975 58999999987542 2234568889999999999999999999999999999999
Q ss_pred eecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCC
Q 002774 632 FVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEK 711 (882)
Q Consensus 632 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 711 (882)
|+++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 82 ~~~g~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--- 153 (333)
T cd05600 82 YVPGGDFRTLLNNLG--VLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--- 153 (333)
T ss_pred CCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc---
Confidence 999999999997543 5788899999999999999999998 99999999999999999999999999986543
Q ss_pred ceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCCC
Q 002774 712 DHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGL 791 (882)
Q Consensus 712 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 791 (882)
......||+.|+|||++.+..++.++|||||||++|||++|..||..... .+....+..... .+......
T Consensus 154 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~-~~~~~~i~~~~~-------~~~~~~~~ 223 (333)
T cd05600 154 --YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP-NETWENLKYWKE-------TLQRPVYD 223 (333)
T ss_pred --ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCH-HHHHHHHHhccc-------cccCCCCC
Confidence 12345699999999999999999999999999999999999999965332 222221111110 00000000
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 792 STTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 792 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
........++.+++.+||+.+|++||+++|++++
T Consensus 224 ~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 224 DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred ccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 0011234678899999999999999999999976
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=355.67 Aligned_cols=259 Identities=26% Similarity=0.384 Sum_probs=212.8
Q ss_pred CCCCCCeeeccCcEEEEEEEecCC-cEEEEEEcccCCcccHHHHHHHHHHHHhcc-CCCeeeEEEE-EEe------CCce
Q 002774 556 NFSDANDVGSGGYGKVYKGTLPNG-QLIAIKRAQQGSMQGGQEFKMEIELLSRVH-HKNLVSLLGF-CFD------RGEQ 626 (882)
Q Consensus 556 ~~~~~~~lG~G~fg~Vy~~~~~~g-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~-~~~------~~~~ 626 (882)
+.++.++|.+|||+.||.|+...+ ..||+|++-..+....+...+|+++|++|+ |+|||.+++. ... .-+.
T Consensus 38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Ev 117 (738)
T KOG1989|consen 38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEV 117 (738)
T ss_pred EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEE
Confidence 456778999999999999997655 999999998777777788999999999997 9999999993 221 1367
Q ss_pred EEEEEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeeccccccc
Q 002774 627 MLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSM 706 (882)
Q Consensus 627 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~ 706 (882)
+|.||||.+|.|-|++..+....|++.++++|+.|+++|+++||... +||||||||-+||||+.++..||||||.|+-.
T Consensus 118 llLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFGSatt~ 196 (738)
T KOG1989|consen 118 LLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFGSATTK 196 (738)
T ss_pred EeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCcccccccc
Confidence 89999999999999998665556999999999999999999999875 88999999999999999999999999998643
Q ss_pred CCCCCcee-e------eeeeccCCCCCHHHHh---hCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhh
Q 002774 707 SDSEKDHI-T------TQVKGTMGYLDPEYYM---TQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKK 776 (882)
Q Consensus 707 ~~~~~~~~-~------~~~~gt~~y~aPE~~~---~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~ 776 (882)
........ . -....|+-|+|||++. +...++|+|||||||+||-|+....||+....+
T Consensus 197 ~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l------------ 264 (738)
T KOG1989|consen 197 ILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL------------ 264 (738)
T ss_pred cCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce------------
Confidence 32211000 0 0134789999999986 567899999999999999999999999865322
Q ss_pred hhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHc
Q 002774 777 ELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQA 833 (882)
Q Consensus 777 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~ 833 (882)
.+++..............|.+||..||++||++||++.+|+..+.++....
T Consensus 265 ------aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~ 315 (738)
T KOG1989|consen 265 ------AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP 315 (738)
T ss_pred ------eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence 233333333334567789999999999999999999999999998886554
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=337.58 Aligned_cols=260 Identities=26% Similarity=0.464 Sum_probs=207.8
Q ss_pred HHcCCCCCCeeeccCcEEEEEEEec------CCcEEEEEEcccCCc-ccHHHHHHHHHHHHhc-cCCCeeeEEEEEEeCC
Q 002774 553 YTNNFSDANDVGSGGYGKVYKGTLP------NGQLIAIKRAQQGSM-QGGQEFKMEIELLSRV-HHKNLVSLLGFCFDRG 624 (882)
Q Consensus 553 ~~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~ 624 (882)
..++|+..+.||+|+||.||+|... +...||+|++..... ....++.+|+++++++ +|+||+++++++..++
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 3456788899999999999999864 236899999875432 2335688999999999 7999999999999999
Q ss_pred ceEEEEEeecCCCcccccCCC--------------CCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEc
Q 002774 625 EQMLIYEFVPNGSLGDSLSGK--------------NGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLD 690 (882)
Q Consensus 625 ~~~lV~e~~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~ 690 (882)
..++||||+++|+|.++++.. ....+++..+++++.|++.||+|||+.+ |+||||||+||+++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~ 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVT 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEc
Confidence 999999999999999988542 2346899999999999999999999988 99999999999999
Q ss_pred CCCceeEeecccccccCCCCCceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHh-CCCCCCCCchHHHHHH
Q 002774 691 ERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIR 769 (882)
Q Consensus 691 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~t-g~~P~~~~~~~~~~~~ 769 (882)
+++.+||+|||+++.+.............++..|+|||++.+..++.++|||||||++|||++ |..||..... .+...
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-~~~~~ 245 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV-EELFK 245 (293)
T ss_pred CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCH-HHHHH
Confidence 999999999999987654332222223345678999999998999999999999999999998 8888864332 11111
Q ss_pred HHHHhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 002774 770 TVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENIL 830 (882)
Q Consensus 770 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~ 830 (882)
...... ...........+.+++.+||+.+|++|||+.|+++.|++++
T Consensus 246 -~~~~~~-------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 246 -LLKEGY-------------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred -HHHcCC-------------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 111110 00111223467889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=334.79 Aligned_cols=263 Identities=23% Similarity=0.328 Sum_probs=198.2
Q ss_pred cCCCCCCeeeccCcEEEEEEEec--CCcEEEEEEcccCCcc--cHHHHHHHHHHHHhc---cCCCeeeEEEEEEe-----
Q 002774 555 NNFSDANDVGSGGYGKVYKGTLP--NGQLIAIKRAQQGSMQ--GGQEFKMEIELLSRV---HHKNLVSLLGFCFD----- 622 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~~~~~--~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~H~niv~l~~~~~~----- 622 (882)
++|...+.||+|+||+||+|+.. +++.||||+++..... ....+.+|+++++.+ +||||++++++|..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36888899999999999999862 4688999998753322 234566788877766 69999999999853
Q ss_pred CCceEEEEEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeeccc
Q 002774 623 RGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGL 702 (882)
Q Consensus 623 ~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGl 702 (882)
....++||||++ ++|.+++.......+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccccc
Confidence 346899999996 68988887655556899999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhh--hh
Q 002774 703 SKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKEL--YN 780 (882)
Q Consensus 703 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~--~~ 780 (882)
++...... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||...... +.+..+....... ..
T Consensus 157 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~-~~~~~i~~~~~~~~~~~ 232 (290)
T cd07862 157 ARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-DQLGKILDVIGLPGEED 232 (290)
T ss_pred eEeccCCc---ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHH-HHHHHHHHHhCCCChhh
Confidence 98764331 223456899999999999889999999999999999999999999755432 2222222211000 00
Q ss_pred hh-------hccCCcCCC---CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 781 LY-------ELIDPTIGL---STTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 781 ~~-------~~~d~~l~~---~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
.. ....+.... .........+.+++.+||+.||++|||+.|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 233 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred chhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 00 000000000 0001123567899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=330.65 Aligned_cols=258 Identities=27% Similarity=0.425 Sum_probs=203.1
Q ss_pred cCCCCCCeeeccCcEEEEEEEec-CCc----EEEEEEcccCCcc-cHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEE
Q 002774 555 NNFSDANDVGSGGYGKVYKGTLP-NGQ----LIAIKRAQQGSMQ-GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQML 628 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~----~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 628 (882)
++|...+.||+|+||+||+|++. +++ .||+|.+...... ...++..|+.++++++||||+++++++. ....++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 35677889999999999999864 344 4788887643222 2356778888999999999999999875 455789
Q ss_pred EEEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCC
Q 002774 629 IYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSD 708 (882)
Q Consensus 629 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~ 708 (882)
|+||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++....
T Consensus 86 i~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHR-DSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYP 161 (279)
T ss_pred EEEeCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence 999999999999997543 36899999999999999999999988 99999999999999999999999999987654
Q ss_pred CCCceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCC
Q 002774 709 SEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDP 787 (882)
Q Consensus 709 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 787 (882)
...........++..|+|||.+.++.++.++|||||||++|||++ |..||..... ........... ....+
T Consensus 162 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~--~~~~~~~~~~~------~~~~~ 233 (279)
T cd05111 162 DDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP--HEVPDLLEKGE------RLAQP 233 (279)
T ss_pred CCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHHCCC------cCCCC
Confidence 433223334557789999999998899999999999999999998 9989864321 11222222111 00011
Q ss_pred cCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 002774 788 TIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 832 (882)
Q Consensus 788 ~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~ 832 (882)
. .+...+.+++.+||..+|.+|||+.|+++.|..+.+.
T Consensus 234 ~-------~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~ 271 (279)
T cd05111 234 Q-------ICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD 271 (279)
T ss_pred C-------CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence 1 1235678899999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=336.97 Aligned_cols=251 Identities=23% Similarity=0.381 Sum_probs=213.1
Q ss_pred cCCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCCccc--HHHHHHHHHHHHhccCCCeeeEEEEEEeCCc-eEEEE
Q 002774 555 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQG--GQEFKMEIELLSRVHHKNLVSLLGFCFDRGE-QMLIY 630 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~-~~lV~ 630 (882)
++|...+++|+|+||.++.++.+ +++.|++|.+......+ .+...+|+.++++++|||||.+.+.|.+++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 46778899999999999998854 67899999987654332 3457789999999999999999999999998 89999
Q ss_pred EeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCC
Q 002774 631 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE 710 (882)
Q Consensus 631 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~ 710 (882)
+|++||++.+.+...++..+++.++..++.|++.|+.|||+.. |+|||||+.|||++.+..+||+|||+|+.+.+..
T Consensus 84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~ 160 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED 160 (426)
T ss_pred eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence 9999999999998887788999999999999999999999888 9999999999999999999999999999987654
Q ss_pred CceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCC
Q 002774 711 KDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIG 790 (882)
Q Consensus 711 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 790 (882)
.......||+.||.||.+.+..|..|+||||+||++|||++-+++|..... ...+..+.... ++
T Consensus 161 --~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m-~~Li~ki~~~~---------~~---- 224 (426)
T KOG0589|consen 161 --SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNM-SELILKINRGL---------YS---- 224 (426)
T ss_pred --hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccch-HHHHHHHhhcc---------CC----
Confidence 234457899999999999999999999999999999999999999965432 22222222211 11
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 791 LSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 791 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
..+.....++..++..|++.+|+.||++.+++.+
T Consensus 225 -Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 225 -PLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred -CCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 1223345788999999999999999999999976
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=343.75 Aligned_cols=245 Identities=24% Similarity=0.308 Sum_probs=200.9
Q ss_pred cCCCCCCeeeccCcEEEEEEEecC--CcEEEEEEcccCC---cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEE
Q 002774 555 NNFSDANDVGSGGYGKVYKGTLPN--GQLIAIKRAQQGS---MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLI 629 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~~~~~~--g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 629 (882)
++|...+.||+|+||.||+|++.. +..||+|++.... ....+.+.+|+++++.++||||+++++++.+++..++|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 468888999999999999998643 3689999986432 22335688899999999999999999999999999999
Q ss_pred EEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCC
Q 002774 630 YEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDS 709 (882)
Q Consensus 630 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~ 709 (882)
|||+++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 110 ~Ey~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~ 184 (340)
T PTZ00426 110 LEFVIGGEFFTFLRRNK--RFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR 184 (340)
T ss_pred EeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecCCC
Confidence 99999999999997654 5888999999999999999999998 999999999999999999999999999876432
Q ss_pred CCceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcC
Q 002774 710 EKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTI 789 (882)
Q Consensus 710 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 789 (882)
.....||+.|||||++.+..++.++|||||||++|||++|..||....... ....+.... ..+.
T Consensus 185 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~-~~~~i~~~~-------~~~p--- 248 (340)
T PTZ00426 185 -----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLL-IYQKILEGI-------IYFP--- 248 (340)
T ss_pred -----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHH-HHHHHhcCC-------CCCC---
Confidence 123569999999999998889999999999999999999999997543321 111111110 0011
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 002774 790 GLSTTLKGFEKYVDLALKCVQESGDDRP-----TMSEVVKD 825 (882)
Q Consensus 790 ~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~evl~~ 825 (882)
......+.+++.+|++.||++|+ ++++++++
T Consensus 249 -----~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 249 -----KFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred -----CCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 11225678999999999999995 89998875
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=335.39 Aligned_cols=258 Identities=24% Similarity=0.402 Sum_probs=206.4
Q ss_pred cCCCCCCeeeccCcEEEEEEEec------CCcEEEEEEcccCCc-ccHHHHHHHHHHHHhc-cCCCeeeEEEEEEeCCce
Q 002774 555 NNFSDANDVGSGGYGKVYKGTLP------NGQLIAIKRAQQGSM-QGGQEFKMEIELLSRV-HHKNLVSLLGFCFDRGEQ 626 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~ 626 (882)
++|...+.||+|+||.||+|... ++..||||+++.... ...+.+.+|+++++++ +||||+++++++...+..
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 114 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI 114 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence 46888999999999999999741 355899999876432 2345788999999999 799999999999999999
Q ss_pred EEEEEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeeccccccc
Q 002774 627 MLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSM 706 (882)
Q Consensus 627 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~ 706 (882)
++||||+++|+|.++++......+++.++..++.|++.||+|||+.+ |+|+||||+||+++.++.++++|||+++..
T Consensus 115 ~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~ 191 (302)
T cd05055 115 LVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARDI 191 (302)
T ss_pred EEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcccccc
Confidence 99999999999999997654445899999999999999999999988 999999999999999999999999999866
Q ss_pred CCCCCceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHhhhhhhhhhhcc
Q 002774 707 SDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELI 785 (882)
Q Consensus 707 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 785 (882)
.............++..|+|||.+.+..++.++|||||||++|||++ |..||...... ..........
T Consensus 192 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~-~~~~~~~~~~---------- 260 (302)
T cd05055 192 MNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD-SKFYKLIKEG---------- 260 (302)
T ss_pred cCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch-HHHHHHHHcC----------
Confidence 44322112222346778999999999999999999999999999998 89998643321 1111111110
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 002774 786 DPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENI 829 (882)
Q Consensus 786 d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 829 (882)
...........++.+++.+||+.+|++||++.|+++.|.++
T Consensus 261 ---~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 261 ---YRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred ---CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 00001112236789999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=332.27 Aligned_cols=267 Identities=27% Similarity=0.410 Sum_probs=203.8
Q ss_pred CCCCeeeccCcEEEEEEEe-----cCCcEEEEEEcccCCc-ccHHHHHHHHHHHHhccCCCeeeEEEEEEeC--CceEEE
Q 002774 558 SDANDVGSGGYGKVYKGTL-----PNGQLIAIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLVSLLGFCFDR--GEQMLI 629 (882)
Q Consensus 558 ~~~~~lG~G~fg~Vy~~~~-----~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lV 629 (882)
...+.||+|+||+||++.+ .+++.||+|.++.... .....+.+|++++++++||||+++++++... ...++|
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 7788999999999988753 3578999999876432 2346788999999999999999999998764 357899
Q ss_pred EEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCC
Q 002774 630 YEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDS 709 (882)
Q Consensus 630 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~ 709 (882)
|||+++|+|.+++... .+++.++..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++.....
T Consensus 87 ~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 160 (283)
T cd05080 87 MEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 160 (283)
T ss_pred ecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccCCc
Confidence 9999999999998654 4899999999999999999999998 999999999999999999999999999876543
Q ss_pred CCce-eeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCc
Q 002774 710 EKDH-ITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPT 788 (882)
Q Consensus 710 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 788 (882)
.... ......++..|+|||.+....++.++||||||+++|||+||..|+........................+.++..
T Consensus 161 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (283)
T cd05080 161 HEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERG 240 (283)
T ss_pred chhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcC
Confidence 2211 112233566799999999889999999999999999999999998643321111110000000000111111211
Q ss_pred CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 002774 789 IGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENIL 830 (882)
Q Consensus 789 l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~ 830 (882)
.........+.++.+++.+||+.+|++|||++++++.|+++.
T Consensus 241 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 241 MRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred CCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 111122234578999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=331.17 Aligned_cols=259 Identities=27% Similarity=0.455 Sum_probs=204.9
Q ss_pred CCCCCCeeeccCcEEEEEEEec------CCcEEEEEEcccCCc-ccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEE
Q 002774 556 NFSDANDVGSGGYGKVYKGTLP------NGQLIAIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQML 628 (882)
Q Consensus 556 ~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 628 (882)
+|...+.||+|+||+||+|+.. ....+|+|.+..... .....+.+|+.+++.++||||+++++++..++..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4677889999999999999852 235789998875433 234578899999999999999999999999999999
Q ss_pred EEEeecCCCcccccCCC----------------------CCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCc
Q 002774 629 IYEFVPNGSLGDSLSGK----------------------NGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSN 686 (882)
Q Consensus 629 V~e~~~~gsL~~~l~~~----------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~N 686 (882)
|+||+++|+|.+++... ....+++..++.++.|++.||+|||+.+ ++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 99999999999886532 1235789999999999999999999988 9999999999
Q ss_pred eEEcCCCceeEeecccccccCCCCCceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHh-CCCCCCCCchHH
Q 002774 687 ILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIV 765 (882)
Q Consensus 687 Ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~t-g~~P~~~~~~~~ 765 (882)
|++++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||.... ..
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~-~~ 236 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA-PE 236 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC-HH
Confidence 9999999999999999986543322111222345678999999998899999999999999999999 888885432 11
Q ss_pred HHHHHHHHhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 002774 766 REIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 832 (882)
Q Consensus 766 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~ 832 (882)
.. ....... ............+.+++.+||+.+|++||+++|+++.|++++.+
T Consensus 237 ~~-~~~~~~~-------------~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~ 289 (290)
T cd05045 237 RL-FNLLKTG-------------YRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK 289 (290)
T ss_pred HH-HHHHhCC-------------CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence 11 1111110 00111122346788999999999999999999999999998643
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=327.01 Aligned_cols=251 Identities=29% Similarity=0.485 Sum_probs=203.2
Q ss_pred CCCCCCeeeccCcEEEEEEEecCCcEEEEEEcccCCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEeecC
Q 002774 556 NFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPN 635 (882)
Q Consensus 556 ~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~ 635 (882)
+|...+.||+|+||+||+|++.++..||||.++.... ..+++.+|+.++++++||||+++++++.+.+..++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05113 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSN 83 (256)
T ss_pred HeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc-cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCC
Confidence 5677889999999999999987777899999875433 346789999999999999999999999998899999999999
Q ss_pred CCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCceee
Q 002774 636 GSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHIT 715 (882)
Q Consensus 636 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 715 (882)
|+|.+++..... .+++.+++.++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||.++....... ...
T Consensus 84 ~~l~~~i~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-~~~ 158 (256)
T cd05113 84 GCLLNYLREHGK-RFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-TSS 158 (256)
T ss_pred CcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCce-eec
Confidence 999999875433 6899999999999999999999998 99999999999999999999999999986644321 111
Q ss_pred eeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCCCCCC
Q 002774 716 TQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTT 794 (882)
Q Consensus 716 ~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 794 (882)
....++..|+|||.+....++.++|||||||++|||++ |..||...... ......... . .+. ..
T Consensus 159 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~-~~~~~~~~~-~---------~~~----~~ 223 (256)
T cd05113 159 VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS-ETVEKVSQG-L---------RLY----RP 223 (256)
T ss_pred CCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH-HHHHHHhcC-C---------CCC----CC
Confidence 22345678999999998889999999999999999999 99998643321 111111111 0 000 01
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 002774 795 LKGFEKYVDLALKCVQESGDDRPTMSEVVKDIE 827 (882)
Q Consensus 795 ~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~ 827 (882)
......+.+++.+||+.+|.+||++.++++.++
T Consensus 224 ~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 224 HLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 112367899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=345.58 Aligned_cols=259 Identities=24% Similarity=0.425 Sum_probs=204.0
Q ss_pred cCCCCCCeeeccCcEEEEEEEec------CCcEEEEEEcccCCccc-HHHHHHHHHHHHhcc-CCCeeeEEEEEEeCCce
Q 002774 555 NNFSDANDVGSGGYGKVYKGTLP------NGQLIAIKRAQQGSMQG-GQEFKMEIELLSRVH-HKNLVSLLGFCFDRGEQ 626 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~ 626 (882)
++|...+.||+|+||.||+|++. .++.||||+++...... .+.+.+|++++.++. |||||+++++|...+..
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~ 116 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPI 116 (401)
T ss_pred HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCc
Confidence 35677889999999999999853 34689999998643322 346889999999997 99999999999999999
Q ss_pred EEEEEeecCCCcccccCCCC------------------------------------------------------------
Q 002774 627 MLIYEFVPNGSLGDSLSGKN------------------------------------------------------------ 646 (882)
Q Consensus 627 ~lV~e~~~~gsL~~~l~~~~------------------------------------------------------------ 646 (882)
++||||+++|+|.++++...
T Consensus 117 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (401)
T cd05107 117 YIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMK 196 (401)
T ss_pred EEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcch
Confidence 99999999999998885421
Q ss_pred ------------------------------------CccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEc
Q 002774 647 ------------------------------------GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLD 690 (882)
Q Consensus 647 ------------------------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~ 690 (882)
...+++.+...++.|++.||+|||+.+ |+||||||+|||++
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiLl~ 273 (401)
T cd05107 197 GTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVLIC 273 (401)
T ss_pred hhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEEEe
Confidence 123677888999999999999999988 99999999999999
Q ss_pred CCCceeEeecccccccCCCCCceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHh-CCCCCCCCchHHHHHH
Q 002774 691 ERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIR 769 (882)
Q Consensus 691 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~t-g~~P~~~~~~~~~~~~ 769 (882)
+++.+||+|||+++...............++..|||||.+....++.++|||||||++|||++ |+.||....... ...
T Consensus 274 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~-~~~ 352 (401)
T cd05107 274 EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE-QFY 352 (401)
T ss_pred CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH-HHH
Confidence 999999999999986543221111222356788999999998889999999999999999998 888986433211 111
Q ss_pred HHHHhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 002774 770 TVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENIL 830 (882)
Q Consensus 770 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~ 830 (882)
...... .....+.....++.+++.+||+.+|.+||+++|+++.|++++
T Consensus 353 ~~~~~~-------------~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 353 NAIKRG-------------YRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred HHHHcC-------------CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 111111 000111123467899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=340.92 Aligned_cols=244 Identities=31% Similarity=0.473 Sum_probs=203.8
Q ss_pred CCCCCeeeccCcEEEEEEEe-cCCcEEEEEEcccC---CcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEe
Q 002774 557 FSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQG---SMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEF 632 (882)
Q Consensus 557 ~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 632 (882)
|...+.||.|+||.||-|+. .+.++||||++.-. +...+.++..|+.+|++++|||+|.+.|||..+...||||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 44556799999999999984 57899999998743 334567889999999999999999999999999999999999
Q ss_pred ecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCc
Q 002774 633 VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKD 712 (882)
Q Consensus 633 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 712 (882)
| -|+-.|++.-.+ +++.+..+..|..+++.||+|||+++ .||||||+.|||+++.|.||++|||.|....+.
T Consensus 108 C-lGSAsDlleVhk-KplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA--- 179 (948)
T KOG0577|consen 108 C-LGSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAPA--- 179 (948)
T ss_pred H-hccHHHHHHHHh-ccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCch---
Confidence 9 567777775442 47888899999999999999999999 999999999999999999999999999877553
Q ss_pred eeeeeeeccCCCCCHHHHh---hCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcC
Q 002774 713 HITTQVKGTMGYLDPEYYM---TQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTI 789 (882)
Q Consensus 713 ~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 789 (882)
..++|||.|||||++. .+.|+-|+||||+|++..|+...++|+..... ...++-+...-.|.+
T Consensus 180 ---nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA-----------MSALYHIAQNesPtL 245 (948)
T KOG0577|consen 180 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-----------MSALYHIAQNESPTL 245 (948)
T ss_pred ---hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH-----------HHHHHHHHhcCCCCC
Confidence 3478999999999996 68899999999999999999999999865322 112222334444555
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 790 GLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 790 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
. ..+....|..++..|+++-|.+|||.++++++
T Consensus 246 q---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 246 Q---SNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred C---CchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 4 33455778999999999999999999998853
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=339.37 Aligned_cols=240 Identities=25% Similarity=0.312 Sum_probs=195.0
Q ss_pred eeccCcEEEEEEEec-CCcEEEEEEcccCC---cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEeecCCCc
Q 002774 563 VGSGGYGKVYKGTLP-NGQLIAIKRAQQGS---MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSL 638 (882)
Q Consensus 563 lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 638 (882)
||+|+||+||+|+.. +++.||+|+++... ......+.+|++++++++||||+++++++.+.+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999865 58899999987532 22335678899999999999999999999999999999999999999
Q ss_pred ccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCceeeeee
Q 002774 639 GDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQV 718 (882)
Q Consensus 639 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 718 (882)
.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++...... ......
T Consensus 81 ~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~~ 153 (312)
T cd05585 81 FHHLQREG--RFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNTF 153 (312)
T ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Cccccc
Confidence 99987643 5889999999999999999999998 9999999999999999999999999998643222 123345
Q ss_pred eccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCCCCCCHHHH
Q 002774 719 KGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGF 798 (882)
Q Consensus 719 ~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 798 (882)
.||+.|+|||++.+..++.++|||||||++|||++|+.||..... ........... .. .+....
T Consensus 154 ~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~-~~~~~~~~~~~-----------~~----~~~~~~ 217 (312)
T cd05585 154 CGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV-NEMYRKILQEP-----------LR----FPDGFD 217 (312)
T ss_pred cCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH-HHHHHHHHcCC-----------CC----CCCcCC
Confidence 799999999999999999999999999999999999999975432 22222211110 01 111223
Q ss_pred HHHHHHHHHhhccCCCCCCC---HHHHHHH
Q 002774 799 EKYVDLALKCVQESGDDRPT---MSEVVKD 825 (882)
Q Consensus 799 ~~l~~li~~cl~~dp~~RPs---~~evl~~ 825 (882)
.++.+++.+||+.||.+||+ +.|++.+
T Consensus 218 ~~~~~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 218 RDAKDLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred HHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 67889999999999999975 6777654
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=335.46 Aligned_cols=262 Identities=25% Similarity=0.445 Sum_probs=207.7
Q ss_pred cCCCCCCeeeccCcEEEEEEEec--------CCcEEEEEEcccCC-cccHHHHHHHHHHHHhc-cCCCeeeEEEEEEeCC
Q 002774 555 NNFSDANDVGSGGYGKVYKGTLP--------NGQLIAIKRAQQGS-MQGGQEFKMEIELLSRV-HHKNLVSLLGFCFDRG 624 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~~~~~--------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~ 624 (882)
++|...+.||+|+||.||+|+.. ++..||+|.++... .....++.+|+++++.+ +||||+++++++...+
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 56888999999999999999752 23579999998643 22345688899999999 7999999999999999
Q ss_pred ceEEEEEeecCCCcccccCCCC--------------CccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEc
Q 002774 625 EQMLIYEFVPNGSLGDSLSGKN--------------GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLD 690 (882)
Q Consensus 625 ~~~lV~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~ 690 (882)
..++||||+++|+|.+++.... ...+++.++.+++.|++.||+|||+.+ ++||||||+||+++
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~ 174 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVT 174 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEEc
Confidence 9999999999999999986532 125889999999999999999999988 99999999999999
Q ss_pred CCCceeEeecccccccCCCCCceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHh-CCCCCCCCchHHHHHH
Q 002774 691 ERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIR 769 (882)
Q Consensus 691 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~t-g~~P~~~~~~~~~~~~ 769 (882)
+++.+||+|||.++...............+++.|+|||.+.+..++.++|||||||++|||++ |..||... ...+ ..
T Consensus 175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~-~~~~-~~ 252 (307)
T cd05098 175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-PVEE-LF 252 (307)
T ss_pred CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcC-CHHH-HH
Confidence 999999999999986643222111222234578999999998899999999999999999998 77887532 2222 11
Q ss_pred HHHHhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHcC
Q 002774 770 TVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQAG 834 (882)
Q Consensus 770 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~~ 834 (882)
....... ..........++.+++.+||+.+|++||++.++++.|+++++...
T Consensus 253 ~~~~~~~-------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~~ 304 (307)
T cd05098 253 KLLKEGH-------------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALTS 304 (307)
T ss_pred HHHHcCC-------------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHhh
Confidence 1111110 011112234678899999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=341.12 Aligned_cols=242 Identities=23% Similarity=0.280 Sum_probs=196.5
Q ss_pred CeeeccCcEEEEEEEe-cCCcEEEEEEcccCCc---ccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEeecCC
Q 002774 561 NDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSM---QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNG 636 (882)
Q Consensus 561 ~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 636 (882)
+.||+|+||.||+++. .+|+.||+|+++.... .....+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 4699999999999986 4689999999875322 22345778999999999999999999999999999999999999
Q ss_pred CcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCceeee
Q 002774 637 SLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITT 716 (882)
Q Consensus 637 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 716 (882)
+|..++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....... ...
T Consensus 81 ~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~~ 153 (323)
T cd05595 81 ELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMK 153 (323)
T ss_pred cHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCCC--ccc
Confidence 9988886543 6889999999999999999999998 99999999999999999999999999875432221 123
Q ss_pred eeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCCCCCCHH
Q 002774 717 QVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLK 796 (882)
Q Consensus 717 ~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 796 (882)
...||+.|+|||++.+..++.++|||||||++|||++|+.||...... ......... +... +..
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~-~~~~~~~~~-----------~~~~----p~~ 217 (323)
T cd05595 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-RLFELILME-----------EIRF----PRT 217 (323)
T ss_pred cccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH-HHHHHHhcC-----------CCCC----CCC
Confidence 356999999999999999999999999999999999999999654322 111111110 0011 112
Q ss_pred HHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 002774 797 GFEKYVDLALKCVQESGDDRP-----TMSEVVKD 825 (882)
Q Consensus 797 ~~~~l~~li~~cl~~dp~~RP-----s~~evl~~ 825 (882)
...++.+++.+||+.||++|| ++.+++++
T Consensus 218 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 218 LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred CCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 236788999999999999998 89998875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=341.27 Aligned_cols=263 Identities=21% Similarity=0.327 Sum_probs=197.1
Q ss_pred CCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccC--CcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCC-----ceE
Q 002774 556 NFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQG--SMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRG-----EQM 627 (882)
Q Consensus 556 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----~~~ 627 (882)
+|...+.||+|+||.||+|+.. +|+.||||+++.. .......+.+|++++++++||||+++++++.... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4677889999999999999854 6899999998743 2233456889999999999999999999886432 479
Q ss_pred EEEEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccC
Q 002774 628 LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMS 707 (882)
Q Consensus 628 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~ 707 (882)
+||||++ ++|.+++.... .+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 81 lv~e~~~-~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~ 154 (338)
T cd07859 81 VVFELME-SDLHQVIKAND--DLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAF 154 (338)
T ss_pred EEEecCC-CCHHHHHHhcc--cCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCccccccc
Confidence 9999995 68888886543 5889999999999999999999998 9999999999999999999999999998653
Q ss_pred CCCCc-eeeeeeeccCCCCCHHHHhh--CCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhh--------
Q 002774 708 DSEKD-HITTQVKGTMGYLDPEYYMT--QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKK-------- 776 (882)
Q Consensus 708 ~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~-------- 776 (882)
..... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... ...........
T Consensus 155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~ 233 (338)
T cd07859 155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV-HQLDLITDLLGTPSPETIS 233 (338)
T ss_pred cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChH-HHHHHHHHHhCCCCHHHHH
Confidence 32211 12234568999999999875 67899999999999999999999999654321 11111100000
Q ss_pred -----hhhhhhhccCCcCCCC---CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 777 -----ELYNLYELIDPTIGLS---TTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 777 -----~~~~~~~~~d~~l~~~---~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
........+.+..... ........+.+++.+||+.||++|||++|++++
T Consensus 234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0000000011000000 001123567899999999999999999999976
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=340.84 Aligned_cols=242 Identities=23% Similarity=0.277 Sum_probs=197.2
Q ss_pred CeeeccCcEEEEEEEe-cCCcEEEEEEcccCC---cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEeecCC
Q 002774 561 NDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGS---MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNG 636 (882)
Q Consensus 561 ~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 636 (882)
+.||+|+||.||+++. .+|+.||||+++... ......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999985 468999999997542 223356788999999999999999999999999999999999999
Q ss_pred CcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCceeee
Q 002774 637 SLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITT 716 (882)
Q Consensus 637 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 716 (882)
+|.+++.... .+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 ~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~~ 153 (328)
T cd05593 81 ELFFHLSRER--VFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--ATMK 153 (328)
T ss_pred CHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCcc--cccc
Confidence 9988886543 6889999999999999999999998 9999999999999999999999999987543221 1223
Q ss_pred eeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCCCCCCHH
Q 002774 717 QVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLK 796 (882)
Q Consensus 717 ~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 796 (882)
...||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+... +... +..
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~-~~~~~~~~~-----------~~~~----p~~ 217 (328)
T cd05593 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-KLFELILME-----------DIKF----PRT 217 (328)
T ss_pred cccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH-HHHHHhccC-----------CccC----CCC
Confidence 456999999999999999999999999999999999999999654321 111111100 0111 112
Q ss_pred HHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 002774 797 GFEKYVDLALKCVQESGDDRP-----TMSEVVKD 825 (882)
Q Consensus 797 ~~~~l~~li~~cl~~dp~~RP-----s~~evl~~ 825 (882)
...++.+++.+||+.||++|| ++.|++++
T Consensus 218 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 218 LSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 236788999999999999997 89999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=330.72 Aligned_cols=257 Identities=23% Similarity=0.388 Sum_probs=203.1
Q ss_pred HHcCCCCCCeeeccCcEEEEEEEec------CCcEEEEEEcccCC-cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCc
Q 002774 553 YTNNFSDANDVGSGGYGKVYKGTLP------NGQLIAIKRAQQGS-MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGE 625 (882)
Q Consensus 553 ~~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 625 (882)
.+++|+..+.||+|+||+||+|.+. ++..||||++.... .....++.+|+.+++.++||||+++++++.++..
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4567889999999999999999753 35689999986533 2334568899999999999999999999999999
Q ss_pred eEEEEEeecCCCcccccCCCC--------CccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeE
Q 002774 626 QMLIYEFVPNGSLGDSLSGKN--------GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKV 697 (882)
Q Consensus 626 ~~lV~e~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl 697 (882)
.++||||+++|+|.+++.... ...+++.++..++.|++.||+|||+.+ ++||||||+||++++++.++|
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 999999999999999886422 124678899999999999999999988 999999999999999999999
Q ss_pred eecccccccCCCCCceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHhhh
Q 002774 698 ADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKK 776 (882)
Q Consensus 698 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~t-g~~P~~~~~~~~~~~~~~~~~~~ 776 (882)
+|||+++...............+++.|||||++.++.++.++|||||||++|||++ |..||.... .............
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~-~~~~~~~~~~~~~ 239 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMS-NEQVLRFVMEGGL 239 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC-HHHHHHHHHcCCc
Confidence 99999986544332111122345778999999998899999999999999999999 677875432 2222221111100
Q ss_pred hhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 002774 777 ELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIE 827 (882)
Q Consensus 777 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~ 827 (882)
+. .....+..+.+++.+||+.+|++|||+.|+++.|+
T Consensus 240 ----------~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 240 ----------LD----KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred ----------CC----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 00 01123467899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=308.14 Aligned_cols=262 Identities=26% Similarity=0.383 Sum_probs=211.5
Q ss_pred cCCCCCCeeeccCcEEEEEEE-ecCCcEEEEEEcccCCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeC-----CceEE
Q 002774 555 NNFSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDR-----GEQML 628 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~~~l 628 (882)
++|.+.+.||+|||+-||.++ ..+++.+|+|++.-...++.+...+|++..++++||||+++++++..+ .+.||
T Consensus 21 ~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yl 100 (302)
T KOG2345|consen 21 KRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYL 100 (302)
T ss_pred ceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEE
Confidence 467888999999999999998 567899999999877767778889999999999999999999887543 34899
Q ss_pred EEEeecCCCcccccCCCC--CccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeeccccccc
Q 002774 629 IYEFVPNGSLGDSLSGKN--GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSM 706 (882)
Q Consensus 629 V~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~ 706 (882)
+++|...|+|.+.+.... +..+++.+.+.|+.++++||++||+.. ++++||||||.|||+.+.+.+++.|||.++..
T Consensus 101 l~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a 179 (302)
T KOG2345|consen 101 LLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSATQA 179 (302)
T ss_pred EeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCcccc
Confidence 999999999999886543 446899999999999999999999986 68999999999999999999999999998865
Q ss_pred CCCCCce-------eeeeeeccCCCCCHHHHh---hCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhh
Q 002774 707 SDSEKDH-------ITTQVKGTMGYLDPEYYM---TQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKK 776 (882)
Q Consensus 707 ~~~~~~~-------~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~ 776 (882)
.-.-.+. .......|..|+|||.+. +...++++|||||||+||+|+.|..||+.. .+.+.
T Consensus 180 ~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~----------~~~Gg 249 (302)
T KOG2345|consen 180 PIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERI----------YQQGG 249 (302)
T ss_pred ceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHH----------hhcCC
Confidence 3211000 011235788999999986 456789999999999999999999999621 11111
Q ss_pred hhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 002774 777 ELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENI 829 (882)
Q Consensus 777 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 829 (882)
.+ ...+..+.+.........+.+.+++++|++.||.+||++.+++..+..+
T Consensus 250 Sl--aLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 250 SL--ALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred eE--EEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 00 1223333444333444668899999999999999999999999988765
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=325.73 Aligned_cols=250 Identities=27% Similarity=0.460 Sum_probs=201.9
Q ss_pred CCCCCCeeeccCcEEEEEEEecCCcEEEEEEcccCCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEeecC
Q 002774 556 NFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPN 635 (882)
Q Consensus 556 ~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~ 635 (882)
+|+..+.||+|+||.||+|.+.++..+|+|.+..... ...++.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 4677889999999999999987778899999875433 335788999999999999999999999999999999999999
Q ss_pred CCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCceee
Q 002774 636 GSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHIT 715 (882)
Q Consensus 636 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 715 (882)
++|.+++..... .+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++...+... ...
T Consensus 84 ~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~-~~~ 158 (256)
T cd05059 84 GCLLNYLRERKG-KLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY-TSS 158 (256)
T ss_pred CCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccc-ccc
Confidence 999999875432 6899999999999999999999998 99999999999999999999999999986643221 111
Q ss_pred eeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCCCCCC
Q 002774 716 TQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTT 794 (882)
Q Consensus 716 ~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 794 (882)
....++..|+|||.+.+..++.++||||||+++|||++ |..||...... +..... .. ..... ..
T Consensus 159 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-~~~~~~-~~---------~~~~~----~~ 223 (256)
T cd05059 159 QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS-EVVESV-SA---------GYRLY----RP 223 (256)
T ss_pred CCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH-HHHHHH-Hc---------CCcCC----CC
Confidence 12234567999999998999999999999999999999 78888643321 111111 11 01111 11
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 002774 795 LKGFEKYVDLALKCVQESGDDRPTMSEVVKDI 826 (882)
Q Consensus 795 ~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L 826 (882)
...+.++.+++.+||+.+|++|||+.|+++.|
T Consensus 224 ~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 224 KLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 12346789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=329.83 Aligned_cols=261 Identities=22% Similarity=0.378 Sum_probs=209.0
Q ss_pred HcCCCCCCeeeccCcEEEEEEEecC-----CcEEEEEEcccCCc-ccHHHHHHHHHHHHhccCCCeeeEEEEEEe-CCce
Q 002774 554 TNNFSDANDVGSGGYGKVYKGTLPN-----GQLIAIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLVSLLGFCFD-RGEQ 626 (882)
Q Consensus 554 ~~~~~~~~~lG~G~fg~Vy~~~~~~-----g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~~ 626 (882)
.++|...+.||+|+||.||+|...+ +..||+|+++.... ...+.+.+|+.++++++|+||+++++++.. +...
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4577888999999999999999765 68899999875432 234668899999999999999999998876 4678
Q ss_pred EEEEEeecCCCcccccCCCCC------ccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeec
Q 002774 627 MLIYEFVPNGSLGDSLSGKNG------IRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADF 700 (882)
Q Consensus 627 ~lV~e~~~~gsL~~~l~~~~~------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~Df 700 (882)
++++||+++|+|.+++..... ..+++.++..++.|++.||+|||+.+ ++||||||+||++++++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECCC
Confidence 999999999999998865321 46899999999999999999999988 999999999999999999999999
Q ss_pred ccccccCCCCCceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHhhhhhh
Q 002774 701 GLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELY 779 (882)
Q Consensus 701 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~ 779 (882)
|+++.+.............++..|+|||++....++.++|||||||++||+++ |+.||..... .+.. .......
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-~~~~-~~~~~~~--- 236 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP-FEMA-AYLKDGY--- 236 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH-HHHH-HHHHcCC---
Confidence 99987654432222223346778999999998899999999999999999999 9999865322 1211 1111110
Q ss_pred hhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 002774 780 NLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 832 (882)
Q Consensus 780 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~ 832 (882)
........+..+.+++.+||+.||++|||+.|+++.|+++.++
T Consensus 237 ----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 237 ----------RLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred ----------CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 0011112346789999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=336.83 Aligned_cols=261 Identities=25% Similarity=0.411 Sum_probs=202.3
Q ss_pred HcCCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCCc-ccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEE
Q 002774 554 TNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYE 631 (882)
Q Consensus 554 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e 631 (882)
.++|+..+.||+|+||+||+|+.. ++..+|+|+++.... .....+.+|++++++++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 367889999999999999999965 688999998875422 233568899999999999999999999999999999999
Q ss_pred eecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhc-CCCCeeecCCCCCceEEcCCCceeEeecccccccCCCC
Q 002774 632 FVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHEL-ANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE 710 (882)
Q Consensus 632 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~ 710 (882)
|+++|+|.+++.... .+++.....++.+++.||+|||+. + |+||||||+||++++++.+||+|||++..+....
T Consensus 84 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~ 158 (333)
T cd06650 84 HMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 158 (333)
T ss_pred cCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc
Confidence 999999999987543 578888999999999999999974 5 9999999999999999999999999997653321
Q ss_pred CceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhh------------
Q 002774 711 KDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKEL------------ 778 (882)
Q Consensus 711 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~------------ 778 (882)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||...... ............
T Consensus 159 ----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 232 (333)
T cd06650 159 ----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAK--ELELMFGCPVEGDPAESETSPRPR 232 (333)
T ss_pred ----cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchh--HHHHHhcCcccCCccccccCcccC
Confidence 22346899999999999888999999999999999999999999643321 111110000000
Q ss_pred -------------------hhhhhc-cCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 779 -------------------YNLYEL-IDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 779 -------------------~~~~~~-~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
...... ...............++.+++.+||+.||++|||+.|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h 299 (333)
T cd06650 233 PPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH 299 (333)
T ss_pred CccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence 000000 00000000000123568899999999999999999999875
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=325.20 Aligned_cols=255 Identities=29% Similarity=0.476 Sum_probs=205.5
Q ss_pred cCCCCCCeeeccCcEEEEEEEecCCcEEEEEEcccCCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEeec
Q 002774 555 NNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVP 634 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 634 (882)
++|...++||+|+||+||+|+..++..||+|+++.... ..+.+.+|+++++.++||||+++++++. .+..++||||++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS 83 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCC
Confidence 45788899999999999999987777899999986433 3467899999999999999999999874 456799999999
Q ss_pred CCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCcee
Q 002774 635 NGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHI 714 (882)
Q Consensus 635 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 714 (882)
+|+|.+++.......+++..+..++.|+++||+|||+.+ ++||||||+||++++++.+||+|||.++.+...... .
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~-~ 159 (262)
T cd05071 84 KGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-A 159 (262)
T ss_pred CCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccccccc-c
Confidence 999999997654456899999999999999999999988 999999999999999999999999999876543321 1
Q ss_pred eeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCCCCC
Q 002774 715 TTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLST 793 (882)
Q Consensus 715 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 793 (882)
.....++..|+|||+.....++.++|||||||++|||+| |..||...... +..... ... .. ...
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~-~~~~~~-~~~---------~~----~~~ 224 (262)
T cd05071 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-EVLDQV-ERG---------YR----MPC 224 (262)
T ss_pred ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH-HHHHHH-hcC---------CC----CCC
Confidence 122346778999999998899999999999999999999 77787643221 111111 000 00 011
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 002774 794 TLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENIL 830 (882)
Q Consensus 794 ~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~ 830 (882)
....+..+.+++.+||+.+|++||+++++++.|+..+
T Consensus 225 ~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 225 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred ccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 1234467899999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=347.26 Aligned_cols=253 Identities=23% Similarity=0.354 Sum_probs=198.1
Q ss_pred CCCCCCeeeccCcEEEEEEEe-cCCcEEEEEEcccCCc---ccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEE
Q 002774 556 NFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSM---QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYE 631 (882)
Q Consensus 556 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e 631 (882)
.|...+.||+|+||+||+|+. .+++.||||++..... ...+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 577889999999999999985 4688999999975432 223568899999999999999999999999999999999
Q ss_pred eecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCC
Q 002774 632 FVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEK 711 (882)
Q Consensus 632 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 711 (882)
|+++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 82 ~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~ 156 (381)
T cd05626 82 YIPGGDMMSLLIRME--VFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN 156 (381)
T ss_pred cCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence 999999999987544 5788888999999999999999998 99999999999999999999999999864321000
Q ss_pred ---------------------------------------------ceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHH
Q 002774 712 ---------------------------------------------DHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGV 746 (882)
Q Consensus 712 ---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gv 746 (882)
........||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~ 236 (381)
T cd05626 157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV 236 (381)
T ss_pred cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence 00012346999999999999889999999999999
Q ss_pred HHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHH--hhccCCCCCCCHHHHHH
Q 002774 747 LMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALK--CVQESGDDRPTMSEVVK 824 (882)
Q Consensus 747 ll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~--cl~~dp~~RPs~~evl~ 824 (882)
++|||++|..||......... ........ ............++.+++.+ |+..++..||+++|+++
T Consensus 237 il~elltG~~Pf~~~~~~~~~-~~i~~~~~-----------~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~ 304 (381)
T cd05626 237 ILFEMLVGQPPFLAPTPTETQ-LKVINWEN-----------TLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKA 304 (381)
T ss_pred HHHHHHhCCCCCcCCCHHHHH-HHHHcccc-----------ccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhc
Confidence 999999999999754432211 11111000 00011111223567788888 45566667999999997
Q ss_pred H
Q 002774 825 D 825 (882)
Q Consensus 825 ~ 825 (882)
+
T Consensus 305 h 305 (381)
T cd05626 305 H 305 (381)
T ss_pred C
Confidence 6
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=333.88 Aligned_cols=262 Identities=25% Similarity=0.452 Sum_probs=208.2
Q ss_pred HcCCCCCCeeeccCcEEEEEEEec--------CCcEEEEEEcccCC-cccHHHHHHHHHHHHhc-cCCCeeeEEEEEEeC
Q 002774 554 TNNFSDANDVGSGGYGKVYKGTLP--------NGQLIAIKRAQQGS-MQGGQEFKMEIELLSRV-HHKNLVSLLGFCFDR 623 (882)
Q Consensus 554 ~~~~~~~~~lG~G~fg~Vy~~~~~--------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~ 623 (882)
.++|...+.||+|+||.||+|+.. ++..||+|.++... ....+++.+|+.+++.+ +||||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 346778899999999999999741 34579999987543 23346788999999999 899999999999999
Q ss_pred CceEEEEEeecCCCcccccCCCC--------------CccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEE
Q 002774 624 GEQMLIYEFVPNGSLGDSLSGKN--------------GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILL 689 (882)
Q Consensus 624 ~~~~lV~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll 689 (882)
+..++||||+++|+|.+++.... ...+++.++..++.|+++||+|||+.+ ++||||||+||++
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEE
Confidence 99999999999999999886532 235788899999999999999999998 9999999999999
Q ss_pred cCCCceeEeecccccccCCCCCceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHh-CCCCCCCCchHHHHH
Q 002774 690 DERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREI 768 (882)
Q Consensus 690 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~t-g~~P~~~~~~~~~~~ 768 (882)
++++.+||+|||+++...............+++.|+|||++.+..++.++||||||+++|||++ |..||... ...+..
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~-~~~~~~ 249 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVEELF 249 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC-CHHHHH
Confidence 9999999999999987654332222223346678999999998899999999999999999998 77777532 222222
Q ss_pred HHHHHhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHc
Q 002774 769 RTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQA 833 (882)
Q Consensus 769 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~ 833 (882)
... .... ........+..+.+++.+||+.+|++||++.|+++.|+++..-.
T Consensus 250 ~~~-~~~~-------------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~ 300 (304)
T cd05101 250 KLL-KEGH-------------RMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLT 300 (304)
T ss_pred HHH-HcCC-------------cCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhh
Confidence 211 1110 00111233467889999999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=326.53 Aligned_cols=254 Identities=25% Similarity=0.389 Sum_probs=197.5
Q ss_pred CCCCeeeccCcEEEEEEEecC-Cc--EEEEEEcccCC--cccHHHHHHHHHHHHhccCCCeeeEEEEEEeC------Cce
Q 002774 558 SDANDVGSGGYGKVYKGTLPN-GQ--LIAIKRAQQGS--MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDR------GEQ 626 (882)
Q Consensus 558 ~~~~~lG~G~fg~Vy~~~~~~-g~--~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~~~ 626 (882)
...+.||+|+||.||+|++.+ +. .||+|.++... ....+.+.+|+++++.++|+||+++++++... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 456789999999999999754 33 68999887542 23346788999999999999999999987542 246
Q ss_pred EEEEEeecCCCcccccCC----CCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeeccc
Q 002774 627 MLIYEFVPNGSLGDSLSG----KNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGL 702 (882)
Q Consensus 627 ~lV~e~~~~gsL~~~l~~----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGl 702 (882)
++||||+++|+|.+++.. .....+++.....++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCCc
Confidence 899999999999887632 12335889999999999999999999988 99999999999999999999999999
Q ss_pred ccccCCCCCceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHhhhhhhhh
Q 002774 703 SKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNL 781 (882)
Q Consensus 703 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 781 (882)
++.+.............+++.|+|||++....++.++|||||||++|||++ |+.||..... ..... .......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-~~~~~-~~~~~~~---- 232 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN-SEIYD-YLRQGNR---- 232 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH-HHHHH-HHHcCCC----
Confidence 987654332111222346778999999999999999999999999999999 7888854322 11111 1111110
Q ss_pred hhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 002774 782 YELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENI 829 (882)
Q Consensus 782 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 829 (882)
. .........+.+++.+||+.||++|||+.++++.|+++
T Consensus 233 -------~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 233 -------L--KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred -------C--CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0 01112346789999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=317.87 Aligned_cols=264 Identities=23% Similarity=0.320 Sum_probs=202.3
Q ss_pred cCCCCCCeeeccCcEEEEEEEe-cCCcEEEEEEcccCCcc--cHHHHHHHHHHHHhccCCC-eeeEEEEEEeCC------
Q 002774 555 NNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQ--GGQEFKMEIELLSRVHHKN-LVSLLGFCFDRG------ 624 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~n-iv~l~~~~~~~~------ 624 (882)
..|...++||+|+||+||+|+. .+|+.||+|+++-.... ......+|+.+++.++|+| ||++.+++....
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 3455567799999999999984 57899999998765432 2245678999999999999 999999998877
Q ss_pred ceEEEEEeecCCCcccccCCCCC--ccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeeccc
Q 002774 625 EQMLIYEFVPNGSLGDSLSGKNG--IRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGL 702 (882)
Q Consensus 625 ~~~lV~e~~~~gsL~~~l~~~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGl 702 (882)
..++|+||++ -+|..++..... ..++...+..++.|+++||+|||+++ |+||||||.||||+++|.+||+|||+
T Consensus 91 ~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccch
Confidence 7889999995 588888876542 35677889999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCceeeeeeeccCCCCCHHHHhhC-CCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhh-----
Q 002774 703 SKSMSDSEKDHITTQVKGTMGYLDPEYYMTQ-QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKK----- 776 (882)
Q Consensus 703 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~----- 776 (882)
|+...-+.. ..+..++|.+|+|||++.+. .|+...||||+|||+.||++++.-| .+....++...+.....
T Consensus 167 Ara~~ip~~--~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LF-pG~se~~ql~~If~~lGtP~e~ 243 (323)
T KOG0594|consen 167 ARAFSIPMR--TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLF-PGDSEIDQLFRIFRLLGTPNEK 243 (323)
T ss_pred HHHhcCCcc--cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCC-CCCcHHHHHHHHHHHcCCCCcc
Confidence 997653332 24556789999999999976 7999999999999999999976555 44444555554443211
Q ss_pred hhhhhhhccCC--cCCCCC-C-------HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 777 ELYNLYELIDP--TIGLST-T-------LKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 777 ~~~~~~~~~d~--~l~~~~-~-------~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
.+.......+- ...... . .....+..+++.+|++.+|.+|.|++.++++
T Consensus 244 ~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 244 DWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 11111100010 000000 0 0111467899999999999999999999976
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=330.21 Aligned_cols=268 Identities=27% Similarity=0.450 Sum_probs=203.5
Q ss_pred cCCCCCCeeeccCcEEEEEEEec-----CCcEEEEEEcccCCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeC--CceE
Q 002774 555 NNFSDANDVGSGGYGKVYKGTLP-----NGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDR--GEQM 627 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~~~~~-----~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~ 627 (882)
.+|...+.||+|+||+||+|.+. +++.||+|+++.......+.+.+|++++++++||||+++++++... ...+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 46778899999999999999752 5789999999866555567889999999999999999999987543 4678
Q ss_pred EEEEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccC
Q 002774 628 LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMS 707 (882)
Q Consensus 628 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~ 707 (882)
+||||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++...
T Consensus 84 lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVLP 159 (284)
T ss_pred EEEEecCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCccccccc
Confidence 9999999999999986542 35899999999999999999999998 9999999999999999999999999998765
Q ss_pred CCCCcee-eeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhh----hhhhhh
Q 002774 708 DSEKDHI-TTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKK----ELYNLY 782 (882)
Q Consensus 708 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~----~~~~~~ 782 (882)
....... .....++..|+|||++.+..++.++|||||||++|||++|..|+...... .. ....... ....+.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~--~~-~~~~~~~~~~~~~~~~~ 236 (284)
T cd05081 160 QDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE--FM-RMMGNDKQGQMIVYHLI 236 (284)
T ss_pred CCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh--hh-hhcccccccccchHHHH
Confidence 4332111 11122345699999999889999999999999999999988775432111 00 0000000 000011
Q ss_pred hccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 002774 783 ELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENI 829 (882)
Q Consensus 783 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 829 (882)
+.+............+.++.+++.+||+.+|++|||+.|+++.|+.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 237 ELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 11111111111222346789999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=343.47 Aligned_cols=258 Identities=21% Similarity=0.252 Sum_probs=198.3
Q ss_pred cCCCCCCeeeccCcEEEEEEEe-cCCcEEEEEEcccCCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEee
Q 002774 555 NNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFV 633 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 633 (882)
.+|...+.||+|+||.||+|.. .+++.||+|.... +.+.+|++++++++|||||++++++......++|+|++
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~ 165 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY 165 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence 5689999999999999999985 4689999997542 35678999999999999999999999999999999999
Q ss_pred cCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCce
Q 002774 634 PNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDH 713 (882)
Q Consensus 634 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 713 (882)
. ++|.+++.... .+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+|+....... .
T Consensus 166 ~-~~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~-~ 238 (391)
T PHA03212 166 K-TDLYCYLAAKR--NIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA-N 238 (391)
T ss_pred C-CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccccccc-c
Confidence 5 78888776543 5889999999999999999999998 99999999999999999999999999975433221 1
Q ss_pred eeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCch------HHHHHHHHHHhhh-----------
Q 002774 714 ITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKY------IVREIRTVMDKKK----------- 776 (882)
Q Consensus 714 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~------~~~~~~~~~~~~~----------- 776 (882)
......||+.|+|||++.+..++.++|||||||++|||++|+.|+..... ....+..+.....
T Consensus 239 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~ 318 (391)
T PHA03212 239 KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQ 318 (391)
T ss_pred ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchh
Confidence 22345799999999999999999999999999999999999988753221 1111111111000
Q ss_pred -hhhhhh----h--ccCCcCCC--CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 777 -ELYNLY----E--LIDPTIGL--STTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 777 -~~~~~~----~--~~d~~l~~--~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
.....+ . ...+.... ......+.++.+++.+||+.||.+|||++|++++
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 319 ANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 000000 0 00010000 0011234578899999999999999999999975
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=322.62 Aligned_cols=248 Identities=24% Similarity=0.387 Sum_probs=210.5
Q ss_pred CCCCCCeeeccCcEEEEEEEe-cCCcEEEEEEcccCCcccHHH---HHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEE
Q 002774 556 NFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQGGQE---FKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYE 631 (882)
Q Consensus 556 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~---~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e 631 (882)
+|...+.||+|.||.|-+|.. ..|+.||||.+++....+.++ +.+|++||..|+||||+.++.+|...+...||||
T Consensus 54 RyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivME 133 (668)
T KOG0611|consen 54 RYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVME 133 (668)
T ss_pred HHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEE
Confidence 456667899999999999984 679999999999876666554 6789999999999999999999999999999999
Q ss_pred eecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCC
Q 002774 632 FVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEK 711 (882)
Q Consensus 632 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 711 (882)
|..+|.|++|+..++ .+++.....++.||..|+.|+|.++ ++|||||.+|||+|+++++||+|||++-.+.+..
T Consensus 134 YaS~GeLYDYiSer~--~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~~k- 207 (668)
T KOG0611|consen 134 YASGGELYDYISERG--SLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYADKK- 207 (668)
T ss_pred ecCCccHHHHHHHhc--cccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhcccc-
Confidence 999999999998766 6999999999999999999999988 9999999999999999999999999998876543
Q ss_pred ceeeeeeeccCCCCCHHHHhhCCCC-chhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCC
Q 002774 712 DHITTQVKGTMGYLDPEYYMTQQLT-EKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIG 790 (882)
Q Consensus 712 ~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 790 (882)
..+.++|++-|.+||.+.+..|. +.+|-||+||+||-|+.|..||++. +....++++-... ...|.
T Consensus 208 --fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~-Dhk~lvrQIs~Ga--------YrEP~-- 274 (668)
T KOG0611|consen 208 --FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGR-DHKRLVRQISRGA--------YREPE-- 274 (668)
T ss_pred --HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCc-hHHHHHHHhhccc--------ccCCC--
Confidence 35568999999999999998885 6899999999999999999999643 3333333322211 11121
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 002774 791 LSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIEN 828 (882)
Q Consensus 791 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~ 828 (882)
.+....-||++|+..+|++|.|..+|..++|-
T Consensus 275 ------~PSdA~gLIRwmLmVNP~RRATieDiAsHWWv 306 (668)
T KOG0611|consen 275 ------TPSDASGLIRWMLMVNPERRATIEDIASHWWV 306 (668)
T ss_pred ------CCchHHHHHHHHHhcCcccchhHHHHhhhhee
Confidence 12455689999999999999999999998763
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=324.06 Aligned_cols=253 Identities=28% Similarity=0.478 Sum_probs=204.2
Q ss_pred cCCCCCCeeeccCcEEEEEEEecCCcEEEEEEcccCCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEeec
Q 002774 555 NNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVP 634 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 634 (882)
++|+..++||+|+||.||+|...++..||+|.++.... ..+.+.+|+.++++++|+|++++++++. ....++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS 83 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence 46778899999999999999988888999999876443 3467999999999999999999999875 456899999999
Q ss_pred CCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCcee
Q 002774 635 NGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHI 714 (882)
Q Consensus 635 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 714 (882)
+++|.++++......+++.++..++.+++.||+|||+.+ ++||||||+||++++++.++|+|||++..+...... .
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~-~ 159 (260)
T cd05070 84 KGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT-A 159 (260)
T ss_pred CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcccc-c
Confidence 999999997655556899999999999999999999998 999999999999999999999999999876443211 1
Q ss_pred eeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCCCCC
Q 002774 715 TTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLST 793 (882)
Q Consensus 715 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 793 (882)
.....++..|+|||++....++.++||||||+++|||++ |..||..... .+..... ... ..+ ..
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~-~~~~~~~-~~~---------~~~----~~ 224 (260)
T cd05070 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN-REVLEQV-ERG---------YRM----PC 224 (260)
T ss_pred ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH-HHHHHHH-HcC---------CCC----CC
Confidence 122335678999999988899999999999999999999 8888864322 1211111 110 000 11
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 002774 794 TLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIEN 828 (882)
Q Consensus 794 ~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~ 828 (882)
....+..+.+++.+||+.+|++|||+.++.+.|+.
T Consensus 225 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 225 PQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 12234678999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=326.65 Aligned_cols=255 Identities=27% Similarity=0.419 Sum_probs=201.2
Q ss_pred CCCCCeeeccCcEEEEEEEec-C---CcEEEEEEcccCCc--ccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCc-----
Q 002774 557 FSDANDVGSGGYGKVYKGTLP-N---GQLIAIKRAQQGSM--QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGE----- 625 (882)
Q Consensus 557 ~~~~~~lG~G~fg~Vy~~~~~-~---g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~----- 625 (882)
|...+.||+|+||.||+|... + +..||||+++.... .....+.+|+++++.++||||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 456788999999999999864 2 36899999875432 233578899999999999999999999876554
Q ss_pred -eEEEEEeecCCCcccccCCC----CCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeec
Q 002774 626 -QMLIYEFVPNGSLGDSLSGK----NGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADF 700 (882)
Q Consensus 626 -~~lV~e~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~Df 700 (882)
.++|+||+++|+|..++... ....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 79999999999998887432 2346899999999999999999999988 999999999999999999999999
Q ss_pred ccccccCCCCCceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHhhhhhh
Q 002774 701 GLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELY 779 (882)
Q Consensus 701 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~ 779 (882)
|+++...............++..|+|||++....++.++|||||||++|||++ |..||...... +..... ....
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~-~~~~~~-~~~~--- 232 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH-EIYDYL-RHGN--- 232 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHH-HcCC---
Confidence 99987654332222222345678999999988899999999999999999999 88888643321 111111 1110
Q ss_pred hhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 002774 780 NLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENI 829 (882)
Q Consensus 780 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 829 (882)
.+. .......++.+++.+||+.||++||++.|+++.|+++
T Consensus 233 ------~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 233 ------RLK----QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred ------CCC----CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 011 1122346789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=329.86 Aligned_cols=255 Identities=24% Similarity=0.454 Sum_probs=204.5
Q ss_pred cCCCCCCeeeccCcEEEEEEEec------CCcEEEEEEcccCCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEE
Q 002774 555 NNFSDANDVGSGGYGKVYKGTLP------NGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQML 628 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 628 (882)
.+|+..++||+|+||+||+|... ++..+|+|.++.......+.+.+|+++++.++|+||+++++++.+.+..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 35677889999999999999642 366899999887665556789999999999999999999999999999999
Q ss_pred EEEeecCCCcccccCCCCC-------------ccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCce
Q 002774 629 IYEFVPNGSLGDSLSGKNG-------------IRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNA 695 (882)
Q Consensus 629 V~e~~~~gsL~~~l~~~~~-------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~ 695 (882)
||||+++|+|.+++..... ..+++.+++.++.|++.|++|||+.+ ++||||||+||++++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence 9999999999998865321 35789999999999999999999988 9999999999999999999
Q ss_pred eEeecccccccCCCCCceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHh
Q 002774 696 KVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDK 774 (882)
Q Consensus 696 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~t-g~~P~~~~~~~~~~~~~~~~~ 774 (882)
||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||...... +........
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-~~~~~~~~~ 240 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT-EAIECITQG 240 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH-HHHHHHHcC
Confidence 9999999986543322222223345788999999999999999999999999999998 88888643321 111111110
Q ss_pred hhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 002774 775 KKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIE 827 (882)
Q Consensus 775 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~ 827 (882)
. .+ ......+..+.+++.+||+.||.+||++.||++.|+
T Consensus 241 -~---------~~----~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 241 -R---------EL----ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred -c---------cC----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 0 00 011123467889999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=323.90 Aligned_cols=258 Identities=23% Similarity=0.349 Sum_probs=207.1
Q ss_pred cCCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCC---cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEE
Q 002774 555 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS---MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIY 630 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 630 (882)
++|...+.||+|+||.||+|+.. +++.||||.++... ......+.+|+++++.++||||+++++++.+.+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 46888899999999999999864 78999999876432 223356889999999999999999999999999999999
Q ss_pred EeecCCCcccccCCC--CCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCC
Q 002774 631 EFVPNGSLGDSLSGK--NGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSD 708 (882)
Q Consensus 631 e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~ 708 (882)
||+++|+|.+++... ....+++..+..++.|+++||+|||+.+ ++||||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 999999998887532 2235788899999999999999999988 99999999999999999999999999987643
Q ss_pred CCCceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCc
Q 002774 709 SEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPT 788 (882)
Q Consensus 709 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 788 (882)
... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||................. ..+.
T Consensus 159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~---------~~~~ 227 (267)
T cd08228 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQC---------DYPP 227 (267)
T ss_pred hhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcC---------CCCC
Confidence 321 11234588899999999988899999999999999999999999865432211111111110 0111
Q ss_pred CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 002774 789 IGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENI 829 (882)
Q Consensus 789 l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 829 (882)
. ........+.+++.+||+.+|++||++.++++.++++
T Consensus 228 ~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 228 L---PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred C---ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 1 1122346789999999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=340.57 Aligned_cols=246 Identities=28% Similarity=0.393 Sum_probs=191.9
Q ss_pred CCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCCc-ccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEeec
Q 002774 557 FSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVP 634 (882)
Q Consensus 557 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 634 (882)
|...+.||+|+||+||+|+.. +++.||||++..... ...+.+.+|+++++.++|+||+++++++.+.+..++||||++
T Consensus 76 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 155 (353)
T PLN00034 76 LERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMD 155 (353)
T ss_pred HhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCC
Confidence 445678999999999999864 689999999865432 234678899999999999999999999999999999999999
Q ss_pred CCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCcee
Q 002774 635 NGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHI 714 (882)
Q Consensus 635 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 714 (882)
+|+|.+.. ..++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+..... .
T Consensus 156 ~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--~ 224 (353)
T PLN00034 156 GGSLEGTH------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD--P 224 (353)
T ss_pred CCcccccc------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccccc--c
Confidence 99986543 2456677889999999999999998 99999999999999999999999999987643221 1
Q ss_pred eeeeeccCCCCCHHHHhh-----CCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcC
Q 002774 715 TTQVKGTMGYLDPEYYMT-----QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTI 789 (882)
Q Consensus 715 ~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 789 (882)
.....||..|+|||++.. ...+.++|||||||++|||++|+.||...... ++... ..... ....+.
T Consensus 225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~-~~~~~-~~~~~------~~~~~~- 295 (353)
T PLN00034 225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG-DWASL-MCAIC------MSQPPE- 295 (353)
T ss_pred ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc-cHHHH-HHHHh------ccCCCC-
Confidence 233568999999998743 23456899999999999999999999732211 11111 10000 000011
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 790 GLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 790 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
.......++.+++.+||+.||++||++.|++++
T Consensus 296 ---~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 296 ---APATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred ---CCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111234678999999999999999999999985
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=328.50 Aligned_cols=256 Identities=27% Similarity=0.440 Sum_probs=202.2
Q ss_pred HcCCCCCCeeeccCcEEEEEEEec------CCcEEEEEEcccCCc-ccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCce
Q 002774 554 TNNFSDANDVGSGGYGKVYKGTLP------NGQLIAIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQ 626 (882)
Q Consensus 554 ~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 626 (882)
+++|...+.||+|+||.||+|.+. .+..||+|.+..... .....|.+|+.++++++|+||+++++++.+.+..
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 456888899999999999999874 357899998875432 2345689999999999999999999999999999
Q ss_pred EEEEEeecCCCcccccCCCC-----CccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCC---ceeEe
Q 002774 627 MLIYEFVPNGSLGDSLSGKN-----GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERL---NAKVA 698 (882)
Q Consensus 627 ~lV~e~~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~---~~kl~ 698 (882)
++||||+++++|.+++.... ...+++.++.+++.||+.||+|||+.+ ++||||||+||+++.++ .+||+
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEec
Confidence 99999999999999886543 135899999999999999999999998 99999999999998764 59999
Q ss_pred ecccccccCCCCCceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHhhhh
Q 002774 699 DFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKE 777 (882)
Q Consensus 699 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~t-g~~P~~~~~~~~~~~~~~~~~~~~ 777 (882)
|||+++................+..|+|||++.+..++.++|||||||++|||++ |..||...... .....+... .
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~-~~~~~~~~~-~- 238 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ-EVMEFVTGG-G- 238 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-HHHHHHHcC-C-
Confidence 9999987643221111112233568999999999999999999999999999997 88888643321 111111110 0
Q ss_pred hhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 002774 778 LYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIE 827 (882)
Q Consensus 778 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~ 827 (882)
....+...+..+.+++.+||+.+|++||++.+|+++|.
T Consensus 239 ------------~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 239 ------------RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred ------------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 01111223467889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=355.42 Aligned_cols=256 Identities=22% Similarity=0.317 Sum_probs=205.0
Q ss_pred HHHcCCCCCCeeeccCcEEEEEEEe-cCCcEEEEEEcccCCc--ccHHHHHHHHHHHHhccCCCeeeEEEEEEeCC----
Q 002774 552 KYTNNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSM--QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRG---- 624 (882)
Q Consensus 552 ~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~---- 624 (882)
...++|...+.||+|+||+||+|+. .+|+.||||++..... .....+.+|+.++..++|+||+++.+.+...+
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 3356889999999999999999985 4789999999875432 23356788999999999999999988775432
Q ss_pred ----ceEEEEEeecCCCcccccCCCC--CccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEe
Q 002774 625 ----EQMLIYEFVPNGSLGDSLSGKN--GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVA 698 (882)
Q Consensus 625 ----~~~lV~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~ 698 (882)
..++||||+++|+|.++++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL~ 185 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKLG 185 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEEE
Confidence 2579999999999999886432 346889999999999999999999988 9999999999999999999999
Q ss_pred ecccccccCCCCCceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhh
Q 002774 699 DFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKEL 778 (882)
Q Consensus 699 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~ 778 (882)
|||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+........
T Consensus 186 DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~-~~~~~~~~~~~---- 260 (496)
T PTZ00283 186 DFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN-MEEVMHKTLAG---- 260 (496)
T ss_pred ecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC-HHHHHHHHhcC----
Confidence 9999987654333333345679999999999999999999999999999999999999996533 22222221111
Q ss_pred hhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 779 YNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 779 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
..++ .+.....++.+++.+||+.||.+||++.+++++
T Consensus 261 -----~~~~-----~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 261 -----RYDP-----LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred -----CCCC-----CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 0111 111234678999999999999999999999864
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=330.06 Aligned_cols=252 Identities=25% Similarity=0.341 Sum_probs=201.6
Q ss_pred CCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCCcc---cHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEE
Q 002774 556 NFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQ---GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYE 631 (882)
Q Consensus 556 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e 631 (882)
.|+..++||+|+||+||++... +++.||||++...... ....+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 3677889999999999999864 6899999998753322 22457789999999999999999999999999999999
Q ss_pred eecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCC
Q 002774 632 FVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEK 711 (882)
Q Consensus 632 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 711 (882)
|+++|+|.+++.......+++..+..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||+++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET 157 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc
Confidence 999999998886544456899999999999999999999998 99999999999999999999999999987543221
Q ss_pred ceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCCC
Q 002774 712 DHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGL 791 (882)
Q Consensus 712 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 791 (882)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||....... .......... . .. .
T Consensus 158 ---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~-~~~~~~~~~~------~-~~----~ 222 (285)
T cd05605 158 ---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV-KREEVERRVK------E-DQ----E 222 (285)
T ss_pred ---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh-HHHHHHHHhh------h-cc----c
Confidence 223468999999999998899999999999999999999999997533211 1111111000 0 00 0
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 002774 792 STTLKGFEKYVDLALKCVQESGDDRP-----TMSEVVKD 825 (882)
Q Consensus 792 ~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~evl~~ 825 (882)
.........+.+++.+||+.||++|| ++++++++
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 223 EYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred ccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 11122346788999999999999999 77787764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=322.80 Aligned_cols=248 Identities=25% Similarity=0.426 Sum_probs=196.5
Q ss_pred CeeeccCcEEEEEEEec-CCcEEEEEEcccCCc-ccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEeecCCCc
Q 002774 561 NDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSL 638 (882)
Q Consensus 561 ~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 638 (882)
+.||+|+||+||+|+.. +++.||+|.+..... .....+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 36899999999999864 789999998865432 2345789999999999999999999999999999999999999999
Q ss_pred ccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCceeeeee
Q 002774 639 GDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQV 718 (882)
Q Consensus 639 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 718 (882)
.+++.... ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++..............
T Consensus 81 ~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 156 (252)
T cd05084 81 LTFLRTEG-PRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK 156 (252)
T ss_pred HHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCCC
Confidence 99986542 35889999999999999999999988 999999999999999999999999998765432111111111
Q ss_pred eccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCCCCCCHHH
Q 002774 719 KGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKG 797 (882)
Q Consensus 719 ~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 797 (882)
.++..|+|||.+.++.++.++|||||||++|||++ |..||...... ......... .. .......
T Consensus 157 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~--~~~~~~~~~---------~~----~~~~~~~ 221 (252)
T cd05084 157 QIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ--QTREAIEQG---------VR----LPCPELC 221 (252)
T ss_pred CCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH--HHHHHHHcC---------CC----CCCcccC
Confidence 23457999999998899999999999999999998 88888543221 111111110 00 1111223
Q ss_pred HHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 002774 798 FEKYVDLALKCVQESGDDRPTMSEVVKDIE 827 (882)
Q Consensus 798 ~~~l~~li~~cl~~dp~~RPs~~evl~~L~ 827 (882)
+..+.+++.+||+.+|++|||+.|+++.|.
T Consensus 222 ~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 222 PDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 467899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=337.50 Aligned_cols=242 Identities=28% Similarity=0.372 Sum_probs=195.7
Q ss_pred CeeeccCcEEEEEEEe----cCCcEEEEEEcccCC----cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEe
Q 002774 561 NDVGSGGYGKVYKGTL----PNGQLIAIKRAQQGS----MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEF 632 (882)
Q Consensus 561 ~~lG~G~fg~Vy~~~~----~~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 632 (882)
+.||+|+||.||+++. .+++.||||+++... ......+.+|+++++.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6799999999999985 357899999987532 12234577899999999999999999999999999999999
Q ss_pred ecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCc
Q 002774 633 VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKD 712 (882)
Q Consensus 633 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 712 (882)
+++|+|.+++.... .+.+..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 155 (323)
T cd05584 82 LSGGELFMHLEREG--IFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT- 155 (323)
T ss_pred CCCchHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC-
Confidence 99999999886543 5778888889999999999999998 99999999999999999999999999875433221
Q ss_pred eeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCCCC
Q 002774 713 HITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLS 792 (882)
Q Consensus 713 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 792 (882)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+.... ..+.
T Consensus 156 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~-~~~~~~~~~~-------~~~~------ 220 (323)
T cd05584 156 -VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK-KTIDKILKGK-------LNLP------ 220 (323)
T ss_pred -cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH-HHHHHHHcCC-------CCCC------
Confidence 223356999999999999888999999999999999999999999754322 1111111110 0011
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 002774 793 TTLKGFEKYVDLALKCVQESGDDRP-----TMSEVVKD 825 (882)
Q Consensus 793 ~~~~~~~~l~~li~~cl~~dp~~RP-----s~~evl~~ 825 (882)
.....++.+++.+||+.||++|| ++.+++++
T Consensus 221 --~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 221 --PYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred --CCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 11236788999999999999999 88888874
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=323.87 Aligned_cols=254 Identities=30% Similarity=0.481 Sum_probs=206.5
Q ss_pred HcCCCCCCeeeccCcEEEEEEEecCCcEEEEEEcccCCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEee
Q 002774 554 TNNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFV 633 (882)
Q Consensus 554 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 633 (882)
.++|...++||+|+||.||+|...+++.||+|.+..... ...++.+|+.++++++|+||+++++++ ..+..++||||+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~v~e~~ 82 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVV-TQEPIYIITEYM 82 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEE-ccCCcEEEEEcC
Confidence 456788899999999999999988899999999886543 346789999999999999999999986 456789999999
Q ss_pred cCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCce
Q 002774 634 PNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDH 713 (882)
Q Consensus 634 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 713 (882)
++++|.+++.......+++.++..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++........ .
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~ 158 (260)
T cd05067 83 ENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEY-T 158 (260)
T ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCc-c
Confidence 9999999987665567899999999999999999999988 99999999999999999999999999987653221 1
Q ss_pred eeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCCCC
Q 002774 714 ITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLS 792 (882)
Q Consensus 714 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 792 (882)
......++..|+|||++....++.++||||||+++|||++ |+.||..... .+.... +.... ...
T Consensus 159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-~~~~~~-~~~~~---------~~~---- 223 (260)
T cd05067 159 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN-PEVIQN-LERGY---------RMP---- 223 (260)
T ss_pred cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh-HHHHHH-HHcCC---------CCC----
Confidence 1223346778999999998889999999999999999999 9999864432 111111 11110 001
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 002774 793 TTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIEN 828 (882)
Q Consensus 793 ~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~ 828 (882)
.....+.++.+++.+||+.+|++||++++++..|+.
T Consensus 224 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 224 RPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 111223679999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=341.80 Aligned_cols=254 Identities=26% Similarity=0.406 Sum_probs=198.0
Q ss_pred cCCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCCc---ccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEE
Q 002774 555 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM---QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIY 630 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 630 (882)
++|+..+.||+|+||+||+|+.. +++.||||+++.... .....+.+|+.++.+++|+||+++++++.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 46888999999999999999854 689999999875322 22346788999999999999999999999999999999
Q ss_pred EeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCC
Q 002774 631 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE 710 (882)
Q Consensus 631 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~ 710 (882)
||+++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 81 E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~ 155 (363)
T cd05628 81 EFLPGGDMMTLLMKKD--TLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH 155 (363)
T ss_pred cCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence 9999999999987643 6889999999999999999999998 9999999999999999999999999997653211
Q ss_pred Cc---------------------------------eeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCC
Q 002774 711 KD---------------------------------HITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRP 757 (882)
Q Consensus 711 ~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P 757 (882)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~P 235 (363)
T cd05628 156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (363)
T ss_pred cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCC
Confidence 00 001235699999999999999999999999999999999999999
Q ss_pred CCCCchHHHHHHHHHHhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhc--cCCCCCCCHHHHHHH
Q 002774 758 IERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQ--ESGDDRPTMSEVVKD 825 (882)
Q Consensus 758 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~--~dp~~RPs~~evl~~ 825 (882)
|..... .+....+...... -.+.+.. ....++.+++.+++. .++..||+++|++++
T Consensus 236 f~~~~~-~~~~~~i~~~~~~-----~~~p~~~------~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 236 FCSETP-QETYKKVMNWKET-----LIFPPEV------PISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCCCCH-HHHHHHHHcCcCc-----ccCCCcC------CCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 965432 2222222211100 0011111 122456777777554 334456999999986
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=328.53 Aligned_cols=254 Identities=24% Similarity=0.399 Sum_probs=201.3
Q ss_pred CCCCCCeeeccCcEEEEEEEec------CCcEEEEEEcccCCcc-cHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEE
Q 002774 556 NFSDANDVGSGGYGKVYKGTLP------NGQLIAIKRAQQGSMQ-GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQML 628 (882)
Q Consensus 556 ~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 628 (882)
+|...+.||+|+||+||+|... +++.||||+++..... ....+.+|+.++..++||||+++++++.+.+..++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 3556778999999999999853 2578999999754332 23568899999999999999999999999999999
Q ss_pred EEEeecCCCcccccCCCC--------------CccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCc
Q 002774 629 IYEFVPNGSLGDSLSGKN--------------GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLN 694 (882)
Q Consensus 629 V~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~ 694 (882)
++||+++++|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCc
Confidence 999999999988874211 235788899999999999999999998 999999999999999999
Q ss_pred eeEeecccccccCCCCCceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHHH
Q 002774 695 AKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMD 773 (882)
Q Consensus 695 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~t-g~~P~~~~~~~~~~~~~~~~ 773 (882)
+||+|||+++...............+++.|+|||.+..+.++.++|||||||++|||++ |..||..... .+....+..
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-~~~~~~i~~ 241 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-QDVIEMIRN 241 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH-HHHHHHHHc
Confidence 99999999987654332222233446789999999998899999999999999999998 7778754322 222221111
Q ss_pred hhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 002774 774 KKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIE 827 (882)
Q Consensus 774 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~ 827 (882)
.. ........+..+.+++.+||+.+|++||+++++++.|+
T Consensus 242 -~~-------------~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~ 281 (283)
T cd05091 242 -RQ-------------VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLR 281 (283)
T ss_pred -CC-------------cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhh
Confidence 11 00111234467899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=326.21 Aligned_cols=258 Identities=26% Similarity=0.454 Sum_probs=203.7
Q ss_pred cCCCCCCeeeccCcEEEEEEEec-CCc----EEEEEEcccCCc-ccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEE
Q 002774 555 NNFSDANDVGSGGYGKVYKGTLP-NGQ----LIAIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQML 628 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 628 (882)
++|...++||+|+||+||+|++. +|+ .||+|+++.... ...+++.+|+.+++.++|+||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l 85 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQL 85 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEE
Confidence 46778899999999999999853 444 489999875433 334678899999999999999999999875 45789
Q ss_pred EEEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCC
Q 002774 629 IYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSD 708 (882)
Q Consensus 629 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~ 708 (882)
++||+++|+|.++++... ..+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++.+..
T Consensus 86 ~~~~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~ 161 (279)
T cd05109 86 VTQLMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLDI 161 (279)
T ss_pred EEEcCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeeccc
Confidence 999999999999987543 36889999999999999999999988 99999999999999999999999999987754
Q ss_pred CCCceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCC
Q 002774 709 SEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDP 787 (882)
Q Consensus 709 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 787 (882)
...........++..|+|||...+..++.++|||||||++|||++ |..||..... ........... . +
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~~~~~~~~~-------~--~ 230 (279)
T cd05109 162 DETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA--REIPDLLEKGE-------R--L 230 (279)
T ss_pred ccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHHCCC-------c--C
Confidence 332222222345678999999998899999999999999999998 8888864322 11111111111 0 0
Q ss_pred cCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 002774 788 TIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 832 (882)
Q Consensus 788 ~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~ 832 (882)
........++.+++.+||+.||++||++.++++.|+.+.+.
T Consensus 231 ----~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05109 231 ----PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD 271 (279)
T ss_pred ----CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence 01112346788999999999999999999999998877543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=337.78 Aligned_cols=261 Identities=27% Similarity=0.438 Sum_probs=202.9
Q ss_pred cCCCCCCeeeccCcEEEEEEEe------cCCcEEEEEEcccCCcc-cHHHHHHHHHHHHhc-cCCCeeeEEEEEEeC-Cc
Q 002774 555 NNFSDANDVGSGGYGKVYKGTL------PNGQLIAIKRAQQGSMQ-GGQEFKMEIELLSRV-HHKNLVSLLGFCFDR-GE 625 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~~~~------~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~-~~ 625 (882)
++|...+.||+|+||+||+|++ .+++.||||+++..... ....+.+|++++.++ +||||+++++++... ..
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 86 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence 4688899999999999999973 34789999999754322 335688899999999 689999999988664 46
Q ss_pred eEEEEEeecCCCcccccCCCC-----------------------------------------------------------
Q 002774 626 QMLIYEFVPNGSLGDSLSGKN----------------------------------------------------------- 646 (882)
Q Consensus 626 ~~lV~e~~~~gsL~~~l~~~~----------------------------------------------------------- 646 (882)
.++||||+++|+|.++++...
T Consensus 87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (343)
T cd05103 87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 166 (343)
T ss_pred eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence 789999999999988875321
Q ss_pred ------CccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCceeeeeeec
Q 002774 647 ------GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKG 720 (882)
Q Consensus 647 ------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~g 720 (882)
...+++.++.+++.|+++||+|||+.+ |+||||||+||++++++.+||+|||+++...............+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd05103 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243 (343)
T ss_pred hhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence 123678889999999999999999998 99999999999999999999999999986543322112222345
Q ss_pred cCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCCCCCCHHHHH
Q 002774 721 TMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFE 799 (882)
Q Consensus 721 t~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 799 (882)
+..|+|||.+.+..++.++||||||+++|||++ |..||........ ......... ..... .....
T Consensus 244 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-~~~~~~~~~---------~~~~~----~~~~~ 309 (343)
T cd05103 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-FCRRLKEGT---------RMRAP----DYTTP 309 (343)
T ss_pred CcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH-HHHHHhccC---------CCCCC----CCCCH
Confidence 678999999998899999999999999999997 8888864322111 111111110 00000 11225
Q ss_pred HHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 002774 800 KYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 832 (882)
Q Consensus 800 ~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~ 832 (882)
++.+++.+||+.+|++||++.|++++|+.+++.
T Consensus 310 ~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 310 EMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 688999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=345.17 Aligned_cols=253 Identities=23% Similarity=0.386 Sum_probs=201.6
Q ss_pred cCCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCC---cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEE
Q 002774 555 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS---MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIY 630 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 630 (882)
++|+..+.||+|+||+||+|+.. +|+.||||+++... ......+.+|+++++.++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 36888999999999999999964 68999999997532 222356788999999999999999999999999999999
Q ss_pred EeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCC
Q 002774 631 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE 710 (882)
Q Consensus 631 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~ 710 (882)
||+++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 81 E~~~~g~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 155 (364)
T cd05599 81 EYLPGGDMMTLLMKKD--TFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH 155 (364)
T ss_pred CCCCCcHHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceeccccc
Confidence 9999999999987644 5889999999999999999999998 9999999999999999999999999987653221
Q ss_pred Cce------------------------------------eeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhC
Q 002774 711 KDH------------------------------------ITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTG 754 (882)
Q Consensus 711 ~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg 754 (882)
... ......||+.|+|||++....++.++|||||||++|||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G 235 (364)
T cd05599 156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235 (364)
T ss_pred cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcC
Confidence 100 01123589999999999999999999999999999999999
Q ss_pred CCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCC---HHHHHHH
Q 002774 755 RRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPT---MSEVVKD 825 (882)
Q Consensus 755 ~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs---~~evl~~ 825 (882)
..||..... .+....+..... .+...........+.+++.+|+. +|.+|++ ++|++++
T Consensus 236 ~~Pf~~~~~-~~~~~~i~~~~~-----------~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 236 YPPFCSDNP-QETYRKIINWKE-----------TLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCCCCCH-HHHHHHHHcCCC-----------ccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 999975432 222222221110 00011111223577899999996 9999997 9999875
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=321.03 Aligned_cols=247 Identities=26% Similarity=0.412 Sum_probs=196.3
Q ss_pred eeeccCcEEEEEEEe---cCCcEEEEEEcccCCcc--cHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEeecCC
Q 002774 562 DVGSGGYGKVYKGTL---PNGQLIAIKRAQQGSMQ--GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNG 636 (882)
Q Consensus 562 ~lG~G~fg~Vy~~~~---~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 636 (882)
.||+|+||+||+|.+ .+++.||+|+++..... ..+++.+|+.+++.++||||+++++++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 589999999999975 35789999998754322 3467889999999999999999999885 45778999999999
Q ss_pred CcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCcee-e
Q 002774 637 SLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHI-T 715 (882)
Q Consensus 637 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~-~ 715 (882)
+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++.+........ .
T Consensus 81 ~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05116 81 PLNKFLQKNK--HVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK 155 (257)
T ss_pred cHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeec
Confidence 9999986543 5889999999999999999999988 99999999999999999999999999987654332111 1
Q ss_pred eeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCCCCCC
Q 002774 716 TQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTT 794 (882)
Q Consensus 716 ~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 794 (882)
....++..|+|||.+....++.++|||||||++|||++ |..||..... .+... .+.... . + ..+
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-~~~~~-~i~~~~-------~--~----~~~ 220 (257)
T cd05116 156 THGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG-NEVTQ-MIESGE-------R--M----ECP 220 (257)
T ss_pred CCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH-HHHHH-HHHCCC-------C--C----CCC
Confidence 12234578999999988889999999999999999998 9999864322 11111 111111 0 1 111
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 002774 795 LKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENI 829 (882)
Q Consensus 795 ~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 829 (882)
...+.++.+++.+||+.||++||++++|.+.|+..
T Consensus 221 ~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 221 QRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 12346788999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=326.53 Aligned_cols=246 Identities=22% Similarity=0.346 Sum_probs=195.1
Q ss_pred eeccCcEEEEEEEec-CCcEEEEEEcccCCcc---cHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEeecCCCc
Q 002774 563 VGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQ---GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSL 638 (882)
Q Consensus 563 lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 638 (882)
||+|+||+||+++.. +|+.||+|++...... ..+.+..|+++++.++|+||+++.+++..++..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999864 6899999998754322 224567899999999999999999999999999999999999999
Q ss_pred ccccCCC--CCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCceeee
Q 002774 639 GDSLSGK--NGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITT 716 (882)
Q Consensus 639 ~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 716 (882)
.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++.+..... ...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence 8776432 2346899999999999999999999998 99999999999999999999999999987654322 123
Q ss_pred eeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCCCCCCHH
Q 002774 717 QVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLK 796 (882)
Q Consensus 717 ~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 796 (882)
...||+.|+|||++.+..++.++|||||||++|||++|+.||.......... ..... ..... ......
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~-~~~~~---------~~~~~--~~~~~~ 223 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENK-ELKQR---------ILNDS--VTYPDK 223 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHH-HHHHh---------hcccC--CCCccc
Confidence 4568999999999999999999999999999999999999997533211110 00000 00000 011122
Q ss_pred HHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 002774 797 GFEKYVDLALKCVQESGDDRP-----TMSEVVKD 825 (882)
Q Consensus 797 ~~~~l~~li~~cl~~dp~~RP-----s~~evl~~ 825 (882)
....+.+++.+||+.||++|| ++++++++
T Consensus 224 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 224 FSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 346788999999999999999 66777764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=328.00 Aligned_cols=263 Identities=26% Similarity=0.400 Sum_probs=205.3
Q ss_pred HcCCCCCCeeeccCcEEEEEEEecC-----------------CcEEEEEEcccCCc-ccHHHHHHHHHHHHhccCCCeee
Q 002774 554 TNNFSDANDVGSGGYGKVYKGTLPN-----------------GQLIAIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLVS 615 (882)
Q Consensus 554 ~~~~~~~~~lG~G~fg~Vy~~~~~~-----------------g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~ 615 (882)
.++|...+.||+|+||.||+|+..+ +..||+|++..... ...+.+.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3578889999999999999997542 24689999876433 33467889999999999999999
Q ss_pred EEEEEEeCCceEEEEEeecCCCcccccCCCC---------CccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCc
Q 002774 616 LLGFCFDRGEQMLIYEFVPNGSLGDSLSGKN---------GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSN 686 (882)
Q Consensus 616 l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~---------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~N 686 (882)
+++++..++..++||||+++++|.+++.... ...+++..++.++.|++.||+|||+.+ |+||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 9999999999999999999999999886533 126899999999999999999999998 9999999999
Q ss_pred eEEcCCCceeEeecccccccCCCCCceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHh--CCCCCCCCchH
Q 002774 687 ILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT--GRRPIERGKYI 764 (882)
Q Consensus 687 Ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~t--g~~P~~~~~~~ 764 (882)
|++++++.++|+|||+++...............++..|+|||++....++.++|||||||++|||++ |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 9999999999999999986654433222334456788999999998899999999999999999998 66777543221
Q ss_pred HHHHHHHHHhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 002774 765 VREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIE 827 (882)
Q Consensus 765 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~ 827 (882)
..+....... ...............+.++.+++.+||+.||.+|||+.|+++.|+
T Consensus 241 -~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 241 -QVIENAGHFF-------RDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred -HHHHHHHhcc-------ccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 1111111100 000001111111223467999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=338.34 Aligned_cols=242 Identities=21% Similarity=0.265 Sum_probs=195.8
Q ss_pred CeeeccCcEEEEEEEe-cCCcEEEEEEcccCC---cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEeecCC
Q 002774 561 NDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGS---MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNG 636 (882)
Q Consensus 561 ~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 636 (882)
+.||+|+||+||+|+. .+|+.||+|+++... ......+..|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999985 468999999987532 222356778999999999999999999999999999999999999
Q ss_pred CcccccCCCCCccccHHHHHHHHHHHHHHHhhhhh-cCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCceee
Q 002774 637 SLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHE-LANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHIT 715 (882)
Q Consensus 637 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 715 (882)
+|.+++.... .+++..+..++.|++.||+|||+ .+ |+||||||+|||+++++.+||+|||+++....... ..
T Consensus 81 ~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~ 153 (325)
T cd05594 81 ELFFHLSRER--VFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--TM 153 (325)
T ss_pred cHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc--cc
Confidence 9998886543 68899999999999999999997 67 99999999999999999999999999875432221 12
Q ss_pred eeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCCCCCCH
Q 002774 716 TQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTL 795 (882)
Q Consensus 716 ~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 795 (882)
....||+.|+|||++.+..++.++|||||||++|||++|..||...... .....+... .... +.
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~-~~~~~i~~~-----------~~~~----p~ 217 (325)
T cd05594 154 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-KLFELILME-----------EIRF----PR 217 (325)
T ss_pred ccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH-HHHHHHhcC-----------CCCC----CC
Confidence 3456999999999999999999999999999999999999999654321 111111110 0011 11
Q ss_pred HHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 002774 796 KGFEKYVDLALKCVQESGDDRP-----TMSEVVKD 825 (882)
Q Consensus 796 ~~~~~l~~li~~cl~~dp~~RP-----s~~evl~~ 825 (882)
....++.+++.+||+.||++|+ ++++++++
T Consensus 218 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 218 TLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 1236788999999999999996 89999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=344.18 Aligned_cols=253 Identities=24% Similarity=0.346 Sum_probs=205.3
Q ss_pred cCCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCC---cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEE
Q 002774 555 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS---MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIY 630 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 630 (882)
++|...+.||+|+||+||+|+.. +|+.||||+++... ......+.+|++++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 36888899999999999999965 68999999987532 133456889999999999999999999999999999999
Q ss_pred EeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCC
Q 002774 631 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE 710 (882)
Q Consensus 631 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~ 710 (882)
||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 81 e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 155 (350)
T cd05573 81 EYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK 155 (350)
T ss_pred cCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence 999999999998765 36888999999999999999999988 9999999999999999999999999998765432
Q ss_pred ---------------------------CceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCch
Q 002774 711 ---------------------------KDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKY 763 (882)
Q Consensus 711 ---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~ 763 (882)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~ 235 (350)
T cd05573 156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL 235 (350)
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCH
Confidence 00112335689999999999999999999999999999999999999976542
Q ss_pred HHHHHHHHHHhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCC-HHHHHHH
Q 002774 764 IVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPT-MSEVVKD 825 (882)
Q Consensus 764 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs-~~evl~~ 825 (882)
. .....+..... ............++.+++.+|++ ||.+||+ ++|++++
T Consensus 236 ~-~~~~~i~~~~~-----------~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 236 Q-ETYNKIINWKE-----------SLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred H-HHHHHHhccCC-----------cccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 2 22222211000 00011111134678899999998 9999999 9999976
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=325.65 Aligned_cols=246 Identities=24% Similarity=0.386 Sum_probs=195.3
Q ss_pred eeccCcEEEEEEEec-CCcEEEEEEcccCCc---ccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEeecCCCc
Q 002774 563 VGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM---QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSL 638 (882)
Q Consensus 563 lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 638 (882)
||+|+||+||+++.. +|+.||+|++..... ...+.+..|++++++++||||+++.+++.++...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999864 689999999864322 1234456799999999999999999999999999999999999999
Q ss_pred ccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCceeeeee
Q 002774 639 GDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQV 718 (882)
Q Consensus 639 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 718 (882)
.+++.......+++..+..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||++....... .....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~~ 154 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQR 154 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eeecc
Confidence 98886655556899999999999999999999998 9999999999999999999999999998764322 22345
Q ss_pred eccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCCCCCCHHHH
Q 002774 719 KGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGF 798 (882)
Q Consensus 719 ~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 798 (882)
.|+..|+|||++.+..++.++||||+||++|||++|+.||.......... ...... ....... ......
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~-~~~~~~---------~~~~~~~-~~~~~~ 223 (277)
T cd05607 155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKE-ELKRRT---------LEDEVKF-EHQNFT 223 (277)
T ss_pred CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHH-HHHHHh---------hcccccc-ccccCC
Confidence 68999999999998889999999999999999999999996432211110 110000 0000000 001233
Q ss_pred HHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 799 EKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 799 ~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
.++.+++.+||+.||++||+++|+++.
T Consensus 224 ~~~~~li~~~L~~~P~~R~~~~~~~~~ 250 (277)
T cd05607 224 EESKDICRLFLAKKPEDRLGSREKNDD 250 (277)
T ss_pred HHHHHHHHHHhccCHhhCCCCccchhh
Confidence 678899999999999999999877644
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=329.05 Aligned_cols=241 Identities=26% Similarity=0.370 Sum_probs=191.4
Q ss_pred CeeeccCcEEEEEEEec-CCcEEEEEEcccCC---cccHHHHHHHHHHHHhc-cCCCeeeEEEEEEeCCceEEEEEeecC
Q 002774 561 NDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS---MQGGQEFKMEIELLSRV-HHKNLVSLLGFCFDRGEQMLIYEFVPN 635 (882)
Q Consensus 561 ~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~~ 635 (882)
+.||+|+||+||+|+.. +++.||||+++... ....+.+..|..++... +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999864 57899999987532 12234456677777654 899999999999999999999999999
Q ss_pred CCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCceee
Q 002774 636 GSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHIT 715 (882)
Q Consensus 636 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 715 (882)
|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~ 153 (316)
T cd05592 81 GDLMFHIQSSG--RFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKA 153 (316)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Ccc
Confidence 99998886543 5888899999999999999999988 9999999999999999999999999998653322 223
Q ss_pred eeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCCCCCCH
Q 002774 716 TQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTL 795 (882)
Q Consensus 716 ~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 795 (882)
....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+....+... .+... .
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~-~~~~~~i~~~-----------~~~~~----~ 217 (316)
T cd05592 154 STFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE-DELFDSILND-----------RPHFP----R 217 (316)
T ss_pred ccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH-HHHHHHHHcC-----------CCCCC----C
Confidence 345699999999999998999999999999999999999999975432 1211111110 11111 1
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCHH-HHHH
Q 002774 796 KGFEKYVDLALKCVQESGDDRPTMS-EVVK 824 (882)
Q Consensus 796 ~~~~~l~~li~~cl~~dp~~RPs~~-evl~ 824 (882)
....++.+++.+||+.||.+||++. ++++
T Consensus 218 ~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 218 WISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred CCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 1235678999999999999999875 5544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=328.59 Aligned_cols=258 Identities=27% Similarity=0.435 Sum_probs=203.5
Q ss_pred cCCCCCCeeeccCcEEEEEEEec-CCc--EEEEEEcccCC-cccHHHHHHHHHHHHhc-cCCCeeeEEEEEEeCCceEEE
Q 002774 555 NNFSDANDVGSGGYGKVYKGTLP-NGQ--LIAIKRAQQGS-MQGGQEFKMEIELLSRV-HHKNLVSLLGFCFDRGEQMLI 629 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV 629 (882)
++|+..+.||+|+||.||+|... ++. .+|+|.++... ....+.+.+|+++++++ +||||+++++++.+.+..++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 46788899999999999999864 333 47888887432 23346788999999999 799999999999999999999
Q ss_pred EEeecCCCcccccCCCC--------------CccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCce
Q 002774 630 YEFVPNGSLGDSLSGKN--------------GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNA 695 (882)
Q Consensus 630 ~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~ 695 (882)
+||+++|+|.++++... ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 99999999999886432 124788999999999999999999988 9999999999999999999
Q ss_pred eEeecccccccCCCCCceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHh
Q 002774 696 KVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDK 774 (882)
Q Consensus 696 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~t-g~~P~~~~~~~~~~~~~~~~~ 774 (882)
||+|||++....... .......+..|+|||++....++.++|||||||++|||++ |..||..... .........
T Consensus 159 kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~-~~~~~~~~~- 233 (297)
T cd05089 159 KIADFGLSRGEEVYV---KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC-AELYEKLPQ- 233 (297)
T ss_pred EECCcCCCcccccee---ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH-HHHHHHHhc-
Confidence 999999986432110 1111223567999999998889999999999999999998 9999864332 111111110
Q ss_pred hhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHc
Q 002774 775 KKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQA 833 (882)
Q Consensus 775 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~ 833 (882)
...+ .........+.+++.+||+.+|.+||+++++++.|+.+.+..
T Consensus 234 ---------~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 234 ---------GYRM----EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred ---------CCCC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 0011 111123467889999999999999999999999999998665
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=337.93 Aligned_cols=253 Identities=22% Similarity=0.319 Sum_probs=203.5
Q ss_pred cCCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCCc---ccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEE
Q 002774 555 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM---QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIY 630 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 630 (882)
++|...+.||+|+||+||+|+.. +|+.||+|+++.... ...+.+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 36888899999999999999864 689999999975422 23456888999999999999999999999999999999
Q ss_pred EeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCC
Q 002774 631 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE 710 (882)
Q Consensus 631 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~ 710 (882)
||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.+....
T Consensus 81 e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 156 (330)
T cd05601 81 EYQPGGDLLSLLNRYE-DQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTANK 156 (330)
T ss_pred CCCCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCCC
Confidence 9999999999987642 36889999999999999999999998 9999999999999999999999999998765433
Q ss_pred CceeeeeeeccCCCCCHHHHh------hCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhc
Q 002774 711 KDHITTQVKGTMGYLDPEYYM------TQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYEL 784 (882)
Q Consensus 711 ~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 784 (882)
. .......||+.|+|||++. ...++.++|||||||++|||++|+.||....... ....+..... .
T Consensus 157 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~-~~~~i~~~~~-------~ 227 (330)
T cd05601 157 M-VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK-TYNNIMNFQR-------F 227 (330)
T ss_pred c-eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH-HHHHHHcCCC-------c
Confidence 2 2223356899999999987 4567899999999999999999999997654322 2222221110 0
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 785 IDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 785 ~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
............+.+++.+|++ +|.+||++++++++
T Consensus 228 ----~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 228 ----LKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred ----cCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 0001111234678899999998 99999999999865
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=327.86 Aligned_cols=262 Identities=25% Similarity=0.392 Sum_probs=200.7
Q ss_pred cCCCCCCeeeccCcEEEEEEEecC---------------CcEEEEEEcccCCcc-cHHHHHHHHHHHHhccCCCeeeEEE
Q 002774 555 NNFSDANDVGSGGYGKVYKGTLPN---------------GQLIAIKRAQQGSMQ-GGQEFKMEIELLSRVHHKNLVSLLG 618 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~~~~~~---------------g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~ 618 (882)
++|...+.||+|+||.||+|+..+ ...||+|+++..... ....|.+|++++++++|+||+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 468888999999999999987532 235899998754322 3356889999999999999999999
Q ss_pred EEEeCCceEEEEEeecCCCcccccCCCC----------CccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceE
Q 002774 619 FCFDRGEQMLIYEFVPNGSLGDSLSGKN----------GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNIL 688 (882)
Q Consensus 619 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIl 688 (882)
++...+..++||||+++++|.+++.... ...+++..++.++.|+++||+|||+.+ ++||||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEE
Confidence 9999999999999999999998885432 124688999999999999999999998 999999999999
Q ss_pred EcCCCceeEeecccccccCCCCCceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHh--CCCCCCCCchHHH
Q 002774 689 LDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT--GRRPIERGKYIVR 766 (882)
Q Consensus 689 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~t--g~~P~~~~~~~~~ 766 (882)
+++++.+||+|||+++...............++..|+|||++..+.++.++|||||||++|||++ |..||..... ..
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~-~~ 240 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD-EQ 240 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh-HH
Confidence 99999999999999986644332222233345778999999998899999999999999999998 5667754221 11
Q ss_pred HHHHHHHhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 002774 767 EIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIE 827 (882)
Q Consensus 767 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~ 827 (882)
.......... ..............+..+.+++.+||+.||++||++.+|++.|.
T Consensus 241 ~~~~~~~~~~-------~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 241 VIENTGEFFR-------NQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HHHHHHHhhh-------hccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 1111111000 00000000011113367899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=337.62 Aligned_cols=250 Identities=28% Similarity=0.344 Sum_probs=198.7
Q ss_pred CCCCCCeeeccCcEEEEEEEe----cCCcEEEEEEcccCC----cccHHHHHHHHHHHHhc-cCCCeeeEEEEEEeCCce
Q 002774 556 NFSDANDVGSGGYGKVYKGTL----PNGQLIAIKRAQQGS----MQGGQEFKMEIELLSRV-HHKNLVSLLGFCFDRGEQ 626 (882)
Q Consensus 556 ~~~~~~~lG~G~fg~Vy~~~~----~~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~ 626 (882)
+|...+.||+|+||+||+++. .+++.||+|++++.. ....+.+.+|+.+++.+ +|+||+++++++..++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 477889999999999999975 358899999986432 22235678899999999 599999999999999999
Q ss_pred EEEEEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeeccccccc
Q 002774 627 MLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSM 706 (882)
Q Consensus 627 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~ 706 (882)
++||||+++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~~ 155 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRD--NFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence 99999999999999886543 5888999999999999999999998 999999999999999999999999999865
Q ss_pred CCCCCceeeeeeeccCCCCCHHHHhhC-CCCchhHHHHHHHHHHHHHhCCCCCCCCc--hHHHHHHHHHHhhhhhhhhhh
Q 002774 707 SDSEKDHITTQVKGTMGYLDPEYYMTQ-QLTEKSDVYSFGVLMLELLTGRRPIERGK--YIVREIRTVMDKKKELYNLYE 783 (882)
Q Consensus 707 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvll~el~tg~~P~~~~~--~~~~~~~~~~~~~~~~~~~~~ 783 (882)
...... ......||+.|||||++.+. .++.++|||||||++|||+||+.||.... .....+.....
T Consensus 156 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~---------- 224 (332)
T cd05614 156 LSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRIL---------- 224 (332)
T ss_pred cccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHh----------
Confidence 433221 22345799999999999865 47889999999999999999999996321 11111111111
Q ss_pred ccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 002774 784 LIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRP-----TMSEVVKD 825 (882)
Q Consensus 784 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~evl~~ 825 (882)
..++... ......+.+++.+||+.||++|| ++++++++
T Consensus 225 ~~~~~~~----~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 225 KCDPPFP----SFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred cCCCCCC----CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 1112211 11235688999999999999999 77888865
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=323.03 Aligned_cols=256 Identities=27% Similarity=0.507 Sum_probs=204.7
Q ss_pred cCCCCCCeeeccCcEEEEEEEec-CC---cEEEEEEcccCC-cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEE
Q 002774 555 NNFSDANDVGSGGYGKVYKGTLP-NG---QLIAIKRAQQGS-MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLI 629 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~~~~~-~g---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 629 (882)
++|+..+.||+|+||.||+|+.. ++ ..+|+|+++... ....+.+..|++++++++|+||+++.+++.+.+..++|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 46778899999999999999864 33 379999987543 23346788999999999999999999999999999999
Q ss_pred EEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCC
Q 002774 630 YEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDS 709 (882)
Q Consensus 630 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~ 709 (882)
|||+++++|.+++.... ..+++.++..++.|++.|++|||+.+ ++||||||+||++++++.+|++|||++......
T Consensus 85 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 160 (268)
T cd05063 85 TEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160 (268)
T ss_pred EEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecccc
Confidence 99999999999986543 36899999999999999999999998 999999999999999999999999999866543
Q ss_pred CCceee-eeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCC
Q 002774 710 EKDHIT-TQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDP 787 (882)
Q Consensus 710 ~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 787 (882)
...... .....+..|+|||++....++.++|||||||++|||++ |..||..... .+....+.. .
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~-~~~~~~i~~-~------------ 226 (268)
T cd05063 161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN-HEVMKAIND-G------------ 226 (268)
T ss_pred cccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH-HHHHHHHhc-C------------
Confidence 221111 11223567999999998899999999999999999998 9999864332 122111111 0
Q ss_pred cCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 002774 788 TIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENI 829 (882)
Q Consensus 788 ~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 829 (882)
.........+..+.+++.+||+.+|++||++.+|++.|+++
T Consensus 227 -~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 227 -FRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred -CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 01111122346789999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=332.24 Aligned_cols=262 Identities=24% Similarity=0.449 Sum_probs=207.0
Q ss_pred cCCCCCCeeeccCcEEEEEEEec--------CCcEEEEEEcccCCc-ccHHHHHHHHHHHHhc-cCCCeeeEEEEEEeCC
Q 002774 555 NNFSDANDVGSGGYGKVYKGTLP--------NGQLIAIKRAQQGSM-QGGQEFKMEIELLSRV-HHKNLVSLLGFCFDRG 624 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~~~~~--------~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~ 624 (882)
.+|...+.||+|+||.||+|+.. .+..||+|.++.... ...+++.+|+++++++ +||||++++++|..++
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 35788899999999999999742 123689998875422 2346788999999999 7999999999999999
Q ss_pred ceEEEEEeecCCCcccccCCCC--------------CccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEc
Q 002774 625 EQMLIYEFVPNGSLGDSLSGKN--------------GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLD 690 (882)
Q Consensus 625 ~~~lV~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~ 690 (882)
..++||||+++|+|.+++.... ...+++.++..++.|++.||+|||+.+ ++||||||+||+++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEc
Confidence 9999999999999999886422 235788999999999999999999998 99999999999999
Q ss_pred CCCceeEeecccccccCCCCCceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHh-CCCCCCCCchHHHHHH
Q 002774 691 ERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIR 769 (882)
Q Consensus 691 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~t-g~~P~~~~~~~~~~~~ 769 (882)
+++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.... ..+...
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~-~~~~~~ 247 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP-VEELFK 247 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC-HHHHHH
Confidence 999999999999987644322222222334567999999999999999999999999999999 788875432 222222
Q ss_pred HHHHhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHcC
Q 002774 770 TVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQAG 834 (882)
Q Consensus 770 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~~ 834 (882)
..... . ..........++.+++.+||+.+|++||++.|+++.|+.+.....
T Consensus 248 ~~~~~-~-------------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~ 298 (334)
T cd05100 248 LLKEG-H-------------RMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTS 298 (334)
T ss_pred HHHcC-C-------------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcC
Confidence 11110 0 001111234678899999999999999999999999999976554
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=320.00 Aligned_cols=253 Identities=29% Similarity=0.461 Sum_probs=203.4
Q ss_pred cCCCCCCeeeccCcEEEEEEEecCCcEEEEEEcccCCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEeec
Q 002774 555 NNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVP 634 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 634 (882)
++|...+.||+|+||.||+|...++..||+|++..... ..+.+.+|++++++++|+|++++++++. .+..++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM-MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc-cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 45777889999999999999987777899999875432 3467889999999999999999999875 456899999999
Q ss_pred CCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCcee
Q 002774 635 NGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHI 714 (882)
Q Consensus 635 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 714 (882)
+|+|.++++......+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||+++........ .
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~-~ 159 (260)
T cd05069 84 KGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT-A 159 (260)
T ss_pred CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCccc-c
Confidence 999999997655556899999999999999999999988 999999999999999999999999999876433211 1
Q ss_pred eeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCCCCC
Q 002774 715 TTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLST 793 (882)
Q Consensus 715 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 793 (882)
.....++..|+|||+..+..++.++|||||||++|||++ |..||...... +..... ... ..+ ..
T Consensus 160 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-~~~~~~-~~~---------~~~----~~ 224 (260)
T cd05069 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR-EVLEQV-ERG---------YRM----PC 224 (260)
T ss_pred cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHH-HcC---------CCC----CC
Confidence 122346778999999998899999999999999999999 88888653321 111111 110 000 01
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 002774 794 TLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIEN 828 (882)
Q Consensus 794 ~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~ 828 (882)
....+..+.+++.+||+.||++||+++++++.|++
T Consensus 225 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 225 PQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 11234678999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=331.79 Aligned_cols=244 Identities=23% Similarity=0.306 Sum_probs=194.4
Q ss_pred CeeeccCcEEEEEEEec-CCcEEEEEEcccCCc---ccHHHHHHHHHHHHhc-cCCCeeeEEEEEEeCCceEEEEEeecC
Q 002774 561 NDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM---QGGQEFKMEIELLSRV-HHKNLVSLLGFCFDRGEQMLIYEFVPN 635 (882)
Q Consensus 561 ~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~~ 635 (882)
++||+|+||+||+|+.. +++.||||+++.... ...+.+.+|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999864 688999999975422 2234578899999998 699999999999999999999999999
Q ss_pred CCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCceee
Q 002774 636 GSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHIT 715 (882)
Q Consensus 636 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 715 (882)
|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--~~~ 153 (329)
T cd05588 81 GDLMFHMQRQR--KLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG--DTT 153 (329)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccCC--Ccc
Confidence 99988886543 6899999999999999999999998 9999999999999999999999999987532211 123
Q ss_pred eeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCc-------hHHHHHHHHHHhhhhhhhhhhccCCc
Q 002774 716 TQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGK-------YIVREIRTVMDKKKELYNLYELIDPT 788 (882)
Q Consensus 716 ~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~d~~ 788 (882)
....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ...+.....+... ...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~----------~~~ 223 (329)
T cd05588 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEK----------QIR 223 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcC----------CCC
Confidence 34579999999999999999999999999999999999999996211 1111111111110 001
Q ss_pred CCCCCCHHHHHHHHHHHHHhhccCCCCCCC------HHHHHHH
Q 002774 789 IGLSTTLKGFEKYVDLALKCVQESGDDRPT------MSEVVKD 825 (882)
Q Consensus 789 l~~~~~~~~~~~l~~li~~cl~~dp~~RPs------~~evl~~ 825 (882)
+ +.....++.+++.+||+.||.+||+ +++++++
T Consensus 224 ~----p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 224 I----PRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred C----CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 1 1112356889999999999999997 6777754
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=320.30 Aligned_cols=250 Identities=26% Similarity=0.443 Sum_probs=205.7
Q ss_pred CCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccC--CcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEe
Q 002774 556 NFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQG--SMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEF 632 (882)
Q Consensus 556 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 632 (882)
+|...+.||+|+||.||+|+.. +++.||+|.+... .....+++.+|+++++.++||||+++++++.+++..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4677789999999999999864 6899999998643 233456788999999999999999999999999999999999
Q ss_pred ecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCc
Q 002774 633 VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKD 712 (882)
Q Consensus 633 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 712 (882)
+++++|.++++......+++.++..++.+++.||.|||+.+ ++||||||+||++++++.++|+|||+++.+.....
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~- 156 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN- 156 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc-
Confidence 99999999997654557899999999999999999999988 99999999999999999999999999987654322
Q ss_pred eeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCCCC
Q 002774 713 HITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLS 792 (882)
Q Consensus 713 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 792 (882)
......|++.|+|||+..+..++.++|||||||++|||++|+.||..... .......... .. +..
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~~---------~~-~~~--- 221 (256)
T cd08529 157 -FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ-GALILKIIRG---------VF-PPV--- 221 (256)
T ss_pred -hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHcC---------CC-CCC---
Confidence 12334688999999999999999999999999999999999999975442 1111111110 00 111
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 793 TTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 793 ~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
.......+.+++.+||+.+|++||++.+++++
T Consensus 222 -~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 222 -SQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred -ccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 11234678999999999999999999999874
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=334.00 Aligned_cols=246 Identities=31% Similarity=0.451 Sum_probs=203.7
Q ss_pred eeeccCcEEEEEEEec-CCcEEEEEEcccCCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEeecCCCccc
Q 002774 562 DVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGD 640 (882)
Q Consensus 562 ~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~~ 640 (882)
+||+|.||+||.|+.. +...+|||-+.....+..+.+.+|+.+.+.++|+|||+++|.|.+++..-+.||-+|||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 7999999999999964 466789999987777777889999999999999999999999999999999999999999999
Q ss_pred ccCCCCC-ccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEc-CCCceeEeecccccccCCCCCceeeeee
Q 002774 641 SLSGKNG-IRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLD-ERLNAKVADFGLSKSMSDSEKDHITTQV 718 (882)
Q Consensus 641 ~l~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~-~~~~~kl~DfGla~~~~~~~~~~~~~~~ 718 (882)
.++...+ ..-.+.++-.+..||++||.|||+.. |||||||-+||||+ -.|.+||+|||.++.+... +..+..+
T Consensus 662 LLrskWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi--nP~TETF 736 (1226)
T KOG4279|consen 662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI--NPCTETF 736 (1226)
T ss_pred HHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccC--Ccccccc
Confidence 9987653 22367778889999999999999988 99999999999996 4789999999999887543 3456678
Q ss_pred eccCCCCCHHHHhhC--CCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCCCCCCHH
Q 002774 719 KGTMGYLDPEYYMTQ--QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLK 796 (882)
Q Consensus 719 ~gt~~y~aPE~~~~~--~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 796 (882)
.||.-|||||++..+ .|..++|||||||++.||.||++||..-......+-++- ++ ..-|.+ +.+
T Consensus 737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVG--------my-KvHP~i----Pee 803 (1226)
T KOG4279|consen 737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVG--------MY-KVHPPI----PEE 803 (1226)
T ss_pred ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhc--------ce-ecCCCC----cHH
Confidence 899999999999854 689999999999999999999999975443322221110 11 112222 334
Q ss_pred HHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 797 GFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 797 ~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
...+...+|.+|+.+||.+||++++++++
T Consensus 804 lsaeak~FilrcFepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 804 LSAEAKNFILRCFEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred HHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence 45778899999999999999999999975
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=322.45 Aligned_cols=258 Identities=22% Similarity=0.351 Sum_probs=207.6
Q ss_pred cCCCCCCeeeccCcEEEEEEEe-cCCcEEEEEEcccCCc---ccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEE
Q 002774 555 NNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSM---QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIY 630 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 630 (882)
++|...+.||+|+||.||+|+. .+++.||||.+..... ...+++.+|+++++.++|+||+++++++.+++..++||
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 3577788999999999999995 5789999998865322 23357889999999999999999999999999999999
Q ss_pred EeecCCCcccccCCC--CCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCC
Q 002774 631 EFVPNGSLGDSLSGK--NGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSD 708 (882)
Q Consensus 631 e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~ 708 (882)
||+++++|.+++... ....+++.++..++.|++.||+|||+.+ ++|+||||+||+++.++.++++|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 999999999987632 2346899999999999999999999998 99999999999999999999999999886643
Q ss_pred CCCceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCc
Q 002774 709 SEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPT 788 (882)
Q Consensus 709 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 788 (882)
... ......|+..|+|||++.+..++.++||||||+++|||++|..||............... ....+.
T Consensus 159 ~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---------~~~~~~ 227 (267)
T cd08229 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE---------QCDYPP 227 (267)
T ss_pred CCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhh---------cCCCCC
Confidence 221 122346889999999999889999999999999999999999998643321111111110 111111
Q ss_pred CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 002774 789 IGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENI 829 (882)
Q Consensus 789 l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 829 (882)
.. .......+.+++.+||+.+|++|||+.+|++.++++
T Consensus 228 ~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 228 LP---SDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred CC---cccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 11 112446789999999999999999999999998876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=334.76 Aligned_cols=245 Identities=25% Similarity=0.350 Sum_probs=194.8
Q ss_pred CCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCC---cccHHHHHHHHHHH---HhccCCCeeeEEEEEEeCCceEEE
Q 002774 557 FSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS---MQGGQEFKMEIELL---SRVHHKNLVSLLGFCFDRGEQMLI 629 (882)
Q Consensus 557 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~H~niv~l~~~~~~~~~~~lV 629 (882)
|...+.||+|+||+||+|... +++.||||+++... ....+.+.+|.+++ +.++||||+++++++.+.+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 566789999999999999864 68999999997532 12234566676655 456799999999999999999999
Q ss_pred EEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCC
Q 002774 630 YEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDS 709 (882)
Q Consensus 630 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~ 709 (882)
|||+++|+|..+++.. .+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++.....
T Consensus 81 ~E~~~~~~L~~~~~~~---~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05589 81 MEYAAGGDLMMHIHTD---VFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF 154 (324)
T ss_pred EcCCCCCcHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence 9999999998888643 5899999999999999999999998 999999999999999999999999998754322
Q ss_pred CCceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcC
Q 002774 710 EKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTI 789 (882)
Q Consensus 710 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 789 (882)
. .......|++.|||||.+.+..++.++|||||||++|||++|+.||..... .+....+.... +..
T Consensus 155 ~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~-~~~~~~i~~~~-----------~~~ 220 (324)
T cd05589 155 G--DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE-EEVFDSIVNDE-----------VRY 220 (324)
T ss_pred C--CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhCC-----------CCC
Confidence 2 122345699999999999999999999999999999999999999965432 12221111110 001
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 002774 790 GLSTTLKGFEKYVDLALKCVQESGDDRP-----TMSEVVKD 825 (882)
Q Consensus 790 ~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~evl~~ 825 (882)
+......+.+++.+||+.||.+|| ++.+++++
T Consensus 221 ----p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 221 ----PRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred ----CCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 111236788999999999999999 56666654
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=315.65 Aligned_cols=248 Identities=26% Similarity=0.435 Sum_probs=210.0
Q ss_pred CCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEeecC
Q 002774 557 FSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPN 635 (882)
Q Consensus 557 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~ 635 (882)
|.+..+||+|+||.||||.++ .|++||||++... .+.+++..|+.+|++.+.|++|+++|.+......|+|||||.-
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 556788999999999999865 6999999998754 4568899999999999999999999999999999999999999
Q ss_pred CCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCceee
Q 002774 636 GSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHIT 715 (882)
Q Consensus 636 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 715 (882)
|+..+.++.++ +++++.++..+..+.++||+|||... -+|||||+.|||++.+|.+|++|||.|..+.+.-. ..
T Consensus 113 GSiSDI~R~R~-K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA--KR 186 (502)
T KOG0574|consen 113 GSISDIMRARR-KPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA--KR 186 (502)
T ss_pred CcHHHHHHHhc-CCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhHH--hh
Confidence 99999998653 58999999999999999999999988 89999999999999999999999999987754321 22
Q ss_pred eeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCCCCCCH
Q 002774 716 TQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTL 795 (882)
Q Consensus 716 ~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 795 (882)
..+.||+.|||||++..-.|+.++||||+|+...||..|++||.+-.. .+.++-+... |......+.
T Consensus 187 NTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHP-----------MRAIFMIPT~--PPPTF~KPE 253 (502)
T KOG0574|consen 187 NTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHP-----------MRAIFMIPTK--PPPTFKKPE 253 (502)
T ss_pred CccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccc-----------cceeEeccCC--CCCCCCChH
Confidence 356799999999999999999999999999999999999999964211 1111112222 222234555
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 796 KGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 796 ~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
....++.+++++|+.+.|++|-|+.+++++
T Consensus 254 ~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 254 EWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred hhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 667889999999999999999999999875
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=344.26 Aligned_cols=253 Identities=24% Similarity=0.352 Sum_probs=198.1
Q ss_pred cCCCCCCeeeccCcEEEEEEEe-cCCcEEEEEEcccCC---cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEE
Q 002774 555 NNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGS---MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIY 630 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 630 (882)
++|...+.||+|+||+||+|+. .+++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 3688889999999999999985 478999999986532 122356788999999999999999999999999999999
Q ss_pred EeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCC
Q 002774 631 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE 710 (882)
Q Consensus 631 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~ 710 (882)
||+++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 81 E~~~gg~L~~~l~~~~--~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~ 155 (377)
T cd05629 81 EFLPGGDLMTMLIKYD--TFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH 155 (377)
T ss_pred eCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 9999999999987543 5788888899999999999999999 9999999999999999999999999996432210
Q ss_pred Cc---------------------------------------------eeeeeeeccCCCCCHHHHhhCCCCchhHHHHHH
Q 002774 711 KD---------------------------------------------HITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFG 745 (882)
Q Consensus 711 ~~---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G 745 (882)
.. .......||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 235 (377)
T cd05629 156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLG 235 (377)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecc
Confidence 00 000124699999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCC---CCHHHH
Q 002774 746 VLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDR---PTMSEV 822 (882)
Q Consensus 746 vll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~R---Ps~~ev 822 (882)
|++|||++|..||..... .+....+..... .+..........++.+++.+|++ +|.+| +++.|+
T Consensus 236 vil~elltG~~Pf~~~~~-~~~~~~i~~~~~-----------~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~ 302 (377)
T cd05629 236 AIMFECLIGWPPFCSENS-HETYRKIINWRE-----------TLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEI 302 (377)
T ss_pred hhhhhhhcCCCCCCCCCH-HHHHHHHHccCC-----------ccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHH
Confidence 999999999999965432 222222211100 00001111123568899999997 66665 699999
Q ss_pred HHH
Q 002774 823 VKD 825 (882)
Q Consensus 823 l~~ 825 (882)
+++
T Consensus 303 l~h 305 (377)
T cd05629 303 KSH 305 (377)
T ss_pred hcC
Confidence 976
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=331.52 Aligned_cols=244 Identities=23% Similarity=0.312 Sum_probs=193.2
Q ss_pred CeeeccCcEEEEEEEec-CCcEEEEEEcccCCc---ccHHHHHHHHHHHHhc-cCCCeeeEEEEEEeCCceEEEEEeecC
Q 002774 561 NDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM---QGGQEFKMEIELLSRV-HHKNLVSLLGFCFDRGEQMLIYEFVPN 635 (882)
Q Consensus 561 ~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~~ 635 (882)
+.||+|+||+||+|+.. +++.||+|+++.... ...+.+.+|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999864 688999999976422 2334577889888877 799999999999999999999999999
Q ss_pred CCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCceee
Q 002774 636 GSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHIT 715 (882)
Q Consensus 636 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 715 (882)
|+|..++.... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++...... ...
T Consensus 81 ~~L~~~~~~~~--~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~--~~~ 153 (329)
T cd05618 81 GDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DTT 153 (329)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCC--Ccc
Confidence 99988876543 6889999999999999999999998 9999999999999999999999999997543222 122
Q ss_pred eeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCc-------hHHHHHHHHHHhhhhhhhhhhccCCc
Q 002774 716 TQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGK-------YIVREIRTVMDKKKELYNLYELIDPT 788 (882)
Q Consensus 716 ~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~d~~ 788 (882)
....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ....+........ ...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~----------~~~ 223 (329)
T cd05618 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK----------QIR 223 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcC----------CCC
Confidence 34579999999999999999999999999999999999999995211 1111111111110 001
Q ss_pred CCCCCCHHHHHHHHHHHHHhhccCCCCCCC------HHHHHHH
Q 002774 789 IGLSTTLKGFEKYVDLALKCVQESGDDRPT------MSEVVKD 825 (882)
Q Consensus 789 l~~~~~~~~~~~l~~li~~cl~~dp~~RPs------~~evl~~ 825 (882)
+ +.....++.+++.+||+.||++||+ +.+++++
T Consensus 224 ~----p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 224 I----PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred C----CCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 1 1122367889999999999999998 4677654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=306.71 Aligned_cols=252 Identities=23% Similarity=0.329 Sum_probs=203.6
Q ss_pred HcCCCCCCeeeccCcEEEEEEEe-cCCcEEEEEEccc--CCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEE
Q 002774 554 TNNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQ--GSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIY 630 (882)
Q Consensus 554 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 630 (882)
++.|+..++||+|.|+.||++.. .+|+.+|+|.+.. -+..+.+++.+|+.+-+.|+|||||++...+.+.+..|+|+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 45677778899999999999974 5789999988753 23446688999999999999999999999999999999999
Q ss_pred EeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEc---CCCceeEeecccccccC
Q 002774 631 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLD---ERLNAKVADFGLSKSMS 707 (882)
Q Consensus 631 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~---~~~~~kl~DfGla~~~~ 707 (882)
|+|.+++|..-+-.+ .-+++..+-..+.||+++|.|+|..+ |||||+||+|+++- ...-+|++|||+|..+.
T Consensus 90 e~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~ 164 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN 164 (355)
T ss_pred ecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence 999999997655433 35778888899999999999999999 99999999999994 33458999999999887
Q ss_pred CCCCceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCC
Q 002774 708 DSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDP 787 (882)
Q Consensus 708 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 787 (882)
++ .......|||+|||||++...+|+..+|||+.||+||-++.|..||.+... .+....++... ++. +
T Consensus 165 ~g---~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~-~rlye~I~~g~------yd~-~- 232 (355)
T KOG0033|consen 165 DG---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-HRLYEQIKAGA------YDY-P- 232 (355)
T ss_pred Cc---cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccH-HHHHHHHhccc------cCC-C-
Confidence 32 345678899999999999999999999999999999999999999975322 12222222211 111 1
Q ss_pred cCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 788 TIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 788 ~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
........++..+|+++|+..||.+|.|+.|.+++
T Consensus 233 ---~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 233 ---SPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred ---CcccCcCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence 11222333677899999999999999999999854
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=343.89 Aligned_cols=253 Identities=23% Similarity=0.324 Sum_probs=202.0
Q ss_pred HcCCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCC---cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEE
Q 002774 554 TNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS---MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLI 629 (882)
Q Consensus 554 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 629 (882)
.++|...+.||+|+||+||+|+.. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+++..++|
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv 121 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV 121 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence 457888999999999999999864 68899999986432 22334577899999999999999999999999999999
Q ss_pred EEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCC
Q 002774 630 YEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDS 709 (882)
Q Consensus 630 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~ 709 (882)
|||+++|+|.+++... .++...+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 122 ~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~ 195 (370)
T cd05596 122 MEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN 195 (370)
T ss_pred EcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeeccCC
Confidence 9999999999988654 4777888889999999999999998 999999999999999999999999999876433
Q ss_pred CCceeeeeeeccCCCCCHHHHhhC----CCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhcc
Q 002774 710 EKDHITTQVKGTMGYLDPEYYMTQ----QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELI 785 (882)
Q Consensus 710 ~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 785 (882)
.. .......||+.|+|||++... .++.++|||||||++|||++|+.||..... ......+.....
T Consensus 196 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~-~~~~~~i~~~~~--------- 264 (370)
T cd05596 196 GM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL-VGTYSKIMDHKN--------- 264 (370)
T ss_pred Cc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH-HHHHHHHHcCCC---------
Confidence 21 112345699999999998753 478999999999999999999999975433 222222221111
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 002774 786 DPTIGLSTTLKGFEKYVDLALKCVQESGDD--RPTMSEVVKD 825 (882)
Q Consensus 786 d~~l~~~~~~~~~~~l~~li~~cl~~dp~~--RPs~~evl~~ 825 (882)
.+..........++.+++.+|++.+|++ |+++.|++++
T Consensus 265 --~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 265 --SLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred --cCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 0111111123467889999999999988 9999999876
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=319.12 Aligned_cols=248 Identities=25% Similarity=0.427 Sum_probs=196.3
Q ss_pred eeeccCcEEEEEEEec---CCcEEEEEEcccCCcc-cHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEeecCCC
Q 002774 562 DVGSGGYGKVYKGTLP---NGQLIAIKRAQQGSMQ-GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGS 637 (882)
Q Consensus 562 ~lG~G~fg~Vy~~~~~---~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 637 (882)
.||+|+||.||+|++. ++..||+|++...... ..+.+.+|+.++++++||||+++++++. .+..++||||+++|+
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 3899999999999763 3567999998765332 3356889999999999999999999875 457899999999999
Q ss_pred cccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCcee-ee
Q 002774 638 LGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHI-TT 716 (882)
Q Consensus 638 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~-~~ 716 (882)
|.+++.... ..+++..+.+++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++.......... ..
T Consensus 81 L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05115 81 LNKFLSGKK-DEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARS 156 (257)
T ss_pred HHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceeccC
Confidence 999886532 36899999999999999999999998 99999999999999999999999999986544322111 11
Q ss_pred eeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCCCCCCH
Q 002774 717 QVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTL 795 (882)
Q Consensus 717 ~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 795 (882)
...++..|+|||.+....++.++|||||||++||+++ |..||...... +.... ..... ....+.
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-~~~~~-~~~~~-------------~~~~~~ 221 (257)
T cd05115 157 AGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP-EVMSF-IEQGK-------------RLDCPA 221 (257)
T ss_pred CCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH-HHHHH-HHCCC-------------CCCCCC
Confidence 2234578999999988889999999999999999996 99999654321 11111 11111 011122
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 002774 796 KGFEKYVDLALKCVQESGDDRPTMSEVVKDIENI 829 (882)
Q Consensus 796 ~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 829 (882)
....++.+++.+||+.+|++||++.+|.+.|+.+
T Consensus 222 ~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 222 ECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 2347888999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=333.89 Aligned_cols=242 Identities=25% Similarity=0.338 Sum_probs=194.3
Q ss_pred CeeeccCcEEEEEEEec-CCcEEEEEEcccCC---cccHHHHHHHHHHHHhc-cCCCeeeEEEEEEeCCceEEEEEeecC
Q 002774 561 NDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS---MQGGQEFKMEIELLSRV-HHKNLVSLLGFCFDRGEQMLIYEFVPN 635 (882)
Q Consensus 561 ~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~~ 635 (882)
+.||+|+||+||+|+.. +++.||||+++... ....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999864 68899999987532 22335567788888877 699999999999999999999999999
Q ss_pred CCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCceee
Q 002774 636 GSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHIT 715 (882)
Q Consensus 636 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 715 (882)
|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~i~~~~--~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~~~ 153 (320)
T cd05590 81 GDLMFHIQKSR--RFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KTT 153 (320)
T ss_pred chHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--Ccc
Confidence 99998886543 5889999999999999999999998 9999999999999999999999999987543221 123
Q ss_pred eeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCCCCCCH
Q 002774 716 TQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTL 795 (882)
Q Consensus 716 ~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 795 (882)
....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+.... . .. +.
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~-~~~~~~i~~~~--------~---~~----~~ 217 (320)
T cd05590 154 STFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE-DDLFEAILNDE--------V---VY----PT 217 (320)
T ss_pred cccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH-HHHHHHHhcCC--------C---CC----CC
Confidence 345699999999999988999999999999999999999999975432 22222211110 0 00 11
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCH------HHHHHH
Q 002774 796 KGFEKYVDLALKCVQESGDDRPTM------SEVVKD 825 (882)
Q Consensus 796 ~~~~~l~~li~~cl~~dp~~RPs~------~evl~~ 825 (882)
....++.+++.+||+.||++||++ ++++++
T Consensus 218 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h 253 (320)
T cd05590 218 WLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH 253 (320)
T ss_pred CCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence 123678899999999999999998 566553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=334.33 Aligned_cols=242 Identities=24% Similarity=0.332 Sum_probs=195.3
Q ss_pred CeeeccCcEEEEEEEec-CCcEEEEEEcccCC---cccHHHHHHHHHHHHhc-cCCCeeeEEEEEEeCCceEEEEEeecC
Q 002774 561 NDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS---MQGGQEFKMEIELLSRV-HHKNLVSLLGFCFDRGEQMLIYEFVPN 635 (882)
Q Consensus 561 ~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~~ 635 (882)
++||+|+||+||+|+.. +++.||||+++... ....+.+..|.+++..+ +||||+++++++.+++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999865 57899999987532 22334567889998876 799999999999999999999999999
Q ss_pred CCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCceee
Q 002774 636 GSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHIT 715 (882)
Q Consensus 636 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 715 (882)
|+|..++.... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++...... ...
T Consensus 81 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~~ 153 (321)
T cd05591 81 GDLMFQIQRSR--KFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--VTT 153 (321)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCC--ccc
Confidence 99998886543 5888999999999999999999998 9999999999999999999999999997643322 123
Q ss_pred eeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCCCCCCH
Q 002774 716 TQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTL 795 (882)
Q Consensus 716 ~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 795 (882)
....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+.... ...| .
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~-~~~~~~i~~~~--------~~~p-------~ 217 (321)
T cd05591 154 TTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE-DDLFESILHDD--------VLYP-------V 217 (321)
T ss_pred cccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCH-HHHHHHHHcCC--------CCCC-------C
Confidence 345699999999999998999999999999999999999999975432 22222211110 0001 1
Q ss_pred HHHHHHHHHHHHhhccCCCCCC-------CHHHHHHH
Q 002774 796 KGFEKYVDLALKCVQESGDDRP-------TMSEVVKD 825 (882)
Q Consensus 796 ~~~~~l~~li~~cl~~dp~~RP-------s~~evl~~ 825 (882)
....++.+++.+||+.||++|| ++++++++
T Consensus 218 ~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 218 WLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 1236788999999999999999 78888765
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=321.06 Aligned_cols=253 Identities=25% Similarity=0.365 Sum_probs=193.2
Q ss_pred CeeeccCcEEEEEEEecC---CcEEEEEEcccCCc-ccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEeecCC
Q 002774 561 NDVGSGGYGKVYKGTLPN---GQLIAIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNG 636 (882)
Q Consensus 561 ~~lG~G~fg~Vy~~~~~~---g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 636 (882)
+.||+|+||.||+|.+.+ +..+|+|+++.... .....+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 358999999999998643 45799999875432 33357888999999999999999999999999999999999999
Q ss_pred CcccccCCCC---CccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCce
Q 002774 637 SLGDSLSGKN---GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDH 713 (882)
Q Consensus 637 sL~~~l~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 713 (882)
+|.++++... ....++..+..++.|+++|++|||+.+ ++||||||+||+++.++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 9999986432 234677788899999999999999988 9999999999999999999999999997654332222
Q ss_pred eeeeeeccCCCCCHHHHhhC-------CCCchhHHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHhhhhhhhhhhcc
Q 002774 714 ITTQVKGTMGYLDPEYYMTQ-------QLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELI 785 (882)
Q Consensus 714 ~~~~~~gt~~y~aPE~~~~~-------~~~~~sDv~S~Gvll~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 785 (882)
......++..|+|||++... .++.++|||||||++|||++ |..||............ .... .....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~-~~~~-----~~~~~ 231 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYT-VREQ-----QLKLP 231 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHH-hhcc-----cCCCC
Confidence 22234577889999998632 35789999999999999997 99999654332211111 1110 11111
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 002774 786 DPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIE 827 (882)
Q Consensus 786 d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~ 827 (882)
++.... .....+.+++.+|| .+|++|||++||++.|+
T Consensus 232 ~~~~~~----~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 232 KPRLKL----PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCccCC----CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 222211 12356788999999 68999999999998764
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=323.44 Aligned_cols=254 Identities=24% Similarity=0.366 Sum_probs=202.4
Q ss_pred cCCCCCCeeeccCcEEEEEEEe-cCCcEEEEEEcccCCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEee
Q 002774 555 NNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFV 633 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 633 (882)
.+|...+.||+|+||.||+|+. .+++.||+|++..........+.+|+.++++++||||+++++++..++..++||||+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 4688889999999999999996 568899999987654444567888999999999999999999999999999999999
Q ss_pred cCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCce
Q 002774 634 PNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDH 713 (882)
Q Consensus 634 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 713 (882)
++++|.++++... .+++.++..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 89 ~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~-- 161 (267)
T cd06646 89 GGGSLQDIYHVTG--PLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIA-- 161 (267)
T ss_pred CCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeeccccc--
Confidence 9999999886543 5789999999999999999999988 99999999999999999999999999986643221
Q ss_pred eeeeeeccCCCCCHHHHh---hCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCC
Q 002774 714 ITTQVKGTMGYLDPEYYM---TQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIG 790 (882)
Q Consensus 714 ~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 790 (882)
......|+..|+|||.+. ...++.++|||||||++|||++|+.||........... . .. .....+...
T Consensus 162 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~-~---~~-----~~~~~~~~~ 232 (267)
T cd06646 162 KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFL-M---SK-----SNFQPPKLK 232 (267)
T ss_pred ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhee-e---ec-----CCCCCCCCc
Confidence 122346889999999985 34578899999999999999999999854322111000 0 00 000011111
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 002774 791 LSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDI 826 (882)
Q Consensus 791 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L 826 (882)
........+.+++.+||+.+|++||+++++++++
T Consensus 233 --~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 233 --DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred --cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 1112346788999999999999999999998764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=320.21 Aligned_cols=255 Identities=29% Similarity=0.481 Sum_probs=208.2
Q ss_pred HcCCCCCCeeeccCcEEEEEEEecCCcEEEEEEcccCCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEee
Q 002774 554 TNNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFV 633 (882)
Q Consensus 554 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 633 (882)
.++|...++||+|+||+||+|..++++.||||.+..... ..+++.+|+.++++++|+||+++++++......++||||+
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM 83 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence 457888899999999999999988888999999886433 3467999999999999999999999999889999999999
Q ss_pred cCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCce
Q 002774 634 PNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDH 713 (882)
Q Consensus 634 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 713 (882)
++++|.+++.......+++.++..++.+++.|++|||+.+ ++|+||||+||++++++.+|++|||+++....... .
T Consensus 84 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~-~ 159 (261)
T cd05034 84 SKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEY-T 159 (261)
T ss_pred CCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhh-h
Confidence 9999999998765557899999999999999999999998 99999999999999999999999999987653221 1
Q ss_pred eeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCCCC
Q 002774 714 ITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLS 792 (882)
Q Consensus 714 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 792 (882)
......++..|+|||.+.+..++.++||||||+++|||++ |+.||..... .......... ... .
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~-~~~~~~~~~~----------~~~----~ 224 (261)
T cd05034 160 AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN-REVLEQVERG----------YRM----P 224 (261)
T ss_pred hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHHcC----------CCC----C
Confidence 1112235678999999998899999999999999999999 8988864322 1211111110 000 0
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 002774 793 TTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIEN 828 (882)
Q Consensus 793 ~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~ 828 (882)
.....+.++.+++.+||+.+|++||+++++.+.|+.
T Consensus 225 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 225 RPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 111124678999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=325.40 Aligned_cols=260 Identities=22% Similarity=0.364 Sum_probs=204.2
Q ss_pred HHcCCCCCCeeeccCcEEEEEEEec------CCcEEEEEEcccCCc-ccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCc
Q 002774 553 YTNNFSDANDVGSGGYGKVYKGTLP------NGQLIAIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGE 625 (882)
Q Consensus 553 ~~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 625 (882)
.+++|...++||+|+||.||+|... .+..||+|.++.... .....+.+|+.+++.++||||+++++++.+.+.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 3567889999999999999999753 245899998875432 233567889999999999999999999999999
Q ss_pred eEEEEEeecCCCcccccCCCC--------CccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeE
Q 002774 626 QMLIYEFVPNGSLGDSLSGKN--------GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKV 697 (882)
Q Consensus 626 ~~lV~e~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl 697 (882)
.++||||+++|+|.+++.... ....++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence 999999999999999986422 134567788999999999999999988 999999999999999999999
Q ss_pred eecccccccCCCCCceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHhhh
Q 002774 698 ADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKK 776 (882)
Q Consensus 698 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~t-g~~P~~~~~~~~~~~~~~~~~~~ 776 (882)
+|||+++...............++..|+|||.+.++.++.++|||||||++|||++ |..||.... ..+........ .
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~-~~~~~~~~~~~-~ 238 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS-NEQVLKFVMDG-G 238 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCC-HHHHHHHHHcC-C
Confidence 99999986544332221222345678999999998899999999999999999999 677875422 11211111111 0
Q ss_pred hhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 002774 777 ELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENIL 830 (882)
Q Consensus 777 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~ 830 (882)
.+. .....+..+.+++.+||+.||++|||+.++++.+.+.+
T Consensus 239 ---------~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 239 ---------YLD----QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred ---------CCC----CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 000 11122367899999999999999999999999888763
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=330.20 Aligned_cols=241 Identities=26% Similarity=0.362 Sum_probs=192.6
Q ss_pred CeeeccCcEEEEEEEec-CCcEEEEEEcccCC---cccHHHHHHHHHHHHhc-cCCCeeeEEEEEEeCCceEEEEEeecC
Q 002774 561 NDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS---MQGGQEFKMEIELLSRV-HHKNLVSLLGFCFDRGEQMLIYEFVPN 635 (882)
Q Consensus 561 ~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~~ 635 (882)
+.||+|+||+||+|+.. +++.||||+++... ....+.+..|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999965 57899999987532 12334566788888764 899999999999999999999999999
Q ss_pred CCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCceee
Q 002774 636 GSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHIT 715 (882)
Q Consensus 636 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 715 (882)
|+|.+++.... .+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~ 153 (316)
T cd05619 81 GDLMFHIQSCH--KFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--AKT 153 (316)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--Cce
Confidence 99999887543 5788899999999999999999998 9999999999999999999999999987543222 122
Q ss_pred eeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCCCCCCH
Q 002774 716 TQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTL 795 (882)
Q Consensus 716 ~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 795 (882)
....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+....+ .. ..+... .
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~-~~~~~~i-~~----------~~~~~~----~ 217 (316)
T cd05619 154 CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE-EELFQSI-RM----------DNPCYP----R 217 (316)
T ss_pred eeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH-HHHHHHH-Hh----------CCCCCC----c
Confidence 345699999999999998999999999999999999999999975432 1111111 10 011111 1
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCHH-HHHH
Q 002774 796 KGFEKYVDLALKCVQESGDDRPTMS-EVVK 824 (882)
Q Consensus 796 ~~~~~l~~li~~cl~~dp~~RPs~~-evl~ 824 (882)
....++.+++.+||+.||++||++. ++.+
T Consensus 218 ~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 218 WLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred cCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 1235678999999999999999997 5654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=318.74 Aligned_cols=258 Identities=24% Similarity=0.376 Sum_probs=208.4
Q ss_pred cCCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCC---cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEE
Q 002774 555 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS---MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIY 630 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 630 (882)
++|+..+.||+|+||.||+|... +|+.||+|.++... ....+.+.+|++++++++|+||+++++++.+.+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57888899999999999999976 78999999886432 223467889999999999999999999999999999999
Q ss_pred EeecCCCcccccCCC--CCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCC
Q 002774 631 EFVPNGSLGDSLSGK--NGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSD 708 (882)
Q Consensus 631 e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~ 708 (882)
||+++|+|.+++... ....+++.++..++.+++.||+|||+.+ |+||||+|+||+++.++.++|+|||+++....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 999999999887542 2345889999999999999999999998 99999999999999999999999999886543
Q ss_pred CCCceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCc
Q 002774 709 SEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPT 788 (882)
Q Consensus 709 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 788 (882)
... ......++..|+|||.+.+..++.++|||||||++|||++|+.||................. ..+.
T Consensus 159 ~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---------~~~~ 227 (267)
T cd08224 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKC---------DYPP 227 (267)
T ss_pred CCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcC---------CCCC
Confidence 221 12234688999999999988999999999999999999999999864432111111111100 0011
Q ss_pred CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 002774 789 IGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENI 829 (882)
Q Consensus 789 l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 829 (882)
.. .......+.+++.+||..+|++||++.++++.++.+
T Consensus 228 ~~---~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 228 LP---ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred CC---hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 11 112346788999999999999999999999998876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=325.08 Aligned_cols=262 Identities=23% Similarity=0.405 Sum_probs=201.8
Q ss_pred cCCCCCCeeeccCcEEEEEEEec-----------------CCcEEEEEEcccCCc-ccHHHHHHHHHHHHhccCCCeeeE
Q 002774 555 NNFSDANDVGSGGYGKVYKGTLP-----------------NGQLIAIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLVSL 616 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~~~~~-----------------~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l 616 (882)
++|+..+.||+|+||+||++... ++..||+|+++.... ...+++.+|+++++.++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 46888899999999999998532 244799999875432 234678999999999999999999
Q ss_pred EEEEEeCCceEEEEEeecCCCcccccCCCC---------CccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCce
Q 002774 617 LGFCFDRGEQMLIYEFVPNGSLGDSLSGKN---------GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNI 687 (882)
Q Consensus 617 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~---------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NI 687 (882)
++++..++..++||||+++|+|.+++.... ...+++.++..++.|++.||+|||+.+ ++||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheE
Confidence 999999999999999999999999886532 124778899999999999999999998 99999999999
Q ss_pred EEcCCCceeEeecccccccCCCCCceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHh--CCCCCCCCchHH
Q 002774 688 LLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT--GRRPIERGKYIV 765 (882)
Q Consensus 688 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~t--g~~P~~~~~~~~ 765 (882)
++++++.++|+|||+++.+.............+++.|+|||....+.++.++|||||||++|||++ |..||..... .
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~-~ 240 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD-E 240 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh-H
Confidence 999999999999999986644332222222345678999999988899999999999999999998 6778754322 1
Q ss_pred HHHHHHHHhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 002774 766 REIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIE 827 (882)
Q Consensus 766 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~ 827 (882)
+.......... .............++..+.+++.+||+.||++||++.||++.|+
T Consensus 241 ~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 241 QVIENTGEFFR-------DQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred HHHHHHHHHHh-------hccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 11111110000 00000000111123467899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=326.57 Aligned_cols=270 Identities=26% Similarity=0.424 Sum_probs=202.3
Q ss_pred CCCCCCeeeccCcEEEEEEEe-----cCCcEEEEEEcccCC-cccHHHHHHHHHHHHhccCCCeeeEEEEEEeC--CceE
Q 002774 556 NFSDANDVGSGGYGKVYKGTL-----PNGQLIAIKRAQQGS-MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDR--GEQM 627 (882)
Q Consensus 556 ~~~~~~~lG~G~fg~Vy~~~~-----~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~ 627 (882)
.|...+.||+|+||.||+|++ .++..||+|.++... ....+.+.+|+++++.++||||+++.+++.+. ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 467788999999999999974 357899999987543 22346789999999999999999999998875 5688
Q ss_pred EEEEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccC
Q 002774 628 LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMS 707 (882)
Q Consensus 628 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~ 707 (882)
+||||+++++|.+++.... ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++.+.
T Consensus 85 lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIE 160 (284)
T ss_pred EEEEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccccc
Confidence 9999999999999986542 35899999999999999999999998 9999999999999999999999999998765
Q ss_pred CCCCc-eeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccC
Q 002774 708 DSEKD-HITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELID 786 (882)
Q Consensus 708 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 786 (882)
..... .......++..|+|||++.+..++.++|||||||++|||++++.|...........................+.
T Consensus 161 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05079 161 TDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLE 240 (284)
T ss_pred cCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHH
Confidence 43221 11223456778999999998899999999999999999999877653221100000000000000000000000
Q ss_pred CcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 002774 787 PTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENI 829 (882)
Q Consensus 787 ~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 829 (882)
...........+.++.+++.+||+.+|++||+++++++.++++
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 241 EGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred cCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 0000111122347899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=329.47 Aligned_cols=261 Identities=25% Similarity=0.459 Sum_probs=205.3
Q ss_pred cCCCCCCeeeccCcEEEEEEEec--------CCcEEEEEEcccCCc-ccHHHHHHHHHHHHhc-cCCCeeeEEEEEEeCC
Q 002774 555 NNFSDANDVGSGGYGKVYKGTLP--------NGQLIAIKRAQQGSM-QGGQEFKMEIELLSRV-HHKNLVSLLGFCFDRG 624 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~~~~~--------~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~ 624 (882)
++|...+.||+|+||.||+|+.. ....||+|+++.... ....++..|+++++++ +||||+++++++.+.+
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 46778899999999999999742 245799999875432 2345688999999999 6999999999999999
Q ss_pred ceEEEEEeecCCCcccccCCCC--------------CccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEc
Q 002774 625 EQMLIYEFVPNGSLGDSLSGKN--------------GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLD 690 (882)
Q Consensus 625 ~~~lV~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~ 690 (882)
..++||||+++|+|.+++.... ...+++.++.+++.|++.||+|||+.+ ++||||||+||+++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~ 168 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLVT 168 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEEc
Confidence 9999999999999999886432 235889999999999999999999988 99999999999999
Q ss_pred CCCceeEeecccccccCCCCCceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHh-CCCCCCCCchHHHHHH
Q 002774 691 ERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIR 769 (882)
Q Consensus 691 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~t-g~~P~~~~~~~~~~~~ 769 (882)
+++.+||+|||+++...............++..|||||.+.+..++.++|||||||++|||++ |..||.... ..+...
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~-~~~~~~ 247 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIP-VEELFK 247 (314)
T ss_pred CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCC-HHHHHH
Confidence 999999999999986643322111112234567999999998899999999999999999999 888885432 111111
Q ss_pred HHHHhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHc
Q 002774 770 TVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQA 833 (882)
Q Consensus 770 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~ 833 (882)
. ..... ........+.++.+++.+||+.+|++||++.|+++.|+++....
T Consensus 248 ~-~~~~~-------------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 297 (314)
T cd05099 248 L-LREGH-------------RMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAV 297 (314)
T ss_pred H-HHcCC-------------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHh
Confidence 1 11110 00111223467889999999999999999999999999986553
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=302.23 Aligned_cols=263 Identities=27% Similarity=0.393 Sum_probs=212.6
Q ss_pred HHHHHcCCCCCCeeeccCcEEEEEEEe-cCCcEEEEEEcccCCcc----cH----HHHHHHHHHHHhc-cCCCeeeEEEE
Q 002774 550 VKKYTNNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQ----GG----QEFKMEIELLSRV-HHKNLVSLLGF 619 (882)
Q Consensus 550 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~----~~----~~~~~E~~~l~~l-~H~niv~l~~~ 619 (882)
-+...+.|...++||+|..++|-++.. .+|+.+|+|++...... .. ++-.+|+++|+++ .||+|+++.++
T Consensus 12 a~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ 91 (411)
T KOG0599|consen 12 AKGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDV 91 (411)
T ss_pred HhhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeee
Confidence 345667888889999999999999875 46889999998643221 11 3345699999998 59999999999
Q ss_pred EEeCCceEEEEEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEee
Q 002774 620 CFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVAD 699 (882)
Q Consensus 620 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~D 699 (882)
+..+...++|+|.|+.|.|.|+|...- .+++.+..+|+.|+.+|++|||... ||||||||+|||+|++.++||+|
T Consensus 92 yes~sF~FlVFdl~prGELFDyLts~V--tlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isD 166 (411)
T KOG0599|consen 92 YESDAFVFLVFDLMPRGELFDYLTSKV--TLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISD 166 (411)
T ss_pred ccCcchhhhhhhhcccchHHHHhhhhe--eecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEec
Confidence 999999999999999999999997653 7899999999999999999999998 99999999999999999999999
Q ss_pred cccccccCCCCCceeeeeeeccCCCCCHHHHh------hCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHH
Q 002774 700 FGLSKSMSDSEKDHITTQVKGTMGYLDPEYYM------TQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMD 773 (882)
Q Consensus 700 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~ 773 (882)
||.|+.+.+++. ....+|||+|+|||.+. ...|+..+|+||+||++|-++.|.+||...+... .++.+++
T Consensus 167 FGFa~~l~~Gek---LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQml-MLR~Ime 242 (411)
T KOG0599|consen 167 FGFACQLEPGEK---LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQML-MLRMIME 242 (411)
T ss_pred cceeeccCCchh---HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHH-HHHHHHh
Confidence 999999877654 34578999999999986 2468889999999999999999999997544322 2233333
Q ss_pred hhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHHHHHH
Q 002774 774 KKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD--IENILQQ 832 (882)
Q Consensus 774 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~--L~~~~~~ 832 (882)
... +. ......+......+||.+|++.||.+|.|++|++++ +..+.++
T Consensus 243 Gky------qF-----~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~~ 292 (411)
T KOG0599|consen 243 GKY------QF-----RSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQQ 292 (411)
T ss_pred ccc------cc-----CCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHHh
Confidence 221 11 111223344667899999999999999999999976 4444443
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=340.69 Aligned_cols=254 Identities=21% Similarity=0.323 Sum_probs=201.0
Q ss_pred HHcCCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCC---cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEE
Q 002774 553 YTNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS---MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQML 628 (882)
Q Consensus 553 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 628 (882)
..++|...+.||+|+||.||+|+.. +++.||+|++.+.. ....+.+.+|+.+++.++||||+++++++.+++..++
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l 120 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM 120 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 3567889999999999999999965 58899999986422 2233567889999999999999999999999999999
Q ss_pred EEEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCC
Q 002774 629 IYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSD 708 (882)
Q Consensus 629 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~ 708 (882)
||||+++|+|.+++... .+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 121 v~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~ 194 (370)
T cd05621 121 VMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE 194 (370)
T ss_pred EEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceeccc
Confidence 99999999999998654 4788889999999999999999998 99999999999999999999999999987643
Q ss_pred CCCceeeeeeeccCCCCCHHHHhhC----CCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhc
Q 002774 709 SEKDHITTQVKGTMGYLDPEYYMTQ----QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYEL 784 (882)
Q Consensus 709 ~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 784 (882)
... .......||+.|||||++... .++.++||||+||++|||++|+.||..... ......+.....
T Consensus 195 ~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~-~~~~~~i~~~~~-------- 264 (370)
T cd05621 195 TGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL-VGTYSKIMDHKN-------- 264 (370)
T ss_pred CCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH-HHHHHHHHhCCc--------
Confidence 321 122345699999999999754 378899999999999999999999975432 222222221111
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 002774 785 IDPTIGLSTTLKGFEKYVDLALKCVQESGDD--RPTMSEVVKD 825 (882)
Q Consensus 785 ~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~--RPs~~evl~~ 825 (882)
.+...........+.+++.+|++.++.+ |+++.|++++
T Consensus 265 ---~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 265 ---SLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred ---ccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 0111111123466789999999865544 8999999986
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=325.33 Aligned_cols=256 Identities=23% Similarity=0.390 Sum_probs=204.3
Q ss_pred HcCCCCCCeeeccCcEEEEEEEec------CCcEEEEEEcccCCc-ccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCce
Q 002774 554 TNNFSDANDVGSGGYGKVYKGTLP------NGQLIAIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQ 626 (882)
Q Consensus 554 ~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 626 (882)
.++|...+.||+|+||.||+|... ++..||+|.+..... .....+.+|+.+++.++||||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 357788899999999999999864 246899999875432 3345788999999999999999999999999999
Q ss_pred EEEEEeecCCCcccccCCCC--------CccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEe
Q 002774 627 MLIYEFVPNGSLGDSLSGKN--------GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVA 698 (882)
Q Consensus 627 ~lV~e~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~ 698 (882)
++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence 99999999999999886432 124788899999999999999999988 9999999999999999999999
Q ss_pred ecccccccCCCCCceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHhhhh
Q 002774 699 DFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKE 777 (882)
Q Consensus 699 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~t-g~~P~~~~~~~~~~~~~~~~~~~~ 777 (882)
|||+++...............++..|+|||.+..+.++.++|||||||++||+++ |..||.... ..+...... ...
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~-~~~~~~~~~-~~~- 238 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLS-NEEVLKFVI-DGG- 238 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCC-HHHHHHHHh-cCC-
Confidence 9999986654332222233456789999999998899999999999999999998 888885432 122111111 110
Q ss_pred hhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 002774 778 LYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIE 827 (882)
Q Consensus 778 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~ 827 (882)
.+.. +...+.++.+++.+||+.+|++|||+.++++.|+
T Consensus 239 --------~~~~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 239 --------HLDL----PENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred --------CCCC----CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 0011 1122467899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=332.46 Aligned_cols=247 Identities=23% Similarity=0.308 Sum_probs=197.1
Q ss_pred CCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCC---cccHHHHHHHHHHHHhccC-CCeeeEEEEEEeCCceEEEE
Q 002774 556 NFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS---MQGGQEFKMEIELLSRVHH-KNLVSLLGFCFDRGEQMLIY 630 (882)
Q Consensus 556 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H-~niv~l~~~~~~~~~~~lV~ 630 (882)
+|...+.||+|+||+||+|+.. +++.||||+++... ....+.+..|.+++..++| ++|+++++++.+.+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4778899999999999999865 57899999987532 2233567789999999975 56889999999999999999
Q ss_pred EeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCC
Q 002774 631 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE 710 (882)
Q Consensus 631 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~ 710 (882)
||+++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 81 E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05587 81 EYVNGGDLMYHIQQVG--KFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG 155 (324)
T ss_pred cCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCCC
Confidence 9999999998886543 5788999999999999999999998 9999999999999999999999999987543222
Q ss_pred CceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCC
Q 002774 711 KDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIG 790 (882)
Q Consensus 711 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 790 (882)
. ......||+.|+|||++.+..++.++||||+||++|||+||+.||..... .+....+... .+..
T Consensus 156 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~-~~~~~~i~~~-----------~~~~- 220 (324)
T cd05587 156 K--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE-DELFQSIMEH-----------NVSY- 220 (324)
T ss_pred C--ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH-HHHHHHHHcC-----------CCCC-
Confidence 1 23345699999999999999999999999999999999999999975432 1222211111 0111
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCH-----HHHHHH
Q 002774 791 LSTTLKGFEKYVDLALKCVQESGDDRPTM-----SEVVKD 825 (882)
Q Consensus 791 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~-----~evl~~ 825 (882)
+.....++.+++.+||+.||.+|++. ++++++
T Consensus 221 ---~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 221 ---PKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred ---CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 11223678899999999999999976 566543
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=318.84 Aligned_cols=249 Identities=28% Similarity=0.471 Sum_probs=205.5
Q ss_pred cCCCCCCeeeccCcEEEEEEEecCCcEEEEEEcccCCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEeec
Q 002774 555 NNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVP 634 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 634 (882)
++|...+.||+|+||.||+|... |+.||+|.++.... ..+.+.+|+.++++++|+||+++++++.+.+..++||||++
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 83 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA 83 (256)
T ss_pred hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence 46778899999999999999875 78999999986544 45778999999999999999999999999999999999999
Q ss_pred CCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCcee
Q 002774 635 NGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHI 714 (882)
Q Consensus 635 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 714 (882)
+++|.+++.......+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||.++.......
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~--- 157 (256)
T cd05039 84 KGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD--- 157 (256)
T ss_pred CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc---
Confidence 999999997665456899999999999999999999998 99999999999999999999999999987632211
Q ss_pred eeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCCCCC
Q 002774 715 TTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLST 793 (882)
Q Consensus 715 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 793 (882)
....+..|+|||++..+.++.++||||||+++|||++ |..||..... .+ ......... .+. .
T Consensus 158 --~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-~~-~~~~~~~~~---------~~~----~ 220 (256)
T cd05039 158 --SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-KD-VVPHVEKGY---------RME----A 220 (256)
T ss_pred --cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH-HH-HHHHHhcCC---------CCC----C
Confidence 2335678999999998899999999999999999998 9888864321 11 111111100 001 1
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 002774 794 TLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIEN 828 (882)
Q Consensus 794 ~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~ 828 (882)
....+..+.+++.+||+.+|++||++.|+++.|+.
T Consensus 221 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 221 PEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred ccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 11234678999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=331.33 Aligned_cols=241 Identities=25% Similarity=0.340 Sum_probs=192.6
Q ss_pred CeeeccCcEEEEEEEec-CCcEEEEEEcccCC---cccHHHHHHHHHHHHhc-cCCCeeeEEEEEEeCCceEEEEEeecC
Q 002774 561 NDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS---MQGGQEFKMEIELLSRV-HHKNLVSLLGFCFDRGEQMLIYEFVPN 635 (882)
Q Consensus 561 ~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~~ 635 (882)
++||+|+||.||+|+.. +|+.||+|+++... ....+.+..|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999965 68899999987532 12334566788888765 899999999999999999999999999
Q ss_pred CCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCceee
Q 002774 636 GSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHIT 715 (882)
Q Consensus 636 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 715 (882)
|+|.+++.... .+++.++..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~i~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~ 153 (316)
T cd05620 81 GDLMFHIQDKG--RFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--NRA 153 (316)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCC--Cce
Confidence 99998886543 5788899999999999999999998 9999999999999999999999999987532221 123
Q ss_pred eeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCCCCCCH
Q 002774 716 TQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTL 795 (882)
Q Consensus 716 ~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 795 (882)
....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .......... .+....
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~-~~~~~~~~~~-----------~~~~~~---- 217 (316)
T cd05620 154 STFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE-DELFESIRVD-----------TPHYPR---- 217 (316)
T ss_pred eccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH-HHHHHHHHhC-----------CCCCCC----
Confidence 346799999999999999999999999999999999999999965432 1111111100 111111
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCHH-HHHH
Q 002774 796 KGFEKYVDLALKCVQESGDDRPTMS-EVVK 824 (882)
Q Consensus 796 ~~~~~l~~li~~cl~~dp~~RPs~~-evl~ 824 (882)
....++.+++.+||+.||++||++. ++++
T Consensus 218 ~~~~~~~~li~~~l~~dP~~R~~~~~~~~~ 247 (316)
T cd05620 218 WITKESKDILEKLFERDPTRRLGVVGNIRG 247 (316)
T ss_pred CCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 1235788999999999999999985 5653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=344.04 Aligned_cols=252 Identities=22% Similarity=0.333 Sum_probs=196.6
Q ss_pred CCCCCCeeeccCcEEEEEEEe-cCCcEEEEEEcccCCc---ccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEE
Q 002774 556 NFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSM---QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYE 631 (882)
Q Consensus 556 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e 631 (882)
.|...++||+|+||+||+|+. .+++.||+|++..... ...+.+.+|++++++++|||||++++++.+++..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 578889999999999999986 4688999999875322 223568889999999999999999999999999999999
Q ss_pred eecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCC
Q 002774 632 FVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEK 711 (882)
Q Consensus 632 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 711 (882)
|+++|+|.+++.... .+++.....++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 82 ~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~ 156 (382)
T cd05625 82 YIPGGDMMSLLIRMG--IFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (382)
T ss_pred CCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCcccccccc
Confidence 999999999987543 5788888899999999999999998 99999999999999999999999999854321000
Q ss_pred ---------------------------------------------ceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHH
Q 002774 712 ---------------------------------------------DHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGV 746 (882)
Q Consensus 712 ---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gv 746 (882)
........||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv 236 (382)
T cd05625 157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236 (382)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechH
Confidence 00012246899999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCC---HHHHH
Q 002774 747 LMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPT---MSEVV 823 (882)
Q Consensus 747 ll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs---~~evl 823 (882)
++|||++|+.||........ ...+.... .............++.+++.+|+ .+|.+|++ +.|++
T Consensus 237 il~elltG~~Pf~~~~~~~~-~~~i~~~~-----------~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~ 303 (382)
T cd05625 237 ILYEMLVGQPPFLAQTPLET-QMKVINWQ-----------TSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIK 303 (382)
T ss_pred HHHHHHhCCCCCCCCCHHHH-HHHHHccC-----------CCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHh
Confidence 99999999999975433221 11111100 00111111122356778888875 59999987 88887
Q ss_pred HH
Q 002774 824 KD 825 (882)
Q Consensus 824 ~~ 825 (882)
++
T Consensus 304 ~h 305 (382)
T cd05625 304 AH 305 (382)
T ss_pred cC
Confidence 64
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=323.94 Aligned_cols=253 Identities=30% Similarity=0.440 Sum_probs=201.7
Q ss_pred HHcCCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCCcccHHHHHHHHHHHHhc-cCCCeeeEEEEEEeC------C
Q 002774 553 YTNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQGGQEFKMEIELLSRV-HHKNLVSLLGFCFDR------G 624 (882)
Q Consensus 553 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~------~ 624 (882)
+++.|+..+.||+|+||+||+|... +++.||+|++.... .....+.+|+.++.++ +|+||+++++++... .
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 4567888889999999999999864 68899999987543 3446788999999998 699999999998763 3
Q ss_pred ceEEEEEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeeccccc
Q 002774 625 EQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSK 704 (882)
Q Consensus 625 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~ 704 (882)
..++||||+++|+|.+++.......+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~~~ 159 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSA 159 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCCce
Confidence 5789999999999999987655557899999999999999999999988 9999999999999999999999999998
Q ss_pred ccCCCCCceeeeeeeccCCCCCHHHHh-----hCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhh
Q 002774 705 SMSDSEKDHITTQVKGTMGYLDPEYYM-----TQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELY 779 (882)
Q Consensus 705 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~ 779 (882)
....... ......|+..|+|||++. ...++.++|||||||++|||++|+.||............ .
T Consensus 160 ~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~-~------- 229 (272)
T cd06637 160 QLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI-P------- 229 (272)
T ss_pred ecccccc--cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHH-h-------
Confidence 6543221 223456899999999986 346888999999999999999999999654322211110 0
Q ss_pred hhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 780 NLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 780 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
....+... ......++.+++.+||+.+|.+|||+.|++++
T Consensus 230 ---~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 230 ---RNPAPRLK---SKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred ---cCCCCCCC---CCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 00011111 11233678999999999999999999999864
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=320.62 Aligned_cols=252 Identities=26% Similarity=0.402 Sum_probs=203.3
Q ss_pred cCCCCCCeeeccCcEEEEEEEe-cCCcEEEEEEcccCCcc-----cHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEE
Q 002774 555 NNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQ-----GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQML 628 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 628 (882)
++|...+.||+|+||.||+|.. .+++.||+|.+...... ..+.+.+|++++++++||||+++++++.+++..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 4688899999999999999985 46899999998643221 22468889999999999999999999999999999
Q ss_pred EEEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCC
Q 002774 629 IYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSD 708 (882)
Q Consensus 629 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~ 708 (882)
|+||+++++|.+++.... .+++.....++.|++.||+|||+.+ |+||||+|+||++++++.++|+|||+++....
T Consensus 82 v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~ 156 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYG--ALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQT 156 (263)
T ss_pred EEEECCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence 999999999999886543 5788889999999999999999998 99999999999999999999999999986543
Q ss_pred CCCcee-eeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCC
Q 002774 709 SEKDHI-TTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDP 787 (882)
Q Consensus 709 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 787 (882)
...... .....++..|+|||.+.+..++.++||||+|+++|||++|+.||........... ..... ..+
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~-~~~~~---------~~~ 226 (263)
T cd06625 157 ICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFK-IATQP---------TNP 226 (263)
T ss_pred cccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHH-HhccC---------CCC
Confidence 221111 1234578899999999998899999999999999999999999975433322111 11000 011
Q ss_pred cCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 788 TIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 788 ~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
..+......+.+++.+||..+|++|||+.|++++
T Consensus 227 ----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 227 ----QLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred ----CCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 1112234678899999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=328.83 Aligned_cols=258 Identities=30% Similarity=0.484 Sum_probs=202.9
Q ss_pred cCCCCCCeeeccCcEEEEEEEec-CCc--EEEEEEcccCC-cccHHHHHHHHHHHHhc-cCCCeeeEEEEEEeCCceEEE
Q 002774 555 NNFSDANDVGSGGYGKVYKGTLP-NGQ--LIAIKRAQQGS-MQGGQEFKMEIELLSRV-HHKNLVSLLGFCFDRGEQMLI 629 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV 629 (882)
++|+..+.||+|+||.||+|.+. ++. .+|+|+++... ....+.+.+|++++.++ +|+||+++++++.+++..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 46778899999999999999864 454 46888776532 22345788999999999 899999999999999999999
Q ss_pred EEeecCCCcccccCCCC--------------CccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCce
Q 002774 630 YEFVPNGSLGDSLSGKN--------------GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNA 695 (882)
Q Consensus 630 ~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~ 695 (882)
|||+++|+|.++++... ...+++.+++.++.|++.||+|||+.+ ++||||||+|||+++++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence 99999999999886432 235789999999999999999999988 9999999999999999999
Q ss_pred eEeecccccccCCCCCceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHh
Q 002774 696 KVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDK 774 (882)
Q Consensus 696 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~t-g~~P~~~~~~~~~~~~~~~~~ 774 (882)
||+|||+++...... ......++..|+|||++....++.++|||||||++|||+| |..||..... .+..... ..
T Consensus 164 kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-~~~~~~~-~~ 238 (303)
T cd05088 164 KIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-AELYEKL-PQ 238 (303)
T ss_pred EeCccccCcccchhh---hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCCh-HHHHHHH-hc
Confidence 999999986432111 1111234668999999988889999999999999999998 9999864322 1111111 00
Q ss_pred hhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHc
Q 002774 775 KKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQA 833 (882)
Q Consensus 775 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~ 833 (882)
.............+.+++.+||+.+|++||++.++++.++++++..
T Consensus 239 -------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~ 284 (303)
T cd05088 239 -------------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 284 (303)
T ss_pred -------------CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 0000111123457889999999999999999999999999987665
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=355.27 Aligned_cols=262 Identities=23% Similarity=0.341 Sum_probs=205.5
Q ss_pred cCCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCCcc---cHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEE
Q 002774 555 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQ---GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIY 630 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 630 (882)
++|...++||+|+||+||+|+.. +|+.||||+++..... ..++|.+|++++++++||||+++++++.+++..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 46888999999999999999864 6899999998754222 2357889999999999999999999999999999999
Q ss_pred EeecCCCcccccCCC---------CCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecc
Q 002774 631 EFVPNGSLGDSLSGK---------NGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFG 701 (882)
Q Consensus 631 e~~~~gsL~~~l~~~---------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfG 701 (882)
||+++|+|.+++... .....++..+++++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 999999999887531 1234567788999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCCc----------------eeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHH
Q 002774 702 LSKSMSDSEKD----------------HITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIV 765 (882)
Q Consensus 702 la~~~~~~~~~----------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~ 765 (882)
+++........ .......||+.|||||++.+..++.++|||||||++|||+||+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 99876211100 00112469999999999999999999999999999999999999996532211
Q ss_pred HHHHHHHHhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCC-CHHHHHHHHHHHHHH
Q 002774 766 REIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRP-TMSEVVKDIENILQQ 832 (882)
Q Consensus 766 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-s~~evl~~L~~~~~~ 832 (882)
...... ..+|.. .......+..+.+++.+|++.||++|| +++++.+.|+..++.
T Consensus 239 i~~~~~------------i~~P~~-~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 239 ISYRDV------------ILSPIE-VAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred hhhhhh------------ccChhh-ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 111100 001100 001112346788999999999999995 677788888888764
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=345.15 Aligned_cols=260 Identities=19% Similarity=0.327 Sum_probs=192.8
Q ss_pred HcCCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeC--------C
Q 002774 554 TNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDR--------G 624 (882)
Q Consensus 554 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--------~ 624 (882)
..+|...++||+|+||+||+|+.. +++.||||++.... ....+|+.+++.++|||||++++++... .
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 357888999999999999999864 68999999886432 2345799999999999999999987542 1
Q ss_pred ceEEEEEeecCCCcccccCC--CCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCC-ceeEeecc
Q 002774 625 EQMLIYEFVPNGSLGDSLSG--KNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERL-NAKVADFG 701 (882)
Q Consensus 625 ~~~lV~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~-~~kl~DfG 701 (882)
..++||||+++ +|.+++.. .....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 141 ~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 141 FLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred EEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeeccc
Confidence 35689999974 66665542 12346889999999999999999999998 99999999999999665 69999999
Q ss_pred cccccCCCCCceeeeeeeccCCCCCHHHHhh-CCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhh-hhh
Q 002774 702 LSKSMSDSEKDHITTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKK-ELY 779 (882)
Q Consensus 702 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~-~~~ 779 (882)
+|+.+..... .....||+.|+|||++.+ ..++.++|||||||++|||++|..||...... +.+........ ...
T Consensus 217 la~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~-~~~~~i~~~~~~p~~ 292 (440)
T PTZ00036 217 SAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSV-DQLVRIIQVLGTPTE 292 (440)
T ss_pred cchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCH
Confidence 9987644322 223468999999999875 46899999999999999999999999754332 22222221100 000
Q ss_pred hhhhccCC--------cCC-----CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 780 NLYELIDP--------TIG-----LSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 780 ~~~~~~d~--------~l~-----~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
.......+ ... ...+...+.++.+++.+||+.||.+|||+.|++++
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 293 DQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred HHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 00000000 000 00111234678999999999999999999999976
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=318.60 Aligned_cols=252 Identities=29% Similarity=0.458 Sum_probs=194.2
Q ss_pred CeeeccCcEEEEEEEec----CCcEEEEEEcccCC-cccHHHHHHHHHHHHhccCCCeeeEEEEEEe-CCceEEEEEeec
Q 002774 561 NDVGSGGYGKVYKGTLP----NGQLIAIKRAQQGS-MQGGQEFKMEIELLSRVHHKNLVSLLGFCFD-RGEQMLIYEFVP 634 (882)
Q Consensus 561 ~~lG~G~fg~Vy~~~~~----~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~~~lV~e~~~ 634 (882)
+.||+|+||+||+|.+. ++..||+|++.... ....+.+.+|+.+++.++||||+++++++.. ++..++||||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999853 24579999986432 2334678899999999999999999998764 556899999999
Q ss_pred CCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCcee
Q 002774 635 NGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHI 714 (882)
Q Consensus 635 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 714 (882)
+|+|.+++.... ...++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++..........
T Consensus 81 ~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~ 156 (262)
T cd05058 81 HGDLRNFIRSET-HNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV 156 (262)
T ss_pred CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCcceee
Confidence 999999987543 24677788999999999999999988 99999999999999999999999999986543221111
Q ss_pred --eeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCCCC
Q 002774 715 --TTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLS 792 (882)
Q Consensus 715 --~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 792 (882)
.....++..|+|||++....++.++|||||||++|||++|+.|+................ . .+.
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~-~---------~~~---- 222 (262)
T cd05058 157 HNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQG-R---------RLL---- 222 (262)
T ss_pred cccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC-C---------CCC----
Confidence 112345778999999998899999999999999999999655433332222222211110 0 000
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 002774 793 TTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENIL 830 (882)
Q Consensus 793 ~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~ 830 (882)
.....+..+.+++.+||+.+|++||++.|+++.|+++.
T Consensus 223 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 223 QPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 01112367889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=322.34 Aligned_cols=255 Identities=28% Similarity=0.495 Sum_probs=202.4
Q ss_pred CCCCCCeeeccCcEEEEEEEec-CC---cEEEEEEcccCC-cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEE
Q 002774 556 NFSDANDVGSGGYGKVYKGTLP-NG---QLIAIKRAQQGS-MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIY 630 (882)
Q Consensus 556 ~~~~~~~lG~G~fg~Vy~~~~~-~g---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 630 (882)
+|...+.||+|+||.||+|+.. ++ ..||||.++... ....++|..|+.+++.++||||+++++++.+++..++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 4677889999999999999864 33 369999987642 233467999999999999999999999999999999999
Q ss_pred EeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCC
Q 002774 631 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE 710 (882)
Q Consensus 631 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~ 710 (882)
||+++|+|.+++.... ..+++.+++.++.|++.||+|||+.+ ++||||||+||+++.++.+|++|||+++......
T Consensus 85 e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 85 EFMENGALDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred ecCCCCcHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 9999999999987543 35899999999999999999999998 9999999999999999999999999998664432
Q ss_pred Cceeeeeee---ccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHhhhhhhhhhhccC
Q 002774 711 KDHITTQVK---GTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELID 786 (882)
Q Consensus 711 ~~~~~~~~~---gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 786 (882)
......... .+..|+|||++....++.++|||||||++|||++ |..||...... +....+ ....
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~-~~~~~i-~~~~---------- 228 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ-DVINAI-EQDY---------- 228 (269)
T ss_pred cccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH-HHHHHH-HcCC----------
Confidence 211111111 2457999999999999999999999999999887 99998654321 111111 1000
Q ss_pred CcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 002774 787 PTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENI 829 (882)
Q Consensus 787 ~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 829 (882)
........+..+.+++.+||+.+|.+||++.+++..|+++
T Consensus 229 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 229 ---RLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ---cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0011122346788999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=325.52 Aligned_cols=250 Identities=22% Similarity=0.381 Sum_probs=205.1
Q ss_pred cCCCCCCeeeccCcEEEEEEEe-cCCcEEEEEEcccCCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEee
Q 002774 555 NNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFV 633 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 633 (882)
.+|...+.||+|+||.||+|+. .+++.||+|.+........+.+.+|+.+++.++|+||+++++++..+...++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 3677888999999999999985 468899999988765555677889999999999999999999999999999999999
Q ss_pred cCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCce
Q 002774 634 PNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDH 713 (882)
Q Consensus 634 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 713 (882)
++++|.+++... .+++.++..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 100 ~~~~L~~~~~~~---~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~-- 171 (296)
T cd06654 100 AGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-- 171 (296)
T ss_pred CCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhcccccc--
Confidence 999999988643 4788999999999999999999998 99999999999999999999999999886543221
Q ss_pred eeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCCCCC
Q 002774 714 ITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLST 793 (882)
Q Consensus 714 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 793 (882)
......|++.|+|||.+.+..++.++|||||||++|||++|+.||........... ..... .+.. ..
T Consensus 172 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~-~~~~~----------~~~~--~~ 238 (296)
T cd06654 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL-IATNG----------TPEL--QN 238 (296)
T ss_pred ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHH-HhcCC----------CCCC--CC
Confidence 12234688999999999988899999999999999999999999975433221111 11000 0111 11
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 794 TLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 794 ~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
.......+.+++.+||..+|++||++.|++++
T Consensus 239 ~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 239 PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred ccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 22234678899999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=324.78 Aligned_cols=256 Identities=26% Similarity=0.465 Sum_probs=203.2
Q ss_pred HcCCCCCCeeeccCcEEEEEEEec------CCcEEEEEEcccCCc-ccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCce
Q 002774 554 TNNFSDANDVGSGGYGKVYKGTLP------NGQLIAIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQ 626 (882)
Q Consensus 554 ~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 626 (882)
.++|...+.||+|+||.||+|... ++..||+|++..... ...+++.+|+.++++++||||+++++++.+++..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 456888899999999999999853 467899999875432 3346788999999999999999999999999999
Q ss_pred EEEEEeecCCCcccccCCCC--------------------CccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCc
Q 002774 627 MLIYEFVPNGSLGDSLSGKN--------------------GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSN 686 (882)
Q Consensus 627 ~lV~e~~~~gsL~~~l~~~~--------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~N 686 (882)
++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+.+ ++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 99999999999998886321 124788899999999999999999988 9999999999
Q ss_pred eEEcCCCceeEeecccccccCCCCCceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHh-CCCCCCCCchHH
Q 002774 687 ILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIV 765 (882)
Q Consensus 687 Ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~t-g~~P~~~~~~~~ 765 (882)
|++++++.++|+|||+++.+..............+..|+|||.+.+..++.++|||||||++|||++ |..||..... .
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~-~ 239 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH-E 239 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH-H
Confidence 9999999999999999886543322111222335678999999998999999999999999999998 7788854322 2
Q ss_pred HHHHHHHHhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 002774 766 REIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIE 827 (882)
Q Consensus 766 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~ 827 (882)
+..... .... . .......+.++.+++.+||+.+|++|||+.|+++.|+
T Consensus 240 ~~~~~~-~~~~-------~------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 240 EVIYYV-RDGN-------V------LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred HHHHHH-hcCC-------C------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 222111 1110 0 0011123467899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=343.91 Aligned_cols=252 Identities=22% Similarity=0.343 Sum_probs=198.1
Q ss_pred CCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCCc---ccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEE
Q 002774 556 NFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM---QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYE 631 (882)
Q Consensus 556 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e 631 (882)
+|...+.||+|+||+||+|+.. +++.||||++..... ...+.+.+|++++++++|+||+++++.+.+++..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 6888999999999999999854 689999999864321 233568889999999999999999999999999999999
Q ss_pred eecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCC-
Q 002774 632 FVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE- 710 (882)
Q Consensus 632 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~- 710 (882)
|+++|+|.+++.... .+++.....++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|..+....
T Consensus 82 ~~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~ 156 (376)
T cd05598 82 YIPGGDMMSLLIRLG--IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (376)
T ss_pred CCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCcccccccc
Confidence 999999999987654 5788888889999999999999998 9999999999999999999999999985331100
Q ss_pred ----------------------------------------CceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHH
Q 002774 711 ----------------------------------------KDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLE 750 (882)
Q Consensus 711 ----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~e 750 (882)
.........||+.|||||++.+..++.++|||||||++||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilye 236 (376)
T cd05598 157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236 (376)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeee
Confidence 0000123469999999999999999999999999999999
Q ss_pred HHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCC---CHHHHHHH
Q 002774 751 LLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRP---TMSEVVKD 825 (882)
Q Consensus 751 l~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP---s~~evl~~ 825 (882)
|++|+.||....... ....+.... .............++.+++.+|+ .+|.+|+ ++.|++++
T Consensus 237 ll~G~~Pf~~~~~~~-~~~~i~~~~-----------~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 237 MLVGQPPFLADTPAE-TQLKVINWE-----------TTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred hhhCCCCCCCCCHHH-HHHHHhccC-----------ccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 999999997544321 111111100 00001111122356778888876 5999999 89999976
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=320.32 Aligned_cols=249 Identities=31% Similarity=0.491 Sum_probs=195.7
Q ss_pred CeeeccCcEEEEEEEec-CCc--EEEEEEcccCC-cccHHHHHHHHHHHHhc-cCCCeeeEEEEEEeCCceEEEEEeecC
Q 002774 561 NDVGSGGYGKVYKGTLP-NGQ--LIAIKRAQQGS-MQGGQEFKMEIELLSRV-HHKNLVSLLGFCFDRGEQMLIYEFVPN 635 (882)
Q Consensus 561 ~~lG~G~fg~Vy~~~~~-~g~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~~ 635 (882)
+.||+|+||.||+|+.. ++. .+|+|.++... ....+.+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 36899999999999875 343 56889887533 23346788999999999 799999999999999999999999999
Q ss_pred CCcccccCCCC--------------CccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecc
Q 002774 636 GSLGDSLSGKN--------------GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFG 701 (882)
Q Consensus 636 gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfG 701 (882)
|+|.+++.... ...+++.++..++.|++.||+|||+.+ ++||||||+||++++++.+|++|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 99999886432 124789999999999999999999988 9999999999999999999999999
Q ss_pred cccccCCCCCceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHhhhhhhh
Q 002774 702 LSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYN 780 (882)
Q Consensus 702 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~ 780 (882)
+++...... .......+..|+|||++....++.++|||||||++|||++ |..||..... .+.......
T Consensus 158 l~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~-~~~~~~~~~------- 226 (270)
T cd05047 158 LSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-AELYEKLPQ------- 226 (270)
T ss_pred Cccccchhh---hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH-HHHHHHHhC-------
Confidence 986322111 1111234567999999988899999999999999999997 9999854321 111111100
Q ss_pred hhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 002774 781 LYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENIL 830 (882)
Q Consensus 781 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~ 830 (882)
............++.+++.+||+.+|.+|||+.|+++.|.+++
T Consensus 227 -------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 227 -------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred -------CCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 0000111123367889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=317.85 Aligned_cols=249 Identities=25% Similarity=0.420 Sum_probs=201.2
Q ss_pred CeeeccCcEEEEEEEecC--C--cEEEEEEcccCCc-ccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEeecC
Q 002774 561 NDVGSGGYGKVYKGTLPN--G--QLIAIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPN 635 (882)
Q Consensus 561 ~~lG~G~fg~Vy~~~~~~--g--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~ 635 (882)
+.||+|+||.||+|.+.+ + ..||||.+..... ...+.+.+|+.++++++||||+++++++.+ ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998643 3 3699999987665 455789999999999999999999999988 889999999999
Q ss_pred CCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCce-e
Q 002774 636 GSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDH-I 714 (882)
Q Consensus 636 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~-~ 714 (882)
|+|.+++.......+++.....++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++.+....... .
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 99999987654346899999999999999999999998 9999999999999999999999999998775432211 1
Q ss_pred eeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCCCCC
Q 002774 715 TTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLST 793 (882)
Q Consensus 715 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 793 (882)
.....++..|+|||++....++.++|||||||++|||++ |..||...... +.......... .. ..
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-~~~~~~~~~~~-----------~~--~~ 222 (257)
T cd05040 157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS-QILKKIDKEGE-----------RL--ER 222 (257)
T ss_pred ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHHhcCC-----------cC--CC
Confidence 123457789999999998899999999999999999999 99998643221 22221111100 00 01
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 002774 794 TLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIE 827 (882)
Q Consensus 794 ~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~ 827 (882)
....+..+.+++.+||+.+|++||++.|+++.|.
T Consensus 223 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 223 PEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 1123467899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=309.33 Aligned_cols=269 Identities=22% Similarity=0.336 Sum_probs=223.9
Q ss_pred HHHHHHHHcCCCCCCeeeccCcEEEEEEEec------CCcEEEEEEcccCCcc-cHHHHHHHHHHHHhccCCCeeeEEEE
Q 002774 547 FEEVKKYTNNFSDANDVGSGGYGKVYKGTLP------NGQLIAIKRAQQGSMQ-GGQEFKMEIELLSRVHHKNLVSLLGF 619 (882)
Q Consensus 547 ~~e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~ 619 (882)
..|+.....+++....+-+|.||.||+|.|. +.+.|-||.++....+ ....+..|.-.+..+.|||+.++.+.
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 4456666677888888999999999999764 3456778888764332 33567889999999999999999999
Q ss_pred EEeC-CceEEEEEeecCCCcccccCC------CCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCC
Q 002774 620 CFDR-GEQMLIYEFVPNGSLGDSLSG------KNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDER 692 (882)
Q Consensus 620 ~~~~-~~~~lV~e~~~~gsL~~~l~~------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~ 692 (882)
+.+. +..+.+|.++.-|+|..++.. ...+.++..+...++.|++.|++|||.++ +||.||.++|++||+.
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQ 432 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhh
Confidence 8764 567899999999999999972 22456888899999999999999999999 9999999999999999
Q ss_pred CceeEeecccccccCCCCCceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHH
Q 002774 693 LNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTV 771 (882)
Q Consensus 693 ~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~t-g~~P~~~~~~~~~~~~~~ 771 (882)
.++||+|=.++|.+.+.+..........+.+||+||.+....|+.++|||||||++|||+| |+.|+.+-+...
T Consensus 433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfE------ 506 (563)
T KOG1024|consen 433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFE------ 506 (563)
T ss_pred eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHH------
Confidence 9999999999999999888777777778999999999999999999999999999999999 999986543221
Q ss_pred HHhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHc
Q 002774 772 MDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQA 833 (882)
Q Consensus 772 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~ 833 (882)
++..+....+...+..++++++.++..||+.+|++||+++|++.-|.++-.+.
T Consensus 507 ---------m~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~ql 559 (563)
T KOG1024|consen 507 ---------MEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQL 559 (563)
T ss_pred ---------HHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHH
Confidence 11222223334556678899999999999999999999999999999886553
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=315.04 Aligned_cols=247 Identities=28% Similarity=0.446 Sum_probs=198.6
Q ss_pred CeeeccCcEEEEEEEecCCcEEEEEEcccCCcc-cHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEeecCCCcc
Q 002774 561 NDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQ-GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLG 639 (882)
Q Consensus 561 ~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 639 (882)
++||+|+||.||+|...+++.||+|+++..... ....+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 368999999999999888999999998765432 2346889999999999999999999999999999999999999999
Q ss_pred cccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCceeeeeee
Q 002774 640 DSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVK 719 (882)
Q Consensus 640 ~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 719 (882)
+++.... ..+++..+..++.|++.||.|+|+.+ ++||||||+||++++++.+||+|||+++....... .......
T Consensus 81 ~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~ 155 (250)
T cd05085 81 SFLRKKK-DELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY-SSSGLKQ 155 (250)
T ss_pred HHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceecccccc-ccCCCCC
Confidence 9886543 35789999999999999999999988 99999999999999999999999999976433221 1111223
Q ss_pred ccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCCCCCCHHHH
Q 002774 720 GTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGF 798 (882)
Q Consensus 720 gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 798 (882)
++..|+|||++..+.++.++||||||+++||+++ |..||...... ..... ..... . .......+
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~-~~~~~-~~~~~---------~----~~~~~~~~ 220 (250)
T cd05085 156 IPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ-QAREQ-VEKGY---------R----MSCPQKCP 220 (250)
T ss_pred CcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH-HHHHH-HHcCC---------C----CCCCCCCC
Confidence 4678999999998899999999999999999999 88898643221 11111 11100 0 01111234
Q ss_pred HHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 002774 799 EKYVDLALKCVQESGDDRPTMSEVVKDIE 827 (882)
Q Consensus 799 ~~l~~li~~cl~~dp~~RPs~~evl~~L~ 827 (882)
.++.+++.+||+.+|++||++.|+++.|.
T Consensus 221 ~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 221 DDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 67899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=317.22 Aligned_cols=248 Identities=27% Similarity=0.454 Sum_probs=200.9
Q ss_pred cCCCCCCeeeccCcEEEEEEEecCCcEEEEEEcccCCcccHHHHHHHHHHHHhccCCCeeeEEEEEEe-CCceEEEEEee
Q 002774 555 NNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFD-RGEQMLIYEFV 633 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~~~lV~e~~ 633 (882)
.+|...+.||+|+||.||+|... |+.||+|.++... ..+.+.+|+.++++++|+|++++++++.. ++..++||||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 36778899999999999999874 7889999987543 34678999999999999999999998654 45789999999
Q ss_pred cCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCce
Q 002774 634 PNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDH 713 (882)
Q Consensus 634 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 713 (882)
++++|.++++......+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--- 156 (256)
T cd05082 83 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--- 156 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC---
Confidence 9999999987665556899999999999999999999988 9999999999999999999999999987653322
Q ss_pred eeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCCCC
Q 002774 714 ITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLS 792 (882)
Q Consensus 714 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 792 (882)
....++..|+|||++....++.++|||||||++|||++ |+.||.... ..+....+... ..+.
T Consensus 157 --~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~-~~~~~~~~~~~----------~~~~---- 219 (256)
T cd05082 157 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-LKDVVPRVEKG----------YKMD---- 219 (256)
T ss_pred --CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC-HHHHHHHHhcC----------CCCC----
Confidence 12335668999999998899999999999999999998 888885432 22211111110 0011
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 002774 793 TTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIEN 828 (882)
Q Consensus 793 ~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~ 828 (882)
.....+..+.+++.+||+.+|++|||+.++++.|+.
T Consensus 220 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 220 APDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 111234678899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=330.00 Aligned_cols=242 Identities=24% Similarity=0.331 Sum_probs=195.6
Q ss_pred CeeeccCcEEEEEEEec-CCcEEEEEEcccCC---cccHHHHHHHHHHHHhc-cCCCeeeEEEEEEeCCceEEEEEeecC
Q 002774 561 NDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS---MQGGQEFKMEIELLSRV-HHKNLVSLLGFCFDRGEQMLIYEFVPN 635 (882)
Q Consensus 561 ~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~~ 635 (882)
+.||+|+||+||+|+.. +++.||||+++... ......+..|.++++.+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999865 57899999987542 22335577889999888 699999999999999999999999999
Q ss_pred CCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCceee
Q 002774 636 GSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHIT 715 (882)
Q Consensus 636 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 715 (882)
|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++...... ...
T Consensus 81 ~~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~~ 153 (318)
T cd05570 81 GDLMFHIQRSG--RFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--VTT 153 (318)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCC--Ccc
Confidence 99998886543 6899999999999999999999998 9999999999999999999999999987532222 122
Q ss_pred eeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCCCCCCH
Q 002774 716 TQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTL 795 (882)
Q Consensus 716 ~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 795 (882)
....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .......... .... +.
T Consensus 154 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~-~~~~~~i~~~-----------~~~~----~~ 217 (318)
T cd05570 154 STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE-DELFQSILED-----------EVRY----PR 217 (318)
T ss_pred cceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH-HHHHHHHHcC-----------CCCC----CC
Confidence 345689999999999999999999999999999999999999965432 1111111111 0001 11
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCH-----HHHHHH
Q 002774 796 KGFEKYVDLALKCVQESGDDRPTM-----SEVVKD 825 (882)
Q Consensus 796 ~~~~~l~~li~~cl~~dp~~RPs~-----~evl~~ 825 (882)
.....+.+++.+||+.||.+||++ .+++++
T Consensus 218 ~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 218 WLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred cCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 123678899999999999999999 888764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=332.34 Aligned_cols=247 Identities=24% Similarity=0.310 Sum_probs=197.2
Q ss_pred CCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCCc---ccHHHHHHHHHHHHhc-cCCCeeeEEEEEEeCCceEEEE
Q 002774 556 NFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM---QGGQEFKMEIELLSRV-HHKNLVSLLGFCFDRGEQMLIY 630 (882)
Q Consensus 556 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~ 630 (882)
+|...+.||+|+||+||+|+.. +++.||||+++.... ...+.+..|..++..+ +|++|+++++++.+.+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4778899999999999999865 578999999875422 2224566788888877 5899999999999999999999
Q ss_pred EeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCC
Q 002774 631 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE 710 (882)
Q Consensus 631 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~ 710 (882)
||+++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 81 E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~ 155 (323)
T cd05616 81 EYVNGGDLMYQIQQVG--RFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG 155 (323)
T ss_pred cCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCCC
Confidence 9999999998886543 5888999999999999999999998 9999999999999999999999999997543222
Q ss_pred CceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCC
Q 002774 711 KDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIG 790 (882)
Q Consensus 711 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 790 (882)
.......||+.|+|||++....++.++|||||||++|||+||+.||..... ......+.... ..
T Consensus 156 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~-~~~~~~i~~~~-----------~~-- 219 (323)
T cd05616 156 --VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-DELFQSIMEHN-----------VA-- 219 (323)
T ss_pred --CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH-HHHHHHHHhCC-----------CC--
Confidence 122345689999999999999999999999999999999999999975432 22222211110 00
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCH-----HHHHHH
Q 002774 791 LSTTLKGFEKYVDLALKCVQESGDDRPTM-----SEVVKD 825 (882)
Q Consensus 791 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~-----~evl~~ 825 (882)
.+.....++.+++.+|++.||.+|++. .++.++
T Consensus 220 --~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05616 220 --YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 257 (323)
T ss_pred --CCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence 111223678899999999999999984 566543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=322.58 Aligned_cols=251 Identities=24% Similarity=0.347 Sum_probs=200.2
Q ss_pred CCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCCcc---cHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEe
Q 002774 557 FSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQ---GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEF 632 (882)
Q Consensus 557 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 632 (882)
|+..+.||+|+||+||+|... +++.||+|.+...... ....+.+|+++++.++|+||+++.+++..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 566788999999999999864 6899999998754322 234577899999999999999999999999999999999
Q ss_pred ecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCc
Q 002774 633 VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKD 712 (882)
Q Consensus 633 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 712 (882)
+++++|.+++.......+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||++........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~- 157 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES- 157 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCCc-
Confidence 99999998886554456999999999999999999999998 99999999999999999999999999976543221
Q ss_pred eeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCCCC
Q 002774 713 HITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLS 792 (882)
Q Consensus 713 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 792 (882)
.....|+..|+|||++.+..++.++|+|||||++|||++|..||........ ......... .. .+ .
T Consensus 158 --~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~-~~~~~~~~~------~~-~~----~ 223 (285)
T cd05632 158 --IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK-REEVDRRVL------ET-EE----V 223 (285)
T ss_pred --ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhhh------cc-cc----c
Confidence 2234689999999999988999999999999999999999999975433211 111111000 00 00 0
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 002774 793 TTLKGFEKYVDLALKCVQESGDDRPT-----MSEVVKD 825 (882)
Q Consensus 793 ~~~~~~~~l~~li~~cl~~dp~~RPs-----~~evl~~ 825 (882)
........+.+++.+||+.||++||+ +.+++++
T Consensus 224 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 224 YSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred cCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 11122356789999999999999999 6666654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=322.95 Aligned_cols=249 Identities=23% Similarity=0.358 Sum_probs=201.0
Q ss_pred CCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCCcc---cHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEe
Q 002774 557 FSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQ---GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEF 632 (882)
Q Consensus 557 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 632 (882)
|+..+.||+|+||+||+|... +++.||||.+...... ..+.+.+|+.++++++|+||+++++.+.+.+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 667788999999999999864 6899999998754322 224577899999999999999999999999999999999
Q ss_pred ecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCc
Q 002774 633 VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKD 712 (882)
Q Consensus 633 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 712 (882)
+++++|.+++.......+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++........
T Consensus 82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~- 157 (285)
T cd05630 82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT- 157 (285)
T ss_pred cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc-
Confidence 99999999886554456899999999999999999999988 99999999999999999999999999976543221
Q ss_pred eeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHH--HHHHHHHHhhhhhhhhhhccCCcCC
Q 002774 713 HITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIV--REIRTVMDKKKELYNLYELIDPTIG 790 (882)
Q Consensus 713 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~--~~~~~~~~~~~~~~~~~~~~d~~l~ 790 (882)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||....... ........... ...
T Consensus 158 --~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~----------~~~- 224 (285)
T cd05630 158 --IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQ----------EEY- 224 (285)
T ss_pred --ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhh----------hhc-
Confidence 123468999999999999999999999999999999999999997533211 11111111110 001
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 002774 791 LSTTLKGFEKYVDLALKCVQESGDDRPT-----MSEVVKD 825 (882)
Q Consensus 791 ~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~evl~~ 825 (882)
.......+.+++.+||+.||++||| ++|++++
T Consensus 225 ---~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 225 ---SEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred ---CccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 1112356889999999999999999 8888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=319.49 Aligned_cols=256 Identities=26% Similarity=0.472 Sum_probs=204.1
Q ss_pred cCCCCCCeeeccCcEEEEEEEec----CCcEEEEEEcccCCc-ccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEE
Q 002774 555 NNFSDANDVGSGGYGKVYKGTLP----NGQLIAIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLI 629 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~~~~~----~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 629 (882)
++|...+.||+|+||.||+|+.. .+..||+|.++.... ...+.+..|+.++++++||||+++++++.+++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 46778899999999999999863 234799999875432 2346789999999999999999999999999999999
Q ss_pred EEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCC
Q 002774 630 YEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDS 709 (882)
Q Consensus 630 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~ 709 (882)
|||+++++|.+++.... ..+++.++..++.|++.||+|||+.+ ++||||||+||+++.++.++++|||+++.+...
T Consensus 84 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd05066 84 TEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159 (267)
T ss_pred EEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence 99999999999997543 35799999999999999999999998 999999999999999999999999999876543
Q ss_pred CCcee-eeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCC
Q 002774 710 EKDHI-TTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDP 787 (882)
Q Consensus 710 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 787 (882)
..... .....++..|+|||++.+..++.++|||||||++||+++ |..||...... +..... .... .+
T Consensus 160 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~-~~~~~~-~~~~---------~~ 228 (267)
T cd05066 160 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ-DVIKAI-EEGY---------RL 228 (267)
T ss_pred cceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH-HHHHHH-hCCC---------cC
Confidence 22111 111223568999999998899999999999999999887 99998654321 111111 1110 00
Q ss_pred cCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 002774 788 TIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENI 829 (882)
Q Consensus 788 ~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 829 (882)
......+..+.+++.+||+.+|.+||++.++++.|.++
T Consensus 229 ----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 229 ----PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred ----CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 11112346788999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=316.88 Aligned_cols=252 Identities=25% Similarity=0.396 Sum_probs=190.5
Q ss_pred CeeeccCcEEEEEEEecC---CcEEEEEEcccCCc-ccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEeecCC
Q 002774 561 NDVGSGGYGKVYKGTLPN---GQLIAIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNG 636 (882)
Q Consensus 561 ~~lG~G~fg~Vy~~~~~~---g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 636 (882)
+.||+|+||+||+|+..+ ...+|+|.+..... .....+.+|+++++.++|+||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 358999999999997543 45788998765432 23356889999999999999999999999999999999999999
Q ss_pred CcccccCCCCC---ccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCce
Q 002774 637 SLGDSLSGKNG---IRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDH 713 (882)
Q Consensus 637 sL~~~l~~~~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 713 (882)
+|.+++..... ...++.....++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 99999865432 23567788899999999999999998 9999999999999999999999999987543322211
Q ss_pred eeeeeeccCCCCCHHHHhh-------CCCCchhHHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHhhhhhhhhhhcc
Q 002774 714 ITTQVKGTMGYLDPEYYMT-------QQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELI 785 (882)
Q Consensus 714 ~~~~~~gt~~y~aPE~~~~-------~~~~~~sDv~S~Gvll~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 785 (882)
......++..|+|||++.. ..++.++|||||||++|||++ |..||....... .......... ....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-~~~~~~~~~~-----~~~~ 231 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ-VLKQVVREQD-----IKLP 231 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH-HHHHHhhccC-----ccCC
Confidence 1223345778999999853 356789999999999999999 777876443322 1222111111 1111
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 002774 786 DPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDI 826 (882)
Q Consensus 786 d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L 826 (882)
++.. .......+.+++..|| .||++||+++||++.|
T Consensus 232 ~~~~----~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 232 KPQL----DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred CCcc----cccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 1111 1123366778899999 5999999999999876
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=338.82 Aligned_cols=261 Identities=20% Similarity=0.233 Sum_probs=198.1
Q ss_pred HcCCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEe
Q 002774 554 TNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEF 632 (882)
Q Consensus 554 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 632 (882)
...|...+.||+|+||.||+|... .++.||||.... ..+.+|++++++++|+|||++++++..++..++|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 346888899999999999999975 578999996432 3467899999999999999999999999999999999
Q ss_pred ecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCc
Q 002774 633 VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKD 712 (882)
Q Consensus 633 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 712 (882)
+ .++|.+++.... ..+++.++..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++........
T Consensus 242 ~-~~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~ 316 (461)
T PHA03211 242 Y-RSDLYTYLGARL-RPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST 316 (461)
T ss_pred c-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceeccccccc
Confidence 9 478888876432 36899999999999999999999998 999999999999999999999999999876443322
Q ss_pred eeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCc------hHHHHHHHHHHhhhhh-hhhhh--
Q 002774 713 HITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGK------YIVREIRTVMDKKKEL-YNLYE-- 783 (882)
Q Consensus 713 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~------~~~~~~~~~~~~~~~~-~~~~~-- 783 (882)
.......||+.|+|||++.+..++.++|||||||++|||++|..|+.... .....+...+...... ..+..
T Consensus 317 ~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~ 396 (461)
T PHA03211 317 PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHA 396 (461)
T ss_pred ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCc
Confidence 22334569999999999999999999999999999999999887754221 1111122222111100 00000
Q ss_pred --------------ccCCcCCCC---CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 784 --------------LIDPTIGLS---TTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 784 --------------~~d~~l~~~---~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
...+..... ........+.+|+.+||+.||.+|||+.|++++
T Consensus 397 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 397 GSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred chHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 000000000 000122467899999999999999999999975
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=328.03 Aligned_cols=237 Identities=27% Similarity=0.347 Sum_probs=189.0
Q ss_pred CeeeccCcEEEEEEEec-CCcEEEEEEcccCCc---ccHHHHHHHHH-HHHhccCCCeeeEEEEEEeCCceEEEEEeecC
Q 002774 561 NDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM---QGGQEFKMEIE-LLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPN 635 (882)
Q Consensus 561 ~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~ 635 (882)
+.||+|+||+||+|+.. +|+.||||++..... ...+.+.+|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999964 689999999875321 22234455544 56788999999999999999999999999999
Q ss_pred CCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCceee
Q 002774 636 GSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHIT 715 (882)
Q Consensus 636 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 715 (882)
|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++...... ...
T Consensus 81 g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~ 153 (323)
T cd05575 81 GELFFHLQRER--SFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS--KTT 153 (323)
T ss_pred CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCC--Ccc
Confidence 99998887543 6888899999999999999999998 9999999999999999999999999987543222 123
Q ss_pred eeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCCCCCCH
Q 002774 716 TQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTL 795 (882)
Q Consensus 716 ~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 795 (882)
....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+....+.... ..+.+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~-~~~~~~i~~~~-------~~~~~-------- 217 (323)
T cd05575 154 STFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT-AEMYDNILNKP-------LRLKP-------- 217 (323)
T ss_pred ccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH-HHHHHHHHcCC-------CCCCC--------
Confidence 345699999999999999999999999999999999999999975432 22222221110 00111
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCHH
Q 002774 796 KGFEKYVDLALKCVQESGDDRPTMS 820 (882)
Q Consensus 796 ~~~~~l~~li~~cl~~dp~~RPs~~ 820 (882)
.....+.+++.+|++.||.+||++.
T Consensus 218 ~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 218 NISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 1236788999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=316.60 Aligned_cols=248 Identities=31% Similarity=0.503 Sum_probs=203.5
Q ss_pred CeeeccCcEEEEEEEecC----CcEEEEEEcccCCccc-HHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEeecC
Q 002774 561 NDVGSGGYGKVYKGTLPN----GQLIAIKRAQQGSMQG-GQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPN 635 (882)
Q Consensus 561 ~~lG~G~fg~Vy~~~~~~----g~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~ 635 (882)
+.||+|+||.||+|.... +..||+|.++...... .+.+.+|+++++.++|+||+++++++.+....++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 468999999999999653 7899999998654433 57889999999999999999999999999999999999999
Q ss_pred CCcccccCCCC-------CccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCC
Q 002774 636 GSLGDSLSGKN-------GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSD 708 (882)
Q Consensus 636 gsL~~~l~~~~-------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~ 708 (882)
++|.+++.... ...+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||.++....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 99999997652 247899999999999999999999988 99999999999999999999999999987765
Q ss_pred CCCceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCC
Q 002774 709 SEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDP 787 (882)
Q Consensus 709 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 787 (882)
...........++..|+|||.+....++.++||||+||++|||++ |..||..... .+....... ..
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-~~~~~~~~~-~~----------- 224 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN-EEVLEYLRK-GY----------- 224 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH-HHHHHHHHc-CC-----------
Confidence 432222334567889999999998899999999999999999999 5888865422 111111111 00
Q ss_pred cCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 002774 788 TIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDI 826 (882)
Q Consensus 788 ~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L 826 (882)
........+.++.+++.+||+.+|++|||+.|+++.|
T Consensus 225 --~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l 261 (262)
T cd00192 225 --RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERL 261 (262)
T ss_pred --CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 0111122346789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=324.78 Aligned_cols=270 Identities=26% Similarity=0.422 Sum_probs=205.6
Q ss_pred CCCCCCeeeccCcEEEEEEEec-----CCcEEEEEEcccCCcc-cHHHHHHHHHHHHhccCCCeeeEEEEEEe--CCceE
Q 002774 556 NFSDANDVGSGGYGKVYKGTLP-----NGQLIAIKRAQQGSMQ-GGQEFKMEIELLSRVHHKNLVSLLGFCFD--RGEQM 627 (882)
Q Consensus 556 ~~~~~~~lG~G~fg~Vy~~~~~-----~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~ 627 (882)
.|...+.||+|+||.||+|++. +++.||||+++..... ..+.|.+|+++++.++|+||+++++++.. +...+
T Consensus 5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05038 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR 84 (284)
T ss_pred hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence 4667789999999999999863 3689999999865443 45789999999999999999999999887 55789
Q ss_pred EEEEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccC
Q 002774 628 LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMS 707 (882)
Q Consensus 628 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~ 707 (882)
+||||+++++|.+++.... ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++....
T Consensus 85 lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05038 85 LIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKVLP 160 (284)
T ss_pred EEEecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence 9999999999999997643 25899999999999999999999998 9999999999999999999999999998775
Q ss_pred CCCCcee-eeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccC
Q 002774 708 DSEKDHI-TTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELID 786 (882)
Q Consensus 708 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 786 (882)
....... .....++..|+|||.+.+..++.++||||||+++|||++|+.|+......................+.+.+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05038 161 EDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK 240 (284)
T ss_pred cCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHH
Confidence 3322111 112345667999999998899999999999999999999999976432111000000000000000001111
Q ss_pred CcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 002774 787 PTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENI 829 (882)
Q Consensus 787 ~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 829 (882)
...........+.++.+++.+||+.+|++||++.|+++.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 241 EGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred cCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 1111111223346799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=334.23 Aligned_cols=238 Identities=31% Similarity=0.386 Sum_probs=193.0
Q ss_pred CeeeccCcEEEEEEEe----cCCcEEEEEEcccCCc--ccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEeec
Q 002774 561 NDVGSGGYGKVYKGTL----PNGQLIAIKRAQQGSM--QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVP 634 (882)
Q Consensus 561 ~~lG~G~fg~Vy~~~~----~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 634 (882)
+.||+|+||+||+++. .+|+.||+|+++.... .....+..|++++++++||||+++++++.+++..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999874 3588999999875322 233457789999999999999999999999999999999999
Q ss_pred CCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCcee
Q 002774 635 NGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHI 714 (882)
Q Consensus 635 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 714 (882)
+|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++....... .
T Consensus 82 ~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~--~ 154 (318)
T cd05582 82 GGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK--K 154 (318)
T ss_pred CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC--c
Confidence 999999886543 6899999999999999999999998 99999999999999999999999999986543321 2
Q ss_pred eeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCCCCCC
Q 002774 715 TTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTT 794 (882)
Q Consensus 715 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 794 (882)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||..... ......+.... ... +
T Consensus 155 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~-~~~~~~i~~~~-----------~~~----p 218 (318)
T cd05582 155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR-KETMTMILKAK-----------LGM----P 218 (318)
T ss_pred eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH-HHHHHHHHcCC-----------CCC----C
Confidence 2345689999999999988899999999999999999999999975432 12111111110 001 1
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHH
Q 002774 795 LKGFEKYVDLALKCVQESGDDRPTMSE 821 (882)
Q Consensus 795 ~~~~~~l~~li~~cl~~dp~~RPs~~e 821 (882)
......+.+++.+||+.||++||++.+
T Consensus 219 ~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 219 QFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 112367889999999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=317.69 Aligned_cols=254 Identities=26% Similarity=0.463 Sum_probs=205.4
Q ss_pred HcCCCCCCeeeccCcEEEEEEEecCCcEEEEEEcccCCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEee
Q 002774 554 TNNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFV 633 (882)
Q Consensus 554 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 633 (882)
.++|...+.||+|+||.||+|...++..+|+|.++... ...+.+.+|++++++++|+||+++.+++.+ ...++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 82 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence 35678889999999999999998778889999887543 234678899999999999999999999887 7789999999
Q ss_pred cCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCce
Q 002774 634 PNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDH 713 (882)
Q Consensus 634 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 713 (882)
++|+|.+++.......+++.++..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||.+........ .
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~ 158 (260)
T cd05073 83 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY-T 158 (260)
T ss_pred CCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCc-c
Confidence 9999999997655557899999999999999999999988 99999999999999999999999999986643322 1
Q ss_pred eeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCCCC
Q 002774 714 ITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLS 792 (882)
Q Consensus 714 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 792 (882)
......++..|+|||++....++.++|||||||++||+++ |..||...... .... ...... . ..
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~-~~~~-~~~~~~---------~----~~ 223 (260)
T cd05073 159 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP-EVIR-ALERGY---------R----MP 223 (260)
T ss_pred cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH-HHHH-HHhCCC---------C----CC
Confidence 1222345678999999998889999999999999999999 88888643221 1111 111100 0 01
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 002774 793 TTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIEN 828 (882)
Q Consensus 793 ~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~ 828 (882)
.....+.++.+++.+||+.+|++||++.++.+.|+.
T Consensus 224 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 224 RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 111234678899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=314.63 Aligned_cols=253 Identities=25% Similarity=0.338 Sum_probs=208.8
Q ss_pred CCCCCCeeeccCcEEEEEEEecC-CcEEEEEEcccCCcccH---HHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEE
Q 002774 556 NFSDANDVGSGGYGKVYKGTLPN-GQLIAIKRAQQGSMQGG---QEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYE 631 (882)
Q Consensus 556 ~~~~~~~lG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~~~---~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e 631 (882)
.|...+.||.|.-|+||+++..+ +..+|+|++.+...... .+.+.|-+||+.++||.+..+++.+..++..++|||
T Consensus 78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~me 157 (459)
T KOG0610|consen 78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVME 157 (459)
T ss_pred HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEe
Confidence 34556789999999999999764 58999999987655433 456679999999999999999999999999999999
Q ss_pred eecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCC--
Q 002774 632 FVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDS-- 709 (882)
Q Consensus 632 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~-- 709 (882)
||+||+|...++.+.+..+++..+..++..|+.||+|||..| ||.|||||+||||.++|++-|+||.|+......
T Consensus 158 yCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt 234 (459)
T KOG0610|consen 158 YCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPT 234 (459)
T ss_pred cCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCCCe
Confidence 999999999999988889999999999999999999999999 999999999999999999999999987544210
Q ss_pred ------------------------------C-C---------------------ceeeeeeeccCCCCCHHHHhhCCCCc
Q 002774 710 ------------------------------E-K---------------------DHITTQVKGTMGYLDPEYYMTQQLTE 737 (882)
Q Consensus 710 ------------------------------~-~---------------------~~~~~~~~gt~~y~aPE~~~~~~~~~ 737 (882)
. . +..+..++||-.|.|||++.+...+.
T Consensus 235 ~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgs 314 (459)
T KOG0610|consen 235 LVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGS 314 (459)
T ss_pred eeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCc
Confidence 0 0 01112356889999999999999999
Q ss_pred hhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCC
Q 002774 738 KSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRP 817 (882)
Q Consensus 738 ~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP 817 (882)
++|+|+|||++|||+.|..||.+...-.. +. .++-..+...........+.+||++.|.+||.+|.
T Consensus 315 AVDWWtfGIflYEmLyG~TPFKG~~~~~T-l~-------------NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRl 380 (459)
T KOG0610|consen 315 AVDWWTFGIFLYEMLYGTTPFKGSNNKET-LR-------------NIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRL 380 (459)
T ss_pred hhhHHHHHHHHHHHHhCCCCcCCCCchhh-HH-------------HHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhh
Confidence 99999999999999999999976544322 22 22222333333334557889999999999999998
Q ss_pred C----HHHHHHH
Q 002774 818 T----MSEVVKD 825 (882)
Q Consensus 818 s----~~evl~~ 825 (882)
. ++||-++
T Consensus 381 g~~rGA~eIK~H 392 (459)
T KOG0610|consen 381 GSKRGAAEIKRH 392 (459)
T ss_pred ccccchHHhhcC
Confidence 8 7777664
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=315.67 Aligned_cols=248 Identities=27% Similarity=0.456 Sum_probs=198.0
Q ss_pred CeeeccCcEEEEEEEecC----CcEEEEEEcccCCcc-cHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEeecC
Q 002774 561 NDVGSGGYGKVYKGTLPN----GQLIAIKRAQQGSMQ-GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPN 635 (882)
Q Consensus 561 ~~lG~G~fg~Vy~~~~~~----g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~ 635 (882)
++||+|+||.||+|++.. +..||+|.+...... ..+++.+|+.+++.+.|+||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 469999999999998532 368999998865442 4467899999999999999999999875 4568999999999
Q ss_pred CCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCcee-
Q 002774 636 GSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHI- 714 (882)
Q Consensus 636 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~- 714 (882)
|+|.+++.... .+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++..........
T Consensus 80 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~ 154 (257)
T cd05060 80 GPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRA 154 (257)
T ss_pred CcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCccccc
Confidence 99999997654 6899999999999999999999988 99999999999999999999999999987644332111
Q ss_pred eeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCCCCC
Q 002774 715 TTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLST 793 (882)
Q Consensus 715 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 793 (882)
.....++..|+|||.+....++.++|||||||++|||++ |..||..... .+.... ..... ....
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~-~~~~~~-~~~~~-------------~~~~ 219 (257)
T cd05060 155 TTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG-AEVIAM-LESGE-------------RLPR 219 (257)
T ss_pred ccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH-HHHHHH-HHcCC-------------cCCC
Confidence 111224568999999998899999999999999999998 9999865432 111111 11111 0011
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 002774 794 TLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENI 829 (882)
Q Consensus 794 ~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 829 (882)
....+..+.+++.+||..+|++||++.++++.|+++
T Consensus 220 ~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 220 PEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 122346788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=318.61 Aligned_cols=258 Identities=27% Similarity=0.371 Sum_probs=203.5
Q ss_pred HHHHHcCCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEE
Q 002774 550 VKKYTNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQML 628 (882)
Q Consensus 550 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 628 (882)
++.+++++.....||+|+||.||+|+.. ++..||+|.+........+.+.+|+++++.++|+||+++++++..++..++
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 3445667777789999999999999854 678899999887665566789999999999999999999999999999999
Q ss_pred EEEeecCCCcccccCCCC-CccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcC-CCceeEeeccccccc
Q 002774 629 IYEFVPNGSLGDSLSGKN-GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDE-RLNAKVADFGLSKSM 706 (882)
Q Consensus 629 V~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~-~~~~kl~DfGla~~~ 706 (882)
|+||+++++|.++++... ....++..+..++.|++.||+|||+.+ |+||||||+||+++. ++.++|+|||++...
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~ 159 (268)
T cd06624 83 FMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRL 159 (268)
T ss_pred EEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheec
Confidence 999999999999987542 112378888899999999999999988 999999999999986 679999999999765
Q ss_pred CCCCCceeeeeeeccCCCCCHHHHhhC--CCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhc
Q 002774 707 SDSEKDHITTQVKGTMGYLDPEYYMTQ--QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYEL 784 (882)
Q Consensus 707 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 784 (882)
..... ......|+..|+|||++... .++.++||||||+++|||++|+.||.............. . ..
T Consensus 160 ~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~--------~-~~ 228 (268)
T cd06624 160 AGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVG--------M-FK 228 (268)
T ss_pred ccCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhh--------h-hc
Confidence 43221 12234588999999998754 378899999999999999999999864332211111000 0 00
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 785 IDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 785 ~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
..+.. +.....++.+++.+||+.+|++|||+.|++++
T Consensus 229 ~~~~~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 229 IHPEI----PESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred cCCCC----CcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 01111 11233678899999999999999999999864
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=313.98 Aligned_cols=248 Identities=28% Similarity=0.471 Sum_probs=198.8
Q ss_pred CeeeccCcEEEEEEEecCCcEEEEEEcccCCcc-cHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEeecCCCcc
Q 002774 561 NDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQ-GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLG 639 (882)
Q Consensus 561 ~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 639 (882)
++||+|+||.||+|...+++.||+|+++..... ..+.+.+|++++++++|+||+++++++.+....++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 468999999999999877999999998765443 4567899999999999999999999999999999999999999999
Q ss_pred cccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCceeeeeee
Q 002774 640 DSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVK 719 (882)
Q Consensus 640 ~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 719 (882)
+++.... ..+++..+..++.+++.||+|||+.+ ++||||||+||+++.++.+||+|||+++...............
T Consensus 81 ~~l~~~~-~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (251)
T cd05041 81 TFLRKKK-NRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQ 156 (251)
T ss_pred HHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCc
Confidence 9986543 25788999999999999999999998 9999999999999999999999999998654322111111223
Q ss_pred ccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCCCCCCHHHH
Q 002774 720 GTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGF 798 (882)
Q Consensus 720 gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 798 (882)
.+..|+|||.+.++.++.++|||||||++|||+| |..||..... ... ....... .........+
T Consensus 157 ~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~-~~~-~~~~~~~-------------~~~~~~~~~~ 221 (251)
T cd05041 157 IPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSN-QQT-RERIESG-------------YRMPAPQLCP 221 (251)
T ss_pred ceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCH-HHH-HHHHhcC-------------CCCCCCccCC
Confidence 4567999999998899999999999999999999 7778754322 111 1111110 0011112234
Q ss_pred HHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 002774 799 EKYVDLALKCVQESGDDRPTMSEVVKDIE 827 (882)
Q Consensus 799 ~~l~~li~~cl~~dp~~RPs~~evl~~L~ 827 (882)
.++.+++.+||+.+|++||++.|+++.|.
T Consensus 222 ~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 222 EEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred HHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 67899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=325.97 Aligned_cols=263 Identities=22% Similarity=0.338 Sum_probs=198.8
Q ss_pred cCCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCCc-ccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEe
Q 002774 555 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEF 632 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 632 (882)
++|...+.||+|+||+||+|+.. +++.||+|+++.... .....+.+|++++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 46788899999999999999864 678999999875432 2234678899999999999999999999999999999999
Q ss_pred ecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCc
Q 002774 633 VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKD 712 (882)
Q Consensus 633 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 712 (882)
+++ +|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++.......
T Consensus 86 ~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~- 159 (309)
T cd07872 86 LDK-DLKQYMDDCG-NIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTK- 159 (309)
T ss_pred CCC-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCcc-
Confidence 975 7877775443 35788899999999999999999998 99999999999999999999999999976533221
Q ss_pred eeeeeeeccCCCCCHHHHhh-CCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhh-hhhhhhhcc-----
Q 002774 713 HITTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKK-ELYNLYELI----- 785 (882)
Q Consensus 713 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~-~~~~~~~~~----- 785 (882)
......+++.|+|||.+.+ ..++.++|||||||++|||+||+.||..... .+.......... .....+..+
T Consensus 160 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07872 160 -TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTV-EDELHLIFRLLGTPTEETWPGISSNDE 237 (309)
T ss_pred -ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCCHHHHhhhcchhh
Confidence 1223457899999999875 5689999999999999999999999965432 122211111000 000000000
Q ss_pred -----CCcCCC----CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 786 -----DPTIGL----STTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 786 -----d~~l~~----~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
.+.... ........++.+++.+|++.||.+|||++|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 238 FKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred hhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 000000 0001123567899999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=325.62 Aligned_cols=244 Identities=24% Similarity=0.300 Sum_probs=193.4
Q ss_pred CeeeccCcEEEEEEEec-CCcEEEEEEcccCCc---ccHHHHHHHHHHHHhc-cCCCeeeEEEEEEeCCceEEEEEeecC
Q 002774 561 NDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM---QGGQEFKMEIELLSRV-HHKNLVSLLGFCFDRGEQMLIYEFVPN 635 (882)
Q Consensus 561 ~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~~ 635 (882)
+.||+|+||+||+|+.. +++.||+|+++.... ...+.+.+|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999864 678999999986432 2235578899999888 699999999999999999999999999
Q ss_pred CCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCceee
Q 002774 636 GSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHIT 715 (882)
Q Consensus 636 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 715 (882)
|+|..++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~~L~~~~~~~~--~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~ 153 (327)
T cd05617 81 GDLMFHMQRQR--KLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG--DTT 153 (327)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCC--Cce
Confidence 99988876543 5899999999999999999999998 9999999999999999999999999987533221 123
Q ss_pred eeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCc-----hHHHHHHHHHHhhhhhhhhhhccCCcCC
Q 002774 716 TQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGK-----YIVREIRTVMDKKKELYNLYELIDPTIG 790 (882)
Q Consensus 716 ~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 790 (882)
....||+.|+|||++.+..++.++|||||||++|||++|..||.... .............. ...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~----------~~~- 222 (327)
T cd05617 154 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKP----------IRI- 222 (327)
T ss_pred ecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCC----------CCC-
Confidence 34579999999999999999999999999999999999999995311 11111111111110 001
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCH------HHHHHH
Q 002774 791 LSTTLKGFEKYVDLALKCVQESGDDRPTM------SEVVKD 825 (882)
Q Consensus 791 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~------~evl~~ 825 (882)
+......+.+++.+||+.||.+|+++ .+++++
T Consensus 223 ---p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 223 ---PRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred ---CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence 11123567899999999999999985 566544
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=320.37 Aligned_cols=249 Identities=31% Similarity=0.483 Sum_probs=198.0
Q ss_pred CeeeccCcEEEEEEEecC-------CcEEEEEEcccCC-cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEe
Q 002774 561 NDVGSGGYGKVYKGTLPN-------GQLIAIKRAQQGS-MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEF 632 (882)
Q Consensus 561 ~~lG~G~fg~Vy~~~~~~-------g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 632 (882)
+.||+|+||.||+|+..+ ++.||+|.+.... ......+.+|+.+++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999998642 2579999886543 23456788999999999999999999999999999999999
Q ss_pred ecCCCcccccCCCC-----CccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCC-----ceeEeeccc
Q 002774 633 VPNGSLGDSLSGKN-----GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERL-----NAKVADFGL 702 (882)
Q Consensus 633 ~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~-----~~kl~DfGl 702 (882)
+++++|.+++.... ...+++.+++.++.|++.||+|||+.+ ++|+||||+||+++.++ .++++|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999986432 234789999999999999999999988 99999999999999887 899999999
Q ss_pred ccccCCCCCceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHhhhhhhhh
Q 002774 703 SKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNL 781 (882)
Q Consensus 703 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 781 (882)
++...............++..|+|||++.++.++.++|||||||++|||++ |+.||....... .... ....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~-~~~~-~~~~------ 229 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE-VLQH-VTAG------ 229 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH-HHHH-HhcC------
Confidence 986644332222223345788999999999999999999999999999998 999986443221 1111 1100
Q ss_pred hhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 002774 782 YELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIE 827 (882)
Q Consensus 782 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~ 827 (882)
.........+..+.+++.+||+.+|.+||++.++++.|+
T Consensus 230 -------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 230 -------GRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred -------CccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 001111223467889999999999999999999998875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=316.84 Aligned_cols=239 Identities=23% Similarity=0.385 Sum_probs=188.9
Q ss_pred CeeeccCcEEEEEEEecC-------------CcEEEEEEcccCCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceE
Q 002774 561 NDVGSGGYGKVYKGTLPN-------------GQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQM 627 (882)
Q Consensus 561 ~~lG~G~fg~Vy~~~~~~-------------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 627 (882)
+.||+|+||.||+|++.+ ...||+|.+..........|.+|+.+++.++||||+++++++..+...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 368999999999998532 2358999887654444567889999999999999999999999999999
Q ss_pred EEEEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCc-------eeEeec
Q 002774 628 LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLN-------AKVADF 700 (882)
Q Consensus 628 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~-------~kl~Df 700 (882)
+||||+++|+|..++.... ..+++..+.+++.|+++||+|||+.+ |+||||||+|||++.++. ++++||
T Consensus 81 lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKS-DVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred EEEecccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 9999999999988876533 35889999999999999999999988 999999999999987664 899999
Q ss_pred ccccccCCCCCceeeeeeeccCCCCCHHHHh-hCCCCchhHHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHhhhhh
Q 002774 701 GLSKSMSDSEKDHITTQVKGTMGYLDPEYYM-TQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKEL 778 (882)
Q Consensus 701 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDv~S~Gvll~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~ 778 (882)
|++...... ....++..|+|||.+. ...++.++|||||||++|||++ |..|+.... ..+ .......
T Consensus 157 g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~-~~~-~~~~~~~---- 224 (262)
T cd05077 157 GIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKT-LAE-KERFYEG---- 224 (262)
T ss_pred CCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcc-hhH-HHHHHhc----
Confidence 998755322 2245788999999987 5678999999999999999984 777775322 111 1111000
Q ss_pred hhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 002774 779 YNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDI 826 (882)
Q Consensus 779 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L 826 (882)
.... ......++.+++.+||+.||++||++.++++.+
T Consensus 225 --~~~~---------~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 225 --QCML---------VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred --CccC---------CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 0000 111236788999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=334.92 Aligned_cols=262 Identities=23% Similarity=0.325 Sum_probs=198.4
Q ss_pred CCCCCCeeeccCcEEEEEEEe-cCCcEEEEEEcccCC--cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCC-----ceE
Q 002774 556 NFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGS--MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRG-----EQM 627 (882)
Q Consensus 556 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----~~~ 627 (882)
+|+..+.||+|+||+||+|.. .+|+.||||++.... ....+.+.+|+++++.++|+||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 477889999999999999985 478999999986532 223467889999999999999999999998776 789
Q ss_pred EEEEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccC
Q 002774 628 LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMS 707 (882)
Q Consensus 628 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~ 707 (882)
+|+||+. ++|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 81 lv~e~~~-~~l~~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~ 154 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSPQ--PLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEE 154 (372)
T ss_pred EEeeccc-cCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeecc
Confidence 9999996 57777775443 6889999999999999999999998 9999999999999999999999999998654
Q ss_pred CCCCceeeeeeeccCCCCCHHHHhhC-CCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhh----------
Q 002774 708 DSEKDHITTQVKGTMGYLDPEYYMTQ-QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKK---------- 776 (882)
Q Consensus 708 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~---------- 776 (882)
.... .......+++.|+|||++.+. .++.++||||+||++|||++|+.||...... +....+.....
T Consensus 155 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~i~~~~g~~~~~~~~~~ 232 (372)
T cd07853 155 PDES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPI-QQLDLITDLLGTPSLEAMRSA 232 (372)
T ss_pred cCcc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHH-HHHHHHHHHcCCCCHHHHHHh
Confidence 3322 122334578999999999864 5799999999999999999999999654322 22221111000
Q ss_pred --hhh-hhh-hccCC-cCC--CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 777 --ELY-NLY-ELIDP-TIG--LSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 777 --~~~-~~~-~~~d~-~l~--~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
... .+. ....+ ... .........++.+++.+||+.||++|||+.|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 233 CEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred hHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 000 000 00000 000 00011124678899999999999999999999976
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=315.56 Aligned_cols=250 Identities=22% Similarity=0.343 Sum_probs=203.3
Q ss_pred CCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCC-cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEee
Q 002774 556 NFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS-MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFV 633 (882)
Q Consensus 556 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 633 (882)
+|...+.||+|+||.||+++.. +++.||+|.++... ....+.+.+|+.+++.++|+||+++++++.+++..++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4677889999999999999864 68899999986432 334467888999999999999999999999999999999999
Q ss_pred cCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCce
Q 002774 634 PNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDH 713 (882)
Q Consensus 634 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 713 (882)
++|+|.+++.......+++.....++.|++.||.|||+.+ |+|+||||+||++++++.++++|||+++.......
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-- 155 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-- 155 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccccc--
Confidence 9999999886554456889999999999999999999998 99999999999999999999999999986643221
Q ss_pred eeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCCCCC
Q 002774 714 ITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLST 793 (882)
Q Consensus 714 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 793 (882)
......|++.|+|||++.+..++.++||||||+++|+|++|..||..... ........... ...+
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~-~~~~~~~~~~~------~~~~-------- 220 (255)
T cd08219 156 YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW-KNLILKVCQGS------YKPL-------- 220 (255)
T ss_pred ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH-HHHHHHHhcCC------CCCC--------
Confidence 22335688999999999988899999999999999999999999975332 11111111100 0001
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 794 TLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 794 ~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
.......+.+++.+||+.||++||++.|++..
T Consensus 221 ~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 221 PSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 11223568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=332.47 Aligned_cols=259 Identities=24% Similarity=0.356 Sum_probs=207.6
Q ss_pred CCCCCCeeeccCcEEEEEEEe-cCCcEEEEEEcccCCcccHHHHHHHHHHHHhcc-C-----CCeeeEEEEEEeCCceEE
Q 002774 556 NFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVH-H-----KNLVSLLGFCFDRGEQML 628 (882)
Q Consensus 556 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H-----~niv~l~~~~~~~~~~~l 628 (882)
+|.+.+.||+|+||.|-||.. .+++.||||+++....- ..+-..|+.+|..++ | -|+|++++++...++.+|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f-~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRF-LRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHH-HHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 788899999999999999984 57999999999865322 244567999999996 4 489999999999999999
Q ss_pred EEEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCC--CceeEeeccccccc
Q 002774 629 IYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDER--LNAKVADFGLSKSM 706 (882)
Q Consensus 629 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~--~~~kl~DfGla~~~ 706 (882)
|+|.+ .-+|.++++.++...++...+..|+.||+.||..||+.+ |||+||||+||||.+. ..+||+|||.|+..
T Consensus 266 VfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 266 VFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred eehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEeccccccc
Confidence 99999 569999999888778999999999999999999999999 9999999999999754 46999999999876
Q ss_pred CCCCCceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhh----------
Q 002774 707 SDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKK---------- 776 (882)
Q Consensus 707 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~---------- 776 (882)
... +. ....+..|+|||++.+..|+.+.||||||||++||++| .|+..|.+..+++..+++-..
T Consensus 342 ~q~----vy-tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG-~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~ 415 (586)
T KOG0667|consen 342 SQR----VY-TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTG-EPLFPGDNEYDQLARIIEVLGLPPPKMLDTA 415 (586)
T ss_pred CCc----ce-eeeeccccccchhhccCCCCCccceeehhhhHHhHhcC-ccccCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 432 22 45678899999999999999999999999999999999 577778887777766554111
Q ss_pred -hhhhhhhc------------------------------cCCcCC-CC------CCHHHHHHHHHHHHHhhccCCCCCCC
Q 002774 777 -ELYNLYEL------------------------------IDPTIG-LS------TTLKGFEKYVDLALKCVQESGDDRPT 818 (882)
Q Consensus 777 -~~~~~~~~------------------------------~d~~l~-~~------~~~~~~~~l~~li~~cl~~dp~~RPs 818 (882)
......+. .+...+ .. ........+.+++++|+..||.+|+|
T Consensus 416 ~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~t 495 (586)
T KOG0667|consen 416 KKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERIT 495 (586)
T ss_pred cccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCC
Confidence 00000000 000000 00 00122356899999999999999999
Q ss_pred HHHHHHH
Q 002774 819 MSEVVKD 825 (882)
Q Consensus 819 ~~evl~~ 825 (882)
+.|++++
T Consensus 496 p~qal~H 502 (586)
T KOG0667|consen 496 PAQALNH 502 (586)
T ss_pred HHHHhcC
Confidence 9999986
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=327.26 Aligned_cols=263 Identities=19% Similarity=0.271 Sum_probs=195.4
Q ss_pred CCeeecc--CcEEEEEEEe-cCCcEEEEEEcccCCcc--cHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEeec
Q 002774 560 ANDVGSG--GYGKVYKGTL-PNGQLIAIKRAQQGSMQ--GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVP 634 (882)
Q Consensus 560 ~~~lG~G--~fg~Vy~~~~-~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 634 (882)
.++||+| +|++||+++. .+|+.||+|+++..... ..+.+.+|+++++.++||||+++++++..++..++||||++
T Consensus 3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 82 (327)
T cd08227 3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 82 (327)
T ss_pred hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccC
Confidence 4679999 7899999986 47899999999754322 23467789999999999999999999999999999999999
Q ss_pred CCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCce-
Q 002774 635 NGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDH- 713 (882)
Q Consensus 635 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~- 713 (882)
+|+|.+++.......+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++++|||.+..........
T Consensus 83 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~ 159 (327)
T cd08227 83 YGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLR 159 (327)
T ss_pred CCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccccccc
Confidence 999999986544446899999999999999999999998 9999999999999999999999998764432211100
Q ss_pred ----eeeeeeccCCCCCHHHHhh--CCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhh-------
Q 002774 714 ----ITTQVKGTMGYLDPEYYMT--QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYN------- 780 (882)
Q Consensus 714 ----~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~------- 780 (882)
......++..|+|||++.+ ..++.++|||||||++|||++|+.||......................
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (327)
T cd08227 160 VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAE 239 (327)
T ss_pred ccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhh
Confidence 1112346778999999976 468999999999999999999999997533221111111000000000
Q ss_pred -h-----hhccCCcC-----------------CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 781 -L-----YELIDPTI-----------------GLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 781 -~-----~~~~d~~l-----------------~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
. ....+... ...........+.+++.+||+.||++|||++|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~ 307 (327)
T cd08227 240 ELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 307 (327)
T ss_pred hcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence 0 00000000 000111223578899999999999999999999975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=336.43 Aligned_cols=261 Identities=20% Similarity=0.304 Sum_probs=204.0
Q ss_pred HHHHHHHHcCCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCC---cccHHHHHHHHHHHHhccCCCeeeEEEEEEe
Q 002774 547 FEEVKKYTNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS---MQGGQEFKMEIELLSRVHHKNLVSLLGFCFD 622 (882)
Q Consensus 547 ~~e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~ 622 (882)
..++....++|...+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 3344555678999999999999999999965 68899999986422 2233557889999999999999999999999
Q ss_pred CCceEEEEEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeeccc
Q 002774 623 RGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGL 702 (882)
Q Consensus 623 ~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGl 702 (882)
++..++||||+++|+|.+++... .++...+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~ 188 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGT 188 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCc
Confidence 99999999999999999988654 4788888899999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCceeeeeeeccCCCCCHHHHhhC----CCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhh
Q 002774 703 SKSMSDSEKDHITTQVKGTMGYLDPEYYMTQ----QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKEL 778 (882)
Q Consensus 703 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~ 778 (882)
++....... .......||+.|||||++... .++.++|||||||++|||++|..||..... ......+.....
T Consensus 189 a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-~~~~~~i~~~~~-- 264 (371)
T cd05622 189 CMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL-VGTYSKIMNHKN-- 264 (371)
T ss_pred eeEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH-HHHHHHHHcCCC--
Confidence 987653321 122345699999999999754 378999999999999999999999975433 222222221111
Q ss_pred hhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHHH
Q 002774 779 YNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDD--RPTMSEVVKDI 826 (882)
Q Consensus 779 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~--RPs~~evl~~L 826 (882)
.+...........+.+++.+|+..++.+ |+++.|++++.
T Consensus 265 ---------~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 265 ---------SLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred ---------cccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 0001111123467889999999844433 78999999864
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=326.69 Aligned_cols=252 Identities=24% Similarity=0.348 Sum_probs=211.7
Q ss_pred HcCCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCCccc---HHHHHHHHHHHHhcc-CCCeeeEEEEEEeCCceEE
Q 002774 554 TNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQG---GQEFKMEIELLSRVH-HKNLVSLLGFCFDRGEQML 628 (882)
Q Consensus 554 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~l 628 (882)
...|...+.||+|.||.||+++.+ +|+.+|+|.+.+..... ...+.+|+++|+++. |||||.+.+++.+....++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 456777789999999999999965 59999999998765433 358899999999998 9999999999999999999
Q ss_pred EEEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCC----CceeEeeccccc
Q 002774 629 IYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDER----LNAKVADFGLSK 704 (882)
Q Consensus 629 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~----~~~kl~DfGla~ 704 (882)
|||++.+|.|.+.+... .+++.....++.|++.++.|||+.| |+||||||+|+|+... +.+|++|||++.
T Consensus 114 vmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~ 187 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGLAK 187 (382)
T ss_pred EEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCCce
Confidence 99999999999998766 3899999999999999999999999 9999999999999543 579999999999
Q ss_pred ccCCCCCceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhc
Q 002774 705 SMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYEL 784 (882)
Q Consensus 705 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 784 (882)
.... .......+||+.|+|||++....|+..+||||+||++|.|++|..||.......... .+...
T Consensus 188 ~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-~i~~~---------- 253 (382)
T KOG0032|consen 188 FIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-AILRG---------- 253 (382)
T ss_pred EccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-HHHcC----------
Confidence 8765 234566889999999999999999999999999999999999999997654333222 11111
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 002774 785 IDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDI 826 (882)
Q Consensus 785 ~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L 826 (882)
+..............+.+++.+|+..||.+|+|+.+++++-
T Consensus 254 -~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~Hp 294 (382)
T KOG0032|consen 254 -DFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHP 294 (382)
T ss_pred -CCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCc
Confidence 11122223333457788999999999999999999999963
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=332.54 Aligned_cols=261 Identities=25% Similarity=0.312 Sum_probs=197.8
Q ss_pred HHcCCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCCc--ccHHHHHHHHHHHHhccCCCeeeEEEEEEeCC-----
Q 002774 553 YTNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM--QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRG----- 624 (882)
Q Consensus 553 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----- 624 (882)
..++|...+.||+|+||.||+|... .++.||||++..... ...+.+.+|+.+++.++||||+++++++....
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4568999999999999999999854 688999999875422 23356788999999999999999999886533
Q ss_pred -ceEEEEEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccc
Q 002774 625 -EQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLS 703 (882)
Q Consensus 625 -~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla 703 (882)
..++||||+++ ++.+.+.. .+++.++..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~~ 166 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCccc
Confidence 46999999965 56665542 4788889999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhh-------
Q 002774 704 KSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKK------- 776 (882)
Q Consensus 704 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~------- 776 (882)
+...... ......||..|+|||++.+..++.++|||||||++|||++|+.||........+ ...+....
T Consensus 167 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~ 242 (355)
T cd07874 167 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQW-NKVIEQLGTPCPEFM 242 (355)
T ss_pred ccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHHhCCCCHHHH
Confidence 8654322 223456899999999999989999999999999999999999999754432221 11111000
Q ss_pred -----hhhhhhh-------ccCCc------CC--CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 777 -----ELYNLYE-------LIDPT------IG--LSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 777 -----~~~~~~~-------~~d~~------l~--~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
......+ ...+. .. .........++.+++.+|++.||++|||+.|++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 0000000 00000 00 00011123567899999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=332.88 Aligned_cols=243 Identities=27% Similarity=0.435 Sum_probs=202.1
Q ss_pred CeeeccCcEEEEEEEec-CCcEEEEEEcc---c-CCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCc--eEEEEEee
Q 002774 561 NDVGSGGYGKVYKGTLP-NGQLIAIKRAQ---Q-GSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGE--QMLIYEFV 633 (882)
Q Consensus 561 ~~lG~G~fg~Vy~~~~~-~g~~vavK~~~---~-~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~--~~lV~e~~ 633 (882)
.+||+|+|-+||||... +|-.||--.++ . .+....+.|..|+++|+.|+|||||+++.+|.+... .-+|+|.|
T Consensus 46 evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~ 125 (632)
T KOG0584|consen 46 EVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELF 125 (632)
T ss_pred hhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeecc
Confidence 46999999999999864 57777633222 1 123334789999999999999999999999988665 67899999
Q ss_pred cCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcC-CCceeEeecccccccCCCCCc
Q 002774 634 PNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDE-RLNAKVADFGLSKSMSDSEKD 712 (882)
Q Consensus 634 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~-~~~~kl~DfGla~~~~~~~~~ 712 (882)
..|+|..|++..+ +.+.....+|++||++||.|||++. |||||||||.+||+|+. .|.+||+|+|||+......
T Consensus 126 TSGtLr~Y~kk~~--~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~-- 200 (632)
T KOG0584|consen 126 TSGTLREYRKKHR--RVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH-- 200 (632)
T ss_pred cCCcHHHHHHHhc--cCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhccc--
Confidence 9999999998765 5778889999999999999999975 89999999999999975 5899999999999875433
Q ss_pred eeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCCCC
Q 002774 713 HITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLS 792 (882)
Q Consensus 713 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 792 (882)
.....|||.|||||++. ..|+..+||||||+.++||+|+..||..-.+..+..+++....+. ..+..+-|
T Consensus 201 --aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP-~sl~kV~d------ 270 (632)
T KOG0584|consen 201 --AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKP-AALSKVKD------ 270 (632)
T ss_pred --cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCH-HHhhccCC------
Confidence 22378999999999986 889999999999999999999999999888888887777765542 11222222
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 793 TTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 793 ~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
.++.++|.+|+.. ..+|||+.|+|++
T Consensus 271 ------Pevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 271 ------PEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred ------HHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 5678999999999 9999999999975
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=337.62 Aligned_cols=261 Identities=19% Similarity=0.259 Sum_probs=201.1
Q ss_pred HcCCCCCCeeeccCcEEEEEEEec---CCcEEEEEEcccCCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEE
Q 002774 554 TNNFSDANDVGSGGYGKVYKGTLP---NGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIY 630 (882)
Q Consensus 554 ~~~~~~~~~lG~G~fg~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 630 (882)
..+|...+.||+|+||.||+|... .+..||||.+... +.+.+|++++++++|||||++++++......++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 457899999999999999999753 3678999988643 34568999999999999999999999999999999
Q ss_pred EeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCC
Q 002774 631 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE 710 (882)
Q Consensus 631 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~ 710 (882)
|++. ++|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 166 e~~~-~~l~~~l~~~--~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~ 239 (392)
T PHA03207 166 PKYK-CDLFTYVDRS--GPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP 239 (392)
T ss_pred hhcC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence 9995 6888888433 36899999999999999999999998 9999999999999999999999999998765443
Q ss_pred CceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCch--HHHHHHHHHHhhhhh----------
Q 002774 711 KDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKY--IVREIRTVMDKKKEL---------- 778 (882)
Q Consensus 711 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~--~~~~~~~~~~~~~~~---------- 778 (882)
.........||+.|+|||++....++.++|||||||++|||++|+.||..... ....+..+.......
T Consensus 240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~ 319 (392)
T PHA03207 240 DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGST 319 (392)
T ss_pred ccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccch
Confidence 33333346799999999999999999999999999999999999999964321 122222222111000
Q ss_pred ------hhhhhccCCcCCCCC---CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 779 ------YNLYELIDPTIGLST---TLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 779 ------~~~~~~~d~~l~~~~---~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
........+...... ......++.+++.+||+.||++|||+.|++.+
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 320 NLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred hHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000000000000000 00123567899999999999999999999986
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=321.30 Aligned_cols=262 Identities=24% Similarity=0.331 Sum_probs=195.9
Q ss_pred CCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCCcc--cHHHHHHHHHHHHhc---cCCCeeeEEEEEEeC-----C
Q 002774 556 NFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQ--GGQEFKMEIELLSRV---HHKNLVSLLGFCFDR-----G 624 (882)
Q Consensus 556 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~H~niv~l~~~~~~~-----~ 624 (882)
+|...+.||+|+||+||+|+.. +++.||+|.++..... ....+.+|+++++.+ +||||+++++++... .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4777889999999999999864 6899999998753222 224566777777766 699999999988652 3
Q ss_pred ceEEEEEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeeccccc
Q 002774 625 EQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSK 704 (882)
Q Consensus 625 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~ 704 (882)
..++||||++ ++|.+++.......+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCccc
Confidence 4789999997 58888887654456899999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCCceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhh-----hhh
Q 002774 705 SMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKK-----ELY 779 (882)
Q Consensus 705 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~-----~~~ 779 (882)
....... .....||..|+|||++.+..++.++||||+||++|||++|+.||...... +.......... ...
T Consensus 157 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~-~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07863 157 IYSCQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA-DQLGKIFDLIGLPPEDDWP 232 (288)
T ss_pred cccCccc---CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHH-HHHHHHHHHhCCCChhhCc
Confidence 7643221 22346899999999999889999999999999999999999998654332 22222221100 000
Q ss_pred hhh----hccCCcCC---CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 780 NLY----ELIDPTIG---LSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 780 ~~~----~~~d~~l~---~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
... ....+... .........++.+++.+|++.||++|||+.|++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 233 RDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred ccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000 00000000 00011233667899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=314.11 Aligned_cols=251 Identities=29% Similarity=0.553 Sum_probs=202.8
Q ss_pred cCCCCCCeeeccCcEEEEEEEecCCcEEEEEEcccCCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEeec
Q 002774 555 NNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVP 634 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 634 (882)
.+|+..+.||+|+||.||+|.+.+++.+|+|.++.... ...++.+|++++++++|||++++++++......++||||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 35677889999999999999987788999999875433 34678999999999999999999999999999999999999
Q ss_pred CCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCcee
Q 002774 635 NGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHI 714 (882)
Q Consensus 635 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 714 (882)
+++|.+++.... ..+++..+..++.+++.|++|||+.+ ++||||||+||+++.++.+||+|||+++....... ..
T Consensus 83 ~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~~ 157 (256)
T cd05112 83 HGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY-TS 157 (256)
T ss_pred CCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcc-cc
Confidence 999999887543 25789999999999999999999998 99999999999999999999999999986543221 11
Q ss_pred eeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCCCCC
Q 002774 715 TTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLST 793 (882)
Q Consensus 715 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 793 (882)
.....++.+|+|||++.++.++.++||||||+++|||++ |..||..... .......... .....+..
T Consensus 158 ~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-~~~~~~~~~~-------~~~~~~~~---- 225 (256)
T cd05112 158 STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN-SEVVETINAG-------FRLYKPRL---- 225 (256)
T ss_pred cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH-HHHHHHHhCC-------CCCCCCCC----
Confidence 122335678999999998899999999999999999998 8889864332 1111111100 01111111
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 002774 794 TLKGFEKYVDLALKCVQESGDDRPTMSEVVKDI 826 (882)
Q Consensus 794 ~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L 826 (882)
....+.+++.+||+.+|++||++.|+++.|
T Consensus 226 ---~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 226 ---ASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred ---CCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 236789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=313.30 Aligned_cols=250 Identities=29% Similarity=0.443 Sum_probs=204.7
Q ss_pred cCCCCCCeeeccCcEEEEEEEecC-CcEEEEEEcccCCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEee
Q 002774 555 NNFSDANDVGSGGYGKVYKGTLPN-GQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFV 633 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 633 (882)
++|+..+.||+|+||.||+|+..+ ++.||+|.++.... .+++.+|++++++++|+||+++++++.+++..++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 567888999999999999999764 78999999875432 578999999999999999999999999999999999999
Q ss_pred cCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCce
Q 002774 634 PNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDH 713 (882)
Q Consensus 634 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 713 (882)
++++|.+++.... ..+++..+..++.|+++||.|||+.+ ++||||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-- 154 (256)
T cd06612 81 GAGSVSDIMKITN-KTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-- 154 (256)
T ss_pred CCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc--
Confidence 9999999986432 36899999999999999999999988 99999999999999999999999999987654321
Q ss_pred eeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCCCCC
Q 002774 714 ITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLST 793 (882)
Q Consensus 714 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 793 (882)
......++..|+|||++.+..++.++|||||||++|||++|+.||........... ......+.. ..
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~-----------~~~~~~~~~--~~ 221 (256)
T cd06612 155 KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM-----------IPNKPPPTL--SD 221 (256)
T ss_pred ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhh-----------hccCCCCCC--Cc
Confidence 22334588899999999988999999999999999999999999875332211110 000001111 11
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 794 TLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 794 ~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
.......+.+++.+||+.+|++|||+.|++++
T Consensus 222 ~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 222 PEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred hhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 12233678999999999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=318.03 Aligned_cols=258 Identities=28% Similarity=0.474 Sum_probs=205.0
Q ss_pred cCCCCCCeeeccCcEEEEEEEec-CCc----EEEEEEcccCCc-ccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEE
Q 002774 555 NNFSDANDVGSGGYGKVYKGTLP-NGQ----LIAIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQML 628 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 628 (882)
.+|...+.||+|+||+||+|.+. +|+ .||+|.++.... ....++.+|+.++++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 45677899999999999999864 333 689998876543 234678899999999999999999999987 78899
Q ss_pred EEEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCC
Q 002774 629 IYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSD 708 (882)
Q Consensus 629 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~ 708 (882)
||||+++|+|.+++..... .+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++....
T Consensus 86 v~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHKD-NIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161 (279)
T ss_pred EEecCCCCcHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccccccC
Confidence 9999999999999876432 5899999999999999999999988 99999999999999999999999999987654
Q ss_pred CCCceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCC
Q 002774 709 SEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDP 787 (882)
Q Consensus 709 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 787 (882)
...........++..|+|||.+....++.++||||||+++||+++ |+.||..... .+. ........ .
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-~~~-~~~~~~~~------~---- 229 (279)
T cd05057 162 DEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA-VEI-PDLLEKGE------R---- 229 (279)
T ss_pred cccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH-HHH-HHHHhCCC------C----
Confidence 332221122234578999999988899999999999999999999 9999865322 121 11111111 0
Q ss_pred cCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 002774 788 TIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 832 (882)
Q Consensus 788 ~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~ 832 (882)
...+......+.+++.+||..+|.+||++.++++.|.++.+.
T Consensus 230 ---~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 230 ---LPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred ---CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 001111235688999999999999999999999999998643
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=326.22 Aligned_cols=255 Identities=22% Similarity=0.283 Sum_probs=199.0
Q ss_pred cCCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCC---cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEE
Q 002774 555 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS---MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIY 630 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 630 (882)
++|...+.||+|+||+||+++.. +++.||+|.+.... ......+.+|..++..++|+||+++++++.+++..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888999999999999999864 67899999986522 122345788999999999999999999999999999999
Q ss_pred EeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCC
Q 002774 631 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE 710 (882)
Q Consensus 631 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~ 710 (882)
||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 Ey~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 156 (331)
T cd05624 81 DYYVGGDLLTLLSKFE-DRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG 156 (331)
T ss_pred eCCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCCC
Confidence 9999999999997532 25788889999999999999999998 9999999999999999999999999998765432
Q ss_pred CceeeeeeeccCCCCCHHHHhh-----CCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhcc
Q 002774 711 KDHITTQVKGTMGYLDPEYYMT-----QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELI 785 (882)
Q Consensus 711 ~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 785 (882)
. .......||+.|+|||++.+ +.++.++|||||||++|||++|+.||..... .+....+...... . .+
T Consensus 157 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~-~~~~~~i~~~~~~----~-~~ 229 (331)
T cd05624 157 T-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL-VETYGKIMNHEER----F-QF 229 (331)
T ss_pred c-eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH-HHHHHHHHcCCCc----c-cC
Confidence 2 12233569999999999875 5678899999999999999999999975432 2222222111100 0 00
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 002774 786 DPTIGLSTTLKGFEKYVDLALKCVQESGDD--RPTMSEVVKD 825 (882)
Q Consensus 786 d~~l~~~~~~~~~~~l~~li~~cl~~dp~~--RPs~~evl~~ 825 (882)
.+. ......++.+++.+|++.++++ |+++++++++
T Consensus 230 p~~-----~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 230 PSH-----ITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred CCc-----cccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 000 1122467889999999876554 4688888875
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=329.74 Aligned_cols=240 Identities=25% Similarity=0.323 Sum_probs=189.4
Q ss_pred CeeeccCcEEEEEEEec-CCcEEEEEEcccCCc---ccHHHHHHHH-HHHHhccCCCeeeEEEEEEeCCceEEEEEeecC
Q 002774 561 NDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM---QGGQEFKMEI-ELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPN 635 (882)
Q Consensus 561 ~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~-~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~ 635 (882)
+.||+|+||+||+|+.. +++.||+|++..... .....+..|. .+++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999865 578899999875321 2223344444 456788999999999999999999999999999
Q ss_pred CCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCceee
Q 002774 636 GSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHIT 715 (882)
Q Consensus 636 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 715 (882)
|+|.+++.... .+.+.....++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~~L~~~~~~~~--~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~--~~~ 153 (325)
T cd05602 81 GELFYHLQRER--CFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--GTT 153 (325)
T ss_pred CcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCC--CCc
Confidence 99999887543 5777888889999999999999998 9999999999999999999999999997543222 123
Q ss_pred eeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCCCCCCH
Q 002774 716 TQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTL 795 (882)
Q Consensus 716 ~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 795 (882)
....||+.|+|||++.+..++.++|||||||++|||++|..||..... .+......... ....+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-~~~~~~i~~~~-------~~~~~-------- 217 (325)
T cd05602 154 STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT-AEMYDNILNKP-------LQLKP-------- 217 (325)
T ss_pred ccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH-HHHHHHHHhCC-------cCCCC--------
Confidence 345699999999999999999999999999999999999999975432 22222221110 00111
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 002774 796 KGFEKYVDLALKCVQESGDDRPTMSEVV 823 (882)
Q Consensus 796 ~~~~~l~~li~~cl~~dp~~RPs~~evl 823 (882)
.....+.+++.+|++.||.+||++.+.+
T Consensus 218 ~~~~~~~~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 218 NITNSARHLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred CCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence 2236788999999999999999887543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=319.20 Aligned_cols=248 Identities=25% Similarity=0.407 Sum_probs=197.0
Q ss_pred CCCCCCeeeccCcEEEEEEEe-cCCcEEEEEEcccCC-cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEee
Q 002774 556 NFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGS-MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFV 633 (882)
Q Consensus 556 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 633 (882)
+|...+.||+|+||.||+|+. .+++.||+|++.... ....+++.+|++++++++||||+++++++...+..++||||+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence 567788999999999999985 578999999986542 223467889999999999999999999999999999999999
Q ss_pred cCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCce
Q 002774 634 PNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDH 713 (882)
Q Consensus 634 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 713 (882)
++++|..+. .+++.....++.|++.||+|||+.+ |+|+||||+||+++.++.++|+|||++.......
T Consensus 82 ~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~--- 149 (279)
T cd06619 82 DGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI--- 149 (279)
T ss_pred CCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceeccccc---
Confidence 999986542 3677888899999999999999998 9999999999999999999999999998654322
Q ss_pred eeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHH--HHHHHhhhhhhhhhhccCCcCCC
Q 002774 714 ITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREI--RTVMDKKKELYNLYELIDPTIGL 791 (882)
Q Consensus 714 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~--~~~~~~~~~~~~~~~~~d~~l~~ 791 (882)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||.......... ...... ......+...
T Consensus 150 -~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~------~~~~~~~~~~- 221 (279)
T cd06619 150 -AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQC------IVDEDPPVLP- 221 (279)
T ss_pred -ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHH------HhccCCCCCC-
Confidence 223568999999999998899999999999999999999999986421110000 000000 0000111111
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 792 STTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 792 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
......++.+++.+||+.+|++||+++|++++
T Consensus 222 --~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 222 --VGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred --CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 11123578899999999999999999999976
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=315.05 Aligned_cols=252 Identities=26% Similarity=0.450 Sum_probs=202.2
Q ss_pred CCCCCCeeeccCcEEEEEEEecCCcEEEEEEcccCCcc------cHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEE
Q 002774 556 NFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQ------GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLI 629 (882)
Q Consensus 556 ~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 629 (882)
+|...+.||+|+||+||+|...+++.+|||.++..... ..+.+.+|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 46778899999999999999888999999988643211 124588899999999999999999999999999999
Q ss_pred EEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCC
Q 002774 630 YEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDS 709 (882)
Q Consensus 630 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~ 709 (882)
|||+++++|.+++.... .+++..+..++.|++.||+|||+.+ |+|+||+|+||++++++.++|+|||+++.....
T Consensus 81 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 155 (265)
T cd06631 81 MEFVPGGSISSILNRFG--PLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWV 155 (265)
T ss_pred EecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhhc
Confidence 99999999999986543 5788899999999999999999988 999999999999999999999999999865321
Q ss_pred CC----ceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhcc
Q 002774 710 EK----DHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELI 785 (882)
Q Consensus 710 ~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 785 (882)
.. ........|+..|+|||++.+..++.++|||||||++|||++|..||........... .... ...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~-~~~~--------~~~ 226 (265)
T cd06631 156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFY-IGAH--------RGL 226 (265)
T ss_pred cccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHH-hhhc--------cCC
Confidence 11 1112234688999999999988899999999999999999999999975433222111 1000 001
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 786 DPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 786 d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
.+... .....++.+++.+||+.+|++||++.|++++
T Consensus 227 ~~~~~----~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 262 (265)
T cd06631 227 MPRLP----DSFSAAAIDFVTSCLTRDQHERPSALQLLRH 262 (265)
T ss_pred CCCCC----CCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 11111 1234678999999999999999999999863
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=323.11 Aligned_cols=259 Identities=27% Similarity=0.413 Sum_probs=202.3
Q ss_pred cCCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCCc-ccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEe
Q 002774 555 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEF 632 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 632 (882)
++|+..+.||+|+||+||+|+.. ++..||+|.++.... .....+.+|++++++++||||+++++++.+++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 36888999999999999999864 688999999875422 2235688999999999999999999999999999999999
Q ss_pred ecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhh-cCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCC
Q 002774 633 VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHE-LANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEK 711 (882)
Q Consensus 633 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 711 (882)
+++++|.++++... .+++..+..++.|+++||+|||+ .+ ++||||||+||++++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 154 (308)
T cd06615 81 MDGGSLDQVLKKAG--RIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 154 (308)
T ss_pred cCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCcccccccc-
Confidence 99999999997653 57888899999999999999997 46 9999999999999999999999999987653321
Q ss_pred ceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhh-----------
Q 002774 712 DHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYN----------- 780 (882)
Q Consensus 712 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~----------- 780 (882)
.....|+..|+|||.+.+..++.++|||||||++|||++|..||..... . ..............
T Consensus 155 ---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~-~-~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (308)
T cd06615 155 ---ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDA-K-ELEAMFGRPVSEGEAKESHRPVSGH 229 (308)
T ss_pred ---cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcch-h-hHHHhhcCccccccccCCcccccCC
Confidence 2235688999999999888899999999999999999999999864331 1 11111110000000
Q ss_pred ----------------hhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 002774 781 ----------------LYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIE 827 (882)
Q Consensus 781 ----------------~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~ 827 (882)
......|... ......++.+++.+||+.+|++||++.|++++-.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~ 289 (308)
T cd06615 230 PPDSPRPMAIFELLDYIVNEPPPKLP---SGAFSDEFQDFVDKCLKKNPKERADLKELTKHPF 289 (308)
T ss_pred CCCccchhhHHHHHHHHhcCCCccCc---CcccCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence 0000001110 0113356899999999999999999999998743
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=327.75 Aligned_cols=241 Identities=23% Similarity=0.301 Sum_probs=193.3
Q ss_pred CCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCC---cccHHHHHHHHHHHHhcc-CCCeeeEEEEEEeCCceEEEE
Q 002774 556 NFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS---MQGGQEFKMEIELLSRVH-HKNLVSLLGFCFDRGEQMLIY 630 (882)
Q Consensus 556 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~ 630 (882)
+|...+.||+|+||+||+|+.. +|+.||+|+++... ....+.+..|..++..+. |++|+++.+++.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 3667789999999999999864 68999999987532 223355778889988885 678889999999999999999
Q ss_pred EeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCC
Q 002774 631 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE 710 (882)
Q Consensus 631 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~ 710 (882)
||+++|+|.+++.... .+++.++..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 81 Ey~~~g~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~ 155 (323)
T cd05615 81 EYVNGGDLMYHIQQVG--KFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG 155 (323)
T ss_pred cCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence 9999999999886543 5889999999999999999999998 9999999999999999999999999987543222
Q ss_pred CceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCC
Q 002774 711 KDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIG 790 (882)
Q Consensus 711 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 790 (882)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+.... ..
T Consensus 156 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~-~~~~~~i~~~~-----------~~-- 219 (323)
T cd05615 156 V--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE-DELFQSIMEHN-----------VS-- 219 (323)
T ss_pred c--cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH-HHHHHHHHhCC-----------CC--
Confidence 1 12335689999999999988999999999999999999999999975432 22222221110 00
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCH
Q 002774 791 LSTTLKGFEKYVDLALKCVQESGDDRPTM 819 (882)
Q Consensus 791 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~ 819 (882)
.+.....++.+++.+||+.+|.+|++.
T Consensus 220 --~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 220 --YPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred --CCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 111223577899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=332.59 Aligned_cols=262 Identities=24% Similarity=0.292 Sum_probs=197.3
Q ss_pred HHcCCCCCCeeeccCcEEEEEEEe-cCCcEEEEEEcccCC--cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCC-----
Q 002774 553 YTNNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGS--MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRG----- 624 (882)
Q Consensus 553 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----- 624 (882)
..++|...+.||+|+||.||+|+. .+|+.||||++.... ......+.+|+.+++.++||||+++++++...+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 356899999999999999999986 468999999987532 233456788999999999999999999986543
Q ss_pred -ceEEEEEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccc
Q 002774 625 -EQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLS 703 (882)
Q Consensus 625 -~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla 703 (882)
..++||||+++ +|.+.++. .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~a 170 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIHM----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 170 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHhc----cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCCc
Confidence 46999999965 56555532 4778888999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhh------
Q 002774 704 KSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKE------ 777 (882)
Q Consensus 704 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~------ 777 (882)
+...... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||........+ .........
T Consensus 171 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~-~~~~~~~~~~~~~~~ 246 (359)
T cd07876 171 RTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQW-NKVIEQLGTPSAEFM 246 (359)
T ss_pred cccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHhcCCCcHHHH
Confidence 7643321 223456899999999999999999999999999999999999999754332211 111110000
Q ss_pred -----hhhhhhccCCcCCC----------------CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 002774 778 -----LYNLYELIDPTIGL----------------STTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDI 826 (882)
Q Consensus 778 -----~~~~~~~~d~~l~~----------------~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L 826 (882)
....+..-.+.... ........++.+++.+||+.||++|||+.|++++-
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 316 (359)
T cd07876 247 NRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHP 316 (359)
T ss_pred HHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCc
Confidence 00000000000000 00011235688999999999999999999999863
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=323.69 Aligned_cols=255 Identities=23% Similarity=0.312 Sum_probs=198.3
Q ss_pred cCCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccC---CcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEE
Q 002774 555 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQG---SMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIY 630 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 630 (882)
++|...+.||+|+||+||+++.. +++.||||++.+. .....+.+.+|..++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 46888999999999999999964 6899999998642 1223356888999999999999999999999999999999
Q ss_pred EeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCC
Q 002774 631 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE 710 (882)
Q Consensus 631 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~ 710 (882)
||+++|+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 81 e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (331)
T cd05597 81 DYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG 156 (331)
T ss_pred ecCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCCC
Confidence 999999999998643 235888899999999999999999998 9999999999999999999999999997664432
Q ss_pred CceeeeeeeccCCCCCHHHHhh-----CCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhcc
Q 002774 711 KDHITTQVKGTMGYLDPEYYMT-----QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELI 785 (882)
Q Consensus 711 ~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 785 (882)
. .......||+.|||||++.. ..++.++|||||||++|||++|+.||..... .+....+..... ... +
T Consensus 157 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~-~~~~~~i~~~~~----~~~-~ 229 (331)
T cd05597 157 T-VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL-VETYGKIMNHKE----HFQ-F 229 (331)
T ss_pred C-ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH-HHHHHHHHcCCC----ccc-C
Confidence 2 12223469999999999973 4578899999999999999999999965432 222222221110 000 0
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHhhccCCC--CCCCHHHHHHH
Q 002774 786 DPTIGLSTTLKGFEKYVDLALKCVQESGD--DRPTMSEVVKD 825 (882)
Q Consensus 786 d~~l~~~~~~~~~~~l~~li~~cl~~dp~--~RPs~~evl~~ 825 (882)
.+. .......+.+++.+|+..+++ .||++.+++++
T Consensus 230 ~~~-----~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 230 PPD-----VTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred CCc-----cCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 110 111346678899998765443 37899999987
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=315.68 Aligned_cols=251 Identities=33% Similarity=0.528 Sum_probs=200.4
Q ss_pred CCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCCcccHH--HHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEee
Q 002774 557 FSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQGGQ--EFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFV 633 (882)
Q Consensus 557 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~--~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 633 (882)
|+..+.||+|+||+||+++.. +++.||+|++......... ...+|+.++++++||||+++++++.+....++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 456688999999999999965 5679999999876544332 3356999999999999999999999999999999999
Q ss_pred cCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCce
Q 002774 634 PNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDH 713 (882)
Q Consensus 634 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 713 (882)
++++|.+++.. ...+++..+..++.|+++||+|||+.+ |+||||||+||++++++.++|+|||.+..... ...
T Consensus 81 ~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~--~~~ 153 (260)
T PF00069_consen 81 PGGSLQDYLQK--NKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSE--NNE 153 (260)
T ss_dssp TTEBHHHHHHH--HSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTS--TTS
T ss_pred ccccccccccc--ccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc--ccc
Confidence 99999999972 236899999999999999999999998 99999999999999999999999999976421 122
Q ss_pred eeeeeeccCCCCCHHHHh-hCCCCchhHHHHHHHHHHHHHhCCCCCCCCc--hHHHHHHHHHHhhhhhhhhhhccCCcCC
Q 002774 714 ITTQVKGTMGYLDPEYYM-TQQLTEKSDVYSFGVLMLELLTGRRPIERGK--YIVREIRTVMDKKKELYNLYELIDPTIG 790 (882)
Q Consensus 714 ~~~~~~gt~~y~aPE~~~-~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~--~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 790 (882)
......++..|+|||.+. ...++.++||||+|+++|+|++|..||.... .............. .....
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~-----~~~~~---- 224 (260)
T PF00069_consen 154 NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPL-----PSSSQ---- 224 (260)
T ss_dssp EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHH-----HHHTT----
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccc-----ccccc----
Confidence 334456899999999998 8889999999999999999999999998652 11111111111110 00000
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 791 LSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 791 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
........+.+++.+||+.||++||++.+++++
T Consensus 225 --~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 225 --QSREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp --SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred --ccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000112689999999999999999999999864
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=317.81 Aligned_cols=263 Identities=24% Similarity=0.332 Sum_probs=199.1
Q ss_pred CCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCCc--ccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEe
Q 002774 556 NFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM--QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEF 632 (882)
Q Consensus 556 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 632 (882)
+|...+.||+|+||+||+|+.. +++.||||+++.... ...+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4677889999999999999864 689999999865322 2336788899999999999999999999999999999999
Q ss_pred ecCCCcccccCCCC-CccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCC
Q 002774 633 VPNGSLGDSLSGKN-GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEK 711 (882)
Q Consensus 633 ~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 711 (882)
++ ++|.+++.... ...+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 155 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV- 155 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence 97 68888776433 246899999999999999999999988 9999999999999999999999999997654322
Q ss_pred ceeeeeeeccCCCCCHHHHhhC-CCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhh-----------hhh
Q 002774 712 DHITTQVKGTMGYLDPEYYMTQ-QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKK-----------ELY 779 (882)
Q Consensus 712 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~-----------~~~ 779 (882)
.......+++.|+|||.+.+. .++.++|||||||++|||+||+.||........... ...... ...
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 233 (285)
T cd07861 156 -RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFR-IFRILGTPTEDVWPGVTSLP 233 (285)
T ss_pred -ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH-HHHHhCCCChhhhhcchhhH
Confidence 112234578899999998754 578999999999999999999999975433222111 111000 000
Q ss_pred hhhhccCCcCCC---CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 780 NLYELIDPTIGL---STTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 780 ~~~~~~d~~l~~---~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
......+..... ........++.+++.+||+.||++|||+.+++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 234 DYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred HHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 000000000000 0011123677899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=318.50 Aligned_cols=253 Identities=25% Similarity=0.370 Sum_probs=201.2
Q ss_pred cCCCCCCeeeccCcEEEEEEEe-cCCcEEEEEEcccCCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEee
Q 002774 555 NNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFV 633 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 633 (882)
++|...+.||+|+||.||+|+. .+++.||+|.++.........+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 3566678899999999999986 468999999987654444566888999999999999999999999999999999999
Q ss_pred cCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCce
Q 002774 634 PNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDH 713 (882)
Q Consensus 634 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 713 (882)
++++|.+++...+ .+++.+...++.|++.|+.|||+.+ ++||||||+||+++.++.+||+|||++....... .
T Consensus 89 ~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~--~ 161 (267)
T cd06645 89 GGGSLQDIYHVTG--PLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATI--A 161 (267)
T ss_pred CCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCcc--c
Confidence 9999999886544 6889999999999999999999998 9999999999999999999999999987654321 1
Q ss_pred eeeeeeccCCCCCHHHHh---hCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCC
Q 002774 714 ITTQVKGTMGYLDPEYYM---TQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIG 790 (882)
Q Consensus 714 ~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 790 (882)
......|+..|+|||++. ...++.++|||||||++|||++|..||............ ... ....+...
T Consensus 162 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~-~~~--------~~~~~~~~ 232 (267)
T cd06645 162 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM-TKS--------NFQPPKLK 232 (267)
T ss_pred ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhh-hcc--------CCCCCccc
Confidence 123356899999999985 456889999999999999999999998643322111110 000 00011110
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 791 LSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 791 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
........+.+++.+||+.+|++||++++++++
T Consensus 233 --~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 233 --DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred --ccCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 011123568899999999999999999998864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=312.90 Aligned_cols=250 Identities=30% Similarity=0.506 Sum_probs=201.2
Q ss_pred CCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCCccc---------HHHHHHHHHHHHhccCCCeeeEEEEEEeCCc
Q 002774 556 NFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQG---------GQEFKMEIELLSRVHHKNLVSLLGFCFDRGE 625 (882)
Q Consensus 556 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~---------~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 625 (882)
+|.....||+|+||.||+|... +++.||+|.+....... .+.+.+|+.++++++||||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 3667789999999999999864 68899999886543221 1467889999999999999999999999999
Q ss_pred eEEEEEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccc
Q 002774 626 QMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKS 705 (882)
Q Consensus 626 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~ 705 (882)
.++||||+++++|.+++.... .+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.+||+|||+++.
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~~ 155 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYG--AFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKK 155 (267)
T ss_pred cEEEEEecCCCCHHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCcc
Confidence 999999999999999997543 5788889999999999999999988 99999999999999999999999999987
Q ss_pred cCCCCCc----eeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhh
Q 002774 706 MSDSEKD----HITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNL 781 (882)
Q Consensus 706 ~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 781 (882)
....... .......|+..|+|||.+.+..++.++|||||||++|||++|+.||........ ....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~~---------- 224 (267)
T cd06628 156 LEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQA-IFKI---------- 224 (267)
T ss_pred cccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHH-HHHH----------
Confidence 6532111 011224578899999999988899999999999999999999999975433211 1111
Q ss_pred hhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 782 YELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 782 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
.....+... ......+.+++.+||+.||.+||++.|++++
T Consensus 225 ~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 225 GENASPEIP----SNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred hccCCCcCC----cccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 111111111 1234678899999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=321.72 Aligned_cols=249 Identities=22% Similarity=0.392 Sum_probs=205.3
Q ss_pred CCCCCCeeeccCcEEEEEEEe-cCCcEEEEEEcccCCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEeec
Q 002774 556 NFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVP 634 (882)
Q Consensus 556 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 634 (882)
+|+..+.||.|+||+||+|.. .+++.||+|.+........+.+.+|+++++.++||||+++++++...+..++|+||++
T Consensus 20 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 99 (296)
T cd06655 20 KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLA 99 (296)
T ss_pred eEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecC
Confidence 577888999999999999985 5789999999876555556778899999999999999999999999999999999999
Q ss_pred CCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCcee
Q 002774 635 NGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHI 714 (882)
Q Consensus 635 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 714 (882)
+++|.+++... .+++.++..++.+++.|++|||+.+ ++||||||+||+++.++.+||+|||++........ .
T Consensus 100 ~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~--~ 171 (296)
T cd06655 100 GGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS--K 171 (296)
T ss_pred CCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccccc--c
Confidence 99999988643 4899999999999999999999998 99999999999999999999999999886544322 1
Q ss_pred eeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCCCCCC
Q 002774 715 TTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTT 794 (882)
Q Consensus 715 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 794 (882)
.....++..|+|||.+.+..++.++|||||||++|||++|+.||......... ....... .+.+ ...
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~-~~~~~~~----------~~~~--~~~ 238 (296)
T cd06655 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL-YLIATNG----------TPEL--QNP 238 (296)
T ss_pred CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHhcC----------Cccc--CCc
Confidence 22346888999999999888999999999999999999999999765433221 1111100 0001 111
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 795 LKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 795 ~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
......+.+++.+||+.||++||++.+++++
T Consensus 239 ~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 239 EKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred ccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 2234678899999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=331.66 Aligned_cols=238 Identities=26% Similarity=0.332 Sum_probs=189.4
Q ss_pred CeeeccCcEEEEEEEe-cCCcEEEEEEcccCC---cccHHHHHHHHH-HHHhccCCCeeeEEEEEEeCCceEEEEEeecC
Q 002774 561 NDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGS---MQGGQEFKMEIE-LLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPN 635 (882)
Q Consensus 561 ~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~ 635 (882)
+.||+|+||+||+|+. .+|+.||+|++.... ....+.+..|.. +++.++||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 4699999999999986 468999999986532 122344555554 46778999999999999999999999999999
Q ss_pred CCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCceee
Q 002774 636 GSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHIT 715 (882)
Q Consensus 636 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 715 (882)
|+|..++.... .+++..+..++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++...... ...
T Consensus 81 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~ 153 (325)
T cd05604 81 GELFFHLQRER--SFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS--DTT 153 (325)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCC--CCc
Confidence 99988886543 6889999999999999999999998 9999999999999999999999999987543221 122
Q ss_pred eeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCCCCCCH
Q 002774 716 TQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTL 795 (882)
Q Consensus 716 ~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 795 (882)
....||+.|+|||++.+..++.++|||||||++|||++|..||..... .+......... ..+.+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~-~~~~~~~~~~~-------~~~~~-------- 217 (325)
T cd05604 154 TTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDV-AEMYDNILHKP-------LVLRP-------- 217 (325)
T ss_pred ccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCH-HHHHHHHHcCC-------ccCCC--------
Confidence 345699999999999999999999999999999999999999975432 22222211110 01111
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCHHH
Q 002774 796 KGFEKYVDLALKCVQESGDDRPTMSE 821 (882)
Q Consensus 796 ~~~~~l~~li~~cl~~dp~~RPs~~e 821 (882)
.....+.+++.+|++.+|.+||++.+
T Consensus 218 ~~~~~~~~ll~~ll~~~p~~R~~~~~ 243 (325)
T cd05604 218 GASLTAWSILEELLEKDRQRRLGAKE 243 (325)
T ss_pred CCCHHHHHHHHHHhccCHHhcCCCCC
Confidence 12356789999999999999998763
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=322.11 Aligned_cols=258 Identities=27% Similarity=0.476 Sum_probs=202.3
Q ss_pred cCCCCCCeeeccCcEEEEEEEec-CCc----EEEEEEcccCCcc-cHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEE
Q 002774 555 NNFSDANDVGSGGYGKVYKGTLP-NGQ----LIAIKRAQQGSMQ-GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQML 628 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~----~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 628 (882)
++|...+.||+|+||.||+|++. +|+ .||+|.+...... ...++.+|+.+++.++||||++++|+|... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 45677889999999999999863 444 5789988754332 234688999999999999999999998754 5679
Q ss_pred EEEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCC
Q 002774 629 IYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSD 708 (882)
Q Consensus 629 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~ 708 (882)
|+||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++.+..
T Consensus 86 v~e~~~~g~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~ 161 (303)
T cd05110 86 VTQLMPHGCLLDYVHEHK-DNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEG 161 (303)
T ss_pred eehhcCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccccC
Confidence 999999999999987543 35788999999999999999999988 99999999999999999999999999987654
Q ss_pred CCCceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCC
Q 002774 709 SEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDP 787 (882)
Q Consensus 709 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 787 (882)
...........++..|+|||++.+..++.++|||||||++|||++ |+.||..... ............ . +
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~--~~~~~~~~~~~~-------~-~ 231 (303)
T cd05110 162 DEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT--REIPDLLEKGER-------L-P 231 (303)
T ss_pred cccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHCCCC-------C-C
Confidence 332222223345778999999998999999999999999999998 8899864321 112222211110 0 0
Q ss_pred cCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 002774 788 TIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 832 (882)
Q Consensus 788 ~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~ 832 (882)
........+.+++.+||..+|++||+++++++.++++.+.
T Consensus 232 -----~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 232 -----QPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred -----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 0111235788999999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=318.90 Aligned_cols=239 Identities=21% Similarity=0.411 Sum_probs=189.7
Q ss_pred CeeeccCcEEEEEEEecC--------CcEEEEEEcccCCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEe
Q 002774 561 NDVGSGGYGKVYKGTLPN--------GQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEF 632 (882)
Q Consensus 561 ~~lG~G~fg~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 632 (882)
+.||+|+||+||+|.... ...||+|.+........+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 368999999999998532 235888888765545556788999999999999999999999999999999999
Q ss_pred ecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCc--------eeEeeccccc
Q 002774 633 VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLN--------AKVADFGLSK 704 (882)
Q Consensus 633 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~--------~kl~DfGla~ 704 (882)
+++|+|.++++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++. ++++|||++.
T Consensus 81 ~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 81 VKFGSLDTYLKKNK-NLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred CCCCcHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 99999999997653 26789999999999999999999998 999999999999987765 5999999987
Q ss_pred ccCCCCCceeeeeeeccCCCCCHHHHhh-CCCCchhHHHHHHHHHHHHHhCC-CCCCCCchHHHHHHHHHHhhhhhhhhh
Q 002774 705 SMSDSEKDHITTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGR-RPIERGKYIVREIRTVMDKKKELYNLY 782 (882)
Q Consensus 705 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvll~el~tg~-~P~~~~~~~~~~~~~~~~~~~~~~~~~ 782 (882)
..... ....++..|+|||++.+ ..++.++|||||||++|||++|. .|+..... ..... .....
T Consensus 157 ~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~-~~~~~-~~~~~------- 221 (258)
T cd05078 157 TVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS-QKKLQ-FYEDR------- 221 (258)
T ss_pred ccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccH-HHHHH-HHHcc-------
Confidence 55322 22457889999999986 45799999999999999999985 44432221 11111 11100
Q ss_pred hccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 002774 783 ELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDI 826 (882)
Q Consensus 783 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L 826 (882)
..+. .....++.+++.+||+.||++|||++++++.|
T Consensus 222 ----~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 222 ----HQLP----APKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred ----ccCC----CCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 0111 11225788999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=321.22 Aligned_cols=250 Identities=23% Similarity=0.380 Sum_probs=204.8
Q ss_pred cCCCCCCeeeccCcEEEEEEEe-cCCcEEEEEEcccCCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEee
Q 002774 555 NNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFV 633 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 633 (882)
.+|...+.||+|+||.||+|.. .+++.||+|.+........+.+.+|+.+++.++|+||+++++++..++..++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 4788889999999999999985 578999999997655555677889999999999999999999999999999999999
Q ss_pred cCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCce
Q 002774 634 PNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDH 713 (882)
Q Consensus 634 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 713 (882)
++++|.+++... .+++.++..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++........
T Consensus 99 ~~~~L~~~~~~~---~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~-- 170 (297)
T cd06656 99 AGGSLTDVVTET---CMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-- 170 (297)
T ss_pred CCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCcc--
Confidence 999999988643 4788899999999999999999988 99999999999999999999999999986544322
Q ss_pred eeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCCCCC
Q 002774 714 ITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLST 793 (882)
Q Consensus 714 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 793 (882)
......+++.|+|||.+.+..++.++|||||||++|+|++|..||........... .... -.+. ...
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~-~~~~----------~~~~--~~~ 237 (297)
T cd06656 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-IATN----------GTPE--LQN 237 (297)
T ss_pred CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee-eccC----------CCCC--CCC
Confidence 12234688899999999998899999999999999999999999965332111100 0000 0001 111
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 794 TLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 794 ~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
.......+.+++.+||+.+|++||++++++++
T Consensus 238 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 238 PERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 12233667899999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=318.19 Aligned_cols=238 Identities=23% Similarity=0.382 Sum_probs=187.2
Q ss_pred eeeccCcEEEEEEEecC-------------------------CcEEEEEEcccCCcccHHHHHHHHHHHHhccCCCeeeE
Q 002774 562 DVGSGGYGKVYKGTLPN-------------------------GQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSL 616 (882)
Q Consensus 562 ~lG~G~fg~Vy~~~~~~-------------------------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 616 (882)
.||+|+||.||+|.+.. ...||+|++.........+|.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 58999999999997421 13589999876544445678889999999999999999
Q ss_pred EEEEEeCCceEEEEEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCC---
Q 002774 617 LGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERL--- 693 (882)
Q Consensus 617 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~--- 693 (882)
+++|.+....++||||+++|+|..++.... ..+++..+..++.|+++||+|||+.+ |+||||||+||+++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEK-GRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCccc
Confidence 999999999999999999999998886532 36788899999999999999999988 99999999999997644
Q ss_pred ----ceeEeecccccccCCCCCceeeeeeeccCCCCCHHHHhh-CCCCchhHHHHHHHHHHHHH-hCCCCCCCCchHHHH
Q 002774 694 ----NAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELL-TGRRPIERGKYIVRE 767 (882)
Q Consensus 694 ----~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvll~el~-tg~~P~~~~~~~~~~ 767 (882)
.+|++|||++...... ....++..|+|||.+.+ ..++.++|||||||++|||+ +|+.||.......
T Consensus 158 ~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-- 229 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE-- 229 (274)
T ss_pred CccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH--
Confidence 3799999988654322 12347788999999875 56899999999999999995 6888886432211
Q ss_pred HHHHHHhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 002774 768 IRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDI 826 (882)
Q Consensus 768 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L 826 (882)
......... .... ....++.+++.+||+.+|++||++.++++.|
T Consensus 230 ~~~~~~~~~-----------~~~~----~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 230 KERFYEKKH-----------RLPE----PSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred HHHHHHhcc-----------CCCC----CCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 111111100 0000 1124688999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=314.34 Aligned_cols=252 Identities=22% Similarity=0.365 Sum_probs=189.5
Q ss_pred eeeccCcEEEEEEEecCC---cEEEEEEcccCC-cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEeecCCC
Q 002774 562 DVGSGGYGKVYKGTLPNG---QLIAIKRAQQGS-MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGS 637 (882)
Q Consensus 562 ~lG~G~fg~Vy~~~~~~g---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 637 (882)
.||+|+||+||+|+..++ ..+++|.++... ....+.+.+|+.+++.++||||++++++|.+....++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 589999999999975433 356677766433 2344678999999999999999999999999999999999999999
Q ss_pred cccccCCCC--CccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCceee
Q 002774 638 LGDSLSGKN--GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHIT 715 (882)
Q Consensus 638 L~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 715 (882)
|.++++... ....++.....++.|+++||+|||+.+ ++||||||+|||++.++.+||+|||++............
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 999987542 234667778899999999999999988 999999999999999999999999998643222111112
Q ss_pred eeeeccCCCCCHHHHhh-------CCCCchhHHHHHHHHHHHHHhC-CCCCCCCchHHHHHHHHHHhhhhhhhhhhccCC
Q 002774 716 TQVKGTMGYLDPEYYMT-------QQLTEKSDVYSFGVLMLELLTG-RRPIERGKYIVREIRTVMDKKKELYNLYELIDP 787 (882)
Q Consensus 716 ~~~~gt~~y~aPE~~~~-------~~~~~~sDv~S~Gvll~el~tg-~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 787 (882)
....++..|+|||++.. ..++.++|||||||++|||+++ ..||..... .+.......... ....+|
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~-~~~~~~~~~~~~-----~~~~~~ 232 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD-REVLNHVIKDQQ-----VKLFKP 232 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHHhhcc-----cccCCC
Confidence 23457889999999853 2457899999999999999984 567754332 222222222111 122233
Q ss_pred cCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 002774 788 TIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIE 827 (882)
Q Consensus 788 ~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~ 827 (882)
..... ....+.+++..|| .+|++||++++|++.|.
T Consensus 233 ~~~~~----~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 233 QLELP----YSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred ccCCC----CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 33222 2356788999999 67999999999998763
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=313.04 Aligned_cols=250 Identities=24% Similarity=0.378 Sum_probs=205.4
Q ss_pred CCCCCCeeeccCcEEEEEEEe-cCCcEEEEEEcccCC--cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEe
Q 002774 556 NFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGS--MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEF 632 (882)
Q Consensus 556 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 632 (882)
+|+..++||+|+||.||.++. .+++.|++|.+.... ....+++.+|++++++++|+||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 477889999999999999985 468899999876542 33446788999999999999999999999999999999999
Q ss_pred ecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCc
Q 002774 633 VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKD 712 (882)
Q Consensus 633 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 712 (882)
+++|+|.+++.......+++.++..++.|++.||+|||+.+ ++||||+|+||++++++.+||+|||+++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~- 156 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS- 156 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence 99999999997654557899999999999999999999988 99999999999999999999999999987644331
Q ss_pred eeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCCCC
Q 002774 713 HITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLS 792 (882)
Q Consensus 713 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 792 (882)
......+++.|+|||++.+..++.++||||||+++|||++|..||..... .+........ . ..+
T Consensus 157 -~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~-~~~~~~~~~~-~--------~~~----- 220 (256)
T cd08221 157 -MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP-LNLVVKIVQG-N--------YTP----- 220 (256)
T ss_pred -cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH-HHHHHHHHcC-C--------CCC-----
Confidence 22335689999999999888899999999999999999999999865332 2222221110 0 001
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 793 TTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 793 ~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
.......++.+++.+||+.+|++||++.|++++
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 221 VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred CccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 011234678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=315.64 Aligned_cols=257 Identities=25% Similarity=0.405 Sum_probs=204.1
Q ss_pred cCCCCCCeeeccCcEEEEEEEecC----CcEEEEEEcccCC-cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEE
Q 002774 555 NNFSDANDVGSGGYGKVYKGTLPN----GQLIAIKRAQQGS-MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLI 629 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~~~~~~----g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 629 (882)
.+|...+.||+|+||.||+|.+.+ ...||||...... ....+.+.+|+.++++++||||+++++++.+ +..++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 357778899999999999998643 3478999887654 3345678999999999999999999998865 567899
Q ss_pred EEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCC
Q 002774 630 YEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDS 709 (882)
Q Consensus 630 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~ 709 (882)
|||+++|+|.+++.... ..+++..+..++.+++.||+|||+.+ ++||||||+||+++.++.+|++|||+++.....
T Consensus 85 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 160 (270)
T cd05056 85 MELAPLGELRSYLQVNK-YSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE 160 (270)
T ss_pred EEcCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeecccc
Confidence 99999999999997543 35899999999999999999999988 999999999999999999999999999876443
Q ss_pred CCceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCc
Q 002774 710 EKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPT 788 (882)
Q Consensus 710 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 788 (882)
.. .......++..|+|||.+....++.++||||||+++||+++ |..||...... +.... ..... ..
T Consensus 161 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~-~~~~~-~~~~~---------~~- 227 (270)
T cd05056 161 SY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN-DVIGR-IENGE---------RL- 227 (270)
T ss_pred cc-eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH-HHHHH-HHcCC---------cC-
Confidence 21 11222334568999999988889999999999999999996 99999654332 11111 11111 00
Q ss_pred CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 002774 789 IGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 832 (882)
Q Consensus 789 l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~ 832 (882)
......+..+.+++.+|+..+|++|||+.++++.|+++...
T Consensus 228 ---~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 228 ---PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred ---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 01112346789999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=325.88 Aligned_cols=237 Identities=25% Similarity=0.339 Sum_probs=187.5
Q ss_pred CeeeccCcEEEEEEEec-CCcEEEEEEcccCCc---ccHHHHHHHHH-HHHhccCCCeeeEEEEEEeCCceEEEEEeecC
Q 002774 561 NDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM---QGGQEFKMEIE-LLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPN 635 (882)
Q Consensus 561 ~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~ 635 (882)
++||+|+||+||+|+.. +++.||+|++..... .....+.+|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999964 689999999865321 22234555554 67889999999999999999999999999999
Q ss_pred CCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCceee
Q 002774 636 GSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHIT 715 (882)
Q Consensus 636 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 715 (882)
|+|..++.... .+++..+..++.||++||+|||+.+ |+||||||+||+++.++.+||+|||+++...... ...
T Consensus 81 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~ 153 (321)
T cd05603 81 GELFFHLQRER--CFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--ETT 153 (321)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--Ccc
Confidence 99988876543 5788888899999999999999988 9999999999999999999999999987542222 123
Q ss_pred eeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCCCCCCH
Q 002774 716 TQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTL 795 (882)
Q Consensus 716 ~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 795 (882)
....||+.|+|||.+.+..++.++|||||||++|||++|..||..... ......+... .. ..+.
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-~~~~~~i~~~-------------~~--~~~~ 217 (321)
T cd05603 154 STFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV-SQMYDNILHK-------------PL--QLPG 217 (321)
T ss_pred ccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH-HHHHHHHhcC-------------CC--CCCC
Confidence 345689999999999988999999999999999999999999975432 2222211110 00 0111
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCHH
Q 002774 796 KGFEKYVDLALKCVQESGDDRPTMS 820 (882)
Q Consensus 796 ~~~~~l~~li~~cl~~dp~~RPs~~ 820 (882)
.....+.+++.+|++.||.+||++.
T Consensus 218 ~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 218 GKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCHHHHHHHHHHccCCHhhcCCCC
Confidence 2235788999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=318.58 Aligned_cols=250 Identities=26% Similarity=0.418 Sum_probs=199.5
Q ss_pred CCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEeecC
Q 002774 557 FSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPN 635 (882)
Q Consensus 557 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~ 635 (882)
|+..+.||+|+||.||+|... ++..+|+|.+........+.+.+|+++++.++||||+++++++..++..++||||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 456678999999999999965 5788999998765555557788999999999999999999999999999999999999
Q ss_pred CCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCceee
Q 002774 636 GSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHIT 715 (882)
Q Consensus 636 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 715 (882)
++|..++.... ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++....... ...
T Consensus 87 ~~l~~~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~~~ 160 (282)
T cd06643 87 GAVDAVMLELE-RPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QRR 160 (282)
T ss_pred CcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccc--ccc
Confidence 99988776432 36899999999999999999999998 9999999999999999999999999987653321 122
Q ss_pred eeeeccCCCCCHHHHh-----hCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCC
Q 002774 716 TQVKGTMGYLDPEYYM-----TQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIG 790 (882)
Q Consensus 716 ~~~~gt~~y~aPE~~~-----~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 790 (882)
....++..|+|||++. ...++.++|||||||++|||++|+.||...... +......... .+...
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-~~~~~~~~~~----------~~~~~ 229 (282)
T cd06643 161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM-RVLLKIAKSE----------PPTLA 229 (282)
T ss_pred ccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH-HHHHHHhhcC----------CCCCC
Confidence 3356899999999984 345788999999999999999999998653321 1111111110 01110
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 791 LSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 791 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
.+.....++.+++.+||+.+|.+||++.+++++
T Consensus 230 --~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 230 --QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred --CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111233678999999999999999999998865
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=334.07 Aligned_cols=253 Identities=26% Similarity=0.411 Sum_probs=198.3
Q ss_pred cCCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCC---cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEE
Q 002774 555 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS---MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIY 630 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 630 (882)
++|+..+.||+|+||+||+|+.. +++.||||+++... ......+.+|++++..++|+||+++++++.+++..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36788899999999999999864 68999999987532 223356788999999999999999999999999999999
Q ss_pred EeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCC
Q 002774 631 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE 710 (882)
Q Consensus 631 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~ 710 (882)
||+++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 81 E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~ 155 (360)
T cd05627 81 EFLPGGDMMTLLMKKD--TLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH 155 (360)
T ss_pred eCCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence 9999999999987544 5888999999999999999999998 9999999999999999999999999987553211
Q ss_pred Cc---------------------------------eeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCC
Q 002774 711 KD---------------------------------HITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRP 757 (882)
Q Consensus 711 ~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P 757 (882)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~P 235 (360)
T cd05627 156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (360)
T ss_pred ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCC
Confidence 00 001134699999999999999999999999999999999999999
Q ss_pred CCCCchHHHHHHHHHHhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCC---HHHHHHH
Q 002774 758 IERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPT---MSEVVKD 825 (882)
Q Consensus 758 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs---~~evl~~ 825 (882)
|..... ......+...... -.+.+. .....++.+++.+|+ .||.+|++ +.|++++
T Consensus 236 f~~~~~-~~~~~~i~~~~~~-----~~~p~~------~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 236 FCSETP-QETYRKVMNWKET-----LVFPPE------VPISEKAKDLILRFC-TDSENRIGSNGVEEIKSH 293 (360)
T ss_pred CCCCCH-HHHHHHHHcCCCc-----eecCCC------CCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcC
Confidence 965432 2222222111100 001111 112356778888876 49999985 6777765
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=329.95 Aligned_cols=261 Identities=23% Similarity=0.304 Sum_probs=197.7
Q ss_pred HHcCCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCC--cccHHHHHHHHHHHHhccCCCeeeEEEEEEeC------
Q 002774 553 YTNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS--MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDR------ 623 (882)
Q Consensus 553 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------ 623 (882)
..++|...+.||+|+||.||+|... .++.||||++.... ....+.+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 3568899999999999999999854 68899999987532 23345678899999999999999999987543
Q ss_pred CceEEEEEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccc
Q 002774 624 GEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLS 703 (882)
Q Consensus 624 ~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla 703 (882)
...++||||+++ +|.+.+.. .+++.++..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a 173 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 173 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCCc
Confidence 346999999965 66666642 4788889999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhh-hhhhh
Q 002774 704 KSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKE-LYNLY 782 (882)
Q Consensus 704 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~-~~~~~ 782 (882)
+...... ......||..|+|||++.+..++.++|||||||++|||++|+.||........ ...++..... .....
T Consensus 174 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~ 249 (364)
T cd07875 174 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ-WNKVIEQLGTPCPEFM 249 (364)
T ss_pred cccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCCCCHHHH
Confidence 8654322 22345689999999999999999999999999999999999999975443222 2222111000 00000
Q ss_pred ----------------------hccCCcCCC----CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 783 ----------------------ELIDPTIGL----STTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 783 ----------------------~~~d~~l~~----~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
+.+.+.... ........++.+++.+|++.||.+|||+.|++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 250 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000000000 0001123568899999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=314.47 Aligned_cols=255 Identities=28% Similarity=0.482 Sum_probs=200.5
Q ss_pred CCCCCCeeeccCcEEEEEEEe-cCCcEEEEEEcccCCcc----------cHHHHHHHHHHHHhccCCCeeeEEEEEEeCC
Q 002774 556 NFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQ----------GGQEFKMEIELLSRVHHKNLVSLLGFCFDRG 624 (882)
Q Consensus 556 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~----------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~ 624 (882)
+|...+.||+|+||.||+|.. .+|+.||+|.++..... ..+.+.+|+.+++.++||||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 466778999999999999985 46899999987632111 1235788999999999999999999999999
Q ss_pred ceEEEEEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeeccccc
Q 002774 625 EQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSK 704 (882)
Q Consensus 625 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~ 704 (882)
..++||||+++++|.++++... .+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++++|||+++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~~ 156 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYG--RFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISK 156 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeeccccc
Confidence 9999999999999999987653 6888899999999999999999988 9999999999999999999999999998
Q ss_pred ccCCCCCceeeeeeeccCCCCCHHHHhhCC--CCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhh
Q 002774 705 SMSDSEKDHITTQVKGTMGYLDPEYYMTQQ--LTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLY 782 (882)
Q Consensus 705 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 782 (882)
...............|+..|+|||.+.... ++.++||||||+++||+++|..||........... ..... ..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~-~~~~~-----~~ 230 (272)
T cd06629 157 KSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFK-LGNKR-----SA 230 (272)
T ss_pred cccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHH-hhccc-----cC
Confidence 654322222223456889999999988654 88999999999999999999999965433222111 11000 00
Q ss_pred hccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 783 ELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 783 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
..+++ .........+.+++.+||+.+|++||++.+++++
T Consensus 231 ~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 231 PPIPP----DVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred CcCCc----cccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 11111 1111234678899999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=321.21 Aligned_cols=195 Identities=26% Similarity=0.400 Sum_probs=159.7
Q ss_pred CCeeeccCcEEEEEEEec---CCcEEEEEEcccCCcccHHHHHHHHHHHHhccCCCeeeEEEEEEe--CCceEEEEEeec
Q 002774 560 ANDVGSGGYGKVYKGTLP---NGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFD--RGEQMLIYEFVP 634 (882)
Q Consensus 560 ~~~lG~G~fg~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~lV~e~~~ 634 (882)
.++||+|+||+||+|+.. +++.||+|.++.... ...+.+|++++++++||||+++++++.. +...++||||++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 467999999999999864 467899999875432 3567889999999999999999998865 446789999985
Q ss_pred CCCcccccCCC-------CCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEE----cCCCceeEeecccc
Q 002774 635 NGSLGDSLSGK-------NGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILL----DERLNAKVADFGLS 703 (882)
Q Consensus 635 ~gsL~~~l~~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll----~~~~~~kl~DfGla 703 (882)
++|.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 4776665421 1235888899999999999999999998 9999999999999 46678999999999
Q ss_pred cccCCCCCc-eeeeeeeccCCCCCHHHHhh-CCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 002774 704 KSMSDSEKD-HITTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIER 760 (882)
Q Consensus 704 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvll~el~tg~~P~~~ 760 (882)
+........ .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||..
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~ 218 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence 876543221 12234568999999999986 4589999999999999999999999963
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=311.87 Aligned_cols=254 Identities=27% Similarity=0.422 Sum_probs=206.0
Q ss_pred cCCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEee
Q 002774 555 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFV 633 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 633 (882)
++|...+.||+|+||.||+|... +++.+|+|.+........+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 56788899999999999999864 57899999998665555678999999999999999999999999999999999999
Q ss_pred cCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCce
Q 002774 634 PNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDH 713 (882)
Q Consensus 634 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 713 (882)
++++|.+++.... ..+++.++..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||++....... .
T Consensus 83 ~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~ 156 (262)
T cd06613 83 GGGSLQDIYQVTR-GPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATI--A 156 (262)
T ss_pred CCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhh--h
Confidence 9999999886542 36889999999999999999999988 9999999999999999999999999998664322 1
Q ss_pred eeeeeeccCCCCCHHHHhhC---CCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCC
Q 002774 714 ITTQVKGTMGYLDPEYYMTQ---QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIG 790 (882)
Q Consensus 714 ~~~~~~gt~~y~aPE~~~~~---~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 790 (882)
......++..|+|||.+... .++.++|||||||++|||++|+.||........... .... ....+.
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~-~~~~--------~~~~~~-- 225 (262)
T cd06613 157 KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFL-ISKS--------NFPPPK-- 225 (262)
T ss_pred ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHhc--------cCCCcc--
Confidence 12335688899999999876 889999999999999999999999975432221111 1000 000111
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 791 LSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 791 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
.........++.+++.+||+.+|.+|||+.+++.+
T Consensus 226 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 226 LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 11223345678999999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=314.96 Aligned_cols=263 Identities=22% Similarity=0.318 Sum_probs=201.1
Q ss_pred cCCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCC--cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEE
Q 002774 555 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS--MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYE 631 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e 631 (882)
++|+..+.||+|+||.||+|+.. +|+.||+|++.... ....+.+.+|++++++++|+||+++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 36788899999999999999975 68999999886432 2233568899999999999999999999999999999999
Q ss_pred eecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCC
Q 002774 632 FVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEK 711 (882)
Q Consensus 632 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 711 (882)
|+++++|..++.... .+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++........
T Consensus 81 ~~~~~~l~~~~~~~~--~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07847 81 YCDHTVLNELEKNPR--GVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPGD 155 (286)
T ss_pred ccCccHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence 999988887765433 5899999999999999999999988 99999999999999999999999999987654332
Q ss_pred ceeeeeeeccCCCCCHHHHhh-CCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhh-hhhhh------
Q 002774 712 DHITTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKEL-YNLYE------ 783 (882)
Q Consensus 712 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~-~~~~~------ 783 (882)
......++..|+|||++.+ ..++.++|||||||++|||++|+.||........ ........... .....
T Consensus 156 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07847 156 --DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQ-LYLIRKTLGDLIPRHQQIFSTNQ 232 (286)
T ss_pred --cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCChHHhhhccccc
Confidence 1223457889999999875 5678999999999999999999999975443221 11111100000 00000
Q ss_pred ----ccCCcCCCCCC-----HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 784 ----LIDPTIGLSTT-----LKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 784 ----~~d~~l~~~~~-----~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
...+....... ......+.+++.+||+.+|++||++.|++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 233 FFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred ccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 00011000000 1123668899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=328.26 Aligned_cols=192 Identities=23% Similarity=0.351 Sum_probs=165.5
Q ss_pred HcCCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEe
Q 002774 554 TNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEF 632 (882)
Q Consensus 554 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 632 (882)
..+|...+.||+|+||.||+|+.. +++.||+|..... ....|+.++++++||||+++++++.+.+..++|+||
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 138 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPH 138 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEc
Confidence 457999999999999999999965 5788999985432 235699999999999999999999999999999999
Q ss_pred ecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCc
Q 002774 633 VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKD 712 (882)
Q Consensus 633 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 712 (882)
+ .++|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 139 ~-~~~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-- 211 (357)
T PHA03209 139 Y-SSDLYTYLTKR-SRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP-- 211 (357)
T ss_pred c-CCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccCc--
Confidence 9 46888887643 236899999999999999999999998 9999999999999999999999999997543221
Q ss_pred eeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 002774 713 HITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIE 759 (882)
Q Consensus 713 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~ 759 (882)
......||+.|+|||++.+..++.++|||||||++|||+++..|+.
T Consensus 212 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f 257 (357)
T PHA03209 212 -AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIF 257 (357)
T ss_pred -ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccc
Confidence 1234569999999999999999999999999999999999766653
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=322.54 Aligned_cols=255 Identities=22% Similarity=0.280 Sum_probs=198.5
Q ss_pred cCCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCC---cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEE
Q 002774 555 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS---MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIY 630 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 630 (882)
++|...++||+|+||+||+++.. +++.||+|++.+.. ......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 36888899999999999999965 57889999986422 122345788999999999999999999999999999999
Q ss_pred EeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCC
Q 002774 631 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE 710 (882)
Q Consensus 631 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~ 710 (882)
||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 81 ey~~~g~L~~~l~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~ 156 (332)
T cd05623 81 DYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 156 (332)
T ss_pred eccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccCC
Confidence 9999999999997532 35888889999999999999999998 9999999999999999999999999997654322
Q ss_pred CceeeeeeeccCCCCCHHHHh-----hCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhcc
Q 002774 711 KDHITTQVKGTMGYLDPEYYM-----TQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELI 785 (882)
Q Consensus 711 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 785 (882)
. .......||+.|+|||++. ...++.++|||||||++|||++|+.||..... .+....+......
T Consensus 157 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~-~~~~~~i~~~~~~-------- 226 (332)
T cd05623 157 T-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL-VETYGKIMNHKER-------- 226 (332)
T ss_pred c-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH-HHHHHHHhCCCcc--------
Confidence 2 2223356999999999986 34688999999999999999999999975432 2222222211110
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 002774 786 DPTIGLSTTLKGFEKYVDLALKCVQESGDD--RPTMSEVVKD 825 (882)
Q Consensus 786 d~~l~~~~~~~~~~~l~~li~~cl~~dp~~--RPs~~evl~~ 825 (882)
.... ........++.+++.+|+..++++ |++++|++++
T Consensus 227 -~~~p-~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 227 -FQFP-AQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred -ccCC-CccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 0000 001123467889999988665444 6899999987
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=311.11 Aligned_cols=250 Identities=22% Similarity=0.373 Sum_probs=201.7
Q ss_pred CCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCCc--ccHHHHHHHHHHHHhccCCCeeeEEEEEEeC-CceEEEEE
Q 002774 556 NFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM--QGGQEFKMEIELLSRVHHKNLVSLLGFCFDR-GEQMLIYE 631 (882)
Q Consensus 556 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-~~~~lV~e 631 (882)
+|...+.||+|+||.||+++.. +++.||+|++..... ...+.+.+|++++++++|+|++++++.+... ...++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4778899999999999999864 578999999865332 2345688899999999999999999987644 45789999
Q ss_pred eecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCC
Q 002774 632 FVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEK 711 (882)
Q Consensus 632 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 711 (882)
|+++++|.+++.......+++.++..++.+++.|++|||+.+ ++||||||+||+++.++.++|+|||++........
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~ 157 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD 157 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence 999999999987654556899999999999999999999998 99999999999999999999999999987643221
Q ss_pred ceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCCC
Q 002774 712 DHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGL 791 (882)
Q Consensus 712 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 791 (882)
......+++.|+|||++.+..++.++|||||||+++||++|+.||..... .......... .. +..
T Consensus 158 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~-~~~~~~~~~~---------~~-~~~-- 222 (257)
T cd08223 158 --MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM-NSLVYRIIEG---------KL-PPM-- 222 (257)
T ss_pred --ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHHhc---------CC-CCC--
Confidence 22335688999999999999999999999999999999999999864332 2221111110 00 111
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 792 STTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 792 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
......++.+++.+||+.+|++||++.+++++
T Consensus 223 --~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 223 --PKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred --ccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 12234678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=314.56 Aligned_cols=255 Identities=26% Similarity=0.429 Sum_probs=203.0
Q ss_pred cCCCCCCeeeccCcEEEEEEEec------CCcEEEEEEcccCCcc-cHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceE
Q 002774 555 NNFSDANDVGSGGYGKVYKGTLP------NGQLIAIKRAQQGSMQ-GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQM 627 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 627 (882)
++|+....||+|+||+||+|+.. +.+.||+|.+...... ..+++.+|++++++++|+||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 46788899999999999999853 3467999988754433 3467899999999999999999999999989999
Q ss_pred EEEEeecCCCcccccCCCCC-------ccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeec
Q 002774 628 LIYEFVPNGSLGDSLSGKNG-------IRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADF 700 (882)
Q Consensus 628 lV~e~~~~gsL~~~l~~~~~-------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~Df 700 (882)
+||||+++|+|.+++..... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 99999999999999875441 25899999999999999999999998 999999999999999999999999
Q ss_pred ccccccCCCCCceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHhhhhhh
Q 002774 701 GLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELY 779 (882)
Q Consensus 701 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~ 779 (882)
|+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |..||...... ...... ....
T Consensus 162 ~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~-~~~~~~-~~~~--- 235 (275)
T cd05046 162 SLSKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE-EVLNRL-QAGK--- 235 (275)
T ss_pred ccccccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH-HHHHHH-HcCC---
Confidence 99875433221 11223356778999999988889999999999999999999 77788543221 111111 1000
Q ss_pred hhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 002774 780 NLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIE 827 (882)
Q Consensus 780 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~ 827 (882)
.........+..+.+++.+||+.+|++||++.|+++.|.
T Consensus 236 ---------~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 236 ---------LELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred ---------cCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 001111223467899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=313.37 Aligned_cols=248 Identities=28% Similarity=0.418 Sum_probs=203.7
Q ss_pred CCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCC-cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEee
Q 002774 556 NFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS-MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFV 633 (882)
Q Consensus 556 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 633 (882)
+|...+.||.|+||.||+|+.. +++.||+|.+.... ......+.+|+++++.++|+||+++++++.++...++|+||+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC 81 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence 5777889999999999999864 68999999987543 333467889999999999999999999999999999999999
Q ss_pred cCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCce
Q 002774 634 PNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDH 713 (882)
Q Consensus 634 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 713 (882)
++++|.+++... ++++..+..++.|++.|+.|||+.+ ++||||+|+||++++++.++|+|||+++.......
T Consensus 82 ~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-- 153 (274)
T cd06609 82 GGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS-- 153 (274)
T ss_pred CCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeeccccc--
Confidence 999999998754 6899999999999999999999988 99999999999999999999999999987754321
Q ss_pred eeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCCCCC
Q 002774 714 ITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLST 793 (882)
Q Consensus 714 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 793 (882)
......++..|+|||++.+..++.++|||||||++|||+||+.||...... ....... ....+.....
T Consensus 154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~-~~~~~~~----------~~~~~~~~~~- 221 (274)
T cd06609 154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM-RVLFLIP----------KNNPPSLEGN- 221 (274)
T ss_pred ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH-HHHHHhh----------hcCCCCCccc-
Confidence 123346888999999999888999999999999999999999999654311 1111110 1111111111
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 794 TLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 794 ~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
.....+.+++.+||..+|++||++++++++
T Consensus 222 --~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 222 --KFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred --ccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 134578899999999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=317.34 Aligned_cols=258 Identities=26% Similarity=0.377 Sum_probs=202.5
Q ss_pred cCCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCC-cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEe
Q 002774 555 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS-MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEF 632 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 632 (882)
++|+..+.||+|+||+||+|... +|+.||+|++.... ....+.+.+|+++++.++||||+++++++...+..++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 45677788999999999999864 68899999876543 23346789999999999999999999999999999999999
Q ss_pred ecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhh-cCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCC
Q 002774 633 VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHE-LANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEK 711 (882)
Q Consensus 633 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 711 (882)
+++++|.+++...+ .+++.....++.+++.||.|||+ .+ ++||||||+||++++++.++|+|||++.......
T Consensus 85 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~- 158 (284)
T cd06620 85 MDCGSLDRIYKKGG--PIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI- 158 (284)
T ss_pred CCCCCHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhhhc-
Confidence 99999998886543 58899999999999999999997 46 9999999999999999999999999987553221
Q ss_pred ceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHH---HHHHHHHhhhhhhhhhhccCCc
Q 002774 712 DHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVR---EIRTVMDKKKELYNLYELIDPT 788 (882)
Q Consensus 712 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~---~~~~~~~~~~~~~~~~~~~d~~ 788 (882)
.....|+..|+|||++.+..++.++|||||||++|||++|..||.......+ ........... ......+.
T Consensus 159 ---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 232 (284)
T cd06620 159 ---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQ---IVQEPPPR 232 (284)
T ss_pred ---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHH---HhhccCCC
Confidence 1234689999999999888999999999999999999999999974322100 00000000000 00000111
Q ss_pred CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 002774 789 IGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIE 827 (882)
Q Consensus 789 l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~ 827 (882)
. .....+.++.+++.+||+.||++||++.|++++..
T Consensus 233 ~---~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~ 268 (284)
T cd06620 233 L---PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPP 268 (284)
T ss_pred C---CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence 1 11123467889999999999999999999998643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=350.47 Aligned_cols=257 Identities=21% Similarity=0.406 Sum_probs=201.6
Q ss_pred HHHHcCCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCCc--ccHHHHHHHHHHHHhccCCCeeeEEEEEEeC--Cc
Q 002774 551 KKYTNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM--QGGQEFKMEIELLSRVHHKNLVSLLGFCFDR--GE 625 (882)
Q Consensus 551 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~ 625 (882)
....++|.+.+.||+|+||+||+|+.. ++..||+|.+..... .....|..|+.++++++|||||++++++.+. ..
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 344568999999999999999999864 578899998875422 2346788999999999999999999988653 46
Q ss_pred eEEEEEeecCCCcccccCCCC--CccccHHHHHHHHHHHHHHHhhhhhcCC----CCeeecCCCCCceEEcC--------
Q 002774 626 QMLIYEFVPNGSLGDSLSGKN--GIRLDWIRRLKIALGAARGLSYLHELAN----PPIIHRDIKSSNILLDE-------- 691 (882)
Q Consensus 626 ~~lV~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~----~~ivHrDlk~~NIll~~-------- 691 (882)
.||||||+++|+|.++|.... ...+++..++.|+.||+.||+|||+.+. .+||||||||+||||+.
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 899999999999999886422 2368999999999999999999998542 34999999999999964
Q ss_pred ---------CCceeEeecccccccCCCCCceeeeeeeccCCCCCHHHHhh--CCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 002774 692 ---------RLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMT--QQLTEKSDVYSFGVLMLELLTGRRPIER 760 (882)
Q Consensus 692 ---------~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~S~Gvll~el~tg~~P~~~ 760 (882)
.+.+||+|||+++.+.... ......||+.|+|||++.. ..++.++|||||||++|||+||..||..
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~ 245 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245 (1021)
T ss_pred cccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 3348999999998764322 1234569999999999864 4588999999999999999999999976
Q ss_pred CchHHHHHHHHHHhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 761 GKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 761 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
.......+.... .. +.+.. .....++.+||.+||+.+|.+||++.|++.+
T Consensus 246 ~~~~~qli~~lk-~~-----------p~lpi---~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h 295 (1021)
T PTZ00266 246 ANNFSQLISELK-RG-----------PDLPI---KGKSKELNILIKNLLNLSAKERPSALQCLGY 295 (1021)
T ss_pred CCcHHHHHHHHh-cC-----------CCCCc---CCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence 554433222211 10 11111 1123678899999999999999999999964
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=311.42 Aligned_cols=247 Identities=26% Similarity=0.396 Sum_probs=202.7
Q ss_pred CCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCC-cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEee
Q 002774 556 NFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS-MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFV 633 (882)
Q Consensus 556 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 633 (882)
.|+..+.||+|+||.||+|... +++.||+|.++... ....+.+.+|+++++.++||||+++++++.++...++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 4667788999999999999864 58899999987543 233467889999999999999999999999999999999999
Q ss_pred cCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCce
Q 002774 634 PNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDH 713 (882)
Q Consensus 634 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 713 (882)
++|+|.+++... ++++.+...++.|++.||+|||+.+ ++|+||+|+||+++.++.++++|||++........
T Consensus 85 ~~~~L~~~i~~~---~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-- 156 (277)
T cd06640 85 GGGSALDLLRAG---PFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-- 156 (277)
T ss_pred CCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcc--
Confidence 999999988653 5788899999999999999999988 99999999999999999999999999977644321
Q ss_pred eeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCCCCC
Q 002774 714 ITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLST 793 (882)
Q Consensus 714 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 793 (882)
......++..|+|||++.+..++.++|||||||++|||++|..||....... ... .. ........
T Consensus 157 ~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-~~~-~~-------------~~~~~~~~ 221 (277)
T cd06640 157 KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR-VLF-LI-------------PKNNPPTL 221 (277)
T ss_pred ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh-Hhh-hh-------------hcCCCCCC
Confidence 1223457889999999998889999999999999999999999986533211 110 00 00011112
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 794 TLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 794 ~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
....+..+.+++.+||+.+|++||++.+++++
T Consensus 222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 222 TGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred chhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 23455778999999999999999999999876
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=311.57 Aligned_cols=251 Identities=28% Similarity=0.420 Sum_probs=196.2
Q ss_pred cCCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCCc-----ccHHHHHHHHHHHHhccCCCeeeEEEEEEeC--Cce
Q 002774 555 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM-----QGGQEFKMEIELLSRVHHKNLVSLLGFCFDR--GEQ 626 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~ 626 (882)
.+|...+.||+|+||.||+|... +++.||+|++..... ...+.+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 36888999999999999999864 689999998864322 1234688899999999999999999988753 567
Q ss_pred EEEEEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeeccccccc
Q 002774 627 MLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSM 706 (882)
Q Consensus 627 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~ 706 (882)
++|+||+++++|.+++.... .+++.....++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~~ 156 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYG--ALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRL 156 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCcccc
Confidence 89999999999999987543 5788899999999999999999988 999999999999999999999999999865
Q ss_pred CCCCC-ceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhcc
Q 002774 707 SDSEK-DHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELI 785 (882)
Q Consensus 707 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 785 (882)
..... ........++..|+|||++.+..++.++|||||||++|||++|+.||.......... .... ...
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~-~~~~---------~~~ 226 (266)
T cd06651 157 QTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIF-KIAT---------QPT 226 (266)
T ss_pred ccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHH-HHhc---------CCC
Confidence 43211 111123458899999999998889999999999999999999999997543222111 1100 001
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 786 DPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 786 d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
.+.. +......+.+++ +||..+|++||+++|++++
T Consensus 227 ~~~~----~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 227 NPQL----PSHISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred CCCC----chhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 1111 112234566676 7888999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=328.42 Aligned_cols=261 Identities=25% Similarity=0.385 Sum_probs=197.3
Q ss_pred HHHcCCCCCCeeeccCcEEEEEEEe-cCCcEEEEEEcccCCc--ccHHHHHHHHHHHHhccCCCeeeEEEEEEeC-----
Q 002774 552 KYTNNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSM--QGGQEFKMEIELLSRVHHKNLVSLLGFCFDR----- 623 (882)
Q Consensus 552 ~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~----- 623 (882)
...++|...+.||+|+||+||+|.. .+++.||||++..... ...+.+.+|++++++++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 4467899999999999999999985 4688999999875322 2335677899999999999999999987543
Q ss_pred -CceEEEEEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeeccc
Q 002774 624 -GEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGL 702 (882)
Q Consensus 624 -~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGl 702 (882)
...++++|++ +++|.+++... .+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~ 164 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKCQ---KLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGL 164 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCcc
Confidence 3568999988 78888877543 5899999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCceeeeeeeccCCCCCHHHHhh-CCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhh-hhhh
Q 002774 703 SKSMSDSEKDHITTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKK-ELYN 780 (882)
Q Consensus 703 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~-~~~~ 780 (882)
++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... +.+........ ....
T Consensus 165 ~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~ 238 (343)
T cd07878 165 ARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYI-DQLKRIMEVVGTPSPE 238 (343)
T ss_pred ceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHHhCCCCHH
Confidence 9865432 223468999999999976 56899999999999999999999999654322 22221111000 0000
Q ss_pred hhhccC-----------CcCCCCC----CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 781 LYELID-----------PTIGLST----TLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 781 ~~~~~d-----------~~l~~~~----~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
....+. +...... .......+.+++.+|++.||.+|||+.|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 239 VLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000 0000000 00112457899999999999999999999976
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=317.25 Aligned_cols=252 Identities=26% Similarity=0.418 Sum_probs=201.6
Q ss_pred cCCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEee
Q 002774 555 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFV 633 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 633 (882)
+.|+..++||+|+||.||+|+.. +++.||+|.+........+.+.+|+++++.++|+||+++++++..++..++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 45778889999999999999865 58999999998765555677889999999999999999999999999999999999
Q ss_pred cCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCce
Q 002774 634 PNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDH 713 (882)
Q Consensus 634 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 713 (882)
++++|..++.... ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++....... .
T Consensus 92 ~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~--~ 165 (292)
T cd06644 92 PGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL--Q 165 (292)
T ss_pred CCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceeccccc--c
Confidence 9999988775432 35889999999999999999999988 9999999999999999999999999987643321 1
Q ss_pred eeeeeeccCCCCCHHHHh-----hCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCc
Q 002774 714 ITTQVKGTMGYLDPEYYM-----TQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPT 788 (882)
Q Consensus 714 ~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 788 (882)
......++..|+|||++. ...++.++|||||||++|||++|..||...... ........ ...+.
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-~~~~~~~~----------~~~~~ 234 (292)
T cd06644 166 RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM-RVLLKIAK----------SEPPT 234 (292)
T ss_pred ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH-HHHHHHhc----------CCCcc
Confidence 123456889999999985 345788999999999999999999998653321 11111110 00111
Q ss_pred CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 789 IGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 789 l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
. ........++.+++.+||+.+|++||++.|++++
T Consensus 235 ~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 235 L--SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred C--CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 1 1111233578899999999999999999999874
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=318.84 Aligned_cols=263 Identities=26% Similarity=0.398 Sum_probs=204.5
Q ss_pred cCHHHHHHHHcCCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCCcccHHHHHHHHHHHHhc-cCCCeeeEEEEEEe
Q 002774 545 FSFEEVKKYTNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQGGQEFKMEIELLSRV-HHKNLVSLLGFCFD 622 (882)
Q Consensus 545 ~~~~e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~ 622 (882)
+.++.+..+.++|...+.||+|+||+||+|... +++.+|+|+++... .....+.+|+.+++++ +||||+++++++..
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 445566667889999999999999999999864 68899999886532 2235688899999999 69999999998853
Q ss_pred -----CCceEEEEEeecCCCcccccCCC--CCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCce
Q 002774 623 -----RGEQMLIYEFVPNGSLGDSLSGK--NGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNA 695 (882)
Q Consensus 623 -----~~~~~lV~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~ 695 (882)
++..++||||+++++|.+++... ....+++..+..++.|+++||.|||+.+ |+||||||+||++++++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~ 163 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGV 163 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCE
Confidence 45689999999999999877532 2346788899999999999999999988 9999999999999999999
Q ss_pred eEeecccccccCCCCCceeeeeeeccCCCCCHHHHhh-----CCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHH
Q 002774 696 KVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMT-----QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRT 770 (882)
Q Consensus 696 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~ 770 (882)
||+|||+++....... ......|++.|+|||++.. ..++.++|||||||++|||++|+.||.......... .
T Consensus 164 kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~-~ 240 (286)
T cd06638 164 KLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALF-K 240 (286)
T ss_pred EEccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHh-h
Confidence 9999999987643221 1223468999999999853 457889999999999999999999997543322111 1
Q ss_pred HHHhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 002774 771 VMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDI 826 (882)
Q Consensus 771 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L 826 (882)
.. ....+... .......++.+++.+||+.||++|||+.|++++.
T Consensus 241 ~~----------~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 241 IP----------RNPPPTLH--QPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred cc----------ccCCCccc--CCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 00 00011110 1111235688999999999999999999999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=317.94 Aligned_cols=263 Identities=22% Similarity=0.358 Sum_probs=199.2
Q ss_pred cCCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCCc-ccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEe
Q 002774 555 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEF 632 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 632 (882)
++|...+.||+|+||.||+|+.. +++.||+|.++.... .....+.+|+.+++.++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 46788899999999999999864 688999999875432 2335677899999999999999999999999999999999
Q ss_pred ecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCc
Q 002774 633 VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKD 712 (882)
Q Consensus 633 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 712 (882)
++ ++|.+++.... ..+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+||+|||+++.......
T Consensus 86 ~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~- 159 (301)
T cd07873 86 LD-KDLKQYLDDCG-NSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK- 159 (301)
T ss_pred cc-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC-
Confidence 97 58888876542 35788899999999999999999998 99999999999999999999999999976543221
Q ss_pred eeeeeeeccCCCCCHHHHhh-CCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhh-hhhhh-hccC---
Q 002774 713 HITTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKE-LYNLY-ELID--- 786 (882)
Q Consensus 713 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~-~~~~~-~~~d--- 786 (882)
......+++.|+|||.+.+ ..++.++|||||||++|||++|+.||..... .+........... ....+ ..++
T Consensus 160 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (301)
T cd07873 160 -TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTV-EEQLHFIFRILGTPTEETWPGILSNEE 237 (301)
T ss_pred -cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHcCCCChhhchhhhcccc
Confidence 1223457889999999875 4578899999999999999999999965432 2222211111000 00000 0000
Q ss_pred ------CcCCC----CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 787 ------PTIGL----STTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 787 ------~~l~~----~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
+.... .........+.+++.+|++.||.+|||++|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 238 FKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred ccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 00000 0011223567899999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=316.54 Aligned_cols=252 Identities=27% Similarity=0.411 Sum_probs=203.5
Q ss_pred cCCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEee
Q 002774 555 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFV 633 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 633 (882)
++|...+.||+|+||+||+|+.. +++.||+|.++.......+.+.+|++++++++||||+++++++..++..++||||+
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC 84 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence 45778888999999999999964 68999999987665555578999999999999999999999999999999999999
Q ss_pred cCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCce
Q 002774 634 PNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDH 713 (882)
Q Consensus 634 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 713 (882)
++++|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||++........
T Consensus 85 ~~~~L~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-- 158 (280)
T cd06611 85 DGGALDSIMLELE-RGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ-- 158 (280)
T ss_pred CCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhccccc--
Confidence 9999999886542 36899999999999999999999998 99999999999999999999999999876543221
Q ss_pred eeeeeeccCCCCCHHHHh-----hCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCc
Q 002774 714 ITTQVKGTMGYLDPEYYM-----TQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPT 788 (882)
Q Consensus 714 ~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 788 (882)
......+++.|+|||.+. ...++.++|||||||++|||++|+.||....... ....... ...+.
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~----------~~~~~ 227 (280)
T cd06611 159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR-VLLKILK----------SEPPT 227 (280)
T ss_pred ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH-HHHHHhc----------CCCCC
Confidence 223456899999999985 3446789999999999999999999996543221 1111110 00111
Q ss_pred CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 789 IGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 789 l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
+ ........++.+++.+||+.+|.+||++.+++++
T Consensus 228 ~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 228 L--DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred c--CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 1 1111233578899999999999999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=311.10 Aligned_cols=246 Identities=28% Similarity=0.474 Sum_probs=198.8
Q ss_pred cCCCCCCeeeccCcEEEEEEEecCCcEEEEEEcccCCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEeec
Q 002774 555 NNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVP 634 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 634 (882)
++|...+.||+|+||.||+|.. +++.||+|.++... ..+.+.+|+.++++++|||++++++++... ..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 3577889999999999999975 57889999986532 346788999999999999999999998654 5799999999
Q ss_pred CCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCcee
Q 002774 635 NGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHI 714 (882)
Q Consensus 635 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 714 (882)
+++|.+++.......+++..+..++.|++.|++|||+.+ ++||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~---- 154 (254)
T cd05083 82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV---- 154 (254)
T ss_pred CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccccC----
Confidence 999999997665556899999999999999999999988 9999999999999999999999999987643221
Q ss_pred eeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCCCCC
Q 002774 715 TTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLST 793 (882)
Q Consensus 715 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 793 (882)
.....+..|+|||++.+..++.++|||||||++|||++ |..||..... .+. ........ ..+ .
T Consensus 155 -~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-~~~-~~~~~~~~-------~~~------~ 218 (254)
T cd05083 155 -DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL-KEV-KECVEKGY-------RME------P 218 (254)
T ss_pred -CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH-HHH-HHHHhCCC-------CCC------C
Confidence 12234567999999998899999999999999999998 8888864432 111 11111100 011 1
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 002774 794 TLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIE 827 (882)
Q Consensus 794 ~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~ 827 (882)
....+..+.+++.+||+.+|++||+++++++.|+
T Consensus 219 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 252 (254)
T cd05083 219 PEGCPADVYVLMTSCWETEPKKRPSFHKLREKLE 252 (254)
T ss_pred CCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHc
Confidence 1123467889999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=311.09 Aligned_cols=237 Identities=23% Similarity=0.415 Sum_probs=189.4
Q ss_pred CeeeccCcEEEEEEEecCC-----------cEEEEEEcccCCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEE
Q 002774 561 NDVGSGGYGKVYKGTLPNG-----------QLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLI 629 (882)
Q Consensus 561 ~~lG~G~fg~Vy~~~~~~g-----------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 629 (882)
+.||+|+||.||+|...+. ..|++|.+...... ...+.+|+.++++++||||+++++++.. +..++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 4689999999999997543 25788887654333 5788999999999999999999999988 788999
Q ss_pred EEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCC-------ceeEeeccc
Q 002774 630 YEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERL-------NAKVADFGL 702 (882)
Q Consensus 630 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~-------~~kl~DfGl 702 (882)
|||+++|+|.+++..... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++ .+||+|||+
T Consensus 79 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 79 EEYVKFGPLDVFLHREKN-NVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred EEcCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 999999999999876432 6888999999999999999999988 99999999999999888 799999999
Q ss_pred ccccCCCCCceeeeeeeccCCCCCHHHHhhC--CCCchhHHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHhhhhhh
Q 002774 703 SKSMSDSEKDHITTQVKGTMGYLDPEYYMTQ--QLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELY 779 (882)
Q Consensus 703 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDv~S~Gvll~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~ 779 (882)
++.... .....++..|+|||++... .++.++|||||||++|||++ |..|+..... ..... .....
T Consensus 155 a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~-~~~~~-~~~~~---- 222 (259)
T cd05037 155 PITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSS-SEKER-FYQDQ---- 222 (259)
T ss_pred cccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCc-hhHHH-HHhcC----
Confidence 986543 1223467789999999876 78999999999999999999 5667654321 11111 11100
Q ss_pred hhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 002774 780 NLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDI 826 (882)
Q Consensus 780 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L 826 (882)
. .... .....+.+++.+||..+|.+||++.|+++.|
T Consensus 223 ---~----~~~~----~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 223 ---H----RLPM----PDCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred ---C----CCCC----CCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 0 0000 0116788999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=308.57 Aligned_cols=250 Identities=32% Similarity=0.505 Sum_probs=201.7
Q ss_pred CCCCeeeccCcEEEEEEEecC-----CcEEEEEEcccCCcc-cHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEE
Q 002774 558 SDANDVGSGGYGKVYKGTLPN-----GQLIAIKRAQQGSMQ-GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYE 631 (882)
Q Consensus 558 ~~~~~lG~G~fg~Vy~~~~~~-----g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e 631 (882)
...+.||+|+||.||+|+..+ +..||+|.++..... ..+.+.+|+++++.++|+||+++++++.+.+..++|||
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e 81 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVME 81 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence 456889999999999999753 488999999765443 45789999999999999999999999999999999999
Q ss_pred eecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCC
Q 002774 632 FVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEK 711 (882)
Q Consensus 632 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 711 (882)
|+++++|.+++.......+++.++..++.|++.||+|||+.+ ++||||||+||++++++.++++|||+++.......
T Consensus 82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (258)
T smart00219 82 YMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY 158 (258)
T ss_pred ccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccccc
Confidence 999999999997654333899999999999999999999998 99999999999999999999999999987654422
Q ss_pred ceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCC
Q 002774 712 DHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIG 790 (882)
Q Consensus 712 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 790 (882)
.. .....++..|+|||.+.+..++.++||||+|++++||++ |..||... ........... .. . +
T Consensus 159 ~~-~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~-~~~~~~~~~~~-~~------~---~--- 223 (258)
T smart00219 159 YK-KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGM-SNEEVLEYLKK-GY------R---L--- 223 (258)
T ss_pred cc-cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHhc-CC------C---C---
Confidence 11 112337789999999988889999999999999999999 77777542 22222211111 11 0 0
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 002774 791 LSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDI 826 (882)
Q Consensus 791 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L 826 (882)
......+.++.+++.+||..+|++|||+.|+++.|
T Consensus 224 -~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 224 -PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred -CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 01111346789999999999999999999998753
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=339.76 Aligned_cols=264 Identities=19% Similarity=0.284 Sum_probs=194.4
Q ss_pred HHHHHHcCCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCCcccHHHHHHHHHHHHhccC------CCeeeEEEEEE
Q 002774 549 EVKKYTNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHH------KNLVSLLGFCF 621 (882)
Q Consensus 549 e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H------~niv~l~~~~~ 621 (882)
++...+++|...++||+|+||+||+|... .++.||||+++... ...+++..|+.+++.++| .+++++++++.
T Consensus 123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 33445678999999999999999999864 57899999986532 223456778888887755 45889999887
Q ss_pred eC-CceEEEEEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhh-cCCCCeeecCCCCCceEEcCCC------
Q 002774 622 DR-GEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHE-LANPPIIHRDIKSSNILLDERL------ 693 (882)
Q Consensus 622 ~~-~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDlk~~NIll~~~~------ 693 (882)
.. +..++|||++ +++|.+++.... .+++..+..++.||+.||+|||+ .+ ||||||||+|||++.++
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~ 275 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIMKHG--PFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPV 275 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcccccc
Confidence 64 4678999988 778888886543 68899999999999999999997 47 99999999999998765
Q ss_pred ----------ceeEeecccccccCCCCCceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCch
Q 002774 694 ----------NAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKY 763 (882)
Q Consensus 694 ----------~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~ 763 (882)
.+||+|||.+..... ......||+.|||||++.+..++.++|||||||++|||++|+.||.....
T Consensus 276 ~~~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~ 350 (467)
T PTZ00284 276 TNRALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDN 350 (467)
T ss_pred cccccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 499999998864322 22346799999999999999999999999999999999999999975443
Q ss_pred HHHHHHHHHHhh----------------hhhhhhhhccCCcCCC---------C--CCHHHHHHHHHHHHHhhccCCCCC
Q 002774 764 IVREIRTVMDKK----------------KELYNLYELIDPTIGL---------S--TTLKGFEKYVDLALKCVQESGDDR 816 (882)
Q Consensus 764 ~~~~~~~~~~~~----------------~~~~~~~~~~d~~l~~---------~--~~~~~~~~l~~li~~cl~~dp~~R 816 (882)
... +..+.... .........+.+.... . ........+.+|+.+||+.||++|
T Consensus 351 ~~~-~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R 429 (467)
T PTZ00284 351 LEH-LHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKR 429 (467)
T ss_pred HHH-HHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhC
Confidence 211 11111000 0000000000000000 0 000112567899999999999999
Q ss_pred CCHHHHHHH
Q 002774 817 PTMSEVVKD 825 (882)
Q Consensus 817 Ps~~evl~~ 825 (882)
||++|++++
T Consensus 430 ~ta~e~L~H 438 (467)
T PTZ00284 430 LNARQMTTH 438 (467)
T ss_pred CCHHHHhcC
Confidence 999999975
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=311.79 Aligned_cols=252 Identities=24% Similarity=0.409 Sum_probs=199.8
Q ss_pred CCCCCCeeeccCcEEEEEEEecC--CcEEEEEEcccCC----------cccHHHHHHHHHHHHh-ccCCCeeeEEEEEEe
Q 002774 556 NFSDANDVGSGGYGKVYKGTLPN--GQLIAIKRAQQGS----------MQGGQEFKMEIELLSR-VHHKNLVSLLGFCFD 622 (882)
Q Consensus 556 ~~~~~~~lG~G~fg~Vy~~~~~~--g~~vavK~~~~~~----------~~~~~~~~~E~~~l~~-l~H~niv~l~~~~~~ 622 (882)
+|+..+.||+|+||+||+|.... ++.+|+|.+.... .....++.+|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 36778899999999999999754 6889999875321 1122456778888875 699999999999999
Q ss_pred CCceEEEEEeecCCCcccccCC--CCCccccHHHHHHHHHHHHHHHhhhhh-cCCCCeeecCCCCCceEEcCCCceeEee
Q 002774 623 RGEQMLIYEFVPNGSLGDSLSG--KNGIRLDWIRRLKIALGAARGLSYLHE-LANPPIIHRDIKSSNILLDERLNAKVAD 699 (882)
Q Consensus 623 ~~~~~lV~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDlk~~NIll~~~~~~kl~D 699 (882)
++..++||||+++++|.+++.. .....+++..++.++.|++.||.|||+ .+ ++||||+|+||+++.++.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence 9999999999999999988743 123468899999999999999999996 56 99999999999999999999999
Q ss_pred cccccccCCCCCceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhh
Q 002774 700 FGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELY 779 (882)
Q Consensus 700 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~ 779 (882)
||++....... ......|+..|+|||.+.++.++.++||||||+++|||++|+.||...... ..........
T Consensus 158 fg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~-~~~~~~~~~~---- 229 (269)
T cd08528 158 FGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML-SLATKIVEAV---- 229 (269)
T ss_pred ccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH-HHHHHHhhcc----
Confidence 99998765432 233456899999999999888999999999999999999999998654322 1111111100
Q ss_pred hhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 002774 780 NLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIE 827 (882)
Q Consensus 780 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~ 827 (882)
..+.. .......+.+++.+||+.||++||++.|+.+++.
T Consensus 230 -----~~~~~----~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 230 -----YEPLP----EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred -----CCcCC----cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 00100 1122367889999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=310.16 Aligned_cols=250 Identities=22% Similarity=0.397 Sum_probs=204.2
Q ss_pred CCCCCCeeeccCcEEEEEEEe-cCCcEEEEEEcccCC--cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEe
Q 002774 556 NFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGS--MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEF 632 (882)
Q Consensus 556 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 632 (882)
+|+..+.||+|+||+||+++. .+|+.||+|++.... ....+++.+|+.++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 477889999999999999985 468999999986432 23345788999999999999999999999999999999999
Q ss_pred ecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCc
Q 002774 633 VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKD 712 (882)
Q Consensus 633 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 712 (882)
+++++|.+++.......+++.++..++.|++.|++|||+.+ ++|+||+|+||+++.++.++++|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~- 156 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE- 156 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh-
Confidence 99999999887654456889999999999999999999988 99999999999999999999999999986643221
Q ss_pred eeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCCCC
Q 002774 713 HITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLS 792 (882)
Q Consensus 713 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 792 (882)
......|++.|+|||++.+..++.++|||||||+++||++|+.||...... +......... .+..
T Consensus 157 -~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~-~~~~~~~~~~----------~~~~--- 221 (256)
T cd08218 157 -LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK-NLVLKIIRGS----------YPPV--- 221 (256)
T ss_pred -hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHH-HHHHHHhcCC----------CCCC---
Confidence 112345888999999999889999999999999999999999999754322 2221111110 0111
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 793 TTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 793 ~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
......++.+++.+||+.+|++||++.||+++
T Consensus 222 -~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 222 -SSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred -cccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 11234678999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=316.34 Aligned_cols=246 Identities=26% Similarity=0.408 Sum_probs=199.6
Q ss_pred CCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCC-cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEeec
Q 002774 557 FSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS-MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVP 634 (882)
Q Consensus 557 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 634 (882)
|+..+.||+|+||.||+|... +++.||+|.++... ....+.+.+|++++++++||||+++++++..++..++||||++
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG 85 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence 455677999999999999864 57899999987543 2334578899999999999999999999999999999999999
Q ss_pred CCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCcee
Q 002774 635 NGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHI 714 (882)
Q Consensus 635 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 714 (882)
+++|.+++... .+++..+..++.|+++|+.|||+.+ ++|+||+|+||++++++.++++|||++..+..... .
T Consensus 86 ~~~L~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~--~ 157 (277)
T cd06642 86 GGSALDLLKPG---PLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--K 157 (277)
T ss_pred CCcHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcch--h
Confidence 99999988643 5889999999999999999999988 99999999999999999999999999987643221 1
Q ss_pred eeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCCCCCC
Q 002774 715 TTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTT 794 (882)
Q Consensus 715 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 794 (882)
.....++..|+|||++.+..++.++|||||||++|||++|+.|+....... ... .. .....+.. .
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-~~~-~~---------~~~~~~~~----~ 222 (277)
T cd06642 158 RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR-VLF-LI---------PKNSPPTL----E 222 (277)
T ss_pred hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh-HHh-hh---------hcCCCCCC----C
Confidence 223457889999999998899999999999999999999999986432111 100 00 01111111 1
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 795 LKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 795 ~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
......+.+++.+||+.+|++||++.+++++
T Consensus 223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 223 GQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred cccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 2234678899999999999999999999985
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=308.24 Aligned_cols=248 Identities=29% Similarity=0.468 Sum_probs=201.0
Q ss_pred CCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCCc-----ccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEE
Q 002774 556 NFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM-----QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLI 629 (882)
Q Consensus 556 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 629 (882)
+|+..+.||+|+||+||+|... +++.||+|.+..... ...+.+.+|+++++.++|+||+++++++.+++..++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 3667789999999999999975 789999998865331 2336788999999999999999999999999999999
Q ss_pred EEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCC
Q 002774 630 YEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDS 709 (882)
Q Consensus 630 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~ 709 (882)
|||+++++|.+++.... .+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||++......
T Consensus 81 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~ 155 (258)
T cd06632 81 LELVPGGSLAKLLKKYG--SFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVEF 155 (258)
T ss_pred EEecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence 99999999999987543 5889999999999999999999998 999999999999999999999999998865433
Q ss_pred CCceeeeeeeccCCCCCHHHHhhCC-CCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCc
Q 002774 710 EKDHITTQVKGTMGYLDPEYYMTQQ-LTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPT 788 (882)
Q Consensus 710 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 788 (882)
. ......|+..|+|||.+.... ++.++|+|||||++|||++|+.||........ ......... . +.
T Consensus 156 ~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~----~-----~~ 222 (258)
T cd06632 156 S---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAA-VFKIGRSKE----L-----PP 222 (258)
T ss_pred c---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHH-HHHHHhccc----C-----CC
Confidence 2 123456889999999998766 89999999999999999999999975442111 111110000 0 00
Q ss_pred CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 789 IGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 789 l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
. .......+.+++.+||+.+|++||++.+++++
T Consensus 223 ~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 223 I----PDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred c----CCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 1 11223678899999999999999999999863
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=316.44 Aligned_cols=261 Identities=28% Similarity=0.443 Sum_probs=204.9
Q ss_pred cCHHHHHHHHcCCCCCCeeeccCcEEEEEEEe-cCCcEEEEEEcccCCcccHHHHHHHHHHHHhc-cCCCeeeEEEEEEe
Q 002774 545 FSFEEVKKYTNNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQGGQEFKMEIELLSRV-HHKNLVSLLGFCFD 622 (882)
Q Consensus 545 ~~~~e~~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~ 622 (882)
.++.++....+.|+..+.||+|+||+||+|+. .+++.||+|.+.... ....++..|+.++.++ +|+||+++++++..
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 84 (282)
T cd06636 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIK 84 (282)
T ss_pred hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence 34555556677889999999999999999996 468899999986543 2335688899999998 69999999999853
Q ss_pred ------CCceEEEEEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCcee
Q 002774 623 ------RGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAK 696 (882)
Q Consensus 623 ------~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~k 696 (882)
....++||||+++|+|.+++.......+++..+..++.|++.||+|||+.+ |+||||||+||++++++.++
T Consensus 85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~ 161 (282)
T cd06636 85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVK 161 (282)
T ss_pred ccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEE
Confidence 456799999999999999887655556888889999999999999999998 99999999999999999999
Q ss_pred EeecccccccCCCCCceeeeeeeccCCCCCHHHHh-----hCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHH
Q 002774 697 VADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYM-----TQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTV 771 (882)
Q Consensus 697 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~ 771 (882)
|+|||+++....... ......|+..|+|||.+. ...++.++|||||||++|||++|..||.......... ..
T Consensus 162 l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~-~~ 238 (282)
T cd06636 162 LVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF-LI 238 (282)
T ss_pred EeeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh-hH
Confidence 999999876532211 122356889999999986 3467889999999999999999999996543221111 00
Q ss_pred HHhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 772 MDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 772 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
.....+.. .......++.+++.+||+.||.+||++.|++++
T Consensus 239 ----------~~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 239 ----------PRNPPPKL---KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred ----------hhCCCCCC---cccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 00111111 111234678999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=318.62 Aligned_cols=195 Identities=26% Similarity=0.406 Sum_probs=159.5
Q ss_pred CCeeeccCcEEEEEEEec---CCcEEEEEEcccCCcccHHHHHHHHHHHHhccCCCeeeEEEEEEe--CCceEEEEEeec
Q 002774 560 ANDVGSGGYGKVYKGTLP---NGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFD--RGEQMLIYEFVP 634 (882)
Q Consensus 560 ~~~lG~G~fg~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~lV~e~~~ 634 (882)
..+||+|+||+||+|+.. ++..||+|.++.... ...+.+|++++++++||||+++++++.. +...++||||++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 357999999999999864 457899999875432 3467889999999999999999998854 456789999996
Q ss_pred CCCcccccCCC-------CCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEE----cCCCceeEeecccc
Q 002774 635 NGSLGDSLSGK-------NGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILL----DERLNAKVADFGLS 703 (882)
Q Consensus 635 ~gsL~~~l~~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll----~~~~~~kl~DfGla 703 (882)
+ +|.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+||++ ++++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 4 666665321 1235888999999999999999999998 9999999999999 56789999999999
Q ss_pred cccCCCCCc-eeeeeeeccCCCCCHHHHhh-CCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 002774 704 KSMSDSEKD-HITTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIER 760 (882)
Q Consensus 704 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvll~el~tg~~P~~~ 760 (882)
+........ .......||+.|+|||++.+ ..++.++|||||||++|||+||+.||..
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 876543221 11234568999999999976 4589999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=311.32 Aligned_cols=257 Identities=27% Similarity=0.401 Sum_probs=206.7
Q ss_pred cCCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCC-cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEe
Q 002774 555 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS-MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEF 632 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 632 (882)
++|+..+.||.|+||+||+|... ++..+|+|++.... ....+.+.+|+++++.++|+||+++++.+..++..++||||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 36888999999999999999854 68899999987543 23457789999999999999999999999999999999999
Q ss_pred ecCCCcccccCCCCC-ccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCC
Q 002774 633 VPNGSLGDSLSGKNG-IRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEK 711 (882)
Q Consensus 633 ~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 711 (882)
+++++|.++++.... ..+++.....++.|++.||+|||+.+ ++||||+|+||++++++.++|+|||++..+.....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999999999875432 46899999999999999999999988 99999999999999999999999999987665432
Q ss_pred ce--eeeeeeccCCCCCHHHHhhC-CCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCc
Q 002774 712 DH--ITTQVKGTMGYLDPEYYMTQ-QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPT 788 (882)
Q Consensus 712 ~~--~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 788 (882)
.. ......|+..|+|||++... .++.++|||||||++|||++|+.||........ ....... ..+.
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~-~~~~~~~----------~~~~ 226 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV-LMLTLQN----------DPPS 226 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh-HHHHhcC----------CCCC
Confidence 21 22334688999999999877 789999999999999999999999975433211 1111111 0111
Q ss_pred CCCCC-CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 789 IGLST-TLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 789 l~~~~-~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
..... .......+.+++.+||+.||++||++.+++++
T Consensus 227 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 227 LETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred cCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 11111 11334678999999999999999999999864
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=318.76 Aligned_cols=253 Identities=24% Similarity=0.313 Sum_probs=203.3
Q ss_pred CCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCCcc---cHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEE
Q 002774 556 NFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQ---GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYE 631 (882)
Q Consensus 556 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e 631 (882)
+|...+.||+|+||+||+|... +++.||+|.+...... ..+.+.+|+++++.++|+||+++++.+.+.+..++|||
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD 81 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence 6788899999999999999865 5899999998765333 33568889999999999999999999999999999999
Q ss_pred eecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCC
Q 002774 632 FVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEK 711 (882)
Q Consensus 632 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 711 (882)
|+++++|.+++.......+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++........
T Consensus 82 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 158 (316)
T cd05574 82 YCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP 158 (316)
T ss_pred ecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccccc
Confidence 999999999987655557899999999999999999999998 99999999999999999999999999876533211
Q ss_pred ce---------------------------eeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchH
Q 002774 712 DH---------------------------ITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYI 764 (882)
Q Consensus 712 ~~---------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~ 764 (882)
.. ......|+..|+|||++.+..++.++||||||+++|||++|+.||......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~ 238 (316)
T cd05574 159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRD 238 (316)
T ss_pred ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchH
Confidence 00 011235788999999999888999999999999999999999999654332
Q ss_pred HHHHHHHHHhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCC----HHHHHHH
Q 002774 765 VREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPT----MSEVVKD 825 (882)
Q Consensus 765 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs----~~evl~~ 825 (882)
.. ...... ..............+.+++.+||+.||++||+ ++|++++
T Consensus 239 ~~-~~~~~~-------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 239 ET-FSNILK-------------KEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred HH-HHHHhc-------------CCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 11 111111 11111111113478899999999999999999 6666653
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=317.99 Aligned_cols=263 Identities=28% Similarity=0.403 Sum_probs=201.5
Q ss_pred cCCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCCcc--cHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEE
Q 002774 555 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQ--GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYE 631 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e 631 (882)
++|+..+.||+|+||.||+|... +++.||+|++...... ..+.+.+|+++++.++||||+++++++.+++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 36788899999999999999975 5899999998654322 34568899999999999999999999999999999999
Q ss_pred eecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCC
Q 002774 632 FVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEK 711 (882)
Q Consensus 632 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 711 (882)
|+++++|.++..... .+++.++..++.|++.||+|||+.+ ++||||+|+||++++++.++|+|||++........
T Consensus 81 ~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07846 81 FVDHTVLDDLEKYPN--GLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE 155 (286)
T ss_pred cCCccHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc
Confidence 999998887765433 4899999999999999999999988 99999999999999999999999999987644322
Q ss_pred ceeeeeeeccCCCCCHHHHhh-CCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhh-------hhh-
Q 002774 712 DHITTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELY-------NLY- 782 (882)
Q Consensus 712 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~-------~~~- 782 (882)
......++..|+|||++.+ ..++.++||||||+++|||++|..||....... ............. ...
T Consensus 156 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07846 156 --VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDID-QLYHIIKCLGNLIPRHQEIFQKNP 232 (286)
T ss_pred --ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHH-HHHHHHHHhCCCchhhHHHhccch
Confidence 2233457889999999875 457889999999999999999998886544322 2211111000000 000
Q ss_pred ---hccCCcCCCC-----CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 783 ---ELIDPTIGLS-----TTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 783 ---~~~d~~l~~~-----~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
....+..... ........+.+++.+||+.+|++||++++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 233 LFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred HhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 0000110000 011224678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=310.60 Aligned_cols=255 Identities=25% Similarity=0.387 Sum_probs=198.0
Q ss_pred CCCCCeeeccCcEEEEEEEec----CCcEEEEEEcccCCc--ccHHHHHHHHHHHHhccCCCeeeEEEEEEeCC------
Q 002774 557 FSDANDVGSGGYGKVYKGTLP----NGQLIAIKRAQQGSM--QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRG------ 624 (882)
Q Consensus 557 ~~~~~~lG~G~fg~Vy~~~~~----~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------ 624 (882)
|...+.||+|+||+||+|.+. +++.||||+++.... ...+++.+|++++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 456788999999999999853 368899999875432 23457889999999999999999999886542
Q ss_pred ceEEEEEeecCCCcccccCCC----CCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeec
Q 002774 625 EQMLIYEFVPNGSLGDSLSGK----NGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADF 700 (882)
Q Consensus 625 ~~~lV~e~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~Df 700 (882)
..++++||+++|+|.+++... ....+++....+++.|++.||+|||+.+ |+||||||+||++++++.+|++||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 247899999999998776421 1235788899999999999999999988 999999999999999999999999
Q ss_pred ccccccCCCCCceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHhhhhhh
Q 002774 701 GLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELY 779 (882)
Q Consensus 701 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~ 779 (882)
|+++...............++..|++||.+....++.++|||||||++|||++ |+.||..... ........ ...
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~-~~~~~~~~-~~~--- 232 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN-SEIYNYLI-KGN--- 232 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH-HHHHHHHH-cCC---
Confidence 99987644332222223345678999999998899999999999999999999 7888754322 11111111 100
Q ss_pred hhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 002774 780 NLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENI 829 (882)
Q Consensus 780 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 829 (882)
.. .........+.+++.+||+.+|++||++.|+++.|+++
T Consensus 233 ------~~----~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 233 ------RL----KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred ------cC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00 01112346889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=314.59 Aligned_cols=263 Identities=21% Similarity=0.309 Sum_probs=199.9
Q ss_pred CCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCCc--ccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEe
Q 002774 556 NFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM--QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEF 632 (882)
Q Consensus 556 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 632 (882)
+|...+.||+|+||+||+|+.. +|+.||+|+++.... .....+.+|++++++++||||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 3677889999999999999964 689999999865322 2225677899999999999999999999999999999999
Q ss_pred ecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCc
Q 002774 633 VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKD 712 (882)
Q Consensus 633 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 712 (882)
++ ++|.+++.... ..+++..+..++.||++||.|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~- 154 (284)
T cd07839 81 CD-QDLKKYFDSCN-GDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR- 154 (284)
T ss_pred CC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCCC-
Confidence 96 57877765432 35899999999999999999999998 99999999999999999999999999986543221
Q ss_pred eeeeeeeccCCCCCHHHHhhC-CCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhh-----hhhhhhccC
Q 002774 713 HITTQVKGTMGYLDPEYYMTQ-QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKE-----LYNLYELID 786 (882)
Q Consensus 713 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~d 786 (882)
......++..|+|||.+.+. .++.++|||||||++|||+||+.|+..+.+.............. ........+
T Consensus 155 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07839 155 -CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPD 233 (284)
T ss_pred -CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccc
Confidence 12234578899999998764 47899999999999999999999976555444333332211100 000000000
Q ss_pred C----cCCC-----CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 787 P----TIGL-----STTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 787 ~----~l~~-----~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
. .... ........++.+++.+||+.||.+|||++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 234 YKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred ccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 0 0000 0011234678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=310.48 Aligned_cols=247 Identities=22% Similarity=0.338 Sum_probs=206.9
Q ss_pred cCCCCCCeeeccCcEEEEEEEe-cCCcEEEEEEcccCCcc--cHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEE
Q 002774 555 NNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQ--GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYE 631 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e 631 (882)
.-|...+.||+|.|..|-.|++ -+|++||||++.+.... ....+.+|++.|+.++|||||+++.+...+...|||+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 3466677899999999999984 48999999999876443 33567889999999999999999999999999999999
Q ss_pred eecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEE-cCCCceeEeecccccccCCCC
Q 002774 632 FVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILL-DERLNAKVADFGLSKSMSDSE 710 (882)
Q Consensus 632 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll-~~~~~~kl~DfGla~~~~~~~ 710 (882)
+-++|+|++|+-.+. ..+.+.-..+++.||..|+.|+|+.+ +|||||||+||.+ ..-|-+||+|||++-.+.++.
T Consensus 98 LGD~GDl~DyImKHe-~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~ 173 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHE-EGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK 173 (864)
T ss_pred ecCCchHHHHHHhhh-ccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCcc
Confidence 999999999996553 35788888999999999999999999 9999999999866 567889999999998876655
Q ss_pred CceeeeeeeccCCCCCHHHHhhCCCC-chhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcC
Q 002774 711 KDHITTQVKGTMGYLDPEYYMTQQLT-EKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTI 789 (882)
Q Consensus 711 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 789 (882)
. .+..+|+..|-|||.+.+..|+ +++||||+|||||-|++|+.||....+... +..++|...
T Consensus 174 k---L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET--------------LTmImDCKY 236 (864)
T KOG4717|consen 174 K---LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET--------------LTMIMDCKY 236 (864)
T ss_pred h---hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh--------------hhhhhcccc
Confidence 4 3457899999999999999887 578999999999999999999976543221 222333322
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002774 790 GLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVK 824 (882)
Q Consensus 790 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~ 824 (882)
..+.....+..+||..|++.||.+|.+.+||..
T Consensus 237 --tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 237 --TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred --cCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 223445688999999999999999999999875
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=316.57 Aligned_cols=246 Identities=24% Similarity=0.378 Sum_probs=199.8
Q ss_pred CCCeeeccCcEEEEEEEec-CCcEEEEEEcccCCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEeecCCC
Q 002774 559 DANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGS 637 (882)
Q Consensus 559 ~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 637 (882)
....||+|+||.||++... ++..||||++........+.+.+|+.+++.++|+||+++++.+..++..++||||+++++
T Consensus 26 ~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~ 105 (292)
T cd06658 26 SFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGA 105 (292)
T ss_pred hhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCc
Confidence 3466999999999999864 688999999876554555678899999999999999999999999999999999999999
Q ss_pred cccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCceeeee
Q 002774 638 LGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQ 717 (882)
Q Consensus 638 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~ 717 (882)
|.+++... .+++..+..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||++........ ....
T Consensus 106 L~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~~ 177 (292)
T cd06658 106 LTDIVTHT---RMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP--KRKS 177 (292)
T ss_pred HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcccccc--cCce
Confidence 99988543 4788999999999999999999998 99999999999999999999999999876543221 1233
Q ss_pred eeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCCCCCCHHH
Q 002774 718 VKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKG 797 (882)
Q Consensus 718 ~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 797 (882)
..|+..|+|||++.+..++.++|||||||++|||++|+.||........ .... .....+.... ....
T Consensus 178 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~-~~~~----------~~~~~~~~~~--~~~~ 244 (292)
T cd06658 178 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA-MRRI----------RDNLPPRVKD--SHKV 244 (292)
T ss_pred eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHH----------HhcCCCcccc--cccc
Confidence 5689999999999888899999999999999999999999975433211 1111 0111111111 1122
Q ss_pred HHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 798 FEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 798 ~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
...+.+++.+||+.||.+|||++|++++
T Consensus 245 ~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 245 SSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 3568899999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=315.34 Aligned_cols=252 Identities=23% Similarity=0.395 Sum_probs=205.1
Q ss_pred cCCCCCCeeeccCcEEEEEEEecCCcEEEEEEcccC--CcccHHHHHHHHHHHHhcc-CCCeeeEEEEEEeCCceEEEEE
Q 002774 555 NNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQG--SMQGGQEFKMEIELLSRVH-HKNLVSLLGFCFDRGEQMLIYE 631 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~e 631 (882)
..|++.+.||+||.+.||++...+.+.||+|++... +.+...-|..|++.|.+++ |.+||++++|-..++..|||||
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE 440 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME 440 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence 357778899999999999999888889999987543 3344467999999999995 9999999999999999999999
Q ss_pred eecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCC
Q 002774 632 FVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEK 711 (882)
Q Consensus 632 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 711 (882)
|- ..+|..+|.........| .+..+..|++.++.++|.+| |||.||||.|+|+- .|.+||+|||+|..+.....
T Consensus 441 ~G-d~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DTT 514 (677)
T KOG0596|consen 441 CG-DIDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDTT 514 (677)
T ss_pred cc-cccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEE-eeeEEeeeechhcccCcccc
Confidence 86 569999998877656666 67789999999999999999 99999999999886 46899999999998887766
Q ss_pred ceeeeeeeccCCCCCHHHHhhCC-----------CCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhh
Q 002774 712 DHITTQVKGTMGYLDPEYYMTQQ-----------LTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYN 780 (882)
Q Consensus 712 ~~~~~~~~gt~~y~aPE~~~~~~-----------~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~ 780 (882)
.......+||+.||+||.+.... .++++||||+|||||+|+.|+.||..-.+...-
T Consensus 515 sI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aK------------- 581 (677)
T KOG0596|consen 515 SIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAK------------- 581 (677)
T ss_pred ceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHH-------------
Confidence 66667788999999999997432 568999999999999999999999643322221
Q ss_pred hhhccCCcCCCCCCH-HHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 781 LYELIDPTIGLSTTL-KGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 781 ~~~~~d~~l~~~~~~-~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
+..+.||.....++. ....+++++++.||+.||++||+..|++++
T Consensus 582 l~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 582 LHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred HHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 233444433222111 111338999999999999999999999974
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=308.38 Aligned_cols=250 Identities=25% Similarity=0.345 Sum_probs=206.0
Q ss_pred cCCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCCc---ccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEE
Q 002774 555 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM---QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIY 630 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 630 (882)
+.|+.-++||+|+||+||-++.. +|+.+|.|++.+... ....-...|-.+|.++..+.||.+-.++.+.+..++|+
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL 264 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL 264 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence 46778899999999999999854 699999998865432 22344567999999999999999999999999999999
Q ss_pred EeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCC
Q 002774 631 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE 710 (882)
Q Consensus 631 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~ 710 (882)
..|.||+|.-+|...+...+++.++..++.+|+.||++||... ||.||+||+|||+|+.|+++|+|.|+|..+....
T Consensus 265 tlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~ 341 (591)
T KOG0986|consen 265 TLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPEGK 341 (591)
T ss_pred EeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCCCC
Confidence 9999999999999887778999999999999999999999998 9999999999999999999999999999887654
Q ss_pred CceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHH--HHHHHHHhhhhhhhhhhccCCc
Q 002774 711 KDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVR--EIRTVMDKKKELYNLYELIDPT 788 (882)
Q Consensus 711 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~--~~~~~~~~~~~~~~~~~~~d~~ 788 (882)
. ....+||.+|||||++..+.|+...|.||+||++|||+.|+.||...+.-+. ++...... |
T Consensus 342 ~---~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~-----------~-- 405 (591)
T KOG0986|consen 342 P---IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLE-----------D-- 405 (591)
T ss_pred c---cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhc-----------c--
Confidence 3 3345899999999999999999999999999999999999999964332211 11111111 1
Q ss_pred CCCCCCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 002774 789 IGLSTTLKGFEKYVDLALKCVQESGDDRPT-----MSEVVK 824 (882)
Q Consensus 789 l~~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~evl~ 824 (882)
...++.+..++..++....|++||.+|.. +++|.+
T Consensus 406 -~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~ 445 (591)
T KOG0986|consen 406 -PEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKE 445 (591)
T ss_pred -hhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhh
Confidence 11223344577889999999999999964 445554
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=315.83 Aligned_cols=262 Identities=28% Similarity=0.432 Sum_probs=204.6
Q ss_pred cCHHHHHHHHcCCCCCCeeeccCcEEEEEEEe-cCCcEEEEEEcccCCcccHHHHHHHHHHHHhc-cCCCeeeEEEEEEe
Q 002774 545 FSFEEVKKYTNNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQGGQEFKMEIELLSRV-HHKNLVSLLGFCFD 622 (882)
Q Consensus 545 ~~~~e~~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~ 622 (882)
+.+.++..++++|...+.||+|+||.||+|.. .+++.+|+|++.... .....+.+|+.+++++ +|||++++++++..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 44455666788999999999999999999986 468899999986532 2335678899999999 79999999999875
Q ss_pred C-----CceEEEEEeecCCCcccccCCC--CCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCce
Q 002774 623 R-----GEQMLIYEFVPNGSLGDSLSGK--NGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNA 695 (882)
Q Consensus 623 ~-----~~~~lV~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~ 695 (882)
. +..++||||+++|+|.++++.. ....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCE
Confidence 4 3579999999999999887532 2346889999999999999999999988 9999999999999999999
Q ss_pred eEeecccccccCCCCCceeeeeeeccCCCCCHHHHhhC-----CCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHH
Q 002774 696 KVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQ-----QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRT 770 (882)
Q Consensus 696 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~ 770 (882)
||+|||+++....... ......|+..|+|||.+... .++.++|||||||++|||++|+.||......... ..
T Consensus 168 kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~-~~ 244 (291)
T cd06639 168 KLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTL-FK 244 (291)
T ss_pred EEeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHH-HH
Confidence 9999999986643221 12234588999999998643 3688999999999999999999999754322111 11
Q ss_pred HHHhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 771 VMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 771 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
... ...+.. ....+....+.+++.+||+.+|++||++.|++++
T Consensus 245 ~~~----------~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 245 IPR----------NPPPTL--LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred Hhc----------CCCCCC--CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 100 001111 1112233578999999999999999999999874
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=342.49 Aligned_cols=261 Identities=27% Similarity=0.424 Sum_probs=211.5
Q ss_pred HcCCCCCCeeeccCcEEEEEEEec----C----CcEEEEEEcccCCcc-cHHHHHHHHHHHHhc-cCCCeeeEEEEEEeC
Q 002774 554 TNNFSDANDVGSGGYGKVYKGTLP----N----GQLIAIKRAQQGSMQ-GGQEFKMEIELLSRV-HHKNLVSLLGFCFDR 623 (882)
Q Consensus 554 ~~~~~~~~~lG~G~fg~Vy~~~~~----~----g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~ 623 (882)
.+++...+.||+|.||.|++|... . ...||||.++..... +.+.+..|+++|+.+ +|+||+.++|+|..+
T Consensus 295 ~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~ 374 (609)
T KOG0200|consen 295 RENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQD 374 (609)
T ss_pred hhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccC
Confidence 344455569999999999999742 1 457999999865443 457899999999999 699999999999999
Q ss_pred CceEEEEEeecCCCcccccCCCC------------C--ccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEE
Q 002774 624 GEQMLIYEFVPNGSLGDSLSGKN------------G--IRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILL 689 (882)
Q Consensus 624 ~~~~lV~e~~~~gsL~~~l~~~~------------~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll 689 (882)
+..++|+||+..|+|.++++... . ..++..+.+.++.|||.|++||++.. +|||||.++|||+
T Consensus 375 ~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRNVLi 451 (609)
T KOG0200|consen 375 GPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARNVLI 451 (609)
T ss_pred CceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhhEEe
Confidence 99999999999999999997654 0 13888999999999999999999988 9999999999999
Q ss_pred cCCCceeEeecccccccCCCCCceeeeeee--ccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHh-CCCCCCCCchHHH
Q 002774 690 DERLNAKVADFGLSKSMSDSEKDHITTQVK--GTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVR 766 (882)
Q Consensus 690 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~t-g~~P~~~~~~~~~ 766 (882)
.++..+||+|||+|+...+.+..... ... -+.+|||||.+....|+.|+|||||||+|||++| |..||..-....+
T Consensus 452 ~~~~~~kIaDFGlar~~~~~~~y~~~-~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~ 530 (609)
T KOG0200|consen 452 TKNKVIKIADFGLARDHYNKDYYRTK-SSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEE 530 (609)
T ss_pred cCCCEEEEccccceeccCCCCceEec-CCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHH
Confidence 99999999999999976555443222 112 3567999999999999999999999999999999 8888854221122
Q ss_pred HHHHHHHhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 002774 767 EIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 832 (882)
Q Consensus 767 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~ 832 (882)
. ...+. +..+...+..+..+++++|+.||+.+|++||++.|+.+.+...++.
T Consensus 531 l-~~~l~-------------~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~~ 582 (609)
T KOG0200|consen 531 L-LEFLK-------------EGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQD 582 (609)
T ss_pred H-HHHHh-------------cCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHHH
Confidence 1 11222 2223344455678999999999999999999999999999997654
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=307.07 Aligned_cols=253 Identities=28% Similarity=0.437 Sum_probs=203.6
Q ss_pred CCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCCcc--cHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEe
Q 002774 556 NFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQ--GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEF 632 (882)
Q Consensus 556 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 632 (882)
+|...+.||+|+||.||+|... +++.||+|.++..... ..+.+.+|+++++.++|+||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4677889999999999999864 6899999998765443 457789999999999999999999999999999999999
Q ss_pred ecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCc
Q 002774 633 VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKD 712 (882)
Q Consensus 633 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 712 (882)
+++++|.+++.... .+++..+..++.+++.||+|||+.+ ++|+||+|+||++++++.+||+|||++.........
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 81 CSGGTLEELLEHGR--ILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred CCCCcHHHHHhhcC--CCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence 99999999987643 5788899999999999999999998 999999999999999999999999999876543321
Q ss_pred ee--eeeeeccCCCCCHHHHhhCC---CCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCC
Q 002774 713 HI--TTQVKGTMGYLDPEYYMTQQ---LTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDP 787 (882)
Q Consensus 713 ~~--~~~~~gt~~y~aPE~~~~~~---~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 787 (882)
.. .....++..|+|||++.... ++.++||||||+++|||++|+.||............... ...+
T Consensus 156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~----------~~~~ 225 (264)
T cd06626 156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA----------GHKP 225 (264)
T ss_pred ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc----------CCCC
Confidence 11 11345788999999998766 889999999999999999999999754322221111110 0111
Q ss_pred cCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 788 TIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 788 ~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
... ........+.+++.+||+.+|++||++.|++.+
T Consensus 226 ~~~--~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~ 261 (264)
T cd06626 226 PIP--DSLQLSPEGKDFLDRCLESDPKKRPTASELLQH 261 (264)
T ss_pred CCC--cccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 111 111224677899999999999999999998753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=314.66 Aligned_cols=245 Identities=23% Similarity=0.362 Sum_probs=199.5
Q ss_pred CCeeeccCcEEEEEEEec-CCcEEEEEEcccCCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEeecCCCc
Q 002774 560 ANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSL 638 (882)
Q Consensus 560 ~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 638 (882)
...||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.++||||+++++++..++..++||||+++++|
T Consensus 26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L 105 (297)
T cd06659 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105 (297)
T ss_pred hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence 346999999999999864 6899999998765555556788999999999999999999999999999999999999999
Q ss_pred ccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCceeeeee
Q 002774 639 GDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQV 718 (882)
Q Consensus 639 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 718 (882)
.+++... .+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++........ .....
T Consensus 106 ~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~~~ 177 (297)
T cd06659 106 TDIVSQT---RLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--KRKSL 177 (297)
T ss_pred HHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccccc--cccce
Confidence 9877543 5889999999999999999999998 99999999999999999999999999876543221 12335
Q ss_pred eccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCCCCCCHHHH
Q 002774 719 KGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGF 798 (882)
Q Consensus 719 ~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 798 (882)
.|+..|+|||++.+..++.++|||||||++|||++|+.||....... ..... ... ..+.. .......
T Consensus 178 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-~~~~~-~~~---------~~~~~--~~~~~~~ 244 (297)
T cd06659 178 VGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ-AMKRL-RDS---------PPPKL--KNAHKIS 244 (297)
T ss_pred ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHH-hcc---------CCCCc--cccCCCC
Confidence 68999999999998889999999999999999999999997543221 11111 100 00000 0111223
Q ss_pred HHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 799 EKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 799 ~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
..+.+++.+||+.+|++||++.+++++
T Consensus 245 ~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 245 PVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred HHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 568899999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=326.04 Aligned_cols=241 Identities=24% Similarity=0.283 Sum_probs=187.4
Q ss_pred eeccCcEEEEEEEec-CCcEEEEEEcccCCcc---cHHHHHHHHHHHHhc---cCCCeeeEEEEEEeCCceEEEEEeecC
Q 002774 563 VGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQ---GGQEFKMEIELLSRV---HHKNLVSLLGFCFDRGEQMLIYEFVPN 635 (882)
Q Consensus 563 lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l---~H~niv~l~~~~~~~~~~~lV~e~~~~ 635 (882)
||+|+||+||+|+.. +++.||||++...... ....+..|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999864 6899999998643221 123345566776655 699999999999999999999999999
Q ss_pred CCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCceee
Q 002774 636 GSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHIT 715 (882)
Q Consensus 636 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 715 (882)
|+|.+++.... .+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 g~L~~~l~~~~--~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~--~~ 153 (330)
T cd05586 81 GELFWHLQKEG--RFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNK--TT 153 (330)
T ss_pred ChHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC--Cc
Confidence 99998886543 6889999999999999999999998 99999999999999999999999999975433221 22
Q ss_pred eeeeccCCCCCHHHHhhC-CCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCCCCCC
Q 002774 716 TQVKGTMGYLDPEYYMTQ-QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTT 794 (882)
Q Consensus 716 ~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 794 (882)
....||+.|+|||.+.+. .++.++|||||||++|||++|+.||..... .+....+.... .....
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~-~~~~~~i~~~~-----------~~~~~--- 218 (330)
T cd05586 154 NTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT-QQMYRNIAFGK-----------VRFPK--- 218 (330)
T ss_pred cCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH-HHHHHHHHcCC-----------CCCCC---
Confidence 345699999999999754 489999999999999999999999965432 12111111100 00110
Q ss_pred HHHHHHHHHHHHHhhccCCCCCC----CHHHHHHH
Q 002774 795 LKGFEKYVDLALKCVQESGDDRP----TMSEVVKD 825 (882)
Q Consensus 795 ~~~~~~l~~li~~cl~~dp~~RP----s~~evl~~ 825 (882)
.....++.+++.+||+.||.+|| ++.+++++
T Consensus 219 ~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h 253 (330)
T cd05586 219 NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEH 253 (330)
T ss_pred ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence 01235678999999999999998 56666653
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=307.53 Aligned_cols=251 Identities=26% Similarity=0.372 Sum_probs=196.9
Q ss_pred cCCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCC--c---ccHHHHHHHHHHHHhccCCCeeeEEEEEEeC--Cce
Q 002774 555 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS--M---QGGQEFKMEIELLSRVHHKNLVSLLGFCFDR--GEQ 626 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~ 626 (882)
++|...+.||+|+||.||+|... +|+.||||.+.... . ...+.+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 46888899999999999999864 58999999875322 1 1235678899999999999999999988764 457
Q ss_pred EEEEEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeeccccccc
Q 002774 627 MLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSM 706 (882)
Q Consensus 627 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~ 706 (882)
++||||+++++|.+++.... .+++....+++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||+++..
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~ 156 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYG--ALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRL 156 (265)
T ss_pred EEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCcccccc
Confidence 89999999999999886543 4788888999999999999999998 999999999999999999999999999865
Q ss_pred CCCCCc-eeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhcc
Q 002774 707 SDSEKD-HITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELI 785 (882)
Q Consensus 707 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 785 (882)
...... .......|+..|+|||.+.+..++.++|||||||++|||++|+.||......... ..... ...
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~-~~~~~---------~~~ 226 (265)
T cd06652 157 QTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAI-FKIAT---------QPT 226 (265)
T ss_pred ccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHH-HHHhc---------CCC
Confidence 432111 1122345888999999999888999999999999999999999999654322211 11100 000
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 786 DPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 786 d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
.+ ..+......+.+++.+|+. +|++||+++|++++
T Consensus 227 ~~----~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 227 NP----VLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred CC----CCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 11 1122334678899999995 99999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=310.14 Aligned_cols=249 Identities=28% Similarity=0.449 Sum_probs=203.0
Q ss_pred CCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCCc-ccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEee
Q 002774 556 NFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFV 633 (882)
Q Consensus 556 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 633 (882)
+|+..+.||+|+||.||+|... +++.||+|++..... ...+++.+|++++++++||||+++++++..++..++|+||+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 5677788999999999999875 689999999876533 33467889999999999999999999999999999999999
Q ss_pred cCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhh-cCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCc
Q 002774 634 PNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHE-LANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKD 712 (882)
Q Consensus 634 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 712 (882)
++++|.+++.... ..+++.....++.|++.||+|||+ .+ ++||||||+||++++++.++|+|||.+........
T Consensus 82 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~- 156 (265)
T cd06605 82 DGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA- 156 (265)
T ss_pred CCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHHh-
Confidence 9999999987543 468888999999999999999999 77 99999999999999999999999999876543221
Q ss_pred eeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCc----hHHHHHHHHHHhhhhhhhhhhccCCc
Q 002774 713 HITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGK----YIVREIRTVMDKKKELYNLYELIDPT 788 (882)
Q Consensus 713 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~----~~~~~~~~~~~~~~~~~~~~~~~d~~ 788 (882)
....++..|+|||++.+..++.++||||||+++|+|++|+.||.... ............ ..+.
T Consensus 157 ---~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----------~~~~ 223 (265)
T cd06605 157 ---KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNE----------PPPR 223 (265)
T ss_pred ---hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcC----------CCCC
Confidence 12568889999999999999999999999999999999999996542 222222111111 0111
Q ss_pred CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 789 IGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 789 l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
+.. .....++.+++.+||..+|++|||+.|++.+
T Consensus 224 ~~~---~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 224 LPS---GKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred CCh---hhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 111 1134678899999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=314.52 Aligned_cols=263 Identities=22% Similarity=0.321 Sum_probs=199.6
Q ss_pred CCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCCcc--cHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEe
Q 002774 556 NFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQ--GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEF 632 (882)
Q Consensus 556 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 632 (882)
+|+..+.||+|+||.||+|+.. +|+.||||+++..... ..+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4778899999999999999864 6899999998754322 235688999999999999999999999999999999999
Q ss_pred ecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCc
Q 002774 633 VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKD 712 (882)
Q Consensus 633 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 712 (882)
++ ++|.+++.......+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.+||+|||+++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~- 155 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR- 155 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCcc-
Confidence 95 68888886655557899999999999999999999988 99999999999999999999999999876543221
Q ss_pred eeeeeeeccCCCCCHHHHhhCC-CCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhh-----------hhh
Q 002774 713 HITTQVKGTMGYLDPEYYMTQQ-LTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKE-----------LYN 780 (882)
Q Consensus 713 ~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~-----------~~~ 780 (882)
......++..|+|||.+.+.. ++.++|||||||++|||+||+.||..........+ ....... ...
T Consensus 156 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07860 156 -TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR-IFRTLGTPDEVVWPGVTSLPD 233 (284)
T ss_pred -ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH-HHHHhCCCChhhhhhhhHHHH
Confidence 122335788999999887544 68899999999999999999999975543322211 1111000 000
Q ss_pred hhhccCCcCCC---CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 781 LYELIDPTIGL---STTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 781 ~~~~~d~~l~~---~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
........... ........++.+++.+||+.||.+|||++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 234 YKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred HHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 00000000000 0001123567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=306.52 Aligned_cols=249 Identities=25% Similarity=0.401 Sum_probs=202.4
Q ss_pred CCCCCCeeeccCcEEEEEEEe-cCCcEEEEEEcccCCc--ccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEe
Q 002774 556 NFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSM--QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEF 632 (882)
Q Consensus 556 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 632 (882)
+|+..+.||+|+||.||+|.. .+++.+|||++..... ...+.+.+|+++++.++||||+++++.+..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 477789999999999999986 4688999999875432 2346788999999999999999999999999999999999
Q ss_pred ecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCC-CceeEeecccccccCCCCC
Q 002774 633 VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDER-LNAKVADFGLSKSMSDSEK 711 (882)
Q Consensus 633 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~-~~~kl~DfGla~~~~~~~~ 711 (882)
+++++|.+++.......+++..+..++.+++.||+|||+.+ ++||||||+||+++++ +.+|++|||++........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK 157 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence 99999999997655556899999999999999999999988 9999999999999865 4689999999987654322
Q ss_pred ceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCCC
Q 002774 712 DHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGL 791 (882)
Q Consensus 712 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 791 (882)
.....++..|+|||.+.+..++.++||||||+++|+|++|+.||..... ............ +..
T Consensus 158 ---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~-~~~~~~~~~~~~----------~~~-- 221 (256)
T cd08220 158 ---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL-PALVLKIMSGTF----------API-- 221 (256)
T ss_pred ---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCch-HHHHHHHHhcCC----------CCC--
Confidence 1234588999999999988899999999999999999999999865432 222211111100 001
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 792 STTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 792 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
......++.+++.+||+.+|++|||+.|++++
T Consensus 222 --~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 222 --SDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred --CCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 11234678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=305.64 Aligned_cols=250 Identities=26% Similarity=0.442 Sum_probs=207.5
Q ss_pred cCCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCCc-ccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEe
Q 002774 555 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEF 632 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 632 (882)
++|...+.||+|++|.||+|+.. +++.||||++..... ...+.+.+|++.+.+++|+||+++++++...+..++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 36788899999999999999976 589999999876544 3457799999999999999999999999999999999999
Q ss_pred ecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhh-cCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCC
Q 002774 633 VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHE-LANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEK 711 (882)
Q Consensus 633 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 711 (882)
+++++|.+++... ..+++..+..++.|+++|++|||+ .+ ++||||+|+||+++.++.++|+|||.+........
T Consensus 81 ~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~ 155 (264)
T cd06623 81 MDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD 155 (264)
T ss_pred cCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCCC
Confidence 9999999999754 368999999999999999999999 88 99999999999999999999999999987654332
Q ss_pred ceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCc--hHHHHHHHHHHhhhhhhhhhhccCCcC
Q 002774 712 DHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGK--YIVREIRTVMDKKKELYNLYELIDPTI 789 (882)
Q Consensus 712 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~--~~~~~~~~~~~~~~~~~~~~~~~d~~l 789 (882)
. .....++..|+|||.+....++.++||||||+++|||++|+.||.... ...+........ ..+..
T Consensus 156 ~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~----------~~~~~ 223 (264)
T cd06623 156 Q--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDG----------PPPSL 223 (264)
T ss_pred c--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcC----------CCCCC
Confidence 1 123468899999999999899999999999999999999999997554 222222221111 11111
Q ss_pred CCCCCHH-HHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 790 GLSTTLK-GFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 790 ~~~~~~~-~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
... .+..+.+++.+||+.+|++||++.|++++
T Consensus 224 ----~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 224 ----PAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred ----CcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 111 34678999999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=312.73 Aligned_cols=251 Identities=26% Similarity=0.417 Sum_probs=199.2
Q ss_pred CCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCC-cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEee
Q 002774 556 NFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS-MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFV 633 (882)
Q Consensus 556 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 633 (882)
+|+..+.||+|+||+||+|... +|+.||+|.++... ......+.+|++++++++|+||+++++++...+..++||||+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence 5777889999999999999975 78999999887542 223357889999999999999999999999999999999999
Q ss_pred cCCCcccccCCCC-CccccHHHHHHHHHHHHHHHhhhhh-cCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCC
Q 002774 634 PNGSLGDSLSGKN-GIRLDWIRRLKIALGAARGLSYLHE-LANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEK 711 (882)
Q Consensus 634 ~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 711 (882)
++++|..++.... ...+++..+..++.+++.||.|||+ .+ |+||||||+||+++.++.+||+|||++..+....
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 157 (286)
T cd06622 82 DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL- 157 (286)
T ss_pred CCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCCc-
Confidence 9999988886532 2368999999999999999999996 46 9999999999999999999999999997653322
Q ss_pred ceeeeeeeccCCCCCHHHHhhC------CCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhcc
Q 002774 712 DHITTQVKGTMGYLDPEYYMTQ------QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELI 785 (882)
Q Consensus 712 ~~~~~~~~gt~~y~aPE~~~~~------~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 785 (882)
.....++..|+|||.+.+. .++.++|||||||++|||++|+.||...... .... .+... ....
T Consensus 158 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~-~~~~~------~~~~ 226 (286)
T cd06622 158 ---AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA-NIFA-QLSAI------VDGD 226 (286)
T ss_pred ---cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh-hHHH-HHHHH------hhcC
Confidence 2234578899999998644 3588999999999999999999999653221 1111 11100 0000
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 786 DPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 786 d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
.+.. ......++.+++.+||+.+|++||++.+++++
T Consensus 227 ~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 227 PPTL----PSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred CCCC----CcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 1111 12244778899999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=311.86 Aligned_cols=251 Identities=28% Similarity=0.466 Sum_probs=195.3
Q ss_pred cCCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCCc-ccHHHHHHHHHH-HHhccCCCeeeEEEEEEeCCceEEEEE
Q 002774 555 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM-QGGQEFKMEIEL-LSRVHHKNLVSLLGFCFDRGEQMLIYE 631 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~-l~~l~H~niv~l~~~~~~~~~~~lV~e 631 (882)
++|+..+.||+|+||.||+|+.. +|+.||+|+++.... .....+..|+.. ++..+||||+++++++..++..++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 36788899999999999999865 699999999876432 233455566665 566689999999999999999999999
Q ss_pred eecCCCcccccCCC--CCccccHHHHHHHHHHHHHHHhhhhhc-CCCCeeecCCCCCceEEcCCCceeEeecccccccCC
Q 002774 632 FVPNGSLGDSLSGK--NGIRLDWIRRLKIALGAARGLSYLHEL-ANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSD 708 (882)
Q Consensus 632 ~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~ 708 (882)
|++ |+|.+++... ....+++..+..++.|++.||+|||+. + ++||||||+||+++.++.+||+|||+++....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 996 6777766432 234689999999999999999999986 6 99999999999999999999999999986543
Q ss_pred CCCceeeeeeeccCCCCCHHHHhh----CCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhc
Q 002774 709 SEKDHITTQVKGTMGYLDPEYYMT----QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYEL 784 (882)
Q Consensus 709 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 784 (882)
.. ......++..|+|||.+.+ ..++.++|+|||||++|||++|+.||.......+........
T Consensus 157 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~---------- 223 (283)
T cd06617 157 SV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEE---------- 223 (283)
T ss_pred cc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhc----------
Confidence 21 1223458889999998864 456889999999999999999999996533322222222111
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 785 IDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 785 ~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
..+... ....+.++.+++.+||..+|++||++.+++++
T Consensus 224 ~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 224 PSPQLP---AEKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred CCCCCC---ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111111 11134678999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=314.27 Aligned_cols=253 Identities=27% Similarity=0.416 Sum_probs=195.9
Q ss_pred CCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCCc-ccHHHHHHHHHHHHhcc-CCCeeeEEEEEEeCCceEEEEEe
Q 002774 556 NFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM-QGGQEFKMEIELLSRVH-HKNLVSLLGFCFDRGEQMLIYEF 632 (882)
Q Consensus 556 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~e~ 632 (882)
+|...+.||+|+||+||++... +++.||+|.+..... .....+.+|+.++.++. |+||+++++++..++..++||||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 3445678999999999999864 689999999875432 33457889999999996 99999999999999999999999
Q ss_pred ecCCCcccc---cCCCCCccccHHHHHHHHHHHHHHHhhhhhc-CCCCeeecCCCCCceEEcCCCceeEeecccccccCC
Q 002774 633 VPNGSLGDS---LSGKNGIRLDWIRRLKIALGAARGLSYLHEL-ANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSD 708 (882)
Q Consensus 633 ~~~gsL~~~---l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~ 708 (882)
++. ++.++ +.......+++.....++.+++.||+|||+. + ++||||||+||+++.++.+||+|||+++.+..
T Consensus 85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 863 54433 2222234689999999999999999999974 6 99999999999999999999999999986543
Q ss_pred CCCceeeeeeeccCCCCCHHHHhhC---CCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhcc
Q 002774 709 SEKDHITTQVKGTMGYLDPEYYMTQ---QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELI 785 (882)
Q Consensus 709 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 785 (882)
... .....|+..|+|||.+... .++.++|||||||++|||++|+.||............... ..
T Consensus 161 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~----------~~ 227 (288)
T cd06616 161 SIA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVK----------GD 227 (288)
T ss_pred CCc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcC----------CC
Confidence 221 1233588999999999866 6899999999999999999999999654322222211111 11
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 786 DPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 786 d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
.+.+..........++.+++.+||+.+|++|||+.+++++
T Consensus 228 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 228 PPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1222222222345678999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=311.98 Aligned_cols=262 Identities=24% Similarity=0.358 Sum_probs=200.0
Q ss_pred CCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCCcc-----cHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEE
Q 002774 556 NFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQ-----GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLI 629 (882)
Q Consensus 556 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 629 (882)
+|...+.||+|+||.||+|... +|+.||||+++..... ....+..|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 3677789999999999999864 6899999999765433 234567899999999999999999999999999999
Q ss_pred EEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCC
Q 002774 630 YEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDS 709 (882)
Q Consensus 630 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~ 709 (882)
|||+ +|+|.+++.... ..+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.++|+|||+++.....
T Consensus 81 ~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 155 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSP 155 (298)
T ss_pred Eccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence 9999 999999997653 36899999999999999999999998 999999999999999999999999999876543
Q ss_pred CCceeeeeeeccCCCCCHHHHhh-CCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhh--------hhh
Q 002774 710 EKDHITTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKE--------LYN 780 (882)
Q Consensus 710 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~--------~~~ 780 (882)
.. ......+++.|+|||.+.+ ..++.++|||||||++|||++|..||..... .+........... ...
T Consensus 156 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 232 (298)
T cd07841 156 NR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSD-IDQLGKIFEALGTPTEENWPGVTS 232 (298)
T ss_pred Cc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCcc-HHHHHHHHHHcCCCchhhhhhccc
Confidence 22 1223346788999999864 4678999999999999999999766654332 2222222111000 000
Q ss_pred hhhccCCcCCCCC-----CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 781 LYELIDPTIGLST-----TLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 781 ~~~~~d~~l~~~~-----~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
............. .......+.+++.+||+.+|++|||++|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 233 LPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred ccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0000000000000 11224678899999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=311.85 Aligned_cols=264 Identities=24% Similarity=0.394 Sum_probs=198.7
Q ss_pred cCCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCCcc-cHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEe
Q 002774 555 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQ-GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEF 632 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 632 (882)
++|...+.||+|+||+||+|+.. +++.||||.+...... ....+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 56888899999999999999865 6899999998754322 234567899999999999999999999999999999999
Q ss_pred ecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCc
Q 002774 633 VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKD 712 (882)
Q Consensus 633 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 712 (882)
++ ++|.+++..... .+++.....++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 85 ~~-~~L~~~~~~~~~-~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~- 158 (291)
T cd07844 85 LD-TDLKQYMDDCGG-GLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSK- 158 (291)
T ss_pred CC-CCHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCc-
Confidence 97 489888865432 6788999999999999999999998 99999999999999999999999999875432221
Q ss_pred eeeeeeeccCCCCCHHHHhh-CCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhh-hhhh-------h
Q 002774 713 HITTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKEL-YNLY-------E 783 (882)
Q Consensus 713 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~-~~~~-------~ 783 (882)
......++..|+|||++.+ ..++.++||||+|+++|||++|+.||.......+............ ...+ .
T Consensus 159 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (291)
T cd07844 159 -TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPE 237 (291)
T ss_pred -cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccc
Confidence 1122346888999999875 4588999999999999999999999965543333322222110000 0000 0
Q ss_pred ccCCcCCC-------C--CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 784 LIDPTIGL-------S--TTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 784 ~~d~~l~~-------~--~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
........ . .......++.+++.+|++.+|++|||+.|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 238 FKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred cccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 00000000 0 000112567899999999999999999998863
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=313.49 Aligned_cols=254 Identities=22% Similarity=0.287 Sum_probs=198.7
Q ss_pred cCCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCCc---ccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEE
Q 002774 555 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM---QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIY 630 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 630 (882)
++|...+.||+|+||.||++... +++.||+|.+..... ...+.+.+|+++++.++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36788899999999999999864 578999999876432 22356788999999999999999999999999999999
Q ss_pred EeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCC
Q 002774 631 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE 710 (882)
Q Consensus 631 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~ 710 (882)
||+++++|.+++.... .+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+|++|||+++......
T Consensus 81 e~~~g~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~ 155 (305)
T cd05609 81 EYVEGGDCATLLKNIG--ALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL 155 (305)
T ss_pred ecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence 9999999999996543 5888899999999999999999988 9999999999999999999999999987421110
Q ss_pred C-------------ceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhh
Q 002774 711 K-------------DHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKE 777 (882)
Q Consensus 711 ~-------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~ 777 (882)
. ........++..|+|||++....++.++|+|||||++|||++|..||..... .+.........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~-~~~~~~~~~~~-- 232 (305)
T cd05609 156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP-EELFGQVISDD-- 232 (305)
T ss_pred cccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhcc--
Confidence 0 0011123578899999999988999999999999999999999999964322 22222111110
Q ss_pred hhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 002774 778 LYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDI 826 (882)
Q Consensus 778 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L 826 (882)
...+... ...+..+.+++.+||+.+|++||++.++.+.+
T Consensus 233 ------~~~~~~~----~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll 271 (305)
T cd05609 233 ------IEWPEGD----EALPADAQDLISRLLRQNPLERLGTGGAFEVK 271 (305)
T ss_pred ------cCCCCcc----ccCCHHHHHHHHHHhccChhhccCccCHHHHH
Confidence 0111110 12346788999999999999999965554443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=312.56 Aligned_cols=250 Identities=24% Similarity=0.386 Sum_probs=204.3
Q ss_pred cCCCCCCeeeccCcEEEEEEEe-cCCcEEEEEEcccCCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEee
Q 002774 555 NNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFV 633 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 633 (882)
.+|...+.||+|+||.||+|.. .+++.||+|.+........+.+.+|+.++++++||||+++++++...+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 5678889999999999999985 468899999987555555567889999999999999999999999999999999999
Q ss_pred cCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCce
Q 002774 634 PNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDH 713 (882)
Q Consensus 634 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 713 (882)
++++|.+++... .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++........
T Consensus 99 ~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~-- 170 (293)
T cd06647 99 AGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-- 170 (293)
T ss_pred CCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc--
Confidence 999999998754 4788899999999999999999998 99999999999999999999999999876644322
Q ss_pred eeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCCCCC
Q 002774 714 ITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLST 793 (882)
Q Consensus 714 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 793 (882)
......|++.|+|||.+....++.++|||||||++||+++|+.||........ ...... .+......
T Consensus 171 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~-~~~~~~------------~~~~~~~~ 237 (293)
T cd06647 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-LYLIAT------------NGTPELQN 237 (293)
T ss_pred ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh-eeehhc------------CCCCCCCC
Confidence 12234688899999999888899999999999999999999999965432211 110000 00001111
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 794 TLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 794 ~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
.......+.+++.+||+.+|++||++.+++.+
T Consensus 238 ~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 238 PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 12234578899999999999999999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=311.27 Aligned_cols=263 Identities=24% Similarity=0.321 Sum_probs=201.3
Q ss_pred CCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCC--cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEe
Q 002774 556 NFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS--MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEF 632 (882)
Q Consensus 556 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 632 (882)
+|+..+.||+|+||.||+|... +++.||||+++... ....+.+.+|++++++++|+||+++++++..++..++||||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 81 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY 81 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence 5788899999999999999865 58899999987532 22346789999999999999999999999999999999999
Q ss_pred ecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCc
Q 002774 633 VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKD 712 (882)
Q Consensus 633 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 712 (882)
++++.+..+.... ..+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.+||+|||++........
T Consensus 82 ~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~- 155 (288)
T cd07833 82 VERTLLELLEASP--GGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPA- 155 (288)
T ss_pred CCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCcc-
Confidence 9987776655443 25889999999999999999999988 99999999999999999999999999987654432
Q ss_pred eeeeeeeccCCCCCHHHHhhC-CCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhh-hhhc--cCCc
Q 002774 713 HITTQVKGTMGYLDPEYYMTQ-QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYN-LYEL--IDPT 788 (882)
Q Consensus 713 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~-~~~~--~d~~ 788 (882)
.......++..|+|||++.+. .++.++||||||+++|||++|+.||...... +.............. .... .++.
T Consensus 156 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07833 156 SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDI-DQLYLIQKCLGPLPPSHQELFSSNPR 234 (288)
T ss_pred ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCHHHhhhcccCcc
Confidence 122335678899999999887 8899999999999999999999998644322 211111110000000 0000 0000
Q ss_pred CCC--------------CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 789 IGL--------------STTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 789 l~~--------------~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
... ........++.+++++||..+|++||++++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 235 FAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred ccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 000 0111125778999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=307.62 Aligned_cols=254 Identities=26% Similarity=0.450 Sum_probs=201.1
Q ss_pred CCCCCCeeeccCcEEEEEEEe-cCCcEEEEEEcccCCcc------cHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEE
Q 002774 556 NFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQ------GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQML 628 (882)
Q Consensus 556 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 628 (882)
+|+..+.||+|+||.||+|.. .+++.||+|.+...... ..+.+.+|++++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477788999999999999985 57899999998753321 23578899999999999999999999999999999
Q ss_pred EEEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCC-ceeEeecccccccC
Q 002774 629 IYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERL-NAKVADFGLSKSMS 707 (882)
Q Consensus 629 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~-~~kl~DfGla~~~~ 707 (882)
||||+++++|.+++.... ++++..+..++.|++.||.|||+.+ ++||||||+||+++.++ .+||+|||.+..+.
T Consensus 81 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~ 155 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYG--AFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLA 155 (268)
T ss_pred EEeccCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence 999999999999986543 6888999999999999999999998 99999999999998776 59999999998765
Q ss_pred CCCCc--eeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhcc
Q 002774 708 DSEKD--HITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELI 785 (882)
Q Consensus 708 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 785 (882)
..... .......++..|+|||.+.+..++.++||||+|++++||++|..||........ ......... ...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~------~~~ 228 (268)
T cd06630 156 AKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH-LALIFKIAS------ATT 228 (268)
T ss_pred cccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch-HHHHHHHhc------cCC
Confidence 43211 112234688999999999888899999999999999999999999864322111 111111000 000
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 786 DPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 786 d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
.+ ..+.....++.+++.+||+.+|++||++.|++++
T Consensus 229 ~~----~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 229 AP----SIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred CC----CCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 11 1122334678899999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=309.27 Aligned_cols=256 Identities=27% Similarity=0.384 Sum_probs=200.3
Q ss_pred cCCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCCc-ccHHHHHHHHHHHHhccCCCeeeEEEEEEeC--CceEEEE
Q 002774 555 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLVSLLGFCFDR--GEQMLIY 630 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lV~ 630 (882)
++|...+.||.|++|.||+|... +++.||+|.+..... .....+.+|++++++++||||+++++++.+. +..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 35778889999999999999974 689999999875433 3346789999999999999999999998654 3689999
Q ss_pred EeecCCCcccccCC--CCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCC
Q 002774 631 EFVPNGSLGDSLSG--KNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSD 708 (882)
Q Consensus 631 e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~ 708 (882)
||+++++|.+++.. .....+++.....++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 99999999887643 12345788899999999999999999998 99999999999999999999999999876543
Q ss_pred CCCceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCch----HHHHHHHHHHhhhhhhhhhhc
Q 002774 709 SEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKY----IVREIRTVMDKKKELYNLYEL 784 (882)
Q Consensus 709 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~----~~~~~~~~~~~~~~~~~~~~~ 784 (882)
... ....++..|+|||.+.+..++.++||||+||++|||++|+.||..... ..+...... ... . ..
T Consensus 158 ~~~----~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~----~-~~ 227 (287)
T cd06621 158 SLA----GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIV-NMP----N-PE 227 (287)
T ss_pred ccc----ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHh-cCC----c-hh
Confidence 221 234578899999999989999999999999999999999999975421 111111111 000 0 00
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 785 IDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 785 ~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
+.... .........+.+++.+||+.+|.+|||+.|++++
T Consensus 228 ~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 228 LKDEP--GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred hccCC--CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 00000 1111234678999999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=290.51 Aligned_cols=247 Identities=26% Similarity=0.445 Sum_probs=198.5
Q ss_pred CCeeeccCcEEEEEEEec-CCcEEEEEEcccCCc-ccHHHHHHHHHHHHhcc-CCCeeeEEEEEEeCCceEEEEEeecCC
Q 002774 560 ANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM-QGGQEFKMEIELLSRVH-HKNLVSLLGFCFDRGEQMLIYEFVPNG 636 (882)
Q Consensus 560 ~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~e~~~~g 636 (882)
...||.|+-|+||++++. .|..+|||.+..... ...+++.+.++++..-+ +|.||+.+|||..+...++.||.|..
T Consensus 97 l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~- 175 (391)
T KOG0983|consen 97 LGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMST- 175 (391)
T ss_pred HHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHHH-
Confidence 456999999999999975 589999999986544 34467777888777664 89999999999999999999999853
Q ss_pred CcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCceeee
Q 002774 637 SLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITT 716 (882)
Q Consensus 637 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 716 (882)
.+..+++.- ..++++.-.-++...+++||.||.+.+ .|+|||+||+|||+|+.|++|+||||++..+.+... .+
T Consensus 176 C~ekLlkri-k~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA---ht 249 (391)
T KOG0983|consen 176 CAEKLLKRI-KGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA---HT 249 (391)
T ss_pred HHHHHHHHh-cCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecccc---cc
Confidence 333333322 235788778889999999999997643 399999999999999999999999999988765433 34
Q ss_pred eeeccCCCCCHHHHhh---CCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCCCCC
Q 002774 717 QVKGTMGYLDPEYYMT---QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLST 793 (882)
Q Consensus 717 ~~~gt~~y~aPE~~~~---~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 793 (882)
...|.+.|||||.+.- ..|+.++||||||+.++||+||+.||..-+...+.+..+..+. .|.++..
T Consensus 250 rsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~e----------PP~L~~~- 318 (391)
T KOG0983|consen 250 RSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEE----------PPLLPGH- 318 (391)
T ss_pred cccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcC----------CCCCCcc-
Confidence 5679999999999973 4689999999999999999999999987766666666655432 2333222
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 794 TLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 794 ~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
.....+|.+++..|+++|+.+||...+++++
T Consensus 319 -~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 319 -MGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred -cCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 2245789999999999999999999999975
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=306.35 Aligned_cols=247 Identities=27% Similarity=0.418 Sum_probs=200.8
Q ss_pred CCCCCCeeeccCcEEEEEEEe-cCCcEEEEEEcccCCc-ccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEee
Q 002774 556 NFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFV 633 (882)
Q Consensus 556 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 633 (882)
-|+..+.||+|+||.||+|.. .+++.||||.+..... ...+.+.+|+.++++++||||+++++++.+++..++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 466778899999999999986 4688999999864432 23357889999999999999999999999999999999999
Q ss_pred cCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCce
Q 002774 634 PNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDH 713 (882)
Q Consensus 634 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 713 (882)
++++|.+++... .+++.....++.+++.|+.|||+.+ ++|+||+|+||+++.++.++++|||++........
T Consensus 85 ~~~~l~~~i~~~---~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~-- 156 (277)
T cd06641 85 GGGSALDLLEPG---PLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-- 156 (277)
T ss_pred CCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchh--
Confidence 999999988643 5889999999999999999999988 99999999999999999999999999876643221
Q ss_pred eeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCCCCC
Q 002774 714 ITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLST 793 (882)
Q Consensus 714 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 793 (882)
......++..|+|||.+....++.++|||||||++|||++|..||...... ..... .... ..+..
T Consensus 157 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-~~~~~-~~~~---------~~~~~---- 221 (277)
T cd06641 157 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM-KVLFL-IPKN---------NPPTL---- 221 (277)
T ss_pred hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH-HHHHH-HhcC---------CCCCC----
Confidence 122345788999999998888999999999999999999999998643221 11111 1110 01111
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 794 TLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 794 ~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
.......+.+++.+||+.+|.+||++.+++++
T Consensus 222 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 222 EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 11234678899999999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=310.63 Aligned_cols=265 Identities=23% Similarity=0.320 Sum_probs=198.8
Q ss_pred HcCCCCCCeeeccCcEEEEEEEe-cCCcEEEEEEcccCCcc-cHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEE
Q 002774 554 TNNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQ-GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYE 631 (882)
Q Consensus 554 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e 631 (882)
+++|...+.||+|+||.||+|.. .+|+.||+|++...... ....+.+|+++++.++|+||+++.+++.+++..++|||
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 46788899999999999999985 46899999998754322 23467889999999999999999999999999999999
Q ss_pred eecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCC
Q 002774 632 FVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEK 711 (882)
Q Consensus 632 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 711 (882)
|++ +++.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 84 ~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 158 (291)
T cd07870 84 YMH-TDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ 158 (291)
T ss_pred ccc-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCCCC
Confidence 995 67766665432 25678888899999999999999998 99999999999999999999999999976433221
Q ss_pred ceeeeeeeccCCCCCHHHHhhC-CCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhh-----------hh
Q 002774 712 DHITTQVKGTMGYLDPEYYMTQ-QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKE-----------LY 779 (882)
Q Consensus 712 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~-----------~~ 779 (882)
......++..|+|||.+.+. .++.++|||||||++|||++|..||.......+.+......... ..
T Consensus 159 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (291)
T cd07870 159 --TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLP 236 (291)
T ss_pred --CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcc
Confidence 12234578899999998754 57889999999999999999999997654433333322211000 00
Q ss_pred hhhhccC----Cc-CCC-CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 780 NLYELID----PT-IGL-STTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 780 ~~~~~~d----~~-l~~-~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
....... +. ... .........+.+++.+|++.||.+|||+.|++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 237 NYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred cccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 0000000 00 000 0001123567899999999999999999998863
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=307.21 Aligned_cols=248 Identities=23% Similarity=0.408 Sum_probs=200.5
Q ss_pred CCCCCCeeeccCcEEEEEEEe-cCCcEEEEEEcccCC-cccHHHHHHHHHHHHhcc---CCCeeeEEEEEEeCCceEEEE
Q 002774 556 NFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGS-MQGGQEFKMEIELLSRVH---HKNLVSLLGFCFDRGEQMLIY 630 (882)
Q Consensus 556 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~~~~~lV~ 630 (882)
.|+..+.||+|+||.||+|.. .+++.||+|.++... ....+++.+|+.++++++ |||++++++++.++...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 466778899999999999996 478999999987542 233467889999999996 999999999999999999999
Q ss_pred EeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCC
Q 002774 631 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE 710 (882)
Q Consensus 631 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~ 710 (882)
||+++++|.+++... .+++.....++.|++.||.|||+.+ |+||||+|+||++++++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06917 82 EYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS 155 (277)
T ss_pred ecCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCCc
Confidence 999999999988653 5889999999999999999999998 9999999999999999999999999998775443
Q ss_pred CceeeeeeeccCCCCCHHHHhhC-CCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcC
Q 002774 711 KDHITTQVKGTMGYLDPEYYMTQ-QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTI 789 (882)
Q Consensus 711 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 789 (882)
. ......|+..|+|||.+.++ .++.++|||||||++|||++|..||...... ..... ......+.+
T Consensus 156 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~-~~~~~----------~~~~~~~~~ 222 (277)
T cd06917 156 S--KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF-RAMML----------IPKSKPPRL 222 (277)
T ss_pred c--ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChh-hhhhc----------cccCCCCCC
Confidence 2 12334688999999998754 4689999999999999999999999653221 11100 001111111
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 790 GLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 790 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
... ....++.+++.+||+.||++||++.|++++
T Consensus 223 ~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 223 EDN---GYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred Ccc---cCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 111 134678899999999999999999999875
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=299.75 Aligned_cols=250 Identities=30% Similarity=0.494 Sum_probs=205.9
Q ss_pred CCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEeec
Q 002774 556 NFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVP 634 (882)
Q Consensus 556 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 634 (882)
+|...+.||+|++|.||++... +++.|++|++........+.+.+|++++++++|+|++++++++......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4677889999999999999975 689999999987655456789999999999999999999999999999999999999
Q ss_pred CCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCcee
Q 002774 635 NGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHI 714 (882)
Q Consensus 635 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 714 (882)
+++|.+++.... ..+++..+..++.+++.||+|||+.+ ++||||+|+||++++++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--- 153 (253)
T cd05122 81 GGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--- 153 (253)
T ss_pred CCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc---
Confidence 999999887653 46899999999999999999999988 99999999999999999999999999987654432
Q ss_pred eeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCCCCCC
Q 002774 715 TTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTT 794 (882)
Q Consensus 715 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 794 (882)
.....++..|+|||.+....++.++||||||+++++|++|+.||........... ... . ..+... ..
T Consensus 154 ~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~-~~~--~--------~~~~~~--~~ 220 (253)
T cd05122 154 RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFK-IAT--N--------GPPGLR--NP 220 (253)
T ss_pred ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHH-HHh--c--------CCCCcC--cc
Confidence 2345688999999999988899999999999999999999999975432211111 100 0 000110 11
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 795 LKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 795 ~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
......+.+++.+||+.||++|||+.|++++
T Consensus 221 ~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 221 EKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred cccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1123678999999999999999999999864
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=309.35 Aligned_cols=262 Identities=23% Similarity=0.314 Sum_probs=199.7
Q ss_pred CCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCCc--ccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEee
Q 002774 557 FSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM--QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFV 633 (882)
Q Consensus 557 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 633 (882)
|+..+.||+|++|+||+|... +|+.||+|++..... ...+.+.+|+++++.++|||++++++++.+++..++||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 566788999999999999864 799999999875432 22356888999999999999999999999999999999999
Q ss_pred cCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCce
Q 002774 634 PNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDH 713 (882)
Q Consensus 634 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 713 (882)
+ ++|.+++.......+++..+..++.|+++||+|||+.+ ++||||+|+||+++.++.++|+|||+++.......
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-- 154 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR-- 154 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc--
Confidence 5 68998887655456899999999999999999999988 99999999999999999999999999976543221
Q ss_pred eeeeeeccCCCCCHHHHhhC-CCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhh-----------hhhh
Q 002774 714 ITTQVKGTMGYLDPEYYMTQ-QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKE-----------LYNL 781 (882)
Q Consensus 714 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~-----------~~~~ 781 (882)
......++..|+|||++.+. .++.++||||||+++|||++|+.||.......... ........ ....
T Consensus 155 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd07835 155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLF-RIFRTLGTPDEDVWPGVTSLPDY 233 (283)
T ss_pred ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHHHhCCCChHHhhhhhhchhh
Confidence 11223568899999988654 57899999999999999999999997554432221 11111000 0000
Q ss_pred hhccC---CcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 782 YELID---PTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 782 ~~~~d---~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
..... ..............+.+++.+||+.||++|||++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 234 KPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00000 000000011123678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=307.01 Aligned_cols=254 Identities=30% Similarity=0.460 Sum_probs=201.6
Q ss_pred HHcCCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCCcccHHHHHHHHHHHHhc-cCCCeeeEEEEEEeCC------
Q 002774 553 YTNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQGGQEFKMEIELLSRV-HHKNLVSLLGFCFDRG------ 624 (882)
Q Consensus 553 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~------ 624 (882)
.+++|...+.||+|+||+||+|... +++.||+|++..... ..+.+.+|+++++++ +|+||+++++++.+..
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 4678999999999999999999974 678999999875433 346789999999999 6999999999997654
Q ss_pred ceEEEEEeecCCCcccccCCCC--CccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeeccc
Q 002774 625 EQMLIYEFVPNGSLGDSLSGKN--GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGL 702 (882)
Q Consensus 625 ~~~lV~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGl 702 (882)
..++||||+++++|.+++.... ...+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCcc
Confidence 3899999999999999886533 457899999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCceeeeeeeccCCCCCHHHHhh-----CCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhh
Q 002774 703 SKSMSDSEKDHITTQVKGTMGYLDPEYYMT-----QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKE 777 (882)
Q Consensus 703 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~ 777 (882)
+........ ......|+..|+|||++.. ..++.++|||||||++|||++|+.||........ .....
T Consensus 160 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~~~----- 231 (275)
T cd06608 160 SAQLDSTLG--RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA-LFKIP----- 231 (275)
T ss_pred ceecccchh--hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHH-HHHhh-----
Confidence 976543221 1233468899999999863 3467899999999999999999999964322111 11111
Q ss_pred hhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 778 LYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 778 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
....+.. .........+.+++.+||..||++|||+.|++++
T Consensus 232 -----~~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 232 -----RNPPPTL--KSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred -----ccCCCCC--CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 0011111 1112234678999999999999999999999863
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=308.18 Aligned_cols=248 Identities=23% Similarity=0.389 Sum_probs=201.5
Q ss_pred CCCCCeeeccCcEEEEEEEe-cCCcEEEEEEcccCCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEeecC
Q 002774 557 FSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPN 635 (882)
Q Consensus 557 ~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~ 635 (882)
|...+.||+|++|.||+|.. .+++.||+|++........+.+.+|+.+++.++||||+++++++...+..++|+||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 44567899999999999985 46899999998755444556788999999999999999999999999999999999999
Q ss_pred CCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCceee
Q 002774 636 GSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHIT 715 (882)
Q Consensus 636 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 715 (882)
++|.+++... ++++..+..++.|++.||+|||+.+ ++||||+|+||+++.++.++++|||.+........ ..
T Consensus 101 ~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~--~~ 172 (285)
T cd06648 101 GALTDIVTHT---RMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--RR 172 (285)
T ss_pred CCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCc--cc
Confidence 9999988762 5889999999999999999999998 99999999999999999999999998876543221 12
Q ss_pred eeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCCCCCCH
Q 002774 716 TQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTL 795 (882)
Q Consensus 716 ~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 795 (882)
....|+..|+|||.+.+..++.++|||||||++|||++|+.||...... ......... ..+... ...
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~-~~~~~~~~~----------~~~~~~--~~~ 239 (285)
T cd06648 173 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL-QAMKRIRDN----------LPPKLK--NLH 239 (285)
T ss_pred ccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH-HHHHHHHhc----------CCCCCc--ccc
Confidence 2345889999999999888999999999999999999999998654322 111111111 111111 111
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 796 KGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 796 ~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
.....+.+++.+||+.+|++||++.+++++
T Consensus 240 ~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 240 KVSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred cCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 133678999999999999999999999964
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=310.47 Aligned_cols=245 Identities=25% Similarity=0.371 Sum_probs=201.1
Q ss_pred cCCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCCc---ccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEE
Q 002774 555 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM---QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIY 630 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 630 (882)
++|...+.||+|+||.||+|... +++.||+|.++.... ...+.+.+|++++++++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 36788899999999999999864 689999999865322 23456888999999999999999999999999999999
Q ss_pred EeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCC
Q 002774 631 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE 710 (882)
Q Consensus 631 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~ 710 (882)
||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~~--~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~- 154 (290)
T cd05580 81 EYVPGGELFSHLRKSG--RFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR- 154 (290)
T ss_pred ecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC-
Confidence 9999999999987653 6889999999999999999999988 999999999999999999999999999876543
Q ss_pred CceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCC
Q 002774 711 KDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIG 790 (882)
Q Consensus 711 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 790 (882)
.....+++.|+|||.+.+...+.++||||||+++|||++|..||...... ......... ...+.
T Consensus 155 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~-----------~~~~~ 218 (290)
T cd05580 155 ----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI-QIYEKILEG-----------KVRFP 218 (290)
T ss_pred ----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHhcC-----------CccCC
Confidence 22346889999999998888899999999999999999999999754421 111111110 00111
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 002774 791 LSTTLKGFEKYVDLALKCVQESGDDRP-----TMSEVVKD 825 (882)
Q Consensus 791 ~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~evl~~ 825 (882)
......+.+++.+||+.||.+|+ +++|++++
T Consensus 219 ----~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 219 ----SFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred ----ccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 11236788999999999999998 77777754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=309.60 Aligned_cols=263 Identities=21% Similarity=0.299 Sum_probs=201.9
Q ss_pred CCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCCc--ccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEe
Q 002774 556 NFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM--QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEF 632 (882)
Q Consensus 556 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 632 (882)
+|...+.||+|+||.||+|+.. +|+.||||++..... ...+.+.+|+.++++++||||+++++++..+...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4677889999999999999964 689999999876542 2346789999999999999999999999999999999999
Q ss_pred ecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCc
Q 002774 633 VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKD 712 (882)
Q Consensus 633 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 712 (882)
+ +++|.+++.... ..+++.++..++.|+++||+|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 81 ~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (286)
T cd07832 81 M-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP- 154 (286)
T ss_pred c-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-
Confidence 9 999999886543 46899999999999999999999998 99999999999999999999999999987654332
Q ss_pred eeeeeeeccCCCCCHHHHhhC-CCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhh-----------hh
Q 002774 713 HITTQVKGTMGYLDPEYYMTQ-QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKEL-----------YN 780 (882)
Q Consensus 713 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~-----------~~ 780 (882)
.......|+..|+|||.+.+. .++.++||||+||+++||++|..||..... .............. ..
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07832 155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEND-IEQLAIVFRTLGTPNEETWPGLTSLPD 233 (286)
T ss_pred CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCH-HHHHHHHHHHcCCCChHHHhhccCcch
Confidence 122334688999999998654 468999999999999999999777754332 22222222211000 00
Q ss_pred hhhccCCcCCC----CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 781 LYELIDPTIGL----STTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 781 ~~~~~d~~l~~----~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
......+.... .........+.+++.+|++.+|++||++++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 234 YNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred hhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000000000 0001223778999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=320.29 Aligned_cols=250 Identities=25% Similarity=0.395 Sum_probs=200.8
Q ss_pred CCCCCeeeccCcEEEEEEEecC-CcEEEEEEcccCCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEeecC
Q 002774 557 FSDANDVGSGGYGKVYKGTLPN-GQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPN 635 (882)
Q Consensus 557 ~~~~~~lG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~ 635 (882)
|.++..||.|+||.||||+.++ +-..|-|++...+....++|.-|++||...+||+||++++.|+..+.+++..|||.|
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~G 113 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGG 113 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCC
Confidence 3445668999999999999764 444567888766666678899999999999999999999999999999999999999
Q ss_pred CCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCceee
Q 002774 636 GSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHIT 715 (882)
Q Consensus 636 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 715 (882)
|.....+-.- +..+.+.++.-++.+++.||.|||+.. |||||||+.|||++-+|.++|+|||.+....... ...
T Consensus 114 GAVDaimlEL-~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~--qkR 187 (1187)
T KOG0579|consen 114 GAVDAIMLEL-GRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTR--QKR 187 (1187)
T ss_pred chHhHHHHHh-ccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchhHH--hhh
Confidence 9988776543 246889999999999999999999988 9999999999999999999999999986432211 123
Q ss_pred eeeeccCCCCCHHHHh-----hCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCC
Q 002774 716 TQVKGTMGYLDPEYYM-----TQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIG 790 (882)
Q Consensus 716 ~~~~gt~~y~aPE~~~-----~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 790 (882)
..+.|||+|||||+.+ ...|+.++||||||+.|.||..+.+|-..-.. ...+..+. ..-.|.+.
T Consensus 188 DsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp-MRVllKia----------KSePPTLl 256 (1187)
T KOG0579|consen 188 DSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP-MRVLLKIA----------KSEPPTLL 256 (1187)
T ss_pred ccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch-HHHHHHHh----------hcCCCccc
Confidence 4578999999999986 56799999999999999999999988643222 12222111 11122221
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 791 LSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 791 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
.+......|.+++.+|+.++|+.||++++++++
T Consensus 257 --qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 257 --QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred --CcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 233455789999999999999999999999964
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=304.34 Aligned_cols=253 Identities=23% Similarity=0.363 Sum_probs=200.4
Q ss_pred CCCCCCeeeccCcEEEEEEEe-cCCcEEEEEEcccCCc--ccHHHHHHHHHHHHhccCCCeeeEEEEEEe--CCceEEEE
Q 002774 556 NFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSM--QGGQEFKMEIELLSRVHHKNLVSLLGFCFD--RGEQMLIY 630 (882)
Q Consensus 556 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~lV~ 630 (882)
+|+..+.||+|+||.||+|.. .+++.||+|+++.... ...+.+..|++++++++|+||+++++++.. +...++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 467788999999999999985 4688999999875432 234568889999999999999999998764 34578999
Q ss_pred EeecCCCcccccCCC--CCccccHHHHHHHHHHHHHHHhhhhhcC--CCCeeecCCCCCceEEcCCCceeEeeccccccc
Q 002774 631 EFVPNGSLGDSLSGK--NGIRLDWIRRLKIALGAARGLSYLHELA--NPPIIHRDIKSSNILLDERLNAKVADFGLSKSM 706 (882)
Q Consensus 631 e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~ 706 (882)
||+++++|.+++... ....+++..++.++.+++.||+|||..+ ...++|+||||+||++++++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999988643 2346899999999999999999999332 333999999999999999999999999999876
Q ss_pred CCCCCceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccC
Q 002774 707 SDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELID 786 (882)
Q Consensus 707 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 786 (882)
..... ......++..|+|||.+....++.++||||||+++|+|++|+.||.... ..... ....... .
T Consensus 161 ~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-~~~~~-~~~~~~~---------~ 227 (265)
T cd08217 161 GHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN-QLQLA-SKIKEGK---------F 227 (265)
T ss_pred cCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC-HHHHH-HHHhcCC---------C
Confidence 54332 1233468999999999998889999999999999999999999997543 11111 1111110 0
Q ss_pred CcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 787 PTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 787 ~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
+. .......++.+++.+|++.+|++||++.+|+++
T Consensus 228 ~~----~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 228 RR----IPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred CC----CccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 11 112234678999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=300.59 Aligned_cols=252 Identities=28% Similarity=0.411 Sum_probs=206.9
Q ss_pred CCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCCc--ccHHHHHHHHHHHHhccCCCeeeEEEEEEeC--CceEEEE
Q 002774 556 NFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM--QGGQEFKMEIELLSRVHHKNLVSLLGFCFDR--GEQMLIY 630 (882)
Q Consensus 556 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lV~ 630 (882)
+|+..+.||+|++|.||+|... +++.|++|++..... ...+.+.+|++++++++|+||+++++.+.+. ...++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4677889999999999999975 689999999876543 3456789999999999999999999999988 8899999
Q ss_pred EeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCC
Q 002774 631 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE 710 (882)
Q Consensus 631 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~ 710 (882)
||+++++|.+++.... .+++..+..++.+++.||+|||+.+ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 155 (260)
T cd06606 81 EYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIE 155 (260)
T ss_pred EecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEeccccc
Confidence 9999999999987654 7899999999999999999999988 9999999999999999999999999998775543
Q ss_pred CceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCC
Q 002774 711 KDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIG 790 (882)
Q Consensus 711 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 790 (882)
.........++..|+|||.+.....+.++||||||+++++|++|..||............... ....
T Consensus 156 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-------------~~~~ 222 (260)
T cd06606 156 TGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGS-------------SGEP 222 (260)
T ss_pred ccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccc-------------cCCC
Confidence 211123456888999999999888999999999999999999999999765422222211110 0000
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 791 LSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 791 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
...+......+.+++.+|++.+|++||++.|++++
T Consensus 223 ~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 223 PEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred cCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 11112224788999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=311.70 Aligned_cols=247 Identities=29% Similarity=0.442 Sum_probs=196.8
Q ss_pred cCCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCCcc---cHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEE
Q 002774 555 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQ---GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIY 630 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 630 (882)
..|...+.||+|+||+||+|+.. +++.||+|.+...... ..+++.+|+++++.++||||+++.++|.+++..++||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 34777889999999999999864 6899999998643322 2356889999999999999999999999999999999
Q ss_pred EeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCC
Q 002774 631 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE 710 (882)
Q Consensus 631 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~ 710 (882)
||++ |++.+++.... ..+++..+..++.|++.||.|||+.+ |+||||+|+||++++++.+||+|||++.......
T Consensus 95 e~~~-g~l~~~~~~~~-~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~~ 169 (307)
T cd06607 95 EYCL-GSASDILEVHK-KPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPAN 169 (307)
T ss_pred HhhC-CCHHHHHHHcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCCCC
Confidence 9996 56666664332 35899999999999999999999988 9999999999999999999999999987654321
Q ss_pred CceeeeeeeccCCCCCHHHHh---hCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCC
Q 002774 711 KDHITTQVKGTMGYLDPEYYM---TQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDP 787 (882)
Q Consensus 711 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 787 (882)
...++..|+|||++. .+.++.++||||||+++|||+||..||.......... .... ...+
T Consensus 170 ------~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~-~~~~----------~~~~ 232 (307)
T cd06607 170 ------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-HIAQ----------NDSP 232 (307)
T ss_pred ------CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHH-HHhc----------CCCC
Confidence 245788999999874 4568899999999999999999999986543322111 1100 0011
Q ss_pred cCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 002774 788 TIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDI 826 (882)
Q Consensus 788 ~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L 826 (882)
.. ........+.+++.+||+.+|++||++.+++.+.
T Consensus 233 ~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 268 (307)
T cd06607 233 TL---SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR 268 (307)
T ss_pred CC---CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 11 1122346789999999999999999999999753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=303.69 Aligned_cols=250 Identities=25% Similarity=0.451 Sum_probs=202.3
Q ss_pred CCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCC--cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEe
Q 002774 556 NFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS--MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEF 632 (882)
Q Consensus 556 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 632 (882)
+|...+.||+|+||.||+|... +|..||+|.+.... ....+.+.+|+.+++.++|+||+++++.+.+.+..++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4677889999999999999965 58899999986532 23345788999999999999999999999999999999999
Q ss_pred ecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCc-eeEeecccccccCCCCC
Q 002774 633 VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLN-AKVADFGLSKSMSDSEK 711 (882)
Q Consensus 633 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~-~kl~DfGla~~~~~~~~ 711 (882)
+++++|.+++.......+++..+..++.|++.||+|||+.+ ++|+||||+||++++++. +|++|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence 99999999987655556899999999999999999999988 999999999999998854 69999999987654321
Q ss_pred ceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCCC
Q 002774 712 DHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGL 791 (882)
Q Consensus 712 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 791 (882)
......|++.|+|||+.....++.++||||||+++|||++|+.||.... ..+........ ...+ .
T Consensus 158 --~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-~~~~~~~~~~~---------~~~~-~-- 222 (257)
T cd08225 158 --LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN-LHQLVLKICQG---------YFAP-I-- 222 (257)
T ss_pred --cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-HHHHHHHHhcc---------cCCC-C--
Confidence 1223458899999999988889999999999999999999999986432 22222221111 0111 0
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 792 STTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 792 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
......++.+++.+||+.+|++|||+.|++++
T Consensus 223 --~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 223 --SPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred --CCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 11123578899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=307.39 Aligned_cols=253 Identities=26% Similarity=0.447 Sum_probs=206.3
Q ss_pred HHcCCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEE
Q 002774 553 YTNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYE 631 (882)
Q Consensus 553 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e 631 (882)
.++.|...+.||+|+||.||+|... +++.||+|++..... ..+.+.+|+++++.++|+|++++++++...+..++|+|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 3556777788999999999999976 688999999976544 45678899999999999999999999999999999999
Q ss_pred eecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCC
Q 002774 632 FVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEK 711 (882)
Q Consensus 632 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 711 (882)
|+++++|.+++.... ..+++..+..++.+++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 96 ~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 171 (286)
T cd06614 96 YMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS 171 (286)
T ss_pred ccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccchh
Confidence 999999999997653 36899999999999999999999988 99999999999999999999999999876543221
Q ss_pred ceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCCC
Q 002774 712 DHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGL 791 (882)
Q Consensus 712 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 791 (882)
......++..|+|||.+.+..++.++|||||||++|||++|+.||.......... ...... . +..
T Consensus 172 --~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~-~~~~~~---------~-~~~-- 236 (286)
T cd06614 172 --KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALF-LITTKG---------I-PPL-- 236 (286)
T ss_pred --hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHhcC---------C-CCC--
Confidence 1223457889999999988889999999999999999999999987544332211 111100 0 000
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 792 STTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 792 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
......+..+.+++.+||+.+|.+||++.+++++
T Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 237 KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred cchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 1111134678899999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=307.75 Aligned_cols=263 Identities=22% Similarity=0.310 Sum_probs=199.0
Q ss_pred cCCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCCccc--HHHHHHHHHHHHhccCCCeeeEEEEEEeC--CceEEE
Q 002774 555 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQG--GQEFKMEIELLSRVHHKNLVSLLGFCFDR--GEQMLI 629 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lV 629 (882)
++|...+.||+|+||.||+|+.. +++.||+|.++...... ...+.+|+.++++++||||+++++++... +..++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46778899999999999999975 68899999987543222 23567899999999999999999999887 889999
Q ss_pred EEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCC
Q 002774 630 YEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDS 709 (882)
Q Consensus 630 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~ 709 (882)
|||++ ++|.+++.... ..+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++.....
T Consensus 85 ~e~~~-~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 159 (293)
T cd07843 85 MEYVE-HDLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSP 159 (293)
T ss_pred ehhcC-cCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccCC
Confidence 99997 58888876543 26899999999999999999999998 999999999999999999999999999876543
Q ss_pred CCceeeeeeeccCCCCCHHHHhhC-CCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhh-----------h
Q 002774 710 EKDHITTQVKGTMGYLDPEYYMTQ-QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKK-----------E 777 (882)
Q Consensus 710 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~-----------~ 777 (882)
.. ......++..|+|||.+.+. .++.++|+||||+++|||++|..||...... ........... .
T Consensus 160 ~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 236 (293)
T cd07843 160 LK--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEI-DQLNKIFKLLGTPTEKIWPGFSE 236 (293)
T ss_pred cc--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCchHHHHHhhc
Confidence 21 12234578899999998754 4689999999999999999999999754332 22221111000 0
Q ss_pred hhhhh-----hccCCcCCCCCCHH-HHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 778 LYNLY-----ELIDPTIGLSTTLK-GFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 778 ~~~~~-----~~~d~~l~~~~~~~-~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
+.... ......+....... ....+.+++.+||+.+|++|||+.|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 237 LPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred cchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 00000 00000000011111 24668899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=306.85 Aligned_cols=264 Identities=21% Similarity=0.303 Sum_probs=197.9
Q ss_pred cCCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCCc--ccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEE
Q 002774 555 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM--QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYE 631 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e 631 (882)
++|...+.||+|++|+||+|+.. +|+.||+|++..... ...+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46888899999999999999865 689999999865432 223568889999999999999999999999999999999
Q ss_pred eecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcC-CCceeEeecccccccCCCC
Q 002774 632 FVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDE-RLNAKVADFGLSKSMSDSE 710 (882)
Q Consensus 632 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~-~~~~kl~DfGla~~~~~~~ 710 (882)
|++ ++|.+++.......+++.....++.|++.||+|||+.+ ++||||+|+||++++ ++.+||+|||++.......
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~ 157 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence 996 57877776554445688888899999999999999988 999999999999985 5679999999997654321
Q ss_pred CceeeeeeeccCCCCCHHHHhh-CCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhh-hhhhhh------
Q 002774 711 KDHITTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKK-ELYNLY------ 782 (882)
Q Consensus 711 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~-~~~~~~------ 782 (882)
. ......+++.|+|||++.+ ..++.++|||||||++|||+||..||...... +.......... .....+
T Consensus 158 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 234 (294)
T PLN00009 158 R--TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEI-DELFKIFRILGTPNEETWPGVTSL 234 (294)
T ss_pred c--ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCChhhccccccc
Confidence 1 1123457889999999876 45789999999999999999999999754332 22222211100 000000
Q ss_pred -h--ccCCcCCCC----CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 783 -E--LIDPTIGLS----TTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 783 -~--~~d~~l~~~----~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
. ..-+..... .......++.+++.+|++.+|++||++.+++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 235 PDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred hhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 000000000 011123568899999999999999999999974
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=309.65 Aligned_cols=248 Identities=29% Similarity=0.470 Sum_probs=197.3
Q ss_pred CCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCCcc---cHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEe
Q 002774 557 FSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQ---GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEF 632 (882)
Q Consensus 557 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 632 (882)
|...+.||+|+||+||+|+.. ++..||+|++...... ..+.+.+|++++++++|||++++++++.+++..++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 566788999999999999864 6899999998643222 235688899999999999999999999999999999999
Q ss_pred ecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCc
Q 002774 633 VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKD 712 (882)
Q Consensus 633 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 712 (882)
++ |+|.+.+... ..++++.++..++.+++.||.|||+.+ |+||||+|+||+++.++.+||+|||++......
T Consensus 107 ~~-g~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~--- 178 (317)
T cd06635 107 CL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPA--- 178 (317)
T ss_pred CC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCCc---
Confidence 96 5777766533 235899999999999999999999998 999999999999999999999999998754332
Q ss_pred eeeeeeeccCCCCCHHHHh---hCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcC
Q 002774 713 HITTQVKGTMGYLDPEYYM---TQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTI 789 (882)
Q Consensus 713 ~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 789 (882)
....|+..|+|||++. .+.++.++|||||||++|||++|+.||........ ........ .+..
T Consensus 179 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~-~~~~~~~~----------~~~~ 244 (317)
T cd06635 179 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-LYHIAQNE----------SPTL 244 (317)
T ss_pred ---ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH-HHHHHhcc----------CCCC
Confidence 2345888999999984 45789999999999999999999999865432211 11111110 0001
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 002774 790 GLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENI 829 (882)
Q Consensus 790 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 829 (882)
........+.+++.+||+.+|.+||++.+++++...+
T Consensus 245 ---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~ 281 (317)
T cd06635 245 ---QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVL 281 (317)
T ss_pred ---CCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhh
Confidence 1112345788999999999999999999999876654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=308.34 Aligned_cols=264 Identities=20% Similarity=0.280 Sum_probs=196.8
Q ss_pred cCCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCCc--ccHHHHHHHHHHHHhcc-CCCeeeEEEEEEeCCc-----
Q 002774 555 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM--QGGQEFKMEIELLSRVH-HKNLVSLLGFCFDRGE----- 625 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~----- 625 (882)
++|+..+.||+|+||+||+|... +++.||||+++.... .....+.+|+.+++.++ ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 36788899999999999999964 689999998765422 22356888999999995 6999999999987665
Q ss_pred eEEEEEeecCCCcccccCCCC---CccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcC-CCceeEeecc
Q 002774 626 QMLIYEFVPNGSLGDSLSGKN---GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDE-RLNAKVADFG 701 (882)
Q Consensus 626 ~~lV~e~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~-~~~~kl~DfG 701 (882)
.++||||+++ +|.+++.... ...+++..+..++.||+.||+|||+.+ |+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999985 7888775432 236899999999999999999999998 999999999999998 8999999999
Q ss_pred cccccCCCCCceeeeeeeccCCCCCHHHHhh-CCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhh-h
Q 002774 702 LSKSMSDSEKDHITTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKEL-Y 779 (882)
Q Consensus 702 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~-~ 779 (882)
+++.+..... ......+++.|+|||++.+ ..++.++||||||+++|||++|..||......... .......... .
T Consensus 157 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~-~~~~~~~~~~~~ 233 (295)
T cd07837 157 LGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQL-LHIFKLLGTPTE 233 (295)
T ss_pred cceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHH-HHHHHHhCCCCh
Confidence 9986543221 1122356888999999875 45789999999999999999999999754433322 2221110000 0
Q ss_pred hhh-hc---c----CCcCC----CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 780 NLY-EL---I----DPTIG----LSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 780 ~~~-~~---~----d~~l~----~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
..+ .. . -+... .........++.+++.+||+.||.+||++.|++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 234 QVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred hhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 000 00 0 00000 00001234668899999999999999999999864
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=314.75 Aligned_cols=261 Identities=25% Similarity=0.335 Sum_probs=198.7
Q ss_pred HHcCCCCCCeeeccCcEEEEEEEe-cCCcEEEEEEcccC--CcccHHHHHHHHHHHHhccCCCeeeEEEEEEeC------
Q 002774 553 YTNNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQG--SMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDR------ 623 (882)
Q Consensus 553 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------ 623 (882)
..++|...+.||+|+||+||+|+. .+++.||||++... .....+.+.+|+.++++++|+||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 457899999999999999999985 47899999998643 223345677899999999999999999988644
Q ss_pred CceEEEEEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccc
Q 002774 624 GEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLS 703 (882)
Q Consensus 624 ~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla 703 (882)
...++||||++ ++|.+.+... +++.++..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 165 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 165 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhhc----CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCccc
Confidence 34699999995 5777776532 788889999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhh-h----
Q 002774 704 KSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKE-L---- 778 (882)
Q Consensus 704 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~-~---- 778 (882)
+....... .....++..|+|||.+.+..++.++|||||||++|+|++|+.||........ ...+...... .
T Consensus 166 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~ 241 (353)
T cd07850 166 RTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQ-WNKIIEQLGTPSDEFM 241 (353)
T ss_pred eeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHH-HHHHHHhcCCCCHHHH
Confidence 87643221 2234578899999999999999999999999999999999999975433221 1111110000 0
Q ss_pred -------------------hhhhhccC----CcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 779 -------------------YNLYELID----PTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 779 -------------------~~~~~~~d----~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
..+..... +.............+.+++.+||+.||++|||+.|++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 242 SRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000000 000000011234568899999999999999999999976
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=304.53 Aligned_cols=244 Identities=24% Similarity=0.364 Sum_probs=193.4
Q ss_pred eeccCcEEEEEEEec-CCcEEEEEEcccCCc---ccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEeecCCCc
Q 002774 563 VGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM---QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSL 638 (882)
Q Consensus 563 lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 638 (882)
||+|+||+||+|... +|+.||+|.+..... .....+.+|+++++.++||||+++++++...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999854 689999999865322 2234567899999999999999999999999999999999999999
Q ss_pred ccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCceeeeee
Q 002774 639 GDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQV 718 (882)
Q Consensus 639 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 718 (882)
.+++.......+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.+||+|||.+....... .....
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~ 154 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKGR 154 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCC---ccccc
Confidence 99987655556899999999999999999999998 9999999999999999999999999988654321 12234
Q ss_pred eccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCCCCCCHHHH
Q 002774 719 KGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGF 798 (882)
Q Consensus 719 ~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 798 (882)
.++..|+|||++.+..++.++|||||||++++|++|+.||.......... . +.... .. ... .......
T Consensus 155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-~-~~~~~-----~~-~~~----~~~~~~~ 222 (277)
T cd05577 155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKE-E-LKRRT-----LE-MAV----EYPDKFS 222 (277)
T ss_pred cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHH-H-HHhcc-----cc-ccc----cCCccCC
Confidence 57889999999988889999999999999999999999996543211100 0 00000 00 000 1111224
Q ss_pred HHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 002774 799 EKYVDLALKCVQESGDDRP-----TMSEVVK 824 (882)
Q Consensus 799 ~~l~~li~~cl~~dp~~RP-----s~~evl~ 824 (882)
..+.+++.+||+.+|.+|| ++.++++
T Consensus 223 ~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 223 PEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred HHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 6788999999999999999 6666664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=304.03 Aligned_cols=258 Identities=17% Similarity=0.162 Sum_probs=181.9
Q ss_pred cCCCCCCeeeccCcEEEEEEEecC----CcEEEEEEcccCCccc--H---------HHHHHHHHHHHhccCCCeeeEEEE
Q 002774 555 NNFSDANDVGSGGYGKVYKGTLPN----GQLIAIKRAQQGSMQG--G---------QEFKMEIELLSRVHHKNLVSLLGF 619 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~~~~~~----g~~vavK~~~~~~~~~--~---------~~~~~E~~~l~~l~H~niv~l~~~ 619 (882)
.+|...++||+|+||+||+|++.+ +..+|+|+........ . .....+...+..++|+|+++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 468888999999999999999654 4566666543222111 0 112233445556789999999998
Q ss_pred EEeCC----ceEEEEEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCce
Q 002774 620 CFDRG----EQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNA 695 (882)
Q Consensus 620 ~~~~~----~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~ 695 (882)
+.... ..++++|++. .++.+.+.... ..++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+
T Consensus 92 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~~~ 165 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLV-ENTKEIFKRIK--CKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNNRG 165 (294)
T ss_pred eeEecCCceEEEEEEehhc-cCHHHHHHhhc--cCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCcE
Confidence 76544 2366777663 34444443321 3567788899999999999999988 9999999999999999999
Q ss_pred eEeecccccccCCCCCc-----eeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHH
Q 002774 696 KVADFGLSKSMSDSEKD-----HITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRT 770 (882)
Q Consensus 696 kl~DfGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~ 770 (882)
+|+|||+|+.+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||............
T Consensus 166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~ 245 (294)
T PHA02882 166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHA 245 (294)
T ss_pred EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHH
Confidence 99999999876432211 1112346999999999999999999999999999999999999999754222221111
Q ss_pred HHHhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 002774 771 VMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDI 826 (882)
Q Consensus 771 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L 826 (882)
..... ......+... ....+..+.+++..||..+|++||++.++++.+
T Consensus 246 ~~~~~-----~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 246 AKCDF-----IKRLHEGKIK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred hHHHH-----HHHhhhhhhc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 11000 0000001110 111246789999999999999999999999865
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=308.30 Aligned_cols=266 Identities=23% Similarity=0.309 Sum_probs=195.4
Q ss_pred CCCCCCeeeccCcEEEEEEEec---CCcEEEEEEcccCC---cccHHHHHHHHHHHHhccCCCeeeEEEEEEeC--CceE
Q 002774 556 NFSDANDVGSGGYGKVYKGTLP---NGQLIAIKRAQQGS---MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDR--GEQM 627 (882)
Q Consensus 556 ~~~~~~~lG~G~fg~Vy~~~~~---~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~ 627 (882)
.|...+.||+|+||.||+|+.. +++.||+|.+.... ....+.+.+|+.+++.++||||+++++++.+. +..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 3677889999999999999964 47899999998633 22335678899999999999999999999988 7899
Q ss_pred EEEEeecCCCcccccCCCC---CccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcC----CCceeEeec
Q 002774 628 LIYEFVPNGSLGDSLSGKN---GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDE----RLNAKVADF 700 (882)
Q Consensus 628 lV~e~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~----~~~~kl~Df 700 (882)
+||||+++ ++.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 6666553221 236888999999999999999999998 999999999999999 999999999
Q ss_pred ccccccCCCCC-ceeeeeeeccCCCCCHHHHhh-CCCCchhHHHHHHHHHHHHHhCCCCCCCCchHH--------HHHHH
Q 002774 701 GLSKSMSDSEK-DHITTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIV--------REIRT 770 (882)
Q Consensus 701 Gla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~--------~~~~~ 770 (882)
|+++....... ........++..|+|||.+.+ ..++.++|||||||+++||++|+.||....... .....
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99987644322 111223467889999998876 457899999999999999999999986332111 01111
Q ss_pred HHHhhh-----------hhhhhhh---ccC-CcCCCCCCH-------HHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 771 VMDKKK-----------ELYNLYE---LID-PTIGLSTTL-------KGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 771 ~~~~~~-----------~~~~~~~---~~d-~~l~~~~~~-------~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
.+.... ....... ... ......... ....++.+++.+|++.||++|||+.|++++
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 111000 0000000 000 000000000 223568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=302.87 Aligned_cols=259 Identities=24% Similarity=0.313 Sum_probs=193.4
Q ss_pred CCCCCeeeccCcEEEEEEEe-cCCcEEEEEEcccCCc-ccHHHHHHHHHHHHhcc-CCCeeeEEEEEEeC--CceEEEEE
Q 002774 557 FSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSM-QGGQEFKMEIELLSRVH-HKNLVSLLGFCFDR--GEQMLIYE 631 (882)
Q Consensus 557 ~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~--~~~~lV~e 631 (882)
|...+.||+|+||.||+|+. .+++.||+|+++.... .......+|+.++.++. |+||+++++++.++ +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 45678899999999999985 4689999999875422 22234557889999885 99999999999987 88999999
Q ss_pred eecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCC
Q 002774 632 FVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEK 711 (882)
Q Consensus 632 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 711 (882)
|++ |+|.+++.... ..+++.++..++.|++.||+|||+.+ ++||||||+||+++. +.+||+|||+++.......
T Consensus 81 ~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~ 154 (282)
T cd07831 81 LMD-MNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP 154 (282)
T ss_pred cCC-ccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCCC
Confidence 996 57877776532 36899999999999999999999998 999999999999999 9999999999987643322
Q ss_pred ceeeeeeeccCCCCCHHHHhh-CCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhh-hhhhhhccC---
Q 002774 712 DHITTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKE-LYNLYELID--- 786 (882)
Q Consensus 712 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~-~~~~~~~~d--- 786 (882)
.....++..|+|||++.. ..++.++|||||||++|||++|..||..... .+.+......... ...+.....
T Consensus 155 ---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
T cd07831 155 ---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNE-LDQIAKIHDVLGTPDAEVLKKFRKSR 230 (282)
T ss_pred ---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCH-HHHHHHHHHHcCCCCHHHHHhhcccc
Confidence 122457889999998754 5578899999999999999999999965432 2222111110000 000000000
Q ss_pred ------CcCCC----CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 787 ------PTIGL----STTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 787 ------~~l~~----~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
+.... .........+.+++.+||+.+|++||++++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 231 HMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred cccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 00000 0011234789999999999999999999999864
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=310.72 Aligned_cols=261 Identities=21% Similarity=0.298 Sum_probs=194.2
Q ss_pred eeecc--CcEEEEEEEe-cCCcEEEEEEcccCCcc--cHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEeecCC
Q 002774 562 DVGSG--GYGKVYKGTL-PNGQLIAIKRAQQGSMQ--GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNG 636 (882)
Q Consensus 562 ~lG~G--~fg~Vy~~~~-~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 636 (882)
.||+| +||+||+|+. .+|+.||||++...... ..+.+.+|+.+++.++||||+++++++..++..++|+||++++
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~ 84 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence 46666 9999999986 47999999998754322 2367888999999999999999999999999999999999999
Q ss_pred CcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCce-e-
Q 002774 637 SLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDH-I- 714 (882)
Q Consensus 637 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~-~- 714 (882)
+|.+++.......+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++++|||.+.......... .
T Consensus 85 ~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (328)
T cd08226 85 SANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVV 161 (328)
T ss_pred CHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccc
Confidence 9999887654446889999999999999999999988 9999999999999999999999998654332211100 0
Q ss_pred ---eeeeeccCCCCCHHHHhhC--CCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhh----------
Q 002774 715 ---TTQVKGTMGYLDPEYYMTQ--QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELY---------- 779 (882)
Q Consensus 715 ---~~~~~gt~~y~aPE~~~~~--~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~---------- 779 (882)
.....++..|||||++.+. .++.++|||||||++|||++|+.||.....................
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (328)
T cd08226 162 YDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEES 241 (328)
T ss_pred ccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhh
Confidence 0112346679999999763 5789999999999999999999999754332221111100000000
Q ss_pred -------hh----h----------hccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 780 -------NL----Y----------ELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 780 -------~~----~----------~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
.. . ...+..+...........+.+++.+||+.||++|||+.|++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 242 RMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred hhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 00 0 0001111111223345778999999999999999999999976
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=301.90 Aligned_cols=263 Identities=22% Similarity=0.357 Sum_probs=199.5
Q ss_pred CCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCCcc-cHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEee
Q 002774 556 NFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQ-GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFV 633 (882)
Q Consensus 556 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 633 (882)
+|+..+.||+|++|+||+|+.. +|+.||||+++..... ..+.+.+|++++++++|+||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 4778899999999999999975 6899999998764332 2356778999999999999999999999999999999999
Q ss_pred cCCCcccccCCCC-CccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCc
Q 002774 634 PNGSLGDSLSGKN-GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKD 712 (882)
Q Consensus 634 ~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 712 (882)
++ +|.+++.... ...+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++++|||+++.......
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence 84 8888776433 346899999999999999999999998 99999999999999999999999999976543221
Q ss_pred eeeeeeeccCCCCCHHHHhh-CCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhh-----hhhh--hc
Q 002774 713 HITTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKEL-----YNLY--EL 784 (882)
Q Consensus 713 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~-----~~~~--~~ 784 (882)
......++..|++||++.+ ..++.++|||||||++|||++|+.||..... .+............ ..+. ..
T Consensus 156 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07836 156 -TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNN-EDQLLKIFRIMGTPTESTWPGISQLPE 233 (284)
T ss_pred -ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCc-HHHHHHHHHHhCCCChhhHHHHhcCch
Confidence 1223457889999999875 4578999999999999999999999975432 22222221110000 0000 00
Q ss_pred cCCcCCC-------CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 785 IDPTIGL-------STTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 785 ~d~~l~~-------~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
....... .........+.+++.+|++.||.+||+++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0000000 0001223668899999999999999999999853
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=299.06 Aligned_cols=241 Identities=24% Similarity=0.342 Sum_probs=195.8
Q ss_pred eeccCcEEEEEEEec-CCcEEEEEEcccCCc---ccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEeecCCCc
Q 002774 563 VGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM---QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSL 638 (882)
Q Consensus 563 lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 638 (882)
||+|+||.||+|+.. +++.||+|++..... ...+.+.+|+++++.++||||+++++++.++...++||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999975 589999999875432 2346788999999999999999999999999999999999999999
Q ss_pred ccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCceeeeee
Q 002774 639 GDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQV 718 (882)
Q Consensus 639 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 718 (882)
.+++.... .+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||+++...... .....
T Consensus 81 ~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~ 152 (262)
T cd05572 81 WTILRDRG--LFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTF 152 (262)
T ss_pred HHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccccc
Confidence 99997653 5888999999999999999999988 9999999999999999999999999998765432 12234
Q ss_pred eccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCch-HHHHHHHHHHhhhhhhhhhhccCCcCCCCCCHHH
Q 002774 719 KGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKY-IVREIRTVMDKKKELYNLYELIDPTIGLSTTLKG 797 (882)
Q Consensus 719 ~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~-~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 797 (882)
.++..|+|||.+....++.++|+||||+++|||++|..||..... ............ .....+...
T Consensus 153 ~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~ 219 (262)
T cd05572 153 CGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGN-------------GKLEFPNYI 219 (262)
T ss_pred cCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccC-------------CCCCCCccc
Confidence 688899999999888899999999999999999999999975442 122222111100 001111112
Q ss_pred HHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 002774 798 FEKYVDLALKCVQESGDDRPT-----MSEVVK 824 (882)
Q Consensus 798 ~~~l~~li~~cl~~dp~~RPs-----~~evl~ 824 (882)
..++.+++.+||+.+|++||+ ++|+++
T Consensus 220 ~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 220 DKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred CHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 467899999999999999999 666665
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=304.13 Aligned_cols=251 Identities=24% Similarity=0.408 Sum_probs=201.1
Q ss_pred CeeeccCcEEEEEEEe-cCCcEEEEEEcccCCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEeecCCCcc
Q 002774 561 NDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLG 639 (882)
Q Consensus 561 ~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 639 (882)
.+||+|+||.||+|.. .+++.||||++..........+.+|+.+++.++|+||+++++++..++..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 5699999999999986 478999999986554445567889999999999999999999999999999999999999999
Q ss_pred cccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCceeeeeee
Q 002774 640 DSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVK 719 (882)
Q Consensus 640 ~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 719 (882)
+++... .+++.....++.|++.|++|||+.+ ++||||+|+||++++++.++|+|||++........ ......
T Consensus 106 ~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~~~~ 177 (292)
T cd06657 106 DIVTHT---RMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKSLV 177 (292)
T ss_pred HHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccc--cccccc
Confidence 887543 4788999999999999999999998 99999999999999999999999999876543221 123346
Q ss_pred ccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCCCCCCHHHHH
Q 002774 720 GTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFE 799 (882)
Q Consensus 720 gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 799 (882)
|+..|+|||.+.+..++.++|||||||++|||++|..||...... ......... ..+... .......
T Consensus 178 ~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~-~~~~~~~~~----------~~~~~~--~~~~~~~ 244 (292)
T cd06657 178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL-KAMKMIRDN----------LPPKLK--NLHKVSP 244 (292)
T ss_pred cCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhh----------CCcccC--CcccCCH
Confidence 889999999998888999999999999999999999998643322 111111111 111111 0112235
Q ss_pred HHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHcC
Q 002774 800 KYVDLALKCVQESGDDRPTMSEVVKDIENILQQAG 834 (882)
Q Consensus 800 ~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~~ 834 (882)
.+.+++.+||+.+|.+||++.+++++ ..+...+
T Consensus 245 ~l~~li~~~l~~~P~~R~~~~~ll~~--~~~~~~~ 277 (292)
T cd06657 245 SLKGFLDRLLVRDPAQRATAAELLKH--PFLAKAG 277 (292)
T ss_pred HHHHHHHHHHhCCcccCcCHHHHhcC--hHHhccC
Confidence 67899999999999999999999984 4444443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=344.17 Aligned_cols=254 Identities=28% Similarity=0.387 Sum_probs=204.1
Q ss_pred HHcCCCCCCeeeccCcEEEEEEE-ecCCcEEEEEEcccCC--cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEE
Q 002774 553 YTNNFSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGS--MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLI 629 (882)
Q Consensus 553 ~~~~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 629 (882)
.+-+|.....||.|.||.||-|. .++|+..|||-++... ...-+.+.+|+.++..++|||+|+++|+-.+++..+|.
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence 35577888999999999999998 5679999999876432 23336688999999999999999999999999999999
Q ss_pred EEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCC
Q 002774 630 YEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDS 709 (882)
Q Consensus 630 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~ 709 (882)
||||++|+|.+.+.... -.++.....+..|++.|++|||++| ||||||||.||+++.+|.+|++|||.|..+...
T Consensus 1313 MEyC~~GsLa~ll~~gr--i~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~ 1387 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLEHGR--IEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNN 1387 (1509)
T ss_pred HHHhccCcHHHHHHhcc--hhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecCc
Confidence 99999999999987543 3566666678899999999999999 999999999999999999999999999877654
Q ss_pred CC--ceeeeeeeccCCCCCHHHHhhC---CCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhc
Q 002774 710 EK--DHITTQVKGTMGYLDPEYYMTQ---QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYEL 784 (882)
Q Consensus 710 ~~--~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 784 (882)
.. ........||+.|||||++.+. ....++||||+|||+.||+||++||..-++....+..+....
T Consensus 1388 ~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh--------- 1458 (1509)
T KOG4645|consen 1388 AQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGH--------- 1458 (1509)
T ss_pred hhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccC---------
Confidence 21 1122346799999999999854 356789999999999999999999986554443333222111
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 785 IDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 785 ~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
.|.++ .....+-.+++.+|++.||+.|.++.|++++
T Consensus 1459 -~Pq~P----~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1459 -KPQIP----ERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred -CCCCc----hhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 12222 2234566799999999999999999888764
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=355.67 Aligned_cols=312 Identities=30% Similarity=0.477 Sum_probs=218.0
Q ss_pred CccccCccccCCCCCCEEeccCCCCCccCCCccccCCCCCcEEEeeCCcCCccccccccCCCCCCEEEccCCcCCCCCCc
Q 002774 3 LKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPP 82 (882)
Q Consensus 3 ~~~~l~~~~~~l~~L~~L~L~~n~~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~ 82 (882)
+++.+|..|.++++|++|+|++|. +.+.+|..|+++++|++|+|++|++++.+|..|+++++|++|+|++|++.+.+|.
T Consensus 152 ~~~~~p~~~~~l~~L~~L~L~~n~-l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~ 230 (968)
T PLN00113 152 LSGEIPNDIGSFSSLKVLDLGGNV-LVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPY 230 (968)
T ss_pred ccccCChHHhcCCCCCEEECccCc-ccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCCh
Confidence 456677777777777777777775 6667777777777777777777777766777777777777777777777766777
Q ss_pred CccCCCCCcEeeccCceeeeecCCCCCCCchhh------------------hhhcccceeccCCeeeecCCccccCCccc
Q 002774 83 SIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLD------------------MLVRAKHFHFGKNQLSGSIPEKLFRPDMV 144 (882)
Q Consensus 83 ~~~~l~~L~~L~Ls~N~i~~~~p~~~~~~~~l~------------------~L~~L~~L~L~~N~l~~~ip~~~f~~~~~ 144 (882)
.|+++++|++|+|++|++++.+|..+++++.|+ .+.+|++|+|++|.+++.+|. .|..+++
T Consensus 231 ~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~-~~~~l~~ 309 (968)
T PLN00113 231 EIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPE-LVIQLQN 309 (968)
T ss_pred hHhcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCCh-hHcCCCC
Confidence 777777777777777777666666655544333 345788888888888866664 4566788
Q ss_pred ceeeeccCCcccccCCccccCCCCCCEEEccCCCCCCCCCccCCCCCCCCEEEccCCcccccCCC-CCCCCCCCEEECcC
Q 002774 145 LIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPN-LTGLSVLSYLDMSN 223 (882)
Q Consensus 145 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~-~~~l~~L~~L~Ls~ 223 (882)
|+.|++++|.+++..|..+..+++|+.|++++|.+.+.+|..+..+++|+.|+|++|++++..+. +..+++|+.|++++
T Consensus 310 L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~ 389 (968)
T PLN00113 310 LEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFS 389 (968)
T ss_pred CcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcC
Confidence 99999999999888888888999999999999999888888888888899999988888866553 66667777777777
Q ss_pred CCCCCCCCCccccCCCCCCEEECcCCcccccCCccCCCCCCCCEEEccCCccceecCCC-CcccccccccccCCcccccc
Q 002774 224 NSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLG-TSYSENLLVNLQNNRISAYT 302 (882)
Q Consensus 224 N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~-~~~~~L~~L~L~~N~i~~~~ 302 (882)
|++.+ .+|..+..+++|+.|+|++|++++.+|..+..+++|+.|+|++|++++.++.. ..+++|+.|+|++|++....
T Consensus 390 n~l~~-~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~ 468 (968)
T PLN00113 390 NSLEG-EIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGL 468 (968)
T ss_pred CEecc-cCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeec
Confidence 77763 55666666666666666666666666666666666666666666666544332 33555555555555555433
Q ss_pred CCCCCCccceEEecCc
Q 002774 303 ERGGAPAVNLTLIDNP 318 (882)
Q Consensus 303 ~~~~~~~~~L~~l~~~ 318 (882)
+..+ ...+|+.||..
T Consensus 469 p~~~-~~~~L~~L~ls 483 (968)
T PLN00113 469 PDSF-GSKRLENLDLS 483 (968)
T ss_pred Cccc-ccccceEEECc
Confidence 3322 22444444443
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=308.02 Aligned_cols=259 Identities=22% Similarity=0.252 Sum_probs=192.8
Q ss_pred eeccCcEEEEEEEecCCcEEEEEEcccC--CcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEeecCCCccc
Q 002774 563 VGSGGYGKVYKGTLPNGQLIAIKRAQQG--SMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGD 640 (882)
Q Consensus 563 lG~G~fg~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~~ 640 (882)
+|.|+++.||++.. +++.||||+++.. .....+.+.+|+++++.++|+||+++++++.+.+..+++|||+++|+|.+
T Consensus 10 ~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 88 (314)
T cd08216 10 FEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCED 88 (314)
T ss_pred hcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHH
Confidence 44455555555544 6899999998754 23344678999999999999999999999999999999999999999999
Q ss_pred ccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCC-----ceee
Q 002774 641 SLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEK-----DHIT 715 (882)
Q Consensus 641 ~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~-----~~~~ 715 (882)
++.......+++.....++.|++.||+|||+.+ |+||||||+||+++.++.+|++|||.+..+..... ....
T Consensus 89 ~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~ 165 (314)
T cd08216 89 LLKTHFPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFP 165 (314)
T ss_pred HHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeecccccccccccccc
Confidence 997654456888899999999999999999998 99999999999999999999999999875543221 1112
Q ss_pred eeeeccCCCCCHHHHhh--CCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhh----------hhhh
Q 002774 716 TQVKGTMGYLDPEYYMT--QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELY----------NLYE 783 (882)
Q Consensus 716 ~~~~gt~~y~aPE~~~~--~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~----------~~~~ 783 (882)
....++..|+|||++.. ..++.++|||||||++|||++|+.||..................... ....
T Consensus 166 ~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (314)
T cd08216 166 KSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQ 245 (314)
T ss_pred ccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCc
Confidence 23457788999999975 35889999999999999999999999754433222221111000000 0000
Q ss_pred ----ccCCcC----CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 784 ----LIDPTI----GLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 784 ----~~d~~l----~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
..++.. ..........++.+++.+||+.||++|||+++++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 246 SRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred ccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 000000 001112223578899999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=298.21 Aligned_cols=251 Identities=23% Similarity=0.334 Sum_probs=194.1
Q ss_pred HHHHHHHHcCCCCCCee--eccCcEEEEEEEe-cCCcEEEEEEcccCCcccHHHHHHHHHHHHhc-cCCCeeeEEEEEEe
Q 002774 547 FEEVKKYTNNFSDANDV--GSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQGGQEFKMEIELLSRV-HHKNLVSLLGFCFD 622 (882)
Q Consensus 547 ~~e~~~~~~~~~~~~~l--G~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~ 622 (882)
..+.....++|...+.+ |+|+||.||+++. .++..+|+|.+....... .|+.....+ +||||+++++++..
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~ 80 (267)
T PHA03390 6 LSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTT 80 (267)
T ss_pred HHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEec
Confidence 34445556677777766 9999999999985 468899999986532221 123333323 69999999999999
Q ss_pred CCceEEEEEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCC-ceeEeecc
Q 002774 623 RGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERL-NAKVADFG 701 (882)
Q Consensus 623 ~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~-~~kl~DfG 701 (882)
.+..++||||+++|+|.+++.... .+++..+..++.|+++||+|||+.+ ++||||||+||+++.++ .++|+|||
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg 155 (267)
T PHA03390 81 LKGHVLIMDYIKDGDLFDLLKKEG--KLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYG 155 (267)
T ss_pred CCeeEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCc
Confidence 999999999999999999997654 7899999999999999999999998 99999999999999998 99999999
Q ss_pred cccccCCCCCceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhh
Q 002774 702 LSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNL 781 (882)
Q Consensus 702 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 781 (882)
+++...... ...++..|+|||++.+..++.++|||||||++|||++|+.||.................
T Consensus 156 ~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~------ 223 (267)
T PHA03390 156 LCKIIGTPS------CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ------ 223 (267)
T ss_pred cceecCCCc------cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh------
Confidence 988654322 23588999999999988999999999999999999999999974322111111111000
Q ss_pred hhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCC-HHHHHHH
Q 002774 782 YELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPT-MSEVVKD 825 (882)
Q Consensus 782 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs-~~evl~~ 825 (882)
.... .........+.+++.+||+.+|.+||+ ++|++++
T Consensus 224 ----~~~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 224 ----QKKL--PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred ----cccC--CcccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence 0000 111123467899999999999999996 6888753
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=307.46 Aligned_cols=264 Identities=25% Similarity=0.348 Sum_probs=197.6
Q ss_pred HcCCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCCccc--HHHHHHHHHHHHhccCCCeeeEEEEEEeC--CceEE
Q 002774 554 TNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQG--GQEFKMEIELLSRVHHKNLVSLLGFCFDR--GEQML 628 (882)
Q Consensus 554 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~l 628 (882)
.++|...+.||+|+||+||+|... +|+.||+|+++...... ...+.+|++++++++|+||+++++++.+. +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 357888999999999999999964 68999999987543222 23466899999999999999999998765 46899
Q ss_pred EEEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCC
Q 002774 629 IYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSD 708 (882)
Q Consensus 629 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~ 708 (882)
||||++ ++|.+++.... ..+++.++..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++....
T Consensus 86 v~e~~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~ 160 (309)
T cd07845 86 VMEYCE-QDLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGL 160 (309)
T ss_pred EEecCC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence 999996 47877776432 46899999999999999999999999 99999999999999999999999999987654
Q ss_pred CCCceeeeeeeccCCCCCHHHHhh-CCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhh-hhhhhh---
Q 002774 709 SEKDHITTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKE-LYNLYE--- 783 (882)
Q Consensus 709 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~-~~~~~~--- 783 (882)
... ......++..|+|||.+.+ ..++.++||||+||++|||++|+.||..... .+....+...... ....+.
T Consensus 161 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07845 161 PAK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSE-IEQLDLIIQLLGTPNESIWPGFS 237 (309)
T ss_pred ccC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHhcCCCChhhchhhh
Confidence 321 1222345788999999875 5678999999999999999999999965432 2222222221100 000000
Q ss_pred ------ccC-CcCCCCC----CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 784 ------LID-PTIGLST----TLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 784 ------~~d-~~l~~~~----~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
... +...... .......+.+++.+|++.||++|||+.|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 238 DLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred cccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000 0000000 00124667899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=303.65 Aligned_cols=247 Identities=26% Similarity=0.349 Sum_probs=201.6
Q ss_pred CCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCCc---ccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEE
Q 002774 556 NFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM---QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYE 631 (882)
Q Consensus 556 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e 631 (882)
+|...+.||.|+||.||+|... +++.||+|.+..... ...+.+.+|++++++++||||+++++++.++...++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4778899999999999999975 589999999875432 234678899999999999999999999999999999999
Q ss_pred eecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCC
Q 002774 632 FVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEK 711 (882)
Q Consensus 632 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 711 (882)
|+++++|.+++... ..+++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~- 154 (258)
T cd05578 81 LLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT- 154 (258)
T ss_pred CCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc-
Confidence 99999999998765 36889999999999999999999988 9999999999999999999999999998765432
Q ss_pred ceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchH-HHHHHHHHHhhhhhhhhhhccCCcCC
Q 002774 712 DHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYI-VREIRTVMDKKKELYNLYELIDPTIG 790 (882)
Q Consensus 712 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~-~~~~~~~~~~~~~~~~~~~~~d~~l~ 790 (882)
......|+..|+|||.+....++.++||||||+++|+|++|..||...... ..+....... ..
T Consensus 155 --~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~----------~~---- 218 (258)
T cd05578 155 --LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET----------AD---- 218 (258)
T ss_pred --cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc----------cc----
Confidence 123356888999999999888999999999999999999999999754431 1111111100 00
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCH--HHHHH
Q 002774 791 LSTTLKGFEKYVDLALKCVQESGDDRPTM--SEVVK 824 (882)
Q Consensus 791 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~--~evl~ 824 (882)
...+...+..+.+++.+||+.||.+||++ +|+++
T Consensus 219 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 219 VLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred ccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence 01111233788899999999999999999 66553
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=304.71 Aligned_cols=267 Identities=24% Similarity=0.337 Sum_probs=200.1
Q ss_pred HHHcCCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCCc--ccHHHHHHHHHHHHhccCCCeeeEEEEEEeCC----
Q 002774 552 KYTNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM--QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRG---- 624 (882)
Q Consensus 552 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~---- 624 (882)
...++|+..+.||+|+||+||+|... +|+.||+|+++.... .....+.+|++++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 45678899999999999999999975 589999999875432 22356788999999999999999999987654
Q ss_pred ------ceEEEEEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEe
Q 002774 625 ------EQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVA 698 (882)
Q Consensus 625 ------~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~ 698 (882)
..++|+||+++ ++.+.+... ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl~ 158 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLA 158 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEeC
Confidence 78999999976 666666543 236899999999999999999999998 9999999999999999999999
Q ss_pred ecccccccCCCCCceeeeeeeccCCCCCHHHHhh-CCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhh-
Q 002774 699 DFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKK- 776 (882)
Q Consensus 699 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~- 776 (882)
|||++........ .......++..|+|||.+.+ ..++.++|||||||++|||++|+.||...... .....+.....
T Consensus 159 dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~-~~~~~~~~~~~~ 236 (302)
T cd07864 159 DFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQEL-AQLELISRLCGS 236 (302)
T ss_pred cccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCC
Confidence 9999987654332 11222346788999998864 45789999999999999999999999754432 22222222110
Q ss_pred hhhhhh-h--------ccCCcCCC-----CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 777 ELYNLY-E--------LIDPTIGL-----STTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 777 ~~~~~~-~--------~~d~~l~~-----~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
.....+ + ..++.... ......+..+.+++.+||+.||.+||++.+++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 237 PCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred CChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 000000 0 00000000 0001124678999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=302.36 Aligned_cols=241 Identities=24% Similarity=0.319 Sum_probs=187.2
Q ss_pred eeeccCcEEEEEEEe-cCCcEEEEEEcccCCcc---cHHHHHHHHHHHHh---ccCCCeeeEEEEEEeCCceEEEEEeec
Q 002774 562 DVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQ---GGQEFKMEIELLSR---VHHKNLVSLLGFCFDRGEQMLIYEFVP 634 (882)
Q Consensus 562 ~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~---l~H~niv~l~~~~~~~~~~~lV~e~~~ 634 (882)
.||+|+||.||++.. .+++.||+|.+...... ....+.+|..+++. .+||||+++++++..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999986 46899999988654221 12334445444443 479999999999999999999999999
Q ss_pred CCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCcee
Q 002774 635 NGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHI 714 (882)
Q Consensus 635 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 714 (882)
+|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+||++++++.++++|||++.......
T Consensus 81 ~~~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---- 151 (279)
T cd05633 81 GGDLHYHLSQHG--VFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---- 151 (279)
T ss_pred CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC----
Confidence 999998887544 5899999999999999999999998 9999999999999999999999999997654322
Q ss_pred eeeeeccCCCCCHHHHhh-CCCCchhHHHHHHHHHHHHHhCCCCCCCCchH-HHHHHHHHHhhhhhhhhhhccCCcCCCC
Q 002774 715 TTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGKYI-VREIRTVMDKKKELYNLYELIDPTIGLS 792 (882)
Q Consensus 715 ~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~-~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 792 (882)
.....|+..|+|||.+.. ..++.++|||||||++|||++|..||...... ........ ...+..+
T Consensus 152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~----------~~~~~~~--- 218 (279)
T cd05633 152 PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT----------LTVNVEL--- 218 (279)
T ss_pred ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHh----------hcCCcCC---
Confidence 123468999999999874 56899999999999999999999999643211 11111110 0011111
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 002774 793 TTLKGFEKYVDLALKCVQESGDDRP-----TMSEVVKD 825 (882)
Q Consensus 793 ~~~~~~~~l~~li~~cl~~dp~~RP-----s~~evl~~ 825 (882)
+.....++.+++.+||+.||.+|| +++|++++
T Consensus 219 -~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 219 -PDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred -ccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 122346788999999999999999 59888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=305.90 Aligned_cols=252 Identities=25% Similarity=0.448 Sum_probs=195.5
Q ss_pred cCCCCCCeeeccCcEEEEEEEecC-CcEEEEEEcccCCcc-cHHHHHHHHHHHHhcc-CCCeeeEEEEEEeCCceEEEEE
Q 002774 555 NNFSDANDVGSGGYGKVYKGTLPN-GQLIAIKRAQQGSMQ-GGQEFKMEIELLSRVH-HKNLVSLLGFCFDRGEQMLIYE 631 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~e 631 (882)
++|...+.||+|+||+||+|++.+ ++.||||+++..... ....+.+|+.++.+.. |+||+++++++.+....++|||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 457788999999999999999864 899999999754332 3355677887777775 9999999999999999999999
Q ss_pred eecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhh-cCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCC
Q 002774 632 FVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHE-LANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE 710 (882)
Q Consensus 632 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~ 710 (882)
|++ +++.+++.... ..+++..+..++.|+++||+|||+ .+ |+||||+|+||++++++.+||+|||++..+....
T Consensus 95 ~~~-~~l~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~ 169 (296)
T cd06618 95 LMS-TCLDKLLKRIQ-GPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK 169 (296)
T ss_pred ccC-cCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccCCC
Confidence 985 46665554322 268999999999999999999997 46 9999999999999999999999999998664322
Q ss_pred CceeeeeeeccCCCCCHHHHhhCC----CCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccC
Q 002774 711 KDHITTQVKGTMGYLDPEYYMTQQ----LTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELID 786 (882)
Q Consensus 711 ~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 786 (882)
. .....++..|+|||.+.... ++.++||||||+++|||++|+.||.......+......... .
T Consensus 170 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~----------~ 236 (296)
T cd06618 170 A---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEE----------P 236 (296)
T ss_pred c---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCC----------C
Confidence 2 12235788999999987543 78899999999999999999999965433222222222111 0
Q ss_pred CcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 002774 787 PTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDI 826 (882)
Q Consensus 787 ~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L 826 (882)
+... .......++.+++.+||+.||++||++.+++++-
T Consensus 237 ~~~~--~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~ 274 (296)
T cd06618 237 PSLP--PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHP 274 (296)
T ss_pred CCCC--CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence 1111 1112346789999999999999999999999763
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=324.73 Aligned_cols=269 Identities=20% Similarity=0.268 Sum_probs=190.2
Q ss_pred HHHHcCCCCCCeeeccCcEEEEEEEecC--CcEEEEE------------------EcccCCcccHHHHHHHHHHHHhccC
Q 002774 551 KKYTNNFSDANDVGSGGYGKVYKGTLPN--GQLIAIK------------------RAQQGSMQGGQEFKMEIELLSRVHH 610 (882)
Q Consensus 551 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~--g~~vavK------------------~~~~~~~~~~~~~~~E~~~l~~l~H 610 (882)
....++|...+.||+|+||+||+|.++. +..+++| .++. .......+.+|+.++++++|
T Consensus 144 ~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~-~~~~~~~~~~Ei~il~~l~H 222 (501)
T PHA03210 144 DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKA-GSRAAIQLENEILALGRLNH 222 (501)
T ss_pred hhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhc-chHHHHHHHHHHHHHHhCCC
Confidence 3456789999999999999999987532 2222222 1111 11223567899999999999
Q ss_pred CCeeeEEEEEEeCCceEEEEEeecCCCcccccCCCC---CccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCce
Q 002774 611 KNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKN---GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNI 687 (882)
Q Consensus 611 ~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NI 687 (882)
||||++++++.+.+..++|+|++. ++|.+++.... .......+...++.|++.||+|||+.+ |+||||||+||
T Consensus 223 pnIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NI 298 (501)
T PHA03210 223 ENILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENI 298 (501)
T ss_pred CCcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHE
Confidence 999999999999999999999984 56666654322 112335567789999999999999998 99999999999
Q ss_pred EEcCCCceeEeecccccccCCCCCceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCC-CCCC-chHH
Q 002774 688 LLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRP-IERG-KYIV 765 (882)
Q Consensus 688 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P-~~~~-~~~~ 765 (882)
|++.++.+||+|||+++.+..... .......||..|+|||++.+..++.++|||||||++|||++|..+ +... ....
T Consensus 299 Ll~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~ 377 (501)
T PHA03210 299 FLNCDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPG 377 (501)
T ss_pred EECCCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHH
Confidence 999999999999999987654322 122345799999999999999999999999999999999998754 4322 1222
Q ss_pred HHHHHHHHhhhh----h----hhhhhccCCcCC---CCC------CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 766 REIRTVMDKKKE----L----YNLYELIDPTIG---LST------TLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 766 ~~~~~~~~~~~~----~----~~~~~~~d~~l~---~~~------~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
..+..++..... . ..+.+.++.... ... ......++.+++.+|++.||.+|||+.|++++
T Consensus 378 ~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 378 KQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 222222221100 0 000111100000 000 00112457788999999999999999999975
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=298.32 Aligned_cols=251 Identities=26% Similarity=0.363 Sum_probs=197.8
Q ss_pred cCCCCCCeeeccCcEEEEEEEe-cCCcEEEEEEcccCC-----cccHHHHHHHHHHHHhccCCCeeeEEEEEEeC--Cce
Q 002774 555 NNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGS-----MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDR--GEQ 626 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~ 626 (882)
.+|...+.||+|+||.||+|+. .+++.||+|.+.... ....+.+.+|++++++++|+||+++++++.+. +..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 4688899999999999999985 468999999875321 12335788999999999999999999998764 457
Q ss_pred EEEEEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeeccccccc
Q 002774 627 MLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSM 706 (882)
Q Consensus 627 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~ 706 (882)
++|+||+++++|.+++.... .+++....+++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||+++..
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 156 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYG--ALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRI 156 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcccccccc
Confidence 89999999999999887543 4788889999999999999999998 999999999999999999999999999865
Q ss_pred CCCCCc-eeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhcc
Q 002774 707 SDSEKD-HITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELI 785 (882)
Q Consensus 707 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 785 (882)
...... .......++..|+|||++.+..++.++|||||||++|||++|+.||........ +..... ...
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~---------~~~ 226 (264)
T cd06653 157 QTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAA-IFKIAT---------QPT 226 (264)
T ss_pred ccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHH-HHHHHc---------CCC
Confidence 432111 112234688999999999988899999999999999999999999975432221 111110 001
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 786 DPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 786 d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
.+. .+....+.+.+++.+||+ +|..||++.+++.+
T Consensus 227 ~~~----~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 227 KPM----LPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred CCC----CCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 111 122234678999999999 57999999988764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=312.75 Aligned_cols=264 Identities=23% Similarity=0.368 Sum_probs=196.6
Q ss_pred HcCCCCCCeeeccCcEEEEEEEe-cCCcEEEEEEcccCC-cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCC-----ce
Q 002774 554 TNNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGS-MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRG-----EQ 626 (882)
Q Consensus 554 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----~~ 626 (882)
.++|...+.||+|+||+||+|+. .+|+.||||+++... ......+.+|+.++++++|+||+++++++.... ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 46789999999999999999985 468999999986432 223456788999999999999999999876543 47
Q ss_pred EEEEEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeeccccccc
Q 002774 627 MLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSM 706 (882)
Q Consensus 627 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~ 706 (882)
++|+||++ ++|.+.+... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 84 ~lv~e~~~-~~l~~~~~~~---~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~ 156 (336)
T cd07849 84 YIVQELME-TDLYKLIKTQ---HLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIA 156 (336)
T ss_pred EEEehhcc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceeec
Confidence 99999996 4777776543 5899999999999999999999998 999999999999999999999999999866
Q ss_pred CCCCCc-eeeeeeeccCCCCCHHHHhh-CCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhh--hhhhhh
Q 002774 707 SDSEKD-HITTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKK--ELYNLY 782 (882)
Q Consensus 707 ~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~--~~~~~~ 782 (882)
...... .......|+..|+|||.+.+ ..++.++|||||||++|||++|+.||...... ........... ......
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~-~~~~~~~~~~~~~~~~~~~ 235 (336)
T cd07849 157 DPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYL-HQLNLILGVLGTPSQEDLN 235 (336)
T ss_pred cccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHcCCCCHHHHH
Confidence 432211 11223468899999998764 56899999999999999999999999654322 11111111000 000000
Q ss_pred hc-----------cC--CcCCCC-CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 783 EL-----------ID--PTIGLS-TTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 783 ~~-----------~d--~~l~~~-~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
.. .. +..... .......++.+++.+||+.+|++|||+.|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 236 CIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00 00 000000 001123568899999999999999999999986
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=316.97 Aligned_cols=269 Identities=25% Similarity=0.375 Sum_probs=205.5
Q ss_pred CCCCCeeeccCcEEEEEEE-ecCCcEEEEEEcccCC-cccHHHHHHHHHHHHhccCCCeeeEEEEEEeC------CceEE
Q 002774 557 FSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGS-MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDR------GEQML 628 (882)
Q Consensus 557 ~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~~~~l 628 (882)
|...+.||+|+||.||+|+ ..+|+.||||.++... ....+...+|+++|++++|+|||++++.=.+. ....+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 3456789999999999999 4579999999998743 44557788999999999999999999875443 35789
Q ss_pred EEEeecCCCcccccCCCC-CccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEE--cCCCc--eeEeecccc
Q 002774 629 IYEFVPNGSLGDSLSGKN-GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILL--DERLN--AKVADFGLS 703 (882)
Q Consensus 629 V~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll--~~~~~--~kl~DfGla 703 (882)
|||||.+|||...+.... ...+++.+.+.+..+++.||.|||+++ |+||||||.||++ .++|+ -||+|||.|
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 999999999999998754 456999999999999999999999998 9999999999998 33344 699999999
Q ss_pred cccCCCCCceeeeeeeccCCCCCHHHHh-hCCCCchhHHHHHHHHHHHHHhCCCCCCCCchH---HHHHHHHHHhhhhhh
Q 002774 704 KSMSDSEKDHITTQVKGTMGYLDPEYYM-TQQLTEKSDVYSFGVLMLELLTGRRPIERGKYI---VREIRTVMDKKKELY 779 (882)
Q Consensus 704 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~---~~~~~~~~~~~~~~~ 779 (882)
+.+.++. ..+...||..|.+||++. .+.|+..+|.|||||++||++||..||..-... .+.........+..
T Consensus 172 rel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~- 247 (732)
T KOG4250|consen 172 RELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSG- 247 (732)
T ss_pred ccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCc-
Confidence 9887654 466789999999999999 488899999999999999999999999743322 11211111111100
Q ss_pred hhhhccCCcC------------CCCCCHHHHHHHHHHHHHhhccCCCCCC--CHHHHHHHHHHHHHHc
Q 002774 780 NLYELIDPTI------------GLSTTLKGFEKYVDLALKCVQESGDDRP--TMSEVVKDIENILQQA 833 (882)
Q Consensus 780 ~~~~~~d~~l------------~~~~~~~~~~~l~~li~~cl~~dp~~RP--s~~evl~~L~~~~~~~ 833 (882)
..-..++.. ...........+..++..++..+|++|- .+.+....+..|++..
T Consensus 248 -v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~~ 314 (732)
T KOG4250|consen 248 -VAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNLK 314 (732)
T ss_pred -eeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhhh
Confidence 000011111 1112233346677888889999999998 7777776666666553
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=294.75 Aligned_cols=247 Identities=30% Similarity=0.457 Sum_probs=203.7
Q ss_pred CCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCCc--ccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEe
Q 002774 556 NFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM--QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEF 632 (882)
Q Consensus 556 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 632 (882)
+|+..+.||+|++|.||+|+.. +++.||+|.+..... ...+.+.+|++++++++|+|++++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4677889999999999999865 678999999986544 3446789999999999999999999999999999999999
Q ss_pred ecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCc
Q 002774 633 VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKD 712 (882)
Q Consensus 633 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 712 (882)
+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++.........
T Consensus 81 ~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 155 (254)
T cd06627 81 AENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD 155 (254)
T ss_pred CCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCccc
Confidence 9999999988765 36899999999999999999999998 999999999999999999999999999877543321
Q ss_pred eeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCCCC
Q 002774 713 HITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLS 792 (882)
Q Consensus 713 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 792 (882)
.....++..|+|||......++.++||||+|+++|+|++|..||............. . . ..+..
T Consensus 156 --~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~-~--~--------~~~~~--- 219 (254)
T cd06627 156 --DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV-Q--D--------DHPPL--- 219 (254)
T ss_pred --ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh-c--c--------CCCCC---
Confidence 233468899999999988888999999999999999999999997544322211111 0 0 00111
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002774 793 TTLKGFEKYVDLALKCVQESGDDRPTMSEVVK 824 (882)
Q Consensus 793 ~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~ 824 (882)
.......+.+++.+||..+|++||++.+++.
T Consensus 220 -~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 220 -PEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred -CCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 1122467889999999999999999999985
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=296.48 Aligned_cols=250 Identities=25% Similarity=0.449 Sum_probs=205.7
Q ss_pred CCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCCc--ccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEe
Q 002774 556 NFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM--QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEF 632 (882)
Q Consensus 556 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 632 (882)
+|...+.||+|+||.||++... +++.||+|++..... ...+.+.+|+++++.++|+|++++.+.+..++..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4677889999999999999965 689999999876533 4456788999999999999999999999999999999999
Q ss_pred ecCCCcccccCCCC--CccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCC
Q 002774 633 VPNGSLGDSLSGKN--GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE 710 (882)
Q Consensus 633 ~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~ 710 (882)
+++++|.+++.... ...+++..+..++.+++.||+|||+.+ ++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999887643 357899999999999999999999998 9999999999999999999999999998765432
Q ss_pred CceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCC
Q 002774 711 KDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIG 790 (882)
Q Consensus 711 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 790 (882)
.......|++.|+|||......++.++||||+|+++++|++|+.||..... .+........ . .+.+.
T Consensus 158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-~~~~~~~~~~---------~-~~~~~ 224 (258)
T cd08215 158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL-LELALKILKG---------Q-YPPIP 224 (258)
T ss_pred --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH-HHHHHHHhcC---------C-CCCCC
Confidence 123345688999999999988899999999999999999999999965432 1111111110 0 01111
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 791 LSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 791 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
......+.+++.+||..+|++||++.|++++
T Consensus 225 ----~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 225 ----SQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred ----CCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1234678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=300.23 Aligned_cols=261 Identities=25% Similarity=0.325 Sum_probs=197.8
Q ss_pred CCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCCcc--cHHHHHHHHHHHHhc---cCCCeeeEEEEEEeCCc-----
Q 002774 557 FSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQ--GGQEFKMEIELLSRV---HHKNLVSLLGFCFDRGE----- 625 (882)
Q Consensus 557 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~H~niv~l~~~~~~~~~----- 625 (882)
|+..+.||+|+||.||+|+.. +++.||+|+++..... ....+.+|+++++++ +|+||+++++++.+.+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 566788999999999999976 4899999999753222 224566788877766 59999999999988776
Q ss_pred eEEEEEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccc
Q 002774 626 QMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKS 705 (882)
Q Consensus 626 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~ 705 (882)
.+++|||++ ++|.+++.......+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++..
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCccee
Confidence 899999996 58888886544446899999999999999999999988 99999999999999999999999999987
Q ss_pred cCCCCCceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhh----
Q 002774 706 MSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNL---- 781 (882)
Q Consensus 706 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~---- 781 (882)
+..... .....++..|+|||++.+..++.++|||||||++|||++|..||.... ..+....+.+........
T Consensus 157 ~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07838 157 YSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTS-EADQLDKIFDVIGLPSEEEWPR 232 (287)
T ss_pred ccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCC-hHHHHHHHHHHcCCCChHhcCC
Confidence 644322 122357889999999999899999999999999999999988886433 233333333221100000
Q ss_pred -----hhccCCcCC---CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 782 -----YELIDPTIG---LSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 782 -----~~~~d~~l~---~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
......... ..........+.+++.+||+.||.+||++.|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 233 NVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred CcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 000000000 00111234677899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=312.30 Aligned_cols=265 Identities=24% Similarity=0.371 Sum_probs=198.8
Q ss_pred HHcCCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccC--CcccHHHHHHHHHHHHhc-cCCCeeeEEEEEEeC--Cce
Q 002774 553 YTNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQG--SMQGGQEFKMEIELLSRV-HHKNLVSLLGFCFDR--GEQ 626 (882)
Q Consensus 553 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~--~~~ 626 (882)
..++|...+.||+|+||.||+|... +++.||||++... .......+.+|+.+++++ +||||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 4567888899999999999999865 6889999988642 223335677899999999 999999999998654 357
Q ss_pred EEEEEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeeccccccc
Q 002774 627 MLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSM 706 (882)
Q Consensus 627 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~ 706 (882)
++||||++ ++|..++... .+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++..
T Consensus 85 ~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~~ 157 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSL 157 (337)
T ss_pred EEEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence 99999997 5888888654 5789999999999999999999988 999999999999999999999999999876
Q ss_pred CCCCCc---eeeeeeeccCCCCCHHHHhh-CCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhh-----
Q 002774 707 SDSEKD---HITTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKE----- 777 (882)
Q Consensus 707 ~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~----- 777 (882)
...... .......|+..|+|||.+.+ ..++.++||||||+++|||++|+.||........ ..........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~-~~~~~~~~~~~~~~~ 236 (337)
T cd07852 158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQ-LEKIIEVIGPPSAED 236 (337)
T ss_pred ccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCHHH
Confidence 543321 12234568999999998764 5678899999999999999999999864333221 1111111000
Q ss_pred --------hhhhhhccCCcCC---CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 778 --------LYNLYELIDPTIG---LSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 778 --------~~~~~~~~d~~l~---~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
...+...+..... .........++.+++.+||+.||++|||+.+++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 237 IESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0000000000000 00001134678999999999999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=301.41 Aligned_cols=261 Identities=23% Similarity=0.345 Sum_probs=201.2
Q ss_pred CCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCCcc--cHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEee
Q 002774 557 FSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQ--GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFV 633 (882)
Q Consensus 557 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 633 (882)
|...+.||+|++|.||+|... +++.+|+|+++..... ....+.+|++++++++|+||+++++++..++..++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 456788999999999999864 6899999998754332 3467888999999999999999999999999999999999
Q ss_pred cCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCce
Q 002774 634 PNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDH 713 (882)
Q Consensus 634 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 713 (882)
++ ++.+++.... ..+++..+..++.|++.||+|||+.+ |+|+||||+||++++++.+||+|||.+........
T Consensus 81 ~~-~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~-- 153 (283)
T cd05118 81 DT-DLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR-- 153 (283)
T ss_pred CC-CHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc--
Confidence 75 8888776543 46899999999999999999999998 99999999999999999999999999987754431
Q ss_pred eeeeeeccCCCCCHHHHhhC-CCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhh-hhhhhccC-----
Q 002774 714 ITTQVKGTMGYLDPEYYMTQ-QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKEL-YNLYELID----- 786 (882)
Q Consensus 714 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~-~~~~~~~d----- 786 (882)
......++..|+|||.+.+. .++.++||||||+++|+|+||+.||....... ............ ........
T Consensus 154 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd05118 154 PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEID-QLFKIFRTLGTPDPEVWPKFTSLARN 232 (283)
T ss_pred cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHcCCCchHhcccchhhhhh
Confidence 12234578889999999876 78999999999999999999999986554332 222221110000 00000000
Q ss_pred -----CcCC----CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 787 -----PTIG----LSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 787 -----~~l~----~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
+... .........++.+++.+||+.||.+||++.+++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 233 YKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 0000 00111234678999999999999999999999864
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=302.25 Aligned_cols=262 Identities=23% Similarity=0.360 Sum_probs=199.3
Q ss_pred CCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCC--cccHHHHHHHHHHHHhccCCCeeeEEEEEEeC--CceEEEEE
Q 002774 557 FSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS--MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDR--GEQMLIYE 631 (882)
Q Consensus 557 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lV~e 631 (882)
|...+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+++++.++|+|++++++++.+. +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 556788999999999999975 58999999998653 23345688999999999999999999999888 88999999
Q ss_pred eecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCC
Q 002774 632 FVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEK 711 (882)
Q Consensus 632 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 711 (882)
|+++ +|.+++.... ..+++..+..++.|+++||+|||+.+ ++|+||||+||++++++.+||+|||++........
T Consensus 81 ~~~~-~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~ 155 (287)
T cd07840 81 YMDH-DLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS 155 (287)
T ss_pred cccc-cHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCCc
Confidence 9974 8888876542 36899999999999999999999988 99999999999999999999999999987654432
Q ss_pred ceeeeeeeccCCCCCHHHHhh-CCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhh-----hhh----
Q 002774 712 DHITTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKEL-----YNL---- 781 (882)
Q Consensus 712 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~-----~~~---- 781 (882)
.......++..|+|||.+.+ ..++.++||||||+++|||++|+.||..... .............. ...
T Consensus 156 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07840 156 -ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTE-LEQLEKIFELCGSPTDENWPGVSKLP 233 (287)
T ss_pred -ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCchhhccccccch
Confidence 12233456888999998764 4678999999999999999999999975442 22222222111000 000
Q ss_pred -hhccCCcCCC------CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 782 -YELIDPTIGL------STTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 782 -~~~~d~~l~~------~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
.....+.... .....+...+.+++.+||+.+|++||++.+++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 234 WFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred hhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 0000000000 0000124678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=286.70 Aligned_cols=268 Identities=23% Similarity=0.307 Sum_probs=197.7
Q ss_pred HcCCCCCCeeeccCcEEEEEEEec---C--CcEEEEEEcccCCccc--HHHHHHHHHHHHhccCCCeeeEEEEEEe-CCc
Q 002774 554 TNNFSDANDVGSGGYGKVYKGTLP---N--GQLIAIKRAQQGSMQG--GQEFKMEIELLSRVHHKNLVSLLGFCFD-RGE 625 (882)
Q Consensus 554 ~~~~~~~~~lG~G~fg~Vy~~~~~---~--g~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~ 625 (882)
...|.....||+|.||.||||.-. + .+.+|+|+++...... .....+|+.+++.++||||+.+..++.. +..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 346788899999999999999632 2 2378999998653322 2567789999999999999999998877 778
Q ss_pred eEEEEEeecCCCcccccCCCC---CccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCC----CceeEe
Q 002774 626 QMLIYEFVPNGSLGDSLSGKN---GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDER----LNAKVA 698 (882)
Q Consensus 626 ~~lV~e~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~----~~~kl~ 698 (882)
.++++||.+. +|.+.++.+. ...++...+.+|+.||+.|+.|||+.. |+||||||.|||+..+ |.+||+
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEee
Confidence 8999999987 7877775432 346888899999999999999999999 9999999999999877 999999
Q ss_pred ecccccccCCCCCce-eeeeeeccCCCCCHHHHhh-CCCCchhHHHHHHHHHHHHHhCCCCCCCCc--------hHHHHH
Q 002774 699 DFGLSKSMSDSEKDH-ITTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGK--------YIVREI 768 (882)
Q Consensus 699 DfGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvll~el~tg~~P~~~~~--------~~~~~~ 768 (882)
|||+||.+.+.-... ....++-|++|+|||.+.+ ..||.+.||||.|||+.||+|-++-|...+ ...+++
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl 258 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQL 258 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHH
Confidence 999999887654322 3345778999999999986 568999999999999999999766554211 112223
Q ss_pred HHHHHhhh-----hhhhhhhccCC---------cCCCCCCH-H-------HHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 769 RTVMDKKK-----ELYNLYELIDP---------TIGLSTTL-K-------GFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 769 ~~~~~~~~-----~~~~~~~~~d~---------~l~~~~~~-~-------~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
..+++-.. .+..+....+- ........ . .....++|+.+++..||.+|.|+++++++
T Consensus 259 ~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh 337 (438)
T KOG0666|consen 259 DRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH 337 (438)
T ss_pred HHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence 33322100 00000000000 00000000 0 01236799999999999999999999986
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=299.82 Aligned_cols=243 Identities=26% Similarity=0.395 Sum_probs=194.6
Q ss_pred eeccCcEEEEEEEec-CCcEEEEEEcccCCc---ccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEeecCCCc
Q 002774 563 VGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM---QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSL 638 (882)
Q Consensus 563 lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 638 (882)
||+|+||.||+|+.. +|+.||+|.+..... ...+.+.+|++++++++||||+++++.+..+...++||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999976 489999999876443 3346788899999999999999999999999999999999999999
Q ss_pred ccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCC------c
Q 002774 639 GDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEK------D 712 (882)
Q Consensus 639 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~------~ 712 (882)
.+++.... .+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.++|+|||++........ .
T Consensus 81 ~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 155 (265)
T cd05579 81 ASLLENVG--SLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE 155 (265)
T ss_pred HHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence 99987644 6899999999999999999999988 99999999999999999999999999876543321 1
Q ss_pred eeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCCCC
Q 002774 713 HITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLS 792 (882)
Q Consensus 713 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 792 (882)
.......++..|+|||.......+.++||||||+++||+++|..||..... ........... .. ..
T Consensus 156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-~~~~~~~~~~~---------~~----~~ 221 (265)
T cd05579 156 KEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP-EEIFQNILNGK---------IE----WP 221 (265)
T ss_pred ccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHhcCC---------cC----CC
Confidence 122334578899999999988899999999999999999999999965432 11111111100 00 00
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002774 793 TTLKGFEKYVDLALKCVQESGDDRPTMSEVVK 824 (882)
Q Consensus 793 ~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~ 824 (882)
........+.+++.+||+.+|++|||+.++.+
T Consensus 222 ~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~ 253 (265)
T cd05579 222 EDVEVSDEAIDLISKLLVPDPEKRLGAKSIEE 253 (265)
T ss_pred ccccCCHHHHHHHHHHhcCCHhhcCCCccHHH
Confidence 01112467899999999999999999944443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=291.90 Aligned_cols=250 Identities=26% Similarity=0.407 Sum_probs=196.5
Q ss_pred CCeeeccCcEEEEEEEec-CCcEEEEEEcccCCc-ccHHHHHHHHHHHHhc-cCCCeeeEEEEEEeCCceEEEEEeecCC
Q 002774 560 ANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM-QGGQEFKMEIELLSRV-HHKNLVSLLGFCFDRGEQMLIYEFVPNG 636 (882)
Q Consensus 560 ~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~~g 636 (882)
...||.|+||+|+|-.++ .|+..|||+++.... .+.+++..|.+...+- ++||||+++|++..++..|+.||+|+ .
T Consensus 69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd-~ 147 (361)
T KOG1006|consen 69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD-I 147 (361)
T ss_pred HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh-h
Confidence 456999999999999864 699999999987655 4557788888876655 79999999999999999999999994 4
Q ss_pred Ccccc---cCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCce
Q 002774 637 SLGDS---LSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDH 713 (882)
Q Consensus 637 sL~~~---l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 713 (882)
|+..+ ++......+++.-.-.|....+.||.||.+.- .|||||+||+|||+|..|.+||||||.+..+.++ .
T Consensus 148 SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S---i 222 (361)
T KOG1006|consen 148 SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS---I 222 (361)
T ss_pred hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHH---H
Confidence 55433 22233446778777888888899999997643 3999999999999999999999999999876442 2
Q ss_pred eeeeeeccCCCCCHHHHhh--CCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCCC
Q 002774 714 ITTQVKGTMGYLDPEYYMT--QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGL 791 (882)
Q Consensus 714 ~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 791 (882)
..+.-.|...|||||.+.. ..|+.+|||||+|++|+|+.||..|+..-.+..+++..+..... |.+..
T Consensus 223 AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdp----------p~l~~ 292 (361)
T KOG1006|consen 223 AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDP----------PILLF 292 (361)
T ss_pred HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCC----------CeecC
Confidence 2344568899999999973 35899999999999999999999999765555555555443322 11211
Q ss_pred C-CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 792 S-TTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 792 ~-~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
+ ...+....+..++.-|+.+|-.+||++.++.+.
T Consensus 293 ~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 293 DKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred cccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 1 123345778999999999999999999999874
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=329.16 Aligned_cols=254 Identities=26% Similarity=0.386 Sum_probs=189.6
Q ss_pred HHHHcCCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCC-cccHHHHHHHHHHHHhccCCCeeeEEEEEEeC-----
Q 002774 551 KKYTNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS-MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDR----- 623 (882)
Q Consensus 551 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~----- 623 (882)
-+...+|...+.||+||||.|||++.+ ||+.||||++.-.. ......+.+|+.++++|+|||||+++..|.+.
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 456778888999999999999999965 89999999997653 22235678899999999999999987543210
Q ss_pred --------------------------------------------------------------------------------
Q 002774 624 -------------------------------------------------------------------------------- 623 (882)
Q Consensus 624 -------------------------------------------------------------------------------- 623 (882)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred ----------------------------------CceEEEEEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhh
Q 002774 624 ----------------------------------GEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYL 669 (882)
Q Consensus 624 ----------------------------------~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yL 669 (882)
...||-||||+..++.++++.+.... .....++++.+|++||+|+
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-~~d~~wrLFreIlEGLaYI 713 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS-QRDEAWRLFREILEGLAYI 713 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-hhHHHHHHHHHHHHHHHHH
Confidence 01367788887777777776543111 3556789999999999999
Q ss_pred hhcCCCCeeecCCCCCceEEcCCCceeEeecccccccC----C------------CCCceeeeeeeccCCCCCHHHHhhC
Q 002774 670 HELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMS----D------------SEKDHITTQVKGTMGYLDPEYYMTQ 733 (882)
Q Consensus 670 H~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~----~------------~~~~~~~~~~~gt~~y~aPE~~~~~ 733 (882)
|+.| ||||||||.||++|++..+||+|||+|+... . .......+..+||.-|+|||++.+.
T Consensus 714 H~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~ 790 (1351)
T KOG1035|consen 714 HDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT 790 (1351)
T ss_pred HhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence 9999 9999999999999999999999999998721 0 1112234567899999999999854
Q ss_pred ---CCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCCCC--CCHHHHHHHHHHHHHh
Q 002774 734 ---QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLS--TTLKGFEKYVDLALKC 808 (882)
Q Consensus 734 ---~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~--~~~~~~~~l~~li~~c 808 (882)
.|+.|+|+||+|||++||+. ||...-.-.. ++.. + -++.++.. ...+....=..+|++|
T Consensus 791 ~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~----iL~~------L---R~g~iP~~~~f~~~~~~~e~slI~~L 854 (1351)
T KOG1035|consen 791 SSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERAS----ILTN------L---RKGSIPEPADFFDPEHPEEASLIRWL 854 (1351)
T ss_pred ccccccchhhhHHHHHHHHHHhc---cCCchHHHHH----HHHh------c---ccCCCCCCcccccccchHHHHHHHHH
Confidence 49999999999999999984 6653211111 1111 1 12222222 2222334456899999
Q ss_pred hccCCCCCCCHHHHHH
Q 002774 809 VQESGDDRPTMSEVVK 824 (882)
Q Consensus 809 l~~dp~~RPs~~evl~ 824 (882)
++.||.+|||+.|+++
T Consensus 855 l~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 855 LSHDPSKRPTATELLN 870 (1351)
T ss_pred hcCCCccCCCHHHHhh
Confidence 9999999999999985
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=296.73 Aligned_cols=248 Identities=27% Similarity=0.409 Sum_probs=202.3
Q ss_pred CCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCCc--ccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEe
Q 002774 556 NFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM--QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEF 632 (882)
Q Consensus 556 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 632 (882)
+|+..+.||+|+||.||+++.. +++.+|+|.+..... ....++.+|+++++.++|+||+++.+++.+....++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4677889999999999999854 688999999875432 2345678899999999999999999999999999999999
Q ss_pred ecCCCcccccCCCC--CccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCC
Q 002774 633 VPNGSLGDSLSGKN--GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE 710 (882)
Q Consensus 633 ~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~ 710 (882)
+++++|.+++.... ...+++..++.++.|++.||+|||+.+ ++|+||+|+||++++++.+|++|||+++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 157 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKNM 157 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence 99999999886522 246889999999999999999999998 9999999999999999999999999998765431
Q ss_pred CceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCC
Q 002774 711 KDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIG 790 (882)
Q Consensus 711 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 790 (882)
.....++..|+|||...+..++.++|+||+|+++|||++|+.||...... ..... .... . -+.
T Consensus 158 ----~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~-~~~~~-~~~~--------~-~~~-- 220 (256)
T cd08530 158 ----AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ-DLRYK-VQRG--------K-YPP-- 220 (256)
T ss_pred ----cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHH-HhcC--------C-CCC--
Confidence 22345788999999999989999999999999999999999999754321 11111 1110 0 011
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 791 LSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 791 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
.......++.+++.+|++.+|++||++.|++++
T Consensus 221 --~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 221 --IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred --CchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 111344778999999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=303.25 Aligned_cols=267 Identities=24% Similarity=0.351 Sum_probs=194.4
Q ss_pred HcCCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCCcc--cHHHHHHHHHHHHhccCCCeeeEEEEEEeCCc-----
Q 002774 554 TNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQ--GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGE----- 625 (882)
Q Consensus 554 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~----- 625 (882)
.++|...+.||+|+||.||+|+.. +++.||||++...... ....+.+|++++++++||||+++++++...+.
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 346888999999999999999864 6899999988643222 23456789999999999999999999876543
Q ss_pred ---eEEEEEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeeccc
Q 002774 626 ---QMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGL 702 (882)
Q Consensus 626 ---~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGl 702 (882)
.++||||+. ++|.+.+.... ..+++.++..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+
T Consensus 91 ~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~ 165 (310)
T cd07865 91 KGSFYLVFEFCE-HDLAGLLSNKN-VKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGL 165 (310)
T ss_pred CceEEEEEcCCC-cCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCCC
Confidence 499999996 47777775432 35899999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCc--eeeeeeeccCCCCCHHHHhhC-CCCchhHHHHHHHHHHHHHhCCCCCCCCchHHH--HHHHHHHhhh-
Q 002774 703 SKSMSDSEKD--HITTQVKGTMGYLDPEYYMTQ-QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVR--EIRTVMDKKK- 776 (882)
Q Consensus 703 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~--~~~~~~~~~~- 776 (882)
+..+...... .......++..|+|||.+.+. .++.++||||||+++|||++|..||........ .+........
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (310)
T cd07865 166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITP 245 (310)
T ss_pred cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 9876443221 112234578899999998754 478899999999999999999999865432211 1111110000
Q ss_pred hhh------hhhhcc-CCcCCCC------CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 777 ELY------NLYELI-DPTIGLS------TTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 777 ~~~------~~~~~~-d~~l~~~------~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
... .....+ .+..... ........+.+++.+||+.||.+|||++|++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 246 EVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred hhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 000 000000 0000000 000012456799999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-33 Score=295.16 Aligned_cols=239 Identities=23% Similarity=0.297 Sum_probs=185.9
Q ss_pred CeeeccCcEEEEEEEec-CCcEEEEEEcccCCccc---HHHHHHHHHHH-HhccCCCeeeEEEEEEeCCceEEEEEeecC
Q 002774 561 NDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQG---GQEFKMEIELL-SRVHHKNLVSLLGFCFDRGEQMLIYEFVPN 635 (882)
Q Consensus 561 ~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~---~~~~~~E~~~l-~~l~H~niv~l~~~~~~~~~~~lV~e~~~~ 635 (882)
+.||+|+||.||+|... +|+.||||.++...... ...+..|..++ ...+|+|++++++++..++..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 46899999999999864 68999999987543221 12344555544 345899999999999999999999999999
Q ss_pred CCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCceee
Q 002774 636 GSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHIT 715 (882)
Q Consensus 636 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 715 (882)
++|.+++.... .+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.+||+|||+++.... .
T Consensus 82 ~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~ 150 (260)
T cd05611 82 GDCASLIKTLG--GLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------N 150 (260)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc------c
Confidence 99999987543 5788889999999999999999988 99999999999999999999999999875432 1
Q ss_pred eeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCCCCCCH
Q 002774 716 TQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTL 795 (882)
Q Consensus 716 ~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 795 (882)
....++..|+|||.+.+..++.++||||||+++|||++|..||...... .......... .+ .......
T Consensus 151 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~---------~~--~~~~~~~ 218 (260)
T cd05611 151 KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD-AVFDNILSRR---------IN--WPEEVKE 218 (260)
T ss_pred ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHhcc---------cC--CCCcccc
Confidence 2345888999999998888999999999999999999999999654321 1111111100 00 0000111
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCHHHH
Q 002774 796 KGFEKYVDLALKCVQESGDDRPTMSEV 822 (882)
Q Consensus 796 ~~~~~l~~li~~cl~~dp~~RPs~~ev 822 (882)
.....+.+++.+||+.+|++||++.++
T Consensus 219 ~~~~~~~~~i~~~l~~~p~~R~~~~~~ 245 (260)
T cd05611 219 FCSPEAVDLINRLLCMDPAKRLGANGY 245 (260)
T ss_pred cCCHHHHHHHHHHccCCHHHccCCCcH
Confidence 234678999999999999999976543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=308.35 Aligned_cols=261 Identities=24% Similarity=0.374 Sum_probs=195.0
Q ss_pred HcCCCCCCeeeccCcEEEEEEEe-cCCcEEEEEEcccCCc--ccHHHHHHHHHHHHhccCCCeeeEEEEEEeCC------
Q 002774 554 TNNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSM--QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRG------ 624 (882)
Q Consensus 554 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------ 624 (882)
.++|...+.||+|+||.||+|+. .+|+.||||+++.... .....+.+|+++++.++||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 46888899999999999999985 4689999999875322 22356788999999999999999999987543
Q ss_pred ceEEEEEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeeccccc
Q 002774 625 EQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSK 704 (882)
Q Consensus 625 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~ 704 (882)
..++|+||+.. +|..++. ..+++..+..++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||+++
T Consensus 94 ~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~~ 165 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 165 (342)
T ss_pred eEEEEeccccc-CHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCCc
Confidence 46899999964 6655442 25788999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCCceeeeeeeccCCCCCHHHHhh-CCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhh-h-----
Q 002774 705 SMSDSEKDHITTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKK-E----- 777 (882)
Q Consensus 705 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~-~----- 777 (882)
...... ....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...... ..+........ .
T Consensus 166 ~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~ 239 (342)
T cd07879 166 HADAEM-----TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL-DQLTQILKVTGVPGPEFV 239 (342)
T ss_pred CCCCCC-----CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCCHHHH
Confidence 653221 23457889999999876 46889999999999999999999999754322 22222221100 0
Q ss_pred -------hhhhhhccCCcCCCCC----CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHHH
Q 002774 778 -------LYNLYELIDPTIGLST----TLKGFEKYVDLALKCVQESGDDRPTMSEVVKD--IENI 829 (882)
Q Consensus 778 -------~~~~~~~~d~~l~~~~----~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~--L~~~ 829 (882)
........ +...... ......++.+++.+||+.||++||+++|++.+ ++..
T Consensus 240 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~ 303 (342)
T cd07879 240 QKLEDKAAKSYIKSL-PKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303 (342)
T ss_pred HHhcccchHHHHhhc-CCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence 00000000 0000000 01123568899999999999999999999975 4443
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=285.77 Aligned_cols=249 Identities=25% Similarity=0.286 Sum_probs=202.9
Q ss_pred HcCCCCCCeeeccCcEEEEEEEe-cCCcEEEEEEcccCCcccHHHH---HHHHHHHHhccCCCeeeEEEEEEeCCceEEE
Q 002774 554 TNNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQGGQEF---KMEIELLSRVHHKNLVSLLGFCFDRGEQMLI 629 (882)
Q Consensus 554 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~---~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 629 (882)
.++|...++||+|.||.|-.++- .+|+.+|+|++++...-..++. ..|-++|+..+||.+..+...++..+..++|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 35677889999999999999985 4799999999998765554443 4588999999999999999999999999999
Q ss_pred EEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCC
Q 002774 630 YEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDS 709 (882)
Q Consensus 630 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~ 709 (882)
|||..+|.|.-+|.... .+++.+.......|+.||.|||+.+ ||.||+|.+|.|+|.||++||+|||+++.--
T Consensus 247 MeyanGGeLf~HLsrer--~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I-- 319 (516)
T KOG0690|consen 247 MEYANGGELFFHLSRER--VFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEI-- 319 (516)
T ss_pred EEEccCceEeeehhhhh--cccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcc--
Confidence 99999999998887654 6888888889999999999999988 9999999999999999999999999997532
Q ss_pred CCceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcC
Q 002774 710 EKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTI 789 (882)
Q Consensus 710 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 789 (882)
.....+..++||+.|+|||++....|..++|.|.+|||+|||++|+.||.......-.-...+.+.+
T Consensus 320 ~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~k------------- 386 (516)
T KOG0690|consen 320 KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLK------------- 386 (516)
T ss_pred cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhcc-------------
Confidence 2334566789999999999999999999999999999999999999999754432211111111111
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 002774 790 GLSTTLKGFEKYVDLALKCVQESGDDRP-----TMSEVVKD 825 (882)
Q Consensus 790 ~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~evl~~ 825 (882)
++.....+...|+...+.+||.+|. .+.||.++
T Consensus 387 ---FPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h 424 (516)
T KOG0690|consen 387 ---FPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRH 424 (516)
T ss_pred ---CCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence 1112235677899999999999994 45666653
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-33 Score=302.61 Aligned_cols=246 Identities=28% Similarity=0.448 Sum_probs=194.3
Q ss_pred CCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCCc---ccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEe
Q 002774 557 FSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM---QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEF 632 (882)
Q Consensus 557 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 632 (882)
|...+.||+|+||+||+|+.. +++.||+|.+..... ...+++.+|+++++.++|+|++++++++......++||||
T Consensus 17 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 96 (308)
T cd06634 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY 96 (308)
T ss_pred HHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEc
Confidence 556678999999999999964 688999998864322 2235678899999999999999999999999999999999
Q ss_pred ecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCc
Q 002774 633 VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKD 712 (882)
Q Consensus 633 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 712 (882)
+. |++.+.+.... ..+++.++..++.|++.|+.|||+.+ ++||||||+||+++.++.++|+|||++......
T Consensus 97 ~~-~~l~~~~~~~~-~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~--- 168 (308)
T cd06634 97 CL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--- 168 (308)
T ss_pred cC-CCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc---
Confidence 96 67777665332 35789999999999999999999988 999999999999999999999999998765432
Q ss_pred eeeeeeeccCCCCCHHHHh---hCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcC
Q 002774 713 HITTQVKGTMGYLDPEYYM---TQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTI 789 (882)
Q Consensus 713 ~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 789 (882)
....++..|+|||.+. .+.++.++|||||||++|||++|..||....... ........ ..+..
T Consensus 169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~~~~~----------~~~~~ 234 (308)
T cd06634 169 ---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIAQN----------ESPAL 234 (308)
T ss_pred ---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH-HHHHHhhc----------CCCCc
Confidence 2345888999999985 3568889999999999999999999986532211 11111100 00111
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 002774 790 GLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIE 827 (882)
Q Consensus 790 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~ 827 (882)
........+.+++.+||+.+|++||++.+++++-.
T Consensus 235 ---~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 235 ---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred ---CcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence 11123466889999999999999999999998644
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-33 Score=299.49 Aligned_cols=254 Identities=26% Similarity=0.317 Sum_probs=197.0
Q ss_pred CCCCCCeeeccCcEEEEEEEe----cCCcEEEEEEcccCCc----ccHHHHHHHHHHHHhc-cCCCeeeEEEEEEeCCce
Q 002774 556 NFSDANDVGSGGYGKVYKGTL----PNGQLIAIKRAQQGSM----QGGQEFKMEIELLSRV-HHKNLVSLLGFCFDRGEQ 626 (882)
Q Consensus 556 ~~~~~~~lG~G~fg~Vy~~~~----~~g~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~ 626 (882)
+|...+.||+|+||.||+|+. .+++.||||.++.... ...+.+.+|++++.++ +||||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 366778999999999999974 3578999999875321 2335678899999999 599999999999999999
Q ss_pred EEEEEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeeccccccc
Q 002774 627 MLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSM 706 (882)
Q Consensus 627 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~ 706 (882)
++||||+++|+|.+++.... .+++..+..++.|+++||+|||+.+ ++||||||+||+++.++.++|+|||+++..
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 155 (288)
T cd05583 81 HLILDYVNGGELFTHLYQRE--HFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (288)
T ss_pred EEEEecCCCCcHHHHHhhcC--CcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECcccccc
Confidence 99999999999999886543 5888899999999999999999988 999999999999999999999999999876
Q ss_pred CCCCCceeeeeeeccCCCCCHHHHhhCC--CCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhc
Q 002774 707 SDSEKDHITTQVKGTMGYLDPEYYMTQQ--LTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYEL 784 (882)
Q Consensus 707 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 784 (882)
..... .......|+..|+|||.+.+.. .+.++||||||+++|||++|..||......... ....... ..
T Consensus 156 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~-~~~~~~~------~~- 226 (288)
T cd05583 156 LAEEE-ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQ-SEISRRI------LK- 226 (288)
T ss_pred ccccc-cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchH-HHHHHHH------Hc-
Confidence 44322 1222346889999999987655 788999999999999999999998532211110 0100000 00
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 002774 785 IDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIE 827 (882)
Q Consensus 785 ~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~ 827 (882)
..+... ......+.+++.+||+.||++|||+.++.+.|+
T Consensus 227 ~~~~~~----~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~ 265 (288)
T cd05583 227 SKPPFP----KTMSAEARDFIQKLLEKDPKKRLGANGADEIKN 265 (288)
T ss_pred cCCCCC----cccCHHHHHHHHHHhcCCHhhccCcchHHHHhc
Confidence 011111 112356789999999999999999887766544
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-33 Score=307.20 Aligned_cols=267 Identities=24% Similarity=0.358 Sum_probs=201.3
Q ss_pred CHHHHHHHHcCCCCCCeeeccCcEEEEEEEe-cCCcEEEEEEcccCC--cccHHHHHHHHHHHHhccCCCeeeEEEEEEe
Q 002774 546 SFEEVKKYTNNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGS--MQGGQEFKMEIELLSRVHHKNLVSLLGFCFD 622 (882)
Q Consensus 546 ~~~e~~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~ 622 (882)
...++...+++|...+.||+|+||.||+|.. .+++.||+|+++... ....+.+.+|++++++++||||+++++++..
T Consensus 8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~ 87 (345)
T cd07877 8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 87 (345)
T ss_pred HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence 3456777889999999999999999999985 578999999987532 2224567889999999999999999998864
Q ss_pred C------CceEEEEEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCcee
Q 002774 623 R------GEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAK 696 (882)
Q Consensus 623 ~------~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~k 696 (882)
. ...+++++++ +++|.+++... .+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+|
T Consensus 88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~k 160 (345)
T cd07877 88 ARSLEEFNDVYLVTHLM-GADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELK 160 (345)
T ss_pred cccccccccEEEEehhc-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEE
Confidence 3 3467888887 78888877643 4889999999999999999999998 99999999999999999999
Q ss_pred EeecccccccCCCCCceeeeeeeccCCCCCHHHHhh-CCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhh
Q 002774 697 VADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKK 775 (882)
Q Consensus 697 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~ 775 (882)
|+|||+++..... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...... ..........
T Consensus 161 l~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~-~~~~~~~~~~ 234 (345)
T cd07877 161 ILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLV 234 (345)
T ss_pred Eeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHh
Confidence 9999999865322 223467889999999876 56889999999999999999999998643322 1111111100
Q ss_pred h-hhhhhh------------hccCCcCCC---CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 776 K-ELYNLY------------ELIDPTIGL---STTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 776 ~-~~~~~~------------~~~d~~l~~---~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
. ...... ..++..... ........++.+++.+|++.||.+||++.+++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 235 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred CCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 0 000000 000000000 0000123568899999999999999999999976
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=306.73 Aligned_cols=265 Identities=20% Similarity=0.357 Sum_probs=199.4
Q ss_pred HcCCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCCc--ccHHHHHHHHHHHHhccCCCeeeEEEEEEe----CCce
Q 002774 554 TNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM--QGGQEFKMEIELLSRVHHKNLVSLLGFCFD----RGEQ 626 (882)
Q Consensus 554 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~ 626 (882)
.++|...+.||+|+||.||+|+.. +|+.||+|++..... ...+.+.+|+.++++++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 367888899999999999999854 689999999875422 234667889999999999999999998753 3467
Q ss_pred EEEEEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeeccccccc
Q 002774 627 MLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSM 706 (882)
Q Consensus 627 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~ 706 (882)
++||||+. |+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++..
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~ 157 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQ--PLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGL 157 (334)
T ss_pred EEEEehhh-hhHHHHhccCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccceee
Confidence 99999995 68988886543 5899999999999999999999988 999999999999999999999999999765
Q ss_pred CCCCCc--eeeeeeeccCCCCCHHHHhh-CCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhh-------
Q 002774 707 SDSEKD--HITTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKK------- 776 (882)
Q Consensus 707 ~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~------- 776 (882)
...... .......|+..|+|||.+.. ..++.++|||||||++|||++|+.||....... .+........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~-~~~~~~~~~g~~~~~~~ 236 (334)
T cd07855 158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVH-QLKLILSVLGSPSEEVL 236 (334)
T ss_pred cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHH-HHHHHHHHhCCChhHhh
Confidence 432211 11223468899999999865 468899999999999999999999996543321 1111111000
Q ss_pred ------hhhhhhhccCCcCCCC---CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 777 ------ELYNLYELIDPTIGLS---TTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 777 ------~~~~~~~~~d~~l~~~---~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
......+......... .......++.+++.+||+.+|++||++++++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0000000000000000 001234678999999999999999999999985
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=307.85 Aligned_cols=262 Identities=22% Similarity=0.348 Sum_probs=197.8
Q ss_pred HcCCCCCCeeeccCcEEEEEEEe-cCCcEEEEEEcccC--CcccHHHHHHHHHHHHhccCCCeeeEEEEEEeC-----Cc
Q 002774 554 TNNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQG--SMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDR-----GE 625 (882)
Q Consensus 554 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~ 625 (882)
.++|...+.||+|+||+||+|+. .+++.||||+++.. .....+.+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 35688899999999999999985 46899999998753 222345677899999999999999999988654 34
Q ss_pred eEEEEEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccc
Q 002774 626 QMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKS 705 (882)
Q Consensus 626 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~ 705 (882)
.++||||+. ++|.+++.... .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++.
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 157 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSSQ--TLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLART 157 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCccccc
Confidence 799999995 68888886543 6889999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCCceeeeeeeccCCCCCHHHHhh-CCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhh--------
Q 002774 706 MSDSEKDHITTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKK-------- 776 (882)
Q Consensus 706 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~-------- 776 (882)
..... .......++..|+|||.+.. ..++.++|||||||++|||++|+.||..... ............
T Consensus 158 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~ 234 (337)
T cd07858 158 TSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDY-VHQLKLITELLGSPSEEDLG 234 (337)
T ss_pred cCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCh-HHHHHHHHHHhCCCChHHhh
Confidence 64332 11233457889999999875 5688999999999999999999999964322 111111110000
Q ss_pred -----hhhhhhh----ccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 777 -----ELYNLYE----LIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 777 -----~~~~~~~----~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
....... ..++... ........++.+++.+||+.+|++|||++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 235 FIRNEKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred hcCchhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 0000000 0000000 0011234678899999999999999999999987
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=295.99 Aligned_cols=241 Identities=24% Similarity=0.310 Sum_probs=187.4
Q ss_pred eeeccCcEEEEEEEe-cCCcEEEEEEcccCCcc---cHHHHHHHHH---HHHhccCCCeeeEEEEEEeCCceEEEEEeec
Q 002774 562 DVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQ---GGQEFKMEIE---LLSRVHHKNLVSLLGFCFDRGEQMLIYEFVP 634 (882)
Q Consensus 562 ~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~---~~~~~~~E~~---~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 634 (882)
.||+|+||.||+|.. .+++.||+|.+...... ....+..|.. .++...||||+++++++.+.+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999986 46889999998754322 1122344443 3444579999999999999999999999999
Q ss_pred CCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCcee
Q 002774 635 NGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHI 714 (882)
Q Consensus 635 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 714 (882)
+|+|.+++.... .+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+||+|||+++.......
T Consensus 81 g~~L~~~l~~~~--~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~--- 152 (278)
T cd05606 81 GGDLHYHLSQHG--VFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP--- 152 (278)
T ss_pred CCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccCC---
Confidence 999998886543 6899999999999999999999988 99999999999999999999999999976543221
Q ss_pred eeeeeccCCCCCHHHHhhC-CCCchhHHHHHHHHHHHHHhCCCCCCCCchHH-HHHHHHHHhhhhhhhhhhccCCcCCCC
Q 002774 715 TTQVKGTMGYLDPEYYMTQ-QLTEKSDVYSFGVLMLELLTGRRPIERGKYIV-REIRTVMDKKKELYNLYELIDPTIGLS 792 (882)
Q Consensus 715 ~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~-~~~~~~~~~~~~~~~~~~~~d~~l~~~ 792 (882)
....|+..|+|||.+.++ .++.++||||+||++|||++|+.||....... ....... ...++...
T Consensus 153 -~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~----------~~~~~~~~-- 219 (278)
T cd05606 153 -HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT----------LTMAVELP-- 219 (278)
T ss_pred -cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHh----------hccCCCCC--
Confidence 234689999999999754 68999999999999999999999997542211 1111100 01111111
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 002774 793 TTLKGFEKYVDLALKCVQESGDDRP-----TMSEVVKD 825 (882)
Q Consensus 793 ~~~~~~~~l~~li~~cl~~dp~~RP-----s~~evl~~ 825 (882)
.....++.+++.+|+..+|.+|| ++.+++++
T Consensus 220 --~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 220 --DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred --CcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 11246788999999999999999 99999863
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=298.84 Aligned_cols=250 Identities=28% Similarity=0.361 Sum_probs=195.2
Q ss_pred CCCCCCeeeccCcEEEEEEEe----cCCcEEEEEEcccCCc----ccHHHHHHHHHHHHhc-cCCCeeeEEEEEEeCCce
Q 002774 556 NFSDANDVGSGGYGKVYKGTL----PNGQLIAIKRAQQGSM----QGGQEFKMEIELLSRV-HHKNLVSLLGFCFDRGEQ 626 (882)
Q Consensus 556 ~~~~~~~lG~G~fg~Vy~~~~----~~g~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~ 626 (882)
+|+..+.||+|+||.||+|+. .+|+.||+|+++.... ...+.+.+|+++++++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 367788999999999999985 3689999999875322 2335678899999999 599999999999998899
Q ss_pred EEEEEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeeccccccc
Q 002774 627 MLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSM 706 (882)
Q Consensus 627 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~ 706 (882)
++||||+++++|.+++.... .+++.....++.|+++||+|||+.+ ++||||+|+||++++++.+||+|||+++..
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 155 (290)
T cd05613 81 HLILDYINGGELFTHLSQRE--RFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEF 155 (290)
T ss_pred EEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCccceec
Confidence 99999999999999987543 5788888999999999999999988 999999999999999999999999999876
Q ss_pred CCCCCceeeeeeeccCCCCCHHHHhhC--CCCchhHHHHHHHHHHHHHhCCCCCCCCchH--HHHHHHHHHhhhhhhhhh
Q 002774 707 SDSEKDHITTQVKGTMGYLDPEYYMTQ--QLTEKSDVYSFGVLMLELLTGRRPIERGKYI--VREIRTVMDKKKELYNLY 782 (882)
Q Consensus 707 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~--~~~~~~~~~~~~~~~~~~ 782 (882)
..... .......|+..|+|||.+... .++.++||||||+++|||++|..||...... ..........
T Consensus 156 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~-------- 226 (290)
T cd05613 156 HEDEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILK-------- 226 (290)
T ss_pred ccccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhc--------
Confidence 44322 112234588999999998753 4678999999999999999999998632111 1111111000
Q ss_pred hccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 002774 783 ELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRP-----TMSEVVKD 825 (882)
Q Consensus 783 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~evl~~ 825 (882)
..+.. +......+.+++.+||+.||++|| ++.+++++
T Consensus 227 --~~~~~----~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 227 --SEPPY----PQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred --cCCCC----CccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 01111 112336788999999999999997 66666653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=306.37 Aligned_cols=263 Identities=24% Similarity=0.364 Sum_probs=198.5
Q ss_pred HHHHHcCCCCCCeeeccCcEEEEEEEe-cCCcEEEEEEcccCCc--ccHHHHHHHHHHHHhccCCCeeeEEEEEEeCC--
Q 002774 550 VKKYTNNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSM--QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRG-- 624 (882)
Q Consensus 550 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-- 624 (882)
+....++|...+.||+|+||+||+|.. .+|+.||||++..... ...+.+.+|++++++++||||+++++++....
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence 334567899999999999999999985 4789999999864322 22356788999999999999999999987653
Q ss_pred ----ceEEEEEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeec
Q 002774 625 ----EQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADF 700 (882)
Q Consensus 625 ----~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~Df 700 (882)
..++||||+ +++|.+++... .+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+|++||
T Consensus 90 ~~~~~~~lv~e~~-~~~l~~~~~~~---~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~df 162 (343)
T cd07880 90 DRFHDFYLVMPFM-GTDLGKLMKHE---KLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDF 162 (343)
T ss_pred cccceEEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeec
Confidence 358999999 77888877643 5889999999999999999999998 999999999999999999999999
Q ss_pred ccccccCCCCCceeeeeeeccCCCCCHHHHhh-CCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhh-h
Q 002774 701 GLSKSMSDSEKDHITTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKE-L 778 (882)
Q Consensus 701 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~-~ 778 (882)
|+++...... ....+++.|+|||.+.+ ..++.++|||||||++|++++|..||...... ......+..... .
T Consensus 163 g~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~ 236 (343)
T cd07880 163 GLARQTDSEM-----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHL-DQLMEIMKVTGTPS 236 (343)
T ss_pred ccccccccCc-----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCC
Confidence 9998654321 23457889999999876 46889999999999999999999999754332 222221111000 0
Q ss_pred hhhhhccC-----------CcCCC----CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 779 YNLYELID-----------PTIGL----STTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 779 ~~~~~~~d-----------~~l~~----~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
..+...+. +.... ........++.+++.+|++.||++|||+.+++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~ 298 (343)
T cd07880 237 KEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH 298 (343)
T ss_pred HHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000 00000 0001223568899999999999999999999964
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=300.39 Aligned_cols=261 Identities=22% Similarity=0.345 Sum_probs=197.7
Q ss_pred CCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCCc-ccHHHHHHHHHHHHhcc-CCCeeeEEEEEEeCCceEEEEEee
Q 002774 557 FSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM-QGGQEFKMEIELLSRVH-HKNLVSLLGFCFDRGEQMLIYEFV 633 (882)
Q Consensus 557 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~e~~ 633 (882)
|...+.||+|+||+||+|+.. +++.||||++..... .......+|+..+++++ |+||+++++++.+++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 566788999999999999975 578999999875432 22334567999999999 999999999999999999999999
Q ss_pred cCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCce
Q 002774 634 PNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDH 713 (882)
Q Consensus 634 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 713 (882)
+|+|.+++.......+++..+..++.|++.+|.|||+.+ ++|+||+|+||++++++.++|+|||+++.......
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 154 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP-- 154 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCC--
Confidence 889998887655457899999999999999999999998 99999999999999999999999999986643222
Q ss_pred eeeeeeccCCCCCHHHHh-hCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhh--------hhhhhhc
Q 002774 714 ITTQVKGTMGYLDPEYYM-TQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKE--------LYNLYEL 784 (882)
Q Consensus 714 ~~~~~~gt~~y~aPE~~~-~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~--------~~~~~~~ 784 (882)
.....++..|+|||.+. ...++.++||||||++++||++|+.||...... +........... .......
T Consensus 155 -~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07830 155 -YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEI-DQLYKICSVLGTPTKQDWPEGYKLASK 232 (283)
T ss_pred -cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChH-HHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence 22345788999999885 456789999999999999999999888543321 111111110000 0000000
Q ss_pred cCCcCCC-------CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 785 IDPTIGL-------STTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 785 ~d~~l~~-------~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
++..... ........++.+++.+||+.+|++||++.|++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 0000000 0000113678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=315.01 Aligned_cols=302 Identities=18% Similarity=0.203 Sum_probs=145.6
Q ss_pred ccCccccCCCCCCEEeccCCCCCccCCCccccCCCCCcEEEeeCCcCCccccccccCCCCCCEEEccCCcCCCCCCcCcc
Q 002774 6 QLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIG 85 (882)
Q Consensus 6 ~l~~~~~~l~~L~~L~L~~n~~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~ 85 (882)
.||.-.....+|+.|+|.+|. |..+-.+++..++.|+.|||+.|.|+.+.-.+|..-.++++|+|++|.|+......|.
T Consensus 116 ~IP~f~~~sghl~~L~L~~N~-I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~ 194 (873)
T KOG4194|consen 116 RIPRFGHESGHLEKLDLRHNL-ISSVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFD 194 (873)
T ss_pred hcccccccccceeEEeeeccc-cccccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeecccccccccccccc
Confidence 344444444445555555553 4544455555555555555555555533334444445555555555555555555555
Q ss_pred CCCCCcEeeccCceeeeecCCCCCCCchhhhhhcccceeccCCeeeecCCccccCCcccceeeeccCCcccccCCccccC
Q 002774 86 NLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGL 165 (882)
Q Consensus 86 ~l~~L~~L~Ls~N~i~~~~p~~~~~~~~l~~L~~L~~L~L~~N~l~~~ip~~~f~~~~~L~~L~L~~N~l~~~~~~~~~~ 165 (882)
++.+|.+|.|++|+|+ .+|. ..|+.|++|+.|+|..|+|. .+..-.|.++++|+.|.|..|+|....-..|..
T Consensus 195 ~lnsL~tlkLsrNrit-tLp~-----r~Fk~L~~L~~LdLnrN~ir-ive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~ 267 (873)
T KOG4194|consen 195 SLNSLLTLKLSRNRIT-TLPQ-----RSFKRLPKLESLDLNRNRIR-IVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYG 267 (873)
T ss_pred ccchheeeecccCccc-ccCH-----HHhhhcchhhhhhcccccee-eehhhhhcCchhhhhhhhhhcCcccccCcceee
Confidence 5555555555555555 3332 22344444444555555554 444444555555555555555554444444445
Q ss_pred CCCCCEEEccCCCCCCCCCccCCCCCCCCEEEccCCcccccCCC-CCCCCCCCEEECcCCCCCCCCCCccccCCCCCCEE
Q 002774 166 VKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPN-LTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTL 244 (882)
Q Consensus 166 l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L 244 (882)
|.++++|+|..|++...-.+.+.++++|+.|+||+|.|..+..+ +.-.++|++|+|++|+|+ ...+..|..|..|++|
T Consensus 268 l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~-~l~~~sf~~L~~Le~L 346 (873)
T KOG4194|consen 268 LEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRIT-RLDEGSFRVLSQLEEL 346 (873)
T ss_pred ecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccc-cCChhHHHHHHHhhhh
Confidence 55555555555555444444444455555555555554444332 333444555555555544 2334444444445555
Q ss_pred ECcCCcccccCCccCCCCCCCCEEEccCCccceecCCC----CcccccccccccCCccccccCCCCCCccceEEec
Q 002774 245 MMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLG----TSYSENLLVNLQNNRISAYTERGGAPAVNLTLID 316 (882)
Q Consensus 245 ~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~----~~~~~L~~L~L~~N~i~~~~~~~~~~~~~L~~l~ 316 (882)
+|++|+|+..-..+|..+.+|++|||++|.|+..++.. -+++.|+.|+|.+|+|..++..+|.++.+|+.||
T Consensus 347 nLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~Ld 422 (873)
T KOG4194|consen 347 NLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLD 422 (873)
T ss_pred cccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceec
Confidence 55555544444444444444555555555444433222 1244444444555555555544554444444444
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=259.18 Aligned_cols=263 Identities=23% Similarity=0.332 Sum_probs=204.6
Q ss_pred CCCCCCeeeccCcEEEEEEE-ecCCcEEEEEEcccCCccc--HHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEe
Q 002774 556 NFSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQG--GQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEF 632 (882)
Q Consensus 556 ~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 632 (882)
+|...++||+|.||+||||+ +++++.||+|+++..+..+ .....+|+-+++.++|+|||++++....+...-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 45667889999999999998 5578999999987543322 35678999999999999999999999999999999999
Q ss_pred ecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCc
Q 002774 633 VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKD 712 (882)
Q Consensus 633 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 712 (882)
|. -+|..+....++ .++.....+++.|+.+||.++|++. +.|||+||.|.||+.+|+.|++|||+|+.++-+-
T Consensus 83 cd-qdlkkyfdslng-~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipv-- 155 (292)
T KOG0662|consen 83 CD-QDLKKYFDSLNG-DLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPV-- 155 (292)
T ss_pred hh-HHHHHHHHhcCC-cCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCce--
Confidence 95 477766655432 5788889999999999999999999 9999999999999999999999999999875432
Q ss_pred eeeeeeeccCCCCCHHHHhhC-CCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhh-----hhhhhhhccC
Q 002774 713 HITTQVKGTMGYLDPEYYMTQ-QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKK-----ELYNLYELID 786 (882)
Q Consensus 713 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~d 786 (882)
.-..+.+-|.+|.+|.++.+. -|+...|+||-||++.|+....+|...+.+..+++..++..-. .+..+....|
T Consensus 156 rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpd 235 (292)
T KOG0662|consen 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPD 235 (292)
T ss_pred EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCC
Confidence 234456789999999999865 5888999999999999999988898888888777777664321 1111111111
Q ss_pred CcCCCCCC---------HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 787 PTIGLSTT---------LKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 787 ~~l~~~~~---------~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
-.....++ .+....=.+++++.+.-+|.+|.++++.+++
T Consensus 236 yk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 236 YKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred CcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 11000000 0111223688889999999999999888764
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=281.66 Aligned_cols=263 Identities=22% Similarity=0.343 Sum_probs=206.5
Q ss_pred CHHHHHHHHcCCCCCCeeeccCcEEEEEEE-ecCCcEEEEEEcccCCcccHHHHHHHHHHHHhcc-CCCeeeEEEEEEeC
Q 002774 546 SFEEVKKYTNNFSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVH-HKNLVSLLGFCFDR 623 (882)
Q Consensus 546 ~~~e~~~~~~~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~ 623 (882)
.|+|+...|+ +.||+|+|+.|--++ ..+|..+|||++.+.....+..+.+|++++...+ |+||+++++++.++
T Consensus 74 ~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd 148 (463)
T KOG0607|consen 74 KFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD 148 (463)
T ss_pred hHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence 4777777765 579999999999887 6789999999999887778888999999999995 99999999999999
Q ss_pred CceEEEEEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCc---eeEeec
Q 002774 624 GEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLN---AKVADF 700 (882)
Q Consensus 624 ~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~---~kl~Df 700 (882)
..+|||||-|.+|+|...++.+. .+++.++.++..+||.||.+||..| |.|||+||+|||...... +|||||
T Consensus 149 ~~FYLVfEKm~GGplLshI~~~~--~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDf 223 (463)
T KOG0607|consen 149 TRFYLVFEKMRGGPLLSHIQKRK--HFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDF 223 (463)
T ss_pred ceEEEEEecccCchHHHHHHHhh--hccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeecc
Confidence 99999999999999999997654 6899999999999999999999999 999999999999976544 799999
Q ss_pred ccccccCCCC-----CceeeeeeeccCCCCCHHHHh-----hCCCCchhHHHHHHHHHHHHHhCCCCCC----------C
Q 002774 701 GLSKSMSDSE-----KDHITTQVKGTMGYLDPEYYM-----TQQLTEKSDVYSFGVLMLELLTGRRPIE----------R 760 (882)
Q Consensus 701 Gla~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~S~Gvll~el~tg~~P~~----------~ 760 (882)
.++.-+.-.. .+......+|+..|||||+.. ...|+.+.|.||+|||+|-|++|..||. .
T Consensus 224 DLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdr 303 (463)
T KOG0607|consen 224 DLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDR 303 (463)
T ss_pred ccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccC
Confidence 8875432111 111122356888999999885 2357889999999999999999999985 2
Q ss_pred CchHHHHHHHHHHhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 761 GKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 761 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
|+.-..-....++..++. .++. +...+.....+..+++...+..|+.+|.++.+++++
T Consensus 304 Ge~Cr~CQ~~LFesIQEG--kYeF-----PdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnh 361 (463)
T KOG0607|consen 304 GEVCRVCQNKLFESIQEG--KYEF-----PDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNH 361 (463)
T ss_pred CCccHHHHHHHHHHHhcc--CCcC-----ChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCC
Confidence 222222222222222211 1111 111223334667899999999999999999999974
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=299.40 Aligned_cols=244 Identities=28% Similarity=0.454 Sum_probs=193.3
Q ss_pred CCCCCeeeccCcEEEEEEEe-cCCcEEEEEEcccCCcc---cHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEe
Q 002774 557 FSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQ---GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEF 632 (882)
Q Consensus 557 ~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 632 (882)
|...+.||+|+||+||+|+. .+|+.||+|++...... ..+.+.+|+++++.++|||++++++++.+....++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 55567899999999999986 46889999998653322 235678899999999999999999999999999999999
Q ss_pred ecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCc
Q 002774 633 VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKD 712 (882)
Q Consensus 633 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 712 (882)
+. |++.+++.... ..+++.++..++.|++.|++|||+.+ ++||||+|+||++++++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~---- 173 (313)
T cd06633 103 CL-GSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP---- 173 (313)
T ss_pred CC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC----
Confidence 95 57777765432 36899999999999999999999998 99999999999999999999999999864322
Q ss_pred eeeeeeeccCCCCCHHHHh---hCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcC
Q 002774 713 HITTQVKGTMGYLDPEYYM---TQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTI 789 (882)
Q Consensus 713 ~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 789 (882)
.....|+..|+|||++. ...++.++|||||||++|||++|..||.......... ..... ..+..
T Consensus 174 --~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~-~~~~~----------~~~~~ 240 (313)
T cd06633 174 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-HIAQN----------DSPTL 240 (313)
T ss_pred --CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH-HHHhc----------CCCCC
Confidence 12346889999999984 4568899999999999999999999986543322211 11100 00111
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 790 GLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 790 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
. .......+.+++.+||+.+|.+||++.+++.+
T Consensus 241 ~---~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 241 Q---SNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred C---ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1 11122568899999999999999999999965
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-33 Score=305.62 Aligned_cols=263 Identities=24% Similarity=0.351 Sum_probs=202.2
Q ss_pred CCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCC--cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCC-----ceE
Q 002774 556 NFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS--MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRG-----EQM 627 (882)
Q Consensus 556 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----~~~ 627 (882)
+|...+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+++++.++|+||+++++++...+ ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4777889999999999999965 58999999987643 334467899999999999999999999988775 789
Q ss_pred EEEEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccC
Q 002774 628 LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMS 707 (882)
Q Consensus 628 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~ 707 (882)
+||||++ ++|.+++.... .+++..+..++.+++.||+|||+.+ |+||||||+||++++++.++|+|||++....
T Consensus 81 lv~e~~~-~~l~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~~ 154 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQ--PLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVD 154 (330)
T ss_pred EEecchh-hhHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEeec
Confidence 9999997 58888886544 7899999999999999999999998 9999999999999999999999999998765
Q ss_pred CCCCc-eeeeeeeccCCCCCHHHHhhC-CCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhh-hhh--
Q 002774 708 DSEKD-HITTQVKGTMGYLDPEYYMTQ-QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELY-NLY-- 782 (882)
Q Consensus 708 ~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~-~~~-- 782 (882)
..... .......++..|+|||.+.+. .++.++||||||+++|+|++|..||...... +....+........ ...
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~ 233 (330)
T cd07834 155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYI-DQLNLIVEVLGTPSEEDLKF 233 (330)
T ss_pred ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHH-HHHHHHHHhcCCCChhHhhh
Confidence 54310 112334578899999999877 8899999999999999999999999654332 22222222110000 000
Q ss_pred -------hc---cCCcCCCC---CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 783 -------EL---IDPTIGLS---TTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 783 -------~~---~d~~l~~~---~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
.. ........ ........+.+++.+||+.+|++||++.+++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 234 ITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred ccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 00 00000000 001124678899999999999999999999976
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-33 Score=297.68 Aligned_cols=250 Identities=25% Similarity=0.367 Sum_probs=202.9
Q ss_pred cCCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCC---cccHHHHHHHHHHHHhcc-CCCeeeEEEEEEeCCceEEE
Q 002774 555 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS---MQGGQEFKMEIELLSRVH-HKNLVSLLGFCFDRGEQMLI 629 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV 629 (882)
++|...+.||+|+||.||+|+.. +|+.||+|++.... ....+.+.+|++++++++ |+||+++++++.+++..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 36788899999999999999864 78999999987532 223356888999999998 99999999999999999999
Q ss_pred EEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCC
Q 002774 630 YEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDS 709 (882)
Q Consensus 630 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~ 709 (882)
|||+++++|.+++.... .+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++++|||++......
T Consensus 81 ~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~ 155 (280)
T cd05581 81 LEYAPNGELLQYIRKYG--SLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPN 155 (280)
T ss_pred EcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence 99999999999997654 6899999999999999999999998 999999999999999999999999999866543
Q ss_pred CCc------------------eeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHH
Q 002774 710 EKD------------------HITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTV 771 (882)
Q Consensus 710 ~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~ 771 (882)
... .......++..|+|||......++.++||||||++++++++|..||....... .....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~~ 234 (280)
T cd05581 156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL-TFQKI 234 (280)
T ss_pred cccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHH-HHHHH
Confidence 211 11223457889999999998889999999999999999999999997554211 11111
Q ss_pred HHhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCH----HHHHHH
Q 002774 772 MDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTM----SEVVKD 825 (882)
Q Consensus 772 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~----~evl~~ 825 (882)
... . ..........+.+++.+||+.+|.+||++ ++++++
T Consensus 235 ~~~-----------~----~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 235 LKL-----------E----YSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred Hhc-----------C----CCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 110 0 01111224678999999999999999999 777653
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=303.57 Aligned_cols=264 Identities=22% Similarity=0.322 Sum_probs=196.0
Q ss_pred cCCCC-CCeeeccCcEEEEEEEec-CCcEEEEEEcccCCccc--------------HHHHHHHHHHHHhccCCCeeeEEE
Q 002774 555 NNFSD-ANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQG--------------GQEFKMEIELLSRVHHKNLVSLLG 618 (882)
Q Consensus 555 ~~~~~-~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~H~niv~l~~ 618 (882)
++|.. .+.||+|+||+||+|... +++.||||.++...... ...+.+|+++++.++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 34543 467999999999999854 68999999986543221 125778999999999999999999
Q ss_pred EEEeCCceEEEEEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEe
Q 002774 619 FCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVA 698 (882)
Q Consensus 619 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~ 698 (882)
++..++..++||||++ |+|.+++.... .+++.....++.|++.||+|||+.+ ++||||+|+||+++.++.+||+
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl~ 161 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRKI--RLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIA 161 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEEC
Confidence 9999999999999996 68988886543 5888999999999999999999998 9999999999999999999999
Q ss_pred ecccccccCCCCC------------ceeeeeeeccCCCCCHHHHhhC-CCCchhHHHHHHHHHHHHHhCCCCCCCCchHH
Q 002774 699 DFGLSKSMSDSEK------------DHITTQVKGTMGYLDPEYYMTQ-QLTEKSDVYSFGVLMLELLTGRRPIERGKYIV 765 (882)
Q Consensus 699 DfGla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~ 765 (882)
|||+++....... ........++..|+|||.+.+. .++.++|||||||++|||++|+.||......
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~- 240 (335)
T PTZ00024 162 DFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI- 240 (335)
T ss_pred CccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-
Confidence 9999986641110 0111223468889999998754 4789999999999999999999998754432
Q ss_pred HHHHHHHHhhhhhhh--hhh--------ccCCcCCC---CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 766 REIRTVMDKKKELYN--LYE--------LIDPTIGL---STTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 766 ~~~~~~~~~~~~~~~--~~~--------~~d~~l~~---~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
+....+......... +.+ ...+.... ........++.+++.+||+.+|++||+++|++.+
T Consensus 241 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 241 DQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred HHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 222222211100000 000 00000000 0001123668899999999999999999999974
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=305.47 Aligned_cols=251 Identities=24% Similarity=0.355 Sum_probs=206.7
Q ss_pred HcCCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCCcc--cHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEE
Q 002774 554 TNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQ--GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIY 630 (882)
Q Consensus 554 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 630 (882)
...|.....||+|.|++|..|+.. ++..||||.+.+.... ..+.+.+|+++|..+.|||||+++.+...+...|+||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 457788899999999999999864 6899999999875433 2345889999999999999999999999999999999
Q ss_pred EeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCC
Q 002774 631 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE 710 (882)
Q Consensus 631 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~ 710 (882)
||+.+|.+++++...+ +........+..|+.+|++|||+++ |||||||++||||+.+.++||+|||++..+...
T Consensus 135 eya~~ge~~~yl~~~g--r~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~- 208 (596)
T KOG0586|consen 135 EYASGGELFDYLVKHG--RMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDYG- 208 (596)
T ss_pred EeccCchhHHHHHhcc--cchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeeccc-
Confidence 9999999999998776 3445778889999999999999999 999999999999999999999999999988643
Q ss_pred CceeeeeeeccCCCCCHHHHhhCCC-CchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcC
Q 002774 711 KDHITTQVKGTMGYLDPEYYMTQQL-TEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTI 789 (882)
Q Consensus 711 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 789 (882)
......+|++.|.|||++.+..| .+++|+||+|+++|-|+.|..||++. ++.+....++... +
T Consensus 209 --~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~-~lk~Lr~rvl~gk-------------~ 272 (596)
T KOG0586|consen 209 --LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQ-NLKELRPRVLRGK-------------Y 272 (596)
T ss_pred --ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCc-ccccccchheeee-------------e
Confidence 33456789999999999998776 47899999999999999999999643 2222211111111 1
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 002774 790 GLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIEN 828 (882)
Q Consensus 790 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~ 828 (882)
+..+. ...+..+++++++..+|.+|++++++.++-+.
T Consensus 273 rIp~~--ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~ 309 (596)
T KOG0586|consen 273 RIPFY--MSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWR 309 (596)
T ss_pred cccce--eechhHHHHHHhhccCccccCCHHHhhhhccc
Confidence 11111 12456799999999999999999999987443
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=300.40 Aligned_cols=266 Identities=23% Similarity=0.335 Sum_probs=195.5
Q ss_pred HcCCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCCccc--HHHHHHHHHHHHhccCCCeeeEEEEEEeCC------
Q 002774 554 TNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQG--GQEFKMEIELLSRVHHKNLVSLLGFCFDRG------ 624 (882)
Q Consensus 554 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------ 624 (882)
.++|...+.||+|+||.||+|+.. +++.||||++......+ ...+.+|++++++++||||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 468889999999999999999964 68999999986543222 246778999999999999999999875543
Q ss_pred --ceEEEEEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeeccc
Q 002774 625 --EQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGL 702 (882)
Q Consensus 625 --~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGl 702 (882)
..++|+||++. ++...+... ...+++.++..++.|+++||+|||+.+ |+||||||+||++++++.+||+|||+
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~ 161 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENP-SVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGL 161 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCcc
Confidence 46999999964 666665543 236899999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCc---------eeeeeeeccCCCCCHHHHhhC-CCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHH
Q 002774 703 SKSMSDSEKD---------HITTQVKGTMGYLDPEYYMTQ-QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVM 772 (882)
Q Consensus 703 a~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~ 772 (882)
++........ ...+...+++.|+|||.+.+. .++.++|||||||++|||++|+.||...... .......
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~-~~~~~~~ 240 (311)
T cd07866 162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDI-DQLHLIF 240 (311)
T ss_pred chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHH
Confidence 9865433211 111234678889999998754 5889999999999999999999998644332 2222222
Q ss_pred Hhhhhh--------hhhhhcc----CCcCCCC---CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 773 DKKKEL--------YNLYELI----DPTIGLS---TTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 773 ~~~~~~--------~~~~~~~----d~~l~~~---~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
...... ..+.... ....... ........+.+++.+|++.||++|||+.|++.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred HHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 111000 0000000 0000000 001112568899999999999999999998864
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=305.35 Aligned_cols=263 Identities=20% Similarity=0.303 Sum_probs=195.5
Q ss_pred cCCCCCCeeeccCcEEEEEEEe-cCCcEEEEEEcccCCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeC----------
Q 002774 555 NNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDR---------- 623 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~---------- 623 (882)
.+|...+.||+|+||+||+|.. .+|+.||+|++........+.+.+|++++++++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 5788889999999999999986 46899999998766555567788999999999999999999876553
Q ss_pred ----CceEEEEEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEc-CCCceeEe
Q 002774 624 ----GEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLD-ERLNAKVA 698 (882)
Q Consensus 624 ----~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~-~~~~~kl~ 698 (882)
...++||||++ ++|.+++... .+++.....++.|++.||+|||+.+ |+||||||+||+++ +++.+|++
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~kl~ 157 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLEQG---PLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIG 157 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEEEC
Confidence 35789999997 5888777543 5888999999999999999999998 99999999999997 45678999
Q ss_pred ecccccccCCCCCc-eeeeeeeccCCCCCHHHHhh-CCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhh
Q 002774 699 DFGLSKSMSDSEKD-HITTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKK 776 (882)
Q Consensus 699 DfGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~ 776 (882)
|||+++........ .......++..|+|||.+.. ..++.++|||||||++|||++|+.||........ .........
T Consensus 158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~-~~~~~~~~~ 236 (342)
T cd07854 158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQ-MQLILESVP 236 (342)
T ss_pred CcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcC
Confidence 99999865432111 11122357889999998764 5688899999999999999999999975443222 211111100
Q ss_pred --------hh-hhhhhccC-CcCCCCCC-----HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 777 --------EL-YNLYELID-PTIGLSTT-----LKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 777 --------~~-~~~~~~~d-~~l~~~~~-----~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
.. ......+. ........ .....++.+++.+||+.||++|||+.|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 237 VVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred CCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 00 00000000 00000000 1123568899999999999999999999875
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=291.80 Aligned_cols=249 Identities=22% Similarity=0.342 Sum_probs=195.0
Q ss_pred CCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCC-----cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEE
Q 002774 556 NFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS-----MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLI 629 (882)
Q Consensus 556 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 629 (882)
+|...+.||+|+||+||+++.. .+..+++|.++... ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 4677889999999999999864 34456666654321 12234567799999999999999999999999999999
Q ss_pred EEeecCCCcccccCC--CCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccC
Q 002774 630 YEFVPNGSLGDSLSG--KNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMS 707 (882)
Q Consensus 630 ~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~ 707 (882)
|||+++++|.+++.. .....+++..+..++.|++.||.|||+.+ ++|+||||+||++++ +.+||+|||+++...
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 999999999988753 22346899999999999999999999988 999999999999975 569999999998764
Q ss_pred CCCCceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCC
Q 002774 708 DSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDP 787 (882)
Q Consensus 708 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 787 (882)
.... ......|++.|+|||.+....++.++||||||+++|+|++|..||..... ......... ...+
T Consensus 157 ~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~-~~~~~~~~~----------~~~~ 223 (260)
T cd08222 157 GSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF-LSVVLRIVE----------GPTP 223 (260)
T ss_pred CCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH-HHHHHHHHc----------CCCC
Confidence 3321 22334588899999999888899999999999999999999999964332 222111111 0111
Q ss_pred cCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 788 TIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 788 ~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
.. ......++.+++.+||+.+|++||++.|++++
T Consensus 224 ~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 224 SL----PETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred CC----cchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 11 12334678999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=297.86 Aligned_cols=244 Identities=23% Similarity=0.347 Sum_probs=204.5
Q ss_pred CCeeeccCcEEEEEEEe-cCCcEEEEEEcccCC--cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEeecCC
Q 002774 560 ANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGS--MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNG 636 (882)
Q Consensus 560 ~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 636 (882)
.++||+|.||+||-|+. ++|+.||||++.+.. ......+.+|+.||++++||.||.+...|+..+..++|||-+ +|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cc
Confidence 57899999999999986 579999999997643 334467889999999999999999999999999999999999 66
Q ss_pred CcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCC---CceeEeecccccccCCCCCce
Q 002774 637 SLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDER---LNAKVADFGLSKSMSDSEKDH 713 (882)
Q Consensus 637 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~---~~~kl~DfGla~~~~~~~~~~ 713 (882)
+..+.+-.....++++.....++.||+.||.|||..+ |+|+||||+|||+... .++||||||.||.++....
T Consensus 648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF-- 722 (888)
T KOG4236|consen 648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF-- 722 (888)
T ss_pred hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhhh--
Confidence 7666665555557888888889999999999999999 9999999999999643 4699999999999876543
Q ss_pred eeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCCCCC
Q 002774 714 ITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLST 793 (882)
Q Consensus 714 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 793 (882)
...++||+.|+|||++....|...-|+||.|||+|.-++|..||.+++++.++++.. ..+-|.- .
T Consensus 723 -RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNA-----------aFMyPp~---P 787 (888)
T KOG4236|consen 723 -RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNA-----------AFMYPPN---P 787 (888)
T ss_pred -hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhcc-----------ccccCCC---c
Confidence 335689999999999999999999999999999999999999999888877665432 1122211 2
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002774 794 TLKGFEKYVDLALKCVQESGDDRPTMSEVVK 824 (882)
Q Consensus 794 ~~~~~~~l~~li~~cl~~dp~~RPs~~evl~ 824 (882)
+.+.....+++|...++..-.+|-|....+.
T Consensus 788 W~eis~~AidlIn~LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 788 WSEISPEAIDLINNLLQVKMRKRYSVDKSLS 818 (888)
T ss_pred hhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence 3334467889999999999999999887664
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=293.26 Aligned_cols=261 Identities=26% Similarity=0.361 Sum_probs=199.7
Q ss_pred CCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCC--cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEee
Q 002774 557 FSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS--MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFV 633 (882)
Q Consensus 557 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 633 (882)
|+..+.||+|+||.||+|+.. +++.||+|.+.... ....+.+..|++++++++|+|++++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 456678999999999999965 58999999988653 223366788999999999999999999999999999999999
Q ss_pred cCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCce
Q 002774 634 PNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDH 713 (882)
Q Consensus 634 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 713 (882)
+ ++|.+++.... ..+++..+..++.+++.||+|||+.+ |+||||+|+||++++++.+||+|||+++.......
T Consensus 81 ~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-- 153 (282)
T cd07829 81 D-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-- 153 (282)
T ss_pred C-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc--
Confidence 7 58999887652 36899999999999999999999998 99999999999999999999999999987644322
Q ss_pred eeeeeeccCCCCCHHHHhhC-CCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhh----h-h---hhh--h
Q 002774 714 ITTQVKGTMGYLDPEYYMTQ-QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKK----E-L---YNL--Y 782 (882)
Q Consensus 714 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~----~-~---~~~--~ 782 (882)
......++..|+|||.+.+. .++.++|||||||++|||++|..||...... ........... . . ... .
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
T cd07829 154 TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEI-DQLFKIFQILGTPTEESWPGVTKLPDY 232 (282)
T ss_pred ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHH-HHHHHHHHHhCCCcHHHHHhhcccccc
Confidence 12234467889999999866 8899999999999999999999888654322 22222111100 0 0 000 0
Q ss_pred hccCCcCCC----CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 783 ELIDPTIGL----STTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 783 ~~~d~~l~~----~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
...-+.... .........+.+++.+||+.+|++||++.+++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 233 KPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred cccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 000000000 0001114678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=300.26 Aligned_cols=264 Identities=24% Similarity=0.341 Sum_probs=197.7
Q ss_pred HHHHHcCCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCC--cccHHHHHHHHHHHHhccCCCeeeEEEEEEe-CCc
Q 002774 550 VKKYTNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS--MQGGQEFKMEIELLSRVHHKNLVSLLGFCFD-RGE 625 (882)
Q Consensus 550 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~ 625 (882)
+..++++|+..+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++||||+++.+++.. ...
T Consensus 5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 84 (328)
T cd07856 5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED 84 (328)
T ss_pred eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence 3456788999999999999999999854 78999999876432 2234678889999999999999999998866 557
Q ss_pred eEEEEEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccc
Q 002774 626 QMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKS 705 (882)
Q Consensus 626 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~ 705 (882)
.++|+||+ +++|.++++.. .+++.....++.|+++||+|||+.+ |+||||+|+||++++++.++|+|||+++.
T Consensus 85 ~~lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~ 157 (328)
T cd07856 85 IYFVTELL-GTDLHRLLTSR---PLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI 157 (328)
T ss_pred EEEEeehh-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccc
Confidence 89999998 56888877643 4778888899999999999999998 99999999999999999999999999975
Q ss_pred cCCCCCceeeeeeeccCCCCCHHHHhh-CCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHH--HHHHHHHhh-------
Q 002774 706 MSDSEKDHITTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVR--EIRTVMDKK------- 775 (882)
Q Consensus 706 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~--~~~~~~~~~------- 775 (882)
..... ....++..|+|||.+.+ ..++.++|||||||++|||++|+.||........ .+.......
T Consensus 158 ~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (328)
T cd07856 158 QDPQM-----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINT 232 (328)
T ss_pred cCCCc-----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 43221 22457889999998765 5789999999999999999999999865432111 111110000
Q ss_pred ---hhhhhhhhccCCcCCCC---CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 776 ---KELYNLYELIDPTIGLS---TTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 776 ---~~~~~~~~~~d~~l~~~---~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
.....+........... ........+.+++.+||+.+|++||++++++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 233 ICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred ccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000000000000 001123678999999999999999999999865
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-32 Score=299.47 Aligned_cols=263 Identities=22% Similarity=0.332 Sum_probs=193.0
Q ss_pred CCCCCCeeeccCcEEEEEEEec-C--CcEEEEEEcccCCc--ccHHHHHHHHHHHHhc-cCCCeeeEEEEEEeC----Cc
Q 002774 556 NFSDANDVGSGGYGKVYKGTLP-N--GQLIAIKRAQQGSM--QGGQEFKMEIELLSRV-HHKNLVSLLGFCFDR----GE 625 (882)
Q Consensus 556 ~~~~~~~lG~G~fg~Vy~~~~~-~--g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~----~~ 625 (882)
+|...+.||+|+||.||+|+.. . +..||+|++..... ...+.+.+|+++++++ +||||+++++++... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 3677789999999999999964 3 78999999874321 2245678899999999 599999999976432 35
Q ss_pred eEEEEEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccc
Q 002774 626 QMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKS 705 (882)
Q Consensus 626 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~ 705 (882)
.++++||+. ++|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++.
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~~ 154 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSGQ--PLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARG 154 (332)
T ss_pred EEEEEeccc-CCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCcee
Confidence 688899885 68888886543 6889999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCCc--eeeeeeeccCCCCCHHHHhh-CCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhh------
Q 002774 706 MSDSEKD--HITTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKK------ 776 (882)
Q Consensus 706 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~------ 776 (882)
+...... .......|+..|+|||++.+ ..++.++|||||||++|+|++|..||...... ......+....
T Consensus 155 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~ 233 (332)
T cd07857 155 FSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYV-DQLNQILQVLGTPDEET 233 (332)
T ss_pred cccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHH-HHHHHHHHHhCCCCHHH
Confidence 6533221 11223468999999998875 46899999999999999999999998654322 11111111000
Q ss_pred -------hhhhhhhccC--CcCCC-CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 777 -------ELYNLYELID--PTIGL-STTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 777 -------~~~~~~~~~d--~~l~~-~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
.......... +.... .........+.+++.+|++.||.+|||+.|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 234 LSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred HHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000000000 00000 0001123578899999999999999999999865
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.5e-33 Score=279.35 Aligned_cols=254 Identities=23% Similarity=0.298 Sum_probs=203.0
Q ss_pred HHHcCCCCC-CeeeccCcEEEEEEEe-cCCcEEEEEEcccCCcccHHHHHHHHHHHHhc-cCCCeeeEEEEEEe----CC
Q 002774 552 KYTNNFSDA-NDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQGGQEFKMEIELLSRV-HHKNLVSLLGFCFD----RG 624 (882)
Q Consensus 552 ~~~~~~~~~-~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~----~~ 624 (882)
..+++|++. ++||-|-.|.|-.+.. .+|+++|+|++... ....+|+++.-.. .|||||.+++++.. ..
T Consensus 58 ~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rk 132 (400)
T KOG0604|consen 58 SITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRK 132 (400)
T ss_pred cchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCce
Confidence 346667654 5799999999999975 47999999998753 3456788765555 69999999998754 45
Q ss_pred ceEEEEEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcC---CCceeEeecc
Q 002774 625 EQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDE---RLNAKVADFG 701 (882)
Q Consensus 625 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~---~~~~kl~DfG 701 (882)
..++|||.|+||.|...++.++...+++.++..|+.||+.|+.|||+.. |.||||||+|+|... +..+||+|||
T Consensus 133 cLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 133 CLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred eeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccc
Confidence 6789999999999999999998889999999999999999999999999 999999999999964 5678999999
Q ss_pred cccccCCCCCceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCC--chHHHHHHHHHHhhhhhh
Q 002774 702 LSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERG--KYIVREIRTVMDKKKELY 779 (882)
Q Consensus 702 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~--~~~~~~~~~~~~~~~~~~ 779 (882)
+|+.-.. .......+-|+.|.|||++...+|+...|+||+||++|-|++|.+||... ..+....+..+..+.
T Consensus 210 FAK~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gq--- 283 (400)
T KOG0604|consen 210 FAKETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQ--- 283 (400)
T ss_pred cccccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccC---
Confidence 9986532 12234457899999999999999999999999999999999999999742 222222222222221
Q ss_pred hhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 002774 780 NLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDI 826 (882)
Q Consensus 780 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L 826 (882)
++. +...+....++..++|+.+|..+|.+|.|+.|++++=
T Consensus 284 --y~F-----P~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hp 323 (400)
T KOG0604|consen 284 --YEF-----PEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHP 323 (400)
T ss_pred --ccC-----CChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCc
Confidence 121 2223445567889999999999999999999999763
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-32 Score=309.36 Aligned_cols=258 Identities=29% Similarity=0.466 Sum_probs=213.6
Q ss_pred HHHHHHcCCCCCCeeeccCcEEEEEEE-ecCCcEEEEEEcccCCcccHHHHHHHHHHHHhc-cCCCeeeEEEEEEe----
Q 002774 549 EVKKYTNNFSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRV-HHKNLVSLLGFCFD---- 622 (882)
Q Consensus 549 e~~~~~~~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~---- 622 (882)
.+...++.|.+.++||.|.+|.||+++ .++++.+|+|++...... .++...|.++++.. .|||++.++|++..
T Consensus 13 ~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~-deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~ 91 (953)
T KOG0587|consen 13 SLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE-EEEIELEYNMLKKYSHHPNVATFYGAFIKKDPG 91 (953)
T ss_pred hCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc-cHHHHHHHHHHHhccCCCCcceEEEEEEEecCC
Confidence 333446678888999999999999998 457999999998765433 36788899999988 69999999999865
Q ss_pred -CCceEEEEEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecc
Q 002774 623 -RGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFG 701 (882)
Q Consensus 623 -~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfG 701 (882)
++..|||||||.+||..|+++.-.+.++.|..+.-|+..+++|+.+||... ++|||||-.|||++.++.+|++|||
T Consensus 92 ~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvDFG 168 (953)
T KOG0587|consen 92 NGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVDFG 168 (953)
T ss_pred CCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEeeee
Confidence 568999999999999999998777778999999999999999999999988 9999999999999999999999999
Q ss_pred cccccCCCCCceeeeeeeccCCCCCHHHHh-----hCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhh
Q 002774 702 LSKSMSDSEKDHITTQVKGTMGYLDPEYYM-----TQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKK 776 (882)
Q Consensus 702 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~ 776 (882)
++..+.... .......||+.|||||++. ...|+.++|+||+|++..||.-|.+|+.+... .+
T Consensus 169 vSaQldsT~--grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHP-----------mr 235 (953)
T KOG0587|consen 169 VSAQLDSTV--GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHP-----------MR 235 (953)
T ss_pred eeeeeeccc--ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcch-----------hh
Confidence 998875433 2334567999999999996 23577899999999999999999999865321 22
Q ss_pred hhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 777 ELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 777 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
.++.+.. .|......+.+..++|.++|..|+.+|.++||++.+++++
T Consensus 236 aLF~IpR--NPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 236 ALFLIPR--NPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred hhccCCC--CCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 2222222 3333344566777899999999999999999999999853
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=321.45 Aligned_cols=145 Identities=29% Similarity=0.408 Sum_probs=130.0
Q ss_pred cCCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCCccc---HHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEE
Q 002774 555 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQG---GQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIY 630 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 630 (882)
++|...++||+|+||+||+|... +++.||||+++...... ...+.+|+.+++.++||||+++++++...+..++||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 56888899999999999999975 68999999997543322 356888999999999999999999999999999999
Q ss_pred EeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeeccccc
Q 002774 631 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSK 704 (882)
Q Consensus 631 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~ 704 (882)
||+++++|.+++.... .+++..++.++.||+.||+|||..+ |+||||||+|||++.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~~--~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIYG--YFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999986543 5788889999999999999999988 9999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.5e-32 Score=303.29 Aligned_cols=260 Identities=25% Similarity=0.367 Sum_probs=197.9
Q ss_pred HHcCCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCC--cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCc----
Q 002774 553 YTNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS--MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGE---- 625 (882)
Q Consensus 553 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~---- 625 (882)
..++|...+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++|+||+++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 4567888999999999999999975 68899999986532 2233567789999999999999999998766554
Q ss_pred --eEEEEEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccc
Q 002774 626 --QMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLS 703 (882)
Q Consensus 626 --~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla 703 (882)
.++|+||+ +++|.+++... .+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+||+|||++
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~~---~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~~ 165 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKCQ---KLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLA 165 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEcccccc
Confidence 89999998 67898888653 5899999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCceeeeeeeccCCCCCHHHHhh-CCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhh-hhhh
Q 002774 704 KSMSDSEKDHITTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKE-LYNL 781 (882)
Q Consensus 704 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~-~~~~ 781 (882)
...... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...... ............ ...+
T Consensus 166 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~-~~~~~i~~~~~~~~~~~ 239 (343)
T cd07851 166 RHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHI-DQLKRIMNLVGTPDEEL 239 (343)
T ss_pred cccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHhcCCCCHHH
Confidence 866432 223457889999999875 46789999999999999999999999654332 222222211000 0000
Q ss_pred hh------------ccCCcCCCCC---CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 782 YE------------LIDPTIGLST---TLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 782 ~~------------~~d~~l~~~~---~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
.. .+........ ......++.+++.+||+.||++|||+.|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 240 LQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred HhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 00 0000000000 00124678999999999999999999999875
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.2e-33 Score=318.75 Aligned_cols=260 Identities=23% Similarity=0.310 Sum_probs=212.8
Q ss_pred HHHHHHHHcCCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCC---cccHHHHHHHHHHHHhccCCCeeeEEEEEEe
Q 002774 547 FEEVKKYTNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS---MQGGQEFKMEIELLSRVHHKNLVSLLGFCFD 622 (882)
Q Consensus 547 ~~e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~ 622 (882)
..+++--.++|.+.++||+|+||.|..++.+ ++++||+|++.+.. ..+..-|.+|-++|..-+.+=||.+..+|.+
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 4556666789999999999999999999964 68999999998743 2344668999999999999999999999999
Q ss_pred CCceEEEEEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeeccc
Q 002774 623 RGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGL 702 (882)
Q Consensus 623 ~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGl 702 (882)
....|+|||||+||+|-.++.... ++++..+..++..|+-||.-||+.| +|||||||+|||||..|++||+|||.
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGs 221 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGS 221 (1317)
T ss_pred ccceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchh
Confidence 999999999999999999998765 5777777888999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCceeeeeeeccCCCCCHHHHh----h-CCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhh
Q 002774 703 SKSMSDSEKDHITTQVKGTMGYLDPEYYM----T-QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKE 777 (882)
Q Consensus 703 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~ 777 (882)
+-.+...+. -.+...+|||.|.+||++. + +.|+...|.||+||++|||+.|..||.. ..+++....++.....
T Consensus 222 Clkm~~dG~-V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa-dslveTY~KIm~hk~~ 299 (1317)
T KOG0612|consen 222 CLKMDADGT-VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA-DSLVETYGKIMNHKES 299 (1317)
T ss_pred HHhcCCCCc-EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH-HHHHHHHHHHhchhhh
Confidence 987765443 3455678999999999997 2 5789999999999999999999999964 3445555555544321
Q ss_pred hhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCC---HHHHHHH
Q 002774 778 LYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPT---MSEVVKD 825 (882)
Q Consensus 778 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs---~~evl~~ 825 (882)
+..+...+...+..+||++.+. +|+.|.. +.++-.+
T Consensus 300 -----------l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 300 -----------LSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNH 338 (1317)
T ss_pred -----------cCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhC
Confidence 1111112345778899988775 5777877 8888765
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.5e-32 Score=284.85 Aligned_cols=236 Identities=29% Similarity=0.367 Sum_probs=193.3
Q ss_pred eeccCcEEEEEEEec-CCcEEEEEEcccCCcc---cHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEeecCCCc
Q 002774 563 VGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQ---GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSL 638 (882)
Q Consensus 563 lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 638 (882)
||+|+||.||++... +++.||+|.+...... ....+..|++++++++|+||+++++.+..++..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999965 5899999998765332 335788999999999999999999999999999999999999999
Q ss_pred ccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCceeeeee
Q 002774 639 GDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQV 718 (882)
Q Consensus 639 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 718 (882)
.+++.... .+++.....++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++....... ......
T Consensus 81 ~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~ 153 (250)
T cd05123 81 FSHLSKEG--RFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTF 153 (250)
T ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccCC
Confidence 99987653 5889999999999999999999988 9999999999999999999999999998764432 122345
Q ss_pred eccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCCCCCCHHHH
Q 002774 719 KGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGF 798 (882)
Q Consensus 719 ~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 798 (882)
.++..|+|||...+...+.++|+||||+++|||++|+.||..... ......... . .. ..+....
T Consensus 154 ~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-~~~~~~~~~-~----------~~----~~~~~~~ 217 (250)
T cd05123 154 CGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR-KEIYEKILK-D----------PL----RFPEFLS 217 (250)
T ss_pred cCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-HHHHHHHhc-C----------CC----CCCCCCC
Confidence 688899999999988899999999999999999999999965432 111111111 0 00 1111124
Q ss_pred HHHHHHHHHhhccCCCCCCCHHH
Q 002774 799 EKYVDLALKCVQESGDDRPTMSE 821 (882)
Q Consensus 799 ~~l~~li~~cl~~dp~~RPs~~e 821 (882)
..+.+++.+||..||++||++++
T Consensus 218 ~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 218 PEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred HHHHHHHHHHhcCCHhhCCCccc
Confidence 67889999999999999999944
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-33 Score=302.67 Aligned_cols=304 Identities=21% Similarity=0.222 Sum_probs=277.1
Q ss_pred cccCccccCCCCCCEEeccCCCCCccCCCccccCCCCCcEEEeeCCcCCccccccccCCCCCCEEEccCCcCCCCCCcCc
Q 002774 5 GQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSI 84 (882)
Q Consensus 5 ~~l~~~~~~l~~L~~L~L~~n~~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~ 84 (882)
+.=+++++.++.|+.||||.|. |..+.-.+|..-.++++|+|++|+|+....+.|.++.+|..|.|++|+|+.+.+..|
T Consensus 139 sv~se~L~~l~alrslDLSrN~-is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~F 217 (873)
T KOG4194|consen 139 SVTSEELSALPALRSLDLSRNL-ISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSF 217 (873)
T ss_pred cccHHHHHhHhhhhhhhhhhch-hhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHHHh
Confidence 3445678889999999999996 888888889999999999999999998889999999999999999999998888899
Q ss_pred cCCCCCcEeeccCceeeeecCCCCCCCchhhhhhcccceeccCCeeeecCCccccCCcccceeeeccCCcccccCCcccc
Q 002774 85 GNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLG 164 (882)
Q Consensus 85 ~~l~~L~~L~Ls~N~i~~~~p~~~~~~~~l~~L~~L~~L~L~~N~l~~~ip~~~f~~~~~L~~L~L~~N~l~~~~~~~~~ 164 (882)
.+|++|+.|+|..|+|. +..--.|+.|++|+.|.|..|.|+ .+.+++|-++.+++.|+|+.|+++..-..++-
T Consensus 218 k~L~~L~~LdLnrN~ir------ive~ltFqgL~Sl~nlklqrN~I~-kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lf 290 (873)
T KOG4194|consen 218 KRLPKLESLDLNRNRIR------IVEGLTFQGLPSLQNLKLQRNDIS-KLDDGAFYGLEKMEHLNLETNRLQAVNEGWLF 290 (873)
T ss_pred hhcchhhhhhcccccee------eehhhhhcCchhhhhhhhhhcCcc-cccCcceeeecccceeecccchhhhhhccccc
Confidence 99999999999999998 222345788899999999999999 99999999999999999999999988888999
Q ss_pred CCCCCCEEEccCCCCCCCCCccCCCCCCCCEEEccCCcccccCCC-CCCCCCCCEEECcCCCCCCCCCCccccCCCCCCE
Q 002774 165 LVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPN-LTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTT 243 (882)
Q Consensus 165 ~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~ 243 (882)
++++|+.|+||.|.|..+.++....+++|+.|+|++|+|+.+++. |..+..|+.|.|++|.|+. .-...|.++.+|+.
T Consensus 291 gLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~-l~e~af~~lssL~~ 369 (873)
T KOG4194|consen 291 GLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDH-LAEGAFVGLSSLHK 369 (873)
T ss_pred ccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHH-HHhhHHHHhhhhhh
Confidence 999999999999999999999999999999999999999999886 8999999999999999974 56678999999999
Q ss_pred EECcCCcccccCCc---cCCCCCCCCEEEccCCccceecCCCC-cccccccccccCCccccccCCCCCCccceEEecCc
Q 002774 244 LMMENTNLKGQIPA---DLFSIPHLQTVVMKTNELNGTLDLGT-SYSENLLVNLQNNRISAYTERGGAPAVNLTLIDNP 318 (882)
Q Consensus 244 L~Ls~N~l~~~~~~---~~~~l~~L~~L~Ls~N~l~~~~~~~~-~~~~L~~L~L~~N~i~~~~~~~~~~~~~L~~l~~~ 318 (882)
|||++|.|+..+.+ .|.+|++|+.|+|.||+|..+....+ ++..|+.|||.+|.|..+..++|.++ +|+.|-+.
T Consensus 370 LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~n 447 (873)
T KOG4194|consen 370 LDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVMN 447 (873)
T ss_pred hcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceeecccccccc-hhhhhhhc
Confidence 99999999986654 57789999999999999999887665 59999999999999999999999998 88877543
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-33 Score=271.18 Aligned_cols=263 Identities=24% Similarity=0.400 Sum_probs=194.7
Q ss_pred CCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCC--cccHHHHHHHHHHHHhccCCCeeeEEEEEEe--------CCc
Q 002774 557 FSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS--MQGGQEFKMEIELLSRVHHKNLVSLLGFCFD--------RGE 625 (882)
Q Consensus 557 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--------~~~ 625 (882)
|....+||+|.||+||+|+.. +|++||+|++-.+. ..-.....+|+++|..++|+|++.+++.|.. ...
T Consensus 19 yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t 98 (376)
T KOG0669|consen 19 YEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRAT 98 (376)
T ss_pred HHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccce
Confidence 445577999999999999864 68889998764322 2223456789999999999999999988754 235
Q ss_pred eEEEEEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccc
Q 002774 626 QMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKS 705 (882)
Q Consensus 626 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~ 705 (882)
.|+||.+++. +|...+... ..+++..++.+++.++..||.|+|... |+|||+||.|+||+.++.+||+|||+|+.
T Consensus 99 ~ylVf~~ceh-DLaGlLsn~-~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGlar~ 173 (376)
T KOG0669|consen 99 FYLVFDFCEH-DLAGLLSNR-KVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGLARA 173 (376)
T ss_pred eeeeHHHhhh-hHHHHhcCc-cccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeeccccccc
Confidence 7999999976 777777654 357888999999999999999999988 99999999999999999999999999987
Q ss_pred cCCCCC--ceeeeeeeccCCCCCHHHHhh-CCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHH---Hhh-hh-
Q 002774 706 MSDSEK--DHITTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVM---DKK-KE- 777 (882)
Q Consensus 706 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~---~~~-~~- 777 (882)
+...+. ....+..+.|.+|++||.+.+ +.|+.+.|||.-|||+.||+||.+-+ .+......+.-+. ... ++
T Consensus 174 fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspim-qgnteqqql~~Is~LcGs~tkev 252 (376)
T KOG0669|consen 174 FSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIM-QGNTEQQQLHLISQLCGSITKEV 252 (376)
T ss_pred eecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccc-cCChHHHHHHHHHHHhccCCccc
Confidence 654332 223455667999999999985 67999999999999999999977544 4444433332211 100 00
Q ss_pred -----hhhhhhccCCc-CCCCCC---HHH------HHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 778 -----LYNLYELIDPT-IGLSTT---LKG------FEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 778 -----~~~~~~~~d~~-l~~~~~---~~~------~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
-..+++.+.-+ ++.... .+. ..+..+|+.+++..||.+|+++.+++.+
T Consensus 253 WP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 253 WPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred CCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 01122222111 111100 111 1367899999999999999999999965
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=279.99 Aligned_cols=221 Identities=23% Similarity=0.194 Sum_probs=176.7
Q ss_pred cCcEEEEEEEe-cCCcEEEEEEcccCCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEeecCCCcccccCC
Q 002774 566 GGYGKVYKGTL-PNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSG 644 (882)
Q Consensus 566 G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~ 644 (882)
|.||.||+++. .+++.||+|+++... .+.+|...+....||||+++++++.+.+..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 89999999986 468999999987642 234455555566799999999999999999999999999999998865
Q ss_pred CCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCceeeeeeeccCCC
Q 002774 645 KNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGY 724 (882)
Q Consensus 645 ~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y 724 (882)
.. .+++.....++.|+++||+|||+.+ |+||||||+||+++.++.++++|||.+....... ....++..|
T Consensus 79 ~~--~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~y 148 (237)
T cd05576 79 FL--NIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAVENMY 148 (237)
T ss_pred hc--CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCCcCccc
Confidence 43 5889999999999999999999988 9999999999999999999999999887654321 223456789
Q ss_pred CCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCCCCCCHHHHHHHHHH
Q 002774 725 LDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDL 804 (882)
Q Consensus 725 ~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l 804 (882)
+|||.+....++.++||||+|+++|||++|..|+....... . ....... +......+.++
T Consensus 149 ~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-------~---------~~~~~~~----~~~~~~~~~~l 208 (237)
T cd05576 149 CAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI-------N---------THTTLNI----PEWVSEEARSL 208 (237)
T ss_pred cCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-------c---------cccccCC----cccCCHHHHHH
Confidence 99999988889999999999999999999998864321100 0 0000001 11123678899
Q ss_pred HHHhhccCCCCCCCHHH
Q 002774 805 ALKCVQESGDDRPTMSE 821 (882)
Q Consensus 805 i~~cl~~dp~~RPs~~e 821 (882)
+.+|++.||++||++.+
T Consensus 209 i~~~l~~dp~~R~~~~~ 225 (237)
T cd05576 209 LQQLLQFNPTERLGAGV 225 (237)
T ss_pred HHHHccCCHHHhcCCCc
Confidence 99999999999999733
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-31 Score=298.71 Aligned_cols=265 Identities=22% Similarity=0.332 Sum_probs=183.5
Q ss_pred HcCCCCCCeeeccCcEEEEEEEe-----------------cCCcEEEEEEcccCCcccHHH--------------HHHHH
Q 002774 554 TNNFSDANDVGSGGYGKVYKGTL-----------------PNGQLIAIKRAQQGSMQGGQE--------------FKMEI 602 (882)
Q Consensus 554 ~~~~~~~~~lG~G~fg~Vy~~~~-----------------~~g~~vavK~~~~~~~~~~~~--------------~~~E~ 602 (882)
.++|...++||+|+||+||+|.. .+++.||||+++.......++ +..|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 66899999999999999999964 235689999987543222223 33477
Q ss_pred HHHHhccCCCe-----eeEEEEEEe--------CCceEEEEEeecCCCcccccCCCC----------------------C
Q 002774 603 ELLSRVHHKNL-----VSLLGFCFD--------RGEQMLIYEFVPNGSLGDSLSGKN----------------------G 647 (882)
Q Consensus 603 ~~l~~l~H~ni-----v~l~~~~~~--------~~~~~lV~e~~~~gsL~~~l~~~~----------------------~ 647 (882)
.++.+++|.++ ++++++|.. .+..+|||||+++|+|.++++... .
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 77777766554 678888753 356899999999999998886421 1
Q ss_pred ccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCceeeeeeeccCCCCCH
Q 002774 648 IRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDP 727 (882)
Q Consensus 648 ~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 727 (882)
..++|..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++....... .......+|+.|+||
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSPP 379 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeCh
Confidence 13467788899999999999999988 99999999999999999999999999976543221 111223357899999
Q ss_pred HHHhhCCC----------------------CchhHHHHHHHHHHHHHhCCC-CCCCCchHHHHHHHHHHhhhhhhhhhhc
Q 002774 728 EYYMTQQL----------------------TEKSDVYSFGVLMLELLTGRR-PIERGKYIVREIRTVMDKKKELYNLYEL 784 (882)
Q Consensus 728 E~~~~~~~----------------------~~~sDv~S~Gvll~el~tg~~-P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 784 (882)
|.+..... ..+.||||+||+++||++|.. |+.............-..... +...
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~---~r~~ 456 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNR---WRMY 456 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHH---HHhh
Confidence 99864321 234799999999999999875 664322222211111000000 0000
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHhhccCC---CCCCCHHHHHHH
Q 002774 785 IDPTIGLSTTLKGFEKYVDLALKCVQESG---DDRPTMSEVVKD 825 (882)
Q Consensus 785 ~d~~l~~~~~~~~~~~l~~li~~cl~~dp---~~RPs~~evl~~ 825 (882)
..................+++.+|+..+| .+|+|++|++++
T Consensus 457 ~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 457 KGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred cccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 00011111112233677899999999866 689999999975
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=294.32 Aligned_cols=243 Identities=25% Similarity=0.300 Sum_probs=195.7
Q ss_pred HHcCCCCCCeeeccCcEEEEEEEe-cCCcEEEEEEcccCCcccHHHHHHHHHHHHhc-cCCCeeeEEEEEEeCCceEEEE
Q 002774 553 YTNNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQGGQEFKMEIELLSRV-HHKNLVSLLGFCFDRGEQMLIY 630 (882)
Q Consensus 553 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~ 630 (882)
+++.|.....+|.|+|+.|-.+.. .+++..+||++.+.. .+-.+|+.++... +||||+++.+.+.++.+.|+||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 356777777899999999999885 468899999997652 2345577666666 6999999999999999999999
Q ss_pred EeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEE-cCCCceeEeecccccccCCC
Q 002774 631 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILL-DERLNAKVADFGLSKSMSDS 709 (882)
Q Consensus 631 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll-~~~~~~kl~DfGla~~~~~~ 709 (882)
|++.++-+.+.+.... .....+..|+.+|+.|+.|||++| +||||+||+|||+ +++++++|+|||.++.....
T Consensus 396 e~l~g~ell~ri~~~~---~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSKP---EFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred hhccccHHHHHHHhcc---hhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 9999998877776543 222677789999999999999999 9999999999999 69999999999999877544
Q ss_pred CCceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcC
Q 002774 710 EKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTI 789 (882)
Q Consensus 710 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 789 (882)
....+-|..|.|||++....|++++|+||||++||+|++|+.||.......+ +...+...
T Consensus 470 -----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~e-i~~~i~~~-------------- 529 (612)
T KOG0603|consen 470 -----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIE-IHTRIQMP-------------- 529 (612)
T ss_pred -----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHH-HHHhhcCC--------------
Confidence 2234568889999999999999999999999999999999999985544321 11111111
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 002774 790 GLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIE 827 (882)
Q Consensus 790 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~ 827 (882)
...........+|+.+||+.||.+||+|.++..+=+
T Consensus 530 --~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w 565 (612)
T KOG0603|consen 530 --KFSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPW 565 (612)
T ss_pred --ccccccCHHHHHHHHHhccCChhhCcChhhhccCcc
Confidence 111233467889999999999999999999987633
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-32 Score=282.65 Aligned_cols=258 Identities=25% Similarity=0.402 Sum_probs=200.0
Q ss_pred cCCCCCCeeeccCcEEEEEEE-ecCCcEEEEEEcccCC-ccc------HHHHHHHHHHHHhccCCCeeeEEEEEEe-CCc
Q 002774 555 NNFSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGS-MQG------GQEFKMEIELLSRVHHKNLVSLLGFCFD-RGE 625 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~~~~~~-~~~------~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~ 625 (882)
++|-.+..||+|+|++||||. +...+.||||+-.... ..+ .+...+|.+|.+.|+||.||++++|+.- .+.
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 355567789999999999997 4567899999865321 111 1345679999999999999999999864 567
Q ss_pred eEEEEEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEc---CCCceeEeeccc
Q 002774 626 QMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLD---ERLNAKVADFGL 702 (882)
Q Consensus 626 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~---~~~~~kl~DfGl 702 (882)
++-|+|||++.+|.-+|+.+. .+++..+..|+.||+.||.||.+. ++||||-||||.|||+- .-|.+||+|||+
T Consensus 543 FCTVLEYceGNDLDFYLKQhk--lmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFGL 619 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLKQHK--LMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFGL 619 (775)
T ss_pred ceeeeeecCCCchhHHHHhhh--hhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecch
Confidence 889999999999999998765 688999999999999999999987 48899999999999995 357899999999
Q ss_pred ccccCCCCCce-----eeeeeeccCCCCCHHHHhhC----CCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHH
Q 002774 703 SKSMSDSEKDH-----ITTQVKGTMGYLDPEYYMTQ----QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMD 773 (882)
Q Consensus 703 a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~----~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~ 773 (882)
++.+.+...+. .+....||++|++||.+.-+ ..+.|+||||.|||+|..+.|++||.......+.+..
T Consensus 620 SKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqe--- 696 (775)
T KOG1151|consen 620 SKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQE--- 696 (775)
T ss_pred hhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhh---
Confidence 99997765442 24457899999999998744 5788999999999999999999999765443332221
Q ss_pred hhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 774 KKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 774 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
.. +....++ ..........+..++|++|++..-++|....++..+
T Consensus 697 -NT-IlkAtEV-----qFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~d 741 (775)
T KOG1151|consen 697 -NT-ILKATEV-----QFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACD 741 (775)
T ss_pred -hc-hhcceec-----cCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccC
Confidence 11 0000111 111111233567899999999999999998887754
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=276.97 Aligned_cols=241 Identities=24% Similarity=0.322 Sum_probs=195.8
Q ss_pred HcCCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCCcccHHH---HHHHHHHHHhc-cCCCeeeEEEEEEeCCceEE
Q 002774 554 TNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQGGQE---FKMEIELLSRV-HHKNLVSLLGFCFDRGEQML 628 (882)
Q Consensus 554 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~---~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~l 628 (882)
..+|....+||+|+||.|-+|..+ +.+.+|||++++...-..++ -..|-++|+.. +-|.++++..+++.-+.+|+
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 357888999999999999999854 46789999998764432222 24466777766 57899999999999999999
Q ss_pred EEEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCC
Q 002774 629 IYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSD 708 (882)
Q Consensus 629 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~ 708 (882)
||||+.+|+|--.++.-+ ++.+..+..+|..||-||-+||+.| |+.||||.+||++|.+|.+||+|||+++.---
T Consensus 428 VMEyvnGGDLMyhiQQ~G--kFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~ 502 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQQVG--KFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIF 502 (683)
T ss_pred EEEEecCchhhhHHHHhc--ccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccccccccc
Confidence 999999999988887655 4667788899999999999999999 99999999999999999999999999975322
Q ss_pred CCCceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCc
Q 002774 709 SEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPT 788 (882)
Q Consensus 709 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 788 (882)
. ...+..++||+.|+|||.+....|...+|.|||||+||||+.|+.||++ ++..+..+.+++..
T Consensus 503 ~--~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdG-eDE~elF~aI~ehn------------- 566 (683)
T KOG0696|consen 503 D--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDG-EDEDELFQAIMEHN------------- 566 (683)
T ss_pred C--CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHHHcc-------------
Confidence 2 2345568999999999999999999999999999999999999999964 44444444443321
Q ss_pred CCCCCCHHHHHHHHHHHHHhhccCCCCCC
Q 002774 789 IGLSTTLKGFEKYVDLALKCVQESGDDRP 817 (882)
Q Consensus 789 l~~~~~~~~~~~l~~li~~cl~~dp~~RP 817 (882)
..++.....+..++.+..+.+.|.+|.
T Consensus 567 --vsyPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 567 --VSYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred --CcCcccccHHHHHHHHHHhhcCCcccc
Confidence 112223346778899999999999994
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=271.10 Aligned_cols=238 Identities=31% Similarity=0.458 Sum_probs=194.9
Q ss_pred CcEEEEEEEec-CCcEEEEEEcccCCccc-HHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEeecCCCcccccCC
Q 002774 567 GYGKVYKGTLP-NGQLIAIKRAQQGSMQG-GQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSG 644 (882)
Q Consensus 567 ~fg~Vy~~~~~-~g~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~ 644 (882)
+||.||+|+.. +|+.||+|++....... .+.+.+|++.+++++|+||+++++++......++|+||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999976 48999999998665544 67899999999999999999999999999999999999999999999876
Q ss_pred CCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCceeeeeeeccCCC
Q 002774 645 KNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGY 724 (882)
Q Consensus 645 ~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y 724 (882)
.. .+++..+..++.+++++++|||+.+ ++|+||+|+||++++++.++++|||.+....... ......++..|
T Consensus 81 ~~--~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~ 152 (244)
T smart00220 81 RG--RLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEY 152 (244)
T ss_pred cc--CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCC
Confidence 44 3889999999999999999999998 9999999999999999999999999998765432 22345688899
Q ss_pred CCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCCCCCCHHHHHHHHHH
Q 002774 725 LDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDL 804 (882)
Q Consensus 725 ~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l 804 (882)
++||.+....++.++||||||+++++|++|..||............. .... .. .. ........++.++
T Consensus 153 ~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~-~~~~-----~~---~~---~~~~~~~~~~~~~ 220 (244)
T smart00220 153 MAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKI-GKPK-----PP---FP---PPEWKISPEAKDL 220 (244)
T ss_pred CCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH-hccC-----CC---Cc---cccccCCHHHHHH
Confidence 99999998889999999999999999999999996533322222211 1110 00 00 0000033678999
Q ss_pred HHHhhccCCCCCCCHHHHHH
Q 002774 805 ALKCVQESGDDRPTMSEVVK 824 (882)
Q Consensus 805 i~~cl~~dp~~RPs~~evl~ 824 (882)
+.+||..+|++||++.++++
T Consensus 221 i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 221 IRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHccCCchhccCHHHHhh
Confidence 99999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=252.57 Aligned_cols=217 Identities=28% Similarity=0.422 Sum_probs=175.9
Q ss_pred HHcCCCCCCeeeccCcEEEEEEEe-cCCcEEEEEEcccCCc-ccHHHHHHHHHHHHhc-cCCCeeeEEEEEEeCCceEEE
Q 002774 553 YTNNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSM-QGGQEFKMEIELLSRV-HHKNLVSLLGFCFDRGEQMLI 629 (882)
Q Consensus 553 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV 629 (882)
..+++.....||+|+||.|-+-++ .+|+..|||+++..-. +..+...+|+++..+- .+|.+|.++|.....+..++.
T Consensus 44 ~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIc 123 (282)
T KOG0984|consen 44 PADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWIC 123 (282)
T ss_pred chhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEe
Confidence 344555667899999999988875 5799999999986433 3446677888876655 799999999999999999999
Q ss_pred EEeecCCCcccccCC--CCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccC
Q 002774 630 YEFVPNGSLGDSLSG--KNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMS 707 (882)
Q Consensus 630 ~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~ 707 (882)
||.|. .||..+-+. ..+...++.-.-+||..+.+||.|||++- .++|||+||+||||+.+|++|+||||.+..+.
T Consensus 124 ME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~ 200 (282)
T KOG0984|consen 124 MELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLV 200 (282)
T ss_pred HHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeeh
Confidence 99994 466554332 22346788888899999999999999854 49999999999999999999999999998775
Q ss_pred CCCCceeeeeeeccCCCCCHHHHhh----CCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhh
Q 002774 708 DSEKDHITTQVKGTMGYLDPEYYMT----QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKK 775 (882)
Q Consensus 708 ~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~ 775 (882)
++- ..+...|...|||||.+.. ..|+-|+||||+|+.+.||.+++.||+...+..++++.++++.
T Consensus 201 dSi---Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep 269 (282)
T KOG0984|consen 201 DSI---AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEP 269 (282)
T ss_pred hhh---HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCC
Confidence 432 1223458889999999863 3789999999999999999999999998888777777766543
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=302.71 Aligned_cols=263 Identities=19% Similarity=0.263 Sum_probs=171.4
Q ss_pred HHcCCCCCCeeeccCcEEEEEEEec-C----CcEEEEEEcccCCcccHHHHHHHHHHHHhccCCCeeeEEEE------EE
Q 002774 553 YTNNFSDANDVGSGGYGKVYKGTLP-N----GQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGF------CF 621 (882)
Q Consensus 553 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~----g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~------~~ 621 (882)
..++|...+.||+|+||+||+|++. + +..||||++...... +.+..| .+....+.+++.++.. +.
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 4568899999999999999999964 4 689999998643211 111111 1222222233222221 24
Q ss_pred eCCceEEEEEeecCCCcccccCCCCC------------------ccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCC
Q 002774 622 DRGEQMLIYEFVPNGSLGDSLSGKNG------------------IRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIK 683 (882)
Q Consensus 622 ~~~~~~lV~e~~~~gsL~~~l~~~~~------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk 683 (882)
.+...++||||+++++|.+++..... .......+..++.|++.||+|||+.+ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 56688999999999999988865321 01122345679999999999999988 9999999
Q ss_pred CCceEEcC-CCceeEeecccccccCCCCCceeeeeeeccCCCCCHHHHhhC----------------------CCCchhH
Q 002774 684 SSNILLDE-RLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQ----------------------QLTEKSD 740 (882)
Q Consensus 684 ~~NIll~~-~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~sD 740 (882)
|+|||+++ ++.+||+|||+|+.+.... ........+++.|||||.+... .++.++|
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~-~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGI-NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCcccccccc-ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 99999986 5799999999998664332 2233456789999999976422 2345679
Q ss_pred HHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCCCC------CCHHHHHHHHHHHHHhhccCCC
Q 002774 741 VYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLS------TTLKGFEKYVDLALKCVQESGD 814 (882)
Q Consensus 741 v~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~------~~~~~~~~l~~li~~cl~~dp~ 814 (882)
||||||++|||+++..|... ..................+...+.+..... ..........+|+.+|++.||+
T Consensus 362 VwSlGviL~el~~~~~~~~~--~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~ 439 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDS--NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGR 439 (566)
T ss_pred cHHHHHHHHHHHhCcCCCch--HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcc
Confidence 99999999999997666432 111111111111111111111111111000 0000113456899999999999
Q ss_pred CCCCHHHHHHH
Q 002774 815 DRPTMSEVVKD 825 (882)
Q Consensus 815 ~RPs~~evl~~ 825 (882)
+|||++|++++
T Consensus 440 kR~ta~e~L~H 450 (566)
T PLN03225 440 QRISAKAALAH 450 (566)
T ss_pred cCCCHHHHhCC
Confidence 99999999985
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-31 Score=271.27 Aligned_cols=262 Identities=21% Similarity=0.302 Sum_probs=201.2
Q ss_pred HcCCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCCcccHHHHHHHHHHHHhcc-C-C----CeeeEEEEEEeCCce
Q 002774 554 TNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQGGQEFKMEIELLSRVH-H-K----NLVSLLGFCFDRGEQ 626 (882)
Q Consensus 554 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H-~----niv~l~~~~~~~~~~ 626 (882)
+++|.+...+|+|+||.|-++... .+..||||+++.-. ...+.-.-|+++++++. + | -+|.+.+|+...++.
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi 166 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI 166 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence 678899999999999999999753 47899999997532 23345567999999993 2 2 378888999999999
Q ss_pred EEEEEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEc----------------
Q 002774 627 MLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLD---------------- 690 (882)
Q Consensus 627 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~---------------- 690 (882)
++|+|.+ |-|+.+++..++-.+++...+..|+.|+++++++||+.+ ++|-||||+|||+.
T Consensus 167 Civfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~~~ 242 (415)
T KOG0671|consen 167 CIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKVCF 242 (415)
T ss_pred EEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCccce
Confidence 9999998 669999999988889999999999999999999999998 99999999999983
Q ss_pred ----CCCceeEeecccccccCCCCCceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHH
Q 002774 691 ----ERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVR 766 (882)
Q Consensus 691 ----~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~ 766 (882)
....+||+|||.|+.-... ....+.|..|.|||++.+-.+++++||||+||||.|+.||..-|...++...
T Consensus 243 ~r~~ks~~I~vIDFGsAtf~~e~-----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EH 317 (415)
T KOG0671|consen 243 IRPLKSTAIKVIDFGSATFDHEH-----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEH 317 (415)
T ss_pred eccCCCcceEEEecCCcceeccC-----cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHH
Confidence 1345899999999864332 2456789999999999999999999999999999999999998875543332
Q ss_pred --HHHHHHHhhhh-h--------hhhhhccC---------------CcC----CCCCCHHHHHHHHHHHHHhhccCCCCC
Q 002774 767 --EIRTVMDKKKE-L--------YNLYELID---------------PTI----GLSTTLKGFEKYVDLALKCVQESGDDR 816 (882)
Q Consensus 767 --~~~~~~~~~~~-~--------~~~~~~~d---------------~~l----~~~~~~~~~~~l~~li~~cl~~dp~~R 816 (882)
.+..++...+. + +-....+| +.. .......+..++++|+++|+..||.+|
T Consensus 318 LaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~R 397 (415)
T KOG0671|consen 318 LAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARR 397 (415)
T ss_pred HHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcccc
Confidence 12212111000 0 00000111 000 001122334679999999999999999
Q ss_pred CCHHHHHHH
Q 002774 817 PTMSEVVKD 825 (882)
Q Consensus 817 Ps~~evl~~ 825 (882)
+|+.|++.+
T Consensus 398 iTl~EAL~H 406 (415)
T KOG0671|consen 398 ITLREALSH 406 (415)
T ss_pred ccHHHHhcC
Confidence 999999864
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.8e-31 Score=251.22 Aligned_cols=258 Identities=21% Similarity=0.331 Sum_probs=200.2
Q ss_pred HcCCCCCCeeeccCcEEEEEEE-ecCCcEEEEEEcccCCcccHHHHHHHHHHHHhcc-CCCeeeEEEEEEeCC--ceEEE
Q 002774 554 TNNFSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVH-HKNLVSLLGFCFDRG--EQMLI 629 (882)
Q Consensus 554 ~~~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~--~~~lV 629 (882)
.++|+..+++|+|.|++||.|. ..+.++++||+++.- ..+.+.+|+.+|+.++ ||||+++++...++. ...||
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 4577788899999999999998 457889999999853 3367899999999997 999999999998754 56899
Q ss_pred EEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCC-CceeEeecccccccCC
Q 002774 630 YEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDER-LNAKVADFGLSKSMSD 708 (882)
Q Consensus 630 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~-~~~kl~DfGla~~~~~ 708 (882)
+||+.+.+...... .++...+...+.++++||.|+|+.| |+|||+||.|++||.. ...+|+|+|+|.++.+
T Consensus 114 FE~v~n~Dfk~ly~-----tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp 185 (338)
T KOG0668|consen 114 FEYVNNTDFKQLYP-----TLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185 (338)
T ss_pred hhhhccccHHHHhh-----hhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcCC
Confidence 99999877665543 4666778889999999999999999 9999999999999864 5699999999999877
Q ss_pred CCCceeeeeeeccCCCCCHHHHhh-CCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHH---hhh---hhhhh
Q 002774 709 SEKDHITTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMD---KKK---ELYNL 781 (882)
Q Consensus 709 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~---~~~---~~~~~ 781 (882)
..... ..+.+..|--||.+.. ..|+..-|+|||||++.+|+..+.||..|.+-.+++..+.. ... .+...
T Consensus 186 ~~eYn---VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY 262 (338)
T KOG0668|consen 186 GKEYN---VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKY 262 (338)
T ss_pred Cceee---eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHH
Confidence 65433 3456778999999975 56888999999999999999999999877665555433322 111 00001
Q ss_pred hhccCCcCCC---CC-------------CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 782 YELIDPTIGL---ST-------------TLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 782 ~~~~d~~l~~---~~-------------~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
.-.+||.... .. ..-...+.++++.+.+..|-.+|+|++|.+.+
T Consensus 263 ~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 263 QIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred ccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 1113333211 00 00112678899999999999999999999875
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.1e-30 Score=257.67 Aligned_cols=243 Identities=23% Similarity=0.314 Sum_probs=194.9
Q ss_pred HcCCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCCcc---cHHHHHHHHHHHHhc-cCCCeeeEEEEEEeCCceEE
Q 002774 554 TNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQ---GGQEFKMEIELLSRV-HHKNLVSLLGFCFDRGEQML 628 (882)
Q Consensus 554 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~l 628 (882)
.++|...++||+|+|.+|..+++. +.+.+|+|++++.-.. +.+-.+.|-.+..+. +||.+|-+..++..+...++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 457889999999999999999864 6789999999875332 223456677777776 69999999999999999999
Q ss_pred EEEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCC
Q 002774 629 IYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSD 708 (882)
Q Consensus 629 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~ 708 (882)
|.||+++|+|--.++.+. .+++..+..+...|.-||.|||+.| |+.||+|.+|||+|..|.+|++|+|+++.--.
T Consensus 329 vieyv~ggdlmfhmqrqr--klpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l~ 403 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG 403 (593)
T ss_pred EEEEecCcceeeehhhhh--cCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCCC
Confidence 999999999987776654 6888889999999999999999999 99999999999999999999999999975322
Q ss_pred CCCceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCC------CchHHHHHHHHHHhhhhhhhhh
Q 002774 709 SEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIER------GKYIVREIRTVMDKKKELYNLY 782 (882)
Q Consensus 709 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~------~~~~~~~~~~~~~~~~~~~~~~ 782 (882)
....+..++||+.|.|||.+.+..|...+|.|++||+++||+.|+.||+- ..+-.+.+-.++-+.+
T Consensus 404 --~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekq------ 475 (593)
T KOG0695|consen 404 --PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQ------ 475 (593)
T ss_pred --CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhc------
Confidence 23446678999999999999999999999999999999999999999971 1222233322222211
Q ss_pred hccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCC
Q 002774 783 ELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRP 817 (882)
Q Consensus 783 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP 817 (882)
++... ....+...+++.-+.+||.+|.
T Consensus 476 ------iripr--slsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 476 ------IRIPR--SLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred ------ccccc--eeehhhHHHHHHhhcCCcHHhc
Confidence 11111 1123456788899999999995
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.3e-31 Score=295.27 Aligned_cols=246 Identities=27% Similarity=0.418 Sum_probs=188.4
Q ss_pred CCCCCeeeccCcEE-EEEEEecCCcEEEEEEcccCCcccHHHHHHHHHHHHhc-cCCCeeeEEEEEEeCCceEEEEEeec
Q 002774 557 FSDANDVGSGGYGK-VYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRV-HHKNLVSLLGFCFDRGEQMLIYEFVP 634 (882)
Q Consensus 557 ~~~~~~lG~G~fg~-Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~ 634 (882)
|...+++|.|+-|+ ||+|.+ +|+.||||++-.+.. .-..+|+..|+.- +|||||++++.-.++...|++.|.|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~~---~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC- 585 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEEFF---DFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC- 585 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhhHhH---HHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-
Confidence 44556789999985 899999 478999999864322 3457899999988 5999999999988899999999999
Q ss_pred CCCcccccCCC--CCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcC---C--CceeEeecccccccC
Q 002774 635 NGSLGDSLSGK--NGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDE---R--LNAKVADFGLSKSMS 707 (882)
Q Consensus 635 ~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~---~--~~~kl~DfGla~~~~ 707 (882)
..+|.+++... ..........+....|+++||++||+.+ ||||||||.||||+. + .+++|+|||+++.+.
T Consensus 586 ~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 586 ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 56999999874 1111222455778899999999999998 999999999999975 3 579999999999887
Q ss_pred CCCCce-eeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhC-CCCCCCCchHHHHHHHHHHhhhhhhhhhhcc
Q 002774 708 DSEKDH-ITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTG-RRPIERGKYIVREIRTVMDKKKELYNLYELI 785 (882)
Q Consensus 708 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg-~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 785 (882)
.+.... ......||-+|+|||.+....-+.++||||+|||+|+.++| .+||.+.. ..+. .++.....+ .. +
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~--~R~~-NIl~~~~~L---~~-L 735 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSL--ERQA-NILTGNYTL---VH-L 735 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchH--Hhhh-hhhcCccce---ee-e
Confidence 654322 23456799999999999998888999999999999999995 88986421 1111 111111111 01 0
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 786 DPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 786 d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
. ...++ +..+||.+|++++|..||++.+|+.+
T Consensus 736 ~------~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 736 E------PLPDC--EAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred c------cCchH--HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 0 01111 67899999999999999999999954
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-30 Score=274.69 Aligned_cols=249 Identities=22% Similarity=0.322 Sum_probs=203.7
Q ss_pred CCCCCCeeeccCcEEEEEEEecCCc-EEEEEEcccCCc---ccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEE
Q 002774 556 NFSDANDVGSGGYGKVYKGTLPNGQ-LIAIKRAQQGSM---QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYE 631 (882)
Q Consensus 556 ~~~~~~~lG~G~fg~Vy~~~~~~g~-~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e 631 (882)
++.....||-|+||.|-.++..... .+|+|.+++... ...+.+..|-.+|...+.|.||+++-.+.+....|+.||
T Consensus 421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmE 500 (732)
T KOG0614|consen 421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLME 500 (732)
T ss_pred hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHH
Confidence 3445567999999999999875433 489998887533 333557779999999999999999999999999999999
Q ss_pred eecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCC
Q 002774 632 FVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEK 711 (882)
Q Consensus 632 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 711 (882)
-|-+|.|...++.++ .++......++..+.+|++|||+++ ||.|||||+|.++|.+|.+||.|||+|+.+..+..
T Consensus 501 aClGGElWTiLrdRg--~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~K 575 (732)
T KOG0614|consen 501 ACLGGELWTILRDRG--SFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRK 575 (732)
T ss_pred hhcCchhhhhhhhcC--CcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccCCc
Confidence 999999999998876 6788888899999999999999999 99999999999999999999999999999876654
Q ss_pred ceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCCC
Q 002774 712 DHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGL 791 (882)
Q Consensus 712 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 791 (882)
+-.++||+.|.|||.+.....+.++|.||+|+++|||++|.+||........ ...++.... . .
T Consensus 576 ---TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmkt-Yn~ILkGid-------~------i 638 (732)
T KOG0614|consen 576 ---TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKT-YNLILKGID-------K------I 638 (732)
T ss_pred ---eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHH-HHHHHhhhh-------h------h
Confidence 4468999999999999999999999999999999999999999976543322 222222211 0 1
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHHH
Q 002774 792 STTLKGFEKYVDLALKCVQESGDDRPT-----MSEVVKDI 826 (882)
Q Consensus 792 ~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~evl~~L 826 (882)
..+........+++++.+..+|.+|.. ..||-++-
T Consensus 639 ~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~ 678 (732)
T KOG0614|consen 639 EFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHR 678 (732)
T ss_pred hcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhh
Confidence 112223356779999999999999976 56666653
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.9e-30 Score=276.61 Aligned_cols=202 Identities=24% Similarity=0.394 Sum_probs=170.2
Q ss_pred cCCCCCCeeeccCcEEEEEEEe-cCCcEEEEEEcccCCccc---HHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEE
Q 002774 555 NNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQG---GQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIY 630 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 630 (882)
.-|..++.||-|+||+|.+++. ++...+|+|.+++.+.-. ...++.|-+||...+.+=||+++..|.+.+.+|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 3567788999999999999974 456789999998764432 245788999999999999999999999999999999
Q ss_pred EeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccC---
Q 002774 631 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMS--- 707 (882)
Q Consensus 631 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~--- 707 (882)
||++||++-.+|-..+ -+.+..+..++..+.+|+++.|..| +|||||||+|||||.+|.+||+||||++-+.
T Consensus 709 dYIPGGDmMSLLIrmg--IFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTH 783 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLIRMG--IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 783 (1034)
T ss_pred eccCCccHHHHHHHhc--cCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceecc
Confidence 9999999998887654 4677777788889999999999999 9999999999999999999999999986331
Q ss_pred ------CCCC---c----------------------------eeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHH
Q 002774 708 ------DSEK---D----------------------------HITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLE 750 (882)
Q Consensus 708 ------~~~~---~----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~e 750 (882)
.++. + ......+||+.|+|||++....|+...|.||.||||||
T Consensus 784 dskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~e 863 (1034)
T KOG0608|consen 784 DSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYE 863 (1034)
T ss_pred ccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHH
Confidence 0000 0 00012469999999999999999999999999999999
Q ss_pred HHhCCCCCCCC
Q 002774 751 LLTGRRPIERG 761 (882)
Q Consensus 751 l~tg~~P~~~~ 761 (882)
|+.|+.||-..
T Consensus 864 m~~g~~pf~~~ 874 (1034)
T KOG0608|consen 864 MLVGQPPFLAD 874 (1034)
T ss_pred HhhCCCCccCC
Confidence 99999999643
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-30 Score=252.97 Aligned_cols=263 Identities=24% Similarity=0.352 Sum_probs=193.4
Q ss_pred CCCCCeeeccCcEEEEEEEe-cCCcEEEEEEcccC--CcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCC-----ceEE
Q 002774 557 FSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQG--SMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRG-----EQML 628 (882)
Q Consensus 557 ~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----~~~l 628 (882)
.+..+.||-|+||.||.++. ++|+.||+|++... .....+.+.+|+++|...+|.|++..++...-.. +.|+
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 35568899999999999985 58999999998642 2234477889999999999999999888765432 4688
Q ss_pred EEEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCC
Q 002774 629 IYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSD 708 (882)
Q Consensus 629 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~ 708 (882)
|+|.| ..+|...+-... .++...+.-+..||++||.|||+.+ |.||||||.|.|++.+...||||||+|+....
T Consensus 135 ~TELm-QSDLHKIIVSPQ--~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 135 LTELM-QSDLHKIIVSPQ--ALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQ 208 (449)
T ss_pred HHHHH-HhhhhheeccCC--CCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccch
Confidence 99998 468888886544 6777788889999999999999999 99999999999999999999999999997655
Q ss_pred CCCceeeeeeeccCCCCCHHHHhh-CCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhh--hhhhh-----
Q 002774 709 SEKDHITTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKK--KELYN----- 780 (882)
Q Consensus 709 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~--~~~~~----- 780 (882)
.+. ...+..+-|..|+|||.+++ +.|+.+.||||.||++.|++..+--|..... .+++..+.+-- .....
T Consensus 209 d~~-~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~P-iqQL~lItdLLGTPs~EaMr~AC 286 (449)
T KOG0664|consen 209 RDR-LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGP-IEQLQMIIDLLGTPSQEAMKYAC 286 (449)
T ss_pred hhh-hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccCh-HHHHHHHHHHhCCCcHHHHHHHh
Confidence 443 23455667899999999996 5799999999999999999976655543222 22222111100 00000
Q ss_pred ---hhhccC-----CcCC----CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 002774 781 ---LYELID-----PTIG----LSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIE 827 (882)
Q Consensus 781 ---~~~~~d-----~~l~----~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~ 827 (882)
-.+++. |... .........+...+..+++..||+.|.+..+.+.++.
T Consensus 287 EGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 287 EGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred hhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 001111 1110 0111122355678889999999999999999887643
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=5e-27 Score=240.15 Aligned_cols=210 Identities=37% Similarity=0.591 Sum_probs=183.0
Q ss_pred eeccCcEEEEEEEecC-CcEEEEEEcccCCcc-cHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEeecCCCccc
Q 002774 563 VGSGGYGKVYKGTLPN-GQLIAIKRAQQGSMQ-GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGD 640 (882)
Q Consensus 563 lG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~~ 640 (882)
||+|++|.||+++..+ ++.+++|++...... ..+.+.+|++.++.++|++++++++++......++++||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999754 899999999865432 34678999999999999999999999999999999999999999999
Q ss_pred ccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcC-CCceeEeecccccccCCCCCceeeeeee
Q 002774 641 SLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDE-RLNAKVADFGLSKSMSDSEKDHITTQVK 719 (882)
Q Consensus 641 ~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~-~~~~kl~DfGla~~~~~~~~~~~~~~~~ 719 (882)
++.... ..+++..+..++.+++++++|||+.+ ++|+||+|.||+++. ++.++|+|||.+........ ......
T Consensus 81 ~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~ 154 (215)
T cd00180 81 LLKENE-GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIV 154 (215)
T ss_pred HHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhccc
Confidence 987542 35889999999999999999999998 999999999999999 89999999999987654321 122345
Q ss_pred ccCCCCCHHHHhhC-CCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCCCCCCHHHH
Q 002774 720 GTMGYLDPEYYMTQ-QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGF 798 (882)
Q Consensus 720 gt~~y~aPE~~~~~-~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 798 (882)
+...|++||..... .++.++|+|++|+++++|
T Consensus 155 ~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------------- 187 (215)
T cd00180 155 GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------------- 187 (215)
T ss_pred CCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------------------
Confidence 78899999999877 888999999999999999
Q ss_pred HHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 799 EKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 799 ~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
..+.+++.+|++.+|++||++.++++.
T Consensus 188 ~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 245689999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9e-29 Score=270.33 Aligned_cols=252 Identities=26% Similarity=0.396 Sum_probs=204.5
Q ss_pred HcCCCCCCeeeccCcEEEEEEEe-cCCcEEEEEEcccCCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEe
Q 002774 554 TNNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEF 632 (882)
Q Consensus 554 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 632 (882)
.++|....++|+|+||.||||+. ..++..|||.++.....+-+-.++|+-+++..+|||||.++|.+...+..+++|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 35678889999999999999985 57899999999987776667788999999999999999999999999999999999
Q ss_pred ecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCc
Q 002774 633 VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKD 712 (882)
Q Consensus 633 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 712 (882)
+.+|+|.+.-+.-+ ++++.++...++...+|++|||+.+ -+|||||-.||++++.|.+|++|||.+..+...-
T Consensus 94 cgggslQdiy~~Tg--plselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitati-- 166 (829)
T KOG0576|consen 94 CGGGSLQDIYHVTG--PLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITATI-- 166 (829)
T ss_pred cCCCcccceeeecc--cchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhhh--
Confidence 99999999887655 7899999999999999999999999 8999999999999999999999999987664321
Q ss_pred eeeeeeeccCCCCCHHHHh---hCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccC-Cc
Q 002774 713 HITTQVKGTMGYLDPEYYM---TQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELID-PT 788 (882)
Q Consensus 713 ~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d-~~ 788 (882)
.....+.||+.|||||+.. .+.|.+++|||+.|+...|+-.-+.|..+-... + ...+..+. ..+ |.
T Consensus 167 ~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpm-r--~l~LmTkS-------~~qpp~ 236 (829)
T KOG0576|consen 167 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPM-R--ALFLMTKS-------GFQPPT 236 (829)
T ss_pred hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchH-H--HHHHhhcc-------CCCCCc
Confidence 1233578999999999885 567999999999999999999888886432111 1 11111111 111 22
Q ss_pred CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002774 789 IGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVK 824 (882)
Q Consensus 789 l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~ 824 (882)
+. ...+..+-|-++++.|+-++|++||++..+++
T Consensus 237 lk--Dk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 237 LK--DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred cc--CCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 21 12223356779999999999999999998875
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-28 Score=247.39 Aligned_cols=258 Identities=24% Similarity=0.312 Sum_probs=193.7
Q ss_pred CCCCCCeeeccCcEEEEEEEe-cCCcEEEEEEcccC--CcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCC------ce
Q 002774 556 NFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQG--SMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRG------EQ 626 (882)
Q Consensus 556 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------~~ 626 (882)
+|...+.+|.|+- .|..|.. -.++.||+|++... .....+...+|..++..+.|+||++++.++.-.. +.
T Consensus 18 Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~ 96 (369)
T KOG0665|consen 18 RYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEV 96 (369)
T ss_pred eeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhH
Confidence 5666778899888 5555543 25889999987643 2334567788999999999999999999986443 56
Q ss_pred EEEEEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeeccccccc
Q 002774 627 MLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSM 706 (882)
Q Consensus 627 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~ 706 (882)
|+||||| .++|...++- .++-.+...|..|+++|+.|||+.+ |+||||||+||++..+..+||.|||+|+.-
T Consensus 97 y~v~e~m-~~nl~~vi~~----elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar~e 168 (369)
T KOG0665|consen 97 YLVMELM-DANLCQVILM----ELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLARTE 168 (369)
T ss_pred HHHHHhh-hhHHHHHHHH----hcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhccc
Confidence 9999999 5688877762 4777889999999999999999999 999999999999999999999999999864
Q ss_pred CCCCCceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhh--------
Q 002774 707 SDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKEL-------- 778 (882)
Q Consensus 707 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~-------- 778 (882)
.. +...+..+.|..|.|||++.+..+...+||||.||++.||++|+.-|.+...+.+|.+.+-.-+..-
T Consensus 169 ~~---~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~ 245 (369)
T KOG0665|consen 169 DT---DFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQ 245 (369)
T ss_pred Cc---ccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhh
Confidence 32 2345667889999999999988899999999999999999999988764444444433221100000
Q ss_pred ---------------hhhhhccCCcC---CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 779 ---------------YNLYELIDPTI---GLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 779 ---------------~~~~~~~d~~l---~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
....+.+...+ ...........+.+++.+||..+|++|.++++++++
T Consensus 246 ~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 246 PTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 00011110000 000111123567899999999999999999999975
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-27 Score=256.68 Aligned_cols=197 Identities=25% Similarity=0.353 Sum_probs=169.1
Q ss_pred HcCCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCCccc--------HHHHHHHHHHHHhcc---CCCeeeEEEEEE
Q 002774 554 TNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQG--------GQEFKMEIELLSRVH---HKNLVSLLGFCF 621 (882)
Q Consensus 554 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~--------~~~~~~E~~~l~~l~---H~niv~l~~~~~ 621 (882)
..+|...+.+|+|+||.|+.|.++ +...|+||.+.+...-. .-.+-.|+.||..++ |+||++++++|+
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 346888999999999999999975 46789999887653211 112456999999997 999999999999
Q ss_pred eCCceEEEEEeec-CCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeec
Q 002774 622 DRGEQMLIYEFVP-NGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADF 700 (882)
Q Consensus 622 ~~~~~~lV~e~~~-~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~Df 700 (882)
+++.+||+||-.. +.+|.+++..+. .+++....-|..||+.|+++||+.+ |||||||-+||.++.+|-+||+||
T Consensus 640 ddd~yyl~te~hg~gIDLFd~IE~kp--~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFIEFKP--RMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhhhccC--ccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeec
Confidence 9999999999764 559999998765 6888999999999999999999999 999999999999999999999999
Q ss_pred ccccccCCCCCceeeeeeeccCCCCCHHHHhhCCCCc-hhHHHHHHHHHHHHHhCCCCCC
Q 002774 701 GLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTE-KSDVYSFGVLMLELLTGRRPIE 759 (882)
Q Consensus 701 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~sDv~S~Gvll~el~tg~~P~~ 759 (882)
|.|.....+. ...++||.+|.|||++.+..|-- .-|||++|++||-++....||.
T Consensus 715 gsaa~~ksgp----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 715 GSAAYTKSGP----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred cchhhhcCCC----cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 9998765433 34578999999999999888754 5799999999999998888874
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.1e-26 Score=237.66 Aligned_cols=199 Identities=34% Similarity=0.522 Sum_probs=173.2
Q ss_pred CCCCCeeeccCcEEEEEEEecC-CcEEEEEEcccCCcc-cHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEeec
Q 002774 557 FSDANDVGSGGYGKVYKGTLPN-GQLIAIKRAQQGSMQ-GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVP 634 (882)
Q Consensus 557 ~~~~~~lG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 634 (882)
|...+.||+|++|+||+|...+ ++.+|+|.+...... ..+.+.+|++.+++++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4566889999999999999764 899999999865544 56788999999999999999999999999999999999999
Q ss_pred CCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCcee
Q 002774 635 NGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHI 714 (882)
Q Consensus 635 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 714 (882)
+++|.+++..... .+++.....++.+++.++.|||+.+ ++|+||+|+||+++.++.++|+|||.+......... .
T Consensus 81 ~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~-~ 155 (225)
T smart00221 81 GGDLFDYLRKKGG-KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA-L 155 (225)
T ss_pred CCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc-c
Confidence 9999999876432 1789999999999999999999988 999999999999999999999999999877554211 1
Q ss_pred eeeeeccCCCCCHHHH-hhCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 002774 715 TTQVKGTMGYLDPEYY-MTQQLTEKSDVYSFGVLMLELLTGRRPIER 760 (882)
Q Consensus 715 ~~~~~gt~~y~aPE~~-~~~~~~~~sDv~S~Gvll~el~tg~~P~~~ 760 (882)
.....++..|++||.. ....++.++|||+||++++||++|+.||..
T Consensus 156 ~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 156 LKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 2335678899999998 667788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3e-29 Score=270.54 Aligned_cols=299 Identities=23% Similarity=0.310 Sum_probs=239.8
Q ss_pred ccCccccCCCCCCEEeccCCCCCccCCCccccCCCCCcEEEeeCCcCCccccccccCCCCCCEEEccCCcCCCCCCcCcc
Q 002774 6 QLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIG 85 (882)
Q Consensus 6 ~l~~~~~~l~~L~~L~L~~n~~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~ 85 (882)
++-++++.|+.|+.+++.+|+.-..-+|..+.+|..|+.|+||+|+++ ..|..+...+++-.|+|++|+|..+....|-
T Consensus 69 ~vhGELs~Lp~LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfi 147 (1255)
T KOG0444|consen 69 SVHGELSDLPRLRSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFI 147 (1255)
T ss_pred hhhhhhccchhhHHHhhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHH
Confidence 566788899999999999998555568889999999999999999999 8899999999999999999999865555678
Q ss_pred CCCCCcEeeccCceeeeecCCCCCCCchhhhhhcccceeccCCeeeecCCccccCCcccceeeeccCCccc-ccCCcccc
Q 002774 86 NLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLT-GELPATLG 164 (882)
Q Consensus 86 ~l~~L~~L~Ls~N~i~~~~p~~~~~~~~l~~L~~L~~L~L~~N~l~~~ip~~~f~~~~~L~~L~L~~N~l~-~~~~~~~~ 164 (882)
+|+.|-.||||+|++. .+| +..+.|..|+.|.|++|.+. .....-...+.+|..|.+++.+-+ .-+|.++.
T Consensus 148 nLtDLLfLDLS~NrLe-~LP------PQ~RRL~~LqtL~Ls~NPL~-hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld 219 (1255)
T KOG0444|consen 148 NLTDLLFLDLSNNRLE-MLP------PQIRRLSMLQTLKLSNNPLN-HFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLD 219 (1255)
T ss_pred hhHhHhhhccccchhh-hcC------HHHHHHhhhhhhhcCCChhh-HHHHhcCccchhhhhhhcccccchhhcCCCchh
Confidence 8999999999999998 555 45677888889999999775 222222223667788888876654 45788888
Q ss_pred CCCCCCEEEccCCCCCCCCCccCCCCCCCCEEEccCCcccccCCCCCCCCCCCEEECcCCCCCCCCCCccccCCCCCCEE
Q 002774 165 LVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTL 244 (882)
Q Consensus 165 ~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L 244 (882)
.+.+|..+|+|.|.+. ..|+.+.++.+|+.|+||+|+|+.+......+.+|++|+||.|+++ .+|.++..|+.|+.|
T Consensus 220 ~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~iteL~~~~~~W~~lEtLNlSrNQLt--~LP~avcKL~kL~kL 296 (1255)
T KOG0444|consen 220 DLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKITELNMTEGEWENLETLNLSRNQLT--VLPDAVCKLTKLTKL 296 (1255)
T ss_pred hhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCceeeeeccHHHHhhhhhhccccchhc--cchHHHhhhHHHHHH
Confidence 8888888888888888 7888888888888888888888887777777888888888888884 688888888888888
Q ss_pred ECcCCcccc-cCCccCCCCCCCCEEEccCCccceecCCCCcccccccccccCCccccccCCCCCCccceEEecC
Q 002774 245 MMENTNLKG-QIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENLLVNLQNNRISAYTERGGAPAVNLTLIDN 317 (882)
Q Consensus 245 ~Ls~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~~~~L~~l~~ 317 (882)
.+.+|+++- -+|..+++|.+|+.+..++|++.-.++.......|+.|.|+.|++.++|.. ..-++.|..||.
T Consensus 297 y~n~NkL~FeGiPSGIGKL~~Levf~aanN~LElVPEglcRC~kL~kL~L~~NrLiTLPea-IHlL~~l~vLDl 369 (1255)
T KOG0444|consen 297 YANNNKLTFEGIPSGIGKLIQLEVFHAANNKLELVPEGLCRCVKLQKLKLDHNRLITLPEA-IHLLPDLKVLDL 369 (1255)
T ss_pred HhccCcccccCCccchhhhhhhHHHHhhccccccCchhhhhhHHHHHhcccccceeechhh-hhhcCCcceeec
Confidence 888888873 567888888888888888888887777777788888888888888887653 344555666653
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.4e-29 Score=268.54 Aligned_cols=297 Identities=23% Similarity=0.319 Sum_probs=259.8
Q ss_pred ccCccccCCCCCCEEeccCCCCCccCCCccccCCCCCcEEEeeCCcCCc-cccccccCCCCCCEEEccCCcCCCCCCcCc
Q 002774 6 QLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSG-PIPDSIGSLQELVLLSLNSNGFSGRVPPSI 84 (882)
Q Consensus 6 ~l~~~~~~l~~L~~L~L~~n~~i~~~~p~~~~~l~~L~~L~L~~n~i~~-~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~ 84 (882)
++|++++.+.+|+.|.+++|+ ...+-+.++.|+.|+.+.+.+|++.. -+|..+..|..|+.|||++|+++ ..|..+
T Consensus 46 ~vPeEL~~lqkLEHLs~~HN~--L~~vhGELs~Lp~LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~L 122 (1255)
T KOG0444|consen 46 QVPEELSRLQKLEHLSMAHNQ--LISVHGELSDLPRLRSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNL 122 (1255)
T ss_pred hChHHHHHHhhhhhhhhhhhh--hHhhhhhhccchhhHHHhhhccccccCCCCchhcccccceeeecchhhhh-hcchhh
Confidence 689999999999999999998 55778899999999999999999973 37888999999999999999999 899999
Q ss_pred cCCCCCcEeeccCceeeeecCCCCCCCchhhhhhcccceeccCCeeeecCCccccCCcccceeeeccCCcccccCCcccc
Q 002774 85 GNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLG 164 (882)
Q Consensus 85 ~~l~~L~~L~Ls~N~i~~~~p~~~~~~~~l~~L~~L~~L~L~~N~l~~~ip~~~f~~~~~L~~L~L~~N~l~~~~~~~~~ 164 (882)
...+++-.|+||+|+|. +||..+ +.+|.-|-.|+|++|++. .+|..+ +.+..|++|.|++|.+....-..+-
T Consensus 123 E~AKn~iVLNLS~N~Ie-tIPn~l-----finLtDLLfLDLS~NrLe-~LPPQ~-RRL~~LqtL~Ls~NPL~hfQLrQLP 194 (1255)
T KOG0444|consen 123 EYAKNSIVLNLSYNNIE-TIPNSL-----FINLTDLLFLDLSNNRLE-MLPPQI-RRLSMLQTLKLSNNPLNHFQLRQLP 194 (1255)
T ss_pred hhhcCcEEEEcccCccc-cCCchH-----HHhhHhHhhhccccchhh-hcCHHH-HHHhhhhhhhcCCChhhHHHHhcCc
Confidence 99999999999999998 888654 667788889999999999 888865 4467899999999999876666777
Q ss_pred CCCCCCEEEccCCCCC-CCCCccCCCCCCCCEEEccCCcccccCCCCCCCCCCCEEECcCCCCCCCCCCccccCCCCCCE
Q 002774 165 LVKSLEVVRFDRNSLS-GPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTT 243 (882)
Q Consensus 165 ~l~~L~~L~Ls~N~l~-~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~ 243 (882)
.+++|++|.|++.+-+ .-+|.++..+.+|..+|||.|.+.-+|..+..+++|+.|+||+|+|+ .+........+|++
T Consensus 195 smtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp~vPecly~l~~LrrLNLS~N~it--eL~~~~~~W~~lEt 272 (1255)
T KOG0444|consen 195 SMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLPIVPECLYKLRNLRRLNLSGNKIT--ELNMTEGEWENLET 272 (1255)
T ss_pred cchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCCcchHHHhhhhhhheeccCcCcee--eeeccHHHHhhhhh
Confidence 8899999999987654 36899999999999999999999988888999999999999999995 56666777889999
Q ss_pred EECcCCcccccCCccCCCCCCCCEEEccCCccc--eecCCCCcccccccccccCCccccccCCCCCCccceEEecC
Q 002774 244 LMMENTNLKGQIPADLFSIPHLQTVVMKTNELN--GTLDLGTSYSENLLVNLQNNRISAYTERGGAPAVNLTLIDN 317 (882)
Q Consensus 244 L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~--~~~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~~~~L~~l~~ 317 (882)
|+||.|+++ .+|+++.+|++|+.|.+.+|+++ |++...-.+.+|+.+.+++|.+.-+|. ++..+..|+.|..
T Consensus 273 LNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LElVPE-glcRC~kL~kL~L 346 (1255)
T KOG0444|consen 273 LNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLELVPE-GLCRCVKLQKLKL 346 (1255)
T ss_pred hccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccccCch-hhhhhHHHHHhcc
Confidence 999999999 99999999999999999999997 455555569999999999999976654 4666666666644
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=228.32 Aligned_cols=249 Identities=20% Similarity=0.311 Sum_probs=183.5
Q ss_pred HcCCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCCcccHHHHHHHHHHHHhc-cCCCeeeEEEE-EEeCCceEEEE
Q 002774 554 TNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQGGQEFKMEIELLSRV-HHKNLVSLLGF-CFDRGEQMLIY 630 (882)
Q Consensus 554 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~-~~~~~~~~lV~ 630 (882)
.+.|.+.+.+|+|.||.+-+++++ ..+.+++|.+.... ...++|.+|...--.| .|.||+.-++. +...+.+++++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 456788899999999999999975 56789999887643 3347899998876666 59999987764 56677888999
Q ss_pred EeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEc--CCCceeEeecccccccCC
Q 002774 631 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLD--ERLNAKVADFGLSKSMSD 708 (882)
Q Consensus 631 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~--~~~~~kl~DfGla~~~~~ 708 (882)
||+|.|+|.+-+...+ +.+....+++.|++.|+.|+|+.. +||||||.+||||- +..++||||||+.+..+.
T Consensus 102 E~aP~gdL~snv~~~G---igE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~ 175 (378)
T KOG1345|consen 102 EFAPRGDLRSNVEAAG---IGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT 175 (378)
T ss_pred ccCccchhhhhcCccc---ccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccCc
Confidence 9999999999887654 777888899999999999999999 99999999999992 345799999999875432
Q ss_pred CCCceeeeeeeccCCCCCHHHHhhC-----CCCchhHHHHHHHHHHHHHhCCCCCCCCc----hHHHHHHHHHHhhhhhh
Q 002774 709 SEKDHITTQVKGTMGYLDPEYYMTQ-----QLTEKSDVYSFGVLMLELLTGRRPIERGK----YIVREIRTVMDKKKELY 779 (882)
Q Consensus 709 ~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDv~S~Gvll~el~tg~~P~~~~~----~~~~~~~~~~~~~~~~~ 779 (882)
......-+..|.|||..... ...+.+|||.||++++.++||..||.... ...++.... +
T Consensus 176 -----tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~---~---- 243 (378)
T KOG1345|consen 176 -----TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWL---K---- 243 (378)
T ss_pred -----eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHh---c----
Confidence 12223456679999988632 35678999999999999999999997322 112222111 1
Q ss_pred hhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCC---CCHHHHHHHH
Q 002774 780 NLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDR---PTMSEVVKDI 826 (882)
Q Consensus 780 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~R---Ps~~evl~~L 826 (882)
...+.++..+ ....+.+.++.++-+.++|++| -+++...+.+
T Consensus 244 ----rk~~~~P~~F-~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~ 288 (378)
T KOG1345|consen 244 ----RKNPALPKKF-NPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCL 288 (378)
T ss_pred ----ccCccCchhh-cccCHHHHHHHHHhcCCcccccchhHHHHHHHHHH
Confidence 1111111111 0122566788889999999999 4444444433
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.1e-26 Score=241.71 Aligned_cols=266 Identities=23% Similarity=0.344 Sum_probs=196.2
Q ss_pred HHHHHcCCCCCCeeeccCcEEEEEEEec----CCcEEEEEEcccCCcccHHHHHHHHHHHHhcc-CCCeeeEEEEEEeCC
Q 002774 550 VKKYTNNFSDANDVGSGGYGKVYKGTLP----NGQLIAIKRAQQGSMQGGQEFKMEIELLSRVH-HKNLVSLLGFCFDRG 624 (882)
Q Consensus 550 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~ 624 (882)
+....+.|...++||+|+|++||+|... ..+.||+|.+...+. ...+..|+++|..+. +.||+++.+++..++
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 3344567889999999999999999853 467999999975443 356889999999995 999999999999999
Q ss_pred ceEEEEEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcC-CCceeEeecccc
Q 002774 625 EQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDE-RLNAKVADFGLS 703 (882)
Q Consensus 625 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~-~~~~kl~DfGla 703 (882)
...+|+||+++....++... ++...+......+..||+++|..| ||||||||+|+|.+. .+.-.|.|||+|
T Consensus 109 ~v~ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgLA 180 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGLA 180 (418)
T ss_pred eeEEEecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechhH
Confidence 99999999999887777753 567788889999999999999999 999999999999975 467899999999
Q ss_pred cccCCCC--------------------------------Cce----------eeeeeeccCCCCCHHHHhh-CCCCchhH
Q 002774 704 KSMSDSE--------------------------------KDH----------ITTQVKGTMGYLDPEYYMT-QQLTEKSD 740 (882)
Q Consensus 704 ~~~~~~~--------------------------------~~~----------~~~~~~gt~~y~aPE~~~~-~~~~~~sD 740 (882)
....... ... ..-...||+||.|||++.. ...+.++|
T Consensus 181 ~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiD 260 (418)
T KOG1167|consen 181 QRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAID 260 (418)
T ss_pred HHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccc
Confidence 7221000 000 0012459999999999985 56789999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCchHHHHHHHHH---Hhh---------hh--hh------h------hhhccC-CcCC---
Q 002774 741 VYSFGVLMLELLTGRRPIERGKYIVREIRTVM---DKK---------KE--LY------N------LYELID-PTIG--- 790 (882)
Q Consensus 741 v~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~---~~~---------~~--~~------~------~~~~~d-~~l~--- 790 (882)
|||.|||++-+++++.||....+..+.+..+. ... .. +. . -++.++ ....
T Consensus 261 iws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~ 340 (418)
T KOG1167|consen 261 IWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSR 340 (418)
T ss_pred eeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccc
Confidence 99999999999999999974433222221111 000 00 00 0 001111 0000
Q ss_pred ------CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 791 ------LSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 791 ------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
.......+..+++++.+|+..||.+|.|++|++++
T Consensus 341 q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 341 QPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred ccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 00111112468999999999999999999999975
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-25 Score=237.08 Aligned_cols=132 Identities=25% Similarity=0.310 Sum_probs=111.9
Q ss_pred cCCCCCCeeeccCcEEEEEEEe-cCCcEEEEEEcccCCcccHHHHHHHHHHHHhcc-----C---CCeeeEEEEEEe---
Q 002774 555 NNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVH-----H---KNLVSLLGFCFD--- 622 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----H---~niv~l~~~~~~--- 622 (882)
.+|.+.++||=|.|++||+|-. .+.+.||+|+.+.. ..-.+....|+++|++++ | .+||+|++.|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 5788999999999999999974 56789999999853 233456678999999984 2 479999999875
Q ss_pred -CCceEEEEEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEc
Q 002774 623 -RGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLD 690 (882)
Q Consensus 623 -~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~ 690 (882)
+.+.+||+|++ |-+|..+|.....+.++...+.+|+.||+.||.|||..+ .|||-||||+|||+.
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLC 222 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeee
Confidence 34789999999 678888888777677899999999999999999999865 499999999999983
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-26 Score=246.71 Aligned_cols=270 Identities=21% Similarity=0.241 Sum_probs=203.1
Q ss_pred CHHHHHHHHcCCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCCcccHHHHHHHHHHHHhcc------CCCeeeEEE
Q 002774 546 SFEEVKKYTNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQGGQEFKMEIELLSRVH------HKNLVSLLG 618 (882)
Q Consensus 546 ~~~e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------H~niv~l~~ 618 (882)
.+.-.+..-..|.+.-..|+|-|++|.+|... -|..||||++.....- .+.=..|+++|++|. --|+++++-
T Consensus 423 rv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M-~KtGl~EleiLkKL~~AD~Edk~Hclrl~r 501 (752)
T KOG0670|consen 423 RVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM-HKTGLKELEILKKLNDADPEDKFHCLRLFR 501 (752)
T ss_pred EEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH-hhhhhHHHHHHHHhhccCchhhhHHHHHHH
Confidence 33333445678888888999999999999854 4789999999864322 144567999999995 358999999
Q ss_pred EEEeCCceEEEEEeecCCCcccccCCCC-CccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCC-Ccee
Q 002774 619 FCFDRGEQMLIYEFVPNGSLGDSLSGKN-GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDER-LNAK 696 (882)
Q Consensus 619 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~-~~~k 696 (882)
.|....++|||+|-+ ..+|.+.|+.-+ ...+....+..++.|+.-||..|...+ |+|.||||.|||+++. ...|
T Consensus 502 ~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLK 577 (752)
T KOG0670|consen 502 HFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILK 577 (752)
T ss_pred HhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceee
Confidence 999999999999987 568888887543 456778888999999999999999998 9999999999999876 4579
Q ss_pred EeecccccccCCCCCceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhh
Q 002774 697 VADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKK 776 (882)
Q Consensus 697 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~ 776 (882)
|||||.|......+. +....+..|.|||.+.+-.|+...|+||.||.||||.||+--|.+ .+-.++++-.++-..
T Consensus 578 LCDfGSA~~~~enei----tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG-~TNN~MLrl~me~KG 652 (752)
T KOG0670|consen 578 LCDFGSASFASENEI----TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPG-RTNNQMLRLFMELKG 652 (752)
T ss_pred eccCccccccccccc----cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCC-CCcHHHHHHHHHhcC
Confidence 999999988765443 233456679999999999999999999999999999999988753 333333333332111
Q ss_pred hhh----------------------------------hhhhccCCc------C-----CCCCCHHHHHHHHHHHHHhhcc
Q 002774 777 ELY----------------------------------NLYELIDPT------I-----GLSTTLKGFEKYVDLALKCVQE 811 (882)
Q Consensus 777 ~~~----------------------------------~~~~~~d~~------l-----~~~~~~~~~~~l~~li~~cl~~ 811 (882)
... .+...+.|. + ..........+|.+|+.+|+..
T Consensus 653 k~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~L 732 (752)
T KOG0670|consen 653 KFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLIL 732 (752)
T ss_pred CCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhcc
Confidence 000 011111121 0 0112233457799999999999
Q ss_pred CCCCCCCHHHHHHH
Q 002774 812 SGDDRPTMSEVVKD 825 (882)
Q Consensus 812 dp~~RPs~~evl~~ 825 (882)
||++|.|..++|++
T Consensus 733 dP~KRit~nqAL~H 746 (752)
T KOG0670|consen 733 DPEKRITVNQALKH 746 (752)
T ss_pred ChhhcCCHHHHhcC
Confidence 99999999998864
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.4e-25 Score=218.01 Aligned_cols=245 Identities=23% Similarity=0.388 Sum_probs=190.9
Q ss_pred CCeeeccCcEEEEEEEecCCcEEEEEEcccC--CcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEeecCCC
Q 002774 560 ANDVGSGGYGKVYKGTLPNGQLIAIKRAQQG--SMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGS 637 (882)
Q Consensus 560 ~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 637 (882)
.-+|.+...|+.|+|+|+ |..+++|+++.. .....++|.+|.-.|+...||||+.++|.|.......++..||+.|+
T Consensus 195 ~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gs 273 (448)
T KOG0195|consen 195 ITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGS 273 (448)
T ss_pred hhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchH
Confidence 345788899999999997 445666766543 33344789999999999999999999999999999999999999999
Q ss_pred cccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEe--ecccccccCCCCCceee
Q 002774 638 LGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVA--DFGLSKSMSDSEKDHIT 715 (882)
Q Consensus 638 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~--DfGla~~~~~~~~~~~~ 715 (882)
|+..+++....-.+..+..+++.++|+|++|||+.. +-|.---+.++.|+||++.+++|. |--++- ..
T Consensus 274 lynvlhe~t~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarismad~kfsf---------qe 343 (448)
T KOG0195|consen 274 LYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISMADTKFSF---------QE 343 (448)
T ss_pred HHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheecccceeee---------ec
Confidence 999999988888899999999999999999999975 334445688999999999998874 221111 11
Q ss_pred eeeeccCCCCCHHHHhhCCCC---chhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCCCC
Q 002774 716 TQVKGTMGYLDPEYYMTQQLT---EKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLS 792 (882)
Q Consensus 716 ~~~~gt~~y~aPE~~~~~~~~---~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 792 (882)
....-.+.||+||.+....-+ .++|+|||++++||+.|...||.+-....--.+..++. +.-.+.|.
T Consensus 344 ~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeg------lrv~ippg---- 413 (448)
T KOG0195|consen 344 VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEG------LRVHIPPG---- 413 (448)
T ss_pred cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhcc------ccccCCCC----
Confidence 123346789999999865543 47899999999999999999997544332222222221 22233333
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 002774 793 TTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENI 829 (882)
Q Consensus 793 ~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 829 (882)
....+.+++.-|+..||.+||.+..++-.|+++
T Consensus 414 ----is~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 414 ----ISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred ----ccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 336788999999999999999999999988876
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.4e-28 Score=248.05 Aligned_cols=287 Identities=28% Similarity=0.388 Sum_probs=229.4
Q ss_pred CCccccCccccCCCCCCEEeccCCCCCccCCCccccCCCCCcEEEeeCCcCCccccccc-cCCCCCCEEEccCCcCCCCC
Q 002774 2 GLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSI-GSLQELVLLSLNSNGFSGRV 80 (882)
Q Consensus 2 ~~~~~l~~~~~~l~~L~~L~L~~n~~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~~~~~-~~l~~L~~L~L~~N~i~~~~ 80 (882)
++-+.||++++.+..|..|+|..|+ .-.+| +|+.+..|+.|.+..|.|. .+|... .++++|..|||.+|+++ ..
T Consensus 193 N~L~tlP~~lg~l~~L~~LyL~~Nk--i~~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~ 267 (565)
T KOG0472|consen 193 NLLETLPPELGGLESLELLYLRRNK--IRFLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EV 267 (565)
T ss_pred hhhhcCChhhcchhhhHHHHhhhcc--cccCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cC
Confidence 4567899999999999999999998 44666 7888888888888888888 566554 48888888888888887 77
Q ss_pred CcCccCCCCCcEeeccCceeeeecCCCCCCCchhhhh-------------------------------------------
Q 002774 81 PPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDML------------------------------------------- 117 (882)
Q Consensus 81 ~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~~~~l~~L------------------------------------------- 117 (882)
|+.+..+.+|+.||+|+|.|+ .+|.+++++ .|+.|
T Consensus 268 Pde~clLrsL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e 345 (565)
T KOG0472|consen 268 PDEICLLRSLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTE 345 (565)
T ss_pred chHHHHhhhhhhhcccCCccc-cCCcccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCccccc
Confidence 888888888888888888887 677777775 44433
Q ss_pred ----------------hcccceeccCCeeeecCCccccCCcc--cceeeeccCCcccccCCccccCCCCCCEE-EccCCC
Q 002774 118 ----------------VRAKHFHFGKNQLSGSIPEKLFRPDM--VLIHVLFDSNNLTGELPATLGLVKSLEVV-RFDRNS 178 (882)
Q Consensus 118 ----------------~~L~~L~L~~N~l~~~ip~~~f~~~~--~L~~L~L~~N~l~~~~~~~~~~l~~L~~L-~Ls~N~ 178 (882)
.+.+.|++++-+++ .+|+++|..-. -.+.++++.|++. .+|..+..+..+.+. .+++|.
T Consensus 346 ~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt-~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~ 423 (565)
T KOG0472|consen 346 TAMTLPSESFPDIYAIITTKILDVSDKQLT-LVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNK 423 (565)
T ss_pred ccCCCCCCcccchhhhhhhhhhcccccccc-cCCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCc
Confidence 24677777777777 88888887543 3677888888887 667777766666554 444444
Q ss_pred CCCCCCccCCCCCCCCEEEccCCcccccCCCCCCCCCCCEEECcCCCCCCCCCCccccCCCCCCEEECcCCcccccCCcc
Q 002774 179 LSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPAD 258 (882)
Q Consensus 179 l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~ 258 (882)
++ -+|..++.+++|..|+|++|.+..+|.+++.+..|+.|++|.|++ ...|..+-.+..|+.+-.++|++....+..
T Consensus 424 is-fv~~~l~~l~kLt~L~L~NN~Ln~LP~e~~~lv~Lq~LnlS~NrF--r~lP~~~y~lq~lEtllas~nqi~~vd~~~ 500 (565)
T KOG0472|consen 424 IS-FVPLELSQLQKLTFLDLSNNLLNDLPEEMGSLVRLQTLNLSFNRF--RMLPECLYELQTLETLLASNNQIGSVDPSG 500 (565)
T ss_pred cc-cchHHHHhhhcceeeecccchhhhcchhhhhhhhhheeccccccc--ccchHHHhhHHHHHHHHhccccccccChHH
Confidence 44 788888999999999999999998888888888899999999988 468888888888888888889998666666
Q ss_pred CCCCCCCCEEEccCCccceecCCCCcccccccccccCCcccc
Q 002774 259 LFSIPHLQTVVMKTNELNGTLDLGTSYSENLLVNLQNNRISA 300 (882)
Q Consensus 259 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~N~i~~ 300 (882)
+.+|.+|..|||.+|.+..+++..-++.+|+.|+|.+|+++.
T Consensus 501 l~nm~nL~tLDL~nNdlq~IPp~LgnmtnL~hLeL~gNpfr~ 542 (565)
T KOG0472|consen 501 LKNMRNLTTLDLQNNDLQQIPPILGNMTNLRHLELDGNPFRQ 542 (565)
T ss_pred hhhhhhcceeccCCCchhhCChhhccccceeEEEecCCccCC
Confidence 888999999999999999888888889999999999999883
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.4e-24 Score=215.12 Aligned_cols=170 Identities=23% Similarity=0.257 Sum_probs=130.4
Q ss_pred CCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCceee
Q 002774 636 GSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHIT 715 (882)
Q Consensus 636 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 715 (882)
|+|.++++.. +..+++.++..++.|+++||+|||+.+ ||+||+++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~----- 63 (176)
T smart00750 1 VSLADILEVR-GRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ----- 63 (176)
T ss_pred CcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc-----
Confidence 6788888753 236999999999999999999999865 999999999999999 99998764322
Q ss_pred eeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCCCCCCH
Q 002774 716 TQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTL 795 (882)
Q Consensus 716 ~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 795 (882)
..||+.|||||++.+..++.++|||||||++|||+||+.||.................. ..++... ....
T Consensus 64 --~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~-------~~~~~~~-~~~~ 133 (176)
T smart00750 64 --SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMP-------ADDPRDR-SNLE 133 (176)
T ss_pred --CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhc-------cCCcccc-ccHH
Confidence 25889999999999999999999999999999999999999754433333333222111 0011100 0111
Q ss_pred HHHH--HHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 002774 796 KGFE--KYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 832 (882)
Q Consensus 796 ~~~~--~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~ 832 (882)
.... ++.+++.+||+.+|++||++.|+++++..+..+
T Consensus 134 ~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~ 172 (176)
T smart00750 134 SVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFAE 172 (176)
T ss_pred HHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHH
Confidence 2222 689999999999999999999999998877544
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.3e-25 Score=272.11 Aligned_cols=197 Identities=21% Similarity=0.258 Sum_probs=140.7
Q ss_pred hccC-CCeeeEEEEE-------EeCCceEEEEEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCee
Q 002774 607 RVHH-KNLVSLLGFC-------FDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPII 678 (882)
Q Consensus 607 ~l~H-~niv~l~~~~-------~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iv 678 (882)
.++| +||+++++++ .+.+..+.++||+ +++|.+++... ...+++.+++.++.||++||+|||+.+ |+
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~g---Iv 102 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHSQG---IV 102 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 3455 6888888877 2234567888987 66999999753 346899999999999999999999998 99
Q ss_pred ecCCCCCceEEcC-------------------CCceeEeecccccccCCCCC--------------ceeeeeeeccCCCC
Q 002774 679 HRDIKSSNILLDE-------------------RLNAKVADFGLSKSMSDSEK--------------DHITTQVKGTMGYL 725 (882)
Q Consensus 679 HrDlk~~NIll~~-------------------~~~~kl~DfGla~~~~~~~~--------------~~~~~~~~gt~~y~ 725 (882)
||||||+||||+. ++.+|++|||+++....... ........||+.||
T Consensus 103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 182 (793)
T PLN00181 103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT 182 (793)
T ss_pred eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence 9999999999954 44566667776654211000 00011235788999
Q ss_pred CHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHH
Q 002774 726 DPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLA 805 (882)
Q Consensus 726 aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li 805 (882)
|||++.+..++.++|||||||++|||++|..|+........... . ...++.. .....+..+++
T Consensus 183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~~~~~~----~--------~~~~~~~-----~~~~~~~~~~~ 245 (793)
T PLN00181 183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRTMSSLR----H--------RVLPPQI-----LLNWPKEASFC 245 (793)
T ss_pred ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHHHHHHH----H--------hhcChhh-----hhcCHHHHHHH
Confidence 99999999999999999999999999998888643211111110 0 0111111 11123456888
Q ss_pred HHhhccCCCCCCCHHHHHHH
Q 002774 806 LKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 806 ~~cl~~dp~~RPs~~evl~~ 825 (882)
.+||+++|.+||++.|++++
T Consensus 246 ~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 246 LWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHhCCCChhhCcChHHHhhc
Confidence 99999999999999999864
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.3e-25 Score=230.43 Aligned_cols=285 Identities=19% Similarity=0.203 Sum_probs=178.0
Q ss_pred CCccccCccccCCCCCCEEeccCCCCCccCCCccccCCCCCcEEEeeCCcCCccccccccCCCCCCEEEccC-CcCCCCC
Q 002774 2 GLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNS-NGFSGRV 80 (882)
Q Consensus 2 ~~~~~l~~~~~~l~~L~~L~L~~n~~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~-N~i~~~~ 80 (882)
||+ .+|.++. .+.++++|..|+ |..+.+++|+.+++|++|+|++|+|+.+-|++|.++.+|..|-+.+ |+|+.+.
T Consensus 57 GL~-eVP~~LP--~~tveirLdqN~-I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~ 132 (498)
T KOG4237|consen 57 GLT-EVPANLP--PETVEIRLDQNQ-ISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLP 132 (498)
T ss_pred Ccc-cCcccCC--CcceEEEeccCC-cccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhh
Confidence 444 5666665 456677777786 7777777888888888888888888877788888888777666555 7788777
Q ss_pred CcCccCCCCCcEeeccCceeeeecCCCCCCCchhhhhhcccceeccCCeeeecCCccccCCcccceeeeccCCccc----
Q 002774 81 PPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLT---- 156 (882)
Q Consensus 81 ~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~~~~l~~L~~L~~L~L~~N~l~~~ip~~~f~~~~~L~~L~L~~N~l~---- 156 (882)
..+|++|..|+.|.+.-|++..... ..|+.|++|..|.+.+|.+. +|+...|..+.+++.+.+..|.+.
T Consensus 133 k~~F~gL~slqrLllNan~i~Cir~------~al~dL~~l~lLslyDn~~q-~i~~~tf~~l~~i~tlhlA~np~icdCn 205 (498)
T KOG4237|consen 133 KGAFGGLSSLQRLLLNANHINCIRQ------DALRDLPSLSLLSLYDNKIQ-SICKGTFQGLAAIKTLHLAQNPFICDCN 205 (498)
T ss_pred hhHhhhHHHHHHHhcChhhhcchhH------HHHHHhhhcchhcccchhhh-hhccccccchhccchHhhhcCccccccc
Confidence 7778888888888888888774433 34666777777777777777 777777777777777777777632
Q ss_pred --------ccCCccccCCCCCCEEEccCCCCCCCCCccCCCCCCCCEE--Ec-cCCcccccCCC--CCCCCCCCEEECcC
Q 002774 157 --------GELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDL--YL-SNNKLTGAMPN--LTGLSVLSYLDMSN 223 (882)
Q Consensus 157 --------~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L--~L-s~N~l~~~~~~--~~~l~~L~~L~Ls~ 223 (882)
...|..+++..-..-..|..+++..+.+..|.-. ++.+ .+ +.....++-|. |.++++|+.|+|++
T Consensus 206 L~wla~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~--~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsn 283 (498)
T KOG4237|consen 206 LPWLADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCS--LESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSN 283 (498)
T ss_pred cchhhhHHhhchhhcccceecchHHHHHHHhcccchhhhhhh--HHhHHHhhccccCcCCcChHHHHhhcccceEeccCC
Confidence 2233444444444444555555543333333211 2111 11 11112222221 56666666666666
Q ss_pred CCCCCCCCCccccCCCCCCEEECcCCcccccCCccCCCCCCCCEEEccCCccceecCCCCc-ccccccccccCCcccc
Q 002774 224 NSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTS-YSENLLVNLQNNRISA 300 (882)
Q Consensus 224 N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~-~~~L~~L~L~~N~i~~ 300 (882)
|+|+. +-+.+|.++..|++|.|..|+|.......|.++..|+.|+|++|+|+...+.+|. +..|..|+|-.|++.+
T Consensus 284 N~i~~-i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~C 360 (498)
T KOG4237|consen 284 NKITR-IEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNC 360 (498)
T ss_pred Cccch-hhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccC
Confidence 66653 4556666666666666666666655555666666666666666666665555553 5555666666665544
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.6e-26 Score=236.37 Aligned_cols=271 Identities=26% Similarity=0.383 Sum_probs=205.8
Q ss_pred CCCCEEeccCCCCCccCCCccccCCCCCcEEEeeCCcCCccccccccCCCCCCEEEccCCcCCCCCCcCccCCCCCcEee
Q 002774 15 TELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLD 94 (882)
Q Consensus 15 ~~L~~L~L~~n~~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~ 94 (882)
..|+.|+|++|. ...+.+.+.++..|++|++.+|+++ ..|.+++.+..++.|+.++|++. .+|..+..+.+|..|+
T Consensus 45 v~l~~lils~N~--l~~l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~ 120 (565)
T KOG0472|consen 45 VDLQKLILSHND--LEVLREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLD 120 (565)
T ss_pred cchhhhhhccCc--hhhccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhh
Confidence 456777888876 4455666777888888888888888 67777888888888888888887 6777788888888888
Q ss_pred ccCceeeeecCCCCCCCchhhhhhcccceeccCCeeeecCCccccCCcccceeeeccCCcccccCCccccCCCCCCEEEc
Q 002774 95 LTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRF 174 (882)
Q Consensus 95 Ls~N~i~~~~p~~~~~~~~l~~L~~L~~L~L~~N~l~~~ip~~~f~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 174 (882)
++.|.+. .+|++++. +-.|..|+..+|+++ ++|.+++. +.+|..+++.+|+++...|+.+. ++.|++||.
T Consensus 121 ~s~n~~~-el~~~i~~------~~~l~dl~~~~N~i~-slp~~~~~-~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~ 190 (565)
T KOG0472|consen 121 CSSNELK-ELPDSIGR------LLDLEDLDATNNQIS-SLPEDMVN-LSKLSKLDLEGNKLKALPENHIA-MKRLKHLDC 190 (565)
T ss_pred cccccee-ecCchHHH------Hhhhhhhhccccccc-cCchHHHH-HHHHHHhhccccchhhCCHHHHH-HHHHHhccc
Confidence 8888877 66666555 334455577788887 77777665 34677788888888866555555 788888888
Q ss_pred cCCCCCCCCCccCCCCCCCCEEEccCCcccccCCCCCCCCCCCEEECcCCCCCCCCCCcccc-CCCCCCEEECcCCcccc
Q 002774 175 DRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFS-SMQSLTTLMMENTNLKG 253 (882)
Q Consensus 175 s~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~-~l~~L~~L~Ls~N~l~~ 253 (882)
..|.+. .+|..++.+.+|.-|+|.+|+|...| +|.++..|++|+++.|+|. .+|.... .+.+|..|||.+|+++
T Consensus 191 ~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~~lP-ef~gcs~L~Elh~g~N~i~--~lpae~~~~L~~l~vLDLRdNklk- 265 (565)
T KOG0472|consen 191 NSNLLE-TLPPELGGLESLELLYLRRNKIRFLP-EFPGCSLLKELHVGENQIE--MLPAEHLKHLNSLLVLDLRDNKLK- 265 (565)
T ss_pred chhhhh-cCChhhcchhhhHHHHhhhcccccCC-CCCccHHHHHHHhcccHHH--hhHHHHhcccccceeeeccccccc-
Confidence 888887 77888888888888888888888655 7888888888888888884 5666554 7888888888888887
Q ss_pred cCCccCCCCCCCCEEEccCCccceecCCCCcccccccccccCCccccccCCC
Q 002774 254 QIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENLLVNLQNNRISAYTERG 305 (882)
Q Consensus 254 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~N~i~~~~~~~ 305 (882)
..|+.+.-+.+|.+||||+|.|++.+....++ .|+.|-+.+|++.++..+.
T Consensus 266 e~Pde~clLrsL~rLDlSNN~is~Lp~sLgnl-hL~~L~leGNPlrTiRr~i 316 (565)
T KOG0472|consen 266 EVPDEICLLRSLERLDLSNNDISSLPYSLGNL-HLKFLALEGNPLRTIRREI 316 (565)
T ss_pred cCchHHHHhhhhhhhcccCCccccCCcccccc-eeeehhhcCCchHHHHHHH
Confidence 77888888888888888888888877776666 7888888888888875543
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.8e-22 Score=218.79 Aligned_cols=265 Identities=20% Similarity=0.274 Sum_probs=201.1
Q ss_pred CCCCCCeeeccCcEEEEEEEecCC--cEEEEEEcccCCcccHHHHHHHHHHHHhccC----CCeeeEEEEE-EeCCceEE
Q 002774 556 NFSDANDVGSGGYGKVYKGTLPNG--QLIAIKRAQQGSMQGGQEFKMEIELLSRVHH----KNLVSLLGFC-FDRGEQML 628 (882)
Q Consensus 556 ~~~~~~~lG~G~fg~Vy~~~~~~g--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H----~niv~l~~~~-~~~~~~~l 628 (882)
+|...+.||+|+||.||+|..... ..+|+|............+..|+.++..+.+ +++.++++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 788999999999999999996543 4788888776543333378889999999873 6888999888 47778899
Q ss_pred EEEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCC-----CceeEeecccc
Q 002774 629 IYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDER-----LNAKVADFGLS 703 (882)
Q Consensus 629 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~-----~~~kl~DfGla 703 (882)
||+.+ +.+|.++........++..+.++|+.|++.+|+++|+.| ++||||||.|+++... ..+.+.|||+|
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99988 789999776555568999999999999999999999999 9999999999999754 46999999999
Q ss_pred c--ccCCCCCc----e-e-eeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhh
Q 002774 704 K--SMSDSEKD----H-I-TTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKK 775 (882)
Q Consensus 704 ~--~~~~~~~~----~-~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~ 775 (882)
+ .+...... . . .....||.+|+++....+...+.+.|+||++.++.|+..|..||......... .......
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~-~~~~~~~ 253 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLK-SKFEKDP 253 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchH-HHHHHHh
Confidence 9 43222211 1 1 12356999999999999999999999999999999999999999654332221 1111111
Q ss_pred hhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHcCC
Q 002774 776 KELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQAGL 835 (882)
Q Consensus 776 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~~~ 835 (882)
. .....+ .....+..+.++...+-..+..++|....+.+.+.......+.
T Consensus 254 ~-----~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~~~ 303 (322)
T KOG1164|consen 254 R-----KLLTDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSEGS 303 (322)
T ss_pred h-----hhcccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhcCC
Confidence 0 000010 1111235566777777779999999999999999888777643
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.7e-23 Score=224.96 Aligned_cols=167 Identities=19% Similarity=0.182 Sum_probs=130.0
Q ss_pred HHHcCCCCCCeeeccCcEEEEEEEec--CCcEEEEEEcccCC-----cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCC
Q 002774 552 KYTNNFSDANDVGSGGYGKVYKGTLP--NGQLIAIKRAQQGS-----MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRG 624 (882)
Q Consensus 552 ~~~~~~~~~~~lG~G~fg~Vy~~~~~--~g~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~ 624 (882)
...++|...+.||+|+||+||+|++. +++.||||++.... ....+.|.+|+++|++++|+|+++.+.. .+
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~ 91 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TG 91 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cC
Confidence 34567999999999999999999864 57888999875331 1124568999999999999999953322 24
Q ss_pred ceEEEEEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCC-CCCceEEcCCCceeEeecccc
Q 002774 625 EQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDI-KSSNILLDERLNAKVADFGLS 703 (882)
Q Consensus 625 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDl-k~~NIll~~~~~~kl~DfGla 703 (882)
..++||||+++++|... ... . ...++.++++||+|||+.+ |+|||| ||+|||++.++.+||+|||+|
T Consensus 92 ~~~LVmE~~~G~~L~~~-~~~-----~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFGlA 159 (365)
T PRK09188 92 KDGLVRGWTEGVPLHLA-RPH-----G---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQLA 159 (365)
T ss_pred CcEEEEEccCCCCHHHh-Ccc-----c---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECccc
Confidence 68999999999999632 111 1 1467889999999999998 999999 999999999999999999999
Q ss_pred cccCCCCCcee------eeeeeccCCCCCHHHHhhC
Q 002774 704 KSMSDSEKDHI------TTQVKGTMGYLDPEYYMTQ 733 (882)
Q Consensus 704 ~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~ 733 (882)
+.+........ .+...+++.|+|||++...
T Consensus 160 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 160 SVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred eecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 97765432111 1345688899999998743
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.2e-22 Score=191.94 Aligned_cols=266 Identities=18% Similarity=0.264 Sum_probs=204.8
Q ss_pred HcCCCCCCeeeccCcEEEEEEE-ecCCcEEEEEEcccCCcccHHHHHHHHHHHHhccC-CCeeeEEEEEEeCCceEEEEE
Q 002774 554 TNNFSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHH-KNLVSLLGFCFDRGEQMLIYE 631 (882)
Q Consensus 554 ~~~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~~~~~~~~~~~lV~e 631 (882)
...|...++||+|+||.+|.|. ..+|+.||||.-...... ..+..|.++.+.++| ..|..+..|..+...-.+||+
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h--pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH--PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC--cchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 4678899999999999999998 568999999987654333 467789999999975 677777788888888999999
Q ss_pred eecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCC---CceeEeecccccccCC
Q 002774 632 FVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDER---LNAKVADFGLSKSMSD 708 (882)
Q Consensus 632 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~---~~~kl~DfGla~~~~~ 708 (882)
.+ +-||.+.+.-.. ..++..+.+-.|-|++.-++|+|.++ ++||||||+|.|..-+ ..+.++|||+|+.+.+
T Consensus 92 LL-GPsLEdLfnfC~-R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d 166 (341)
T KOG1163|consen 92 LL-GPSLEDLFNFCS-RRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRD 166 (341)
T ss_pred cc-CccHHHHHHHHh-hhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhcc
Confidence 98 778888776543 36889999999999999999999999 9999999999999643 4588999999998866
Q ss_pred CCCce-----eeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHH-HHHHhhhhhhhhh
Q 002774 709 SEKDH-----ITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIR-TVMDKKKELYNLY 782 (882)
Q Consensus 709 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~-~~~~~~~~~~~~~ 782 (882)
..... ......||.+|.+-....+-..+.+.|+-|+|.+|...-.|..||.+-.......+ ..+.+.+... ..
T Consensus 167 ~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~-~i 245 (341)
T KOG1163|consen 167 IRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMST-PI 245 (341)
T ss_pred ccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCC-CH
Confidence 44321 12345699999998888888889999999999999999999999975433222111 1111111111 11
Q ss_pred hccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHcCC
Q 002774 783 ELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQAGL 835 (882)
Q Consensus 783 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~~~ 835 (882)
+.+. ...+.++.-.+..|-....++-|...-+.+.+..+....+.
T Consensus 246 e~LC--------~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~ 290 (341)
T KOG1163|consen 246 EVLC--------KGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNH 290 (341)
T ss_pred HHHh--------CCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhccc
Confidence 1111 12346788899999999999999999888877777666554
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.6e-22 Score=232.45 Aligned_cols=249 Identities=21% Similarity=0.259 Sum_probs=142.1
Q ss_pred CCEEeccCCCCCccCCCccccCCCCCcEEEeeCCcCCccccccccCCCCCCEEEccCCcCCCCCCcCccCCCCCcEeecc
Q 002774 17 LHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLT 96 (882)
Q Consensus 17 L~~L~L~~n~~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls 96 (882)
-..|+|++|+ ++ .+|..+. ++|+.|+|.+|+|+ .+|. .+++|++|+|++|+|+ .+|.. .++|++|+|+
T Consensus 203 ~~~LdLs~~~-Lt-sLP~~l~--~~L~~L~L~~N~Lt-~LP~---lp~~Lk~LdLs~N~Lt-sLP~l---p~sL~~L~Ls 270 (788)
T PRK15387 203 NAVLNVGESG-LT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLT-SLPVL---PPGLLELSIF 270 (788)
T ss_pred CcEEEcCCCC-CC-cCCcchh--cCCCEEEccCCcCC-CCCC---CCCCCcEEEecCCccC-cccCc---ccccceeecc
Confidence 4566777775 33 5666654 36777777777777 4443 2466777777777776 34432 3566777777
Q ss_pred CceeeeecCCCCCCCchhhhhhcccceeccCCeeeecCCccccCCcccceeeeccCCcccccCCccccCCCCCCEEEccC
Q 002774 97 DNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDR 176 (882)
Q Consensus 97 ~N~i~~~~p~~~~~~~~l~~L~~L~~L~L~~N~l~~~ip~~~f~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~ 176 (882)
+|+|+ .+|.. ..+|+.|+|++|+|+ .+|. .+++|+.|+|++|+|+++ |.. ..+|+.|++++
T Consensus 271 ~N~L~-~Lp~l---------p~~L~~L~Ls~N~Lt-~LP~----~p~~L~~LdLS~N~L~~L-p~l---p~~L~~L~Ls~ 331 (788)
T PRK15387 271 SNPLT-HLPAL---------PSGLCKLWIFGNQLT-SLPV----LPPGLQELSVSDNQLASL-PAL---PSELCKLWAYN 331 (788)
T ss_pred CCchh-hhhhc---------hhhcCEEECcCCccc-cccc----cccccceeECCCCccccC-CCC---ccccccccccc
Confidence 77765 33321 134556667777776 5554 235677777777766643 321 23466666677
Q ss_pred CCCCCCCCccCCCCCCCCEEEccCCcccccCCCCCCCCCCCEEECcCCCCCCCCCCccccCCCCCCEEECcCCcccccCC
Q 002774 177 NSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIP 256 (882)
Q Consensus 177 N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~ 256 (882)
|.|++ +|.. ..+|+.|+|++|+|+++++. ..+|+.|++++|+|+ .+|.. ..+|+.|+|++|+|+ .+|
T Consensus 332 N~L~~-LP~l---p~~Lq~LdLS~N~Ls~LP~l---p~~L~~L~Ls~N~L~--~LP~l---~~~L~~LdLs~N~Lt-~LP 398 (788)
T PRK15387 332 NQLTS-LPTL---PSGLQELSVSDNQLASLPTL---PSELYKLWAYNNRLT--SLPAL---PSGLKELIVSGNRLT-SLP 398 (788)
T ss_pred Ccccc-cccc---ccccceEecCCCccCCCCCC---Ccccceehhhccccc--cCccc---ccccceEEecCCccc-CCC
Confidence 76663 3321 14566777777776665432 245666666666664 24432 245666677777666 344
Q ss_pred ccCCCCCCCCEEEccCCccceecCCCCcccccccccccCCccccccCCCCCCccceEEec
Q 002774 257 ADLFSIPHLQTVVMKTNELNGTLDLGTSYSENLLVNLQNNRISAYTERGGAPAVNLTLID 316 (882)
Q Consensus 257 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~~~~L~~l~ 316 (882)
.. .++|+.|+|++|+|++++.. ..+|+.|+|++|+|+.+|.. +..+.+|+.++
T Consensus 399 ~l---~s~L~~LdLS~N~LssIP~l---~~~L~~L~Ls~NqLt~LP~s-l~~L~~L~~Ld 451 (788)
T PRK15387 399 VL---PSELKELMVSGNRLTSLPML---PSGLLSLSVYRNQLTRLPES-LIHLSSETTVN 451 (788)
T ss_pred Cc---ccCCCEEEccCCcCCCCCcc---hhhhhhhhhccCcccccChH-HhhccCCCeEE
Confidence 32 24566667777766654321 23456666677776666543 33444444443
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.2e-21 Score=195.73 Aligned_cols=264 Identities=19% Similarity=0.282 Sum_probs=209.0
Q ss_pred CCCCCCeeeccCcEEEEEEE-ecCCcEEEEEEcccCCcccHHHHHHHHHHHHhcc-CCCeeeEEEEEEeCCceEEEEEee
Q 002774 556 NFSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVH-HKNLVSLLGFCFDRGEQMLIYEFV 633 (882)
Q Consensus 556 ~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~e~~ 633 (882)
.|.+.++||+|+||+.+.|+ +-+++.||||.-...+ +..++..|.+..+.|. .++|...+.+..++..-.||+|++
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL 106 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL 106 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence 57889999999999999998 5578999999865432 3356788999999884 799999998888888889999998
Q ss_pred cCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCC-----CceeEeecccccccCC
Q 002774 634 PNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDER-----LNAKVADFGLSKSMSD 708 (882)
Q Consensus 634 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~-----~~~kl~DfGla~~~~~ 708 (882)
+-||.|+..-. +.+++..++..+|.|++.-++|+|++. +|.|||||+|+||... ..+.++|||+|+.+.+
T Consensus 107 -GPSLEDLFD~C-gR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrD 181 (449)
T KOG1165|consen 107 -GPSLEDLFDLC-GRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRD 181 (449)
T ss_pred -CcCHHHHHHHh-cCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhhcC
Confidence 77888877544 347999999999999999999999999 9999999999999643 4589999999999877
Q ss_pred CCCce-----eeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCc--hHHHHHHHHHHhhhhhhhh
Q 002774 709 SEKDH-----ITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGK--YIVREIRTVMDKKKELYNL 781 (882)
Q Consensus 709 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~--~~~~~~~~~~~~~~~~~~~ 781 (882)
..... ......||.+||+-....+++.+.+.|+-|+|-|++..+.|..||.+-+ +..+...++ .+.+....+
T Consensus 182 p~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKI-Ge~Kr~T~i 260 (449)
T KOG1165|consen 182 PKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKI-GETKRSTPI 260 (449)
T ss_pred ccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHh-ccccccCCH
Confidence 65321 1234579999999999999999999999999999999999999997432 222222222 222222222
Q ss_pred hhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHcCCC
Q 002774 782 YELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQAGLN 836 (882)
Q Consensus 782 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~~~~ 836 (882)
.+.+ ...+.+|..-+...-..+.++-|..+-+...+.+++.+.|..
T Consensus 261 ~~Lc---------~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~t 306 (449)
T KOG1165|consen 261 EVLC---------EGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGET 306 (449)
T ss_pred HHHH---------hcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCCc
Confidence 2221 123467778888888889999999999999999999887753
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.9e-20 Score=205.40 Aligned_cols=259 Identities=30% Similarity=0.418 Sum_probs=198.6
Q ss_pred CCCCCeeeccCcEEEEEEEecCCcEEEEEEcccCCcc---cHHHHHHHHHHHHhccCC-CeeeEEEEEEeCCceEEEEEe
Q 002774 557 FSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQ---GGQEFKMEIELLSRVHHK-NLVSLLGFCFDRGEQMLIYEF 632 (882)
Q Consensus 557 ~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~-niv~l~~~~~~~~~~~lV~e~ 632 (882)
|...+.||.|+||.||++... ..+|+|.+...... ....+.+|+.+++.+.|+ +++++.+++......+++++|
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 556778999999999999976 78999998765443 357799999999999988 799999999777778999999
Q ss_pred ecCCCcccccCCCCC-ccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCC-ceeEeecccccccCCCC
Q 002774 633 VPNGSLGDSLSGKNG-IRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERL-NAKVADFGLSKSMSDSE 710 (882)
Q Consensus 633 ~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~-~~kl~DfGla~~~~~~~ 710 (882)
+.++++.+++..... ..+.......++.+++.++.|+|+.+ ++|||+||+||+++..+ .++++|||.++......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999966654321 25788899999999999999999999 99999999999999998 79999999998665433
Q ss_pred Cce----eeeeeeccCCCCCHHHHhh---CCCCchhHHHHHHHHHHHHHhCCCCCCCCchH--HHHHHHHHHhhhhhhhh
Q 002774 711 KDH----ITTQVKGTMGYLDPEYYMT---QQLTEKSDVYSFGVLMLELLTGRRPIERGKYI--VREIRTVMDKKKELYNL 781 (882)
Q Consensus 711 ~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~--~~~~~~~~~~~~~~~~~ 781 (882)
... ......|+..|+|||.+.. ..+....|+||+|++++++++|..|+...... .......+.....
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~---- 232 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPT---- 232 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCC----
Confidence 221 2355679999999999987 57889999999999999999999997654431 1122111111110
Q ss_pred hhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 782 YELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 782 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
..................+.+++.+|+..+|..|.++.+....
T Consensus 233 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 233 -PSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred -cccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 0000011100001223567899999999999999999888765
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.4e-23 Score=217.42 Aligned_cols=293 Identities=17% Similarity=0.180 Sum_probs=196.8
Q ss_pred CCCccccCCCCCcEEEeeCCcCCccccccccCCCCCCEEEccCCcCCCCCCcCccCCCCCcEeeccC-ceeeeecCCCCC
Q 002774 31 PLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTD-NKLEGEIPVSDG 109 (882)
Q Consensus 31 ~~p~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~-N~i~~~~p~~~~ 109 (882)
.+|..+. +.-..|+|..|+|+.+.+.+|+.+++|+.|||++|+|+.+.|++|.++++|..|-+.+ |+|+ .+|..
T Consensus 60 eVP~~LP--~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~-~l~k~-- 134 (498)
T KOG4237|consen 60 EVPANLP--PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKIT-DLPKG-- 134 (498)
T ss_pred cCcccCC--CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchh-hhhhh--
Confidence 4454443 2455677777777766667777777777777777777777777777777766664444 7776 44432
Q ss_pred CCchhhhhhcccceeccCCeeeecCCccccCCcccceeeeccCCcccccCCccccCCCCCCEEEccCCCC----------
Q 002774 110 NSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSL---------- 179 (882)
Q Consensus 110 ~~~~l~~L~~L~~L~L~~N~l~~~ip~~~f~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l---------- 179 (882)
.|..|..|+.|.+.-|++. .++.++|..+++|..|.+..|.+..+-..+|..+.+++.+.+..|.+
T Consensus 135 ---~F~gL~slqrLllNan~i~-Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla 210 (498)
T KOG4237|consen 135 ---AFGGLSSLQRLLLNANHIN-CIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLA 210 (498)
T ss_pred ---HhhhHHHHHHHhcChhhhc-chhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhh
Confidence 3455666666667777776 66777777777777777777776655445667777777777766662
Q ss_pred --CCCCCccCCCCCCCCEEEccCCcccccCCC-C-CCCCCCCEEECcCCCCCCCCCCccccCCCCCCEEECcCCcccccC
Q 002774 180 --SGPVPSNLNNLTSVNDLYLSNNKLTGAMPN-L-TGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQI 255 (882)
Q Consensus 180 --~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~-~-~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 255 (882)
....|-.++...-.....|.++++..+.+. | ..+..+..--.+.......-....|..|++|+.|+|++|+|+++-
T Consensus 211 ~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~ 290 (498)
T KOG4237|consen 211 DDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIE 290 (498)
T ss_pred hHHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhh
Confidence 122344445555555555555555555443 2 222233222222232332233456999999999999999999999
Q ss_pred CccCCCCCCCCEEEccCCccceecCCCC-cccccccccccCCccccccCCCCCCccceEEe---cCc-cccccCC--ccc
Q 002774 256 PADLFSIPHLQTVVMKTNELNGTLDLGT-SYSENLLVNLQNNRISAYTERGGAPAVNLTLI---DNP-ICQELGT--AKG 328 (882)
Q Consensus 256 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~-~~~~L~~L~L~~N~i~~~~~~~~~~~~~L~~l---~~~-~c~~~~~--~~~ 328 (882)
+.+|.++..|++|.|..|+|..+-...+ ++..|+.|+|++|+|+.+...+|.++..|..| .|| .|.+--+ .+|
T Consensus 291 ~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~wl~~W 370 (498)
T KOG4237|consen 291 DGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLAWLGEW 370 (498)
T ss_pred hhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccchHHHHHH
Confidence 9999999999999999999998666554 59999999999999999999999986666555 688 5544222 355
Q ss_pred cccc
Q 002774 329 YCQL 332 (882)
Q Consensus 329 ~~~~ 332 (882)
+...
T Consensus 371 lr~~ 374 (498)
T KOG4237|consen 371 LRKK 374 (498)
T ss_pred HhhC
Confidence 5444
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=7e-24 Score=240.46 Aligned_cols=178 Identities=22% Similarity=0.257 Sum_probs=98.8
Q ss_pred cccceeeeccCCcccccCCccccCCCCCCEEEccCCCCCC----------------------CCCccCCCCCCCCEEEcc
Q 002774 142 DMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSG----------------------PVPSNLNNLTSVNDLYLS 199 (882)
Q Consensus 142 ~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~----------------------~~p~~l~~l~~L~~L~Ls 199 (882)
..+|+++++++|++++. |+++..+.+|+.|+..+|.|.. -+|..+..+++|++|+|.
T Consensus 240 p~nl~~~dis~n~l~~l-p~wi~~~~nle~l~~n~N~l~~lp~ri~~~~~L~~l~~~~nel~yip~~le~~~sL~tLdL~ 318 (1081)
T KOG0618|consen 240 PLNLQYLDISHNNLSNL-PEWIGACANLEALNANHNRLVALPLRISRITSLVSLSAAYNELEYIPPFLEGLKSLRTLDLQ 318 (1081)
T ss_pred cccceeeecchhhhhcc-hHHHHhcccceEecccchhHHhhHHHHhhhhhHHHHHhhhhhhhhCCCcccccceeeeeeeh
Confidence 34566677777777643 4667777777777766666641 234444555666666666
Q ss_pred CCcccccCCCCC--------------------------CCCCCCEEECcCCCCCCCCCCccccCCCCCCEEECcCCcccc
Q 002774 200 NNKLTGAMPNLT--------------------------GLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKG 253 (882)
Q Consensus 200 ~N~l~~~~~~~~--------------------------~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~ 253 (882)
.|+|...++.+. .++.|+.|.|.+|.++... -..+-++++|+.|+|++|+|..
T Consensus 319 ~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c-~p~l~~~~hLKVLhLsyNrL~~ 397 (1081)
T KOG0618|consen 319 SNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSC-FPVLVNFKHLKVLHLSYNRLNS 397 (1081)
T ss_pred hccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccc-hhhhccccceeeeeeccccccc
Confidence 666554433110 0122333444444443222 2224455555555555555552
Q ss_pred cCCccCCCCCCCCEEEccCCccceecC----------------------CCCcccccccccccCCccccccCCCCCCccc
Q 002774 254 QIPADLFSIPHLQTVVMKTNELNGTLD----------------------LGTSYSENLLVNLQNNRISAYTERGGAPAVN 311 (882)
Q Consensus 254 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~----------------------~~~~~~~L~~L~L~~N~i~~~~~~~~~~~~~ 311 (882)
.....+.++..|++|+||||+++..+. ....++.|+.+||+.|+|+.+....-.++++
T Consensus 398 fpas~~~kle~LeeL~LSGNkL~~Lp~tva~~~~L~tL~ahsN~l~~fPe~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~ 477 (1081)
T KOG0618|consen 398 FPASKLRKLEELEELNLSGNKLTTLPDTVANLGRLHTLRAHSNQLLSFPELAQLPQLKVLDLSCNNLSEVTLPEALPSPN 477 (1081)
T ss_pred CCHHHHhchHHhHHHhcccchhhhhhHHHHhhhhhHHHhhcCCceeechhhhhcCcceEEecccchhhhhhhhhhCCCcc
Confidence 222234455555555555555553322 4455677777788888888777777777778
Q ss_pred eEEecCcccc
Q 002774 312 LTLIDNPICQ 321 (882)
Q Consensus 312 L~~l~~~~c~ 321 (882)
|++||..+..
T Consensus 478 LkyLdlSGN~ 487 (1081)
T KOG0618|consen 478 LKYLDLSGNT 487 (1081)
T ss_pred cceeeccCCc
Confidence 8888765443
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=9.3e-21 Score=222.85 Aligned_cols=254 Identities=27% Similarity=0.329 Sum_probs=202.2
Q ss_pred CCccccCccccCCCCCCEEeccCCCCCccCCCccccCCCCCcEEEeeCCcCCccccccccCCCCCCEEEccCCcCCCCCC
Q 002774 2 GLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVP 81 (882)
Q Consensus 2 ~~~~~l~~~~~~l~~L~~L~L~~n~~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~ 81 (882)
+|+ .||+.+. .+|+.|+|++|+ ++ .+|.. +++|++|+|++|+|+ .+|.. .++|+.|+|++|.|+ .+|
T Consensus 212 ~Lt-sLP~~l~--~~L~~L~L~~N~-Lt-~LP~l---p~~Lk~LdLs~N~Lt-sLP~l---p~sL~~L~Ls~N~L~-~Lp 278 (788)
T PRK15387 212 GLT-TLPDCLP--AHITTLVIPDNN-LT-SLPAL---PPELRTLEVSGNQLT-SLPVL---PPGLLELSIFSNPLT-HLP 278 (788)
T ss_pred CCC-cCCcchh--cCCCEEEccCCc-CC-CCCCC---CCCCcEEEecCCccC-cccCc---ccccceeeccCCchh-hhh
Confidence 566 6888886 489999999998 44 46643 589999999999999 56643 468999999999998 455
Q ss_pred cCccCCCCCcEeeccCceeeeecCCCCCCCchhhhhhcccceeccCCeeeecCCccccCCcccceeeeccCCcccccCCc
Q 002774 82 PSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPA 161 (882)
Q Consensus 82 ~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~~~~l~~L~~L~~L~L~~N~l~~~ip~~~f~~~~~L~~L~L~~N~l~~~~~~ 161 (882)
..+ ++|+.|+|++|+|+ .+|.. +++|+.|+|++|+|+ .+|.. ..+|+.|++++|+|++ +|.
T Consensus 279 ~lp---~~L~~L~Ls~N~Lt-~LP~~---------p~~L~~LdLS~N~L~-~Lp~l----p~~L~~L~Ls~N~L~~-LP~ 339 (788)
T PRK15387 279 ALP---SGLCKLWIFGNQLT-SLPVL---------PPGLQELSVSDNQLA-SLPAL----PSELCKLWAYNNQLTS-LPT 339 (788)
T ss_pred hch---hhcCEEECcCCccc-ccccc---------ccccceeECCCCccc-cCCCC----cccccccccccCcccc-ccc
Confidence 433 67899999999998 56632 367899999999999 77752 3568999999999985 443
Q ss_pred cccCCCCCCEEEccCCCCCCCCCccCCCCCCCCEEEccCCcccccCCCCCCCCCCCEEECcCCCCCCCCCCccccCCCCC
Q 002774 162 TLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSL 241 (882)
Q Consensus 162 ~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L 241 (882)
...+|+.|+|++|+|++ +|.. ..+|+.|++++|+|+.++.. ..+|+.|+|++|+|+ .+|.. .++|
T Consensus 340 ---lp~~Lq~LdLS~N~Ls~-LP~l---p~~L~~L~Ls~N~L~~LP~l---~~~L~~LdLs~N~Lt--~LP~l---~s~L 404 (788)
T PRK15387 340 ---LPSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLTSLPAL---PSGLKELIVSGNRLT--SLPVL---PSEL 404 (788)
T ss_pred ---cccccceEecCCCccCC-CCCC---CcccceehhhccccccCccc---ccccceEEecCCccc--CCCCc---ccCC
Confidence 22589999999999994 5543 36788999999999976543 357999999999996 35543 3679
Q ss_pred CEEECcCCcccccCCccCCCCCCCCEEEccCCccceecCCCCcccccccccccCCccccccCCCC
Q 002774 242 TTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENLLVNLQNNRISAYTERGG 306 (882)
Q Consensus 242 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~N~i~~~~~~~~ 306 (882)
+.|++++|+|+ .+|.. ..+|+.|+|++|+|+.++..+..+.+|..|+|++|+|+......+
T Consensus 405 ~~LdLS~N~Ls-sIP~l---~~~L~~L~Ls~NqLt~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L 465 (788)
T PRK15387 405 KELMVSGNRLT-SLPML---PSGLLSLSVYRNQLTRLPESLIHLSSETTVNLEGNPLSERTLQAL 465 (788)
T ss_pred CEEEccCCcCC-CCCcc---hhhhhhhhhccCcccccChHHhhccCCCeEECCCCCCCchHHHHH
Confidence 99999999998 56753 347889999999999877767779999999999999997544433
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.8e-22 Score=233.18 Aligned_cols=254 Identities=20% Similarity=0.247 Sum_probs=188.1
Q ss_pred CCCeeeccCcEEEEEEEe-cCCcEEEEEEcccC--CcccH----HHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEE
Q 002774 559 DANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQG--SMQGG----QEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYE 631 (882)
Q Consensus 559 ~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~--~~~~~----~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e 631 (882)
..+++|.|++|.|+.+.. ...+..+.|.+... ..... ..+..|+.+-..+.|+|++..+..+.+....+-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 457899999998887763 34444555544311 11111 225567888888899999988887777777767799
Q ss_pred eecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCC
Q 002774 632 FVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEK 711 (882)
Q Consensus 632 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 711 (882)
|+++ +|..++.... .+...++-.+..|+..|+.|+|+.| |.|||+|++|++++.+|.+||+|||.+....-+..
T Consensus 402 ~~~~-Dlf~~~~~~~--~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e 475 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSNG--KLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE 475 (601)
T ss_pred cccH-HHHHHHhccc--ccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence 9999 9999987653 5778888999999999999999999 99999999999999999999999999976654433
Q ss_pred c--eeeeeeeccCCCCCHHHHhhCCCCch-hHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCc
Q 002774 712 D--HITTQVKGTMGYLDPEYYMTQQLTEK-SDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPT 788 (882)
Q Consensus 712 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~-sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 788 (882)
. .......|+..|+|||.+....|++. .||||.|+++..|++|+.||................. +.-...
T Consensus 476 ~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~-------~~~~~~ 548 (601)
T KOG0590|consen 476 KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSD-------QRNIFE 548 (601)
T ss_pred hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhcccc-------cccccc
Confidence 3 44566889999999999999999875 7999999999999999999974433222110000000 000000
Q ss_pred CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 789 IGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 789 l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
-........+.+...++.+|++.||.+|.|+++|+++
T Consensus 549 ~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 549 GPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred ChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 0011112234667899999999999999999999975
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.84 E-value=3e-20 Score=235.14 Aligned_cols=296 Identities=19% Similarity=0.213 Sum_probs=172.6
Q ss_pred cCccccCCC-CCCEEeccCCCCCccCCCccccCCCCCcEEEeeCCcCCccccccccCCCCCCEEEccCCcCCCCCCcCcc
Q 002774 7 LSGDITGLT-ELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIG 85 (882)
Q Consensus 7 l~~~~~~l~-~L~~L~L~~n~~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~ 85 (882)
+|+.|..++ +|+.|++.++. ...+|..| ...+|+.|+|.+|+|. .++..+..+++|+.|+|++|...+.+|. +.
T Consensus 580 lp~~~~~lp~~Lr~L~~~~~~--l~~lP~~f-~~~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls 654 (1153)
T PLN03210 580 LPEGFDYLPPKLRLLRWDKYP--LRCMPSNF-RPENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIPD-LS 654 (1153)
T ss_pred cCcchhhcCcccEEEEecCCC--CCCCCCcC-CccCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCCc-cc
Confidence 444444442 35555555443 33444444 3455555555555555 4444455555555555555443223332 55
Q ss_pred CCCCCcEeeccCceeeeecCCCCCCCchhhhhhcccceeccCCeeeecCCccccCCcccceeeeccCCcccccCCccccC
Q 002774 86 NLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGL 165 (882)
Q Consensus 86 ~l~~L~~L~Ls~N~i~~~~p~~~~~~~~l~~L~~L~~L~L~~N~l~~~ip~~~f~~~~~L~~L~L~~N~l~~~~~~~~~~ 165 (882)
.+++|++|+|++|.....+|..+ ..|.+|+.|++++|..-..+|... .+++|+.|+|++|...+.+|..
T Consensus 655 ~l~~Le~L~L~~c~~L~~lp~si------~~L~~L~~L~L~~c~~L~~Lp~~i--~l~sL~~L~Lsgc~~L~~~p~~--- 723 (1153)
T PLN03210 655 MATNLETLKLSDCSSLVELPSSI------QYLNKLEDLDMSRCENLEILPTGI--NLKSLYRLNLSGCSRLKSFPDI--- 723 (1153)
T ss_pred cCCcccEEEecCCCCccccchhh------hccCCCCEEeCCCCCCcCccCCcC--CCCCCCEEeCCCCCCccccccc---
Confidence 55555555555554433444332 234445555555543222555443 3455555555555444444432
Q ss_pred CCCCCEEEccCCCCCCCCCccCCCCCCCCEEEccCCcccccC-------CC-CCCCCCCCEEECcCCCCCCCCCCccccC
Q 002774 166 VKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAM-------PN-LTGLSVLSYLDMSNNSFDASEVPSWFSS 237 (882)
Q Consensus 166 l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~-------~~-~~~l~~L~~L~Ls~N~l~~~~~p~~~~~ 237 (882)
.++|++|++++|.+. .+|..+ .+++|+.|++.++....+. +. ....++|+.|+|++|... ..+|..+.+
T Consensus 724 ~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l-~~lP~si~~ 800 (1153)
T PLN03210 724 STNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSL-VELPSSIQN 800 (1153)
T ss_pred cCCcCeeecCCCccc-cccccc-cccccccccccccchhhccccccccchhhhhccccchheeCCCCCCc-cccChhhhC
Confidence 245555566665555 344333 3455555555543221111 11 122468889999988765 368888999
Q ss_pred CCCCCEEECcCCcccccCCccCCCCCCCCEEEccCCccceecCCCCcccccccccccCCccccccCCCCCCccceEEecC
Q 002774 238 MQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENLLVNLQNNRISAYTERGGAPAVNLTLIDN 317 (882)
Q Consensus 238 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~~~~L~~l~~ 317 (882)
+++|+.|+|++|...+.+|..+ .+++|+.|+|++|......+.. ..+|+.|+|++|.|+.++. .+..+.+|+.|+.
T Consensus 801 L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~--~~nL~~L~Ls~n~i~~iP~-si~~l~~L~~L~L 876 (1153)
T PLN03210 801 LHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI--STNISDLNLSRTGIEEVPW-WIEKFSNLSFLDM 876 (1153)
T ss_pred CCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc--ccccCEeECCCCCCccChH-HHhcCCCCCEEEC
Confidence 9999999999986555778766 7899999999998655433332 3578889999999998875 4677888999988
Q ss_pred ccccccCC
Q 002774 318 PICQELGT 325 (882)
Q Consensus 318 ~~c~~~~~ 325 (882)
..|..+..
T Consensus 877 ~~C~~L~~ 884 (1153)
T PLN03210 877 NGCNNLQR 884 (1153)
T ss_pred CCCCCcCc
Confidence 88877654
|
syringae 6; Provisional |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.9e-23 Score=234.42 Aligned_cols=264 Identities=23% Similarity=0.292 Sum_probs=203.1
Q ss_pred CCcEEEeeCCcCCccccccccCCCCCCEEEccCCcCCCCCCcCccCCCCCcEeeccCceeeeecCCCCCCCchhhhhhcc
Q 002774 41 KLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRA 120 (882)
Q Consensus 41 ~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~~~~l~~L~~L 120 (882)
+|+++++++|+++ .+|..+..+.+|+.|+..+|+|. .+|..+...++|+.|++.+|.++ -+|. .++.++.|
T Consensus 242 nl~~~dis~n~l~-~lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~------~le~~~sL 312 (1081)
T KOG0618|consen 242 NLQYLDISHNNLS-NLPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIPP------FLEGLKSL 312 (1081)
T ss_pred cceeeecchhhhh-cchHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCC------ccccccee
Confidence 4555555555555 34455555555555555555554 44555555555555555555554 2332 23345678
Q ss_pred cceeccCCeeeecCCccccCCccc-ceeeeccCCcccccCCccccCCCCCCEEEccCCCCCCCCCccCCCCCCCCEEEcc
Q 002774 121 KHFHFGKNQLSGSIPEKLFRPDMV-LIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLS 199 (882)
Q Consensus 121 ~~L~L~~N~l~~~ip~~~f~~~~~-L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls 199 (882)
++|+|..|+|. .+|+..|..+.. |..|..+.|++.......=..++.|+.|++.+|.+++..-..|.+..+|+.|+|+
T Consensus 313 ~tLdL~~N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLs 391 (1081)
T KOG0618|consen 313 RTLDLQSNNLP-SLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLS 391 (1081)
T ss_pred eeeeehhcccc-ccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeec
Confidence 88899999998 888888877666 8888888888885543334466789999999999998888899999999999999
Q ss_pred CCcccccCCC-CCCCCCCCEEECcCCCCCCCCCCccccCCCCCCEEECcCCcccccCCccCCCCCCCCEEEccCCccce-
Q 002774 200 NNKLTGAMPN-LTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNG- 277 (882)
Q Consensus 200 ~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~- 277 (882)
+|+|..++.. +.+++.|++|+||+|+++ .+|..+..++.|++|...+|+|. ..| .+..++.|+.+|||.|.|+.
T Consensus 392 yNrL~~fpas~~~kle~LeeL~LSGNkL~--~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~ 467 (1081)
T KOG0618|consen 392 YNRLNSFPASKLRKLEELEELNLSGNKLT--TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEV 467 (1081)
T ss_pred ccccccCCHHHHhchHHhHHHhcccchhh--hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhh
Confidence 9999988875 899999999999999995 58999999999999999999998 788 89999999999999999997
Q ss_pred ecCCCCcccccccccccCCccccccCCCCCCccceEEecCc
Q 002774 278 TLDLGTSYSENLLVNLQNNRISAYTERGGAPAVNLTLIDNP 318 (882)
Q Consensus 278 ~~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~~~~L~~l~~~ 318 (882)
..+....+++|+.|||++|.-...+...|..+..+...+..
T Consensus 468 ~l~~~~p~p~LkyLdlSGN~~l~~d~~~l~~l~~l~~~~i~ 508 (1081)
T KOG0618|consen 468 TLPEALPSPNLKYLDLSGNTRLVFDHKTLKVLKSLSQMDIT 508 (1081)
T ss_pred hhhhhCCCcccceeeccCCcccccchhhhHHhhhhhheecc
Confidence 55555667999999999999877777777777776666543
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.3e-21 Score=226.53 Aligned_cols=247 Identities=22% Similarity=0.319 Sum_probs=173.1
Q ss_pred CCCCEEeccCCCCCccCCCccccCCCCCcEEEeeCCcCCccccccccCCCCCCEEEccCCcCCCCCCcCccCCCCCcEee
Q 002774 15 TELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLD 94 (882)
Q Consensus 15 ~~L~~L~L~~n~~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~ 94 (882)
.+.+.|+|++++ ...+|..+. ++|+.|+|++|+|+ .+|..+. .+|+.|+|++|+|+ .+|..+. .+|+.|+
T Consensus 178 ~~~~~L~L~~~~--LtsLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~ 247 (754)
T PRK15370 178 NNKTELRLKILG--LTTIPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEME 247 (754)
T ss_pred cCceEEEeCCCC--cCcCCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEE
Confidence 356788888886 345676664 47888888888888 5665554 47888888888888 4566554 4788888
Q ss_pred ccCceeeeecCCCCCCCchhhhhhcccceeccCCeeeecCCccccCCcccceeeeccCCcccccCCccccCCCCCCEEEc
Q 002774 95 LTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRF 174 (882)
Q Consensus 95 Ls~N~i~~~~p~~~~~~~~l~~L~~L~~L~L~~N~l~~~ip~~~f~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 174 (882)
|++|+|. .+|..+. .+|+.|+|++|+|+ .+|..++ .+|+.|+|++|+|+. +|..+. ++|+.|++
T Consensus 248 Ls~N~L~-~LP~~l~--------s~L~~L~Ls~N~L~-~LP~~l~---~sL~~L~Ls~N~Lt~-LP~~lp--~sL~~L~L 311 (754)
T PRK15370 248 LSINRIT-ELPERLP--------SALQSLDLFHNKIS-CLPENLP---EELRYLSVYDNSIRT-LPAHLP--SGITHLNV 311 (754)
T ss_pred CcCCccC-cCChhHh--------CCCCEEECcCCccC-ccccccC---CCCcEEECCCCcccc-Ccccch--hhHHHHHh
Confidence 8888887 6665432 36778888888888 7777654 468888888888874 344332 46788888
Q ss_pred cCCCCCCCCCccCCCCCCCCEEEccCCcccccCCCCCCCCCCCEEECcCCCCCCCCCCccccCCCCCCEEECcCCccccc
Q 002774 175 DRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQ 254 (882)
Q Consensus 175 s~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 254 (882)
++|.++. +|..+. ++|+.|++++|.+++++..+. ++|+.|+|++|+|+ .+|..+. ++|+.|+|++|+|+ .
T Consensus 312 s~N~Lt~-LP~~l~--~sL~~L~Ls~N~Lt~LP~~l~--~sL~~L~Ls~N~L~--~LP~~lp--~~L~~LdLs~N~Lt-~ 381 (754)
T PRK15370 312 QSNSLTA-LPETLP--PGLKTLEAGENALTSLPASLP--PELQVLDVSKNQIT--VLPETLP--PTITTLDVSRNALT-N 381 (754)
T ss_pred cCCcccc-CCcccc--ccceeccccCCccccCChhhc--CcccEEECCCCCCC--cCChhhc--CCcCEEECCCCcCC-C
Confidence 8888873 454443 578888888888887665553 67888888888875 3565443 57888888888887 5
Q ss_pred CCccCCCCCCCCEEEccCCccceecCCCCc----ccccccccccCCccc
Q 002774 255 IPADLFSIPHLQTVVMKTNELNGTLDLGTS----YSENLLVNLQNNRIS 299 (882)
Q Consensus 255 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~----~~~L~~L~L~~N~i~ 299 (882)
+|..+. ..|+.|++++|+|++.+..... ++++..|+|.+|+|+
T Consensus 382 LP~~l~--~sL~~LdLs~N~L~~LP~sl~~~~~~~~~l~~L~L~~Npls 428 (754)
T PRK15370 382 LPENLP--AALQIMQASRNNLVRLPESLPHFRGEGPQPTRIIVEYNPFS 428 (754)
T ss_pred CCHhHH--HHHHHHhhccCCcccCchhHHHHhhcCCCccEEEeeCCCcc
Confidence 555443 3577888888888765443322 356677788888776
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.83 E-value=7.1e-20 Score=231.81 Aligned_cols=298 Identities=17% Similarity=0.179 Sum_probs=229.9
Q ss_pred cccCccccCCCCCCEEeccCCCCCccCCCccccCCCCCcEEEeeCCcCCccccccccCCCCCCEEEccCCcCCCCCCcCc
Q 002774 5 GQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSI 84 (882)
Q Consensus 5 ~~l~~~~~~l~~L~~L~L~~n~~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~ 84 (882)
..+|..| .+.+|++|+|++|+ ...++..+..+++|+.|+|++|.....+|. ++.+++|++|+|++|.....+|..+
T Consensus 602 ~~lP~~f-~~~~L~~L~L~~s~--l~~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si 677 (1153)
T PLN03210 602 RCMPSNF-RPENLVKLQMQGSK--LEKLWDGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSI 677 (1153)
T ss_pred CCCCCcC-CccCCcEEECcCcc--ccccccccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhh
Confidence 4677777 57999999999997 556788899999999999998875546764 8899999999999987666899999
Q ss_pred cCCCCCcEeeccCceeeeecCCCCCCCchhhhhhcccceeccCCeeeecCCccccCCcccceeeeccCCcccccCCcccc
Q 002774 85 GNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLG 164 (882)
Q Consensus 85 ~~l~~L~~L~Ls~N~i~~~~p~~~~~~~~l~~L~~L~~L~L~~N~l~~~ip~~~f~~~~~L~~L~L~~N~l~~~~~~~~~ 164 (882)
.++++|+.|++++|.....+|..+ .+++|+.|+|++|...+.+|. ...+|+.|+|++|.+. .+|..+
T Consensus 678 ~~L~~L~~L~L~~c~~L~~Lp~~i-------~l~sL~~L~Lsgc~~L~~~p~----~~~nL~~L~L~~n~i~-~lP~~~- 744 (1153)
T PLN03210 678 QYLNKLEDLDMSRCENLEILPTGI-------NLKSLYRLNLSGCSRLKSFPD----ISTNISWLDLDETAIE-EFPSNL- 744 (1153)
T ss_pred hccCCCCEEeCCCCCCcCccCCcC-------CCCCCCEEeCCCCCCcccccc----ccCCcCeeecCCCccc-cccccc-
Confidence 999999999999976555777544 367888999999876656664 2468999999999987 456555
Q ss_pred CCCCCCEEEccCCCCC-------CCCCccCCCCCCCCEEEccCCcccc-cCCCCCCCCCCCEEECcCCCCCCCCCCcccc
Q 002774 165 LVKSLEVVRFDRNSLS-------GPVPSNLNNLTSVNDLYLSNNKLTG-AMPNLTGLSVLSYLDMSNNSFDASEVPSWFS 236 (882)
Q Consensus 165 ~l~~L~~L~Ls~N~l~-------~~~p~~l~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~ 236 (882)
.+++|++|++.++... ...+..+...++|+.|+|++|.... ++..+.++++|+.|+|++|... ..+|..+
T Consensus 745 ~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L-~~LP~~~- 822 (1153)
T PLN03210 745 RLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINL-ETLPTGI- 822 (1153)
T ss_pred cccccccccccccchhhccccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCc-CeeCCCC-
Confidence 5788888888774432 1122223345789999999986544 4446888999999999987543 2566655
Q ss_pred CCCCCCEEECcCCcccccCCccCCCCCCCCEEEccCCccceecCCCCcccccccccccC-CccccccCCCCCCccceEEe
Q 002774 237 SMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENLLVNLQN-NRISAYTERGGAPAVNLTLI 315 (882)
Q Consensus 237 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~-N~i~~~~~~~~~~~~~L~~l 315 (882)
++++|+.|+|++|.....+|.. .++|+.|+|++|.++..+.....+++|+.|+|++ |++..++. ....+..|+.+
T Consensus 823 ~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~i~~iP~si~~l~~L~~L~L~~C~~L~~l~~-~~~~L~~L~~L 898 (1153)
T PLN03210 823 NLESLESLDLSGCSRLRTFPDI---STNISDLNLSRTGIEEVPWWIEKFSNLSFLDMNGCNNLQRVSL-NISKLKHLETV 898 (1153)
T ss_pred CccccCEEECCCCCcccccccc---ccccCEeECCCCCCccChHHHhcCCCCCEEECCCCCCcCccCc-ccccccCCCee
Confidence 7889999999998765555543 4678999999999987766666788999999988 67777655 35678888888
Q ss_pred cCccccccCC
Q 002774 316 DNPICQELGT 325 (882)
Q Consensus 316 ~~~~c~~~~~ 325 (882)
+...|..+..
T Consensus 899 ~l~~C~~L~~ 908 (1153)
T PLN03210 899 DFSDCGALTE 908 (1153)
T ss_pred ecCCCccccc
Confidence 8888877654
|
syringae 6; Provisional |
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.6e-20 Score=186.20 Aligned_cols=139 Identities=17% Similarity=0.197 Sum_probs=107.9
Q ss_pred CCeeeccCcEEEEEEEecCCcEEEEEEcccCCcc--c-------HHH-----------------HHHHHHHHHhccCCCe
Q 002774 560 ANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQ--G-------GQE-----------------FKMEIELLSRVHHKNL 613 (882)
Q Consensus 560 ~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~--~-------~~~-----------------~~~E~~~l~~l~H~ni 613 (882)
...||+|+||.||+|...+|+.||||+++..... . ... ...|++.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 3579999999999999878999999999754221 1 011 2349999999987776
Q ss_pred eeEEEEEEeCCceEEEEEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhh-hhcCCCCeeecCCCCCceEEcCC
Q 002774 614 VSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYL-HELANPPIIHRDIKSSNILLDER 692 (882)
Q Consensus 614 v~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~ivHrDlk~~NIll~~~ 692 (882)
.....+. ....+|||||++++++....... ..+++.+...++.|++.+|.|+ |+.+ |+||||||+||+++ +
T Consensus 82 ~~p~~~~--~~~~~iVmE~i~g~~l~~~~~~~--~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~-~ 153 (190)
T cd05147 82 PCPEPIL--LKSHVLVMEFIGDDGWAAPRLKD--APLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH-D 153 (190)
T ss_pred CCCcEEE--ecCCEEEEEEeCCCCCcchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-C
Confidence 4333222 22348999999988776543222 3588889999999999999999 6888 99999999999998 4
Q ss_pred CceeEeeccccccc
Q 002774 693 LNAKVADFGLSKSM 706 (882)
Q Consensus 693 ~~~kl~DfGla~~~ 706 (882)
+.++|+|||+|...
T Consensus 154 ~~v~LiDFG~a~~~ 167 (190)
T cd05147 154 GKLYIIDVSQSVEH 167 (190)
T ss_pred CcEEEEEccccccC
Confidence 78999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.7e-20 Score=190.35 Aligned_cols=171 Identities=13% Similarity=0.142 Sum_probs=135.5
Q ss_pred HHcCCCCCCeeeccCcEEEEEEEecCCcEEEEEEcccCCcccHHH---------HHHHHHHHHhccCCCeeeEEEEEEeC
Q 002774 553 YTNNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQE---------FKMEIELLSRVHHKNLVSLLGFCFDR 623 (882)
Q Consensus 553 ~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l~H~niv~l~~~~~~~ 623 (882)
...+|...+++|.|+||.||.+.. ++..+|||.+........+. +.+|+..+.+++|++|.....++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 467899999999999999999766 57789999997654333222 68899999999999999999886543
Q ss_pred --------CceEEEEEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCce
Q 002774 624 --------GEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNA 695 (882)
Q Consensus 624 --------~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~ 695 (882)
+..++||||++|.+|.++.. ++. ....+++.++..+|+.| ++|||+||+||+++.++ +
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g-i 173 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG-L 173 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-E
Confidence 35789999999999977632 222 24568899999999999 99999999999999988 9
Q ss_pred eEeecccccccCCCCCceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHH
Q 002774 696 KVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELL 752 (882)
Q Consensus 696 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~ 752 (882)
+++|||..+....... -..+...+.+..++|+|+||+.+.-..
T Consensus 174 ~liDfg~~~~~~e~~a--------------~d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 174 RIIDLSGKRCTAQRKA--------------KDRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEECCCcccccchhh--------------HHHHHHHhHhcccccccceeEeehHHH
Confidence 9999998875532211 111455667788999999999987654
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=3e-20 Score=220.09 Aligned_cols=237 Identities=25% Similarity=0.400 Sum_probs=192.4
Q ss_pred CCccccCccccCCCCCCEEeccCCCCCccCCCccccCCCCCcEEEeeCCcCCccccccccCCCCCCEEEccCCcCCCCCC
Q 002774 2 GLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVP 81 (882)
Q Consensus 2 ~~~~~l~~~~~~l~~L~~L~L~~n~~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~ 81 (882)
+|+ .+|..+. ++|+.|+|++|+ +. .+|..+. ++|++|+|++|+|+ .+|..+. .+|+.|+|++|+|. .+|
T Consensus 189 ~Lt-sLP~~Ip--~~L~~L~Ls~N~-Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~-~LP 257 (754)
T PRK15370 189 GLT-TIPACIP--EQITTLILDNNE-LK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELSINRIT-ELP 257 (754)
T ss_pred CcC-cCCcccc--cCCcEEEecCCC-CC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECcCCccC-cCC
Confidence 455 5677665 589999999998 55 5676664 59999999999999 6776654 48999999999999 677
Q ss_pred cCccCCCCCcEeeccCceeeeecCCCCCCCchhhhhhcccceeccCCeeeecCCccccCCcccceeeeccCCcccccCCc
Q 002774 82 PSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPA 161 (882)
Q Consensus 82 ~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~~~~l~~L~~L~~L~L~~N~l~~~ip~~~f~~~~~L~~L~L~~N~l~~~~~~ 161 (882)
..+. ++|+.|+|++|+|+ .+|..+. .+|+.|++++|+|+ .+|..+. .+|+.|++++|+++. +|.
T Consensus 258 ~~l~--s~L~~L~Ls~N~L~-~LP~~l~--------~sL~~L~Ls~N~Lt-~LP~~lp---~sL~~L~Ls~N~Lt~-LP~ 321 (754)
T PRK15370 258 ERLP--SALQSLDLFHNKIS-CLPENLP--------EELRYLSVYDNSIR-TLPAHLP---SGITHLNVQSNSLTA-LPE 321 (754)
T ss_pred hhHh--CCCCEEECcCCccC-ccccccC--------CCCcEEECCCCccc-cCcccch---hhHHHHHhcCCcccc-CCc
Confidence 7665 58999999999998 6786542 36899999999999 7887653 579999999999995 454
Q ss_pred cccCCCCCCEEEccCCCCCCCCCccCCCCCCCCEEEccCCcccccCCCCCCCCCCCEEECcCCCCCCCCCCccccCCCCC
Q 002774 162 TLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSL 241 (882)
Q Consensus 162 ~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L 241 (882)
.+ .++|+.|++++|.+++ +|..+. ++|+.|+|++|+|+.++..+. ++|+.|+|++|+|+ .+|..+. ..|
T Consensus 322 ~l--~~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~~LP~~lp--~~L~~LdLs~N~Lt--~LP~~l~--~sL 390 (754)
T PRK15370 322 TL--PPGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQITVLPETLP--PTITTLDVSRNALT--NLPENLP--AAL 390 (754)
T ss_pred cc--cccceeccccCCcccc-CChhhc--CcccEEECCCCCCCcCChhhc--CCcCEEECCCCcCC--CCCHhHH--HHH
Confidence 43 3689999999999994 676664 799999999999997765553 68999999999996 4676654 379
Q ss_pred CEEECcCCcccccCCccC----CCCCCCCEEEccCCccce
Q 002774 242 TTLMMENTNLKGQIPADL----FSIPHLQTVVMKTNELNG 277 (882)
Q Consensus 242 ~~L~Ls~N~l~~~~~~~~----~~l~~L~~L~Ls~N~l~~ 277 (882)
+.|++++|+|. .+|..+ ..++++..|+|.+|+++.
T Consensus 391 ~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls~ 429 (754)
T PRK15370 391 QIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFSE 429 (754)
T ss_pred HHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCccH
Confidence 99999999998 566543 446899999999999973
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.4e-20 Score=216.80 Aligned_cols=247 Identities=21% Similarity=0.284 Sum_probs=179.2
Q ss_pred CCCCCCeeeccCcEEEEEEEecCCcEEEEEEcccCC-cccHHHHHHHHHH--HHhccCCCeeeEEEEEEeCCceEEEEEe
Q 002774 556 NFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGS-MQGGQEFKMEIEL--LSRVHHKNLVSLLGFCFDRGEQMLIYEF 632 (882)
Q Consensus 556 ~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~--l~~l~H~niv~l~~~~~~~~~~~lV~e~ 632 (882)
++...+.||++.|=+|.+|+.+.|. |+||++-+.. .-..+.|.++++- ...++|||++++.-+...+...|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 4667788999999999999998887 8888875443 3344555554443 4445899999998887777788999999
Q ss_pred ecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccC--CC-
Q 002774 633 VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMS--DS- 709 (882)
Q Consensus 633 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~--~~- 709 (882)
+.+ +|+|.+..+. -+...+...|+.|++.||..+|..| |+|+|||.+||||+.-..+.|+||..-+... .+
T Consensus 103 vkh-nLyDRlSTRP--FL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN 176 (1431)
T KOG1240|consen 103 VKH-NLYDRLSTRP--FLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN 176 (1431)
T ss_pred Hhh-hhhhhhccch--HHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence 954 8999997654 5777888899999999999999999 9999999999999999999999998655321 11
Q ss_pred --CCceeeeeeeccCCCCCHHHHhhC-----------CCCchhHHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHhh
Q 002774 710 --EKDHITTQVKGTMGYLDPEYYMTQ-----------QLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKK 775 (882)
Q Consensus 710 --~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~sDv~S~Gvll~el~t-g~~P~~~~~~~~~~~~~~~~~~ 775 (882)
+.............|.|||.+... ..+++.||||.||+++|+++ |++||.- .+.........
T Consensus 177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L----SQL~aYr~~~~ 252 (1431)
T KOG1240|consen 177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL----SQLLAYRSGNA 252 (1431)
T ss_pred cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH----HHHHhHhccCc
Confidence 111112223344579999998642 15778999999999999999 5666631 11111100000
Q ss_pred hhhhhhh-hccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 776 KELYNLY-ELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 776 ~~~~~~~-~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
....... .+-| ..+++++..|++.||.+|.++++.++.
T Consensus 253 ~~~e~~Le~Ied------------~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 253 DDPEQLLEKIED------------VSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred cCHHHHHHhCcC------------ccHHHHHHHHHccCchhccCHHHHHHh
Confidence 0000011 1111 346799999999999999999999975
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.8e-19 Score=179.49 Aligned_cols=140 Identities=15% Similarity=0.198 Sum_probs=111.1
Q ss_pred CCeeeccCcEEEEEEEecCCcEEEEEEcccCCccc--------------------------HHHHHHHHHHHHhccCCCe
Q 002774 560 ANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQG--------------------------GQEFKMEIELLSRVHHKNL 613 (882)
Q Consensus 560 ~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~--------------------------~~~~~~E~~~l~~l~H~ni 613 (882)
...||+|+||+||+|+..+|+.||||+++...... ...+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 46799999999999997789999999987642210 1123578999999999987
Q ss_pred eeEEEEEEeCCceEEEEEeecCCCcccc-cCCCCCccccHHHHHHHHHHHHHHHhhhhh-cCCCCeeecCCCCCceEEcC
Q 002774 614 VSLLGFCFDRGEQMLIYEFVPNGSLGDS-LSGKNGIRLDWIRRLKIALGAARGLSYLHE-LANPPIIHRDIKSSNILLDE 691 (882)
Q Consensus 614 v~l~~~~~~~~~~~lV~e~~~~gsL~~~-l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDlk~~NIll~~ 691 (882)
.....+... ..++||||++++++... +.. ..++......++.+++.++.++|+ .| |+||||||+||+++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~---~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~- 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD---VPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH- 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhh---ccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-
Confidence 544444333 34899999998865443 322 246778889999999999999999 88 99999999999999
Q ss_pred CCceeEeecccccccCC
Q 002774 692 RLNAKVADFGLSKSMSD 708 (882)
Q Consensus 692 ~~~~kl~DfGla~~~~~ 708 (882)
++.++|+|||+++....
T Consensus 153 ~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 DGKPYIIDVSQAVELDH 169 (190)
T ss_pred CCCEEEEEcccceecCC
Confidence 88999999999986643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.3e-19 Score=200.85 Aligned_cols=217 Identities=29% Similarity=0.476 Sum_probs=163.8
Q ss_pred HHhccCCCeeeEEEEEEeCCceEEEEEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCC
Q 002774 605 LSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKS 684 (882)
Q Consensus 605 l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~ 684 (882)
|+.+.|.|+.+++|.+.++...+.|.+|+..|+|.|.+... ...++|.-...+.++|++||+|||... -..|+.+++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~-~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~s 77 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE-DIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALKS 77 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc-ccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeecc
Confidence 45789999999999999999999999999999999999863 467999999999999999999999854 239999999
Q ss_pred CceEEcCCCceeEeecccccccCCCCCceeeeeeeccCCCCCHHHHhhC-------CCCchhHHHHHHHHHHHHHhCCCC
Q 002774 685 SNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQ-------QLTEKSDVYSFGVLMLELLTGRRP 757 (882)
Q Consensus 685 ~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~sDv~S~Gvll~el~tg~~P 757 (882)
+|+++|....+|++|||+.................-..-|.|||.+... ..+.+.||||||++++|+++.+.|
T Consensus 78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~ 157 (484)
T KOG1023|consen 78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP 157 (484)
T ss_pred ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence 9999999999999999998876431111112222345579999999863 146789999999999999999999
Q ss_pred CCCCchHHH--HHHHHHHhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHH
Q 002774 758 IERGKYIVR--EIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQ 831 (882)
Q Consensus 758 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~ 831 (882)
|.......+ ++...+... ......|.+.... +...++..++.+||..+|.+||+++++-..++.+..
T Consensus 158 ~~~~~~~~~~~eii~~~~~~-----~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 158 FDLRNLVEDPDEIILRVKKG-----GSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred cccccccCChHHHHHHHHhc-----CCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 975322111 111111110 1112222222111 334578999999999999999999999887776644
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.2e-18 Score=172.78 Aligned_cols=185 Identities=15% Similarity=0.084 Sum_probs=140.5
Q ss_pred CCCCeeeccCcEEEEEEEecCCcEEEEEEcccCCccc----HHHHHHHHHHHHhcc-CCCeeeEEEEEEeCCceEEEEEe
Q 002774 558 SDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQG----GQEFKMEIELLSRVH-HKNLVSLLGFCFDRGEQMLIYEF 632 (882)
Q Consensus 558 ~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~----~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~e~ 632 (882)
.....|++|+||+||.+.- ++.+++.+.+.....-. ...+.+|+++|+++. |+++.+++++ +..+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 3567899999999997765 67888888877544321 235789999999995 5889999886 346999999
Q ss_pred ecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCC-CCCceEEcCCCceeEeecccccccCCCCC
Q 002774 633 VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDI-KSSNILLDERLNAKVADFGLSKSMSDSEK 711 (882)
Q Consensus 633 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDl-k~~NIll~~~~~~kl~DfGla~~~~~~~~ 711 (882)
+++.+|...+.. ....++.+++++|+++|+.| |+|||| ||.|||++.++.++|+|||+|........
T Consensus 80 I~G~~L~~~~~~---------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 80 LAGAAMYQRPPR---------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred ecCccHHhhhhh---------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence 999888654321 11346788999999999999 999999 79999999999999999999986543321
Q ss_pred c----ee-------eeeeeccCCCCCHHHHhhC-CCC-chhHHHHHHHHHHHHHhCCCCCC
Q 002774 712 D----HI-------TTQVKGTMGYLDPEYYMTQ-QLT-EKSDVYSFGVLMLELLTGRRPIE 759 (882)
Q Consensus 712 ~----~~-------~~~~~gt~~y~aPE~~~~~-~~~-~~sDv~S~Gvll~el~tg~~P~~ 759 (882)
. .. ......++.|++|+...-- ..+ .+.+.++-|+-+|.++|++.+..
T Consensus 148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~ 208 (218)
T PRK12274 148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW 208 (218)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence 0 00 1112367888888865422 333 57799999999999999988864
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=7.4e-20 Score=202.15 Aligned_cols=225 Identities=29% Similarity=0.348 Sum_probs=179.3
Q ss_pred eeeccCcEEEEEEE----ecCCcEEEEEEcccCCccc--HHHHHHHHHHHHhcc-CCCeeeEEEEEEeCCceEEEEEeec
Q 002774 562 DVGSGGYGKVYKGT----LPNGQLIAIKRAQQGSMQG--GQEFKMEIELLSRVH-HKNLVSLLGFCFDRGEQMLIYEFVP 634 (882)
Q Consensus 562 ~lG~G~fg~Vy~~~----~~~g~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~e~~~ 634 (882)
++|+|+||.|+.++ .+.|..+|+|.+++..... ......|..++...+ ||.+|++...+..+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999999875 2357889999887653322 124556888999997 9999999999999999999999999
Q ss_pred CCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCcee
Q 002774 635 NGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHI 714 (882)
Q Consensus 635 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 714 (882)
+|.|...+.... .++..........+|-+++++|+.+ |+|||+|++||+++.+|.+++.|||+++..-+.+..
T Consensus 81 gg~lft~l~~~~--~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~-- 153 (612)
T KOG0603|consen 81 GGDLFTRLSKEV--MFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA-- 153 (612)
T ss_pred cchhhhccccCC--chHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhhc--
Confidence 999988887654 5666777777888899999999999 999999999999999999999999999876554432
Q ss_pred eeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCCCCCC
Q 002774 715 TTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTT 794 (882)
Q Consensus 715 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 794 (882)
+||..|||||.+. ....++|.||||++++||+||..||.. +....+.... ...+
T Consensus 154 ----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-----~~~~~Il~~~---------------~~~p 207 (612)
T KOG0603|consen 154 ----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-----DTMKRILKAE---------------LEMP 207 (612)
T ss_pred ----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-----HHHHHHhhhc---------------cCCc
Confidence 7999999999997 677899999999999999999999965 2222222111 1112
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCH
Q 002774 795 LKGFEKYVDLALKCVQESGDDRPTM 819 (882)
Q Consensus 795 ~~~~~~l~~li~~cl~~dp~~RPs~ 819 (882)
........+++.++...+|..|.-.
T Consensus 208 ~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 208 RELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred hhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 2233566788889999999999654
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.77 E-value=4e-18 Score=178.22 Aligned_cols=231 Identities=20% Similarity=0.248 Sum_probs=147.6
Q ss_pred CCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCC---cccHHHHHHHHHHHHhcc----------CCCeeeEEEEEE-
Q 002774 557 FSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS---MQGGQEFKMEIELLSRVH----------HKNLVSLLGFCF- 621 (882)
Q Consensus 557 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~----------H~niv~l~~~~~- 621 (882)
+...+.||.|+|+.||.++.. +++.+|||++.... ....+++++|.-....+. |-.++.-++...
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 345678999999999999975 58999999875432 223466777665554432 212222222221
Q ss_pred --------eC---C-----ceEEEEEeecCCCcccccCC-----CCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeec
Q 002774 622 --------DR---G-----EQMLIYEFVPNGSLGDSLSG-----KNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHR 680 (882)
Q Consensus 622 --------~~---~-----~~~lV~e~~~~gsL~~~l~~-----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHr 680 (882)
.. . ..+++|+-+ .+||.+++.. .....+....++.+..|+++.+++||+.| ++|+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHg 169 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHG 169 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEES
T ss_pred cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEec
Confidence 11 1 235677766 5677766531 11234666777888899999999999999 9999
Q ss_pred CCCCCceEEcCCCceeEeecccccccCCCCCceeeeeeeccCCCCCHHHHhhC--------CCCchhHHHHHHHHHHHHH
Q 002774 681 DIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQ--------QLTEKSDVYSFGVLMLELL 752 (882)
Q Consensus 681 Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~~sDv~S~Gvll~el~ 752 (882)
||+|+|++++++|.++|+||+.....+. . ......+..|.+||..... .++.+.|.|++|+++|.|+
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~----~-~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW 244 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGT----R-YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW 244 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTE----E-EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCc----e-eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence 9999999999999999999998775432 1 1113456789999988643 4788999999999999999
Q ss_pred hCCCCCCCCchHHHHHHHHHHhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCC
Q 002774 753 TGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDR 816 (882)
Q Consensus 753 tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~R 816 (882)
+|..||........ .+.... ... +.++.+..||..+++.+|++|
T Consensus 245 C~~lPf~~~~~~~~------------------~~~~f~-~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 245 CGRLPFGLSSPEAD------------------PEWDFS-RCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HSS-STCCCGGGST------------------SGGGGT-TSS----HHHHHHHHHHT-SSGGGS
T ss_pred HccCCCCCCCcccc------------------ccccch-hcC-CcCHHHHHHHHHHccCCcccC
Confidence 99999974321100 000111 112 556889999999999999988
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=6.9e-18 Score=171.11 Aligned_cols=137 Identities=20% Similarity=0.219 Sum_probs=107.3
Q ss_pred CCCCCeeeccCcEEEEEEEecCCcEEEEEEcccCCcccHHHHHHHHHHHHhc-----cCCCeeeEEEEEEeCC---c-eE
Q 002774 557 FSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRV-----HHKNLVSLLGFCFDRG---E-QM 627 (882)
Q Consensus 557 ~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~H~niv~l~~~~~~~~---~-~~ 627 (882)
+...+.||+|+||.||. .-.++.. +||++........+.+.+|+.+++.+ .||||++++|++.++. . ..
T Consensus 4 L~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred cCCcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 45567899999999996 3234444 79988765445567899999999999 5799999999998863 3 33
Q ss_pred EEEEe--ecCCCcccccCCCCCccccHHHHHHHHHHHHHHH-hhhhhcCCCCeeecCCCCCceEEcC----CCceeEeec
Q 002774 628 LIYEF--VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGL-SYLHELANPPIIHRDIKSSNILLDE----RLNAKVADF 700 (882)
Q Consensus 628 lV~e~--~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL-~yLH~~~~~~ivHrDlk~~NIll~~----~~~~kl~Df 700 (882)
+|+|| +++|+|.+++... .+++. ..++.+++.++ +|||+.+ |+||||||+|||++. +++++|+||
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred EEecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 78999 5579999999653 24444 35677888777 9999999 999999999999974 347999995
Q ss_pred ccc
Q 002774 701 GLS 703 (882)
Q Consensus 701 Gla 703 (882)
+-+
T Consensus 154 ~G~ 156 (210)
T PRK10345 154 IGE 156 (210)
T ss_pred CCC
Confidence 544
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.4e-17 Score=197.06 Aligned_cols=255 Identities=20% Similarity=0.269 Sum_probs=186.0
Q ss_pred HHHHHcCCCCCCeeeccCcEEEEEEEecCCcEEEEEEcccCCcccHHHHHHHHHHHHhcc---CCCeeeEEEEEEeCCce
Q 002774 550 VKKYTNNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVH---HKNLVSLLGFCFDRGEQ 626 (882)
Q Consensus 550 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~~~~ 626 (882)
.+..-+.|.+.+.||+|+||+||+|...+|+.||+|+-+..... +|--=.+++.+|+ -+.|..+..++.-.+..
T Consensus 693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S 769 (974)
T KOG1166|consen 693 FEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQNAS 769 (974)
T ss_pred eeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccCCcc
Confidence 33445678888999999999999999888999999998765443 2222233444444 24455555666667888
Q ss_pred EEEEEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEc-------CCCceeEee
Q 002774 627 MLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLD-------ERLNAKVAD 699 (882)
Q Consensus 627 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~-------~~~~~kl~D 699 (882)
+||+||.+.|+|.+++... ...+|.-.+.+..|+++.+++||..+ |||+||||+|.+|. +...++|+|
T Consensus 770 ~lv~ey~~~Gtlld~~N~~--~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lID 844 (974)
T KOG1166|consen 770 VLVSEYSPYGTLLDLINTN--KVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLID 844 (974)
T ss_pred eeeeeccccccHHHhhccC--CCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEe
Confidence 9999999999999999844 36899999999999999999999999 99999999999994 244589999
Q ss_pred cccccccCCCCCceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhh
Q 002774 700 FGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELY 779 (882)
Q Consensus 700 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~ 779 (882)
||.+-.+.--.........++|-.+-.+|...++.++..+|.|.++-+++-|+.|+.- . ...+.
T Consensus 845 fG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~-----------q--~~~g~--- 908 (974)
T KOG1166|consen 845 FGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM-----------E--VKNGS--- 908 (974)
T ss_pred cccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH-----------H--hcCCc---
Confidence 9998765433223345667889999999999999999999999999999999988632 1 11111
Q ss_pred hhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHc
Q 002774 780 NLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQA 833 (882)
Q Consensus 780 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~ 833 (882)
. ..+++.++.-... +.+.+++..+|..|-..=|...++...++.++.+.
T Consensus 909 -~-~~~~~~~~Ry~~~---~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~~ 957 (974)
T KOG1166|consen 909 -S-WMVKTNFPRYWKR---DMWNKFFDLLLNPDCDTLPNLQELRTELEEVLAEH 957 (974)
T ss_pred -c-eeccccchhhhhH---HHHHHHHHHHhCcCcccchhHHHHHHHHHHHHHHH
Confidence 0 1111111111111 23446666666655555588888888888776553
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=8.8e-20 Score=168.57 Aligned_cols=166 Identities=28% Similarity=0.511 Sum_probs=125.5
Q ss_pred ccCCCCCCEEEccCCcCCCCCCcCccCCCCCcEeeccCceeeeecCCCCCCCchhhhhhcccceeccCCeeeecCCcccc
Q 002774 60 IGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLF 139 (882)
Q Consensus 60 ~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~~~~l~~L~~L~~L~L~~N~l~~~ip~~~f 139 (882)
+.++.+.+.|.|++|+++ .+|..+..+.+|+.|++++|+|+ .+|.++ ..|++|++|+++-|++.
T Consensus 29 Lf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~i------ssl~klr~lnvgmnrl~-------- 92 (264)
T KOG0617|consen 29 LFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSI------SSLPKLRILNVGMNRLN-------- 92 (264)
T ss_pred ccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhh------hhchhhhheecchhhhh--------
Confidence 445566777777888877 66667777778888888888777 555443 33555556666666655
Q ss_pred CCcccceeeeccCCcccccCCccccCCCCCCEEEccCCCCCC-CCCccCCCCCCCCEEEccCCcccccCCCCCCCCCCCE
Q 002774 140 RPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSG-PVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSY 218 (882)
Q Consensus 140 ~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~ 218 (882)
+.|..|+.++.|+.|||+.|++.. .+|+.|..++.|+.|+|++|.+.-+++++..+++|+.
T Consensus 93 ------------------~lprgfgs~p~levldltynnl~e~~lpgnff~m~tlralyl~dndfe~lp~dvg~lt~lqi 154 (264)
T KOG0617|consen 93 ------------------ILPRGFGSFPALEVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFEILPPDVGKLTNLQI 154 (264)
T ss_pred ------------------cCccccCCCchhhhhhccccccccccCCcchhHHHHHHHHHhcCCCcccCChhhhhhcceeE
Confidence 677788888888888888888864 5788888888888888888888888888888888888
Q ss_pred EECcCCCCCCCCCCccccCCCCCCEEECcCCcccccCCccCCCC
Q 002774 219 LDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSI 262 (882)
Q Consensus 219 L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l 262 (882)
|.+..|.+ ..+|..++.+..|++|++.+|+++ .+|..++.+
T Consensus 155 l~lrdndl--l~lpkeig~lt~lrelhiqgnrl~-vlppel~~l 195 (264)
T KOG0617|consen 155 LSLRDNDL--LSLPKEIGDLTRLRELHIQGNRLT-VLPPELANL 195 (264)
T ss_pred EeeccCch--hhCcHHHHHHHHHHHHhcccceee-ecChhhhhh
Confidence 88888888 467888888888888888888887 666655543
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.9e-19 Score=197.89 Aligned_cols=271 Identities=20% Similarity=0.243 Sum_probs=164.4
Q ss_pred EEeccCCCCCc-cCCCccccCCCCCcEEEeeCCcCCc----cccccccCCCCCCEEEccCCcCCC------CCCcCccCC
Q 002774 19 TLDLSNNKDLR-GPLPTTIGNLKKLSNLMLVGCSFSG----PIPDSIGSLQELVLLSLNSNGFSG------RVPPSIGNL 87 (882)
Q Consensus 19 ~L~L~~n~~i~-~~~p~~~~~l~~L~~L~L~~n~i~~----~~~~~~~~l~~L~~L~L~~N~i~~------~~~~~~~~l 87 (882)
.|+|.++. +. ......|..+.+|+.|+|++|.++. .++..+...++|++|+++++.+.+ .++..+.++
T Consensus 2 ~l~L~~~~-l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~ 80 (319)
T cd00116 2 QLSLKGEL-LKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKG 80 (319)
T ss_pred ccccccCc-ccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhc
Confidence 35565554 33 3344555666677777777777742 244455566667777777777652 223345667
Q ss_pred CCCcEeeccCceeeeecCCCCCCCchhhhhhc---ccceeccCCeeee----cCCccccCCc-ccceeeeccCCccccc-
Q 002774 88 SNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVR---AKHFHFGKNQLSG----SIPEKLFRPD-MVLIHVLFDSNNLTGE- 158 (882)
Q Consensus 88 ~~L~~L~Ls~N~i~~~~p~~~~~~~~l~~L~~---L~~L~L~~N~l~~----~ip~~~f~~~-~~L~~L~L~~N~l~~~- 158 (882)
++|+.|++++|.+.+..+. .+..+.. |++|++++|++++ .+... +... ++|+.|++++|.+++.
T Consensus 81 ~~L~~L~l~~~~~~~~~~~------~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~-l~~~~~~L~~L~L~~n~l~~~~ 153 (319)
T cd00116 81 CGLQELDLSDNALGPDGCG------VLESLLRSSSLQELKLNNNGLGDRGLRLLAKG-LKDLPPALEKLVLGRNRLEGAS 153 (319)
T ss_pred CceeEEEccCCCCChhHHH------HHHHHhccCcccEEEeeCCccchHHHHHHHHH-HHhCCCCceEEEcCCCcCCchH
Confidence 7777777777777533322 2223333 6777777776652 11111 1223 6777778887777732
Q ss_pred ---CCccccCCCCCCEEEccCCCCCCC----CCccCCCCCCCCEEEccCCcccccCC-----CCCCCCCCCEEECcCCCC
Q 002774 159 ---LPATLGLVKSLEVVRFDRNSLSGP----VPSNLNNLTSVNDLYLSNNKLTGAMP-----NLTGLSVLSYLDMSNNSF 226 (882)
Q Consensus 159 ---~~~~~~~l~~L~~L~Ls~N~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~~~~-----~~~~l~~L~~L~Ls~N~l 226 (882)
++..+..+++|++|+|++|.+++. ++..+..+++|+.|+|++|.+++... .+..+++|++|++++|.+
T Consensus 154 ~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l 233 (319)
T cd00116 154 CEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNL 233 (319)
T ss_pred HHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcC
Confidence 334566777888888888888742 33345556788888888888764332 255677888888888887
Q ss_pred CCCCCCccc-c----CCCCCCEEECcCCccc----ccCCccCCCCCCCCEEEccCCcccee----cCCCC-cc-cccccc
Q 002774 227 DASEVPSWF-S----SMQSLTTLMMENTNLK----GQIPADLFSIPHLQTVVMKTNELNGT----LDLGT-SY-SENLLV 291 (882)
Q Consensus 227 ~~~~~p~~~-~----~l~~L~~L~Ls~N~l~----~~~~~~~~~l~~L~~L~Ls~N~l~~~----~~~~~-~~-~~L~~L 291 (882)
+... ...+ . ..+.|+.|++++|.++ ..+...+..+++|++|++++|+++.. ....+ .. +.++.|
T Consensus 234 ~~~~-~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~ 312 (319)
T cd00116 234 TDAG-AAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESLLEPGNELESL 312 (319)
T ss_pred chHH-HHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHHHhhcCCchhhc
Confidence 5311 1112 1 2367888888888876 23344555667888888888888753 22222 23 466677
Q ss_pred cccCCcc
Q 002774 292 NLQNNRI 298 (882)
Q Consensus 292 ~L~~N~i 298 (882)
++.+|++
T Consensus 313 ~~~~~~~ 319 (319)
T cd00116 313 WVKDDSF 319 (319)
T ss_pred ccCCCCC
Confidence 7777653
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.70 E-value=9e-17 Score=165.45 Aligned_cols=134 Identities=21% Similarity=0.339 Sum_probs=113.7
Q ss_pred CeeeccCcEEEEEEEecCCcEEEEEEcccCCccc--------HHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEe
Q 002774 561 NDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQG--------GQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEF 632 (882)
Q Consensus 561 ~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~--------~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 632 (882)
+.||+|++|.||+|.+ +|..|+||+........ ...+.+|++++..++|+++.....++.+.+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999988 67789999866433211 13577899999999999998877777778889999999
Q ss_pred ecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccc
Q 002774 633 VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKS 705 (882)
Q Consensus 633 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~ 705 (882)
+++++|.+++.... + .+..++.+++.+|.++|+.+ ++|||++|+||+++ ++.++++|||.++.
T Consensus 81 ~~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG-----M-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999998885432 2 78899999999999999998 99999999999999 78899999998864
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.70 E-value=7e-18 Score=183.20 Aligned_cols=175 Identities=27% Similarity=0.387 Sum_probs=131.3
Q ss_pred ceEEEEEeecCCCcccccCCCC-CccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccc
Q 002774 625 EQMLIYEFVPNGSLGDSLSGKN-GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLS 703 (882)
Q Consensus 625 ~~~lV~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla 703 (882)
..|+.|+++.-.+|.+||..+. ....++.....++.|++.|++| ++ .+|||+||.||+...+..+||+|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence 5789999999999999997443 4567888999999999999999 66 999999999999999999999999999
Q ss_pred cccCCCC----CceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhh
Q 002774 704 KSMSDSE----KDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELY 779 (882)
Q Consensus 704 ~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~ 779 (882)
....... .....+...||..||+||.+.+..|+.|+||||+|++|+|++. +|.....-.....++ +
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~---~f~T~~er~~t~~d~----r--- 473 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI---QFSTQFERIATLTDI----R--- 473 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH---HhccHHHHHHhhhhh----h---
Confidence 8776554 1223456789999999999999999999999999999999996 232111100000000 0
Q ss_pred hhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 002774 780 NLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEV 822 (882)
Q Consensus 780 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ev 822 (882)
...++|....++ .+=+.++.+++.+.|.+||++.++
T Consensus 474 --~g~ip~~~~~d~-----p~e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 474 --DGIIPPEFLQDY-----PEEYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred --cCCCChHHhhcC-----cHHHHHHHHhcCCCcccCchHHHH
Confidence 011121211112 223589999999999999955444
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.5e-16 Score=161.98 Aligned_cols=144 Identities=18% Similarity=0.173 Sum_probs=111.9
Q ss_pred HHHHHcCCCCCCeeeccCcEEEEEEEecCCcEEEEEEcccCCcc----------------------cHHHHHHHHHHHHh
Q 002774 550 VKKYTNNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQ----------------------GGQEFKMEIELLSR 607 (882)
Q Consensus 550 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~----------------------~~~~~~~E~~~l~~ 607 (882)
+......|...+.||+|+||.||+|...+|+.||||+++..... ....+..|..++..
T Consensus 10 ~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 89 (198)
T cd05144 10 LVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKA 89 (198)
T ss_pred HHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHH
Confidence 33333347778999999999999999888999999987643210 11235678999999
Q ss_pred ccCC--CeeeEEEEEEeCCceEEEEEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCC
Q 002774 608 VHHK--NLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSS 685 (882)
Q Consensus 608 l~H~--niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~ 685 (882)
+.|+ .+.+.++ ....++||||+++++|...... .....++.+++.++.++|+.+ |+||||||+
T Consensus 90 l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~ 154 (198)
T cd05144 90 LYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKHG---IIHGDLSEF 154 (198)
T ss_pred HHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCcc
Confidence 9887 4445444 2456899999999998765431 234578889999999999988 999999999
Q ss_pred ceEEcCCCceeEeecccccccCC
Q 002774 686 NILLDERLNAKVADFGLSKSMSD 708 (882)
Q Consensus 686 NIll~~~~~~kl~DfGla~~~~~ 708 (882)
||++++++.++|+|||++.....
T Consensus 155 Nill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 155 NILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred cEEEcCCCcEEEEECCccccCCC
Confidence 99999999999999999975543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.69 E-value=6.3e-17 Score=187.20 Aligned_cols=254 Identities=25% Similarity=0.326 Sum_probs=163.6
Q ss_pred HcCCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEe
Q 002774 554 TNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEF 632 (882)
Q Consensus 554 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 632 (882)
..+|..++.|-.|+||.||..+++ ..+.+|+|+-++.- +.+- ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~l------ilRn--ilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNL------ILRN--ILTFAGNPFVV------------------ 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcccccch------hhhc--cccccCCccee------------------
Confidence 347888899999999999999875 46788884433211 1100 22222233332
Q ss_pred ecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCc
Q 002774 633 VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKD 712 (882)
Q Consensus 633 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 712 (882)
|+-...++.-+..+. +++.+++|||+.+ |+|||+||+|.+|+.-|.+|++|||+.+.-......
T Consensus 136 ---gDc~tllk~~g~lPv----------dmvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at 199 (1205)
T KOG0606|consen 136 ---GDCATLLKNIGPLPV----------DMVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT 199 (1205)
T ss_pred ---chhhhhcccCCCCcc----------hhhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhccc
Confidence 444444544332222 2277899999999 999999999999999999999999998753221100
Q ss_pred -------------eeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhh
Q 002774 713 -------------HITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELY 779 (882)
Q Consensus 713 -------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~ 779 (882)
.....++||+.|.|||++....|...+|+|++|+|+||.+-|..||.. ++..+.+..++.....
T Consensus 200 nl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffG-dtpeelfg~visd~i~-- 276 (1205)
T KOG0606|consen 200 NLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFG-DTPEELFGQVISDDIE-- 276 (1205)
T ss_pred hhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccC-CCHHHHHhhhhhhhcc--
Confidence 011246899999999999999999999999999999999999999964 3334444444433221
Q ss_pred hhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCC---CHHHHHHH-------HHHHHHH-cCCCCCCCCCCCcccc
Q 002774 780 NLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRP---TMSEVVKD-------IENILQQ-AGLNPNAESASSSASY 848 (882)
Q Consensus 780 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP---s~~evl~~-------L~~~~~~-~~~~~~~~~~~~s~~~ 848 (882)
+.+. ....+.+..+++.+.++.+|.+|- .+.+|.++ +..++++ +.+.+.- ......+|
T Consensus 277 -wpE~---------dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~~llRqkaefvpql-~~eddtsy 345 (1205)
T KOG0606|consen 277 -WPEE---------DEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWKSLLRQKAEFVPQL-ESEDDTSY 345 (1205)
T ss_pred -cccc---------CcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccchhhhhhccccccc-cccccchh
Confidence 1111 222346788999999999999994 33333322 2333333 3333222 22334556
Q ss_pred cccCCCCCCCCCCCC
Q 002774 849 EDASKGNFHHPYCNE 863 (882)
Q Consensus 849 ~~~~~~~~~~p~~~~ 863 (882)
.+......+|.+...
T Consensus 346 fdTRs~Ryh~~~se~ 360 (1205)
T KOG0606|consen 346 FDTRSDRYHHFESED 360 (1205)
T ss_pred hcccchheeeccccC
Confidence 666666666655444
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.69 E-value=2e-16 Score=164.50 Aligned_cols=143 Identities=15% Similarity=0.171 Sum_probs=111.0
Q ss_pred CCCCCCeeeccCcEEEEEEE--ecCCcEEEEEEcccCCcc------------------------cHHHHHHHHHHHHhcc
Q 002774 556 NFSDANDVGSGGYGKVYKGT--LPNGQLIAIKRAQQGSMQ------------------------GGQEFKMEIELLSRVH 609 (882)
Q Consensus 556 ~~~~~~~lG~G~fg~Vy~~~--~~~g~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~ 609 (882)
.|...+.||+|+||.||+|. ..+|+.||||+++..... ....+..|++.+.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 46678899999999999998 568999999998753210 0123567999999997
Q ss_pred CC--CeeeEEEEEEeCCceEEEEEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCce
Q 002774 610 HK--NLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNI 687 (882)
Q Consensus 610 H~--niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NI 687 (882)
+. .+.+.+++ ...++||||+++++|........ .....+...++.|++.++++||+.+ .|+||||||+||
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp~NI 180 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV--EPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSEYNI 180 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccccC--CcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCChhhE
Confidence 53 33444443 23589999999988877653322 3556667889999999999999866 399999999999
Q ss_pred EEcCCCceeEeecccccccC
Q 002774 688 LLDERLNAKVADFGLSKSMS 707 (882)
Q Consensus 688 ll~~~~~~kl~DfGla~~~~ 707 (882)
+++ ++.++|+|||.+....
T Consensus 181 li~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 181 LVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred EEE-CCCEEEEEChhhhccC
Confidence 999 8899999999987543
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.7e-16 Score=161.76 Aligned_cols=130 Identities=24% Similarity=0.364 Sum_probs=106.7
Q ss_pred eeeccCcEEEEEEEecCCcEEEEEEcccCCcc--------cHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEee
Q 002774 562 DVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQ--------GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFV 633 (882)
Q Consensus 562 ~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 633 (882)
.||+|+||+||+|.+ +|..|++|+....... ....+.+|++++..++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 389999999999996 5788999986543211 1245678999999999887665555566677789999999
Q ss_pred cCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccc
Q 002774 634 PNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKS 705 (882)
Q Consensus 634 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~ 705 (882)
++++|.+.+.... . .++.+++.+|.++|+.+ ++|||++|+||+++ ++.+++.|||+++.
T Consensus 80 ~g~~l~~~~~~~~--~-------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGN--D-------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcH--H-------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999988775432 0 78999999999999998 99999999999999 88999999999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.2e-18 Score=161.10 Aligned_cols=164 Identities=30% Similarity=0.495 Sum_probs=113.2
Q ss_pred cCCCCCCEEeccCCCCCccCCCccccCCCCCcEEEeeCCcCCccccccccCCCCCCEEEccCCcCCCCCCcCccCCCCCc
Q 002774 12 TGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLY 91 (882)
Q Consensus 12 ~~l~~L~~L~L~~n~~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~ 91 (882)
-++++++.|.||+|+ ...+|..+..+.+|+.|++++|+|. .+|..++.+++|+.|+++-|++. ..|..|+.++.|+
T Consensus 30 f~~s~ITrLtLSHNK--l~~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~le 105 (264)
T KOG0617|consen 30 FNMSNITRLTLSHNK--LTVVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALE 105 (264)
T ss_pred cchhhhhhhhcccCc--eeecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhh
Confidence 356677777788877 5566777777788888888888777 67777777888888888877776 7777777777788
Q ss_pred EeeccCceeeeecCCCCCCCchhhhhhcccceeccCCeeeecCCccccCCcccceeeeccCCcccccCCccccCCCCCCE
Q 002774 92 WLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEV 171 (882)
Q Consensus 92 ~L~Ls~N~i~~~~p~~~~~~~~l~~L~~L~~L~L~~N~l~~~ip~~~f~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 171 (882)
.|||+.|++... ++|..+| .+..|+.|+|+.|.+. ++|..++++++|+.
T Consensus 106 vldltynnl~e~-----------------------------~lpgnff-~m~tlralyl~dndfe-~lp~dvg~lt~lqi 154 (264)
T KOG0617|consen 106 VLDLTYNNLNEN-----------------------------SLPGNFF-YMTTLRALYLGDNDFE-ILPPDVGKLTNLQI 154 (264)
T ss_pred hhhccccccccc-----------------------------cCCcchh-HHHHHHHHHhcCCCcc-cCChhhhhhcceeE
Confidence 888777776511 2333222 3445555566666555 66666777777777
Q ss_pred EEccCCCCCCCCCccCCCCCCCCEEEccCCcccccCCCCC
Q 002774 172 VRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLT 211 (882)
Q Consensus 172 L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~ 211 (882)
|.+..|.+- .+|..++.++.|++|.+.+|+++-++|++.
T Consensus 155 l~lrdndll-~lpkeig~lt~lrelhiqgnrl~vlppel~ 193 (264)
T KOG0617|consen 155 LSLRDNDLL-SLPKEIGDLTRLRELHIQGNRLTVLPPELA 193 (264)
T ss_pred EeeccCchh-hCcHHHHHHHHHHHHhcccceeeecChhhh
Confidence 777777766 567777777777777777777766665543
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.67 E-value=1.7e-16 Score=185.93 Aligned_cols=141 Identities=20% Similarity=0.304 Sum_probs=112.8
Q ss_pred HHHcCCCCCCeeeccCcEEEEEEEecCCcEEEEEEcccC-Cc------ccHHHHHHHHHHHHhccCCCeeeEEEEEEeCC
Q 002774 552 KYTNNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQG-SM------QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRG 624 (882)
Q Consensus 552 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~-~~------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~ 624 (882)
.....|...+.||+|+||+||+|.+.+...++.++..+. .. ...+.+.+|+++++.++|++++....++.+..
T Consensus 330 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~ 409 (535)
T PRK09605 330 EVKRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE 409 (535)
T ss_pred ccccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC
Confidence 334455678899999999999998765443332222221 11 11245788999999999999998888888878
Q ss_pred ceEEEEEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeeccccc
Q 002774 625 EQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSK 704 (882)
Q Consensus 625 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~ 704 (882)
..++||||+++++|.+++. ....++.+++++|.|||+.+ ++||||||+||++ +++.++|+|||+++
T Consensus 410 ~~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~ 475 (535)
T PRK09605 410 EKTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGK 475 (535)
T ss_pred CCEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCcccc
Confidence 8899999999999988764 35678999999999999998 9999999999999 67799999999997
Q ss_pred cc
Q 002774 705 SM 706 (882)
Q Consensus 705 ~~ 706 (882)
..
T Consensus 476 ~~ 477 (535)
T PRK09605 476 YS 477 (535)
T ss_pred cC
Confidence 53
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.66 E-value=7.9e-19 Score=192.99 Aligned_cols=267 Identities=22% Similarity=0.251 Sum_probs=200.7
Q ss_pred ccCccccCCCCCCEEeccCCCCCcc----CCCccccCCCCCcEEEeeCCcCCc------cccccccCCCCCCEEEccCCc
Q 002774 6 QLSGDITGLTELHTLDLSNNKDLRG----PLPTTIGNLKKLSNLMLVGCSFSG------PIPDSIGSLQELVLLSLNSNG 75 (882)
Q Consensus 6 ~l~~~~~~l~~L~~L~L~~n~~i~~----~~p~~~~~l~~L~~L~L~~n~i~~------~~~~~~~~l~~L~~L~L~~N~ 75 (882)
....-|..+.+|++|+|+++. +.. .++..+...++|++|+++++.+.+ .++..|..+++|+.|+|++|.
T Consensus 14 ~~~~~~~~l~~L~~l~l~~~~-l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~ 92 (319)
T cd00116 14 RATELLPKLLCLQVLRLEGNT-LGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNA 92 (319)
T ss_pred chHHHHHHHhhccEEeecCCC-CcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcCceeEEEccCCC
Confidence 344556677889999999997 533 256667788889999999998872 345668889999999999999
Q ss_pred CCCCCCcCccCCCC---CcEeeccCceeeeecCCCCCCCchhhhh-hcccceeccCCeeeecCCc---cccCCcccceee
Q 002774 76 FSGRVPPSIGNLSN---LYWLDLTDNKLEGEIPVSDGNSPGLDML-VRAKHFHFGKNQLSGSIPE---KLFRPDMVLIHV 148 (882)
Q Consensus 76 i~~~~~~~~~~l~~---L~~L~Ls~N~i~~~~p~~~~~~~~l~~L-~~L~~L~L~~N~l~~~ip~---~~f~~~~~L~~L 148 (882)
+.+..+..+..+.+ |++|++++|++++.....+ ...+..+ ++|+.|++++|.+++.... ..|..+..|+.|
T Consensus 93 ~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l--~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L 170 (319)
T cd00116 93 LGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLL--AKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKEL 170 (319)
T ss_pred CChhHHHHHHHHhccCcccEEEeeCCccchHHHHHH--HHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEE
Confidence 98766666666655 9999999999873111111 1234455 7899999999999843222 234556789999
Q ss_pred eccCCccccc----CCccccCCCCCCEEEccCCCCCCC----CCccCCCCCCCCEEEccCCcccccCC-CC-----CCCC
Q 002774 149 LFDSNNLTGE----LPATLGLVKSLEVVRFDRNSLSGP----VPSNLNNLTSVNDLYLSNNKLTGAMP-NL-----TGLS 214 (882)
Q Consensus 149 ~L~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~~~~-~~-----~~l~ 214 (882)
++++|.+++. ++..+..+++|+.|+|++|.+.+. +...+..+++|+.|++++|.+++... .+ ...+
T Consensus 171 ~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~ 250 (319)
T cd00116 171 NLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNI 250 (319)
T ss_pred ECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHHHHHHhccCC
Confidence 9999999853 344566778999999999999744 34567788999999999999986322 11 1358
Q ss_pred CCCEEECcCCCCCC---CCCCccccCCCCCCEEECcCCccccc----CCccCCCC-CCCCEEEccCCcc
Q 002774 215 VLSYLDMSNNSFDA---SEVPSWFSSMQSLTTLMMENTNLKGQ----IPADLFSI-PHLQTVVMKTNEL 275 (882)
Q Consensus 215 ~L~~L~Ls~N~l~~---~~~p~~~~~l~~L~~L~Ls~N~l~~~----~~~~~~~l-~~L~~L~Ls~N~l 275 (882)
.|+.|++++|.++. ..+...+..+++|++|++++|.++.. ....+... +.|++|++.+|++
T Consensus 251 ~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (319)
T cd00116 251 SLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDDSF 319 (319)
T ss_pred CceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCCCC
Confidence 99999999999952 12344567778999999999999954 45555555 7899999999875
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.65 E-value=3.5e-16 Score=162.60 Aligned_cols=196 Identities=21% Similarity=0.282 Sum_probs=135.5
Q ss_pred cCCCeeeEEEEEEe---------------------------CCceEEEEEeecCCCcccccCCCCCccccHHHHHHHHHH
Q 002774 609 HHKNLVSLLGFCFD---------------------------RGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALG 661 (882)
Q Consensus 609 ~H~niv~l~~~~~~---------------------------~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ 661 (882)
+|||||++.++|.+ +...|+||.-.+ .+|.+++..+. .+.....-|..|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~~---~s~r~~~~~laQ 349 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTRH---RSYRTGRVILAQ 349 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcCC---CchHHHHHHHHH
Confidence 59999999987653 234688887764 48888886553 555667778999
Q ss_pred HHHHHhhhhhcCCCCeeecCCCCCceEE--cCCC--ceeEeecccccccCCCC----CceeeeeeeccCCCCCHHHHhhC
Q 002774 662 AARGLSYLHELANPPIIHRDIKSSNILL--DERL--NAKVADFGLSKSMSDSE----KDHITTQVKGTMGYLDPEYYMTQ 733 (882)
Q Consensus 662 ia~gL~yLH~~~~~~ivHrDlk~~NIll--~~~~--~~kl~DfGla~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~ 733 (882)
+++|+.|||.+| |.|||+|++|||+ |+|+ ...|+|||.+---.... ........-|.-.-||||+....
T Consensus 350 lLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~ 426 (598)
T KOG4158|consen 350 LLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAV 426 (598)
T ss_pred HHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcC
Confidence 999999999999 9999999999999 4443 46889999874221100 00011123467789999998743
Q ss_pred C------CCchhHHHHHHHHHHHHHhCCCCCCC-CchHHHHHHHHHHhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHH
Q 002774 734 Q------LTEKSDVYSFGVLMLELLTGRRPIER-GKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLAL 806 (882)
Q Consensus 734 ~------~~~~sDv~S~Gvll~el~tg~~P~~~-~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~ 806 (882)
. --.|+|.|+.|.+.||+++...||.. ++...+. +. ..+.--|.+ +..++..+.+++.
T Consensus 427 PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~-r~----------Yqe~qLPal----p~~vpp~~rqlV~ 491 (598)
T KOG4158|consen 427 PGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDT-RT----------YQESQLPAL----PSRVPPVARQLVF 491 (598)
T ss_pred CCCceeeccchhhhhhhhhhHHHHhccCCcccccchheech-hh----------hhhhhCCCC----cccCChHHHHHHH
Confidence 2 23589999999999999999999975 2221111 11 111111222 2234467789999
Q ss_pred HhhccCCCCCCCHHHHHHHH
Q 002774 807 KCVQESGDDRPTMSEVVKDI 826 (882)
Q Consensus 807 ~cl~~dp~~RPs~~evl~~L 826 (882)
..++.||.+|+++.-....+
T Consensus 492 ~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 492 DLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred HHhcCCccccCCccHHHhHH
Confidence 99999999999876555543
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.60 E-value=9.9e-15 Score=141.09 Aligned_cols=135 Identities=19% Similarity=0.210 Sum_probs=115.1
Q ss_pred CCCeeeccCcEEEEEEEecCCcEEEEEEcccCCcccHHHHHHHHHHHHhccC--CCeeeEEEEEEeCCceEEEEEeecCC
Q 002774 559 DANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHH--KNLVSLLGFCFDRGEQMLIYEFVPNG 636 (882)
Q Consensus 559 ~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~~~~~~~~~~~lV~e~~~~g 636 (882)
..+.||+|.++.||++...+ ..+++|....... ...+.+|+.+++.++| .++.+++++...++..+++|||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 35679999999999999854 7899999876433 4678999999999976 58999999888888899999999988
Q ss_pred CcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccc
Q 002774 637 SLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKS 705 (882)
Q Consensus 637 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~ 705 (882)
.+..+ +......++.+++++++++|.....+++|+|++|+||++++.+.+++.|||.++.
T Consensus 79 ~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 77654 4556778899999999999986445599999999999999999999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.60 E-value=5.8e-15 Score=148.86 Aligned_cols=137 Identities=18% Similarity=0.238 Sum_probs=100.0
Q ss_pred CCeeeccCcEEEEEEEecCCcEEEEEEcccCCccc--HHH----------------------HHHHHHHHHhccCCC--e
Q 002774 560 ANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQG--GQE----------------------FKMEIELLSRVHHKN--L 613 (882)
Q Consensus 560 ~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~--~~~----------------------~~~E~~~l~~l~H~n--i 613 (882)
.+.||+|+||+||+|...+|+.||||+++...... ... ...|.+.+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 46799999999999998789999999987532211 111 134666666665432 4
Q ss_pred eeEEEEEEeCCceEEEEEeecCCCcccc-cCCCCCccccHHHHHHHHHHHHHHHhhhhh-cCCCCeeecCCCCCceEEcC
Q 002774 614 VSLLGFCFDRGEQMLIYEFVPNGSLGDS-LSGKNGIRLDWIRRLKIALGAARGLSYLHE-LANPPIIHRDIKSSNILLDE 691 (882)
Q Consensus 614 v~l~~~~~~~~~~~lV~e~~~~gsL~~~-l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDlk~~NIll~~ 691 (882)
.+.+++ ...++||||++++++... +.... .. .+...++.+++.++.++|. .+ |+||||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~- 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD- 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-
Confidence 444443 246899999999654322 21111 11 5667899999999999999 77 99999999999999
Q ss_pred CCceeEeecccccccCC
Q 002774 692 RLNAKVADFGLSKSMSD 708 (882)
Q Consensus 692 ~~~~kl~DfGla~~~~~ 708 (882)
++.++++|||.+.....
T Consensus 150 ~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 150 DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred CCcEEEEECcccccccC
Confidence 89999999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.53 E-value=4.4e-14 Score=147.32 Aligned_cols=135 Identities=20% Similarity=0.206 Sum_probs=105.2
Q ss_pred CCeee-ccCcEEEEEEEecCCcEEEEEEcccCC-------------cccHHHHHHHHHHHHhccCCCe--eeEEEEEEeC
Q 002774 560 ANDVG-SGGYGKVYKGTLPNGQLIAIKRAQQGS-------------MQGGQEFKMEIELLSRVHHKNL--VSLLGFCFDR 623 (882)
Q Consensus 560 ~~~lG-~G~fg~Vy~~~~~~g~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~H~ni--v~l~~~~~~~ 623 (882)
...|| .|+.|+||++... +..++||++.... ......+.+|++++.+++|++| ++.+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 45788 8999999999875 6789999885321 1122457889999999998775 6777765443
Q ss_pred Cc----eEEEEEeecC-CCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEe
Q 002774 624 GE----QMLIYEFVPN-GSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVA 698 (882)
Q Consensus 624 ~~----~~lV~e~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~ 698 (882)
.. .++||||+++ .+|.+++... .++.. .+.+++.++.+||+.| |+||||||.|||++.++.++|+
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~---~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LI 184 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA---PLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLI 184 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC---CCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEE
Confidence 22 2599999997 6888887543 24432 3568899999999999 9999999999999999999999
Q ss_pred ecccccc
Q 002774 699 DFGLSKS 705 (882)
Q Consensus 699 DfGla~~ 705 (882)
|||.++.
T Consensus 185 Dfg~~~~ 191 (239)
T PRK01723 185 DFDRGEL 191 (239)
T ss_pred ECCCccc
Confidence 9998875
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.53 E-value=9.4e-16 Score=178.85 Aligned_cols=256 Identities=22% Similarity=0.272 Sum_probs=189.3
Q ss_pred CCCCCCeeeccCcEEEEEEEec--CCcEEEEEEcccCC--cccHHHHHHHHHHHHhcc-CCCeeeEEEEEEeCCceEEEE
Q 002774 556 NFSDANDVGSGGYGKVYKGTLP--NGQLIAIKRAQQGS--MQGGQEFKMEIELLSRVH-HKNLVSLLGFCFDRGEQMLIY 630 (882)
Q Consensus 556 ~~~~~~~lG~G~fg~Vy~~~~~--~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~ 630 (882)
.|...+.||+|+|+.|-..... ....+|+|.+.... .........|..+-..+. |+|++.+++...+.+..+++.
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~ 100 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL 100 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence 4556677999999999887653 34567777765443 122233445777777776 999999999999999999999
Q ss_pred EeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhh-hcCCCCeeecCCCCCceEEcCCC-ceeEeecccccccCC
Q 002774 631 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLH-ELANPPIIHRDIKSSNILLDERL-NAKVADFGLSKSMSD 708 (882)
Q Consensus 631 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~ivHrDlk~~NIll~~~~-~~kl~DfGla~~~~~ 708 (882)
+|..++++.+-+........+....-....|+..++.|+| ..+ +.|||+||+|.+++..+ ..+++|||+|..+..
T Consensus 101 ~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 101 SYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred CcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhccccc
Confidence 9999999999883222213445566678899999999999 888 99999999999999999 999999999998877
Q ss_pred -CCCceeeeeeec-cCCCCCHHHHhhC-CCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhhhhcc
Q 002774 709 -SEKDHITTQVKG-TMGYLDPEYYMTQ-QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELI 785 (882)
Q Consensus 709 -~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 785 (882)
.+.........| ++.|+|||...+. -.....|+||.|+++.-+++|..|+..................
T Consensus 178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~--------- 248 (601)
T KOG0590|consen 178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKG--------- 248 (601)
T ss_pred cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeeccccc---------
Confidence 555555566778 9999999999875 4456789999999999999999998754332211111111100
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 786 DPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 786 d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
...............++..+++..+|..|.+.+++-.+
T Consensus 249 --~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d 286 (601)
T KOG0590|consen 249 --RFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLD 286 (601)
T ss_pred --ccccCccccCChhhhhcccccccCCchhcccccccccc
Confidence 00001111222456788889999999999999888754
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.44 E-value=3.7e-13 Score=152.58 Aligned_cols=145 Identities=20% Similarity=0.254 Sum_probs=102.1
Q ss_pred CCCCCCeeeccCcEEEEEEEecCCcEEEEEEcccCCccc----------------------------------------H
Q 002774 556 NFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQG----------------------------------------G 595 (882)
Q Consensus 556 ~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~----------------------------------------~ 595 (882)
.|+ .+.||+|++|.||+|++.+|+.||||+.+...... +
T Consensus 119 ~fd-~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~E 197 (437)
T TIGR01982 119 EFE-EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRE 197 (437)
T ss_pred hCC-CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHH
Confidence 344 36899999999999999999999999986542110 0
Q ss_pred HHHHHHHHHHHhcc----CCCeeeEEEEE-EeCCceEEEEEeecCCCcccccCCCCCccccHHHHHHHHHHHHH-HHhhh
Q 002774 596 QEFKMEIELLSRVH----HKNLVSLLGFC-FDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAAR-GLSYL 669 (882)
Q Consensus 596 ~~~~~E~~~l~~l~----H~niv~l~~~~-~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~-gL~yL 669 (882)
-+|.+|++.+.+++ |.+-+.+-..+ ......+|||||+++++|.+....... .. .+..++..++. .+..+
T Consensus 198 ldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~-~~---~~~~ia~~~~~~~l~ql 273 (437)
T TIGR01982 198 LDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA-GL---DRKALAENLARSFLNQV 273 (437)
T ss_pred HCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc-CC---CHHHHHHHHHHHHHHHH
Confidence 02445665555552 32223332222 224467999999999999887643211 12 23456666665 46788
Q ss_pred hhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCC
Q 002774 670 HELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSD 708 (882)
Q Consensus 670 H~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~ 708 (882)
|..| ++|+|+||.||+++++++++++|||++..+.+
T Consensus 274 ~~~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 274 LRDG---FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred HhCC---ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 9888 99999999999999999999999999987643
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.41 E-value=2e-13 Score=151.85 Aligned_cols=248 Identities=22% Similarity=0.207 Sum_probs=182.1
Q ss_pred CCCCCCeeec--cCcEEEEEEEe---cCCcEEEEEEcccC--CcccHHHHHHHHHHHHhcc-CCCeeeEEEEEEeCCceE
Q 002774 556 NFSDANDVGS--GGYGKVYKGTL---PNGQLIAIKRAQQG--SMQGGQEFKMEIELLSRVH-HKNLVSLLGFCFDRGEQM 627 (882)
Q Consensus 556 ~~~~~~~lG~--G~fg~Vy~~~~---~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~ 627 (882)
.|.....+|+ |.+|.||.+.. .++..+|+|+-+.. .......=.+|+....+++ |+|.++....+.+.+..+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 4567788999 99999999986 36889999984432 2233344456777777774 999999999999999999
Q ss_pred EEEEeecCCCcccccCCCCCccccHHHHHHHHHHHHH----HHhhhhhcCCCCeeecCCCCCceEEcCC-CceeEeeccc
Q 002774 628 LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAAR----GLSYLHELANPPIIHRDIKSSNILLDER-LNAKVADFGL 702 (882)
Q Consensus 628 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~----gL~yLH~~~~~~ivHrDlk~~NIll~~~-~~~kl~DfGl 702 (882)
+-+|++. .+|.++.+.... .++....+....+... |+.++|... ++|-|+||.||++..+ ..++++|||+
T Consensus 195 iqtE~~~-~sl~~~~~~~~~-~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df~~ 269 (524)
T KOG0601|consen 195 IQTELCG-ESLQSYCHTPCN-FLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDFGL 269 (524)
T ss_pred eeecccc-chhHHhhhcccc-cCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCcce
Confidence 9999984 677777765432 2455566666666666 999999988 9999999999999999 8999999999
Q ss_pred ccccCCCCCceeee---eeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhh
Q 002774 703 SKSMSDSEKDHITT---QVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELY 779 (882)
Q Consensus 703 a~~~~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~ 779 (882)
...+.+........ ...|...|++||.. .+.++.++|+|++|.+..|..++..+...+.+. .|. .
T Consensus 270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~-~W~-----~----- 337 (524)
T KOG0601|consen 270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKNS-SWS-----Q----- 337 (524)
T ss_pred eEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCCC-Ccc-----c-----
Confidence 99887765332221 22577889999986 567789999999999999999988776544211 000 0
Q ss_pred hhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002774 780 NLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVK 824 (882)
Q Consensus 780 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~ 824 (882)
+.... +...+......++...+..|++.+|..|++.+.+..
T Consensus 338 -~r~~~---ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 338 -LRQGY---IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred -ccccc---CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 00000 111111122245556899999999999999988875
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.40 E-value=6.5e-15 Score=159.97 Aligned_cols=177 Identities=32% Similarity=0.438 Sum_probs=106.6
Q ss_pred CEEEccCCcCCCCCCcCccCCCCCcEeeccCceeeeecCCCCCCCchhhhhhcccceeccCCeeeecCCccccCCcccce
Q 002774 67 VLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLI 146 (882)
Q Consensus 67 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~~~~l~~L~~L~~L~L~~N~l~~~ip~~~f~~~~~L~ 146 (882)
...||+.|++. .+|..+..+..|+.|.|.+|.|. .+|..+.+ |..|++|+|+.|+++ .+|..++... |+
T Consensus 78 ~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~------L~~lt~l~ls~NqlS-~lp~~lC~lp--Lk 146 (722)
T KOG0532|consen 78 VFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICN------LEALTFLDLSSNQLS-HLPDGLCDLP--LK 146 (722)
T ss_pred hhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhh------hhHHHHhhhccchhh-cCChhhhcCc--ce
Confidence 33444444444 44444444444444444444444 34433322 233333444444444 5555554432 66
Q ss_pred eeeccCCcccccCCccccCCCCCCEEEccCCCCCCCCCccCCCCCCCCEEEccCCcccccCCCCCCCCCCCEEECcCCCC
Q 002774 147 HVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSF 226 (882)
Q Consensus 147 ~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l 226 (882)
.|.+++|+++ .+|..++.+.+|..||.+.|.|. .+|..++++.+|+.|.+..|++..+++++. .-.|..||+|.|++
T Consensus 147 vli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~~lp~El~-~LpLi~lDfScNki 223 (722)
T KOG0532|consen 147 VLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLEDLPEELC-SLPLIRLDFSCNKI 223 (722)
T ss_pred eEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhhhCCHHHh-CCceeeeecccCce
Confidence 6666777766 56666667777777777777777 677777777777777777777777777766 34567777777777
Q ss_pred CCCCCCccccCCCCCCEEECcCCcccccCCccCC
Q 002774 227 DASEVPSWFSSMQSLTTLMMENTNLKGQIPADLF 260 (882)
Q Consensus 227 ~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 260 (882)
+ .+|..|..|+.|++|-|.+|.|. ..|..+.
T Consensus 224 s--~iPv~fr~m~~Lq~l~LenNPLq-SPPAqIC 254 (722)
T KOG0532|consen 224 S--YLPVDFRKMRHLQVLQLENNPLQ-SPPAQIC 254 (722)
T ss_pred e--ecchhhhhhhhheeeeeccCCCC-CChHHHH
Confidence 4 46777777777777777777776 4444433
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.37 E-value=1.9e-14 Score=156.42 Aligned_cols=194 Identities=26% Similarity=0.355 Sum_probs=153.1
Q ss_pred CCCCcEEEeeCCcCCccccccccCCCCCCEEEccCCcCCCCCCcCccCCCCCcEeeccCceeeeecCCCCCCCchhhhhh
Q 002774 39 LKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLV 118 (882)
Q Consensus 39 l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~~~~l~~L~ 118 (882)
+.--...+|+.|++. .+|..+..+..|+.|.|++|.|. .+|..+.+|..|+.|||+.|+++ .+|..+..++
T Consensus 74 ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp------ 144 (722)
T KOG0532|consen 74 LTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP------ 144 (722)
T ss_pred ccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc------
Confidence 444456777888887 77777777777888888888887 67777888888888888888877 6666555432
Q ss_pred cccceeccCCeeeecCCccccCCcccceeeeccCCcccccCCccccCCCCCCEEEccCCCCCCCCCccCCCCCCCCEEEc
Q 002774 119 RAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYL 198 (882)
Q Consensus 119 ~L~~L~L~~N~l~~~ip~~~f~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 198 (882)
|+.|-+++|+++ .+|+++- ....|..|+.+.|++. .+|..++.+.+|+.|.+..|++. .+|..+. .-.|..||+
T Consensus 145 -Lkvli~sNNkl~-~lp~~ig-~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~-~LpLi~lDf 218 (722)
T KOG0532|consen 145 -LKVLIVSNNKLT-SLPEEIG-LLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELC-SLPLIRLDF 218 (722)
T ss_pred -ceeEEEecCccc-cCCcccc-cchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHh-CCceeeeec
Confidence 677778888887 8888887 7888999999999998 67778999999999999999999 6777777 456899999
Q ss_pred cCCcccccCCCCCCCCCCCEEECcCCCCCCCCCCccccCCCC---CCEEECcCC
Q 002774 199 SNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQS---LTTLMMENT 249 (882)
Q Consensus 199 s~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~---L~~L~Ls~N 249 (882)
|.|++..+|-.|..|..|++|-|.+|.++ ..|..+...-. .++|+..-+
T Consensus 219 ScNkis~iPv~fr~m~~Lq~l~LenNPLq--SPPAqIC~kGkVHIFKyL~~qA~ 270 (722)
T KOG0532|consen 219 SCNKISYLPVDFRKMRHLQVLQLENNPLQ--SPPAQICEKGKVHIFKYLSTQAC 270 (722)
T ss_pred ccCceeecchhhhhhhhheeeeeccCCCC--CChHHHHhccceeeeeeecchhc
Confidence 99999999999999999999999999996 46666543322 455555555
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.36 E-value=9.3e-13 Score=149.26 Aligned_cols=201 Identities=32% Similarity=0.444 Sum_probs=139.6
Q ss_pred EEEeeCCcCCccccccccCCCCCCEEEccCCcCCCCCCcCccCCC-CCcEeeccCceeeeecCCCCCCCchhhhhhcccc
Q 002774 44 NLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLS-NLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKH 122 (882)
Q Consensus 44 ~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~-~L~~L~Ls~N~i~~~~p~~~~~~~~l~~L~~L~~ 122 (882)
.|.++.|.+. .....+..++.++.|++.+|.++ .++.....++ +|+.|++++|++. .+| ..+..++.|+.
T Consensus 97 ~l~~~~~~~~-~~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~------~~~~~l~~L~~ 167 (394)
T COG4886 97 SLDLNLNRLR-SNISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLP------SPLRNLPNLKN 167 (394)
T ss_pred eeeccccccc-cCchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhh------hhhhccccccc
Confidence 5677777664 23334555567777777777777 4555555553 7777777777776 333 23455666677
Q ss_pred eeccCCeeeecCCccccCCcccceeeeccCCcccccCCccccCCCCCCEEEccCCCCCCCCCccCCCCCCCCEEEccCCc
Q 002774 123 FHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNK 202 (882)
Q Consensus 123 L~L~~N~l~~~ip~~~f~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~ 202 (882)
|++++|+++ .+|.... ..++|+.|++++|+++ .+|.....+..|++|++++|.+. ..+..+.++.++..|.+++|+
T Consensus 168 L~l~~N~l~-~l~~~~~-~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~ 243 (394)
T COG4886 168 LDLSFNDLS-DLPKLLS-NLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNK 243 (394)
T ss_pred cccCCchhh-hhhhhhh-hhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCce
Confidence 777777777 6665432 4567777888888777 45555555666888888888655 567778888888888888888
Q ss_pred ccccCCCCCCCCCCCEEECcCCCCCCCCCCccccCCCCCCEEECcCCcccccCCccCC
Q 002774 203 LTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLF 260 (882)
Q Consensus 203 l~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 260 (882)
+...+..+..+++|++|++++|.++ .++. +..+.+|+.|++++|.+....+....
T Consensus 244 ~~~~~~~~~~l~~l~~L~~s~n~i~--~i~~-~~~~~~l~~L~~s~n~~~~~~~~~~~ 298 (394)
T COG4886 244 LEDLPESIGNLSNLETLDLSNNQIS--SISS-LGSLTNLRELDLSGNSLSNALPLIAL 298 (394)
T ss_pred eeeccchhccccccceecccccccc--cccc-ccccCccCEEeccCccccccchhhhc
Confidence 8877666778888888888888885 3444 78888888888888888855555433
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.36 E-value=7.5e-13 Score=150.01 Aligned_cols=246 Identities=28% Similarity=0.389 Sum_probs=148.6
Q ss_pred EEeccCCCCCccCCCccccCCCCCcEEEeeCCcCCccccccccCCCCCCEEEccCCcCCCCCCcCccCCCCCcEeeccCc
Q 002774 19 TLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDN 98 (882)
Q Consensus 19 ~L~L~~n~~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N 98 (882)
.+.+..+. ....+..+.....+....-+.+..- ...........+..|++..|.+. .....+..++.++.|++.+|
T Consensus 51 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~l-~~~~~~~~~~~~~~l~~~~~~~~-~~~~~~~~~~~l~~L~l~~n 126 (394)
T COG4886 51 ALNLSSNT--LLLLPSSLSRLLSLDLLSPSGISSL-DGSENLLNLLPLPSLDLNLNRLR-SNISELLELTNLTSLDLDNN 126 (394)
T ss_pred cccCCcch--hhhhhcchhhhhhhcccCcCCcccc-cccccccCCCCCceeeccccccc-cCchhhhcccceeEEecCCc
Confidence 34444432 4445555554444444433322222 11122222222347999999985 34555777799999999999
Q ss_pred eeeeecCCCCCCCchhhhhhcccceeccCCeeeecCCccccCCcccceeeeccCCcccccCCccccCCCCCCEEEccCCC
Q 002774 99 KLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNS 178 (882)
Q Consensus 99 ~i~~~~p~~~~~~~~l~~L~~L~~L~L~~N~l~~~ip~~~f~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 178 (882)
.++ .+|...+... .+|+.|++++|++. .+|. -...+++|+.|++++|+++ .+|...+.+++|+.|++++|+
T Consensus 127 ~i~-~i~~~~~~~~-----~nL~~L~l~~N~i~-~l~~-~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~ls~N~ 197 (394)
T COG4886 127 NIT-DIPPLIGLLK-----SNLKELDLSDNKIE-SLPS-PLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNK 197 (394)
T ss_pred ccc-cCccccccch-----hhcccccccccchh-hhhh-hhhccccccccccCCchhh-hhhhhhhhhhhhhheeccCCc
Confidence 998 5554433211 37788888888888 6642 2234667777777777777 334444466677777777777
Q ss_pred CCCCCCccCCCCCCCCEEEccCCcccccCCCCCCCCCCCEEECcCCCCCCCCCCccccCCCCCCEEECcCCcccccCCcc
Q 002774 179 LSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPAD 258 (882)
Q Consensus 179 l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~ 258 (882)
++ .+|.....+..|++|++++|.+...+..+..+.++..|.+++|++. ..+..+..+++|++|++++|.++ .++.
T Consensus 198 i~-~l~~~~~~~~~L~~l~~~~N~~~~~~~~~~~~~~l~~l~l~~n~~~--~~~~~~~~l~~l~~L~~s~n~i~-~i~~- 272 (394)
T COG4886 198 IS-DLPPEIELLSALEELDLSNNSIIELLSSLSNLKNLSGLELSNNKLE--DLPESIGNLSNLETLDLSNNQIS-SISS- 272 (394)
T ss_pred cc-cCchhhhhhhhhhhhhhcCCcceecchhhhhcccccccccCCceee--eccchhccccccceecccccccc-cccc-
Confidence 77 5555544555577777777765555555666666666667777663 33556666666777777777766 3333
Q ss_pred CCCCCCCCEEEccCCccceecCCC
Q 002774 259 LFSIPHLQTVVMKTNELNGTLDLG 282 (882)
Q Consensus 259 ~~~l~~L~~L~Ls~N~l~~~~~~~ 282 (882)
+..+.+|+.|++++|.+...++..
T Consensus 273 ~~~~~~l~~L~~s~n~~~~~~~~~ 296 (394)
T COG4886 273 LGSLTNLRELDLSGNSLSNALPLI 296 (394)
T ss_pred ccccCccCEEeccCccccccchhh
Confidence 666666777777776666554443
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.32 E-value=4.2e-13 Score=137.01 Aligned_cols=201 Identities=24% Similarity=0.319 Sum_probs=139.6
Q ss_pred HHHHHhccCCCeeeEEEEEEeCC-----ceEEEEEeecCCCcccccCCCC--CccccHHHHHHHHHHHHHHHhhhhhcCC
Q 002774 602 IELLSRVHHKNLVSLLGFCFDRG-----EQMLIYEFVPNGSLGDSLSGKN--GIRLDWIRRLKIALGAARGLSYLHELAN 674 (882)
Q Consensus 602 ~~~l~~l~H~niv~l~~~~~~~~-----~~~lV~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 674 (882)
.+-+-.+.|.|||+++.|+.+.. ...+++|||.-|++..+|++-. ...+......+|+-||..||.|||+. .
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~ 196 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-D 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-C
Confidence 44455667999999999987643 4689999999999999997532 34566677788999999999999996 5
Q ss_pred CCeeecCCCCCceEEcCCCceeEeecccccccCCC---CCceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHH
Q 002774 675 PPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDS---EKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLEL 751 (882)
Q Consensus 675 ~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el 751 (882)
|+|+|+++..+-|++..++-+|++--.-. ..... ..........+-++|.|||+-.....+.++|||+||+..+||
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~ap~-s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlem 275 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPD-STHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEM 275 (458)
T ss_pred CccccCCcchhheeecCCceEEecccCcc-ccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHH
Confidence 89999999999999999988887532111 01000 000111123467899999988777788899999999999999
Q ss_pred HhCCCCCCCCch--HHHH-HHHHHHhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002774 752 LTGRRPIERGKY--IVRE-IRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 752 ~tg~~P~~~~~~--~~~~-~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 825 (882)
.-+.---..+.. ..+. ...+. ...-++ .=..++.+|++..|..||+|.+++.+
T Consensus 276 ailEiq~tnseS~~~~ee~ia~~i---------~~len~------------lqr~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 276 AILEIQSTNSESKVEVEENIANVI---------IGLENG------------LQRGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred HHheeccCCCcceeehhhhhhhhe---------eeccCc------------cccCcCcccccCCCCCCcchhhhhcC
Confidence 876543211111 1110 00000 000010 11367889999999999999998854
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.30 E-value=1.8e-13 Score=144.80 Aligned_cols=161 Identities=22% Similarity=0.197 Sum_probs=68.0
Q ss_pred CCCCCCEEEccCCcCCCCCC--cCccCCCCCcEeeccCceeeeecCCCCCCCchhhhhhcccceeccCCeeeecCCcccc
Q 002774 62 SLQELVLLSLNSNGFSGRVP--PSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLF 139 (882)
Q Consensus 62 ~l~~L~~L~L~~N~i~~~~~--~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~~~~l~~L~~L~~L~L~~N~l~~~ip~~~f 139 (882)
++.+|+.+.|.+..+. ..+ .....+++++.|||++|-+....| -+.-.+.|++|+.|+|+.|++.--.....-
T Consensus 119 n~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~----v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~ 193 (505)
T KOG3207|consen 119 NLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFP----VLKIAEQLPSLENLNLSSNRLSNFISSNTT 193 (505)
T ss_pred hHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHH----HHHHHHhcccchhcccccccccCCccccch
Confidence 3344444444444444 222 233444555555555554431111 112223344444444444444311111111
Q ss_pred CCcccceeeeccCCccccc-CCccccCCCCCCEEEccCCCCCCCCCccCCCCCCCCEEEccCCcccccC--CCCCCCCCC
Q 002774 140 RPDMVLIHVLFDSNNLTGE-LPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAM--PNLTGLSVL 216 (882)
Q Consensus 140 ~~~~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~--~~~~~l~~L 216 (882)
..++.|+.|.|+.|+++.. +-..+..+++|+.|+|..|..-.........+..|+.|||++|.+.... .....++.|
T Consensus 194 ~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L 273 (505)
T KOG3207|consen 194 LLLSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGL 273 (505)
T ss_pred hhhhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccch
Confidence 1234455555555555421 1112334555555555555422233333344455555555555554443 224444455
Q ss_pred CEEECcCCCCC
Q 002774 217 SYLDMSNNSFD 227 (882)
Q Consensus 217 ~~L~Ls~N~l~ 227 (882)
..|+++.+.+.
T Consensus 274 ~~Lnls~tgi~ 284 (505)
T KOG3207|consen 274 NQLNLSSTGIA 284 (505)
T ss_pred hhhhccccCcc
Confidence 55555555444
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.30 E-value=4.1e-11 Score=137.32 Aligned_cols=145 Identities=15% Similarity=0.195 Sum_probs=95.0
Q ss_pred HHcCCCCCCeeeccCcEEEEEEEecC-CcEEEEEEcccCCcc----------------------------------cHH-
Q 002774 553 YTNNFSDANDVGSGGYGKVYKGTLPN-GQLIAIKRAQQGSMQ----------------------------------GGQ- 596 (882)
Q Consensus 553 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~----------------------------------~~~- 596 (882)
....|+. +.||+|++|.||+|++.+ |+.||||+.++.... -.+
T Consensus 118 ~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~ 196 (537)
T PRK04750 118 WFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKT 196 (537)
T ss_pred HHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHH
Confidence 3456776 789999999999999887 999999999754210 001
Q ss_pred -----HHHHHHHHHHhcc----CCCeeeEEEEEEe-CCceEEEEEeecCCCcccc--cCCCCC--ccccHHHHHHHHHHH
Q 002774 597 -----EFKMEIELLSRVH----HKNLVSLLGFCFD-RGEQMLIYEFVPNGSLGDS--LSGKNG--IRLDWIRRLKIALGA 662 (882)
Q Consensus 597 -----~~~~E~~~l~~l~----H~niv~l~~~~~~-~~~~~lV~e~~~~gsL~~~--l~~~~~--~~l~~~~~~~i~~~i 662 (882)
+|.+|+..+.+++ +.+.+.+=..+.+ ....+|||||++|+.+.+. +...+. ..+.......++.
T Consensus 197 l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~-- 274 (537)
T PRK04750 197 LHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFT-- 274 (537)
T ss_pred HHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHH--
Confidence 2344544444442 3333433333332 4567899999999999764 222210 1122222222333
Q ss_pred HHHHhhhhhcCCCCeeecCCCCCceEEcCCC----ceeEeecccccccCC
Q 002774 663 ARGLSYLHELANPPIIHRDIKSSNILLDERL----NAKVADFGLSKSMSD 708 (882)
Q Consensus 663 a~gL~yLH~~~~~~ivHrDlk~~NIll~~~~----~~kl~DfGla~~~~~ 708 (882)
.++..| ++|+|+||.||+++.++ ++++.|||++..+++
T Consensus 275 -----Qif~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 275 -----QVFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred -----HHHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 334567 99999999999999988 999999999886643
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.29 E-value=1.3e-11 Score=122.18 Aligned_cols=130 Identities=18% Similarity=0.130 Sum_probs=97.6
Q ss_pred CCeeeccCcEEEEEEEecCCcEEEEEEcccCCcccHHHHHHHHHHHHhccCCCee-eEEEEEEeCCceEEEEEeecCCCc
Q 002774 560 ANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLV-SLLGFCFDRGEQMLIYEFVPNGSL 638 (882)
Q Consensus 560 ~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~~~~~~~~~~~lV~e~~~~gsL 638 (882)
.+.|+.|.++.||+++.. ++.|++|....... ....+..|+++++.+.+.+++ +++++. ....++||||+++.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence 356889999999999875 77899999765432 223567899999998765554 444433 3346899999999887
Q ss_pred ccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcC--CCCeeecCCCCCceEEcCCCceeEeeccccc
Q 002774 639 GDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELA--NPPIIHRDIKSSNILLDERLNAKVADFGLSK 704 (882)
Q Consensus 639 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivHrDlk~~NIll~~~~~~kl~DfGla~ 704 (882)
.+.- .....++.+++++|+.||..+ ...++|+|++|.||+++ ++.++++|||.+.
T Consensus 79 ~~~~----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 79 LTED----------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred cccc----------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 6541 011245678999999999876 23369999999999999 6689999999876
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.24 E-value=7.7e-13 Score=150.24 Aligned_cols=246 Identities=23% Similarity=0.258 Sum_probs=182.2
Q ss_pred cCCCCCcEEEeeCCcCCccccccccCCCCCCEEEccCCcCCCCCCcCccCCCCCcEeeccCceeeeecCCCCCCCchhhh
Q 002774 37 GNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDM 116 (882)
Q Consensus 37 ~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~~~~l~~ 116 (882)
..+..++.+++..|.|. .+-..+..+.+|+.|++.+|+|.. +...+..+++|++|+|++|+|+ .+..+..
T Consensus 69 ~~l~~l~~l~l~~n~i~-~~~~~l~~~~~l~~l~l~~n~i~~-i~~~l~~~~~L~~L~ls~N~I~--------~i~~l~~ 138 (414)
T KOG0531|consen 69 ESLTSLKELNLRQNLIA-KILNHLSKLKSLEALDLYDNKIEK-IENLLSSLVNLQVLDLSFNKIT--------KLEGLST 138 (414)
T ss_pred HHhHhHHhhccchhhhh-hhhcccccccceeeeeccccchhh-cccchhhhhcchheeccccccc--------cccchhh
Confidence 45677888889999988 455568888999999999999983 4444788899999999999987 3455777
Q ss_pred hhcccceeccCCeeeecCCccccCCcccceeeeccCCcccccCC-ccccCCCCCCEEEccCCCCCCCCCccCCCCCCCCE
Q 002774 117 LVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELP-ATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVND 195 (882)
Q Consensus 117 L~~L~~L~L~~N~l~~~ip~~~f~~~~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~ 195 (882)
+..|+.|++.+|.|+ .+.. |..+..|+.+++++|++..+.+ . ...+.+|+.+++.+|.+.. ...+..+..+..
T Consensus 139 l~~L~~L~l~~N~i~-~~~~--~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~--i~~~~~~~~l~~ 212 (414)
T KOG0531|consen 139 LTLLKELNLSGNLIS-DISG--LESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIRE--IEGLDLLKKLVL 212 (414)
T ss_pred ccchhhheeccCcch-hccC--CccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhc--ccchHHHHHHHH
Confidence 777899999999998 5554 4457889999999999886655 3 5778899999999999873 334555566666
Q ss_pred EEccCCcccccCCCCCCCC--CCCEEECcCCCCCCCCCCccccCCCCCCEEECcCCcccccCCccCCCCCCCCEEEccCC
Q 002774 196 LYLSNNKLTGAMPNLTGLS--VLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTN 273 (882)
Q Consensus 196 L~Ls~N~l~~~~~~~~~l~--~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 273 (882)
+++..|.++.+.+ +..+. .|+.+++++|.+. ..+..+..+.++..|++.+|++... ..+...+.+..+.+..|
T Consensus 213 ~~l~~n~i~~~~~-l~~~~~~~L~~l~l~~n~i~--~~~~~~~~~~~l~~l~~~~n~~~~~--~~~~~~~~~~~~~~~~~ 287 (414)
T KOG0531|consen 213 LSLLDNKISKLEG-LNELVMLHLRELYLSGNRIS--RSPEGLENLKNLPVLDLSSNRISNL--EGLERLPKLSELWLNDN 287 (414)
T ss_pred hhcccccceeccC-cccchhHHHHHHhcccCccc--cccccccccccccccchhhcccccc--ccccccchHHHhccCcc
Confidence 6888888875543 22223 4889999999985 3446677888899999999988732 23456677888888888
Q ss_pred cccee---cCC--CCcccccccccccCCccccccC
Q 002774 274 ELNGT---LDL--GTSYSENLLVNLQNNRISAYTE 303 (882)
Q Consensus 274 ~l~~~---~~~--~~~~~~L~~L~L~~N~i~~~~~ 303 (882)
++... ... ......+..+.+.+|++.....
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (414)
T KOG0531|consen 288 KLALSEAISQEYITSAAPTLVTLTLELNPIRKISS 322 (414)
T ss_pred hhcchhhhhccccccccccccccccccCccccccc
Confidence 88742 222 3346777788888888877654
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.22 E-value=1.6e-12 Score=130.98 Aligned_cols=226 Identities=19% Similarity=0.193 Sum_probs=120.3
Q ss_pred CCCCEEeccCCC-------CCccCCCccccCCCCCcEEEeeCCcCCccccccccCCCCCCEEEccCCcCCCCCCcCccCC
Q 002774 15 TELHTLDLSNNK-------DLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNL 87 (882)
Q Consensus 15 ~~L~~L~L~~n~-------~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l 87 (882)
..|.+|-++.-+ ++...+|-.+.-+++|+.+.++.|.-. .+.+.-..-+.|++|...+..+.. .| .+-..
T Consensus 182 ~~l~~l~vs~~~~p~~~sni~~~~l~f~l~~f~~l~~~~~s~~~~~-~i~~~~~~kptl~t~~v~~s~~~~-~~-~l~pe 258 (490)
T KOG1259|consen 182 TQLVALVVTPVKDPIDRSNIIPNRLSFNLNAFRNLKTLKFSALSTE-NIVDIELLKPTLQTICVHNTTIQD-VP-SLLPE 258 (490)
T ss_pred hheeEEEecCCCCCCccccccccccccchHHhhhhheeeeeccchh-heeceeecCchhheeeeecccccc-cc-cccch
Confidence 445566555422 344556777778889999999988766 333333344789999888887762 22 22222
Q ss_pred CCCcEeeccCceeeeecCCCCCCCchhhhhhcccceeccCCeeeecCCccccCCcccceeeeccCCcccccCCccccCCC
Q 002774 88 SNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVK 167 (882)
Q Consensus 88 ~~L~~L~Ls~N~i~~~~p~~~~~~~~l~~L~~L~~L~L~~N~l~~~ip~~~f~~~~~L~~L~L~~N~l~~~~~~~~~~l~ 167 (882)
+.+..+.-+.-... .-....++|. ...|+.|+||+|.|+ .+-.+..-.+
T Consensus 259 ~~~~D~~~~E~~t~-------------------------~G~~~~~~dT-----Wq~LtelDLS~N~I~-~iDESvKL~P 307 (490)
T KOG1259|consen 259 TILADPSGSEPSTS-------------------------NGSALVSADT-----WQELTELDLSGNLIT-QIDESVKLAP 307 (490)
T ss_pred hhhcCccCCCCCcc-------------------------CCceEEecch-----Hhhhhhccccccchh-hhhhhhhhcc
Confidence 33322222111100 0000001111 123444444444444 3334455566
Q ss_pred CCCEEEccCCCCCCCCCccCCCCCCCCEEEccCCcccccCCCCCCCCCCCEEECcCCCCCCCCCCccccCCCCCCEEECc
Q 002774 168 SLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMME 247 (882)
Q Consensus 168 ~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls 247 (882)
.++.|++|+|.|.. + +.+..+++|+.||||+|.++.....-..+-+++.|.|++|.|.. -..+..|-+|..||++
T Consensus 308 kir~L~lS~N~i~~-v-~nLa~L~~L~~LDLS~N~Ls~~~Gwh~KLGNIKtL~La~N~iE~---LSGL~KLYSLvnLDl~ 382 (490)
T KOG1259|consen 308 KLRRLILSQNRIRT-V-QNLAELPQLQLLDLSGNLLAECVGWHLKLGNIKTLKLAQNKIET---LSGLRKLYSLVNLDLS 382 (490)
T ss_pred ceeEEeccccceee-e-hhhhhcccceEeecccchhHhhhhhHhhhcCEeeeehhhhhHhh---hhhhHhhhhheecccc
Confidence 66666666666662 2 23666666677777777666554444455666666666666631 2234455556666666
Q ss_pred CCcccccC-CccCCCCCCCCEEEccCCccceec
Q 002774 248 NTNLKGQI-PADLFSIPHLQTVVMKTNELNGTL 279 (882)
Q Consensus 248 ~N~l~~~~-~~~~~~l~~L~~L~Ls~N~l~~~~ 279 (882)
+|+|.... -..+++||-|++|.|.+|++.+.+
T Consensus 383 ~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~v 415 (490)
T KOG1259|consen 383 SNQIEELDEVNHIGNLPCLETLRLTGNPLAGSV 415 (490)
T ss_pred ccchhhHHHhcccccccHHHHHhhcCCCccccc
Confidence 66665321 234555666666666666655443
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.18 E-value=2.2e-12 Score=136.70 Aligned_cols=184 Identities=21% Similarity=0.251 Sum_probs=126.3
Q ss_pred cCCCCCcEEEeeCCcCCcccc--ccccCCCCCCEEEccCCcCCCC--CCcCccCCCCCcEeeccCceeeeecCCCCCCCc
Q 002774 37 GNLKKLSNLMLVGCSFSGPIP--DSIGSLQELVLLSLNSNGFSGR--VPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSP 112 (882)
Q Consensus 37 ~~l~~L~~L~L~~n~i~~~~~--~~~~~l~~L~~L~L~~N~i~~~--~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~~~ 112 (882)
.++.+|+.+.|.++.+. ..+ .....|++++.|||++|-+... +..-...|++|+.|+|+.|++..... +..
T Consensus 118 sn~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~----s~~ 192 (505)
T KOG3207|consen 118 SNLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFIS----SNT 192 (505)
T ss_pred hhHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCcc----ccc
Confidence 45777888888887776 333 3566788888888888877632 22234567888888888888762221 111
Q ss_pred hhhhhhcccceeccCCeeeecCCccccCCcccceeeeccCCcccccCCccccCCCCCCEEEccCCCCCCCCC--ccCCCC
Q 002774 113 GLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVP--SNLNNL 190 (882)
Q Consensus 113 ~l~~L~~L~~L~L~~N~l~~~ip~~~f~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p--~~l~~l 190 (882)
. ..++.|+.|.|++|.++..=-..+....++|+.|+|..|....+......-+..|++|||++|++-. .+ ...+.+
T Consensus 193 ~-~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~-~~~~~~~~~l 270 (505)
T KOG3207|consen 193 T-LLLSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLID-FDQGYKVGTL 270 (505)
T ss_pred h-hhhhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccc-cccccccccc
Confidence 1 1567788888888888732222344457889999999997554555566778899999999999873 33 466788
Q ss_pred CCCCEEEccCCcccccC-CC------CCCCCCCCEEECcCCCCC
Q 002774 191 TSVNDLYLSNNKLTGAM-PN------LTGLSVLSYLDMSNNSFD 227 (882)
Q Consensus 191 ~~L~~L~Ls~N~l~~~~-~~------~~~l~~L~~L~Ls~N~l~ 227 (882)
+.|+.|+++.+.|..+- ++ ....++|++|+++.|+|.
T Consensus 271 ~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~ 314 (505)
T KOG3207|consen 271 PGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIR 314 (505)
T ss_pred cchhhhhccccCcchhcCCCccchhhhcccccceeeecccCccc
Confidence 99999999999988653 22 234566677777777663
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.17 E-value=7e-11 Score=140.28 Aligned_cols=91 Identities=27% Similarity=0.470 Sum_probs=75.4
Q ss_pred CCCEEEccCCcccccCCC-CCCCCCCCEEECcCCCCCCCCCCccccCCCCCCEEECcCCcccccCCccCCCCCCCCEEEc
Q 002774 192 SVNDLYLSNNKLTGAMPN-LTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVM 270 (882)
Q Consensus 192 ~L~~L~Ls~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 270 (882)
.++.|+|++|.+++..+. +..+++|+.|+|++|.+++ .+|..+..+++|+.|+|++|++++.+|..+..|++|+.|+|
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g-~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~L 497 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRG-NIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNL 497 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccC-cCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEEC
Confidence 367888888888876664 7888888888888888875 67878888888999999999998888888888999999999
Q ss_pred cCCccceecCCCC
Q 002774 271 KTNELNGTLDLGT 283 (882)
Q Consensus 271 s~N~l~~~~~~~~ 283 (882)
++|++++.+|..+
T Consensus 498 s~N~l~g~iP~~l 510 (623)
T PLN03150 498 NGNSLSGRVPAAL 510 (623)
T ss_pred cCCcccccCChHH
Confidence 9998888666543
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.16 E-value=3.1e-12 Score=145.34 Aligned_cols=246 Identities=24% Similarity=0.313 Sum_probs=190.4
Q ss_pred CCCCCCEEeccCCCCCccCCCccccCCCCCcEEEeeCCcCCccccccccCCCCCCEEEccCCcCCCCCCcCccCCCCCcE
Q 002774 13 GLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYW 92 (882)
Q Consensus 13 ~l~~L~~L~L~~n~~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~ 92 (882)
.+..++.+.+..|. .+.+-..++.+++|+.|++.+|+|. .+...+..+++|++|+|++|+|+.+.+ +..++.|+.
T Consensus 70 ~l~~l~~l~l~~n~--i~~~~~~l~~~~~l~~l~l~~n~i~-~i~~~l~~~~~L~~L~ls~N~I~~i~~--l~~l~~L~~ 144 (414)
T KOG0531|consen 70 SLTSLKELNLRQNL--IAKILNHLSKLKSLEALDLYDNKIE-KIENLLSSLVNLQVLDLSFNKITKLEG--LSTLTLLKE 144 (414)
T ss_pred HhHhHHhhccchhh--hhhhhcccccccceeeeeccccchh-hcccchhhhhcchheeccccccccccc--hhhccchhh
Confidence 45677778888886 3344556888999999999999999 455558889999999999999996544 788888999
Q ss_pred eeccCceeeeecCCCCCCCchhhhhhcccceeccCCeeeecCCc-cccCCcccceeeeccCCcccccCCccccCCCCCCE
Q 002774 93 LDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPE-KLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEV 171 (882)
Q Consensus 93 L~Ls~N~i~~~~p~~~~~~~~l~~L~~L~~L~L~~N~l~~~ip~-~~f~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 171 (882)
|++++|.|+ ....+..+..|+.+++++|++. .++. . ...+.+++.+.+++|.+..+. .+..+..+..
T Consensus 145 L~l~~N~i~--------~~~~~~~l~~L~~l~l~~n~i~-~ie~~~-~~~~~~l~~l~l~~n~i~~i~--~~~~~~~l~~ 212 (414)
T KOG0531|consen 145 LNLSGNLIS--------DISGLESLKSLKLLDLSYNRIV-DIENDE-LSELISLEELDLGGNSIREIE--GLDLLKKLVL 212 (414)
T ss_pred heeccCcch--------hccCCccchhhhcccCCcchhh-hhhhhh-hhhccchHHHhccCCchhccc--chHHHHHHHH
Confidence 999999998 2345666889999999999999 6665 2 356778999999999987443 3445556666
Q ss_pred EEccCCCCCCCCCccCCCCC--CCCEEEccCCcccccCCCCCCCCCCCEEECcCCCCCCCCCCccccCCCCCCEEECcCC
Q 002774 172 VRFDRNSLSGPVPSNLNNLT--SVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENT 249 (882)
Q Consensus 172 L~Ls~N~l~~~~p~~l~~l~--~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N 249 (882)
+++..|.++..-+ +..+. .|+.|++++|.+......+..+..+..|++.+|++.. -..+.....+..+.+..|
T Consensus 213 ~~l~~n~i~~~~~--l~~~~~~~L~~l~l~~n~i~~~~~~~~~~~~l~~l~~~~n~~~~---~~~~~~~~~~~~~~~~~~ 287 (414)
T KOG0531|consen 213 LSLLDNKISKLEG--LNELVMLHLRELYLSGNRISRSPEGLENLKNLPVLDLSSNRISN---LEGLERLPKLSELWLNDN 287 (414)
T ss_pred hhcccccceeccC--cccchhHHHHHHhcccCccccccccccccccccccchhhccccc---cccccccchHHHhccCcc
Confidence 7999999983322 22333 3899999999999776678888999999999999964 233566778888899999
Q ss_pred ccccc---CCcc-CCCCCCCCEEEccCCccceecC
Q 002774 250 NLKGQ---IPAD-LFSIPHLQTVVMKTNELNGTLD 280 (882)
Q Consensus 250 ~l~~~---~~~~-~~~l~~L~~L~Ls~N~l~~~~~ 280 (882)
.+... .... ....+.+..+.+.+|++.....
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (414)
T KOG0531|consen 288 KLALSEAISQEYITSAAPTLVTLTLELNPIRKISS 322 (414)
T ss_pred hhcchhhhhccccccccccccccccccCccccccc
Confidence 87732 2222 5678899999999999987544
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.16 E-value=8.7e-12 Score=125.68 Aligned_cols=226 Identities=13% Similarity=0.186 Sum_probs=155.4
Q ss_pred CCCCCcEEEeeCCc--------CCccccccccCCCCCCEEEccCCcCCCCCCcCccCCCCCcEeeccCceeeeecCCCCC
Q 002774 38 NLKKLSNLMLVGCS--------FSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDG 109 (882)
Q Consensus 38 ~l~~L~~L~L~~n~--------i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~ 109 (882)
-..+|..|..+... +...+|-.+.-..+|+.+.++++.-. .+-+-...-|.|+++...+.-+. ..|.
T Consensus 180 f~~~l~~l~vs~~~~p~~~sni~~~~l~f~l~~f~~l~~~~~s~~~~~-~i~~~~~~kptl~t~~v~~s~~~-~~~~--- 254 (490)
T KOG1259|consen 180 FCTQLVALVVTPVKDPIDRSNIIPNRLSFNLNAFRNLKTLKFSALSTE-NIVDIELLKPTLQTICVHNTTIQ-DVPS--- 254 (490)
T ss_pred hhhheeEEEecCCCCCCccccccccccccchHHhhhhheeeeeccchh-heeceeecCchhheeeeeccccc-cccc---
Confidence 35678888876532 22344555556678888888887654 22222223377888888766554 1111
Q ss_pred CCchhhhhhcccceeccCCeeeecCCccccCCcccceeeeccCCcccccCCccccCCCCCCEEEccCCCCCCCCCccCCC
Q 002774 110 NSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNN 189 (882)
Q Consensus 110 ~~~~l~~L~~L~~L~L~~N~l~~~ip~~~f~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~ 189 (882)
|-... .+-+.+|.. ..-.+|..-..+.....|++||||+|.|+ .+.++..-
T Consensus 255 ----l~pe~--------------~~~D~~~~E----------~~t~~G~~~~~~dTWq~LtelDLS~N~I~-~iDESvKL 305 (490)
T KOG1259|consen 255 ----LLPET--------------ILADPSGSE----------PSTSNGSALVSADTWQELTELDLSGNLIT-QIDESVKL 305 (490)
T ss_pred ----ccchh--------------hhcCccCCC----------CCccCCceEEecchHhhhhhccccccchh-hhhhhhhh
Confidence 00000 011111111 01122333334555678999999999999 78888888
Q ss_pred CCCCCEEEccCCcccccCCCCCCCCCCCEEECcCCCCCCCCCCccccCCCCCCEEECcCCcccccCCccCCCCCCCCEEE
Q 002774 190 LTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVV 269 (882)
Q Consensus 190 l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 269 (882)
++.++.|++|+|.|..+.. +..+++|+.||||+|.++ .+..|-..|-+.+.|.|+.|.|. .-..+.+|-+|..||
T Consensus 306 ~Pkir~L~lS~N~i~~v~n-La~L~~L~~LDLS~N~Ls--~~~Gwh~KLGNIKtL~La~N~iE--~LSGL~KLYSLvnLD 380 (490)
T KOG1259|consen 306 APKLRRLILSQNRIRTVQN-LAELPQLQLLDLSGNLLA--ECVGWHLKLGNIKTLKLAQNKIE--TLSGLRKLYSLVNLD 380 (490)
T ss_pred ccceeEEeccccceeeehh-hhhcccceEeecccchhH--hhhhhHhhhcCEeeeehhhhhHh--hhhhhHhhhhheecc
Confidence 9999999999999986654 888999999999999995 46667778899999999999986 233466778899999
Q ss_pred ccCCccce--ecCCCCcccccccccccCCcccccc
Q 002774 270 MKTNELNG--TLDLGTSYSENLLVNLQNNRISAYT 302 (882)
Q Consensus 270 Ls~N~l~~--~~~~~~~~~~L~~L~L~~N~i~~~~ 302 (882)
+++|+|.. .....-+++-|+.+.|.+|+|..++
T Consensus 381 l~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~v 415 (490)
T KOG1259|consen 381 LSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSV 415 (490)
T ss_pred ccccchhhHHHhcccccccHHHHHhhcCCCccccc
Confidence 99999987 4445556888999999999988764
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.14 E-value=1.6e-12 Score=134.44 Aligned_cols=133 Identities=21% Similarity=0.264 Sum_probs=68.2
Q ss_pred cccceeeeccCCccccc----CCccccCCCCCCEEEccCCCCCCC----CCccCCCCCCCCEEEccCCcccccCC-----
Q 002774 142 DMVLIHVLFDSNNLTGE----LPATLGLVKSLEVVRFDRNSLSGP----VPSNLNNLTSVNDLYLSNNKLTGAMP----- 208 (882)
Q Consensus 142 ~~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~~~~----- 208 (882)
.+.|+.+...+|++... +...|...+.|+.+.++.|.|... +...|..+++|+.|||.+|.++....
T Consensus 156 ~~~Lrv~i~~rNrlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~Lak 235 (382)
T KOG1909|consen 156 KPKLRVFICGRNRLENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAK 235 (382)
T ss_pred CcceEEEEeeccccccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHH
Confidence 34566666666666532 223455666777777777776521 23445666777777777776653221
Q ss_pred CCCCCCCCCEEECcCCCCCCCCCCccc-----cCCCCCCEEECcCCcccc----cCCccCCCCCCCCEEEccCCcc
Q 002774 209 NLTGLSVLSYLDMSNNSFDASEVPSWF-----SSMQSLTTLMMENTNLKG----QIPADLFSIPHLQTVVMKTNEL 275 (882)
Q Consensus 209 ~~~~l~~L~~L~Ls~N~l~~~~~p~~~-----~~l~~L~~L~Ls~N~l~~----~~~~~~~~l~~L~~L~Ls~N~l 275 (882)
.+..+++|+.|+++++.++. .....| ...++|+.|.|.+|.|+. .+.......|.|..|+|++|++
T Consensus 236 aL~s~~~L~El~l~dcll~~-~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l 310 (382)
T KOG1909|consen 236 ALSSWPHLRELNLGDCLLEN-EGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRL 310 (382)
T ss_pred Hhcccchheeeccccccccc-ccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCcccc
Confidence 25555666666666666642 111111 123455555555555542 1122233344444444444444
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.14 E-value=2.8e-11 Score=134.96 Aligned_cols=250 Identities=19% Similarity=0.181 Sum_probs=180.3
Q ss_pred HHHHHcCCCCCCeeeccCcEEEEEEEec--CCcEEEEEEcccCCcccHHHH--HHHHHHHHhc-cCCCeeeEEEEEEeCC
Q 002774 550 VKKYTNNFSDANDVGSGGYGKVYKGTLP--NGQLIAIKRAQQGSMQGGQEF--KMEIELLSRV-HHKNLVSLLGFCFDRG 624 (882)
Q Consensus 550 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~--~g~~vavK~~~~~~~~~~~~~--~~E~~~l~~l-~H~niv~l~~~~~~~~ 624 (882)
....+.+|..+..||.|.|+.|++...+ ++..|++|.+.+.......+. ..|+-+...+ .|.+++.....|...+
T Consensus 260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r 339 (524)
T KOG0601|consen 260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR 339 (524)
T ss_pred ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccc
Confidence 4455678999999999999999998743 678999998876554433332 3466666666 4899999888888888
Q ss_pred ceEEEEEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCC-CceeEeecccc
Q 002774 625 EQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDER-LNAKVADFGLS 703 (882)
Q Consensus 625 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~-~~~kl~DfGla 703 (882)
..|+--||++++++...... ...++...++++..+++.++.++|+.. ++|+|+||+||++..+ +..+++|||.+
T Consensus 340 ~~~ip~e~~~~~s~~l~~~~--~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~ 414 (524)
T KOG0601|consen 340 QGYIPLEFCEGGSSSLRSVT--SQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCW 414 (524)
T ss_pred cccCchhhhcCcchhhhhHH--HHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccccccc
Confidence 88899999999988766522 235677788899999999999999888 9999999999999886 88899999998
Q ss_pred cccCCCCCceeeeeeeccCCCC--CHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhhhhhhhh
Q 002774 704 KSMSDSEKDHITTQVKGTMGYL--DPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNL 781 (882)
Q Consensus 704 ~~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 781 (882)
+.+.-. .......-+++ +|+......+..+.|+||||.-+.|.+++..--..+.. + ..+
T Consensus 415 t~~~~~-----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~---~-----------~~i 475 (524)
T KOG0601|consen 415 TRLAFS-----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ---S-----------LTI 475 (524)
T ss_pred ccccee-----cccccccccccccchhhccccccccccccccccccccccccCcccCccccc---c-----------eee
Confidence 743211 11122333444 55555577888999999999999999987643222111 0 001
Q ss_pred hhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 002774 782 YELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIEN 828 (882)
Q Consensus 782 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~ 828 (882)
..-.-+... ....++..+.+.+..+++..||.+.++..+.+.
T Consensus 476 ~~~~~p~~~-----~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 476 RSGDTPNLP-----GLKLQLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred ecccccCCC-----chHHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence 111111111 112567788899999999999999888765443
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.12 E-value=6.9e-10 Score=114.95 Aligned_cols=142 Identities=22% Similarity=0.321 Sum_probs=111.1
Q ss_pred CeeeccCcEEEEEEEecCCcEEEEEEcccCCc-ccHHHHHHHHHHHHhccC--CCeeeEEEEEEeCC---ceEEEEEeec
Q 002774 561 NDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSM-QGGQEFKMEIELLSRVHH--KNLVSLLGFCFDRG---EQMLIYEFVP 634 (882)
Q Consensus 561 ~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H--~niv~l~~~~~~~~---~~~lV~e~~~ 634 (882)
+.|+.|.++.||+++..+|+.+++|....... .....+..|+++++.+++ ..+.+++.+..... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 56899999999999987778999999765432 134578899999999975 44577777766542 5689999999
Q ss_pred CCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcC-----------------------------------------
Q 002774 635 NGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELA----------------------------------------- 673 (882)
Q Consensus 635 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~----------------------------------------- 673 (882)
+.++.+.+.. ..++..++..++.+++++|.+||+..
T Consensus 84 G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 84 GRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred CEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 9988886642 14677778888888888888888521
Q ss_pred ------------CCCeeecCCCCCceEEcC--CCceeEeecccccc
Q 002774 674 ------------NPPIIHRDIKSSNILLDE--RLNAKVADFGLSKS 705 (882)
Q Consensus 674 ------------~~~ivHrDlk~~NIll~~--~~~~kl~DfGla~~ 705 (882)
...++|+|+++.||+++. ++.+.|+||+.+..
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 245899999999999998 66789999998763
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.11 E-value=9.8e-10 Score=109.55 Aligned_cols=136 Identities=15% Similarity=0.132 Sum_probs=98.0
Q ss_pred CeeeccCcEEEEEEEecC-------CcEEEEEEcccCCc----------------------ccHHHHH----HHHHHHHh
Q 002774 561 NDVGSGGYGKVYKGTLPN-------GQLIAIKRAQQGSM----------------------QGGQEFK----MEIELLSR 607 (882)
Q Consensus 561 ~~lG~G~fg~Vy~~~~~~-------g~~vavK~~~~~~~----------------------~~~~~~~----~E~~~l~~ 607 (882)
..||.|.-+.||.|...+ +..+|||+.+.... ...+.+. +|++.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999998543 47999998753100 0112233 79999999
Q ss_pred cc--CCCeeeEEEEEEeCCceEEEEEeecCCCccc-ccCCCCCccccHHHHHHHHHHHHHHHhhh-hhcCCCCeeecCCC
Q 002774 608 VH--HKNLVSLLGFCFDRGEQMLIYEFVPNGSLGD-SLSGKNGIRLDWIRRLKIALGAARGLSYL-HELANPPIIHRDIK 683 (882)
Q Consensus 608 l~--H~niv~l~~~~~~~~~~~lV~e~~~~gsL~~-~l~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~ivHrDlk 683 (882)
+. .-++.+.+++ ...+|||||+.+..+.. .++. ..++..+...+..+++.+|.++ |..+ +||+||+
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd---~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDLs 152 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD---AKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADLS 152 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc---cccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCCC
Confidence 85 3455566654 46789999997654422 2222 1244455667789999999999 7888 9999999
Q ss_pred CCceEEcCCCceeEeecccccccC
Q 002774 684 SSNILLDERLNAKVADFGLSKSMS 707 (882)
Q Consensus 684 ~~NIll~~~~~~kl~DfGla~~~~ 707 (882)
+.||+++ ++.+.++|||.+....
T Consensus 153 ~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 153 EYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred HHHEEEE-CCcEEEEECCCceeCC
Confidence 9999997 4679999999887553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.07 E-value=6.3e-11 Score=115.71 Aligned_cols=85 Identities=28% Similarity=0.413 Sum_probs=22.4
Q ss_pred CCCCCEEEccCCcccccCCCCCCCCCCCEEECcCCCCCCCCCCccc-cCCCCCCEEECcCCcccccC-CccCCCCCCCCE
Q 002774 190 LTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWF-SSMQSLTTLMMENTNLKGQI-PADLFSIPHLQT 267 (882)
Q Consensus 190 l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~-~~~~~~l~~L~~ 267 (882)
+.+|+.|+|++|.|+.+ +.+..+++|+.|++++|+|+ .+...+ ..+++|+.|+|++|+|.... -..++.+++|+.
T Consensus 41 l~~L~~L~Ls~N~I~~l-~~l~~L~~L~~L~L~~N~I~--~i~~~l~~~lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~~ 117 (175)
T PF14580_consen 41 LDKLEVLDLSNNQITKL-EGLPGLPRLKTLDLSNNRIS--SISEGLDKNLPNLQELYLSNNKISDLNELEPLSSLPKLRV 117 (175)
T ss_dssp -TT--EEE-TTS--S---TT----TT--EEE--SS-----S-CHHHHHH-TT--EEE-TTS---SCCCCGGGGG-TT--E
T ss_pred hcCCCEEECCCCCCccc-cCccChhhhhhcccCCCCCC--ccccchHHhCCcCCEEECcCCcCCChHHhHHHHcCCCcce
Confidence 34444444444444432 23444444444444444443 122222 23444555555555544211 123444555555
Q ss_pred EEccCCccce
Q 002774 268 VVMKTNELNG 277 (882)
Q Consensus 268 L~Ls~N~l~~ 277 (882)
|+|.+|+++.
T Consensus 118 L~L~~NPv~~ 127 (175)
T PF14580_consen 118 LSLEGNPVCE 127 (175)
T ss_dssp EE-TT-GGGG
T ss_pred eeccCCcccc
Confidence 5555555543
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.07 E-value=3.2e-11 Score=117.78 Aligned_cols=56 Identities=21% Similarity=0.224 Sum_probs=20.0
Q ss_pred CCCCCEEEccCCCCCCC-CCccCCCCCCCCEEEccCCcccccCCC----CCCCCCCCEEEC
Q 002774 166 VKSLEVVRFDRNSLSGP-VPSNLNNLTSVNDLYLSNNKLTGAMPN----LTGLSVLSYLDM 221 (882)
Q Consensus 166 l~~L~~L~Ls~N~l~~~-~p~~l~~l~~L~~L~Ls~N~l~~~~~~----~~~l~~L~~L~L 221 (882)
+++|++|+|++|+|... .-..+..+++|+.|+|.+|.++....- +..+|+|+.||-
T Consensus 87 lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD~ 147 (175)
T PF14580_consen 87 LPNLQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLDG 147 (175)
T ss_dssp -TT--EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEETT
T ss_pred CCcCCEEECcCCcCCChHHhHHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhheeCC
Confidence 34444444444444421 123444555666666666665544321 445666666654
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.05 E-value=1.2e-09 Score=122.84 Aligned_cols=166 Identities=19% Similarity=0.218 Sum_probs=121.6
Q ss_pred ecCCcEEEEEEcccCCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEeecCCCcccccCCCCCccccHHHH
Q 002774 576 LPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRR 655 (882)
Q Consensus 576 ~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~ 655 (882)
..++..|.|...+...........+-++.|+.+|||||++++..+...+..|||+|-+. .|..++... .....
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l-----~~~~v 106 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL-----GKEEV 106 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh-----HHHHH
Confidence 44688888888876554333456778899999999999999999999999999999874 344444332 23344
Q ss_pred HHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCCCCceeeeeeeccCCCCCHHHHhhCCC
Q 002774 656 LKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQL 735 (882)
Q Consensus 656 ~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 735 (882)
.-.+.||+.||.+||+.+. ++|++|.-.-|++++.|+.||++|.++........ ......--..|..|+.+....
T Consensus 107 ~~Gl~qIl~AL~FL~~d~~--lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~- 181 (690)
T KOG1243|consen 107 CLGLFQILAALSFLNDDCN--LVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE- 181 (690)
T ss_pred HHHHHHHHHHHHHHhccCC--eeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc-
Confidence 5577899999999986553 99999999999999999999999998865432211 001111122356666543222
Q ss_pred CchhHHHHHHHHHHHHHhC
Q 002774 736 TEKSDVYSFGVLMLELLTG 754 (882)
Q Consensus 736 ~~~sDv~S~Gvll~el~tg 754 (882)
-..|.|-|||+++|++.|
T Consensus 182 -~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 -WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred -cchhhhhHHHHHHHHhCc
Confidence 346999999999999998
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.98 E-value=5e-10 Score=133.08 Aligned_cols=110 Identities=31% Similarity=0.469 Sum_probs=73.5
Q ss_pred CcEEEeeCCcCCccccccccCCCCCCEEEccCCcCCCCCCcCccCCCCCcEeeccCceeeeecCCCCCCCchhhhhhccc
Q 002774 42 LSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAK 121 (882)
Q Consensus 42 L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~~~~l~~L~~L~ 121 (882)
++.|+|++|.+++.+|..|..+++|+.|+|++|+|.+.+|..++++++|+.|+|++|+++|.+|..+++ |++|+
T Consensus 420 v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~------L~~L~ 493 (623)
T PLN03150 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQ------LTSLR 493 (623)
T ss_pred EEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhc------CCCCC
Confidence 566677777777666766777777777777777776666666777777777777777776666654433 45566
Q ss_pred ceeccCCeeeecCCccccCCcccceeeeccCCcccc
Q 002774 122 HFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTG 157 (882)
Q Consensus 122 ~L~L~~N~l~~~ip~~~f~~~~~L~~L~L~~N~l~~ 157 (882)
.|+|++|+++|.+|..+.....++..+++.+|....
T Consensus 494 ~L~Ls~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc 529 (623)
T PLN03150 494 ILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLC 529 (623)
T ss_pred EEECcCCcccccCChHHhhccccCceEEecCCcccc
Confidence 667777777777776655444566677788776543
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.97 E-value=8.4e-12 Score=129.14 Aligned_cols=241 Identities=20% Similarity=0.264 Sum_probs=174.7
Q ss_pred cccCCCCCCEEeccCCCCCccC----CCccccCCCCCcEEEeeCCcC---Ccccc-------ccccCCCCCCEEEccCCc
Q 002774 10 DITGLTELHTLDLSNNKDLRGP----LPTTIGNLKKLSNLMLVGCSF---SGPIP-------DSIGSLQELVLLSLNSNG 75 (882)
Q Consensus 10 ~~~~l~~L~~L~L~~n~~i~~~----~p~~~~~l~~L~~L~L~~n~i---~~~~~-------~~~~~l~~L~~L~L~~N~ 75 (882)
.+..+..+++|+||+|. +... +-..+.+.++|+..++++--. ...+| .++..+++|++||||+|-
T Consensus 25 ~~~~~~s~~~l~lsgnt-~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA 103 (382)
T KOG1909|consen 25 ELEPMDSLTKLDLSGNT-FGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNA 103 (382)
T ss_pred HhcccCceEEEeccCCc-hhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccc
Confidence 45567889999999997 3332 344467788899988886322 22333 345577899999999999
Q ss_pred CCCCCCcCc----cCCCCCcEeeccCceeeeecCCCCCC-C------chhhhhhcccceeccCCeeeecCC----ccccC
Q 002774 76 FSGRVPPSI----GNLSNLYWLDLTDNKLEGEIPVSDGN-S------PGLDMLVRAKHFHFGKNQLSGSIP----EKLFR 140 (882)
Q Consensus 76 i~~~~~~~~----~~l~~L~~L~Ls~N~i~~~~p~~~~~-~------~~l~~L~~L~~L~L~~N~l~~~ip----~~~f~ 140 (882)
|+...+..| ..+..|++|.|.+|.+.-.--..++. + .....-++|+++..+.|++. .-+ ...|+
T Consensus 104 ~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrle-n~ga~~~A~~~~ 182 (382)
T KOG1909|consen 104 FGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRLE-NGGATALAEAFQ 182 (382)
T ss_pred cCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeeccccc-cccHHHHHHHHH
Confidence 985444443 56789999999999986111111111 0 11112257899999999997 333 24667
Q ss_pred CcccceeeeccCCccccc----CCccccCCCCCCEEEccCCCCCCC----CCccCCCCCCCCEEEccCCcccccCC----
Q 002774 141 PDMVLIHVLFDSNNLTGE----LPATLGLVKSLEVVRFDRNSLSGP----VPSNLNNLTSVNDLYLSNNKLTGAMP---- 208 (882)
Q Consensus 141 ~~~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~~~~---- 208 (882)
..+.|+.+.+..|.|... +...|..+++|+.|||.+|.++.. +...+..+++|+.|++++|.++.-..
T Consensus 183 ~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~~Ga~a~~ 262 (382)
T KOG1909|consen 183 SHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLENEGAIAFV 262 (382)
T ss_pred hccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccccccccccHHHHH
Confidence 778999999999998733 345688999999999999999843 46778889999999999999986443
Q ss_pred -CC-CCCCCCCEEECcCCCCCCC---CCCccccCCCCCCEEECcCCccc
Q 002774 209 -NL-TGLSVLSYLDMSNNSFDAS---EVPSWFSSMQSLTTLMMENTNLK 252 (882)
Q Consensus 209 -~~-~~l~~L~~L~Ls~N~l~~~---~~p~~~~~l~~L~~L~Ls~N~l~ 252 (882)
.+ .+.++|+.|.|.+|.|+.. .+..+....+.|..|+|++|++.
T Consensus 263 ~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l~ 311 (382)
T KOG1909|consen 263 DALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRLG 311 (382)
T ss_pred HHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCccccc
Confidence 12 3489999999999999731 22334566899999999999993
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.96 E-value=4.6e-09 Score=100.80 Aligned_cols=131 Identities=20% Similarity=0.309 Sum_probs=97.6
Q ss_pred CeeeccCcEEEEEEEecCCcEEEEE-EcccCCccc-------HHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEEEe
Q 002774 561 NDVGSGGYGKVYKGTLPNGQLIAIK-RAQQGSMQG-------GQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEF 632 (882)
Q Consensus 561 ~~lG~G~fg~Vy~~~~~~g~~vavK-~~~~~~~~~-------~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 632 (882)
..+++|+-+.+|.+.+.+. .+++| ++++.-... ...-.+|+.++.+++--.|.--.=+..+.+...|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~g~-~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLGL-PAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeeccCc-ceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 3578999999999987543 45555 344332211 12346799999998754554444455677788999999
Q ss_pred ecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccc
Q 002774 633 VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKS 705 (882)
Q Consensus 633 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~ 705 (882)
+++-.|.+.+... +..++..+-+-+.-||..| |+|+||.++||.+..+. +.++|||++..
T Consensus 81 I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA---------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc---------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9998888777644 2456677777788899999 99999999999998775 99999999874
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.92 E-value=2.8e-08 Score=108.47 Aligned_cols=167 Identities=17% Similarity=0.277 Sum_probs=126.5
Q ss_pred EEEEEEEe-cCCcEEEEEEcccCCcccHHHHHHHHHHHHhccCCCeeeEEEEEEe----CCceEEEEEeecC-CCccccc
Q 002774 569 GKVYKGTL-PNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFD----RGEQMLIYEFVPN-GSLGDSL 642 (882)
Q Consensus 569 g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~~lV~e~~~~-gsL~~~l 642 (882)
.+.||+.. .||..|++||+..........-..-+++++++.|.|+|++.+++.. +...++||+|.|+ ++|.+.-
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~ 369 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY 369 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence 57899974 4899999999954433322223446889999999999999998763 4467999999996 4665543
Q ss_pred CCC-------------CCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCC
Q 002774 643 SGK-------------NGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDS 709 (882)
Q Consensus 643 ~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~ 709 (882)
... .+...++...|.++.|++.||.++|+.| ...+-|.+++|+++.+.+++|...|....+..+
T Consensus 370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d 446 (655)
T KOG3741|consen 370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQED 446 (655)
T ss_pred ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence 211 1235678899999999999999999999 999999999999999999999988877655433
Q ss_pred CCceeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCC
Q 002774 710 EKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRP 757 (882)
Q Consensus 710 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P 757 (882)
.. |.+. --++-|.-.||.+++.|.||..-
T Consensus 447 ~~----------------~~le---~~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 447 PT----------------EPLE---SQQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CC----------------cchh---HHhhhhHHHHHHHHHHHhhcccc
Confidence 20 1111 12467889999999999998644
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.92 E-value=6.9e-09 Score=98.88 Aligned_cols=143 Identities=22% Similarity=0.255 Sum_probs=102.3
Q ss_pred CCCeeeccCcEEEEEEEecCCcEEEEE-EcccCCcc-------cHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEEE
Q 002774 559 DANDVGSGGYGKVYKGTLPNGQLIAIK-RAQQGSMQ-------GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIY 630 (882)
Q Consensus 559 ~~~~lG~G~fg~Vy~~~~~~g~~vavK-~~~~~~~~-------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 630 (882)
....|-+|+-+.|+++.+. |+...|| ++.+.-.. ..+.-++|++.+.+++--.|.--.=++.+...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 4567889999999999985 6776666 34332221 1245678999999986444433333455666678999
Q ss_pred EeecC-CCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCC---ceeEeecccccc
Q 002774 631 EFVPN-GSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERL---NAKVADFGLSKS 705 (882)
Q Consensus 631 e~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~---~~kl~DfGla~~ 705 (882)
||+++ .++.+++................+..|-+.+.-||..+ |+|+||..+||++..++ .+.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 99976 37777775543323333344678888999999999999 99999999999996554 358999999864
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.87 E-value=3.9e-10 Score=131.83 Aligned_cols=249 Identities=20% Similarity=0.217 Sum_probs=167.2
Q ss_pred HcCCCCCCeeeccCcEEEEEEEec-CCcEEEEEEcccCCcc---cHHHHHHHHHHHHhccCCCeeeEEEEEEeCCceEEE
Q 002774 554 TNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQ---GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLI 629 (882)
Q Consensus 554 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 629 (882)
.+.+...+-+-+|+++.++.+.-. .|...+.|.......- +.+....+-.++-..+||-++.....+......+||
T Consensus 803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~ 882 (1205)
T KOG0606|consen 803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLV 882 (1205)
T ss_pred CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchh
Confidence 455666777889999999988632 3545555554432211 112222333333334567777666555567788999
Q ss_pred EEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCC
Q 002774 630 YEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDS 709 (882)
Q Consensus 630 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~ 709 (882)
++|..+++|...++... ..+..-.......+..+++|||... +.|||++|.|.++..++..+++|||......-.
T Consensus 883 ~~~~~~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~ 957 (1205)
T KOG0606|consen 883 GHYLNGGDLPSKLHNSG--CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLI 957 (1205)
T ss_pred hHHhccCCchhhhhcCC--CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCccccccccccc
Confidence 99999999999988754 2333333445556678899999876 899999999999999999999999844322110
Q ss_pred ---------------------C------Cc--eeeeeeeccCCCCCHHHHhhCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 002774 710 ---------------------E------KD--HITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIER 760 (882)
Q Consensus 710 ---------------------~------~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el~tg~~P~~~ 760 (882)
. .+ .......||+.|.+||...+......+|.|+.|++++|.++|..||..
T Consensus 958 ~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na 1037 (1205)
T KOG0606|consen 958 PPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNA 1037 (1205)
T ss_pred cCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCC
Confidence 0 00 112235689999999999999999999999999999999999999975
Q ss_pred CchHHHHHHHHHHhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 002774 761 GKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMS 820 (882)
Q Consensus 761 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ 820 (882)
.... + +++. +....-+.. ...........+++.+.+..+|.+|-.+.
T Consensus 1038 ~tpq-~----~f~n------i~~~~~~~p--~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1038 ETPQ-Q----IFEN------ILNRDIPWP--EGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred cchh-h----hhhc------cccCCCCCC--CCccccChhhhhhhhhhhccCchhccCcc
Confidence 3221 1 1111 111111111 11122335567888999999999997776
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.80 E-value=5.1e-08 Score=102.94 Aligned_cols=141 Identities=17% Similarity=0.077 Sum_probs=100.3
Q ss_pred CeeeccCcEEEEEEEecCCcEEEEEEcccCCcc-----------cHHHHHHHHHHHHhccCC--CeeeEEEEEEe-----
Q 002774 561 NDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQ-----------GGQEFKMEIELLSRVHHK--NLVSLLGFCFD----- 622 (882)
Q Consensus 561 ~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~H~--niv~l~~~~~~----- 622 (882)
+.+-+.....|++..+ +|+.|.||+....... ....+.+|...+.++... .+.+.+++...
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 4444444455777766 5788999977543211 112477899999888432 33344555543
Q ss_pred CCceEEEEEeecCC-CcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcC-------CCc
Q 002774 623 RGEQMLIYEFVPNG-SLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDE-------RLN 694 (882)
Q Consensus 623 ~~~~~lV~e~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~-------~~~ 694 (882)
....++|||++++. +|.+++......+.+...+..++.+++..+.-||..| |+|+|++++|||++. ++.
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~ 183 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLK 183 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCce
Confidence 23468999999876 7888875322223455677789999999999999999 999999999999975 568
Q ss_pred eeEeecccccc
Q 002774 695 AKVADFGLSKS 705 (882)
Q Consensus 695 ~kl~DfGla~~ 705 (882)
+.++||+.++.
T Consensus 184 ~~LIDl~r~~~ 194 (268)
T PRK15123 184 LSVIDLHRAQI 194 (268)
T ss_pred EEEEECCcccc
Confidence 99999998753
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.79 E-value=3.9e-09 Score=84.80 Aligned_cols=60 Identities=35% Similarity=0.530 Sum_probs=32.8
Q ss_pred CCcEEEeeCCcCCccccccccCCCCCCEEEccCCcCCCCCCcCccCCCCCcEeeccCcee
Q 002774 41 KLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKL 100 (882)
Q Consensus 41 ~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i 100 (882)
+|++|+|++|+|+...+..|.++++|++|+|++|+|+...+.+|.++++|++|++++|+|
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 455555555555544444555555555555555555555555555555555555555543
|
... |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.74 E-value=7.6e-09 Score=83.10 Aligned_cols=61 Identities=36% Similarity=0.520 Sum_probs=57.4
Q ss_pred CCCCEEeccCCCCCccCCCccccCCCCCcEEEeeCCcCCccccccccCCCCCCEEEccCCcC
Q 002774 15 TELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGF 76 (882)
Q Consensus 15 ~~L~~L~L~~n~~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i 76 (882)
++|++|+|++|+ +..+.++.|.++++|++|+|++|.|+...+.+|.++++|++|+|++|+|
T Consensus 1 p~L~~L~l~~n~-l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNK-LTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSST-ESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCC-CCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 579999999997 8888888999999999999999999988889999999999999999986
|
... |
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.72 E-value=4.3e-09 Score=127.65 Aligned_cols=266 Identities=23% Similarity=0.256 Sum_probs=121.4
Q ss_pred CCCEEeccCCCC-CccCCCccccCCCCCcEEEeeCCcCCccccccccCCCCCCEEEccCCcCCCCCCcCccCCCCCcEee
Q 002774 16 ELHTLDLSNNKD-LRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLD 94 (882)
Q Consensus 16 ~L~~L~L~~n~~-i~~~~p~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~ 94 (882)
+|++|-+..|.. +.....+.|..++.|++|+|++|.=-+.+|..++.|-+|++|+|++..|+ .+|..+.+|+.|.+|+
T Consensus 546 ~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~~Ln 624 (889)
T KOG4658|consen 546 KLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGLGNLKKLIYLN 624 (889)
T ss_pred ccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc-ccchHHHHHHhhheec
Confidence 455555555531 23233333555666666666655444456666666666666666666665 5555566666666666
Q ss_pred ccCceeeeecCCCCCCCchhhhhhcccceeccCCeeee-cCCccccCCcccceeeeccCCcccccCCccccCCCCCC---
Q 002774 95 LTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSG-SIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLE--- 170 (882)
Q Consensus 95 Ls~N~i~~~~p~~~~~~~~l~~L~~L~~L~L~~N~l~~-~ip~~~f~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~--- 170 (882)
+..+.-...+|.. +..|.+|++|.+..-.... ..-..-...+.+|+.+....... .+-..+..++.|.
T Consensus 625 l~~~~~l~~~~~i------~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~~~~s~--~~~e~l~~~~~L~~~~ 696 (889)
T KOG4658|consen 625 LEVTGRLESIPGI------LLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSITISSV--LLLEDLLGMTRLRSLL 696 (889)
T ss_pred cccccccccccch------hhhcccccEEEeeccccccchhhHHhhhcccchhhheeecchh--HhHhhhhhhHHHHHHh
Confidence 6555533222211 2224444444444332110 00000011222233332222111 0011122222222
Q ss_pred -EEEccCCCCCCCCCccCCCCCCCCEEEccCCcccccCCC-CCC------CCCCCEEECcCCCCCCCCCCccccCCCCCC
Q 002774 171 -VVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPN-LTG------LSVLSYLDMSNNSFDASEVPSWFSSMQSLT 242 (882)
Q Consensus 171 -~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~-~~~------l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~ 242 (882)
.+.+.++... ..+..+..+.+|+.|.+.++.+...... ... ++++..+...++.. ...+.+.--.++|+
T Consensus 697 ~~l~~~~~~~~-~~~~~~~~l~~L~~L~i~~~~~~e~~~~~~~~~~~~~~f~~l~~~~~~~~~~--~r~l~~~~f~~~L~ 773 (889)
T KOG4658|consen 697 QSLSIEGCSKR-TLISSLGSLGNLEELSILDCGISEIVIEWEESLIVLLCFPNLSKVSILNCHM--LRDLTWLLFAPHLT 773 (889)
T ss_pred Hhhhhcccccc-eeecccccccCcceEEEEcCCCchhhcccccccchhhhHHHHHHHHhhcccc--ccccchhhccCccc
Confidence 2222222222 4555666677777777777766543221 111 11222222222221 22344444557777
Q ss_pred EEECcCCcccccCCccCCCCCCCCEEEccCCcccee--cCCCCcccccccccc
Q 002774 243 TLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGT--LDLGTSYSENLLVNL 293 (882)
Q Consensus 243 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~--~~~~~~~~~L~~L~L 293 (882)
.|.+..+.....+......+..++.+.+..+.+.+. ......++++..+.+
T Consensus 774 ~l~l~~~~~~e~~i~~~k~~~~l~~~i~~f~~~~~l~~~~~l~~l~~i~~~~l 826 (889)
T KOG4658|consen 774 SLSLVSCRLLEDIIPKLKALLELKELILPFNKLEGLRMLCSLGGLPQLYWLPL 826 (889)
T ss_pred EEEEecccccccCCCHHHHhhhcccEEecccccccceeeecCCCCceeEeccc
Confidence 777777776656666566666666666666666653 233333444444333
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.70 E-value=8.4e-08 Score=95.44 Aligned_cols=126 Identities=22% Similarity=0.336 Sum_probs=80.5
Q ss_pred EEEEEEecCCcEEEEEEcccCCc-------------c--------c-----HHHHHHHHHHHHhccCC--CeeeEEEEEE
Q 002774 570 KVYKGTLPNGQLIAIKRAQQGSM-------------Q--------G-----GQEFKMEIELLSRVHHK--NLVSLLGFCF 621 (882)
Q Consensus 570 ~Vy~~~~~~g~~vavK~~~~~~~-------------~--------~-----~~~~~~E~~~l~~l~H~--niv~l~~~~~ 621 (882)
.||.|...+|..+|||+.+.... . . .....+|++.|.++..- ++.+.+++-
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 48999988999999998753210 0 0 12356799999999754 455555442
Q ss_pred eCCceEEEEEeec--CCCcccccCCCCCccccHHHHHHHHHHHHHHHhh-hhhcCCCCeeecCCCCCceEEcCCCceeEe
Q 002774 622 DRGEQMLIYEFVP--NGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSY-LHELANPPIIHRDIKSSNILLDERLNAKVA 698 (882)
Q Consensus 622 ~~~~~~lV~e~~~--~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~y-LH~~~~~~ivHrDlk~~NIll~~~~~~kl~ 698 (882)
...|||||++ +..+.. +.... ++......++.+++..+.. +|..| |+|+|+.+.||+++++ .+.++
T Consensus 80 ---~~~ivME~I~~~G~~~~~-l~~~~---~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~iI 148 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPR-LKDVD---LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYII 148 (188)
T ss_dssp ---TTEEEEE--EETTEEGGC-HHHCG---GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE-
T ss_pred ---CCEEEEEecCCCccchhh-HHhcc---ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEEE
Confidence 4579999998 444433 32211 1123445567777775555 57888 9999999999999988 99999
Q ss_pred ecccccccC
Q 002774 699 DFGLSKSMS 707 (882)
Q Consensus 699 DfGla~~~~ 707 (882)
|||.+....
T Consensus 149 Df~qav~~~ 157 (188)
T PF01163_consen 149 DFGQAVDSS 157 (188)
T ss_dssp -GTTEEETT
T ss_pred ecCcceecC
Confidence 999887543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.69 E-value=1.1e-08 Score=124.14 Aligned_cols=290 Identities=20% Similarity=0.211 Sum_probs=177.3
Q ss_pred ccCCCCCCEEeccCCCCCccCCCccccCCCCCcEEEeeCCc--CCccccccccCCCCCCEEEccCCcCCCCCCcCccCCC
Q 002774 11 ITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCS--FSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLS 88 (882)
Q Consensus 11 ~~~l~~L~~L~L~~n~~i~~~~p~~~~~l~~L~~L~L~~n~--i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~ 88 (882)
..+....+.+.+.+|+ ...++....+ ++|++|-+.+|. +.....+.|..++.|+.|||++|.=.+.+|..+++|-
T Consensus 519 ~~~~~~~rr~s~~~~~--~~~~~~~~~~-~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li 595 (889)
T KOG4658|consen 519 VKSWNSVRRMSLMNNK--IEHIAGSSEN-PKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELV 595 (889)
T ss_pred ccchhheeEEEEeccc--hhhccCCCCC-CccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhh
Confidence 3455677888888887 4455555444 379999999997 6645555688899999999999887778999999999
Q ss_pred CCcEeeccCceeeeecCCCCCCCchhhhhhcccceeccCCeeeecCCccccCCcccceeeeccCCc--ccccCCccccCC
Q 002774 89 NLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNN--LTGELPATLGLV 166 (882)
Q Consensus 89 ~L~~L~Ls~N~i~~~~p~~~~~~~~l~~L~~L~~L~L~~N~l~~~ip~~~f~~~~~L~~L~L~~N~--l~~~~~~~~~~l 166 (882)
+|++|+|++..|. .+|.. +..|++|.+|++..+.-...+ .++...+.+|++|.+.... .+...-..+.++
T Consensus 596 ~LryL~L~~t~I~-~LP~~------l~~Lk~L~~Lnl~~~~~l~~~-~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~L 667 (889)
T KOG4658|consen 596 HLRYLDLSDTGIS-HLPSG------LGNLKKLIYLNLEVTGRLESI-PGILLELQSLRVLRLPRSALSNDKLLLKELENL 667 (889)
T ss_pred hhhcccccCCCcc-ccchH------HHHHHhhheeccccccccccc-cchhhhcccccEEEeeccccccchhhHHhhhcc
Confidence 9999999999998 77754 566888888899888766233 5566667888888876554 222233344555
Q ss_pred CCCCEEEccCCCCCCCCCccCCCCCCCC----EEEccCCcccccCCCCCCCCCCCEEECcCCCCCCCCCCccccCC----
Q 002774 167 KSLEVVRFDRNSLSGPVPSNLNNLTSVN----DLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSM---- 238 (882)
Q Consensus 167 ~~L~~L~Ls~N~l~~~~p~~l~~l~~L~----~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l---- 238 (882)
.+|+.|....... .+-..+..++.|. .+.+.++........+..+.+|+.|.+.++.+.. ....++...
T Consensus 668 e~L~~ls~~~~s~--~~~e~l~~~~~L~~~~~~l~~~~~~~~~~~~~~~~l~~L~~L~i~~~~~~e-~~~~~~~~~~~~~ 744 (889)
T KOG4658|consen 668 EHLENLSITISSV--LLLEDLLGMTRLRSLLQSLSIEGCSKRTLISSLGSLGNLEELSILDCGISE-IVIEWEESLIVLL 744 (889)
T ss_pred cchhhheeecchh--HhHhhhhhhHHHHHHhHhhhhcccccceeecccccccCcceEEEEcCCCch-hhcccccccchhh
Confidence 5555555543333 1112223333333 3443444444555567778888888888887752 112222221
Q ss_pred --CCCCEEECcCCcccccCCccCCCCCCCCEEEccCCccceec-CCCCcccccccccccCCcccccc-CCCCCCccceEE
Q 002774 239 --QSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTL-DLGTSYSENLLVNLQNNRISAYT-ERGGAPAVNLTL 314 (882)
Q Consensus 239 --~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~-~~~~~~~~L~~L~L~~N~i~~~~-~~~~~~~~~L~~ 314 (882)
++|..+...++..- ..+.+.-..++|+.|.+..++....+ +..-.+..+..+-+..+.+.... ......++++..
T Consensus 745 ~f~~l~~~~~~~~~~~-r~l~~~~f~~~L~~l~l~~~~~~e~~i~~~k~~~~l~~~i~~f~~~~~l~~~~~l~~l~~i~~ 823 (889)
T KOG4658|consen 745 CFPNLSKVSILNCHML-RDLTWLLFAPHLTSLSLVSCRLLEDIIPKLKALLELKELILPFNKLEGLRMLCSLGGLPQLYW 823 (889)
T ss_pred hHHHHHHHHhhccccc-cccchhhccCcccEEEEecccccccCCCHHHHhhhcccEEecccccccceeeecCCCCceeEe
Confidence 12222222222222 33344445688888888887776633 33333444444445555555442 333334444433
Q ss_pred e
Q 002774 315 I 315 (882)
Q Consensus 315 l 315 (882)
+
T Consensus 824 ~ 824 (889)
T KOG4658|consen 824 L 824 (889)
T ss_pred c
Confidence 3
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.65 E-value=5e-10 Score=125.29 Aligned_cols=127 Identities=27% Similarity=0.306 Sum_probs=78.1
Q ss_pred CCCEEEccCCCCCCCCCccCCCCCCCCEEEccCCcccccCCCCCCCCCCCEEECcCCCCCCCCCCcc-ccCCCCCCEEEC
Q 002774 168 SLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSW-FSSMQSLTTLMM 246 (882)
Q Consensus 168 ~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~-~~~l~~L~~L~L 246 (882)
.|...+.+.|.+. ....++.-++.|+.|+|++|+++... .+..+++|+.|||++|.+. .+|.. -.++. |+.|+|
T Consensus 165 ~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v~-~Lr~l~~LkhLDlsyN~L~--~vp~l~~~gc~-L~~L~l 239 (1096)
T KOG1859|consen 165 KLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKVD-NLRRLPKLKHLDLSYNCLR--HVPQLSMVGCK-LQLLNL 239 (1096)
T ss_pred hHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhhH-HHHhcccccccccccchhc--cccccchhhhh-heeeee
Confidence 4555566666665 55556666666666666666666544 5566666666666666664 23331 12233 677777
Q ss_pred cCCcccccCCccCCCCCCCCEEEccCCccce--ecCCCCcccccccccccCCccccc
Q 002774 247 ENTNLKGQIPADLFSIPHLQTVVMKTNELNG--TLDLGTSYSENLLVNLQNNRISAY 301 (882)
Q Consensus 247 s~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~--~~~~~~~~~~L~~L~L~~N~i~~~ 301 (882)
+||.++. -..+.+|.+|+.|||++|-|.+ .....+.+..|..|+|.+|++.+-
T Consensus 240 rnN~l~t--L~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~ 294 (1096)
T KOG1859|consen 240 RNNALTT--LRGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCA 294 (1096)
T ss_pred cccHHHh--hhhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccC
Confidence 7777652 2235667777777777777776 334445677777888888877664
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.62 E-value=4.6e-09 Score=106.43 Aligned_cols=61 Identities=18% Similarity=0.293 Sum_probs=25.8
Q ss_pred CCCCEEEccCCcccccCCC--CCCCCCCCEEECcCCCCCCCCCCccccCCCCCCEEECcCCcc
Q 002774 191 TSVNDLYLSNNKLTGAMPN--LTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNL 251 (882)
Q Consensus 191 ~~L~~L~Ls~N~l~~~~~~--~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l 251 (882)
+++..+-+..|.|+..... +..++.+..|+|+.|+|..-..-+.+.++++|..|.+++|.|
T Consensus 199 pnv~sv~v~e~PlK~~s~ek~se~~p~~~~LnL~~~~idswasvD~Ln~f~~l~dlRv~~~Pl 261 (418)
T KOG2982|consen 199 PNVNSVFVCEGPLKTESSEKGSEPFPSLSCLNLGANNIDSWASVDALNGFPQLVDLRVSENPL 261 (418)
T ss_pred ccchheeeecCcccchhhcccCCCCCcchhhhhcccccccHHHHHHHcCCchhheeeccCCcc
Confidence 4445555555555443321 333444444555555443222222333444444444444444
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.58 E-value=1.3e-06 Score=93.34 Aligned_cols=287 Identities=16% Similarity=0.151 Sum_probs=165.7
Q ss_pred CCCeeeccCcEEEEEEEecCCcEEEEEEcccCCcccHHHHHHHHHHHHhc-cCCCeeeEEEEE------EeCCc-eEEEE
Q 002774 559 DANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRV-HHKNLVSLLGFC------FDRGE-QMLIY 630 (882)
Q Consensus 559 ~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~------~~~~~-~~lV~ 630 (882)
..+.||+|+-+.+|-.-- -+..| -|+..........+ .++.|.+. .||-+-.=+.+= -+++. ..+.|
T Consensus 15 ~gr~LgqGgea~ly~l~e-~~d~V-AKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 15 PGRPLGQGGEADLYTLGE-VRDQV-AKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CCccccCCccceeeecch-hhchh-heeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 456799999999995421 12223 35554332222121 23334333 465443311110 11112 45666
Q ss_pred EeecCC-CcccccCC----CCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCceeEeecccccc
Q 002774 631 EFVPNG-SLGDSLSG----KNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKS 705 (882)
Q Consensus 631 e~~~~g-sL~~~l~~----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~ 705 (882)
..+++. ...++... +.-...+|.-.++.++.+|.+.+.||..| .+-+|+.++|+|+.+++.+.+.|-..-..
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccceee
Confidence 666543 12222211 11235789999999999999999999999 88899999999999999999987543322
Q ss_pred cCCCCCceeeeeeeccCCCCCHHHHh-----hCCCCchhHHHHHHHHHHHHHhC-CCCCCCC-------chHHHHHH-HH
Q 002774 706 MSDSEKDHITTQVKGTMGYLDPEYYM-----TQQLTEKSDVYSFGVLMLELLTG-RRPIERG-------KYIVREIR-TV 771 (882)
Q Consensus 706 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~S~Gvll~el~tg-~~P~~~~-------~~~~~~~~-~~ 771 (882)
. ..+......+|...|.+||.-. +-.-+...|.|.+||++++++.| ++||.+- ......+. -.
T Consensus 167 ~---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~ 243 (637)
T COG4248 167 N---ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGR 243 (637)
T ss_pred c---cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcce
Confidence 2 1223334456888999999876 23456679999999999999996 8898621 11110110 00
Q ss_pred HHhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccC--CCCCCCHHHHHHHHHHHHHHcCCCCCCCCCCCccccc
Q 002774 772 MDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQES--GDDRPTMSEVVKDIENILQQAGLNPNAESASSSASYE 849 (882)
Q Consensus 772 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~d--p~~RPs~~evl~~L~~~~~~~~~~~~~~~~~~s~~~~ 849 (882)
+...+. ...-..|........-.+..+..+..+|+... +.-|||++..+..|..+.++........ .-
T Consensus 244 f~ya~~---~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~C~v~a-------~H 313 (637)
T COG4248 244 FAYASD---QRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKKCTVSA-------MH 313 (637)
T ss_pred eeechh---ccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhhhhhcc-------cc
Confidence 000000 00001111111112223466788888998753 5689999999999888877765432211 01
Q ss_pred ccCCCCCCCCCCCCCCc
Q 002774 850 DASKGNFHHPYCNEEGF 866 (882)
Q Consensus 850 ~~~~~~~~~p~~~~~~~ 866 (882)
.-+..-..+|||..+..
T Consensus 314 ~y~~hl~~CPwCa~~~~ 330 (637)
T COG4248 314 VYPVHLTDCPWCALDNQ 330 (637)
T ss_pred cccCCCCCCchhhhccc
Confidence 11234456677766443
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.58 E-value=7e-10 Score=124.17 Aligned_cols=128 Identities=24% Similarity=0.294 Sum_probs=78.6
Q ss_pred cceeeeccCCcccccCCccccCCCCCCEEEccCCCCCCCCCccCCCCCCCCEEEccCCcccccCCC-CCCCCCCCEEECc
Q 002774 144 VLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPN-LTGLSVLSYLDMS 222 (882)
Q Consensus 144 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~-~~~l~~L~~L~Ls 222 (882)
.|...+.+.|.++ ..-.++.-++.|+.|+|++|++.... .+..|++|++|||++|.++.++-- ..++. |+.|.|+
T Consensus 165 ~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~lr 240 (1096)
T KOG1859|consen 165 KLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLNLR 240 (1096)
T ss_pred hHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhccccccchhhhh-heeeeec
Confidence 4555556666655 44455666667777777777776322 666677777777777777655532 33333 7777777
Q ss_pred CCCCCCCCCCccccCCCCCCEEECcCCcccccC-CccCCCCCCCCEEEccCCcccee
Q 002774 223 NNSFDASEVPSWFSSMQSLTTLMMENTNLKGQI-PADLFSIPHLQTVVMKTNELNGT 278 (882)
Q Consensus 223 ~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-~~~~~~l~~L~~L~Ls~N~l~~~ 278 (882)
+|.++. -..+.+|++|+.|||++|-|.+-. -..++.|..|+.|+|.||++-..
T Consensus 241 nN~l~t---L~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~ 294 (1096)
T KOG1859|consen 241 NNALTT---LRGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCA 294 (1096)
T ss_pred ccHHHh---hhhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccC
Confidence 777642 223566777777777777776422 22344566777777777777653
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.50 E-value=1.5e-06 Score=86.91 Aligned_cols=148 Identities=14% Similarity=0.078 Sum_probs=107.9
Q ss_pred HcCCCCCCeeeccCcEEEEEEEecCCcEEEEEEcccC---C---cccHHHHHHHHHHHHhccC--CCeeeEEEEEEeC--
Q 002774 554 TNNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQG---S---MQGGQEFKMEIELLSRVHH--KNLVSLLGFCFDR-- 623 (882)
Q Consensus 554 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~---~---~~~~~~~~~E~~~l~~l~H--~niv~l~~~~~~~-- 623 (882)
..++-..---|+||-+-|++-.+. |+.+-+|+-... + ......|.+|+..+.++.. -.+.+...+....
T Consensus 17 ~~~wve~pN~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~ 95 (216)
T PRK09902 17 EGDWVEEPNYRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIE 95 (216)
T ss_pred CCceecCCCcCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccC
Confidence 333433344578999999998874 557889987521 1 2355789999999999953 2344444222221
Q ss_pred --CceEEEEEeecC-CCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCc--eeEe
Q 002774 624 --GEQMLIYEFVPN-GSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLN--AKVA 698 (882)
Q Consensus 624 --~~~~lV~e~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~--~kl~ 698 (882)
-..+||+|-+++ -+|.+++....-.+.+...+..+..++++.+.-||+.| +.|+|+.++||+++.++. ++++
T Consensus 96 ~~~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lI 172 (216)
T PRK09902 96 GEWRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFL 172 (216)
T ss_pred CceEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEE
Confidence 135799998764 48888876544335677788899999999999999999 999999999999986666 9999
Q ss_pred ecccccc
Q 002774 699 DFGLSKS 705 (882)
Q Consensus 699 DfGla~~ 705 (882)
||.-++.
T Consensus 173 DlEk~r~ 179 (216)
T PRK09902 173 DLEKSRR 179 (216)
T ss_pred Ehhccch
Confidence 9987653
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.50 E-value=8.4e-07 Score=90.52 Aligned_cols=134 Identities=19% Similarity=0.233 Sum_probs=92.7
Q ss_pred CCCeeeccCcEEEEEEEecCCcEEEEEEcccCCcc----------------------cHHHHHHHHHHHHhccCC--Cee
Q 002774 559 DANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQ----------------------GGQEFKMEIELLSRVHHK--NLV 614 (882)
Q Consensus 559 ~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~----------------------~~~~~~~E~~~l~~l~H~--niv 614 (882)
..+.||.|.-+.||.|..+.|.++|||.-+.+..+ .....++|.++|.+|.-. .+.
T Consensus 95 iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~VP 174 (304)
T COG0478 95 IGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKVP 174 (304)
T ss_pred hccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCCC
Confidence 45789999999999999999999999975432111 112356799999998643 555
Q ss_pred eEEEEEEeCCceEEEEEeecCCCcccccCCCCCccccHHHHHHHHHHHHHHHhhhhhcCCCCeeecCCCCCceEEcCCCc
Q 002774 615 SLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLN 694 (882)
Q Consensus 615 ~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~ 694 (882)
+-+++ +...+||||+++--|...-- +....-.++..|.+-+.-+-..| |||+|+.+-||++++||.
T Consensus 175 ~P~~~----nRHaVvMe~ieG~eL~~~r~-------~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~dg~ 240 (304)
T COG0478 175 KPIAW----NRHAVVMEYIEGVELYRLRL-------DVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTEDGD 240 (304)
T ss_pred Ccccc----ccceeeeehcccceeecccC-------cccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEecCCC
Confidence 55543 45689999998866544321 11122223333333333333567 999999999999999999
Q ss_pred eeEeeccccccc
Q 002774 695 AKVADFGLSKSM 706 (882)
Q Consensus 695 ~kl~DfGla~~~ 706 (882)
+.++||-.+...
T Consensus 241 ~~vIDwPQ~v~~ 252 (304)
T COG0478 241 IVVIDWPQAVPI 252 (304)
T ss_pred EEEEeCcccccC
Confidence 999999876544
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.41 E-value=1.2e-06 Score=89.56 Aligned_cols=106 Identities=26% Similarity=0.261 Sum_probs=83.4
Q ss_pred HHHHHHHHHHHhcc--CCCeeeEEEEEEeCC----ceEEEEEeecCC-CcccccCCCCCccccHHHHHHHHHHHHHHHhh
Q 002774 596 QEFKMEIELLSRVH--HKNLVSLLGFCFDRG----EQMLIYEFVPNG-SLGDSLSGKNGIRLDWIRRLKIALGAARGLSY 668 (882)
Q Consensus 596 ~~~~~E~~~l~~l~--H~niv~l~~~~~~~~----~~~lV~e~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~y 668 (882)
....+|...+..++ .=.+.+.+++..... ..++|+|++++. +|.+++..... .+......++.++++.++-
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~~ 133 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLIAK 133 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHHHH
Confidence 45778988888885 333456666665532 358999999874 78888875332 5556778899999999999
Q ss_pred hhhcCCCCeeecCCCCCceEEcCCC---ceeEeeccccccc
Q 002774 669 LHELANPPIIHRDIKSSNILLDERL---NAKVADFGLSKSM 706 (882)
Q Consensus 669 LH~~~~~~ivHrDlk~~NIll~~~~---~~kl~DfGla~~~ 706 (882)
||+.| |+|+|++++|||++.+. .+.++||+-++..
T Consensus 134 lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 134 LHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 99999 99999999999999887 8999999987653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.38 E-value=1.5e-06 Score=99.41 Aligned_cols=147 Identities=18% Similarity=0.251 Sum_probs=95.8
Q ss_pred cCCCCCCeeeccCcEEEEEEEecCCcEEEEEEcccCCccc----------------------------------------
Q 002774 555 NNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQG---------------------------------------- 594 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~---------------------------------------- 594 (882)
..|+. +.|+.++-|.||+|++++|+.||||+.+.+-...
T Consensus 126 ~eF~~-~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ 204 (517)
T COG0661 126 SEFEP-EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLRE 204 (517)
T ss_pred HHcCC-CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHH
Confidence 34443 6789999999999999999999999986531110
Q ss_pred HHHHHHHHHHHHhcc-----CCCeeeEEEEEEeCCceEEEEEeecCCCcccccCCCCCccccHHHHHHHHHHHHHH-Hhh
Q 002774 595 GQEFKMEIELLSRVH-----HKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARG-LSY 668 (882)
Q Consensus 595 ~~~~~~E~~~l~~l~-----H~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~g-L~y 668 (882)
+-++.+|..-+.+++ .+++.=-.=|+.-.+...|+|||++|-.+.+...-.. ...+.. .++..++++ +..
T Consensus 205 ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k---~ia~~~~~~f~~q 280 (517)
T COG0661 205 ELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRK---ELAELLVRAFLRQ 280 (517)
T ss_pred HhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHH---HHHHHHHHHHHHH
Confidence 001344555555542 2333211222333567889999999998888742211 123322 233333322 333
Q ss_pred hhhcCCCCeeecCCCCCceEEcCCCceeEeecccccccCCC
Q 002774 669 LHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDS 709 (882)
Q Consensus 669 LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DfGla~~~~~~ 709 (882)
+-..| +.|.|..|.||+++.++++.+.|||+...+.+.
T Consensus 281 ~~~dg---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 281 LLRDG---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred HHhcC---ccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence 33456 999999999999999999999999999877654
|
|
| >COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.37 E-value=9.3e-09 Score=102.96 Aligned_cols=220 Identities=21% Similarity=0.214 Sum_probs=126.9
Q ss_pred CCCCCCEEeccCCCCCccCC----CccccCCCCCcEEEeeCCcCC---cc-------ccccccCCCCCCEEEccCCcCCC
Q 002774 13 GLTELHTLDLSNNKDLRGPL----PTTIGNLKKLSNLMLVGCSFS---GP-------IPDSIGSLQELVLLSLNSNGFSG 78 (882)
Q Consensus 13 ~l~~L~~L~L~~n~~i~~~~----p~~~~~l~~L~~L~L~~n~i~---~~-------~~~~~~~l~~L~~L~L~~N~i~~ 78 (882)
-+..++++|||+|. |.+.- -..+.+-.+|+..++++--.. .. +..++-+|++|+..+||+|.++.
T Consensus 28 ~~d~~~evdLSGNt-igtEA~e~l~~~ia~~~~L~vvnfsd~ftgr~kde~~~~L~~Ll~aLlkcp~l~~v~LSDNAfg~ 106 (388)
T COG5238 28 MMDELVEVDLSGNT-IGTEAMEELCNVIANVRNLRVVNFSDAFTGRDKDELYSNLVMLLKALLKCPRLQKVDLSDNAFGS 106 (388)
T ss_pred hhcceeEEeccCCc-ccHHHHHHHHHHHhhhcceeEeehhhhhhcccHHHHHHHHHHHHHHHhcCCcceeeeccccccCc
Confidence 36678888999987 54443 333556677888887764332 11 23456678888889999988886
Q ss_pred CCCcC----ccCCCCCcEeeccCceeeeecCCC-CCCCchhhhhhcccceeccCCeeeecCCccccCCcccceeeeccCC
Q 002774 79 RVPPS----IGNLSNLYWLDLTDNKLEGEIPVS-DGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSN 153 (882)
Q Consensus 79 ~~~~~----~~~l~~L~~L~Ls~N~i~~~~p~~-~~~~~~l~~L~~L~~L~L~~N~l~~~ip~~~f~~~~~L~~L~L~~N 153 (882)
..|.. ++.-+.|++|.|++|.+. .+... ++ ..|.+|. .|+-. ...+.|+.+....|
T Consensus 107 ~~~e~L~d~is~~t~l~HL~l~NnGlG-p~aG~rig--kal~~la--------~nKKa--------a~kp~Le~vicgrN 167 (388)
T COG5238 107 EFPEELGDLISSSTDLVHLKLNNNGLG-PIAGGRIG--KALFHLA--------YNKKA--------ADKPKLEVVICGRN 167 (388)
T ss_pred ccchHHHHHHhcCCCceeEEeecCCCC-ccchhHHH--HHHHHHH--------HHhhh--------ccCCCceEEEeccc
Confidence 55544 456678888888888875 22111 11 1222221 11100 12334555555555
Q ss_pred ccccc----CCccccCCCCCCEEEccCCCCCCC-----CCccCCCCCCCCEEEccCCcccccCC-----CCCCCCCCCEE
Q 002774 154 NLTGE----LPATLGLVKSLEVVRFDRNSLSGP-----VPSNLNNLTSVNDLYLSNNKLTGAMP-----NLTGLSVLSYL 219 (882)
Q Consensus 154 ~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~-----~p~~l~~l~~L~~L~Ls~N~l~~~~~-----~~~~l~~L~~L 219 (882)
++..- ....|..-.+|+++.+..|.|.-. +-..+..+.+|+.|||.+|.++.... .++.++.|+.|
T Consensus 168 Rlengs~~~~a~~l~sh~~lk~vki~qNgIrpegv~~L~~~gl~y~~~LevLDlqDNtft~~gS~~La~al~~W~~lrEL 247 (388)
T COG5238 168 RLENGSKELSAALLESHENLKEVKIQQNGIRPEGVTMLAFLGLFYSHSLEVLDLQDNTFTLEGSRYLADALCEWNLLREL 247 (388)
T ss_pred hhccCcHHHHHHHHHhhcCceeEEeeecCcCcchhHHHHHHHHHHhCcceeeeccccchhhhhHHHHHHHhcccchhhhc
Confidence 55421 122344446788888888888722 11234566788888888888775433 25667777777
Q ss_pred ECcCCCCCCCCCCcccc-----CCCCCCEEECcCCccc
Q 002774 220 DMSNNSFDASEVPSWFS-----SMQSLTTLMMENTNLK 252 (882)
Q Consensus 220 ~Ls~N~l~~~~~p~~~~-----~l~~L~~L~Ls~N~l~ 252 (882)
.+..|-++..-....+. ..++|+.|-..+|.+.
T Consensus 248 ~lnDClls~~G~~~v~~~f~e~~~p~l~~L~~~Yne~~ 285 (388)
T COG5238 248 RLNDCLLSNEGVKSVLRRFNEKFVPNLMPLPGDYNERR 285 (388)
T ss_pred cccchhhccccHHHHHHHhhhhcCCCccccccchhhhc
Confidence 77777776422222211 2345555555555544
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.35 E-value=1.3e-08 Score=91.92 Aligned_cols=106 Identities=20% Similarity=0.197 Sum_probs=50.1
Q ss_pred CCEEEccCCcccccCCCCC-CCCCCCEEECcCCCCCCCCCCccccCCCCCCEEECcCCcccccCCccCCCCCCCCEEEcc
Q 002774 193 VNDLYLSNNKLTGAMPNLT-GLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMK 271 (882)
Q Consensus 193 L~~L~Ls~N~l~~~~~~~~-~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 271 (882)
|+..+|++|.++..++.|. ..+.++.|+|++|.| +++|..+..++.|+.|++++|.+. ..|..+..|.+|-.|+..
T Consensus 55 l~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~nei--sdvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Lds~ 131 (177)
T KOG4579|consen 55 LTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEI--SDVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDMLDSP 131 (177)
T ss_pred EEEEecccchhhhCCHHHhhccchhhhhhcchhhh--hhchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHhcCC
Confidence 3344555555555554432 233555555555555 244555555555555555555554 444444445555555555
Q ss_pred CCccceecCCCCcccccccccccCCccccc
Q 002774 272 TNELNGTLDLGTSYSENLLVNLQNNRISAY 301 (882)
Q Consensus 272 ~N~l~~~~~~~~~~~~L~~L~L~~N~i~~~ 301 (882)
+|.+..++-..+.-...-..++.++++..-
T Consensus 132 ~na~~eid~dl~~s~~~al~~lgnepl~~~ 161 (177)
T KOG4579|consen 132 ENARAEIDVDLFYSSLPALIKLGNEPLGDE 161 (177)
T ss_pred CCccccCcHHHhccccHHHHHhcCCccccc
Confidence 555544333322222222344444544443
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 882 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-52 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-51 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-50 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 8e-50 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 7e-36 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-35 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-35 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-34 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-23 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-23 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 4e-22 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 4e-22 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 4e-22 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 5e-22 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 6e-22 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 6e-22 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 6e-22 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-22 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 6e-22 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 7e-22 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 7e-22 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 7e-22 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 7e-22 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 7e-22 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 7e-22 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 8e-22 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 8e-22 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 8e-22 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 9e-22 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-21 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 1e-21 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-21 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 2e-21 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-21 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 5e-21 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 6e-21 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-20 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-20 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-20 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-20 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-20 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-20 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-20 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-20 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-20 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-20 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-20 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-20 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-20 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-20 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 5e-20 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-20 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 6e-20 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 6e-20 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 7e-20 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 7e-20 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 7e-20 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-20 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 7e-20 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 9e-20 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 9e-20 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-19 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-19 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-19 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-19 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-19 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-19 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-19 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-19 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-19 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-19 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-19 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-19 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-19 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-19 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-19 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-19 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-19 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-19 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-19 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-19 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-19 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-19 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-19 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-19 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-19 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-19 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-19 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-19 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-19 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-19 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-19 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-19 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-19 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-19 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-19 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-19 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-19 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-19 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-19 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 4e-19 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-19 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 4e-19 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 4e-19 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 5e-19 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 5e-19 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 5e-19 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 5e-19 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 5e-19 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 6e-19 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-19 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 6e-19 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 6e-19 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 6e-19 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 6e-19 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 6e-19 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 7e-19 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-19 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 7e-19 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 9e-19 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 9e-19 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 9e-19 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 9e-19 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-18 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-18 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-18 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-18 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-18 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-18 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-18 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-18 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-18 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-18 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-18 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-18 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-18 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-18 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-18 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-18 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-18 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-18 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 4e-18 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 4e-18 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 4e-18 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 4e-18 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 4e-18 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 4e-18 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 5e-18 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-18 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 6e-18 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-18 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 6e-18 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 6e-18 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 6e-18 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 7e-18 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 7e-18 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 7e-18 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 7e-18 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 9e-18 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 9e-18 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 9e-18 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-17 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-17 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-17 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-17 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-17 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-17 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-17 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-17 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-17 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-17 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-17 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-17 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-17 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-17 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-17 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-17 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-17 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 3e-17 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-17 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 3e-17 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-17 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-17 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-17 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 4e-17 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 4e-17 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-17 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-17 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 4e-17 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-17 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 5e-17 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 5e-17 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 5e-17 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 5e-17 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 5e-17 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 5e-17 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 6e-17 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 6e-17 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 7e-17 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-17 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 9e-17 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 9e-17 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-16 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-16 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-16 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-16 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-16 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-16 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-16 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-16 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-16 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-16 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-16 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 3e-16 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-16 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-16 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-16 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 4e-16 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-16 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 4e-16 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 4e-16 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-16 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 5e-16 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-16 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 5e-16 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-16 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 7e-16 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-16 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 7e-16 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 8e-16 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-16 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 9e-16 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 9e-16 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-16 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-15 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-15 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-15 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-15 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-15 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-15 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-15 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-15 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-15 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-15 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-15 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-15 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-15 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-15 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-15 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-15 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-15 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-15 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-15 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-15 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-15 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-15 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-15 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-15 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-15 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-15 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-15 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-15 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-15 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-15 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-15 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-15 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-15 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-15 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 4e-15 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 4e-15 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 4e-15 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 4e-15 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 4e-15 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-15 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 6e-15 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 6e-15 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 6e-15 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 8e-15 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 8e-15 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-15 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-14 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-14 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-14 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-14 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-14 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-14 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-14 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-14 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-14 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-14 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-14 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-14 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-14 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 3e-14 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-14 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-14 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 4e-14 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-14 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 5e-14 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 6e-14 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 6e-14 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 7e-14 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-14 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-14 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 9e-14 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-13 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-13 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-13 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-13 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-13 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-13 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-13 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-13 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-13 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-13 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-13 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-13 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-13 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-13 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-13 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-13 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-13 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-13 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-13 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-13 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-13 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-13 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-13 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-13 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-13 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-13 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-13 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-13 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 3e-13 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-13 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-13 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-13 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-13 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-13 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 4e-13 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 4e-13 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 4e-13 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 4e-13 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-13 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 4e-13 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 4e-13 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 5e-13 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-13 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 5e-13 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 5e-13 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 5e-13 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 5e-13 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 6e-13 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 6e-13 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 6e-13 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 6e-13 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 7e-13 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 7e-13 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 7e-13 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 8e-13 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 8e-13 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 9e-13 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 9e-13 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-12 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-12 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-12 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-12 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-12 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-12 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-12 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-12 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-12 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-12 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-12 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-12 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-12 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-12 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-12 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-12 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-12 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-12 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-12 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-12 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-12 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-12 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-12 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-12 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 4e-12 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 4e-12 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 4e-12 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-12 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-12 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 4e-12 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 4e-12 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 4e-12 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 4e-12 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 5e-12 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 5e-12 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 5e-12 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 5e-12 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 6e-12 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 6e-12 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 6e-12 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-12 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 6e-12 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 7e-12 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 7e-12 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 7e-12 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 7e-12 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 7e-12 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 8e-12 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 8e-12 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 8e-12 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 8e-12 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 8e-12 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 8e-12 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 8e-12 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 8e-12 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 9e-12 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 9e-12 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 9e-12 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-11 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-11 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-11 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-11 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-11 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-11 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-11 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-11 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-11 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-11 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-11 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-11 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-11 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-11 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-11 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-11 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-11 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-11 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-11 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-11 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-11 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-11 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-11 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-11 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-11 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-11 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-11 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-11 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-11 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-11 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-11 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-11 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-11 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-11 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-11 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-11 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-11 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-11 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-11 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 4e-11 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 4e-11 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-11 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 4e-11 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-11 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 4e-11 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 4e-11 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-11 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 7e-11 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 7e-11 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-11 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 8e-11 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 9e-11 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 9e-11 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-10 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-10 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-10 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-10 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-10 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-10 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-10 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-10 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-10 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-10 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-10 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-10 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-10 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-10 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-10 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-10 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-10 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-10 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-10 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-10 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-10 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-10 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-10 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-10 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-10 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-10 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-10 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-10 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-10 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-10 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-10 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-10 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-10 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-10 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-10 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-10 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 3e-10 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 3e-10 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 3e-10 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-10 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-10 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 3e-10 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 3e-10 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-10 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-10 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-10 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 3e-10 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 4e-10 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-10 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-10 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-10 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 4e-10 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-10 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-10 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 5e-10 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-10 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 5e-10 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 5e-10 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 5e-10 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 5e-10 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 5e-10 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 6e-10 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 6e-10 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 6e-10 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 6e-10 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 6e-10 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-10 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 6e-10 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 6e-10 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 7e-10 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 7e-10 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 7e-10 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 7e-10 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 7e-10 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 7e-10 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 7e-10 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 7e-10 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 7e-10 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 8e-10 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 8e-10 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 8e-10 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 8e-10 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 8e-10 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 8e-10 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 8e-10 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 8e-10 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 9e-10 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 9e-10 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 9e-10 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 9e-10 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 9e-10 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-09 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-09 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-09 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-09 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-09 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-09 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-09 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-09 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-09 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-09 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-09 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-09 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-09 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-09 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-09 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-09 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-09 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-09 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-09 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-09 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-09 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-09 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-09 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-09 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-09 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-09 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-09 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-09 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-09 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-09 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-09 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-09 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-09 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-09 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-09 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-09 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-09 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-09 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-09 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-09 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-09 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-09 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-09 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-09 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-09 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-09 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-09 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-09 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-09 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-09 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-09 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-09 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-09 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-09 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-09 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-09 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-09 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-09 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-09 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-09 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-09 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-09 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-09 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-09 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-09 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-09 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-09 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-09 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-09 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-09 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-09 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-09 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-09 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-09 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-09 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-09 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-09 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-09 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-09 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-09 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-09 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-09 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-09 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-09 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-09 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-09 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-09 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-09 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-09 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-09 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-09 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-09 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-09 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-09 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-09 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-09 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-09 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-09 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-09 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-09 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-09 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-09 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-09 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-09 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-09 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 3e-09 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-09 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-09 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-09 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-09 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-09 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-09 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-09 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 4e-09 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 4e-09 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 4e-09 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 4e-09 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 4e-09 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 4e-09 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 4e-09 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-09 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 4e-09 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 4e-09 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-09 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 4e-09 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 4e-09 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 4e-09 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 4e-09 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 4e-09 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 4e-09 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 4e-09 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-09 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 4e-09 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 4e-09 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 4e-09 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-09 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 5e-09 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-09 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 5e-09 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-09 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 5e-09 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 5e-09 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 5e-09 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 5e-09 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 5e-09 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 5e-09 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 5e-09 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 5e-09 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 5e-09 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 6e-09 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 6e-09 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 6e-09 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 6e-09 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 6e-09 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 6e-09 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 6e-09 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-09 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 6e-09 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 6e-09 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 6e-09 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 7e-09 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 7e-09 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 7e-09 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 7e-09 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-09 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 7e-09 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-09 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 7e-09 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 7e-09 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 8e-09 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 8e-09 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 8e-09 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 8e-09 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 9e-09 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-08 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-08 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-08 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-08 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-08 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-08 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-08 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-08 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-08 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-08 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-08 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-08 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-08 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-08 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-08 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-08 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-08 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-08 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-08 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-08 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-08 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-08 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-08 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-08 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-08 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-08 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-08 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-08 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-08 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-08 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-08 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 3e-08 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-08 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-08 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 3e-08 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-08 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 3e-08 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-08 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 3e-08 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-08 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 3e-08 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 3e-08 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 3e-08 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 3e-08 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-08 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-08 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 4e-08 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 4e-08 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-08 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 4e-08 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 4e-08 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 4e-08 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 4e-08 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 4e-08 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 4e-08 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-08 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 4e-08 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 4e-08 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 4e-08 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 4e-08 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 4e-08 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 5e-08 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 5e-08 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 5e-08 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 5e-08 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-08 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 5e-08 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 5e-08 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-08 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 5e-08 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 6e-08 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 6e-08 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 6e-08 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 6e-08 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 6e-08 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 6e-08 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 7e-08 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 7e-08 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 7e-08 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 7e-08 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 7e-08 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 8e-08 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 8e-08 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 8e-08 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 8e-08 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 8e-08 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 9e-08 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 9e-08 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 9e-08 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 9e-08 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 9e-08 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 9e-08 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 9e-08 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 9e-08 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 9e-08 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 9e-08 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 9e-08 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 9e-08 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-07 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-07 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-07 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-07 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-07 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-07 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-07 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-07 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-07 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-07 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-07 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-07 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-07 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-07 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-07 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-07 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-07 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-07 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-07 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-07 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-07 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-07 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 1e-07 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-07 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-07 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-07 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-07 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-07 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-07 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-07 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-07 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-07 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-07 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-07 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-07 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-07 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-07 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-07 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-07 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-07 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-07 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-07 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-07 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-07 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-07 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-07 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-07 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-07 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-07 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-07 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-07 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-07 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-07 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-07 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-07 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-07 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-07 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-07 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-07 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-07 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-07 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-07 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-07 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-07 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-07 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-07 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-07 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-07 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 3e-07 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-07 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 3e-07 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-07 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 3e-07 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 4e-07 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 4e-07 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 4e-07 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 4e-07 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-07 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 4e-07 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 4e-07 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 4e-07 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 4e-07 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 5e-07 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 5e-07 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 5e-07 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 5e-07 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 6e-07 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 6e-07 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 7e-07 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 8e-07 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 8e-07 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 8e-07 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 8e-07 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 8e-07 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 8e-07 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 8e-07 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 8e-07 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 8e-07 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 8e-07 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 8e-07 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 8e-07 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 9e-07 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 9e-07 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 9e-07 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 9e-07 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 9e-07 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 9e-07 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-06 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-06 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-06 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-06 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-06 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-06 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-06 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-06 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-06 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-06 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-06 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 1e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-06 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-06 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-06 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-06 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-06 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-06 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-06 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-06 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 3e-06 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-06 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 4e-06 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-06 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 4e-06 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-06 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 4e-06 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 4e-06 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 4e-06 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 4e-06 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 4e-06 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 4e-06 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 4e-06 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-06 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 5e-06 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 5e-06 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 6e-06 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 9e-06 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-05 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-05 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-05 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-05 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-05 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-05 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-05 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 4e-05 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 4e-05 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-05 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-05 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 4e-05 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 6e-05 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 9e-05 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 1e-04 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 1e-04 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 464 bits (1197), Expect = e-158
Identities = 123/307 (40%), Positives = 183/307 (59%), Gaps = 14/307 (4%)
Query: 532 SSGSIPQLKGARCFSFEEVKKYTNNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGS 591
S S + ++++ TNNF +G G +GKVYKG L +G +A+KR S
Sbjct: 16 LSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPES 75
Query: 592 MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNG--IR 649
QG +EF+ EIE LS H +LVSL+GFC +R E +LIY+++ NG+L L G + +
Sbjct: 76 SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMS 135
Query: 650 LDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDS 709
+ W +RL+I +GAARGL YLH IIHRD+KS NILLDE K+ DFG+SK ++
Sbjct: 136 MSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISKKGTEL 192
Query: 710 EKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGK-----YI 764
++ H++T VKGT+GY+DPEY++ +LTEKSDVYSFGV++ E+L R I + +
Sbjct: 193 DQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNL 252
Query: 765 VREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVK 824
+ L +++DP + + K+ D A+KC+ S +DRP+M +V+
Sbjct: 253 AEWAVESHNNG----QLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLW 308
Query: 825 DIENILQ 831
+E L+
Sbjct: 309 KLEYALR 315
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 416 bits (1072), Expect = e-139
Identities = 122/292 (41%), Positives = 189/292 (64%), Gaps = 7/292 (2%)
Query: 539 LKGARCFSFEEVKKYTNNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQ-E 597
L + FS E++ ++NFS+ N +G GG+GKVYKG L +G L+A+KR ++ QGG+ +
Sbjct: 14 LGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQ 73
Query: 598 FKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNG--IRLDWIRR 655
F+ E+E++S H+NL+ L GFC E++L+Y ++ NGS+ L + LDW +R
Sbjct: 74 FQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKR 133
Query: 656 LKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHIT 715
+IALG+ARGL+YLH+ +P IIHRD+K++NILLDE A V DFGL+K M + H+T
Sbjct: 134 QRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY-KDTHVT 192
Query: 716 TQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKK 775
T V+GT+G++ PEY T + +EK+DV+ +GV++LEL+TG+R + + + ++D
Sbjct: 193 TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 252
Query: 776 KELY---NLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVK 824
K L L L+D + + + E+ + +AL C Q S +RP MSEVV+
Sbjct: 253 KGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVR 304
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 391 bits (1006), Expect = e-130
Identities = 107/302 (35%), Positives = 173/302 (57%), Gaps = 23/302 (7%)
Query: 543 RCFSFEEVKKYTNNFSD------ANDVGSGGYGKVYKGTLPNGQLIAIKR----AQQGSM 592
FSF E+K TNNF + N +G GG+G VYKG + N +A+K+ +
Sbjct: 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTE 71
Query: 593 QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIR-LD 651
+ Q+F EI+++++ H+NLV LLGF D + L+Y ++PNGSL D LS +G L
Sbjct: 72 ELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLS 131
Query: 652 WIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEK 711
W R KIA GAA G+++LHE IHRDIKS+NILLDE AK++DFGL+++ +
Sbjct: 132 WHMRCKIAQGAANGINFLHE---NHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 188
Query: 712 DHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGK---YIVREI 768
+T+++ GT Y+ PE + ++T KSD+YSFGV++LE++TG ++ + ++
Sbjct: 189 TVMTSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIK 247
Query: 769 RTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIEN 828
+ D++K + + ID + E +A +C+ E + RP + +V + ++
Sbjct: 248 EEIEDEEK---TIEDYIDKKMN-DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQE 303
Query: 829 IL 830
+
Sbjct: 304 MT 305
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 277 bits (710), Expect = 3e-86
Identities = 69/313 (22%), Positives = 119/313 (38%), Gaps = 32/313 (10%)
Query: 545 FSFEEVKKYTNNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIEL 604
E + + G +G V+K + +A+K Q + + E+
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQ-LLNEYVAVKIFPIQDKQS-WQNEYEVYS 71
Query: 605 LSRVHHKNLVSLLGFC----FDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIAL 660
L + H+N++ +G + LI F GSL D L + W IA
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN---VVSWNELCHIAE 128
Query: 661 GAARGLSYLHE-------LANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDH 713
ARGL+YLHE P I HRDIKS N+LL L A +ADFGL+ +
Sbjct: 129 TMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAG 188
Query: 714 ITTQVKGTMGYLDPEY-----YMTQQLTEKSDVYSFGVLMLELLTGRRPIE--RGKY--- 763
T GT Y+ PE + + D+Y+ G+++ EL + + +Y
Sbjct: 189 DTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLP 248
Query: 764 ---IVREIRTVMDKKKELYNLYELIDPTIGLS-TTLKGFEKYVDLALKCVQESGDDRPTM 819
+ + ++ D ++ +++ P + G + +C + R +
Sbjct: 249 FEEEIGQHPSLEDMQE--VVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSA 306
Query: 820 SEVVKDIENILQQ 832
V + I + +
Sbjct: 307 GCVGERITQMQRL 319
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 240 bits (614), Expect = 1e-72
Identities = 83/319 (26%), Positives = 140/319 (43%), Gaps = 24/319 (7%)
Query: 526 HWDMNKSSGSIPQLKGARCFSFEEVKKYTNNFSD---ANDVGSGGYGKVYKGTLPNGQLI 582
H S IP + + + D +G+G +G V++ +G +
Sbjct: 5 HHHHPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDV 63
Query: 583 AIK--RAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGD 640
A+K Q + EF E+ ++ R+ H N+V +G ++ E++ GSL
Sbjct: 64 AVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYR 123
Query: 641 SLSGKNGIR-LDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVAD 699
L LD RRL +A A+G++YLH NPPI+HR++KS N+L+D++ KV D
Sbjct: 124 LLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR-NPPIVHRNLKSPNLLVDKKYTVKVCD 182
Query: 700 FGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIE 759
FGLS+ + + + GT ++ PE + EKSDVYSFGV++ EL T ++P
Sbjct: 183 FGLSRLKASTFLS--SKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWG 240
Query: 760 RGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTM 819
+ + V K K I + + + C RP+
Sbjct: 241 -NLNPAQVVAAVGFKCKR---------LEIPRNLN----PQVAAIIEGCWTNEPWKRPSF 286
Query: 820 SEVVKDIENILQQAGLNPN 838
+ ++ + +++ A PN
Sbjct: 287 ATIMDLLRPLIKSAVPPPN 305
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 238 bits (609), Expect = 6e-72
Identities = 70/272 (25%), Positives = 125/272 (45%), Gaps = 25/272 (9%)
Query: 563 VGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFD 622
VG G +G V K + +AIK+ + S + + F +E+ LSRV+H N+V L G C +
Sbjct: 16 VGRGAFGVVCKAKW-RAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGACLN 72
Query: 623 RGEQMLIYEFVPNGSLGDSL-SGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRD 681
L+ E+ GSL + L + + L ++G++YLH + +IHRD
Sbjct: 73 --PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRD 130
Query: 682 IKSSNILLDERLN-AKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSD 740
+K N+LL K+ DFG + + T KG+ ++ PE + +EK D
Sbjct: 131 LKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPEVFEGSNYSEKCD 185
Query: 741 VYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEK 800
V+S+G+++ E++T R+P + I + P + + +
Sbjct: 186 VFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTR---------PPLIKNLP----KP 232
Query: 801 YVDLALKCVQESGDDRPTMSEVVKDIENILQQ 832
L +C + RP+M E+VK + ++++
Sbjct: 233 IESLMTRCWSKDPSQRPSMEEIVKIMTHLMRY 264
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 232 bits (595), Expect = 4e-70
Identities = 83/303 (27%), Positives = 141/303 (46%), Gaps = 41/303 (13%)
Query: 546 SFEEVKKYTNNFSD---ANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGG------ 595
F + + T ++ +G GG+G V+KG + + ++AIK G +G
Sbjct: 7 EFPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEK 66
Query: 596 -QEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIR 654
QEF+ E+ ++S ++H N+V L G + ++ EFVP G L L + W
Sbjct: 67 FQEFQREVFIMSNLNHPNIVKLYGLMHN--PPRMVMEFVPCGDLYHRLL-DKAHPIKWSV 123
Query: 655 RLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDER-----LNAKVADFGLSKSMSDS 709
+L++ L A G+ Y+ NPPI+HRD++S NI L + AKVADFGLS+
Sbjct: 124 KLRLMLDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ----- 177
Query: 710 EKDHITTQVKGTMGYLDPEYYMTQQL--TEKSDVYSFGVLMLELLTGRRPIERGKYI-VR 766
+ H + + G ++ PE ++ TEK+D YSF +++ +LTG P + Y ++
Sbjct: 178 QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIK 237
Query: 767 EIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDI 826
I + ++ PTI + ++ C RP S +VK++
Sbjct: 238 FINMIREEGLR---------PTIPEDCP----PRLRNVIELCWSGDPKKRPHFSYIVKEL 284
Query: 827 ENI 829
+
Sbjct: 285 SEL 287
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 232 bits (592), Expect = 3e-69
Identities = 73/351 (20%), Positives = 128/351 (36%), Gaps = 54/351 (15%)
Query: 545 FSFEEVKKYTNNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIE- 603
+ E +N +G G YG VYKG+L + + +A+K S Q F E
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVF---SFANRQNFINEKNI 58
Query: 604 -LLSRVHHKNLVSLLGFC-----FDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLK 657
+ + H N+ + R E +L+ E+ PNGSL LS DW+ +
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH---TSDWVSSCR 115
Query: 658 IALGAARGLSYLHE------LANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDS-- 709
+A RGL+YLH P I HRD+ S N+L+ ++DFGLS ++ +
Sbjct: 116 LAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRL 175
Query: 710 ----EKDHITTQVKGTMGYLDPEYYM-------TQQLTEKSDVYSFGVLMLELLTGRRPI 758
E+D+ GT+ Y+ PE + ++ D+Y+ G++ E+ +
Sbjct: 176 VRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL 235
Query: 759 ERGKYIVREIRTV-MDKKKELYNLYELID--------PTI--GLSTTLKGFEKYVDLALK 807
G+ V E + + ++ P +
Sbjct: 236 FPGE-SVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIED 294
Query: 808 CVQESGDDRPTMSEVVKDIENILQQAGLNPNAESASSSASYEDASKGNFHH 858
C + + R T + + ++ N + + + HH
Sbjct: 295 CWDQDAEARLTAQXAEERMAELMMIWERNKSVSPTAHH---------HHHH 336
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 225 bits (577), Expect = 7e-68
Identities = 80/279 (28%), Positives = 126/279 (45%), Gaps = 34/279 (12%)
Query: 563 VGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGG----QEFKMEIELLSRVHHKNLVSLLG 618
+G GG+GKVY+ G +A+K A+ + + + E +L + + H N+++L G
Sbjct: 15 IGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 619 FCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPII 678
C L+ EF G L LSGK R+ + A+ ARG++YLH+ A PII
Sbjct: 74 VCLKEPNLCLVMEFARGGPLNRVLSGK---RIPPDILVNWAVQIARGMNYLHDEAIVPII 130
Query: 679 HRDIKSSNILLDERL--------NAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYY 730
HRD+KSSNIL+ +++ K+ DFGL++ + K G ++ PE
Sbjct: 131 HRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK----MSAAGAYAWMAPEVI 186
Query: 731 MTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIG 790
++ SDV+S+GVL+ ELLTG P G + V K I
Sbjct: 187 RASMFSKGSDVWSYGVLLWELLTGEVPFR-GIDGLAVAYGVAMNKLA---------LPIP 236
Query: 791 LSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENI 829
+ E + L C RP+ + ++ + I
Sbjct: 237 STCP----EPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 222 bits (569), Expect = 1e-66
Identities = 61/287 (21%), Positives = 110/287 (38%), Gaps = 50/287 (17%)
Query: 563 VGSGGYGKVYKGTLPNGQLIAIK--RAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFC 620
+ G+++KG G I +K + + S + ++F E L H N++ +LG C
Sbjct: 18 LNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGAC 76
Query: 621 FDRGEQ--MLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPII 678
LI ++P GSL + L +D + +K AL ARG+++LH L P I
Sbjct: 77 QSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL-EPLIP 135
Query: 679 HRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQL--- 735
+ S ++++DE + A+++ + S ++ PE +
Sbjct: 136 RHALNSRSVMIDEDMTARISMADVKFSFQS-------PGRMYAPAWVAPEALQKKPEDTN 188
Query: 736 TEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPT-IGLSTT 794
+D++SF VL+ EL+T P + + IG+
Sbjct: 189 RRSADMWSFAVLLWELVTREVP------------------------FADLSNMEIGMKVA 224
Query: 795 LKGF---------EKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 832
L+G L C+ E RP +V +E + +
Sbjct: 225 LEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQDK 271
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 212 bits (543), Expect = 8e-63
Identities = 75/278 (26%), Positives = 132/278 (47%), Gaps = 28/278 (10%)
Query: 563 VGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGG--QEFKMEIELLSRVHHKNLVSLLGFC 620
+GSG +G VYKG +G +A+K + Q FK E+ +L + H N++ +G+
Sbjct: 32 IGSGSFGTVYKGKW-HGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 621 FDRGEQM-LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIH 679
Q+ ++ ++ SL L + + + + + IA ARG+ YLH IIH
Sbjct: 90 --TAPQLAIVTQWCEGSSLYHHLH-ASETKFEMKKLIDIARQTARGMDYLH---AKSIIH 143
Query: 680 RDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQL---T 736
RD+KS+NI L E K+ DFGL+ S H Q+ G++ ++ PE Q +
Sbjct: 144 RDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYS 203
Query: 737 EKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTV--MDKKKELYNLYELIDPTIGLSTT 794
+SDVY+FG+++ EL+TG+ P + I V +L +
Sbjct: 204 FQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPK------- 256
Query: 795 LKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 832
+ L +C+++ D+RP+ ++ +IE + ++
Sbjct: 257 -----RMKRLMAECLKKKRDERPSFPRILAEIEELARE 289
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 213 bits (545), Expect = 1e-62
Identities = 68/252 (26%), Positives = 114/252 (45%), Gaps = 12/252 (4%)
Query: 9 GDITGLTELHTLDLSNNKDLRG--PLPTTIGNLKKLSNLMLVG-CSFSGPIPDSIGSLQE 65
T ++ LDLS L P+P+++ NL L+ L + G + GPIP +I L +
Sbjct: 44 DTDTQTYRVNNLDLSGLN-LPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQ 102
Query: 66 LVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHF 125
L L + SG +P + + L LD + N L G +P S + P L + F
Sbjct: 103 LHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGI------TF 156
Query: 126 GKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPS 185
N++SG+IP+ + + N LTG++P T + +L V RN L G
Sbjct: 157 DGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASV 215
Query: 186 NLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLM 245
+ + ++L+ N L + + L+ LD+ NN + +P + ++ L +L
Sbjct: 216 LFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGT-LPQGLTQLKFLHSLN 274
Query: 246 MENTNLKGQIPA 257
+ NL G+IP
Sbjct: 275 VSFNNLCGEIPQ 286
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 3e-60
Identities = 71/251 (28%), Positives = 113/251 (45%), Gaps = 12/251 (4%)
Query: 5 GQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQ 64
+ + L L+ L + +L GP+P I L +L L + + SG IPD + ++
Sbjct: 66 YPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIK 125
Query: 65 ELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFH 124
LV L + N SG +PPSI +L NL + N++ G IP S G+ L
Sbjct: 126 TLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKL-----FTSMT 180
Query: 125 FGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVP 184
+N+L+G IP + L V N L G+ G K+ + + +NSL+ +
Sbjct: 181 ISRNRLTGKIPPTFAN--LNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG 238
Query: 185 SNLNNLTSVNDLYLSNNKLTGAMP-NLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTT 243
+ ++N L L NN++ G +P LT L L L++S N+ E+P ++Q
Sbjct: 239 K-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLC-GEIPQ-GGNLQRFDV 295
Query: 244 L-MMENTNLKG 253
N L G
Sbjct: 296 SAYANNKCLCG 306
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 2e-44
Identities = 65/290 (22%), Positives = 127/290 (43%), Gaps = 20/290 (6%)
Query: 21 DLSNNKDLRGPL--PTTIGNLKKLSN----LMLVGCSFSGPIPDSIGSLQELVLLSLNSN 74
+L N +D + L +GN LS+ ++ G + D+ + L L+
Sbjct: 1 ELCNPQDKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGL 60
Query: 75 GFSGR--VPPSIGNLSNLYWLDLTD-NKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLS 131
+P S+ NL L +L + N L G IP + L + + +S
Sbjct: 61 NLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQL------HYLYITHTNVS 114
Query: 132 GSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLT 191
G+IP+ L + L+ + F N L+G LP ++ + +L + FD N +SG +P + + +
Sbjct: 115 GAIPDFLSQIKT-LVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFS 173
Query: 192 S-VNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTN 250
+ +S N+LTG +P L+++D+S N + + F S ++ + + +
Sbjct: 174 KLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLE-GDASVLFGSDKNTQKIHLAKNS 232
Query: 251 LKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENL-LVNLQNNRIS 299
L + + +L + ++ N + GTL G + + L +N+ N +
Sbjct: 233 LAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLC 281
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 3e-42
Identities = 64/208 (30%), Positives = 98/208 (47%), Gaps = 19/208 (9%)
Query: 6 QLSGDI----TGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIG 61
+SG I + + L TLD S N L G LP +I +L L + G SG IPDS G
Sbjct: 112 NVSGAIPDFLSQIKTLVTLDFSYNA-LSGTLPPSISSLPNLVGITFDGNRISGAIPDSYG 170
Query: 62 SLQELV-LLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRA 120
S +L ++++ N +G++PP+ NL NL ++DL+ N LEG+ V G+ +
Sbjct: 171 SFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKI--- 226
Query: 121 KHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLS 180
H KN L+ + + + L + +N + G LP L +K L + N+L
Sbjct: 227 ---HLAKNSLAFDLGK-VGLSKN-LNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLC 281
Query: 181 GPVPS--NLNNLTSVNDLYLSNNKLTGA 206
G +P NL Y +N L G+
Sbjct: 282 GEIPQGGNLQRFDVSA--YANNKCLCGS 307
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 210 bits (537), Expect = 1e-61
Identities = 60/285 (21%), Positives = 116/285 (40%), Gaps = 34/285 (11%)
Query: 563 VGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCF 621
+G G +G+ K T G+++ +K + + + F E++++ + H N++ +G +
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 622 DRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRD 681
I E++ G+L + + W +R+ A A G++YLH + IIHRD
Sbjct: 78 KDKRLNFITEYIKGGTLRGIIK-SMDSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRD 133
Query: 682 IKSSNILLDERLNAKVADFGLSKSMSDSEKD------------HITTQVKGTMGYLDPEY 729
+ S N L+ E N VADFGL++ M D + V G ++ PE
Sbjct: 134 LNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEM 193
Query: 730 YMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLY--ELIDP 787
+ EK DV+SFG+++ E++ + + + Y P
Sbjct: 194 INGRSYDEKVDVFSFGIVLCEIIGRVNADP---DYLPRTMDFGLNVRGFLDRYCPPNCPP 250
Query: 788 TIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 832
+ + ++C + RP+ ++ +E +
Sbjct: 251 SF------------FPITVRCCDLDPEKRPSFVKLEHWLETLRMH 283
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 209 bits (534), Expect = 4e-61
Identities = 59/284 (20%), Positives = 111/284 (39%), Gaps = 35/284 (12%)
Query: 563 VGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGG--QEFKMEIELLSRVHHKNLVSLLGFC 620
+G G +G+VY G +G+ +AI+ + FK E+ + H+N+V +G C
Sbjct: 41 IGKGRFGQVYHGRW-HGE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGAC 98
Query: 621 FDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHR 680
+I +L + I LD + +IA +G+ YLH I+H+
Sbjct: 99 MSPPHLAIITSLCKGRTLYSVVRDAK-IVLDVNKTRQIAQEIVKGMGYLH---AKGILHK 154
Query: 681 DIKSSNILLDERLNAKVADFGLSKSMSD---SEKDHITTQVKGTMGYLDPEYYMTQQL-- 735
D+KS N+ D + DFGL ++ G + +L PE
Sbjct: 155 DLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDT 213
Query: 736 -------TEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPT 788
++ SDV++ G + EL P + + ++ + + P
Sbjct: 214 EEDKLPFSKHSDVFALGTIWYELHAREWPFKT-----------QPAEAIIWQMGTGMKPN 262
Query: 789 IGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 832
+ K D+ L C ++RPT ++++ +E + ++
Sbjct: 263 LSQIGMGKEI---SDILLFCWAFEQEERPTFTKLMDMLEKLPKR 303
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 198 bits (505), Expect = 2e-57
Identities = 68/303 (22%), Positives = 119/303 (39%), Gaps = 54/303 (17%)
Query: 563 VGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIEL--LSRVHHKNLVSLLGFC 620
VG G YG+V++G+ G+ +A+K S + + + E EL + H+N++ +
Sbjct: 16 VGKGRYGEVWRGSW-QGENVAVKIF---SSRDEKSWFRETELYNTVMLRHENILGFIASD 71
Query: 621 ----FDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELA--- 673
+ LI + GSL D L LD + L+I L A GL++LH
Sbjct: 72 MTSRHSSTQLWLITHYHEMGSLYDYLQLT---TLDTVSCLRIVLSIASGLAHLHIEIFGT 128
Query: 674 --NPPIIHRDIKSSNILLDERLNAKVADFGLS--KSMSDSEKDHITTQVKGTMGYLDPE- 728
P I HRD+KS NIL+ + +AD GL+ S S ++ D GT Y+ PE
Sbjct: 129 QGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEV 188
Query: 729 -----YYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYE 783
++ D+++FG+++ E+ +++ K +
Sbjct: 189 LDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNG-----------IVEDYKPPFYDVV 237
Query: 784 LIDPTIGLSTTLKGFEK-----------------YVDLALKCVQESGDDRPTMSEVVKDI 826
DP+ + ++ L +C ++ R T + K +
Sbjct: 238 PNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTL 297
Query: 827 ENI 829
I
Sbjct: 298 TKI 300
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 2e-56
Identities = 67/306 (21%), Positives = 111/306 (36%), Gaps = 54/306 (17%)
Query: 563 VGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIE--LLSRVHHKNLVSLLGFC 620
+G G YG+V+ G G+ +A+K + E E + H+N++ +
Sbjct: 45 IGKGRYGEVWMGKW-RGEKVAVKVF---FTTEEASWFRETEIYQTVLMRHENILGFIAAD 100
Query: 621 ----FDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELA--- 673
+ LI ++ NGSL D L LD LK+A + GL +LH
Sbjct: 101 IKGTGSWTQLYLITDYHENGSLYDYLKSTT---LDAKSMLKLAYSSVSGLCHLHTEIFST 157
Query: 674 --NPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEK--DHITTQVKGTMGYLDPE- 728
P I HRD+KS NIL+ + +AD GL+ D GT Y+ PE
Sbjct: 158 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEV 217
Query: 729 -----YYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYE 783
Q +D+YSFG+++ E+ ++++ + Y+
Sbjct: 218 LDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGG-----------IVEEYQLPYHDLV 266
Query: 784 LIDPTIGLSTTLKGFEK-----------------YVDLALKCVQESGDDRPTMSEVVKDI 826
DP+ + +K L +C + R T V K +
Sbjct: 267 PSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTL 326
Query: 827 ENILQQ 832
+ +
Sbjct: 327 AKMSES 332
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 204 bits (522), Expect = 2e-55
Identities = 80/309 (25%), Positives = 131/309 (42%), Gaps = 30/309 (9%)
Query: 6 QLSGDI-------TGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPD 58
+SG G EL L +S NK + G + + L L + +FS IP
Sbjct: 162 SISGANVVGWVLSDGCGELKHLAISGNK-ISGDVD--VSRCVNLEFLDVSSNNFSTGIP- 217
Query: 59 SIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLV 118
+G L L ++ N SG +I + L L+++ N+ G IP L
Sbjct: 218 FLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSL---- 271
Query: 119 RAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNS 178
++ +N+ +G IP+ L L + N+ G +P G LE + N+
Sbjct: 272 --QYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNN 329
Query: 179 LSGPVP-SNLNNLTSVNDLYLSNNKLTGAMPN-LTGLSV-LSYLDMSNNSFDASEVPSWF 235
SG +P L + + L LS N+ +G +P LT LS L LD+S+N+F +
Sbjct: 330 FSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFS-GPILPNL 388
Query: 236 --SSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTL--DLGTSYSENL-L 290
+ +L L ++N G+IP L + L ++ + N L+GT+ LG+ L
Sbjct: 389 CQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGS--LSKLRD 446
Query: 291 VNLQNNRIS 299
+ L N +
Sbjct: 447 LKLWLNMLE 455
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 199 bits (509), Expect = 8e-54
Identities = 79/303 (26%), Positives = 128/303 (42%), Gaps = 18/303 (5%)
Query: 3 LKGQLSGDITGLT-ELHTLDLSNNKDLRGPLPTTIGN--LKKLSNLMLVGCSFSGPIPDS 59
G+L +T L+ L TLDLS+N GP+ + L L L F+G IP +
Sbjct: 355 FSGELPESLTNLSASLLTLDLSSNN-FSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPT 413
Query: 60 IGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVR 119
+ + ELV L L+ N SG +P S+G+LS L L L N LEGEIP L+ L
Sbjct: 414 LSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETL-- 471
Query: 120 AKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSL 179
N L+G IP L L + +N LTGE+P +G +++L +++ NS
Sbjct: 472 ----ILDFNDLTGEIPSGLSNCTN-LNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSF 526
Query: 180 SGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQ 239
SG +P+ L + S+ L L+ N G +P + S ++ N + + +
Sbjct: 527 SGNIPAELGDCRSLIWLDLNTNLFNGTIP--AAMFKQS-GKIAANFIA-GKRYVYIKNDG 582
Query: 240 SLTTLMMEN--TNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENLLV-NLQNN 296
+G L + + + G + +++ ++ N
Sbjct: 583 MKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYN 642
Query: 297 RIS 299
+S
Sbjct: 643 MLS 645
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 2e-53
Identities = 75/271 (27%), Positives = 121/271 (44%), Gaps = 20/271 (7%)
Query: 3 LKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGS 62
L+G++ ++ + L TL L N L G +P+ + N L+ + L +G IP IG
Sbjct: 454 LEGEIPQELMYVKTLETLILDFND-LTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGR 512
Query: 63 LQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGL-------- 114
L+ L +L L++N FSG +P +G+ +L WLDL N G IP + G
Sbjct: 513 LENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAG 572
Query: 115 --------DMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLV 166
D + + H + G E+L R S G T
Sbjct: 573 KRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLST-RNPCNITSRVYGGHTSPTFDNN 631
Query: 167 KSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMP-NLTGLSVLSYLDMSNNS 225
S+ + N LSG +P + ++ + L L +N ++G++P + L L+ LD+S+N
Sbjct: 632 GSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNK 691
Query: 226 FDASEVPSWFSSMQSLTTLMMENTNLKGQIP 256
D +P S++ LT + + N NL G IP
Sbjct: 692 LD-GRIPQAMSALTMLTEIDLSNNNLSGPIP 721
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 2e-50
Identities = 72/279 (25%), Positives = 129/279 (46%), Gaps = 16/279 (5%)
Query: 3 LKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGS 62
G++ ++ +EL +L LS N L G +P+++G+L KL +L L G IP +
Sbjct: 406 FTGKIPPTLSNCSELVSLHLSFNY-LSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMY 464
Query: 63 LQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKH 122
++ L L L+ N +G +P + N +NL W+ L++N+L GEIP G L +L
Sbjct: 465 VKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILK---- 520
Query: 123 FHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGP 182
N SG+IP +L LI + ++N G +PA + N ++G
Sbjct: 521 --LSNNSFSGNIPAELGDCRS-LIWLDLNTNLFNGTIPAAMFKQSGKI----AANFIAGK 573
Query: 183 VPSNLNNLTSVNDLYLSNN--KLTGAMPN-LTGLSVLSYLDMSNNSFDASEVPSWFSSMQ 239
+ N + + + N + G L LS + ++++ + F +
Sbjct: 574 RYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYG-GHTSPTFDNNG 632
Query: 240 SLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGT 278
S+ L M L G IP ++ S+P+L + + N+++G+
Sbjct: 633 SMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGS 671
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 4e-50
Identities = 76/298 (25%), Positives = 128/298 (42%), Gaps = 21/298 (7%)
Query: 2 GLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPD--S 59
+S + LT L +L LSN+ + G + L++L L S SGP+ S
Sbjct: 64 VGFSAVSSSLLSLTGLESLFLSNS-HINGSVS-GFKCSASLTSLDLSRNSLSGPVTTLTS 121
Query: 60 IGSLQELVLLSLNSNGFSGRVP-PSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLV 118
+GS L L+++SN L++L LDL+ N + G V S G L
Sbjct: 122 LGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGEL- 180
Query: 119 RAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNS 178
KH N++SG + L + SNN + +P LG +L+ + N
Sbjct: 181 --KHLAISGNKISGDVDVSRCVN---LEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNK 234
Query: 179 LSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSW-FSS 237
LSG ++ T + L +S+N+ G +P L L YL ++ N F E+P + +
Sbjct: 235 LSGDFSRAISTCTELKLLNISSNQFVGPIPP-LPLKSLQYLSLAENKFT-GEIPDFLSGA 292
Query: 238 MQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENLLVNLQN 295
+LT L + + G +P S L+++ + +N +G L + L+ ++
Sbjct: 293 CDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGEL------PMDTLLKMRG 344
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 1e-47
Identities = 66/292 (22%), Positives = 121/292 (41%), Gaps = 21/292 (7%)
Query: 17 LHTLDLSNN--KDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSN 74
+ ++DLS+ + +++ +L L +L L +G + L L L+ N
Sbjct: 52 VTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLSRN 110
Query: 75 GFSGRVPP--SIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSG 132
SG V S+G+ S L +L+++ N L+ VS G L + N +SG
Sbjct: 111 SLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLK-----LNSLEVLDLSANSISG 165
Query: 133 SIPEKLFRPDMV--LIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNL 190
+ D L H+ N ++G++ + +LE + N+ S +P L +
Sbjct: 166 ANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPF-LGDC 222
Query: 191 TSVNDLYLSNNKLTGAMP-NLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENT 249
+++ L +S NKL+G ++ + L L++S+N F +P ++SL L +
Sbjct: 223 SALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFV-GPIPP--LPLKSLQYLSLAEN 279
Query: 250 NLKGQIPADLF-SIPHLQTVVMKTNELNGTLDLGTSYSENLLV-NLQNNRIS 299
G+IP L + L + + N G + L L +N S
Sbjct: 280 KFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFS 331
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 5e-36
Identities = 47/226 (20%), Positives = 85/226 (37%), Gaps = 16/226 (7%)
Query: 3 LKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGS 62
G + ++ L LDL+ N G +P + + +G I +
Sbjct: 526 FSGNIPAELGDCRSLIWLDLNTNL-FNGTIPAAMFKQS----GKIAANFIAGKRYVYIKN 580
Query: 63 LQELVLLSLNSNG--FSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRA 120
N F G + LS ++T G + N+ + L
Sbjct: 581 DGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFL--- 637
Query: 121 KHFHFGKNQLSGSIPEKLFRPDMVLIHVL-FDSNNLTGELPATLGLVKSLEVVRFDRNSL 179
N LSG IP+++ M + +L N+++G +P +G ++ L ++ N L
Sbjct: 638 ---DMSYNMLSGYIPKEIG--SMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKL 692
Query: 180 SGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNS 225
G +P ++ LT + ++ LSNN L+G +P + NN
Sbjct: 693 DGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNP 738
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 2e-33
Identities = 52/245 (21%), Positives = 99/245 (40%), Gaps = 18/245 (7%)
Query: 61 GSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRA 120
+ + L S N V S+ +L+ L L L+++ + G + S L
Sbjct: 50 DKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASL------ 102
Query: 121 KHFHFGKNQLSGSIPEKLFRPDMVLIHVL-FDSNNLTGELPATLGL-VKSLEVVRFDRNS 178
+N LSG + + L SN L + GL + SLEV+ NS
Sbjct: 103 TSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANS 162
Query: 179 LSGPVPSNL---NNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWF 235
+SG + + L +S NK++G + ++ L +LD+S+N+F ++ +P
Sbjct: 163 ISGANVVGWVLSDGCGELKHLAISGNKISGDVD-VSRCVNLEFLDVSSNNF-STGIPF-L 219
Query: 236 SSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENLLV-NLQ 294
+L L + L G + + L+ + + +N+ G + ++L +L
Sbjct: 220 GDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIP--PLPLKSLQYLSLA 277
Query: 295 NNRIS 299
N+ +
Sbjct: 278 ENKFT 282
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 6e-14
Identities = 33/155 (21%), Positives = 62/155 (40%), Gaps = 13/155 (8%)
Query: 166 VKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNS 225
V S+++ N V S+L +LT + L+LSN+ + G++ + L+ LD+S NS
Sbjct: 52 VTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRNS 111
Query: 226 FDASEVPS--WFSSMQSLTTLMMENTNLKGQIPA-DLFSIPHLQTVVMKTNELNGTLDLG 282
+ V + S L L + + L + L+ + + N ++G +G
Sbjct: 112 L-SGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVG 170
Query: 283 TSYSENL----LVNLQNNRISAYTERGGAPAVNLT 313
S+ + + N+IS G
Sbjct: 171 WVLSDGCGELKHLAISGNKIS-----GDVDVSRCV 200
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 1e-54
Identities = 64/302 (21%), Positives = 120/302 (39%), Gaps = 40/302 (13%)
Query: 563 VGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIE--LLSRVHHKNLVSLLGFC 620
+G G +G+V++G G+ +A+K S + + + E E + H+N++ +
Sbjct: 50 IGKGRFGEVWRGKW-RGEEVAVKIF---SSREERSWFREAEIYQTVMLRHENILGFIAAD 105
Query: 621 FDRGEQ----MLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHE----- 671
L+ ++ +GSL D L+ + +K+AL A GL++LH
Sbjct: 106 NKDNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAHLHMEIVGT 162
Query: 672 LANPPIIHRDIKSSNILLDERLNAKVADFGLS--KSMSDSEKDHITTQVKGTMGYLDPE- 728
P I HRD+KS NIL+ + +AD GL+ + D GT Y+ PE
Sbjct: 163 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 222
Query: 729 -----YYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTV-MDKKKELYNLY 782
+ +++D+Y+ G++ E+ I + + D ++
Sbjct: 223 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG----IHEDYQLPYYDLVPSDPSVE 278
Query: 783 ELID--------PTI-GLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQA 833
E+ P I + + + +C +G R T + K + + QQ
Sbjct: 279 EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 338
Query: 834 GL 835
G+
Sbjct: 339 GI 340
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 5e-46
Identities = 66/286 (23%), Positives = 118/286 (41%), Gaps = 50/286 (17%)
Query: 564 GSGGYGKVYKGTL-PNGQLIAIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLVSLLGFCF 621
G G +G+V+ G L + L+A+K ++ +F E +L + H N+V L+G C
Sbjct: 123 GRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCT 182
Query: 622 DRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRD 681
+ ++ E V G L G RL L++ AA G+ YL IHRD
Sbjct: 183 QKQPIYIVMELVQGGDFLTFL-RTEGARLRVKTLLQMVGDAAAGMEYLESK---CCIHRD 238
Query: 682 IKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQ----VKGTMGYLDPEYYMTQQLTE 737
+ + N L+ E+ K++DFG+S+ +D VK T PE + +
Sbjct: 239 LAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTA----PEALNYGRYSS 294
Query: 738 KSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELY----------NLYELID 786
+SDV+SFG+L+ E + G P Y + + ++ ++ L+
Sbjct: 295 ESDVWSFGILLWETFSLGASP-----YPNLSNQQTREFVEKGGRLPCPELCPDAVFRLM- 348
Query: 787 PTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 832
+C RP+ S + +++++I ++
Sbjct: 349 -------------------EQCWAYEPGQRPSFSTIYQELQSIRKR 375
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 2e-44
Identities = 73/291 (25%), Positives = 128/291 (43%), Gaps = 41/291 (14%)
Query: 564 GSGGYGKVYKGTLP-----NGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLG 618
G G +G V G+++A+K+ Q + + ++F+ EIE+L + H N+V G
Sbjct: 19 GKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKG 78
Query: 619 FCFDRGEQ--MLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPP 676
C+ G + LI E++P GSL D L K+ R+D I+ L+ +G+ YL
Sbjct: 79 VCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYTSQICKGMEYLGTKR--- 134
Query: 677 IIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGT-----MGYLDPEYYM 731
IHRD+ + NIL++ K+ DFGL+K + + + + G PE
Sbjct: 135 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDK-EFFKVKEPGESPIFWYA---PESLT 190
Query: 732 TQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIG 790
+ + SDV+SFGV++ EL T + +R I + +++L EL+
Sbjct: 191 ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK---- 246
Query: 791 LSTTLKGF----------EKYVDLALKCVQESGDDRPTMSEVVKDIENILQ 831
E Y + +C + + RP+ ++ ++ I
Sbjct: 247 -----NNGRLPRPDGCPDEIY-MIMTECWNNNVNQRPSFRDLALRVDQIRD 291
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 2e-44
Identities = 81/350 (23%), Positives = 146/350 (41%), Gaps = 52/350 (14%)
Query: 506 VYAYHQKRRAEKANEQNPFAHWDMNKSSGSIPQLKGARCFSFEEVKKYTNNFSDANDVGS 565
Y +H + +N + + GS + + F +K +G
Sbjct: 3 YYHHHHHHDYDIPTTENLYF----QGAMGSAFEDRDPTQFEERHLKF-------LQQLGK 51
Query: 566 GGYGKVYKGTLP-----NGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFC 620
G +G V G+++A+K+ Q + + ++F+ EIE+L + H N+V G C
Sbjct: 52 GNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVC 111
Query: 621 FDRGEQ--MLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPII 678
+ G + LI E++P GSL D L K+ R+D I+ L+ +G+ YL I
Sbjct: 112 YSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYTSQICKGMEYLGTKR---YI 167
Query: 679 HRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGT-----MGYLDPEYYMTQ 733
HRD+ + NIL++ K+ DFGL+K + + ++ + G PE
Sbjct: 168 HRDLATRNILVENENRVKIGDFGLTKVLPQDK-EYYKVKEPGESPIFWYA---PESLTES 223
Query: 734 QLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLS 792
+ + SDV+SFGV++ EL T + +R I + +++L EL+
Sbjct: 224 KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK------ 277
Query: 793 TTLKGF----------EKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 832
E Y + +C + + RP+ ++ ++ I Q
Sbjct: 278 ---NNGRLPRPDGCPDEIY-MIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 7e-44
Identities = 79/310 (25%), Positives = 133/310 (42%), Gaps = 43/310 (13%)
Query: 564 GSGGYGKVYKGTLP-----NGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLG 618
G G +G V G L+A+K+ Q ++F+ EI++L +H +V G
Sbjct: 32 GKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRG 91
Query: 619 FCFDRGEQ--MLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPP 676
+ G Q L+ E++P+G L D L ++ RLD R L + +G+ YL
Sbjct: 92 VSYGPGRQSLRLVMEYLPSGCLRDFLQ-RHRARLDASRLLLYSSQICKGMEYLGSRR--- 147
Query: 677 IIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGT-----MGYLDPEYYM 731
+HRD+ + NIL++ + K+ADFGL+K + +KD+ + G PE
Sbjct: 148 CVHRDLAARNILVESEAHVKIADFGLAKLL-PLDKDYYVVREPGQSPIFWYA---PESLS 203
Query: 732 TQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIG 790
+ +SDV+SFGV++ EL T + +R + D L L EL++
Sbjct: 204 DNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPA-LSRLLELLE---- 258
Query: 791 LSTTLKGF----------EKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ-AGLNPNA 839
+G E + +L C S DRP+ S + ++ + G +A
Sbjct: 259 -----EGQRLPAPPACPAEVH-ELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETHA 312
Query: 840 ESASSSASYE 849
+A +
Sbjct: 313 FTAHPEGKHH 322
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 1e-43
Identities = 67/271 (24%), Positives = 114/271 (42%), Gaps = 29/271 (10%)
Query: 563 VGSGGYGKVYKGT-LPNGQLIAIKRAQ--QGSMQGGQEFKMEIELLSRVHHKNLVSLLGF 619
+G G + VYKG +A Q + + Q FK E E+L + H N+V
Sbjct: 34 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 93
Query: 620 CFDRGEQM----LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANP 675
+ L+ E + +G+L L +++ +R +GL +LH P
Sbjct: 94 WESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRS--WCRQILKGLQFLHT-RTP 150
Query: 676 PIIHRDIKSSNILLDERL-NAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQ 734
PIIHRD+K NI + + K+ D GL+ S V GT ++ PE Y ++
Sbjct: 151 PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF----AKAVIGTPEFMAPEMY-EEK 205
Query: 735 LTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTT 794
E DVY+FG+ MLE+ T P + + R V K + ++ P
Sbjct: 206 YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPA-SFDKVAIP------E 258
Query: 795 LKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825
+K C++++ D+R ++ +++
Sbjct: 259 VKEI------IEGCIRQNKDERYSIKDLLNH 283
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 1e-42
Identities = 77/281 (27%), Positives = 126/281 (44%), Gaps = 42/281 (14%)
Query: 564 GSGGYGKVYKGTLPN-GQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFD 622
G G YG+VY+G +A+K ++ +M+ +EF E ++ + H NLV LLG C
Sbjct: 229 GGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCTR 287
Query: 623 RGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDI 682
+I EF+ G+L D L N + + L +A + + YL + IHR++
Sbjct: 288 EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNL 344
Query: 683 KSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVY 742
+ N L+ E KVADFGLS+ M+ K + + PE + + KSDV+
Sbjct: 345 AARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 403
Query: 743 SFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELY----------NLYELIDPTIGL 791
+FGVL+ E+ T G P Y ++ V + ++ Y +YEL+
Sbjct: 404 AFGVLLWEIATYGMSP-----YPGIDLSQVYELLEKDYRMERPEGCPEKVYELM------ 452
Query: 792 STTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 832
C Q + DRP+ +E+ + E + Q+
Sbjct: 453 --------------RACWQWNPSDRPSFAEIHQAFETMFQE 479
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 4e-42
Identities = 80/276 (28%), Positives = 132/276 (47%), Gaps = 32/276 (11%)
Query: 564 GSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDR 623
GSG +G V+ G N +AIK ++G+M ++F E E++ ++ H LV L G C ++
Sbjct: 17 GSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLYGVCLEQ 75
Query: 624 GEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIK 683
L+ EF+ +G L D L L + L G++YL E A +IHRD+
Sbjct: 76 APICLVTEFMEHGCLSDYLR-TQRGLFAAETLLGMCLDVCEGMAYL-EEAC--VIHRDLA 131
Query: 684 SSNILLDERLNAKVADFGLSKSMSDSEKDHITTQ-----VKGTMGYLDPEYYMTQQLTEK 738
+ N L+ E KV+DFG+++ + D + + ++ VK PE + + + K
Sbjct: 132 ARNCLVGENQVIKVSDFGMTRFVLDDQ--YTSSTGTKFPVKWAS----PEVFSFSRYSSK 185
Query: 739 SDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKG 797
SDV+SFGVLM E+ + G+ P Y R V++ + LY ST +
Sbjct: 186 SDVWSFGVLMWEVFSEGKIP-----YENRSNSEVVEDISTGFRLY----KPRLASTHV-- 234
Query: 798 FEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQA 833
Y + C +E +DRP S +++ + I +
Sbjct: 235 ---Y-QIMNHCWRERPEDRPAFSRLLRQLAEIAESG 266
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 4e-42
Identities = 75/304 (24%), Positives = 134/304 (44%), Gaps = 61/304 (20%)
Query: 561 NDVGSGGYGKVYKGTLP-----NGQLIAIKRAQQGSMQGG-QEFKMEIELLSRVHHKNLV 614
D+G G +GKV G+ +A+K + S + K EIE+L ++H+N+V
Sbjct: 27 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 615 SLLGFCFDRGEQ--MLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHEL 672
G C + G LI EF+P+GSL + L KN +++ ++LK A+ +G+ YL
Sbjct: 87 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLP-KNKNKINLKQQLKYAVQICKGMDYLGSR 145
Query: 673 ANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGT-----MGYLDP 727
+HRD+ + N+L++ K+ DFGL+K++ +++K++ T + P
Sbjct: 146 Q---YVHRDLAARNVLVESEHQVKIGDFGLTKAI-ETDKEYYTVKDDRDSPVFWYA---P 198
Query: 728 EYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRT---------VMDKKKE 777
E M + SDV+SFGV + ELLT ++ I +++ KE
Sbjct: 199 ECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKE 258
Query: 778 LY----------NLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIE 827
+Y+L+ KC + +R + +++ E
Sbjct: 259 GKRLPCPPNCPDEVYQLM--------------------RKCWEFQPSNRTSFQNLIEGFE 298
Query: 828 NILQ 831
+L+
Sbjct: 299 ALLK 302
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 6e-42
Identities = 82/294 (27%), Positives = 140/294 (47%), Gaps = 41/294 (13%)
Query: 564 GSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDR 623
G G +G+V+ GT +AIK + G+M + F E +++ ++ H+ LV L +
Sbjct: 193 GQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVSEE 251
Query: 624 GEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIK 683
++ E++ GSL D L G+ G L + + +A A G++Y+ + +HRD++
Sbjct: 252 P-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLR 307
Query: 684 SSNILLDERLNAKVADFGLSKSMSDSE---KDHITTQVKGTMGYLDPEYYMTQQLTEKSD 740
++NIL+ E L KVADFGL++ + D+E + +K T PE + + T KSD
Sbjct: 308 AANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTA----PEAALYGRFTIKSD 363
Query: 741 VYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELID-PTIGLSTTLKGF 798
V+SFG+L+ EL T GR P Y R V+D+ + Y + + P
Sbjct: 364 VWSFGILLTELTTKGRVP-----YPGMVNREVLDQVERGYRMPCPPECP----------- 407
Query: 799 EKYVDLALKCVQESGDDRPTMSEVVKDIENILQQAGLNPNAESASSSASYEDAS 852
E DL +C ++ ++RPT + +E+ S+ Y+
Sbjct: 408 ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT-----------STEPQYQPGE 450
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 1e-41
Identities = 82/283 (28%), Positives = 127/283 (44%), Gaps = 46/283 (16%)
Query: 564 GSGGYGKVYKGTLPNGQL-IAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFD 622
G G YG+VY+G L +A+K ++ +M+ +EF E ++ + H NLV LLG C
Sbjct: 22 GGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCTR 80
Query: 623 RGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDI 682
+I EF+ G+L D L N + + L +A + + YL E N IHRD+
Sbjct: 81 EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL-EKKN--FIHRDL 137
Query: 683 KSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGY--LDPEYYMTQQLTEKSD 740
+ N L+ E KVADFGLS+ M+ D T PE + + KSD
Sbjct: 138 AARNCLVGENHLVKVADFGLSRLMTG---DTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 194
Query: 741 VYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELY----------NLYELIDPTI 789
V++FGVL+ E+ T G P Y ++ V + ++ Y +YEL+
Sbjct: 195 VWAFGVLLWEIATYGMSP-----YPGIDLSQVYELLEKDYRMERPEGCPEKVYELM---- 245
Query: 790 GLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 832
C Q + DRP+ +E+ + E + Q+
Sbjct: 246 ----------------RACWQWNPSDRPSFAEIHQAFETMFQE 272
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 2e-41
Identities = 73/282 (25%), Positives = 125/282 (44%), Gaps = 52/282 (18%)
Query: 564 GSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCF-D 622
G G +G V G G +A+K + + Q F E +++++ H NLV LLG +
Sbjct: 202 GKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVEE 258
Query: 623 RGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDI 682
+G ++ E++ GSL D L + L LK +L + YL +HRD+
Sbjct: 259 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDL 315
Query: 683 KSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQ--VKGTMGYLDPEYYMTQQLTEKSD 740
+ N+L+ E AKV+DFGL+K ++ T + VK T PE ++ + KSD
Sbjct: 316 AARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKLPVKWTA----PEALREKKFSTKSD 368
Query: 741 VYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELY----------NLYELIDPTI 789
V+SFG+L+ E+ + GR P Y ++ V+ + ++ Y +Y+++
Sbjct: 369 VWSFGILLWEIYSFGRVP-----YPRIPLKDVVPRVEKGYKMDAPDGCPPAVYDVM---- 419
Query: 790 GLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQ 831
C RPT ++ + +E+I
Sbjct: 420 ----------------KNCWHLDAATRPTFLQLREQLEHIRT 445
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 3e-41
Identities = 67/276 (24%), Positives = 126/276 (45%), Gaps = 27/276 (9%)
Query: 564 GSGGYGKVYKGTL----PNGQL-IAIKRAQQGSMQGG-QEFKMEIELLSRVHHKNLVSLL 617
GSG +G VYKG ++ +AIK ++ + +E E +++ V + ++ LL
Sbjct: 24 GSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLL 83
Query: 618 GFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPI 677
G C LI + +P G L D + ++ + L + A+G++YL + +
Sbjct: 84 GICLTS-TVQLITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIAKGMNYLEDRR---L 138
Query: 678 IHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTE 737
+HRD+ + N+L+ + K+ DFGL+K + EK++ K + ++ E + + T
Sbjct: 139 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTH 198
Query: 738 KSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLK 796
+SDV+S+GV + EL+T G +P Y + ++ L + TI +
Sbjct: 199 QSDVWSYGVTVWELMTFGSKP-----YDGIPASEISSILEKGERLPQPPICTIDV----- 248
Query: 797 GFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 832
Y + KC D RP E++ + + +
Sbjct: 249 ----Y-MIMRKCWMIDADSRPKFRELIIEFSKMARD 279
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 4e-41
Identities = 73/275 (26%), Positives = 131/275 (47%), Gaps = 32/275 (11%)
Query: 564 GSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDR 623
GSG +G V G +A+K ++GSM EF E + + ++ H LV G C
Sbjct: 17 GSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE-DEFFQEAQTMMKLSHPKLVKFYGVCSKE 75
Query: 624 GEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIK 683
++ E++ NG L + L +G L+ + L++ G+++L E IHRD+
Sbjct: 76 YPIYIVTEYISNGCLLNYLR-SHGKGLEPSQLLEMCYDVCEGMAFL-ESHQ--FIHRDLA 131
Query: 684 SSNILLDERLNAKVADFGLSKSMSDSEKDHITTQ-----VKGTMGYLDPEYYMTQQLTEK 738
+ N L+D L KV+DFG+++ + D + ++++ VK + PE + + + K
Sbjct: 132 ARNCLVDRDLCVKVSDFGMTRYVLDDQ--YVSSVGTKFPVKWSA----PEVFHYFKYSSK 185
Query: 739 SDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKG 797
SDV++FG+LM E+ + G+ P Y + V+ K + + L S T+
Sbjct: 186 SDVWAFGILMWEVFSLGKMP-----YDLYTNSEVVLKVSQGHRL----YRPHLASDTI-- 234
Query: 798 FEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 832
Y + C E + RPT +++ IE + ++
Sbjct: 235 ---Y-QIMYSCWHELPEKRPTFQQLLSSIEPLREK 265
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 4e-41
Identities = 76/273 (27%), Positives = 129/273 (47%), Gaps = 32/273 (11%)
Query: 564 GSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCF-D 622
G G +G V G G +A+K + + Q F E +++++ H NLV LLG +
Sbjct: 30 GKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVEE 86
Query: 623 RGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDI 682
+G ++ E++ GSL D L + L LK +L + YL E N +HRD+
Sbjct: 87 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL-EGNN--FVHRDL 143
Query: 683 KSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQ--VKGTMGYLDPEYYMTQQLTEKSD 740
+ N+L+ E AKV+DFGL+K ++ T + VK T PE ++ + KSD
Sbjct: 144 AARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKLPVKWTA----PEALREKKFSTKSD 196
Query: 741 VYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFE 799
V+SFG+L+ E+ + GR P Y ++ V+ + ++ Y + P G +
Sbjct: 197 VWSFGILLWEIYSFGRVP-----YPRIPLKDVVPRVEKGYKMDA---PD-GCPPAV---- 243
Query: 800 KYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 832
Y ++ C RP+ ++ + +E+I
Sbjct: 244 -Y-EVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 6e-41
Identities = 72/276 (26%), Positives = 123/276 (44%), Gaps = 34/276 (12%)
Query: 564 GSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDR 623
G+G +G V G +AIK ++GSM EF E +++ + H+ LV L G C +
Sbjct: 33 GTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVCTKQ 91
Query: 624 GEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIK 683
+I E++ NG L + L + R + L++ + YL E +HRD+
Sbjct: 92 RPIFIITEYMANGCLLNYLR-EMRHRFQTQQLLEMCKDVCEAMEYL-ESKQ--FLHRDLA 147
Query: 684 SSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGT------MGYLDPEYYMTQQLTE 737
+ N L++++ KV+DFGLS+ + D E T G+ PE M + +
Sbjct: 148 ARNCLVNDQGVVKVSDFGLSRYVLDDE----YTSSVGSKFPVRWSP---PEVLMYSKFSS 200
Query: 738 KSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLK 796
KSD+++FGVLM E+ + G+ P Y + + L S +
Sbjct: 201 KSDIWAFGVLMWEIYSLGKMP-----YERFTNSETAEHIAQGLRL----YRPHLASEKV- 250
Query: 797 GFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 832
Y + C E D+RPT ++ +I +++ +
Sbjct: 251 ----Y-TIMYSCWHEKADERPTFKILLSNILDVMDE 281
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 6e-41
Identities = 82/294 (27%), Positives = 140/294 (47%), Gaps = 41/294 (13%)
Query: 564 GSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDR 623
G G +G+V+ GT +AIK + G+M + F E +++ ++ H+ LV L +
Sbjct: 276 GQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVSEE 334
Query: 624 GEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIK 683
++ E++ GSL D L G+ G L + + +A A G++Y+ + +HRD++
Sbjct: 335 P-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLR 390
Query: 684 SSNILLDERLNAKVADFGLSKSMSDSE---KDHITTQVKGTMGYLDPEYYMTQQLTEKSD 740
++NIL+ E L KVADFGL++ + D+E + +K T PE + + T KSD
Sbjct: 391 AANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTA----PEAALYGRFTIKSD 446
Query: 741 VYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELID-PTIGLSTTLKGF 798
V+SFG+L+ EL T GR P Y R V+D+ + Y + + P
Sbjct: 447 VWSFGILLTELTTKGRVP-----YPGMVNREVLDQVERGYRMPCPPECP----------- 490
Query: 799 EKYVDLALKCVQESGDDRPTMSEVVKDIENILQQAGLNPNAESASSSASYEDAS 852
E DL +C ++ ++RPT + +E+ S+ Y+
Sbjct: 491 ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT-----------STEPQYQPGE 533
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 2e-40
Identities = 68/292 (23%), Positives = 129/292 (44%), Gaps = 47/292 (16%)
Query: 551 KKYTNNFSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVH 609
K++ +F + +GSGG+G+V+K +G+ IKR + + + + E++ L+++
Sbjct: 7 KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE----KAEREVKALAKLD 62
Query: 610 HKNLVSLLGFCFDRGEQM----------------LIYEFVPNGSLGDSLSGKNGIRLDWI 653
H N+V G + EF G+L + + G +LD +
Sbjct: 63 HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKV 122
Query: 654 RRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDH 713
L++ +G+ Y+H +I+RD+K SNI L + K+ DFGL S+ + K
Sbjct: 123 LALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK-- 177
Query: 714 ITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMD 773
T+ KGT+ Y+ PE +Q ++ D+Y+ G+++ ELL ++R
Sbjct: 178 -RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLR---- 232
Query: 774 KKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825
+ +++ K L K + + +DRP SE+++
Sbjct: 233 -DGIISDIF---------DKKEK------TLLQKLLSKKPEDRPNTSEILRT 268
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 3e-40
Identities = 41/314 (13%), Positives = 94/314 (29%), Gaps = 29/314 (9%)
Query: 1 MGLKGQLSGDITGLTELHTLDLSNNKDLRGP---LPTTIGNLKKLSNLMLVGCSFSGPIP 57
G G++ I LTEL L L ++ + P I + +
Sbjct: 91 FGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFV 150
Query: 58 DSIGSLQ--ELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLD 115
D +L+ +NS+ + S + N + + + L
Sbjct: 151 DYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKL- 208
Query: 116 MLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFD 175
+ F+ G + + + + +K L V
Sbjct: 209 -----RQFYMGNSPFVAENICEA------WENENSEYAQQYKTEDLKWDNLKDLTDVEVY 257
Query: 176 RNSLSGPVPSNLNNLTSVNDLYLSNNKLTGA---------MPNLTGLSVLSYLDMSNNSF 226
+P+ L L + + ++ N+ + + + + + N+
Sbjct: 258 NCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNL 317
Query: 227 DASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYS 286
V + M+ L L L+G++PA S L ++ + N++ ++
Sbjct: 318 KTFPVETSLQKMKKLGMLECLYNQLEGKLPA-FGSEIKLASLNLAYNQITEIPANFCGFT 376
Query: 287 ENLLV-NLQNNRIS 299
E + + +N++
Sbjct: 377 EQVENLSFAHNKLK 390
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 2e-38
Identities = 41/301 (13%), Positives = 98/301 (32%), Gaps = 21/301 (6%)
Query: 7 LSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQEL 66
+S + LT+L + N+ + +L++L
Sbjct: 198 VSKAVMRLTKLRQFYMGNSP-FVAENICEAWENENSEYA-----QQYKTEDLKWDNLKDL 251
Query: 67 VLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEG--EIPVSDGNSPGLDMLVRAKHFH 124
+ + + ++P + L + +++ N+ ++ + + + +
Sbjct: 252 TDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIY 311
Query: 125 FGKNQL-SGSIPEKLFRPDMVLIHVLF-DSNNLTGELPATLGLVKSLEVVRFDRNSLSGP 182
G N L + + L + M + +L N L G+LPA G L + N ++
Sbjct: 312 IGYNNLKTFPVETSLQK--MKKLGMLECLYNQLEGKLPA-FGSEIKLASLNLAYNQITEI 368
Query: 183 VPSNLNNLTSVNDLYLSNNKLTG--AMPNLTGLSVLSYLDMSNNSF------DASEVPSW 234
+ V +L ++NKL + + +SV+S +D S N + +
Sbjct: 369 PANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPT 428
Query: 235 FSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENLLVNLQ 294
+++++ + N + + L ++ + N L N
Sbjct: 429 PFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTY 488
Query: 295 N 295
Sbjct: 489 L 489
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 3e-35
Identities = 54/313 (17%), Positives = 104/313 (33%), Gaps = 26/313 (8%)
Query: 5 GQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQ 64
+ + + +L L+ N+ L G LP G+ KL++L L + + G +
Sbjct: 320 FPVETSLQKMKKLGMLECLYNQ-LEGKLPA-FGSEIKLASLNLAYNQITEIPANFCGFTE 377
Query: 65 ELVLLSLNSNGFSGRVPP--SIGNLSNLYWLDLTDNKLEGEIPVSDGNSP-GLDMLVRAK 121
++ LS N +P ++S + +D + N++ + +
Sbjct: 378 QVENLSFAHNKLKY-IPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVS 436
Query: 122 HFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTG-------ELPATLGLVKSLEVVRF 174
+ NQ+S E LF L + N LT + L +
Sbjct: 437 SINLSNNQISKFPKE-LFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDL 495
Query: 175 DRNSLSG-PVPSNLNNLTSVNDLYLSNNKLT------GAMPNLTGLSVLSYLDMSNNSFD 227
N L+ L + + LS N + L G + + D N
Sbjct: 496 RFNKLTKLSDDFRATTLPYLVGIDLSYNSFSKFPTQPLNSSTLKGFGIRNQRDAQGNRTL 555
Query: 228 ASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGT-LDLGTSYS 286
E P + SLT L + + +++ + + P++ + +K N L Y
Sbjct: 556 -REWPEGITLCPSLTQLQIGSNDIRK-VNEKIT--PNISVLDIKDNPNISIDLSYVCPYI 611
Query: 287 ENLLVNLQNNRIS 299
E + L ++
Sbjct: 612 EAGMYMLFYDKTQ 624
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 5e-31
Identities = 56/314 (17%), Positives = 105/314 (33%), Gaps = 43/314 (13%)
Query: 21 DLSNNKDLRGPLP-TTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSG- 78
+ + D+ G P ++ + +++ L L G SG +PD+IG L EL +L+L S+G
Sbjct: 61 NFNKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVN 120
Query: 79 ---RVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIP 135
P I + + D D++ + SI
Sbjct: 121 ERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLI----KDCINSDPQQKSIK 176
Query: 136 EKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGP------------- 182
K R + + SNN+T + + + L +
Sbjct: 177 -KSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEY 234
Query: 183 ------VPSNLNNLTSVNDLYLSNNKLTGAMPN-LTGLSVLSYLDMSNNSFDASEV---- 231
+NL + D+ + N +P L L + ++++ N + E
Sbjct: 235 AQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDD 294
Query: 232 ---PSWFSSMQSLTTLMMENTNLK-GQIPADLFSIPHLQTVVMKTNELNGTLD-LGTSYS 286
+ + + + + NLK + L + L + N+L G L G+
Sbjct: 295 WQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPAFGS--E 352
Query: 287 ENLLV-NLQNNRIS 299
L NL N+I+
Sbjct: 353 IKLASLNLAYNQIT 366
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 3e-40
Identities = 73/329 (22%), Positives = 126/329 (38%), Gaps = 69/329 (20%)
Query: 564 GSGGYGKVYKGTLPNG----QLIAIKRAQQGSMQGGQ--EFKMEIELLSRVHHKNLVSLL 617
G G +G V + L +A+K + + EF E + H ++ L+
Sbjct: 32 GKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLV 91
Query: 618 GFCFDRGEQ------MLIYEFVPNGSLGDSL----SGKNGIRLDWIRRLKIALGAARGLS 667
G + M+I F+ +G L L G+N L ++ + A G+
Sbjct: 92 GVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGME 151
Query: 668 YLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYL-- 725
YL ++ IHRD+ + N +L E + VADFGLS+ + + +G L
Sbjct: 152 YL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGD-----YYRQGCASKLPV 203
Query: 726 ---DPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRP------IERGKYIVREIRTVMDK- 774
E T SDV++FGV M E++T G+ P E Y++ R + +
Sbjct: 204 KWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNR--LKQP 261
Query: 775 ---KKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQ 831
+E+Y+ L +C RP+ + + ++ENIL
Sbjct: 262 PECMEEVYD-----------------------LMYQCWSADPKQRPSFTCLRMELENILG 298
Query: 832 QAGLNPNAESASSSASYEDASKGNFHHPY 860
+ + S S Y + + + HH +
Sbjct: 299 ----HLSVLSTSQDPLYINIERAHHHHHH 323
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 3e-40
Identities = 69/303 (22%), Positives = 118/303 (38%), Gaps = 65/303 (21%)
Query: 564 GSGGYGKVYKGTLPN-----GQLIAIK--RAQQGSMQGGQEFKMEIELLSRVHHKNLVSL 616
G G +GKV G+++A+K +A G +K EI++L ++H++++
Sbjct: 40 GEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHR-SGWKQEIDILRTLYHEHIIKY 98
Query: 617 LGFCFDRGEQ--MLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELAN 674
G C D G L+ E+VP GSL D L + + L A G++YLH
Sbjct: 99 KGCCEDAGAASLQLVMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLHAQH- 154
Query: 675 PPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGT-----MGYLDPEY 729
IHRD+ + N+LLD K+ DFGL+K++ + ++ + G PE
Sbjct: 155 --YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH-EYYRVREDGDSPVFWYA---PEC 208
Query: 730 YMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRT---------VMDKKKELY 779
+ SDV+SFGV + ELLT + I + + +
Sbjct: 209 LKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGE 268
Query: 780 ----------NLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENI 829
+Y L+ C + RPT ++ ++ +
Sbjct: 269 RLPRPDKCPAEVYHLM--------------------KNCWETEASFRPTFENLIPILKTV 308
Query: 830 LQQ 832
++
Sbjct: 309 HEK 311
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 5e-40
Identities = 82/282 (29%), Positives = 133/282 (47%), Gaps = 48/282 (17%)
Query: 564 GSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDR 623
G+G +G+V+ G +A+K +QGSM F E L+ ++ H+ LV L
Sbjct: 22 GAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYAVVTQE 80
Query: 624 GEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIK 683
+I E++ NGSL D L +GI+L + L +A A G++++ E N IHRD++
Sbjct: 81 P-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI-EERN--YIHRDLR 136
Query: 684 SSNILLDERLNAKVADFGLSKSMSDSE---KDHITTQVKGTMGYLDPEYYMTQQLTEKSD 740
++NIL+ + L+ K+ADFGL++ + D+E ++ +K T PE T KSD
Sbjct: 137 AANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTA----PEAINYGTFTIKSD 192
Query: 741 VYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELY----------NLYELIDPTI 789
V+SFG+L+ E++T GR P Y V+ + Y LY+L+
Sbjct: 193 VWSFGILLTEIVTHGRIP-----YPGMTNPEVIQNLERGYRMVRPDNCPEELYQLM---- 243
Query: 790 GLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQ 831
C +E +DRPT + +E+
Sbjct: 244 ----------------RLCWKERPEDRPTFDYLRSVLEDFFT 269
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 1e-39
Identities = 66/213 (30%), Positives = 96/213 (45%), Gaps = 36/213 (16%)
Query: 563 VGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCF 621
+G G YG VY G L N IAIK + + Q EI L + HKN+V LG
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 622 DRGEQMLIYEFVPNGSLGDSLSGKNG--------IRLDWIRRLKIALGAARGLSYLHELA 673
+ G + E VP GSL L K G I + +++ L GL YLH+
Sbjct: 90 ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGF-YTKQI---L---EGLKYLHDNQ 142
Query: 674 NPPIIHRDIKSSNILLDERL-NAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYM- 731
I+HRDIK N+L++ K++DFG SK ++ T GT+ YM
Sbjct: 143 ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGTL------QYMA 191
Query: 732 -------TQQLTEKSDVYSFGVLMLELLTGRRP 757
+ + +D++S G ++E+ TG+ P
Sbjct: 192 PEIIDKGPRGYGKAADIWSLGCTIIEMATGKPP 224
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 1e-39
Identities = 81/295 (27%), Positives = 137/295 (46%), Gaps = 38/295 (12%)
Query: 564 GSGGYGKVYKGTL--PNGQLI--AIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLVSLLG 618
GSG G+V G L P + + AIK + G + ++F E ++ + H N++ L G
Sbjct: 58 GSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEG 117
Query: 619 FCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPII 678
M++ E++ NGSL L + + ++ + + G G+ YL +L +
Sbjct: 118 VVTRGRLAMIVTEYMENGSLDTFLR-THDGQFTIMQLVGMLRGVGAGMRYLSDLG---YV 173
Query: 679 HRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQ-----VKGTMGYLDPEYYMTQ 733
HRD+ + N+L+D L KV+DFGLS+ + D TT ++ T PE +
Sbjct: 174 HRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTA----PEAIAFR 229
Query: 734 QLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLS 792
+ SDV+SFGV+M E+L G RP Y R V+ +E Y L +G
Sbjct: 230 TFSSASDVWSFGVVMWEVLAYGERP-----YWNMTNRDVISSVEEGYRLP----APMGCP 280
Query: 793 TTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQAGLNPNAESASSSAS 847
L + L L C + RP S++V ++ +++ +P + A+++ S
Sbjct: 281 HAL-----H-QLMLDCWHKDRAQRPRFSQIVSVLDALIR----SPESLRATATVS 325
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 2e-39
Identities = 67/277 (24%), Positives = 119/277 (42%), Gaps = 30/277 (10%)
Query: 564 GSGGYGKVYKGTLPNGQL---IAIKRAQQGSM--QGGQEFKMEIELLSRVHHKNLVSLLG 618
GSG +G V KG ++ +A+K + + E E ++ ++ + +V ++G
Sbjct: 26 GSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIG 85
Query: 619 FCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPII 678
C + ML+ E G L L + + +++ + G+ YL E +N +
Sbjct: 86 IC-EAESWMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYL-EESN--FV 139
Query: 679 HRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTM--GYLDPEYYMTQQLT 736
HRD+ + N+LL + AK++DFGLSK++ E ++ Q G + PE + +
Sbjct: 140 HRDLAARNVLLVTQHYAKISDFGLSKALRADE-NYYKAQTHGKWPVKWYAPECINYYKFS 198
Query: 737 EKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTL 795
KSDV+SFGVLM E + G++P Y + V ++ + +
Sbjct: 199 SKSDVWSFGVLMWEAFSYGQKP-----YRGMKGSEVTAMLEKGERMGCPAGCPREM---- 249
Query: 796 KGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 832
Y DL C ++RP + V + N
Sbjct: 250 -----Y-DLMNLCWTYDVENRPGFAAVELRLRNYYYD 280
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 2e-39
Identities = 77/281 (27%), Positives = 118/281 (41%), Gaps = 34/281 (12%)
Query: 563 VGSGGYGKVYKGTLPNG----QLIAIKRAQQG-SMQGGQEFKMEIELLSRVHHKNLVSLL 617
+G G +G VY GTL + A+K + + +F E ++ H N++SLL
Sbjct: 33 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 92
Query: 618 GFCFDRGEQ-MLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPP 676
G C +++ ++ +G L + + + L A+G+ YL
Sbjct: 93 GICLRSEGSPLVVLPYMKHGDLRNFIR-NETHNPTVKDLIGFGLQVAKGMKYLASKK--- 148
Query: 677 IIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYL-----DPEYYM 731
+HRD+ + N +LDE+ KVADFGL++ M D E + T L E
Sbjct: 149 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE---YYSVHNKTGAKLPVKWMALESLQ 205
Query: 732 TQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIG 790
TQ+ T KSDV+SFGVL+ EL+T G P Y + + L
Sbjct: 206 TQKFTTKSDVWSFGVLLWELMTRGAPP-----YPDVNTFDITVYLLQGRRL----LQPEY 256
Query: 791 LSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQ 831
L Y ++ LKC + RP+ SE+V I I
Sbjct: 257 CPDPL-----Y-EVMLKCWHPKAEMRPSFSELVSRISAIFS 291
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 2e-39
Identities = 78/307 (25%), Positives = 136/307 (44%), Gaps = 71/307 (23%)
Query: 564 GSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDR 623
G+G +G+V+ T +A+K + GSM + F E ++ + H LV L
Sbjct: 197 GAGQFGEVWMATYNKHTKVAVKTMKPGSMSV-EAFLAEANVMKTLQHDKLVKLHAVVTKE 255
Query: 624 GEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIK 683
+I EF+ GSL D L G + + + + A G++++ E N IHRD++
Sbjct: 256 P-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI-EQRN--YIHRDLR 311
Query: 684 SSNILLDERLNAKVADFGLSKSMSDSE---KDHITTQVKGTMGYLDPEYYMTQQLTEKSD 740
++NIL+ L K+ADFGL++ + D+E ++ +K T PE T KSD
Sbjct: 312 AANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTA----PEAINFGSFTIKSD 367
Query: 741 VYSFGVLMLELLT-GRRP------------IERGKYIVREIRTVMDK----KKELYNLYE 783
V+SFG+L++E++T GR P +ERG Y R M + +ELY
Sbjct: 368 VWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG-Y--R-----MPRPENCPEELY---- 415
Query: 784 LIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQAGLNPNAESAS 843
++ ++C + ++RPT + +++ +
Sbjct: 416 -------------------NIMMRCWKNRPEERPTFEYIQSVLDDFYT-----------A 445
Query: 844 SSASYED 850
+ + YE+
Sbjct: 446 TESQYEE 452
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 5e-39
Identities = 69/285 (24%), Positives = 119/285 (41%), Gaps = 48/285 (16%)
Query: 564 GSGGYGKVYKGTL--PNGQL-IAIKRAQQGSMQGG-QEFKMEIELLSRVHHKNLVSLLGF 619
G G +G V +G Q+ +AIK +QG+ + +E E +++ ++ + +V L+G
Sbjct: 19 GCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGV 78
Query: 620 CFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIH 679
C ML+ E G L L + ++ + G+ YL E N +H
Sbjct: 79 C-QAEALMLVMEMAGGGPLHKFLV-GKREEIPVSNVAELLHQVSMGMKYL-EEKN--FVH 133
Query: 680 RDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTM--GYLDPEYYMTQQLTE 737
RD+ + N+LL R AK++DFGLSK++ + + T + G + PE ++ +
Sbjct: 134 RDLAARNVLLVNRHYAKISDFGLSKALGADD-SYYTARSAGKWPLKWYAPECINFRKFSS 192
Query: 738 KSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELY----------NLYELID 786
+SDV+S+GV M E L+ G++P Y + VM ++ LY L+
Sbjct: 193 RSDVWSYGVTMWEALSYGQKP-----YKKMKGPEVMAFIEQGKRMECPPECPPELYALM- 246
Query: 787 PTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQ 831
C +DRP V + +
Sbjct: 247 -------------------SDCWIYKWEDRPDFLTVEQRMRACYY 272
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 6e-39
Identities = 58/289 (20%), Positives = 116/289 (40%), Gaps = 49/289 (16%)
Query: 564 GSGGYGKVYKGTL--------PNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVS 615
G G + K++KG + + +K + + F ++S++ HK+LV
Sbjct: 17 GQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVL 76
Query: 616 LLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANP 675
G C E +L+ EFV GSL L KN ++ + +L++A A + +L E
Sbjct: 77 NYGVCVCGDENILVQEFVKFGSLDTYLK-KNKNCINILWKLEVAKQLAAAMHFL-EENT- 133
Query: 676 PIIHRDIKSSNILLD--------ERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDP 727
+IH ++ + NILL K++D G+S ++ D + ++ P
Sbjct: 134 -LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK--DILQERIPWVP----P 186
Query: 728 E---YYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYE 783
E + L +D +SFG + E+ + G +P + + + ++ + L
Sbjct: 187 ECIENP--KNLNLATDKWSFGTTLWEICSGGDKP-----LSALDSQRKLQFYEDRHQLPA 239
Query: 784 LIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 832
+ +L C+ D RP+ +++D+ ++
Sbjct: 240 PKAAEL-----------A-NLINNCMDYEPDHRPSFRAIIRDLNSLFTP 276
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 7e-39
Identities = 79/300 (26%), Positives = 124/300 (41%), Gaps = 37/300 (12%)
Query: 563 VGSGGYGKVYKGTLPNG----QLIAIKRAQQG-SMQGGQEFKMEIELLSRVHHKNLVSLL 617
+G G +G VY GTL + A+K + + +F E ++ H N++SLL
Sbjct: 97 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 156
Query: 618 GFCFDRGEQ-MLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPP 676
G C +++ ++ +G L + + + L A+G+ +L
Sbjct: 157 GICLRSEGSPLVVLPYMKHGDLRNFIR-NETHNPTVKDLIGFGLQVAKGMKFLASKK--- 212
Query: 677 IIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYL-----DPEYYM 731
+HRD+ + N +LDE+ KVADFGL++ M D E D + T L E
Sbjct: 213 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD---SVHNKTGAKLPVKWMALESLQ 269
Query: 732 TQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIG 790
TQ+ T KSDV+SFGVL+ EL+T G P Y + + L
Sbjct: 270 TQKFTTKSDVWSFGVLLWELMTRGAPP-----YPDVNTFDITVYLLQGRRL----LQPEY 320
Query: 791 LSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQAGLNPNAESASSSASYED 850
L Y ++ LKC + RP+ SE+V I I +A+Y +
Sbjct: 321 CPDPL-----Y-EVMLKCWHPKAEMRPSFSELVSRISAIFST---FIGEHYVHVNATYVN 371
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 7e-39
Identities = 61/331 (18%), Positives = 113/331 (34%), Gaps = 25/331 (7%)
Query: 3 LKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGS 62
L+ + + T ++L +LD+ N + P L L L L S +
Sbjct: 37 LRRLPAANFTRYSQLTSLDVGFNT-ISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAF 95
Query: 63 LQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKH 122
L L L SN NL LDL+ N L + L +
Sbjct: 96 CTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENL------QE 149
Query: 123 FHFGKNQLSGSIPEKL-FRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSG 181
N++ E+L + L + SN + P + L + + L
Sbjct: 150 LLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGP 209
Query: 182 PVPSNL---NNLTSVNDLYLSNNKLTGAMPN-LTGLSV--LSYLDMSNNSFDASEVPSWF 235
+ L TS+ +L LSN++L+ GL L+ LD+S N+ + F
Sbjct: 210 SLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVG-NDSF 268
Query: 236 SSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLG--TSYSENLL--- 290
+ + L +E N++ L + +++ + +K + ++ L +
Sbjct: 269 AWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWL 328
Query: 291 -----VNLQNNRISAYTERGGAPAVNLTLID 316
+N+++N I +NL +
Sbjct: 329 KCLEHLNMEDNDIPGIKSNMFTGLINLKYLS 359
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 8e-34
Identities = 49/272 (18%), Positives = 99/272 (36%), Gaps = 17/272 (6%)
Query: 14 LTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNS 73
T + L+L++N+ LR +L++L + + S P+ L L +L+L
Sbjct: 24 PTNITVLNLTHNQ-LRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQH 82
Query: 74 NGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGS 133
N S + +NL L L N ++ L N LS +
Sbjct: 83 NELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNL------ITLDLSHNGLSST 136
Query: 134 IPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVK--SLEVVRFDRNSLSGPVPSNLNNLT 191
+ + L +L +N + L + SL+ + N + P + +
Sbjct: 137 KLGTQVQLEN-LQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIG 195
Query: 192 SVNDLYLSNNKLTGAMPN----LTGLSVLSYLDMSNNSFDASEVPSWFSSMQ--SLTTLM 245
+ L+L+N +L ++ + + L +SN+ + + F ++ +LT L
Sbjct: 196 RLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTS-NTTFLGLKWTNLTMLD 254
Query: 246 MENTNLKGQIPADLFSIPHLQTVVMKTNELNG 277
+ NL +P L+ ++ N +
Sbjct: 255 LSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQH 286
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 4e-31
Identities = 52/319 (16%), Positives = 97/319 (30%), Gaps = 51/319 (15%)
Query: 3 LKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNL---------MLVGCSFS 53
L + L +L L N ++ ++ L + L + S
Sbjct: 260 LNVVGNDSFAWLPQLEYFFLEYNN-IQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLP 318
Query: 54 GPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPG 113
S L+ L L++ N G L NL +L L+++
Sbjct: 319 KIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSL----------- 367
Query: 114 LDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVR 173
L+ L L + N ++ + LEV+
Sbjct: 368 --------------RTLTNETFVSLAHSP--LHILNLTKNKISKIESDAFSWLGHLEVLD 411
Query: 174 FDRNSLSGPVPSN-LNNLTSVNDLYLSNNKLTGAMPN-LTGLSVLSYLDMSNNSF-DASE 230
N + + L ++ ++YLS NK N + L L + + +
Sbjct: 412 LGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDS 471
Query: 231 VPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENLL 290
PS F +++LT L + N N+ L + L+ + ++ N L L + +
Sbjct: 472 SPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLA-RLWKHANPGGPIY 530
Query: 291 V----------NLQNNRIS 299
NL++N
Sbjct: 531 FLKGLSHLHILNLESNGFD 549
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-29
Identities = 52/276 (18%), Positives = 88/276 (31%), Gaps = 22/276 (7%)
Query: 3 LKGQLSGDITGLTELHTLDLSNNKDLRGPLP-TTIGNLKKLSNLMLVGCSFSGPIPDSIG 61
+ S + L L LDL N+ + L L+ + + L + +S
Sbjct: 393 ISKIESDAFSWLGHLEVLDLGLNE-IGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFA 451
Query: 62 SLQELVLLSLNSNGFSG--RVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVR 119
+ L L L P L NL LDL++N + L
Sbjct: 452 LVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKL----- 506
Query: 120 AKHFHFGKNQLSGSIPEKLFRPDMVLIHVL-------FDSNNLTGELPATLGLVKSLEVV 172
+ N L+ + + L +SN + L+++
Sbjct: 507 -EILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKII 565
Query: 173 RFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNL--TGLSVLSYLDMSNNSFD-AS 229
N+L+ S NN S+ L L N +T + L+ LDM N FD
Sbjct: 566 DLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTC 625
Query: 230 EVPSWFSSM--QSLTTLMMENTNLKGQIPADLFSIP 263
E +WF + ++ T + +++ P P
Sbjct: 626 ESIAWFVNWINETHTNIPELSSHYLCNTPPHYHGFP 661
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 5e-29
Identities = 54/294 (18%), Positives = 94/294 (31%), Gaps = 21/294 (7%)
Query: 15 TELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSN 74
D S+ K L +P + ++ L L + +L L + N
Sbjct: 4 VSHEVADCSHLK-LTQ-VPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFN 59
Query: 75 GFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSI 134
S P L L L+L N+L + L H N + I
Sbjct: 60 TISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNL------TELHLMSNSIQ-KI 112
Query: 135 PEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLN--NLTS 192
F LI + N L+ T +++L+ + N + L+ +S
Sbjct: 113 KNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSS 172
Query: 193 VNDLYLSNNKLTGAMPN-LTGLSVLSYLDMSNNSFDASEVPSWFS--SMQSLTTLMMENT 249
+ L LS+N++ P + L L ++N S + S+ L + N+
Sbjct: 173 LKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNS 232
Query: 250 NLKGQIPADLFS---IPHLQTVVMKTNELNGTLDLGTSYSENLLV-NLQNNRIS 299
L F +L + + N LN + ++ L L+ N I
Sbjct: 233 QLST-TSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQ 285
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 4e-22
Identities = 48/242 (19%), Positives = 80/242 (33%), Gaps = 25/242 (10%)
Query: 3 LKGQLSGDITGLTELHTLDLSNNKDLRG--PLPTTIGNLKKLSNLMLVGCSFSGPIPDSI 60
+ L L L L+ P+ L+ L+ L L + + D +
Sbjct: 442 YLQLTRNSFALVPSLQRLMLRRVA-LKNVDSSPSPFQPLRNLTILDLSNNNIANINDDML 500
Query: 61 GSLQELVLLSLNSN--------GFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSP 112
L++L +L L N G + LS+L+ L+L N + +
Sbjct: 501 EGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLF 560
Query: 113 GLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLG-LVKSLEV 171
L ++ G N L+ +P +F + L + N +T G ++L
Sbjct: 561 ELKII------DLGLNNLNT-LPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTE 613
Query: 172 VRFDRNSLSGPVPS-----NLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSF 226
+ N S N N T N LS++ L P+ G V D S+
Sbjct: 614 LDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHYLCNTPPHYHGFPVRL-FDTSSCKD 672
Query: 227 DA 228
A
Sbjct: 673 SA 674
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 4e-11
Identities = 21/106 (19%), Positives = 36/106 (33%), Gaps = 4/106 (3%)
Query: 2 GLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIG 61
G + GL+ LH L+L +N +L +L + L + +
Sbjct: 523 ANPGGPIYFLKGLSHLHILNLESNG-FDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFN 581
Query: 62 SLQELVLLSLNSNGFSGRVPPSI--GNLSNLYWLDLTDNKLEGEIP 105
+ L L+L N + V + NL LD+ N +
Sbjct: 582 NQVSLKSLNLQKNLITS-VEKKVFGPAFRNLTELDMRFNPFDCTCE 626
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 8e-39
Identities = 67/276 (24%), Positives = 127/276 (46%), Gaps = 27/276 (9%)
Query: 564 GSGGYGKVYKGTL----PNGQL-IAIKRAQQGSMQGG-QEFKMEIELLSRVHHKNLVSLL 617
GSG +G VYKG ++ +AIK ++ + +E E +++ V + ++ LL
Sbjct: 24 GSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLL 83
Query: 618 GFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPI 677
G C LI + +P G L D + ++ + L + A+G++YL + +
Sbjct: 84 GICLTS-TVQLITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIAKGMNYLEDRR---L 138
Query: 678 IHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTE 737
+HRD+ + N+L+ + K+ DFGL+K + EK++ K + ++ E + + T
Sbjct: 139 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTH 198
Query: 738 KSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLK 796
+SDV+S+GV + EL+T G +P Y + ++ L + TI +
Sbjct: 199 QSDVWSYGVTVWELMTFGSKP-----YDGIPASEISSILEKGERLPQPPICTIDV----- 248
Query: 797 GFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 832
Y + +KC D RP E++ + + +
Sbjct: 249 ----Y-MIMVKCWMIDADSRPKFRELIIEFSKMARD 279
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 8e-39
Identities = 62/273 (22%), Positives = 110/273 (40%), Gaps = 37/273 (13%)
Query: 563 VGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKM---EIELLSRVHHKNLVSLLG 618
+G G + +VY+ L +G +A+K+ Q + + EI+LL +++H N++
Sbjct: 40 IGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 99
Query: 619 FCFDRGEQMLIYEFVPNGSLGDSLS--GKNGIRLDWIRRLKIALGAARGLSYLHELANPP 676
+ E ++ E G L + K + K + L ++H
Sbjct: 100 SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR--- 156
Query: 677 IIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLT 736
++HRDIK +N+ + K+ D GL + S S+ + V GT Y+ PE
Sbjct: 157 VMHRDIKPANVFITATGVVKLGDLGLGRFFS-SKTTAAHSLV-GTPYYMSPERIHENGYN 214
Query: 737 EKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELID-------PTI 789
KSD++S G L+ E+ + P K LY+L + I+ P+
Sbjct: 215 FKSDIWSLGCLLYEMAALQSPFY-------------GDKMNLYSLCKKIEQCDYPPLPSD 261
Query: 790 GLSTTLKGFEKYVDLALKCVQESGDDRPTMSEV 822
S L+ L C+ + RP ++ V
Sbjct: 262 HYSEELR------QLVNMCINPDPEKRPDVTYV 288
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 8e-39
Identities = 79/310 (25%), Positives = 142/310 (45%), Gaps = 34/310 (10%)
Query: 564 GSGGYGKVYKGTLPNG----QLIAIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLVSLLG 618
G+G +G+V G L +AIK + G + ++F E ++ + H N++ L G
Sbjct: 54 GAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEG 113
Query: 619 FCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPII 678
M++ E++ NGSL L K+ + I+ + + G A G+ YL ++ +
Sbjct: 114 VVTKSKPVMIVTEYMENGSLDSFLR-KHDAQFTVIQLVGMLRGIASGMKYLSDMG---YV 169
Query: 679 HRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQ-----VKGTMGYLDPEYYMTQ 733
HRD+ + NIL++ L KV+DFGL + + D + TT+ ++ T PE +
Sbjct: 170 HRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTS----PEAIAYR 225
Query: 734 QLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLS 792
+ T SDV+S+G+++ E+++ G RP Y + V+ E Y L +D L
Sbjct: 226 KFTSASDVWSYGIVLWEVMSYGERP-----YWEMSNQDVIKAVDEGYRLPPPMDCPAAL- 279
Query: 793 TTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQAGLNPNAESASSSASYEDAS 852
Y L L C Q+ ++RP ++V ++ +++ G SA++ S
Sbjct: 280 --------Y-QLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAARPSNLLLD 330
Query: 853 KGNFHHPYCN 862
+ N
Sbjct: 331 QSNVDITTFR 340
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 8e-39
Identities = 57/284 (20%), Positives = 104/284 (36%), Gaps = 33/284 (11%)
Query: 563 VGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCF 621
+G GG+ V L +G A+KR Q +E + E ++ +H N++ L+ +C
Sbjct: 37 LGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCL 96
Query: 622 DRGEQM----LIYEFVPNGSLGDSLS--GKNGIRLDWIRRLKIALGAARGLSYLHELANP 675
L+ F G+L + + G L + L + LG RGL +H
Sbjct: 97 RERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA---K 153
Query: 676 PIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQV-------KGTMGYLDPE 728
HRD+K +NILL + + D G + + T+ Y PE
Sbjct: 154 GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPE 213
Query: 729 ---YYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELI 785
+ E++DV+S G ++ ++ G P + + + + I
Sbjct: 214 LFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLS-------I 266
Query: 786 DPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENI 829
+ S+ L L + RP + ++ +E +
Sbjct: 267 PQSPRHSSALW------QLLNSMMTVDPHQRPHIPLLLSQLEAL 304
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 1e-38
Identities = 61/303 (20%), Positives = 116/303 (38%), Gaps = 64/303 (21%)
Query: 561 NDVGSGGYGKVYKGTLPNG------QLIAIKRAQQGSMQG-GQEFKMEIELLSRVHHKNL 613
++G G +G VY+G +AIK + + EF E ++ + ++
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90
Query: 614 VSLLGFCFDRGEQMLIYEFVPNGSL--------GDSLSGKNGIRLDWIRRLKIALGAARG 665
V LLG ++I E + G L + + +++A A G
Sbjct: 91 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150
Query: 666 LSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYL 725
++YL+ +HRD+ + N ++ E K+ DFG+++ + +++ KG G L
Sbjct: 151 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD-----YYRKGGKGLL 202
Query: 726 -----DPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPI------ERGKYIVREIRTVMD 773
PE T SDV+SFGV++ E+ T +P + ++++ +D
Sbjct: 203 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL--LD 260
Query: 774 K----KKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENI 829
K L+ L C Q + RP+ E++ I+
Sbjct: 261 KPDNCPDMLFE-----------------------LMRMCWQYNPKMRPSFLEIISSIKEE 297
Query: 830 LQQ 832
++
Sbjct: 298 MEP 300
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 1e-38
Identities = 87/320 (27%), Positives = 143/320 (44%), Gaps = 57/320 (17%)
Query: 564 GSGGYGKVYKGTLPNG---QLIAIKRAQQGSMQG-GQEFKMEIELLSRV-HHKNLVSLLG 618
G G +G+V K + AIKR ++ + + ++F E+E+L ++ HH N+++LLG
Sbjct: 34 GEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLG 93
Query: 619 FCFDRGEQMLIYEFVPNGSL--------------GDSLSGKNGIRLDWIRRLKIALGAAR 664
C RG L E+ P+G+L +++ L + L A AR
Sbjct: 94 ACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVAR 153
Query: 665 GLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGY 724
G+ Y L+ IHRD+ + NIL+ E AK+ADFGLS+ E VK TMG
Sbjct: 154 GMDY---LSQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQE-----VYVKKTMGR 202
Query: 725 L-----DPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKEL 778
L E T SDV+S+GVL+ E+++ G P Y + +K +
Sbjct: 203 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP-----YCGMTCAELYEKLPQG 257
Query: 779 YNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ------ 832
Y L + + + Y DL +C +E +RP+ ++++ + +L++
Sbjct: 258 YRL----EKPLNCDDEV-----Y-DLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVN 307
Query: 833 AGLNPNAESASSSASYEDAS 852
L A S E+A+
Sbjct: 308 TTLYEKFTYAGIDCSAEEAA 327
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 1e-38
Identities = 76/280 (27%), Positives = 134/280 (47%), Gaps = 35/280 (12%)
Query: 564 GSGGYGKVYKGTL--PNGQ---LIAIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLVSLL 617
G+G +G+VYKG L +G+ +AIK + G + +F E ++ + H N++ L
Sbjct: 53 GAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLE 112
Query: 618 GFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPI 677
G M+I E++ NG+L L + ++ + + G A G+ YL +
Sbjct: 113 GVISKYKPMMIITEYMENGALDKFLR-EKDGEFSVLQLVGMLRGIAAGMKYLANMN---Y 168
Query: 678 IHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQ-----VKGTMGYLDPEYYMT 732
+HRD+ + NIL++ L KV+DFGLS+ + D + TT ++ T PE
Sbjct: 169 VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA----PEAISY 224
Query: 733 QQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGL 791
++ T SDV+SFG++M E++T G RP Y VM + + L +D +
Sbjct: 225 RKFTSASDVWSFGIVMWEVMTYGERP-----YWELSNHEVMKAINDGFRLPTPMDCPSAI 279
Query: 792 STTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQ 831
Y L ++C Q+ RP +++V ++ +++
Sbjct: 280 ---------Y-QLMMQCWQQERARRPKFADIVSILDKLIR 309
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 1e-38
Identities = 61/318 (19%), Positives = 123/318 (38%), Gaps = 44/318 (13%)
Query: 526 HWDMNKSSGSIPQLKGARCFSFEEVKKYTNNFSDANDVGSGGYGKVYKGTLPNGQLIAIK 585
H + SSG + F+ + +S +GSGG KV++ Q+ AIK
Sbjct: 2 HHHHHHSSGVDLGTENLY---FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIK 58
Query: 586 R-----AQQGSMQGGQEFKMEIELLSRVHHKNL--VSLLGFCFDRGEQMLIYEFVPNGSL 638
A ++ ++ EI L+++ + + L + ++ E N L
Sbjct: 59 YVNLEEADNQTLDS---YRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDL 114
Query: 639 GDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVA 698
L K I + + + +H+ I+H D+K +N L+ + K+
Sbjct: 115 NSWLKKKKSIDPWERKSYWKNM--LEAVHTIHQHG---IVHSDLKPANFLIVDG-MLKLI 168
Query: 699 DFGLSKSMSDSEKDHITTQVKGTMGYLDPE-----------YYMTQQLTEKSDVYSFGVL 747
DFG++ M + GT+ Y+ PE +++ KSDV+S G +
Sbjct: 169 DFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCI 228
Query: 748 MLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALK 807
+ + G+ P ++ + ++ ++D +E+ P I L+ D+
Sbjct: 229 LYYMTYGKTPFQQIINQISKLHAIIDPN------HEIEFPDI-PEKDLQ------DVLKC 275
Query: 808 CVQESGDDRPTMSEVVKD 825
C++ R ++ E++
Sbjct: 276 CLKRDPKQRISIPELLAH 293
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 2e-38
Identities = 73/290 (25%), Positives = 117/290 (40%), Gaps = 54/290 (18%)
Query: 564 GSGGYGKVYKGTLPNG----QLIAIKRAQQG-SMQGGQEFKMEIELLSRVHHKNLVSLLG 618
G G +G VY G + AIK + MQ + F E L+ ++H N+++L+G
Sbjct: 30 GKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIG 89
Query: 619 FCFDR-GEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPI 677
G ++ ++ +G L + + L ARG+ YL E
Sbjct: 90 IMLPPEGLPHVLLPYMCHGDLLQFIR-SPQRNPTVKDLISFGLQVARGMEYLAEQK---F 145
Query: 678 IHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYL-----DPEYYMT 732
+HRD+ + N +LDE KVADFGL++ + D E + + L E T
Sbjct: 146 VHRDLAARNCMLDESFTVKVADFGLARDILDRE---YYSVQQHRHARLPVKWTALESLQT 202
Query: 733 QQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELY----------NL 781
+ T KSDV+SFGVL+ ELLT G P Y + + + +L
Sbjct: 203 YRFTTKSDVWSFGVLLWELLTRGAPP-----YRHIDPFDLTHFLAQGRRLPQPEYCPDSL 257
Query: 782 YELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQ 831
Y+++ +C + RPT +V ++E I+
Sbjct: 258 YQVM--------------------QQCWEADPAVRPTFRVLVGEVEQIVS 287
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 3e-38
Identities = 48/198 (24%), Positives = 91/198 (45%), Gaps = 8/198 (4%)
Query: 563 VGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGG--QEFKMEIELLSRVHHKNLVSLLGF 619
+G G +GK +G+ IK M +E + E+ +L+ + H N+V
Sbjct: 32 IGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRES 91
Query: 620 CFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIH 679
+ G ++ ++ G L ++ + G+ + L + L ++H+ I+H
Sbjct: 92 FEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK---ILH 148
Query: 680 RDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKS 739
RDIKS NI L + ++ DFG+++ ++ S + + GT YL PE + KS
Sbjct: 149 RDIKSQNIFLTKDGTVQLGDFGIARVLN-STVELARACI-GTPYYLSPEICENKPYNNKS 206
Query: 740 DVYSFGVLMLELLTGRRP 757
D+++ G ++ EL T +
Sbjct: 207 DIWALGCVLYELCTLKHA 224
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 4e-38
Identities = 74/299 (24%), Positives = 116/299 (38%), Gaps = 64/299 (21%)
Query: 564 GSGGYGKVYKGTLPNG----QLIAIK--RAQQGSMQGGQEFKMEIELLSRVHHKNLVSLL 617
G G +G V +G L +A+K + S + +EF E + H N++ LL
Sbjct: 43 GEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLL 102
Query: 618 GFCFDRGEQ-----MLIYEFVPNGSLGDSL----SGKNGIRLDWIRRLKIALGAARGLSY 668
G C + Q M+I F+ G L L + LK + A G+ Y
Sbjct: 103 GVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEY 162
Query: 669 LHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYL--- 725
L +N +HRD+ + N +L + + VADFGLSK + + +G + +
Sbjct: 163 L---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGD-----YYRQGRIAKMPVK 214
Query: 726 --DPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRP------IERGKYIVREIRTVMDK-- 774
E + T KSDV++FGV M E+ T G P E Y++ R + +
Sbjct: 215 WIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHR--LKQPE 272
Query: 775 --KKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQ 831
ELY + C + DRPT S + +E +L+
Sbjct: 273 DCLDELYE-----------------------IMYSCWRTDPLDRPTFSVLRLQLEKLLE 308
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 4e-38
Identities = 71/292 (24%), Positives = 121/292 (41%), Gaps = 59/292 (20%)
Query: 564 GSGGYGKVYKGTL--PNGQLI--AIKRAQQGSMQGG-QEFKMEIELLSRVHHKNLVSLLG 618
G G +G+VY+G G+ I A+K ++ ++F E ++ + H ++V L+G
Sbjct: 21 GEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIG 80
Query: 619 FCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPII 678
+ +I E P G LG L +N L + + +L + ++YL E N +
Sbjct: 81 II-EEEPTWIIMELYPYGELGHYLE-RNKNSLKVLTLVLYSLQICKAMAYL-ESIN--CV 135
Query: 679 HRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGT------MGYLDPEYYMT 732
HRDI NIL+ K+ DFGLS+ + D + + T M PE
Sbjct: 136 HRDIAVRNILVASPECVKLGDFGLSRYIEDED----YYKASVTRLPIKWMS---PESINF 188
Query: 733 QQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELY----------NL 781
++ T SDV+ F V M E+L+ G++P + E + V+ ++ L
Sbjct: 189 RRFTTASDVWMFAVCMWEILSFGKQP-----FFWLENKDVIGVLEKGDRLPKPDLCPPVL 243
Query: 782 YELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQA 833
Y L+ +C DRP +E+V + ++ Q
Sbjct: 244 YTLM--------------------TRCWDYDPSDRPRFTELVCSLSDVYQME 275
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 4e-38
Identities = 53/278 (19%), Positives = 108/278 (38%), Gaps = 35/278 (12%)
Query: 563 VGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGG--QEFKMEIELLSRVHHKNL--VSLLG 618
+GSGG KV++ Q+ AIK ++ EI L+++ + + L
Sbjct: 17 IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 76
Query: 619 FCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPII 678
+ ++ E N L L K I + + + +H+ I+
Sbjct: 77 YEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNM--LEAVHTIHQHG---IV 130
Query: 679 HRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPE---------- 728
H D+K +N L+ + K+ DFG++ M + GT+ Y+ PE
Sbjct: 131 HSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRE 189
Query: 729 -YYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDP 787
+++ KSDV+S G ++ + G+ P ++ + ++ ++D +E+ P
Sbjct: 190 NGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN------HEIEFP 243
Query: 788 TIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825
L+ D+ C++ R ++ E++
Sbjct: 244 D-IPEKDLQ------DVLKCCLKRDPKQRISIPELLAH 274
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 5e-38
Identities = 71/310 (22%), Positives = 128/310 (41%), Gaps = 81/310 (26%)
Query: 564 GSGGYGKVYKGTLPNG------QLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLL 617
G G +GKV+ N L+A+K + ++ ++F+ E ELL+ + H+++V
Sbjct: 24 GEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFY 83
Query: 618 GFCFDRGEQMLIYEFVPNGSL--------------GDSLSGKNGIRLDWIRRLKIALGAA 663
G C D ++++E++ +G L D + L + L IA A
Sbjct: 84 GVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIA 143
Query: 664 RGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMG 723
G+ YL +HRD+ + N L+ L K+ DFG+S+ + ++ G
Sbjct: 144 SGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTD-----YYRVGGHT 195
Query: 724 YL-----DPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRP------------IERGKYIV 765
L PE M ++ T +SDV+SFGV++ E+ T G++P I +G+
Sbjct: 196 MLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGR--- 252
Query: 766 REIRTVMDK----KKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSE 821
V+++ KE+Y+ + L C Q R + E
Sbjct: 253 -----VLERPRVCPKEVYD-----------------------VMLGCWQREPQQRLNIKE 284
Query: 822 VVKDIENILQ 831
+ K + + +
Sbjct: 285 IYKILHALGK 294
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 1e-37
Identities = 67/312 (21%), Positives = 127/312 (40%), Gaps = 80/312 (25%)
Query: 561 NDVGSGGYGKVYKGTLPNG------QLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLV 614
++G G +GKV+ N L+A+K ++ S Q+F+ E ELL+ + H+++V
Sbjct: 47 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106
Query: 615 SLLGFCFDRGEQMLIYEFVPNGSL-------------GDSLSGKNGIRLDWIRRLKIALG 661
G C + ++++E++ +G L L + L +A
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166
Query: 662 AARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGT 721
A G+ YL L +HRD+ + N L+ + L K+ DFG+S+ + ++ G
Sbjct: 167 VAAGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD-----YYRVGG 218
Query: 722 MGYL-----DPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRP------------IERGKY 763
L PE + ++ T +SDV+SFGV++ E+ T G++P I +G+
Sbjct: 219 RTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGR- 277
Query: 764 IVREIRTVMDK----KKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTM 819
+++ E+Y + C Q R ++
Sbjct: 278 -------ELERPRACPPEVYA-----------------------IMRGCWQREPQQRHSI 307
Query: 820 SEVVKDIENILQ 831
+V ++ + Q
Sbjct: 308 KDVHARLQALAQ 319
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 3e-37
Identities = 62/222 (27%), Positives = 95/222 (42%), Gaps = 23/222 (10%)
Query: 563 VGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGG--QEFKMEIELLSRVHHKNLVSLLGF 619
+G+G YG+ K +G+++ K GSM Q E+ LL + H N+V
Sbjct: 14 IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 620 CFDRGEQML--IYEFVPNGSLGDSLS--GKNGIRLDWIRRLKIALGAARGLSYLHE--LA 673
DR L + E+ G L ++ K LD L++ L H
Sbjct: 74 IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 674 NPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQ 733
++HRD+K +N+ LD + N K+ DFGL++ ++ + T V GT Y+ PE
Sbjct: 134 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN-HDTSFAKTFV-GTPYYMSPEQMNRM 191
Query: 734 QLTEKSDVYSFGVLMLELLTGRRP------------IERGKY 763
EKSD++S G L+ EL P I GK+
Sbjct: 192 SYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF 233
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 3e-37
Identities = 68/276 (24%), Positives = 125/276 (45%), Gaps = 29/276 (10%)
Query: 564 GSGGYGKVYKGTL----PNGQL-IAIK--RAQQGSMQGGQEFKMEIELLSRVHHKNLVSL 616
GSG +G V+KG + ++ + IK + G Q + + + H ++V L
Sbjct: 22 GSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSF-QAVTDHMLAIGSLDHAHIVRL 80
Query: 617 LGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPP 676
LG C L+ +++P GSL D + ++ L L + A+G+ YL E
Sbjct: 81 LGLCPGS-SLQLVTQYLPLGSLLDHVR-QHRGALGPQLLLNWGVQIAKGMYYLEEHG--- 135
Query: 677 IIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLT 736
++HR++ + N+LL +VADFG++ + +K + ++ K + ++ E + T
Sbjct: 136 MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYT 195
Query: 737 EKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTL 795
+SDV+S+GV + EL+T G P Y + V D ++ L + TI +
Sbjct: 196 HQSDVWSYGVTVWELMTFGAEP-----YAGLRLAEVPDLLEKGERLAQPQICTIDV---- 246
Query: 796 KGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQ 831
Y + +KC + RPT E+ + + +
Sbjct: 247 -----Y-MVMVKCWMIDENIRPTFKELANEFTRMAR 276
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 3e-37
Identities = 75/304 (24%), Positives = 124/304 (40%), Gaps = 62/304 (20%)
Query: 564 GSGGYGKVYKGTL--PNGQL-IAIKRAQQGSMQGG-QEFKMEIELLSRVHHKNLVSLLGF 619
G G +G V +G Q+ +AIK +QG+ + +E E +++ ++ + +V L+G
Sbjct: 345 GCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGV 404
Query: 620 CFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIH 679
C ML+ E G L L + ++ + G+ YL E N +H
Sbjct: 405 C-QAEALMLVMEMAGGGPLHKFLV-GKREEIPVSNVAELLHQVSMGMKYL-EEKN--FVH 459
Query: 680 RDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGY--LDPEYYMTQQLTE 737
R++ + N+LL R AK++DFGLSK++ + + T + G PE ++ +
Sbjct: 460 RNLAARNVLLVNRHYAKISDFGLSKALGADD-SYYTARSAGKWPLKWYAPECINFRKFSS 518
Query: 738 KSDVYSFGVLMLELLT-GRRP------------IERGKYIVREIRTVMDK----KKELYN 780
+SDV+S+GV M E L+ G++P IE+GK R M+ ELY
Sbjct: 519 RSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK---R-----MECPPECPPELY- 569
Query: 781 LYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQAGLNPNAE 840
L C +DRP V + + L E
Sbjct: 570 ----------------------ALMSDCWIYKWEDRPDFLTVEQRMRACYY--SLASKVE 605
Query: 841 SASS 844
S+
Sbjct: 606 GGSA 609
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 4e-37
Identities = 49/202 (24%), Positives = 81/202 (40%), Gaps = 19/202 (9%)
Query: 563 VGSGGYGKVYKGT-LPNGQLIAIK--RAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGF 619
VG G +G+V++ G A+K R + ++ E+ + + +V L G
Sbjct: 66 VGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE-------ELVACAGLSSPRIVPLYGA 118
Query: 620 CFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIH 679
+ + E + GSLG + + D A GL YLH I+H
Sbjct: 119 VREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRAL--YYLGQALEGLEYLHTRR---ILH 173
Query: 680 RDIKSSNILLDER-LNAKVADFGLSKSMSDSEKDHITTQ---VKGTMGYLDPEYYMTQQL 735
D+K+ N+LL A + DFG + + + GT ++ PE M +
Sbjct: 174 GDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPC 233
Query: 736 TEKSDVYSFGVLMLELLTGRRP 757
K D++S +ML +L G P
Sbjct: 234 DAKVDIWSSCCMMLHMLNGCHP 255
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 4e-37
Identities = 75/307 (24%), Positives = 123/307 (40%), Gaps = 69/307 (22%)
Query: 564 GSGGYGKVYKGTLPN------GQLIAIKRAQQGSMQG-GQEFKMEIELLSRV-HHKNLVS 615
G G +G+V + + +A+K ++G+ + E+++L + HH N+V+
Sbjct: 36 GRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 95
Query: 616 LLGFCFDRGE-QMLIYEFVPNGSLGDSL--------------SGKNGIRLDWIRRLKIAL 660
LLG C G M+I EF G+L L L + +
Sbjct: 96 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSF 155
Query: 661 GAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKG 720
A+G+ +L A+ IHRD+ + NILL E+ K+ DFGL++ + V+
Sbjct: 156 QVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP-----DYVRK 207
Query: 721 TMGYL-----DPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRP---IERGKYIVREIRT- 770
L PE + T +SDV+SFGVL+ E+ + G P ++ + R ++
Sbjct: 208 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG 267
Query: 771 -VMDK----KKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825
M E+Y L C RPT SE+V+
Sbjct: 268 TRMRAPDYTTPEMYQT-----------------------MLDCWHGEPSQRPTFSELVEH 304
Query: 826 IENILQQ 832
+ N+LQ
Sbjct: 305 LGNLLQA 311
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 4e-37
Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 24/208 (11%)
Query: 564 GSGGYGKVYKGTL--PNGQLI--AIKRAQQGSMQGG---QEFKMEIELLSRVHHKNLVSL 616
G G +G V +G P+G+ + A+K + + +F E+ + + H+NL+ L
Sbjct: 27 GDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRL 86
Query: 617 LGFCFDRGEQ-MLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANP 675
G ++ E P GSL D L K+ + A+ A G+ YL E
Sbjct: 87 YGVVL--TPPMKMVTELAPLGSLLDRLR-KHQGHFLLGTLSRYAVQVAEGMGYL-ESKR- 141
Query: 676 PIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQ-----VKGTMGYLDPEYY 730
IHRD+ + N+LL R K+ DFGL +++ ++ ++ + PE
Sbjct: 142 -FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA----PESL 196
Query: 731 MTQQLTEKSDVYSFGVLMLELLT-GRRP 757
T+ + SD + FGV + E+ T G+ P
Sbjct: 197 KTRTFSHASDTWMFGVTLWEMFTYGQEP 224
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 5e-37
Identities = 75/375 (20%), Positives = 134/375 (35%), Gaps = 87/375 (23%)
Query: 507 YAYHQKRRAEKANEQNPFAHWDMNKSSGSI-PQLKGARCFSFEEVKKYT---NNFSDAND 562
+ Y ++ R E M + +GS + +E K+ N
Sbjct: 1 HKYKKQFRYES--------QLQMVQVTGSSDNEYFYVDFREYEYDLKWEFPRENLEFGKV 52
Query: 563 VGSGGYGKVYKGTLPNG------QLIAIKRAQQGSMQG-GQEFKMEIELLSRV-HHKNLV 614
+GSG +GKV T +A+K ++ + + E+++++++ H+N+V
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 112
Query: 615 SLLGFCFDRGEQMLIYEFVPNGSLGDSL---------------------SGKNGIRLDWI 653
+LLG C G LI+E+ G L + L ++ L +
Sbjct: 113 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 172
Query: 654 RRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDH 713
L A A+G+ +L +HRD+ + N+L+ K+ DFGL++ +
Sbjct: 173 DLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDS--- 226
Query: 714 ITTQVKGTMGYL-----DPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRP---IERGKYI 764
V L PE T KSDV+S+G+L+ E+ + G P I
Sbjct: 227 --NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANF 284
Query: 765 VREIRT--VMDK----KKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPT 818
+ I+ MD+ +E+Y + C RP+
Sbjct: 285 YKLIQNGFKMDQPFYATEEIY-----------------------IIMQSCWAFDSRKRPS 321
Query: 819 MSEVVKDIENILQQA 833
+ + L A
Sbjct: 322 FPNLTSFLGCQLADA 336
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 6e-37
Identities = 57/343 (16%), Positives = 119/343 (34%), Gaps = 49/343 (14%)
Query: 509 YHQKRRAEKANEQNPFAHWDMNKSSGSIPQLKGARCFSFEEVKKYTNNFSDAND------ 562
+H + + K ++ N
Sbjct: 2 HHHHHSSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSIL 61
Query: 563 --VGSGGYGKVYKGTLPNGQLIAIKR-----AQQGSMQGGQEFKMEIELLSRVHHKNL-- 613
+GSGG KV++ Q+ AIK A ++ ++ EI L+++ +
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDS---YRNEIAYLNKLQQHSDKI 118
Query: 614 VSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELA 673
+ L + ++ E N L L K I + + + +H+
Sbjct: 119 IRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNM--LEAVHTIHQHG 175
Query: 674 NPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPE----- 728
I+H D+K +N L+ + K+ DFG++ M + G + Y+ PE
Sbjct: 176 ---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDM 231
Query: 729 ------YYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLY 782
+++ KSDV+S G ++ + G+ P ++ + ++ ++D +
Sbjct: 232 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN------H 285
Query: 783 ELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825
E+ P I L+ D+ C++ R ++ E++
Sbjct: 286 EIEFPDI-PEKDLQ------DVLKCCLKRDPKQRISIPELLAH 321
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 7e-37
Identities = 75/317 (23%), Positives = 133/317 (41%), Gaps = 84/317 (26%)
Query: 564 GSGGYGKVYKGTLPNG------QLIAIKRAQQGSMQG-GQEFKMEIELLSRVHHKNLVSL 616
G G +GKV K T + +A+K ++ + ++ E +L +V+H +++ L
Sbjct: 32 GEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKL 91
Query: 617 LGFCFDRGEQMLIYEFVPNGSL----------------------GDSLSGKNGIRLDWIR 654
G C G +LI E+ GSL SL + L
Sbjct: 92 YGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGD 151
Query: 655 RLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHI 714
+ A ++G+ Y LA ++HRD+ + NIL+ E K++DFGLS+ + + +
Sbjct: 152 LISFAWQISQGMQY---LAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED---- 204
Query: 715 TTQVKGTMGYL-----DPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKY----- 763
+ VK + G + E T +SDV+SFGVL+ E++T G P Y
Sbjct: 205 -SYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP-----YPGIPP 258
Query: 764 --IVREIRT--VMDK----KKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDD 815
+ ++T M++ +E+Y L L+C ++ D
Sbjct: 259 ERLFNLLKTGHRMERPDNCSEEMY-----------------------RLMLQCWKQEPDK 295
Query: 816 RPTMSEVVKDIENILQQ 832
RP +++ KD+E ++ +
Sbjct: 296 RPVFADISKDLEKMMVK 312
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 8e-37
Identities = 68/287 (23%), Positives = 110/287 (38%), Gaps = 51/287 (17%)
Query: 564 GSGGYGKVYKGTL--PNGQLI--AIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLVSLLG 618
G G +G V++G P + AIK + + ++F E + + H ++V L+G
Sbjct: 24 GEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIG 83
Query: 619 FCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPII 678
+I E G L L LD + A + L+YL +
Sbjct: 84 VI-TENPVWIIMELCTLGELRSFLQ-VRKYSLDLASLILYAYQLSTALAYLESKR---FV 138
Query: 679 HRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTM--GYLDPEYYMTQQLT 736
HRDI + N+L+ K+ DFGLS+ M DS KG + ++ PE ++ T
Sbjct: 139 HRDIAARNVLVSSNDCVKLGDFGLSRYMEDST---YYKASKGKLPIKWMAPESINFRRFT 195
Query: 737 EKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELY----------NLYELI 785
SDV+ FGV M E+L G +P + + V+ + + LY L+
Sbjct: 196 SASDVWMFGVCMWEILMHGVKP-----FQGVKNNDVIGRIENGERLPMPPNCPPTLYSLM 250
Query: 786 DPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 832
KC RP +E+ + IL++
Sbjct: 251 --------------------TKCWAYDPSRRPRFTELKAQLSTILEE 277
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 1e-36
Identities = 75/315 (23%), Positives = 124/315 (39%), Gaps = 85/315 (26%)
Query: 564 GSGGYGKVYKGTL--------PNGQLIAIKRAQQGSMQG-GQEFKMEIELLSRV-HHKNL 613
G G +G+V +A+K + + + + E+E++ + HKN+
Sbjct: 90 GEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 149
Query: 614 VSLLGFCFDRGEQMLIYEFVPNGSLGDSL--------------SGKNGIRLDWIRRLKIA 659
++LLG C G +I E+ G+L + L + ++ + +
Sbjct: 150 INLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCT 209
Query: 660 LGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVK 719
ARG+ YL A+ IHRD+ + N+L+ E K+ADFGL++ +++ + K
Sbjct: 210 YQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID-----YYKK 261
Query: 720 GTMGYL-----DPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRP------------IERG 761
T G L PE + T +SDV+SFGVLM E+ T G P ++ G
Sbjct: 262 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG 321
Query: 762 KYIVREIRTVMDK----KKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRP 817
MDK ELY + C RP
Sbjct: 322 H--------RMDKPANCTNELYM-----------------------MMRDCWHAVPSQRP 350
Query: 818 TMSEVVKDIENILQQ 832
T ++V+D++ IL
Sbjct: 351 TFKQLVEDLDRILTL 365
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-36
Identities = 75/316 (23%), Positives = 124/316 (39%), Gaps = 85/316 (26%)
Query: 564 GSGGYGKVYKGTLP--------NGQLIAIKRAQQGSMQG-GQEFKMEIELLSRV-HHKNL 613
G G +G+V +A+K + + + + E+E++ + HKN+
Sbjct: 44 GEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 103
Query: 614 VSLLGFCFDRGEQMLIYEFVPNGSLGDSL--------------SGKNGIRLDWIRRLKIA 659
++LLG C G +I E+ G+L + L + ++ + +
Sbjct: 104 INLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCT 163
Query: 660 LGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVK 719
ARG+ YL A+ IHRD+ + N+L+ E K+ADFGL++ +++ + K
Sbjct: 164 YQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID-----YYKK 215
Query: 720 GTMGYL-----DPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRP------------IERG 761
T G L PE + T +SDV+SFGVLM E+ T G P ++ G
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG 275
Query: 762 KYIVREIRTVMDK----KKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRP 817
MDK ELY + C RP
Sbjct: 276 H--------RMDKPANCTNELYM-----------------------MMRDCWHAVPSQRP 304
Query: 818 TMSEVVKDIENILQQA 833
T ++V+D++ IL
Sbjct: 305 TFKQLVEDLDRILTLT 320
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 3e-36
Identities = 63/301 (20%), Positives = 120/301 (39%), Gaps = 49/301 (16%)
Query: 552 KYTNNFSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQ-GGQEFKMEIELLSRVH 609
+Y +F +G GG+G V++ + AIKR + + + ++ E++ L+++
Sbjct: 2 RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 61
Query: 610 HKNLVSLLGFCFDRGE---------QMLIY---EFVPNGSLGDSLSGKNGIR-LDWIRRL 656
H +V ++ ++ +Y + +L D ++G+ I + L
Sbjct: 62 HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121
Query: 657 KIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHIT- 715
I L A + +LH ++HRD+K SNI KV DFGL +M E++
Sbjct: 122 HIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 178
Query: 716 ---------TQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVR 766
T GT Y+ PE + K D++S G+++ ELL P
Sbjct: 179 TPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFS------- 228
Query: 767 EIRTVMDKKKELYNLYELIDPTI--GLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVK 824
T M++ + L ++ L P + + + S +RP +++
Sbjct: 229 ---TQMERVRTLTDVRNLKFPPLFTQKYPCEY------VMVQDMLSPSPMERPEAINIIE 279
Query: 825 D 825
+
Sbjct: 280 N 280
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 4e-36
Identities = 69/309 (22%), Positives = 121/309 (39%), Gaps = 70/309 (22%)
Query: 564 GSGGYGKVYKGTLPN------GQLIAIKRAQQGSMQG-GQEFKMEIELLSRV-HHKNLVS 615
G+G +GKV + T +A+K + + + E+++LS + +H N+V+
Sbjct: 32 GAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVN 91
Query: 616 LLGFCFDRGEQMLIYEFVPNGSL----------------GDSLSGKNGIRLDWIRRLKIA 659
LLG C G ++I E+ G L ++ + + LD L +
Sbjct: 92 LLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFS 151
Query: 660 LGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVK 719
A+G+++L A+ IHRD+ + NILL K+ DFGL++ + + V
Sbjct: 152 YQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS-----NYVV 203
Query: 720 GTMGYL-----DPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRP---IERGKYIVREIRT 770
L PE T +SDV+S+G+ + EL + G P + + I+
Sbjct: 204 KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKE 263
Query: 771 --VMDK----KKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVK 824
M E+Y D+ C RPT ++V+
Sbjct: 264 GFRMLSPEHAPAEMY-----------------------DIMKTCWDADPLKRPTFKQIVQ 300
Query: 825 DIENILQQA 833
IE + ++
Sbjct: 301 LIEKQISES 309
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 4e-36
Identities = 63/307 (20%), Positives = 118/307 (38%), Gaps = 58/307 (18%)
Query: 552 KYTNNFSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHH 610
+Y ++F + +G G +G+V K + + AIK+ + + E+ LL+ ++H
Sbjct: 3 RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKL-STILSEVMLLASLNH 61
Query: 611 KNLVSLLGFCFDRGEQML----------IY---EFVPNGSLGDSLSGKNGIRLDWIRRLK 657
+ +V +R + ++ E+ NG+L D + + +
Sbjct: 62 QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIH-SENLNQQRDEYWR 120
Query: 658 IALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDS-------- 709
+ LSY+H IIHRD+K NI +DE N K+ DFGL+K++ S
Sbjct: 121 LFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177
Query: 710 -----EKDHITTQVKGTMGYLDPE------YYMTQQLTEKSDVYSFGVLMLELLTGRRPI 758
D++T+ + GT Y+ E +Y EK D+YS G++ E++
Sbjct: 178 QNLPGSSDNLTSAI-GTAMYVATEVLDGTGHY-----NEKIDMYSLGIIFFEMIYPFSTG 231
Query: 759 ERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPT 818
I++++R D K + + + RP
Sbjct: 232 MERVNILKKLR------SVSIEFPPDFDDNK--MKVEK------KIIRLLIDHDPNKRPG 277
Query: 819 MSEVVKD 825
++
Sbjct: 278 ARTLLNS 284
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 4e-36
Identities = 74/321 (23%), Positives = 124/321 (38%), Gaps = 68/321 (21%)
Query: 564 GSGGYGKVYKGTLPNG------QLIAIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLVSL 616
G G +G+VY+G + +A+K + Q +F ME ++S+ +H+N+V
Sbjct: 39 GHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRC 98
Query: 617 LGFCFDRGEQMLIYEFVPNGSLGDSL-----SGKNGIRLDWIRRLKIALGAARGLSYLHE 671
+G + ++ E + G L L L + L +A A G YL E
Sbjct: 99 IGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE 158
Query: 672 LANPPIIHRDIKSSNILLD---ERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYL--- 725
IHRDI + N LL AK+ DFG+++ + + KG L
Sbjct: 159 NH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS-----YYRKGGCAMLPVK 210
Query: 726 --DPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPI------ERGKYIVREIRTVMDK-- 774
PE +M T K+D +SFGVL+ E+ + G P E +++ R MD
Sbjct: 211 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR--MDPPK 268
Query: 775 --KKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 832
+Y + +C Q +DRP + +++ IE Q
Sbjct: 269 NCPGPVYR-----------------------IMTQCWQHQPEDRPNFAIILERIEYCTQ- 304
Query: 833 AGLNPNAESASSSASYEDASK 853
+P+ + + Y +
Sbjct: 305 ---DPDVINTALPIEYGPLVE 322
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 5e-36
Identities = 67/307 (21%), Positives = 116/307 (37%), Gaps = 58/307 (18%)
Query: 563 VGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRV-HHKNLVSLLGFC 620
+ GG+ VY+ + +G+ A+KR + + E+ + ++ H N+V
Sbjct: 36 LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAA 95
Query: 621 FDRGEQM-------LIYEFVPNGSLGDSL-SGKNGIRLDWIRRLKIALGAARGLSYLHEL 672
E+ L+ + G L + L ++ L LKI R + ++H
Sbjct: 96 SIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ 155
Query: 673 ANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVK----------GTM 722
PPIIHRD+K N+LL + K+ DFG + ++S + Q + T
Sbjct: 156 -KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTP 214
Query: 723 GYLDPE---YYMTQQLTEKSDVYSFGVLMLELLTGRRP--------IERGKYIVREIRTV 771
Y PE Y + EK D+++ G ++ L + P I GKY
Sbjct: 215 MYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNGKY-------- 266
Query: 772 MDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQ 831
I P T L +Q + ++R +++EVV ++ I
Sbjct: 267 ------------SIPPHDTQYTVFH------SLIRAMLQVNPEERLSIAEVVHQLQEIAA 308
Query: 832 QAGLNPN 838
+NP
Sbjct: 309 ARNVNPK 315
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 9e-36
Identities = 63/304 (20%), Positives = 115/304 (37%), Gaps = 66/304 (21%)
Query: 564 GSGGYGKVYKGTL------PNGQLIAIKRAQQGSMQG-GQEFKMEIELLSRV-HHKNLVS 615
G+G +GKV + T +A+K + + + E++++S + H+N+V+
Sbjct: 55 GAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVN 114
Query: 616 LLGFCFDRGEQMLIYEFVPNGSL------------GDSLSGKNGIRLDWIRRLKIALGAA 663
LLG C G ++I E+ G L D L + A
Sbjct: 115 LLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVA 174
Query: 664 RGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMG 723
+G+++L A+ IHRD+ + N+LL AK+ DFGL++ + + +
Sbjct: 175 QGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS-----NYIVKGNA 226
Query: 724 YL-----DPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRP---IERGKYIVREIRT--VM 772
L PE T +SDV+S+G+L+ E+ + G P I + ++ M
Sbjct: 227 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQM 286
Query: 773 DK----KKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIEN 828
+ K +Y + C RPT ++ ++
Sbjct: 287 AQPAFAPKNIY-----------------------SIMQACWALEPTHRPTFQQICSFLQE 323
Query: 829 ILQQ 832
Q+
Sbjct: 324 QAQE 327
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 9e-36
Identities = 80/350 (22%), Positives = 129/350 (36%), Gaps = 92/350 (26%)
Query: 564 GSGGYGKVYKGTLPN--------GQLIAIKRAQQGSMQG-GQEFKMEIELLSRV-HHKNL 613
G G +G+V +A+K + + + + E+E++ + HKN+
Sbjct: 78 GEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNI 137
Query: 614 VSLLGFCFDRGEQMLIYEFVPNGSLGDSL--------------SGKNGIRLDWIRRLKIA 659
++LLG C G +I E+ G+L + L S +L + A
Sbjct: 138 INLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCA 197
Query: 660 LGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVK 719
ARG+ YL A+ IHRD+ + N+L+ E K+ADFGL++ + + K
Sbjct: 198 YQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID-----YYKK 249
Query: 720 GTMGYL-----DPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRP------------IERG 761
T G L PE + T +SDV+SFGVL+ E+ T G P ++ G
Sbjct: 250 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEG 309
Query: 762 KYIVREIRTVMDK----KKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRP 817
MDK ELY + C RP
Sbjct: 310 H--------RMDKPSNCTNELYM-----------------------MMRDCWHAVPSQRP 338
Query: 818 TMSEVVKDIENILQQAGLNPNAESASSSASYEDASKGNFHHPYCNEEGFD 867
T ++V+D++ I+ S Y ++ P F+
Sbjct: 339 TFKQLVEDLDRIVA-------LTSNQEMGYYHHHHHHDYDIPTTENLYFN 381
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 1e-35
Identities = 48/266 (18%), Positives = 86/266 (32%), Gaps = 12/266 (4%)
Query: 3 LKGQLSGDITGLTELHTLDLSNNK-DLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIG 61
KG + L L LDLS N +G + L L L + +
Sbjct: 335 NKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFL 393
Query: 62 SLQELVLLSLNSNGFSGRVPPSI-GNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRA 120
L++L L + S+ +L NL +LD++ L
Sbjct: 394 GLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSL------ 447
Query: 121 KHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLS 180
+ N + +F L + L P + SL+V+ N+
Sbjct: 448 EVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFF 507
Query: 181 GPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTG--LSVLSYLDMSNNSFDASEVPSWFSS- 237
L S+ L S N + + S L++L+++ N F + F
Sbjct: 508 SLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQW 567
Query: 238 MQSLTTLMMENTNLKGQIPADLFSIP 263
++ L++E ++ P+D +P
Sbjct: 568 IKDQRQLLVEVERMECATPSDKQGMP 593
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-33
Identities = 59/302 (19%), Positives = 101/302 (33%), Gaps = 24/302 (7%)
Query: 5 GQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQ 64
+ LT + + L + + +L LV C F + SL+
Sbjct: 272 DDIIDLFNCLTNVSSFSLVSVT-IERVKD--FSYNFGWQHLELVNCKFGQFPTLKLKSLK 328
Query: 65 ELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKL--EGEIPVSDGNSPGLDMLVRAKH 122
L S S +L +L +LDL+ N L +G SD + L K+
Sbjct: 329 RLTFTSNKGGN-----AFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSL------KY 377
Query: 123 FHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPA-TLGLVKSLEVVRFDRNSLSG 181
N + F L H+ F +NL +++L +
Sbjct: 378 LDLSFNGVITMSSN--FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRV 435
Query: 182 PVPSNLNNLTSVNDLYLSNNKLTGAMP--NLTGLSVLSYLDMSNNSFDASEVPSWFSSMQ 239
N L+S+ L ++ N T L L++LD+S + P+ F+S+
Sbjct: 436 AFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLS 494
Query: 240 SLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENLL--VNLQNNR 297
SL L M + N + LQ + N + + + + L +NL N
Sbjct: 495 SLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQND 554
Query: 298 IS 299
+
Sbjct: 555 FA 556
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 8e-32
Identities = 49/317 (15%), Positives = 98/317 (30%), Gaps = 25/317 (7%)
Query: 3 LKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGS 62
L+ S EL LDLS + ++ +L LS L+L G +
Sbjct: 40 LRHLGSYSFFSFPELQVLDLSRCE-IQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSG 98
Query: 63 LQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEG-EIPVSDGNSPGLDMLVRAK 121
L L L + IG+L L L++ N ++ ++P N L +
Sbjct: 99 LSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNL------E 152
Query: 122 HFHFGKNQLSGSIPE---KLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNS 178
H N++ L + ++ + + N + P + L + N
Sbjct: 153 HLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNF 211
Query: 179 LSGPVPSN-LNNLTSVNDLYLSNNKLTG-------AMPNLTGLSVLSYLDMSNNSFDAS- 229
S V + L + L + L GL L+ + D
Sbjct: 212 DSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYL 271
Query: 230 -EVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSEN 288
++ F+ + ++++ + + ++ Q + + + S
Sbjct: 272 DDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNF--GWQHLELVNCKFGQ-FPTLKLKSLK 328
Query: 289 LLVNLQNNRISAYTERG 305
L N +A++E
Sbjct: 329 RLTFTSNKGGNAFSEVD 345
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-31
Identities = 51/286 (17%), Positives = 83/286 (29%), Gaps = 39/286 (13%)
Query: 17 LHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGF 76
LDLS N LR + + +L L L C + SL L L L N
Sbjct: 30 TKNLDLSFNP-LRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI 88
Query: 77 SGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPE 136
+ LS+L L + L G+ L K + N +
Sbjct: 89 QSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTL------KELNVAHNLIQS---- 138
Query: 137 KLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTS---- 192
+LP + +LE + N + ++L L
Sbjct: 139 --------------------FKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLL 178
Query: 193 VNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLK 252
L LS N + P L L + NN + + + + L + +
Sbjct: 179 NLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFR 238
Query: 253 GQI---PADLFSIPHLQTVVMKTNELNGTLDLGTSYSENLLVNLQN 295
+ D ++ L + ++ L LD +L L N
Sbjct: 239 NEGNLEKFDKSALEGLCNLTIEEFRLA-YLDYYLDDIIDLFNCLTN 283
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-30
Identities = 46/331 (13%), Positives = 97/331 (29%), Gaps = 42/331 (12%)
Query: 3 LKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGS 62
L + I L L L++++N LP NL L +L L +
Sbjct: 112 LASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRV 171
Query: 63 LQEL----VLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIP-VSDGNSPGLDML 117
L ++ + L L+ N + + P L+ L L +N + GL++
Sbjct: 172 LHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVH 230
Query: 118 VRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLT------GELPATLGLVKSLEV 171
+ L L L ++ + L ++ + ++
Sbjct: 231 RLVLGEFRNEGNLEKFDKSALEG----LCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSS 286
Query: 172 VRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTG----AMPNLTGLSV------------ 215
++ + + L L N K + +L L+
Sbjct: 287 FSLVSVTIER--VKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEV 344
Query: 216 ----LSYLDMSNNSFDASEV-PSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVM 270
L +LD+S N SL L + + + ++ + L+ +
Sbjct: 345 DLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDF 403
Query: 271 KTNELNGTLDLGT-SYSENLLV-NLQNNRIS 299
+ + L + NL+ ++ +
Sbjct: 404 QHSNLKQMSEFSVFLSLRNLIYLDISHTHTR 434
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 6e-30
Identities = 57/300 (19%), Positives = 94/300 (31%), Gaps = 27/300 (9%)
Query: 13 GLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSG------PIPDSIGSLQEL 66
LH L L NN D + T I L L LV F ++ L L
Sbjct: 198 KEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNL 257
Query: 67 VLLSLNSN---GFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHF 123
+ + + L+N+ L +E S +H
Sbjct: 258 TIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFS--------YNFGWQHL 309
Query: 124 HFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLS--G 181
+ P + L + G + + SLE + RN LS G
Sbjct: 310 ELVNCKFGQ-FPTLKLKSLKRL-----TFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKG 363
Query: 182 PVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSL 241
+ TS+ L LS N + N GL L +LD +++ S F S+++L
Sbjct: 364 CCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNL 423
Query: 242 TTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGT-SYSENLLV-NLQNNRIS 299
L + +T+ + + L+ + M N + NL +L ++
Sbjct: 424 IYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE 483
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 2e-19
Identities = 35/244 (14%), Positives = 78/244 (31%), Gaps = 42/244 (17%)
Query: 62 SLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAK 121
+ + + N + +P ++ + LDL+ N L S + P L +
Sbjct: 6 VVPNITYQCMELNFYK--IPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPEL------Q 55
Query: 122 HFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSG 181
+ ++ + L + N +
Sbjct: 56 VLDLSRCEIQTIEDG-------------------------AYQSLSHLSTLILTGNPIQS 90
Query: 182 PVPSNLNNLTSVNDLYLSNNKLTGAMPN-LTGLSVLSYLDMSNNSFDASEVPSWFSSMQS 240
+ L+S+ L L + L L L++++N + ++P +FS++ +
Sbjct: 91 LALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTN 150
Query: 241 LTTLMMENTNLKGQIPADLFSIPHLQTVVMK----TNELNGTLDLGTSYSENLLV-NLQN 295
L L + + ++ DL + + + + N +N + G L L+N
Sbjct: 151 LEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKLTLRN 209
Query: 296 NRIS 299
N S
Sbjct: 210 NFDS 213
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 2e-07
Identities = 19/138 (13%), Positives = 37/138 (26%), Gaps = 30/138 (21%)
Query: 2 GLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIG 61
L+ L+ L L++S+N F
Sbjct: 481 QLEQLSPTAFNSLSSLQVLNMSHNN-------------------------FFSLDTFPYK 515
Query: 62 SLQELVLLSLNSNGFSGRVPPSIGNL-SNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRA 120
L L +L + N + + S+L +L+LT N + L +
Sbjct: 516 CLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE----HQSFLQWIKDQ 571
Query: 121 KHFHFGKNQLSGSIPEKL 138
+ ++ + P
Sbjct: 572 RQLLVEVERMECATPSDK 589
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 3e-35
Identities = 62/308 (20%), Positives = 113/308 (36%), Gaps = 82/308 (26%)
Query: 564 GSGGYGKVYKGTLPNG------QLIAIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLVSL 616
G +GKVYKG L Q +AIK + + +EF+ E L +R+ H N+V L
Sbjct: 18 GEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCL 77
Query: 617 LGFCFDRGEQMLIYEFVPNGSLGDSL--------------SGKNGIRLDWIRRLKIALGA 662
LG +I+ + +G L + L L+ + +
Sbjct: 78 LGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQI 137
Query: 663 ARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTM 722
A G+ YL ++H+D+ + N+L+ ++LN K++D GL + + ++
Sbjct: 138 AAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISDLGLFREVYAAD-----YYKLLGN 189
Query: 723 GYL-----DPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRP------------IERGKYI 764
L PE M + + SD++S+GV++ E+ + G +P I +
Sbjct: 190 SLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQ-- 247
Query: 765 VREIRTVMDK----KKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMS 820
V+ +Y L ++C E RP
Sbjct: 248 ------VLPCPDDCPAWVYA-----------------------LMIECWNEFPSRRPRFK 278
Query: 821 EVVKDIEN 828
++ +
Sbjct: 279 DIHSRLRA 286
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 5e-35
Identities = 65/200 (32%), Positives = 93/200 (46%), Gaps = 13/200 (6%)
Query: 564 GSGGYGKVYKGT-LPNGQLIAIK---RAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGF 619
G G +G VY + ++A+K +AQ + + E+E+ S + H N++ L G+
Sbjct: 18 GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 77
Query: 620 CFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIH 679
D LI E+ P G++ L K + D R A LSY H +IH
Sbjct: 78 FHDATRVYLILEYAPLGTVYRELQ-KLS-KFDEQRTATYITELANALSYCHSKR---VIH 132
Query: 680 RDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKS 739
RDIK N+LL K+ADFG S + S + GT+ YL PE + EK
Sbjct: 133 RDIKPENLLLGSAGELKIADFGWSV-HAPSSRRTDLC---GTLDYLPPEMIEGRMHDEKV 188
Query: 740 DVYSFGVLMLELLTGRRPIE 759
D++S GVL E L G+ P E
Sbjct: 189 DLWSLGVLCYEFLVGKPPFE 208
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 5e-35
Identities = 59/284 (20%), Positives = 106/284 (37%), Gaps = 42/284 (14%)
Query: 546 SFEEVKKYTNNFSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSM--QGGQEFKMEI 602
SF+ + + +G G YG+V+K +G+L A+KR+ + E+
Sbjct: 58 SFQRLSR----------LGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEV 107
Query: 603 ELLSRV-HHKNLVSLLGFCFDRGEQMLIY-EFVPNGSLGDSLSGKNGIRLDWIRRLKIAL 660
+V H V L ++ G + + E SL G L +
Sbjct: 108 GSHEKVGQHPCCVRLEQ-AWEEGGILYLQTELC-GPSLQQHCE-AWGASLPEAQVWGYLR 164
Query: 661 GAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKG 720
L++LH ++H D+K +NI L R K+ DFGL + + +G
Sbjct: 165 DTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA---GEVQEG 218
Query: 721 TMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYN 780
Y+ PE + +DV+S G+ +LE+ G + ++L
Sbjct: 219 DPRYMAPE-LLQGSYGTAADVFSLGLTILEVACNMELPHGG-----------EGWQQLRQ 266
Query: 781 LYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVK 824
Y + T GLS+ L+ + + ++ R T ++
Sbjct: 267 GYLPPEFTAGLSSELR------SVLVMMLEPDPKLRATAEALLA 304
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 8e-35
Identities = 70/277 (25%), Positives = 111/277 (40%), Gaps = 31/277 (11%)
Query: 564 GSGGYGKVYKGTL--PNGQLI--AIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLVSLLG 618
G G +G V++G P + AIK + + ++F E + + H ++V L+G
Sbjct: 399 GEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIG 458
Query: 619 FCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPII 678
+I E G L L LD + A + L+YL +
Sbjct: 459 VI-TENPVWIIMELCTLGELRSFLQ-VRKFSLDLASLILYAYQLSTALAYLESKR---FV 513
Query: 679 HRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTM--GYLDPEYYMTQQLT 736
HRDI + N+L+ K+ DFGLS+ M DS KG + ++ PE ++ T
Sbjct: 514 HRDIAARNVLVSSNDCVKLGDFGLSRYMEDST---YYKASKGKLPIKWMAPESINFRRFT 570
Query: 737 EKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTL 795
SDV+ FGV M E+L G +P + + V+ + + L TL
Sbjct: 571 SASDVWMFGVCMWEILMHGVKP-----FQGVKNNDVIGRIENGERL----PMPPNCPPTL 621
Query: 796 KGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 832
Y L KC RP +E+ + IL++
Sbjct: 622 -----Y-SLMTKCWAYDPSRRPRFTELKAQLSTILEE 652
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 9e-35
Identities = 66/318 (20%), Positives = 126/318 (39%), Gaps = 84/318 (26%)
Query: 564 GSGGYGKVYKGTLPNG------QLIAIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLVSL 616
G G +G+V++ P ++A+K ++ + +F+ E L++ + N+V L
Sbjct: 56 GEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKL 115
Query: 617 LGFCFDRGEQMLIYEFVPNGSL----------------------GDSLSGKNGIRLDWIR 654
LG C L++E++ G L +S L
Sbjct: 116 LGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAE 175
Query: 655 RLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHI 714
+L IA A G++YL E +HRD+ + N L+ E + K+ADFGLS+++ ++
Sbjct: 176 QLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD---- 228
Query: 715 TTQVKGTMGYL-----DPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKY----- 763
+ PE + T +SDV+++GV++ E+ + G +P Y
Sbjct: 229 -YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP-----YYGMAH 282
Query: 764 --IVREIRT--VMDK----KKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDD 815
++ +R ++ ELYN L C + D
Sbjct: 283 EEVIYYVRDGNILACPENCPLELYN-----------------------LMRLCWSKLPAD 319
Query: 816 RPTMSEVVKDIENILQQA 833
RP+ + + ++ + ++A
Sbjct: 320 RPSFCSIHRILQRMCERA 337
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 1e-34
Identities = 75/321 (23%), Positives = 125/321 (38%), Gaps = 68/321 (21%)
Query: 564 GSGGYGKVYKGTLPNG------QLIAIKRAQQG-SMQGGQEFKMEIELLSRVHHKNLVSL 616
G G +G+VY+G + +A+K + S Q +F ME ++S+ +H+N+V
Sbjct: 80 GHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRC 139
Query: 617 LGFCFDRGEQMLIYEFVPNGSLGDSL-----SGKNGIRLDWIRRLKIALGAARGLSYLHE 671
+G + ++ E + G L L L + L +A A G YL E
Sbjct: 140 IGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE 199
Query: 672 LANPPIIHRDIKSSNILLD---ERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYL--- 725
IHRDI + N LL AK+ DFG+++ + + KG L
Sbjct: 200 NH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAG-----YYRKGGCAMLPVK 251
Query: 726 --DPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPI------ERGKYIVREIRTVMDK-- 774
PE +M T K+D +SFGVL+ E+ + G P E +++ R MD
Sbjct: 252 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR--MDPPK 309
Query: 775 --KKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 832
+Y + +C Q +DRP + +++ IE Q
Sbjct: 310 NCPGPVYR-----------------------IMTQCWQHQPEDRPNFAIILERIEYCTQ- 345
Query: 833 AGLNPNAESASSSASYEDASK 853
+P+ + + Y +
Sbjct: 346 ---DPDVINTALPIEYGPLVE 363
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-34
Identities = 66/304 (21%), Positives = 108/304 (35%), Gaps = 44/304 (14%)
Query: 563 VGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQE-FKMEIELLSRVHHKNLVSLLGFC 620
+G G V++G G L AIK S + E E+L +++HKN+V L
Sbjct: 17 LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI- 75
Query: 621 FDRGEQMLIY---EFVPNGSLGDSL-SGKNGIRLDWIRRLKIALGAARGLSYLHELANPP 676
+ EF P GSL L N L L + G+++L E
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--- 132
Query: 677 IIHRDIKSSNILL----DERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYY-- 730
I+HR+IK NI+ D + K+ DFG ++ + D E+ + GT YL P+ Y
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ---FVSLYGTEEYLHPDMYER 189
Query: 731 ------MTQQLTEKSDVYSFGVLMLELLTGRRP----------------IERGKYIVREI 768
++ D++S GV TG P I GK
Sbjct: 190 AVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAIS 249
Query: 769 RTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIEN 828
+ + ++ LS L+ + ++ + + + +
Sbjct: 250 GVQKAENGPIDWSGDMPVSC-SLSRGLQ--VLLTPVLANILEADQEKCWGFDQFFAETSD 306
Query: 829 ILQQ 832
IL +
Sbjct: 307 ILHR 310
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 57/219 (26%), Positives = 89/219 (40%), Gaps = 28/219 (12%)
Query: 564 GSGGYGKVYKGT-LPNGQLIAIK-----RAQQGSMQGGQEFKMEIELLSRVHHKNLVSLL 617
G G + VY+ + G +AIK + M Q + E+++ ++ H +++ L
Sbjct: 20 GKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMV--QRVQNEVKIHCQLKHPSILELY 77
Query: 618 GFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPI 677
+ D L+ E NG + L + G+ YLH I
Sbjct: 78 NYFEDSNYVYLVLEMCHNGEMNRYLKNRVK-PFSENEARHFMHQIITGMLYLHSHG---I 133
Query: 678 IHRDIKSSNILLDERLNAKVADFGLS-KSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLT 736
+HRD+ SN+LL +N K+ADFGL+ + EK + T GT Y+ PE
Sbjct: 134 LHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHY-TLC--GTPNYISPEIATRSAHG 190
Query: 737 EKSDVYSFGVLMLELLTGRRP------------IERGKY 763
+SDV+S G + LL GR P + Y
Sbjct: 191 LESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADY 229
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-34
Identities = 68/320 (21%), Positives = 116/320 (36%), Gaps = 42/320 (13%)
Query: 563 VGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQE-FKMEIELLSRVHHKNLVSLLGFC 620
+G G V++G G L AIK S + E E+L +++HKN+V L
Sbjct: 17 LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIE 76
Query: 621 FDRGEQM--LIYEFVPNGSLGDSLSGK-NGIRLDWIRRLKIALGAARGLSYLHELANPPI 677
+ + LI EF P GSL L N L L + G+++L E I
Sbjct: 77 EETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---I 133
Query: 678 IHRDIKSSNILL----DERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYY--- 730
+HR+IK NI+ D + K+ DFG ++ + D E+ + GT YL P+ Y
Sbjct: 134 VHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ--FVSLY-GTEEYLHPDMYERA 190
Query: 731 -----MTQQLTEKSDVYSFGVLMLELLTGRRP----------------IERGKYIVREIR 769
++ D++S GV TG P I GK
Sbjct: 191 VLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISG 250
Query: 770 TVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENI 829
+ + ++ LS L+ + ++ + + + +I
Sbjct: 251 VQKAENGPIDWSGDMPVSC-SLSRGLQ--VLLTPVLANILEADQEKCWGFDQFFAETSDI 307
Query: 830 LQQAGLNPNAESASSSASYE 849
L + ++ + ++
Sbjct: 308 LHRMVIHVFSLQQMTAHKIY 327
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 4e-34
Identities = 56/203 (27%), Positives = 96/203 (47%), Gaps = 18/203 (8%)
Query: 563 VGSGGYGKVYKGT-LPNGQLIAIK--RAQQGSMQGGQE-FKMEIELLSRVHHKNLVSLLG 618
+G GG VY +AIK + + F+ E+ S++ H+N+VS+
Sbjct: 19 LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM-- 76
Query: 619 FCFDRGEQMLIY----EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELAN 674
D E+ Y E++ +L + + +G L + G+ + H++
Sbjct: 77 --IDVDEEDDCYYLVMEYIEGPTLSEYIE-SHG-PLSVDTAINFTNQILDGIKHAHDMR- 131
Query: 675 PPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQ 734
I+HRDIK NIL+D K+ DFG++K++S++ T V GT+ Y PE +
Sbjct: 132 --IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ-TNHVLGTVQYFSPEQAKGEA 188
Query: 735 LTEKSDVYSFGVLMLELLTGRRP 757
E +D+YS G+++ E+L G P
Sbjct: 189 TDECTDIYSIGIVLYEMLVGEPP 211
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 1e-33
Identities = 56/204 (27%), Positives = 98/204 (48%), Gaps = 14/204 (6%)
Query: 563 VGSGGYGKVYKGT-LPNGQLIAIK--RAQQGSMQGGQE-FKMEIELLSRVHHKNLVSLLG 618
+G GG +V+ L + + +A+K RA F+ E + + ++H +V++
Sbjct: 20 LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 619 FCFDRGEQMLIY----EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELAN 674
+ E+V +L D + G + R +++ A + L++ H+
Sbjct: 80 TGEAETPAGPLPYIVMEYVDGVTLRDIVH-TEG-PMTPKRAIEVIADACQALNFSHQNG- 136
Query: 675 PPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKD-HITTQVKGTMGYLDPEYYMTQ 733
IIHRD+K +NI++ KV DFG++++++DS T V GT YL PE
Sbjct: 137 --IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD 194
Query: 734 QLTEKSDVYSFGVLMLELLTGRRP 757
+ +SDVYS G ++ E+LTG P
Sbjct: 195 SVDARSDVYSLGCVLYEVLTGEPP 218
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-33
Identities = 55/217 (25%), Positives = 94/217 (43%), Gaps = 25/217 (11%)
Query: 564 GSGGYGKVYKGT-LPNGQLIAIK---RAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGF 619
G GG+ K ++ + ++ A K ++ ++ MEI + + H+++V GF
Sbjct: 24 GKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGF 83
Query: 620 CFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIH 679
D ++ E SL + + + R + G YLH +IH
Sbjct: 84 FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQI--VLGCQYLHRNR---VIH 138
Query: 680 RDIKSSNILLDERLNAKVADFGLS-KSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEK 738
RD+K N+ L+E L K+ DFGL+ K D E+ + GT Y+ PE + + +
Sbjct: 139 RDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC---GTPNYIAPEVLSKKGHSFE 195
Query: 739 SDVYSFGVLMLELLTGRRP------------IERGKY 763
DV+S G +M LL G+ P I++ +Y
Sbjct: 196 VDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY 232
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 1e-33
Identities = 51/208 (24%), Positives = 82/208 (39%), Gaps = 28/208 (13%)
Query: 563 VGSGGYGKVYKGTLPN-GQLIAIK--RAQQGSMQGGQE-FKMEIELLSRVHHKNLVSLLG 618
VG GG G VY+ +++A+K S + + E R+ ++V +
Sbjct: 42 VGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPI-- 99
Query: 619 FCFDRGEQ-------MLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHE 671
D GE M + L L + G L R + I L H
Sbjct: 100 --HDFGEIDGQLYVDM---RLINGVDLAAMLR-RQG-PLAPPRAVAIVRQIGSALDAAHA 152
Query: 672 LANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITT--QVKGTMGYLDPEY 729
HRD+K NIL+ A + DFG++ + +D +T GT+ Y+ PE
Sbjct: 153 AG---ATHRDVKPENILVSADDFAYLVDFGIASATTDE---KLTQLGNTVGTLYYMAPER 206
Query: 730 YMTQQLTEKSDVYSFGVLMLELLTGRRP 757
+ T ++D+Y+ ++ E LTG P
Sbjct: 207 FSESHATYRADIYALTCVLYECLTGSPP 234
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 65/200 (32%), Positives = 93/200 (46%), Gaps = 13/200 (6%)
Query: 564 GSGGYGKVYKG-TLPNGQLIAIK---RAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGF 619
G G +G VY N ++A+K ++Q + + EIE+ S + H N++ + +
Sbjct: 23 GKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNY 82
Query: 620 CFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIH 679
DR L+ EF P G L L K+G R D R A L Y HE +IH
Sbjct: 83 FHDRKRIYLMLEFAPRGELYKELQ-KHG-RFDEQRSATFMEELADALHYCHERK---VIH 137
Query: 680 RDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKS 739
RDIK N+L+ + K+ADFG S + S + GT+ YL PE + EK
Sbjct: 138 RDIKPENLLMGYKGELKIADFGWSV-HAPSLRRRTMC---GTLDYLPPEMIEGKTHDEKV 193
Query: 740 DVYSFGVLMLELLTGRRPIE 759
D++ GVL E L G P +
Sbjct: 194 DLWCAGVLCYEFLVGMPPFD 213
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 2e-33
Identities = 55/217 (25%), Positives = 94/217 (43%), Gaps = 25/217 (11%)
Query: 564 GSGGYGKVYKGT-LPNGQLIAIK---RAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGF 619
G GG+ K ++ + ++ A K ++ ++ MEI + + H+++V GF
Sbjct: 50 GKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGF 109
Query: 620 CFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIH 679
D ++ E SL + + + R + G YLH +IH
Sbjct: 110 FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQI--VLGCQYLHRNR---VIH 164
Query: 680 RDIKSSNILLDERLNAKVADFGLS-KSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEK 738
RD+K N+ L+E L K+ DFGL+ K D E+ + GT Y+ PE + + +
Sbjct: 165 RDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC---GTPNYIAPEVLSKKGHSFE 221
Query: 739 SDVYSFGVLMLELLTGRRP------------IERGKY 763
DV+S G +M LL G+ P I++ +Y
Sbjct: 222 VDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY 258
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-33
Identities = 59/294 (20%), Positives = 95/294 (32%), Gaps = 16/294 (5%)
Query: 13 GLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLN 72
L TL L+ N L T + K L +L + S + + + L L L
Sbjct: 79 SQHRLDTLVLTANP-LIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLG 137
Query: 73 SNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSG 132
SN S P L LD +N + + L + N ++
Sbjct: 138 SNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNL----SLNLNGNDIA- 192
Query: 133 SIPEKLFRPDMVLIHVLFDSNNLTGELPATLGL--VKSLEVVRFDRNSLSGPVPSNLNNL 190
I F V + F + L ++SL + F+ P+ L
Sbjct: 193 GIEPGAFD-SAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGL 251
Query: 191 --TSVNDLYLSNNKLTGAMPN-LTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMME 247
SV + L + N S L LD++ SE+PS + +L L++
Sbjct: 252 CEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHL--SELPSGLVGLSTLKKLVLS 309
Query: 248 NTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGT-SYSENLLV-NLQNNRIS 299
+ + P L + +K N L G ENL +L ++ I
Sbjct: 310 ANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIE 363
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 5e-32
Identities = 53/283 (18%), Positives = 111/283 (39%), Gaps = 16/283 (5%)
Query: 6 QLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPI-PDSIGSLQ 64
+L + GL+ L L LS NK + N L++L + G + + + +L+
Sbjct: 292 ELPSGLVGLSTLKKLVLSANK-FENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLE 350
Query: 65 ELVLLSLNSN--GFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKH 122
L L L+ + S + NLS+L L+L+ N+ + P L +
Sbjct: 351 NLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQL------EL 404
Query: 123 FHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSG- 181
+L + F+ +L + + L + +L+ + N
Sbjct: 405 LDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKG 464
Query: 182 --PVPSNLNNLTSVNDLYLSNNKLTGAMPN-LTGLSVLSYLDMSNNSFDASEVPSWFSSM 238
++L L + L LS L+ + T L +++++D+S+N S S +
Sbjct: 465 NIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLT-SSSIEALSHL 523
Query: 239 QSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDL 281
+ + L + + ++ +P+ L + +T+ ++ N L+ T
Sbjct: 524 KGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCSN 565
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 4e-28
Identities = 53/307 (17%), Positives = 98/307 (31%), Gaps = 21/307 (6%)
Query: 5 GQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGN-LKKLSNLMLVGCSFSGPIPDSIGSL 63
+ +L+ ++L + ++ L P L
Sbjct: 192 AGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGL 251
Query: 64 QELVL--LSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAK 121
E+ + ++L + F + S L LDLT L E+P L K
Sbjct: 252 CEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTL------K 304
Query: 122 HFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGEL-PATLGLVKSLEVVRFDRNSL- 179
N+ + + L H+ N EL L +++L + + +
Sbjct: 305 KLVLSANKFEN-LCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIE 363
Query: 180 -SGPVPSNLNNLTSVNDLYLSNNKLTGAMPN-LTGLSVLSYLDMSNNSFDASEVPSWFSS 237
S L NL+ + L LS N+ L LD++ + S F +
Sbjct: 364 TSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQN 423
Query: 238 MQSLTTLMMENTNLKGQIPADLFS-IPHLQTVVMKTNELNGTLDLGTSYSENL----LVN 292
+ L L + ++ L LF +P LQ + ++ N T+ + L ++
Sbjct: 424 LHLLKVLNLSHSLLDI-SSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILV 482
Query: 293 LQNNRIS 299
L +S
Sbjct: 483 LSFCDLS 489
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 9e-25
Identities = 46/315 (14%), Positives = 94/315 (29%), Gaps = 31/315 (9%)
Query: 17 LHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGF 76
L+ S N L TT L L+ L L C D+ S L L L +N
Sbjct: 35 TECLEFSFNV-LPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPL 93
Query: 77 SGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDML------------------V 118
++ L L + + N L+ L
Sbjct: 94 IFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTE 153
Query: 119 RAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFD-SNNLTGELPATLGLVKSLEVVRFDRN 177
+ K F N + + ++ ++ + + N + + + F
Sbjct: 154 KLKVLDFQNNAIH-YLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGT 212
Query: 178 SLSGPVPSNL--NNLTSVNDLYLSNNKLT----GAMPNLTGLSVLSYLDMSNNSFDASEV 231
+ L + + S+ + L +S + +++ + F
Sbjct: 213 QNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMS-VESINLQKHYFFNIS- 270
Query: 232 PSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENLLV 291
+ F L L + T+L ++P+ L + L+ +V+ N+ + S +L
Sbjct: 271 SNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTH 329
Query: 292 -NLQNNRISAYTERG 305
+++ N G
Sbjct: 330 LSIKGNTKRLELGTG 344
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 3e-18
Identities = 43/233 (18%), Positives = 81/233 (34%), Gaps = 15/233 (6%)
Query: 69 LSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKN 128
+ + G + +P ++ ++ L+ + N L + L +
Sbjct: 17 YNCENLGLN-EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINL------TFLDLTRC 67
Query: 129 QLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLN 188
Q+ I E F+ L ++ +N L L K+L+ + F + +S L+
Sbjct: 68 QIY-WIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLH 126
Query: 189 NLTSVNDLYLSNNKLTG-AMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMME 247
N ++ LYL +N ++ +P L LD NN+ SS+Q T L +
Sbjct: 127 NQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLS-KEDMSSLQQATNLSLN 185
Query: 248 -NTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENLLVNLQNNRIS 299
N N I F Q++ + + G S + +L
Sbjct: 186 LNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNST--IQSLWLGTFE 236
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 1e-12
Identities = 30/160 (18%), Positives = 60/160 (37%), Gaps = 6/160 (3%)
Query: 142 DMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNN 201
V ++ L E+P TL S E + F N L + + L ++ L L+
Sbjct: 11 KEVNKTYNCENLGLN-EIPGTLP--NSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRC 67
Query: 202 KLTGAMPN-LTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLF 260
++ + L L ++ N + S ++L L T + L
Sbjct: 68 QIYWIHEDTFQSQHRLDTLVLTANPLIFMA-ETALSGPKALKHLFFIQTGISSIDFIPLH 126
Query: 261 SIPHLQTVVMKTNELNGTLDLGTSYSENL-LVNLQNNRIS 299
+ L+++ + +N ++ +E L +++ QNN I
Sbjct: 127 NQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIH 166
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 2e-09
Identities = 22/101 (21%), Positives = 41/101 (40%), Gaps = 2/101 (1%)
Query: 2 GLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIG 61
Q + + L L L LS L +LK ++++ L + +++
Sbjct: 463 KGNIQKTNSLQTLGRLEILVLSFCD-LSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALS 521
Query: 62 SLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEG 102
L+ + L+L SN S +P + LS ++L N L+
Sbjct: 522 HLKGIY-LNLASNHISIILPSLLPILSQQRTINLRQNPLDC 561
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-33
Identities = 60/206 (29%), Positives = 105/206 (50%), Gaps = 10/206 (4%)
Query: 555 NNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQ-QGSMQGGQEFKMEIELLSRVHHKN 612
++F +++G+G G V+K + P+G ++A K + + E+++L +
Sbjct: 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92
Query: 613 LVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHEL 672
+V G + GE + E + GSL L I + K+++ +GL+YL E
Sbjct: 93 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG--KVSIAVIKGLTYLREK 150
Query: 673 ANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMT 732
I+HRD+K SNIL++ R K+ DFG+S + DS + + V GT Y+ PE
Sbjct: 151 HK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN---SFV-GTRSYMSPERLQG 204
Query: 733 QQLTEKSDVYSFGVLMLELLTGRRPI 758
+ +SD++S G+ ++E+ GR PI
Sbjct: 205 THYSVQSDIWSMGLSLVEMAVGRYPI 230
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 2e-33
Identities = 74/247 (29%), Positives = 116/247 (46%), Gaps = 22/247 (8%)
Query: 564 GSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQE-FKMEIELLSRVHHKNLVSLL---- 617
G+GG+G V + G+ +AIK+ +Q +E + +EI+++ +++H N+VS
Sbjct: 23 GTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPD 82
Query: 618 --GFCFDRGEQMLIYEFVPNGSLGDSLSGK---NGIRLDWIRRLKIALGAARGLSYLHEL 672
+L E+ G L L+ G++ IR L + +A L YLHE
Sbjct: 83 GLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA--LRYLHEN 140
Query: 673 ANPPIIHRDIKSSNILLD---ERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEY 729
IIHRD+K NI+L +RL K+ D G +K + E T V GT+ YL PE
Sbjct: 141 R---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL--CTEFV-GTLQYLAPEL 194
Query: 730 YMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTI 789
++ T D +SFG L E +TG RP V+ V +K E +Y+ + +
Sbjct: 195 LEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAV 254
Query: 790 GLSTTLK 796
S+ L
Sbjct: 255 KFSSVLP 261
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 1e-32
Identities = 48/207 (23%), Positives = 78/207 (37%), Gaps = 31/207 (14%)
Query: 563 VGSGGYGKVYKG--TLPNGQLIAIKRAQQGSMQGGQE-FKMEIELLSRVHHKNLVSLLGF 619
+ GG G +Y NG+ + +K Q E + L+ V H ++V +
Sbjct: 88 IAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQI--- 144
Query: 620 CFDRGE------QMLIY---EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLH 670
F+ E + Y E+V SL S +L + L LSYLH
Sbjct: 145 -FNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLH 199
Query: 671 ELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYY 730
+ +++ D+K NI+L E K+ D G ++ + GT G+ PE
Sbjct: 200 SI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS------FGYLYGTPGFQAPEIV 249
Query: 731 MTQQLTEKSDVYSFGVLMLELLTGRRP 757
T T +D+Y+ G + L
Sbjct: 250 RTGP-TVATDIYTVGRTLAALTLDLPT 275
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 135 bits (340), Expect = 1e-32
Identities = 49/311 (15%), Positives = 106/311 (34%), Gaps = 31/311 (9%)
Query: 8 SGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGS-LQEL 66
S + + +L LD +NK +R G KL++L L IP+ + ++
Sbjct: 566 SASLQKMVKLGLLDCVHNK-VRHL--EAFGTNVKLTDLKLDYNQIEE-IPEDFCAFTDQV 621
Query: 67 VLLSLNSNGFSGRVPP--SIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFH 124
L + N +P + ++ + +D + NK+ + S + A
Sbjct: 622 EGLGFSHNKLKY-IPNIFNAKSVYVMGSVDFSYNKIGS-EGRNISCSMDDYKGINASTVT 679
Query: 125 FGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLT-------GELPATLGLVKSLEVVRFDRN 177
N++ E LF + ++ +N +T L + N
Sbjct: 680 LSYNEIQKFPTE-LFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFN 738
Query: 178 SLSG-PVPSNLNNLTSVNDLYLSNNKLT------GAMPNLTGLSVLSYLDMSNNSFDASE 230
L+ L ++++ +S N + L + D N +
Sbjct: 739 KLTSLSDDFRATTLPYLSNMDVSYNCFSSFPTQPLNSSQLKAFGIRHQRDAEGNRI-LRQ 797
Query: 231 VPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGT--SYSEN 288
P+ ++ SL L + + +++ + L P L + + N ++D+ + Y E
Sbjct: 798 WPTGITTCPSLIQLQIGSNDIRK-VDEKLT--PQLYILDIADNPNI-SIDVTSVCPYIEA 853
Query: 289 LLVNLQNNRIS 299
+ L ++
Sbjct: 854 GMYVLLYDKTQ 864
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-31
Identities = 50/311 (16%), Positives = 103/311 (33%), Gaps = 27/311 (8%)
Query: 7 LSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQEL 66
+S I LT+L + +N+ S +L++L
Sbjct: 440 ISKAIQRLTKLQIIYFANSP-FTYDNIAVDWEDANSDYAKQ-----YENEELSWSNLKDL 493
Query: 67 VLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNS---PGLDMLVRAKHF 123
+ L + ++P + +L L L++ N+ + + D + + F
Sbjct: 494 TDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIF 553
Query: 124 HFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPV 183
+ G N L + + L + N + L A G L ++ D N +
Sbjct: 554 YMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR-HLEA-FGTNVKLTDLKLDYNQIEEIP 611
Query: 184 PSNLNNLTSVNDLYLSNNKLTG--AMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQ-- 239
V L S+NKL + N + V+ +D S N SE + SM
Sbjct: 612 EDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIG-SEGRNISCSMDDY 670
Query: 240 ---SLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNEL-------NGTLDLGTSYSENL 289
+ +T+ + ++ + + T+++ N + D + L
Sbjct: 671 KGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLL 730
Query: 290 LV-NLQNNRIS 299
+L+ N+++
Sbjct: 731 TTIDLRFNKLT 741
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 5e-29
Identities = 40/306 (13%), Positives = 84/306 (27%), Gaps = 61/306 (19%)
Query: 14 LTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNS 73
L + +L+N + I L KL + F+ + + +
Sbjct: 425 LKDTQIGNLTNRI---TFISKAIQRLTKLQIIYFANSPFTYDNIAV-----DWEDANSDY 476
Query: 74 NGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGS 133
S NL +L ++L + ++P + P L + + N+
Sbjct: 477 AKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPEL------QSLNIACNRGIS- 529
Query: 134 IPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSG-PVPSNLNNLTS 192
L +++ N+L P ++L +
Sbjct: 530 ---------------AAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVK 574
Query: 193 VNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVP-SWFSSMQSLTTLMMENTNL 251
+ L +NK+ + L+ L + N E+P + + + L + L
Sbjct: 575 LGLLDCVHNKVR-HLEAFGTNVKLTDLKLDYNQI--EEIPEDFCAFTDQVEGLGFSHNKL 631
Query: 252 KGQIPADLF--SIPHLQTVVMKTNELNGTLDLGTSYSENLLVNLQNNRISAYTERGGAPA 309
K IP S+ + +V + N+I +
Sbjct: 632 KY-IPNIFNAKSVYVMGSV-----------------------DFSYNKIGSEGRNISCSM 667
Query: 310 VNLTLI 315
+ I
Sbjct: 668 DDYKGI 673
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-26
Identities = 42/261 (16%), Positives = 88/261 (33%), Gaps = 19/261 (7%)
Query: 50 CSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDG 109
+ + + + LSL G GRVP +IG L+ L L + +
Sbjct: 309 DMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGD 368
Query: 110 NSPGLDMLVRAKH-FHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKS 168
DM KH ++ ++L D L+ + N + +
Sbjct: 369 EELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSD--LLQDAINRNPEMKPIKKDSRISLK 426
Query: 169 LEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDA 228
+ N ++ + + LT + +Y +N+ T + S + +
Sbjct: 427 DTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEEL 485
Query: 229 SEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSE- 287
S +S+++ LT + + N Q+P L+ +P LQ++ + N L ++
Sbjct: 486 S-----WSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRL 540
Query: 288 --------NLLV-NLQNNRIS 299
+ + + N +
Sbjct: 541 ADDEDTGPKIQIFYMGYNNLE 561
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 79.5 bits (196), Expect = 3e-15
Identities = 28/204 (13%), Positives = 55/204 (26%), Gaps = 50/204 (24%)
Query: 3 LKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGS 62
++ + + + T+ LSNN + + L P + +
Sbjct: 685 IQKFPTELFATGSPISTIILSNN------------LMTSIPENSL------KPKDGNYKN 726
Query: 63 LQELVLLSLNSNGFSGRVPPSI--GNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRA 120
L + L N + + L L +D++ N P NS L
Sbjct: 727 TYLLTTIDLRFNKLTS-LSDDFRATTLPYLSNMDVSYNCFS-SFPTQPLNSSQL------ 778
Query: 121 KHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLS 180
K F + + N + + P + SL ++ N +
Sbjct: 779 KAFGIRHQR-------------------DAEGNRILRQWPTGITTCPSLIQLQIGSNDIR 819
Query: 181 GPVPSNLNNLTSVNDLYLSNNKLT 204
L L +++N
Sbjct: 820 KVDEKLTPQLYI---LDIADNPNI 840
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 76.5 bits (188), Expect = 2e-14
Identities = 28/159 (17%), Positives = 46/159 (28%), Gaps = 19/159 (11%)
Query: 5 GQLSGDITGLTELHTLDLSNNKDLRG-PLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSL 63
G+ L T+DL NK L L LSN+ + FS P +
Sbjct: 718 KPKDGNYKNTYLLTTIDLRFNK-LTSLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNS 775
Query: 64 QELVLLSL------NSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDML 117
+L + N + P I +L L + N + ++ + +P L
Sbjct: 776 SQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVD--EKLTPQL--- 829
Query: 118 VRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLT 156
N SI P + + +
Sbjct: 830 ---YILDIADNPNI-SIDVTSVCPYIEAGMYVLLYDKTQ 864
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 46.8 bits (111), Expect = 3e-05
Identities = 18/182 (9%), Positives = 44/182 (24%), Gaps = 35/182 (19%)
Query: 151 DSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPN- 209
+ + + L + + G VP + LT + L + T +
Sbjct: 307 ELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLF 366
Query: 210 -------------------------LTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTL 244
L L+ D+ ++ + P ++ + +
Sbjct: 367 GDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAI--NRNPE-MKPIKKDSRI 423
Query: 245 MMENTNLKG------QIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENLLVNLQNNRI 298
+++T + I + + LQ + + N Q
Sbjct: 424 SLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENE 483
Query: 299 SA 300
Sbjct: 484 EL 485
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-32
Identities = 57/271 (21%), Positives = 107/271 (39%), Gaps = 30/271 (11%)
Query: 564 GSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRV-HHKNLVSLLGFCFD 622
G G G + + + + +A+KR E++LL H N++ D
Sbjct: 33 GHGAEGTIVYRGMFDNRDVAVKRILPECFSFADR---EVQLLRESDEHPNVIRYFCTEKD 89
Query: 623 RGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDI 682
R Q + E +L + + K+ L + + + GL++LH L I+HRD+
Sbjct: 90 RQFQYIAIELCA-ATLQEYVEQKDFAHLG-LEPITLLQQTTSGLAHLHSLN---IVHRDL 144
Query: 683 KSSNILLDE-----RLNAKVADFGLSKSMSDSEK-DHITTQVKGTMGYLDPEYY---MTQ 733
K NIL+ ++ A ++DFGL K ++ + V GT G++ PE +
Sbjct: 145 KPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKE 204
Query: 734 QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLST 793
T D++S G + +++ GK + R+ ++ + + P
Sbjct: 205 NPTYTVDIFSAGCVFYYVISEGSHP-FGKSLQRQANILLGACS-----LDCLHPEKHEDV 258
Query: 794 TLKGFEKYVDLALKCVQESGDDRPTMSEVVK 824
+ +L K + RP+ V+K
Sbjct: 259 IAR------ELIEKMIAMDPQKRPSAKHVLK 283
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 3e-32
Identities = 47/238 (19%), Positives = 91/238 (38%), Gaps = 45/238 (18%)
Query: 564 GSGGYGKVYKGTLPNGQLIAIK-----------------RAQQGSMQGGQEFKMEIELLS 606
G + K+ + + A+K + +FK E+++++
Sbjct: 40 NQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIIT 98
Query: 607 RVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGA---- 662
+ ++ ++ G + E +IYE++ N S+ + ++ + I +
Sbjct: 99 DIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIK 158
Query: 663 --ARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKG 720
SY+H N I HRD+K SNIL+D+ K++DFG S+ M D I G
Sbjct: 159 SVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK---KIKGSR-G 212
Query: 721 TMGYLDPEYYMTQQLT--EKSDVYSFGVLMLELLTGRRP-------------IERGKY 763
T ++ PE++ + K D++S G+ + + P I
Sbjct: 213 TYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNI 270
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-31
Identities = 66/278 (23%), Positives = 122/278 (43%), Gaps = 32/278 (11%)
Query: 555 NNFSDANDVGSGGYGKVYKGT-LPNGQLIAIKR-AQQGSMQGGQEFKMEIE-LLSRVHHK 611
++ ++G G YG V K +P+GQ++A+KR + Q + M+++ + V
Sbjct: 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66
Query: 612 NLVSLLGFCFDRGEQMLIYEFVPNGSLGDSL----SGKNGIRLDWIRRLKIALGAARGLS 667
V+ G F G+ + E + + SL I D + KIA+ + L
Sbjct: 67 FTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILG--KIAVSIVKALE 123
Query: 668 YLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDP 727
+LH + +IHRD+K SN+L++ K+ DFG+S + D G Y+ P
Sbjct: 124 HLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAK--DIDA-GCKPYMAP 178
Query: 728 E----YYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYE 783
E + + KSD++S G+ M+EL R P + ++++ V+++
Sbjct: 179 ERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEP-------- 230
Query: 784 LIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSE 821
P + F + +C++++ +RPT E
Sbjct: 231 --SPQLPADKFSAEFVDFTS---QCLKKNSKERPTYPE 263
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 9e-31
Identities = 63/302 (20%), Positives = 110/302 (36%), Gaps = 59/302 (19%)
Query: 552 KYTNNFSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGG--QEFKMEIELLSRV 608
+YT F + +GSG +G V+K +G + AIKR+++ Q E+ + +
Sbjct: 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL 67
Query: 609 -HHKNLVSLLGFCFDRGEQMLIY-EFVPNGSLGDSLS--GKNGIRLDWIRRLKIALGAAR 664
H ++V + + MLI E+ GSL D++S + + L R
Sbjct: 68 GQHSHVVRYFS-AWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 126
Query: 665 GLSYLHELANPPIIHRDIKSSNILLDE-------------------RLNAKVADFGLSKS 705
GL Y+H ++ ++H DIK SNI + ++ K+ D G
Sbjct: 127 GLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR 183
Query: 706 MSDSEKDHITTQVKGTMGYLDPEYYM-TQQLTEKSDVYSFGVLMLELLTGRRPIERGKYI 764
+S +G +L E K+D+++ + ++ G
Sbjct: 184 ISS------PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD-Q 236
Query: 765 VREIRTVMDKKKELYNLYELIDPTI--GLSTTLKGFEKYVDLALKCVQESGDDRPTMSEV 822
EIR + L P I LS +L + + RP+ +
Sbjct: 237 WHEIR-----QGRL--------PRIPQVLSQEFT------ELLKVMIHPDPERRPSAMAL 277
Query: 823 VK 824
VK
Sbjct: 278 VK 279
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 9e-31
Identities = 40/244 (16%), Positives = 73/244 (29%), Gaps = 23/244 (9%)
Query: 563 VGSGGYGKVYKGT------LPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSL 616
+G G + +VY+ T N Q +K + + +E L +
Sbjct: 73 LGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKF 132
Query: 617 LGFCFDRGEQMLIYEFVPNGSLGD---SLSGKNGIRLDWIRRLKIALGAARGLSYLHELA 673
+ +L+ E G+L + + + A+ + +H+
Sbjct: 133 YSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE 192
Query: 674 NPPIIHRDIKSSNILL-----------DERLNAKVADFGLSKSMSDSEKDHITTQVKGTM 722
IIH DIK N +L D + D G S M K I T T
Sbjct: 193 ---IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETS 249
Query: 723 GYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLY 782
G+ E + + D + + +L G + + + + + L
Sbjct: 250 GFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWN 309
Query: 783 ELID 786
E
Sbjct: 310 EFFH 313
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-30
Identities = 65/215 (30%), Positives = 100/215 (46%), Gaps = 20/215 (9%)
Query: 555 NNFSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQ-QGSMQGGQEFKMEIE-LLSRVHHK 611
+ D ++G G YG V K P+GQ++A+KR + + ++ M+++ ++
Sbjct: 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCP 81
Query: 612 NLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLS-----GKNGIRLDWIRRLKIALGAARGL 666
+V G F G+ + E + + S + I + + KI L + L
Sbjct: 82 YIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILG--KITLATVKAL 138
Query: 667 SYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLD 726
++L E IIHRDIK SNILLD N K+ DFG+S + DS T G Y+
Sbjct: 139 NHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK--TRDA-GCRPYMA 193
Query: 727 PE----YYMTQQLTEKSDVYSFGVLMLELLTGRRP 757
PE Q +SDV+S G+ + EL TGR P
Sbjct: 194 PERIDPSASRQGYDVRSDVWSLGITLYELATGRFP 228
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 3e-30
Identities = 25/299 (8%), Positives = 64/299 (21%), Gaps = 53/299 (17%)
Query: 564 GSGGYGKVYKGT-LPNGQLIAIK---RAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGF 619
G V+ + + A+K + S + +R+ ++
Sbjct: 71 RVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDR 130
Query: 620 C--------------------------FDRGEQMLIYEFVPNGSLGDSLS-----GKNGI 648
+ +L+ + L S
Sbjct: 131 RRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPA-ASVDLELLFSTLDFVYVFRG 189
Query: 649 RLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSD 708
+ + R + L ++H N+ + + D +
Sbjct: 190 DEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT 246
Query: 709 SEKDHITTQVKGTMGYLDPEYYM--TQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVR 766
+ Y E+ T T + + G+ + + P ++
Sbjct: 247 R-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIK 301
Query: 767 EIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825
+ + L +K L + + R E ++
Sbjct: 302 GSWKRPSLRVPGTDSLAF-GSCTPLPDFVK------TLIGRFLNFDRRRRLLPLEAMET 353
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 5e-30
Identities = 57/204 (27%), Positives = 98/204 (48%), Gaps = 12/204 (5%)
Query: 557 FSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGG-QEFKMEIELLSRVHHKNLV 614
F+ +G G +G+V+KG +++AIK + ++ + EI +LS+ +
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 615 SLLGFCFDRGEQM-LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELA 673
G + + ++ +I E++ GS D L + I I +GL YLH
Sbjct: 84 KYYG-SYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIA--TILREILKGLDYLHSEK 139
Query: 674 NPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQ 733
IHRDIK++N+LL E K+ADFG++ ++D++ T GT ++ PE
Sbjct: 140 ---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQS 194
Query: 734 QLTEKSDVYSFGVLMLELLTGRRP 757
K+D++S G+ +EL G P
Sbjct: 195 AYDSKADIWSLGITAIELARGEPP 218
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 6e-30
Identities = 54/209 (25%), Positives = 103/209 (49%), Gaps = 16/209 (7%)
Query: 557 FSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVS 615
+ ++G G +GKVYK G L A K + S + +++ +EIE+L+ H +V
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80
Query: 616 LLGFCFDRGEQM-LIYEFVPNGSLGDSL-SGKNGIRLDWIRRLKIALGAARGLSYLHELA 673
LLG + ++ ++ EF P G++ + G+ I+ + L++LH
Sbjct: 81 LLG-AYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV--VCRQMLEALNFLHSKR 137
Query: 674 NPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQ 733
IIHRD+K+ N+L+ + ++ADFG+S + + + GT ++ PE M +
Sbjct: 138 ---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FIGTPYWMAPEVVMCE 192
Query: 734 QLTE-----KSDVYSFGVLMLELLTGRRP 757
+ + K+D++S G+ ++E+ P
Sbjct: 193 TMKDTPYDYKADIWSLGITLIEMAQIEPP 221
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 6e-30
Identities = 44/208 (21%), Positives = 80/208 (38%), Gaps = 21/208 (10%)
Query: 564 GSGGYGKVYKGT-LPNGQLIAIKRA--QQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFC 620
G V P G+ + ++R + S + + E+ + +H N+V
Sbjct: 36 GFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRA-T 94
Query: 621 FDRGEQM-LIYEFVPNGSLGDSLSGKNGIRLD--WIRRLKIALGAARGLSYLHELANPPI 677
F ++ ++ F+ GS D + ++ I I G + L Y+H +
Sbjct: 95 FIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIA--YILQGVLKALDYIHHMG---Y 149
Query: 678 IHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVK-----GTMGYLDPEYYMT 732
+HR +K+S+IL+ ++ + SM + + +L PE +
Sbjct: 150 VHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPE-VLQ 208
Query: 733 QQL---TEKSDVYSFGVLMLELLTGRRP 757
Q L KSD+YS G+ EL G P
Sbjct: 209 QNLQGYDAKSDIYSVGITACELANGHVP 236
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 6e-30
Identities = 56/211 (26%), Positives = 98/211 (46%), Gaps = 15/211 (7%)
Query: 555 NNFSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQ-QGSMQGGQEFKMEIE-LLSRVHHK 611
N+ + ++GSG G+V+K G +IA+K+ + G+ + + M+++ +L
Sbjct: 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCP 84
Query: 612 NLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHE 671
+V G + + E + + + I + K+ + + L YL E
Sbjct: 85 YIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILG--KMTVAIVKALYYLKE 142
Query: 672 LANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYM 731
+IHRD+K SNILLDER K+ DFG+S + D + G Y+ PE
Sbjct: 143 KHG--VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK--DRSA-GCAAYMAPERID 197
Query: 732 TQQLTE-----KSDVYSFGVLMLELLTGRRP 757
T+ ++DV+S G+ ++EL TG+ P
Sbjct: 198 PPDPTKPDYDIRADVWSLGISLVELATGQFP 228
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 1e-29
Identities = 51/203 (25%), Positives = 96/203 (47%), Gaps = 11/203 (5%)
Query: 557 FSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVS 615
++ +G G G VY + GQ +AI++ + EI ++ + N+V+
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 616 LLGFCFDRGEQM-LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELAN 674
L + G+++ ++ E++ GSL D ++ + + I + + L +LH
Sbjct: 82 YLD-SYLVGDELWVVMEYLAGGSLTDVVT-ETCMDEGQIAA--VCRECLQALEFLHSNQ- 136
Query: 675 PPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQ 734
+IHRDIKS NILL + K+ DFG ++ + T + GT ++ PE +
Sbjct: 137 --VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKA 192
Query: 735 LTEKSDVYSFGVLMLELLTGRRP 757
K D++S G++ +E++ G P
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGEPP 215
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 3e-29
Identities = 74/326 (22%), Positives = 131/326 (40%), Gaps = 44/326 (13%)
Query: 509 YHQKRRAEKANEQNPFAHWDMNKSSGSIPQLKGARCFSFEEVKKYTNNFSDANDVGSGGY 568
+H + +N + D+ + G K + K +GSG Y
Sbjct: 2 HHHHHHSS--GRENLYFQGDLQATPGMFITSKKGHLSEMYQRVK---------KLGSGAY 50
Query: 569 GKVYKGT-LPNGQLIAIKRAQQGSMQGG--QEFKMEIELLSRVHHKNLVSLLGFCFDRGE 625
G+V AIK ++ S+ + E+ +L + H N++ L F D+
Sbjct: 51 GEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRN 110
Query: 626 QMLIYEFVPNGSLGDSLSGKNGIRLDWIRRL-KIALGAARGLSYLHELANPPIIHRDIKS 684
L+ E G L D + + + K L ++YLH+ I+HRD+K
Sbjct: 111 YYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSG---VTYLHKHN---IVHRDLKP 164
Query: 685 SNILL---DERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDV 741
N+LL ++ K+ DFGLS + +K + ++ GT Y+ PE + ++ EK DV
Sbjct: 165 ENLLLESKEKDALIKIVDFGLSAVFENQKK--MKERL-GTAYYIAPE-VLRKKYDEKCDV 220
Query: 742 YSFGVLMLELLTGRRPI--ERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFE 799
+S GV++ LL G P + + I+R++ +K Y +S K
Sbjct: 221 WSIGVILFILLAGYPPFGGQTDQEILRKV------EKGKYTFDS--PEWKNVSEGAK--- 269
Query: 800 KYVDLALKCVQESGDDRPTMSEVVKD 825
DL + +Q R + + ++
Sbjct: 270 ---DLIKQMLQFDSQRRISAQQALEH 292
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 4e-29
Identities = 65/217 (29%), Positives = 97/217 (44%), Gaps = 35/217 (16%)
Query: 563 VGSGGYGKVYKGT-LPNGQLIAIKR----AQQGSMQGGQEFKMEIELLSRVHHKNLVSLL 617
+GSG V P + +AIKR Q SM E EI+ +S+ HH N+VS
Sbjct: 23 IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMD---ELLKEIQAMSQCHHPNIVSYY 79
Query: 618 GFCFDRGEQM-LIYEFVPNGSLGDSLSGKNGIRLDWIRRLK---IAL---GAARGLSYLH 670
F +++ L+ + + GS+ D + L IA GL YLH
Sbjct: 80 T-SFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH 138
Query: 671 ELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVK---GTMGYLDP 727
+ IHRD+K+ NILL E + ++ADFG+S ++ K GT P
Sbjct: 139 KNG---QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGT-----P 190
Query: 728 EYYM----TQQLT---EKSDVYSFGVLMLELLTGRRP 757
+M +Q+ K+D++SFG+ +EL TG P
Sbjct: 191 -CWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP 226
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 5e-29
Identities = 62/207 (29%), Positives = 100/207 (48%), Gaps = 13/207 (6%)
Query: 554 TNNFSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKN 612
F +G G YG VYK GQ++AIK Q QE EI ++ + +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIK--QVPVESDLQEIIKEISIMQQCDSPH 85
Query: 613 LVSLLGFCFDRGEQM-LIYEFVPNGSLGDSLSGKNG-IRLDWIRRLKIALGAARGLSYLH 670
+V G + + + ++ E+ GS+ D + +N + D I I +GL YLH
Sbjct: 86 VVKYYG-SYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIAT--ILQSTLKGLEYLH 142
Query: 671 ELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYY 730
+ IHRDIK+ NILL+ +AK+ADFG++ ++D+ T V GT ++ PE
Sbjct: 143 FMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT--VIGTPFWMAPEVI 197
Query: 731 MTQQLTEKSDVYSFGVLMLELLTGRRP 757
+D++S G+ +E+ G+ P
Sbjct: 198 QEIGYNCVADIWSLGITAIEMAEGKPP 224
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 5e-29
Identities = 50/313 (15%), Positives = 105/313 (33%), Gaps = 25/313 (7%)
Query: 14 LTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNS 73
++++ L+ L + + + L L G S + +L LL+L+S
Sbjct: 9 GNRYKIEKVTDSS-LKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSS 67
Query: 74 NGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGS 133
N + +LS L LDL +N ++ E+ P ++ L H N +S
Sbjct: 68 NVLYE--TLDLESLSTLRTLDLNNNYVQ-ELL----VGPSIETL------HAANNNIS-R 113
Query: 134 IPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSG-PVPSNLNNLTS 192
+ + ++ +N +T G ++ + N + + +
Sbjct: 114 VSCSRGQG---KKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170
Query: 193 VNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLK 252
+ L L N + + + L LD+S+N + + F S +T + + N L
Sbjct: 171 LEHLNLQYNFIY-DVKGQVVFAKLKTLDLSSNKL--AFMGPEFQSAAGVTWISLRNNKLV 227
Query: 253 GQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENLLVNLQNNRISAYTERGGA--PAV 310
I L +L+ ++ N + + + + T +
Sbjct: 228 -LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVP 286
Query: 311 NLTLIDNPICQEL 323
L C++L
Sbjct: 287 TLGHYGAYCCEDL 299
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 4e-25
Identities = 47/259 (18%), Positives = 87/259 (33%), Gaps = 22/259 (8%)
Query: 9 GDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVL 68
D+ T+L L+LS+N L L + +L L L L + +
Sbjct: 52 ADLAPFTKLELLNLSSNV-LYETLD--LESLSTLRTLDLNNNYVQ-----ELLVGPSIET 103
Query: 69 LSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKN 128
L +N S RV S + L +NK+ + +G + L N
Sbjct: 104 LHAANNNIS-RVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYL------DLKLN 154
Query: 129 QLSGSIPEKLFRPDMVLIHVLF-DSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNL 187
++ ++ + L N + ++ + L+ + N L+ +
Sbjct: 155 EID-TVNFAELAASSDTLEHLNLQYNFIY-DVKGQVVF-AKLKTLDLSSNKLAF-MGPEF 210
Query: 188 NNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMME 247
+ V + L NNKL L L + D+ N F + +FS Q + T+ +
Sbjct: 211 QSAAGVTWISLRNNKLVLIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ 270
Query: 248 NTNLKGQIPADLFSIPHLQ 266
+ ++P L
Sbjct: 271 TVKKLTGQNEEECTVPTLG 289
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 2e-13
Identities = 34/186 (18%), Positives = 58/186 (31%), Gaps = 11/186 (5%)
Query: 8 SGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELV 67
D + + LDL N+ + L +L L + + +L
Sbjct: 137 DLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD-VKGQV-VFAKLK 194
Query: 68 LLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGK 127
L L+SN + + P + + + W+ L +NKL I + S L +HF
Sbjct: 195 TLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNL------EHFDLRG 246
Query: 128 NQLSGSIPEKLFRPDMVLIHVLFDSN-NLTGELPATLGLVKSLEVVRFDRNSLSGPVPSN 186
N F + + V + LTG+ + + L P
Sbjct: 247 NGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADR 306
Query: 187 LNNLTS 192
L L
Sbjct: 307 LIALGH 312
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 3e-04
Identities = 19/121 (15%), Positives = 37/121 (30%), Gaps = 11/121 (9%)
Query: 6 QLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFS-GPIPDSIGSLQ 64
+ + + + L NNK L + + + L + L G F G + D Q
Sbjct: 205 FMGPEFQSAAGVTWISLRNNK-LVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQ 262
Query: 65 ELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFH 124
+ ++ + + + + G D +P D L+ H H
Sbjct: 263 RVQTVAKQTV-------KKLTGQNEEEC-TVPTLGHYGAYCCEDLPAPFADRLIALGHHH 314
Query: 125 F 125
Sbjct: 315 H 315
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 50/203 (24%), Positives = 93/203 (45%), Gaps = 11/203 (5%)
Query: 557 FSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVS 615
+G G G V +G+ +A+K Q + E+ ++ H N+V
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106
Query: 616 LLGFCFDRGEQM-LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELAN 674
+ + GE++ ++ EF+ G+L D +S + + + I + + L+YLH
Sbjct: 107 MYK-SYLVGEELWVLMEFLQGGALTDIVS-QVRLNEEQIAT--VCEAVLQALAYLHAQG- 161
Query: 675 PPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQ 734
+IHRDIKS +ILL K++DFG +S + + GT ++ PE
Sbjct: 162 --VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGTPYWMAPEVISRSL 217
Query: 735 LTEKSDVYSFGVLMLELLTGRRP 757
+ D++S G++++E++ G P
Sbjct: 218 YATEVDIWSLGIMVIEMVDGEPP 240
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-28
Identities = 66/289 (22%), Positives = 106/289 (36%), Gaps = 49/289 (16%)
Query: 564 GSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRV-HHKNLVSLLGFCFD 622
G G G V G+ +A+KR MEI+LL+ H N++
Sbjct: 24 GYGSSGTVVFQGSFQGRPVAVKRMLIDFCD---IALMEIKLLTESDDHPNVIRYYCSETT 80
Query: 623 RGEQMLIYEFVPNGSLGD-----SLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPI 677
+ E N +L D ++S +N + + A G+++LH L I
Sbjct: 81 DRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---I 136
Query: 678 IHRDIKSSNILLD-------------ERLNAKVADFGLSKSMSDSEKDHITT--QVKGTM 722
IHRD+K NIL+ E L ++DFGL K + + T GT
Sbjct: 137 IHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTS 196
Query: 723 GYLDPE-------YYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDK 774
G+ PE ++LT D++S G + +L+ G+ P I
Sbjct: 197 GWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNI------ 250
Query: 775 KKELYNLYELIDPT-IGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEV 822
+ +++L E+ L DL + + RPT +V
Sbjct: 251 IRGIFSLDEMKCLHDRSLIAEAT------DLISQMIDHDPLKRPTAMKV 293
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-28
Identities = 37/309 (11%), Positives = 82/309 (26%), Gaps = 76/309 (24%)
Query: 563 VGSGGYGKVYKGT-LPNGQLIAIK---RAQQGSMQGGQEFKMEIELLSR----------- 607
+G + T G+ + ++ ++ K E+ L
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 608 -----------VHHKNLVSLLGFCFDRGEQMLIYEFVP-------NGSLGDSLS--GKNG 647
V ++ D + ++ F + G+ L
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 648 IRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMS 707
L RL++ L R L+ LH ++H ++ +I+LD+R + F
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 262
Query: 708 DSEKDHITTQVKGTMGYLDPEY----------YMTQQLTEKSDVYSFGVLMLELLTGRRP 757
+ G+ PE + +T D ++ G+ + + P
Sbjct: 263 A------SAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316
Query: 758 IERGKYIVREIRTVMDKKKELYNLYELI-DPTIGLSTTLKGFEKYVDLALKCVQESGDDR 816
E I + ++ L ++ +DR
Sbjct: 317 NTDD---------------AALGGSEWIFRSCKNIPQPVR------ALLEGFLRYPKEDR 355
Query: 817 PTMSEVVKD 825
+ ++
Sbjct: 356 LLPLQAMET 364
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-28
Identities = 66/354 (18%), Positives = 122/354 (34%), Gaps = 100/354 (28%)
Query: 552 KYTNNFSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQE-FKMEIELLSRVH 609
+Y +F +G GG+G V++ + AIKR + + + +E E++ L+++
Sbjct: 3 RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 62
Query: 610 HKNLVSLLGFCFDRGEQML-----------------------IYEFVPNGSLGDSLSGKN 646
H +V + + + D S KN
Sbjct: 63 HPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKN 122
Query: 647 GIRL-----------------------DWIRR------------LKIALGAARGLSYLHE 671
+ DW+ R L I + A + +LH
Sbjct: 123 TVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHS 182
Query: 672 LANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHIT----------TQVKGT 721
++HRD+K SNI KV DFGL +M E++ T GT
Sbjct: 183 KG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT 239
Query: 722 MGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNL 781
Y+ PE + K D++S G+++ ELL T M++ + + ++
Sbjct: 240 KLYMSPEQIHGNNYSHKVDIFSLGLILFELLYS-------------FSTQMERVRIITDV 286
Query: 782 YELIDPTIGLSTTLKGFEKY----VDLALKCVQESGDDRPTMSEVVKD--IENI 829
L P + F + + + S +RP ++++++ EN+
Sbjct: 287 RNLKFPLL--------FTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFENL 332
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 3e-28
Identities = 47/305 (15%), Positives = 99/305 (32%), Gaps = 23/305 (7%)
Query: 14 LTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNS 73
++++ L+ L + + + L L G S + +L LL+L+S
Sbjct: 9 GNRYKIEKVTDSS-LKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSS 67
Query: 74 NGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGS 133
N + +LS L LDL +N ++ L + + H N +S
Sbjct: 68 NVLYE--TLDLESLSTLRTLDLNNNYVQ-----------ELLVGPSIETLHAANNNIS-R 113
Query: 134 IPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSG-PVPSNLNNLTS 192
+ + ++ +N +T G ++ + N + + +
Sbjct: 114 VSCSRGQG---KKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170
Query: 193 VNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLK 252
+ L L N + + + L LD+S+N + + F S +T + + N L
Sbjct: 171 LEHLNLQYNFIY-DVKGQVVFAKLKTLDLSSNKL--AFMGPEFQSAAGVTWISLRNNKLV 227
Query: 253 GQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENLLVNLQNNRISAYTERGGAPAVNL 312
I L +L+ ++ N + + + + T +
Sbjct: 228 -LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVP 286
Query: 313 TLIDN 317
TL
Sbjct: 287 TLGHY 291
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 4e-25
Identities = 54/317 (17%), Positives = 99/317 (31%), Gaps = 26/317 (8%)
Query: 9 GDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVL 68
D+ T+L L+LS+N L L + +L L L L + +
Sbjct: 52 ADLAPFTKLELLNLSSNV-LYETLD--LESLSTLRTLDLNNNYVQ-----ELLVGPSIET 103
Query: 69 LSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKN 128
L +N S RV S + L +NK+ + +G + L N
Sbjct: 104 LHAANNNIS-RVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYL------DLKLN 154
Query: 129 QLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLN 188
++ ++ + L N ++ + L+ + N L+ +
Sbjct: 155 EID-TVNFAELAASSDTLEHLNLQYNFIYDVKGQVVF-AKLKTLDLSSNKLAF-MGPEFQ 211
Query: 189 NLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMME- 247
+ V + L NNKL L L + D+ N F + +FS Q + T+ +
Sbjct: 212 SAAGVTWISLRNNKLVLIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQT 271
Query: 248 NTNLKGQIPADLFSIPHLQTVVMKTNEL-NGTLD--LGTSYSENLLVNLQNNRISAYTER 304
L GQ + +L D + E+ L++ Q +
Sbjct: 272 VKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECE 331
Query: 305 GGAPA--VNLTLIDNPI 319
A + +
Sbjct: 332 RENQARQREIDALKEQY 348
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 97.2 bits (242), Expect = 3e-21
Identities = 45/295 (15%), Positives = 83/295 (28%), Gaps = 14/295 (4%)
Query: 8 SGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELV 67
D + + LDL N+ + L +L L + + +L
Sbjct: 137 DLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD-VKGQV-VFAKLK 194
Query: 68 LLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGK 127
L L+SN + + P + + + W+ L +NKL I + S L +HF
Sbjct: 195 TLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNL------EHFDLRG 246
Query: 128 NQLSGSIPEKLFRPDMVLIHVLFDSN-NLTGELPATLGLVKSLEVVRFDRNSLSGPVPSN 186
N F + + V + LTG+ + + L P
Sbjct: 247 NGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADR 306
Query: 187 LNNLTSVN--DLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTL 244
L L L ++ + +D + + + Q+ TL
Sbjct: 307 LIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQY-RTVIDQVTLRKQAKITL 365
Query: 245 MMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENLLVNLQNNRIS 299
+ L Q+ + L + + S L+ R
Sbjct: 366 EQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHATEEQSPLQLLRAIVKRYE 420
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 78.0 bits (192), Expect = 4e-15
Identities = 38/336 (11%), Positives = 80/336 (23%), Gaps = 35/336 (10%)
Query: 11 ITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLS 70
L L+L N + + + KL L L + + S + +S
Sbjct: 165 AASSDTLEHLNLQYNF-IYD-VKGQV-VFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWIS 220
Query: 71 LNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIP--------------------VSDGN 110
L +N + ++ NL DL N ++ N
Sbjct: 221 LRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQN 279
Query: 111 SPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLE 170
+ + + L ++L +L + T L
Sbjct: 280 EEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQR 339
Query: 171 VVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTG--LSVLSYLDMSNNSFDA 228
+ + + + L L + N + L + +
Sbjct: 340 EIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIEL 399
Query: 229 SEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSEN 288
S +Q L ++ + + + + + L EN
Sbjct: 400 QHATEEQSPLQLLRAIVKRYEEMYVEQQSV-----QNNAIRDWDMYQHKETQL---AEEN 451
Query: 289 LLVNLQNNRISAYTERGGAPAVNLTLIDNPICQELG 324
+ N A L + + + +LG
Sbjct: 452 ARLKKLNGEADLALASANATLQELVVREQNLASQLG 487
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 56.8 bits (137), Expect = 2e-08
Identities = 20/220 (9%), Positives = 51/220 (23%), Gaps = 8/220 (3%)
Query: 7 LSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQEL 66
+ + L DL N G L +++ + + +
Sbjct: 229 IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAK--QTVKKLTGQNEEECTVP 286
Query: 67 VLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFG 126
L + P L L + +G + + R +
Sbjct: 287 TLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSET--ERLECERENQARQREIDAL 344
Query: 127 KNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSG--PVP 184
K Q ++ +++ I + L ++ L+
Sbjct: 345 KEQYR-TVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHAT 403
Query: 185 SNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNN 224
+ L + + ++ + + DM +
Sbjct: 404 EEQSPLQLLRAIVKRYEEMYVE-QQSVQNNAIRDWDMYQH 442
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 3e-28
Identities = 79/312 (25%), Positives = 120/312 (38%), Gaps = 72/312 (23%)
Query: 550 VKKYTNNFSDA----NDVGSGGYGKVYKGT-LPNGQLIAIK-------------RAQQGS 591
V+K ++ +GSG YG+V AIK +
Sbjct: 27 VRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNI 86
Query: 592 MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLD 651
+ +E EI LL + H N++ L D+ L+ EF G L +
Sbjct: 87 EKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGEL-----------FE 135
Query: 652 WIRRLKIALG------AAR-------GLSYLHELANPPIIHRDIKSSNILL---DERLNA 695
I I AA G+ YLH+ I+HRDIK NILL + LN
Sbjct: 136 QI----INRHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNI 188
Query: 696 KVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGR 755
K+ DFGLS S K + ++ GT Y+ PE + ++ EK DV+S GV+M LL G
Sbjct: 189 KIVDFGLSSFFSKDYK--LRDRL-GTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGY 244
Query: 756 RPI--ERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESG 813
P + + I++++ +K Y + +S K +L +
Sbjct: 245 PPFGGQNDQDIIKKV------EKGKYYFDF--NDWKNISDEAK------ELIKLMLTYDY 290
Query: 814 DDRPTMSEVVKD 825
+ R T E +
Sbjct: 291 NKRCTAEEALNS 302
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 4e-28
Identities = 53/291 (18%), Positives = 116/291 (39%), Gaps = 30/291 (10%)
Query: 11 ITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLS 70
++ L +L L + NK + + + NL L L L + S P + +L ++ L+
Sbjct: 84 LSNLVKLTNLYIGTNK-ITDI--SALQNLTNLRELYLNEDNISDISP--LANLTKMYSLN 138
Query: 71 LNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQL 130
L +N + N++ L +L +T++K++ + + L NQ+
Sbjct: 139 LGANHNLS-DLSPLSNMTGLNYLTVTESKVK--------DVTPIANLTDLYSLSLNYNQI 189
Query: 131 SGSIP-EKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNN 189
P L L + N +T P + + L ++ N ++ S L N
Sbjct: 190 EDISPLASLTS----LHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDL--SPLAN 241
Query: 190 LTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENT 249
L+ + L + N+++ + + L+ L L++ +N S++ +++ L +L + N
Sbjct: 242 LSQLTWLEIGTNQISD-INAVKDLTKLKMLNVGSNQI--SDISV-LNNLSQLNSLFLNNN 297
Query: 250 NLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENL-LVNLQNNRIS 299
L + + + +L T+ + N + L + + + N I
Sbjct: 298 QLGNEDMEVIGGLTNLTTLFLSQNHITDIRPL--ASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-24
Identities = 58/320 (18%), Positives = 121/320 (37%), Gaps = 47/320 (14%)
Query: 11 ITGLTELHTLDLSNNK--DLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVL 68
L + L ++ K ++G I L L L L G + P + +L +L
Sbjct: 40 QEELESITKLVVAGEKVASIQG-----IEYLTNLEYLNLNGNQITDISP--LSNLVKLTN 92
Query: 69 LSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKN 128
L + +N + ++ NL+NL L L ++ + L L + + G N
Sbjct: 93 LYIGTNKITD--ISALQNLTNLRELYLNEDNISD--------ISPLANLTKMYSLNLGAN 142
Query: 129 QLSGSIPE--KLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSN 186
+ + L ++ + + + + + L + + N + S
Sbjct: 143 HNLSDLSPLSNMTG----LNYLTVTESKVKD-VTP-IANLTDLYSLSLNYNQIED--ISP 194
Query: 187 LNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMM 246
L +LTS++ N++T + + ++ L+ L + NN +++ +++ LT L +
Sbjct: 195 LASLTSLHYFTAYVNQITD-ITPVANMTRLNSLKIGNNKI--TDLSP-LANLSQLTWLEI 250
Query: 247 ENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENL----LVNLQNNRISAYT 302
+ I A + + L+ + + +N+++ L NL + L NN++
Sbjct: 251 GTNQISD-INA-VKDLTKLKMLNVGSNQISDISVLN-----NLSQLNSLFLNNNQLGNED 303
Query: 303 ERGGAPAVNLT---LIDNPI 319
NLT L N I
Sbjct: 304 MEVIGGLTNLTTLFLSQNHI 323
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-23
Identities = 55/311 (17%), Positives = 117/311 (37%), Gaps = 31/311 (9%)
Query: 11 ITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLS 70
L E L + + L+ ++ L++ G + I L L L+
Sbjct: 18 DADLAEGIRAVLQKAS-VTDVVT--QEELESITKLVVAGEKVAS--IQGIEYLTNLEYLN 72
Query: 71 LNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQL 130
LN N + + NL L L + NK+ + L L + + ++ +
Sbjct: 73 LNGNQITD--ISPLSNLVKLTNLYIGTNKIT--------DISALQNLTNLRELYLNEDNI 122
Query: 131 SGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNL 190
S P ++ ++ L N + L + L + + + + + NL
Sbjct: 123 SDISPLA----NLTKMYSLNLGANHNLSDLSPLSNMTGLNYLTVTESKVKD--VTPIANL 176
Query: 191 TSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTN 250
T + L L+ N++ + L L+ L Y N +++ ++M L +L + N
Sbjct: 177 TDLYSLSLNYNQIED-ISPLASLTSLHYFTAYVNQI--TDITP-VANMTRLNSLKIGNNK 232
Query: 251 LKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENL-LVNLQNNRISAYTERGGAPA 309
+ P L ++ L + + TN+++ ++ L ++N+ +N+IS +
Sbjct: 233 ITDLSP--LANLSQLTWLEIGTNQIS-DIN-AVKDLTKLKMLNVGSNQISDISVLNNLSQ 288
Query: 310 -VNLTLIDNPI 319
+L L +N +
Sbjct: 289 LNSLFLNNNQL 299
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 89.5 bits (223), Expect = 2e-19
Identities = 51/287 (17%), Positives = 104/287 (36%), Gaps = 53/287 (18%)
Query: 13 GLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLN 72
G L TL N+ +L + +L S + + L+ + L +
Sbjct: 1 GAATLATLPAPINQI------FPDADLAEGIRAVLQKASVTDVVT--QEELESITKLVVA 52
Query: 73 SNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSG 132
+ I L+NL +L+L N++ P+S+ LV+ + + G N+++
Sbjct: 53 GEKVAS--IQGIEYLTNLEYLNLNGNQITDISPLSN--------LVKLTNLYIGTNKIT- 101
Query: 133 SIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTS 192
I L + +L + + +++S S L NLT
Sbjct: 102 DISA--------------------------LQNLTNLRELYLNEDNISDI--SPLANLTK 133
Query: 193 VNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLK 252
+ L L N + L+ ++ L+YL ++ + +++ L +L + ++
Sbjct: 134 MYSLNLGANHNLSDLSPLSNMTGLNYLTVTESKVKDVTP---IANLTDLYSLSLNYNQIE 190
Query: 253 GQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENLLVNLQNNRIS 299
P L S+ L N++ + N L + NN+I+
Sbjct: 191 DISP--LASLTSLHYFTAYVNQITDITPVANMTRLNSL-KIGNNKIT 234
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 6e-28
Identities = 73/290 (25%), Positives = 123/290 (42%), Gaps = 38/290 (13%)
Query: 550 VKKYTNNFSDA----NDVGSGGYGKVYKGT-LPNGQLIAIK---RAQQGSMQGGQEFKME 601
V+ T FSD +G G +G+V GQ A+K + Q + E
Sbjct: 17 VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLRE 76
Query: 602 IELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRL-KIAL 660
++LL ++ H N++ L F D+G L+ E G L D + + R+ + L
Sbjct: 77 VQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVL 136
Query: 661 GAARGLSYLHELANPPIIHRDIKSSNILL---DERLNAKVADFGLSKSMSDSEKDHITTQ 717
++Y+H+ I+HRD+K N+LL + N ++ DFGLS S+K + +
Sbjct: 137 SG---ITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK--MKDK 188
Query: 718 VKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPI--ERGKYIVREIRTVMDKK 775
+ GT Y+ PE + EK DV+S GV++ LL+G P I++++ +
Sbjct: 189 I-GTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKV------E 240
Query: 776 KELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825
K Y +S + K DL K + R + + +
Sbjct: 241 KGKYTFEL--PQWKKVSESAK------DLIRKMLTYVPSMRISARDALDH 282
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 72/219 (32%), Positives = 104/219 (47%), Gaps = 29/219 (13%)
Query: 557 FSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGG--QEFKMEIELLSRV-HHKN 612
F VG+G YG+VYKG + GQL AIK + G +E K EI +L + HH+N
Sbjct: 26 FELVELVGNGTYGQVYKGRHVKTGQLAAIK---VMDVTGDEEEEIKQEINMLKKYSHHRN 82
Query: 613 LVSLLGFCFDRGEQM-------LIYEFVPNGSLGDSLSGKNGIRL--DWIRRLKIALGAA 663
+ + G F + L+ EF GS+ D + G L +WI I
Sbjct: 83 IATYYG-AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIA--YICREIL 139
Query: 664 RGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMG 723
RGLS+LH+ +IHRDIK N+LL E K+ DFG+S + + T GT
Sbjct: 140 RGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT--FIGTPY 194
Query: 724 YLDPEYYMTQQLTE-----KSDVYSFGVLMLELLTGRRP 757
++ PE + + KSD++S G+ +E+ G P
Sbjct: 195 WMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 3e-27
Identities = 39/309 (12%), Positives = 85/309 (27%), Gaps = 77/309 (24%)
Query: 564 GSGGYGKVYKGT-LPNGQLIAIK------RAQQGSMQGGQEFKMEIELLSRV-------- 608
G + T G+ + R +++ +E + + LL +
Sbjct: 82 GQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKV 141
Query: 609 --------------HHKNLVSLLGFCFDRGEQMLIYEF-VPNGSLGDSLS-----GKNGI 648
K ++ + D + + +L
Sbjct: 142 HLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHK 201
Query: 649 RLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSD 708
L RL++ L R L+ LH ++H ++ +I+LD+R + F
Sbjct: 202 SLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLV---- 254
Query: 709 SEKDHITTQVKGTMGYLDPEYYMTQQL-----------TEKSDVYSFGVLMLELLTGRRP 757
+D + G+ PE + T D ++ G+++ + P
Sbjct: 255 --RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLP 312
Query: 758 IERGKYIVREIRTVMDKKKELYNLYELI-DPTIGLSTTLKGFEKYVDLALKCVQESGDDR 816
I K E I + ++ L ++ +DR
Sbjct: 313 IT---------------KDAALGGSEWIFRSCKNIPQPVR------ALLEGFLRYPKEDR 351
Query: 817 PTMSEVVKD 825
+ ++
Sbjct: 352 LLPLQAMET 360
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 3e-27
Identities = 43/265 (16%), Positives = 94/265 (35%), Gaps = 32/265 (12%)
Query: 14 LTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNS 73
L+L + L P L L ++ + +PD++ L L+L
Sbjct: 80 QPGRVALELRSVP-LPQ-FPDQAFRLSHLQHMTIDAAGLME-LPDTMQQFAGLETLTLAR 136
Query: 74 NGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGS 133
N +P SI +L+ L L + E+P ++ +
Sbjct: 137 NPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVN----------- 184
Query: 134 IPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSV 193
L + + + LPA++ +++L+ ++ + LS + +++L +
Sbjct: 185 -----------LQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKL 231
Query: 194 NDLYLS-NNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMME-NTNL 251
+L L L P G + L L + + S + +P + L L + NL
Sbjct: 232 EELDLRGCTALRNYPPIFGGRAPLKRLILKDCS-NLLTLPLDIHRLTQLEKLDLRGCVNL 290
Query: 252 KGQIPADLFSIPHLQTVVMKTNELN 276
++P+ + +P +++ +
Sbjct: 291 S-RLPSLIAQLPANCIILVPPHLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 51/326 (15%), Positives = 103/326 (31%), Gaps = 62/326 (19%)
Query: 14 LTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPI----------------- 56
+ L + LR P + ++ N +
Sbjct: 11 SSGRENLYFQGSTALR-PYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALK 69
Query: 57 --PDSIGSLQE--LVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSP 112
D + + V L L S + P LS+L + + L E+P +
Sbjct: 70 ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFA 127
Query: 113 GLDMLVRAKHFHFGKNQLSGSIPE---KLFRPDMVLIHVLFDSNNLTGELPATLGLV--- 166
GL + +N L ++P L R L + + ELP L
Sbjct: 128 GL------ETLTLARNPLR-ALPASIASLNR----LRELSIRACPELTELPEPLASTDAS 176
Query: 167 ------KSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLD 220
+L+ +R + + +P+++ NL ++ L + N+ L+ P + L L LD
Sbjct: 177 GEHQGLVNLQSLRLEWTGIRS-LPASIANLQNLKSLKIRNSPLSALGPAIHHLPKLEELD 235
Query: 221 MSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNEL----- 275
+ + P F L L++++ + +P D+ + L+ + ++
Sbjct: 236 LRGCTA-LRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLP 294
Query: 276 --------NGTLDLGTSYSENLLVNL 293
N + + L +
Sbjct: 295 SLIAQLPANCIILVPPHLQAQLDQHR 320
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 6e-24
Identities = 44/215 (20%), Positives = 75/215 (34%), Gaps = 24/215 (11%)
Query: 7 LSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGS---- 62
L + L TL L+ N LR LP +I +L +L L + C +P+ + S
Sbjct: 119 LPDTMQQFAGLETLTLARNP-LRA-LPASIASLNRLRELSIRACPELTELPEPLASTDAS 176
Query: 63 -----LQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDML 117
L L L L G +P SI NL NL L + ++ L + + + L
Sbjct: 177 GEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHH------L 228
Query: 118 VRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLF--DSNNLTGELPATLGLVKSLEVVRFD 175
+ + + P + L D +NL LP + + LE +
Sbjct: 229 PKLEELDLRGCTALRNYPPIFG--GRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLR 285
Query: 176 RNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNL 210
+PS + L + + + + +
Sbjct: 286 GCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHR 320
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 4e-19
Identities = 48/245 (19%), Positives = 85/245 (34%), Gaps = 32/245 (13%)
Query: 36 IGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDL 95
+ NL G + P D + Q N N +N
Sbjct: 8 HHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRW----HSAWRQANSNNPQIETR 63
Query: 96 TDNKLEGEIP--VSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLF-DS 152
T L+ + D PG L L P++ FR + + + D+
Sbjct: 64 TGRALK-ATADLLEDATQPGRVAL------ELRSVPLP-QFPDQAFR--LSHLQHMTIDA 113
Query: 153 NNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLS-NNKLT------- 204
L ELP T+ LE + RN L +P+++ +L + +L + +LT
Sbjct: 114 AGLM-ELPDTMQQFAGLETLTLARNPLRA-LPASIASLNRLRELSIRACPELTELPEPLA 171
Query: 205 --GAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSI 262
A GL L L + +P+ +++Q+L +L + N+ L + + +
Sbjct: 172 STDASGEHQGLVNLQSLRLEWTGI--RSLPASIANLQNLKSLKIRNSPLS-ALGPAIHHL 228
Query: 263 PHLQT 267
P L+
Sbjct: 229 PKLEE 233
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 8e-17
Identities = 26/96 (27%), Positives = 34/96 (35%), Gaps = 1/96 (1%)
Query: 6 QLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQE 65
L I L +L LDL LR P G L L+L CS +P I L +
Sbjct: 220 ALGPAIHHLPKLEELDLRGCTALRN-YPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQ 278
Query: 66 LVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLE 101
L L L R+P I L + + +
Sbjct: 279 LEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 2e-13
Identities = 30/228 (13%), Positives = 69/228 (30%), Gaps = 23/228 (10%)
Query: 57 PDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDM 116
L + + Y D NS +
Sbjct: 5 HHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQA----NSNNPQI 60
Query: 117 LVRAKHFHFGKNQLSGSIPEKLFRPDMV-LIHVLFDSNNLTGELPATLGLVKSLEVVRFD 175
R L + + L + + S L + P + L+ + D
Sbjct: 61 ETR------TGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTID 112
Query: 176 RNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNN--------SFD 227
L +P + + L L+ N L ++ L+ L L +
Sbjct: 113 AAGLME-LPDTMQQFAGLETLTLARNPLRALPASIASLNRLRELSIRACPELTELPEPLA 171
Query: 228 ASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNEL 275
+++ + +L +L +E T ++ +PA + ++ +L+++ ++ + L
Sbjct: 172 STDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPL 218
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-27
Identities = 76/326 (23%), Positives = 126/326 (38%), Gaps = 63/326 (19%)
Query: 546 SFEEVKKYTNNFSDA----NDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGG--QEF 598
S E + F++ +G G +G+V K Q A+K + S +
Sbjct: 9 SGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTI 68
Query: 599 KMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKI 658
E+ELL ++ H N++ L D ++ E G L D I I
Sbjct: 69 LREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGEL-----------FDEI----I 113
Query: 659 ALG------AAR-------GLSYLHELANPPIIHRDIKSSNILL---DERLNAKVADFGL 702
AAR G++Y+H+ I+HRD+K NILL ++ + K+ DFGL
Sbjct: 114 KRKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGL 170
Query: 703 SKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPI--ER 760
S + K + ++ GT Y+ PE + EK DV+S GV++ LL+G P +
Sbjct: 171 STCFQQNTK--MKDRI-GTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTPPFYGKN 226
Query: 761 GKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMS 820
I++ + + Y +S K DL K + R T +
Sbjct: 227 EYDILKRV------ETGKYAFDL--PQWRTISDDAK------DLIRKMLTFHPSLRITAT 272
Query: 821 EVVKD--IENILQQAGLNPNAESASS 844
+ ++ I+ + + S S
Sbjct: 273 QCLEHPWIQKYSSETPTISDLPSLES 298
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 9e-27
Identities = 63/210 (30%), Positives = 103/210 (49%), Gaps = 22/210 (10%)
Query: 557 FSDANDVGSGGYGKVYKGT-LPNGQLIAIKR---AQQGSMQGGQEFKMEIELLSRVHHKN 612
FSD ++G G +G VY + N +++AIK+ + + S + Q+ E+ L ++ H N
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 613 LVSLLGFCFDRGEQM-LIYEFVPNGSLGDSLSGKNG-IRLDWIRRLKIALGAARGLSYLH 670
+ G C+ R L+ E+ GS D L ++ I + GA +GL+YLH
Sbjct: 116 TIQYRG-CYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAA--VTHGALQGLAYLH 171
Query: 671 ELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYY 730
+IHRD+K+ NILL E K+ DFG + M+ + + V GT ++ PE
Sbjct: 172 SHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-----NSFV-GTPYWMAPEVI 222
Query: 731 MTQQLTE---KSDVYSFGVLMLELLTGRRP 757
+ + K DV+S G+ +EL + P
Sbjct: 223 LAMDEGQYDGKVDVWSLGITCIELAERKPP 252
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-26
Identities = 57/306 (18%), Positives = 95/306 (31%), Gaps = 26/306 (8%)
Query: 6 QLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSG------PIPDS 59
+ +LH L L N + + T + NL L L+ F P
Sbjct: 195 FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSI 254
Query: 60 IGSLQELVL--LSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDML 117
+ L ++ + L L+N+ + L ++ L
Sbjct: 255 MEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY--LEDVPKHFKWQSL 312
Query: 118 VRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRN 177
+ QL L + L + N + L SL + RN
Sbjct: 313 ------SIIRCQLKQFPTLDLPF-----LKSLTLTMNKGSISFKKVAL-PSLSYLDLSRN 360
Query: 178 SLSGPVPSNLNNL--TSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWF 235
+LS + ++L S+ L LS N N GL L +LD +++ S F
Sbjct: 361 ALSFSGCCSYSDLGTNSLRHLDLSFNGAIIMSANFMGLEELQHLDFQHSTLKRVTEFSAF 420
Query: 236 SSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYS-ENLLV-NL 293
S++ L L + TN K + L T+ M N + NL +L
Sbjct: 421 LSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDL 480
Query: 294 QNNRIS 299
++
Sbjct: 481 SKCQLE 486
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 5e-26
Identities = 54/356 (15%), Positives = 98/356 (27%), Gaps = 55/356 (15%)
Query: 2 GLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIG 61
L S I L L L++++N LP NL L ++ L + +
Sbjct: 115 KLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQ 174
Query: 62 SLQEL----VLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIP-VSDGNSPGLDM 116
L+E + L ++ N + L+ L L N I N GL +
Sbjct: 175 FLRENPQVNLSLDMSLNPIDF-IQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHV 233
Query: 117 LVRAKHFHFGKNQLSGSIPEKLFR--PDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRF 174
+ L + D+ + N + + ++ +
Sbjct: 234 HRLILGEFKDERNLE-IFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSL 292
Query: 175 DRNSLSGPVP----SNL---------------NNLTSVNDLYLSNNKLTGAMPNLTGLSV 215
S+ +L + L L+ NK + + L
Sbjct: 293 AGVSIKYLEDVPKHFKWQSLSIIRCQLKQFPTLDLPFLKSLTLTMNKGSIS-FKKVALPS 351
Query: 216 LSYLDMSNNSFDA------------------------SEVPSWFSSMQSLTTLMMENTNL 251
LSYLD+S N+ + + F ++ L L +++ L
Sbjct: 352 LSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAIIMSANFMGLEELQHLDFQHSTL 411
Query: 252 KGQIPADLF-SIPHLQTVVMKTNELNGTLDLGTSYSENLLV-NLQNNRISAYTERG 305
K F S+ L + + D +L + N T
Sbjct: 412 KRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSN 467
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 1e-25
Identities = 59/325 (18%), Positives = 106/325 (32%), Gaps = 43/325 (13%)
Query: 8 SGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELV 67
S + +EL LDLS + + L LSNL+L G P S L L
Sbjct: 49 SYSFSNFSELQWLDLSRCE-IETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLE 107
Query: 68 LLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEG-EIPVSDGNSPGLDML--------- 117
L + IG L L L++ N + ++P N L +
Sbjct: 108 NLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQT 167
Query: 118 VRAKHF-------------HFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLG 164
+ N + I ++ F+ + L + N + + T
Sbjct: 168 ITVNDLQFLRENPQVNLSLDMSLNPID-FIQDQAFQ-GIKLHELTLRGNFNSSNIMKTCL 225
Query: 165 L-VKSLEVVR------FDRNSLSGPVPSNLNNLT--SVNDLYLSNNKLTGAMPN-LTGLS 214
+ L V R D +L PS + L ++++ L+ L+
Sbjct: 226 QNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLA 285
Query: 215 VLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNE 274
+S + ++ S + +L + LK DL P L+++ + N+
Sbjct: 286 NVSAMSLAGVSI--KYLED-VPKHFKWQSLSIIRCQLKQFPTLDL---PFLKSLTLTMNK 339
Query: 275 LNGTLDLGTSYSENLLVNLQNNRIS 299
+ + S + L +L N +S
Sbjct: 340 GSISFKKVALPSLSYL-DLSRNALS 363
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-25
Identities = 51/290 (17%), Positives = 90/290 (31%), Gaps = 30/290 (10%)
Query: 8 SGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELV 67
L + + L+ ++ K +L ++ C + L+ L
Sbjct: 278 IVKFHCLANVSAMSLAGVS-IKYLEDVP--KHFKWQSLSIIRCQLKQFPTLDLPFLKSL- 333
Query: 68 LLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGN----------------- 110
+L N G + L +L +LDL+ N L S +
Sbjct: 334 --TLTMN--KGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI 389
Query: 111 --SPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKS 168
S L +H F + L F L+++ N + + S
Sbjct: 390 IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTS 449
Query: 169 LEVVRFDRNSLSGPVPSN-LNNLTSVNDLYLSNNKLTGAMPN-LTGLSVLSYLDMSNNSF 226
L ++ NS SN N T++ L LS +L L L L+MS+N+
Sbjct: 450 LNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNL 509
Query: 227 DASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELN 276
S ++ + SL+TL ++ L + N +
Sbjct: 510 -LFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 4e-25
Identities = 63/318 (19%), Positives = 107/318 (33%), Gaps = 24/318 (7%)
Query: 11 ITGLTELHTLDLSNNK-DLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLL 69
+ GL ++ + + L +S + L G S + + + L
Sbjct: 255 MEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYL--EDVPKHFKWQSL 312
Query: 70 SLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQ 129
S+ +L L L LT NK I P L L +N
Sbjct: 313 SIIRCQLKQ---FPTLDLPFLKSLTLTMNKGS--ISFKKVALPSLSYL------DLSRNA 361
Query: 130 LSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSG-PVPSNLN 188
LS S + L S N + A ++ L+ + F ++L S
Sbjct: 362 LSFSGCCSYSDLGTNSLRHLDLSFNGAIIMSANFMGLEELQHLDFQHSTLKRVTEFSAFL 421
Query: 189 NLTSVNDLYLSNNKLTGAMPN-LTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMME 247
+L + L +S GL+ L+ L M+ NSF + + + F++ +LT L +
Sbjct: 422 SLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLS 481
Query: 248 NTNLKGQIPADLFS-IPHLQTVVMKTNELNGTLDLGT-SYSENLLV-NLQNNRISAYTER 304
L+ I +F + LQ + M N L LD + +L + NRI
Sbjct: 482 KCQLEQ-ISWGVFDTLHRLQLLNMSHNNLLF-LDSSHYNQLYSLSTLDCSFNRIETSKGI 539
Query: 305 GGAPAVNLTLID---NPI 319
+L + N +
Sbjct: 540 LQHFPKSLAFFNLTNNSV 557
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-23
Identities = 44/260 (16%), Positives = 83/260 (31%), Gaps = 11/260 (4%)
Query: 4 KGQLSGDITGLTELHTLDLSNNK-DLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGS 62
KG +S L L LDLS N G + L +L L + +
Sbjct: 339 KGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMG 397
Query: 63 LQELVLLSLNSNGFSGRVPPS-IGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAK 121
L+EL L + S +L L +LD++ + + L
Sbjct: 398 LEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSL------N 451
Query: 122 HFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSG 181
N + +F L + L + L+++ N+L
Sbjct: 452 TLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLF 511
Query: 182 PVPSNLNNLTSVNDLYLSNNKLTGAMPN-LTGLSVLSYLDMSNNSFDASEVPSWFSS-MQ 239
S+ N L S++ L S N++ + L++ +++NNS F ++
Sbjct: 512 LDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVACICEHQKFLQWVK 571
Query: 240 SLTTLMMENTNLKGQIPADL 259
++ + P ++
Sbjct: 572 EQKQFLVNVEQMTCATPVEM 591
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 5e-23
Identities = 49/338 (14%), Positives = 90/338 (26%), Gaps = 46/338 (13%)
Query: 3 LKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSG-PIPDSIG 61
++ G +GLT L L K L IG L L L + +P
Sbjct: 92 IQSFSPGSFSGLTSLENLVAVETK-LASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFS 150
Query: 62 SLQELVLLSLNSNGFSG---------------------------RVPPSIGNLSNLYWLD 94
+L LV + L+ N + L+ L
Sbjct: 151 NLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELT 210
Query: 95 LTDNKLEGEIP-VSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFR--PDMVLIHVLFD 151
L N I N GL + + L + D+ +
Sbjct: 211 LRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLE-IFEPSIMEGLCDVTIDEFRLT 269
Query: 152 SNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLT 211
N + + ++ + S+ ++ L + +L
Sbjct: 270 YTNDFSDDIVKFHCLANVSAMSLAGVSIKY--LEDVPKHFKWQSLSIIRCQLKQ--FPTL 325
Query: 212 GLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSI---PHLQTV 268
L L L ++ N + ++ SL+ L + L +S L+ +
Sbjct: 326 DLPFLKSLTLTMNKGS---ISFKKVALPSLSYLDLSRNALSF-SGCCSYSDLGTNSLRHL 381
Query: 269 VMKTNELNGTLDLGTSYSENLLV-NLQNNRISAYTERG 305
+ N + E L + Q++ + TE
Sbjct: 382 DLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFS 418
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 7e-22
Identities = 47/296 (15%), Positives = 85/296 (28%), Gaps = 22/296 (7%)
Query: 17 LHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGF 76
+DLS N L+ + N +L L L C + L L L L N
Sbjct: 34 TKNIDLSFNP-LKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPI 92
Query: 77 SGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPE 136
P S L++L L + KL G L L + N +
Sbjct: 93 QSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKL------NVAHNFIHSCKLP 146
Query: 137 KLFRPDMVLIHVLFDSNNLTGELPATL----GLVKSLEVVRFDRNSLSGPVPSNLNNLTS 192
F L+HV N + L + + N + +
Sbjct: 147 AYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDF-IQDQAFQGIK 205
Query: 193 VNDLYLSNNKLTGAMPN--LTGLSVLSYLDMSNNSFD-----ASEVPSWFSSMQSLTT-- 243
+++L L N + + L L+ L + F PS + +T
Sbjct: 206 LHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDE 265
Query: 244 LMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENLLVNLQNNRIS 299
+ TN + ++ + + + D+ + L ++ ++
Sbjct: 266 FRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQSL-SIIRCQLK 320
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 1e-17
Identities = 44/275 (16%), Positives = 95/275 (34%), Gaps = 23/275 (8%)
Query: 54 GPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPG 113
G + I + + S +VP I S+ +DL+ N L+ S N
Sbjct: 2 GSLNPCIEVVPNITY-QCMDQKLS-KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSE 57
Query: 114 LDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVR 173
L L + ++ +I +K + L +++ N + P + + SLE +
Sbjct: 58 LQWL------DLSRCEIE-TIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLV 110
Query: 174 FDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPN--LTGLSVLSYLDMSNNSFDASEV 231
L+ + L ++ L +++N + + L+ L ++D+S N +
Sbjct: 111 AVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQ-TIT 169
Query: 232 PSWFSSMQSLTTLMME---NTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSEN 288
+ ++ + + + N I F L + ++ N + + +
Sbjct: 170 VNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGNFNSSNIM------KT 223
Query: 289 LLVNLQNNRISAYTERGGAPAVNLTLIDNPICQEL 323
L NL + NL + + I + L
Sbjct: 224 CLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGL 258
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 2e-13
Identities = 29/129 (22%), Positives = 45/129 (34%), Gaps = 6/129 (4%)
Query: 3 LKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGS 62
K G GLT L+TL ++ N L N L+ L L C +
Sbjct: 436 TKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDT 495
Query: 63 LQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKH 122
L L LL+++ N L +L LD + N++E + L
Sbjct: 496 LHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSL------AF 549
Query: 123 FHFGKNQLS 131
F+ N ++
Sbjct: 550 FNLTNNSVA 558
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-26
Identities = 58/292 (19%), Positives = 115/292 (39%), Gaps = 36/292 (12%)
Query: 11 ITGLTELHTLDLSNNK--DLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVL 68
T L ++ TL + G + L L+ + + P + +L +LV
Sbjct: 42 QTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQINFSNNQLTDITP--LKNLTKLVD 94
Query: 69 LSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKN 128
+ +N+N + + NL+NL L L +N++ P+ + L N
Sbjct: 95 ILMNNNQIAD--ITPLANLTNLTGLTLFNNQITDIDPLKN--------LTNLNRLELSSN 144
Query: 129 QLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLN 188
+S + + L N +T P L + +LE + N +S S L
Sbjct: 145 TISDISALS----GLTSLQQLSFGNQVTDLKP--LANLTTLERLDISSNKVSD--ISVLA 196
Query: 189 NLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMEN 248
LT++ L +NN+++ + L L+ L L ++ N ++ + +S+ +LT L + N
Sbjct: 197 KLTNLESLIATNNQISD-ITPLGILTNLDELSLNGNQL--KDIGT-LASLTNLTDLDLAN 252
Query: 249 TNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENL-LVNLQNNRIS 299
+ P L + L + + N+++ L + L + L N++
Sbjct: 253 NQISNLAP--LSGLTKLTELKLGANQISNISPL--AGLTALTNLELNENQLE 300
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 6e-26
Identities = 57/301 (18%), Positives = 114/301 (37%), Gaps = 38/301 (12%)
Query: 11 ITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLS 70
+ LT L+ L+LS+N + + + L L L G + P + +L L L
Sbjct: 130 LKNLTNLNRLELSSNT-ISD--ISALSGLTSLQQLSF-GNQVTDLKP--LANLTTLERLD 183
Query: 71 LNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVS----------DGNS----PGLDM 116
++SN S + L+NL L T+N++ P+ +GN L
Sbjct: 184 ISSNKVSD--ISVLAKLTNLESLIATNNQISDITPLGILTNLDELSLNGNQLKDIGTLAS 241
Query: 117 LVRAKHFHFGKNQLSGSIP-EKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFD 175
L NQ+S P L + L + +N ++ P L + +L + +
Sbjct: 242 LTNLTDLDLANNQISNLAPLSGLTK----LTELKLGANQISNISP--LAGLTALTNLELN 295
Query: 176 RNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWF 235
N L S ++NL ++ L L N ++ + ++ L+ L L NN S
Sbjct: 296 ENQLED--ISPISNLKNLTYLTLYFNNISD-ISPVSSLTKLQRLFFYNNKV---SDVSSL 349
Query: 236 SSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENLLVNLQN 295
+++ ++ L + + P L ++ + + + + + ++ ++N
Sbjct: 350 ANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWT-NAPVNYKANVSIPNTVKN 406
Query: 296 N 296
Sbjct: 407 V 407
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-24
Identities = 65/291 (22%), Positives = 131/291 (45%), Gaps = 34/291 (11%)
Query: 11 ITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLS 70
+ LT+L + ++NN+ + P + NL L+ L L + P + +L L L
Sbjct: 86 LKNLTKLVDILMNNNQ-IADITP--LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLE 140
Query: 71 LNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQL 130
L+SN S ++ L++L L N++ P+++ L + N++
Sbjct: 141 LSSNTISD--ISALSGLTSLQQLSF-GNQVTDLKPLAN--------LTTLERLDISSNKV 189
Query: 131 SG-SIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNN 189
S S+ KL L ++ +N ++ P LG++ +L+ + + N L L +
Sbjct: 190 SDISVLAKLTN----LESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--IGTLAS 241
Query: 190 LTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENT 249
LT++ DL L+NN+++ + L+GL+ L+ L + N S + + + +LT L +
Sbjct: 242 LTNLTDLDLANNQISN-LAPLSGLTKLTELKLGANQI--SNISP-LAGLTALTNLELNEN 297
Query: 250 NLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENLLV-NLQNNRIS 299
L+ P + ++ +L + + N ++ + S L NN++S
Sbjct: 298 QLEDISP--ISNLKNLTYLTLYFNNISDISPV--SSLTKLQRLFFYNNKVS 344
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-24
Identities = 65/290 (22%), Positives = 122/290 (42%), Gaps = 34/290 (11%)
Query: 11 ITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLS 70
+ LT L LD+S+NK + + + L L +L+ S P +G L L LS
Sbjct: 173 LANLTTLERLDISSNK-VSDI--SVLAKLTNLESLIATNNQISDITP--LGILTNLDELS 227
Query: 71 LNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQL 130
LN N ++ +L+NL LDL +N++ P+S L + G NQ+
Sbjct: 228 LNGNQLKD--IGTLASLTNLTDLDLANNQISNLAPLSG--------LTKLTELKLGANQI 277
Query: 131 SGSIP-EKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNN 189
S P L L ++ + N L P + +K+L + N++S S +++
Sbjct: 278 SNISPLAGLTA----LTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISD--ISPVSS 329
Query: 190 LTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENT 249
LT + L+ NNK++ + +L L+ +++L +N S++ +++ +T L + +
Sbjct: 330 LTKLQRLFFYNNKVSD-VSSLANLTNINWLSAGHNQI--SDLTP-LANLTRITQLGLNDQ 385
Query: 250 NLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENLLVNLQNNRIS 299
++ TV + G L + S+ + I+
Sbjct: 386 AWTNAPVNYKANVSIPNTV----KNVTGALIAPATISD--GGSYTEPDIT 429
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-24
Identities = 69/312 (22%), Positives = 124/312 (39%), Gaps = 33/312 (10%)
Query: 10 DITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLL 69
+ LT L L L NN+ + + NL L+ L L + S + L L L
Sbjct: 107 PLANLTNLTGLTLFNNQ-ITD--IDPLKNLTNLNRLELSSNTISDISA--LSGLTSLQQL 161
Query: 70 SLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQ 129
S + + NL+ L LD++ NK+ L L + NQ
Sbjct: 162 SFGNQVTD---LKPLANLTTLERLDISSNKVSDI--------SVLAKLTNLESLIATNNQ 210
Query: 130 LSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNN 189
+S P + L + + N L TL + +L + N +S + L+
Sbjct: 211 ISDITPLGILT---NLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISN--LAPLSG 263
Query: 190 LTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENT 249
LT + +L L N+++ + L GL+ L+ L+++ N ++ S++++LT L +
Sbjct: 264 LTKLTELKLGANQISN-ISPLAGLTALTNLELNENQL--EDISP-ISNLKNLTYLTLYFN 319
Query: 250 NLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENL-LVNLQNNRISAYTERGGAP 308
N+ P + S+ LQ + N+++ L N+ ++ +N+IS T
Sbjct: 320 NISDISP--VSSLTKLQRLFFYNNKVSDVSSLAN--LTNINWLSAGHNQISDLTPLANLT 375
Query: 309 AVN-LTLIDNPI 319
+ L L D
Sbjct: 376 RITQLGLNDQAW 387
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 8e-21
Identities = 58/269 (21%), Positives = 104/269 (38%), Gaps = 27/269 (10%)
Query: 11 ITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLS 70
+ LT L L L+ N+ L+ T+ +L L++L L S P + L +L L
Sbjct: 217 LGILTNLDELSLNGNQ-LKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELK 271
Query: 71 LNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQL 130
L +N S + L+ L L+L +N+LE + + L + N +
Sbjct: 272 LGANQISN--ISPLAGLTALTNLELNENQLE--------DISPISNLKNLTYLTLYFNNI 321
Query: 131 SGSIP-EKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNN 189
S P L + L + F +N ++ ++L + ++ + N +S + L N
Sbjct: 322 SDISPVSSLTK----LQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDL--TPLAN 373
Query: 190 LTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENT 249
LT + L L++ T + + +S + N A P+ S S T +
Sbjct: 374 LTRITQLGLNDQAWTN--APVNYKANVSIPNTVKNVTGALIAPATISDGGSYTEPDITW- 430
Query: 250 NLKGQIPADLFSIPHLQTVVMKTNELNGT 278
NL ++ T+ T +GT
Sbjct: 431 NLPSYTNEVSYTFSQPVTIGKGTTTFSGT 459
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 5e-19
Identities = 45/266 (16%), Positives = 100/266 (37%), Gaps = 49/266 (18%)
Query: 34 TTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWL 93
T L + +L + + + L ++ L + G + L+NL +
Sbjct: 18 FTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQI 73
Query: 94 DLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSN 153
+ ++N+L P+ + L + NQ++ P
Sbjct: 74 NFSNNQLTDITPLKN--------LTKLVDILMNNNQIADITP------------------ 107
Query: 154 NLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGL 213
L + +L + N ++ L NLT++N L LS+N ++ + L+GL
Sbjct: 108 ---------LANLTNLTGLTLFNNQITD--IDPLKNLTNLNRLELSSNTISD-ISALSGL 155
Query: 214 SVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTN 273
+ L L N D +++ +L L + + + + L + +L++++ N
Sbjct: 156 TSLQQLSFGNQVTDLKP----LANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNN 209
Query: 274 ELNGTLDLGTSYSENLLVNLQNNRIS 299
+++ LG + + L +L N++
Sbjct: 210 QISDITPLGILTNLDEL-SLNGNQLK 234
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 2e-13
Identities = 36/195 (18%), Positives = 69/195 (35%), Gaps = 42/195 (21%)
Query: 10 DITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLL 69
+ GLT L L+L+ N+ L P I NLK L+ L L + S P + SL +L L
Sbjct: 282 PLAGLTALTNLELNENQ-LEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRL 336
Query: 70 SLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQ 129
+N S S+ NL+N+ WL N++ P++ L +
Sbjct: 337 FFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTPLA-----NLTRI---TQLGLNDQA 386
Query: 130 LSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNN 189
+ + ++ + + + + P+ +++
Sbjct: 387 WTNAPVNYK--ANVSIPNTVKNVTGAL-------------------------IAPATISD 419
Query: 190 LTSVNDLYLSNNKLT 204
S + ++ N +
Sbjct: 420 GGSYTEPDITWNLPS 434
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 56/231 (24%), Positives = 86/231 (37%), Gaps = 48/231 (20%)
Query: 563 VGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQE-FKMEIELLSRVHHKNLVSLLGFC 620
+GSG +G V+ +G IK + Q E + EIE+L + H N++ +
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 621 FDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALG------AAR-------GLS 667
D ++ E G L L+ I + A L+
Sbjct: 90 EDYHNMYIVMETCEGGEL-----------LERIVSAQARGKALSEGYVAELMKQMMNALA 138
Query: 668 YLHELANPPIIHRDIKSSNILL---DERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGY 724
Y H ++H+D+K NIL K+ DFGL++ E T GT Y
Sbjct: 139 YFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH--STNAA-GTALY 192
Query: 725 LDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRP------------IERGKY 763
+ PE + +T K D++S GV+M LLTG P +
Sbjct: 193 MAPE-VFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEP 242
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 4e-26
Identities = 59/214 (27%), Positives = 100/214 (46%), Gaps = 18/214 (8%)
Query: 564 GSGGYGKVYKGT-LPNGQLIAIK---RAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGF 619
G G YG+V + +A+K + + K EI + ++H+N+V G
Sbjct: 16 GEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEICINKMLNHENVVKFYGH 73
Query: 620 CFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRL---KIALGAARGLSYLHELANPP 676
+ Q L E+ G L D + G+ +R +A G+ YLH +
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-----GVVYLHGIG--- 125
Query: 677 IIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLT 736
I HRDIK N+LLDER N K++DFGL+ + ++ + ++ GT+ Y+ PE ++
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 737 -EKSDVYSFGVLMLELLTGRRPIERGKYIVREIR 769
E DV+S G+++ +L G P ++ +E
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS 219
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 6e-26
Identities = 64/315 (20%), Positives = 110/315 (34%), Gaps = 28/315 (8%)
Query: 8 SGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELV 67
+ + ++ L+L++ + + + L + + P ++ L
Sbjct: 62 AALLDSFRQVELLNLNDLQ-IEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLT 120
Query: 68 LLSLNSNGFSGRVPPSI-GNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFG 126
+L L N S +P I N L L +++N LE I L ++
Sbjct: 121 VLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQ--ATTSL---QNLQLS 173
Query: 127 KNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSN 186
N+L+ + L L H N L+ TL + ++E + NS++
Sbjct: 174 SNRLT-HVDLSLIPS---LFHANVSYNLLS-----TLAIPIAVEELDASHNSINVVRGPV 224
Query: 187 LNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVP-SWFSSMQSLTTLM 245
LT L L +N LT L L +D+S N ++ F MQ L L
Sbjct: 225 NVELTI---LKLQHNNLT-DTAWLLNYPGLVEVDLSYNEL--EKIMYHPFVKMQRLERLY 278
Query: 246 MENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENL-LVNLQNNRISAYTER 304
+ N L + IP L+ + + N L ++ + L + L +N I
Sbjct: 279 ISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLKLS 336
Query: 305 GGAPAVNLTLIDNPI 319
NLTL N
Sbjct: 337 THHTLKNLTLSHNDW 351
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 4e-21
Identities = 49/276 (17%), Positives = 95/276 (34%), Gaps = 26/276 (9%)
Query: 13 GLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLN 72
+ L + N +R P N+ L+ L+L S + +L LS++
Sbjct: 91 YAHTIQKLYMGFNA-IRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMS 149
Query: 73 SNGFSGRVPPSI-GNLSNLYWLDLTDNKLEGEIPVS----------DGNSPG-LDMLVRA 120
+N R+ ++L L L+ N+L + +S N L + +
Sbjct: 150 NNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVDLSLIPSLFHANVSYNLLSTLAIPIAV 207
Query: 121 KHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLS 180
+ N ++ + + L + NNLT + L L V N L
Sbjct: 208 EELDASHNSIN-VVRGPVNVE---LTILKLQHNNLT-DTAWLLNY-PGLVEVDLSYNELE 261
Query: 181 GPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQS 240
+ + + LY+SNN+L + L LD+S+N V
Sbjct: 262 KIMYHPFVKMQRLERLYISNNRLVALNLYGQPIPTLKVLDLSHNHL--LHVERNQPQFDR 319
Query: 241 LTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELN 276
L L +++ ++ + L+ + + N+ +
Sbjct: 320 LENLYLDHNSIV-TLKLSTH--HTLKNLTLSHNDWD 352
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 3e-19
Identities = 43/233 (18%), Positives = 77/233 (33%), Gaps = 25/233 (10%)
Query: 12 TGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSL 71
T L L LS+N+ L + L + + S ++ + L
Sbjct: 162 QATTSLQNLQLSSNRLTHVDL----SLIPSLFHANVSYNLLS-----TLAIPIAVEELDA 212
Query: 72 NSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLS 131
+ N + V + L L L N L ++ L N+L
Sbjct: 213 SHNSIN-VVRGPV--NVELTILKLQHNNLT--------DTAWLLNYPGLVEVDLSYNELE 261
Query: 132 GSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLT 191
I F L + +N L L + +L+V+ N L V N
Sbjct: 262 -KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFD 318
Query: 192 SVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTL 244
+ +LYL +N + + L+ L L +S+N +D + + + F ++
Sbjct: 319 RLENLYLDHNSIV-TLK-LSTHHTLKNLTLSHNDWDCNSLRALFRNVARPAVD 369
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 2e-15
Identities = 38/250 (15%), Positives = 78/250 (31%), Gaps = 29/250 (11%)
Query: 56 IPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLD 115
I ++ + ++ L+N + ++ + ++P + LD
Sbjct: 13 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAAL-----LD 66
Query: 116 MLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFD 175
+ + + Q+ I F + + N + P V L V+ +
Sbjct: 67 SFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLE 125
Query: 176 RNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPN-LTGLSVLSYLDMSNNSFDASEVPSW 234
RN LS +N + L +SNN L + + L L +S+N + V
Sbjct: 126 RNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRL--THVD-- 181
Query: 235 FSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENLLVNLQ 294
S + SL + L L ++ + N + + V L
Sbjct: 182 LSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSI-------NVVRGPVNVELT 229
Query: 295 -----NNRIS 299
+N ++
Sbjct: 230 ILKLQHNNLT 239
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 2e-07
Identities = 23/158 (14%), Positives = 57/158 (36%), Gaps = 9/158 (5%)
Query: 147 HVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGA 206
+ + + + L V D + L + + N+ +
Sbjct: 1 YNVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKL 60
Query: 207 MPN-LTGLSVLSYLDMSNNSFDASEVPS-WFSSMQSLTTLMMENTNLKGQIPADLFS-IP 263
L + L++++ E+ + F+ ++ L M ++ +P +F +P
Sbjct: 61 PAALLDSFRQVELLNLNDLQI--EEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVP 117
Query: 264 HLQTVVMKTNELNGTLDLGT-SYSENLLV-NLQNNRIS 299
L +V++ N+L+ +L G + L ++ NN +
Sbjct: 118 LLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE 154
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 4e-04
Identities = 16/96 (16%), Positives = 26/96 (27%), Gaps = 29/96 (30%)
Query: 6 QLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQE 65
L+ + L LDLS+N +L + +
Sbjct: 286 ALNLYGQPIPTLKVLDLSHN------------HLLH--------------VERNQPQFDR 319
Query: 66 LVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLE 101
L L L+ N + L L L+ N +
Sbjct: 320 LENLYLDHNSIV-TLKL--STHHTLKNLTLSHNDWD 352
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 7e-26
Identities = 68/325 (20%), Positives = 108/325 (33%), Gaps = 36/325 (11%)
Query: 14 LTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNS 73
L + N+ +R + + +++ L L + + L +
Sbjct: 50 LNNQKIVTFKNST-MRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGF 108
Query: 74 NGFSGRVPPSI-GNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSG 132
N +PP + N+ L L L N L +P G L N L
Sbjct: 109 NAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLP--RGIFHNTPKL---TTLSMSNNNLE- 160
Query: 133 SIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSG-PVPSNL---- 187
I + F+ L ++ SN LT + L L+ SL N LS +P +
Sbjct: 161 RIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYNLLSTLAIPIAVEELD 217
Query: 188 ---NNLTSVND--------LYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVP-SWF 235
N++ V L L +N LT L L +D+S N ++ F
Sbjct: 218 ASHNSINVVRGPVNVELTILKLQHNNLT-DTAWLLNYPGLVEVDLSYNEL--EKIMYHPF 274
Query: 236 SSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENL-LVNLQ 294
MQ L L + N L + IP L+ + + N L ++ + L + L
Sbjct: 275 VKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLD 332
Query: 295 NNRISAYTERGGAPAVNLTLIDNPI 319
+N I NLTL N
Sbjct: 333 HNSIVTLKLSTHHTLKNLTLSHNDW 357
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 93.1 bits (231), Expect = 1e-19
Identities = 51/277 (18%), Positives = 98/277 (35%), Gaps = 28/277 (10%)
Query: 13 GLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSI-GSLQELVLLSL 71
+ L + N +R P N+ L+ L+L S +P I + +L LS+
Sbjct: 97 YAHTIQKLYMGFNA-IRYLPPHVFQNVPLLTVLVLERNDLSS-LPRGIFHNTPKLTTLSM 154
Query: 72 NSNGFSGRVPPSI-GNLSNLYWLDLTDNKLEGEIPVS----------DGNS-PGLDMLVR 119
++N R+ ++L L L+ N+L + +S N L + +
Sbjct: 155 SNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVDLSLIPSLFHANVSYNLLSTLAIPIA 212
Query: 120 AKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSL 179
+ N ++ + + L + NNLT + L L V N L
Sbjct: 213 VEELDASHNSIN-VVRGPVNVE---LTILKLQHNNLT-DTAWLLNY-PGLVEVDLSYNEL 266
Query: 180 SGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQ 239
+ + + LY+SNN+L + L LD+S+N V
Sbjct: 267 EKIMYHPFVKMQRLERLYISNNRLVALNLYGQPIPTLKVLDLSHNHL--LHVERNQPQFD 324
Query: 240 SLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELN 276
L L +++ ++ + L+ + + N+ +
Sbjct: 325 RLENLYLDHNSIV-TLKLSTH--HTLKNLTLSHNDWD 358
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 81.9 bits (202), Expect = 4e-16
Identities = 53/323 (16%), Positives = 116/323 (35%), Gaps = 58/323 (17%)
Query: 22 LSNNKDLRGP----LPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFS 77
N R P + + + ++ + + +L +++ ++
Sbjct: 5 QRYNVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR 64
Query: 78 GRVPPSI-GNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPE 136
++P ++ + + L+L D ++E EI + + + G N + +P
Sbjct: 65 -KLPAALLDSFRQVELLNLNDLQIE-EID--TYAFAYAHTI---QKLYMGFNAIR-YLPP 116
Query: 137 KLFRPDMVLIHVLFDSNNLTGELPA-TLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVND 195
+F+ +L ++ + N+L+ LP L + N+L TS+ +
Sbjct: 117 HVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQN 175
Query: 196 LYLSNNKLT----GAMPNLTGLSV-------------LSYLDMSNNSFDASEVP------ 232
L LS+N+LT +P+L +V + LD S+NS + V
Sbjct: 176 LQLSSNRLTHVDLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSI--NVVRGPVNVE 233
Query: 233 --------------SWFSSMQSLTTLMMENTNLKGQIPADLFS-IPHLQTVVMKTNELNG 277
+W + L + + L+ +I F + L+ + + N L
Sbjct: 234 LTILKLQHNNLTDTAWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV- 291
Query: 278 TLDLGTSYSENL-LVNLQNNRIS 299
L+L L +++L +N +
Sbjct: 292 ALNLYGQPIPTLKVLDLSHNHLL 314
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 63.8 bits (155), Expect = 1e-10
Identities = 44/298 (14%), Positives = 88/298 (29%), Gaps = 19/298 (6%)
Query: 9 GDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVL 68
+ L +DLS N+ L + +++L L + + + L +
Sbjct: 248 AWLLNYPGLVEVDLSYNE-LEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKV 305
Query: 69 LSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKN 128
L L+ N V + L L L N + + L K+ N
Sbjct: 306 LDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK--------LSTHHTLKNLTLSHN 355
Query: 129 QLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLV-KSLEVVRFDRNSLSGPVPSNL 187
+ LFR ++ V + + GL K + DR + S +
Sbjct: 356 DWDCNSLRALFR-NVARPAVDDADQHCKIDYQLEHGLCCKESDKPYLDRLLQYIALTSVV 414
Query: 188 NNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMME 247
+ + + + ++ + + N +EV + +Q LT ++
Sbjct: 415 EKVQRAQGRCSATDTINSVQSLSHYITQQGGVPLQGNEQLEAEVNELRAEVQQLTNEQIQ 474
Query: 248 NTNLKGQIPADLFSIPHLQTVVMK-----TNELNGTLDLGTSYSENLLVNLQNNRISA 300
L + A++ + + ++ LN L Q R A
Sbjct: 475 QEQLLQGLHAEIDTNLRRYRLPKDGLARSSDNLNKVFTHLKERQAFKLRETQARRTEA 532
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 46.1 bits (109), Expect = 4e-05
Identities = 43/318 (13%), Positives = 86/318 (27%), Gaps = 48/318 (15%)
Query: 6 QLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQE 65
L+ + L LDLS+N L + + +
Sbjct: 292 ALNLYGQPIPTLKVLDLSHN---------------HLLH-----------VERNQPQFDR 325
Query: 66 LVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEG----EIPVSDGNSPGLDMLVRAK 121
L L L+ N + L L L+ N + + + D K
Sbjct: 326 LENLYLDHNSIV-TLKL--STHHTLKNLTLSHNDWDCNSLRALFRNVARPAVDDADQHCK 382
Query: 122 HFHFGKNQLSGSIPEKLFRP----DMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRN 177
+ ++ L +K + + L V+ G AT + + +
Sbjct: 383 IDYQLEHGLCCKESDKPYLDRLLQYIALTSVVEKVQRAQGRCSATDTINSVQSLSHYITQ 442
Query: 178 SLSGPVPSNLNNLTSVNDLYLSNNKLTG----AMPNLTGLSVLSYLDMSNNSFDASEVPS 233
P+ N VN+L +LT L GL ++ +
Sbjct: 443 QGGVPLQGNEQLEAEVNELRAEVQQLTNEQIQQEQLLQGLHAEIDTNLRRYRLPKDGLAR 502
Query: 234 WFSSMQSLTTLMMENTNLKGQIPADLFS-----IPHLQTVVMKTNELNGTLDLGTSYSEN 288
++ + T + E K + + + + + L LD +
Sbjct: 503 SSDNLNKVFTHLKERQAFKLRETQARRTEADAKQKETEDLEQENIALEKQLDNKRAKQAE 562
Query: 289 LL--VNLQNNRISAYTER 304
L +L+ ++ +
Sbjct: 563 LRQETSLKRQKVKQLEAK 580
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 60/229 (26%), Positives = 94/229 (41%), Gaps = 51/229 (22%)
Query: 564 GSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFD 622
GSG + +V+ G+L A+K ++ + EI +L ++ H+N+V+L
Sbjct: 18 GSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYES 77
Query: 623 RGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALG------AAR-------GLSYL 669
L+ + V G L D I + G A+ + YL
Sbjct: 78 TTHYYLVMQLVSGGEL-----------FDRI----LERGVYTEKDASLVIQQVLSAVKYL 122
Query: 670 HELANPPIIHRDIKSSNILL---DERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLD 726
HE I+HRD+K N+L +E + DFGLSK E++ I + GT GY+
Sbjct: 123 HENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKM----EQNGIMSTACGTPGYVA 175
Query: 727 PEYYMTQQLTEKSDVYSFGVLMLELLTGRRP------------IERGKY 763
PE + ++ D +S GV+ LL G P I+ G Y
Sbjct: 176 PEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYY 224
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 60/264 (22%), Positives = 89/264 (33%), Gaps = 67/264 (25%)
Query: 563 VGSGGYGKVYKGT-LPNGQLIAIK-----RAQQGSMQGGQEFKMEIELLSRVHHKNLVSL 616
+G G YG V + AIK + +Q + + + K E+ L+ ++HH N+ L
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 617 LGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALG--------------- 661
D L+ E G L D L+ +
Sbjct: 94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 662 ----------------AAR-------GLSYLHELANPPIIHRDIKSSNILLDERLNA--K 696
+ L YLH I HRDIK N L + K
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG---ICHRDIKPENFLFSTNKSFEIK 210
Query: 697 VADFGLSK---SMSDSEKDHITTQVKGTMGYLDPE--YYMTQQLTEKSDVYSFGVLMLEL 751
+ DFGLSK +++ E +TT+ GT ++ PE + K D +S GVL+ L
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKA-GTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLL 269
Query: 752 LTGRRP------------IERGKY 763
L G P + K
Sbjct: 270 LMGAVPFPGVNDADTISQVLNKKL 293
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 59/233 (25%), Positives = 97/233 (41%), Gaps = 49/233 (21%)
Query: 564 GSGGYGKVYKGT-LPNGQLIAIK---RAQQGSMQGGQE-FKMEIELLSRVHHKNLVSLLG 618
G G YGKV + A+K + + + G+ K EI+LL R+ HKN++ L+
Sbjct: 14 GEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVD 73
Query: 619 FCFDRGEQM--LIYEFVPNGS--LGDSLSGKNGIRLDWIRRLKIALGAAR--------GL 666
++ +Q ++ E+ G + DS+ K R + A GL
Sbjct: 74 VLYNEEKQKMYMVMEYCVCGMQEMLDSVPEK---------RFPVC--QAHGYFCQLIDGL 122
Query: 667 SYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHI--TTQVKGTMGY 724
YLH I+H+DIK N+LL K++ G+++++ D T+Q G+ +
Sbjct: 123 EYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ--GSPAF 177
Query: 725 LDPEYYMTQQLTE--KSDVYSFGVLMLELLTGRRP------------IERGKY 763
PE K D++S GV + + TG P I +G Y
Sbjct: 178 QPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSY 230
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 3e-25
Identities = 59/275 (21%), Positives = 113/275 (41%), Gaps = 31/275 (11%)
Query: 511 QKRRAEKANEQNPFAHWDMNKSSGS-IPQLKGARCFSFEEVKKYTNNFSDANDV----GS 565
++RR +EQ SS + + + V+ ++ D D+ G+
Sbjct: 108 KRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGT 167
Query: 566 GGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRG 624
G +G V++ T G A K + + EI+ +S + H LV+L D
Sbjct: 168 GAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDN 227
Query: 625 EQMLIYEFVPNGSLGDSLSGKNGI--RLDWIRRLKIALGAARGLSYLHELANPPIIHRDI 682
E ++IYEF+ G L + ++ ++ + + ++ GL ++HE +H D+
Sbjct: 228 EMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCK---GLCHMHENN---YVHLDL 281
Query: 683 KSSNILLDERLNA--KVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSD 740
K NI+ + + K+ DFGL+ + + + GT + PE + + +D
Sbjct: 282 KPENIMFTTKRSNELKLIDFGLTAHLDPKQS--VKVTT-GTAEFAAPEVAEGKPVGYYTD 338
Query: 741 VYSFGVLMLELLTGRRP------------IERGKY 763
++S GVL LL+G P ++ +
Sbjct: 339 MWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDW 373
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-25
Identities = 59/214 (27%), Positives = 100/214 (46%), Gaps = 18/214 (8%)
Query: 564 GSGGYGKVYKGT-LPNGQLIAIK---RAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGF 619
G G YG+V + +A+K + + K EI + ++H+N+V G
Sbjct: 16 GEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEICINKMLNHENVVKFYGH 73
Query: 620 CFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRL---KIALGAARGLSYLHELANPP 676
+ Q L E+ G L D + G+ +R +A G+ YLH +
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-----GVVYLHGIG--- 125
Query: 677 IIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLT 736
I HRDIK N+LLDER N K++DFGL+ + ++ + ++ GT+ Y+ PE ++
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 737 -EKSDVYSFGVLMLELLTGRRPIERGKYIVREIR 769
E DV+S G+++ +L G P ++ +E
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS 219
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 4e-25
Identities = 57/259 (22%), Positives = 94/259 (36%), Gaps = 67/259 (25%)
Query: 551 KKYTNNFSDA----NDVGSGGYGKVYKGT-LPNGQLIAIK---------RAQQGSMQGGQ 596
T+ F + +G G V + P + A+K + + + +
Sbjct: 9 SHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELRE 68
Query: 597 EFKMEIELLSRV-HHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRR 655
E+++L +V H N++ L L+++ + G L D++
Sbjct: 69 ATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL-----------FDYL-- 115
Query: 656 LKIALG------AAR-------GLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGL 702
+ + LH+L I+HRD+K NILLD+ +N K+ DFG
Sbjct: 116 --TEKVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGF 170
Query: 703 SKSMSDSEKDHITTQVKGTMGYLDPE------YYMTQQLTEKSDVYSFGVLMLELLTGRR 756
S + EK + GT YL PE ++ D++S GV+M LL G
Sbjct: 171 SCQLDPGEK--LREVC-GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP 227
Query: 757 P------------IERGKY 763
P I G Y
Sbjct: 228 PFWHRKQMLMLRMIMSGNY 246
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 4e-25
Identities = 53/230 (23%), Positives = 87/230 (37%), Gaps = 51/230 (22%)
Query: 563 VGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCF 621
+G G +G+V A K+ + ++ FK EIE++ + H N++ L
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 76
Query: 622 DRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALG------AAR-------GLSY 668
D + L+ E G L + + + AAR ++Y
Sbjct: 77 DNTDIYLVMELCTGGEL-----------FERV----VHKRVFRESDAARIMKDVLSAVAY 121
Query: 669 LHELANPPIIHRDIKSSNILL---DERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYL 725
H+L + HRD+K N L K+ DFGL+ + + T+V GT Y+
Sbjct: 122 CHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM--MRTKV-GTPYYV 175
Query: 726 DPEYYMTQQLTEKSDVYSFGVLMLELLTGRRP------------IERGKY 763
P+ + + D +S GV+M LL G P I G +
Sbjct: 176 SPQ-VLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTF 224
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 6e-25
Identities = 65/231 (28%), Positives = 98/231 (42%), Gaps = 53/231 (22%)
Query: 564 GSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQE--FKMEIELLSRVHHKNLVSLLGFC 620
G G +G+V K Q A+K + S + E+ELL ++ H N++ L
Sbjct: 31 GKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEIL 90
Query: 621 FDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALG------AAR-------GLS 667
D ++ E G L D I I AAR G++
Sbjct: 91 EDSSSFYIVGELYTGGEL-----------FDEI----IKRKRFSEHDAARIIKQVFSGIT 135
Query: 668 YLHELANPPIIHRDIKSSNILL---DERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGY 724
Y+H+ I+HRD+K NILL ++ + K+ DFGLS + K + ++ GT Y
Sbjct: 136 YMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK--MKDRI-GTAYY 189
Query: 725 LDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRP------------IERGKY 763
+ PE + EK DV+S GV++ LL+G P +E GKY
Sbjct: 190 IAPE-VLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKY 239
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 7e-25
Identities = 63/282 (22%), Positives = 121/282 (42%), Gaps = 36/282 (12%)
Query: 503 LAGVYAYHQKRRAEKANEQNPFAHWDMNKSSGSIPQLKGARCFSFEEVKKYTNNFSDAND 562
+ G + +H + P + D +K I + + + V+ + D D
Sbjct: 1 MRGSHHHHHHGSKVRGKYDGPKIN-DYDKFYEDI-----WKKYVPQPVEVKQGSVYDYYD 54
Query: 563 V----GSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLL 617
+ GSG +G V++ G++ K K EI +++++HH L++L
Sbjct: 55 ILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLH 114
Query: 618 GFCFDRGEQMLIYEFVPNGSLGDSLSGKNGI--RLDWIRRLKIALGAARGLSYLHELANP 675
D+ E +LI EF+ G L D ++ ++ + I ++ A GL ++HE +
Sbjct: 115 DAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACE---GLKHMHEHS-- 169
Query: 676 PIIHRDIKSSNILLDERLNA--KVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQ 733
I+H DIK NI+ + + + K+ DFGL+ ++ E + T + PE +
Sbjct: 170 -IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI--VKVTT-ATAEFAAPEIVDRE 225
Query: 734 QLTEKSDVYSFGVLMLELLTGRRP------------IERGKY 763
+ +D+++ GVL LL+G P ++R +
Sbjct: 226 PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDW 267
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-24
Identities = 65/271 (23%), Positives = 105/271 (38%), Gaps = 48/271 (17%)
Query: 532 SSGSIPQLKGARCFSF-------EEVKKYTNNFSDANDV----GSGGYGKVYKGT-LPNG 579
++ S L +R F ++ Y D + GSG G+V
Sbjct: 101 NNNSEIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTC 160
Query: 580 QLIAIK--------RAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYE 631
+ +AI+ + EIE+L +++H ++ + F FD + ++ E
Sbjct: 161 KKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLE 219
Query: 632 FVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILL-- 689
+ G L D + G ++ + + + YLHE IIHRD+K N+LL
Sbjct: 220 LMEGGELFDKVVGNKRLKEATCKLYFYQM--LLAVQYLHENG---IIHRDLKPENVLLSS 274
Query: 690 -DERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPE---YYMTQQLTEKSDVYSFG 745
+E K+ DFG SK + ++ + T GT YL PE T D +S G
Sbjct: 275 QEEDCLIKITDFGHSKILGETSL--MRTLC-GTPTYLAPEVLVSVGTAGYNRAVDCWSLG 331
Query: 746 VLMLELLTGRRP-------------IERGKY 763
V++ L+G P I GKY
Sbjct: 332 VILFICLSGYPPFSEHRTQVSLKDQITSGKY 362
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 1e-24
Identities = 54/258 (20%), Positives = 94/258 (36%), Gaps = 66/258 (25%)
Query: 551 KKYTNNFSDA----NDVGSGGYGKVYKGT-LPNGQLIAIK-------RAQQGSMQGGQE- 597
F + +G G V + G A+K R ++ +E
Sbjct: 86 WAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREA 145
Query: 598 FKMEIELLSRVH-HKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRL 656
+ E +L +V H ++++L+ L+++ + G L D++
Sbjct: 146 TRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGEL-----------FDYL--- 191
Query: 657 KIALG------AAR-------GLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLS 703
+S+LH I+HRD+K NILLD+ + +++DFG S
Sbjct: 192 -TEKVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFS 247
Query: 704 KSMSDSEKDHITTQVKGTMGYLDPE------YYMTQQLTEKSDVYSFGVLMLELLTGRRP 757
+ EK + GT GYL PE ++ D+++ GV++ LL G P
Sbjct: 248 CHLEPGEK--LRELC-GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304
Query: 758 ------------IERGKY 763
I G+Y
Sbjct: 305 FWHRRQILMLRMIMEGQY 322
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-24
Identities = 63/230 (27%), Positives = 103/230 (44%), Gaps = 38/230 (16%)
Query: 547 FEEVKKYT-NNFSDANDVGSGGYGKVY----KGTLPNGQLIAIK---------RAQQGSM 592
F+E + ++F +G G +GKV T ++ A+K R + ++
Sbjct: 6 FDENEDVNFDHFEILRAIGKGSFGKVCIVQKNDT---KKMYAMKYMNKQKCVERNEVRNV 62
Query: 593 QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQM-LIYEFVPNGSLGDSLSGKNGIRLD 651
E++++ + H LV+L + F E M ++ + + G L L +N +
Sbjct: 63 ------FKELQIMQGLEHPFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHLQ-QNVHFKE 114
Query: 652 WIRRLKIA-LGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE 710
+L I L A L YL IIHRD+K NILLDE + + DF ++ +
Sbjct: 115 ETVKLFICELVMA--LDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET 169
Query: 711 KDHITTQVKGTMGYLDPEYYMTQQLTEKS---DVYSFGVLMLELLTGRRP 757
+ T + GT Y+ PE + +++ S D +S GV ELL GRRP
Sbjct: 170 Q---ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 62/229 (27%), Positives = 96/229 (41%), Gaps = 43/229 (18%)
Query: 564 GSGGYGKVYKGT-LPNGQLIAIKR------AQQGSMQGGQEFKMEIELLSRVHHK--NLV 614
GSGG+G VY G + + +AIK + G + G ME+ LL +V ++
Sbjct: 52 GSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVI 111
Query: 615 SLLGFCFDRGEQMLIYEFV-PNGSLGDSLSGKNGIRLDWIRRLKIALGAAR--------G 665
LL + +LI E P L D ++ + L+ L AR
Sbjct: 112 RLLDWFERPDSFVLILERPEPVQDLFDFITER--------GALQEEL--ARSFFWQVLEA 161
Query: 666 LSYLHELANPPIIHRDIKSSNILLD-ERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGY 724
+ + H ++HRDIK NIL+D R K+ DFG + D+ T GT Y
Sbjct: 162 VRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFD-GTRVY 214
Query: 725 LDPEYYMTQQLT-EKSDVYSFGVLMLELLTGRRP------IERGKYIVR 766
PE+ + + V+S G+L+ +++ G P I RG+ R
Sbjct: 215 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 263
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-24
Identities = 57/247 (23%), Positives = 105/247 (42%), Gaps = 42/247 (17%)
Query: 545 FSFEEVKKYTNNFSD------ANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQE 597
F V + +G G +G+V+K G +A K + M+ +E
Sbjct: 73 FDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEE 132
Query: 598 FKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSL-------GDSLSGKNGIRL 650
K EI +++++ H NL+ L + + +L+ E+V G L +L+ + I
Sbjct: 133 VKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILF 192
Query: 651 DWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNA--KVADFGLSKSMSD 708
++++ G+ ++H++ I+H D+K NIL R K+ DFGL++
Sbjct: 193 --MKQI------CEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP 241
Query: 709 SEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRP----------- 757
EK + GT +L PE ++ +D++S GV+ LL+G P
Sbjct: 242 REK--LKVNF-GTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLN 298
Query: 758 -IERGKY 763
I ++
Sbjct: 299 NILACRW 305
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 58/245 (23%), Positives = 98/245 (40%), Gaps = 56/245 (22%)
Query: 554 TNNFSDA----NDVGSGGYGKVYKGT-LPNGQLIAIK--RAQQGSMQGGQEFKMEIELLS 606
+ FSD ++G G + V + G A K ++ S + Q+ + E +
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60
Query: 607 RVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALG----- 661
++ H N+V L + L+++ V G L + I +A
Sbjct: 61 KLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL-----------FEDI----VAREFYSEA 105
Query: 662 -AAR-------GLSYLHELANPPIIHRDIKSSNILL---DERLNAKVADFGLSKSMSDSE 710
A+ ++Y H I+HR++K N+LL + K+ADFGL+ ++DSE
Sbjct: 106 DASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE 162
Query: 711 KDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRP------------I 758
GT GYL PE ++ D+++ GV++ LL G P I
Sbjct: 163 A--WHGFA-GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 219
Query: 759 ERGKY 763
+ G Y
Sbjct: 220 KAGAY 224
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 5e-24
Identities = 62/229 (27%), Positives = 99/229 (43%), Gaps = 43/229 (18%)
Query: 564 GSGGYGKVYKGT-LPNGQLIAIK----RAQQGSMQGG--QEFKMEIELLSRVHHKNLVSL 616
GSG + V K G A K R + S +G +E + E+ +L +V H N+++L
Sbjct: 21 GSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITL 80
Query: 617 LGFCFDRGEQMLIYEFVPNGSLGD------SLSGKNGIRLDWIRRLKIALGAARGLSYLH 670
+R + +LI E V G L D SLS + I+++ G++YLH
Sbjct: 81 HDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF--IKQI------LDGVNYLH 132
Query: 671 ELANPPIIHRDIKSSNILL----DERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLD 726
I H D+K NI+L + K+ DFGL+ + D + + GT ++
Sbjct: 133 TKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFGTPEFVA 186
Query: 727 PEYYMTQQLTEKSDVYSFGVLMLELLTGRRP------------IERGKY 763
PE + L ++D++S GV+ LL+G P I Y
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSY 235
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 5e-24
Identities = 59/241 (24%), Positives = 89/241 (36%), Gaps = 63/241 (26%)
Query: 564 GSGGYGKVYKGT-LPNGQLIAIK--------RAQQGSMQGGQEFKMEIELLSRVHHKNLV 614
GSG G+V + +AIK + EIE+L +++H ++
Sbjct: 19 GSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCII 78
Query: 615 SLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALG------AAR---- 664
+ F FD + ++ E + G L D + +
Sbjct: 79 KIKNF-FDAEDYYIVLELMEGGEL-----------FDKV----VGNKRLKEATCKLYFYQ 122
Query: 665 ---GLSYLHELANPPIIHRDIKSSNILL---DERLNAKVADFGLSKSMSDSEKDHITTQV 718
+ YLHE IIHRD+K N+LL +E K+ DFG SK + ++ + T
Sbjct: 123 MLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL--MRTLC 177
Query: 719 KGTMGYLDPE---YYMTQQLTEKSDVYSFGVLMLELLTGRRP-------------IERGK 762
GT YL PE T D +S GV++ L+G P I GK
Sbjct: 178 -GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGK 236
Query: 763 Y 763
Y
Sbjct: 237 Y 237
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 9e-24
Identities = 52/228 (22%), Positives = 90/228 (39%), Gaps = 39/228 (17%)
Query: 564 GSGGYGKVYKGT-LPNGQLIAIK-----RAQQGSMQGGQEFKMEIELLSRVHHKNLVSLL 617
G G + V + GQ A+K + ++ K E + + H ++V LL
Sbjct: 33 GKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELL 92
Query: 618 GFCFDRGEQMLIYEFVPNGSLGDSL--SGKNGIRL------DWIRRLKIALGAARGLSYL 669
G +++EF+ L + G ++R++ L A L Y
Sbjct: 93 ETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQI---LEA---LRYC 146
Query: 670 HELANPPIIHRDIKSSNILL---DERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLD 726
H+ IIHRD+K +LL + K+ FG++ + +S + GT ++
Sbjct: 147 HDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGL--VAGGRVGTPHFMA 201
Query: 727 PEYYMTQQLTEKSDVYSFGVLMLELLTGRRP-----------IERGKY 763
PE + + DV+ GV++ LL+G P I +GKY
Sbjct: 202 PEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKY 249
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-23
Identities = 53/231 (22%), Positives = 92/231 (39%), Gaps = 51/231 (22%)
Query: 564 GSGGYGKVYKGT-LPNGQLIAIK--RAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFC 620
G G + V + + GQ A ++ S + Q+ + E + + H N+V L
Sbjct: 20 GKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSI 79
Query: 621 FDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALG------AAR-------GLS 667
+ G LI++ V G L + I +A A+ +
Sbjct: 80 SEEGHHYLIFDLVTGGEL-----------FEDI----VAREYYSEADASHCIQQILEAVL 124
Query: 668 YLHELANPPIIHRDIKSSNILL---DERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGY 724
+ H++ ++HR++K N+LL + K+ADFGL+ + + E+ GT GY
Sbjct: 125 HCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEV-EGEQQAWFGFA-GTPGY 179
Query: 725 LDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRP------------IERGKY 763
L PE + D+++ GV++ LL G P I+ G Y
Sbjct: 180 LSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAY 230
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 53/222 (23%), Positives = 90/222 (40%), Gaps = 31/222 (13%)
Query: 564 GSGGYGKVYKGT-LPNGQLIAIK--RAQQGSMQGGQEFKMEIELLSRV-HHKNLVSLLGF 619
G G + V + GQ A K + ++ E EI +L +++L
Sbjct: 38 GRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEV 97
Query: 620 CFDRGEQMLIYEFVPNGSLGDSLSGKNGIRL---DWIRRLKIALGAARGLSYLHELANPP 676
+ E +LI E+ G + + + D IR +K L G+ YLH+
Sbjct: 98 YENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILE---GVYYLHQNN--- 151
Query: 677 IIHRDIKSSNILL---DERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQ 733
I+H D+K NILL + K+ DFG+S+ + + + + + GT YL PE
Sbjct: 152 IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE--LREIM-GTPEYLAPEILNYD 208
Query: 734 QLTEKSDVYSFGVLMLELLTGRRP------------IERGKY 763
+T +D+++ G++ LLT P I +
Sbjct: 209 PITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNV 250
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 2e-23
Identities = 62/229 (27%), Positives = 98/229 (42%), Gaps = 43/229 (18%)
Query: 564 GSGGYGKVYKGT-LPNGQLIAIK----RAQQGSMQGG--QEFKMEIELLSRVHHKNLVSL 616
GSG + V K G A K R + S +G +E + E+ +L +V H N+++L
Sbjct: 21 GSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITL 80
Query: 617 LGFCFDRGEQMLIYEFVPNGSLGD------SLSGKNGIRLDWIRRLKIALGAARGLSYLH 670
+R + +LI E V G L D SLS + I+++ G++YLH
Sbjct: 81 HDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF--IKQI------LDGVNYLH 132
Query: 671 ELANPPIIHRDIKSSNILL----DERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLD 726
I H D+K NI+L + K+ DFGL+ + D + GT ++
Sbjct: 133 TKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE--FKNIF-GTPEFVA 186
Query: 727 PEYYMTQQLTEKSDVYSFGVLMLELLTGRRP------------IERGKY 763
PE + L ++D++S GV+ LL+G P I Y
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSY 235
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 57/228 (25%), Positives = 90/228 (39%), Gaps = 45/228 (19%)
Query: 564 GSGGYGKVYKGT-LPNGQLIAIKR------AQQGSMQGGQEFKMEIELLSRVH----HKN 612
G GG+G V+ G L + +AIK + +E+ LL +V H
Sbjct: 40 GKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPG 99
Query: 613 LVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWI-RRLKIALGAAR------- 664
++ LL + + ML+ E D L D+I + + G +R
Sbjct: 100 VIRLLDWFETQEGFMLVLERPLPA--QD-L-------FDYITEKGPLGEGPSRCFFGQVV 149
Query: 665 -GLSYLHELANPPIIHRDIKSSNILLD-ERLNAKVADFGLSKSMSDSEKDHITTQVKGTM 722
+ + H ++HRDIK NIL+D R AK+ DFG + D T GT
Sbjct: 150 AAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE---PYTDFD-GTR 202
Query: 723 GYLDPEYYMTQQLT-EKSDVYSFGVLMLELLTGRRP------IERGKY 763
Y PE+ Q + V+S G+L+ +++ G P I +
Sbjct: 203 VYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILEAEL 250
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-23
Identities = 47/269 (17%), Positives = 89/269 (33%), Gaps = 18/269 (6%)
Query: 13 GLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLN 72
L L TL L +N+ L+ L L+ L + + L L L +
Sbjct: 78 NLFNLRTLGLRSNR-LKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVG 136
Query: 73 SNGFSGRVPPSI-GNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLS 131
N + L++L L L L + L L ++
Sbjct: 137 DNDLV-YISHRAFSGLNSLEQLTLEKCNLTS---IPTEALSHLHGL---IVLRLRHLNIN 189
Query: 132 GSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSN-LNNL 190
+I + F+ L + + +L + +L+ VP + +L
Sbjct: 190 -AIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTA-VPYLAVRHL 247
Query: 191 TSVNDLYLSNNKLTGAMPN-LTGLSVLSYLDMSNNSFDASEVPS-WFSSMQSLTTLMMEN 248
+ L LS N ++ + L L L + + + V F + L L +
Sbjct: 248 VYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQL--AVVEPYAFRGLNYLRVLNVSG 305
Query: 249 TNLKGQIPADLF-SIPHLQTVVMKTNELN 276
L + +F S+ +L+T+++ +N L
Sbjct: 306 NQLT-TLEESVFHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 7e-23
Identities = 68/315 (21%), Positives = 118/315 (37%), Gaps = 24/315 (7%)
Query: 15 TELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSN 74
TE LDL N+ ++ + L L L S P + +L L L L SN
Sbjct: 32 TETRLLDLGKNR-IKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSN 90
Query: 75 GFSGRVPPSI-GNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGS 133
+P + LSNL LD+++NK+ + D L L K G N L
Sbjct: 91 RLK-LIPLGVFTGLSNLTKLDISENKIVI---LLDYMFQDLYNL---KSLEVGDNDLV-Y 142
Query: 134 IPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSV 193
I + F L + + NLT L + L V+R +++ + L +
Sbjct: 143 ISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRL 202
Query: 194 NDLYLSNNKLTGAMPN--LTGLSVLSYLDMSNNSFDASEVPSW-FSSMQSLTTLMMENTN 250
L +S+ M L GL+ L+ L +++ + + VP + L L +
Sbjct: 203 KVLEISHWPYLDTMTPNCLYGLN-LTSLSITHCNL--TAVPYLAVRHLVYLRFLNLSYNP 259
Query: 251 LKGQIPADLFS-IPHLQTVVMKTNELNGTLDLGT-SYSENL-LVNLQNNRISAYTERGGA 307
+ I + + LQ + + +L ++ L ++N+ N+++ E
Sbjct: 260 IS-TIEGSMLHELLRLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQLTTLEESVFH 317
Query: 308 PAVNLTLID---NPI 319
NL + NP+
Sbjct: 318 SVGNLETLILDSNPL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 3e-19
Identities = 47/248 (18%), Positives = 84/248 (33%), Gaps = 16/248 (6%)
Query: 56 IPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLD 115
+P+ I E LL L N + +L L+L +N + V G L
Sbjct: 26 VPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSA---VEPGAFNNLF 80
Query: 116 MLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFD 175
L + N+L IP +F L + N + L + +L+ +
Sbjct: 81 NL---RTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVG 136
Query: 176 RNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPN-LTGLSVLSYLDMSNNSFDASEVPSW 234
N L + L S+ L L LT L+ L L L + + + + + +
Sbjct: 137 DNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNI--NAIRDY 194
Query: 235 -FSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGT-SYSENL-LV 291
F + L L + + + + +L ++ + L + + L +
Sbjct: 195 SFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFL 253
Query: 292 NLQNNRIS 299
NL N IS
Sbjct: 254 NLSYNPIS 261
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 2e-15
Identities = 39/220 (17%), Positives = 70/220 (31%), Gaps = 33/220 (15%)
Query: 8 SGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELV 67
+GL L L L L + +L L L L + + S L L
Sbjct: 145 HRAFSGLNSLEQLTLEKCN-LTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLK 203
Query: 68 LLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGK 127
+L ++ + + P+ NL L +T L +P + LV + +
Sbjct: 204 VLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVP-----YLAVRHLVYLRFLNLSY 257
Query: 128 NQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNL 187
N +S +I + L L+ ++ L+ P
Sbjct: 258 NPIS-TIEGSMLH-------------ELL-----------RLQEIQLVGGQLAVVEPYAF 292
Query: 188 NNLTSVNDLYLSNNKLTGAMPNL-TGLSVLSYLDMSNNSF 226
L + L +S N+LT ++ + L L + +N
Sbjct: 293 RGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 6e-11
Identities = 39/173 (22%), Positives = 73/173 (42%), Gaps = 14/173 (8%)
Query: 133 SIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTS 192
++PE + + N + LE + + N +S P NNL +
Sbjct: 25 AVPEGIPTE---TRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFN 81
Query: 193 VNDLYLSNNKLTGAMPN--LTGLSVLSYLDMSNNSFDASEVPS-WFSSMQSLTTLMMENT 249
+ L L +N+L +P TGLS L+ LD+S N + F + +L +L + +
Sbjct: 82 LRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKI--VILLDYMFQDLYNLKSLEVGDN 138
Query: 250 NLKGQIPADLFS-IPHLQTVVMKTNELNGTLDLGT-SYSENLLV-NLQNNRIS 299
+L I FS + L+ + ++ L ++ S+ L+V L++ I+
Sbjct: 139 DLV-YISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNIN 189
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 7e-05
Identities = 27/151 (17%), Positives = 52/151 (34%), Gaps = 36/151 (23%)
Query: 7 LSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQEL 66
++ + L +L +++ NL + ++ L L
Sbjct: 216 MTPNCLYGLNLTSLSITHC------------NLTAVP-------------YLAVRHLVYL 250
Query: 67 VLLSLNSNGFSGRVPPSI-GNLSNLYWLDLTDNKLEGEIPVSDGNSPG-LDMLVRAKHFH 124
L+L+ N S + S+ L L + L +L + P L + +
Sbjct: 251 RFLNLSYNPIS-TIEGSMLHELLRLQEIQLVGGQLA-VVE------PYAFRGLNYLRVLN 302
Query: 125 FGKNQLSGSIPEKLFRPDMVLIHVLFDSNNL 155
NQL+ ++ E +F L ++ DSN L
Sbjct: 303 VSGNQLT-TLEESVFHSVGNLETLILDSNPL 332
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 3e-23
Identities = 60/251 (23%), Positives = 97/251 (38%), Gaps = 56/251 (22%)
Query: 548 EEVKKYTNNFSDANDV----GSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGG--QEFKM 600
E + + FSD DV G G + V + G A K + Q+ +
Sbjct: 18 EFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLER 77
Query: 601 EIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIAL 660
E + ++ H N+V L + L+++ V G L + I +A
Sbjct: 78 EARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL-----------FEDI----VAR 122
Query: 661 G------AAR-------GLSYLHELANPPIIHRDIKSSNILL---DERLNAKVADFGLSK 704
A+ ++Y H I+HR++K N+LL + K+ADFGL+
Sbjct: 123 EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAI 179
Query: 705 SMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRP------- 757
++DSE GT GYL PE ++ D+++ GV++ LL G P
Sbjct: 180 EVNDSEA--WHGFA-GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH 236
Query: 758 -----IERGKY 763
I+ G Y
Sbjct: 237 RLYAQIKAGAY 247
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 43/227 (18%), Positives = 86/227 (37%), Gaps = 45/227 (19%)
Query: 563 VGSGGYGKVYKGT-LPNGQLIAIK----RAQQGSMQGGQEFKMEIELLSRVHHKNLVSLL 617
+G G +G V++ + + K + K EI +L+ H+N++ L
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ-----VLVKKEISILNIARHRNILHLH 67
Query: 618 GFCFDRGEQMLIYEFVPNGSL-------GDSLSGKNGIRLDWIRRLKIALGAARGLSYLH 670
E ++I+EF+ + L+ + + + ++ L +LH
Sbjct: 68 ESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSY--VHQV------CEALQFLH 119
Query: 671 ELANPPIIHRDIKSSNILLDERLNA--KVADFGLSKSMSDSEKDHITTQVKGTMGYLDPE 728
I H DI+ NI+ R ++ K+ +FG ++ + + Y PE
Sbjct: 120 SHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN--FRLLF-TAPEYYAPE 173
Query: 729 YYMTQQLTEKSDVYSFGVLMLELLTGRRP------------IERGKY 763
+ ++ +D++S G L+ LL+G P I +Y
Sbjct: 174 VHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEY 220
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 4e-23
Identities = 56/229 (24%), Positives = 94/229 (41%), Gaps = 43/229 (18%)
Query: 564 GSGGYGKVYKGT-LPNGQLIAIK----RAQQGSMQGG--QEFKMEIELLSRVHHKNLVSL 616
GSG + V K G+ A K R S +G +E + E+ +L + H N+++L
Sbjct: 14 GSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITL 73
Query: 617 LGFCFDRGEQMLIYEFVPNGSLGD------SLSGKNGIRLDWIRRLKIALGAARGLSYLH 670
++ + +LI E V G L D SL+ + ++++ G+ YLH
Sbjct: 74 HDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQF--LKQI------LDGVHYLH 125
Query: 671 ELANPPIIHRDIKSSNILL----DERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLD 726
I H D+K NI+L K+ DFG++ + + GT ++
Sbjct: 126 SKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE--FKNIF-GTPEFVA 179
Query: 727 PEYYMTQQLTEKSDVYSFGVLMLELLTGRRP------------IERGKY 763
PE + L ++D++S GV+ LL+G P I Y
Sbjct: 180 PEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNY 228
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 7e-23
Identities = 65/296 (21%), Positives = 104/296 (35%), Gaps = 66/296 (22%)
Query: 506 VYAYHQKRRAEKANEQNPFAHWDMNKSSGSIPQLKGARCFSFEEVKKYTNNFSDANDV-- 563
++ +H +N + + ++ + P + + + SD +V
Sbjct: 1 MHHHHHHSSGVDLGTENLYFQSMSSVTASAAPG-TASLVPDYWIDGSNRDALSDFFEVES 59
Query: 564 --GSGGYGKVYKGT-LPNGQLIAI----KRAQQGSMQGGQEFKMEIELLSRVHHKNLVSL 616
G G VY+ + A+ K + + + EI +L R+ H N++ L
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK------KIVRTEIGVLLRLSHPNIIKL 113
Query: 617 LGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALG------AAR------ 664
E L+ E V G L D I + G AA
Sbjct: 114 KEIFETPTEISLVLELVTGGEL-----------FDRI----VEKGYYSERDAADAVKQIL 158
Query: 665 -GLSYLHELANPPIIHRDIKSSNILL---DERLNAKVADFGLSKSMSDSEKDHITTQVKG 720
++YLHE I+HRD+K N+L K+ADFGLSK + + T G
Sbjct: 159 EAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL--MKTVC-G 212
Query: 721 TMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRP-------------IERGKY 763
T GY PE + D++S G++ LL G P I +Y
Sbjct: 213 TPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEY 268
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 7e-23
Identities = 57/245 (23%), Positives = 95/245 (38%), Gaps = 30/245 (12%)
Query: 528 DMNKSSGSIPQLKGARCFSFEEVKKYT-NNFSDANDVGSGGYGKVYKGTL-PNGQLIAIK 585
D + + +K +F +G G + V + AIK
Sbjct: 2 DGTAAEPRPGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIK 61
Query: 586 RAQQGSMQGGQEF---KMEIELLSRVHHKNLVSLLGFCF-DRGEQMLIYEFVPNGSLGDS 641
++ + + E +++SR+ H V L F F D + + NG L
Sbjct: 62 ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGEL--- 117
Query: 642 LSGKNGIRLDWIRRL-KIALGAAR--------GLSYLHELANPPIIHRDIKSSNILLDER 692
L +IR++ R L YLH IIHRD+K NILL+E
Sbjct: 118 --------LKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNED 166
Query: 693 LNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELL 752
++ ++ DFG +K +S K GT Y+ PE + + SD+++ G ++ +L+
Sbjct: 167 MHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 226
Query: 753 TGRRP 757
G P
Sbjct: 227 AGLPP 231
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 7e-23
Identities = 50/325 (15%), Positives = 94/325 (28%), Gaps = 40/325 (12%)
Query: 8 SGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELV 67
+ I L L L++++N LP NL L +L L + L ++
Sbjct: 117 NFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMP 176
Query: 68 L---------------------------LSLNSNGFSGRVPP-SIGNLSNLYWLDLTDNK 99
L L+L +N S V I L+ L L +
Sbjct: 177 LLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGE 236
Query: 100 LEGEIPVSDGNSPGLDML--VRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTG 157
E + + L+ L + + F LF + S +
Sbjct: 237 FRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE- 295
Query: 158 ELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLS 217
+ + + L +L L ++NK A + L L
Sbjct: 296 RVKDFSYN-FGWQHLELVNCKFGQFPTLKLKSLKR---LTFTSNKGGNA-FSEVDLPSLE 350
Query: 218 YLDMSNNSFDASEVPS-WFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELN 276
+LD+S N S SL L + + + ++ + L+ + + + L
Sbjct: 351 FLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK 409
Query: 277 GTLDLGTSYSENLLV--NLQNNRIS 299
+ S L+ ++ +
Sbjct: 410 QMSEFSVFLSLRNLIYLDISHTHTR 434
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 8e-21
Identities = 59/297 (19%), Positives = 100/297 (33%), Gaps = 29/297 (9%)
Query: 17 LHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSG------PIPDSIGSLQELVLLS 70
LH L L NN D + T I L L LV F ++ L L +
Sbjct: 202 LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEE 261
Query: 71 LNSNG---FSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGK 127
+ + L+N+ L +E + + + +
Sbjct: 262 FRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVK----DFSYNFGWQHLELVNCKF 316
Query: 128 NQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLS--GPVPS 185
Q + L L ++N G + + L SLE + RN LS G
Sbjct: 317 GQFPTLKLKSL--------KRLTFTSNKGGNAFSEVDL-PSLEFLDLSRNGLSFKGCCSQ 367
Query: 186 NLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLM 245
+ TS+ L LS N + N GL L +LD +++ S F S+++L L
Sbjct: 368 SDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLD 427
Query: 246 MENTNLKGQIPADLFS-IPHLQTVVMKTNELNGTLDLGTSYS-ENLLV-NLQNNRIS 299
+ +T+ + +F+ + L+ + M N NL +L ++
Sbjct: 428 ISHTHTRV-AFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE 483
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 2e-19
Identities = 45/307 (14%), Positives = 98/307 (31%), Gaps = 28/307 (9%)
Query: 8 SGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELV 67
S EL LDLS + ++ +L LS L+L G + L L
Sbjct: 45 SYSFFSFPELQVLDLSRCE-IQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQ 103
Query: 68 LLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGK 127
L + IG+L L L++ N ++ S L +H
Sbjct: 104 KLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ-----SFKLPEYFSNLTNLEHLDLSS 158
Query: 128 NQLSGSIPEKLFRP----DMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPV 183
N++ SI R ++ + + N + + L + N S V
Sbjct: 159 NKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLHKLTLRNNFDSLNV 216
Query: 184 P-------SNLNNLTSVNDLYLSNNKLT----GAMPNLTGLSVLSYLDMSNNSFDASEVP 232
+ L V + + L A+ L L+ + ++ + ++
Sbjct: 217 MKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLT-IEEFRLAYLDYYLDDII 275
Query: 233 SWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENLLVN 292
F+ + ++++ + + ++ ++ ++ Q + + + L + L
Sbjct: 276 DLFNCLTNVSSFSLVSVTIE-RVKDFSYN-FGWQHLELVNCKFGQFPTLKLKSLKRL--T 331
Query: 293 LQNNRIS 299
+N+
Sbjct: 332 FTSNKGG 338
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 5e-19
Identities = 53/319 (16%), Positives = 94/319 (29%), Gaps = 23/319 (7%)
Query: 15 TELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSN 74
LDLS N LR + + +L L L C + SL L L L N
Sbjct: 28 FSTKNLDLSFNP-LRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGN 86
Query: 75 GFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSI 134
+ LS+L L + L G+ L L + N +
Sbjct: 87 PIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKEL------NVAHNLIQSFK 140
Query: 135 PEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVR----FDRNSLSGPVPSNLNNL 190
+ F L H+ SN + L ++ + ++ N ++ +
Sbjct: 141 LPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKE 199
Query: 191 TSVNDLYLSNNKLTGAMPN--LTGLSVLSYLDMSNNSFD-----ASEVPSWFSSMQSLTT 243
++ L L NN + + + GL+ L + F S + +LT
Sbjct: 200 IRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTI 259
Query: 244 LMMENTNLKG---QIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENLLVNLQNNRISA 300
L I + ++ + + + + D ++ L L N +
Sbjct: 260 EEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHL-ELVNCKFGQ 318
Query: 301 YTERGGAPAVNLTLIDNPI 319
+ LT N
Sbjct: 319 FPTLKLKSLKRLTFTSNKG 337
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 1e-18
Identities = 56/279 (20%), Positives = 102/279 (36%), Gaps = 24/279 (8%)
Query: 6 QLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQE 65
+ LT + + L + + + +L LV C F + SL+
Sbjct: 273 DIIDLFNCLTNVSSFSLVSVT-IERVKDFS--YNFGWQHLELVNCKFGQFPTLKLKSLKR 329
Query: 66 LVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHF 125
L S S +L +L +LDL+ N L + G L K+
Sbjct: 330 LTFTSNKGGNA-----FSEVDLPSLEFLDLSRNGLS-FKGCCSQSDFGTTSL---KYLDL 380
Query: 126 GKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPA--TLGLVKSLEVVRFDRNSLSGPV 183
N + ++ F L H+ F +NL ++ +++L +
Sbjct: 381 SFNGVI-TMSS-NFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTRVAF 437
Query: 184 PSNLNNLTSVNDLYLSNNKLTGAMPN--LTGLSVLSYLDMSNNSFDASEVP-SWFSSMQS 240
N L+S+ L ++ N T L L++LD+S ++ + F+S+ S
Sbjct: 438 NGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQL--EQLSPTAFNSLSS 495
Query: 241 LTTLMMENTNLKGQIPADLF-SIPHLQTVVMKTNELNGT 278
L L M + LK +P +F + LQ + + TN + +
Sbjct: 496 LQVLNMASNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCS 533
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 6e-10
Identities = 33/158 (20%), Positives = 59/158 (37%), Gaps = 9/158 (5%)
Query: 146 IHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTG 205
I N ++P L S + + N L + + + L LS ++
Sbjct: 10 ITYQCMELNFY-KIPD--NLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT 66
Query: 206 AMPN-LTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPH 264
LS LS L ++ N + FS + SL L+ TNL + +
Sbjct: 67 IEDGAYQSLSHLSTLILTGNPIQSLA-LGAFSGLSSLQKLVAVETNLASLENFPIGHLKT 125
Query: 265 LQTVVMKTNELNGTLDLGTSYS--ENL-LVNLQNNRIS 299
L+ + + N + + L +S NL ++L +N+I
Sbjct: 126 LKELNVAHNLIQ-SFKLPEYFSNLTNLEHLDLSSNKIQ 162
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 8e-23
Identities = 62/225 (27%), Positives = 95/225 (42%), Gaps = 41/225 (18%)
Query: 564 GSGGYGKVYKGT-LPNGQLIAIK---RAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGF 619
G G +GKV G G +A+K R + S+ + K EI+ L H +++ L
Sbjct: 20 GVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQV 79
Query: 620 CFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAAR--------GLSYLHE 671
+ ++ E+V G L D + R++ AR + Y H
Sbjct: 80 ISTPTDFFMVMEYVSGGELFDYICKH--------GRVEEM--EARRLFQQILSAVDYCHR 129
Query: 672 LANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYM 731
++HRD+K N+LLD +NAK+ADFGLS MSD E + G+ Y PE
Sbjct: 130 HM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNYAAPEVIS 183
Query: 732 TQQLT-EKSDVYSFGVLMLELLTGRRP------------IERGKY 763
+ + D++S GV++ LL G P I G +
Sbjct: 184 GRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVF 228
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 9e-23
Identities = 52/216 (24%), Positives = 95/216 (43%), Gaps = 19/216 (8%)
Query: 555 NNFSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKM----EIELLSRVH 609
+ +G G YG V+K +++A+KR + G EI LL +
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEG--VPSSALREICLLKELK 59
Query: 610 HKNLVSLLGFCFDRGEQMLIYEFVPN--GSLGDSLSGKNGIRLDWIRRLKIALGAARGLS 667
HKN+V L + L++EF DS +G + + ++ L +GL
Sbjct: 60 HKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNG--DLDPEIVKSFLFQL--LKGLG 115
Query: 668 YLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDP 727
+ H ++HRD+K N+L++ K+A+FGL+++ + + + +V T+ Y P
Sbjct: 116 FCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY-SAEVV-TLWYRPP 170
Query: 728 EYYM-TQQLTEKSDVYSFGVLMLELLTGRRPIERGK 762
+ + + D++S G + EL RP+ G
Sbjct: 171 DVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN 206
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-22
Identities = 55/226 (24%), Positives = 108/226 (47%), Gaps = 27/226 (11%)
Query: 545 FSFEEVKKYT-NNFSDANDVGSGGYGKVY----KGTLPNGQLIAIKRAQQGSMQGGQEFK 599
+ + E + T N F +G GG+G+V + T G++ A K+ ++ ++ +
Sbjct: 173 WKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRAT---GKMYACKKLEKKRIKKRKGEA 229
Query: 600 M---EIELLSRVHHKNLVSLLGFCFDRGEQM-LIYEFVPNGSLGDSLS--GKNGIRLDWI 653
M E ++L +V+ + +VSL + ++ + + L+ + G L + G+ G
Sbjct: 230 MALNEKQILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARA 288
Query: 654 R--RLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEK 711
+I G L LH I++RD+K NILLD+ + +++D GL+ + + +
Sbjct: 289 VFYAAEICCG----LEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 341
Query: 712 DHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRP 757
GT+GY+ PE ++ T D ++ G L+ E++ G+ P
Sbjct: 342 ---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-22
Identities = 62/321 (19%), Positives = 102/321 (31%), Gaps = 39/321 (12%)
Query: 8 SGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELV 67
+ L +L L+L + NL L L L PD+ L L
Sbjct: 41 ASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLF 100
Query: 68 LLSLNSNGFSGRVPPS--IGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHF 125
L L G S V NL L LDL+ N++ P L K F
Sbjct: 101 ELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYL-----HPSFGKLNSLKSIDF 155
Query: 126 GKNQLSGSIPEKLFRP--DMVLIHVLFDSNNLTGELPATLGLV------KSLEVVRFDRN 177
NQ+ + E P L +N+L + G LE++ N
Sbjct: 156 SSNQIF-LVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGN 214
Query: 178 SLSGPVPSNLNN------------LTSVNDLYLSNNKLT----GAMPNLTGLSVLSYLDM 221
+ + N +N + + + L S + +LD+
Sbjct: 215 GWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSS-VRHLDL 273
Query: 222 SNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFS-IPHLQTVVMKTNELNGTLD 280
S+ + F +++ L L + + +I + F + +LQ + + N L L
Sbjct: 274 SHGFVFSLN-SRVFETLKDLKVLNLAYNKIN-KIADEAFYGLDNLQVLNLSYNLLG-ELY 330
Query: 281 LGTSYS-ENLLV-NLQNNRIS 299
Y + +LQ N I+
Sbjct: 331 SSNFYGLPKVAYIDLQKNHIA 351
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 94.9 bits (236), Expect = 5e-20
Identities = 53/276 (19%), Positives = 96/276 (34%), Gaps = 28/276 (10%)
Query: 8 SGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELV 67
S L +L L+L+ NK + L L L L + L ++
Sbjct: 283 SRVFETLKDLKVLNLAYNK-INKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVA 341
Query: 68 LLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGK 127
+ L N + + L L LDL DN L + +
Sbjct: 342 YIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT-----------TIHFIPSIPDIFLSG 390
Query: 128 NQLSGSIPEKLFRPDMVLIHVLFDSNNLTG-ELPATLGLVKSLEVVRFDRNSLSG-PVPS 185
N+L ++P+ + N L ++ L V L+++ ++N S
Sbjct: 391 NKLV-TLPKINLT----ANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQ 445
Query: 186 NLNNLTSVNDLYLSNNKLTGAMPN------LTGLSVLSYLDMSNNSFDASEVPSWFSSMQ 239
+ S+ L+L N L A GLS L L +++N ++ P FS +
Sbjct: 446 TPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLP-PGVFSHLT 504
Query: 240 SLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNEL 275
+L L + + L + + +L+ + + N+L
Sbjct: 505 ALRGLSLNSNRLT-VLSHNDLP-ANLEILDISRNQL 538
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 1e-19
Identities = 53/303 (17%), Positives = 102/303 (33%), Gaps = 36/303 (11%)
Query: 6 QLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQE 65
L L L ++D S+N+ + + L+ + SL
Sbjct: 139 YLHPSFGKLNSLKSIDFSSNQ-IFLVCEHELEPLQGKTLSFF--------------SLAA 183
Query: 66 LVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIP------VSDGNSPGLDMLVR 119
L S S + + N+ L LD++ N +I +S + L +
Sbjct: 184 NSLYSRVSVDWG-KCMNPFRNMV-LEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHH 241
Query: 120 AKHFHFGKNQLSGSIPEKLFRP--DMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRN 177
FG + + + F + H+ + +K L+V+ N
Sbjct: 242 IMGAGFGFHNIK-DPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYN 300
Query: 178 SLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPN-LTGLSVLSYLDMSNNSFDASEVPSWFS 236
++ L ++ L LS N L + GL ++Y+D+ N + F
Sbjct: 301 KINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQ-DQTFK 359
Query: 237 SMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENLLVNLQNN 296
++ L TL + + L + IP + + + N+L TL + + +L N
Sbjct: 360 FLEKLQTLDLRDNALT-----TIHFIPSIPDIFLSGNKLV-TLPKINLTANLI--HLSEN 411
Query: 297 RIS 299
R+
Sbjct: 412 RLE 414
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 79.1 bits (195), Expect = 3e-15
Identities = 40/271 (14%), Positives = 83/271 (30%), Gaps = 29/271 (10%)
Query: 47 LVGCSFSG--PIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEI 104
+ F +P + + + L L+ N S L L L+L I
Sbjct: 8 IAFYRFCNLTQVPQVLNTTERL---LLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTI 64
Query: 105 PVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGEL--PAT 162
L + G +++ + F+ L + L+ +
Sbjct: 65 DKEA-----FRNLPNLRILDLGSSKIY-FLHPDAFQGLFHLFELRLYFCGLSDAVLKDGY 118
Query: 163 LGLVKSLEVVRFDRNSLSG-PVPSNLNNLTSVNDLYLSNNKLT----GAMPNLTGLSVLS 217
+K+L + +N + + + L S+ + S+N++ + L G + LS
Sbjct: 119 FRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKT-LS 177
Query: 218 YLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKG----QIPADLFS--IPHLQTVVMK 271
+ ++ NS + W M +++E ++ G FS I Q +
Sbjct: 178 FFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLI 237
Query: 272 TNELNGTLDLG----TSYSENLLVNLQNNRI 298
G +N L + +
Sbjct: 238 LAHHIMGAGFGFHNIKDPDQNTFAGLARSSV 268
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 2e-12
Identities = 49/247 (19%), Positives = 90/247 (36%), Gaps = 26/247 (10%)
Query: 8 SGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELV 67
L +L TLDL +N TTI + + ++ L G +P +
Sbjct: 355 DQTFKFLEKLQTLDLRDNA------LTTIHFIPSIPDIFLSGNKLVT-LPKINLTAN--- 404
Query: 68 LLSLNSNGFSG-RVPPSIGNLSNLYWLDLTDNKLEG-EIPVSDGNSPGLDMLVRAKHFHF 125
L+ L+ N + + + +L L L N+ + +P L +
Sbjct: 405 LIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSL------EQLFL 458
Query: 126 GKNQLSG----SIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSG 181
G+N L + +F L + + N L P + +L + + N L+
Sbjct: 459 GENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTV 518
Query: 182 PVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSL 241
++L ++ L +S N+L PN LS LD+++N F S F + +
Sbjct: 519 LSHNDL--PANLEILDISRNQLL--APNPDVFVSLSVLDITHNKFICECELSTFINWLNH 574
Query: 242 TTLMMEN 248
T + +
Sbjct: 575 TNVTIAG 581
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 1e-22
Identities = 56/229 (24%), Positives = 96/229 (41%), Gaps = 43/229 (18%)
Query: 564 GSGGYGKVYKGT-LPNGQLIAIK----RAQQGSMQGG--QEFKMEIELLSRVHHKNLVSL 616
GSG + V K G A K R + S +G ++ + E+ +L + H N+++L
Sbjct: 20 GSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITL 79
Query: 617 LGFCFDRGEQMLIYEFVPNGSLGD------SLSGKNGIRLDWIRRLKIALGAARGLSYLH 670
++ + +LI E V G L D SL+ + ++++ G+ YLH
Sbjct: 80 HEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEF--LKQI------LNGVYYLH 131
Query: 671 ELANPPIIHRDIKSSNILL----DERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLD 726
L I H D+K NI+L + K+ DFGL+ + + GT ++
Sbjct: 132 SLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE--FKNIF-GTPEFVA 185
Query: 727 PEYYMTQQLTEKSDVYSFGVLMLELLTGRRP------------IERGKY 763
PE + L ++D++S GV+ LL+G P + Y
Sbjct: 186 PEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNY 234
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 2e-22
Identities = 49/232 (21%), Positives = 88/232 (37%), Gaps = 29/232 (12%)
Query: 551 KKYTNNFSDANDVGSGGYGKVYKGT-LPNGQLIAIK--------RAQQGSMQGGQEFKME 601
+Y+ +S + +GSG +G V+ + + +K + +E
Sbjct: 20 GEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLE 79
Query: 602 IELLSRVHHKNLVSLLGFCFDRGEQMLIYEF-VPNGSLGDSLSGKNGIRLDWIRRL--KI 658
I +LSRV H N++ +L ++G L+ E L + + + ++
Sbjct: 80 IAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQL 139
Query: 659 ALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQV 718
+ YL IIHRDIK NI++ E K+ DFG + + + + T
Sbjct: 140 V----SAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFY--TFC 190
Query: 719 KGTMGYLDPEYYMTQQLT-EKSDVYSFGVLMLELLTGRRP------IERGKY 763
GT+ Y PE M + +++S GV + L+ P
Sbjct: 191 -GTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEAAI 241
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 2e-22
Identities = 58/217 (26%), Positives = 97/217 (44%), Gaps = 26/217 (11%)
Query: 564 GSGGYGKVYKGT-LPNGQLIAIK---RAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGF 619
G G + KV + G+ +AIK + Q + F+ E+ ++ ++H N+V L
Sbjct: 24 GKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR-EVRIMKILNHPNIVKLFEV 82
Query: 620 CFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIH 679
LI E+ G + D L ++ R + +A + Y H+ I+H
Sbjct: 83 IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSA--VQYCHQKR---IVH 137
Query: 680 RDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLT-EK 738
RD+K+ N+LLD +N K+ADFG S + K + G Y PE + ++ +
Sbjct: 138 RDLKAENLLLDADMNIKIADFGFSNEFTVGGK--LDAFC-GAPPYAAPELFQGKKYDGPE 194
Query: 739 SDVYSFGVLMLELLTGRRP------------IERGKY 763
DV+S GV++ L++G P + RGKY
Sbjct: 195 VDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY 231
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 2e-22
Identities = 64/242 (26%), Positives = 102/242 (42%), Gaps = 45/242 (18%)
Query: 546 SFEEVKKYTNNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQGGQEFK----M 600
+ E +K + F G G +G V G G +AIK+ Q F+
Sbjct: 14 ADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR-----FRNRELQ 68
Query: 601 EIELLSRVHHKNLVSLLGFCFDRGEQ-------MLIYEFVPNGSLGDSLSGKNGIRLDWI 653
++ L+ +HH N+V L + + GE+ ++ E+VP D+L R +
Sbjct: 69 IMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP-----DTL--HRCCRNYYR 121
Query: 654 RRLKIALG--------AARGLSYLHEL-ANPPIIHRDIKSSNILLDERLNA-KVADFGLS 703
R++ R + LH N + HRDIK N+L++E K+ DFG +
Sbjct: 122 RQVAPPPILIKVFLFQLIRSIGCLHLPSVN--VCHRDIKPHNVLVNEADGTLKLCDFGSA 179
Query: 704 KSMSDSEK--DHITTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIER 760
K +S SE +I ++ Y PE Q T D++S G + E++ G PI R
Sbjct: 180 KKLSPSEPNVAYICSRY-----YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLG-EPIFR 233
Query: 761 GK 762
G
Sbjct: 234 GD 235
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 3e-22
Identities = 63/229 (27%), Positives = 106/229 (46%), Gaps = 41/229 (17%)
Query: 554 TNNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQGGQEFKM-EIELLSRVHHK 611
+++D +G+G +G VY+ L +G+L+AIK+ Q + FK E++++ ++ H
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHC 107
Query: 612 NLVSLLGFCFDRGEQM------LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALG---- 661
N+V L F + GE+ L+ ++VP +++ R + + +
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVP-----ETV--YRVARHYSRAKQTLPVIYVKL 160
Query: 662 ----AARGLSYLHELANPPIIHRDIKSSNILLDERLNA-KVADFGLSKSMSDSEK--DHI 714
R L+Y+H I HRDIK N+LLD K+ DFG +K + E +I
Sbjct: 161 YMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI 217
Query: 715 TTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGK 762
++ Y PE T DV+S G ++ ELL G +PI G
Sbjct: 218 CSRY-----YRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFPGD 260
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 5e-22
Identities = 65/295 (22%), Positives = 110/295 (37%), Gaps = 28/295 (9%)
Query: 15 TELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSN 74
+ LDL NNK + NLK L L+L+ S P + L +L L L+ N
Sbjct: 52 PDTALLDLQNNK-ITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKN 110
Query: 75 GFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQL-SGS 133
+P + L L + +N++ V GL+ + G N L S
Sbjct: 111 QLK-ELPEKM--PKTLQELRVHENEITK---VRKSVFNGLNQM---IVVELGTNPLKSSG 161
Query: 134 IPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSV 193
I F+ L ++ N+T +P GL SL + D N ++ ++L L ++
Sbjct: 162 IENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNKITKVDAASLKGLNNL 218
Query: 194 NDLYLSNNKLTGAMPN-LTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLK 252
L LS N ++ L L L ++NN +VP + + + + + N N+
Sbjct: 219 AKLGLSFNSISAVDNGSLANTPHLRELHLNNNKL--VKVPGGLADHKYIQVVYLHNNNIS 276
Query: 253 GQIPADLF-------SIPHLQTVVMKTNELNGT-LDLGT-SYSENL-LVNLQNNR 297
I ++ F V + +N + + T V L N +
Sbjct: 277 -AIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 5e-21
Identities = 59/275 (21%), Positives = 111/275 (40%), Gaps = 23/275 (8%)
Query: 8 SGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELV 67
GD L LHTL L NNK + P L KL L L +P+ + L
Sbjct: 69 DGDFKNLKNLHTLILINNK-ISKISPGAFAPLVKLERLYLSKNQLKE-LPE--KMPKTLQ 124
Query: 68 LLSLNSNGFSGRVPPSI-GNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFG 126
L ++ N + +V S+ L+ + ++L N L+ + +G G+ L +
Sbjct: 125 ELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLK-SSGIENGAFQGMKKL---SYIRIA 179
Query: 127 KNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPA-TLGLVKSLEVVRFDRNSLSGPVPS 185
++ +IP+ L L + D N +T ++ A +L + +L + NS+S
Sbjct: 180 DTNIT-TIPQGLPPS---LTELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSISAVDNG 234
Query: 186 NLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSF-----DASEVPSWFSSMQS 240
+L N + +L+L+NNKL L + + + NN+ + P + + S
Sbjct: 235 SLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKAS 294
Query: 241 LTTLMMENTNLK-GQIPADLFS-IPHLQTVVMKTN 273
+ + + + ++ +I F + V +
Sbjct: 295 YSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 5e-18
Identities = 59/290 (20%), Positives = 109/290 (37%), Gaps = 56/290 (19%)
Query: 56 IPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPG-L 114
+P + + LL L +N + NL NL+ L L +NK+ +I PG
Sbjct: 46 VPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS-KIS------PGAF 96
Query: 115 DMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRF 174
LV+ + + KNQL +PEK+ + L + N +T + + + VV
Sbjct: 97 APLVKLERLYLSKNQLK-ELPEKMPKT---LQELRVHENEITKVRKSVFNGLNQMIVVEL 152
Query: 175 DRNSL-SGPVPSN-LNNLTSVNDLYLSNNKLT----GAMPNLT----------------- 211
N L S + + + ++ + +++ +T G P+LT
Sbjct: 153 GTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTELHLDGNKITKVDAASL 212
Query: 212 -GLSVLSYLDMSNNSFDASEVPSW-FSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVV 269
GL+ L+ L +S NS S V + ++ L L + N L ++P L ++Q V
Sbjct: 213 KGLNNLAKLGLSFNSI--SAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVY 269
Query: 270 MKTNELNGTLDLGTSYSENLLVNLQNNRISAYTERGGAPAVNLTLIDNPI 319
+ N ++ + + ++L NP+
Sbjct: 270 LHNNNIS-AIGSNDFCPPGYNTKKASYS-------------GVSLFSNPV 305
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 1e-10
Identities = 40/216 (18%), Positives = 68/216 (31%), Gaps = 52/216 (24%)
Query: 12 TGLTELHTLDLSNNKDLRGPLP-TTIGNLKKLSNLMLVGCSFSGPIPDSI-GSLQELVL- 68
GL ++ ++L N + +KKLS + + + + IP + SL EL L
Sbjct: 142 NGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT-IPQGLPPSLTELHLD 200
Query: 69 --------------------LSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSD 108
L L+ N S S+ N +L L L +NKL ++P
Sbjct: 201 GNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGL 259
Query: 109 GNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKS 168
+ + + + N +S +I F P P S
Sbjct: 260 ADHKYI------QVVYLHNNNIS-AIGSNDFCP------------------PGYNTKKAS 294
Query: 169 LEVVRFDRNSLS-GPVPSNL-NNLTSVNDLYLSNNK 202
V N + + + + + L N K
Sbjct: 295 YSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 5e-10
Identities = 41/198 (20%), Positives = 70/198 (35%), Gaps = 44/198 (22%)
Query: 133 SIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTS 192
+P+ L PD L+ +N +T +K+L + N +S P L
Sbjct: 45 KVPKDLP-PDTALLD--LQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVK 101
Query: 193 VNDLYLSNNKLT----GAMPNLT------------------GLSVLSYLDMSNNSFDASE 230
+ LYLS N+L L GL+ + +++ N +S
Sbjct: 102 LERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSG 161
Query: 231 VPS-WFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENL 289
+ + F M+ L+ + + +TN+ IP L P L + + N++ T
Sbjct: 162 IENGAFQGMKKLSYIRIADTNIT-TIPQGLP--PSLTELHLDGNKI-------TKVDAAS 211
Query: 290 LVN--------LQNNRIS 299
L L N IS
Sbjct: 212 LKGLNNLAKLGLSFNSIS 229
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 5e-22
Identities = 58/295 (19%), Positives = 109/295 (36%), Gaps = 29/295 (9%)
Query: 15 TELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSN 74
+ LDL NN + L+ L L+LV S + L++L L ++ N
Sbjct: 54 PDTTLLDLQNND-ISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKN 112
Query: 75 GFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQL-SGS 133
+PP++ S+L L + DN++ V G GL + G N L +
Sbjct: 113 HLV-EIPPNL--PSSLVELRIHDNRIRK---VPKGVFSGLRNM---NCIEMGGNPLENSG 163
Query: 134 IPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSV 193
F + L ++ LT +P L ++L + D N + +L + +
Sbjct: 164 FEPGAFD-GLKLNYLRISEAKLT-GIPK--DLPETLNELHLDHNKIQAIELEDLLRYSKL 219
Query: 194 NDLYLSNNKLTGAMPN-LTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLK 252
L L +N++ L+ L L L + NN S VP+ ++ L + + N+
Sbjct: 220 YRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKL--SRVPAGLPDLKLLQVVYLHTNNIT 277
Query: 253 GQIPADLFS-------IPHLQTVVMKTNEL-NGTLDLGT-SYSENLL-VNLQNNR 297
++ + F + + + N + + T + L + N +
Sbjct: 278 -KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 3e-19
Identities = 54/277 (19%), Positives = 98/277 (35%), Gaps = 28/277 (10%)
Query: 8 SGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELV 67
D GL L+ L L NNK + L+KL L + IP LV
Sbjct: 71 KDDFKGLQHLYALVLVNNK-ISKIHEKAFSPLRKLQKLYISKNHLVE-IPP--NLPSSLV 126
Query: 68 LLSLNSNGFSGRVPPSI-GNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFG 126
L ++ N +VP + L N+ +++ N LE G GL + +
Sbjct: 127 ELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLE-NSGFEPGAFDGL----KLNYLRIS 180
Query: 127 KNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPA-TLGLVKSLEVVRFDRNSLSGPVPS 185
+ +L+ IP+ L L + D N + + L L + N +
Sbjct: 181 EAKLT-GIPKDLPET---LNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIRMIENG 235
Query: 186 NLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPS-------WFSSM 238
+L+ L ++ +L+L NNKL+ L L +L + + N+ ++V +
Sbjct: 236 SLSFLPTLRELHLDNNKLSRVPAGLPDLKLLQVVYLHTNNI--TKVGVNDFCPVGFGVKR 293
Query: 239 QSLTTLMMENTNLK-GQIPADLFS-IPHLQTVVMKTN 273
+ + N + ++ F + +
Sbjct: 294 AYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 4e-17
Identities = 54/283 (19%), Positives = 97/283 (34%), Gaps = 46/283 (16%)
Query: 56 IPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLD 115
+P I + LL L +N S L +LY L L +NK+ + + L
Sbjct: 48 VPKEISP--DTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISK---IHEKAFSPLR 102
Query: 116 MLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFD 175
L + + KN L IP L L+ + N + ++++ +
Sbjct: 103 KL---QKLYISKNHLV-EIPPNLPSS---LVELRIHDNRIRKVPKGVFSGLRNMNCIEMG 155
Query: 176 RNSL-SGPVPSNL-------------NNLTSVND--------LYLSNNKLTGAMPN-LTG 212
N L + LT + L+L +NK+ L
Sbjct: 156 GNPLENSGFEPGAFDGLKLNYLRISEAKLTGIPKDLPETLNELHLDHNKIQAIELEDLLR 215
Query: 213 LSVLSYLDMSNNSFDASEVPS-WFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMK 271
S L L + +N + + S + +L L ++N L ++PA L + LQ V +
Sbjct: 216 YSKLYRLGLGHNQI--RMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLH 272
Query: 272 TNELN-------GTLDLGTSYSENLLVNLQNNRISAYTERGGA 307
TN + + G + ++L NN + + +
Sbjct: 273 TNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPAT 315
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 1e-09
Identities = 34/215 (15%), Positives = 59/215 (27%), Gaps = 51/215 (23%)
Query: 12 TGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVL--- 68
+GL ++ +++ N + KL+ L + +G D +L EL L
Sbjct: 144 SGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTGIPKDLPETLNELHLDHN 203
Query: 69 ------------------LSLNSNGFSGRVPPSI-GNLSNLYWLDLTDNKLEGEIPVSDG 109
L L N + L L L L +NKL +P
Sbjct: 204 KIQAIELEDLLRYSKLYRLGLGHNQIR-MIENGSLSFLPTLRELHLDNNKLS-RVP---- 257
Query: 110 NSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSL 169
GL L + + N ++ + F P +
Sbjct: 258 --AGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRA------------------YY 296
Query: 170 EVVRFDRNSLSGPV--PSNLNNLTSVNDLYLSNNK 202
+ N + P+ +T + N K
Sbjct: 297 NGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 99 bits (249), Expect = 7e-22
Identities = 65/312 (20%), Positives = 100/312 (32%), Gaps = 45/312 (14%)
Query: 6 QLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQE 65
L GL EL LP L KL + G + +P LQE
Sbjct: 95 SLPVLPPGLLELSIFSNPLTH-----LPALPSGLCKLW---IFGNQLTS-LPVLPPGLQE 145
Query: 66 LVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHF 125
LS++ N + +P L L+ +N+L +P+ L L
Sbjct: 146 ---LSVSDNQLA-SLPALPSELCKLW---AYNNQLT-SLPMLPSG---LQEL------SV 188
Query: 126 GKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPS 185
NQL+ S+P L + +N LT LPA L+ + N L+ +P
Sbjct: 189 SDNQLA-SLPTLPSE----LYKLWAYNNRLT-SLPALPS---GLKELIVSGNRLTS-LPV 238
Query: 186 NLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLM 245
+ L L +S N+LT ++P L S L L + N + +P + S TT+
Sbjct: 239 LPSELKE---LMVSGNRLT-SLPML--PSGLLSLSVYRNQL--TRLPESLIHLSSETTVN 290
Query: 246 MENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENLLVNLQNNRISAYTERG 305
+E L + L + + E
Sbjct: 291 LEGNPLS-ERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAREGE 349
Query: 306 GAPAVNLTLIDN 317
APA +
Sbjct: 350 PAPADRWHMFGQ 361
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 98.0 bits (244), Expect = 3e-21
Identities = 58/328 (17%), Positives = 100/328 (30%), Gaps = 53/328 (16%)
Query: 14 LTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNS 73
L++ + L LP + ++ L++ + + +P L+ L ++
Sbjct: 39 NNGNAVLNVGESG-LTT-LPDCLP--AHITTLVIPDNNLTS-LPALPPELRTL---EVSG 90
Query: 74 NGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIP------VSDGNSPGLDMLVRA-KHFHFG 126
N + +P L L L + L +L +
Sbjct: 91 NQLT-SLPVLPPGLLELSIFSNPLTHLPALPSGLCKLWIFGNQLTSLPVLPPGLQELSVS 149
Query: 127 KNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSN 186
NQL+ S+P L + +N LT LP L+ + N L+ +P+
Sbjct: 150 DNQLA-SLPALPSE----LCKLWAYNNQLT-SLPMLPS---GLQELSVSDNQLAS-LPTL 199
Query: 187 LNNLTSVNDLYLSNNKLT---GAMPNLTGLSV--------------LSYLDMSNNSFDAS 229
+ L L+ NN+LT L L V L L +S N +
Sbjct: 200 PSELYK---LWAYNNRLTSLPALPSGLKELIVSGNRLTSLPVLPSELKELMVSGNRL--T 254
Query: 230 EVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENL 289
+P L +L + L ++P L + TV ++ N L+ L
Sbjct: 255 SLPML---PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLS-ERTLQALREITS 309
Query: 290 LVNLQNNRISAYTERGGAPAVNLTLIDN 317
I AP L
Sbjct: 310 APGYSGPIIRFDMAGASAPRETRALHLA 337
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 80.7 bits (199), Expect = 8e-16
Identities = 47/238 (19%), Positives = 78/238 (32%), Gaps = 31/238 (13%)
Query: 13 GLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLN 72
+EL L NN+ L LP L++LS + + +P L +L +
Sbjct: 159 LPSELCKLWAYNNQ-LTS-LPMLPSGLQELS---VSDNQLAS-LPTLPSELYKLWAYNNR 212
Query: 73 SNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSG 132
+P L L ++ N+L +PV L L N+L+
Sbjct: 213 LT----SLPALPSGLK---ELIVSGNRLT-SLPVLPSE---LKEL------MVSGNRLT- 254
Query: 133 SIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTS 192
S+P L+ + N LT LP +L + S V + N LS L +TS
Sbjct: 255 SLPMLPSG----LLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREITS 309
Query: 193 VNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTN 250
+ A + + +L ++ A E + E+
Sbjct: 310 APGYSGPIIRFDMAGASAPRETRALHLAAADWLVPARE--GEPAPADRWHMFGQEDNA 365
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 7e-22
Identities = 59/215 (27%), Positives = 105/215 (48%), Gaps = 19/215 (8%)
Query: 555 NNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKM----EIELLSRVHH 610
+ VG G YG VYK G+++A+KR + + G EI LL +HH
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEG--IPSTAIREISLLKELHH 78
Query: 611 KNLVSLLGFCFDRGEQMLIYEFVPN--GSLGDSLSGKNGIRLDWIRRLKIALGAARGLSY 668
N+VSL+ L++EF+ + D G++ I+ L RG+++
Sbjct: 79 PNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKT--GLQDSQIKIYLYQL--LRGVAH 134
Query: 669 LHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPE 728
H+ I+HRD+K N+L++ K+ADFGL+++ + + T +V T+ Y P+
Sbjct: 135 CHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY-THEVV-TLWYRAPD 189
Query: 729 YYM-TQQLTEKSDVYSFGVLMLELLTGRRPIERGK 762
M +++ + D++S G + E++T +P+ G
Sbjct: 190 VLMGSKKYSTSVDIWSIGCIFAEMIT-GKPLFPGV 223
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 9e-22
Identities = 59/212 (27%), Positives = 86/212 (40%), Gaps = 28/212 (13%)
Query: 563 VGSGGYGKVY----KGTLPNGQLIAIKRAQQGSMQGGQE---FKMEIELLSRVHHKNLVS 615
+G G + +V K T GQ+ A+K + M E F+ E ++L + +
Sbjct: 69 IGRGAFSEVAVVKMKQT---GQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQ 125
Query: 616 LLGFCF-DRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIR-RLKIA-LGAARGLSYLHEL 672
L F F D L+ E+ G L LS K G R+ R +A + A + +H L
Sbjct: 126 LH-FAFQDENYLYLVMEYYVGGDLLTLLS-KFGERIPAEMARFYLAEIVMA--IDSVHRL 181
Query: 673 ANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMT 732
+HRDIK NILLD + ++ADFG + V GT YL PE
Sbjct: 182 G---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAV-GTPDYLSPEILQA 237
Query: 733 QQLTEKSDVY-------SFGVLMLELLTGRRP 757
+ Y + GV E+ G+ P
Sbjct: 238 VGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 1e-21
Identities = 57/252 (22%), Positives = 89/252 (35%), Gaps = 68/252 (26%)
Query: 564 GSGGYGKVYKGT-LPNGQLIAIK--------------------RAQQGSMQGGQEFKM-- 600
G G YG V + A+K + Q
Sbjct: 22 GKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIE 81
Query: 601 ----EIELLSRVHHKNLVSLLGFCFDRGEQML--IYEFVPNGSLGDSLSGKNGIRLDWIR 654
EI +L ++ H N+V L+ D E L ++E V G + ++
Sbjct: 82 QVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV-----------MEVPT 130
Query: 655 RLKIALGAAR--------GLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSM 706
++ AR G+ YLH IIHRDIK SN+L+ E + K+ADFG+S
Sbjct: 131 LKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNEF 187
Query: 707 SDSEKDHITTQVKGTMGYLDPEYYMTQQLT---EKSDVYSFGVLMLELLTGRRP------ 757
S+ T GT ++ PE + + DV++ GV + + G+ P
Sbjct: 188 KGSDALLSNTV--GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI 245
Query: 758 ------IERGKY 763
I+
Sbjct: 246 MCLHSKIKSQAL 257
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 1e-21
Identities = 26/206 (12%), Positives = 55/206 (26%), Gaps = 44/206 (21%)
Query: 562 DVGSGGYGKVYKGT---LPNGQLIAIK--RAQQGSMQGGQE-FKMEIELLSRVHHKNLVS 615
G + ++ L + +A+ Q + LSR+ +
Sbjct: 38 FHGGVPPLQFWQALDTAL--DRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 616 LLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANP 675
+L R +++ E++ GSL + + ++ A H
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVADT----SPSPVGAIRAMQSLAAAADAAHRA--- 148
Query: 676 PIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQL 735
+ S + + + +A TM +P+
Sbjct: 149 GVALSIDHPSRVRVSIDGDVVLAYPA-------------------TMPDANPQ------- 182
Query: 736 TEKSDVYSFGVLMLELLTGRRPIERG 761
D+ G + LL R P+
Sbjct: 183 ---DDIRGIGASLYALLVNRWPLPEA 205
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 1e-21
Identities = 57/312 (18%), Positives = 118/312 (37%), Gaps = 20/312 (6%)
Query: 6 QLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQE 65
++ LT L TL + N + L L+ L + S S+ S+++
Sbjct: 114 GVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRD 173
Query: 66 LVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHF 125
+ L+L+ + + + LS++ +L+L D L + +
Sbjct: 174 IHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGS 233
Query: 126 GKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTG---------ELPATLGLVK--SLEVVRF 174
S + KL R + L V FD L G ++ + LG V+ ++ +
Sbjct: 234 VLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHI 293
Query: 175 DRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPN--LTGLSVLSYLDMSNNSFDASEVP 232
+ L + + + L V + + N+K+ +P L L +LD+S N +
Sbjct: 294 PQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLK 352
Query: 233 SW--FSSMQSLTTLMMENTNLKG-QIPADLFS-IPHLQTVVMKTNELNGTLDLGTSYSEN 288
+ + SL TL++ +L+ Q ++ + +L ++ + N + + + E
Sbjct: 353 NSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEK 411
Query: 289 LLV-NLQNNRIS 299
+ NL + I
Sbjct: 412 MRFLNLSSTGIR 423
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 4e-19
Identities = 44/314 (14%), Positives = 98/314 (31%), Gaps = 38/314 (12%)
Query: 13 GLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSG-PIPDSIGSLQELVLLSL 71
L L LDLS+N L + G L L L L+G + + +L L L +
Sbjct: 72 SLGSLEHLDLSDNH-LSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRI 130
Query: 72 NSNGFSGRVPP-SIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQL 130
+ + L++L L++ L L + H ++
Sbjct: 131 GNVETFSEIRRIDFAGLTSLNELEIKALSLR-NYQSQS-----LKSIRDIHHLTLHLSES 184
Query: 131 SGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNL 190
+ + E + ++ NL + L + + ++ S + N L
Sbjct: 185 A-FLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNEL 243
Query: 191 TSVNDLYLSNNKLT-----------------GAMPNLTGLSVLS--YLDMSNNSFDASEV 231
+ L +++ + L + ++ L +
Sbjct: 244 LKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDL- 302
Query: 232 PSWFSSMQSLTTLMMENTNLKGQIPADLFS-IPHLQTVVMKTNELNGTLDLGTSYSENLL 290
+ +S ++ + + +EN+ + +P + L+ + + N + L S +
Sbjct: 303 STVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMV-EEYLKNSACKGAW 360
Query: 291 VNLQ-----NNRIS 299
+LQ N +
Sbjct: 361 PSLQTLVLSQNHLR 374
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 1e-18
Identities = 52/320 (16%), Positives = 103/320 (32%), Gaps = 38/320 (11%)
Query: 8 SGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGC-SFSGPIPDSIGSLQEL 66
S L+ L L+L N + + NL L L + +FS L L
Sbjct: 91 SSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSL 150
Query: 67 VLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFG 126
L + + S+ ++ +++ L L ++ + + D+L ++
Sbjct: 151 NELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIF------ADILSSVRYLELR 204
Query: 127 KNQLSGSIPEKLFRPDMVLIHVLFDSNNLT-------GELPATLGLVKSLEVVRFDRNSL 179
L+ D V + + + EL L + L V FD +L
Sbjct: 205 DTNLA-RFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTL 263
Query: 180 SGPVPSNLN-----------NLTSVNDLYLSNNKLTGAMPN-LTGLSVLSYLDMSNNSFD 227
+G N + ++ L++ L + + L + + + N+
Sbjct: 264 NGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKV- 322
Query: 228 ASEVPSW-FSSMQSLTTLMMEN---TNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGT 283
VP ++SL L + + A + P LQT+V+ N L ++
Sbjct: 323 -FLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLR-SMQKTG 380
Query: 284 SYSENLL----VNLQNNRIS 299
L +++ N
Sbjct: 381 EILLTLKNLTSLDISRNTFH 400
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 6e-18
Identities = 53/323 (16%), Positives = 107/323 (33%), Gaps = 27/323 (8%)
Query: 14 LTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNS 73
+ +LDLS NK + + L L+L + D+ SL L L L+
Sbjct: 25 TAAMKSLDLSFNK-ITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSD 83
Query: 74 NGFSGRVPPS-IGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSG 132
N S + S G LS+L +L+L N + + G + L + G +
Sbjct: 84 NHLS-SLSSSWFGPLSSLKYLNLMGNPYQ-----TLGVTSLFPNLTNLQTLRIGNVETFS 137
Query: 133 SIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTS 192
I F L + + +L +L ++ + + + + + + L+S
Sbjct: 138 EIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSS 197
Query: 193 VNDLYLSNNKLT----GAMPNLTGLSVLSYLDMSNNSF---DASEVPSWFSSMQSLTTLM 245
V L L + L +P S + L + +E+ + L+ +
Sbjct: 198 VRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVE 257
Query: 246 MENTNLKGQIPADLFSI-----------PHLQTVVMKTNELNGTLDLGTSYSENLLV-NL 293
++ L G + ++ + + L L S E + +
Sbjct: 258 FDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITV 317
Query: 294 QNNRISAYTERGGAPAVNLTLID 316
+N+++ +L +D
Sbjct: 318 ENSKVFLVPCSFSQHLKSLEFLD 340
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 4e-16
Identities = 39/239 (16%), Positives = 87/239 (36%), Gaps = 20/239 (8%)
Query: 69 LSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKN 128
S F+ +P + + + LDL+ NK+ I D L + +
Sbjct: 10 CDGRSRSFT-SIPSGL--TAAMKSLDLSFNKIT-YIGHGD-----LRACANLQVLILKSS 60
Query: 129 QLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSG-PVPSNL 187
+++ +I F L H+ N+L+ + G + SL+ + N V S
Sbjct: 61 RIN-TIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLF 119
Query: 188 NNLTSVNDLYLSNNKLTGAMPNLT--GLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLM 245
NLT++ L + N + + + GL+ L+ L++ S + S++ + L
Sbjct: 120 PNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQ-SQSLKSIRDIHHLT 178
Query: 246 MENTNLKGQIPADLFSI-PHLQTVVMKTNELN----GTLDLGTSYSENLLVNLQNNRIS 299
+ + + I ++ + ++ L L + S + + + ++
Sbjct: 179 LHLSESA-FLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLT 236
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 5e-16
Identities = 48/278 (17%), Positives = 99/278 (35%), Gaps = 25/278 (8%)
Query: 6 QLSGDITGLTELHTLDLSNN--KDLRGPLPTTIGNLKK-----LSNLMLVGCSFSGPIPD 58
+L I L+E+ D + N D + L K + L + +
Sbjct: 245 KLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLST 304
Query: 59 SIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLV 118
L+++ +++ ++ +L +L +LDL++N + E + L
Sbjct: 305 VYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSL- 363
Query: 119 RAKHFHFGKNQLSGSIPE--KLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDR 176
+ +N L S+ + ++ + + L S N +P + + + +
Sbjct: 364 --QTLVLSQNHLR-SMQKTGEILLT-LKNLTSLDISRNTFHPMPDSCQWPEKMRFLNLSS 419
Query: 177 NSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFS 236
+ V + + ++ L +SNN L L L L +S N +P S
Sbjct: 420 TGIRV-VKTCI--PQTLEVLDVSNNNLDSFSLFLPRLQE---LYISRNKL--KTLPDA-S 470
Query: 237 SMQSLTTLMMENTNLKGQIPADLF-SIPHLQTVVMKTN 273
L + + LK +P +F + LQ + + TN
Sbjct: 471 LFPVLLVMKISRNQLK-SVPDGIFDRLTSLQKIWLHTN 507
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 7e-15
Identities = 40/200 (20%), Positives = 64/200 (32%), Gaps = 21/200 (10%)
Query: 8 SGDITGLTELHTLDLSNNK--DLRGPLPTTIGNLKKLSNLMLVGCSFS--GPIPDSIGSL 63
L L LDLS N + G L L+L + + +L
Sbjct: 327 CSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTL 386
Query: 64 QELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHF 123
+ L L ++ N F +P S + +L+L+ + + + +
Sbjct: 387 KNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVK--------TCIPQTLEVL 436
Query: 124 HFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPV 183
N L S L R L + N L LP L V++ RN L
Sbjct: 437 DVSNNNLD-SFSLFLPR----LQELYISRNKLK-TLPDASLF-PVLLVMKISRNQLKSVP 489
Query: 184 PSNLNNLTSVNDLYLSNNKL 203
+ LTS+ ++L N
Sbjct: 490 DGIFDRLTSLQKIWLHTNPW 509
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 1e-21
Identities = 65/228 (28%), Positives = 108/228 (47%), Gaps = 20/228 (8%)
Query: 541 GARCFSFEEVKKYTNNFSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFK 599
G F+ ++KY N VG G YG V K G+++AIK+ + K
Sbjct: 15 GTENLYFQSMEKYEN----LGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKM--VK 68
Query: 600 M----EIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRR 655
EI+LL ++ H+NLV+LL C + L++EFV + L D NG+ +++
Sbjct: 69 KIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQK 128
Query: 656 LKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHIT 715
+ G+ + H IIHRDIK NIL+ + K+ DFG +++++ + +
Sbjct: 129 YLFQI--INGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLA-APGEVYD 182
Query: 716 TQVKGTMGYLDPEYYM-TQQLTEKSDVYSFGVLMLELLTGRRPIERGK 762
+V T Y PE + + + DV++ G L+ E+ G P+ G
Sbjct: 183 DEVA-TRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMG-EPLFPGD 228
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 1e-21
Identities = 64/231 (27%), Positives = 103/231 (44%), Gaps = 35/231 (15%)
Query: 549 EVKKYTNNFSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQE-FKM----EI 602
+VK + + +G G + VYK Q++AIK+ + G ++ EI
Sbjct: 4 DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63
Query: 603 ELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGA 662
+LL + H N++ LL + L+++F+ D L I+ + L
Sbjct: 64 KLLQELSHPNIIGLLDAFGHKSNISLVFDFMET----D-LEV-------IIKDNSLVLTP 111
Query: 663 A----------RGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKD 712
+ +GL YLH+ I+HRD+K +N+LLDE K+ADFGL+KS +
Sbjct: 112 SHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA 168
Query: 713 HITTQVKGTMGYLDPEYYM-TQQLTEKSDVYSFGVLMLELLTGRRPIERGK 762
+ T QV T Y PE + D+++ G ++ ELL R P G
Sbjct: 169 Y-THQVV-TRWYRAPELLFGARMYGVGVDMWAVGCILAELLL-RVPFLPGD 216
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 94.9 bits (237), Expect = 1e-21
Identities = 51/215 (23%), Positives = 97/215 (45%), Gaps = 19/215 (8%)
Query: 555 NNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKM----EIELLSRVHH 610
+ +G G YG VYK G+ A+K+ + G EI +L + H
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEG--IPSTTIREISILKELKH 59
Query: 611 KNLVSLLGFCFDRGEQMLIYEFVPN--GSLGDSLSGKNGIRLDWIRRLKIALGAARGLSY 668
N+V L + +L++E + L D G G+ + + L G++Y
Sbjct: 60 SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEG--GLESVTAKSFLLQL--LNGIAY 115
Query: 669 LHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPE 728
H+ ++HRD+K N+L++ K+ADFGL+++ + + T ++ T+ Y P+
Sbjct: 116 CHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY-THEIV-TLWYRAPD 170
Query: 729 YYM-TQQLTEKSDVYSFGVLMLELLTGRRPIERGK 762
M +++ + D++S G + E++ P+ G
Sbjct: 171 VLMGSKKYSTTIDIWSVGCIFAEMVN-GTPLFPGV 204
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 3e-21
Identities = 55/230 (23%), Positives = 104/230 (45%), Gaps = 32/230 (13%)
Query: 545 FSFEEVKKYT-NNFSDANDVGSGGYGKVY----KGTLPNGQLIAIKRAQQGSMQGGQEFK 599
+ + E + + F D +G GG+G+V+ K T G+L A K+ + ++ + ++
Sbjct: 174 WKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKAT---GKLYACKKLNKKRLKKRKGYQ 230
Query: 600 M---EIELLSRVHHKNLVSLLGFCFDRGEQM-LIYEFVPNGSLGDSLSGKNGIRLDWIRR 655
E ++L++VH + +VSL + F+ + L+ + G + + I
Sbjct: 231 GAMVEKKILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDI------RYHIYNVDEDN 283
Query: 656 LKIALGAAR--------GLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMS 707
A GL +LH+ II+RD+K N+LLD+ N +++D GL+
Sbjct: 284 PGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAV--E 338
Query: 708 DSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRP 757
T GT G++ PE + ++ D ++ GV + E++ R P
Sbjct: 339 LKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 5e-21
Identities = 60/255 (23%), Positives = 96/255 (37%), Gaps = 62/255 (24%)
Query: 547 FEEVKKYTNNFSDA----NDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKME 601
+++ + + F+D D+G G Y + A+K + E
Sbjct: 10 VQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDP----TEE 65
Query: 602 IELLSR-VHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIAL 660
IE+L R H N+++L D ++ E + G L LD I +
Sbjct: 66 IEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGEL-----------LDKI----LRQ 110
Query: 661 G------AAR-------GLSYLHELANPPIIHRDIKSSNILL-DERLNA---KVADFGLS 703
A+ + YLH ++HRD+K SNIL DE N ++ DFG +
Sbjct: 111 KFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFA 167
Query: 704 KSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRP------ 757
K + +E + T T ++ PE Q D++S GVL+ +LTG P
Sbjct: 168 KQL-RAENGLLMTPC-YTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPD 225
Query: 758 ---------IERGKY 763
I GK+
Sbjct: 226 DTPEEILARIGSGKF 240
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 6e-21
Identities = 59/230 (25%), Positives = 102/230 (44%), Gaps = 44/230 (19%)
Query: 554 TNNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKM-EIELLSRVHHKN 612
+++ +G+G +G V++ L +AIK+ Q + FK E++++ V H N
Sbjct: 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQ-----DKRFKNRELQIMRIVKHPN 93
Query: 613 LVSLLGFCFDRGEQM------LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAA--- 663
+V L F + G++ L+ E+VP +++ +LK +
Sbjct: 94 VVDLKAFFYSNGDKKDEVFLNLVLEYVP-----ETVYR----ASRHYAKLKQTMPMLLIK 144
Query: 664 -------RGLSYLHELANPPIIHRDIKSSNILLDERLNA-KVADFGLSKSMSDSEK--DH 713
R L+Y+H + I HRDIK N+LLD K+ DFG +K + E +
Sbjct: 145 LYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSY 201
Query: 714 ITTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGK 762
I ++ Y PE T D++S G +M EL+ G +P+ G+
Sbjct: 202 ICSRY-----YRAPELIFGATNYTTNIDIWSTGCVMAELMQG-QPLFPGE 245
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 9e-21
Identities = 65/225 (28%), Positives = 98/225 (43%), Gaps = 41/225 (18%)
Query: 564 GSGGYGKVYKGT-LPNGQLIAIK---RAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGF 619
G G +GKV G G +A+K R + S+ + + EI+ L H +++ L
Sbjct: 25 GVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQV 84
Query: 620 CFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAAR--------GLSYLHE 671
+ ++ E+V G L D + KNG RL +R G+ Y H
Sbjct: 85 ISTPSDIFMVMEYVSGGELFDYIC-KNG-------RLDEK--ESRRLFQQILSGVDYCHR 134
Query: 672 LANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYM 731
++HRD+K N+LLD +NAK+ADFGLS MSD E + G+ Y PE
Sbjct: 135 HM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNYAAPEVIS 188
Query: 732 TQQLT-EKSDVYSFGVLMLELLTGRRP------------IERGKY 763
+ + D++S GV++ LL G P I G +
Sbjct: 189 GRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIF 233
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 1e-20
Identities = 59/219 (26%), Positives = 109/219 (49%), Gaps = 22/219 (10%)
Query: 555 NNFSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKM----EIELLSRVH 609
+ F +G+G Y VYKG G +A+K + S +G EI L+ +
Sbjct: 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEG---TPSTAIREISLMKELK 61
Query: 610 HKNLVSLLGFCFDRGEQMLIYEFVPN--GSLGDSLSGKN---GIRLDWIRRLKIALGAAR 664
H+N+V L + L++EF+ N DS + N G+ L+ ++ + L +
Sbjct: 62 HENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQL--LQ 119
Query: 665 GLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGY 724
GL++ HE I+HRD+K N+L+++R K+ DFGL+++ +++V T+ Y
Sbjct: 120 GLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTF-SSEVV-TLWY 174
Query: 725 LDPEYYM-TQQLTEKSDVYSFGVLMLELLTGRRPIERGK 762
P+ M ++ + D++S G ++ E++T +P+ G
Sbjct: 175 RAPDVLMGSRTYSTSIDIWSCGCILAEMIT-GKPLFPGT 212
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 2e-20
Identities = 56/216 (25%), Positives = 98/216 (45%), Gaps = 21/216 (9%)
Query: 555 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQGGQEFKM----EIELLSRVH 609
+ + +G G Y VYKG L+A+K + +G E+ LL +
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEG---APCTAIREVSLLKDLK 58
Query: 610 HKNLVSLLGFCFDRGEQMLIYEFVPN--GSLGDSLSGKNGIRLDWIRRLKIALGAARGLS 667
H N+V+L L++E++ D N I + ++ L RGL+
Sbjct: 59 HANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDC--GNIINMHNVKLFLFQL--LRGLA 114
Query: 668 YLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDP 727
Y H ++HRD+K N+L++ER K+ADFGL+++ S K + +V T+ Y P
Sbjct: 115 YCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY-DNEVV-TLWYRPP 169
Query: 728 EYYM-TQQLTEKSDVYSFGVLMLELLTGRRPIERGK 762
+ + + + + D++ G + E+ T RP+ G
Sbjct: 170 DILLGSTDYSTQIDMWGVGCIFYEMAT-GRPLFPGS 204
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 3e-20
Identities = 60/224 (26%), Positives = 95/224 (42%), Gaps = 26/224 (11%)
Query: 555 NNFSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQE-FKM----EIELL--- 605
+ + ++G G YG VYK +G +A+K + + GG + E+ LL
Sbjct: 9 SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRL 68
Query: 606 SRVHHKNLVSLLGFCFDRGEQ-----MLIYEFVPN--GSLGDSLSGKNGIRLDWIRRLKI 658
H N+V L+ C L++E V + D G+ + I+ L
Sbjct: 69 EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPP-GLPAETIKDLMR 127
Query: 659 ALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQV 718
RGL +LH I+HRD+K NIL+ K+ADFGL++ S +T V
Sbjct: 128 QF--LRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA--LTPVV 180
Query: 719 KGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGK 762
T+ Y PE + D++S G + E+ R+P+ G
Sbjct: 181 V-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPLFCGN 222
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 4e-20
Identities = 54/213 (25%), Positives = 88/213 (41%), Gaps = 32/213 (15%)
Query: 563 VGSGGYGKVY----KGTLPNGQLIAIKRAQQGSMQGGQE---FKMEIELLSRVHHKNLVS 615
+G G +G+V K ++ A+K + M E F+ E ++L K + +
Sbjct: 82 IGRGAFGEVAVVKLKNA---DKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITT 138
Query: 616 LLGFCF-DRGEQMLIYEFVPNGSLGDSLSGKNGI-RLDWIR----RLKIALGAARGLSYL 669
L + F D L+ ++ G L LS + R + IA+ +
Sbjct: 139 LH-YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAID------SV 191
Query: 670 HELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEY 729
H+L +HRDIK NIL+D + ++ADFG + + + V GT Y+ PE
Sbjct: 192 HQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYISPEI 247
Query: 730 YMTQQLTEKS-----DVYSFGVLMLELLTGRRP 757
+ + D +S GV M E+L G P
Sbjct: 248 LQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 4e-20
Identities = 57/225 (25%), Positives = 90/225 (40%), Gaps = 42/225 (18%)
Query: 564 GSGGYGKVYKGT-LPNGQLIAIK---RAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGF 619
G G +GKV T Q +A+K R + EI L + H +++ L
Sbjct: 18 GEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDV 77
Query: 620 CFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAAR--------GLSYLHE 671
+ +++ E+ G L D + K +R+ R + Y H
Sbjct: 78 ITTPTDIVMVIEYA-GGELFDYIVEK--------KRMTED--EGRRFFQQIICAIEYCHR 126
Query: 672 LANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYM 731
I+HRD+K N+LLD+ LN K+ADFGLS M+D + G+ Y PE
Sbjct: 127 HK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC---GSPNYAAPEVIN 180
Query: 732 TQQLT-EKSDVYSFGVLMLELLTGRRP------------IERGKY 763
+ + DV+S G+++ +L GR P + Y
Sbjct: 181 GKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVY 225
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 4e-20
Identities = 67/211 (31%), Positives = 102/211 (48%), Gaps = 33/211 (15%)
Query: 563 VGSGGYGKVY----KGTLPNGQLIAIKRAQQGSMQGGQEF--KMEIELLSRVHHKNLVSL 616
+G G +GKV+ QL A+K ++ +++ KME ++L V+H +V L
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 617 LGFCFDRGEQM-LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAAR--------GLS 667
+ F ++ LI +F+ G L LS + + + L
Sbjct: 92 H-YAFQTEGKLYLILDFLRGGDLFTRLS----------KEVMFTEEDVKFYLAELALALD 140
Query: 668 YLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSK-SMSDSEKDHITTQVKGTMGYLD 726
+LH L II+RD+K NILLDE + K+ DFGLSK S+ +K GT+ Y+
Sbjct: 141 HLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK---AYSFCGTVEYMA 194
Query: 727 PEYYMTQQLTEKSDVYSFGVLMLELLTGRRP 757
PE + T+ +D +SFGVLM E+LTG P
Sbjct: 195 PEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 5e-20
Identities = 50/217 (23%), Positives = 94/217 (43%), Gaps = 18/217 (8%)
Query: 555 NNFSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKM--EIELLSRVHHK 611
+ + +G G YG+VYK + +AIKR + + G E+ LL + H+
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHR 93
Query: 612 NLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHE 671
N++ L LI+E+ N L + + + I+ L G+++ H
Sbjct: 94 NIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQL--INGVNFCHS 150
Query: 672 LANPPIIHRDIKSSNILLDERLNA-----KVADFGLSKSMSDSEKDHITTQVKGTMGYLD 726
+HRD+K N+LL + K+ DFGL+++ + T ++ T+ Y
Sbjct: 151 ---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQF-THEII-TLWYRP 205
Query: 727 PEYYM-TQQLTEKSDVYSFGVLMLELLTGRRPIERGK 762
PE + ++ + D++S + E+L + P+ G
Sbjct: 206 PEILLGSRHYSTSVDIWSIACIWAEMLM-KTPLFPGD 241
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 5e-20
Identities = 55/203 (27%), Positives = 86/203 (42%), Gaps = 19/203 (9%)
Query: 562 DVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFC 620
D+GSG +G +L+A+K ++G+ + EI + H N+V
Sbjct: 27 DIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDEN-VQREIINHRSLRHPNIVRFKEVI 85
Query: 621 FDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRL---KIALGAARGLSYLHELANPPI 677
+I E+ G L + + D R ++ G+SY H + I
Sbjct: 86 LTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLS-----GVSYCHSMQ---I 137
Query: 678 IHRDIKSSNILLDE--RLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQL 735
HRD+K N LLD K+ DFG SKS + + V GT Y+ PE + Q+
Sbjct: 138 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK--STV-GTPAYIAPEVLLRQEY 194
Query: 736 T-EKSDVYSFGVLMLELLTGRRP 757
+ +DV+S GV + +L G P
Sbjct: 195 DGKIADVWSCGVTLYVMLVGAYP 217
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 6e-20
Identities = 52/204 (25%), Positives = 92/204 (45%), Gaps = 25/204 (12%)
Query: 563 VGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKM----EIELLSRVHHKNLVSLL 617
+G G YG V+K GQ++AIK+ + K EI +L ++ H NLV+LL
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPV--IKKIALREIRMLKQLKHPNLVNLL 68
Query: 618 GFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPI 677
+ L++E+ + L + + G+ ++ + + +++ H+
Sbjct: 69 EVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQT--LQAVNFCHKHN---C 123
Query: 678 IHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPE------YYM 731
IHRD+K NIL+ + K+ DFG ++ ++ D+ +V T Y PE Y
Sbjct: 124 IHRDVKPENILITKHSVIKLCDFGFARLLT-GPSDYYDDEV-ATRWYRSPELLVGDTQYG 181
Query: 732 TQQLTEKSDVYSFGVLMLELLTGR 755
DV++ G + ELL+G
Sbjct: 182 PP-----VDVWAIGCVFAELLSGV 200
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 6e-20
Identities = 55/270 (20%), Positives = 101/270 (37%), Gaps = 21/270 (7%)
Query: 15 TELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSN 74
+ +LDLSNN+ + + + L L+L + DS SL L L L+ N
Sbjct: 52 EAVKSLDLSNNR-ITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYN 110
Query: 75 GFSGRVPPSI-GNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGS 133
S + S LS+L +L+L N + + + L + + G
Sbjct: 111 YLS-NLSSSWFKPLSSLTFLNLLGNPYK-TLG----ETSLFSHLTKLQILRVGNMDTFTK 164
Query: 134 IPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSV 193
I K F L + D+++L P +L ++++ + + ++ +SV
Sbjct: 165 IQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSV 224
Query: 194 NDLYLSNNKL---------TGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTL 244
L L + L TG +L + +++ S +V + + L L
Sbjct: 225 ECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESL--FQVMKLLNQISGLLEL 282
Query: 245 MMENTNLKGQIPADLF-SIPHLQTVVMKTN 273
LK +P +F + LQ + + TN
Sbjct: 283 EFSRNQLKS-VPDGIFDRLTSLQKIWLHTN 311
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 3e-16
Identities = 43/226 (19%), Positives = 76/226 (33%), Gaps = 20/226 (8%)
Query: 13 GLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSI-GSLQELVLLSL 71
L L LDLS N L + L L+ L L+G + S+ L +L +L +
Sbjct: 98 SLGSLEHLDLSYNY-LSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRV 156
Query: 72 NSNGFSGRVPPSI-GNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQL 130
+ ++ L+ L L++ + L+ L + H Q
Sbjct: 157 GNMDTFTKIQRKDFAGLTFLEELEIDASDLQ-SYE-----PKSLKSIQNVSHLILHMKQH 210
Query: 131 SGSIPEKLFRPDMVLIHVLFDSNNLTG----ELPA----TLGLVKSLEVVRFDRNSLSGP 182
+ E + + +L EL +L + V+ SL
Sbjct: 211 I-LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-Q 268
Query: 183 VPSNLNNLTSVNDLYLSNNKLTGAMPN-LTGLSVLSYLDMSNNSFD 227
V LN ++ + +L S N+L L+ L + + N +D
Sbjct: 269 VMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWD 314
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 3e-07
Identities = 35/176 (19%), Positives = 70/176 (39%), Gaps = 13/176 (7%)
Query: 152 SNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNL- 210
S +L +P+ GL ++++ + N ++ S+L ++ L L++N + +
Sbjct: 40 SGSLN-SIPS--GLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSF 96
Query: 211 TGLSVLSYLDMSNNSFDASEVPS-WFSSMQSLTTLMMENTNLKGQIPADLFS-IPHLQTV 268
+ L L +LD+S N S + S WF + SLT L + K LFS + LQ +
Sbjct: 97 SSLGSLEHLDLSYNYL--SNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQIL 154
Query: 269 VMKTNELNGTLDLGTSYS-ENLLV-NLQNNRISAYTERGGAPAVNLT---LIDNPI 319
+ + + L + + + +Y + N++ L
Sbjct: 155 RVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQH 210
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 6e-20
Identities = 47/233 (20%), Positives = 88/233 (37%), Gaps = 38/233 (16%)
Query: 545 FSFEEVKKYTNNFSDANDV-----GSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEF 598
F+ + +D + G G GKV + GQ A+K + +
Sbjct: 14 VLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALK-----LLYDSPKA 68
Query: 599 KMEIELLSRV-HHKNLVSLLGFCFDRGEQM----LIYEFVPNGSLGDSLSGKNGIRL--- 650
+ E++ + ++V +L + +I E + G L + +
Sbjct: 69 RQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTER 128
Query: 651 ---DWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILL---DERLNAKVADFGLSK 704
+ +R + + +LH I HRD+K N+L ++ K+ DFG +K
Sbjct: 129 EAAEIMRDI------GTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 179
Query: 705 SMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRP 757
+ + + T T Y+ PE ++ + D++S GV+M LL G P
Sbjct: 180 ETTQNA---LQTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPP 228
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 8e-20
Identities = 61/228 (26%), Positives = 111/228 (48%), Gaps = 32/228 (14%)
Query: 555 NNFSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQE-FKM----EIELLSRV 608
+ + +G G +G+V+K GQ +A+K+ M+ +E F + EI++L +
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL---MENEKEGFPITALREIKILQLL 73
Query: 609 HHKNLVSLLGFCFDRGEQM--------LIYEFVPN--GSLGDSLSGKNGIRLDWIRRLKI 658
H+N+V+L+ C + L+++F + L ++ K L I+R+
Sbjct: 74 KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK--FTLSEIKRVMQ 131
Query: 659 ALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHI---T 715
L GL Y+H I+HRD+K++N+L+ K+ADFGL+++ S ++ T
Sbjct: 132 ML--LNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYT 186
Query: 716 TQVKGTMGYLDPEYYM-TQQLTEKSDVYSFGVLMLELLTGRRPIERGK 762
+V T+ Y PE + + D++ G +M E+ T R PI +G
Sbjct: 187 NRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPIMQGN 232
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 93.4 bits (232), Expect = 1e-19
Identities = 65/253 (25%), Positives = 110/253 (43%), Gaps = 35/253 (13%)
Query: 520 EQNPFAHWDMNKSSGSIPQLKGARCFSFEEVKKYT-NNFSDANDVGSGGYGKVY----KG 574
+ F + + Q K + E T N+FS +G GG+G+VY
Sbjct: 158 RGDVFQKFIESDKFTRFCQWK-----NVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKAD 212
Query: 575 TLPNGQLIAIKRAQQGSMQGGQEFKM---EIELLSRVHHKN---LVSLLGFCFDRGEQM- 627
T G++ A+K + ++ Q + E +LS V + +V + + F +++
Sbjct: 213 T---GKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCM-SYAFHTPDKLS 268
Query: 628 LIYEFVPNGSLGDSLSGKNGIRLDWIR--RLKIALGAARGLSYLHELANPPIIHRDIKSS 685
I + + G L LS +R +I LG L ++H +++RD+K +
Sbjct: 269 FILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILG----LEHMHNRF---VVYRDLKPA 321
Query: 686 NILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKS-DVYSF 744
NILLDE + +++D GL+ D K V GT GY+ PE + S D +S
Sbjct: 322 NILLDEHGHVRISDLGLAC---DFSKKKPHASV-GTHGYMAPEVLQKGVAYDSSADWFSL 377
Query: 745 GVLMLELLTGRRP 757
G ++ +LL G P
Sbjct: 378 GCMLFKLLRGHSP 390
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 1e-19
Identities = 49/232 (21%), Positives = 87/232 (37%), Gaps = 54/232 (23%)
Query: 554 TNNFSDANDV-------GSGGYGKVYKGT-LPNGQLIAIK---RAQQGSMQGGQEFKMEI 602
+ F D+ G G + K + Q A+K + + + Q EI
Sbjct: 3 DSPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQ------KEI 56
Query: 603 ELLSRV-HHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALG 661
L H N+V L D+ L+ E + G L + I
Sbjct: 57 TALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL-----------FERI----KKKK 101
Query: 662 ------AAR-------GLSYLHELANPPIIHRDIKSSNILL---DERLNAKVADFGLSKS 705
A+ +S++H++ ++HRD+K N+L ++ L K+ DFG ++
Sbjct: 102 HFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARL 158
Query: 706 MSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRP 757
+ + T T+ Y PE E D++S GV++ +L+G+ P
Sbjct: 159 KPP-DNQPLKTPC-FTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVP 208
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 1e-19
Identities = 70/302 (23%), Positives = 118/302 (39%), Gaps = 57/302 (18%)
Query: 14 LTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNS 73
+ H L+L+N L LP +L+ L C+ +P+ SL+ L++ + N
Sbjct: 70 DRQAHELELNNLG-LS-SLPELPPHLESLV----ASCNSLTELPELPQSLKSLLVDNNNL 123
Query: 74 NGFSGRVP---------------PSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLV 118
S P P + N S L +D+ +N L+ ++P D+
Sbjct: 124 KALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLK-KLP---------DLPP 173
Query: 119 RAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNS 178
+ G NQL +PE P + I+ D+N+L +LP SLE + N
Sbjct: 174 SLEFIAAGNNQLE-ELPELQNLPFLTAIYA--DNNSLK-KLPDLPL---SLESIVAGNNI 226
Query: 179 LSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSM 238
L L NL + +Y NN L +P+L L L++ +N +++P S+
Sbjct: 227 LE--ELPELQNLPFLTTIYADNNLLK-TLPDL--PPSLEALNVRDNYL--TDLPELPQSL 279
Query: 239 QSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENLLV-NLQNNR 297
L + L P+L + +NE+ DL +L N+ NN+
Sbjct: 280 TFLDVSENIFSGLSE-------LPPNLYYLNASSNEIRSLCDL----PPSLEELNVSNNK 328
Query: 298 IS 299
+
Sbjct: 329 LI 330
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 2e-18
Identities = 55/295 (18%), Positives = 100/295 (33%), Gaps = 48/295 (16%)
Query: 6 QLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQE 65
L L ++ NN L + NL L+ + +PD SL+
Sbjct: 206 SLKKLPDLPLSLESIVAGNNI-LE--ELPELQNLPFLTTIYADNNLLKT-LPDLPPSLEA 261
Query: 66 LVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHF 125
L + P +L+ L + + L P L + +
Sbjct: 262 LNVRDNYLTDL----PELPQSLTFLDVSENIFSGLSELP-------PNL------YYLNA 304
Query: 126 GKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPS 185
N++ S+ + L + +N L ELPA LE + N L+ VP
Sbjct: 305 SSNEIR-SLCDLPPS----LEELNVSNNKLI-ELPALPP---RLERLIASFNHLAE-VPE 354
Query: 186 NLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLM 245
NL L++ N L P++ + L M+++ +EVP Q+L L
Sbjct: 355 LPQNLKQ---LHVEYNPLR-EFPDI--PESVEDLRMNSHL---AEVP---ELPQNLKQLH 402
Query: 246 MENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENL-LVNLQNNRIS 299
+E L+ + P S+ L+ M + + + ++ L +++
Sbjct: 403 VETNPLR-EFPDIPESVEDLR---MNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 2e-18
Identities = 63/339 (18%), Positives = 108/339 (31%), Gaps = 81/339 (23%)
Query: 7 LSGDITGLTELHTLDLSNNK-----------DLRG----PLPTTIGNLKKLSNLMLVGCS 51
L L L + + + LP + N L + + S
Sbjct: 106 LPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEKLP-ELQNSSFLKIIDVDNNS 164
Query: 52 FSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVS---- 107
+PD SL+ ++ +N P + NL L + +N L+ ++P
Sbjct: 165 LKK-LPDLPPSLEF---IAAGNNQLE--ELPELQNLPFLTAIYADNNSLK-KLPDLPLSL 217
Query: 108 -----DGNS----PGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGE 158
N P L L + N L ++P+ + L +N +
Sbjct: 218 ESIVAGNNILEELPELQNLPFLTTIYADNNLLK-TLPDLPPS-----LEALNVRDNYLTD 271
Query: 159 LPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLT---GAMPNLTGLSV 215
LP + L+V + L NL L S+N++ P+L L+V
Sbjct: 272 LPELPQSLTFLDVSENIFSGL----SELPPNLYY---LNASSNEIRSLCDLPPSLEELNV 324
Query: 216 --------------LSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFS 261
L L S N +EVP Q+L L +E L+ + P S
Sbjct: 325 SNNKLIELPALPPRLERLIASFNHL--AEVP---ELPQNLKQLHVEYNPLR-EFPDIPES 378
Query: 262 IPHLQTVVMKTNELNGTLDLGTSYSENLLV-NLQNNRIS 299
+ L+ +N L +NL +++ N +
Sbjct: 379 VEDLR--------MNSHLAEVPELPQNLKQLHVETNPLR 409
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 3e-15
Identities = 55/244 (22%), Positives = 88/244 (36%), Gaps = 41/244 (16%)
Query: 56 IPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLD 115
+P +++ + + PP G + L D
Sbjct: 26 MPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDR-------------- 71
Query: 116 MLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFD 175
+A LS S+PE L ++ N+LT ELP +KSL V +
Sbjct: 72 ---QAHELELNNLGLS-SLPELPPH----LESLVASCNSLT-ELPELPQSLKSLLVDNNN 122
Query: 176 RNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWF 235
+L L L +SNN+L +P L S L +D+ NNS ++P
Sbjct: 123 LKAL----SDLPPLLEY---LGVSNNQLE-KLPELQNSSFLKIIDVDNNSL--KKLPDLP 172
Query: 236 SSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENLLVNLQN 295
SL + N L+ ++P +L ++P L + N L DL S E++ N
Sbjct: 173 P---SLEFIAAGNNQLE-ELP-ELQNLPFLTAIYADNNSLKKLPDLPLSL-ESI--VAGN 224
Query: 296 NRIS 299
N +
Sbjct: 225 NILE 228
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 1e-11
Identities = 43/233 (18%), Positives = 80/233 (34%), Gaps = 40/233 (17%)
Query: 80 VPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLF 139
+ P + + L + L E+PV N + ++ ++ + P
Sbjct: 3 INPRNVSNTFLQEPLRHSSNLT-EMPVEAEN------VKSKTEYYNAWSEWERNAPPGNG 55
Query: 140 RPDMVLIHVLFD------------SNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNL 187
+ + L D + L+ LP LE + NSL+ +P
Sbjct: 56 EQREMAVSRLRDCLDRQAHELELNNLGLS-SLPELPP---HLESLVASCNSLT-ELPELP 110
Query: 188 NNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMME 247
+L S+ + L+ P L YL +SNN ++P + L + ++
Sbjct: 111 QSLKSLLVDNNNLKALSDLPPLLE------YLGVSNNQL--EKLPE-LQNSSFLKIIDVD 161
Query: 248 NTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENLLV-NLQNNRIS 299
N +LK ++P P L+ + N+L +L L NN +
Sbjct: 162 NNSLK-KLPD---LPPSLEFIAAGNNQLEELPELQN--LPFLTAIYADNNSLK 208
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 2e-19
Identities = 50/219 (22%), Positives = 84/219 (38%), Gaps = 40/219 (18%)
Query: 564 GSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRV-HHKNLVSLLGFCF 621
G G + +V L Q A+K ++ E+E+L + H+N++ L+ F
Sbjct: 22 GEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFE 81
Query: 622 DRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLK---------IALGAARGLSYLHEL 672
+ L++E + GS+ L I + + + A L +LH
Sbjct: 82 EEDRFYLVFEKMRGGSI-----------LSHIHKRRHFNELEASVVVQDVASALDFLHNK 130
Query: 673 ANPPIIHRDIKSSNILL---DERLNAKVADFGLSKSM------SDSEKDHITTQVKGTMG 723
I HRD+K NIL ++ K+ DF L + S + T G+
Sbjct: 131 G---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC-GSAE 186
Query: 724 YLDPEYYMTQQLTEKS-----DVYSFGVLMLELLTGRRP 757
Y+ PE D++S GV++ LL+G P
Sbjct: 187 YMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 2e-19
Identities = 54/215 (25%), Positives = 90/215 (41%), Gaps = 39/215 (18%)
Query: 563 VGSGGYGKVY----KGTLPNGQLIAIKRAQQGSMQGGQE---FKMEIELLSRVHHKNLVS 615
+G G +G+V K T ++ A+K + M + F E ++++ + +V
Sbjct: 77 IGRGAFGEVQLVRHKST---RKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQ 133
Query: 616 LLGFCF-DRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAAR--------GL 666
L + F D ++ E++P G L ++ + + AR L
Sbjct: 134 LF-YAFQDDRYLYMVMEYMPGGDL-----------VNLMSNYDVPEKWARFYTAEVVLAL 181
Query: 667 SYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLD 726
+H + IHRD+K N+LLD+ + K+ADFG M+ T V GT Y+
Sbjct: 182 DAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYIS 237
Query: 727 PEYYMTQQLTEK----SDVYSFGVLMLELLTGRRP 757
PE +Q D +S GV + E+L G P
Sbjct: 238 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 3e-19
Identities = 57/206 (27%), Positives = 88/206 (42%), Gaps = 24/206 (11%)
Query: 563 VGSGGYGKVY----KGTLPNGQLIAIKRAQQGSMQGGQEF---KMEIELLSRVHHKNLVS 615
+G G +GKV K T G+ A+K ++ + E E +L H L +
Sbjct: 156 LGKGTFGKVILVKEKAT---GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 212
Query: 616 LLGFCFDRGEQM-LIYEFVPNGSLGDSLSGKNGIRLDWIR--RLKIALGAARGLSYLHEL 672
L + F +++ + E+ G L LS + D R +I L YLH
Sbjct: 213 LK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSA----LDYLHSE 267
Query: 673 ANPPIIHRDIKSSNILLDERLNAKVADFGLSK-SMSDSEKDHITTQVKGTMGYLDPEYYM 731
N +++RD+K N++LD+ + K+ DFGL K + D GT YL PE
Sbjct: 268 KN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT---MKTFCGTPEYLAPEVLE 322
Query: 732 TQQLTEKSDVYSFGVLMLELLTGRRP 757
D + GV+M E++ GR P
Sbjct: 323 DNDYGRAVDWWGLGVVMYEMMCGRLP 348
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 4e-19
Identities = 46/228 (20%), Positives = 78/228 (34%), Gaps = 19/228 (8%)
Query: 8 SGDITGLTELHTLDLSNNK-DLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQEL 66
G LT+L L LS+N +G + L L L + + L++L
Sbjct: 45 HGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQL 103
Query: 67 VLLSLNSNGFSGRVPPSI-GNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHF 125
L + S+ +L NL +LD++ +G GL L +
Sbjct: 104 EHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRV---AFNGIFNGLSSL---EVLKM 157
Query: 126 GKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATL--GLVKSLEVVRFDRNSLSGPV 183
N + +F L + L +L T L SL+V+ N+
Sbjct: 158 AGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSL-SSLQVLNMSHNNFFSLD 215
Query: 184 PSNLNNLTSVNDLYLSNNKLT----GAMPNLTGLSVLSYLDMSNNSFD 227
L S+ L S N + + + S L++L+++ N F
Sbjct: 216 TFPYKCLNSLQVLDYSLNHIMTSKKQELQHF--PSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 2e-16
Identities = 47/239 (19%), Positives = 78/239 (32%), Gaps = 14/239 (5%)
Query: 15 TELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGC--SFSGPIPDSIGSLQELVLLSLN 72
+ L+L +NK L+ L +L+ L L SF G S L L L+
Sbjct: 28 SSATRLELESNK-LQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLS 86
Query: 73 SNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSG 132
NG + + L L LD + L+ ++ L L +
Sbjct: 87 FNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMS-EFSVFLSLRNL---IYLDISHTHTR- 139
Query: 133 SIPEKLFRPDMVLIHVLFDSNNLTGELPA-TLGLVKSLEVVRFDRNSLSGPVPSNLNNLT 191
+F L + N+ +++L + + L P+ N+L+
Sbjct: 140 VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLS 199
Query: 192 SVNDLYLSNNKLTGAMPN-LTGLSVLSYLDMSNNSFDASEVPSWFSSMQ-SLTTLMMEN 248
S+ L +S+N L+ L LD S N S+ SL L +
Sbjct: 200 SLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSK-KQELQHFPSSLAFLNLTQ 257
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 1e-12
Identities = 35/172 (20%), Positives = 64/172 (37%), Gaps = 9/172 (5%)
Query: 133 SIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLS--GPVPSNLNNL 190
S+P + + +SN L + L + N LS G +
Sbjct: 21 SVPTGIPSS---ATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGT 77
Query: 191 TSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTN 250
TS+ L LS N + N GL L +LD +++ S F S+++L L + +T+
Sbjct: 78 TSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTH 137
Query: 251 LKGQIPADLFS-IPHLQTVVMKTNELNGTLDLGT-SYSENLLV-NLQNNRIS 299
+ +F+ + L+ + M N + NL +L ++
Sbjct: 138 TR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE 188
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 1e-12
Identities = 34/178 (19%), Positives = 62/178 (34%), Gaps = 11/178 (6%)
Query: 6 QLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQE 65
+S + GL +L LD ++ + + +L+ L L + L
Sbjct: 92 TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSS 151
Query: 66 LVLLSLNSNGFSGRVPPSI-GNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFH 124
L +L + N F P I L NL +LDL+ +LE +S L L + +
Sbjct: 152 LEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQ---LSPTAFNSLSSL---QVLN 205
Query: 125 FGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATL--GLVKSLEVVRFDRNSLS 180
N S+ ++ L + + N++ SL + +N +
Sbjct: 206 MSHNNFF-SLDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 3e-05
Identities = 25/100 (25%), Positives = 35/100 (35%), Gaps = 4/100 (4%)
Query: 3 LKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGS 62
+ L T L L LDLS + L PT +L L L + +F
Sbjct: 163 QENFLPDIFTELRNLTFLDLSQCQ-LEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKC 221
Query: 63 LQELVLLSLNSNGFSGRVPPSI--GNLSNLYWLDLTDNKL 100
L L +L + N S+L +L+LT N
Sbjct: 222 LNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNLTQNDF 260
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 5e-19
Identities = 60/257 (23%), Positives = 93/257 (36%), Gaps = 56/257 (21%)
Query: 547 FEEVKKYTNNFSDANDVGSGGYGKVYKGTLPNGQLIAIKR--AQQGSMQGGQEFKM---- 600
YT + SG YG V G G +AIKR +
Sbjct: 18 HAMQSPYTV----QRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLC 73
Query: 601 -----EIELLSRVHHKNLVSLLG-FCFDRGEQM----LIYEFVPNGSLGDSLSGKNGIRL 650
EI LL+ HH N++ L F M L+ E +
Sbjct: 74 KRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT--------------- 118
Query: 651 DW---IRRLKIALGAA----------RGLSYLHELANPPIIHRDIKSSNILLDERLNAKV 697
D I +I + GL LHE A ++HRD+ NILL + + +
Sbjct: 119 DLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHE-AG--VVHRDLHPGNILLADNNDITI 175
Query: 698 ADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRR 756
DF L++ D+ + T V Y PE M + T+ D++S G +M E+ R+
Sbjct: 176 CDFNLAR--EDTADANKTHYV-THRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMF-NRK 231
Query: 757 PIERGKYIVREIRTVMD 773
+ RG ++ +++
Sbjct: 232 ALFRGSTFYNQLNKIVE 248
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 5e-19
Identities = 59/224 (26%), Positives = 99/224 (44%), Gaps = 28/224 (12%)
Query: 555 NNFSDANDVGSGGYGKVYKG--TLPNGQLIAIKRAQQGSMQGGQEFKM----EIELL--- 605
+ ++G G YGKV+K G+ +A+KR + + + G + E+ +L
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG--MPLSTIREVAVLRHL 68
Query: 606 SRVHHKNLVSLLGFCFDRGEQ-----MLIYEFVPN--GSLGDSLSGKNGIRLDWIRRLKI 658
H N+V L C L++E V + D + G+ + I+ +
Sbjct: 69 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEP-GVPTETIKDMMF 127
Query: 659 ALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQV 718
L RGL +LH ++HRD+K NIL+ K+ADFGL++ S +T+ V
Sbjct: 128 QL--LRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA--LTSVV 180
Query: 719 KGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGK 762
T+ Y PE + D++S G + E+ R+P+ RG
Sbjct: 181 V-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPLFRGS 222
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 88.4 bits (219), Expect = 6e-19
Identities = 50/192 (26%), Positives = 80/192 (41%), Gaps = 46/192 (23%)
Query: 656 LKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHIT 715
+ + A+G+ +L A+ IHRD+ + NILL E+ K+ DFGL++ +
Sbjct: 196 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP----- 247
Query: 716 TQVKGTMGYLD-----PEYYMTQQLTEKSDVYSFGVLMLELLT-GRRP---IERGKYIVR 766
V+ L PE + T +SDV+SFGVL+ E+ + G P ++ + R
Sbjct: 248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 307
Query: 767 EIR--TVMDK----KKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMS 820
++ T M E+Y L C RPT S
Sbjct: 308 RLKEGTRMRAPDYTTPEMY-----------------------QTMLDCWHGEPSQRPTFS 344
Query: 821 EVVKDIENILQQ 832
E+V+ + N+LQ
Sbjct: 345 ELVEHLGNLLQA 356
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 6e-19
Identities = 57/218 (26%), Positives = 84/218 (38%), Gaps = 49/218 (22%)
Query: 563 VGSGGYGKV----YKGTLPNGQLIAIK---------RAQQGSMQGGQEFKMEIELLSRVH 609
+G G +GKV K T G+ A+K + + E +L
Sbjct: 13 LGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHT------VTESRVLQNTR 63
Query: 610 HKNLVSLLGFCFDRGEQM-LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAAR---- 664
H L +L + F +++ + E+ G L LS R AR
Sbjct: 64 HPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLS----------RERVFTEERARFYGA 112
Query: 665 ----GLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSK-SMSDSEKDHITTQVK 719
L YLH +++RDIK N++LD+ + K+ DFGL K +SD
Sbjct: 113 EIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT---MKTFC 166
Query: 720 GTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRP 757
GT YL PE D + GV+M E++ GR P
Sbjct: 167 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 87.6 bits (218), Expect = 8e-19
Identities = 63/216 (29%), Positives = 97/216 (44%), Gaps = 41/216 (18%)
Query: 563 VGSGGYGKVY-------KGTLPNGQLIAIKRAQQGS-MQGGQEF---KMEIELLSRVHHK 611
+G GGYGKV+ T G++ A+K ++ ++ ++ K E +L V H
Sbjct: 25 LGKGGYGKVFQVRKVTGANT---GKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHP 81
Query: 612 NLVSLLGFCFDRGEQM-LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAAR------ 664
+V L+ + F G ++ LI E++ G L L R A
Sbjct: 82 FIVDLI-YAFQTGGKLYLILEYLSGGELFMQLE----------REGIFMEDTACFYLAEI 130
Query: 665 --GLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSK-SMSDSEKDHITTQVKGT 721
L +LH+ II+RD+K NI+L+ + + K+ DFGL K S+ D T GT
Sbjct: 131 SMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTV---THTFCGT 184
Query: 722 MGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRP 757
+ Y+ PE M D +S G LM ++LTG P
Sbjct: 185 IEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 2e-18
Identities = 49/209 (23%), Positives = 86/209 (41%), Gaps = 32/209 (15%)
Query: 564 GSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRV-HHKNLVSLLGFCF 621
G G GKV + + A+K +Q + + E+EL R ++V ++
Sbjct: 71 GLGINGKVLQIFNKRTQEKFALK-----MLQDCPKARREVELHWRASQCPHIVRIVDVYE 125
Query: 622 DRGEQM----LIYEFVPNGSLGDSLSGKNGIRL------DWIRRLKIALGAARGLSYLHE 671
+ ++ E + G L + + + ++ + + YLH
Sbjct: 126 NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSI------GEAIQYLHS 179
Query: 672 LANPPIIHRDIKSSNILL-DERLNA--KVADFGLSKSMSDSEKDHITTQVKGTMGYLDPE 728
+ I HRD+K N+L +R NA K+ DFG +K + +TT T Y+ PE
Sbjct: 180 IN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS--LTTPC-YTPYYVAPE 233
Query: 729 YYMTQQLTEKSDVYSFGVLMLELLTGRRP 757
++ + D++S GV+M LL G P
Sbjct: 234 VLGPEKYDKSCDMWSLGVIMYILLCGYPP 262
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 2e-18
Identities = 57/241 (23%), Positives = 99/241 (41%), Gaps = 45/241 (18%)
Query: 554 TNNFSDANDVGSGGYGKVYKGT-LPNGQLIAIK---RAQQGSMQGGQEFKMEIELLSRVH 609
+ + +GSG G V + +AIK R Q + ++ E+ L+ V+
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVN 82
Query: 610 HKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRL-------DWIRRLKIALGA 662
HKN++ LL F P SL + + + + + +++ L
Sbjct: 83 HKNIIGLLNV------------FTPQKSLEE----FQDVYIVMELMDANLCQVIQMELDH 126
Query: 663 A----------RGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKD 712
G+ +LH A IIHRD+K SNI++ K+ DFGL+++ S
Sbjct: 127 ERMSYLLYQMLCGIKHLHS-AG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--F 181
Query: 713 HITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVM 772
+T V T Y PE + E D++S G +M E++ G + G + + V+
Sbjct: 182 MMTPYV-VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG-GVLFPGTDHIDQWNKVI 239
Query: 773 D 773
+
Sbjct: 240 E 240
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 3e-18
Identities = 60/283 (21%), Positives = 91/283 (32%), Gaps = 40/283 (14%)
Query: 43 SNLMLVGCSFSG--PIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKL 100
+ V C+ G +P I L+L N + +L +L L L N +
Sbjct: 54 NQFSKVVCTRRGLSEVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSI 111
Query: 101 EGEIPVSDGNSPG-LDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGEL 159
+I G + L N L+ IP F L + +N +
Sbjct: 112 R-QIE------VGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIESIP 163
Query: 160 PATLGLVKSLEVVRFDR-NSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSY 218
V SL + L L ++ L L + MPNLT L L
Sbjct: 164 SYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMPNLTPLVGLEE 222
Query: 219 LDMSNNSFDASEVPS-WFSSMQSLTTLMMENTNLKGQIPADLFS-IPHLQTVVMKTNELN 276
L+MS N F E+ F + SL L + N+ + I + F + L + + N L
Sbjct: 223 LEMSGNHF--PEIRPGSFHGLSSLKKLWVMNSQVS-LIERNAFDGLASLVELNLAHNNL- 278
Query: 277 GTLDLGTSYSENLLVNLQNNRISAYTERGGAPAVNLTLIDNPI 319
+S +L L+ L L NP
Sbjct: 279 ------SSLPHDLFTPLRYLV-------------ELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 2e-16
Identities = 48/244 (19%), Positives = 88/244 (36%), Gaps = 39/244 (15%)
Query: 8 SGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELV 67
+ L L L L N +R L L+ L L + + L +L
Sbjct: 92 ADTFRHLHHLEVLQLGRNS-IRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLR 150
Query: 68 LLSLNSNGFSGRVPPSI-GNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFG 126
L L +N +P + +L LDL +
Sbjct: 151 ELWLRNNPIE-SIPSYAFNRVPSLMRLDLGEL---------------------------- 181
Query: 127 KNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSN 186
+L I E F L ++ N+ ++P LV LE + N P +
Sbjct: 182 -KKLE-YISEGAFEGLFNLKYLNLGMCNIK-DMPNLTPLV-GLEELEMSGNHFPEIRPGS 237
Query: 187 LNNLTSVNDLYLSNNKLTGAMPN-LTGLSVLSYLDMSNNSFDASEVP-SWFSSMQSLTTL 244
+ L+S+ L++ N++++ N GL+ L L++++N+ S +P F+ ++ L L
Sbjct: 238 FHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNL--SSLPHDLFTPLRYLVEL 295
Query: 245 MMEN 248
+ +
Sbjct: 296 HLHH 299
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 5e-14
Identities = 45/219 (20%), Positives = 74/219 (33%), Gaps = 38/219 (17%)
Query: 12 TGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSI-GSLQELVLLS 70
GL L+TL+L +N L L KL L L IP + L+ L
Sbjct: 120 NGLASLNTLELFDNW-LTVIPSGAFEYLSKLRELWLRNNPIES-IPSYAFNRVPSLMRLD 177
Query: 71 LNSNGFSGRVPPSI-GNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQ 129
L + L NL +L+L ++ + P L LV + N
Sbjct: 178 LGELKKLEYISEGAFEGLFNLKYLNLGMCNIK--------DMPNLTPLVGLEELEMSGNH 229
Query: 130 LSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNN 189
I F L+ SL+ + + +S + +
Sbjct: 230 FP-EIRPGSFH-------------GLS-----------SLKKLWVMNSQVSLIERNAFDG 264
Query: 190 LTSVNDLYLSNNKLTGAMPN-LTGLSVLSYLDMSNNSFD 227
L S+ +L L++N L+ + T L L L + +N ++
Sbjct: 265 LASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWN 303
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 87.7 bits (217), Expect = 4e-18
Identities = 51/277 (18%), Positives = 91/277 (32%), Gaps = 43/277 (15%)
Query: 6 QLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKL--SNLMLVGCSFSGPIPDSIGSL 63
+ + N+ + I +L + L L +PD++
Sbjct: 28 DYFSAWDKWEKQALPGENRNEAVSLLKECLINQFSELQLNRLNLSS------LPDNLP-- 79
Query: 64 QELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHF 123
++ +L + N +P +L +LD DN+L +P + LD+
Sbjct: 80 PQITVLEITQNALI-SLPELPASLE---YLDACDNRLS-TLPELPASLKHLDV------- 127
Query: 124 HFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPV 183
NQL+ +PE L ++ D+N LT LP SLEV+ N L+ +
Sbjct: 128 --DNNQLT-MLPELPAL----LEYINADNNQLT-MLPELPT---SLEVLSVRNNQLTF-L 175
Query: 184 PSNLNNLTSVNDLYLSNNKLTG---AMPNLTGL-SVLSYLDMSNNSFDASEVPSWFSSMQ 239
P +L L +S N L + N + +P S+
Sbjct: 176 PELPESLE---ALDVSTNLLESLPAVPVRNHHSEETEIFFRCRENRI--THIPENILSLD 230
Query: 240 SLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELN 276
T+++E+ L +I L +
Sbjct: 231 PTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFS 267
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 48.0 bits (114), Expect = 1e-05
Identities = 18/99 (18%), Positives = 27/99 (27%), Gaps = 7/99 (7%)
Query: 14 LTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSG----PIPDSIGSLQELVLL 69
L LD+S N L LP + IP++I SL +
Sbjct: 179 PESLEALDVSTNL-LES-LPAVPVRNHHSEET-EIFFRCRENRITHIPENILSLDPTCTI 235
Query: 70 SLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSD 108
L N S R+ S+ + +
Sbjct: 236 ILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQN 274
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 86.4 bits (214), Expect = 7e-18
Identities = 64/272 (23%), Positives = 117/272 (43%), Gaps = 34/272 (12%)
Query: 516 EKANEQNPFAHWDMNKSSGSIP----QLKGARCFSFEEVKKYTNNFSDANDVGSGGYGKV 571
++ + H++M+KS ++ + F +K+Y + +GSG G V
Sbjct: 26 KQVDVSYIAKHYNMSKSKVDNQFYSVEVGDST---FTVLKRYQ----NLKPIGSGAQGIV 78
Query: 572 YKGT-LPNGQLIAIK---RAQQGSMQGGQEFKMEIELLSRVHHKNLVSLL------GFCF 621
+ +AIK R Q + ++ E+ L+ V+HKN++SLL
Sbjct: 79 CAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVFTPQKTLE 137
Query: 622 DRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRD 681
+ + L+ E + +L + LD R + G+ +LH A IIHRD
Sbjct: 138 EFQDVYLVMEL-----MDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS-AG--IIHRD 189
Query: 682 IKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDV 741
+K SNI++ K+ DFGL+++ +T V T Y PE + E D+
Sbjct: 190 LKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYV-VTRYYRAPEVILGMGYKENVDI 246
Query: 742 YSFGVLMLELLTGRRPIERGKYIVREIRTVMD 773
+S G +M E++ + + G+ + + V++
Sbjct: 247 WSVGCIMGEMVRH-KILFPGRDYIDQWNKVIE 277
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 1e-17
Identities = 52/218 (23%), Positives = 91/218 (41%), Gaps = 25/218 (11%)
Query: 563 VGSGGYGKVYKG---TLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGF 619
VG G YG VYK + + A+K+ + + EI LL + H N++SL
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS--MSACREIALLRELKHPNVISLQKV 86
Query: 620 CFDRGEQ--MLIYEFVPN------GSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHE 671
++ L++++ + S + K ++L + G+ YLH
Sbjct: 87 FLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA 146
Query: 672 LANPPIIHRDIKSSNILLDERLNA----KVADFGLSKSMSDSEKD--HITTQVKGTMGYL 725
++HRD+K +NIL+ K+AD G ++ + K + V T Y
Sbjct: 147 NW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TFWYR 202
Query: 726 DPEYYM-TQQLTEKSDVYSFGVLMLELLTGRRPIERGK 762
PE + + T+ D+++ G + ELLT PI +
Sbjct: 203 APELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCR 239
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 86.6 bits (214), Expect = 1e-17
Identities = 57/207 (27%), Positives = 94/207 (45%), Gaps = 26/207 (12%)
Query: 563 VGSGGYGKV----YKGTLPNGQLIAIKRAQQGSMQGGQEF---KMEIELLSRV-HHKNLV 614
+G G +GKV KGT +L A+K ++ + + +E +L+ L
Sbjct: 349 LGKGSFGKVMLSERKGT---DELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLT 405
Query: 615 SLLGFCFDRGEQM-LIYEFVPNGSLGDSLSGKNGIRLDWIR--RLKIALGAARGLSYLHE 671
L CF +++ + E+V G L + + +IA+G L +L
Sbjct: 406 QLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIG----LFFLQS 460
Query: 672 LANPPIIHRDIKSSNILLDERLNAKVADFGLSK-SMSDSEKDHITTQVKGTMGYLDPEYY 730
II+RD+K N++LD + K+ADFG+ K ++ D T GT Y+ PE
Sbjct: 461 KG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT---TKTFCGTPDYIAPEII 514
Query: 731 MTQQLTEKSDVYSFGVLMLELLTGRRP 757
Q + D ++FGVL+ E+L G+ P
Sbjct: 515 AYQPYGKSVDWWAFGVLLYEMLAGQAP 541
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 2e-17
Identities = 56/219 (25%), Positives = 88/219 (40%), Gaps = 50/219 (22%)
Query: 563 VGSGGYGKV----YKGTLPNGQLIAIK---------RAQQGSMQGGQEFKMEIELLSRV- 608
+G G +GKV KGT +L A+K +E +L+
Sbjct: 28 LGKGSFGKVMLSERKGT---DELYAVKILKKDVVIQDDDVECT------MVEKRVLALPG 78
Query: 609 HHKNLVSLLGFCFDRGEQM-LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAAR--- 664
L L CF +++ + E+V G L + + + A
Sbjct: 79 KPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQ----------QVGRFKEPHAVFYA 127
Query: 665 -----GLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSK-SMSDSEKDHITTQV 718
GL +L II+RD+K N++LD + K+ADFG+ K ++ D T
Sbjct: 128 AEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT---TKTF 181
Query: 719 KGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRP 757
GT Y+ PE Q + D ++FGVL+ E+L G+ P
Sbjct: 182 CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 220
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 2e-17
Identities = 67/277 (24%), Positives = 109/277 (39%), Gaps = 44/277 (15%)
Query: 508 AYHQKRRAEKANEQNPFAHWDMNKSSGSIPQLKGARCFSFEEVKKYTNNFSDAND----- 562
A+H E+ A + G L + + +
Sbjct: 2 AHHHHHHEEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVG-IENFELLK 60
Query: 563 -VGSGGYGKVY----KGTLPNGQLIAIKRAQQGSMQGGQEF----KMEIELLSRV-HHKN 612
+G+G YGKV+ G+L A+K ++ ++ + + E ++L +
Sbjct: 61 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 120
Query: 613 LVSLLGFCF-DRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAAR------- 664
LV+L + F + LI +++ G L LS +R + +
Sbjct: 121 LVTLH-YAFQTETKLHLILDYINGGELFTHLS----------QRERFTEHEVQIYVGEIV 169
Query: 665 -GLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSK-SMSDSEKDHITTQVKGTM 722
L +LH+L II+RDIK NILLD + + DFGLSK ++D + GT+
Sbjct: 170 LALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD--ETERAYDFCGTI 224
Query: 723 GYLDPE--YYMTQQLTEKSDVYSFGVLMLELLTGRRP 757
Y+ P+ + D +S GVLM ELLTG P
Sbjct: 225 EYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 3e-17
Identities = 49/254 (19%), Positives = 99/254 (38%), Gaps = 59/254 (23%)
Query: 554 TNNFSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKM-EIELLSRVHHK 611
+ +S +G+G +G V + + +G+ A+K+ Q +K E++++ + H
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQD-----PRYKNRELDIMKVLDHV 60
Query: 612 NLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWI------------------ 653
N++ L+ + + G++ P+
Sbjct: 61 NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120
Query: 654 -----RRLKIALGAA----------------RGLSYLHELANPPIIHRDIKSSNILLDER 692
+ LK + + R + ++H I HRDIK N+L++ +
Sbjct: 121 PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS-LG--ICHRDIKPQNLLVNSK 177
Query: 693 LNA-KVADFGLSKSMSDSEK--DHITTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLM 748
N K+ DFG +K + SE +I ++ Y PE + + T D++S G +
Sbjct: 178 DNTLKLCDFGSAKKLIPSEPSVAYICSRF-----YRAPELMLGATEYTPSIDLWSIGCVF 232
Query: 749 LELLTGRRPIERGK 762
EL+ G +P+ G+
Sbjct: 233 GELILG-KPLFSGE 245
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 4e-17
Identities = 54/292 (18%), Positives = 102/292 (34%), Gaps = 41/292 (14%)
Query: 10 DITGLTELHTLDLSNNK--DLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELV 67
L L +LD N+ D+ G I L L+ L+ + + + + L
Sbjct: 37 SEEQLATLTSLDCHNSSITDMTG-----IEKLTGLTKLICTSNNITT-LD--LSQNTNLT 88
Query: 68 LLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGK 127
L+ +SN + + L+ L +L+ NKL ++ VS +P L L + +
Sbjct: 89 YLACDSNKLTN---LDVTPLTKLTYLNCDTNKLT-KLDVS--QNPLLTYL------NCAR 136
Query: 128 NQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNL 187
N L+ I L + N +L + L + N ++ ++
Sbjct: 137 NTLT-EIDVSHNT---QLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKITE---LDV 187
Query: 188 NNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMME 247
+ +N L N +T +L L++LD S+N +E+ + + LT
Sbjct: 188 SQNKLLNRLNCDTNNIT--KLDLNQNIQLTFLDCSSNKL--TEID--VTPLTQLTYFDCS 241
Query: 248 NTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENLLVNLQNNRIS 299
L ++ L T+ +L +DL + +I
Sbjct: 242 VNPLT-ELDVSTL--SKLTTLHCIQTDLL-EIDLTHNTQLIYFQAEGCRKIK 289
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 2e-15
Identities = 54/291 (18%), Positives = 98/291 (33%), Gaps = 40/291 (13%)
Query: 10 DITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLL 69
D++ T L L +NK + L KL+ L + + L L
Sbjct: 80 DLSQNTNLTYLACDSNKLTNLD----VTPLTKLTYLNCDTNKLT---KLDVSQNPLLTYL 132
Query: 70 SLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQ 129
+ N + + + + L LD NK ++ V+ L L N+
Sbjct: 133 NCARNTLT---EIDVSHNTQLTELDCHLNKKITKLDVT--PQTQLTTL------DCSFNK 181
Query: 130 LSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNN 189
++ + L + D+NN+T +L L L + N L+ ++
Sbjct: 182 ITELDVSQNKL----LNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLTE---IDVTP 231
Query: 190 LTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENT 249
LT + S N LT +++ LS L+ L E+ + L E
Sbjct: 232 LTQLTYFDCSVNPLT--ELDVSTLSKLTTLHCIQTDL--LEID--LTHNTQLIYFQAEGC 285
Query: 250 NLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENLLV-NLQNNRIS 299
++ D+ L + + + LDL S + L+ L N ++
Sbjct: 286 RKIKEL--DVTHNTQLYLLDCQAAGIT-ELDL--SQNPKLVYLYLNNTELT 331
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 2e-15
Identities = 75/401 (18%), Positives = 130/401 (32%), Gaps = 49/401 (12%)
Query: 10 DITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLL 69
D+T LT+L L+ NK T ++ + L + C+ + + +L L
Sbjct: 101 DVTPLTKLTYLNCDTNK-------LTKLDVSQNPLLTYLNCARNTLTEIDVSHNTQLTEL 153
Query: 70 SLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQ 129
+ N + + L LD + NK+ E+ VS + L + N
Sbjct: 154 DCHLNKKIT--KLDVTPQTQLTTLDCSFNKIT-ELDVS--QNKLL------NRLNCDTNN 202
Query: 130 LSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNN 189
++ + ++ L + SN LT E+ + + L N L+ S L+
Sbjct: 203 IT-KLD---LNQNIQLTFLDCSSNKLT-EID--VTPLTQLTYFDCSVNPLTELDVSTLSK 255
Query: 190 LTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENT 249
LT+ L+ L +LT + L Y + L L +
Sbjct: 256 LTT---LHCIQTDLLEI--DLTHNTQLIYFQAEGCRKIKELD---VTHNTQLYLLDCQAA 307
Query: 250 NLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENL-LVNLQNNRISAYTERGGAP 308
+ DL P L + + EL LD+ S++ L ++ N I ++ G P
Sbjct: 308 GIT---ELDLSQNPKLVYLYLNNTELT-ELDV--SHNTKLKSLSCVNAHIQDFSSVGKIP 361
Query: 309 AVNLTLIDNPICQELGTAKGYCQLSQPISPYSTKQKNCLPAPCNANQSSSPNCQCAYPYT 368
L Q + K + S + N + T
Sbjct: 362 --ALNNNFEAEGQTITMPKETLTNNSLTIAVSPDLLDQFG---NPMNIEPGDGGVYDQAT 416
Query: 369 GTLVFRSLSFSDLGNTTY---YEILEQSVTTSFQSTYKLPI 406
T+ + +LS +D TY E T + PI
Sbjct: 417 NTITWENLS-TDNPAVTYTFTSENGAIVGTVTTPFEAPQPI 456
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 1e-14
Identities = 63/331 (19%), Positives = 105/331 (31%), Gaps = 39/331 (11%)
Query: 8 SGDITGLTELHTLDLSNNK--DLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQE 65
D+T T+L TLD S NK +L + K L+ L + + + +
Sbjct: 163 KLDVTPQTQLTTLDCSFNKITEL------DVSQNKLLNRLNCDTNNITKL---DLNQNIQ 213
Query: 66 LVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHF 125
L L +SN + + L+ L + D + N L E+ VS L L H
Sbjct: 214 LTFLDCSSNKLTE---IDVTPLTQLTYFDCSVNPLT-ELDVS--TLSKLTTL------HC 261
Query: 126 GKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPS 185
+ L I + LI+ + EL + L ++ ++ S
Sbjct: 262 IQTDLL-EID---LTHNTQLIYFQAEGCRKIKELD--VTHNTQLYLLDCQAAGITELDLS 315
Query: 186 NLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLM 245
L LYL+N +LT + ++ + L L N + S + +L
Sbjct: 316 QNPKLVY---LYLNNTELT-ELD-VSHNTKLKSLSCVNAHI--QDFSS-VGKIPALNNNF 367
Query: 246 MENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENLLVNLQNNRISAYTERG 305
L + V + G + + + + N I+
Sbjct: 368 EAEGQTITMPKETLTNNSLTIAVSPDLLDQFGNP-MNIEPGDGGVYDQATNTITWENLST 426
Query: 306 GAPAVNLTLIDNPICQELGTAKGYCQLSQPI 336
PAV T GT + QPI
Sbjct: 427 DNPAVTYTFTSENGAIV-GTVTTPFEAPQPI 456
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 8e-12
Identities = 50/281 (17%), Positives = 94/281 (33%), Gaps = 33/281 (11%)
Query: 40 KKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNK 99
++ + S L L L +++ + I L+ L L T N
Sbjct: 18 DNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITD--MTGIEKLTGLTKLICTSNN 75
Query: 100 LEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGEL 159
+ + +S L + N+L+ ++ P L ++ D+N LT +L
Sbjct: 76 IT-TLDLS-----QNTNL---TYLACDSNKLT-NLD---VTPLTKLTYLNCDTNKLT-KL 121
Query: 160 PATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYL 219
+ L + RN+L+ S+ LT L NK ++T + L+ L
Sbjct: 122 D--VSQNPLLTYLNCARNTLTEIDVSHNTQLTE---LDCHLNKKIT-KLDVTPQTQLTTL 175
Query: 220 DMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTL 279
D S N + S + L L + N+ DL L + +N+L +
Sbjct: 176 DCSFNKITELD----VSQNKLLNRLNCDTNNITK---LDLNQNIQLTFLDCSSNKLT-EI 227
Query: 280 DLGT-SYSENLLVNLQNNRISAYTERGGAPAVNLTLIDNPI 319
D+ + + N ++ + L I +
Sbjct: 228 DVTPLTQLTYF--DCSVNPLTELDVSTLSKLTTLHCIQTDL 266
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 3e-06
Identities = 29/180 (16%), Positives = 63/180 (35%), Gaps = 14/180 (7%)
Query: 141 PDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSN 200
PD + + + + + +L + +S++ + + LT + L ++
Sbjct: 16 PDDNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITDM--TGIEKLTGLTKLICTS 73
Query: 201 NKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLF 260
N +T +L+ + L+YL +N + + + + LT L + L D+
Sbjct: 74 NNITT--LDLSQNTNLTYLACDSNKL--TNLD--VTPLTKLTYLNCDTNKLT---KLDVS 124
Query: 261 SIPHLQTVVMKTNELNGTLDLGTSYSENLLVNLQNNRISAYTERGGAPA-VNLTLIDNPI 319
P L + N L +D+ + L + N+ + L N I
Sbjct: 125 QNPLLTYLNCARNTLT-EIDVSHNTQLTEL-DCHLNKKITKLDVTPQTQLTTLDCSFNKI 182
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 82.6 bits (204), Expect = 5e-17
Identities = 47/223 (21%), Positives = 73/223 (32%), Gaps = 17/223 (7%)
Query: 8 SGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSI-GSLQEL 66
G +G +L +++S N L NL KL + + + I +L L
Sbjct: 47 KGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNL 106
Query: 67 VLLSLNSNGFSGRVPPSI-GNLSNLYWLDLTDNKLEGEIP--VSDGNSPGLDMLVRAKHF 123
L +++ G +P + LD+ DN I G S +L
Sbjct: 107 QYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVIL------ 159
Query: 124 HFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPA-TLGLVKSLEVVRFDRNSLSGP 182
KN + I F + L D+NNL ELP ++ R +
Sbjct: 160 WLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTRIHSL 217
Query: 183 VPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNS 225
L NL + N K +P L L L ++ S
Sbjct: 218 PSYGLENLKKLRARSTYNLK---KLPTLEKLVALMEASLTYPS 257
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 51.0 bits (122), Expect = 9e-07
Identities = 25/155 (16%), Positives = 57/155 (36%), Gaps = 10/155 (6%)
Query: 151 DSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPN- 209
+ +T E+P+ L ++ +RF L + + + +S N + +
Sbjct: 17 QESKVT-EIPS--DLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEAD 73
Query: 210 -LTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLF-SIPHLQT 267
+ L L + + + P F ++ +L L++ NT +K +P
Sbjct: 74 VFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVL 132
Query: 268 VVMKTNELNGTLDLGT--SYSENLLV-NLQNNRIS 299
+ ++ N T++ + S ++ L N I
Sbjct: 133 LDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ 167
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 5e-17
Identities = 46/226 (20%), Positives = 94/226 (41%), Gaps = 30/226 (13%)
Query: 546 SFEEVKKYTNNFSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKMEIEL 604
+ Y +G G Y +V++ + N + + +K + ++ K EI++
Sbjct: 31 EWGNQDDYQ----LVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK---KKIKREIKI 83
Query: 605 LSRV-HHKNLVSLLGFCFDRGEQM--LIYEFVPNG---SLGDSLSGKNGIRLDWIRRLKI 658
L + N+++L D + L++E V N L +L+ IR
Sbjct: 84 LENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLT------DYDIRFYMY 137
Query: 659 ALGAARGLSYLHELANPPIIHRDIKSSNILLD-ERLNAKVADFGLSKSMSDSEKDHITTQ 717
+ + L Y H I+HRD+K N+++D E ++ D+GL++ +
Sbjct: 138 EI--LKALDYCHS-MG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY--HPGQEYNVR 190
Query: 718 VKGTMGYLDPEYYMTQQLTEKS-DVYSFGVLMLELLTGRRPIERGK 762
V + + PE + Q+ + S D++S G ++ ++ + P G
Sbjct: 191 V-ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 235
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 8e-17
Identities = 59/249 (23%), Positives = 105/249 (42%), Gaps = 52/249 (20%)
Query: 547 FEEVKKYTNNFSDANDVGSGGYGKVYKGT-LPNGQLIAIK---RAQQGSMQGGQEFKMEI 602
+E K Y VGSG YG V +G+ +AIK R Q + + ++ E+
Sbjct: 20 WELPKTYV----SPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR-EL 74
Query: 603 ELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRL-------DWIRR 655
LL + H+N++ LL F P SL + L D +
Sbjct: 75 LLLKHMQHENVIGLLDV------------FTPASSLRN----FYDFYLVMPFMQTDLQKI 118
Query: 656 LKIALGAA----------RGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKS 705
+ + +GL Y+H A ++HRD+K N+ ++E K+ DFGL++
Sbjct: 119 MGLKFSEEKIQYLVYQMLKGLKYIHS-AG--VVHRDLKPGNLAVNEDCELKILDFGLARH 175
Query: 706 MSDSEKDHITTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGKYI 764
++ T+ Y PE ++ + D++S G +M E+LTG + + +GK
Sbjct: 176 ADAEMTGYVVTRW-----YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTG-KTLFKGKDY 229
Query: 765 VREIRTVMD 773
+ ++ ++
Sbjct: 230 LDQLTQILK 238
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 1e-16
Identities = 58/219 (26%), Positives = 85/219 (38%), Gaps = 50/219 (22%)
Query: 563 VGSGGYGKVY----KGTLPNGQLIAIK---------RAQQGSMQGGQEFKMEIELLSRV- 608
+G G +GKV K T G L A+K E +LS
Sbjct: 31 LGKGSFGKVMLARVKET---GDLYAVKVLKKDVILQDDDVECT------MTEKRILSLAR 81
Query: 609 HHKNLVSLLGFCFDRGEQM-LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAAR--- 664
+H L L CF +++ + EFV G L + + + AR
Sbjct: 82 NHPFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQ----------KSRRFDEARARFYA 130
Query: 665 -----GLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSK-SMSDSEKDHITTQV 718
L +LH+ II+RD+K N+LLD + K+ADFG+ K + + T
Sbjct: 131 AEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT---TATF 184
Query: 719 KGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRP 757
GT Y+ PE D ++ GVL+ E+L G P
Sbjct: 185 CGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAP 223
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 1e-16
Identities = 59/213 (27%), Positives = 89/213 (41%), Gaps = 38/213 (17%)
Query: 563 VGSGGYGKVY----KGTLPNGQLIAIKRAQQGS-MQGGQEFKMEIE---LLSRVHHKNLV 614
+G G +GKV K A+K Q+ + ++ +E + E LL V H LV
Sbjct: 46 IGKGSFGKVLLARHKAE---EVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 102
Query: 615 SLLGFCFDRGEQM-LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAAR--------G 665
L F F +++ + +++ G L L R AR
Sbjct: 103 GLH-FSFQTADKLYFVLDYINGGELFYHLQ----------RERCFLEPRARFYAAEIASA 151
Query: 666 LSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSK-SMSDSEKDHITTQVKGTMGY 724
L YLH L I++RD+K NILLD + + + DFGL K ++ + T+ GT Y
Sbjct: 152 LGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST---TSTFCGTPEY 205
Query: 725 LDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRP 757
L PE Q D + G ++ E+L G P
Sbjct: 206 LAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 48/218 (22%), Positives = 83/218 (38%), Gaps = 16/218 (7%)
Query: 15 TELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSN 74
+ L N+ + + + L+ L L + + L L L L+ N
Sbjct: 32 AASQRIFLHGNR-ISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN 90
Query: 75 GFSGRVPPSI-GNLSNLYWLDLTDNKLEGEIPVSDGNSPG-LDMLVRAKHFHFGKNQLSG 132
V P+ L L+ L L L+ E+ PG L ++ + N L
Sbjct: 91 AQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELG------PGLFRGLAALQYLYLQDNALQ- 142
Query: 133 SIPEKLFRPDMVLIHVLFDSNNLTGELPATL--GLVKSLEVVRFDRNSLSGPVPSNLNNL 190
++P+ FR L H+ N ++ +P GL SL+ + +N ++ P +L
Sbjct: 143 ALPDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGLH-SLDRLLLHQNRVAHVHPHAFRDL 200
Query: 191 TSVNDLYLSNNKLTGAMPN-LTGLSVLSYLDMSNNSFD 227
+ LYL N L+ L L L YL +++N +
Sbjct: 201 GRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWV 238
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 1e-09
Identities = 30/175 (17%), Positives = 67/175 (38%), Gaps = 15/175 (8%)
Query: 133 SIPEKLFRPDMVLIHVLF-DSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLT 191
++P + +F N ++ A+ ++L ++ N L+ + L
Sbjct: 25 AVPVGIP----AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLA 80
Query: 192 SVNDLYLSNNKLTGAMPN--LTGLSVLSYLDMSNNSFDASEVPS-WFSSMQSLTTLMMEN 248
+ L LS+N ++ GL L L + E+ F + +L L +++
Sbjct: 81 LLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGL--QELGPGLFRGLAALQYLYLQD 138
Query: 249 TNLKGQIPADLFS-IPHLQTVVMKTNELNGTLDLGT-SYSENLLV-NLQNNRISA 300
L+ +P D F + +L + + N ++ ++ +L L NR++
Sbjct: 139 NALQ-ALPDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAH 191
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 1e-16
Identities = 52/216 (24%), Positives = 84/216 (38%), Gaps = 48/216 (22%)
Query: 563 VGSGGYGKVY----KGTLPNGQLIAIK---------RAQQGSMQGGQEFKMEIELLSRVH 609
+G+G +G+V K + G A+K Q E +L V+
Sbjct: 49 LGTGSFGRVMLVKHKES---GNHYAMKILDKQKVVKLKQIEHT------LNEKRILQAVN 99
Query: 610 HKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAAR----- 664
LV L D ++ E+V G + L R + + AR
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR----------RIGRFSEPHARFYAAQ 149
Query: 665 ---GLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGT 721
YLH L +I+RD+K N+L+D++ +V DFG +K T + GT
Sbjct: 150 IVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGT 201
Query: 722 MGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRP 757
L PE +++ + D ++ GVL+ E+ G P
Sbjct: 202 PEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 1e-16
Identities = 61/217 (28%), Positives = 91/217 (41%), Gaps = 46/217 (21%)
Query: 563 VGSGGYGKV----YKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIE--------LLSRVHH 610
+G G +GKV +K T Q AIK ++ + ++E L H
Sbjct: 25 LGKGSFGKVFLAEFKKT---NQFFAIKALKKDVVLM----DDDVECTMVEKRVLSLAWEH 77
Query: 611 KNLVSLLGFCFDRGEQM-LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAAR----- 664
L + F E + + E++ G L + K L A
Sbjct: 78 PFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQ----------SCHKFDLSRATFYAAE 126
Query: 665 ---GLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSK-SMSDSEKDHITTQVKG 720
GL +LH I++RD+K NILLD+ + K+ADFG+ K +M K T G
Sbjct: 127 IILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK---TNTFCG 180
Query: 721 TMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRP 757
T Y+ PE + Q+ D +SFGVL+ E+L G+ P
Sbjct: 181 TPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 2e-16
Identities = 46/244 (18%), Positives = 83/244 (34%), Gaps = 39/244 (15%)
Query: 8 SGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELV 67
L L L LS N +R L L+ L L + + L +L
Sbjct: 81 VNSFKHLRHLEILQLSRNH-IRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLK 139
Query: 68 LLSLNSNGFSGRVPPSI-GNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFG 126
L L +N +P + +L LDL +
Sbjct: 140 ELWLRNNPIE-SIPSYAFNRIPSLRRLDLGEL---------------------------- 170
Query: 127 KNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSN 186
+LS I E F L ++ NL E+P L+ L+ + N LS P +
Sbjct: 171 -KRLS-YISEGAFEGLSNLRYLNLAMCNLR-EIPNLTPLI-KLDELDLSGNHLSAIRPGS 226
Query: 187 LNNLTSVNDLYLSNNKLTGAMPN-LTGLSVLSYLDMSNNSFDASEVP-SWFSSMQSLTTL 244
L + L++ +++ N L L +++++N+ + +P F+ + L +
Sbjct: 227 FQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNL--TLLPHDLFTPLHHLERI 284
Query: 245 MMEN 248
+ +
Sbjct: 285 HLHH 288
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 78.3 bits (193), Expect = 2e-15
Identities = 53/262 (20%), Positives = 100/262 (38%), Gaps = 29/262 (11%)
Query: 69 LSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSD-GNSPGLDMLVRAKHFHFGK 127
+ VP I +N L+L +N+++ I V+ + L++L +
Sbjct: 48 VICVRKNLR-EVPDGI--STNTRLLNLHENQIQ-IIKVNSFKHLRHLEIL------QLSR 97
Query: 128 NQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATL--GLVKSLEVVRFDRNSLSGPVPS 185
N + +I F L + N LT +P L L+ + N +
Sbjct: 98 NHIR-TIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYL-SKLKELWLRNNPIESIPSY 154
Query: 186 NLNNLTSVNDLYLS-NNKLTGAMPN-LTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTT 243
N + S+ L L +L+ GLS L YL+++ + E+P+ + + L
Sbjct: 155 AFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNL--REIPN-LTPLIKLDE 211
Query: 244 LMMENTNLKGQIPADLFS-IPHLQTVVMKTNELNGTLDLGT-SYSENL-LVNLQNNRISA 300
L + +L I F + HLQ + M +++ ++ ++L +NL +N ++
Sbjct: 212 LDLSGNHLS-AIRPGSFQGLMHLQKLWMIQSQIQ-VIERNAFDNLQSLVEINLAHNNLTL 269
Query: 301 YTERGGAPAVNLTLI---DNPI 319
P +L I NP
Sbjct: 270 LPHDLFTPLHHLERIHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 5e-14
Identities = 40/191 (20%), Positives = 65/191 (34%), Gaps = 11/191 (5%)
Query: 12 TGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSL 71
GL L+TL+L +N+ L L KL L L + + L L L
Sbjct: 109 NGLANLNTLELFDNR-LTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDL 167
Query: 72 NSNGFSGRVPPSI-GNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQL 130
+ LSNL +L+L L P L L++ N L
Sbjct: 168 GELKRLSYISEGAFEGLSNLRYLNLAMCNLR--------EIPNLTPLIKLDELDLSGNHL 219
Query: 131 SGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNL 190
S +I F+ M L + + + ++SL + N+L+ L
Sbjct: 220 S-AIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPL 278
Query: 191 TSVNDLYLSNN 201
+ ++L +N
Sbjct: 279 HHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 2e-12
Identities = 36/173 (20%), Positives = 55/173 (31%), Gaps = 11/173 (6%)
Query: 8 SGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSI-GSLQEL 66
+G L++L L L NN + + L L L I + L L
Sbjct: 129 NGAFVYLSKLKELWLRNNP-IESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNL 187
Query: 67 VLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFG 126
L+L P++ L L LDL+ N L I L+ +
Sbjct: 188 RYLNLAMCNLR--EIPNLTPLIKLDELDLSGNHLS-AIRPGS-----FQGLMHLQKLWMI 239
Query: 127 KNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSL 179
++Q+ I F L+ + NNLT + LE + N
Sbjct: 240 QSQIQ-VIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPW 291
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 2e-16
Identities = 55/222 (24%), Positives = 91/222 (40%), Gaps = 60/222 (27%)
Query: 563 VGSGGYGKVY----KGTLPNGQLIAIK---------RAQQGSMQGGQEFKMEIELLSRVH 609
+G+G +G+V+ + G+ A+K Q E +LS V
Sbjct: 14 LGTGSFGRVHLIRSRHN---GRYYAMKVLKKEIVVRLKQVEHT------NDERLMLSIVT 64
Query: 610 HKNLVSLLGFCF-DRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLK----------- 657
H ++ + F D + +I +++ G L +R+ +
Sbjct: 65 HPFIIRMW-GTFQDAQQIFMIMDYIEGGEL-----------FSLLRKSQRFPNPVAKFYA 112
Query: 658 --IALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHIT 715
+ L L YLH II+RD+K NILLD+ + K+ DFG +K +T
Sbjct: 113 AEVCLA----LEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVT 160
Query: 716 TQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRP 757
+ GT Y+ PE T+ + D +SFG+L+ E+L G P
Sbjct: 161 YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 202
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 2e-16
Identities = 57/213 (26%), Positives = 94/213 (44%), Gaps = 38/213 (17%)
Query: 563 VGSGGYGKVY----KGTLPNGQLIAIKRAQQGSMQGGQEF---KMEIELLSRV-HHKNLV 614
+G G Y KV K T ++ A+K ++ + ++ + E + + +H LV
Sbjct: 17 IGRGSYAKVLLVRLKKT---DRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLV 73
Query: 615 SLLGFCFDRGEQM-LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAAR--------G 665
L CF ++ + E+V G L + R+ K+ AR
Sbjct: 74 GLH-SCFQTESRLFFVIEYVNGGDLMFHMQ----------RQRKLPEEHARFYSAEISLA 122
Query: 666 LSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSK-SMSDSEKDHITTQVKGTMGY 724
L+YLHE II+RD+K N+LLD + K+ D+G+ K + + T+ GT Y
Sbjct: 123 LNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT---TSTFCGTPNY 176
Query: 725 LDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRP 757
+ PE + D ++ GVLM E++ GR P
Sbjct: 177 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 209
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 5e-16
Identities = 56/213 (26%), Positives = 94/213 (44%), Gaps = 38/213 (17%)
Query: 563 VGSGGYGKVY----KGTLPNGQLIAIKRAQQGSMQGGQEF---KMEIELLSRV-HHKNLV 614
+G G Y KV K T ++ A++ ++ + ++ + E + + +H LV
Sbjct: 60 IGRGSYAKVLLVRLKKT---DRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLV 116
Query: 615 SLLGFCFDRGEQM-LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAAR--------G 665
L CF ++ + E+V G L + R+ K+ AR
Sbjct: 117 GLH-SCFQTESRLFFVIEYVNGGDLMFHMQ----------RQRKLPEEHARFYSAEISLA 165
Query: 666 LSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSK-SMSDSEKDHITTQVKGTMGY 724
L+YLHE II+RD+K N+LLD + K+ D+G+ K + + T+ GT Y
Sbjct: 166 LNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT---TSTFCGTPNY 219
Query: 725 LDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRP 757
+ PE + D ++ GVLM E++ GR P
Sbjct: 220 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 252
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 1e-15
Identities = 55/314 (17%), Positives = 97/314 (30%), Gaps = 44/314 (14%)
Query: 8 SGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSI-GSLQEL 66
+ L +L L + T L L L L F + L L
Sbjct: 47 ETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQ-LETGAFNGLANL 105
Query: 67 VLLSLNSNGF-SGRVPPSI-GNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFH 124
+L+L + + L++L L L DN ++ P + + R
Sbjct: 106 EVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQP-----ASFFLNMRRFHVLD 160
Query: 125 FGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVP 184
N++ SI E+ N G+ L L S+ + + L
Sbjct: 161 LTFNKVK-SICEEDL-------------LNFQGKHFTLLRL-SSITLQDMNEYWLGWEKC 205
Query: 185 SNLNNLTSVNDLYLSNNKLT----GAMPNLTGLSVLSYLDMSNNSFDASEVPS------- 233
N TS+ L LS N + + + L +SN+ S
Sbjct: 206 GNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPD 265
Query: 234 ----WFSSMQSLTTLMMENTNLKGQIPADLFS-IPHLQTVVMKTNELNGTLDLGTSYS-E 287
+ T + + + + +FS L+ + + NE+N +D +
Sbjct: 266 NFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLT 323
Query: 288 NLLV-NLQNNRISA 300
+LL NL N + +
Sbjct: 324 HLLKLNLSQNFLGS 337
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 6e-14
Identities = 46/277 (16%), Positives = 92/277 (33%), Gaps = 37/277 (13%)
Query: 12 TGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSL 71
+ H LDL+ NK ++ + N + +L L + L +
Sbjct: 151 LNMRRFHVLDLTFNK-VKSICEEDLLNFQGKHFTLL--------------RLSSITLQDM 195
Query: 72 NSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFH------- 124
N + +++ LDL+ N + + ++ + +
Sbjct: 196 NEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSS 255
Query: 125 FGKNQLSGSIPEKLFR--PDMVLIHVLFDSNNLTGELPATL--GLVKSLEVVRFDRNSLS 180
FG F+ + + + L ++ LE + +N ++
Sbjct: 256 FGHTNFK-DPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHF-TDLEQLTLAQNEIN 312
Query: 181 GPVPSNLNNLTSVNDLYLSNNKLTGAMPN--LTGLSVLSYLDMSNNSFDASEVPS-WFSS 237
+ LT + L LS N L ++ + L L LD+S N + F
Sbjct: 313 KIDDNAFWGLTHLLKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHI--RALGDQSFLG 369
Query: 238 MQSLTTLMMENTNLKGQIPADLF-SIPHLQTVVMKTN 273
+ +L L ++ LK +P +F + LQ + + TN
Sbjct: 370 LPNLKELALDTNQLKS-VPDGIFDRLTSLQKIWLHTN 405
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 5e-12
Identities = 44/244 (18%), Positives = 79/244 (32%), Gaps = 27/244 (11%)
Query: 69 LSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGL-DMLVRAKHFHFGK 127
+ L+ N + S L +L +L + I L
Sbjct: 35 VDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIR------NNTFRGLSSLIILKLDY 88
Query: 128 NQLSGSIPEKLFRPDMVLIHVLFDSNNLTG-ELPATL--GLVKSLEVVRFDRNSLSGPVP 184
NQ + F L + NL G L L SLE++ N++ P
Sbjct: 89 NQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPL-TSLEMLVLRDNNIKKIQP 146
Query: 185 SNL-NNLTSVNDLYLSNNKLT----GAMPNLTG-------LSVLSYLDMSNNSFDASEVP 232
++ N+ + L L+ NK+ + N G LS ++ DM+ E
Sbjct: 147 ASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLG-WEKC 205
Query: 233 SWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENLLVN 292
S+TTL + K + F +++ L+ + ++G+S+ +
Sbjct: 206 GNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTK--IQSLILSNSYNMGSSFGHTNFKD 263
Query: 293 LQNN 296
N
Sbjct: 264 PDNF 267
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 6e-11
Identities = 41/221 (18%), Positives = 73/221 (33%), Gaps = 49/221 (22%)
Query: 10 DITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLL 69
D T++ +L LSN+ ++ T N K N G SG +
Sbjct: 234 DAIAGTKIQSLILSNSYNMGSSFGHT--NFKDPDNFTFKGLEASG-----------VKTC 280
Query: 70 SLNSNGFSGRVPPSI-GNLSNLYWLDLTDNKLEGEIPVSDGNSPG-LDMLVRAKHFHFGK 127
L+ + + S+ + ++L L L N++ +I L + +
Sbjct: 281 DLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEIN-KID------DNAFWGLTHLLKLNLSQ 332
Query: 128 NQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNL 187
N L SI ++F NL LEV+ N + +
Sbjct: 333 NFLG-SIDSRMFE-------------NLD-----------KLEVLDLSYNHIRALGDQSF 367
Query: 188 NNLTSVNDLYLSNNKLTGAMPN-LTGLSVLSYLDMSNNSFD 227
L ++ +L L N+L L+ L + + N +D
Sbjct: 368 LGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWD 408
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 5e-15
Identities = 58/243 (23%), Positives = 102/243 (41%), Gaps = 49/243 (20%)
Query: 554 TNNFSDANDVGSGGYGKVYKGT-LPNGQLIAIK---RAQQGSMQGGQEFKMEIELLSRVH 609
+ D VGSG YG V G +AIK R Q + + ++ E+ LL +
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYR-ELRLLKHMR 82
Query: 610 HKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGI------------------RLD 651
H+N++ L+ F P+ +L D +L
Sbjct: 83 HENVIG------------LLDVFTPDETLDDF----TDFYLVMPFMGTDLGKLMKHEKLG 126
Query: 652 WIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEK 711
R + +GL Y+H A IIHRD+K N+ ++E K+ DFGL++
Sbjct: 127 EDRIQFLVYQMLKGLRYIHA-AG--IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMT 183
Query: 712 DHITTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRT 770
++ T+ Y PE + + T+ D++S G +M E++TG + + +G + +++
Sbjct: 184 GYVVTRW-----YRAPEVILNWMRYTQTVDIWSVGCIMAEMITG-KTLFKGSDHLDQLKE 237
Query: 771 VMD 773
+M
Sbjct: 238 IMK 240
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 76.1 bits (187), Expect = 5e-15
Identities = 45/251 (17%), Positives = 76/251 (30%), Gaps = 39/251 (15%)
Query: 11 ITGLTELHTLDLSNNKDLRGPLPTTIGNL--KKLSNLMLVGCSFSGPIPDSIGSLQELVL 68
+ G++ L L L N ++ G P + L+ L L S++ + LQ+ +
Sbjct: 91 VLGISGLQELTLENL-EVTGTAPPPLLEATGPDLNILNLRNVSWAT-RDAWLAELQQWLK 148
Query: 69 -----LSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHF 123
LS+ + L LDL+DN GE + P +
Sbjct: 149 PGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPL--KFPTLQVL 206
Query: 124 HFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSG-P 182
+ +G A L+ + NSL
Sbjct: 207 ALRNAGM----------------------ETPSGVCSALAAARVQLQGLDLSHNSLRDAA 244
Query: 183 VPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLT 242
+ + + +N L LS L L + LS LD+S N PS + +
Sbjct: 245 GAPSCDWPSQLNSLNLSFTGLKQVPKGL--PAKLSVLDLSYNRL--DRNPS-PDELPQVG 299
Query: 243 TLMMENTNLKG 253
L ++
Sbjct: 300 NLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 73.0 bits (179), Expect = 4e-14
Identities = 41/249 (16%), Positives = 77/249 (30%), Gaps = 21/249 (8%)
Query: 62 SLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAK 121
SL+ L + + + +S L L L + ++ G P + G D+
Sbjct: 69 SLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDL----N 124
Query: 122 HFHFGKNQLSG--SIPEKLFRPDMVLIHVLFDSNNLTGELPA-TLGLVKSLEVVRFDRNS 178
+ + + +L + + VL + + + + +L + N
Sbjct: 125 ILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNP 184
Query: 179 LSGPVPSN----LNNLTSVNDLYLSNNKLT----GAMPNLTGLSVLSYLDMSNNSFDASE 230
G ++ L L N + L LD+S+NS +
Sbjct: 185 ELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAA 244
Query: 231 VPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYS-ENL 289
L +L + T LK Q+P L L + + N L+ NL
Sbjct: 245 GAPSCDWPSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRNPSPDELPQVGNL 301
Query: 290 LVNLQNNRI 298
+L+ N
Sbjct: 302 --SLKGNPF 308
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 68.4 bits (167), Expect = 2e-12
Identities = 45/267 (16%), Positives = 77/267 (28%), Gaps = 32/267 (11%)
Query: 50 CSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDG 109
C+FS P PD + L + G G S Y L D + +
Sbjct: 15 CNFSDPKPDWSSAFNCLGAADVELYG---------GGRSLEYLLKRVDTEADLGQFTDII 65
Query: 110 NSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMV--LIHVLFDSNNLTGELPATLGLV- 166
S + K ++ I R + L + ++ +TG P L
Sbjct: 66 KS------LSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEAT 119
Query: 167 -KSLEVVRFDRNSLSGPVP--SNLNNL--TSVNDLYLSNNKLTGAMPNLTG-LSVLSYLD 220
L ++ S + + L + L ++ LS LD
Sbjct: 120 GPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLD 179
Query: 221 MSNN------SFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNE 274
+S+N ++ P F ++Q L G A + LQ + + N
Sbjct: 180 LSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNS 239
Query: 275 LNGTLDLGT-SYSENLLV-NLQNNRIS 299
L + + L NL +
Sbjct: 240 LRDAAGAPSCDWPSQLNSLNLSFTGLK 266
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 36/201 (17%), Positives = 49/201 (24%), Gaps = 45/201 (22%)
Query: 14 LTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPI-------PDSIGSLQEL 66
L L ++ L + LS L L G P +LQ L
Sbjct: 148 KPGLKVLSIAQAHSLNFSCEQ-VRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVL 206
Query: 67 VLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFG 126
L + SG L LDL
Sbjct: 207 ALRNAGMETPSGVCSALAAARVQLQGLDL------------------------------S 236
Query: 127 KNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSG-PVPS 185
N L + L + L ++P GL L V+ N L P P
Sbjct: 237 HNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPK--GLPAKLSVLDLSYNRLDRNPSPD 293
Query: 186 NLNNLTSVNDLYLSNNKLTGA 206
L + + L L N +
Sbjct: 294 ELPQVGN---LSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 45.3 bits (107), Expect = 6e-05
Identities = 22/100 (22%), Positives = 34/100 (34%), Gaps = 5/100 (5%)
Query: 3 LKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGS 62
G S +L LDLS+N + +L++L L +P +
Sbjct: 216 PSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQ-VPKGL-- 272
Query: 63 LQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEG 102
+L +L L+ N PS L + L L N
Sbjct: 273 PAKLSVLDLSYNRLDR--NPSPDELPQVGNLSLKGNPFLD 310
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 77.6 bits (191), Expect = 7e-15
Identities = 55/308 (17%), Positives = 106/308 (34%), Gaps = 17/308 (5%)
Query: 7 LSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQEL 66
+ + LT+L L LS K + L L LV G +S+
Sbjct: 138 VCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPN-T 196
Query: 67 VLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGE-IPVSDGNSPGLDMLVRAKHFHF 125
+L L + S +++ L L L++ KL E L +
Sbjct: 197 TVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTL 256
Query: 126 GKNQLSGSIPEKLFRP--DMVLIHVLFDSNNLTG-----ELPATLGLVKSLEVVRFDRNS 178
+ + KLF+ + ++ + +T E + +KSL +
Sbjct: 257 QHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQV 316
Query: 179 LSGPVPSNLNNLTSVNDLYLSNNKLTG-AMPNLTGLSVLSYLDMSNNSFDASEVPSWFSS 237
+ + +N LS + M S ++L+ + N F V S+
Sbjct: 317 FLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFT-DSVFQGCST 375
Query: 238 MQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELN----GTLDLGTSYSENLLV-N 292
++ L TL+++ LK ++ ++ LN D +++E++LV N
Sbjct: 376 LKRLQTLILQRNGLK-NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLN 434
Query: 293 LQNNRISA 300
L +N ++
Sbjct: 435 LSSNMLTG 442
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 67.6 bits (165), Expect = 8e-12
Identities = 45/242 (18%), Positives = 83/242 (34%), Gaps = 16/242 (6%)
Query: 12 TGLTELHTLDLSNNKDLRGPLPTTIGN-LKKLSNLMLVGCSFSGPIPDSIGSLQELVLLS 70
+ L+ +L+ + + T LK L + F E+ +
Sbjct: 276 RPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKM 335
Query: 71 LNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQL 130
L+ + + S+ +L+ T N +D G L R + +N L
Sbjct: 336 LSISDTPFIHMVCPPSPSSFTFLNFTQNVF------TDSVFQGCSTLKRLQTLILQRNGL 389
Query: 131 SGSIPEKLFRPD--MVLIHVLFDSNNLT-GELPATLGLVKSLEVVRFDRNSLSGPVPSNL 187
+ + L + N+L T +S+ V+ N L+G V L
Sbjct: 390 K-NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCL 448
Query: 188 NNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVP-SWFSSMQSLTTLMM 246
V L L NN++ ++T L L L++++N VP F + SL + +
Sbjct: 449 P--PKVKVLDLHNNRIMSIPKDVTHLQALQELNVASNQL--KSVPDGVFDRLTSLQYIWL 504
Query: 247 EN 248
+
Sbjct: 505 HD 506
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 63.4 bits (154), Expect = 2e-10
Identities = 42/231 (18%), Positives = 80/231 (34%), Gaps = 21/231 (9%)
Query: 4 KGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVG---CSFSGPIPDSI 60
+ + + T L L + N +++ ML P S
Sbjct: 294 REEFTYSETALKSLMIEHVKNQ-VFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSP 352
Query: 61 GSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRA 120
S L + N F+ V L L L L N L+ + + L
Sbjct: 353 SSFTFL---NFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSL--- 405
Query: 121 KHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLS 180
+ N L+ ++ ++ + SN LTG L ++V+ N +
Sbjct: 406 ETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGS--VFRCLPPKVKVLDLHNNRIM 463
Query: 181 GPVPSNLNNLTSVNDLYLSNNKLT----GAMPNLTGLSVLSYLDMSNNSFD 227
+P ++ +L ++ +L +++N+L G LT L Y+ + +N +D
Sbjct: 464 S-IPKDVTHLQALQELNVASNQLKSVPDGVFDRLT---SLQYIWLHDNPWD 510
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 56.0 bits (135), Expect = 3e-08
Identities = 43/297 (14%), Positives = 96/297 (32%), Gaps = 20/297 (6%)
Query: 15 TELHTLDLSNNKDLRGPLPTTIGNLK--KLSNLMLVGCSFSGPIPDSIGSLQELVLLSLN 72
T + L N + ++ L +LSN+ L + + + LL++
Sbjct: 196 TTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVT 255
Query: 73 SNGFSGRVPPSIGNLSNLYW-----LDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGK 127
S+ + L++ + + I + L H
Sbjct: 256 LQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSET-ALKSLMIEHVKN 314
Query: 128 NQLSGSIPEKLFRPDMVLIHVL-FDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSN 186
E L+ +++ ++ S + F +N + V
Sbjct: 315 QVFL-FSKEALYS-VFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQG 372
Query: 187 LNNLTSVNDLYLSNNKLTGAMPN----LTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLT 242
+ L + L L N L +S L LD+S NS ++ + +S+
Sbjct: 373 CSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESIL 431
Query: 243 TLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENLLV-NLQNNRI 298
L + + L G + L P ++ + + N + ++ ++ + L N+ +N++
Sbjct: 432 VLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQL 485
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 53.0 bits (127), Expect = 3e-07
Identities = 58/354 (16%), Positives = 109/354 (30%), Gaps = 56/354 (15%)
Query: 8 SGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELV 67
DI+ L+EL L LS+N+ +R + L L + I + L
Sbjct: 69 MPDISFLSELRVLRLSHNR-IRSLDFHVFLFNQDLEYLDVSHNRLQN-ISC--CPMASLR 124
Query: 68 LLSLNSNGFSGRVPPS--IGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHF 125
L L+ N F +P GNL+ L +L L+ K P + +
Sbjct: 125 HLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAKFR-----QLDLLPVAHLHLSCILLDL 178
Query: 126 GKNQLSGSIPEKLFRPDMVLIHVLFDSNNL---------------------------TGE 158
+ G E L P+ ++H++F N+L
Sbjct: 179 VSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRL 238
Query: 159 LPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVND-----LYLSNNKLTGAMP----- 208
+ L + ++ + ++ L + N +T +
Sbjct: 239 MTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFT 298
Query: 209 -NLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIP-HLQ 266
+ T L L + N F S+ + +S + M+ ++ I P
Sbjct: 299 YSETALKSLMIEHVKNQVFLFSK-EALYSVFAEMNIKMLSISDTP-FIHMVCPPSPSSFT 356
Query: 267 TVVMKTNELNGTLDLGTSYSENL-LVNLQNNRISAYTERGGAPA--VNLTLIDN 317
+ N ++ G S + L + LQ N + + + +L +D
Sbjct: 357 FLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDV 410
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 50.6 bits (121), Expect = 2e-06
Identities = 41/297 (13%), Positives = 87/297 (29%), Gaps = 23/297 (7%)
Query: 15 TELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSI-GSLQELVLLSLNS 73
L LS N + I L +L L L + + Q+L L ++
Sbjct: 52 PRTKALSLSQNS-ISELRMPDISFLSELRVLRLSHNRIRS-LDFHVFLFNQDLEYLDVSH 109
Query: 74 NGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGS 133
N + +++L LDL+ N + L + +
Sbjct: 110 NRLQN-ISC--CPMASLRHLDLSFNDFD-----VLPVCKEFGNLTKLTFLGLSAAKFRQL 161
Query: 134 IPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSV 193
+ + I + S ++ G +L + + + + V N+ ++ ++
Sbjct: 162 DLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNM-SVNAL 220
Query: 194 NDLYLSNNKLTGA--------MPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQ--SLTT 243
L LSN KL + LT L + + + F +
Sbjct: 221 GHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEY 280
Query: 244 LMMENTNLKGQIPADLFSIPHLQTVVMKTNEL-NGTLDLGTSYSENLLVNLQNNRIS 299
L + N + +I + F+ + + N ++ + +S
Sbjct: 281 LNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLS 337
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 47.6 bits (113), Expect = 2e-05
Identities = 40/284 (14%), Positives = 96/284 (33%), Gaps = 25/284 (8%)
Query: 150 FDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPN 209
N+++ + + L V+R N + + L +S+N+L +
Sbjct: 59 LSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NIS- 116
Query: 210 LTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVV 269
++ L +LD+S N FD V F ++ LT L + + DL + HL
Sbjct: 117 CCPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSC 173
Query: 270 MKTNELNGTLDLGTSYSENL-------LVNLQNNRISAYTERGGAPAVNLTLIDNPICQE 322
+ + ++ + G + S + LV N+ S +L L + +
Sbjct: 174 ILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKL--- 230
Query: 323 LGTAKGYCQLSQPISPYSTKQKNCLPAPCNANQSSSPNCQCAYPYTGTLVFRSLSFSDLG 382
+ +L +S + + + + + + V L+ +L
Sbjct: 231 --NDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPV-EYLNIYNL- 286
Query: 383 NTTYYEILEQSVTTSFQSTYKLPIDSISLSNPHKNNFEYLELSI 426
+ + + + + + S+ + + F + + ++
Sbjct: 287 ------TITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEAL 324
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 9e-15
Identities = 54/263 (20%), Positives = 97/263 (36%), Gaps = 65/263 (24%)
Query: 546 SFEEVKKYTNNFSDANDVGSGGYGKVYKGT-LPNGQLIAIK---RAQQGSMQGGQEFKME 601
+ Y + +G G YG VY + +AIK R + + + + E
Sbjct: 21 NVHVPDNYI----IKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILR-E 75
Query: 602 IELLSRVHHKNLVSLL-------GFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIR 654
I +L+R+ ++ L FD E ++ E + D L +
Sbjct: 76 ITILNRLKSDYIIRLYDLIIPDDLLKFD--ELYIVLEIADS----D---------LKKLF 120
Query: 655 RLKIALGAA----------RGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSK 704
+ I L G +++HE + IIHRD+K +N LL++ + KV DFGL++
Sbjct: 121 KTPIFLTEEHIKTILYNLLLGENFIHE-SG--IIHRDLKPANCLLNQDCSVKVCDFGLAR 177
Query: 705 SMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTE--------------------KS-DVYS 743
+++ + +I ++ + +QLT KS D++S
Sbjct: 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWS 237
Query: 744 FGVLMLELLTGRRPIERGKYIVR 766
G + ELL +
Sbjct: 238 TGCIFAELLNMLQSHINDPTNRF 260
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 76.8 bits (189), Expect = 1e-14
Identities = 55/342 (16%), Positives = 112/342 (32%), Gaps = 80/342 (23%)
Query: 504 AGVYAYHQKRRAEKANEQNPFAHWDMNKSSGSIPQLKGARCFSFEEVKKYTNNFSDANDV 563
+ A ++ + + + A + + + + +
Sbjct: 2 SSHEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLI 61
Query: 564 GSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKM-------EIELLSRVHHKNLVS 615
G+G YG V + +++AIK+ + E + EI +L+R++H ++V
Sbjct: 62 GTGSYGHVCEAYDKLEKRVVAIKK-----ILRVFEDLIDCKRILREIAILNRLNHDHVVK 116
Query: 616 LLG-FCFDRGEQM----LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAA------- 663
+L E+ ++ E + D + R + L
Sbjct: 117 VLDIVIPKDVEKFDELYVVLEIADS----D---------FKKLFRTPVYLTELHIKTLLY 163
Query: 664 ---RGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKG 720
G+ Y+H A I+HRD+K +N L+++ + KV DFGL++++ E + +
Sbjct: 164 NLLVGVKYVHS-AG--ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISP 220
Query: 721 T-----MGYLDPEYYMTQQLTE--------------------KS-DVYSFGVLMLELLT- 753
+ + +QLT ++ DV+S G + ELL
Sbjct: 221 REDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280
Query: 754 ---------GRRPIERGKYIVREIRTVMDKKKELYNLYELID 786
R P+ G ++ D
Sbjct: 281 IKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRD 322
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 3e-14
Identities = 29/197 (14%), Positives = 65/197 (32%), Gaps = 21/197 (10%)
Query: 56 IPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLD 115
IPDS + + + L + + + +++L ++ L + + + G++
Sbjct: 17 IPDS--TFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVT--------DLTGIE 63
Query: 116 MLVRAKHFHFGKNQLSGSIP-EKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRF 174
K + P L L + ++T + L + SL ++
Sbjct: 64 YAHNIKDLTINNIHATNYNPISGLSN----LERLRIMGKDVTSDKIPNLSGLTSLTLLDI 119
Query: 175 DRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSW 234
++ + + +N L VN + LS N + L L L L++ +
Sbjct: 120 SHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPLKTLPELKSLNIQFDGVHDY---RG 176
Query: 235 FSSMQSLTTLMMENTNL 251
L L + +
Sbjct: 177 IEDFPKLNQLYAFSQTI 193
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 2e-11
Identities = 30/207 (14%), Positives = 64/207 (30%), Gaps = 45/207 (21%)
Query: 3 LKGQLSGDIT--GLTELHTLDLSNN--KDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPD 58
L + +IT + L + L+N DL G I + +L + + P
Sbjct: 30 LGQSSTANITEAQMNSLTYITLANINVTDLTG-----IEYAHNIKDLTINNIHATNYNP- 83
Query: 59 SIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLV 118
I L L L + + P++ L++L LD++ + + I P ++ +
Sbjct: 84 -ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSID 142
Query: 119 RAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNS 178
N ++ L + L+ + +
Sbjct: 143 -------------------------------LSYNGAITDIMP-LKTLPELKSLNIQFDG 170
Query: 179 LSGPVPSNLNNLTSVNDLYLSNNKLTG 205
+ + + +N LY + + G
Sbjct: 171 VHDY--RGIEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 7e-08
Identities = 22/94 (23%), Positives = 41/94 (43%), Gaps = 4/94 (4%)
Query: 10 DITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLL 69
+++GLT L LD+S++ + T I L K++++ L I + +L EL L
Sbjct: 107 NLSGLTSLTLLDISHSA-HDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSL 164
Query: 70 SLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGE 103
++ +G I + L L + G+
Sbjct: 165 NIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 9e-05
Identities = 18/135 (13%), Positives = 51/135 (37%), Gaps = 9/135 (6%)
Query: 167 KSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSF 226
K+ ++S + + +N+LT + L+N +T + + + L ++N
Sbjct: 23 KAYLNGLLGQSSTANITEAQMNSLTY---ITLANINVTD-LTGIEYAHNIKDLTINNIHA 78
Query: 227 DASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYS 286
+ S + +L L + ++ +L + L + + + + ++ +
Sbjct: 79 ---TNYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTL 135
Query: 287 ENLLV-NLQ-NNRIS 299
+ +L N I+
Sbjct: 136 PKVNSIDLSYNGAIT 150
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 74.9 bits (184), Expect = 4e-14
Identities = 49/327 (14%), Positives = 106/327 (32%), Gaps = 42/327 (12%)
Query: 13 GLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSI------------ 60
L LDLS N P+ GN+ +L L L I
Sbjct: 88 PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVL 147
Query: 61 ----------GSLQELVLLSL-----NSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIP 105
LQ+ SL + F + S+ ++NL ++ + +
Sbjct: 148 GETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCS 207
Query: 106 VSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRP-------DMVLIHVLFDSNNLTGE 158
L + + + + + ++ + + +V +
Sbjct: 208 YFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRD 267
Query: 159 LPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTG-AMPNLTGLSVLS 217
+ +K+L + + + P +++N + + M + +S
Sbjct: 268 FDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFL 327
Query: 218 YLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIP--ADLF-SIPHLQTVVMKTNE 274
+LD SNN V + L TL+++ LK ++ A++ + LQ + + N
Sbjct: 328 HLDFSNNLL-TDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNS 385
Query: 275 LNGTLDLGTSYS-ENLLV-NLQNNRIS 299
++ G ++LL N+ +N ++
Sbjct: 386 VSYDEKKGDCSWTKSLLSLNMSSNILT 412
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 71.0 bits (174), Expect = 6e-13
Identities = 52/301 (17%), Positives = 109/301 (36%), Gaps = 23/301 (7%)
Query: 14 LTELHTLDLSNNKDLRGPLPTTIGNLKKLS------NLMLVGCSFSGPIPDSIGSLQELV 67
LH + +N + L ++ + L L CS+ I + + +L
Sbjct: 165 TESLHIVFPTNK-EFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLS 223
Query: 68 LLSLNSNGFSGRVPPSIGNL---SNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFH 124
L+LN+ + I L + +++ +++ KL+G++ D + G L
Sbjct: 224 NLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTS-LKALSIHQ 282
Query: 125 FGKNQLSGSIPEKLFRPDMVLIHVL-FDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPV 183
+ ++ +++ F + + + F N L+ V
Sbjct: 283 VVSDVFG-FPQSYIYE-IFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTV 340
Query: 184 PSNLNNLTSVNDLYLSNNKLTGAMPNLTG----LSVLSYLDMSNNSFDASEVPSWFSSMQ 239
N +LT + L L N+L + + + L LD+S NS E S +
Sbjct: 341 FENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTK 399
Query: 240 SLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENLLV-NLQNNRI 298
SL +L M + L P ++ + + +N++ ++ E L N+ +N++
Sbjct: 400 SLLSLNMSSNILT-DTIFRCLP-PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQL 456
Query: 299 S 299
Sbjct: 457 K 457
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 70.3 bits (172), Expect = 1e-12
Identities = 35/218 (16%), Positives = 79/218 (36%), Gaps = 11/218 (5%)
Query: 12 TGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSL 71
T L L + ++ P ++ + + L
Sbjct: 273 TSLKALSIHQVVSDV-FGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDF 331
Query: 72 NSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLS 131
++N + V + G+L+ L L L N+L+ E+ + + +N +S
Sbjct: 332 SNNLLTDTVFENCGHLTELETLILQMNQLK-ELSKIAE---MTTQMKSLQQLDISQNSVS 387
Query: 132 GSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLT 191
+ L+ + SN LT + L ++V+ N + +P + L
Sbjct: 388 YDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIKS-IPKQVVKLE 444
Query: 192 SVNDLYLSNNKLTGAMPN--LTGLSVLSYLDMSNNSFD 227
++ +L +++N+L ++P+ L+ L + + N +D
Sbjct: 445 ALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTNPWD 481
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 64.9 bits (158), Expect = 6e-11
Identities = 43/297 (14%), Positives = 89/297 (29%), Gaps = 21/297 (7%)
Query: 15 TELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSN 74
+ L++S N + + I +L KL L++ QEL L L+ N
Sbjct: 21 QKTTILNISQNY-ISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHN 79
Query: 75 GFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSI 134
S NL LDL+ N + + + + K L S
Sbjct: 80 KLVK---ISCHPTVNLKHLDLSFNAFD-----ALPICKEFGNMSQLKFLGLSTTHLEKSS 131
Query: 135 PEKLFRPDMVLIHVLFDSNNLTGELPATLG--LVKSLEVVRFDRNSLSGPVPSNLNNLTS 192
+ ++ + ++ E P L +SL +V + ++ + +
Sbjct: 132 VLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVAN 191
Query: 193 VNDLYLSNNKLTGAM-------PNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQ--SLTT 243
+ + L LS L ++N + + ++
Sbjct: 192 LELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWY 251
Query: 244 LMMENTNLKGQIPADLFSIPHLQTVVMKTNEL-NGTLDLGTSYSENLLVNLQNNRIS 299
+ N L+GQ+ F + +++ + SY + N+ +
Sbjct: 252 FSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFT 308
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 62.6 bits (152), Expect = 3e-10
Identities = 55/312 (17%), Positives = 112/312 (35%), Gaps = 30/312 (9%)
Query: 8 SGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELV 67
+ DI L++L L +S+N+ ++ + ++L L L +L+
Sbjct: 38 TSDILSLSKLRILIISHNR-IQYLDISVFKFNQELEYLDLSHNKLVKISCHPTVNLKH-- 94
Query: 68 LLSLNSNGFSGRVPPS--IGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHF 125
L L+ N F +P GN+S L +L L+ LE + + +L
Sbjct: 95 -LDLSFNAFD-ALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVL-----LVL 147
Query: 126 GKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELP-------ATLGLVKSLEVVRFDRNS 178
G+ PE L + +H++F +N + A L L V+ ++ S
Sbjct: 148 GETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCS 207
Query: 179 LSGPVPSNLNNLTSVNDLYLSNNKLTG----AMPNLTGLSVLSYLDMSNNSFDASEVPSW 234
+ + L +++L L+N + T + L + + Y +SN
Sbjct: 208 YFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRD 267
Query: 235 FS----SMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGT-SYSENL 289
F S+++L+ + + + ++ I + T + + S
Sbjct: 268 FDYSGTSLKALSIHQVVSDVFGF-PQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPF 326
Query: 290 LV-NLQNNRISA 300
L + NN ++
Sbjct: 327 LHLDFSNNLLTD 338
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 57.6 bits (139), Expect = 1e-08
Identities = 40/281 (14%), Positives = 82/281 (29%), Gaps = 17/281 (6%)
Query: 151 DSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNL 210
N ++ + + + L ++ N + S + L LS+NKL +
Sbjct: 29 SQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVKI--SC 86
Query: 211 TGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVM 270
L +LD+S N+FDA + F +M L L + T+L+ + + ++ V++
Sbjct: 87 HPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLE-KSSVLPIAHLNISKVLL 145
Query: 271 KTNELNGTLDLGTSYSENLLVNLQNNRISAYTERGGAPAVNLTLIDNPICQELGTAKGYC 330
E G + + +L + T+ + + +
Sbjct: 146 VLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNK 205
Query: 331 QLSQPISPYSTKQKNCLPAPCNANQSSSPNCQCAYPYTGTLVFRSLSFSDLGNTTYYEIL 390
+ L N ++ N R L Y+ I
Sbjct: 206 CSYFLSILAKLQTNPKLSNLTLNNIETTWNS----------FIRILQLVWHTTVWYFSIS 255
Query: 391 EQSVTTSFQSTYKLPIDSISLSNPHKNNFEYLELSIQFFPS 431
Q S ++ + + + FP
Sbjct: 256 NV----KLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQ 292
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 50.2 bits (120), Expect = 2e-06
Identities = 20/95 (21%), Positives = 37/95 (38%), Gaps = 3/95 (3%)
Query: 6 QLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQE 65
+++ T + L LD+S N K L +L + + I +
Sbjct: 365 KIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPR 422
Query: 66 LVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKL 100
+ +L L+SN +P + L L L++ N+L
Sbjct: 423 IKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQL 456
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 4e-14
Identities = 42/209 (20%), Positives = 74/209 (35%), Gaps = 53/209 (25%)
Query: 564 GSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRV-HHKNLVSLLGFCF 621
G G GKV + + A+K +Q + + E+EL R ++V ++
Sbjct: 27 GLGINGKVLQIFNKRTQEKFALK-----MLQDCPKARREVELHWRASQCPHIVRIVDVYE 81
Query: 622 DRGEQM----LIYEFVPNGSLGDSLSGKNGIRL------DWIRRLKIALGAARGLSYLHE 671
+ ++ E + G L + + + ++ + + YLH
Sbjct: 82 NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSI------GEAIQYLHS 135
Query: 672 LANPPIIHRDIKSSNILL---DERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPE 728
+ I HRD+K N+L K+ DFG +K + G Y
Sbjct: 136 IN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAK------------ETTGE-KY---- 175
Query: 729 YYMTQQLTEKSDVYSFGVLMLELLTGRRP 757
+ D++S GV+M LL G P
Sbjct: 176 -------DKSCDMWSLGVIMYILLCGYPP 197
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 5e-14
Identities = 49/289 (16%), Positives = 100/289 (34%), Gaps = 52/289 (17%)
Query: 13 GLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLN 72
L + + T +L ++ L G + + + L L+ L L
Sbjct: 17 ALANAIKIAAGKSNVTD---TVTQADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELK 71
Query: 73 SNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSG 132
N + + P + NL+ + L+L+ N L+ N + L K Q++
Sbjct: 72 DNQIT-DLAP-LKNLTKITELELSGNPLK--------NVSAIAGLQSIKTLDLTSTQITD 121
Query: 133 SIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTS 192
P L + +L+V+ D N ++ S L LT+
Sbjct: 122 VTP---------------------------LAGLSNLQVLYLDLNQIT--NISPLAGLTN 152
Query: 193 VNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLK 252
+ L + N +++ + L LS L+ L +N S++ +S+ +L + ++N +
Sbjct: 153 LQYLSIGNAQVSD-LTPLANLSKLTTLKADDNKI--SDISP-LASLPNLIEVHLKNNQIS 208
Query: 253 GQIPADLFSIPHLQTVVMKTNEL--NGTLDLGTSYSENLLVNLQNNRIS 299
P L + +L V + + N++ I+
Sbjct: 209 DVSP--LANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPSGAPIA 255
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 9e-14
Identities = 59/257 (22%), Positives = 104/257 (40%), Gaps = 56/257 (21%)
Query: 547 FEEVKKYTNNFSDANDVGSGGYGKVYKGT-LPNGQLIAIK--RAQQGSMQGGQEFKMEIE 603
+ + + +G G YG V T P G+++AIK + + + EI+
Sbjct: 7 YNISSDFQL----KSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIK 61
Query: 604 LLSRVHHKNLVSLLG-FCFDRGEQM----LIYEFVP--------NGSLGDSLSGKNGIRL 650
+L H+N++++ D E +I E + L D +
Sbjct: 62 ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSD-------DHI 114
Query: 651 DWI-----RRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKS 705
+ R +K LH +N +IHRD+K SN+L++ + KV DFGL++
Sbjct: 115 QYFIYQTLRAVK----------VLHG-SN--VIHRDLKPSNLLINSNCDLKVCDFGLARI 161
Query: 706 MSDSEKDHITTQVKG--------TMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRR 756
+ +S D+ + T Y PE +T + + DV+S G ++ EL RR
Sbjct: 162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RR 220
Query: 757 PIERGKYIVREIRTVMD 773
PI G+ ++ +
Sbjct: 221 PIFPGRDYRHQLLLIFG 237
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 1e-13
Identities = 37/113 (32%), Positives = 63/113 (55%), Gaps = 8/113 (7%)
Query: 664 RGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSD--SEKDHITTQVKGT 721
RGL Y+H AN ++HRD+K SN+LL+ + K+ DFGL++ +T V T
Sbjct: 139 RGLKYIHS-AN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV-AT 194
Query: 722 MGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMD 773
Y PE + + T+ D++S G ++ E+L+ RPI GK+ + ++ ++
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPIFPGKHYLDQLNHILG 246
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 1e-13
Identities = 36/111 (32%), Positives = 61/111 (54%), Gaps = 10/111 (9%)
Query: 664 RGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMG 723
RGL Y+H A+ IIHRD+K SN+ ++E K+ DFGL++ +D ++ T+
Sbjct: 143 RGLKYIHS-AD--IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRW----- 194
Query: 724 YLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMD 773
Y PE + + D++S G +M ELLTG R + G + +++ ++
Sbjct: 195 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG-RTLFPGTDHIDQLKLILR 244
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 2e-13
Identities = 41/244 (16%), Positives = 77/244 (31%), Gaps = 45/244 (18%)
Query: 14 LTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNS 73
TL L L+ + + +L + + ++
Sbjct: 30 PPSTQTLKLIETH------------LRTIP-------------SHAFSNLPNISRIYVSI 64
Query: 74 NGFSGRVPPSI-GNLSNLYWLDLTDNKLEGEIPVSDGNSPG-LDMLVRAKHFHFGKNQLS 131
+ ++ NLS + +++ + + I P L L K L
Sbjct: 65 DVTLQQLESHSFYNLSKVTHIEIRNTRNLTYID------PDALKELPLLKFLGIFNTGLK 118
Query: 132 GSIPEKLFRPDMVLIHVL-FDSNNLTGELPATL--GLVKSLEVVRFDRNSLSGPVPSNLN 188
P+ + +L N +P GL ++ N + V
Sbjct: 119 -MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTS-VQGYAF 176
Query: 189 NLTSVNDLYLSNNKLTGAMPN--LTGL-SVLSYLDMSNNSFDASEVPSWFSSMQSLTTLM 245
N T ++ +YL+ NK + G+ S S LD+S S + +PS ++ L L+
Sbjct: 177 NGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSV--TALPS--KGLEHLKELI 232
Query: 246 MENT 249
NT
Sbjct: 233 ARNT 236
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 5e-10
Identities = 29/155 (18%), Positives = 55/155 (35%), Gaps = 14/155 (9%)
Query: 12 TGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPD--SIGSLQELVLL 69
L+++ +++ N ++L P + L L L + PD + S +L
Sbjct: 77 YNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPDLTKVYSTDIFFIL 135
Query: 70 SLNSNGFSGRVPP-SIGNLSN-LYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGK 127
+ N + +P + L N L L +N + N LD + + K
Sbjct: 136 EITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAV------YLNK 188
Query: 128 NQLSGSIPEKLFRPDMVLIHVLF-DSNNLTGELPA 161
N+ I + F +L ++T LP+
Sbjct: 189 NKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPS 222
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 2e-06
Identities = 25/137 (18%), Positives = 48/137 (35%), Gaps = 9/137 (6%)
Query: 168 SLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPN-LTGLSVLSYLDMSNNSF 226
E R + +PS + + L L L + + L +S + +S +
Sbjct: 12 QEEDFRVTCKDIQR-IPSLPPSTQT---LKLIETHLRTIPSHAFSNLPNISRIYVSIDVT 67
Query: 227 DASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFS-IPHLQTVVMKTNELNGTLDLGTSY 285
F ++ +T + + NT I D +P L+ + + L DL Y
Sbjct: 68 LQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKVY 127
Query: 286 SENLLVNL---QNNRIS 299
S ++ L N ++
Sbjct: 128 STDIFFILEITDNPYMT 144
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 4e-05
Identities = 24/161 (14%), Positives = 51/161 (31%), Gaps = 16/161 (9%)
Query: 150 FDSNNLTGELPATL--GLVKSLEVVRFDRNSLSGPVPSNL-NNLTSVNDLYLSNNKLTGA 206
+L +P+ L ++ + + + S+ NL+ V + + N +
Sbjct: 38 LIETHLR-TIPSHAFSNL-PNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTY 95
Query: 207 MPN--LTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFS--I 262
+ L L +L +L + N + S L + + IP + F
Sbjct: 96 IDPDALKELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLC 155
Query: 263 PHLQTVVMKTNEL----NGTLDLGTSYSENLLVNLQNNRIS 299
T+ + N + GT L +N ++
Sbjct: 156 NETLTLKLYNNGFTSVQGYAFN-GTKLDAVYL--NKNKYLT 193
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 2e-13
Identities = 46/215 (21%), Positives = 75/215 (34%), Gaps = 39/215 (18%)
Query: 15 TELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSG-PIPDSIGSLQELVLLSLNS 73
+ L LS N L T+ +L+ L L + + ++ L L L+
Sbjct: 31 KDTTILHLSENL-LYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLPVLGTL---DLSH 86
Query: 74 NGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGL-DMLVRAKHFHFGKNQLSG 132
N +P L L LD++ N+L +P G L + + N+L
Sbjct: 87 NQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLP------LGALRGLGELQELYLKGNELK- 137
Query: 133 SIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTS 192
++P L P L + +NNLT ELPA L + L +
Sbjct: 138 TLPPGLLTPTPKLEKLSLANNNLT-ELPAGL----------LN-------------GLEN 173
Query: 193 VNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFD 227
++ L L N L G +L + + N +
Sbjct: 174 LDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWL 208
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 2e-09
Identities = 41/156 (26%), Positives = 62/156 (39%), Gaps = 17/156 (10%)
Query: 151 DSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNL 210
D NLT LP L K ++ N L + L T + L L +LT +
Sbjct: 18 DKRNLT-ALPP--DLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQVD 73
Query: 211 TGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLF-SIPHLQTVV 269
L VL LD+S+N +P ++ +LT L + L +P + LQ +
Sbjct: 74 GTLPVLGTLDLSHNQL--QSLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELY 130
Query: 270 MKTNEL----NGTLDLGTSYSENL-LVNLQNNRISA 300
+K NEL G L L ++L NN ++
Sbjct: 131 LKGNELKTLPPGLLTPTP----KLEKLSLANNNLTE 162
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 40/145 (27%), Positives = 57/145 (39%), Gaps = 15/145 (10%)
Query: 12 TGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSL 71
L L TLDLS+N+ L+ LP L L+ L + + ++ L EL L L
Sbjct: 74 GTLPVLGTLDLSHNQ-LQS-LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYL 131
Query: 72 NSNGFSGRVPPSI-GNLSNLYWLDLTDNKLEGEIPVSDGNSPGL-DMLVRAKHFHFGKNQ 129
N +PP + L L L +N L E+P GL + L +N
Sbjct: 132 KGNELK-TLPPGLLTPTPKLEKLSLANNNLT-ELP------AGLLNGLENLDTLLLQENS 183
Query: 130 LSGSIPEKLFRPDMVLIHVLFDSNN 154
L +IP+ F L+ F N
Sbjct: 184 LY-TIPKGFF--GSHLLPFAFLHGN 205
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 34/114 (29%), Positives = 66/114 (57%), Gaps = 9/114 (7%)
Query: 664 RGLSYLHELANPPIIHRDIKSSNILLD-ERLNAKVADFGLSKSMS--DSEKDHITTQVKG 720
RGL Y+H AN ++HRD+K +N+ ++ E L K+ DFGL++ M S K H++ +
Sbjct: 131 RGLKYIHS-AN--VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGL-V 186
Query: 721 TMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMD 773
T Y P ++ T+ D+++ G + E+LTG + + G + + +++ +++
Sbjct: 187 TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG-KTLFAGAHELEQMQLILE 239
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 69.4 bits (169), Expect = 3e-12
Identities = 47/291 (16%), Positives = 98/291 (33%), Gaps = 54/291 (18%)
Query: 11 ITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPD--SIGSLQELVL 68
L + + +N+ ++ ++ L N+ + + + + D + +L+ L
Sbjct: 39 QNELNSIDQIIANNSD------IKSVQGIQYLPNVTKLFLNGN-KLTDIKPLTNLKNLGW 91
Query: 69 LSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKN 128
L L+ N + + +L L L L N + + GL L + + + G N
Sbjct: 92 LFLDENKIK-DLSS-LKDLKKLKSLSLEHNGIS--------DINGLVHLPQLESLYLGNN 141
Query: 129 QLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLN 188
+++ I VL + LT L+ + + N +S L
Sbjct: 142 KITD-------------ITVL---SRLT-----------KLDTLSLEDNQISD--IVPLA 172
Query: 189 NLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMEN 248
LT + +LYLS N ++ + L GL L L++ + ++ + S++ T+
Sbjct: 173 GLTKLQNLYLSKNHIS-DLRALAGLKNLDVLELFSQEC-LNKPINHQSNLVVPNTV---- 226
Query: 249 TNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENLLVNLQNNRIS 299
N G + S+ V + +
Sbjct: 227 KNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKAR 277
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 65.9 bits (160), Expect = 3e-11
Identities = 47/347 (13%), Positives = 110/347 (31%), Gaps = 32/347 (9%)
Query: 62 SLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAK 121
+ E + +L + V L+++ + ++ ++ + G+ L
Sbjct: 19 AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK--------SVQGIQYLPNVT 68
Query: 122 HFHFGKNQLSGSIP--EKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSL 179
N+L+ I L L + D N + +L + L K L+ + + N +
Sbjct: 69 KLFLNGNKLT-DIKPLTNLKN----LGWLFLDENKIK-DLSSLKDLKK-LKSLSLEHNGI 121
Query: 180 SGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQ 239
S + L +L + LYL NNK+T + L+ L+ L L + +N S++ + +
Sbjct: 122 S--DINGLVHLPQLESLYLGNNKITD-ITVLSRLTKLDTLSLEDNQI--SDIVP-LAGLT 175
Query: 240 SLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNEL--NGTLDLGTSYSENLLVNLQNNR 297
L L + ++ + A L + +L + + + E N + N +
Sbjct: 176 KLQNLYLSKNHIS-DLRA-LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 233
Query: 298 ISAYTERGGAPAVNLTLIDNPICQELG---TAKGYCQLSQPISPYSTKQKNCLPAPCNAN 354
++ + + + + + + + L +
Sbjct: 234 VTPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKARFHGRVTQPLKEVYTVS 293
Query: 355 QSSSPNCQCAYPYTGTLVFRSLSFSDLGNTTYYEILEQSVTTSFQST 401
GT + + G E++ +
Sbjct: 294 YDVDGTVIKTKVEAGTRITAPKPPTKQGYVFKGWYTEKNGGHEWNFN 340
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 5e-12
Identities = 55/291 (18%), Positives = 101/291 (34%), Gaps = 61/291 (20%)
Query: 13 GLTELHTLDLSNN--KDLRGPLPTTIGNLKKLSNLMLVGC---SFSGPIPDSIGSLQELV 67
E +L D T L + ++ S G I L +
Sbjct: 22 AFAETIKDNLKKKSVTDA-----VTQNELNSIDQIIANNSDIKSVQG-----IQYLPNVT 71
Query: 68 LLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGK 127
L LN N + + P + NL NL WL L +NK++ + L L + K
Sbjct: 72 KLFLNGNKLT-DIKP-LANLKNLGWLFLDENKVK--------DLSSLKDLKKLKSLSLEH 121
Query: 128 NQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNL 187
N +S ++ G L + LE + N ++ + L
Sbjct: 122 NGIS----------------------DING-----LVHLPQLESLYLGNNKITD--ITVL 152
Query: 188 NNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMME 247
+ LT ++ L L +N+++ + L GL+ L L +S N S++ + + +++L L +
Sbjct: 153 SRLTKLDTLSLEDNQIS-DIVPLAGLTKLQNLYLSKNHI--SDLRA-LAGLKNLDVLELF 208
Query: 248 N---TNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENLLVNLQN 295
+ N ++L ++ D G N+ +L
Sbjct: 209 SQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPE 259
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 9e-11
Identities = 45/264 (17%), Positives = 90/264 (34%), Gaps = 49/264 (18%)
Query: 38 NLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTD 97
+ L S + + L + + N++ V I L N+ L L
Sbjct: 22 AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQG-IQYLPNVTKLFLNG 77
Query: 98 NKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTG 157
NKL + L L +N++ D ++L
Sbjct: 78 NKLT--------DIKPLANLKNLGWLFLDENKVK-------------------DLSSLKD 110
Query: 158 ELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLS 217
+K L+ + + N +S + L +L + LYL NNK+T + L+ L+ L
Sbjct: 111 --------LKKLKSLSLEHNGIS--DINGLVHLPQLESLYLGNNKITD-ITVLSRLTKLD 159
Query: 218 YLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNEL-- 275
L + +N S++ + + L L + ++ + A L + +L + + + E
Sbjct: 160 TLSLEDNQI--SDIVP-LAGLTKLQNLYLSKNHIS-DLRA-LAGLKNLDVLELFSQECLN 214
Query: 276 NGTLDLGTSYSENLLVNLQNNRIS 299
N + N + ++
Sbjct: 215 KPINHQSNLVVPNTVKNTDGSLVT 238
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 5e-09
Identities = 49/198 (24%), Positives = 78/198 (39%), Gaps = 28/198 (14%)
Query: 11 ITGLTELHTLDLSNNK--DLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPD--SIGSLQEL 66
I L + L L+ NK D++ + NLK L L L + D S+ L++L
Sbjct: 64 IQYLPNVTKLFLNGNKLTDIKP-----LANLKNLGWLFLDEN----KVKDLSSLKDLKKL 114
Query: 67 VLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFG 126
LSL NG S + +L L L L +NK+ + L L +
Sbjct: 115 KSLSLEHNGIS--DINGLVHLPQLESLYLGNNKIT--------DITVLSRLTKLDTLSLE 164
Query: 127 KNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSN 186
NQ+S I + + L+ S N +L A GL K+L+V+ ++
Sbjct: 165 DNQIS-DIVPL---AGLTKLQNLYLSKNHISDLRALAGL-KNLDVLELFSQECLNKPINH 219
Query: 187 LNNLTSVNDLYLSNNKLT 204
+NL N + ++ L
Sbjct: 220 QSNLVVPNTVKNTDGSLV 237
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 6e-12
Identities = 31/119 (26%), Positives = 53/119 (44%), Gaps = 24/119 (20%)
Query: 664 RGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMG 723
+ + YLH ++HRD+K SNILL+ + KVADFGLS+S + + +
Sbjct: 120 KVIKYLHS-GG--LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINEN 176
Query: 724 YLDPEY---YMT-----------------QQLTEKSDVYSFGVLMLELLTGRRPIERGK 762
+ + +T + T+ D++S G ++ E+L +PI G
Sbjct: 177 TENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEIL-CGKPIFPGS 234
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 66.8 bits (162), Expect = 6e-12
Identities = 38/285 (13%), Positives = 77/285 (27%), Gaps = 65/285 (22%)
Query: 545 FSFEEVKKYTNNFSDANDVGSGGYGKVYKGTLPNGQLIAIK--------RAQQGSMQGGQ 596
F T +G G +G+V++ + +AIK + +
Sbjct: 11 VPFSHCLP-TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFE 68
Query: 597 EFKMEIELLSRVH---------HKNLVSLLGFCFDRGE---------------------- 625
E EI + + + + L +G
Sbjct: 69 EILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDR 128
Query: 626 --------QMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPI 677
++ EF G + + K I L+
Sbjct: 129 PDFFKDDQLFIVLEFEFGGIDLEQMRTK---LSSLATAKSILHQLTASLAVAEASLR--F 183
Query: 678 IHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTE 737
HRD+ N+LL + K+ KS + + + Y +++ +
Sbjct: 184 EHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIID---------YTLSRLERD 234
Query: 738 KSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLY 782
V+ + +L TG + Y R ++ + + Y+ Y
Sbjct: 235 GIVVFCDVSMDEDLFTGDGDYQFDIY--RLMKKENNNRWGEYHPY 277
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 9e-12
Identities = 54/223 (24%), Positives = 95/223 (42%), Gaps = 49/223 (21%)
Query: 564 GSGGYGKVYKGT-LPNGQLIAIK--RAQQGSMQGGQEFKMEIELLSRVH----------- 609
G G + V+ + N +A+K R + + + EI+LL RV+
Sbjct: 28 GWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAE---DEIKLLQRVNDADNTKEDSMG 84
Query: 610 HKNLVSLLGFCFD-RGEQM----LIYEFVPNGSLGDSL------SGKNGIRLDWIRRLKI 658
+++ LL F+ +G +++E LG++L GI L +++ +I
Sbjct: 85 ANHILKLLDH-FNHKGPNGVHVVMVFE-----VLGENLLALIKKYEHRGIPLIYVK--QI 136
Query: 659 ALGAARGLSYLHELANPPIIHRDIKSSNILLDE------RLNAKVADFGLSKSMSDSEKD 712
+ GL Y+H IIH DIK N+L++ + K+AD G + +
Sbjct: 137 SKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLG----NACWYDE 190
Query: 713 HITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGR 755
H T ++ T Y PE + +D++S L+ EL+TG
Sbjct: 191 HYTNSIQ-TREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 1e-10
Identities = 40/203 (19%), Positives = 70/203 (34%), Gaps = 22/203 (10%)
Query: 8 SGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVG---CSFSGPIPDSIGSLQ 64
S EL LDLS + ++ +L LS L+L G S + + SLQ
Sbjct: 45 SYSFFSFPELQVLDLSRCE-IQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQ 103
Query: 65 ELVLLSLNSNGFSGRVPPSI-GNLSNLYWLDLTDNKLEGEIPVSDGNSPGL-DMLVRAKH 122
+ L + + G+L L L++ N ++ P L +H
Sbjct: 104 K---LVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQ-SFK-----LPEYFSNLTNLEH 153
Query: 123 FHFGKNQLSGSIPEKLFRP----DMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNS 178
N++ SI R ++ + + N + + L+ + D N
Sbjct: 154 LDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQ 211
Query: 179 LSGPVPSNLNNLTSVNDLYLSNN 201
L + LTS+ ++L N
Sbjct: 212 LKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 8e-09
Identities = 32/205 (15%), Positives = 71/205 (34%), Gaps = 21/205 (10%)
Query: 128 NQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATL--GLVKSLEVVRFDRNSLSGPVPS 185
N L + F L + + + L L + N + +
Sbjct: 38 NPLR-HLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLS-HLSTLILTGNPIQS-LAL 93
Query: 186 NL-NNLTSVNDLYLSNNKLTGAMPN--LTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLT 242
+ L+S+ L L ++ N + L L L++++N + ++P +FS++ +L
Sbjct: 94 GAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLE 152
Query: 243 TLMMENTNLKGQIPADLF-SIPHLQTVVMK----TNELNGTLDLGTSYSENLLV-NLQNN 296
L + + ++ I + + + + N +N + G L L N
Sbjct: 153 HLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTN 210
Query: 297 RISAYTERGGAPAVNLTLI---DNP 318
++ + + +L I NP
Sbjct: 211 QLKSVPDGIFDRLTSLQKIWLHTNP 235
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 1e-10
Identities = 51/210 (24%), Positives = 84/210 (40%), Gaps = 33/210 (15%)
Query: 563 VGSGGYGKVYKGT-LPNGQLIAIK--RAQQGSMQGGQEFKMEIELLSRV------HHKNL 613
+G G +G+V K + +AIK + ++ + Q +E+ LL + +
Sbjct: 62 IGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQ---IEVRLLELMNKHDTEMKYYI 118
Query: 614 VSLLGFCFDRGEQMLIYEFVPNGSLGDSL------SGKNGIRLDWIRRLKIALGAARGLS 667
V L R L++E L +L + G+ L+ R K A L
Sbjct: 119 VHLKRHFMFRNHLCLVFE-----MLSYNLYDLLRNTNFRGVSLNLTR--KFAQQMCTALL 171
Query: 668 YLHELANPPIIHRDIKSSNILL--DERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYL 725
+L IIH D+K NILL +R K+ DFG S I ++ + Y
Sbjct: 172 FLAT-PELSIIHCDLKPENILLCNPKRSAIKIVDFG----SSCQLGQRIYQYIQ-SRFYR 225
Query: 726 DPEYYMTQQLTEKSDVYSFGVLMLELLTGR 755
PE + D++S G +++E+ TG
Sbjct: 226 SPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 61.4 bits (149), Expect = 5e-10
Identities = 40/206 (19%), Positives = 71/206 (34%), Gaps = 45/206 (21%)
Query: 48 VGCSFSG--PIPDSIGSLQELVLLSLNSNGFSGRVPPSI--GNLSNLYWLDLTDNKLEGE 103
+ CS +P S+ S LL L+ N S R+ L+NL+ L L+ N L
Sbjct: 23 LSCSKQQLPNVPQSLPS--YTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-F 78
Query: 104 IPVSDGNSPG-LDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPAT 162
I + ++ N L ++ E LF +L
Sbjct: 79 IS------SEAFVPVPNLRYLDLSSNHLH-TLDEFLFS-------------DLQ------ 112
Query: 163 LGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLT----GAMPNLTGLSVLSY 218
+LEV+ N + + ++ + LYLS N+++ + + L L
Sbjct: 113 -----ALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLML 167
Query: 219 LDMSNNSFDASEVPSWFSSMQSLTTL 244
LD+S+N + + +
Sbjct: 168 LDLSSNKL-KKLPLTDLQKLPAWVKN 192
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 4e-06
Identities = 43/269 (15%), Positives = 74/269 (27%), Gaps = 101/269 (37%)
Query: 12 TGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSL 71
T LT LH+L LS+N L +
Sbjct: 61 TRLTNLHSLLLSHNH-----------------------------------------LNFI 79
Query: 72 NSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLS 131
+S F + NL +LDL+ N L + L + N +
Sbjct: 80 SSEAFVP--------VPNLRYLDLSSNHLH-TLDEFL-----FSDLQALEVLLLYNNHIV 125
Query: 132 GSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVP----SNL 187
+ F ++ L+ + +N +S P +
Sbjct: 126 -VVDRNAFE-------------DMA-----------QLQKLYLSQNQISR-FPVELIKDG 159
Query: 188 NNLTSVNDLYLSNNKLT----GAMPNLTGLSVLSYLDMSNNSFD----ASEVPSWFSSMQ 239
N L + L LS+NKL + L + L + NN + ++ S + Q
Sbjct: 160 NKLPKLMLLDLSSNKLKKLPLTDLQKLPAWV-KNGLYLHNNPLECDCKLYQLFSHWQYRQ 218
Query: 240 SLTTLMMENT-------NLKGQIPADLFS 261
+ + + L D F+
Sbjct: 219 LSSVMDFQEDLYCMHSKKLHNIFSLDFFN 247
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 41.4 bits (97), Expect = 9e-04
Identities = 22/97 (22%), Positives = 32/97 (32%), Gaps = 8/97 (8%)
Query: 8 SGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIP----DSIGSL 63
+ L L L L NN + ++ +L L L S P L
Sbjct: 105 EFLFSDLQALEVLLLYNNH-IVVVDRNAFEDMAQLQKLYLSQNQISR-FPVELIKDGNKL 162
Query: 64 QELVLLSLNSNGFSGRVPPSIGNLSNLYW--LDLTDN 98
+L+LL L+SN + L L L +N
Sbjct: 163 PKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNN 199
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 8e-10
Identities = 54/210 (25%), Positives = 89/210 (42%), Gaps = 35/210 (16%)
Query: 563 VGSGGYGKVYKGT-LPNGQLIAIK--RAQQGSMQGGQEFKMEIELLSRVHHK------NL 613
+G G +G+V K Q +A+K R ++ + EI +L + + N+
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAA---EEIRILEHLRKQDKDNTMNV 161
Query: 614 VSLLGFCFDRGEQMLIYEFVPNGSLGDSL------SGKNGIRLDWIRRLKIALGAARGLS 667
+ +L R + +E L +L + G L +R K A + L
Sbjct: 162 IHMLENFTFRNHICMTFE-----LLSMNLYELIKKNKFQGFSLPLVR--KFAHSILQCLD 214
Query: 668 YLHELANPPIIHRDIKSSNILLDERLNA--KVADFGLSKSMSDSEKDHITTQVKGTMGYL 725
LH+ IIH D+K NILL ++ + KV DFG S E + T ++ + Y
Sbjct: 215 ALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSC----YEHQRVYTYIQ-SRFYR 266
Query: 726 DPEYYMTQQLTEKSDVYSFGVLMLELLTGR 755
PE + + D++S G ++ ELLTG
Sbjct: 267 APEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 53/217 (24%), Positives = 77/217 (35%), Gaps = 39/217 (17%)
Query: 15 TELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSI-GSLQELVLLSLNS 73
+ LDL +NK L L KL L L +P I L+ L L +
Sbjct: 37 ADTKKLDLQSNK-LSSLPSKAFHRLTKLRLLYLNDNKLQT-LPAGIFKELKNLETLWVTD 94
Query: 74 NGFSGRVPPSI-GNLSNLYWLDLTDNKLEGEIPVSDGNSPGL-DMLVRAKHFHFGKNQLS 131
N +P + L NL L L N+L+ +P P + D L + + G N+L
Sbjct: 95 NKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLP------PRVFDSLTKLTYLSLGYNELQ 146
Query: 132 GSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLT 191
S+P+ +F L + +N L +P FD LT
Sbjct: 147 -SLPKGVFDKLTSLKELRLYNNQLK-RVPEGA----------FD-------------KLT 181
Query: 192 SVNDLYLSNNKLTGAMPNL-TGLSVLSYLDMSNNSFD 227
+ L L NN+L L L L + N +D
Sbjct: 182 ELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWD 218
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 8e-05
Identities = 37/160 (23%), Positives = 66/160 (41%), Gaps = 24/160 (15%)
Query: 152 SNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNL- 210
S LT +P+ + + + N LS + LT + LYL++NKL +
Sbjct: 25 SKKLT-AIPS--NIPADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIF 81
Query: 211 TGLSVLSYLDMSNNSFDASEVPS-WFSSMQSLTTLMMENTNLKGQIPADLF-SIPHLQTV 268
L L L +++N +P F + +L L ++ LK +P +F S+ L +
Sbjct: 82 KELKNLETLWVTDNKL--QALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYL 138
Query: 269 VMKTNELNGTLDLGTSYSENL---LVNLQ-----NNRISA 300
+ NEL S + + L +L+ NN++
Sbjct: 139 SLGYNEL-------QSLPKGVFDKLTSLKELRLYNNQLKR 171
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 59.4 bits (143), Expect = 3e-09
Identities = 47/221 (21%), Positives = 79/221 (35%), Gaps = 19/221 (8%)
Query: 57 PDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDM 116
+ ++L L+ S + + + L L+ +NK + + LD
Sbjct: 342 CRDSATDEQLFRCELSVE-KSTVLQSELESCKELQELEP-ENKWCLLTIILLMRA--LDP 397
Query: 117 LVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDR 176
L+ K + L P + D + L E + V+
Sbjct: 398 LLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLL-------ENSVLKMEYADVRVLHLAH 450
Query: 177 NSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFS 236
L+ V +L L V L LS+N+L P L L L L S+N+ V +
Sbjct: 451 KDLT--VLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNAL--ENVDG-VA 505
Query: 237 SMQSLTTLMMENTNLKGQIPA--DLFSIPHLQTVVMKTNEL 275
++ L L++ N L+ Q A L S P L + ++ N L
Sbjct: 506 NLPRLQELLLCNNRLQ-QSAAIQPLVSCPRLVLLNLQGNSL 545
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 49.4 bits (117), Expect = 4e-06
Identities = 24/94 (25%), Positives = 37/94 (39%), Gaps = 11/94 (11%)
Query: 11 ITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGC---SFSGPIPDSIGSLQELV 67
+ L + LDLS+N+ LR LP + L+ L L + G + +L L
Sbjct: 459 LEQLLLVTHLDLSHNR-LRA-LPPALAALRCLEVLQASDNALENVDG-----VANLPRLQ 511
Query: 68 LLSLNSNGFSG-RVPPSIGNLSNLYWLDLTDNKL 100
L L +N + + L L+L N L
Sbjct: 512 ELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSL 545
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 47.4 bits (112), Expect = 2e-05
Identities = 33/240 (13%), Positives = 70/240 (29%), Gaps = 42/240 (17%)
Query: 4 KGQLSGDITGLTELHTLDLSNNKDLRGP-LPTTIGNLKKLS----------NLMLVGCSF 52
D +L +LS K + L++L L++
Sbjct: 338 PECWCRDSATDEQLFRCELSVEKSTVLQSELESCKELQELEPENKWCLLTIILLMRALDP 397
Query: 53 SGPIPDSIGSLQELVLL--------SLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEI 104
+++ L + + F +++ L L L +
Sbjct: 398 LLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT-VL 456
Query: 105 PVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLG 164
L+ L+ H N+L ++P L + + VL S+N + +
Sbjct: 457 C-------HLEQLLLVTHLDLSHNRLR-ALPPAL--AALRCLEVLQASDNALENVDG-VA 505
Query: 165 LVKSLEVVRFDRNSLSG-PVPSNLNNLTSVNDLYLSNN----------KLTGAMPNLTGL 213
+ L+ + N L L + + L L N +L +P+++ +
Sbjct: 506 NLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 565
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 3e-09
Identities = 41/216 (18%), Positives = 72/216 (33%), Gaps = 50/216 (23%)
Query: 11 ITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPD--SIGSLQELVL 68
GL +L T + + K+LS + S I + L
Sbjct: 15 DPGLANAVKQNLGKQSV------TDLVSQKELSGVQNFNGDNSN-IQSLAGMQFFTNLKE 67
Query: 69 LSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKN 128
L L+ N S + P + +L+ L L + N+L+ ++ S L L N
Sbjct: 68 LHLSHNQIS-DLSP-LKDLTKLEELSVNRNRLKN---LNGIPSACLSRL------FLDNN 116
Query: 129 QLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLN 188
+L L +L +LE++ N L L
Sbjct: 117 ELRD-------------TDSL---IHLK-----------NLEILSIRNNKLK--SIVMLG 147
Query: 189 NLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNN 224
L+ + L L N++T LT L ++++D++
Sbjct: 148 FLSKLEVLDLHGNEIT-NTGGLTRLKKVNWIDLTGQ 182
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 7e-09
Identities = 35/195 (17%), Positives = 67/195 (34%), Gaps = 26/195 (13%)
Query: 60 IGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVR 119
L V +L + V LS + + ++ ++ + G+
Sbjct: 15 DPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ--------SLAGMQFFTN 64
Query: 120 AKHFHFGKNQLSGSIP--EKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRN 177
K H NQ+S + + L + L + + N L L L + D N
Sbjct: 65 LKELHLSHNQIS-DLSPLKDLTK----LEELSVNRNRLK-NLNGIPSA--CLSRLFLDNN 116
Query: 178 SLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSS 237
L +L +L ++ L + NNKL ++ L LS L LD+ N + +
Sbjct: 117 ELRDT--DSLIHLKNLEILSIRNNKLK-SIVMLGFLSKLEVLDLHGNEI--TNTGG-LTR 170
Query: 238 MQSLTTLMMENTNLK 252
++ + + +
Sbjct: 171 LKKVNWIDLTGQKCV 185
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 31/198 (15%), Positives = 60/198 (30%), Gaps = 51/198 (25%)
Query: 11 ITGLTELHTLDLSNNK--DLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVL 68
+ T L L LS+N+ DL + +L KL L + ++ + L
Sbjct: 59 MQFFTNLKELHLSHNQISDLSP-----LKDLTKLEELSVNRNRLK-----NLNGIPSACL 108
Query: 69 --LSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFG 126
L L++N S+ +L NL L + +NKL+ + L L + +
Sbjct: 109 SRLFLDNNELRD--TDSLIHLKNLEILSIRNNKLK--------SIVMLGFLSKLEVLDLH 158
Query: 127 KNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSN 186
N+++ + L +K + +
Sbjct: 159 GNEIT-NTGG--------------------------LTRLKKVNWIDLTGQKCVNEPVKY 191
Query: 187 LNNLTSVNDLYLSNNKLT 204
L N + + +
Sbjct: 192 QPELYITNTVKDPDGRWI 209
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 33/158 (20%), Positives = 56/158 (35%), Gaps = 31/158 (19%)
Query: 11 ITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSG-PIPD--SIGSLQELV 67
+ LT+L L ++ N+ + NL + + L + D S+ L+ L
Sbjct: 81 LKDLTKLEELSVNRNR---------LKNLNGIPSACLSRLFLDNNELRDTDSLIHLKNLE 131
Query: 68 LLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGK 127
+LS+ +N +G LS L LDL N++ N+ GL L +
Sbjct: 132 ILSIRNNKLK--SIVMLGFLSKLEVLDLHGNEIT--------NTGGLTRLKKVNWIDLTG 181
Query: 128 NQLSGS---------IPEKLFRPDMVLIHVLFDSNNLT 156
+ I + PD I + SN +
Sbjct: 182 QKCVNEPVKYQPELYITNTVKDPDGRWISPYYISNGGS 219
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 58.8 bits (142), Expect = 4e-09
Identities = 55/271 (20%), Positives = 87/271 (32%), Gaps = 95/271 (35%)
Query: 563 VGSGGYGKVYKG-TLPNGQLIAIK--RAQQGSMQGGQEFKMEIELLSRVHH-------KN 612
+G G + V+ + + +A+K ++ + + + EI LL V + +
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALD---EIRLLKSVRNSDPNDPNRE 101
Query: 613 LVSLLGFCFD-RGEQMLIYEFVPNGS--------LGDSL------SGKNGIRLDWIRRLK 657
+V L F G NG+ LG L S G+ L +++
Sbjct: 102 MVVQLLDDFKISG---------VNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKK-- 150
Query: 658 IALGAARGLSYLHELANPPIIHRDIKSSNILL---------------------------- 689
I +GL YLH IIH DIK NILL
Sbjct: 151 IIQQVLQGLDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGS 208
Query: 690 ---------------------DERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPE 728
E+L K+AD G + + + I T+ Y E
Sbjct: 209 AVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ-----YRSLE 263
Query: 729 YYMTQQLTEKSDVYSFGVLMLELLTGRRPIE 759
+ +D++S + EL TG E
Sbjct: 264 VLIGSGYNTPADIWSTACMAFELATGDYLFE 294
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 57.4 bits (138), Expect = 7e-09
Identities = 20/109 (18%), Positives = 38/109 (34%), Gaps = 6/109 (5%)
Query: 170 EVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPN--LTGLSVLSYLDMSNNSFD 227
+ +L +L ++ +LY+ N + + L GL L L + +
Sbjct: 12 GLRCTRDGALD--SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR 69
Query: 228 ASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELN 276
P F L+ L + L+ + LQ +V+ N L+
Sbjct: 70 FVA-PDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 55.9 bits (134), Expect = 3e-08
Identities = 21/91 (23%), Positives = 34/91 (37%), Gaps = 1/91 (1%)
Query: 10 DITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLL 69
+ G L L + N + L+ + L +L NL +V PD+ L L
Sbjct: 26 HLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRL 85
Query: 70 SLNSNGFSGRVPPSIGNLSNLYWLDLTDNKL 100
+L+ N + +L L L+ N L
Sbjct: 86 NLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 44.7 bits (105), Expect = 8e-05
Identities = 20/107 (18%), Positives = 39/107 (36%), Gaps = 4/107 (3%)
Query: 194 NDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKG 253
+ L + + ++ +L G L+ L + N + L L + + L+
Sbjct: 11 SGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR- 69
Query: 254 QIPADLFS-IPHLQTVVMKTNELNGTLDLGTSYSENLL-VNLQNNRI 298
+ D F P L + + N L +L T +L + L N +
Sbjct: 70 FVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 43.6 bits (102), Expect = 2e-04
Identities = 17/112 (15%), Positives = 34/112 (30%), Gaps = 11/112 (9%)
Query: 48 VGCSFSG--PIPDSIGSLQELVLLSLNSNGFSGRVPP-SIGNLSNLYWLDLTDNKLEGEI 104
+ C+ G + + L L + + + + L L L + + L
Sbjct: 13 LRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR--- 69
Query: 105 PVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLT 156
V+ L + N L S+ K + + L ++ N L
Sbjct: 70 FVAPDAFHFTPRL---SRLNLSFNALE-SLSWKTVQG-LSLQELVLSGNPLH 116
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 54.8 bits (132), Expect = 6e-08
Identities = 50/269 (18%), Positives = 96/269 (35%), Gaps = 34/269 (12%)
Query: 563 VGSGGYGKVYKGTLPNGQLI------AIKRAQQGSMQGGQEFKMEIEL-----LSRVHHK 611
+G GG+G +Y + + + + +K + E K + +
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102
Query: 612 NLVSLLGFCF-----DRGEQMLIYEFVPNGSLGDSLS---GKNGIRLDWIRRLKIALGAA 663
+ LG + Y F+ G L N R L+++L
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRIL 162
Query: 664 RGLSYLHELANPPIIHRDIKSSNILLDERLNAKV--ADFGLSKSMSDSE-KDHITTQVK- 719
L Y+HE +H DIK+SN+LL+ + +V D+GL+ K
Sbjct: 163 DILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKR 219
Query: 720 ---GTMGY--LDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDK 774
GT+ + +D + + + D+ G M++ LTG P E + +R +
Sbjct: 220 CHDGTIEFTSIDAHNGVAP--SRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIR 277
Query: 775 -KKELYNLYELIDPTIGLSTTLKGFEKYV 802
++ + +L + P + + + V
Sbjct: 278 YRENIASLMDKCFPAANAPGEIAKYMETV 306
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 1e-07
Identities = 54/231 (23%), Positives = 94/231 (40%), Gaps = 59/231 (25%)
Query: 564 GSGGYGKVYKGT-LPNGQLIAIK--RAQQGSMQGGQEFKMEIELLSRV-----HHKNLVS 615
G G +G+V + N + A+K R + + K+E ++L ++ ++ N+V
Sbjct: 44 GDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSA---KIEADILKKIQNDDINNNNIVK 100
Query: 616 LLGFCFD-RGEQMLIYEFVPNGSLGDSL------SGKNGIRLDWIRRLKIALGAARGLSY 668
G F LI+E LG SL + NG ++ I+ + + L+Y
Sbjct: 101 YHG-KFMYYDHMCLIFE-----PLGPSLYEIITRNNYNGFHIEDIK--LYCIEILKALNY 152
Query: 669 LHELANPPIIHRDIKSSNILLDERLNA-------------------------KVADFGLS 703
L +++ + H D+K NILLD+ K+ DFG
Sbjct: 153 LRKMS---LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG-- 207
Query: 704 KSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTG 754
+ + D+ + + T Y PE + SD++SFG ++ EL TG
Sbjct: 208 -CATF-KSDYHGSIIN-TRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTG 255
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 1e-07
Identities = 50/238 (21%), Positives = 87/238 (36%), Gaps = 39/238 (16%)
Query: 563 VGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCF 621
+GSG +G +Y GT + G+ +AIK + + +E ++ K + +G
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIY-----KMMQGGVGIPT 69
Query: 622 DRGEQMLIYEFVPNGS--------LGDSLS---GKNGIRLDWIRRLKIALGAARGLSYLH 670
I G LG SL + L +A + Y+H
Sbjct: 70 -------IRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 122
Query: 671 ELANPPIIHRDIKSSNILLDERLNAK---VADFGLSKSMSDSE-KDHI----TTQVKGTM 722
IHRD+K N L+ + DFGL+K D+ HI + GT
Sbjct: 123 SKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTA 179
Query: 723 GYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRT--VMDKKKEL 778
Y ++ + + + D+ S G +++ G P + K + + + +KK
Sbjct: 180 RYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST 237
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 1e-07
Identities = 49/233 (21%), Positives = 94/233 (40%), Gaps = 27/233 (11%)
Query: 563 VGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLV-SLLGFC 620
+G G +G +++GT L N Q +AIK + S + + E + + ++ F
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFG 75
Query: 621 FDRGEQMLIYEFVPNGSLGDSLS---GKNGIRLDWIRRLKIALGAARGLSYLHELANPPI 677
+ +L+ + LG SL G + A + +HE + +
Sbjct: 76 QEGLHNVLVIDL-----LGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---L 127
Query: 678 IHRDIKSSNILLDERLNAK-----VADFGLSKSMSDSE-KDHI----TTQVKGTMGYLDP 727
++RDIK N L+ + V DFG+ K D K HI + GT Y+
Sbjct: 128 VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSI 187
Query: 728 EYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRT--VMDKKKEL 778
++ ++ + + D+ + G + + L G P + K + + + +KK+
Sbjct: 188 NTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 240
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 1e-07
Identities = 43/221 (19%), Positives = 83/221 (37%), Gaps = 45/221 (20%)
Query: 69 LSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKN 128
+L + L+++ + ++ ++ G+ L ++ G N
Sbjct: 24 ANLKKKSVT-DAVTQNE-LNSIDQIIANNSDIKSV--------QGIQYLPNVRYLALGGN 73
Query: 129 QLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATL--GLVKSLEVVRFDRNSLSGPVPSN 186
+L I + L +++ N L LP + L L+ + N L +P
Sbjct: 74 KLH-DIS--ALKELTNLTYLILTGNQLQ-SLPNGVFDKLTN-LKELVLVENQLQS-LPDG 127
Query: 187 L-NNLTSVNDLYLSNNKLTGAMPNLTG----LSVLSYLDMSNNSFDASEVPS-WFSSMQS 240
+ + LT++ L L++N+L ++P G L+ L+ LD+S N +P F +
Sbjct: 128 VFDKLTNLTYLNLAHNQLQ-SLPK--GVFDKLTNLTELDLSYNQL--QSLPEGVFDKLTQ 182
Query: 241 LTTLMMENTNLKGQIPADLFSIPH--------LQTVVMKTN 273
L L + LK S+P LQ + + N
Sbjct: 183 LKDLRLYQNQLK--------SVPDGVFDRLTSLQYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 1e-05
Identities = 51/223 (22%), Positives = 77/223 (34%), Gaps = 69/223 (30%)
Query: 11 ITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLS 70
I L + L L NK L + + +L L
Sbjct: 59 IQYLPNVRYLALGGNK------------LHDI------------SALKELTNLTY---LI 91
Query: 71 LNSNGFSGRVPPSI-GNLSNLYWLDLTDNKLEGEIPVSDGNSPGL-DMLVRAKHFHFGKN 128
L N +P + L+NL L L +N+L+ +P G+ D L + + N
Sbjct: 92 LTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQ-SLP------DGVFDKLTNLTYLNLAHN 143
Query: 129 QLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLN 188
QL S+P+ +F L + N L LP G+ FD+
Sbjct: 144 QLQ-SLPKGVFDKLTNLTELDLSYNQLQ-SLPE--GV--------FDK------------ 179
Query: 189 NLTSVNDLYLSNNKLT----GAMPNLTGLSVLSYLDMSNNSFD 227
LT + DL L N+L G LT L + +L +N +D
Sbjct: 180 -LTQLKDLRLYQNQLKSVPDGVFDRLTSLQYI-WLH--DNPWD 218
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 2e-07
Identities = 51/238 (21%), Positives = 88/238 (36%), Gaps = 77/238 (32%)
Query: 564 GSGGYGKVYKG--TLPNGQLIAIK--RAQQGSMQGGQEFKMEIELLSRVHHK------NL 613
G G +GKV + G+ +A+K + + + EI++L ++
Sbjct: 23 GEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAA---RSEIQVLEHLNTTDPNSTFRC 79
Query: 614 VSLLGFCFD-RGEQMLIYEFVPNGSLGDSL------SGKNGIRLDWIRRLKIALGAARGL 666
V +L F+ G +++E LG S +G RLD IR K+A + +
Sbjct: 80 VQMLE-WFEHHGHICIVFE-----LLGLSTYDFIKENGFLPFRLDHIR--KMAYQICKSV 131
Query: 667 SYLHELANPPIIHRDIKSSNILLDERLNA-------------------KVADFGLSKSMS 707
++LH + H D+K NIL + KV DFG S +
Sbjct: 132 NFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG---SAT 185
Query: 708 DSEKDHITTQVKGTMGYLD------PE-----YYMTQQLTEKSDVYSFGVLMLELLTG 754
++ H T + PE + ++ DV+S G +++E G
Sbjct: 186 YDDEHHST--------LVSTRHYRAPEVILALGW-----SQPCDVWSIGCILIEYYLG 230
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 3e-07
Identities = 44/183 (24%), Positives = 69/183 (37%), Gaps = 37/183 (20%)
Query: 69 LSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGL-DMLVRAKHFHFGK 127
L L S G + + L+ L WL+L N+L+ + G+ D L
Sbjct: 40 LDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT-LS------AGVFDDLTELGTLGLAN 92
Query: 128 NQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNL 187
NQL+ S+P +F L + N L LP+ + FDR
Sbjct: 93 NQLA-SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGV----------FDR----------- 129
Query: 188 NNLTSVNDLYLSNNKLTGAMPN--LTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLM 245
LT + +L L+ N+L ++P L+ L L +S N S F + L T+
Sbjct: 130 --LTKLKELRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQL-QSVPHGAFDRLGKLQTIT 185
Query: 246 MEN 248
+
Sbjct: 186 LFG 188
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 8e-07
Identities = 43/184 (23%), Positives = 62/184 (33%), Gaps = 36/184 (19%)
Query: 20 LDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGR 79
LDL + T L KL+ L L L EL L L +N +
Sbjct: 40 LDLQSTGLATLS-DATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLA-S 97
Query: 80 VPPSI-GNLSNLYWLDLTDNKLEGEIPVSDGNSPGL-DMLVRAKHFHFGKNQLSGSIPEK 137
+P + +L+ L L L N+L+ +P G+ D L + K NQL SIP
Sbjct: 98 LPLGVFDHLTQLDKLYLGGNQLK-SLP------SGVFDRLTKLKELRLNTNQLQ-SIPAG 149
Query: 138 LFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLY 197
F L + +N L +S+ FD L + +
Sbjct: 150 AFDKLTNLQTLSLSTNQL-----------QSVPHGAFD-------------RLGKLQTIT 185
Query: 198 LSNN 201
L N
Sbjct: 186 LFGN 189
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 7e-07
Identities = 51/228 (22%), Positives = 82/228 (35%), Gaps = 55/228 (24%)
Query: 563 VGSGGYGKVYKG--TLPNGQLIAIK--RAQQGSMQGGQEFKMEIELLSRVHHK------N 612
+G G +GKV + +A+K R + ++EI +L ++ K
Sbjct: 27 LGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAA---RLEINVLKKIKEKDKENKFL 83
Query: 613 LVSLLGFCFD-RGEQMLIYEFVPNGSLGDSL------SGKNGIRLDWIRRLKIALGAARG 665
V + F+ G + +E LG + + L +R +A
Sbjct: 84 CVLMSD-WFNFHGHMCIAFE-----LLGKNTFEFLKENNFQPYPLPHVR--HMAYQLCHA 135
Query: 666 LSYLHELANPPIIHRDIKSSNILLDERLNA-------------------KVADFGLSKSM 706
L +LHE + H D+K NIL +VADFG S +
Sbjct: 136 LRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG-SATF 191
Query: 707 SDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTG 754
+ +H TT V T Y PE + + DV+S G ++ E G
Sbjct: 192 ---DHEHHTTIVA-TRHYRPPEVILELGWAQPCDVWSIGCILFEYYRG 235
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 7e-07
Identities = 26/139 (18%), Positives = 51/139 (36%), Gaps = 24/139 (17%)
Query: 185 SNLNNLTSVNDLYLSNNKLTGAMPNLT-GLSVLSYLDMSNNSFDASEVPSWFSSMQSLTT 243
+ N +L L K+ + NL L +D S+N + F ++ L T
Sbjct: 13 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDG---FPLLRRLKT 68
Query: 244 LMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENLLVNLQNNRISAYTE 303
L++ N + ++P L +++ N L DL + L +L++
Sbjct: 69 LLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDL------DPLASLKSLTY----- 117
Query: 304 RGGAPAVNLTLIDNPICQE 322
L ++ NP+ +
Sbjct: 118 --------LCILRNPVTNK 128
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 7e-07
Identities = 54/261 (20%), Positives = 93/261 (35%), Gaps = 54/261 (20%)
Query: 563 VGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCF 621
+GSGG+G +Y + A + + G F E++ RV K+ +
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLF-SELKFYQRVAKKDCIKKW---- 99
Query: 622 DRGEQMLIYEFVPN----GS---------------LGDSLSGKNGIRLDWIRR------L 656
+ L Y +P G LG L L
Sbjct: 100 -IERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKI----SGQNGTFKKSTVL 154
Query: 657 KIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKV--ADFGLSKSMSDSEKD-H 713
++ + L Y+HE +H DIK++N+LL + +V AD+GLS +
Sbjct: 155 QLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQ 211
Query: 714 ITTQVK----GTMGY--LDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRP---IERGKYI 764
+ GT+ + LD + + +SDV G ML L G+ P +
Sbjct: 212 YQENPRKGHNGTIEFTSLDAHKGVAL--SRRSDVEILGYCMLRWLCGKLPWEQNLKDPVA 269
Query: 765 VREIRT-VMDKKKELYNLYEL 784
V+ +T ++D+ + +
Sbjct: 270 VQTAKTNLLDELPQSVLKWAP 290
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 52/279 (18%), Positives = 101/279 (36%), Gaps = 55/279 (19%)
Query: 563 VGSGGYGKVYKGT---------LPNGQLIAIKR-AQQGSMQGGQEF------KMEIELLS 606
G +Y+ P Q ++K A+ G + Q F +++
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 607 RVHHKNLV---SLLGFCFDRGE-QMLIYEFVPNGSLGDSLSGKNGIRLDWIRR------- 655
+++ L+ + +GF + + + L+ LG SL LD +
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPS-----LGRSLQSA----LDVSPKHVLSERS 160
Query: 656 -LKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKV--ADFGLSKSMSDSEKD 712
L++A L +LHE +H ++ + NI +D ++V A +G + S K
Sbjct: 161 VLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGK- 216
Query: 713 HI------TTQVKGTMGY--LDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYI 764
H+ + +G + + +D + +SD+ S G ML+ L G P
Sbjct: 217 HVAYVEGSRSPHEGDLEFISMDLHKGCGP--SRRSDLQSLGYCMLKWLYGFLPWTNCLPN 274
Query: 765 VREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVD 803
+I K+K + + P + +KY+
Sbjct: 275 TEDIMK--QKQKFVDKPGPFVGPCGHWIRPSETLQKYLK 311
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 51/242 (21%), Positives = 92/242 (38%), Gaps = 47/242 (19%)
Query: 563 VGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCF 621
+GSG +G++Y GT + + +AIK + + E ++ + L G
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKIY-----RILQGGTGIPN 67
Query: 622 DRGEQMLIYEFVPNGS--------LGDSLSGKNGIRLDWIRR-------LKIALGAARGL 666
+ F G LG SL ++ R L +A +
Sbjct: 68 -------VRWFGVEGDYNVLVMDLLGPSLEDL----FNFCSRKLSLKTVLMLADQMINRV 116
Query: 667 SYLHELANPPIIHRDIKSSNILLDERLNAK---VADFGLSKSMSDSE-KDHI----TTQV 718
++H + +HRDIK N L+ A + DFGL+K D+ HI +
Sbjct: 117 EFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNL 173
Query: 719 KGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRT--VMDKKK 776
GT Y ++ + + + D+ S G +++ L G P + K ++ + + +KK
Sbjct: 174 TGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 233
Query: 777 EL 778
Sbjct: 234 AT 235
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 51.0 bits (121), Expect = 2e-06
Identities = 69/616 (11%), Positives = 159/616 (25%), Gaps = 219/616 (35%)
Query: 381 LGNTTYYEILEQSVTTSFQSTYKLPIDSISLSNP-----------HKNNFEYLELSIQFF 429
L I+ + T +L ++ LS + N+++L I+
Sbjct: 46 LSKEEIDHIIMSK--DAVSGTLRL-FWTL-LSKQEEMVQKFVEEVLRINYKFLMSPIKTE 101
Query: 430 PSGQESFNRTGVSSVGFVLSNQIYSPPPLFGPMFFN-GDPYQYFAESGGSHKSTSIGVII 488
R + +++Y+ +F + PY ++ + +I
Sbjct: 102 QRQPSMMTRMYIEQR-----DRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLID 156
Query: 489 GAAAAGCVVLLLLLLA----------GVY----AYHQKRRAEKANEQNPFAHWDMN---- 530
G +G + L + ++ Q D N
Sbjct: 157 GVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSR 216
Query: 531 -KSSGSIPQ----LKGA-----------RCF-------SFEEVKKY---------TNNFS 558
S +I ++ C + + + T
Sbjct: 217 SDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQ 276
Query: 559 DANDVGSGGYGKV----YKGTLPNGQLIAI-------------KRAQQG-----SMQGG- 595
+ + + + + TL ++ ++ + S+
Sbjct: 277 VTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAES 336
Query: 596 -QEFKMEIELLSRVHHKNLVSLLGFCFDR---GEQMLIYE----F-----VPNGSLGDSL 642
++ + V+ L +++ + E +++ F +P L
Sbjct: 337 IRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLS--- 393
Query: 643 SGKNGIRLDW---------------IRRLKIALGAARGLSYLHEL--------ANPPIIH 679
+ W + + + + N +H
Sbjct: 394 ------LI-WFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALH 446
Query: 680 RDIKSSNILLDERLNAKVADFGLSKSMSDSEKD-----HITTQVKGTMGYLDPEYYMTQ- 733
R ++D K D S + D HI G+ ++
Sbjct: 447 R------SIVDHYNIPKTFD---SDDLIPPYLDQYFYSHI--------GH-----HLKNI 484
Query: 734 QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLST 793
+ E+ + F ++ L+ R +E+ K +R T + + N L
Sbjct: 485 EHPERMTL--FRMVFLDF----RFLEQ-K--IRHDSTAWNASGSILNT--LQQ------- 526
Query: 794 TLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIEN----------------ILQQAGLNP 837
LK ++ Y+ D+ P +V I + +L+ A +
Sbjct: 527 -LKFYKPYIC----------DNDPKYERLVNAILDFLPKIEENLICSKYTDLLRIALMAE 575
Query: 838 NAESASSSASYEDASK 853
+ A +E+A K
Sbjct: 576 D------EAIFEEAHK 585
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 37/134 (27%), Positives = 56/134 (41%), Gaps = 10/134 (7%)
Query: 69 LSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGL-DMLVRAKHFHFGK 127
L L+ N + P +L NL L L N+L +P G+ D L + G
Sbjct: 45 LYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALP------VGVFDSLTQLTVLDLGT 97
Query: 128 NQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNL 187
NQL+ +P +F + L + N LT ELP + + L + D+N L
Sbjct: 98 NQLT-VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAF 155
Query: 188 NNLTSVNDLYLSNN 201
+ L+S+ YL N
Sbjct: 156 DRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 4e-04
Identities = 37/142 (26%), Positives = 53/142 (37%), Gaps = 35/142 (24%)
Query: 13 GLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLN 72
L L L L +N+ L L G + D SL +L +L L
Sbjct: 62 SLINLKELYLGSNQ------------LGALP---------VG-VFD---SLTQLTVLDLG 96
Query: 73 SNGFSGRVPPSI-GNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLS 131
+N + +P ++ L +L L + NKL E+P G++ L H +NQL
Sbjct: 97 TNQLT-VLPSAVFDRLVHLKELFMCCNKLT-ELP------RGIERLTHLTHLALDQNQLK 148
Query: 132 GSIPEKLFRPDMVLIHVLFDSN 153
SIP F L H N
Sbjct: 149 -SIPHGAFDRLSSLTHAYLFGN 169
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 3e-06
Identities = 55/240 (22%), Positives = 89/240 (37%), Gaps = 41/240 (17%)
Query: 563 VGSGGYGKVYKGT-LPNGQLIAIK--RAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGF 619
+G G +G++ G L + +AIK + + Q E++ +L S + + F
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDG---IPQVYYF 73
Query: 620 CFDRGEQMLIYEFVPNGSLGDSLS---GKNGIRLDWIRRLKIALGAARGLSYLHELANPP 676
++ E LG SL L IA+ + Y+H
Sbjct: 74 GPCGKYNAMVLEL-----LGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN--- 125
Query: 677 IIHRDIKSSNILLDERLNAK-----VADFGLSKSMSDSE-KDHI----TTQVKGTMGYLD 726
+I+RD+K N L+ N + DF L+K D E K HI + GT
Sbjct: 126 LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTA---- 181
Query: 727 PEYYM---TQQLTEKS---DVYSFGVLMLELLTGRRPIERGKYIVREIRT--VMDKKKEL 778
YM T E+S D+ + G + + L G P + K + R + D K+
Sbjct: 182 --RYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRAT 239
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 7e-06
Identities = 28/136 (20%), Positives = 59/136 (43%), Gaps = 13/136 (9%)
Query: 168 SLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNL-TGLSVLSYLDMSNNSF 226
++ +R ++N++ P + + + LSNN+++ P+ GL L+ L + N
Sbjct: 33 TITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKI 92
Query: 227 DASEVPS-WFSSMQSLTTLMMENTNLKGQIPADLF-SIPHLQTVVMKTNEL----NGTLD 280
+E+P F + SL L++ + + D F + +L + + N+L GT
Sbjct: 93 --TELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFS 149
Query: 281 LGTSYSENLLVNLQNN 296
+ ++L N
Sbjct: 150 PLRAIQ---TMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 8e-06
Identities = 29/127 (22%), Positives = 51/127 (40%), Gaps = 13/127 (10%)
Query: 128 NQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATL--GLVKSLEVVRFDRNSLSGPVPS 185
N + IP F P L + +N ++ EL GL SL + N ++ S
Sbjct: 42 NTIK-VIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLR-SLNSLVLYGNKITELPKS 98
Query: 186 NLNNLTSVNDLYLSNNKLT----GAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSL 241
L S+ L L+ NK+ A +L L+ L + +N + FS ++++
Sbjct: 99 LFEGLFSLQLLLLNANKINCLRVDAFQDLHN---LNLLSLYDNKL-QTIAKGTFSPLRAI 154
Query: 242 TTLMMEN 248
T+ +
Sbjct: 155 QTMHLAQ 161
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 8e-05
Identities = 31/95 (32%), Positives = 47/95 (49%), Gaps = 5/95 (5%)
Query: 8 SGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSI-GSLQEL 66
G + +L +DLSNN+ + P L+ L++L+L G + +P S+ L L
Sbjct: 49 PGAFSPYKKLRRIDLSNNQ-ISELAPDAFQGLRSLNSLVLYGNKITE-LPKSLFEGLFSL 106
Query: 67 VLLSLNSNGFSGRVPPSI-GNLSNLYWLDLTDNKL 100
LL LN+N + + +L NL L L DNKL
Sbjct: 107 QLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKL 140
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 3e-04
Identities = 24/141 (17%), Positives = 50/141 (35%), Gaps = 33/141 (23%)
Query: 62 SLQELVLLSLNSNGFSGRVPPSI-GNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRA 120
++L + L++N S + P L +L L L NK+ E+P S + L
Sbjct: 54 PYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKIT-ELPKSL-----FEGLFSL 106
Query: 121 KHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLS 180
+ N+++ + F+ +L +L ++ N L
Sbjct: 107 QLLLLNANKIN-CLRVDAFQ-------------DLH-----------NLNLLSLYDNKLQ 141
Query: 181 GPVPSNLNNLTSVNDLYLSNN 201
+ L ++ ++L+ N
Sbjct: 142 TIAKGTFSPLRAIQTMHLAQN 162
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 8e-06
Identities = 26/129 (20%), Positives = 54/129 (41%), Gaps = 11/129 (8%)
Query: 151 DSNNLTGELPATLGL--VKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMP 208
++N T L AT + L + F N ++ + VN++ L++N+L +
Sbjct: 40 NNNEFT-VLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLE-NVQ 97
Query: 209 N--LTGLSVLSYLDMSNNSFDASEVPS-WFSSMQSLTTLMMENTNLKGQIPADLF-SIPH 264
+ GL L L + +N + V + F + S+ L + + + + F ++
Sbjct: 98 HKMFKGLESLKTLMLRSNRI--TCVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTLHS 154
Query: 265 LQTVVMKTN 273
L T+ + N
Sbjct: 155 LSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 21/141 (14%), Positives = 41/141 (29%), Gaps = 11/141 (7%)
Query: 15 TELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSN 74
L L+NN+ L +L + + + + + L SN
Sbjct: 32 QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN 91
Query: 75 GFSGRVPPSI-GNLSNLYWLDLTDNKLEGEIPVSDGNSPGL-DMLVRAKHFHFGKNQLSG 132
V + L +L L L N++ + L + NQ++
Sbjct: 92 RLE-NVQHKMFKGLESLKTLMLRSNRIT-CVG------NDSFIGLSSVRLLSLYDNQIT- 142
Query: 133 SIPEKLFRPDMVLIHVLFDSN 153
++ F L + +N
Sbjct: 143 TVAPGAFDTLHSLSTLNLLAN 163
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 5e-05
Identities = 40/164 (24%), Positives = 62/164 (37%), Gaps = 40/164 (24%)
Query: 69 LSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGL-DMLVRAKHFHFGK 127
L L +N L++L L L NKL+ +P G+ + L + +
Sbjct: 33 LDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLP------NGVFNKLTSLTYLNLST 85
Query: 128 NQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNL 187
NQL S+P +F L + ++N L LP + FD+
Sbjct: 86 NQLQ-SLPNGVFDKLTQLKELALNTNQLQ-SLPDGV----------FDK----------- 122
Query: 188 NNLTSVNDLYLSNNKLT----GAMPNLTGLSVLSYLDMSNNSFD 227
LT + DL L N+L G LT L + +L +N +D
Sbjct: 123 --LTQLKDLRLYQNQLKSVPDGVFDRLTSLQYI-WLH--DNPWD 161
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 25/94 (26%), Positives = 43/94 (45%), Gaps = 5/94 (5%)
Query: 183 VPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLT 242
+P + V +LYL N+ T L+ L+ +D+SNN FS+M L
Sbjct: 25 LPKGIP--RDVTELYLDGNQFTLVPKELSNYKHLTLIDLSNNRISTLS-NQSFSNMTQLL 81
Query: 243 TLMMENTNLKGQIPADLF-SIPHLQTVVMKTNEL 275
TL++ L+ IP F + L+ + + N++
Sbjct: 82 TLILSYNRLR-CIPPRTFDGLKSLRLLSLHGNDI 114
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 41.3 bits (97), Expect = 4e-04
Identities = 22/88 (25%), Positives = 33/88 (37%), Gaps = 2/88 (2%)
Query: 14 LTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNS 73
+ L L N K G + L L L+ ++ L +L L L+
Sbjct: 23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI--SVSNLPKLPKLKKLELSE 80
Query: 74 NGFSGRVPPSIGNLSNLYWLDLTDNKLE 101
N G + L NL L+L+ NKL+
Sbjct: 81 NRIFGGLDMLAEKLPNLTHLNLSGNKLK 108
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 40.9 bits (96), Expect = 5e-04
Identities = 25/138 (18%), Positives = 44/138 (31%), Gaps = 28/138 (20%)
Query: 189 NLTSVNDLYLSNNKLT-GAMPNLTG-LSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMM 246
+V +L L N K G + LT L +L + N + + L L +
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISVSN---LPKLPKLKKLEL 78
Query: 247 ENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENL--LVNLQNNRISAYTER 304
+ G + +P+L + + N+L L E L L L+
Sbjct: 79 SENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTL-----EPLKKLECLK---------- 123
Query: 305 GGAPAVNLTLIDNPICQE 322
+L L + +
Sbjct: 124 ------SLDLFNCEVTNL 135
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 4e-04
Identities = 28/123 (22%), Positives = 51/123 (41%), Gaps = 6/123 (4%)
Query: 148 VLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAM 207
VL +S + G+L + LE + L+ +NL L + L LS+N+++G +
Sbjct: 23 VLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT--SIANLPKLNKLKKLELSDNRVSGGL 80
Query: 208 PNL-TGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTL-MMEN--TNLKGQIPADLFSIP 263
L L++L++S N +++L +L + TNL +P
Sbjct: 81 EVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLP 140
Query: 264 HLQ 266
L
Sbjct: 141 QLT 143
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 40.0 bits (94), Expect = 7e-04
Identities = 23/138 (16%), Positives = 45/138 (32%), Gaps = 28/138 (20%)
Query: 189 NLTSVNDLYLSNNKLT-GAMPNLTG-LSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMM 246
+ V +L L N++ G + LT L +L N + + L L +
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSIAN---LPKLNKLKKLEL 71
Query: 247 ENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENL--LVNLQNNRISAYTER 304
+ + G + P+L + + N++ + E L L NL+
Sbjct: 72 SDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTI-----EPLKKLENLK---------- 116
Query: 305 GGAPAVNLTLIDNPICQE 322
+L L + +
Sbjct: 117 ------SLDLFNCEVTNL 128
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 39.7 bits (93), Expect = 9e-04
Identities = 20/90 (22%), Positives = 38/90 (42%), Gaps = 6/90 (6%)
Query: 14 LTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPD--SIGSLQELVLLSL 71
+++ L L N++ G L ++L L + + ++ L +L L L
Sbjct: 16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVG----LTSIANLPKLNKLKKLEL 71
Query: 72 NSNGFSGRVPPSIGNLSNLYWLDLTDNKLE 101
+ N SG + NL L+L+ NK++
Sbjct: 72 SDNRVSGGLEVLAEKCPNLTHLNLSGNKIK 101
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 4e-04
Identities = 24/143 (16%), Positives = 53/143 (37%), Gaps = 30/143 (20%)
Query: 183 VPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLT 242
+ + L+ L + L LS N + + +L+G+ L L + N ++ + + +L
Sbjct: 40 MDATLSTLKACKHLALSTNNIE-KISSLSGMENLRILSLGRNLI--KKIENLDAVADTLE 96
Query: 243 TLMMEN---TNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENLLVNLQNNRIS 299
L + +L G + + +L+ + M N++ ++ L L
Sbjct: 97 ELWISYNQIASLSG-----IEKLVNLRVLYMSNNKITNWGEIDK------LAALDKLE-- 143
Query: 300 AYTERGGAPAVNLTLIDNPICQE 322
+L L NP+ +
Sbjct: 144 -----------DLLLAGNPLYND 155
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 7e-04
Identities = 39/275 (14%), Positives = 79/275 (28%), Gaps = 47/275 (17%)
Query: 15 TELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFS----GPIPDSIGSLQELVLLS 70
++ +LD+ + + L++ + L C + I ++ L L+
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 71 LNSNGFSGRVPPSIGNL-----SNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRA----- 120
L SN + + L L + L G G +L
Sbjct: 63 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGA---------GCGVLSSTLRTLP 113
Query: 121 --KHFHFGKNQLSGS----IPEKLFRPDMVLIHVLFDSNNLTGELPATLGLV----KSLE 170
+ H N L + + E L P L + + +L+ L V +
Sbjct: 114 TLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFK 173
Query: 171 VVRFDRNSLSGPVPSNL-----NNLTSVNDLYLSNNKLTGA-----MPNLTGLSVLSYLD 220
+ N ++ L ++ + L L + +T + + L L
Sbjct: 174 ELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELA 233
Query: 221 MSNNSFDASEV----PSWFSSMQSLTTLMMENTNL 251
+ +N + P L TL + +
Sbjct: 234 LGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGI 268
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
No hit with probability above 80.00
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 882 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 5e-76 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 7e-74 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-70 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-69 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-68 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 7e-68 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-66 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 5e-66 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-65 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-65 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 4e-65 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-64 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-64 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 9e-64 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 6e-62 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-61 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-61 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-61 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-61 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 4e-61 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 5e-61 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 6e-61 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-60 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-60 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 5e-60 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-59 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 7e-58 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-57 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-56 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 5e-56 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-55 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 4e-55 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-54 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-53 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 7e-50 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-49 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 8e-49 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-48 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 8e-48 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 9e-47 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-46 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-45 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 4e-45 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 7e-45 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 8e-45 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 8e-45 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-44 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-44 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-44 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-44 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 4e-44 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 6e-44 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 8e-44 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-43 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 5e-39 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 6e-38 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 9e-38 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-34 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-33 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-32 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-31 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-27 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-22 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 6e-18 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-10 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-09 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-08 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 8e-17 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-15 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 9e-10 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 6e-14 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 6e-09 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-08 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-05 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 1e-12 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 1e-06 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-06 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 6e-12 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 1e-11 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 5e-09 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-08 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 3e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 1e-08 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 4e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 1e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 6e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 5e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 0.003 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.002 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.003 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 7e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 8e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.004 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 2e-05 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 0.002 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 2e-05 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 1e-04 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 7e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 5e-04 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 0.002 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 247 bits (631), Expect = 5e-76
Identities = 73/280 (26%), Positives = 129/280 (46%), Gaps = 18/280 (6%)
Query: 555 NNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLV 614
+ +GSG +G VYKG + + + Q Q FK E+ +L + H N++
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 615 SLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELAN 674
+G+ + ++ ++ SL L + + I+ + IA A+G+ YLH
Sbjct: 68 LFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIET-KFEMIKLIDIARQTAQGMDYLH---A 122
Query: 675 PPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQ 734
IIHRD+KS+NI L E L K+ DFGL+ S H Q+ G++ ++ PE Q
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182
Query: 735 ---LTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGL 791
+ +SDVY+FG+++ EL+TG+ P + ++ Y +L
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQLPYSN----INNRDQIIFMVGRGYLSPDLSKVRSNC 238
Query: 792 STTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQ 831
+K L +C+++ D+RP +++ IE + +
Sbjct: 239 PKAMK------RLMAECLKKKRDERPLFPQILASIELLAR 272
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 241 bits (615), Expect = 7e-74
Identities = 78/276 (28%), Positives = 129/276 (46%), Gaps = 20/276 (7%)
Query: 555 NNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLV 614
+G+G +G+V+ G +A+K +QGSM F E L+ ++ H+ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLV 71
Query: 615 SLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELAN 674
L +I E++ NGSL D L +GI+L + L +A A G++++ E
Sbjct: 72 RLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE--- 127
Query: 675 PPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQ 734
IHRD++++NIL+ + L+ K+ADFGL++ + D+E K + + PE
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-YTAREGAKFPIKWTAPEAINYGT 186
Query: 735 LTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTT 794
T KSDV+SFG+L+ E++T R G I+ + Y ++ P
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG-------YRMVRPD-NCPEE 238
Query: 795 LKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENIL 830
L L C +E +DRPT + +E+
Sbjct: 239 LY------QLMRLCWKERPEDRPTFDYLRSVLEDFF 268
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 231 bits (589), Expect = 2e-70
Identities = 71/277 (25%), Positives = 132/277 (47%), Gaps = 20/277 (7%)
Query: 555 NNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLV 614
+ + ++GSG +G V+ G N +AIK ++G+ ++F E E++ ++ H LV
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLV 63
Query: 615 SLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELAN 674
L G C ++ L++EF+ +G L L + L G++YL E
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCL-SDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE--- 119
Query: 675 PPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQ 734
+IHRD+ + N L+ E KV+DFG+++ + D + +T K + + PE + +
Sbjct: 120 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWASPEVFSFSR 178
Query: 735 LTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTT 794
+ KSDV+SFGVLM E+ + + R+ + +++ + L P + ST
Sbjct: 179 YSSKSDVWSFGVLMWEVFSEGKIPYEN-------RSNSEVVEDISTGFRLYKPRL-ASTH 230
Query: 795 LKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQ 831
+ + C +E +DRP S +++ + I +
Sbjct: 231 VY------QIMNHCWKERPEDRPAFSRLLRQLAEIAE 261
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 230 bits (587), Expect = 2e-69
Identities = 78/312 (25%), Positives = 138/312 (44%), Gaps = 39/312 (12%)
Query: 545 FSFEEVKKYTNNFSDAND---------VGSGGYGKVYKGTLP----NGQLIAIKRAQQGS 591
F+FE+ + F+ D +G+G +G+V G L +AIK + G
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 592 MQGG-QEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRL 650
+ ++F E ++ + H N++ L G M+I EF+ NGSL DS +N +
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSL-DSFLRQNDGQF 125
Query: 651 DWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE 710
I+ + + G A G+ YL + +HRD+ + NIL++ L KV+DFGLS+ + D
Sbjct: 126 TVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182
Query: 711 KDHITTQV---KGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVRE 767
D T K + + PE ++ T SDV+S+G++M E+++
Sbjct: 183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWD------ 236
Query: 768 IRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIE 827
++ I+ L + L L C Q+ + RP ++V ++
Sbjct: 237 --------MTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLD 288
Query: 828 NILQQAGLNPNA 839
+++ NPN+
Sbjct: 289 KMIR----NPNS 296
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 227 bits (580), Expect = 1e-68
Identities = 78/296 (26%), Positives = 138/296 (46%), Gaps = 20/296 (6%)
Query: 546 SFEEVKKYTNNFSDANDVGSGGYGKVYKGTLPN-GQLIAIKRAQQGSMQGGQEFKMEIEL 604
++++ + + + + +G G YG+VY+G +A+K ++ +M+ +EF E +
Sbjct: 8 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAV 66
Query: 605 LSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAAR 664
+ + H NLV LLG C +I EF+ G+L D L N + + L +A +
Sbjct: 67 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 126
Query: 665 GLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGY 724
+ YL + IHRD+ + N L+ E KVADFGLS+ M+ + K + +
Sbjct: 127 AMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKW 182
Query: 725 LDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYEL 784
PE + + KSDV++FGVL+ E+ T +L +YEL
Sbjct: 183 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS--------------PYPGIDLSQVYEL 228
Query: 785 IDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQAGLNPNAE 840
++ + EK +L C Q + DRP+ +E+ + E + Q++ ++ E
Sbjct: 229 LEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVE 284
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 224 bits (571), Expect = 7e-68
Identities = 69/275 (25%), Positives = 125/275 (45%), Gaps = 20/275 (7%)
Query: 555 NNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLV 614
+ + ++G+G +G V G +AIK ++GSM EF E +++ + H+ LV
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLV 62
Query: 615 SLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELAN 674
L G C + +I E++ NG L + L R + L++ + YL +
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLREMRH-RFQTQQLLEMCKDVCEAMEYLE---S 118
Query: 675 PPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQ 734
+HRD+ + N L++++ KV+DFGLS+ + D E + K + + PE M +
Sbjct: 119 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-TSSVGSKFPVRWSPPEVLMYSK 177
Query: 735 LTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTT 794
+ KSD+++FGVLM E+ + + T + + + L P +
Sbjct: 178 FSSKSDIWAFGVLMWEIYSLGKMPYER-------FTNSETAEHIAQGLRLYRPHLAS--- 227
Query: 795 LKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENI 829
EK + C E D+RPT ++ +I ++
Sbjct: 228 ----EKVYTIMYSCWHEKADERPTFKILLSNILDV 258
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 220 bits (561), Expect = 3e-66
Identities = 67/271 (24%), Positives = 117/271 (43%), Gaps = 26/271 (9%)
Query: 563 VGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFD 622
+G G +G V G G +A+K + + Q F E +++++ H NLV LLG +
Sbjct: 15 IGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 71
Query: 623 RGEQM-LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRD 681
+ ++ E++ GSL D L + L LK +L + YL +HRD
Sbjct: 72 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRD 128
Query: 682 IKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDV 741
+ + N+L+ E AKV+DFGL+K S + K + + PE ++ + KSDV
Sbjct: 129 LAARNVLVSEDNVAKVSDFGLTKEASST-----QDTGKLPVKWTAPEALREKKFSTKSDV 183
Query: 742 YSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKY 801
+SFG+L+ E+ + R + + V K +D G +
Sbjct: 184 WSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK--------MDAPDGCPPAVY----- 230
Query: 802 VDLALKCVQESGDDRPTMSEVVKDIENILQQ 832
++ C RP+ ++ + +E+I
Sbjct: 231 -EVMKNCWHLDAAMRPSFLQLREQLEHIKTH 260
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 220 bits (562), Expect = 5e-66
Identities = 60/296 (20%), Positives = 118/296 (39%), Gaps = 28/296 (9%)
Query: 563 VGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFD 622
+G G +G+V++G G+ +A+K + + EI + H+N++ +
Sbjct: 11 IGKGRFGEVWRGKW-RGEEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIAADNK 68
Query: 623 RGEQ----MLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHE-----LA 673
L+ ++ +GSL D L+ + +K+AL A GL++LH
Sbjct: 69 DNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQG 125
Query: 674 NPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEK--DHITTQVKGTMGYLDPEYYM 731
P I HRD+KS NIL+ + +AD GL+ + D GT Y+ PE
Sbjct: 126 KPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLD 185
Query: 732 TQ------QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELI 785
+ +++D+Y+ G++ E+ + ++ + + +++
Sbjct: 186 DSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVV 245
Query: 786 -----DPTI-GLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQAGL 835
P I + + + +C +G R T + K + + QQ G+
Sbjct: 246 CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGI 301
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (557), Expect = 2e-65
Identities = 72/277 (25%), Positives = 129/277 (46%), Gaps = 20/277 (7%)
Query: 555 NNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLV 614
+ +G G +G+V+ GT +AIK + G+M + F E +++ ++ H+ LV
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLV 75
Query: 615 SLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELAN 674
L ++ E++ GSL D L G+ G L + + +A A G++Y+
Sbjct: 76 QLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---R 131
Query: 675 PPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQ 734
+HRD++++NIL+ E L KVADFGL++ + D+E K + + PE + +
Sbjct: 132 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGR 190
Query: 735 LTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTT 794
T KSDV+SFG+L+ EL T R G + + ++ +
Sbjct: 191 FTIKSDVWSFGILLTELTTKGRVPYPG--------------MVNREVLDQVERGYRMPCP 236
Query: 795 LKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQ 831
+ E DL +C ++ ++RPT + +E+
Sbjct: 237 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (559), Expect = 3e-65
Identities = 68/301 (22%), Positives = 127/301 (42%), Gaps = 38/301 (12%)
Query: 554 TNNFSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGG-QEFKMEIELLSRVHHK 611
++F +++G+G G V+K + P+G ++A K + E+++L +
Sbjct: 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSP 64
Query: 612 NLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHE 671
+V G + GE + E + GSL L R+ K+++ +GL+YL E
Sbjct: 65 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLRE 122
Query: 672 LANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYM 731
I+HRD+K SNIL++ R K+ DFG+S + DS GT Y+ PE
Sbjct: 123 KHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYMSPERLQ 176
Query: 732 TQQLTEKSDVYSFGVLMLELLTGRRPIE------------------------RGKYIVRE 767
+ +SD++S G+ ++E+ GR PI R + R
Sbjct: 177 GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236
Query: 768 IRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKY----VDLALKCVQESGDDRPTMSEVV 823
+ + + ++EL+D + + D KC+ ++ +R + +++
Sbjct: 237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLM 296
Query: 824 K 824
Sbjct: 297 V 297
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 218 bits (556), Expect = 4e-65
Identities = 67/306 (21%), Positives = 126/306 (41%), Gaps = 46/306 (15%)
Query: 555 NNFSDANDVGSGGYGKVYKGTLPN------GQLIAIKRAQQGSMQGGQ-EFKMEIELLSR 607
NN D+G G +G+V++ P ++A+K ++ + Q +F+ E L++
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72
Query: 608 VHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSL----------------------SGK 645
+ N+V LLG C L++E++ G L + L S
Sbjct: 73 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132
Query: 646 NGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKS 705
L +L IA A G++YL E +HRD+ + N L+ E + K+ADFGLS++
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRN 189
Query: 706 MSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIV 765
+ ++ + ++ PE + T +SDV+++GV++ E+ + G
Sbjct: 190 IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE 249
Query: 766 REIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825
I V D ++ L +L C + DRP+ + +
Sbjct: 250 EVIYYVRDGN--------ILACPENCPLELY------NLMRLCWSKLPADRPSFCSIHRI 295
Query: 826 IENILQ 831
++ + +
Sbjct: 296 LQRMCE 301
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (554), Expect = 1e-64
Identities = 80/278 (28%), Positives = 123/278 (44%), Gaps = 26/278 (9%)
Query: 563 VGSGGYGKVYKGTLPN----GQLIAIKRAQQGSMQGG-QEFKMEIELLSRVHHKNLVSLL 617
+G G +G VY GTL + A+K + + G +F E ++ H N++SLL
Sbjct: 35 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 94
Query: 618 GFCFDR-GEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPP 676
G C G +++ ++ +G L + + L A+G+ +L +
Sbjct: 95 GICLRSEGSPLVVLPYMKHGDL-RNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---SKK 150
Query: 677 IIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKD--HITTQVKGTMGYLDPEYYMTQQ 734
+HRD+ + N +LDE+ KVADFGL++ M D E D H T K + ++ E TQ+
Sbjct: 151 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQK 210
Query: 735 LTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTT 794
T KSDV+SFGVL+ EL+T P D L L+ P
Sbjct: 211 FTTKSDVWSFGVLLWELMTRGAPPYPDV-------NTFDITVYLLQGRRLLQPE-YCPDP 262
Query: 795 LKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 832
L ++ LKC + RP+ SE+V I I
Sbjct: 263 LY------EVMLKCWHPKAEMRPSFSELVSRISAIFST 294
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (550), Expect = 2e-64
Identities = 72/284 (25%), Positives = 134/284 (47%), Gaps = 25/284 (8%)
Query: 555 NNFSDANDVGSGGYGKVYKGTLPNGQ-----LIAIKRAQQGSMQGGQ-EFKMEIELLSRV 608
+ + +G+G +G+VYKG L +AIK + G + + +F E ++ +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 609 HHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSY 668
H N++ L G M+I E++ NG+L L K+G ++ + + G A G+ Y
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDG-EFSVLQLVGMLRGIAAGMKY 125
Query: 669 LHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSM-SDSEKDHITTQVKGTMGYLDP 727
L N +HRD+ + NIL++ L KV+DFGLS+ + D E + T+ K + + P
Sbjct: 126 LA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP 182
Query: 728 EYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDP 787
E ++ T SDV+SFG++M E++T + + + + I+
Sbjct: 183 EAISYRKFTSASDVWSFGIVMWEVMTYGER--------------PYWELSNHEVMKAIND 228
Query: 788 TIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQ 831
L T + L ++C Q+ RP +++V ++ +++
Sbjct: 229 GFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (547), Expect = 9e-64
Identities = 64/294 (21%), Positives = 124/294 (42%), Gaps = 40/294 (13%)
Query: 563 VGSGGYGKVYKGTL------PNGQLIAIKRAQQGSMQGG-QEFKMEIELLSRV-HHKNLV 614
+G+G +GKV + T +A+K + + + E+++LS + +H N+V
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 615 SLLGFCFDRGEQMLIYEFVPNGSLGDSLSGK----------------NGIRLDWIRRLKI 658
+LLG C G ++I E+ G L + L K + + LD L
Sbjct: 91 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 659 ALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQV 718
+ A+G+++L IHRD+ + NILL K+ DFGL++ + + +
Sbjct: 151 SYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 207
Query: 719 KGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKEL 778
+ + ++ PE T +SDV+S+G+ + EL + G + + ++ +
Sbjct: 208 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEG--- 264
Query: 779 YNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 832
+ ++ P + D+ C RPT ++V+ IE + +
Sbjct: 265 ---FRMLSPE-HAPAEMY------DIMKTCWDADPLKRPTFKQIVQLIEKQISE 308
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (534), Expect = 6e-62
Identities = 84/318 (26%), Positives = 139/318 (43%), Gaps = 40/318 (12%)
Query: 555 NNFSDANDVGSGGYGKVYKGTLPNGQL---IAIKR-AQQGSMQGGQEFKMEIELLSRV-H 609
N+ + +G G +G+V K + L AIKR + S ++F E+E+L ++ H
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 610 HKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSL--------------SGKNGIRLDWIRR 655
H N+++LLG C RG L E+ P+G+L D L + L +
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 656 LKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHIT 715
L A ARG+ YL + IHRD+ + NIL+ E AK+ADFGLS+ K
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK---K 183
Query: 716 TQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKK 775
T + + ++ E T SDV+S+GVL+ E+++ G
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG-------------- 229
Query: 776 KELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQAGL 835
LYE + L L ++ DL +C +E +RP+ ++++ + +L++
Sbjct: 230 MTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 289
Query: 836 NPNAE-SASSSASYEDAS 852
N + + D S
Sbjct: 290 YVNTTLYEKFTYAGIDCS 307
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (529), Expect = 1e-61
Identities = 65/302 (21%), Positives = 119/302 (39%), Gaps = 39/302 (12%)
Query: 564 GSGGYGKVYKGTL---PNGQLIAIKRAQQGSMQGG-QEFKMEIELLSRVHHKNLVSLLGF 619
G G +G V +G +AIK +QG+ + +E E +++ ++ + +V L+G
Sbjct: 18 GCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGV 77
Query: 620 CFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIH 679
C ML+ E G L L GK + ++ + G+ YL +H
Sbjct: 78 CQAEA-LMLVMEMAGGGPLHKFLVGKRE-EIPVSNVAELLHQVSMGMKYLE---EKNFVH 132
Query: 680 RDIKSSNILLDERLNAKVADFGLSKSMSDSEKD-HITTQVKGTMGYLDPEYYMTQQLTEK 738
RD+ + N+LL R AK++DFGLSK++ + + K + + PE ++ + +
Sbjct: 133 RDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSR 192
Query: 739 SDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGF 798
SDV+S+GV M E L+ + + + + I+ + +
Sbjct: 193 SDVWSYGVTMWEALSYGQKPYKK--------------MKGPEVMAFIEQGKRMECPPECP 238
Query: 799 EKYVDLALKCVQESGDDRPTMSEVVKDIENILQQAGLNPNAESASSSASYEDASKGNFHH 858
+ L C +DRP V + + S +G+ HH
Sbjct: 239 PELYALMSDCWIYKWEDRPDFLTVEQRMRACYY---------------SLASKVEGHHHH 283
Query: 859 PY 860
+
Sbjct: 284 HH 285
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (531), Expect = 2e-61
Identities = 70/317 (22%), Positives = 130/317 (41%), Gaps = 26/317 (8%)
Query: 557 FSDANDVGSGGYGKVYKGT-LPNGQLIAIKRA-----QQGSMQGGQEFKMEIELLSRVHH 610
F +GSG +G VYKG +P G+ + I A + S + +E E +++ V +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 611 KNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLH 670
++ LLG C LI + +P G L D + + L + A+G++YL
Sbjct: 71 PHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLE 128
Query: 671 ELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYY 730
+ ++HRD+ + N+L+ + K+ DFGL+K + EK++ K + ++ E
Sbjct: 129 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 185
Query: 731 MTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIG 790
+ + T +SDV+S+GV + EL+T G + +++
Sbjct: 186 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDG--------------IPASEISSILEKGER 231
Query: 791 LSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQAGLNPNAESASSSASYED 850
L + +KC D RP E++ + + + +
Sbjct: 232 LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQG-DERMHLPS 290
Query: 851 ASKGNFHHPYCNEEGFD 867
+ NF+ +EE D
Sbjct: 291 PTDSNFYRALMDEEDMD 307
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (526), Expect = 3e-61
Identities = 67/275 (24%), Positives = 112/275 (40%), Gaps = 25/275 (9%)
Query: 563 VGSGGYGKVYKGTLPN----GQLIAIKRAQQGSMQGGQE-FKMEIELLSRVHHKNLVSLL 617
+G G +G V++G + +AIK + + +E F E + + H ++V L+
Sbjct: 15 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 618 GFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPI 677
G + +I E G L S LD + A + L+YL
Sbjct: 75 GVITE-NPVWIIMELCTLGEL-RSFLQVRKYSLDLASLILYAYQLSTALAYLES---KRF 129
Query: 678 IHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTE 737
+HRDI + N+L+ K+ DFGLS+ M DS + ++ K + ++ PE ++ T
Sbjct: 130 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST-YYKASKGKLPIKWMAPESINFRRFTS 188
Query: 738 KSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKG 797
SDV+ FGV M E+L +G I + + E + PT+
Sbjct: 189 ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI--ENGERLPMPPNCPPTL-------- 238
Query: 798 FEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 832
L KC RP +E+ + IL++
Sbjct: 239 ----YSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (525), Expect = 3e-61
Identities = 73/282 (25%), Positives = 122/282 (43%), Gaps = 34/282 (12%)
Query: 551 KKYT-NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQGGQ---EFKMEIELL 605
+++ +F +G G +G VY + ++A+K + ++ + + E+E+
Sbjct: 1 RQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 60
Query: 606 SRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARG 665
S + H N++ L G+ D LI E+ P G++ L + + D R A
Sbjct: 61 SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANA 118
Query: 666 LSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYL 725
LSY H +IHRDIK N+LL K+ADFG S S T + GT+ YL
Sbjct: 119 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYL 171
Query: 726 DPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELI 785
PE + EK D++S GVL E L G+ P E + +E Y +
Sbjct: 172 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA------------NTYQETYKRISRV 219
Query: 786 DPTI--GLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825
+ T ++ + DL + ++ + RP + EV++
Sbjct: 220 EFTFPDFVTEGAR------DLISRLLKHNPSQRPMLREVLEH 255
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 207 bits (528), Expect = 4e-61
Identities = 72/291 (24%), Positives = 120/291 (41%), Gaps = 41/291 (14%)
Query: 545 FSFEEVKKYTNNFSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGG---QEFKM 600
F ++ +K FSD ++G G +G VY + N +++AIK+ Q Q+
Sbjct: 8 FFKDDPEKL---FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIK 64
Query: 601 EIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIAL 660
E+ L ++ H N + G L+ E+ + K L + +
Sbjct: 65 EVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK--PLQEVEIAAVTH 122
Query: 661 GAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKG 720
GA +GL+YLH +IHRD+K+ NILL E K+ DFG + M+ G
Sbjct: 123 GALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANSFVG 173
Query: 721 TMGYLDPEYYMTQ---QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKE 777
T ++ PE + Q K DV+S G+ +EL + P+ M+
Sbjct: 174 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN-----------MNAMSA 222
Query: 778 LYNLYELIDPTI---GLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825
LY++ + P + S + + C+Q+ DRPT ++K
Sbjct: 223 LYHIAQNESPALQSGHWSEYFR------NFVDSCLQKIPQDRPTSEVLLKH 267
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (524), Expect = 5e-61
Identities = 69/266 (25%), Positives = 118/266 (44%), Gaps = 21/266 (7%)
Query: 563 VGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQE-FKMEIELLSRVHHKNLVSLLGFC 620
+G G YG+V + +A+K E K EI + ++H+N+V G
Sbjct: 13 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 72
Query: 621 FDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHR 680
+ Q L E+ G L D + + I + + G+ YLH + I HR
Sbjct: 73 REGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHR 127
Query: 681 DIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQL-TEKS 739
DIK N+LLDER N K++DFGL+ + ++ + ++ GT+ Y+ PE ++ E
Sbjct: 128 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPV 187
Query: 740 DVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFE 799
DV+S G+++ +L G P ++ +E +KK L +P + +
Sbjct: 188 DVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL-------NPWKKIDSAPL--- 237
Query: 800 KYVDLALKCVQESGDDRPTMSEVVKD 825
L K + E+ R T+ ++ KD
Sbjct: 238 ---ALLHKILVENPSARITIPDIKKD 260
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (524), Expect = 6e-61
Identities = 64/279 (22%), Positives = 109/279 (39%), Gaps = 26/279 (9%)
Query: 556 NFSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGG--QEFKMEIELLSRVHHKN 612
++ +G+G YG+ K +G+++ K GSM Q E+ LL + H N
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 613 LVSLLGFCFDRGEQML--IYEFVPNGSLGDSL--SGKNGIRLDWIRRLKIALGAARGLSY 668
+V DR L + E+ G L + K LD L++ L
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 669 LHEL--ANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLD 726
H ++HRD+K +N+ LD + N K+ DFGL++ ++ GT Y+
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT--SFAKAFVGTPYYMS 182
Query: 727 PEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELID 786
PE EKSD++S G L+ EL P + + K + I
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT-AFSQKELAGKIREGK------FRRIP 235
Query: 787 PTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825
S L ++ + + RP++ E++++
Sbjct: 236 YRY--SDELN------EIITRMLNLKDYHRPSVEEILEN 266
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (522), Expect = 1e-60
Identities = 62/280 (22%), Positives = 115/280 (41%), Gaps = 26/280 (9%)
Query: 559 DANDVGSGGYGKVYKGTLPN---GQLIAIKRAQQGSMQGG--QEFKMEIELLSRVHHKNL 613
+ ++GSG +G V KG + +A+K + + E E ++ ++ + +
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 614 VSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELA 673
V ++G C + ML+ E G L L + +++ + G+ YL
Sbjct: 71 VRMIGIC-EAESWMLVMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLE--- 124
Query: 674 NPPIIHRDIKSSNILLDERLNAKVADFGLSKSM-SDSEKDHITTQVKGTMGYLDPEYYMT 732
+HRD+ + N+LL + AK++DFGLSK++ +D T K + + PE
Sbjct: 125 ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 184
Query: 733 QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLS 792
+ + KSDV+SFGVLM E + + RG + + +++ +
Sbjct: 185 YKFSSKSDVWSFGVLMWEAFSYGQKPYRG--------------MKGSEVTAMLEKGERMG 230
Query: 793 TTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 832
+ DL C ++RP + V + N
Sbjct: 231 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (521), Expect = 2e-60
Identities = 66/288 (22%), Positives = 121/288 (42%), Gaps = 28/288 (9%)
Query: 547 FEEVKKYTN---NFSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKMEI 602
+E V + N + ++G G +GKVYK L A K S + +++ +EI
Sbjct: 1 YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEI 60
Query: 603 ELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGA 662
++L+ H N+V LL + ++ EF G++ D++ + L + +
Sbjct: 61 DILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAV-DAVMLELERPLTESQIQVVCKQT 119
Query: 663 ARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTM 722
L+YLH+ IIHRD+K+ NIL + K+ADFG+S + + GT
Sbjct: 120 LDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--IQRRDSFIGTP 174
Query: 723 GYLDPEYYMTQQL-----TEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKE 777
++ PE M + K+DV+S G+ ++E+ P +R + + +
Sbjct: 175 YWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHH-ELNPMRVLLKIAKSEPP 233
Query: 778 LYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825
D KC++++ D R T S++++
Sbjct: 234 TLAQPSRWSSNF------------KDFLKKCLEKNVDARWTTSQLLQH 269
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (517), Expect = 5e-60
Identities = 64/271 (23%), Positives = 114/271 (42%), Gaps = 29/271 (10%)
Query: 563 VGSGGYGKVYKGTLP-NGQLIAIK--RAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGF 619
+G G + VYKG +A + ++ + Q FK E E+L + H N+V
Sbjct: 17 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76
Query: 620 CFDRGEQ----MLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANP 675
+ +L+ E + +G+L L K + +GL +LH P
Sbjct: 77 WESTVKGKKCIVLVTELMTSGTLKTYL--KRFKVMKIKVLRSWCRQILKGLQFLHTR-TP 133
Query: 676 PIIHRDIKSSNILL-DERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQ 734
PIIHRD+K NI + + K+ D GL+ + V GT ++ PE Y ++
Sbjct: 134 PIIHRDLKCDNIFITGPTGSVKIGDLGLATLK----RASFAKAVIGTPEFMAPEMY-EEK 188
Query: 735 LTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTT 794
E DVY+FG+ MLE+ T P + + R V K + ++ P +
Sbjct: 189 YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPA-SFDKVAIPEV----- 242
Query: 795 LKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825
++ C++++ D+R ++ +++
Sbjct: 243 -------KEIIEGCIRQNKDERYSIKDLLNH 266
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (519), Expect = 1e-59
Identities = 62/337 (18%), Positives = 126/337 (37%), Gaps = 59/337 (17%)
Query: 526 HWDMNKSSGSIPQLKGARCFSFEEVKKYTNNFS---DAND------VGSGGYGKVYKGTL 576
M + +GS + + + ++Y + + +GSG +GKV T
Sbjct: 4 QLQMVQVTGSSDNE-----YFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATA 58
Query: 577 PN------GQLIAIKRAQQGSMQGGQE-FKMEIELLSRV-HHKNLVSLLGFCFDRGEQML 628
+A+K ++ + +E E+++++++ H+N+V+LLG C G L
Sbjct: 59 YGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYL 118
Query: 629 IYEFVPNGSLGDSLSGKNGI---------------------RLDWIRRLKIALGAARGLS 667
I+E+ G L + L K L + L A A+G+
Sbjct: 119 IFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGME 178
Query: 668 YLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDP 727
+L +HRD+ + N+L+ K+ DFGL++ + + + + ++ P
Sbjct: 179 FLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAP 235
Query: 728 EYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDP 787
E T KSDV+S+G+L+ E+ + G + ++ ++ D
Sbjct: 236 ESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKM-------DQ 288
Query: 788 TIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVK 824
+ + + C RP+ +
Sbjct: 289 PFYATEEIY------IIMQSCWAFDSRKRPSFPNLTS 319
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 7e-58
Identities = 60/264 (22%), Positives = 112/264 (42%), Gaps = 22/264 (8%)
Query: 563 VGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCF 621
+G G G VY + GQ +AI++ + EI ++ + N+V+ L
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 622 DRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRD 681
E ++ E++ GSL D ++ +D + + + L +LH +IHRD
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSN---QVIHRD 141
Query: 682 IKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDV 741
IKS NILL + K+ DFG ++ + + GT ++ PE + K D+
Sbjct: 142 IKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRSTMVGTPYWMAPEVVTRKAYGPKVDI 199
Query: 742 YSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKY 801
+S G++ +E++ G P + +R + + EL +P LS +
Sbjct: 200 WSLGIMAIEMIEGEPPY-LNENPLRALYLIATNGT-----PELQNPE-KLSAIFR----- 247
Query: 802 VDLALKCVQESGDDRPTMSEVVKD 825
D +C+ + R + E+++
Sbjct: 248 -DFLNRCLDMDVEKRGSAKELLQH 270
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (500), Expect = 2e-57
Identities = 72/292 (24%), Positives = 120/292 (41%), Gaps = 39/292 (13%)
Query: 563 VGSGGYGKVYKGT------LPNGQLIAIKRAQQGSMQGG-QEFKMEIELLSR-VHHKNLV 614
+G G +G+V + + +A+K ++G+ + E+++L HH N+V
Sbjct: 21 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 80
Query: 615 SLLGFCFDRGEQ-MLIYEFVPNGSLGDSLSGKNG--------------IRLDWIRRLKIA 659
+LLG C G M+I EF G+L L K L + +
Sbjct: 81 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 140
Query: 660 LGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVK 719
A+G+ +L IHRD+ + NILL E+ K+ DFGL++ + +
Sbjct: 141 FQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 197
Query: 720 GTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELY 779
+ ++ PE + T +SDV+SFGVL+ E+ + G I E + + +
Sbjct: 198 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM- 256
Query: 780 NLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQ 831
D T + L C RPT SE+V+ + N+LQ
Sbjct: 257 ---RAPDYTT---------PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 1e-56
Identities = 60/279 (21%), Positives = 109/279 (39%), Gaps = 30/279 (10%)
Query: 563 VGSGGYGKVYKGTLP----NGQLIAIKR---AQQGSMQGGQEFKMEIELLSRVHHKNLVS 615
+G G +G V +G +A+K + +F E+ + + H+NL+
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 616 LLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANP 675
L G ++ E P GSL D L G + A+ A G+ YL
Sbjct: 76 LYGVVLT-PPMKMVTELAPLGSLLDRLRKHQG-HFLLGTLSRYAVQVAEGMGYLES---K 130
Query: 676 PIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHI-TTQVKGTMGYLDPEYYMTQQ 734
IHRD+ + N+LL R K+ DFGL +++ ++ ++ K + PE T+
Sbjct: 131 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT 190
Query: 735 LTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTT 794
+ SD + FGV + E+ T + G + + + + + L +
Sbjct: 191 FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCP--------- 241
Query: 795 LKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQA 833
+ ++ ++C +DRPT + L +A
Sbjct: 242 ----QDIYNVMVQCWAHKPEDRPTFVALRD----FLLEA 272
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 5e-56
Identities = 61/292 (20%), Positives = 119/292 (40%), Gaps = 32/292 (10%)
Query: 555 NNFSDANDVGSGGYGKVYKGTLPN------GQLIAIKRAQQGSMQGG-QEFKMEIELLSR 607
+ + ++G G +G VY+G +AIK + + EF E ++
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 608 VHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIR--------LDWIRRLKIA 659
+ ++V LLG ++I E + G L L + +++A
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 660 LGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVK 719
A G++YL+ +HRD+ + N ++ E K+ DFG+++ + +++ +
Sbjct: 140 GEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 720 GTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELY 779
+ ++ PE T SDV+SFGV++ E+ T +G + +R VM+
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG---- 252
Query: 780 NLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQ 831
L+D L +L C Q + RP+ E++ I+ ++
Sbjct: 253 ----LLDKPDNCPDMLF------ELMRMCWQYNPKMRPSFLEIISSIKEEME 294
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (485), Expect = 3e-55
Identities = 60/285 (21%), Positives = 102/285 (35%), Gaps = 26/285 (9%)
Query: 551 KKYTNNFSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSM---QGGQEFKMEIELLS 606
KK +F +G G + V L + AIK ++ + E +++S
Sbjct: 4 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63
Query: 607 RVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGL 666
R+ H V L D + + NG L + R A +
Sbjct: 64 RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY-----TAEIV 118
Query: 667 SYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLD 726
S L L IIHRD+K NILL+E ++ ++ DFG +K +S K GT Y+
Sbjct: 119 SALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVS 178
Query: 727 PEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELID 786
PE + + SD+++ G ++ +L+ G P R + ++ + D
Sbjct: 179 PELLTEKSACKSSDLWALGCIIYQLVAGLPPF-RAGNEYLIFQKIIKLE---------YD 228
Query: 787 PTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQ 831
+ DL K + R E ++ +
Sbjct: 229 FPEKFFPKAR------DLVEKLLVLDATKRLGCEE-MEGYGPLKA 266
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 4e-55
Identities = 67/293 (22%), Positives = 121/293 (41%), Gaps = 41/293 (13%)
Query: 563 VGSGGYGKVYKGTLP--------NGQLIAIKRAQQGSMQGG-QEFKMEIELLSRV-HHKN 612
+G G +G+V +A+K + + + + E+E++ + HKN
Sbjct: 21 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 613 LVSLLGFCFDRGEQMLIYEFVPNGSLGDSL--------------SGKNGIRLDWIRRLKI 658
+++LLG C G +I E+ G+L + L S +L +
Sbjct: 81 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 140
Query: 659 ALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQV 718
A ARG+ YL IHRD+ + N+L+ E K+ADFGL++ + + TT
Sbjct: 141 AYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 197
Query: 719 KGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKEL 778
+ + ++ PE + T +SDV+SFGVL+ E+ T G +
Sbjct: 198 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG--------------VPV 243
Query: 779 YNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQ 831
L++L+ + + + C RPT ++V+D++ I+
Sbjct: 244 EELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 191 bits (485), Expect = 1e-54
Identities = 62/266 (23%), Positives = 118/266 (44%), Gaps = 22/266 (8%)
Query: 563 VGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCF 621
+G+G +G V++ T G A K + + EI+ +S + H LV+L
Sbjct: 34 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 93
Query: 622 DRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRD 681
D E ++IYEF+ G L + ++ ++ ++ ++ +GL ++HE +H D
Sbjct: 94 DDNEMVMIYEFMSGGELFEKVADEHN-KMSEDEAVEYMRQVCKGLCHMHEN---NYVHLD 149
Query: 682 IKSSNILLDERLN--AKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKS 739
+K NI+ + + K+ DFGL+ + + +TT GT + PE + + +
Sbjct: 150 LKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEVAEGKPVGYYT 206
Query: 740 DVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFE 799
D++S GVL LL+G P + T+ + K +N+ + G+S K
Sbjct: 207 DMWSVGVLSYILLSGLSPFGG----ENDDETLRNVKSCDWNMDDSAFS--GISEDGK--- 257
Query: 800 KYVDLALKCVQESGDDRPTMSEVVKD 825
D K + + R T+ + ++
Sbjct: 258 ---DFIRKLLLADPNTRMTIHQALEH 280
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 187 bits (477), Expect = 2e-53
Identities = 62/266 (23%), Positives = 116/266 (43%), Gaps = 22/266 (8%)
Query: 563 VGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCF 621
+GSG +G V++ G++ K K EI +++++HH L++L
Sbjct: 37 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 96
Query: 622 DRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRD 681
D+ E +LI EF+ G L D ++ ++ + A GL ++HE I+H D
Sbjct: 97 DKYEMVLILEFLSGGELFDRIA-AEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLD 152
Query: 682 IKSSNILLDERLNA--KVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKS 739
IK NI+ + + + K+ DFGL+ ++ D I T + PE + + +
Sbjct: 153 IKPENIMCETKKASSVKIIDFGLATKLNP---DEIVKVTTATAEFAAPEIVDREPVGFYT 209
Query: 740 DVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFE 799
D+++ GVL LL+G P ++ T+ + K+ + E ++ S K
Sbjct: 210 DMWAIGVLGYVLLSGLSPFAGED----DLETLQNVKRCDWEFDEDAFSSV--SPEAK--- 260
Query: 800 KYVDLALKCVQESGDDRPTMSEVVKD 825
D +Q+ R T+ + ++
Sbjct: 261 ---DFIKNLLQKEPRKRLTVHDALEH 283
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 175 bits (444), Expect = 7e-50
Identities = 64/278 (23%), Positives = 121/278 (43%), Gaps = 27/278 (9%)
Query: 563 VGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGG---QEFKMEIELLSRVHHKNLVSLLG 618
+G GG +V+ L + +A+K + + F+ E + + ++H +V++
Sbjct: 15 LGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 74
Query: 619 FCFDRGEQ----MLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELAN 674
++ E+V +L D + + + R +++ A + L++ H+
Sbjct: 75 TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQ--- 129
Query: 675 PPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHI-TTQVKGTMGYLDPEYYMTQ 733
IIHRD+K +NI++ KV DFG++++++DS T V GT YL PE
Sbjct: 130 NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD 189
Query: 734 QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLST 793
+ +SDVYS G ++ E+LTG P + +E GLS
Sbjct: 190 SVDARSDVYSLGCVLYEVLTGEPPFTGDS----PVSVAYQHVREDPIPPSARHE--GLSA 243
Query: 794 TLKGFEKYVDLALKCVQESGDDRP-TMSEVVKDIENIL 830
L + LK + ++ ++R T +E+ D+ +
Sbjct: 244 DLD------AVVLKALAKNPENRYQTAAEMRADLVRVH 275
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 2e-49
Identities = 50/266 (18%), Positives = 101/266 (37%), Gaps = 23/266 (8%)
Query: 563 VGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCF 621
+G G +G V++ + + K + K EI +L+ H+N++ L
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ-VLVKKEISILNIARHRNILHLHESFE 71
Query: 622 DRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRD 681
E ++I+EF+ + + ++ + L+ + L +LH I H D
Sbjct: 72 SMEELVMIFEFISGLDIFERIN-TSAFELNEREIVSYVHQVCEALQFLHSH---NIGHFD 127
Query: 682 IKSSNILLDERLNA--KVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKS 739
I+ NI+ R ++ K+ +FG ++ + + + Y PE + ++ +
Sbjct: 128 IRPENIIYQTRRSSTIKIIEFGQARQLKPGDN---FRLLFTAPEYYAPEVHQHDVVSTAT 184
Query: 740 DVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFE 799
D++S G L+ LL+G P + + + Y E I S
Sbjct: 185 DMWSLGTLVYVLLSGINPFLAET----NQQIIENIMNAEYTFDEEAFKEI--SIEAM--- 235
Query: 800 KYVDLALKCVQESGDDRPTMSEVVKD 825
D + + + R T SE ++
Sbjct: 236 ---DFVDRLLVKERKSRMTASEALQH 258
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 173 bits (438), Expect = 8e-49
Identities = 53/285 (18%), Positives = 108/285 (37%), Gaps = 23/285 (8%)
Query: 563 VGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCF 621
+GSG +G +Y GT + G+ +AIK + + +E ++ + + + +C
Sbjct: 15 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCG 72
Query: 622 DRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRD 681
G+ ++ + SL + L + L +A + Y+H IHRD
Sbjct: 73 AEGDYNVMVMELLGPSL-EDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRD 128
Query: 682 IKSSNIL---LDERLNAKVADFGLSKSMSDSE-----KDHITTQVKGTMGYLDPEYYMTQ 733
+K N L + + DFGL+K D+ + GT Y ++
Sbjct: 129 VKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGI 188
Query: 734 QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLST 793
+ + + D+ S G +++ G P + K + + +K++ E++ G +
Sbjct: 189 EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCK--GYPS 246
Query: 794 TLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQAGLNPN 838
C DD+P S + + N+ + G + +
Sbjct: 247 EFA------TYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYD 285
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 171 bits (433), Expect = 2e-48
Identities = 69/281 (24%), Positives = 111/281 (39%), Gaps = 39/281 (13%)
Query: 563 VGSGGYGKVYKGT-LPNGQLIAIKR---------AQQGSMQGGQEFKMEIELLSRVH-HK 611
+G G V + P + A+K + + + + E+++L +V H
Sbjct: 11 LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 70
Query: 612 NLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHE 671
N++ L L+++ + G L D L + L KI + LH+
Sbjct: 71 NIIQLKDTYETNTFFFLVFDLMKKGELFDYL--TEKVTLSEKETRKIMRALLEVICALHK 128
Query: 672 LANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYM 731
L I+HRD+K NILLD+ +N K+ DFG S + EK +V GT YL PE
Sbjct: 129 L---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREVCGTPSYLAPEIIE 182
Query: 732 TQQL------TEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELI 785
++ D++S GV+M LL G P + + +R +M Y+
Sbjct: 183 CSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF-WHRKQMLMLRMIMSGN------YQFG 235
Query: 786 DPTI-GLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825
P S T+K DL + + R T E +
Sbjct: 236 SPEWDDYSDTVK------DLVSRFLVVQPQKRYTAEEALAH 270
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 170 bits (431), Expect = 8e-48
Identities = 61/284 (21%), Positives = 118/284 (41%), Gaps = 25/284 (8%)
Query: 547 FEEVKKYTNNFSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQE-FKMEIEL 604
+++ + + + + +G+G + +V +L+AIK + +++G + + EI +
Sbjct: 1 WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60
Query: 605 LSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAAR 664
L ++ H N+V+L G LI + V G L D + K ++
Sbjct: 61 LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG--FYTERDASRLIFQVLD 118
Query: 665 GLSYLHELANPPIIHRDIKSSNILL---DERLNAKVADFGLSKSMSDSEKDHITTQVKGT 721
+ YLH+ I+HRD+K N+L DE ++DFGLSK + + GT
Sbjct: 119 AVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP---GSVLSTACGT 172
Query: 722 MGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNL 781
GY+ PE + ++ D +S GV+ LL G P + + ++ + E
Sbjct: 173 PGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFY-DENDAKLFEQILKAEYEF--- 228
Query: 782 YELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825
+S + K D +++ + R T + ++
Sbjct: 229 --DSPYWDDISDSAK------DFIRHLMEKDPEKRFTCEQALQH 264
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 169 bits (428), Expect = 9e-47
Identities = 57/285 (20%), Positives = 111/285 (38%), Gaps = 32/285 (11%)
Query: 555 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQGGQ------EFKMEIELLSR 607
N+FS +G GG+G+VY G++ A+K + ++ Q ++ + L+S
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 608 VHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLS 667
+V + + I + + G L LS +R A GL
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF--YAAEIILGLE 121
Query: 668 YLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDP 727
++H +++RD+K +NILLDE + +++D GL+ S + GT GY+ P
Sbjct: 122 HMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMAP 174
Query: 728 EYYMTQQ-LTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELID 786
E +D +S G ++ +LL G P + + + + + + +
Sbjct: 175 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSP-----FRQHKTKDKHEIDRMTLTMAVELP 229
Query: 787 PTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQ 831
+ S L+ L +Q + R + + + +
Sbjct: 230 DSF--SPELR------SLLEGLLQRDVNRRLGCLG--RGAQEVKE 264
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 164 bits (416), Expect = 4e-46
Identities = 55/286 (19%), Positives = 109/286 (38%), Gaps = 21/286 (7%)
Query: 555 NNFSDANDVGSGGYGKVYKGTLPNGQLIAIK--RAQQGSMQGGQEFKMEIELLSRVHHKN 612
+ +G G YG VYK G+ A+K R ++ EI +L + H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 613 LVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHEL 672
+V L + +L++E + + G L+ + L G++Y H+
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG--LESVTAKSFLLQLLNGIAYCHD- 118
Query: 673 ANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMT 732
++HRD+K N+L++ K+ADFGL+++ + + + +
Sbjct: 119 --RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHE-IVTLWYRAPDVLMGS 175
Query: 733 QQLTEKSDVYSFGVLMLELLTGRRP------------IERGKYIVREIRTVMDKKKELYN 780
++ + D++S G + E++ G I R + Y+
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235
Query: 781 LYELIDPTIGLSTTLKGF-EKYVDLALKCVQESGDDRPTMSEVVKD 825
+ + + LKG E +DL K ++ + R T + ++
Sbjct: 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 2e-45
Identities = 61/305 (20%), Positives = 107/305 (35%), Gaps = 33/305 (10%)
Query: 552 KYTNNFSDANDVGSGGYGKVYKGT--LPNGQLIAIKRAQQGSMQGGQEFKMEIEL----- 604
+ + ++G G YGKV+K G+ +A+KR + + + G E+
Sbjct: 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63
Query: 605 LSRVHHKNLVSLLGFCFDRGEQMLIYEFVPN----GSLGDSLSGKNGIRLDWIRRLKIAL 660
L H N+V L C + L L + +
Sbjct: 64 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123
Query: 661 GAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKG 720
RGL +LH ++HRD+K NIL+ K+ADFGL++ S T V
Sbjct: 124 QLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVVV 177
Query: 721 TMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRP------IERGKYIVREIRTVMDK 774
T+ Y PE + D++S G + E+ + +++ I+ I ++
Sbjct: 178 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 237
Query: 775 KKELYNLYELIDPTIGLSTTLKGFEKYV-----DLALKCVQESGDDRPTMSEV-----VK 824
+ ++ F + DL LKC+ + R + +
Sbjct: 238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 297
Query: 825 DIENI 829
D+E
Sbjct: 298 DLERC 302
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 162 bits (410), Expect = 4e-45
Identities = 48/287 (16%), Positives = 100/287 (34%), Gaps = 25/287 (8%)
Query: 563 VGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCF 621
+G G +G +++GT L N Q +AIK + S + + E + + + +
Sbjct: 13 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYFG 70
Query: 622 DRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRD 681
G ++ + G + L G + A + +HE +++RD
Sbjct: 71 QEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRD 126
Query: 682 IKSSNILLDERLN-----AKVADFGLSKSMSDSE-----KDHITTQVKGTMGYLDPEYYM 731
IK N L+ + V DFG+ K D + GT Y+ ++
Sbjct: 127 IKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHL 186
Query: 732 TQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGL 791
++ + + D+ + G + + L G P + + T K + + +
Sbjct: 187 GREQSRRDDLEALGHVFMYFLRGSLP-----WQGLKAATNKQKYERIGEKKQSTPLRELC 241
Query: 792 STTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQAGLNPN 838
+ + F KY+ + D P + +L++ +
Sbjct: 242 AGFPEEFYKYMH---YARNLAFDATPDYDYLQGLFSKVLERLNTTED 285
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 7e-45
Identities = 64/270 (23%), Positives = 109/270 (40%), Gaps = 32/270 (11%)
Query: 563 VGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQE---FKMEIELLSRV-HHKNLVSLL 617
+G G +GKV+ Q AIK ++ + + +E +LS H L +
Sbjct: 10 LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 69
Query: 618 GFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPI 677
+ + E++ G L + ++ + D R A GL +LH I
Sbjct: 70 CTFQTKENLFFVMEYLNGGDLMYHI--QSCHKFDLSRATFYAAEIILGLQFLHS---KGI 124
Query: 678 IHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTE 737
++RD+K NILLD+ + K+ADFG+ K + GT Y+ PE + Q+
Sbjct: 125 VYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NTFCGTPDYIAPEILLGQKYNH 182
Query: 738 KSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTI--GLSTTL 795
D +SFGVL+ E+L G+ P ++EL++ + +P L
Sbjct: 183 SVDWWSFGVLLYEMLIGQSPFHG------------QDEEELFHSIRMDNPFYPRWLEKEA 230
Query: 796 KGFEKYVDLALKCVQESGDDRPTMSEVVKD 825
K DL +K + R + ++
Sbjct: 231 K------DLLVKLFVREPEKRLGVRGDIRQ 254
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 8e-45
Identities = 67/282 (23%), Positives = 114/282 (40%), Gaps = 26/282 (9%)
Query: 563 VGSGGYGKVYKGTLPN-GQLIAIKRAQQGSMQGGQE-----FKMEIELLSRVHHKNLVSL 616
+G G + VYK N Q++AIK+ + G ++ EI+LL + H N++ L
Sbjct: 6 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 65
Query: 617 LGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPP 676
L + L+++F+ + I+ L +GL YLH+
Sbjct: 66 LDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKA--YMLMTLQGLEYLHQ---HW 120
Query: 677 IIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQL- 735
I+HRD+K +N+LLDE K+ADFGL+KS + + T T Y PE ++
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY--THQVVTRWYRAPELLFGARMY 178
Query: 736 TEKSDVYSFGVLMLELLTGRRP------IERGKYIVREIRT-----VMDKKKELYNLYEL 784
D+++ G ++ ELL +++ I + T D +
Sbjct: 179 GVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238
Query: 785 IDPTIGLSTTLKGF-EKYVDLALKCVQESGDDRPTMSEVVKD 825
P I L + +DL + R T ++ +K
Sbjct: 239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 8e-45
Identities = 66/281 (23%), Positives = 109/281 (38%), Gaps = 43/281 (15%)
Query: 563 VGSGGYGKVYKGT-LPNGQLIAIKR------AQQGSMQGGQEFKMEIELLSRVH--HKNL 613
+GSGG+G VY G + + +AIK + G + G ME+ LL +V +
Sbjct: 12 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 614 VSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELA 673
+ LL + +LI E + G L + + H
Sbjct: 72 IRLLDWFERPDSFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCHNC- 129
Query: 674 NPPIIHRDIKSSNILLD-ERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMT 732
++HRDIK NIL+D R K+ DFG + KD + T GT Y PE+
Sbjct: 130 --GVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWIRY 183
Query: 733 QQL-TEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGL 791
+ + V+S G+L+ +++ G P E + I+R + +
Sbjct: 184 HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR----------------V 227
Query: 792 STTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD--IENIL 830
S+ + L C+ DRPT E+ ++++L
Sbjct: 228 SSECQ------HLIRWCLALRPSDRPTFEEIQNHPWMQDVL 262
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 1e-44
Identities = 57/286 (19%), Positives = 103/286 (36%), Gaps = 21/286 (7%)
Query: 556 NFSDANDVGSGGYGKVYKGT-LPNGQLIAIK--RAQQGSMQGGQEFKMEIELLSRVHHKN 612
NF +G G YG VYK G+++A+K R + EI LL ++H N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 613 LVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHEL 672
+V LL + L++EF+ + L + + +GL++ H
Sbjct: 63 IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS- 120
Query: 673 ANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMT 732
++HRD+K N+L++ K+ADFGL+++ + + T +V
Sbjct: 121 --HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY-THEVVTLWYRAPEILLGC 177
Query: 733 QQLTEKSDVYSFGVLMLELLTGRRP------------IERGKYIVREIRTVMDKKKELYN 780
+ + D++S G + E++T R I R E+ Y
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237
Query: 781 LYELIDPTIGLSTTLKGF-EKYVDLALKCVQESGDDRPTMSEVVKD 825
S + E L + + + R + +
Sbjct: 238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 161 bits (407), Expect = 2e-44
Identities = 59/281 (20%), Positives = 113/281 (40%), Gaps = 32/281 (11%)
Query: 555 NNFSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQE---FKMEIELLSRVHH 610
+F +G+G +G+V+ NG+ A+K ++ + ++ E +LS V H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 611 KNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLH 670
++ + G D + +I +++ G L L + + L
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV-----CLALE 118
Query: 671 ELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYY 730
L + II+RD+K NILLD+ + K+ DFG +K + D T + GT Y+ PE
Sbjct: 119 YLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-----TYTLCGTPDYIAPEVV 173
Query: 731 MTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIG 790
T+ + D +SFG+L+ E+L G P ++ +++ + +
Sbjct: 174 STKPYNKSIDWWSFGILIYEMLAGYTPFY-DSNTMKTYEKILNAE---------LRFPPF 223
Query: 791 LSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQ 831
+ +K DL + + R + E++
Sbjct: 224 FNEDVK------DLLSRLITRDLSQRLGNLQ--NGTEDVKN 256
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 3e-44
Identities = 59/292 (20%), Positives = 110/292 (37%), Gaps = 23/292 (7%)
Query: 554 TNNFSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGG-QEFKMEIELLSRVHHK 611
+++ + +G G YG V N +AIK+ Q Q EI++L R H+
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 612 NLVSLLGFCFDRGEQMLIYEFVPNGSLG-DSLSGKNGIRLDWIRRLKIALGAARGLSYLH 670
N++ + + + ++ +G D L RGL Y+H
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126
Query: 671 ELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHIT-TQVKGTMGYLDPEY 729
++HRD+K SN+LL+ + K+ DFGL++ T+ T Y PE
Sbjct: 127 SA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183
Query: 730 YMTQQL-TEKSDVYSFGVLMLELLTGRRPIE--------------RGKYIVREIRTVMDK 774
+ + T+ D++S G ++ E+L+ R G ++ +++
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243
Query: 775 KKELYNLYELIDPTIGLSTTLKGF-EKYVDLALKCVQESGDDRPTMSEVVKD 825
K Y L + + K +DL K + + R + + +
Sbjct: 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (404), Expect = 3e-44
Identities = 57/274 (20%), Positives = 111/274 (40%), Gaps = 31/274 (11%)
Query: 563 VGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGG------QEFKMEIELLSRVHHKNLVS 615
+GSG + V K G A K ++ + ++ + E+ +L + H N+++
Sbjct: 18 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 77
Query: 616 LLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANP 675
L ++ + +LI E V G L D L+ K + + + L+ ++ L +
Sbjct: 78 LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEF-----LKQILNGVYYLHSL 132
Query: 676 PIIHRDIKSSNILLDER----LNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYM 731
I H D+K NI+L +R K+ DFGL+ + + + GT ++ PE
Sbjct: 133 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVN 189
Query: 732 TQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGL 791
+ L ++D++S GV+ LL+G P + T+ + Y +
Sbjct: 190 YEPLGLEADMWSIGVITYILLSGASPFLGD----TKQETLANVSAVNYEFEDEYFSNT-- 243
Query: 792 STTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825
S K D + + + R T+ + ++
Sbjct: 244 SALAK------DFIRRLLVKDPKKRMTIQDSLQH 271
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 4e-44
Identities = 59/300 (19%), Positives = 108/300 (36%), Gaps = 30/300 (10%)
Query: 563 VGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRV-HHKNLVSLLGFC 620
+G G GKV + + A+K +Q + + E+EL R ++V ++
Sbjct: 20 LGLGINGKVLQIFNKRTQEKFALKM-----LQDCPKARREVELHWRASQCPHIVRIVDVY 74
Query: 621 FD----RGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPP 676
+ R +++ E + G L + + +I + YLH +
Sbjct: 75 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--- 131
Query: 677 IIHRDIKSSNILLDERLN---AKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQ 733
I HRD+K N+L + K+ DFG +K + T Y+ PE +
Sbjct: 132 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT---TPCYTPYYVAPEVLGPE 188
Query: 734 QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLST 793
+ + D++S GV+M LL G P + I M + + +S
Sbjct: 189 KYDKSCDMWSLGVIMYILLCGYPPFYSNHGL--AISPGMKTRIRMGQYEFPNPEWSEVSE 246
Query: 794 TLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQAGLNPNAESASSSASYEDASK 853
+K L ++ R T++E + + Q+ P +S ED +
Sbjct: 247 EVK------MLIRNLLKTEPTQRMTITEFMNH--PWIMQSTKVPQTPLHTSRVLKEDKER 298
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 6e-44
Identities = 67/292 (22%), Positives = 120/292 (41%), Gaps = 31/292 (10%)
Query: 556 NFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLV 614
+++D +G+G +G VY+ L +G+L+AIK+ Q E++++ ++ H N+V
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIV 76
Query: 615 SLLGFCFDRGEQM------LIYEFVPNGSLGDSLS-GKNGIRLDWIRRLKIALGAARGLS 667
L F + GE+ L+ ++VP + + L I R L+
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 668 YLHELANPPIIHRDIKSSNILLD-ERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLD 726
Y+H I HRDIK N+LLD + K+ DFG +K + E + + +
Sbjct: 137 YIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--SYICSRYYRAP 191
Query: 727 PEYYMTQQLTEKSDVYSFGVLMLELLTGRRP------IERGKYIVREIRTVMDK--KKEL 778
+ T DV+S G ++ ELL G+ +++ I++ + T + ++
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251
Query: 779 YNLYELIDPTIGLSTTLKGFEKYV-----DLALKCVQESGDDRPTMSEVVKD 825
N E P I K F L + ++ + R T E
Sbjct: 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 8e-44
Identities = 53/280 (18%), Positives = 105/280 (37%), Gaps = 23/280 (8%)
Query: 563 VGSGGYGKVYKGT-LPNGQLIAIK--RAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGF 619
+G G YG V+K +++A+K R EI LL + HKN+V L
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 620 CFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIH 679
+ L++EF S + + ++ + L L + ++H
Sbjct: 70 LHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSF-----LFQLLKGLGFCHSRNVLH 124
Query: 680 RDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKS 739
RD+K N+L++ K+A+FGL+++ + + + +V + + +
Sbjct: 125 RDLKPQNLLINRNGELKLANFGLARAFGIPVRCY-SAEVVTLWYRPPDVLFGAKLYSTSI 183
Query: 740 DVYSFGVLMLELLTGRRPIERGKYIVREIRTVMD-------------KKKELYNLYELID 786
D++S G + EL RP+ G + +++ + K Y Y +
Sbjct: 184 DMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYP 243
Query: 787 PTIGLSTTLKGF-EKYVDLALKCVQESGDDRPTMSEVVKD 825
T L + DL ++ + R + E ++
Sbjct: 244 ATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 2e-43
Identities = 62/301 (20%), Positives = 122/301 (40%), Gaps = 35/301 (11%)
Query: 555 NNFSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGG--QEFKMEIELLSRVHHK 611
+ + +G G +G+V+K GQ +A+K+ + + G EI++L + H+
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 612 NLVSLLGFCFDRGEQM--------LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAA 663
N+V+L+ C + L+++F + G + L I+R+ L
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML--- 126
Query: 664 RGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHIT--TQVKGT 721
L+ L+ + I+HRD+K++N+L+ K+ADFGL+++ S ++ T T
Sbjct: 127 --LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVT 184
Query: 722 MGYLDPEYYMTQQL-TEKSDVYSFGVLMLELLTGRRP------------IERGKY-IVRE 767
+ Y PE + ++ D++ G +M E+ T I + I E
Sbjct: 185 LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 244
Query: 768 IRTVMDKKKELYNLYELIDPTIGLSTTLKGF---EKYVDLALKCVQESGDDRPTMSEVVK 824
+ +D + L + + LK + +DL K + R + +
Sbjct: 245 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304
Query: 825 D 825
Sbjct: 305 H 305
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 5e-39
Identities = 61/283 (21%), Positives = 100/283 (35%), Gaps = 33/283 (11%)
Query: 555 NNFSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQE---FKMEIELLSRVHH 610
N+F +G G +GKV G+ A+K ++ + E E +L H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 611 KNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLH 670
L +L + E+ G L LS + + R A +S L
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFY-----GAEIVSALE 119
Query: 671 ELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYY 730
L + +++RDIK N++LD+ + K+ DFGL K GT YL PE
Sbjct: 120 YLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGTPEYLAPEVL 177
Query: 731 MTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTI- 789
D + GV+M E++ GR P + L+ L + +
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYN------------QDHERLFELILMEEIRFP 225
Query: 790 -GLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQ 831
LS K L +++ R D + +++
Sbjct: 226 RTLSPEAK------SLLAGLLKKDPKQRLGGGP--SDAKEVME 260
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 143 bits (361), Expect = 6e-38
Identities = 54/247 (21%), Positives = 99/247 (40%), Gaps = 19/247 (7%)
Query: 515 AEKANEQNPFAHWDMNKSSGSIPQLKGARCFSFEEVKKYTNNFSDANDVGSGGYGKVYKG 574
A+K +EQ + + + + + + + F +G+G +G+V
Sbjct: 6 AKKGSEQESVKEFLAKAKEDFLKKWE-----TPSQNTAQLDQFDRIKTLGTGSFGRVMLV 60
Query: 575 T-LPNGQLIAIK---RAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIY 630
+G A+K + + ++ + E +L V+ LV L D ++
Sbjct: 61 KHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120
Query: 631 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLD 690
E+V G + L R A YLH L +I+RD+K N+L+D
Sbjct: 121 EYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLID 175
Query: 691 ERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLE 750
++ +V DFG +K + T + GT L PE +++ + D ++ GVL+ E
Sbjct: 176 QQGYIQVTDFGFAKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYE 230
Query: 751 LLTGRRP 757
+ G P
Sbjct: 231 MAAGYPP 237
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 9e-38
Identities = 68/305 (22%), Positives = 110/305 (36%), Gaps = 31/305 (10%)
Query: 545 FSFEEVKKYTNNFSDA----NDVGSGGYGKVYKGT-LPNGQLIAIK--RAQQGSMQGGQE 597
F +EV K VGSG YG V G +AIK S +
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63
Query: 598 FKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGK--NGIRLDWIRR 655
E+ LL + H+N++ LL +F + GK +L R
Sbjct: 64 AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRI 123
Query: 656 LKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHIT 715
+ +GL Y+H IIHRD+K N+ ++E K+ DFGL++ +T
Sbjct: 124 QFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADS----EMT 176
Query: 716 TQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRP------IERGKYIVREIR 769
V + T+ D++S G +M E++TG+ +++ K I++
Sbjct: 177 GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTG 236
Query: 770 TVMDKKKELYNLYELIDPTIGLSTTLKGF---------EKYVDLALKCVQESGDDRPTMS 820
T + + E + GL K V+L K + + R T
Sbjct: 237 TPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAG 296
Query: 821 EVVKD 825
E +
Sbjct: 297 EALAH 301
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 133 bits (335), Expect = 1e-34
Identities = 54/311 (17%), Positives = 117/311 (37%), Gaps = 48/311 (15%)
Query: 549 EVKKYTNNFSDAND------VGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKME 601
+ + + + + +D +G G Y +V++ + N + + +K + + + K E
Sbjct: 23 DYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKRE 79
Query: 602 IELLSRV-HHKNLVSLLGFCFDRGEQM--LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKI 658
I++L + N+++L D + L++E V N L
Sbjct: 80 IKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ-----TLTDYDIRFY 134
Query: 659 ALGAARGLSYLHELANPPIIHRDIKSSNILLD-ERLNAKVADFGLSKSMSDSEKDHITTQ 717
+ L Y H + I+HRD+K N+++D E ++ D+GL++ ++ ++
Sbjct: 135 MYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV- 190
Query: 718 VKGTMGYLDPEYYMTQQL-TEKSDVYSFGVLMLELLTGRRPIERGK-------YIVREIR 769
+ + PE + Q+ D++S G ++ ++ + P G I + +
Sbjct: 191 --ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG 248
Query: 770 TVMDKKKELYNLYELID--PTIGLSTTLKGFEKYV-------------DLALKCVQESGD 814
T EL I + K +E++V D K ++
Sbjct: 249 TEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQ 308
Query: 815 DRPTMSEVVKD 825
R T E ++
Sbjct: 309 SRLTAREAMEH 319
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (326), Expect = 1e-33
Identities = 66/282 (23%), Positives = 111/282 (39%), Gaps = 35/282 (12%)
Query: 563 VGSGGYGKVYKGTL----PNGQLIAIKRAQQGSM----QGGQEFKMEIELLSRV-HHKNL 613
+G+G YGKV+ G+L A+K ++ ++ + + + E ++L + L
Sbjct: 32 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 91
Query: 614 VSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELA 673
V+L + LI +++ G L LS + ++ + L L
Sbjct: 92 VTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQI-----YVGEIVLALEHLH 146
Query: 674 NPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQ 733
II+RDIK NILLD + + DFGLSK E + GT+ Y+ P+
Sbjct: 147 KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER-AYDFCGTIEYMAPDIVRGG 205
Query: 734 Q--LTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTI-- 789
+ D +S GVLM ELLTG P + + + E+ +P
Sbjct: 206 DSGHDKAVDWWSLGVLMYELLTGASPF--------TVDGEKNSQAEISRRILKSEPPYPQ 257
Query: 790 GLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQ 831
+S K DL + + + R +D + I +
Sbjct: 258 EMSALAK------DLIQRLLMKDPKKRLGCGP--RDADEIKE 291
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 3e-32
Identities = 64/286 (22%), Positives = 104/286 (36%), Gaps = 33/286 (11%)
Query: 563 VGSGGYGKVYKGT-LPNGQLIAIK--RAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGF 619
VGSG YG V G +A+K S+ + E+ LL + H+N++ LL
Sbjct: 26 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 620 CFDR-----GEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELAN 674
+ + + L + + + +L + RGL Y+H
Sbjct: 86 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHS--- 139
Query: 675 PPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQ 734
IIHRD+K SN+ ++E K+ DFGL++ D +T V
Sbjct: 140 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYRAPEIMLNWMH 195
Query: 735 LTEKSDVYSFGVLMLELLTGRRP------------IERGKYIVRE--IRTVMDKKKELYN 780
+ D++S G +M ELLTGR I R ++ + + Y
Sbjct: 196 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 255
Query: 781 LYELIDPTIGLSTTLKGF-EKYVDLALKCVQESGDDRPTMSEVVKD 825
P + + G VDL K + D R T ++ +
Sbjct: 256 QSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 2e-31
Identities = 67/320 (20%), Positives = 115/320 (35%), Gaps = 52/320 (16%)
Query: 547 FEEVKKYTNNFSDAND------VGSGGYGKVYKGT-LPNGQLIAIK--RAQQGSMQGGQE 597
F V+ + F+ +GSG G V + +AIK + +
Sbjct: 3 FYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKR 62
Query: 598 FKMEIELLSRVHHKNLVSLLGFCFDRG------EQMLIYEFVPNGSLGDSLSGKNGIRLD 651
E+ L+ V+HKN++SLL + + L+ E + LD
Sbjct: 63 AYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM-----ELD 117
Query: 652 WIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEK 711
R + G+ +LH IIHRD+K SNI++ K+ DFGL+++ S
Sbjct: 118 HERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM 174
Query: 712 DHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRP------IERGKYIV 765
T T Y PE + E D++S G +M E++ + I++ ++
Sbjct: 175 ---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI 231
Query: 766 REIRT----VMDKKKELYNLYELIDPTIGLSTTLKGFEKYV----------------DLA 805
++ T M K + Y P T K F + DL
Sbjct: 232 EQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLL 291
Query: 806 LKCVQESGDDRPTMSEVVKD 825
K + R ++ + ++
Sbjct: 292 SKMLVIDPAKRISVDDALQH 311
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 111 bits (278), Expect = 4e-27
Identities = 42/211 (19%), Positives = 77/211 (36%), Gaps = 19/211 (9%)
Query: 563 VGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLG--- 618
+G G + V+ + N +A+K + + + + EI+LL RV+ +
Sbjct: 21 LGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT-EAAEDEIKLLQRVNDADNTKEDSMGA 79
Query: 619 -----------FCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLS 667
G +++ V +L + + I +I+ GL
Sbjct: 80 NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLD 139
Query: 668 YLHELANPPIIHRDIKSSNILLDER-LNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLD 726
Y+H IIH DIK N+L++ + ++ + D T T Y
Sbjct: 140 YMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRS 197
Query: 727 PEYYMTQQLTEKSDVYSFGVLMLELLTGRRP 757
PE + +D++S L+ EL+TG
Sbjct: 198 PEVLLGAPWGCGADIWSTACLIFELITGDFL 228
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 93.3 bits (231), Expect = 3e-22
Identities = 30/199 (15%), Positives = 66/199 (33%), Gaps = 26/199 (13%)
Query: 563 VGSGGYGKVYKGTLPNGQLIAIK----------RAQQGSMQGGQEFKMEIELLSRVHHKN 612
+G G V+ +K + ++ G F + +R +
Sbjct: 8 MGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRA 67
Query: 613 LVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHEL 672
L L G + +Y + N L + + K R+ ++ ++ +
Sbjct: 68 LQKLQGLAVPK-----VYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYH- 121
Query: 673 ANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE-KDHITTQVKGTMGYLDPEYYM 731
I+H D+ N+L+ E + DF S + + ++ + V+ + Y Y
Sbjct: 122 --RGIVHGDLSQYNVLVSEE-GIWIIDFPQSVEVGEEGWREILERDVRNIITYFSRTY-- 176
Query: 732 TQQLTEKSDVYSFGVLMLE 750
+ D+ S +L+
Sbjct: 177 ----RTEKDINSAIDRILQ 191
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 84.7 bits (208), Expect = 6e-18
Identities = 40/199 (20%), Positives = 77/199 (38%), Gaps = 20/199 (10%)
Query: 37 GNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLT 96
L L +L+ S P I + L LSLN N ++ +L+NL LDL
Sbjct: 194 AKLTNLESLIATNNQISDITPLGILT--NLDELSLNGNQLKD--IGTLASLTNLTDLDLA 249
Query: 97 DNKLEGEIP-----------VSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVL 145
+N++ P + + L + + L
Sbjct: 250 NNQISNLAPLSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNL 309
Query: 146 IHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTG 205
++ NN++ P + + L+ + F N +S S+L NLT++N L +N+++
Sbjct: 310 TYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISD 365
Query: 206 AMPNLTGLSVLSYLDMSNN 224
+ L L+ ++ L +++
Sbjct: 366 -LTPLANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 60.8 bits (146), Expect = 3e-10
Identities = 60/336 (17%), Positives = 122/336 (36%), Gaps = 43/336 (12%)
Query: 11 ITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLS 70
+ L L ++ SNN+ L P + NL KL ++++ + P + + + L
Sbjct: 62 VEYLNNLTQINFSNNQ-LTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLF 118
Query: 71 LNSNGFSGRVPPSIG---------NLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAK 121
N + +S++ L + + + L L +
Sbjct: 119 NNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLE 178
Query: 122 HFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSG 181
N++S LI +N ++ P ++ +L+ + + N L
Sbjct: 179 RLDISSNKVSDISVLAKLTNLESLIA---TNNQISDITPLG--ILTNLDELSLNGNQLKD 233
Query: 182 PVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQS- 240
L +LT++ DL L+NN+++ + L+GL+ L+ L + N + +++ +
Sbjct: 234 --IGTLASLTNLTDLDLANNQISN-LAPLSGLTKLTELKLGANQISNISPLAGLTALTNL 290
Query: 241 ------------------LTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLG 282
LT L + N+ P + S+ LQ + N+++ L
Sbjct: 291 ELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSDVSSLA 348
Query: 283 TSYSENLLVNLQNNRISAYTERGGAPAV-NLTLIDN 317
+ N L + +N+IS T + L L D
Sbjct: 349 NLTNINWL-SAGHNQISDLTPLANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 58.1 bits (139), Expect = 2e-09
Identities = 44/193 (22%), Positives = 70/193 (36%), Gaps = 44/193 (22%)
Query: 9 GDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVL 68
G + LT L LDL+NN+ + P + L KL+ L L S P + + +
Sbjct: 235 GTLASLTNLTDLDLANNQ-ISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLE 291
Query: 69 LSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKN 128
L+ N I NL NL +L L N + PVS L + + F N
Sbjct: 292 LNENQLED----ISPISNLKNLTYLTLYFNNISDISPVSS--------LTKLQRLFFANN 339
Query: 129 QLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLN 188
++S ++L + ++ + N +S P L
Sbjct: 340 KVSD---------------------------VSSLANLTNINWLSAGHNQISDLTP--LA 370
Query: 189 NLTSVNDLYLSNN 201
NLT + L L++
Sbjct: 371 NLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 53.9 bits (128), Expect = 4e-08
Identities = 43/311 (13%), Positives = 92/311 (29%), Gaps = 40/311 (12%)
Query: 38 NLKKLSNLMLVGCSFSGPIPDS-IGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLT 96
L + +L + + + + + + L L G + L+NL ++ +
Sbjct: 20 ALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQINFS 74
Query: 97 DNKLEGEIPVSD----------------------------GNSPGLDMLVRAKHFHFGKN 128
+N+L P+ + + +
Sbjct: 75 NNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNL 134
Query: 129 QLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLN 188
+ + + ++ L + R D +S S L
Sbjct: 135 NRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLA 194
Query: 189 NLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMEN 248
LT++ L +NN+++ P + L L ++ N + +S+ +LT L + N
Sbjct: 195 KLTNLESLIATNNQISDITPLGILTN-LDELSLNGNQL---KDIGTLASLTNLTDLDLAN 250
Query: 249 TNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENLLVNLQNNRISAYTERGGAP 308
+ P L + L + + N+++ L + L +N
Sbjct: 251 NQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKN 308
Query: 309 AVNLTLIDNPI 319
LTL N I
Sbjct: 309 LTYLTLYFNNI 319
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 80.1 bits (196), Expect = 8e-17
Identities = 54/263 (20%), Positives = 94/263 (35%), Gaps = 16/263 (6%)
Query: 15 TELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSN 74
+ LDL NNK + NLK L L+L+ S P + L +L L L+ N
Sbjct: 31 PDTALLDLQNNK-ITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKN 89
Query: 75 GFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSI 134
L L + K+ + + L + G N L S
Sbjct: 90 QLKELPEKMPKTLQELRVHENEITKVRKSV---------FNGLNQMIVVELGTNPLKSSG 140
Query: 135 PEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVN 194
E M + + ++ +P GL SL + D N ++ ++L L ++
Sbjct: 141 IENGAFQGMKKLSYIRIADTNITTIPQ--GLPPSLTELHLDGNKITKVDAASLKGLNNLA 198
Query: 195 DLYLSNNKLTGAMPNLTG-LSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKG 253
L LS N ++ L L ++NN +VP + + + + + N N+
Sbjct: 199 KLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV--KVPGGLADHKYIQVVYLHNNNISA 256
Query: 254 QIPADLFSIPHLQTVVMKTNELN 276
I ++ F P T + ++
Sbjct: 257 -IGSNDFCPPGYNTKKASYSGVS 278
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 75.8 bits (185), Expect = 2e-15
Identities = 51/270 (18%), Positives = 99/270 (36%), Gaps = 25/270 (9%)
Query: 42 LSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLE 101
+ L L + +L+ L L L +N S P + L L L L+ N+L+
Sbjct: 33 TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK 92
Query: 102 GEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKL-FRPDMVLIHVLFDSNNLTGELP 160
E+P M + +N+++ M+++ + + +G
Sbjct: 93 -ELPEK--------MPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIEN 143
Query: 161 ATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPN-LTGLSVLSYL 219
+K L +R +++ +LT L+L NK+T L GL+ L+ L
Sbjct: 144 GAFQGMKKLSYIRIADTNITTIPQGLPPSLTE---LHLDGNKITKVDAASLKGLNNLAKL 200
Query: 220 DMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTL 279
+S NS + ++ L L + N L ++P L ++Q V + N ++ +
Sbjct: 201 GLSFNSIS-AVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS-AI 257
Query: 280 DLGTSYSENLL--------VNLQNNRISAY 301
V+L +N + +
Sbjct: 258 GSNDFCPPGYNTKKASYSGVSLFSNPVQYW 287
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 58.5 bits (140), Expect = 9e-10
Identities = 40/251 (15%), Positives = 77/251 (30%), Gaps = 45/251 (17%)
Query: 1 MGLKGQLSGDITGLTELHTLDLSNNK--DLRGPLPTTIGNLKKLSN-------------- 44
+ G L +L L LS N+ +L +P T+ L+ N
Sbjct: 65 NKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLN 124
Query: 45 ------LMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDN 98
L SG + +++L + + + +P + +L L L N
Sbjct: 125 QMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGN 181
Query: 99 KLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGE 158
K+ S L L + + + S + L + +NN +
Sbjct: 182 KITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHL--------NNNKLVK 233
Query: 159 LPATLGLVKSLEVVRFDRNSLSG------PVPSNLNNLTSVNDLYLSNNKLT------GA 206
+P L K ++VV N++S P S + + L +N +
Sbjct: 234 VPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPST 293
Query: 207 MPNLTGLSVLS 217
+ + +
Sbjct: 294 FRCVYVRAAVQ 304
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 71.7 bits (174), Expect = 6e-14
Identities = 58/258 (22%), Positives = 91/258 (35%), Gaps = 44/258 (17%)
Query: 12 TGLTELHTLDLSNNKDLRG--PLPTTIGNLKKLSNLMLVGC-SFSGPIPDSIGSLQELVL 68
T ++ LDLS +L P+P+++ NL L+ L + G + GPIP +I L +L
Sbjct: 47 TQTYRVNNLDLSGL-NLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHY 105
Query: 69 LSLNSN------------------------GFSGRVPPSIGNLSNLYWLDLTDNKLEGEI 104
L + SG +PPSI +L NL + N++ G I
Sbjct: 106 LYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAI 165
Query: 105 PVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDM----------------VLIHV 148
P S G+ L + L D+
Sbjct: 166 PDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQK 225
Query: 149 LFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMP 208
+ + N +GL K+L + N + G +P L L ++ L +S N L G +P
Sbjct: 226 IHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP 285
Query: 209 NLTGLSVLSYLDMSNNSF 226
L +NN
Sbjct: 286 QGGNLQRFDVSAYANNKC 303
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 56.3 bits (134), Expect = 6e-09
Identities = 18/66 (27%), Positives = 27/66 (40%), Gaps = 1/66 (1%)
Query: 40 KKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNK 99
K L+ L L G +P + L+ L L+++ N G +P GNL +NK
Sbjct: 244 KNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNK 302
Query: 100 LEGEIP 105
P
Sbjct: 303 CLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 55.1 bits (131), Expect = 1e-08
Identities = 54/264 (20%), Positives = 96/264 (36%), Gaps = 11/264 (4%)
Query: 37 GNLKKLSNLMLVGCSFSG--PIPDSIGSLQELVLLSLNSN-GFSGRVPPSIGNLSNLYWL 93
+++NL L G + PIP S+ +L L L + G +PP+I L+ L++L
Sbjct: 47 TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL 106
Query: 94 DLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSN 153
+T + G IP L F N LSG++P + ++ N
Sbjct: 107 YITHTNVSGAIPDFLSQIKTLV------TLDFSYNALSGTLPPSISSLPNLVGITFD-GN 159
Query: 154 NLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGL 213
++G +P + G L + ++ + LS N L G L G
Sbjct: 160 RISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGS 219
Query: 214 SVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTN 273
+ + A ++ S + N + G +P L + L ++ + N
Sbjct: 220 DKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNN-RIYGTLPQGLTQLKFLHSLNVSFN 278
Query: 274 ELNGTLDLGTSYSENLLVNLQNNR 297
L G + G + + NN+
Sbjct: 279 NLCGEIPQGGNLQRFDVSAYANNK 302
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 45.9 bits (107), Expect = 1e-05
Identities = 17/57 (29%), Positives = 26/57 (45%), Gaps = 4/57 (7%)
Query: 3 LKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSF--SGPIP 57
+ G L +T L LH+L++S N L G +P GNL++ P+P
Sbjct: 256 IYGTLPQGLTQLKFLHSLNVSFNN-LCGEIP-QGGNLQRFDVSAYANNKCLCGSPLP 310
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 67.1 bits (162), Expect = 1e-12
Identities = 46/265 (17%), Positives = 84/265 (31%), Gaps = 15/265 (5%)
Query: 15 TELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSN 74
+ L N+ + + + L+ L L + + L L L L+ N
Sbjct: 32 AASQRIFLHGNR-ISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN 90
Query: 75 GFSGRV-PPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGS 133
V P + L L+ L L L+ P L + + N L
Sbjct: 91 AQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQ------YLYLQDNALQAL 144
Query: 134 IPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSV 193
+ FR L H+ N ++ + SL+ + +N ++ P +L +
Sbjct: 145 PDD-TFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRL 203
Query: 194 NDLYLSNNKLTGAMPNLTGLSV-LSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLK 252
LYL N L+ L YL +++N + L ++ +
Sbjct: 204 MTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPL--WAWLQKFRGSSSEVP 261
Query: 253 GQIPADLFSIPHLQTVVMKTNELNG 277
+P L + + N+L G
Sbjct: 262 CSLPQRLAGRDLKR---LAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.7 bits (114), Expect = 1e-06
Identities = 39/252 (15%), Positives = 72/252 (28%), Gaps = 23/252 (9%)
Query: 48 VGCSFSG--PIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIP 105
C G +P I + + L+ N S S NL L L N L
Sbjct: 16 TSCPQQGLQAVPVGIPA--ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDA 73
Query: 106 VSDGNSPGLDMLVRAKHFHFGK------------------NQLSGSIPEKLFRPDMVLIH 147
+ L+ L + + + LFR L +
Sbjct: 74 AAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQY 133
Query: 148 VLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAM 207
+ N L T + +L + N +S L S++ L L N++
Sbjct: 134 LYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVH 193
Query: 208 PNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQT 267
P+ + ++ + +++L L + + A LQ
Sbjct: 194 PHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPL-WAWLQK 252
Query: 268 VVMKTNELNGTL 279
++E+ +L
Sbjct: 253 FRGSSSEVPCSL 264
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.9 bits (112), Expect = 2e-06
Identities = 31/157 (19%), Positives = 54/157 (34%), Gaps = 12/157 (7%)
Query: 1 MGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSI 60
L+ L L L L N+ + L L L+L + P +
Sbjct: 139 NALQALPDDTFRDLGNLTHLFLHGNR-ISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAF 197
Query: 61 GSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRA 120
L L+ L L +N S ++ L L +L L DN + +
Sbjct: 198 RDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-------RPLWAWL 250
Query: 121 KHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTG 157
+ F +++ S+P++L L + +N+L G
Sbjct: 251 QKFRGSSSEVPCSLPQRLA--GRDLKRL--AANDLQG 283
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 64.7 bits (156), Expect = 6e-12
Identities = 37/213 (17%), Positives = 67/213 (31%), Gaps = 18/213 (8%)
Query: 40 KKLSNLMLVGCSFSG--PIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTD 97
K+++ + V C +P + + +L L+ N ++ + L L+L
Sbjct: 7 SKVASHLEVNCDKRNLTALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLNLDR 64
Query: 98 NKLE--------------GEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDM 143
+L + P L + A S+P R
Sbjct: 65 AELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLG 124
Query: 144 VLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKL 203
L + N L P L LE + N+L+ LN L +++ L L N L
Sbjct: 125 ELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSL 184
Query: 204 TGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFS 236
G +L + + N + + +F
Sbjct: 185 YTIPKGFFGSHLLPFAFLHGNPWLCNCEILYFR 217
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 64.4 bits (155), Expect = 1e-11
Identities = 43/232 (18%), Positives = 81/232 (34%), Gaps = 5/232 (2%)
Query: 5 GQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQ 64
Q + + +DLSN+ L + KL NL L G S PI +++
Sbjct: 36 DQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNS 95
Query: 65 ELVLLSL--NSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKH 122
LV L+L S + + + S L L+L+ E V + + + +
Sbjct: 96 NLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNL 155
Query: 123 FHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDR-NSLSG 181
+ KN + + R ++ L DS L + + L+ + R +
Sbjct: 156 SGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIP 215
Query: 182 PVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPS 233
L + ++ L + G + L L +L ++ + F P+
Sbjct: 216 ETLLELGEIPTLKTLQVFGIVPDGTLQLL--KEALPHLQINCSHFTTIARPT 265
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.3 bits (134), Expect = 5e-09
Identities = 40/255 (15%), Positives = 71/255 (27%), Gaps = 11/255 (4%)
Query: 18 HTLDLSNNKDLRGPLPTTIGNL--KKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNG 75
TLDL+ P G L + + P+ + + + + L+++
Sbjct: 3 QTLDLTGKNLH----PDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFR-VQHMDLSNSV 57
Query: 76 FSGRVPPSI-GNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDML--VRAKHFHFGKNQLSG 132
I S L L L +L I + + L L F Q
Sbjct: 58 IEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLL 117
Query: 133 SIPEKLFRPDMVLIHVLFDSNNLTG-ELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLT 191
S +L ++ + + + +L R +
Sbjct: 118 SSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNL 177
Query: 192 SVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNL 251
DL S L+ L +L +S E + +L TL +
Sbjct: 178 VHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVP 237
Query: 252 KGQIPADLFSIPHLQ 266
G + ++PHLQ
Sbjct: 238 DGTLQLLKEALPHLQ 252
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.7 bits (130), Expect = 2e-08
Identities = 27/204 (13%), Positives = 57/204 (27%), Gaps = 4/204 (1%)
Query: 177 NSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFS 236
+L V L + V + + + + ++D+SN+ + S + S
Sbjct: 10 KNLHPDVTGRLLSQ-GVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILS 68
Query: 237 SMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENLLVNLQNN 296
L L +E L I L +L + + +G + + L
Sbjct: 69 QCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGC--SGFSEFALQTLLSSCSRLDEL 126
Query: 297 RISAYTERGGAPAVNLTLIDNPICQELGTAKGYCQLSQPISPYSTKQKNCLPAPCNANQS 356
+S + + GY + Q + ++ + + S
Sbjct: 127 NLSWCFDFTEKHVQV-AVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDS 185
Query: 357 SSPNCQCAYPYTGTLVFRSLSFSD 380
C + + LS S
Sbjct: 186 VMLKNDCFQEFFQLNYLQHLSLSR 209
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.3 bits (103), Expect = 3e-05
Identities = 20/80 (25%), Positives = 30/80 (37%), Gaps = 3/80 (3%)
Query: 11 ITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLS 70
L L L LS D+ +G + L L + G G + +L L
Sbjct: 196 FFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPHL---Q 252
Query: 71 LNSNGFSGRVPPSIGNLSNL 90
+N + F+ P+IGN N
Sbjct: 253 INCSHFTTIARPTIGNKKNQ 272
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 54.3 bits (129), Expect = 1e-08
Identities = 32/217 (14%), Positives = 66/217 (30%), Gaps = 38/217 (17%)
Query: 38 NLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTD 97
L + + + + + L + LS G + + L+NL L+L D
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTT--IEGVQYLNNLIGLELKD 72
Query: 98 NKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTG 157
N++ P+ + L + SI + +
Sbjct: 73 NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132
Query: 158 EL-------------------------------PATLGLVKSLEVVRFDRNSLSGPVPSN 186
L L + L ++ D N +S P
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP-- 190
Query: 187 LNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSN 223
L +L ++ +++L NN+++ + L S L + ++N
Sbjct: 191 LASLPNLIEVHLKNNQISD-VSPLANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 40.4 bits (93), Expect = 4e-04
Identities = 19/62 (30%), Positives = 29/62 (46%), Gaps = 4/62 (6%)
Query: 36 IGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDL 95
+ NL KL+ L S P + SL L+ + L +N S + N SNL+ + L
Sbjct: 169 LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISD--VSPLANTSNLFIVTL 224
Query: 96 TD 97
T+
Sbjct: 225 TN 226
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 51.2 bits (121), Expect = 1e-07
Identities = 38/208 (18%), Positives = 69/208 (33%), Gaps = 22/208 (10%)
Query: 31 PLPTTIG------NLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSI 84
+PT I + L S + + + L + + N++ I
Sbjct: 9 TVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKS--VQGI 64
Query: 85 GNLSNLYWLDLTDNKLEGEIPVSD---------GNSPGLDMLVRAKHFHFGKNQLSGSIP 135
L N+ L L NKL P+++ + D+ L +
Sbjct: 65 QYLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGI 124
Query: 136 EKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVND 195
+ + N L + L+ + + N +S VP L LT + +
Sbjct: 125 SDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQN 182
Query: 196 LYLSNNKLTGAMPNLTGLSVLSYLDMSN 223
LYLS N ++ + L GL L L++ +
Sbjct: 183 LYLSKNHISD-LRALAGLKNLDVLELFS 209
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 47.0 bits (111), Expect = 6e-07
Identities = 26/124 (20%), Positives = 41/124 (33%), Gaps = 27/124 (21%)
Query: 171 VVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVL-------------- 216
V+ L+ V +L L V L LS+N+L P L L L
Sbjct: 2 VLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVD 59
Query: 217 --------SYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQ--IPADLFS-IPHL 265
L + NN S S L L ++ +L + I L +P +
Sbjct: 60 GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSV 119
Query: 266 QTVV 269
+++
Sbjct: 120 SSIL 123
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 41.6 bits (97), Expect = 5e-05
Identities = 22/96 (22%), Positives = 35/96 (36%), Gaps = 7/96 (7%)
Query: 10 DITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLV-GCSFSGPIPDSIGSLQELVL 68
+ L + LDLS+N+ L L L L ++ + D + +L L
Sbjct: 15 HLEQLLLVTHLDLSHNR-----LRALPPALAALRCLEVLQASDNALENVDGVANLPRLQE 69
Query: 69 LSLNSNGF-SGRVPPSIGNLSNLYWLDLTDNKLEGE 103
L L +N + + L L+L N L E
Sbjct: 70 LLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 40.1 bits (93), Expect = 1e-04
Identities = 23/155 (14%), Positives = 38/155 (24%), Gaps = 45/155 (29%)
Query: 69 LSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKN 128
L L + V + L + LDL+ N+L P L L + N
Sbjct: 3 LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLR-------ALPPALAALRCLEVLQASDN 53
Query: 129 QLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLN 188
L L+ +N L L
Sbjct: 54 ALENVDGVANLPRLQELL---LCNNRLQ-----------------------QSAAIQPLV 87
Query: 189 NLTSVNDLYLSNNKLTG----------AMPNLTGL 213
+ + L L N L +P+++ +
Sbjct: 88 SCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 122
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 36.2 bits (83), Expect = 0.003
Identities = 20/119 (16%), Positives = 38/119 (31%), Gaps = 27/119 (22%)
Query: 152 SNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPS--NLNNLTSVN--------------- 194
+LT L + + + N L P+ L L +
Sbjct: 7 HKDLTV--LCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDGVANL 64
Query: 195 ----DLYLSNNKLTG--AMPNLTGLSVLSYLDMSNNSF--DASEVPSWFSSMQSLTTLM 245
+L L NN+L A+ L L L++ NS + + S+++++
Sbjct: 65 PRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSIL 123
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.2 bits (115), Expect = 1e-06
Identities = 13/89 (14%), Positives = 28/89 (31%), Gaps = 9/89 (10%)
Query: 16 ELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSG----PIPDSIGSLQELVLLSL 71
++ +LD+ + + L++ + L C + I ++ L L+L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 72 NSNGFSGRVPPSIG-----NLSNLYWLDL 95
SN + + L L
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSL 91
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.9 bits (96), Expect = 3e-04
Identities = 15/98 (15%), Positives = 38/98 (38%), Gaps = 13/98 (13%)
Query: 184 PSNLNNLTSVNDLYLSNNKLTGAMPN-----LTGLSVLSYLDMSNNSFDASEVPSWFSSM 238
+ + L+L++ ++ + + L L LD+SNN + + S+
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421
Query: 239 QS----LTTLMMENTNLKGQIPADLFSI----PHLQTV 268
+ L L++ + ++ L ++ P L+ +
Sbjct: 422 RQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 459
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (93), Expect = 6e-04
Identities = 24/110 (21%), Positives = 44/110 (40%), Gaps = 11/110 (10%)
Query: 152 SNNLTGE-LPATLGLVKSLEVVRFDRNSLSG----PVPSNLNNLTSVNDLYLSNNKLT-- 204
L+ L L++ +VVR D L+ + S L ++ +L L +N+L
Sbjct: 11 CEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDV 70
Query: 205 GAMPNLTGLSV----LSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTN 250
G L GL + L + N + S++++L TL + +
Sbjct: 71 GVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLS 120
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.2 bits (89), Expect = 0.002
Identities = 17/103 (16%), Positives = 33/103 (32%), Gaps = 17/103 (16%)
Query: 160 PATLGLVKSLEVVRFDRNSLSG----PVPSNLNNLTSVNDLYLSNNKLT--GAMPNLTGL 213
L V+ +S + + L S+ +L LSNN L G + + +
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421
Query: 214 ----SVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLK 252
+L L + + + L L + +L+
Sbjct: 422 RQPGCLLEQLVLYDIYWSE-------EMEDRLQALEKDKPSLR 457
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.8 bits (88), Expect = 0.003
Identities = 10/78 (12%), Positives = 24/78 (30%), Gaps = 8/78 (10%)
Query: 189 NLTSVNDLYLSNNKLTGAMPN--LTGLSVLSYLDMSNNSF---DASEVPSWFSSMQSLTT 243
++ S L + +L+ A L L + + + ++ S +L
Sbjct: 3 DIQS---LDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAE 59
Query: 244 LMMENTNLKGQIPADLFS 261
L + + L +
Sbjct: 60 LNLRSNELGDVGVHCVLQ 77
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 46.7 bits (109), Expect = 7e-06
Identities = 27/93 (29%), Positives = 42/93 (45%), Gaps = 9/93 (9%)
Query: 174 FDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPS 233
+ N+ S + S + S+ +L +SNNKL +P L L L S N +EVP
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPAL--PPRLERLIASFNHL--AEVP- 320
Query: 234 WFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQ 266
Q+L L +E L+ + P S+ L+
Sbjct: 321 --ELPQNLKQLHVEYNPLR-EFPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 46.7 bits (109), Expect = 8e-06
Identities = 16/78 (20%), Positives = 31/78 (39%), Gaps = 10/78 (12%)
Query: 14 LTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNS 73
L L++SNNK + LP L++L + +P+ +L++ L +
Sbjct: 283 PPSLEELNVSNNKLIE--LPALPPRLERLI---ASFNHLAE-VPELPQNLKQ---LHVEY 333
Query: 74 NGFSGRVPPSIGNLSNLY 91
N P ++ +L
Sbjct: 334 NPLRE-FPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 38.3 bits (87), Expect = 0.004
Identities = 14/61 (22%), Positives = 21/61 (34%), Gaps = 6/61 (9%)
Query: 6 QLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQE 65
+L L L S N +P NLK+L + PD S+++
Sbjct: 295 KLIELPALPPRLERLIASFNHLAE--VPELPQNLKQLH---VEYNPLRE-FPDIPESVED 348
Query: 66 L 66
L
Sbjct: 349 L 349
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.6 bits (101), Expect = 2e-05
Identities = 20/139 (14%), Positives = 39/139 (28%)
Query: 128 NQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNL 187
+ L + + + + +L L + L + ++ L P
Sbjct: 17 RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAF 76
Query: 188 NNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMME 247
+ ++ L LS N L L L +S N S W + +
Sbjct: 77 HFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVP 136
Query: 248 NTNLKGQIPADLFSIPHLQ 266
L+ L +P+
Sbjct: 137 EQKLQCHGQGPLAHMPNAS 155
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.5 bits (85), Expect = 0.002
Identities = 17/116 (14%), Positives = 38/116 (32%), Gaps = 5/116 (4%)
Query: 168 SLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLT--GLSVLSYLDMSNNS 225
+R R+ +L ++ +LY+ N + + GL L L + +
Sbjct: 9 GSSGLRCTRDGALD-SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSG 67
Query: 226 FDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDL 281
++ + + + N + LQ +V+ N L+ + L
Sbjct: 68 LRFVAPDAFHFTPRLSRLNLSFNALE--SLSWKTVQGLSLQELVLSGNPLHCSCAL 121
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 44.3 bits (103), Expect = 2e-05
Identities = 26/189 (13%), Positives = 65/189 (34%), Gaps = 12/189 (6%)
Query: 38 NLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTD 97
L + +L + + + + L ++ L + G + L+NL ++ ++
Sbjct: 16 ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSN 71
Query: 98 NKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTG 157
N+L P+ + ++ + ++ + + +
Sbjct: 72 NQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLN 131
Query: 158 ELPATLGLVKSLEVVRFDRNSLSGPVPSN-------LNNLTSVNDLYLSNNKLTGAMPNL 210
L + + + + + SN L NLT++ L +S+NK++ + L
Sbjct: 132 RLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDISSNKVSD-ISVL 190
Query: 211 TGLSVLSYL 219
L+ L L
Sbjct: 191 AKLTNLESL 199
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 41.7 bits (96), Expect = 1e-04
Identities = 26/165 (15%), Positives = 51/165 (30%), Gaps = 11/165 (6%)
Query: 15 TELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSN 74
L L++N+ R G L L L L +G P++ + L L N
Sbjct: 29 LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN 88
Query: 75 GFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSI 134
L L L+L DN++ +P S + L + N + +
Sbjct: 89 KIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLT------SLNLASNPFNCNC 142
Query: 135 PEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSL 179
F + + + P+ + + +++ +
Sbjct: 143 HLAWFAEWLRKKSL--NGGAARCGAPSKV---RDVQIKDLPHSEF 182
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 39.4 bits (90), Expect = 7e-04
Identities = 22/102 (21%), Positives = 42/102 (41%), Gaps = 5/102 (4%)
Query: 8 SGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELV 67
+ GL +L TL+L +N+ + +P + +L L++L L F+ + L
Sbjct: 95 NKMFLGLHQLKTLNLYDNQ-ISCVMPGSFEHLNSLTSLNLASNPFNC-NCHLAWFAEWLR 152
Query: 68 LLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDG 109
SLN P + ++ DL ++ + S+G
Sbjct: 153 KKSLNGGAARCGAPSK---VRDVQIKDLPHSEFKCSSENSEG 191
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.5 bits (91), Expect = 5e-04
Identities = 19/93 (20%), Positives = 36/93 (38%), Gaps = 5/93 (5%)
Query: 185 SNLNNLTSVNDLYLSNNKLTGAMPNL-TGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTT 243
+ N +L L K+ + NL L +D S+N + F ++ L T
Sbjct: 12 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLD---GFPLLRRLKT 67
Query: 244 LMMENTNLKGQIPADLFSIPHLQTVVMKTNELN 276
L++ N + ++P L +++ N L
Sbjct: 68 LLVNNNRICRIGEGLDQALPDLTELILTNNSLV 100
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.5 bits (86), Expect = 0.002
Identities = 21/139 (15%), Positives = 41/139 (29%), Gaps = 3/139 (2%)
Query: 158 ELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLS 217
+L + D L +L L ++ + L
Sbjct: 11 QLKLIMSKRYDGSQQALDLKGL--RSDPDLVAQNIDVVLNRRSSMAATLRIIEENIPELL 68
Query: 218 YLDMSNNSF-DASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELN 276
L++SNN ++ S +L L + LK + D L+ + + N L+
Sbjct: 69 SLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLS 128
Query: 277 GTLDLGTSYSENLLVNLQN 295
T ++Y +
Sbjct: 129 DTFRDQSTYISAIRERFPK 147
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 882 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 100.0 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 100.0 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 100.0 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 100.0 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 100.0 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 100.0 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.97 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.97 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.95 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.92 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.91 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.91 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.9 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.89 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.89 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.88 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.88 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.87 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.86 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.86 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.85 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.84 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.77 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.77 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.72 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.71 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.71 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.7 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.7 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.65 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.62 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.61 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.56 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.54 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 99.19 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.86 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.82 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.67 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.49 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 98.06 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 98.01 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 98.0 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.97 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 97.18 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=387.40 Aligned_cols=258 Identities=27% Similarity=0.466 Sum_probs=215.7
Q ss_pred CCCCCCCEEECCCCEEEEEEEECCCCEEEEEECCCCCCCCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEEEEEEC
Q ss_conf 19997780202573799999936995899997246985408999999999971367870139888971793699998206
Q 002774 555 NNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVP 634 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 634 (882)
++|...+.||+|+||+||+|++.+++.||||+++... ...++|.+|+.++++++|||||+++|+|.+++..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHCEEEEEEEECCCEEEEEEEECCCCEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCCCCCCCEECCCCCEEEEEEECC
T ss_conf 9958888982088829999998899999999987886-768999999999996689975653524315993379998369
Q ss_pred CCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCCEE
Q ss_conf 99856656889886553999999999999987531102799833058888766986899456940466511589988502
Q 002774 635 NGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHI 714 (882)
Q Consensus 635 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 714 (882)
+|+|.+++.... ..+++..+..++.|+|.||.|||+.+ |+||||||+|||+++++.+||+|||+|+....... ..
T Consensus 84 ~g~L~~~l~~~~-~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~-~~ 158 (263)
T d1sm2a_ 84 HGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TS 158 (263)
T ss_dssp TCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC-------------
T ss_pred CCCHHHHHHCCC-CCCCHHHHHHHHHHHHHHHHHHHCCC---EEECCCCHHHEEECCCCCEEECCCCHHEECCCCCC-EE
T ss_conf 991899752013-47889999999999999877653164---31044315326666887768655321002368873-35
Q ss_pred EEEEECCCCCCCHHHHHHCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCC
Q ss_conf 33333068988977773099995567899999999999499987778007999999997544210010003886899889
Q 002774 715 TTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTT 794 (882)
Q Consensus 715 ~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 794 (882)
.....||+.|+|||++.+..++.++|||||||++|||+|++.|+............+.... .... +
T Consensus 159 ~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~-------~~~~-------p 224 (263)
T d1sm2a_ 159 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF-------RLYK-------P 224 (263)
T ss_dssp ------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTC-------CCCC-------C
T ss_pred ECCEECCCCCCCHHHHCCCCCCCHHHHCCHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCC-------CCCC-------C
T ss_conf 0430017666785786079998403321059999999878988877899999999998068-------8899-------5
Q ss_pred HHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 88899999999980002999999999999999999997
Q 002774 795 LKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 832 (882)
Q Consensus 795 ~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~ 832 (882)
..++.++.+++.+||+.||++||||+|++++|+++.+.
T Consensus 225 ~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 225 RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf 43679999999997657976891999999999999857
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=387.71 Aligned_cols=259 Identities=29% Similarity=0.442 Sum_probs=216.0
Q ss_pred HCCCCCCCEEECCCCEEEEEEEECCCCEEEEEECCCCCCCCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEEEEEE
Q ss_conf 71999778020257379999993699589999724698540899999999997136787013988897179369999820
Q 002774 554 TNNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFV 633 (882)
Q Consensus 554 ~~~~~~~~~lG~G~fg~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 633 (882)
.++|...+.||+|+||+||+|++++++.||||+++... ...+.|.+|+.++++++|||||+++|++.+ +..++||||+
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~ 89 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HHHEEEEEEEECCCCCEEEEEEECCCCEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCEEEEEEEECC-CCEEEEEEEC
T ss_conf 89938867981079828999999999999999986476-888999999999986799988578731045-9769999957
Q ss_pred CCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCCE
Q ss_conf 69985665688988655399999999999998753110279983305888876698689945694046651158998850
Q 002774 634 PNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDH 713 (882)
Q Consensus 634 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 713 (882)
++|+|.+++.......+++..++.|+.||++||.|||+.+ |+||||||+|||+++++.+||+|||+|+....... .
T Consensus 90 ~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~-~ 165 (272)
T d1qpca_ 90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-T 165 (272)
T ss_dssp TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE-E
T ss_pred CCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEEECCCCEEECCCCCEEECCCCCC-C
T ss_conf 8982888875147898878899999999999999997489---54675642251562024404234101477358864-4
Q ss_pred EEEEEECCCCCCCHHHHHHCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 23333306898897777309999556789999999999949998777800799999999754421001000388689988
Q 002774 714 ITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLST 793 (882)
Q Consensus 714 ~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 793 (882)
......||+.|+|||++.++.++.++|||||||++|||+||+.|+.......+....+... ..+ ..
T Consensus 166 ~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~----------~~~----~~ 231 (272)
T d1qpca_ 166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG----------YRM----VR 231 (272)
T ss_dssp CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT----------CCC----CC
T ss_pred CCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHC----------CCC----CC
T ss_conf 2035677444458289837999824564525799999996898888888999999999706----------888----89
Q ss_pred CHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 988899999999980002999999999999999999997
Q 002774 794 TLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 832 (882)
Q Consensus 794 ~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~ 832 (882)
+...+.++.+++.+||+.||++||||+++++.|+.++..
T Consensus 232 p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 232 PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf 655719999999997588976893999999986113213
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=389.62 Aligned_cols=260 Identities=28% Similarity=0.417 Sum_probs=218.3
Q ss_pred HCCCCCCCEEECCCCEEEEEEEEC-CCCEEEEEECCCCCCCCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEEEEE
Q ss_conf 719997780202573799999936-9958999972469854089999999999713678701398889717936999982
Q 002774 554 TNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEF 632 (882)
Q Consensus 554 ~~~~~~~~~lG~G~fg~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 632 (882)
.++|...+.||+|+||+||+|++. +++.||||+++... ...++|.+|+.++++++|||||+++|+|.+++..++||||
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 94 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 94 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEEECCCC-CHHHHHHHHHHHHHHCCCCCEECCCCCEEECCEEEEEEEC
T ss_conf 799398659820888089999999999699999977761-0399999999999867999882677527457854787631
Q ss_pred ECCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCC
Q ss_conf 06998566568898865539999999999999875311027998330588887669868994569404665115899885
Q 002774 633 VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKD 712 (882)
Q Consensus 633 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NIll~~~~~~kl~DfGla~~~~~~~~~ 712 (882)
+++|+|.+++.......+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+|+.......
T Consensus 95 ~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~- 170 (287)
T d1opja_ 95 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY- 170 (287)
T ss_dssp CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS-
T ss_pred CCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEECCCCCEEECCCCCEEECCCCCC-
T ss_conf 46760677753035541579999999999999788898789---30576045768998999289832445465378872-
Q ss_pred EEEEEEECCCCCCCHHHHHHCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 02333330689889777730999955678999999999994999877780079999999975442100100038868998
Q 002774 713 HITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLS 792 (882)
Q Consensus 713 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 792 (882)
.......|++.|+|||++.++.++.++|||||||++|||++|+.|+..+.........+... ....
T Consensus 171 ~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~--------------~~~~ 236 (287)
T d1opja_ 171 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD--------------YRME 236 (287)
T ss_dssp EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT--------------CCCC
T ss_pred EEECCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCC--------------CCCC
T ss_conf 21035566546669278727999810430217899999986799887742599999998558--------------8888
Q ss_pred CCHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 8988899999999980002999999999999999999997
Q 002774 793 TTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 832 (882)
Q Consensus 793 ~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~ 832 (882)
.+...+.++.+|+.+||+.||.+|||++++++.|+.+.++
T Consensus 237 ~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~ 276 (287)
T d1opja_ 237 RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276 (287)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred CCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHH
T ss_conf 8743309999999997577976893999999999999875
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=384.81 Aligned_cols=262 Identities=28% Similarity=0.472 Sum_probs=212.4
Q ss_pred HCCCCCCCEEECCCCEEEEEEEECCCCEEEEEECCCCC--CCCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEEEE
Q ss_conf 71999778020257379999993699589999724698--5408999999999971367870139888971793699998
Q 002774 554 TNNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGS--MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYE 631 (882)
Q Consensus 554 ~~~~~~~~~lG~G~fg~Vy~a~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e 631 (882)
.++|...+.||+|+||+||+|+++ ..||||+++... ....+.|.+|+.++++++|||||+++|++.+ +..++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred CCCEEEEEEEEECCCCEEEEEEEC--CEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC-CEEEEEEE
T ss_conf 451899889830788589999999--989999997346998999999999999984799878645679715-58999996
Q ss_pred EECCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCC
Q ss_conf 20699856656889886553999999999999987531102799833058888766986899456940466511589988
Q 002774 632 FVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEK 711 (882)
Q Consensus 632 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NIll~~~~~~kl~DfGla~~~~~~~~ 711 (882)
|+++|+|.++++... ..+++..+..++.|+|.||+|||+.+ |+||||||+|||++.++.+||+|||+|+.......
T Consensus 84 y~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~ 159 (276)
T d1uwha_ 84 WCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG 159 (276)
T ss_dssp CCCEEEHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC------
T ss_pred CCCCCCHHHHHHHCC-CCCCHHHHHHHHHHHHHHHHHHHCCC---EECCCCCHHHEEECCCCCEEECCCCCEEECCCCCC
T ss_conf 589988899985235-78999999999999999988875099---95161478997981899788750022133355677
Q ss_pred CEEEEEEECCCCCCCHHHHHH---CCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCC
Q ss_conf 502333330689889777730---99995567899999999999499987778007999999997544210010003886
Q 002774 712 DHITTQVKGTMGYLDPEYYMT---QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPT 788 (882)
Q Consensus 712 ~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDVwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 788 (882)
........||+.|||||++.+ ..++.++|||||||++|||+||+.||................ . ..|.
T Consensus 160 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~-~--------~~p~ 230 (276)
T d1uwha_ 160 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRG-Y--------LSPD 230 (276)
T ss_dssp ------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHT-S--------CCCC
T ss_pred CCCCCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCC-C--------CCCC
T ss_conf 631256655743179999950568999953151635999999997889989989699999999658-8--------8986
Q ss_pred CCCCCCHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 89988988899999999980002999999999999999999997
Q 002774 789 IGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 832 (882)
Q Consensus 789 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~ 832 (882)
. .......+.++.+++.+||+.||.+||||+|++++|+.+.+.
T Consensus 231 ~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~ 273 (276)
T d1uwha_ 231 L-SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273 (276)
T ss_dssp G-GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred C-HHCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf 0-003655549999999997588976892999999999999970
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=386.52 Aligned_cols=258 Identities=28% Similarity=0.490 Sum_probs=210.5
Q ss_pred CCCCCCEEECCCCEEEEEEEEC-CC---CEEEEEECCCCCC-CCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEEE
Q ss_conf 9997780202573799999936-99---5899997246985-40899999999997136787013988897179369999
Q 002774 556 NFSDANDVGSGGYGKVYKGTLP-NG---QLIAIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIY 630 (882)
Q Consensus 556 ~~~~~~~lG~G~fg~Vy~a~~~-~g---~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 630 (882)
+|...+.||+|+||+||+|++. ++ ..||||++..... ...+.|.+|+.+|++++|||||+++|+|.+++..++||
T Consensus 27 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~ 106 (299)
T d1jpaa_ 27 CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIIT 106 (299)
T ss_dssp GEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred HCEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEE
T ss_conf 42785698027882999999957997889999999784459899999999999998579988861899996288779999
Q ss_pred EEECCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCC
Q ss_conf 82069985665688988655399999999999998753110279983305888876698689945694046651158998
Q 002774 631 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE 710 (882)
Q Consensus 631 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NIll~~~~~~kl~DfGla~~~~~~~ 710 (882)
||+++|+|.+++.... ..++|.++..++.|+|+||.|||+.+ |+||||||+|||++.++.+||+|||+|+......
T Consensus 107 Ey~~~g~L~~~~~~~~-~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~ 182 (299)
T d1jpaa_ 107 EFMENGSLDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182 (299)
T ss_dssp ECCTTEEHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EECCCCCCEEEECCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEECCCCCEEECCCCCCEECCCCC
T ss_conf 7227985300210456-79999999999999999889885279---8357615044898899919988844315756777
Q ss_pred CCEE---EEEEECCCCCCCHHHHHHCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCC
Q ss_conf 8502---333330689889777730999955678999999999994-999877780079999999975442100100038
Q 002774 711 KDHI---TTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELID 786 (882)
Q Consensus 711 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 786 (882)
.... .....||+.|||||.+.++.++.++|||||||++|||+| |+.||..... .+....+...
T Consensus 183 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~-~~~~~~i~~~------------ 249 (299)
T d1jpaa_ 183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN-QDVINAIEQD------------ 249 (299)
T ss_dssp -------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-HHHHHHHHTT------------
T ss_pred CCCEEEECCCCCCCCCCCCHHHHHCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCH-HHHHHHHHCC------------
T ss_conf 765365025666883003878883699786121445357899998679999999999-9999999737------------
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 8689988988899999999980002999999999999999999997
Q 002774 787 PTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 832 (882)
Q Consensus 787 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~ 832 (882)
.....+...+..+.+++.+||+.||++||||.|+++.|+++++.
T Consensus 250 --~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 250 --YRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp --CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred --CCCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHCC
T ss_conf --88999742269999999997587976892999999999998418
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=382.41 Aligned_cols=254 Identities=26% Similarity=0.398 Sum_probs=210.0
Q ss_pred HCCCCCCCEEECCCCEEEEEEEEC-CCCEEEEEECCCCCC-CCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEEEE
Q ss_conf 719997780202573799999936-995899997246985-408999999999971367870139888971793699998
Q 002774 554 TNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYE 631 (882)
Q Consensus 554 ~~~~~~~~~lG~G~fg~Vy~a~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e 631 (882)
.++|...+.||+|+||+||+|+.. +|+.||||++..... ...+.+.+|++++++++|||||++++++.+++..++|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCEEEEEEE
T ss_conf 74608998972174809999999999979999998456641279999999999985799888469654046743679886
Q ss_pred EECCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCC
Q ss_conf 20699856656889886553999999999999987531102799833058888766986899456940466511589988
Q 002774 632 FVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEK 711 (882)
Q Consensus 632 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NIll~~~~~~kl~DfGla~~~~~~~~ 711 (882)
|+++|+|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+|+.......
T Consensus 84 y~~gg~L~~~l~~~~--~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~ 158 (271)
T d1nvra_ 84 YCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 158 (271)
T ss_dssp CCTTEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred CCCCCCHHHHHHCCC--CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEECCCCCEEECCCHHHEEECCCCC
T ss_conf 458980899975379--9999999999999999999999759---83575468997887899879832314224046886
Q ss_pred CEEEEEEECCCCCCCHHHHHHCCC-CCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCC
Q ss_conf 502333330689889777730999-9556789999999999949998777800799999999754421001000388689
Q 002774 712 DHITTQVKGTMGYLDPEYYMTQQL-TEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIG 790 (882)
Q Consensus 712 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDVwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 790 (882)
.......+||+.|||||++.+..+ +.++||||+||++|||++|+.||.................. .
T Consensus 159 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~-------------~ 225 (271)
T d1nvra_ 159 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT-------------Y 225 (271)
T ss_dssp ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCT-------------T
T ss_pred CCCCCCEEECCCCCCHHHHCCCCCCCCCEEEEHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCC-------------C
T ss_conf 531113255747428728618999997101617379999998299788889859999999863888-------------7
Q ss_pred CCCCHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH
Q ss_conf 98898889999999998000299999999999999
Q 002774 791 LSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 791 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 825 (882)
.........++.+|+.+||+.||.+|||++|++++
T Consensus 226 ~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 226 LNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 88644699999999999767996689099999619
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=379.79 Aligned_cols=258 Identities=23% Similarity=0.390 Sum_probs=211.7
Q ss_pred HCCCCCCCEEECCCCEEEEEEEECC-C-----CEEEEEECCCCC-CCCHHHHHHHHHHHHHC-CCCCEEEEEEEEEECCC
Q ss_conf 7199977802025737999999369-9-----589999724698-54089999999999713-67870139888971793
Q 002774 554 TNNFSDANDVGSGGYGKVYKGTLPN-G-----QLIAIKRAQQGS-MQGGQEFKMEIELLSRV-HHKNLVSLLGFCFDRGE 625 (882)
Q Consensus 554 ~~~~~~~~~lG~G~fg~Vy~a~~~~-g-----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~ 625 (882)
.++|...+.||+|+||+||+|++.. + ..||+|++.... ......+.+|+.++.++ +|||||++++++.+.+.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHEEEEEEEEECCCEEEEEEEECCCCCCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCE
T ss_conf 89939701983078819999998578855420499999966335878999999999999971589968687788862995
Q ss_pred EEEEEEEECCCCCCCCCCCCCC---------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCC
Q ss_conf 6999982069985665688988---------------------6553999999999999987531102799833058888
Q 002774 626 QMLIYEFVPNGSLGDSLSGKNG---------------------IRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKS 684 (882)
Q Consensus 626 ~~lV~e~~~~gsL~~~l~~~~~---------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~ 684 (882)
.++||||+++|+|.++++.... ..+++..++.++.|++.||.|||+.+ |+||||||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp 192 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAA 192 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSG
T ss_pred EEEEEECCCCCCHHHHHHHCCCCCCCHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCH
T ss_conf 899997279995999998625777510221000012220012577899999999999999999997399---05052703
Q ss_pred CCEEECCCCCEEEEECCCCCCCCCCCCCEEEEEEECCCCCCCHHHHHHCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCCH
Q ss_conf 766986899456940466511589988502333330689889777730999955678999999999994-9998777800
Q 002774 685 SNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKY 763 (882)
Q Consensus 685 ~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~il~ellt-g~~P~~~~~~ 763 (882)
+||+++.++.+||+|||+|+...............||+.|||||++.++.++.++|||||||++|||+| |+.||.....
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~ 272 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred HCCCCCCCCEEEEEECCCCCCCCCCCCEEEECCCCCCCCCCCHHHHCCCCCCCCEECCCHHHHHHHHHHCCCCCCCCCCH
T ss_conf 21443459828985142222045778615623435787657838872799996330300039999998389999999898
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHH
Q ss_conf 79999999975442100100038868998898889999999998000299999999999999999
Q 002774 764 IVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIEN 828 (882)
Q Consensus 764 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 828 (882)
... ....+.... ....+...+.++.+|+.+||+.||++|||++||+++|..
T Consensus 273 ~~~-~~~~~~~~~-------------~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 273 DAN-FYKLIQNGF-------------KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp SHH-HHHHHHTTC-------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHH-HHHHHHCCC-------------CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHC
T ss_conf 999-999985699-------------899887678999999999758896689399999999748
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=377.81 Aligned_cols=250 Identities=23% Similarity=0.390 Sum_probs=210.6
Q ss_pred CCCCCCCEEECCCCEEEEEEEE-CCCCEEEEEECCCCCCCCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEEEEEE
Q ss_conf 1999778020257379999993-699589999724698540899999999997136787013988897179369999820
Q 002774 555 NNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFV 633 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~a~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 633 (882)
++|...+.||+|+||+||+|+. .+|+.||||+++.......+.+.+|+.++++++|||||++++++.+++..++||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred CCCEEEEEEECCCCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEEEC
T ss_conf 05388789812858299999998999899999984301727999999999998679998805857798899989999703
Q ss_pred CCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCCE
Q ss_conf 69985665688988655399999999999998753110279983305888876698689945694046651158998850
Q 002774 634 PNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDH 713 (882)
Q Consensus 634 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 713 (882)
++|+|.+++... .+++.++..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.+.....
T Consensus 100 ~gg~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~-- 171 (293)
T d1yhwa1 100 AGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-- 171 (293)
T ss_dssp TTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC--
T ss_pred CCCCHHHHHHCC---CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEECCCCCEEECCCHHHEEECCCCC--
T ss_conf 798089886415---9999999999999999999999879---72267768886887899686425156413213666--
Q ss_pred EEEEEECCCCCCCHHHHHHCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 23333306898897777309999556789999999999949998777800799999999754421001000388689988
Q 002774 714 ITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLST 793 (882)
Q Consensus 714 ~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 793 (882)
......||+.|+|||++.+..++.++||||+||++|||++|+.||........ ......... +. ...
T Consensus 172 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-~~~~~~~~~----------~~--~~~ 238 (293)
T d1yhwa1 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-LYLIATNGT----------PE--LQN 238 (293)
T ss_dssp CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HHHHHHHCS----------CC--CSS
T ss_pred CCCCCCCCCCCCCHHHHCCCCCCCHHCEEHHHHHHHHHHHCCCCCCCCCHHHH-HHHHHHCCC----------CC--CCC
T ss_conf 44444447773682664479988012031372999998048899899799999-999985799----------98--888
Q ss_pred CHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH
Q ss_conf 98889999999998000299999999999999
Q 002774 794 TLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 794 ~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 825 (882)
+......+.+++.+||+.||.+|||++|++++
T Consensus 239 ~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 239 PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp GGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 55379999999999866996689099999649
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=0 Score=372.82 Aligned_cols=253 Identities=23% Similarity=0.326 Sum_probs=211.0
Q ss_pred HCCCCCCCEEECCCCEEEEEEEE-CCCCEEEEEECCCCCCCCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEEEEE
Q ss_conf 71999778020257379999993-69958999972469854089999999999713678701398889717936999982
Q 002774 554 TNNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEF 632 (882)
Q Consensus 554 ~~~~~~~~~lG~G~fg~Vy~a~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 632 (882)
-++|.+.+.||+|+||+||+|+. .+|+.||||++........+.+.+|+.++++++|||||++++++.+++..++||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEEC
T ss_conf 65758988984076819999998899989999998452431699999999999867997999299999989999999985
Q ss_pred ECCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC--CCCEEEEECCCCCCCCCCC
Q ss_conf 06998566568898865539999999999999875311027998330588887669868--9945694046651158998
Q 002774 633 VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDE--RLNAKVADFGLSKSMSDSE 710 (882)
Q Consensus 633 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NIll~~--~~~~kl~DfGla~~~~~~~ 710 (882)
+++|+|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+|+.+....
T Consensus 105 ~~gg~L~~~l~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 180 (350)
T d1koaa2 105 MSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 180 (350)
T ss_dssp CCSCBHHHHHTCTT-SCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred CCCCCHHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCC---CEEEEECHHHEEECCCCCCEEEEEECCHHEECCCCC
T ss_conf 79988999997623-78999999999999999999997569---760001546736416889869995452104425654
Q ss_pred CCEEEEEEECCCCCCCHHHHHHCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCC
Q ss_conf 85023333306898897777309999556789999999999949998777800799999999754421001000388689
Q 002774 711 KDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIG 790 (882)
Q Consensus 711 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 790 (882)
. .....||+.|||||++.+..++.++||||+||++|||++|+.||.... ..+....+..... ...
T Consensus 181 ~---~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~-~~~~~~~i~~~~~-----------~~~ 245 (350)
T d1koaa2 181 S---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN-DDETLRNVKSCDW-----------NMD 245 (350)
T ss_dssp C---EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHTCC-----------CSC
T ss_pred C---CCEECCCCCCCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCC-HHHHHHHHHHCCC-----------CCC
T ss_conf 3---200068624218899758998726765546599999985989989979-9999999984788-----------989
Q ss_pred CCCCHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH
Q ss_conf 98898889999999998000299999999999999
Q 002774 791 LSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 791 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 825 (882)
.........++.+|+.+||+.||.+|||++|++++
T Consensus 246 ~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 246 DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp CGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 42235899999999999756896679089998629
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=375.03 Aligned_cols=260 Identities=27% Similarity=0.450 Sum_probs=212.8
Q ss_pred CCCCCCCEEECCCCEEEEEEEECCC-----CEEEEEECCCCCCC-CHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEE
Q ss_conf 1999778020257379999993699-----58999972469854-08999999999971367870139888971793699
Q 002774 555 NNFSDANDVGSGGYGKVYKGTLPNG-----QLIAIKRAQQGSMQ-GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQML 628 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~a~~~~g-----~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 628 (882)
..|...+.||+|+||+||+|.++.. ..||||+++..... ....|.+|+.++++++|||||+++|++.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHEEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCEEE
T ss_conf 99686159811779099999996899878799999998844596899999999999985689878323677833880389
Q ss_pred EEEEECCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCC
Q ss_conf 99820699856656889886553999999999999987531102799833058888766986899456940466511589
Q 002774 629 IYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSD 708 (882)
Q Consensus 629 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NIll~~~~~~kl~DfGla~~~~~ 708 (882)
||||+.+|++.+.+.... ..+++.++..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.+..
T Consensus 87 v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 162 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 162 (283)
T ss_dssp EEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EEEECCCCCCHHHHHCCC-CCCCHHHHHHHHHHHHHHHHHCCCCC---CCCCCCCCCEEEECCCCEEEECCCCHHHCCCC
T ss_conf 997213574022210234-54208999999999998541212123---42576564427888998499845510300357
Q ss_pred CCC-CEEEEEEECCCCCCCHHHHHHCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Q ss_conf 988-5023333306898897777309999556789999999999949998777800799999999754421001000388
Q 002774 709 SEK-DHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDP 787 (882)
Q Consensus 709 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 787 (882)
... ........||+.|+|||++.++.++.++|||||||++|||++++.|+..+.........+...
T Consensus 163 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~------------- 229 (283)
T d1mqba_ 163 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG------------- 229 (283)
T ss_dssp -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT-------------
T ss_pred CCCCCEEECCCCCCCCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHCC-------------
T ss_conf 8765267426777734348888704999973556344898999996798865568999999998635-------------
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 689988988899999999980002999999999999999999997
Q 002774 788 TIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 832 (882)
Q Consensus 788 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~ 832 (882)
.....+...+.++.+++.+||+.||++||||.||++.|+.+.+.
T Consensus 230 -~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 230 -FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp -CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred -CCCCCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf -78998504579999999997767976893999999999998669
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=372.68 Aligned_cols=259 Identities=26% Similarity=0.423 Sum_probs=209.1
Q ss_pred CCCCCCC-EEECCCCEEEEEEEEC---CCCEEEEEECCCCCC-CCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEE
Q ss_conf 1999778-0202573799999936---995899997246985-4089999999999713678701398889717936999
Q 002774 555 NNFSDAN-DVGSGGYGKVYKGTLP---NGQLIAIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLI 629 (882)
Q Consensus 555 ~~~~~~~-~lG~G~fg~Vy~a~~~---~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 629 (882)
++|...+ +||+|+||+||+|.++ ++..||||+++.... ...+.|.+|++++++++|||||+++|+|.+ +..++|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred CCEEECCCEEECCCCEEEEEEEEECCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECC-CEEEEE
T ss_conf 4718878487306080999999960897689999998820397899999999999986799888068656036-807999
Q ss_pred EEEECCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCC
Q ss_conf 98206998566568898865539999999999999875311027998330588887669868994569404665115899
Q 002774 630 YEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDS 709 (882)
Q Consensus 630 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NIll~~~~~~kl~DfGla~~~~~~ 709 (882)
|||+++|+|.+++.... ..+++..+..++.|+|.||+|||+.+ |+||||||+||+++.++.+||+|||+|+.+...
T Consensus 87 mE~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~ 162 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 162 (285)
T ss_dssp EECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred EEECCCCCHHHHHHCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEECCCCCEEECCCHHHHCCCCC
T ss_conf 98078996899752125-69999999999999999878998688---105767646604546885420331342115543
Q ss_pred CCC-EEEEEEECCCCCCCHHHHHHCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Q ss_conf 885-02333330689889777730999955678999999999994-9998777800799999999754421001000388
Q 002774 710 EKD-HITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDP 787 (882)
Q Consensus 710 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 787 (882)
... .......||+.|+|||++.++.++.++|||||||++|||+| |+.||...... +....+ .... .
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~-~~~~~i-~~~~---------~- 230 (285)
T d1u59a_ 163 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-EVMAFI-EQGK---------R- 230 (285)
T ss_dssp SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH-HHHHHH-HTTC---------C-
T ss_pred CCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCCHH-HHHHHH-HCCC---------C-
T ss_conf 432113562113743358688727999954123220178999993899999997999-999999-8189---------9-
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHC
Q ss_conf 6899889888999999999800029999999999999999999971
Q 002774 788 TIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQA 833 (882)
Q Consensus 788 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~ 833 (882)
...+...+.++.+|+.+||+.||++||||.+|++.|+.+....
T Consensus 231 ---~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~ 273 (285)
T d1u59a_ 231 ---MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 273 (285)
T ss_dssp ---CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ---CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHH
T ss_conf ---9999767899999999975779768909999999999999985
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=0 Score=370.04 Aligned_cols=253 Identities=23% Similarity=0.350 Sum_probs=210.9
Q ss_pred HCCCCCCCEEECCCCEEEEEEEE-CCCCEEEEEECCCCCCCCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEEEEE
Q ss_conf 71999778020257379999993-69958999972469854089999999999713678701398889717936999982
Q 002774 554 TNNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEF 632 (882)
Q Consensus 554 ~~~~~~~~~lG~G~fg~Vy~a~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 632 (882)
.++|.+.+.||+|+||+||+|+. .+|+.||||+++.....+.+.+.+|+.++++++|||||++++++.+++..++||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEEC
T ss_conf 40359989993177829999999899979999998872646799999999999867997989199999989999999982
Q ss_pred ECCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC--CCCCEEEEECCCCCCCCCCC
Q ss_conf 0699856656889886553999999999999987531102799833058888766986--89945694046651158998
Q 002774 633 VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLD--ERLNAKVADFGLSKSMSDSE 710 (882)
Q Consensus 633 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NIll~--~~~~~kl~DfGla~~~~~~~ 710 (882)
+++|+|.+++... ..++++.++..++.||+.||.|||+.+ |+||||||+|||++ .++.+||+|||+|+.+....
T Consensus 108 ~~gg~L~~~~~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~ 183 (352)
T d1koba_ 108 LSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 183 (352)
T ss_dssp CCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred CCCCHHHHHHHHC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCCCCCCCCCCCCEEEEEECCCCEECCCCC
T ss_conf 8998088889863-899899999999999999999999779---265131445531134678848995256303437887
Q ss_pred CCEEEEEEECCCCCCCHHHHHHCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCC
Q ss_conf 85023333306898897777309999556789999999999949998777800799999999754421001000388689
Q 002774 711 KDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIG 790 (882)
Q Consensus 711 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 790 (882)
......||+.|+|||++.+..++.++||||+||++|||++|+.||...... .....+... +....
T Consensus 184 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-~~~~~i~~~-----------~~~~~ 248 (352)
T d1koba_ 184 ---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL-ETLQNVKRC-----------DWEFD 248 (352)
T ss_dssp ---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-HHHHHHHHC-----------CCCCC
T ss_pred ---CEEECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHC-----------CCCCC
T ss_conf ---201004764534899974799897633389899999999688998997999-999999847-----------88989
Q ss_pred CCCCHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH
Q ss_conf 98898889999999998000299999999999999
Q 002774 791 LSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 791 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 825 (882)
.......+.++.+|+.+||+.||.+|||++|++++
T Consensus 249 ~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 249 EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 30024799999999999756996689189999609
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=378.76 Aligned_cols=260 Identities=26% Similarity=0.410 Sum_probs=207.3
Q ss_pred HCCCCCCCEEECCCCEEEEEEEE-CCCCEEEEEECCCCC-CCCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEEEE
Q ss_conf 71999778020257379999993-699589999724698-5408999999999971367870139888971793699998
Q 002774 554 TNNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGS-MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYE 631 (882)
Q Consensus 554 ~~~~~~~~~lG~G~fg~Vy~a~~-~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e 631 (882)
.++|...+.||+|+||+||+|+. .+|+.||+|+++... ......+.+|+.++++++|||||++++++.+++..++|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEE
T ss_conf 56888978971277809999999899969999998754097899999999999986799999949999998999999997
Q ss_pred EECCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCC
Q ss_conf 2069985665688988655399999999999998753110-279983305888876698689945694046651158998
Q 002774 632 FVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHE-LANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE 710 (882)
Q Consensus 632 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDik~~NIll~~~~~~kl~DfGla~~~~~~~ 710 (882)
|+++|+|.+++...+ .+++..+..++.|++.||.|||+ .+ |+||||||+|||++.++.+||+|||+|+.+.+..
T Consensus 85 y~~gg~L~~~l~~~~--~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~ 159 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 159 (322)
T ss_dssp CCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT
T ss_pred CCCCCCHHHHHHHCC--CCCHHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEECCCCCEEEEECCCCCCCCCCC
T ss_conf 679986899874249--99999999999999999999998599---9714457799468789989995487762567886
Q ss_pred CCEEEEEEECCCCCCCHHHHHHCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHH---HHHH----------
Q ss_conf 850233333068988977773099995567899999999999499987778007999999997---5442----------
Q 002774 711 KDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMD---KKKE---------- 777 (882)
Q Consensus 711 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~il~elltg~~P~~~~~~~~~~~~~~~~---~~~~---------- 777 (882)
....+||+.|+|||++.+..|+.++||||+||++|||++|+.||............... ....
T Consensus 160 ----~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (322)
T d1s9ja_ 160 ----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 235 (322)
T ss_dssp ----C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------------
T ss_pred ----CCCCCCCCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCCC
T ss_conf ----2111377141194687589989488899899999999988899899887899999988751775457742123332
Q ss_pred ------------------HHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH
Q ss_conf ------------------100100038868998898889999999998000299999999999999
Q 002774 778 ------------------LYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 778 ------------------~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 825 (882)
.........+... ......++.+++.+||+.||.+|||++|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLP---SGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp ----------CCCCHHHHHHHHHTSCCCCCC---BTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCCCCCCCCCCHHHHHHHHHHHCCCCCCCC---CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHC
T ss_conf 2111122235413477887665026876676---44489999999999868994679089999609
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=371.40 Aligned_cols=253 Identities=28% Similarity=0.466 Sum_probs=212.4
Q ss_pred CCCCCCCEEECCCCEEEEEEEECCCCEEEEEECCCCCCCCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEEEEEEC
Q ss_conf 19997780202573799999936995899997246985408999999999971367870139888971793699998206
Q 002774 555 NNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVP 634 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 634 (882)
++|...+.||+|+||+||+|++++++.||||+++.... ..++|.+|+.++++++|||||+++|+|.+++..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCEEEEEEECCCCC-CHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEEEECCC
T ss_conf 99799689820788399999988998999999874757-78999999999996689860158899850781699997048
Q ss_pred CCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCCEE
Q ss_conf 99856656889886553999999999999987531102799833058888766986899456940466511589988502
Q 002774 635 NGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHI 714 (882)
Q Consensus 635 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 714 (882)
+|+|..++.... ..+++..+.+++.|+++||.|||+.+ |+||||||+||++++++.+||+|||+|+....... ..
T Consensus 83 ~g~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~-~~ 157 (258)
T d1k2pa_ 83 NGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-TS 157 (258)
T ss_dssp TEEHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC-CC
T ss_pred CCCHHHHHHCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCEEEEECCCCCEEECCCHHHEECCCCCC-EE
T ss_conf 993888641024-67768999999999999999875468---43466541358876998479886144202357872-25
Q ss_pred EEEEECCCCCCCHHHHHHCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 333330689889777730999955678999999999994-9998777800799999999754421001000388689988
Q 002774 715 TTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLST 793 (882)
Q Consensus 715 ~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 793 (882)
.....||..|+|||.+.+..++.++||||||+++|||+| |+.||..... .+....+.. .. . ...
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~-~~~~~~i~~-~~------~-------~~~ 222 (258)
T d1k2pa_ 158 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN-SETAEHIAQ-GL------R-------LYR 222 (258)
T ss_dssp CCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH-HHHHHHHHT-TC------C-------CCC
T ss_pred ECCCCCCCCCCCCHHHCCCCCCCCEEECCCCHHHHHHHHCCCCCCCCCCH-HHHHHHHHH-CC------C-------CCC
T ss_conf 24657887757807863799885210336432467397559999889999-999999980-79------7-------899
Q ss_pred CHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHH
Q ss_conf 98889999999998000299999999999999999
Q 002774 794 TLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIEN 828 (882)
Q Consensus 794 ~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 828 (882)
+...+.++.+++.+||+.||++|||+++++++|.+
T Consensus 223 p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 223 PHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHC
T ss_conf 65465999999999766897689399999987418
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=373.95 Aligned_cols=257 Identities=28% Similarity=0.444 Sum_probs=215.4
Q ss_pred CCCCCCCEEECCCCEEEEEEEECCCCEEEEEECCCCCCCCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEEEEEEC
Q ss_conf 19997780202573799999936995899997246985408999999999971367870139888971793699998206
Q 002774 555 NNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVP 634 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 634 (882)
++|.+.+.||+|+||+||+|+++++..||||+++... ...+.|.+|+.++++++|+|||+++|+|.+ +..++||||++
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~ 94 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 94 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred HHEEEEEEEEECCCEEEEEEEECCCCEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCEEEEEEEEEC-CCEEEEEEECC
T ss_conf 9979846993079809999999999999999988044-888999999999986666788689999823-97599999447
Q ss_pred CCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCCEE
Q ss_conf 99856656889886553999999999999987531102799833058888766986899456940466511589988502
Q 002774 635 NGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHI 714 (882)
Q Consensus 635 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 714 (882)
+|+|..++.......++|.+++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+|+....... ..
T Consensus 95 ~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~-~~ 170 (285)
T d1fmka3 95 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TA 170 (285)
T ss_dssp TCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC----------
T ss_pred CCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHHHH---EECCCCCCEEEEECCCCCEEECCCCHHHHCCCCCC-EE
T ss_conf 994354200003553059999999999999999875411---43353123079998999299844255542568873-35
Q ss_pred EEEEECCCCCCCHHHHHHCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCC
Q ss_conf 33333068988977773099995567899999999999499987778007999999997544210010003886899889
Q 002774 715 TTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTT 794 (882)
Q Consensus 715 ~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 794 (882)
.....||+.|+|||++..+.++.++||||||+++|||++|+.|+..+....+....+.... . ...+
T Consensus 171 ~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~----------~----~~~~ 236 (285)
T d1fmka3 171 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY----------R----MPCP 236 (285)
T ss_dssp -----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC----------C----CCCC
T ss_pred ECCCCCCCCCCCHHHHHCCCCCCHHHHHCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCC----------C----CCCC
T ss_conf 2454556654580898379989177413235899999868999998888999999998268----------9----9998
Q ss_pred HHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 8889999999998000299999999999999999999
Q 002774 795 LKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQ 831 (882)
Q Consensus 795 ~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~ 831 (882)
...+.++.+++.+||+.||++||+|++|++.|+.++.
T Consensus 237 ~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~ 273 (285)
T d1fmka3 237 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273 (285)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred CCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHC
T ss_conf 3237999999999756697589199999998766623
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=375.08 Aligned_cols=252 Identities=25% Similarity=0.399 Sum_probs=207.2
Q ss_pred CCCCCCCEEECCCCEEEEEEEEC-CCCEEEEEECCCCCCCCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEEEEEE
Q ss_conf 19997780202573799999936-99589999724698540899999999997136787013988897179369999820
Q 002774 555 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFV 633 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 633 (882)
+.|.+.+.||+|+||+||+|+.. +++.||||+++.......+.+.+|++++++++|||||++++++.+++..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred CCEEEEEEEEECCCCEEEEEEECCCCEEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEECC
T ss_conf 37598479930778199999999999399999987289999999999999998679999884988980099589999627
Q ss_pred CCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCCE
Q ss_conf 69985665688988655399999999999998753110279983305888876698689945694046651158998850
Q 002774 634 PNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDH 713 (882)
Q Consensus 634 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 713 (882)
++|+|.+++.... ..+++.++..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+|+...... .
T Consensus 92 ~~g~L~~~~~~~~-~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~--~ 165 (288)
T d2jfla1 92 AGGAVDAVMLELE-RPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--Q 165 (288)
T ss_dssp TTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHH--H
T ss_pred CCCCHHHHHHHCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EEEEECCHHHEEECCCCCEEEEECHHHHCCCCCC--C
T ss_conf 9981889998628-99999999999999999999999889---8871407003148789998997161230357786--4
Q ss_pred EEEEEECCCCCCCHHHHH-----HCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCC
Q ss_conf 233333068988977773-----099995567899999999999499987778007999999997544210010003886
Q 002774 714 ITTQVKGTMGYLDPEYYM-----TQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPT 788 (882)
Q Consensus 714 ~~~~~~gt~~y~aPE~~~-----~~~~~~~sDVwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 788 (882)
......||+.|+|||++. ...|+.++||||+||++|||++|+.||........ ...+.... .+.
T Consensus 166 ~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~-~~~i~~~~----------~~~ 234 (288)
T d2jfla1 166 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV-LLKIAKSE----------PPT 234 (288)
T ss_dssp HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH-HHHHHHSC----------CCC
T ss_pred CCCCCCCCCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHH-HHHHHCCC----------CCC
T ss_conf 1001025626479999832025788888066578789999998208899999899999-99997079----------987
Q ss_pred CCCCCCHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH
Q ss_conf 8998898889999999998000299999999999999
Q 002774 789 IGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 789 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 825 (882)
...+...+.++.+|+.+||+.||.+|||++|++++
T Consensus 235 --~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 235 --LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp --CSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred --CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf --77656699999999999766996689199999629
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=369.32 Aligned_cols=251 Identities=26% Similarity=0.407 Sum_probs=204.6
Q ss_pred CEEECCCCEEEEEEEEC---CCCEEEEEECCCCCCC--CHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEEEEEECC
Q ss_conf 80202573799999936---9958999972469854--089999999999713678701398889717936999982069
Q 002774 561 NDVGSGGYGKVYKGTLP---NGQLIAIKRAQQGSMQ--GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPN 635 (882)
Q Consensus 561 ~~lG~G~fg~Vy~a~~~---~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~ 635 (882)
++||+|+||+||+|.++ .++.||||+++..... ..+.|.+|++++++++|||||+++|+|.+ +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCCCCCCCEEEEEEEECCCCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEECC-CCEEEEEECCCC
T ss_conf 7834587829999998169738599999988010898999999999999986799898527777505-977999974788
Q ss_pred CCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCCE-E
Q ss_conf 985665688988655399999999999998753110279983305888876698689945694046651158998850-2
Q 002774 636 GSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDH-I 714 (882)
Q Consensus 636 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NIll~~~~~~kl~DfGla~~~~~~~~~~-~ 714 (882)
|+|.++++... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+|++|||+|+.+....... .
T Consensus 92 g~L~~~l~~~~--~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~ 166 (277)
T d1xbba_ 92 GPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 166 (277)
T ss_dssp EEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC
T ss_pred CCHHHHHHHCC--CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCHHHCCCCCCCCCCCCHHHHHHCCCCCCCCCC
T ss_conf 96899975225--7899999999999999976687479---556777611310235675123413453313432344322
Q ss_pred EEEEECCCCCCCHHHHHHCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 333330689889777730999955678999999999994-9998777800799999999754421001000388689988
Q 002774 715 TTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLST 793 (882)
Q Consensus 715 ~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 793 (882)
.....||+.|||||.+.+..++.++|||||||++|||+| |+.||..... .+... .+.... ....
T Consensus 167 ~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~-~~~~~-~i~~~~-------------~~~~ 231 (277)
T d1xbba_ 167 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-SEVTA-MLEKGE-------------RMGC 231 (277)
T ss_dssp ----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH-HHHHH-HHHTTC-------------CCCC
T ss_pred CCCCCCCCEECCCHHHCCCCCCCHHHHCCCHHHHHHHHHCCCCCCCCCCH-HHHHH-HHHCCC-------------CCCC
T ss_conf 44567784203916653799984344303403132896589999999899-99999-998289-------------9999
Q ss_pred CHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 988899999999980002999999999999999999997
Q 002774 794 TLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 832 (882)
Q Consensus 794 ~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~ 832 (882)
+...+.++.+|+.+||+.||.+|||+++|++.|+.+..+
T Consensus 232 p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 232 PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270 (277)
T ss_dssp CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHCHHHH
T ss_conf 865679999999997588976890989999985288750
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=372.31 Aligned_cols=260 Identities=25% Similarity=0.409 Sum_probs=214.2
Q ss_pred HHCCCCCCCEEECCCCEEEEEEEEC------CCCEEEEEECCCCCCCC-HHHHHHHHHHHHHCCCCCEEEEEEEEEECCC
Q ss_conf 9719997780202573799999936------99589999724698540-8999999999971367870139888971793
Q 002774 553 YTNNFSDANDVGSGGYGKVYKGTLP------NGQLIAIKRAQQGSMQG-GQEFKMEIELLSRVHHKNLVSLLGFCFDRGE 625 (882)
Q Consensus 553 ~~~~~~~~~~lG~G~fg~Vy~a~~~------~g~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 625 (882)
.+++|...+.||+|+||+||+|++. +++.||||+++...... .+.|.+|+.++++++||||++++++|.+.+.
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 90 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 90 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred CHHHCEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCCCCCCCCCEEEECCCCC
T ss_conf 98893886798207883999999888765778829999998821085799999999999996689976552466605980
Q ss_pred EEEEEEEECCCCCCCCCCCCC----------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCC
Q ss_conf 699998206998566568898----------------------8655399999999999998753110279983305888
Q 002774 626 QMLIYEFVPNGSLGDSLSGKN----------------------GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIK 683 (882)
Q Consensus 626 ~~lV~e~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik 683 (882)
.++||||+++|+|.++++... ...+++..++.++.|++.||+|||+.+ ++|||||
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrDlK 167 (301)
T d1lufa_ 91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLA 167 (301)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred EEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCC---EEEEEEC
T ss_conf 3899981589929999985275542100001110012103467889899999999999999855413578---6854884
Q ss_pred CCCEEECCCCCEEEEECCCCCCCCCCCCCEEEEEEECCCCCCCHHHHHHCCCCCHHHHHHHHHHHHHHHHCCC-CCCCCC
Q ss_conf 8766986899456940466511589988502333330689889777730999955678999999999994999-877780
Q 002774 684 SSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRR-PIERGK 762 (882)
Q Consensus 684 ~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~il~elltg~~-P~~~~~ 762 (882)
|+|||++.++.+||+|||+|+...+.......+...|++.|+|||.+.+..++.++|||||||++|||++|.. ||.. .
T Consensus 168 p~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~-~ 246 (301)
T d1lufa_ 168 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG-M 246 (301)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT-S
T ss_pred CCCEEECCCCCEEECCCHHHEECCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCHHHHHCCCHHHHHHHHCCCCCCCCC-C
T ss_conf 011689899928983314421136776411157777676767989972688980563025236299998068999999-8
Q ss_pred HHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 07999999997544210010003886899889888999999999800029999999999999999999
Q 002774 763 YIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENIL 830 (882)
Q Consensus 763 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~ 830 (882)
...+....+... . .+ ..+...+.++.+|+.+||+.||++||||.||++.|+++.
T Consensus 247 ~~~e~~~~v~~~-~---------~~----~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 247 AHEEVIYYVRDG-N---------IL----ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp CHHHHHHHHHTT-C---------CC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CHHHHHHHHHCC-C---------CC----CCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHC
T ss_conf 999999999739-9---------78----887325299999999974889657939999999999842
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=369.52 Aligned_cols=246 Identities=30% Similarity=0.456 Sum_probs=206.6
Q ss_pred CCCCCCCEEECCCCEEEEEEEEC-CCCEEEEEECCCCC---CCCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEEE
Q ss_conf 19997780202573799999936-99589999724698---540899999999997136787013988897179369999
Q 002774 555 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS---MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIY 630 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~a~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 630 (882)
++|.+.+.||+|+||+||+|+.. +++.||+|++.... ....+.+.+|+.+++.++|||||++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEE
T ss_conf 37699889851778589999998999499999981688567689999999999998568888885999999899989998
Q ss_pred EEECCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCC
Q ss_conf 82069985665688988655399999999999998753110279983305888876698689945694046651158998
Q 002774 631 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE 710 (882)
Q Consensus 631 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NIll~~~~~~kl~DfGla~~~~~~~ 710 (882)
||+++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+|+......
T Consensus 86 Ey~~~g~L~~~l~~~~--~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~ 160 (263)
T d2j4za1 86 EYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 160 (263)
T ss_dssp ECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC
T ss_pred EECCCCCHHHHHHHCC--CCCHHHHHHHHHHHHHHHHHHHHCC---EEEEEECCCCCEECCCCCEEECCCCEEEECCCCC
T ss_conf 5047985898875048--9999999999999999999999889---4652202344146689987115556335448885
Q ss_pred CCEEEEEEECCCCCCCHHHHHHCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCC
Q ss_conf 85023333306898897777309999556789999999999949998777800799999999754421001000388689
Q 002774 711 KDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIG 790 (882)
Q Consensus 711 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 790 (882)
.....||+.|||||++.+..++.++||||+||++|||++|+.||..... ......+... .+.
T Consensus 161 ----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-~~~~~~i~~~-----------~~~-- 222 (263)
T d2j4za1 161 ----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY-QETYKRISRV-----------EFT-- 222 (263)
T ss_dssp ----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH-HHHHHHHHTT-----------CCC--
T ss_pred ----CCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCH-HHHHHHHHCC-----------CCC--
T ss_conf ----2355788763499997589989314404675999998329999888999-9999999718-----------999--
Q ss_pred CCCCHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH
Q ss_conf 98898889999999998000299999999999999
Q 002774 791 LSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 791 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 825 (882)
.+...+.++.+++.+||+.||.+|||++|++++
T Consensus 223 --~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 223 --FPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp --CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred --CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf --986689999999999764797689099999719
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=372.29 Aligned_cols=255 Identities=23% Similarity=0.384 Sum_probs=207.1
Q ss_pred HCCCCCCCEEECCCCEEEEEEEE-CCCCEEEEEECCCCCCC--CHHHHHHHHHHHHHCCCCCEEEEEEEEEE--CCCEEE
Q ss_conf 71999778020257379999993-69958999972469854--08999999999971367870139888971--793699
Q 002774 554 TNNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQ--GGQEFKMEIELLSRVHHKNLVSLLGFCFD--RGEQML 628 (882)
Q Consensus 554 ~~~~~~~~~lG~G~fg~Vy~a~~-~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~l 628 (882)
.++|...+.||+|+||+||+|+. .+|+.||+|+++..... ..+.+.+|++++++++|||||++++++.+ .+..++
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred CHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEE
T ss_conf 33379967983088919999999999979999998746579799999999999999778999824899999178998999
Q ss_pred EEEEECCCCCCCCCCCC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCEEECCCCCCCEEECCCCCEEEEECCCCC
Q ss_conf 99820699856656889--8865539999999999999875311027--9983305888876698689945694046651
Q 002774 629 IYEFVPNGSLGDSLSGK--NGIRLDWIRRLKIALGAARGLSYLHELA--NPPIIHRDIKSSNILLDERLNAKVADFGLSK 704 (882)
Q Consensus 629 V~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivHrDik~~NIll~~~~~~kl~DfGla~ 704 (882)
||||+++|+|.+++... .+..+++..++.++.|++.||.|||+.+ ..+|+||||||+|||++.++.+||+|||+|+
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCHHHCCCCCCCCEEEEECCCEE
T ss_conf 99568999389999851545789999999999999999999999716778878858676542574788857980010003
Q ss_pred CCCCCCCCEEEEEEECCCCCCCHHHHHHCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHC
Q ss_conf 15899885023333306898897777309999556789999999999949998777800799999999754421001000
Q 002774 705 SMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYEL 784 (882)
Q Consensus 705 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 784 (882)
.+.... .......||+.|||||++.+..++.++||||+||++|||++|+.||..... .+....+....
T Consensus 163 ~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~-~~~~~~i~~~~--------- 230 (269)
T d2java1 163 ILNHDT--SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ-KELAGKIREGK--------- 230 (269)
T ss_dssp HC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHTC---------
T ss_pred ECCCCC--CCCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCH-HHHHHHHHCCC---------
T ss_conf 224577--755667788232799998399999389887527899998018899899899-99999997189---------
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH
Q ss_conf 38868998898889999999998000299999999999999
Q 002774 785 IDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 785 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 825 (882)
.+.+ +...+.++.+++.+||+.||.+|||++|++++
T Consensus 231 -~~~~----~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 231 -FRRI----PYRYSDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp -CCCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -CCCC----CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHC
T ss_conf -9889----74359999999999767995579189999729
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=366.46 Aligned_cols=258 Identities=26% Similarity=0.446 Sum_probs=210.4
Q ss_pred CCCCCCCEEECCCCEEEEEEEEC-CCC----EEEEEECCCC-CCCCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEE
Q ss_conf 19997780202573799999936-995----8999972469-85408999999999971367870139888971793699
Q 002774 555 NNFSDANDVGSGGYGKVYKGTLP-NGQ----LIAIKRAQQG-SMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQML 628 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~a~~~-~g~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 628 (882)
.+|+..+.||+|+||+||+|.+. +|+ .||+|+++.. .....+.|.+|+.++++++|||||+++|+|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECC-CEEE
T ss_conf 999783198208992999999958998898999999965134979999999999999867998881589999619-8369
Q ss_pred EEEEECCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCC
Q ss_conf 99820699856656889886553999999999999987531102799833058888766986899456940466511589
Q 002774 629 IYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSD 708 (882)
Q Consensus 629 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NIll~~~~~~kl~DfGla~~~~~ 708 (882)
++||+.+|+|.+++... ...+++..+.+++.|||.||.|||+.+ |+||||||+|||++.++.+||+|||+|+....
T Consensus 88 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp EEECCTTCBHHHHHHHT-SSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred EEEECCCCCCCCCCCCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCHHHCCEECCCCCEEEECCCCCEECCC
T ss_conf 99842687401011133-457999999999999999999998769---50476212031167998758602552223354
Q ss_pred CCCCEEEEEEECCCCCCCHHHHHHCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Q ss_conf 988502333330689889777730999955678999999999994-9998777800799999999754421001000388
Q 002774 709 SEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDP 787 (882)
Q Consensus 709 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 787 (882)
...........||+.|+|||++.++.++.++|||||||++|||+| |..||..... ..... .+....
T Consensus 164 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~-~~~~~-~i~~~~----------- 230 (317)
T d1xkka_ 164 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEISS-ILEKGE----------- 230 (317)
T ss_dssp TCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCG-GGHHH-HHHHTC-----------
T ss_pred CCCCCCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCH-HHHHH-HHHCCC-----------
T ss_conf 44532236510586446708874699983565440799999999779999999998-99999-997599-----------
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 689988988899999999980002999999999999999999997
Q 002774 788 TIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 832 (882)
Q Consensus 788 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~ 832 (882)
....+...+.++.+++.+||+.||.+|||+.|++++|..+.+.
T Consensus 231 --~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~ 273 (317)
T d1xkka_ 231 --RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 273 (317)
T ss_dssp --CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred --CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf --8999855689999999984789934691999999999998758
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=368.66 Aligned_cols=252 Identities=23% Similarity=0.352 Sum_probs=207.9
Q ss_pred HCCCCCCCEEECCCCEEEEEEEEC-CCCEEEEEECCCCCCC-CHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEEEE
Q ss_conf 719997780202573799999936-9958999972469854-08999999999971367870139888971793699998
Q 002774 554 TNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQ-GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYE 631 (882)
Q Consensus 554 ~~~~~~~~~lG~G~fg~Vy~a~~~-~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e 631 (882)
.+.|...+.||+|+||+||+|+.. +++.||||++...... ..+.+.+|+.+++.++|||||++++++.+++..|+|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred CCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEE
T ss_conf 66669988994065839999999999989999998157731289999999999986799899919899998998889885
Q ss_pred EECCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC---CCCCEEEEECCCCCCCCC
Q ss_conf 20699856656889886553999999999999987531102799833058888766986---899456940466511589
Q 002774 632 FVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLD---ERLNAKVADFGLSKSMSD 708 (882)
Q Consensus 632 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NIll~---~~~~~kl~DfGla~~~~~ 708 (882)
|+++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+||++. +++.+||+|||+|+....
T Consensus 88 ~~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~ 162 (307)
T d1a06a_ 88 LVSGGELFDRIVEKG--FYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP 162 (307)
T ss_dssp CCCSCBHHHHHHTCS--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC--------
T ss_pred CCCCCCHHHHHHCCC--CCCHHHHHHHHHHHHHHHHHHHHCE---EEEEEECCCCEEECCCCCCCEEEEECCCEEEECCC
T ss_conf 268984888653036--7887899999999999987524130---55687046300110468882499831543587258
Q ss_pred CCCCEEEEEEECCCCCCCHHHHHHCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCC
Q ss_conf 98850233333068988977773099995567899999999999499987778007999999997544210010003886
Q 002774 709 SEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPT 788 (882)
Q Consensus 709 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 788 (882)
.. .....+||+.|||||++.+..++.++||||+||++|||++|+.||...... .....+.... ..
T Consensus 163 ~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~-~~~~~i~~~~-----------~~ 227 (307)
T d1a06a_ 163 GS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA-KLFEQILKAE-----------YE 227 (307)
T ss_dssp -------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHTTC-----------CC
T ss_pred CC---EEEEEEECCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHCCC-----------CC
T ss_conf 97---044003284225918873799980787345159999998597999998999-9999986168-----------77
Q ss_pred CCCCCCHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH
Q ss_conf 8998898889999999998000299999999999999
Q 002774 789 IGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 789 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 825 (882)
.........+.++.+++.+||+.||.+|||++|++++
T Consensus 228 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 228 FDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 7876666789999999999760897579189998629
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=370.27 Aligned_cols=246 Identities=27% Similarity=0.440 Sum_probs=202.3
Q ss_pred CCCCCCCEEECCCCEEEEEEEE-CCCCEEEEEECCCCCCCC---HHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEEE
Q ss_conf 1999778020257379999993-699589999724698540---899999999997136787013988897179369999
Q 002774 555 NNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQG---GQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIY 630 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~a~~-~~g~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 630 (882)
..|+..+.||+|+||+||+|+. .+++.||||+++...... .+.+.+|++++++++|||||++++++.+++..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
T ss_conf 85676279701888099999998999399999984444358899999999999999778999823899999899889999
Q ss_pred EEECCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCC
Q ss_conf 82069985665688988655399999999999998753110279983305888876698689945694046651158998
Q 002774 631 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE 710 (882)
Q Consensus 631 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NIll~~~~~~kl~DfGla~~~~~~~ 710 (882)
||+++|+|..++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 95 E~~~~g~l~~~~~~~~--~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~- 168 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHKK--PLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 168 (309)
T ss_dssp ECCSEEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-
T ss_pred EECCCCCHHHHHHHCC--CCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCCCEEEECCCCCEEEEECCCCCCCCCC-
T ss_conf 8069994578997379--9999999999999999999998689---766678842179879997898443653346778-
Q ss_pred CCEEEEEEECCCCCCCHHHHHH---CCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Q ss_conf 8502333330689889777730---9999556789999999999949998777800799999999754421001000388
Q 002774 711 KDHITTQVKGTMGYLDPEYYMT---QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDP 787 (882)
Q Consensus 711 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDVwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 787 (882)
....||+.|||||++.+ +.|+.++||||+||++|||++|..||...... .....+.... .+
T Consensus 169 -----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~-~~~~~i~~~~----------~~ 232 (309)
T d1u5ra_ 169 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-SALYHIAQNE----------SP 232 (309)
T ss_dssp -----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-HHHHHHHHSC----------CC
T ss_pred -----CCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHCC----------CC
T ss_conf -----7313476636889983467888672145455899999998788999997999-9999998289----------99
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH
Q ss_conf 68998898889999999998000299999999999999
Q 002774 788 TIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 788 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 825 (882)
... ....+..+.+|+.+||+.||.+|||++|++++
T Consensus 233 ~~~---~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 233 ALQ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp CCS---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred CCC---CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHC
T ss_conf 888---78889999999999773796579189999719
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=371.57 Aligned_cols=250 Identities=24% Similarity=0.315 Sum_probs=210.0
Q ss_pred CCCCCCCEEECCCCEEEEEEEE-CCCCEEEEEECCCCC---CCCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEEE
Q ss_conf 1999778020257379999993-699589999724698---540899999999997136787013988897179369999
Q 002774 555 NNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGS---MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIY 630 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~a~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 630 (882)
++|.+.+.||+|+||+||+|+. .+++.||||+++... ....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
T ss_conf 87789889850879099999998999799999986577557778999999999998768888617999999899889999
Q ss_pred EEECCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCC
Q ss_conf 82069985665688988655399999999999998753110279983305888876698689945694046651158998
Q 002774 631 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE 710 (882)
Q Consensus 631 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NIll~~~~~~kl~DfGla~~~~~~~ 710 (882)
||+++|+|.+++...+ .+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+|+.+....
T Consensus 88 Ey~~gg~L~~~~~~~~--~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~ 162 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 162 (288)
T ss_dssp CCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred ECCCCCCHHHHHHCCC--CCCHHHHHHHHHHHHHHHHHHCCCC---EECCCCCCCCCCCCCCCEEEECCCCCCEECCCCC
T ss_conf 7048987777653159--9999999999999999997621650---8847677412366888538860321024225677
Q ss_pred CCEEEEEEECCCCCCCHHHHHHCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCC
Q ss_conf 85023333306898897777309999556789999999999949998777800799999999754421001000388689
Q 002774 711 KDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIG 790 (882)
Q Consensus 711 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 790 (882)
.........||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......+... .+.
T Consensus 163 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-~~~~~~i~~~-----------~~~-- 228 (288)
T d1uu3a_ 163 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE-YLIFQKIIKL-----------EYD-- 228 (288)
T ss_dssp -------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHTT-----------CCC--
T ss_pred CCCCCCCCCCCCCCCCCEEECCCCCCCCCCEEHHHHHHHHHHHCCCCCCCCCH-HHHHHHHHCC-----------CCC--
T ss_conf 64333555677552584400268989666230456999998038899899599-9999999718-----------999--
Q ss_pred CCCCHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH
Q ss_conf 98898889999999998000299999999999999
Q 002774 791 LSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 791 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 825 (882)
.+.....++.+|+.+||+.||.+|||++|++++
T Consensus 229 --~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 229 --FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp --CCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred --CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHCCC
T ss_conf --985479999999999855797689197897377
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=367.24 Aligned_cols=263 Identities=27% Similarity=0.419 Sum_probs=210.8
Q ss_pred HCCCCCCCEEECCCCEEEEEEEEC------CCCEEEEEECCCCCC-CCHHHHHHHHHHHHHC-CCCCEEEEEEEEEECC-
Q ss_conf 719997780202573799999936------995899997246985-4089999999999713-6787013988897179-
Q 002774 554 TNNFSDANDVGSGGYGKVYKGTLP------NGQLIAIKRAQQGSM-QGGQEFKMEIELLSRV-HHKNLVSLLGFCFDRG- 624 (882)
Q Consensus 554 ~~~~~~~~~lG~G~fg~Vy~a~~~------~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~- 624 (882)
.++|...+.||+|+||.||+|++. +++.||||+++.... ...+.+.+|...+.++ +|+||+.+++++.+.+
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~ 91 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 91 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred HHHEEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCEEEEEEEEECCCCC
T ss_conf 79979844984167839999998677755578399999986001717899999999998861499849974115404797
Q ss_pred CEEEEEEEECCCCCCCCCCCCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC
Q ss_conf 3699998206998566568898--------------86553999999999999987531102799833058888766986
Q 002774 625 EQMLIYEFVPNGSLGDSLSGKN--------------GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLD 690 (882)
Q Consensus 625 ~~~lV~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NIll~ 690 (882)
..++||||+++|+|.++++... ...+++.++..++.|++.||.|||+.+ |+||||||+|||++
T Consensus 92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NILl~ 168 (299)
T d1ywna1 92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLS 168 (299)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEC
T ss_pred EEEEEEEECCCCCHHHHHHHCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCEEEC
T ss_conf 579999845899299999853666665322202332146899999999999999999887379---71786773106577
Q ss_pred CCCCEEEEECCCCCCCCCCCCCEEEEEEECCCCCCCHHHHHHCCCCCHHHHHHHHHHHHHHHHCC-CCCCCCCHHHHHHH
Q ss_conf 89945694046651158998850233333068988977773099995567899999999999499-98777800799999
Q 002774 691 ERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGR-RPIERGKYIVREIR 769 (882)
Q Consensus 691 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~il~elltg~-~P~~~~~~~~~~~~ 769 (882)
+++.+||+|||+|+...............||+.|+|||++.++.++.++|||||||++|||+++. .||....... ...
T Consensus 169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~-~~~ 247 (299)
T d1ywna1 169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-EFC 247 (299)
T ss_dssp GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH-HHH
T ss_pred CCCCEEECCCCCHHHCCCCCCCCCCCCEEECCCCCCHHHHHCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCHHH-HHH
T ss_conf 9982898457520011356652224751667210203686468899663221367899999868899998999899-999
Q ss_pred HHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHC
Q ss_conf 9997544210010003886899889888999999999800029999999999999999999971
Q 002774 770 TVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQA 833 (882)
Q Consensus 770 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~ 833 (882)
..+.... .+. .+...+.++.+++.+||+.||.+|||++|++++|+.+++..
T Consensus 248 ~~~~~~~---------~~~----~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~n 298 (299)
T d1ywna1 248 RRLKEGT---------RMR----APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 298 (299)
T ss_dssp HHHHHTC---------CCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHCCC---------CCC----CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHCC
T ss_conf 9996389---------888----88657899999999976779667919999999997998677
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=363.38 Aligned_cols=264 Identities=25% Similarity=0.397 Sum_probs=217.2
Q ss_pred HCCCCCCCEEECCCCEEEEEEEE------CCCCEEEEEECCCCCCC-CHHHHHHHHHHHHHC-CCCCEEEEEEEEEECCC
Q ss_conf 71999778020257379999993------69958999972469854-089999999999713-67870139888971793
Q 002774 554 TNNFSDANDVGSGGYGKVYKGTL------PNGQLIAIKRAQQGSMQ-GGQEFKMEIELLSRV-HHKNLVSLLGFCFDRGE 625 (882)
Q Consensus 554 ~~~~~~~~~lG~G~fg~Vy~a~~------~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~ 625 (882)
.++|...+.||+|+||.||+|++ .+++.||||+++..... ....|.+|+.+++++ +|||||+++|+|.+.+.
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHEEEEEEEEECCCEEEEEEEEECCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCE
T ss_conf 89969854982068829999998066447788699999987424877999999999998762699988789989831997
Q ss_pred EEEEEEEECCCCCCCCCCCCC----------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEE
Q ss_conf 699998206998566568898----------------8655399999999999998753110279983305888876698
Q 002774 626 QMLIYEFVPNGSLGDSLSGKN----------------GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILL 689 (882)
Q Consensus 626 ~~lV~e~~~~gsL~~~l~~~~----------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NIll 689 (882)
.++||||+++|+|.++++... ...+++..+..++.||+.||+|||+.+ ++||||||+||++
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred EEEEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCCCCCC
T ss_conf 8999973799879999985356654444453322233458899999999999999999887579---2666241021000
Q ss_pred CCCCCEEEEECCCCCCCCCCCCCEEEEEEECCCCCCCHHHHHHCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH
Q ss_conf 68994569404665115899885023333306898897777309999556789999999999949998777800799999
Q 002774 690 DERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIR 769 (882)
Q Consensus 690 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~il~elltg~~P~~~~~~~~~~~~ 769 (882)
+.++.+|++|||+++...........+...||+.|+|||.+.++.++.++||||||+++|||+|++.|+...........
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~ 258 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHH
T ss_pred CCCCCCCCCCCCHHEECCCCCCCEEEEECCCCHHHCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHH
T ss_conf 02575210234010233678861586201359687677886179999740010258999999858998877899899999
Q ss_pred HHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHC
Q ss_conf 9997544210010003886899889888999999999800029999999999999999999971
Q 002774 770 TVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQA 833 (882)
Q Consensus 770 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~ 833 (882)
..+.... .+ ..+...+..+.+|+.+||+.||.+||||.++++.|++++++.
T Consensus 259 ~~i~~~~---------~~----~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~~ 309 (311)
T d1t46a_ 259 KMIKEGF---------RM----LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309 (311)
T ss_dssp HHHHHTC---------CC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred HHHHCCC---------CC----CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHCCC
T ss_conf 9986689---------88----985436599999999975779657929999999998765349
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=360.97 Aligned_cols=258 Identities=29% Similarity=0.446 Sum_probs=209.1
Q ss_pred CCEEECCCCEEEEEEEECC----CCEEEEEECCCC-CCCCHHHHHHHHHHHHHCCCCCEEEEEEEEEEC-CCEEEEEEEE
Q ss_conf 7802025737999999369----958999972469-854089999999999713678701398889717-9369999820
Q 002774 560 ANDVGSGGYGKVYKGTLPN----GQLIAIKRAQQG-SMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDR-GEQMLIYEFV 633 (882)
Q Consensus 560 ~~~lG~G~fg~Vy~a~~~~----g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-~~~~lV~e~~ 633 (882)
.++||+|+||+||+|++.+ ...||||+++.. .....++|.+|++++++++|||||+++|+|.+. +..++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred CEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEEEE
T ss_conf 66981368809999999779987999999998843697899999999999986789998678678980699438999874
Q ss_pred CCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCC-
Q ss_conf 6998566568898865539999999999999875311027998330588887669868994569404665115899885-
Q 002774 634 PNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKD- 712 (882)
Q Consensus 634 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NIll~~~~~~kl~DfGla~~~~~~~~~- 712 (882)
++|+|.++++... ...++..+++++.|+|.||.|+|+.+ |+||||||+|||+++++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~~~-~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~ 187 (311)
T d1r0pa_ 112 KHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 187 (311)
T ss_dssp TTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCC
T ss_pred ECCCHHHHHCCCC-CCCHHHHHHHHHHHHHHHHHHHCCCC---CCCCCCCHHHEEECCCCCEEEECCCCHHHCCCCCCCC
T ss_conf 0674144210134-54048999999999887652003367---6257766875767799988991065232255665553
Q ss_pred -EEEEEEECCCCCCCHHHHHHCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCCC
Q ss_conf -0233333068988977773099995567899999999999499987778007999999997544210010003886899
Q 002774 713 -HITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGL 791 (882)
Q Consensus 713 -~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 791 (882)
.......||..|+|||.+..+.++.++||||||+++|||+||+.||.......+....+..... +
T Consensus 188 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~----------~---- 253 (311)
T d1r0pa_ 188 VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR----------L---- 253 (311)
T ss_dssp TTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCC----------C----
T ss_pred CEECCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCC----------C----
T ss_conf 10025655564556768874379997457466199999999789999888999999999980898----------8----
Q ss_pred CCCHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHCCC
Q ss_conf 88988899999999980002999999999999999999997199
Q 002774 792 STTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQAGL 835 (882)
Q Consensus 792 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~~ 835 (882)
..+...+.++.+++.+||+.||++||+|.||+++|+++.+....
T Consensus 254 ~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~ 297 (311)
T d1r0pa_ 254 LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 297 (311)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHHHH
T ss_conf 99644759999999997688976893999999999999975201
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=365.28 Aligned_cols=247 Identities=27% Similarity=0.413 Sum_probs=198.4
Q ss_pred CCCCEEECCCCEEEEEEEEC-CCCEEEEEECCCCC--CCCHHHHHHHHHHHHHCCCCCEEEEEEEEEE----CCCEEEEE
Q ss_conf 97780202573799999936-99589999724698--5408999999999971367870139888971----79369999
Q 002774 558 SDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS--MQGGQEFKMEIELLSRVHHKNLVSLLGFCFD----RGEQMLIY 630 (882)
Q Consensus 558 ~~~~~lG~G~fg~Vy~a~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~~lV~ 630 (882)
...++||+|+||+||+|+.. +++.||+|++.... ....+.+.+|++++++++|||||++++++.+ +...++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EEEEEEECCCCCEEEEEEECCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCEEEEEE
T ss_conf 85169700828499999999999599999985122798999999999999985799985069999840334588899999
Q ss_pred EEECCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC-CCCCEEEEECCCCCCCCCC
Q ss_conf 820699856656889886553999999999999987531102799833058888766986-8994569404665115899
Q 002774 631 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLD-ERLNAKVADFGLSKSMSDS 709 (882)
Q Consensus 631 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NIll~-~~~~~kl~DfGla~~~~~~ 709 (882)
||+++|+|.+++.... .+++..+..++.|++.||+|||+.+ ++|+||||||+|||++ +++.+||+|||+|+.....
T Consensus 92 E~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~ 168 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS 168 (270)
T ss_dssp ECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred ECCCCCCHHHHHHCCC--CCCHHHHHHHHHHHHHHHHHHHHCC-CCEEECCCCHHHCEEECCCCCEEEEECCCCEECCCC
T ss_conf 5789894899975135--5469999999999999999999789-979968767435116679998898005765423687
Q ss_pred CCCEEEEEEECCCCCCCHHHHHHCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCC
Q ss_conf 88502333330689889777730999955678999999999994999877780079999999975442100100038868
Q 002774 710 EKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTI 789 (882)
Q Consensus 710 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 789 (882)
. .....||+.|||||++.+ .++.++||||+||++|||++|+.||............+..... +.
T Consensus 169 ~----~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~----------~~- 232 (270)
T d1t4ha_ 169 F----AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK----------PA- 232 (270)
T ss_dssp S----BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC----------CG-
T ss_pred C----CCCCCCCCCCCCHHHHCC-CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCC----------CC-
T ss_conf 6----677553813008988478-9998671100799999998788999876559999999973899----------86-
Q ss_pred CCCCCHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH
Q ss_conf 998898889999999998000299999999999999
Q 002774 790 GLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 790 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 825 (882)
........++.+++.+||+.||++|||++|++++
T Consensus 233 --~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 233 --SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp --GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred --CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf --5675578999999999763797589299999677
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=363.84 Aligned_cols=260 Identities=30% Similarity=0.464 Sum_probs=211.9
Q ss_pred CCCCCCCEEECCCCEEEEEEEEC-CCC--EEEEEECCCCC-CCCHHHHHHHHHHHHHC-CCCCEEEEEEEEEECCCEEEE
Q ss_conf 19997780202573799999936-995--89999724698-54089999999999713-678701398889717936999
Q 002774 555 NNFSDANDVGSGGYGKVYKGTLP-NGQ--LIAIKRAQQGS-MQGGQEFKMEIELLSRV-HHKNLVSLLGFCFDRGEQMLI 629 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~a~~~-~g~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV 629 (882)
++|...++||+|+||+||+|++. ++. .||||+++... ....+.|.+|++++.++ +|||||+++|+|.+++..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHCEEEEEEEECCCCEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEE
T ss_conf 99688779820788289999998999699999999782338579999999999998622899883678888418736999
Q ss_pred EEEECCCCCCCCCCCC--------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCE
Q ss_conf 9820699856656889--------------88655399999999999998753110279983305888876698689945
Q 002774 630 YEFVPNGSLGDSLSGK--------------NGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNA 695 (882)
Q Consensus 630 ~e~~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NIll~~~~~~ 695 (882)
|||+++|+|.++++.. ....+++..+..++.|+|.||.|+|+.+ |+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEECCCCCHHHHHHHCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCC---CCCCCCCCCEEEECCCCCE
T ss_conf 9802898699998640355555123101234578999999999999999987663089---5455505204898688763
Q ss_pred EEEECCCCCCCCCCCCCEEEEEEECCCCCCCHHHHHHCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 69404665115899885023333306898897777309999556789999999999949998777800799999999754
Q 002774 696 KVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKK 775 (882)
Q Consensus 696 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~ 775 (882)
||+|||+|+....... .....||..|+|||.+.++.++.++|||||||++|||++|..|+..+.+..+....+...
T Consensus 167 kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~- 242 (309)
T d1fvra_ 167 KIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG- 242 (309)
T ss_dssp EECCTTCEESSCEECC---C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGT-
T ss_pred EECCCCCCCCCCCCCC---CCCEECCCCCCCHHHHCCCCCCCCCEEEHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHC-
T ss_conf 8743443224442234---553013775555387526999962215313889999983689999999999999999826-
Q ss_pred HHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHCC
Q ss_conf 42100100038868998898889999999998000299999999999999999999719
Q 002774 776 KELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQAG 834 (882)
Q Consensus 776 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~ 834 (882)
.. ...+...+.++.+|+.+||+.||++||||.||++.|++++++..
T Consensus 243 ---------~~----~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~ 288 (309)
T d1fvra_ 243 ---------YR----LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 288 (309)
T ss_dssp ---------CC----CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred ---------CC----CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHCCC
T ss_conf ---------88----88876678999999999767896689499999999999986186
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=361.46 Aligned_cols=252 Identities=23% Similarity=0.348 Sum_probs=206.4
Q ss_pred HCCCCCCCEEECCCCEEEEEEEE-CCCCEEEEEECCCCCC------CCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCE
Q ss_conf 71999778020257379999993-6995899997246985------4089999999999713678701398889717936
Q 002774 554 TNNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSM------QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQ 626 (882)
Q Consensus 554 ~~~~~~~~~lG~G~fg~Vy~a~~-~~g~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 626 (882)
.++|...+.||+|+||+||+|+. .+|+.||||+++.... ...+.+.+|+.++++++|||||++++++.+.+..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEE
T ss_conf 56779827981178959999999999989999998756632134068999999999999867998999388999979989
Q ss_pred EEEEEEECCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCC----CEEEEECCC
Q ss_conf 9999820699856656889886553999999999999987531102799833058888766986899----456940466
Q 002774 627 MLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERL----NAKVADFGL 702 (882)
Q Consensus 627 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NIll~~~~----~~kl~DfGl 702 (882)
++||||+++|+|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+||+++.++ .+|++|||+
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~--~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG~ 163 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGL 163 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEECCCCCCCCCHHCCCC--CCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCCEEEEECCCCCCCCEEECCHHH
T ss_conf 99998677864310010356--4215578999999999987666254---221133301279825898666469643344
Q ss_pred CCCCCCCCCCEEEEEEECCCCCCCHHHHHHCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHH
Q ss_conf 51158998850233333068988977773099995567899999999999499987778007999999997544210010
Q 002774 703 SKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLY 782 (882)
Q Consensus 703 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 782 (882)
|+....... .....||+.|+|||++.+..++.++||||+||++|||++|+.||..... .+....+...... ..
T Consensus 164 a~~~~~~~~---~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-~~~~~~i~~~~~~---~~ 236 (293)
T d1jksa_ 164 AHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK-QETLANVSAVNYE---FE 236 (293)
T ss_dssp CEECTTSCB---CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHTTCCC---CC
T ss_pred HHHCCCCCC---CCCCCCCCCCCCHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCH-HHHHHHHHHCCCC---CC
T ss_conf 210577763---1224777743099998189999766522140999999708899889999-9999999816888---87
Q ss_pred HCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH
Q ss_conf 0038868998898889999999998000299999999999999
Q 002774 783 ELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 783 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 825 (882)
... ....+..+.+|+.+||+.||.+|||++|++++
T Consensus 237 ~~~--------~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 237 DEY--------FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp HHH--------HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CHH--------CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 010--------47889999999999863896689199999619
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=360.04 Aligned_cols=248 Identities=23% Similarity=0.278 Sum_probs=207.1
Q ss_pred CCCCCCCEEECCCCEEEEEEEE-CCCCEEEEEECCCC---CCCCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEEE
Q ss_conf 1999778020257379999993-69958999972469---8540899999999997136787013988897179369999
Q 002774 555 NNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQG---SMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIY 630 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~a~~-~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 630 (882)
++|.+.+.||+|+||.||+|+. .+|+.||+|++++. .....+.+.+|+.+|+.++||||+++++++.+.+..|+||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCCE
T ss_conf 74289889831768499999998999899999981565449799999999999998679998877876403564211100
Q ss_pred EEECCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCC
Q ss_conf 82069985665688988655399999999999998753110279983305888876698689945694046651158998
Q 002774 631 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE 710 (882)
Q Consensus 631 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NIll~~~~~~kl~DfGla~~~~~~~ 710 (882)
||+++|+|.+++.... .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|+......
T Consensus 85 ey~~gg~L~~~~~~~~--~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~ 159 (337)
T d1o6la_ 85 EYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp ECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred ECCCCCCHHHHHHCCC--CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEECCCCCEEEEECCCCCCCCCCC
T ss_conf 0357986055553256--7759999999999965211343159---6224647778476589988882056520035678
Q ss_pred CCEEEEEEECCCCCCCHHHHHHCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCC
Q ss_conf 85023333306898897777309999556789999999999949998777800799999999754421001000388689
Q 002774 711 KDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIG 790 (882)
Q Consensus 711 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 790 (882)
......+||+.|+|||++.+..|+.++||||+||++|||++|+.||..... .......... .+.
T Consensus 160 --~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~-~~~~~~i~~~-----------~~~-- 223 (337)
T d1o6la_ 160 --ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILME-----------EIR-- 223 (337)
T ss_dssp --CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHC-----------CCC--
T ss_pred --CCCCCCEECHHHHHHHHCCCCCCCHHHCCCCHHHHHHHHHHCCCCCCCCCH-HHHHHHHHCC-----------CCC--
T ss_conf --620551008899666650489888333102230678899878999999699-9999998528-----------998--
Q ss_pred CCCCHHHHHHHHHHHHHHHCCCCCCCCC-----HHHHHHH
Q ss_conf 9889888999999999800029999999-----9999999
Q 002774 791 LSTTLKGFEKYVDLALKCVQESGDDRPT-----MSEVVKD 825 (882)
Q Consensus 791 ~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~~ 825 (882)
.+.....++.+|+.+||++||.+|++ ++|++++
T Consensus 224 --~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 224 --FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp --CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred --CCCCCCHHHHHHHHHHCCCCCHHHCCCCCCCHHHHHCC
T ss_conf --98668999999998666389344225652349999729
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=358.92 Aligned_cols=260 Identities=25% Similarity=0.436 Sum_probs=213.2
Q ss_pred CCCCCCCEEECCCCEEEEEEEECC--------CCEEEEEECCCCCCC-CHHHHHHHHHHHHHC-CCCCEEEEEEEEEECC
Q ss_conf 199977802025737999999369--------958999972469854-089999999999713-6787013988897179
Q 002774 555 NNFSDANDVGSGGYGKVYKGTLPN--------GQLIAIKRAQQGSMQ-GGQEFKMEIELLSRV-HHKNLVSLLGFCFDRG 624 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~a~~~~--------g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~ 624 (882)
++|...+.||+|+||.||+|+... +..||||+++..... ....+.+|...+.++ +|||||+++++|.+++
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~ 92 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 92 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHEEEEEEEEECCCCEEEEEEECCCCCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCCCC
T ss_conf 99697009851678289999985787555667549999998811286889999999999998139996973465220188
Q ss_pred CEEEEEEEECCCCCCCCCCCCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC
Q ss_conf 3699998206998566568898--------------86553999999999999987531102799833058888766986
Q 002774 625 EQMLIYEFVPNGSLGDSLSGKN--------------GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLD 690 (882)
Q Consensus 625 ~~~lV~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NIll~ 690 (882)
..++||||+++|+|.+++.... ...+++.+++.++.|++.||+|||+.+ |+||||||+|||++
T Consensus 93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl~ 169 (299)
T d1fgka_ 93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVT 169 (299)
T ss_dssp SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEC
T ss_pred EEEEEEECCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEEEECCCCEEEC
T ss_conf 689999736999099999860677643222334574346799999999999999998766379---78630221022454
Q ss_pred CCCCEEEEECCCCCCCCCCCCCEEEEEEECCCCCCCHHHHHHCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCCHHHHHHH
Q ss_conf 899456940466511589988502333330689889777730999955678999999999994-9998777800799999
Q 002774 691 ERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIR 769 (882)
Q Consensus 691 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~il~ellt-g~~P~~~~~~~~~~~~ 769 (882)
.++.+||+|||+++...............|++.|+|||.+.++.++.++||||||+++|||++ |..||.... .....
T Consensus 170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~-~~~~~- 247 (299)
T d1fgka_ 170 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-VEELF- 247 (299)
T ss_dssp TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-HHHHH-
T ss_pred CCCCEEECCCHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCC-HHHHH-
T ss_conf 7897676221110113555554314667888466326675179888255547758888874017989899999-99999-
Q ss_pred HHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 999754421001000388689988988899999999980002999999999999999999997
Q 002774 770 TVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 832 (882)
Q Consensus 770 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~ 832 (882)
..+.... .+ ..+...+.++.+|+.+||+.||.+|||+.||++.|+++++-
T Consensus 248 ~~i~~~~---------~~----~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~ 297 (299)
T d1fgka_ 248 KLLKEGH---------RM----DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297 (299)
T ss_dssp HHHHTTC---------CC----CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHCCC---------CC----CCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf 9997288---------88----98743529999999997667976793999999999888604
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=362.04 Aligned_cols=252 Identities=27% Similarity=0.433 Sum_probs=207.9
Q ss_pred CCCCCCCEEECCCCEEEEEEEECCCCEEEEEECCCCCCCCHHHHHHHHHHHHHCCCCCEEEEEEEEEE-CCCEEEEEEEE
Q ss_conf 19997780202573799999936995899997246985408999999999971367870139888971-79369999820
Q 002774 555 NNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFD-RGEQMLIYEFV 633 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~~~lV~e~~ 633 (882)
++|...+.||+|+||.||+|+++ |+.||||+++.. ...+.+.+|++++++++||||++++|+|.+ .+..++||||+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HHEEEEEEEECCCCEEEEEEEEC-CEEEEEEEECCH--HHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEECC
T ss_conf 99488579820798089999999-909999998857--779999999999986789898549878872389289999636
Q ss_pred CCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCCE
Q ss_conf 69985665688988655399999999999998753110279983305888876698689945694046651158998850
Q 002774 634 PNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDH 713 (882)
Q Consensus 634 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 713 (882)
++|+|.+++.......++|..+++++.|++.||.|||+.+ |+||||||+||+++.++.+|++|||+++.....
T Consensus 84 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~---- 156 (262)
T d1byga_ 84 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---- 156 (262)
T ss_dssp TTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred CCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHCCCCCCCC---EECCCCCHHHHEECCCCCEEECCCCCCEECCCC----
T ss_conf 9998999987457888899999999999985232113376---553666567601468997763245600344787----
Q ss_pred EEEEEECCCCCCCHHHHHHCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 2333330689889777730999955678999999999994-999877780079999999975442100100038868998
Q 002774 714 ITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLS 792 (882)
Q Consensus 714 ~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 792 (882)
.....++..|+|||++.++.++.++||||||+++|||+| |+.|+... ...+....+.. ...+ .
T Consensus 157 -~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~-~~~~~~~~i~~----------~~~~----~ 220 (262)
T d1byga_ 157 -QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPRVEK----------GYKM----D 220 (262)
T ss_dssp ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS-CGGGHHHHHTT----------TCCC----C
T ss_pred -CCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCC-CHHHHHHHHHC----------CCCC----C
T ss_conf -765566646778178727988858877757999999997899999999-99999999980----------8999----9
Q ss_pred CCHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 8988899999999980002999999999999999999997
Q 002774 793 TTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 832 (882)
Q Consensus 793 ~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~ 832 (882)
.+...+.++.+++.+||+.||.+||||.+++++|+++.++
T Consensus 221 ~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~ 260 (262)
T d1byga_ 221 APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 260 (262)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf 9765799999999997566976893999999999999867
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=358.35 Aligned_cols=259 Identities=25% Similarity=0.381 Sum_probs=210.2
Q ss_pred HCCCCCCCEEECCCCEEEEEEEECC----CCEEEEEECCCCCCC-CHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEE
Q ss_conf 7199977802025737999999369----958999972469854-08999999999971367870139888971793699
Q 002774 554 TNNFSDANDVGSGGYGKVYKGTLPN----GQLIAIKRAQQGSMQ-GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQML 628 (882)
Q Consensus 554 ~~~~~~~~~lG~G~fg~Vy~a~~~~----g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 628 (882)
.++|...+.||+|+||+||+|++.. +..||||+++..... ..+.|.+|+.++++++|||||+++|++. .+..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHEEEEEEEEECCCCEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE-CCEEEE
T ss_conf 8996987799307882999999936996449999999365668799999999999998689999856988995-374799
Q ss_pred EEEEECCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCC
Q ss_conf 99820699856656889886553999999999999987531102799833058888766986899456940466511589
Q 002774 629 IYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSD 708 (882)
Q Consensus 629 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NIll~~~~~~kl~DfGla~~~~~ 708 (882)
||||+++|+|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+|+....
T Consensus 85 v~E~~~~g~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~ 160 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 160 (273)
T ss_dssp EEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC---------
T ss_pred EEEECCCCCHHHHHHCCC-CCCCHHHHHHHHHHHHHHHHHHCCCC---EECCCCCHHHEEECCCCCEEECCCHHHEECCC
T ss_conf 998406980776542247-89999999999999987752302267---44141026553206789678765034213367
Q ss_pred CCCCEEEEEEECCCCCCCHHHHHHCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Q ss_conf 988502333330689889777730999955678999999999994-9998777800799999999754421001000388
Q 002774 709 SEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDP 787 (882)
Q Consensus 709 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 787 (882)
... .......||+.|+|||++.+..++.++|||||||++|||++ |..||...... +....+... . .
T Consensus 161 ~~~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~-~~~~~i~~~-~---------~- 227 (273)
T d1mp8a_ 161 STY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN-DVIGRIENG-E---------R- 227 (273)
T ss_dssp -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-GHHHHHHTT-C---------C-
T ss_pred CCC-EECCCEECCCCCCHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHH-HHHHHHHCC-C---------C-
T ss_conf 762-33054005831032667516998874524442478999982699998889999-999999818-9---------9-
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHC
Q ss_conf 6899889888999999999800029999999999999999999971
Q 002774 788 TIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQA 833 (882)
Q Consensus 788 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~ 833 (882)
...+...+.++.+|+.+||..||.+|||+.||+++|+.++++.
T Consensus 228 ---~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 270 (273)
T d1mp8a_ 228 ---LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 270 (273)
T ss_dssp ---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ---CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHH
T ss_conf ---9898777999999999976879768929999999999997786
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=360.28 Aligned_cols=259 Identities=23% Similarity=0.371 Sum_probs=211.4
Q ss_pred CCCCCCCEEECCCCEEEEEEEEC------CCCEEEEEECCCCCC-CCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEE
Q ss_conf 19997780202573799999936------995899997246985-40899999999997136787013988897179369
Q 002774 555 NNFSDANDVGSGGYGKVYKGTLP------NGQLIAIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQM 627 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~a~~~------~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 627 (882)
++|...+.||+|+||+||+|.+. +++.||||+++.... .....|.+|+.++++++|||||+++|+|...+..+
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~ 99 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 99 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred HHEEEEEEEEECCCEEEEEEEECCCCCCCCCCEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCEE
T ss_conf 99188359820788189999987864477896899999870128689999999999999769998841254784288106
Q ss_pred EEEEEECCCCCCCCCCCCC--------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEE
Q ss_conf 9998206998566568898--------86553999999999999987531102799833058888766986899456940
Q 002774 628 LIYEFVPNGSLGDSLSGKN--------GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVAD 699 (882)
Q Consensus 628 lV~e~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NIll~~~~~~kl~D 699 (882)
+||||+++|+|.+++.... ...+++..+.+++.|+|+||.|||+.+ |+||||||+|||+++++.+||+|
T Consensus 100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~D 176 (308)
T d1p4oa_ 100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGD 176 (308)
T ss_dssp EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEECC
T ss_pred EEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECEECCCCEEECCCCEEEEEE
T ss_conf 777604899889998750332113444688799999999999999999876479---65432867754035996499942
Q ss_pred CCCCCCCCCCCCCEEEEEEECCCCCCCHHHHHHCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHH
Q ss_conf 46651158998850233333068988977773099995567899999999999499987778007999999997544210
Q 002774 700 FGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELY 779 (882)
Q Consensus 700 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 779 (882)
||+|+...............||+.|+|||.+.++.++.++||||||+++|||+||..|+..+.........+.....
T Consensus 177 FGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~--- 253 (308)
T d1p4oa_ 177 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL--- 253 (308)
T ss_dssp TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCC---
T ss_pred CCCCEECCCCCCEEECCCEECCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCC---
T ss_conf 45420235776303134023163237888873699883334443789999999689999999899999999980888---
Q ss_pred HHHHCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 010003886899889888999999999800029999999999999999999
Q 002774 780 NLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENIL 830 (882)
Q Consensus 780 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~ 830 (882)
...+...+..+.+++.+||+.+|++||||.+|++.|++.+
T Consensus 254 -----------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~ 293 (308)
T d1p4oa_ 254 -----------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 293 (308)
T ss_dssp -----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred -----------CCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHC
T ss_conf -----------8886335399999999975779658939999999978761
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=0 Score=355.05 Aligned_cols=245 Identities=25% Similarity=0.358 Sum_probs=205.3
Q ss_pred CCCCCCCEEECCCCEEEEEEEE-CCCCEEEEEECCCC---CCCCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEEE
Q ss_conf 1999778020257379999993-69958999972469---8540899999999997136787013988897179369999
Q 002774 555 NNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQG---SMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIY 630 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~a~~-~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 630 (882)
++|.+.+.||+|+||+||+|+. .+|+.||||+++.. .....+.+.+|+.+++.++|||||++++++.+++..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCHHHEEEEEEECCEEEEEE
T ss_conf 47088889720768089999998999799999984577548899999999999998636967533035685288005676
Q ss_pred EEECCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCC
Q ss_conf 82069985665688988655399999999999998753110279983305888876698689945694046651158998
Q 002774 631 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE 710 (882)
Q Consensus 631 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NIll~~~~~~kl~DfGla~~~~~~~ 710 (882)
||+++|+|..++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+|+......
T Consensus 84 E~~~gg~l~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~ 158 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT 158 (316)
T ss_dssp CCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSCB
T ss_pred EECCCCCCCCCCCCCC--CCCCCHHHHHHHHHHHHHHHHCCCC---EECCCCCCHHEEECCCCCEEEECCCCCEEECCCC
T ss_conf 5037863223432222--1110079999999987655412476---7705568105038689988983175216712456
Q ss_pred CCEEEEEEECCCCCCCHHHHHHCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCC
Q ss_conf 85023333306898897777309999556789999999999949998777800799999999754421001000388689
Q 002774 711 KDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIG 790 (882)
Q Consensus 711 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 790 (882)
....||+.|||||++.+..++.++||||+||++|||++|+.||..... ......+.... ..
T Consensus 159 -----~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~-~~~~~~i~~~~-------~~------ 219 (316)
T d1fota_ 159 -----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT-MKTYEKILNAE-------LR------ 219 (316)
T ss_dssp -----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH-HHHHHHHHHCC-------CC------
T ss_pred -----CCCCCCCCCCCHHHHCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCH-HHHHHHHHCCC-------CC------
T ss_conf -----434576343599998389998043046533368999759899999699-99999997089-------88------
Q ss_pred CCCCHHHHHHHHHHHHHHHCCCCCCCC-----CHHHHHHH
Q ss_conf 988988899999999980002999999-----99999999
Q 002774 791 LSTTLKGFEKYVDLALKCVQESGDDRP-----TMSEVVKD 825 (882)
Q Consensus 791 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~ 825 (882)
.+...+.++.+++.+|+..||.+|+ |+++++++
T Consensus 220 --~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 220 --FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp --CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred --CCCCCCHHHHHHHHHHHHHCHHHCCCCCHHHHHHHHCC
T ss_conf --99778999999999995449976664310219999819
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=352.72 Aligned_cols=252 Identities=20% Similarity=0.276 Sum_probs=207.2
Q ss_pred HCCCCCCCEEECCCCEEEEEEEEC-CCCEEEEEECCCCCCCCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEEEEE
Q ss_conf 719997780202573799999936-9958999972469854089999999999713678701398889717936999982
Q 002774 554 TNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEF 632 (882)
Q Consensus 554 ~~~~~~~~~lG~G~fg~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 632 (882)
.++|.+.+.||+|+||+||+|... +++.||+|.++... .+...+.+|+++|+.++|||||++++++.+++..|+||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEEC
T ss_conf 010588789831778399999998999699999975786-6599999999999857997989098999889988999953
Q ss_pred ECCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC--CCCEEEEECCCCCCCCCCC
Q ss_conf 06998566568898865539999999999999875311027998330588887669868--9945694046651158998
Q 002774 633 VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDE--RLNAKVADFGLSKSMSDSE 710 (882)
Q Consensus 633 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NIll~~--~~~~kl~DfGla~~~~~~~ 710 (882)
+++|+|.+++.... ..+++.++..++.|++.||.|||+.+ |+||||||+|||++. ...+|++|||+++......
T Consensus 83 ~~gg~L~~~i~~~~-~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~ 158 (321)
T d1tkia_ 83 ISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp CCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred CCCCCHHHHHHHCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCEEECCCCCEEEEECCCCHHHCCCCCC
T ss_conf 89980889987538-99999999999999999999998769---975135544434437885189976441110034677
Q ss_pred CCEEEEEEECCCCCCCHHHHHHCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCC
Q ss_conf 85023333306898897777309999556789999999999949998777800799999999754421001000388689
Q 002774 711 KDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIG 790 (882)
Q Consensus 711 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 790 (882)
......+++.|+|||...+..++.++||||+||++|||++|..||..... .+....+...... ......+
T Consensus 159 ---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~-~~~~~~i~~~~~~---~~~~~~~--- 228 (321)
T d1tkia_ 159 ---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN-QQIIENIMNAEYT---FDEEAFK--- 228 (321)
T ss_dssp ---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH-HHHHHHHHHTCCC---CCHHHHT---
T ss_pred ---CCCCCCCCCCCCCCHHCCCCCCCCHHHCCCHHHHHHHHHHCCCCCCCCCH-HHHHHHHHHCCCC---CCHHHCC---
T ss_conf ---53212233222340210487778401130279999999828999999899-9999999838999---8802236---
Q ss_pred CCCCHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH
Q ss_conf 98898889999999998000299999999999999
Q 002774 791 LSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 791 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 825 (882)
....++.+|+.+|+..||.+|||++|++++
T Consensus 229 -----~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 229 -----EISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp -----TSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -----CCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf -----789999999999866996689099999639
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=0 Score=356.24 Aligned_cols=249 Identities=23% Similarity=0.313 Sum_probs=198.6
Q ss_pred CCCCCCCEEECCCCEEEEEEEEC-CCCEEEEEECCCCCC---CCHHHHHH---HHHHHHHCCCCCEEEEEEEEEECCCEE
Q ss_conf 19997780202573799999936-995899997246985---40899999---999997136787013988897179369
Q 002774 555 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM---QGGQEFKM---EIELLSRVHHKNLVSLLGFCFDRGEQM 627 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~a~~~-~g~~vavK~~~~~~~---~~~~~~~~---E~~~l~~l~H~niv~l~~~~~~~~~~~ 627 (882)
++|.+.+.||+|+||.||+|+.. +|+.||||++..... .....+.+ |+.+++.++|||||++++++.+.+..|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEEE
T ss_conf 76851018842889099999999999799999984587542667999999999999985089985889999999899889
Q ss_pred EEEEEECCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCC
Q ss_conf 99982069985665688988655399999999999998753110279983305888876698689945694046651158
Q 002774 628 LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMS 707 (882)
Q Consensus 628 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NIll~~~~~~kl~DfGla~~~~ 707 (882)
+||||+++|+|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.+.
T Consensus 84 ivmE~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~~ 158 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS 158 (364)
T ss_dssp EEECCCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred EEEEECCCCCHHHHHHHCC--CCCHHHHHHHHHHHHHHHHHHHHCC---CCCEEECCCEEEECCCCCEEEEEECEEEECC
T ss_conf 9999148983899987325--5327899999999999999999779---6220444221678588967982201023337
Q ss_pred CCCCCEEEEEEECCCCCCCHHHHHH-CCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCC
Q ss_conf 9988502333330689889777730-999955678999999999994999877780079999999975442100100038
Q 002774 708 DSEKDHITTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELID 786 (882)
Q Consensus 708 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 786 (882)
... .....||+.|+|||++.. ..++.++||||+||++|||++|+.||.......... .... ...
T Consensus 159 ~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~--~~~~---------~~~ 223 (364)
T d1omwa3 159 KKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE--IDRM---------TLT 223 (364)
T ss_dssp SSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHH--HHHH---------SSS
T ss_pred CCC----CCCCCCCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHH--HHHH---------CCC
T ss_conf 886----4331134554216876038999844104677899999985999888899899999--9986---------046
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCC-----HHHHHHH
Q ss_conf 86899889888999999999800029999999-----9999999
Q 002774 787 PTIGLSTTLKGFEKYVDLALKCVQESGDDRPT-----MSEVVKD 825 (882)
Q Consensus 787 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~~ 825 (882)
.. ...+...+.++.+|+.+||+.||.+||| ++|++++
T Consensus 224 ~~--~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 224 MA--VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp CC--CCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred CC--CCCCCCCCHHHHHHHHHHCCCCHHHHCCCCCCCHHHHHCC
T ss_conf 88--8788778999999999985669888088743579999749
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=356.33 Aligned_cols=245 Identities=22% Similarity=0.304 Sum_probs=205.7
Q ss_pred CCCCCCCEEECCCCEEEEEEEEC-CCCEEEEEECCCC---CCCCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEEE
Q ss_conf 19997780202573799999936-9958999972469---8540899999999997136787013988897179369999
Q 002774 555 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQG---SMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIY 630 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~a~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 630 (882)
++|.+.+.||+|+||+||+|+.. +|+.||||++... .....+.+.+|+.+++.++|||||++++++.+....++|+
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCC
T ss_conf 37089889611768089999998999899999982677458899999999999999748772740344443222223222
Q ss_pred EEECCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCC
Q ss_conf 82069985665688988655399999999999998753110279983305888876698689945694046651158998
Q 002774 631 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE 710 (882)
Q Consensus 631 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NIll~~~~~~kl~DfGla~~~~~~~ 710 (882)
||+.+|+|..++...+ .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 121 e~~~~g~l~~~l~~~~--~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~- 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp ECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred CCCCCCCHHHHHHHCC--CCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHCCCCCCCCEEEEECEEEEECCCC-
T ss_conf 2334662266675158--9899999999999999899998599---861767999936077897886101033322566-
Q ss_pred CCEEEEEEECCCCCCCHHHHHHCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCC
Q ss_conf 85023333306898897777309999556789999999999949998777800799999999754421001000388689
Q 002774 711 KDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIG 790 (882)
Q Consensus 711 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 790 (882)
.....||+.|||||++.+..++.++||||+||++|||++|+.||..... ......+.... +
T Consensus 195 ----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~-~~~~~~i~~~~-----------~--- 255 (350)
T d1rdqe_ 195 ----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP-IQIYEKIVSGK-----------V--- 255 (350)
T ss_dssp ----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHCC-----------C---
T ss_pred ----CCCCCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCH-HHHHHHHHCCC-----------C---
T ss_conf ----6433676356788997179988533114500789999758899899599-99999986179-----------8---
Q ss_pred CCCCHHHHHHHHHHHHHHHCCCCCCCC-----CHHHHHHH
Q ss_conf 988988899999999980002999999-----99999999
Q 002774 791 LSTTLKGFEKYVDLALKCVQESGDDRP-----TMSEVVKD 825 (882)
Q Consensus 791 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~ 825 (882)
..+.....++.+++.+||+.||.+|+ |+++++++
T Consensus 256 -~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 256 -RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp -CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred -CCCCCCCHHHHHHHHHHHHHCHHHCCCCCCCCHHHHHCC
T ss_conf -897668999999999983409986065534549999719
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=0 Score=351.37 Aligned_cols=260 Identities=23% Similarity=0.353 Sum_probs=210.9
Q ss_pred HCCCCCCCEEECCCCEEEEEEEE-CCCCEEEEEECCCCCCCC---HHHHHHHHHHHHHCCCCCEEEEEEEEEECCC----
Q ss_conf 71999778020257379999993-699589999724698540---8999999999971367870139888971793----
Q 002774 554 TNNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQG---GQEFKMEIELLSRVHHKNLVSLLGFCFDRGE---- 625 (882)
Q Consensus 554 ~~~~~~~~~lG~G~fg~Vy~a~~-~~g~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~---- 625 (882)
.++|.+.+.||+|+||+||+|+. .+++.||||+++.....+ .+.+.+|+.+++.++|||||++++++...+.
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCCE
T ss_conf 62069868996089929999999999989999998556646989999999999999856999887311435432688766
Q ss_pred EEEEEEEECCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf 69999820699856656889886553999999999999987531102799833058888766986899456940466511
Q 002774 626 QMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKS 705 (882)
Q Consensus 626 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NIll~~~~~~kl~DfGla~~ 705 (882)
.|+||||+++|+|.+++...+ .+++.++..++.|++.||+|||+.+ |+||||||+|||++.++..+++|||.+..
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~--~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~~ 160 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARA 160 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCEE
T ss_pred EEEEEECCCCCEEHHHHCCCC--CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCCCCCCCCCCEEEHHHHHHH
T ss_conf 999997788987101120358--9999999999999999999998579---52763467556657543201003444322
Q ss_pred CCCCCC-CEEEEEEECCCCCCCHHHHHHCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHC
Q ss_conf 589988-5023333306898897777309999556789999999999949998777800799999999754421001000
Q 002774 706 MSDSEK-DHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYEL 784 (882)
Q Consensus 706 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 784 (882)
...... ........||+.|+|||++.+..++.++||||+||++|||+||+.||...... ...........
T Consensus 161 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-~~~~~~~~~~~-------- 231 (277)
T d1o6ya_ 161 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV-SVAYQHVREDP-------- 231 (277)
T ss_dssp CC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHCCC--------
T ss_pred HCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCEECCCCHHHHHHHHHCCCCCCCCCHH-HHHHHHHHCCC--------
T ss_conf 123544333346425762436999983999996632026528999997697998996999-99999984699--------
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCC-CHHHHHHHHHHHH
Q ss_conf 388689988988899999999980002999999-9999999999999
Q 002774 785 IDPTIGLSTTLKGFEKYVDLALKCVQESGDDRP-TMSEVVKDIENIL 830 (882)
Q Consensus 785 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~eil~~L~~~~ 830 (882)
..+. ......+.++.+++.+|+++||.+|| |++++++.|.++.
T Consensus 232 ~~~~---~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 232 IPPS---ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp CCGG---GTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred CCCC---HHCCCCCHHHHHHHHHHCCCCHHHCHHHHHHHHHHHHHHH
T ss_conf 9971---0034789999999999866797677739999999999975
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=357.60 Aligned_cols=253 Identities=21% Similarity=0.269 Sum_probs=201.1
Q ss_pred HCCCCCCC-EEECCCCEEEEEEEE-CCCCEEEEEECCCCCCCCHHHHHHHHHHHHHC-CCCCEEEEEEEEEE----CCCE
Q ss_conf 71999778-020257379999993-69958999972469854089999999999713-67870139888971----7936
Q 002774 554 TNNFSDAN-DVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQGGQEFKMEIELLSRV-HHKNLVSLLGFCFD----RGEQ 626 (882)
Q Consensus 554 ~~~~~~~~-~lG~G~fg~Vy~a~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~----~~~~ 626 (882)
.++|.+.. .||+|+||+||+|+. .+++.||||+++.. ..+.+|+.++.++ +|||||++++++.+ ....
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred CCCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCC-----HHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCCCEE
T ss_conf 148798107965454869999998899989999998974-----779999999998669999782989995034689789
Q ss_pred EEEEEEECCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC---CCCEEEEECCCC
Q ss_conf 99998206998566568898865539999999999999875311027998330588887669868---994569404665
Q 002774 627 MLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDE---RLNAKVADFGLS 703 (882)
Q Consensus 627 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NIll~~---~~~~kl~DfGla 703 (882)
|+||||+++|+|.+++...+...+++.++..++.|++.||.|||+.+ |+||||||+|||++. .+.+||+|||+|
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCCCCCCCCCCCCCCCCCCCEE
T ss_conf 99997789984999998627877579999999999999999999769---864441002201135555663113545512
Q ss_pred CCCCCCCCCEEEEEEECCCCCCCHHHHHHCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHH
Q ss_conf 11589988502333330689889777730999955678999999999994999877780079999999975442100100
Q 002774 704 KSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYE 783 (882)
Q Consensus 704 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 783 (882)
+....... .....||+.|||||++.+..|+.++||||+||++|||+||+.||.......... ..... ..
T Consensus 162 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~-~~~~~-------i~ 230 (335)
T d2ozaa1 162 KETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP-GMKTR-------IR 230 (335)
T ss_dssp EECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC---------C-------CC
T ss_pred EECCCCCC---CCCCCCCCCCCCCHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHHHHHH-HHHHH-------HH
T ss_conf 33368886---432267756379277748988888888764516778865889988988778899-99999-------85
Q ss_pred CCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH
Q ss_conf 038868998898889999999998000299999999999999
Q 002774 784 LIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 784 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 825 (882)
................++.+|+.+||+.||++|||+.|++++
T Consensus 231 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 231 MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp SCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 388888985434699999999999756996579099999709
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=358.36 Aligned_cols=267 Identities=24% Similarity=0.363 Sum_probs=205.1
Q ss_pred CCCCCCCEEECCCCEEEEEEEECCCCEEEEEECCCCCCCCHHHHHH--HHHHHHHCCCCCEEEEEEEEEECC----CEEE
Q ss_conf 1999778020257379999993699589999724698540899999--999997136787013988897179----3699
Q 002774 555 NNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKM--EIELLSRVHHKNLVSLLGFCFDRG----EQML 628 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~--E~~~l~~l~H~niv~l~~~~~~~~----~~~l 628 (882)
++|...+.||+|+||+||+|++ +|+.||||+++.. ..+.+.+ |+..+..++|||||+++++|.+.+ ..++
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred CEEEEEEEEEECCCEEEEEEEE-CCEEEEEEEECCC---CHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCEEEEE
T ss_conf 6899988982078819999999-9989999998720---04679999999999627998683268899837986048999
Q ss_pred EEEEECCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC-----CCCEEECCCCCCCEEECCCCCEEEEECCCC
Q ss_conf 998206998566568898865539999999999999875311027-----998330588887669868994569404665
Q 002774 629 IYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELA-----NPPIIHRDIKSSNILLDERLNAKVADFGLS 703 (882)
Q Consensus 629 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~ivHrDik~~NIll~~~~~~kl~DfGla 703 (882)
||||+++|+|.++++.. .++|..+++++.|+|.||+|+|+.+ .++|+||||||+|||++.++.+||+|||++
T Consensus 79 v~Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~ 155 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEECCCCCCHHHHHHCC---CCCHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCCEEECCCCCEEEEECCCC
T ss_conf 99646698989998658---999899999999999999998876652046898661531731357868877688763866
Q ss_pred CCCCCCCCCE--EEEEEECCCCCCCHHHHHHCC------CCCHHHHHHHHHHHHHHHHCCCCCCCCCH------------
Q ss_conf 1158998850--233333068988977773099------99556789999999999949998777800------------
Q 002774 704 KSMSDSEKDH--ITTQVKGTMGYLDPEYYMTQQ------LTEKSDVYSFGVLMLELLTGRRPIERGKY------------ 763 (882)
Q Consensus 704 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~------~~~~sDVwSlG~il~elltg~~P~~~~~~------------ 763 (882)
+......... ......||+.|+|||++.... ++.++|||||||++|||+||..|+.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T d1vjya_ 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred CCCCCCCCCEECCCCCEECCCCCCCHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHCCCCC
T ss_conf 23467776200135525035476782210565454677767501220159999999628998876631124101225564
Q ss_pred -HHHHHHHHHHHHHHHHHHHHCCCCCCCCC-CCHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHCCCC
Q ss_conf -79999999975442100100038868998-89888999999999800029999999999999999999971999
Q 002774 764 -IVREIRTVMDKKKELYNLYELIDPTIGLS-TTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQAGLN 836 (882)
Q Consensus 764 -~~~~~~~~~~~~~~~~~~~~~~~~~l~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~~~ 836 (882)
......... .....+|.+... ........+.+++.+||+.||.+||||.||++.|+++.++.+..
T Consensus 236 ~~~~~~~~~~--------~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~~~~ 302 (303)
T d1vjya_ 236 PSVEEMRKVV--------CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIK 302 (303)
T ss_dssp CCHHHHHHHH--------TTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHHCCC
T ss_pred CHHHHHHHHH--------HCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHCCCC
T ss_conf 3099999987--------502468887765577689999999999976069858959999999999888865998
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=354.96 Aligned_cols=256 Identities=23% Similarity=0.389 Sum_probs=206.2
Q ss_pred CCCCCCCEEECCCCEEEEEEEEC--CC--CEEEEEECCCCC---CCCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEE
Q ss_conf 19997780202573799999936--99--589999724698---540899999999997136787013988897179369
Q 002774 555 NNFSDANDVGSGGYGKVYKGTLP--NG--QLIAIKRAQQGS---MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQM 627 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~a~~~--~g--~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 627 (882)
++|...+.||+|+||+||+|++. ++ ..||||+++... ....++|.+|+.++++++|||||+++|++.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHEEEEEEEECCCCEEEEEEEEECCCCCEEEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEE-CCHH
T ss_conf 891997898038883999999988999079999999983555798999999999999986899998789877740-1001
Q ss_pred EEEEEECCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCC
Q ss_conf 99982069985665688988655399999999999998753110279983305888876698689945694046651158
Q 002774 628 LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMS 707 (882)
Q Consensus 628 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NIll~~~~~~kl~DfGla~~~~ 707 (882)
+||||+++|++.+.+.... ..+++..+..++.|+|.||.|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 87 lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp EEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEEEECCCCHHHHHHCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EEEEEECHHHHCCCCCCCEEECCCHHHHHCC
T ss_conf 1465423861254442126-89999999999999999998752178---7520566888156556543325611555303
Q ss_pred CCCCCE-EEEEEECCCCCCCHHHHHHCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCC
Q ss_conf 998850-2333330689889777730999955678999999999994-99987778007999999997544210010003
Q 002774 708 DSEKDH-ITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELI 785 (882)
Q Consensus 708 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 785 (882)
...... ......|+..|+|||.+.+..++.++||||||+++|||+| |+.||.... ..+....+....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~-~~~~~~~i~~~~---------- 231 (273)
T d1u46a_ 163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN-GSQILHKIDKEG---------- 231 (273)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC-HHHHHHHHHTSC----------
T ss_pred CCCCCCEECCCCCCCCCCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCC-HHHHHHHHHHCC----------
T ss_conf 588752654763257310799998379999421566148999999968999999969-999999998479----------
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHH
Q ss_conf 88689988988899999999980002999999999999999999
Q 002774 786 DPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENI 829 (882)
Q Consensus 786 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 829 (882)
.....+...+..+.+++.+||+.||++||||++|++.|.+.
T Consensus 232 ---~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 232 ---ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp ---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHC
T ss_conf ---99998544539999999997688966792999999999964
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=0 Score=346.29 Aligned_cols=252 Identities=27% Similarity=0.348 Sum_probs=206.7
Q ss_pred HCCCCCCCEEECCCCEEEEEEEE-CCCCEEEEEECCCCCCC---------CHHHHHHHHHHHHHCC-CCCEEEEEEEEEE
Q ss_conf 71999778020257379999993-69958999972469854---------0899999999997136-7870139888971
Q 002774 554 TNNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQ---------GGQEFKMEIELLSRVH-HKNLVSLLGFCFD 622 (882)
Q Consensus 554 ~~~~~~~~~lG~G~fg~Vy~a~~-~~g~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~-H~niv~l~~~~~~ 622 (882)
.++|...+.||+|+||+||+|+. .+++.||||+++..... ..+.+.+|+.++++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred CCCCEECEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEECCC
T ss_conf 66388852884176849999999999989999999624464114788899999999999999985079974799762146
Q ss_pred CCCEEEEEEEECCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCC
Q ss_conf 79369999820699856656889886553999999999999987531102799833058888766986899456940466
Q 002774 623 RGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGL 702 (882)
Q Consensus 623 ~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NIll~~~~~~kl~DfGl 702 (882)
++..|+||||+++|+|.++++... .+++.++..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~ 156 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGF 156 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred CCCEEEEEECCCCCHHHHHHHHCC--CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEECCCCCEEECCCHH
T ss_conf 760599997689866899998659--9999999999999999999998759---94323462548986899838712403
Q ss_pred CCCCCCCCCCEEEEEEECCCCCCCHHHHHH------CCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 511589988502333330689889777730------99995567899999999999499987778007999999997544
Q 002774 703 SKSMSDSEKDHITTQVKGTMGYLDPEYYMT------QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKK 776 (882)
Q Consensus 703 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDVwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~ 776 (882)
++....... .....||..|+|||.+.+ ..++.++||||+||++|||++|+.||...... .....+.....
T Consensus 157 a~~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~-~~~~~i~~~~~ 232 (277)
T d1phka_ 157 SCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM-LMLRMIMSGNY 232 (277)
T ss_dssp CEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHTCC
T ss_pred EEECCCCCC---EEEEECCCCCCCHHHHHCCCCCCCCCCCCHHEECCCCHHHHHHCCCCCCCCCCCHH-HHHHHHHHCCC
T ss_conf 167268872---13452467888988860534456788992331856560231032288898899999-99999981898
Q ss_pred HHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH
Q ss_conf 2100100038868998898889999999998000299999999999999
Q 002774 777 ELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 777 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 825 (882)
..........+.++.+++.+||++||.+|||++|++++
T Consensus 233 -----------~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 233 -----------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp -----------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred -----------CCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf -----------88985434689999999999765896689199999739
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=351.17 Aligned_cols=248 Identities=25% Similarity=0.363 Sum_probs=202.7
Q ss_pred CCCCCCCEEECCCCEEEEEEEEC-CCCEEEEEECCCCC---CCCHHHHHHHHHHHH-HCCCCCEEEEEEEEEECCCEEEE
Q ss_conf 19997780202573799999936-99589999724698---540899999999997-13678701398889717936999
Q 002774 555 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS---MQGGQEFKMEIELLS-RVHHKNLVSLLGFCFDRGEQMLI 629 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~a~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~-~l~H~niv~l~~~~~~~~~~~lV 629 (882)
++|...+.||+|+||+||+|+.. +++.||||+++... ....+.+..|..++. .++|||||++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEE
T ss_conf 97188658940878289999999999899999980555338489999999999999847999687898897049831677
Q ss_pred EEEECCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCC
Q ss_conf 98206998566568898865539999999999999875311027998330588887669868994569404665115899
Q 002774 630 YEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDS 709 (882)
Q Consensus 630 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NIll~~~~~~kl~DfGla~~~~~~ 709 (882)
|||+++|+|.++++... .+++.++..++.||+.||+|||+.+ |+||||||+|||+++++.+|++|||+|+.....
T Consensus 82 mEy~~~g~L~~~i~~~~--~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~ 156 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 156 (320)
T ss_dssp EECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEECCCCCHHHHHHCCC--CCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCCCEEECCCCCEECCCCCHHHHCCCC
T ss_conf 75037980899864047--8999999999999999999998689---340347654044448996301555302323566
Q ss_pred CCCEEEEEEECCCCCCCHHHHHHCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCC
Q ss_conf 88502333330689889777730999955678999999999994999877780079999999975442100100038868
Q 002774 710 EKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTI 789 (882)
Q Consensus 710 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 789 (882)
. .......||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......+... .+..
T Consensus 157 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~-~~~~~~i~~~-----------~~~~ 222 (320)
T d1xjda_ 157 D--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE-EELFHSIRMD-----------NPFY 222 (320)
T ss_dssp T--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHC-----------CCCC
T ss_pred C--CCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCH-HHHHHHHHCC-----------CCCC
T ss_conf 5--334545787776899998279988323201122789898738899999899-9999999718-----------9989
Q ss_pred CCCCCHHHHHHHHHHHHHHHCCCCCCCCCHH-HHHHH
Q ss_conf 9988988899999999980002999999999-99999
Q 002774 790 GLSTTLKGFEKYVDLALKCVQESGDDRPTMS-EVVKD 825 (882)
Q Consensus 790 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-eil~~ 825 (882)
+...+.++.+|+.+||+.||.+||++. +++++
T Consensus 223 ----p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~h 255 (320)
T d1xjda_ 223 ----PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH 255 (320)
T ss_dssp ----CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred ----CCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHHC
T ss_conf ----756799999999996544898783889999809
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=344.28 Aligned_cols=258 Identities=24% Similarity=0.291 Sum_probs=198.8
Q ss_pred CCEEECCCCEEEEEEEE-CCCCEEEEEECCCCCCCC-----HHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEEEEEE
Q ss_conf 78020257379999993-699589999724698540-----899999999997136787013988897179369999820
Q 002774 560 ANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQG-----GQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFV 633 (882)
Q Consensus 560 ~~~lG~G~fg~Vy~a~~-~~g~~vavK~~~~~~~~~-----~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 633 (882)
.++||+|+||+||+|+. .+|+.||||+++...... .+.+.+|+.++++++|||||++++++.+++..++||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred CEEECCCCCEEEEEEEECCCCCEEEEEEEEHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEHHHHH
T ss_conf 63851272829999999999969999998420212456799999999999998679999868985422587402204553
Q ss_pred CCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCCE
Q ss_conf 69985665688988655399999999999998753110279983305888876698689945694046651158998850
Q 002774 634 PNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDH 713 (882)
Q Consensus 634 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 713 (882)
+++++..+..... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+|+.......
T Consensus 83 ~~~~~~~~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~-- 155 (299)
T d1ua2a_ 83 ETDLEVIIKDNSL--VLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR-- 155 (299)
T ss_dssp SEEHHHHHTTCCS--SCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC--
T ss_pred CCHHHHHHHHCCC--CCCHHHHHHHHHHHHHHHHHHHCCC---EECCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCC--
T ss_conf 4507765541266--7789999999999999998863163---55035776258853778411465761000578755--
Q ss_pred EEEEEECCCCCCCHHHHHHC-CCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHH-----HHHHHHC---
Q ss_conf 23333306898897777309-99955678999999999994999877780079999999975442-----1001000---
Q 002774 714 ITTQVKGTMGYLDPEYYMTQ-QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKE-----LYNLYEL--- 784 (882)
Q Consensus 714 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~-----~~~~~~~--- 784 (882)
......||+.|+|||++... .++.++||||+||++|||++|..||...... +....+...... .......
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~-~~l~~i~~~~~~~~~~~~~~~~~~~~~ 234 (299)
T d1ua2a_ 156 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL-DQLTRIFETLGTPTEEQWPDMCSLPDY 234 (299)
T ss_dssp CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCTTTSSSTTSSTTC
T ss_pred CCCCEECCHHHCCHHHHCCCCCCCHHHHHHHCCHHHHHHHHCCCCCCCCCHH-HHHHHHHHHCCCCCHHHCCCHHCCCHH
T ss_conf 4330204733363999726778880564363042899998596999999999-999999985189972545210002134
Q ss_pred CCCCCCCCCC-----HHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH
Q ss_conf 3886899889-----8889999999998000299999999999999
Q 002774 785 IDPTIGLSTT-----LKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 785 ~~~~l~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 825 (882)
..-....... .....++.+|+.+|++.||++|||++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 235 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp CCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred HHHCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 4303478988678565689999999999763894569089999679
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=344.24 Aligned_cols=264 Identities=21% Similarity=0.346 Sum_probs=203.2
Q ss_pred CCCCCCCEEECCCCEEEEEEEE-CCCCEEEEEECCCCCCC--CHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEEEE
Q ss_conf 1999778020257379999993-69958999972469854--08999999999971367870139888971793699998
Q 002774 555 NNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQ--GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYE 631 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~a~~-~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e 631 (882)
++|...+.||+|+||+||+|+. .+|+.||||+++..... ..+.+.+|+.++++++|||||++++++.+++..++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEECCEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEEE
T ss_conf 99776517723768099999999999799999980222575899999999999986799838874453322432037886
Q ss_pred EECCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCC
Q ss_conf 20699856656889886553999999999999987531102799833058888766986899456940466511589988
Q 002774 632 FVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEK 711 (882)
Q Consensus 632 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NIll~~~~~~kl~DfGla~~~~~~~~ 711 (882)
|+.+ ++.+.+.......+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+|++|||.|+.......
T Consensus 82 ~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~ 157 (298)
T d1gz8a_ 82 FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 157 (298)
T ss_dssp CCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB
T ss_pred ECCC-CHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHCCC---EECCCCCCHHEEECCCCCCEECCCCCCEECCCCCC
T ss_conf 2377-4455544202568888999999999999999865288---99213571140113467621035786134368864
Q ss_pred CEEEEEEECCCCCCCHHHHHHCC-CCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHH----HHH-HHHC-
Q ss_conf 50233333068988977773099-9955678999999999994999877780079999999975442----100-1000-
Q 002774 712 DHITTQVKGTMGYLDPEYYMTQQ-LTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKE----LYN-LYEL- 784 (882)
Q Consensus 712 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDVwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~----~~~-~~~~- 784 (882)
......||+.|+|||.+.... ++.++||||+||++|+|++|+.||...... +........... .+. ....
T Consensus 158 --~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~ 234 (298)
T d1gz8a_ 158 --TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI-DQLFRIFRTLGTPDEVVWPGVTSMP 234 (298)
T ss_dssp --CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred --CCEEECCCCEEEEHHHHCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCHH-HHHHHHHHHCCCCCHHHCCCCCCCC
T ss_conf --1001036521541122136657774221033331342796687998988999-9999999832898333144422242
Q ss_pred -CCCCCCC--CCC-----HHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH
Q ss_conf -3886899--889-----8889999999998000299999999999999
Q 002774 785 -IDPTIGL--STT-----LKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 785 -~~~~l~~--~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 825 (882)
....... ... .....++.+|+.+|++.||.+|||++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp TCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 1243454322220444166789999999999763995579189999678
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=0 Score=340.90 Aligned_cols=263 Identities=22% Similarity=0.325 Sum_probs=205.8
Q ss_pred CCCCCCCEEECCCCEEEEEEEECCCCEEEEEECCCCCCC--CHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEEEEE
Q ss_conf 199977802025737999999369958999972469854--089999999999713678701398889717936999982
Q 002774 555 NNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQ--GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEF 632 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~a~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 632 (882)
++|...++||+|+||+||+|+.++|+.||||+++..... ..+.+.+|+.++++++|||||++++++.+.+..++++|+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCCEECCEEECCCCCEEEEEEECCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEECCCCCCEEEEEEE
T ss_conf 99634318722778189999968999999999812326858999999999999867998687660120467731589974
Q ss_pred ECCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCC
Q ss_conf 06998566568898865539999999999999875311027998330588887669868994569404665115899885
Q 002774 633 VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKD 712 (882)
Q Consensus 633 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NIll~~~~~~kl~DfGla~~~~~~~~~ 712 (882)
+.++.+..+..... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+|++|||.|........
T Consensus 82 ~~~~~~~~~~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~- 155 (286)
T d1ob3a_ 82 LDQDLKKLLDVCEG--GLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR- 155 (286)
T ss_dssp CSEEHHHHHHTSTT--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred EHHHHHHHHHHHCC--CCCHHHHHHHHHHHHHHHHHHCCCC---EEECCCCCCEEEECCCCCEEECCCCCCEECCCCCC-
T ss_conf 00456789986047--7514456899999999999860574---88267877505686899787323664301146765-
Q ss_pred EEEEEEECCCCCCCHHHHHHC-CCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHH-----HHHHHHC--
Q ss_conf 023333306898897777309-99955678999999999994999877780079999999975442-----1001000--
Q 002774 713 HITTQVKGTMGYLDPEYYMTQ-QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKE-----LYNLYEL-- 784 (882)
Q Consensus 713 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~-----~~~~~~~-- 784 (882)
......|++.|+|||.+.+. .++.++||||+||++|||++|+.||....... ....+...... .......
T Consensus 156 -~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (286)
T d1ob3a_ 156 -KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD-QLMRIFRILGTPNSKNWPNVTELPK 233 (286)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred -CCCEECCCCHHHHHHHHHCCCCCCCCEEEHHCCCHHHHHHHCCCCCCCCCHHH-HHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf -41010243110137887178888841002111758999977979989889899-9999998638997110421233322
Q ss_pred CCCCCC-------CCCCHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH
Q ss_conf 388689-------98898889999999998000299999999999999
Q 002774 785 IDPTIG-------LSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 785 ~~~~l~-------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 825 (882)
...... ..........+.+++.+|++.||++|||++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 143333356764666512589999999999866896689099998569
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=337.86 Aligned_cols=264 Identities=22% Similarity=0.303 Sum_probs=196.9
Q ss_pred HCCCCCCCEEECCCCEEEEEEEE-CC-CCEEEEEECCCCCC--CCHHHHHHHHHHHHHC---CCCCEEEEEEEEEE----
Q ss_conf 71999778020257379999993-69-95899997246985--4089999999999713---67870139888971----
Q 002774 554 TNNFSDANDVGSGGYGKVYKGTL-PN-GQLIAIKRAQQGSM--QGGQEFKMEIELLSRV---HHKNLVSLLGFCFD---- 622 (882)
Q Consensus 554 ~~~~~~~~~lG~G~fg~Vy~a~~-~~-g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~H~niv~l~~~~~~---- 622 (882)
.++|.+.+.||+|+||+||+|+. .+ ++.||||+++.... .....+.+|+.+++.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred CCCEEEEEEEECCCCEEEEEEEEECCCCEEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCC
T ss_conf 58979888992155869999999888998999999802324516799999999999987425898802366322146666
Q ss_pred -CCCEEEEEEEECCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECC
Q ss_conf -7936999982069985665688988655399999999999998753110279983305888876698689945694046
Q 002774 623 -RGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFG 701 (882)
Q Consensus 623 -~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NIll~~~~~~kl~DfG 701 (882)
....++++||++++++...... ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+|++|||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~dfg 161 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG 161 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHS-CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSCC
T ss_pred CCCEEEEEEEECCCCCHHHHHHC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCCEEEECCCCCEEECCHH
T ss_conf 67469999974058714444430-3789998999999999999999997588---9835798627898589975421000
Q ss_pred CCCCCCCCCCCEEEEEEECCCCCCCHHHHHHCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHH----
Q ss_conf 6511589988502333330689889777730999955678999999999994999877780079999999975442----
Q 002774 702 LSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKE---- 777 (882)
Q Consensus 702 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~---- 777 (882)
+++...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||...... +....+......
T Consensus 162 ~~~~~~~~~---~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~~~~~~ 237 (305)
T d1blxa_ 162 LARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-DQLGKILDVIGLPGEE 237 (305)
T ss_dssp SCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCCGG
T ss_pred HHHHHCCCC---CCCCCCCCHHHCCCCHHCCCCCCHHEHHHCHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHHHCCCCHH
T ss_conf 101100234---577765485114831001798881110003289999998787998998989-9999999840799611
Q ss_pred HHHH--------HHCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH
Q ss_conf 1001--------00038868998898889999999998000299999999999999
Q 002774 778 LYNL--------YELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 778 ~~~~--------~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 825 (882)
.+.. .....+.............+.+|+.+||+.||.+|||++|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCCCCCCCHHHHHCCCCCCCHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 05321111033302234564544044589999999999874896679189999669
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=340.88 Aligned_cols=240 Identities=25% Similarity=0.404 Sum_probs=195.8
Q ss_pred CCCCCCCEEECCCCEEEEEEEE-CCCCEEEEEECCCCCCC------CHHHHHHHHHHHHHCC--CCCEEEEEEEEEECCC
Q ss_conf 1999778020257379999993-69958999972469854------0899999999997136--7870139888971793
Q 002774 555 NNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQ------GGQEFKMEIELLSRVH--HKNLVSLLGFCFDRGE 625 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~a~~-~~g~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--H~niv~l~~~~~~~~~ 625 (882)
++|.+.+.||+|+||+||+|+. .+|+.||||+++..... ....+.+|+.++++++ |||||++++++.+++.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCE
T ss_conf 83799679840878399999999999799999985688443345567999999999999743589881279999830996
Q ss_pred EEEEEEEECC-CCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCC-CCEEEEECCCC
Q ss_conf 6999982069-985665688988655399999999999998753110279983305888876698689-94569404665
Q 002774 626 QMLIYEFVPN-GSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDER-LNAKVADFGLS 703 (882)
Q Consensus 626 ~~lV~e~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NIll~~~-~~~kl~DfGla 703 (882)
.++||||+.+ +++.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.+ +.+||+|||+|
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~~--~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~a 158 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSG 158 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEEEEECCCCCHHHHHHHCCC--CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCEEEECCCCEEEECCCCCC
T ss_conf 8999983368622899986158--9999999999999999999998779---7556676111477447884897754653
Q ss_pred CCCCCCCCCEEEEEEECCCCCCCHHHHHHCCC-CCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHH
Q ss_conf 11589988502333330689889777730999-95567899999999999499987778007999999997544210010
Q 002774 704 KSMSDSEKDHITTQVKGTMGYLDPEYYMTQQL-TEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLY 782 (882)
Q Consensus 704 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDVwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 782 (882)
+...... .+...||+.|+|||++.+..+ +.++||||+||++|||++|+.||..... +... .
T Consensus 159 ~~~~~~~----~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-------i~~~-------~ 220 (273)
T d1xwsa_ 159 ALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-------IIRG-------Q 220 (273)
T ss_dssp EECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-------HHHC-------C
T ss_pred EECCCCC----CCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCEEEEHHHHHCCCCCCCCHH-------HHHC-------C
T ss_conf 5324445----56656587747999984899788653325540345367568899887367-------7615-------4
Q ss_pred HCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH
Q ss_conf 0038868998898889999999998000299999999999999
Q 002774 783 ELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 783 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 825 (882)
....+ ..+.++.+++.+||+.||.+|||++|++++
T Consensus 221 ~~~~~--------~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 221 VFFRQ--------RVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp CCCSS--------CCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCCCC--------CCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 47787--------799999999999760897589399998539
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=335.39 Aligned_cols=259 Identities=25% Similarity=0.362 Sum_probs=193.6
Q ss_pred CCCCCCEEECCCCEEEEEEEEC-CCCEEEEEECCCCCCCCHHHHHHHHHHHHHCCCCCEEEEEEEEEECC------CEEE
Q ss_conf 9997780202573799999936-99589999724698540899999999997136787013988897179------3699
Q 002774 556 NFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRG------EQML 628 (882)
Q Consensus 556 ~~~~~~~lG~G~fg~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------~~~l 628 (882)
+|...++||+|+||+||+|+.. +|+.||||+++..... ..+|+++|++++|+||+++++++.... ..++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CCEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCCCHH----HHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEEEEE
T ss_conf 767516982176839999999999979999998816068----9999999986689898738789974476577318999
Q ss_pred EEEEECCCCCCCCCCC-CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCC-CEEEEECCCCCCC
Q ss_conf 9982069985665688-9886553999999999999987531102799833058888766986899-4569404665115
Q 002774 629 IYEFVPNGSLGDSLSG-KNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERL-NAKVADFGLSKSM 706 (882)
Q Consensus 629 V~e~~~~gsL~~~l~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NIll~~~~-~~kl~DfGla~~~ 706 (882)
||||++++.+....+. .....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++ .+||+|||+++..
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEECCCCCCHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEEECCCCCEEEECCCCHHHC
T ss_conf 9841688607888863103689999999999999999999998668---7645788603787358971167336605440
Q ss_pred CCCCCCEEEEEEECCCCCCCHHHHHH-CCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHH----H-HHH
Q ss_conf 89988502333330689889777730-99995567899999999999499987778007999999997544----2-100
Q 002774 707 SDSEKDHITTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKK----E-LYN 780 (882)
Q Consensus 707 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~----~-~~~ 780 (882)
..... .....|+..|+|||.+.+ ..++.++||||+||++|||++|+.||....... ....+..... . +..
T Consensus 174 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~-~l~~i~~~~g~~~~~~~~~ 249 (350)
T d1q5ka_ 174 VRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD-QLVEIIKVLGTPTREQIRE 249 (350)
T ss_dssp CTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH-HHHHHHHHHCCCCHHHHHH
T ss_pred CCCCC---CCCCCCCCCCCCHHHHHCCCCCCCCEEECCCCEEEEEHHHCCCCCCCCCHHH-HHHHHHHHHCCCHHHHHHH
T ss_conf 47765---3200255555682776404688821000246527785502879989879999-9999999748981776543
Q ss_pred ----HHHCCCCCCCC-----CCCHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH
Q ss_conf ----10003886899-----8898889999999998000299999999999999
Q 002774 781 ----LYELIDPTIGL-----STTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 781 ----~~~~~~~~l~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 825 (882)
.....-+.... ........++.+|+.+|++.||.+|||+.|++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp HCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HCCCHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 062101103554456744443156899999999999765895579299999669
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=328.86 Aligned_cols=268 Identities=19% Similarity=0.282 Sum_probs=203.1
Q ss_pred CCCCCCCEEECCCCEEEEEEEE-CCCCEEEEEECCCCCCCCHHHHHHHHHHHHHCCCCCE-EEEEEEEEECCCEEEEEEE
Q ss_conf 1999778020257379999993-6995899997246985408999999999971367870-1398889717936999982
Q 002774 555 NNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNL-VSLLGFCFDRGEQMLIYEF 632 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~a~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~lV~e~ 632 (882)
++|.+.+.||+|+||+||+|++ .+++.||||++...... ..+..|+++++.++|+++ +.+.++..+++..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS--CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEEEEEEECCCCEEEEEEECCCCCEEEEEEECHHCCC--HHHHHHHHHHHHCCCCCCCCEEEEEEECCCEEEEEEEE
T ss_conf 8899968985078809999999889989999997210058--88999999999703899601799999519877899987
Q ss_pred ECCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC---CCCCEEEEECCCCCCCCCC
Q ss_conf 0699856656889886553999999999999987531102799833058888766986---8994569404665115899
Q 002774 633 VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLD---ERLNAKVADFGLSKSMSDS 709 (882)
Q Consensus 633 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NIll~---~~~~~kl~DfGla~~~~~~ 709 (882)
+ ++++...+... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++ .+..++++|||+|+.+...
T Consensus 85 ~-~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~ 159 (299)
T d1ckia_ 85 L-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159 (299)
T ss_dssp C-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred C-CCCHHHHHHHC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCHHHCCCCCCCCCCEEEEECCCCCEECCCC
T ss_conf 3-87133324430-688768999999999999999999799---442667876606433577761565046751342554
Q ss_pred CCCE-----EEEEEECCCCCCCHHHHHHCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHC
Q ss_conf 8850-----23333306898897777309999556789999999999949998777800799999999754421001000
Q 002774 710 EKDH-----ITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYEL 784 (882)
Q Consensus 710 ~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 784 (882)
.... ......||+.|||||.+.+..++.++|||||||++|||++|+.||..........................
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (299)
T d1ckia_ 160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 239 (299)
T ss_dssp TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHH
T ss_pred CCCCCEECCCCCCCCCCCCCCCHHHHHCCCCCCHHHEEECCHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCCCCHHH
T ss_conf 45541000135776787353299999189989832188617789999849876655305779999998523567898357
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHCCCCC
Q ss_conf 38868998898889999999998000299999999999999999999719999
Q 002774 785 IDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQAGLNP 837 (882)
Q Consensus 785 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~~~~ 837 (882)
..+ ..+.++.+++.+||+.+|++||+++++.+.|+.+..+.+...
T Consensus 240 ~~~--------~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~~~ 284 (299)
T d1ckia_ 240 LCK--------GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSY 284 (299)
T ss_dssp HTT--------TSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTCCC
T ss_pred HCC--------CCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHCCCCC
T ss_conf 534--------788999999999843995579199999999999999769997
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=329.08 Aligned_cols=265 Identities=22% Similarity=0.334 Sum_probs=199.8
Q ss_pred CCCCCCCEEECCCCEEEEEEEE-CCCCEEEEEECCCCC--CCCHHHHHHHHHHHHHCCCCCEEEEEEEEEE--------C
Q ss_conf 1999778020257379999993-699589999724698--5408999999999971367870139888971--------7
Q 002774 555 NNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGS--MQGGQEFKMEIELLSRVHHKNLVSLLGFCFD--------R 623 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~a~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--------~ 623 (882)
++|.+.+.||+|+||+||+|+. .+|+.||||++.... ....+.+.+|+.+|++++|+||+++++++.. .
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCCCCCC
T ss_conf 79889999722748299999998999799999984222463789999999999998359996606765402465444457
Q ss_pred CCEEEEEEEECCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCC
Q ss_conf 93699998206998566568898865539999999999999875311027998330588887669868994569404665
Q 002774 624 GEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLS 703 (882)
Q Consensus 624 ~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NIll~~~~~~kl~DfGla 703 (882)
+..++||||++++.+........ .++...+..++.|++.||.|||+.+ |+||||||+|||++.++.+|++|||++
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~~~~--~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~~ 164 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSNVLV--KFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLA 164 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTCTTC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred CEEEEEEECCCCCCCCHHHHCCC--CCCCHHHHHHHHHHHHHHHHHCCCC---EEECCCCCHHEEECCCCCEEEEECCEE
T ss_conf 63899985357874101222034--4330899999999999998852299---885676722203668996876313500
Q ss_pred CCCCCCCCC--EEEEEEECCCCCCCHHHHHHC-CCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHH-
Q ss_conf 115899885--023333306898897777309-9995567899999999999499987778007999999997544210-
Q 002774 704 KSMSDSEKD--HITTQVKGTMGYLDPEYYMTQ-QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELY- 779 (882)
Q Consensus 704 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~- 779 (882)
+........ .......||+.|+|||++.+. .++.++||||+||++|||++|+.||....... .............
T Consensus 165 ~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~-~~~~i~~~~~~~~~ 243 (318)
T d3blha1 165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH-QLALISQLCGSITP 243 (318)
T ss_dssp EECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCT
T ss_pred EECCCCCCCCCCCCCCEECCHHHHHHHHHCCCCCCCCHHHCCCCCCEEEEHHHCCCCCCCCCHHH-HHHHHHHHCCCCCH
T ss_conf 22355444321135660249787428997079998917870067864661744879989989999-99999984189982
Q ss_pred H---------HHHCCCCCCCCCCCHH-------HHHHHHHHHHHHHCCCCCCCCCHHHHHHH
Q ss_conf 0---------1000388689988988-------89999999998000299999999999999
Q 002774 780 N---------LYELIDPTIGLSTTLK-------GFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 780 ~---------~~~~~~~~l~~~~~~~-------~~~~l~~li~~cl~~dP~~RPs~~eil~~ 825 (882)
. ................ ....+.+|+.+||+.||++|||++|++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHCCCCCHHHHHHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 55344320344433201334455503340444599899999999873896589099999749
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=0 Score=324.62 Aligned_cols=266 Identities=19% Similarity=0.242 Sum_probs=211.0
Q ss_pred CCCCCCCEEECCCCEEEEEEEEC-CCCEEEEEECCCCCCCCHHHHHHHHHHHHHCCC-CCEEEEEEEEEECCCEEEEEEE
Q ss_conf 19997780202573799999936-995899997246985408999999999971367-8701398889717936999982
Q 002774 555 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHH-KNLVSLLGFCFDRGEQMLIYEF 632 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~~~~~~~~~~~lV~e~ 632 (882)
++|.+.+.||+|+||+||+|+.. +++.||||++..... ...+.+|++.++.++| +|++.+++++.++...++||||
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~ 82 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 82 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCC--CHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEEEEEE
T ss_conf 806997998417882999999988997999999750258--299999999999964899987799996018811799996
Q ss_pred ECCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC-----CCCEEEEECCCCCCCC
Q ss_conf 06998566568898865539999999999999875311027998330588887669868-----9945694046651158
Q 002774 633 VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDE-----RLNAKVADFGLSKSMS 707 (882)
Q Consensus 633 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NIll~~-----~~~~kl~DfGla~~~~ 707 (882)
+ +++|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++. ++.+|++|||+|+.+.
T Consensus 83 ~-~~~l~~~~~~~~-~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~ 157 (293)
T d1csna_ 83 L-GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157 (293)
T ss_dssp C-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred C-CCCHHHHHHHHC-CCHHHHHHHHHHHHHHHHHHHHHHCC---CEECCCCCCCEEECCCCCCCCCCEEECCCCEEEECC
T ss_conf 4-888799997520-31106899999999999999999779---662667713152347543447956872366057714
Q ss_pred CCCCC-----EEEEEEECCCCCCCHHHHHHCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCH--HHHHHHHHHHHHHHHHH
Q ss_conf 99885-----023333306898897777309999556789999999999949998777800--79999999975442100
Q 002774 708 DSEKD-----HITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKY--IVREIRTVMDKKKELYN 780 (882)
Q Consensus 708 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~il~elltg~~P~~~~~~--~~~~~~~~~~~~~~~~~ 780 (882)
..... .......||+.|||||.+.+..++.++||||+|+++|||++|+.||..... .......+..... ...
T Consensus 158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~-~~~ 236 (293)
T d1csna_ 158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ-STP 236 (293)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH-HSC
T ss_pred CCCCCCCEEECCCCCEEECHHHCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHCCC-CCC
T ss_conf 6766541110246762775102679896488888699989831999999869876788530219999999970567-999
Q ss_pred HHHCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHCCCCC
Q ss_conf 100038868998898889999999998000299999999999999999999719999
Q 002774 781 LYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQAGLNP 837 (882)
Q Consensus 781 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~~~~ 837 (882)
..+ +.+ ..+.++.+++..|+..+|++||+++.+.+.|++++++.+...
T Consensus 237 ~~~-l~~--------~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~~ 284 (293)
T d1csna_ 237 LRE-LCA--------GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTE 284 (293)
T ss_dssp HHH-HTT--------TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCS
T ss_pred HHH-HCC--------CCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHCCCCC
T ss_conf 589-657--------998999999999843993008599999999999999759999
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=0 Score=325.68 Aligned_cols=257 Identities=18% Similarity=0.312 Sum_probs=200.0
Q ss_pred CCCCCCCEEECCCCEEEEEEEE-CCCCEEEEEECCCCCCCCHHHHHHHHHHHHHCC-CCCEEEEEEEEEEC--CCEEEEE
Q ss_conf 1999778020257379999993-699589999724698540899999999997136-78701398889717--9369999
Q 002774 555 NNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVH-HKNLVSLLGFCFDR--GEQMLIY 630 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~a~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~--~~~~lV~ 630 (882)
++|.+.++||+|+||+||+|+. .+++.||||+++.. ..+.+.+|+.+|+.++ ||||+++++++... ...++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCCCCEEEEE
T ss_conf 6718978983174819999998899979999998889---9999999999998515799876799999816877126888
Q ss_pred EEECCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCC-CEEEEECCCCCCCCCC
Q ss_conf 820699856656889886553999999999999987531102799833058888766986899-4569404665115899
Q 002774 631 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERL-NAKVADFGLSKSMSDS 709 (882)
Q Consensus 631 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NIll~~~~-~~kl~DfGla~~~~~~ 709 (882)
||+++|+|..+.+ .+++..+..++.|++.||.|||+++ |+||||||+|||++.++ .+|++|||+|+.....
T Consensus 112 e~~~~~~L~~~~~-----~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~ 183 (328)
T d3bqca1 112 EHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 183 (328)
T ss_dssp ECCCSCBGGGTTT-----SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred EECCCCCHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCEEECCCCCEEEECCCCCCEECCCC
T ss_conf 6317985899746-----8999999999999999998876433---4434564412377489983664156542664688
Q ss_pred CCCEEEEEEECCCCCCCHHHHHHC-CCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHH--HHHHH-----
Q ss_conf 885023333306898897777309-9995567899999999999499987778007999999997544--21001-----
Q 002774 710 EKDHITTQVKGTMGYLDPEYYMTQ-QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKK--ELYNL----- 781 (882)
Q Consensus 710 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~--~~~~~----- 781 (882)
.. .....+|+.|+|||.+.+. .++.++||||+||++|||++|+.||..+............... .....
T Consensus 184 ~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 260 (328)
T d3bqca1 184 QE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 260 (328)
T ss_dssp CC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred CC---CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCHHHHHHHHCC
T ss_conf 74---443224864247610268888884523233545558760488999887601899999999878841555554225
Q ss_pred -------HHCCCCC--------CCCCCCHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH
Q ss_conf -------0003886--------8998898889999999998000299999999999999
Q 002774 782 -------YELIDPT--------IGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 782 -------~~~~~~~--------l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 825 (882)
....... ...........++.+|+.+|++.||.+|||++|++++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp CCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCCCCCCHHCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 44474300000333433112115521124489999999999866995689089999649
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=329.78 Aligned_cols=258 Identities=25% Similarity=0.368 Sum_probs=199.7
Q ss_pred HCCCCCCCEEECCCCEEEEEEEE-CCCCEEEEEECCCCCCC--CHHHHHHHHHHHHHCCCCCEEEEEEEEEECC------
Q ss_conf 71999778020257379999993-69958999972469854--0899999999997136787013988897179------
Q 002774 554 TNNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQ--GGQEFKMEIELLSRVHHKNLVSLLGFCFDRG------ 624 (882)
Q Consensus 554 ~~~~~~~~~lG~G~fg~Vy~a~~-~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------ 624 (882)
.++|...+.||+|+||+||+|+. .+|+.||||+++..... ..+.+.+|+.+|+.++|||||++++++...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCCC
T ss_conf 77189988980177819999999999989999998522259699999999999998668987547999863576555541
Q ss_pred CEEEEEEEECCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCC
Q ss_conf 36999982069985665688988655399999999999998753110279983305888876698689945694046651
Q 002774 625 EQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSK 704 (882)
Q Consensus 625 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NIll~~~~~~kl~DfGla~ 704 (882)
..++||||+ +++|..+.+.. .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+|++|||+|+
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a~ 169 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 169 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEEECC-CCCHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCHHHCCCCCCCCCCCCCCEE
T ss_conf 599998405-52189998740---2269999999999999999987378---7645668511112100122113431022
Q ss_pred CCCCCCCCEEEEEEECCCCCCCHHHHHHC-CCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHH------
Q ss_conf 15899885023333306898897777309-99955678999999999994999877780079999999975442------
Q 002774 705 SMSDSEKDHITTQVKGTMGYLDPEYYMTQ-QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKE------ 777 (882)
Q Consensus 705 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~------ 777 (882)
..... .+...||+.|+|||.+.+. .++.++||||+||++|||++|+.||........... .......
T Consensus 170 ~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~~ 243 (346)
T d1cm8a_ 170 QADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKE-IMKVTGTPPAEFV 243 (346)
T ss_dssp ECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-HHHHHCCCCHHHH
T ss_pred CCCCC-----CCCCCCCCCCCCHHHHCCCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCHHHHHHH-HHHCCCCCCHHHH
T ss_conf 06876-----31024553335889981787899650103003899999978699888976899999-9850378848888
Q ss_pred -------HHHHHHCCCCCCCC----CCCHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH
Q ss_conf -------10010003886899----8898889999999998000299999999999999
Q 002774 778 -------LYNLYELIDPTIGL----STTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 778 -------~~~~~~~~~~~l~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 825 (882)
........ +.... .........+.+|+.+|++.||.+|||+.|++++
T Consensus 244 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 244 QRLQSDEAKNYMKGL-PELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp HTCSCHHHHHHHHHS-CCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHCCHHHHHHHCCC-CCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 653000344331157-8666556677556899999999999772995579299999639
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=329.47 Aligned_cols=265 Identities=21% Similarity=0.281 Sum_probs=199.8
Q ss_pred HCCCCCCCEEECCCCEEEEEEEE-CCCCEEEEEECCCCCC-CCHHHHHHHHHHHHHCCCCCEEEEEEEEEECC----CEE
Q ss_conf 71999778020257379999993-6995899997246985-40899999999997136787013988897179----369
Q 002774 554 TNNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRG----EQM 627 (882)
Q Consensus 554 ~~~~~~~~~lG~G~fg~Vy~a~~-~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----~~~ 627 (882)
+.+|.+.+.||+|+||+||+|+. .+|+.||||+++.... ...+.+.+|+.+|+.++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEE
T ss_conf 89859978994064809999999999949999998031095899999999999997689898858889950564554149
Q ss_pred EEEEEECCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCC
Q ss_conf 99982069985665688988655399999999999998753110279983305888876698689945694046651158
Q 002774 628 LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMS 707 (882)
Q Consensus 628 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NIll~~~~~~kl~DfGla~~~~ 707 (882)
++++|+.+|+|.+++... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+|+...
T Consensus 87 ~l~~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~ 160 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVAD 160 (345)
T ss_dssp EEEEECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEEECCCCHHHHHHCC---CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEECCCCCEEECCCCCEEECC
T ss_conf 999962598656644058---9999999999999999999999789---8677787643788799977875457056504
Q ss_pred CCCCC-EEEEEEECCCCCCCHHHHH-HCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHH-------
Q ss_conf 99885-0233333068988977773-09999556789999999999949998777800799999999754421-------
Q 002774 708 DSEKD-HITTQVKGTMGYLDPEYYM-TQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKEL------- 778 (882)
Q Consensus 708 ~~~~~-~~~~~~~gt~~y~aPE~~~-~~~~~~~sDVwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~------- 778 (882)
..... .......||+.|+|||++. ...++.++||||+||++|||++|+.||............ .......
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~ 239 (345)
T d1pmea_ 161 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI-LGILGSPSQEDLNC 239 (345)
T ss_dssp GGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH-HHHHCSCCHHHHHT
T ss_pred CCCCCCEEECCCCCCCEECHHHHHHCCCCCCCHHHHHCCCCEEHHHHHCCCCCCCCCHHHHHHHH-HHHCCCCCHHHHHH
T ss_conf 77764101011026520003878604788874101004670133776697997888889999987-65206997566423
Q ss_pred ------HHHHHCCCCCCCCCC---CHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH
Q ss_conf ------001000388689988---98889999999998000299999999999999
Q 002774 779 ------YNLYELIDPTIGLST---TLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 779 ------~~~~~~~~~~l~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 825 (882)
............... ......++.+|+.+|++.||.+|||+.|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 240 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 43322220244677557787778378999999999999764895679089998619
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=326.54 Aligned_cols=264 Identities=22% Similarity=0.300 Sum_probs=209.7
Q ss_pred CCCCCCCEEECCCCEEEEEEEE-CCCCEEEEEECCCCCC--CCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEEEE
Q ss_conf 1999778020257379999993-6995899997246985--408999999999971367870139888971793699998
Q 002774 555 NNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSM--QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYE 631 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~a~~-~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e 631 (882)
++|...+.||+|+||+||+|+. .+++.||||+++.... .....+.+|+.+++.++||||+++++++.+....++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEEE
T ss_conf 99786269712868199999999999699999980321786899999999999985675788821354444431158863
Q ss_pred EECCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCC
Q ss_conf 20699856656889886553999999999999987531102799833058888766986899456940466511589988
Q 002774 632 FVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEK 711 (882)
Q Consensus 632 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NIll~~~~~~kl~DfGla~~~~~~~~ 711 (882)
++.++++..++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+|++|||.|+.......
T Consensus 82 ~~~~~~l~~~~~~~~--~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~ 156 (292)
T d1unla_ 82 FCDQDLKKYFDSCNG--DLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR 156 (292)
T ss_dssp CCSEEHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS
T ss_pred ECCCCCCCCCCCCCC--CCCHHHHHHHHHHHHHHHHHHHCCC---EEEECCCCCCCCCCCCCCEEEEECCHHHCCCCCCC
T ss_conf 023322211212356--5403678999999999987743399---86001467612113378266520460110468875
Q ss_pred CEEEEEEECCCCCCCHHHHHHCC-CCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHH-----HHHHCC
Q ss_conf 50233333068988977773099-995567899999999999499987778007999999997544210-----010003
Q 002774 712 DHITTQVKGTMGYLDPEYYMTQQ-LTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELY-----NLYELI 785 (882)
Q Consensus 712 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDVwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~ 785 (882)
......++..|+|||.+.... ++.++||||+||++|||++|+.||..+.+..+....+........ ......
T Consensus 157 --~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (292)
T d1unla_ 157 --CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234 (292)
T ss_dssp --CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred --CCEEECCCCCHHHHHHHCCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCCHHHHHHHHHHHCCCCCHHHHHHHHHCC
T ss_conf --100103443101466750698888044402654188998518999988999999999998611899735513443222
Q ss_pred CC---------CCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH
Q ss_conf 88---------68998898889999999998000299999999999999
Q 002774 786 DP---------TIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 786 ~~---------~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 825 (882)
+. .............+.+|+.+|++.||.+|||++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CCCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 1133444544310433065689999999999864996689099999649
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=321.70 Aligned_cols=259 Identities=24% Similarity=0.311 Sum_probs=199.8
Q ss_pred CCCCCCCEEECCCCEEEEEEEEC-CCCEEEEEECCCCCCC--CHHHHHHHHHHHHHCCCCCEEEEEEEEEEC------CC
Q ss_conf 19997780202573799999936-9958999972469854--089999999999713678701398889717------93
Q 002774 555 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQ--GGQEFKMEIELLSRVHHKNLVSLLGFCFDR------GE 625 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~a~~~-~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~~ 625 (882)
++|.+.++||+|+||+||+|+.. +|+.||||+++..... ..+.+.+|+.++++++|||||++++++... ..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCCCCCCE
T ss_conf 77599889621758599999999999899999988233697999999999999986489876489989702564345762
Q ss_pred EEEEEEEECCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf 69999820699856656889886553999999999999987531102799833058888766986899456940466511
Q 002774 626 QMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKS 705 (882)
Q Consensus 626 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NIll~~~~~~kl~DfGla~~ 705 (882)
.|+||||+.++.+ +.+.. .+++..+..++.|++.||.|||+.| |+||||||+|||++.++.++++|||+++.
T Consensus 97 ~~iv~Ey~~~~l~-~~~~~----~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~~ 168 (355)
T d2b1pa1 97 VYLVMELMDANLC-QVIQM----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART 168 (355)
T ss_dssp EEEEEECCSEEHH-HHHTS----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEEEECCCHHHH-HHHHC----CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCCCCCCCCCEEEECHHHHHC
T ss_conf 6999841446778-76503----8999999999999999998865221---12456776321136544313201023211
Q ss_pred CCCCCCCEEEEEEECCCCCCCHHHHHHCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHH---------
Q ss_conf 58998850233333068988977773099995567899999999999499987778007999999997544---------
Q 002774 706 MSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKK--------- 776 (882)
Q Consensus 706 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~--------- 776 (882)
..... ......+|+.|+|||++.+..++.++||||+||+++||++|+.||........ ...+.....
T Consensus 169 ~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~-~~~i~~~~~~~~~~~~~~ 244 (355)
T d2b1pa1 169 AGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ-WNKVIEQLGTPCPEFMKK 244 (355)
T ss_dssp ---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHCCCCHHHHTT
T ss_pred CCCCC---CCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCHHHH-HHHHHHHCCCCCHHHHHH
T ss_conf 46665---53322146555581331477778774333566257898659899888977889-999997205898799987
Q ss_pred --H-HHHHHH------------CCCCC-CCC--CCCHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH
Q ss_conf --2-100100------------03886-899--8898889999999998000299999999999999
Q 002774 777 --E-LYNLYE------------LIDPT-IGL--STTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 777 --~-~~~~~~------------~~~~~-l~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 825 (882)
. ...... ..... ... ........++.+|+.+|++.||++|||++|++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp SCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 6566777764175435666421264333543210133379999999999876994579089999669
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=326.81 Aligned_cols=251 Identities=28% Similarity=0.359 Sum_probs=201.0
Q ss_pred CCCCCCCEEECCCCEEEEEEEE----CCCCEEEEEECCCCCC----CCHHHHHHHHHHHHHCCC-CCEEEEEEEEEECCC
Q ss_conf 1999778020257379999993----6995899997246985----408999999999971367-870139888971793
Q 002774 555 NNFSDANDVGSGGYGKVYKGTL----PNGQLIAIKRAQQGSM----QGGQEFKMEIELLSRVHH-KNLVSLLGFCFDRGE 625 (882)
Q Consensus 555 ~~~~~~~~lG~G~fg~Vy~a~~----~~g~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~H-~niv~l~~~~~~~~~ 625 (882)
++|...+.||+|+||+||+|+. .+|+.||||.++.... ...+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred HCEEEEEEEECCCCEEEEEEEECCCCCCCCEEEEEEEEHHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCC
T ss_conf 02599989832878399999987658879489999983677210168999999999999864679839996200024873
Q ss_pred EEEEEEEECCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf 69999820699856656889886553999999999999987531102799833058888766986899456940466511
Q 002774 626 QMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKS 705 (882)
Q Consensus 626 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NIll~~~~~~kl~DfGla~~ 705 (882)
.++|+||+.+|+|.+++.... .+.+.....++.|++.||+|+|+.+ |+||||||+||+++.++.+||+|||+|+.
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~--~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE 178 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred EEEEEECCCCCHHHHHHHHCC--CCCHHHHHHHHHHHHHHHHHHHCCC---EEECCCCCCCEEECCCCCEEEEECCCHHH
T ss_conf 001231234117999987304--5437888888999999998851499---89654773201246999888741320222
Q ss_pred CCCCCCCEEEEEEECCCCCCCHHHHHHC--CCCCHHHHHHHHHHHHHHHHCCCCCCCCCHH--HHHHHHHHHHHHHHHHH
Q ss_conf 5899885023333306898897777309--9995567899999999999499987778007--99999999754421001
Q 002774 706 MSDSEKDHITTQVKGTMGYLDPEYYMTQ--QLTEKSDVYSFGVLMLELLTGRRPIERGKYI--VREIRTVMDKKKELYNL 781 (882)
Q Consensus 706 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDVwSlG~il~elltg~~P~~~~~~~--~~~~~~~~~~~~~~~~~ 781 (882)
+...... ......|++.|+|||.+.+. .++.++||||+||++|||++|+.||...... ......... .
T Consensus 179 ~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~--~----- 250 (322)
T d1vzoa_ 179 FVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL--K----- 250 (322)
T ss_dssp CCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHH--H-----
T ss_pred HCCCCCC-CCCCCCCCCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHCC--C-----
T ss_conf 0344443-2212223333310687605776887132517777999999768999888877779999998335--6-----
Q ss_pred HHCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCC-----CHHHHHHH
Q ss_conf 000388689988988899999999980002999999-----99999999
Q 002774 782 YELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRP-----TMSEVVKD 825 (882)
Q Consensus 782 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~ 825 (882)
..+. .+.....++.+++.+||++||.+|| |++|++++
T Consensus 251 ---~~~~----~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 251 ---SEPP----YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp ---CCCC----CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred ---CCCC----CCCCCCHHHHHHHHHHCCCCHHHCCCCCCCCHHHHHCC
T ss_conf ---8998----86547999999999974458988199974509999749
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=319.42 Aligned_cols=259 Identities=24% Similarity=0.351 Sum_probs=199.3
Q ss_pred HCCCCCCCEEECCCCEEEEEEEE-CCCCEEEEEECCCCCCC--CHHHHHHHHHHHHHCCCCCEEEEEEEEEEC-----CC
Q ss_conf 71999778020257379999993-69958999972469854--089999999999713678701398889717-----93
Q 002774 554 TNNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQ--GGQEFKMEIELLSRVHHKNLVSLLGFCFDR-----GE 625 (882)
Q Consensus 554 ~~~~~~~~~lG~G~fg~Vy~a~~-~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~ 625 (882)
.++|...+.||+|+||+||+|+. .+|+.||||+++..... ..+.+.+|+.+++.++|+|||++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCCC
T ss_conf 98718888983178839999999999979999998820028689999999999998668987425999996346456686
Q ss_pred EEEEEEEECCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf 69999820699856656889886553999999999999987531102799833058888766986899456940466511
Q 002774 626 QMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKS 705 (882)
Q Consensus 626 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NIll~~~~~~kl~DfGla~~ 705 (882)
.+++++|+.+|+|.+++... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+|++|||+|..
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~---~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~~ 170 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARH 170 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----C
T ss_pred EEEEEEEECCCCHHHHCCCC---CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCCCCCCCCCCCCCCCCHHCC
T ss_conf 49999962588623200224---5309999999999999999997388---76516677633455432200132100012
Q ss_pred CCCCCCCEEEEEEECCCCCCCHHHHHHC-CCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHH-H----
Q ss_conf 5899885023333306898897777309-999556789999999999949998777800799999999754421-0----
Q 002774 706 MSDSEKDHITTQVKGTMGYLDPEYYMTQ-QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKEL-Y---- 779 (882)
Q Consensus 706 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~-~---- 779 (882)
.... .....|++.|+|||...+. .++.++||||+||++|+|++|+.||........ ...+....... .
T Consensus 171 ~~~~-----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~-~~~i~~~~~~~~~~~~~ 244 (348)
T d2gfsa1 171 TDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-LKLILRLVGTPGAELLK 244 (348)
T ss_dssp CTGG-----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCCHHHHT
T ss_pred CCCC-----CCCCCCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHH-HHHHHHHCCCCCHHHHH
T ss_conf 5754-----44434543555835533775678551243205899999768899788988999-99999730799757732
Q ss_pred --------HHHHCCCCCCCCCC----CHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH
Q ss_conf --------01000388689988----98889999999998000299999999999999
Q 002774 780 --------NLYELIDPTIGLST----TLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 825 (882)
Q Consensus 780 --------~~~~~~~~~l~~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 825 (882)
...... +...... ......++.+|+.+|++.||.+|||++|++++
T Consensus 245 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 245 KISSESARNYIQSL-TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp TCCCHHHHHHHTTS-CCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HCCCHHHHHHHHHC-CCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 00102445444303-5578755566267899999999999775883459389998559
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=0 Score=286.42 Aligned_cols=261 Identities=21% Similarity=0.244 Sum_probs=189.8
Q ss_pred CCCCCCEEECCCCEEEEEEEE-CCCCEEEEEECCCCCCCCHHHHHHHHHHHHHCC-----------CCCEEEEEEEEEEC
Q ss_conf 999778020257379999993-699589999724698540899999999997136-----------78701398889717
Q 002774 556 NFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVH-----------HKNLVSLLGFCFDR 623 (882)
Q Consensus 556 ~~~~~~~lG~G~fg~Vy~a~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------H~niv~l~~~~~~~ 623 (882)
+|.+.++||+|+||+||+|+. .+|+.||||+++.... ..+.+.+|+.+++.++ |+||+++++++...
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred CEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCC-CHHHHHHHHHHHHHHCCHHHHHHHHCCCCCEEEEEEEEEEC
T ss_conf 57998997507781899999999997999999834313-36899999999998401455555422767647899876312
Q ss_pred --CCEEEEEEEECCCCCC-CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCCCEEECCCCCCCEEECCCC------
Q ss_conf --9369999820699856-65688988655399999999999998753110-2799833058888766986899------
Q 002774 624 --GEQMLIYEFVPNGSLG-DSLSGKNGIRLDWIRRLKIALGAARGLSYLHE-LANPPIIHRDIKSSNILLDERL------ 693 (882)
Q Consensus 624 --~~~~lV~e~~~~gsL~-~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDik~~NIll~~~~------ 693 (882)
...+++++++..+... ..........+++..+..++.|++.||.|||+ .+ |+||||||+|||++.++
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~~ 169 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENLI 169 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTEE
T ss_pred CCCCEEEEEEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEEECCCCCCCCC
T ss_conf 565202343200035420000012234678689999999999999888764058---64656770570563057656443
Q ss_pred CEEEEECCCCCCCCCCCCCEEEEEEECCCCCCCHHHHHHCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHH-----HHHH
Q ss_conf 45694046651158998850233333068988977773099995567899999999999499987778007-----9999
Q 002774 694 NAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYI-----VREI 768 (882)
Q Consensus 694 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~il~elltg~~P~~~~~~~-----~~~~ 768 (882)
.++++|||.|...... .....||+.|+|||++....++.++||||+||+++||++|+.||...... ....
T Consensus 170 ~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~ 244 (362)
T d1q8ya_ 170 QIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 244 (362)
T ss_dssp EEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred EEEEEECCCCCCCCCC-----CCCCCCCCCCCCHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCHHHHH
T ss_conf 0567531442123445-----42236652105713214667776432012378999998788998987554321026899
Q ss_pred HHHHHHHH----HH-------HHHH------HCCCCC----------CCCCCCHHHHHHHHHHHHHHHCCCCCCCCCHHH
Q ss_conf 99997544----21-------0010------003886----------899889888999999999800029999999999
Q 002774 769 RTVMDKKK----EL-------YNLY------ELIDPT----------IGLSTTLKGFEKYVDLALKCVQESGDDRPTMSE 821 (882)
Q Consensus 769 ~~~~~~~~----~~-------~~~~------~~~~~~----------l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e 821 (882)
...+.... .. .... ..+... ...........++.+|+.+|+..||.+|||++|
T Consensus 245 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e 324 (362)
T d1q8ya_ 245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG 324 (362)
T ss_dssp HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred HHHHHHHCCCCHHHHHCCCCCCCCCCCCHHHHCCCCCCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHH
T ss_conf 99999837998788624532200013201220243235776444210001567435899999999987799457908999
Q ss_pred HHHH
Q ss_conf 9999
Q 002774 822 VVKD 825 (882)
Q Consensus 822 il~~ 825 (882)
++++
T Consensus 325 ~L~H 328 (362)
T d1q8ya_ 325 LVNH 328 (362)
T ss_dssp HHTC
T ss_pred HHCC
T ss_conf 9669
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=2.5e-40 Score=235.55 Aligned_cols=249 Identities=27% Similarity=0.430 Sum_probs=137.5
Q ss_pred CCCEEECCCCCCCCC--CCCCCCCCCCCCCEEEEEC-CCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCE
Q ss_conf 888985568999866--7894666777786898308-7477666512239888878984278587779867658788757
Q 002774 16 ELHTLDLSNNKDLRG--PLPTTIGNLKKLSNLMLVG-CSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYW 92 (882)
Q Consensus 16 ~L~~L~l~~n~~i~~--~~p~~l~~l~~L~~L~L~~-n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~ 92 (882)
.++.|+|+++. +.+ .+|..|+++++|++|+|++ |.+.+.+|..|+++++|++|+|++|++.+..+..+..+.+|+.
T Consensus 51 ~v~~L~L~~~~-l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~ 129 (313)
T d1ogqa_ 51 RVNNLDLSGLN-LPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT 129 (313)
T ss_dssp CEEEEEEECCC-CSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred EEEEEECCCCC-CCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCHHHHCC
T ss_conf 98899898998-88888798478467533520202654333002431145420011020356434433222220111001
Q ss_pred EECCCCEEEEECCCCCCCCCHHHHHHCCCCEECCCCEEEECCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCC-CE
Q ss_conf 66238643220489999995035432025112058710003794434885312000036996456688233489999-89
Q 002774 93 LDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSL-EV 171 (882)
Q Consensus 93 L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~~L~l~~N~l~g~i~~~~f~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L-~~ 171 (882)
+++++|.+.+.+|.. +..++.++.+++++|++.+ .+|..+..+..+ +.
T Consensus 130 l~l~~N~~~~~~p~~------l~~l~~L~~l~l~~n~l~~-------------------------~ip~~~~~l~~l~~~ 178 (313)
T d1ogqa_ 130 LDFSYNALSGTLPPS------ISSLPNLVGITFDGNRISG-------------------------AIPDSYGSFSKLFTS 178 (313)
T ss_dssp EECCSSEEESCCCGG------GGGCTTCCEEECCSSCCEE-------------------------ECCGGGGCCCTTCCE
T ss_pred CCCCCCCCCCCCCHH------HCCCCCCCEEECCCCCCCC-------------------------CCCCCCCCCCCCCCC
T ss_conf 111224555568512------2067400000023553356-------------------------203121443112323
Q ss_pred EECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCC-CCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCEEECCCCC
Q ss_conf 98468988799882587998889898548705446998-77999988898758978988888101289888889774784
Q 002774 172 VRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPN-LTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTN 250 (882)
Q Consensus 172 L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~-l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~ls~N~ 250 (882)
++++.|++++..+..+..+..+ .++++++...+.++. +..++.++.+++++|.+.+ . +..+..+++|+.|++++|+
T Consensus 179 l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~-~-~~~~~~~~~L~~L~Ls~N~ 255 (313)
T d1ogqa_ 179 MTISRNRLTGKIPPTFANLNLA-FVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAF-D-LGKVGLSKNLNGLDLRNNR 255 (313)
T ss_dssp EECCSSEEEEECCGGGGGCCCS-EEECCSSEEEECCGGGCCTTSCCSEEECCSSEECC-B-GGGCCCCTTCCEEECCSSC
T ss_pred CCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-C-CCCCCCCCCCCCCCCCCCE
T ss_conf 1022464353324332222222-33333343322222222222221112222222222-2-2222245544444476570
Q ss_pred CCCCCCCCCCCCCCCCEEECCCCCCCEECCCCCCCCCCCCCCCCCCCCC
Q ss_conf 6113894588999987898127724212278876321320003488422
Q 002774 251 LKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENLLVNLQNNRIS 299 (882)
Q Consensus 251 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~l~l~~N~l~ 299 (882)
++|.+|..+..+++|++|+|++|+++|.+|....+..+..+++++|+..
T Consensus 256 l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~~N~~l 304 (313)
T d1ogqa_ 256 IYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCL 304 (313)
T ss_dssp CEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEE
T ss_pred ECCCCCHHHHCCCCCCEEECCCCCCCCCCCCCCCCCCCCHHHHCCCCCC
T ss_conf 6660876884799999897958835166898666799897886889500
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=1.6e-37 Score=220.16 Aligned_cols=245 Identities=24% Similarity=0.433 Sum_probs=170.2
Q ss_pred CCCCEEEEECCCCCC--CCCCCCCCCCCCCEEECCC-CCCCCCCCCCCCCCCCCCEEECCCCEEEEECCCCCCCCCHHHH
Q ss_conf 778689830874776--6651223988887898427-8587779867658788757662386432204899999950354
Q 002774 40 KKLSNLMLVGCSFSG--PIPDSIGSLQELVLLSLNS-NGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDM 116 (882)
Q Consensus 40 ~~L~~L~L~~n~l~~--~~p~~l~~l~~L~~L~Ls~-N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~ 116 (882)
.+++.|+|++|++.+ .+|..++++++|++|+|++ |++.+.+|..|+++++|++|+|++|++.+..+
T Consensus 50 ~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~----------- 118 (313)
T d1ogqa_ 50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIP----------- 118 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECC-----------
T ss_pred EEEEEEECCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCC-----------
T ss_conf 798899898998888887984784675335202026543330024311454200110203564344332-----------
Q ss_pred HHCCCCEECCCCEEEECCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCC-CE
Q ss_conf 32025112058710003794434885312000036996456688233489999899846898879988258799888-98
Q 002774 117 LVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSV-ND 195 (882)
Q Consensus 117 L~~L~~L~l~~N~l~g~i~~~~f~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L-~~ 195 (882)
..+.....|+.++++.|.+.+.+|..+..++.|+.+++++|.+.+.+|..+..+..+ +.
T Consensus 119 --------------------~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~ 178 (313)
T d1ogqa_ 119 --------------------DFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTS 178 (313)
T ss_dssp --------------------GGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCE
T ss_pred --------------------CCCCCHHHHCCCCCCCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCC
T ss_conf --------------------222201110011112245555685122067400000023553356203121443112323
Q ss_pred EECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCC
Q ss_conf 98548705446998779999888987589789888881012898888897747846113894588999987898127724
Q 002774 196 LYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNEL 275 (882)
Q Consensus 196 L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 275 (882)
+++++|++++..+.......+..++++.|.+.+ .+|..+..++.|+.+++++|.+.+.++ .+..+++|+.|+|++|++
T Consensus 179 l~~~~n~l~~~~~~~~~~l~~~~l~l~~~~~~~-~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l 256 (313)
T d1ogqa_ 179 MTISRNRLTGKIPPTFANLNLAFVDLSRNMLEG-DASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRI 256 (313)
T ss_dssp EECCSSEEEEECCGGGGGCCCSEEECCSSEEEE-CCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCC
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCEE
T ss_conf 102246435332433222222233333343322-222222222221112222222222222-222455444444765706
Q ss_pred CEECCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCC
Q ss_conf 21227887-63213200034884224567999886435882176
Q 002774 276 NGTLDLGT-SYSENLLVNLQNNRISAYTERGGAPAVNLTLIDNP 318 (882)
Q Consensus 276 ~~~~~~~~-~~~~l~~l~l~~N~l~~~~~~~~~~~~~l~~l~~~ 318 (882)
.+.+|..+ .+++|+.|++++|++++..|. +..+.+|+.++..
T Consensus 257 ~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~-~~~L~~L~~l~l~ 299 (313)
T d1ogqa_ 257 YGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYA 299 (313)
T ss_dssp EECCCGGGGGCTTCCEEECCSSEEEEECCC-STTGGGSCGGGTC
T ss_pred CCCCCHHHHCCCCCCEEECCCCCCCCCCCC-CCCCCCCCHHHHC
T ss_conf 660876884799999897958835166898-6667998978868
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.5e-33 Score=198.16 Aligned_cols=267 Identities=22% Similarity=0.271 Sum_probs=208.8
Q ss_pred CCCEEECCCCCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEC
Q ss_conf 88898556899986678946667777868983087477666512239888878984278587779867658788757662
Q 002774 16 ELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDL 95 (882)
Q Consensus 16 ~L~~L~l~~n~~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 95 (882)
.++.+|-++++ ...+|..+. +.+++|+|++|+|+...+.+|.++++|++|++++|.+....|..|.++++|++|++
T Consensus 11 ~~~~~~C~~~~--L~~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l 86 (305)
T d1xkua_ 11 HLRVVQCSDLG--LEKVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYL 86 (305)
T ss_dssp ETTEEECTTSC--CCSCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEEC
T ss_pred CCCEEEECCCC--CCCCCCCCC--CCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCEECC
T ss_conf 59999855999--885198889--99798978499189869657604656523112344344523566527985578315
Q ss_pred CCCEEEEECCCCCCCCCHHHHHHCCCCEECCCCEEEECCCCCCCCCCCCCEEEECCCCCCC--CCCCCCCCCCCCCCEEE
Q ss_conf 3864322048999999503543202511205871000379443488531200003699645--66882334899998998
Q 002774 96 TDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLT--GELPATLGLVKSLEVVR 173 (882)
Q Consensus 96 s~N~l~~~~p~~~~~l~~l~~L~~L~~L~l~~N~l~g~i~~~~f~~~~~L~~L~L~~N~l~--~~~p~~l~~l~~L~~L~ 173 (882)
++|+++ .+|..+ ...+..|.+..|.+. .++...+.....+..+....|... ...+..+..+++|+.++
T Consensus 87 ~~n~l~-~l~~~~--------~~~l~~L~~~~n~l~-~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~ 156 (305)
T d1xkua_ 87 SKNQLK-ELPEKM--------PKTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIR 156 (305)
T ss_dssp CSSCCS-BCCSSC--------CTTCCEEECCSSCCC-BBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEE
T ss_pred CCCCCC-CCCCCH--------HHHHHHHHCCCCCHH-HHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 687567-676400--------111323210246102-3444454013311000012333334677764223456567120
Q ss_pred CCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCC-CCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCC
Q ss_conf 468988799882587998889898548705446998-7799998889875897898888810128988888977478461
Q 002774 174 FDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPN-LTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLK 252 (882)
Q Consensus 174 l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~-l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~ls~N~l~ 252 (882)
+++|.+. .++..+ +++|+.|++++|..+..++. +.+++.++.|++++|.+.. ..+.++..+++|+.|+|++|.|+
T Consensus 157 l~~n~l~-~l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~-~~~~~~~~l~~L~~L~L~~N~L~ 232 (305)
T d1xkua_ 157 IADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISA-VDNGSLANTPHLRELHLNNNKLV 232 (305)
T ss_dssp CCSSCCC-SCCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCE-ECTTTGGGSTTCCEEECCSSCCS
T ss_pred CCCCCCC-CCCCCC--CCCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCEEEECCCCCCC
T ss_conf 3467745-167101--7766789897886778882676413413301544553322-23454334433224302554002
Q ss_pred CCCCCCCCCCCCCCEEECCCCCCCEECCCCC-------CCCCCCCCCCCCCCCCCC
Q ss_conf 1389458899998789812772421227887-------632132000348842245
Q 002774 253 GQIPADLFSIPHLQTVVMKTNELNGTLDLGT-------SYSENLLVNLQNNRISAY 301 (882)
Q Consensus 253 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~-------~~~~l~~l~l~~N~l~~~ 301 (882)
.+|..+..+++|++|+|++|+++......+ ....+..+++.+|++...
T Consensus 233 -~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~~ 287 (305)
T d1xkua_ 233 -KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYW 287 (305)
T ss_dssp -SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGG
T ss_pred -CCCCCCCCCCCCCEEECCCCCCCCCCHHHCCCCCHHCCCCCCCEEECCCCCCCCC
T ss_conf -4631103346789898989865763810026721002158889788989957667
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=100.00 E-value=8.1e-34 Score=199.69 Aligned_cols=284 Identities=22% Similarity=0.279 Sum_probs=192.9
Q ss_pred CCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCC
Q ss_conf 55888888985568999866789466677778689830874776665122398888789842785877798676587887
Q 002774 11 ITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNL 90 (882)
Q Consensus 11 l~~l~~L~~L~l~~n~~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L 90 (882)
...+.+|++|+++++. |... +.+..+++|++|+|++|+|++ ++ .|.++++|++|++++|+|.+. + .++++++|
T Consensus 40 ~~~l~~l~~L~l~~~~-I~~l--~gl~~L~nL~~L~Ls~N~l~~-l~-~l~~L~~L~~L~L~~n~i~~i-~-~l~~l~~L 112 (384)
T d2omza2 40 QTDLDQVTTLQADRLG-IKSI--DGVEYLNNLTQINFSNNQLTD-IT-PLKNLTKLVDILMNNNQIADI-T-PLANLTNL 112 (384)
T ss_dssp HHHHTTCCEEECCSSC-CCCC--TTGGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCCC-G-GGTTCTTC
T ss_pred HHHHCCCCEEECCCCC-CCCC--CCCCCCCCCCEEECCCCCCCC-CC-CCCCCCCCCCCCCCCCCCCCC-C-CCCCCCCC
T ss_conf 8895787899899989-8776--242458999989681881798-86-334771101030134333222-2-11123343
Q ss_pred CEEECCCCEEEEECCCC---------------------------------------------------------CCCCCH
Q ss_conf 57662386432204899---------------------------------------------------------999950
Q 002774 91 YWLDLTDNKLEGEIPVS---------------------------------------------------------DGNSPG 113 (882)
Q Consensus 91 ~~L~Ls~N~l~~~~p~~---------------------------------------------------------~~~l~~ 113 (882)
+.|++++|.+.+..+.. ......
T Consensus 113 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (384)
T d2omza2 113 TGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISV 192 (384)
T ss_dssp CEEECCSSCCCCCGGGTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCCCCGG
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCC
T ss_conf 33443322222222222222221121346631310023222211222221232201111245421101122243332110
Q ss_pred HHHHHCCCCEECCCCEEEECCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCC
Q ss_conf 35432025112058710003794434885312000036996456688233489999899846898879988258799888
Q 002774 114 LDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSV 193 (882)
Q Consensus 114 l~~L~~L~~L~l~~N~l~g~i~~~~f~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L 193 (882)
...++.++.+++++|.+++ ++. +...++|+.|++++|.++.. ..+..+++|+.|++++|.+++.. .+..+++|
T Consensus 193 ~~~l~~~~~l~l~~n~i~~-~~~--~~~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~--~~~~~~~L 265 (384)
T d2omza2 193 LAKLTNLESLIATNNQISD-ITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLA--PLSGLTKL 265 (384)
T ss_dssp GGGCTTCSEEECCSSCCCC-CGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCG--GGTTCTTC
T ss_pred CCCCCCCCEEECCCCCCCC-CCC--CCCCCCCCEEECCCCCCCCC--CHHHCCCCCCHHCCCCCCCCCCC--CCCCCCCC
T ss_conf 0223532333035774478-786--44457787888877777896--13432565341004467447877--53554668
Q ss_pred CEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCC
Q ss_conf 98985487054469987799998889875897898888810128988888977478461138945889999878981277
Q 002774 194 NDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTN 273 (882)
Q Consensus 194 ~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 273 (882)
+.|++++|.+++.. .+..++.++.++++.|.+.+ ...+..++.++.|++++|++.+.. .+..+++|+.|++++|
T Consensus 266 ~~L~l~~~~l~~~~-~~~~~~~l~~l~~~~n~l~~---~~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n 339 (384)
T d2omza2 266 TELKLGANQISNIS-PLAGLTALTNLELNENQLED---ISPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANN 339 (384)
T ss_dssp SEEECCSSCCCCCG-GGTTCTTCSEEECCSSCCSC---CGGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSS
T ss_pred CEEECCCCCCCCCC-CCCCCCCCCCCCCCCCCCCC---CCCCCHHCCCCEEECCCCCCCCCC--CCCCCCCCCEEECCCC
T ss_conf 77545674457877-32356522223323233333---221000024676777788778984--5366898898989899
Q ss_pred CCCEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECC
Q ss_conf 24212278876321320003488422456799988643588217
Q 002774 274 ELNGTLDLGTSYSENLLVNLQNNRISAYTERGGAPAVNLTLIDN 317 (882)
Q Consensus 274 ~l~~~~~~~~~~~~l~~l~l~~N~l~~~~~~~~~~~~~l~~l~~ 317 (882)
+++.. +....+++|+.|++++|+++++++ +..+.+|+.++.
T Consensus 340 ~l~~l-~~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L 380 (384)
T d2omza2 340 KVSDV-SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGL 380 (384)
T ss_dssp CCCCC-GGGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEEC
T ss_pred CCCCC-HHHCCCCCCCEEECCCCCCCCCHH--HCCCCCCCEEEC
T ss_conf 89997-467089999989897995899800--003999999639
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-34 Score=202.77 Aligned_cols=252 Identities=17% Similarity=0.139 Sum_probs=175.7
Q ss_pred EEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCEEEEECCCCCCCCCHHHHHHCCCCE
Q ss_conf 89830874776665122398888789842785877798676587887576623864322048999999503543202511
Q 002774 44 NLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHF 123 (882)
Q Consensus 44 ~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~~L 123 (882)
.+++++++++ .+|..+. ..+++|+|++|+|+++.+.+|.++++|++|++++|++....+..+..+ ..+..+
T Consensus 15 ~v~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~------~~~~~l 85 (284)
T d1ozna_ 15 TTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGL------ALLEQL 85 (284)
T ss_dssp EEECCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTC------TTCCEE
T ss_pred EEECCCCCCC-CCCCCCC--CCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCC------CCCCCC
T ss_conf 9984799989-4497889--998889774881798797786414213000013445433211121222------222222
Q ss_pred EC-CCCEEEECCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCC
Q ss_conf 20-58710003794434885312000036996456688233489999899846898879988258799888989854870
Q 002774 124 HF-GKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNK 202 (882)
Q Consensus 124 ~l-~~N~l~g~i~~~~f~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~ 202 (882)
.. ..|.+. .++...|..+++|+.|+++.|.+....+..+....+|+.+++++|.+++..+..|..+++|+.|++++|+
T Consensus 86 ~~~~~~~~~-~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~ 164 (284)
T d1ozna_ 86 DLSDNAQLR-SVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNR 164 (284)
T ss_dssp ECCSCTTCC-CCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred CCCCCCCCC-CCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCHHCCCCHHHHCCCCCCCCCHHHHCCCCCHHHCCCCCCC
T ss_conf 222102235-4462010101027787568854432013533200012110200143144580574043405022314176
Q ss_pred CCCCCCC-CCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCEECCC
Q ss_conf 5446998-779999888987589789888881012898888897747846113894588999987898127724212278
Q 002774 203 LTGAMPN-LTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDL 281 (882)
Q Consensus 203 l~~~~~~-l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~ 281 (882)
++.+++. +.++++|+.+++++|++++ ..|..|..+++|+.|++++|.+.+..+..+..+++|++|+|++|++.+..+.
T Consensus 165 l~~l~~~~f~~l~~L~~l~l~~N~l~~-i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~~ 243 (284)
T d1ozna_ 165 ISSVPERAFRGLHSLDRLLLHQNRVAH-VHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA 243 (284)
T ss_dssp CCEECTTTTTTCTTCCEEECCSSCCCE-ECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGG
T ss_pred CCCCCHHHHCCCCCCCHHHHHHCCCCC-CCHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCC
T ss_conf 566256665465634131421143466-2816766532000233333522100000235546568898119988787564
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 8763213200034884224567999
Q 002774 282 GTSYSENLLVNLQNNRISAYTERGG 306 (882)
Q Consensus 282 ~~~~~~l~~l~l~~N~l~~~~~~~~ 306 (882)
.+-...++.+....+.+.+..+..+
T Consensus 244 ~~l~~~l~~~~~~~~~~~C~~p~~l 268 (284)
T d1ozna_ 244 RPLWAWLQKFRGSSSEVPCSLPQRL 268 (284)
T ss_dssp HHHHHHHHHCCSEECCCBEEESGGG
T ss_pred HHHHHHHHHCCCCCCCEEECCCHHH
T ss_conf 6999999867388886674796698
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3.5e-32 Score=190.74 Aligned_cols=258 Identities=23% Similarity=0.298 Sum_probs=195.3
Q ss_pred CCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCC
Q ss_conf 97102585655888888985568999866789466677778689830874776665122398888789842785877798
Q 002774 2 GLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVP 81 (882)
Q Consensus 2 ~~~~~l~~~l~~l~~L~~L~l~~n~~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p 81 (882)
+++ ++|..+. +++++|+|++|+ +....+..|.++++|++|++++|.+....|..|.++++|++|++++|+|+ .+|
T Consensus 21 ~L~-~lP~~l~--~~l~~L~Ls~N~-i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n~l~-~l~ 95 (305)
T d1xkua_ 21 GLE-KVPKDLP--PDTALLDLQNNK-ITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELP 95 (305)
T ss_dssp CCC-SCCCSCC--TTCCEEECCSSC-CCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCS-BCC
T ss_pred CCC-CCCCCCC--CCCCEEECCCCC-CCCCCHHHHHCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCEECCCCCCCC-CCC
T ss_conf 988-5198889--997989784991-89869657604656523112344344523566527985578315687567-676
Q ss_pred CCCCCCCCCCEEECCCCEEEEECCCCCCCCCHHHHHHCCCCEECCCCEEEE-CCCCCCCCCCCCCEEEECCCCCCCCCCC
Q ss_conf 676587887576623864322048999999503543202511205871000-3794434885312000036996456688
Q 002774 82 PSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSG-SIPEKLFRPDMVLIHVLFDSNNLTGELP 160 (882)
Q Consensus 82 ~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~~L~l~~N~l~g-~i~~~~f~~~~~L~~L~L~~N~l~~~~p 160 (882)
..+. ..+..|++.+|.+....+. .+.....+..++...|.... ......|..+++|+.+.+++|.+.. ++
T Consensus 96 ~~~~--~~l~~L~~~~n~l~~l~~~------~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~~-l~ 166 (305)
T d1xkua_ 96 EKMP--KTLQELRVHENEITKVRKS------VFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT-IP 166 (305)
T ss_dssp SSCC--TTCCEEECCSSCCCBBCHH------HHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS-CC
T ss_pred CCHH--HHHHHHHCCCCCHHHHHHH------HHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CC
T ss_conf 4001--1132321024610234444------5401331100001233333467776422345656712034677451-67
Q ss_pred CCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCC-CCCCCCCCEEECCCCCCCCCCCCCCCCCCC
Q ss_conf 2334899998998468988799882587998889898548705446998-779999888987589789888881012898
Q 002774 161 ATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPN-LTGLSVLSYLDMSNNSFDASEVPSWFSSMQ 239 (882)
Q Consensus 161 ~~l~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~-l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~ 239 (882)
..+ +++|+.|++++|.+....+..+..++.++.|++++|.+++.++. +.++++|+.|+|++|+++ .+|.+|..++
T Consensus 167 ~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~--~lp~~l~~l~ 242 (305)
T d1xkua_ 167 QGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV--KVPGGLADHK 242 (305)
T ss_dssp SSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS--SCCTTTTTCS
T ss_pred CCC--CCCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCC--CCCCCCCCCC
T ss_conf 101--776678989788677888267641341330154455332223454334433224302554002--4631103346
Q ss_pred CCCEEECCCCCCCCCCCCC------CCCCCCCCEEECCCCCCCE
Q ss_conf 8888977478461138945------8899998789812772421
Q 002774 240 SLTTLMMENTNLKGQIPAD------LFSIPHLQTVVMKTNELNG 277 (882)
Q Consensus 240 ~L~~L~ls~N~l~~~~p~~------~~~l~~L~~L~Ls~N~l~~ 277 (882)
+|+.|++++|+|+...... ...+++|+.|+|++|++..
T Consensus 243 ~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~ 286 (305)
T d1xkua_ 243 YIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQY 286 (305)
T ss_dssp SCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCG
T ss_pred CCCEEECCCCCCCCCCHHHCCCCCHHCCCCCCCEEECCCCCCCC
T ss_conf 78989898986576381002672100215888978898995766
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=100.00 E-value=1.8e-32 Score=192.29 Aligned_cols=257 Identities=20% Similarity=0.330 Sum_probs=119.5
Q ss_pred CCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCEEEEECCCCCCCCCHHHH
Q ss_conf 67777868983087477666512239888878984278587779867658788757662386432204899999950354
Q 002774 37 GNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDM 116 (882)
Q Consensus 37 ~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~ 116 (882)
..+.+|++|++++|+|+. + ..+..+++|++|+|++|+|+. ++ .++++++|++|++++|++.+.. .+..
T Consensus 41 ~~l~~l~~L~l~~~~I~~-l-~gl~~L~nL~~L~Ls~N~l~~-l~-~l~~L~~L~~L~L~~n~i~~i~--------~l~~ 108 (384)
T d2omza2 41 TDLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTD-IT-PLKNLTKLVDILMNNNQIADIT--------PLAN 108 (384)
T ss_dssp HHHTTCCEEECCSSCCCC-C-TTGGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCCCG--------GGTT
T ss_pred HHHCCCCEEECCCCCCCC-C-CCCCCCCCCCEEECCCCCCCC-CC-CCCCCCCCCCCCCCCCCCCCCC--------CCCC
T ss_conf 895787899899989877-6-242458999989681881798-86-3347711010301343332222--------1112
Q ss_pred HHCCCCEECCCCEEEECCC-------------------------------------------------------------
Q ss_conf 3202511205871000379-------------------------------------------------------------
Q 002774 117 LVRAKHFHFGKNQLSGSIP------------------------------------------------------------- 135 (882)
Q Consensus 117 L~~L~~L~l~~N~l~g~i~------------------------------------------------------------- 135 (882)
+++|+.+++.+|.+.+...
T Consensus 109 l~~L~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (384)
T d2omza2 109 LTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVS 188 (384)
T ss_dssp CTTCCEEECCSSCCCCCGGGTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCC
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCC
T ss_conf 33433344332222222222222222112134663131002322221122222123220111124542110112224333
Q ss_pred -CCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCC
Q ss_conf -4434885312000036996456688233489999899846898879988258799888989854870544699877999
Q 002774 136 -EKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLS 214 (882)
Q Consensus 136 -~~~f~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~l~~l~ 214 (882)
...+...+++..+++++|.+.+..+ +..+++|+.|++++|.++. + ..+..+++|+.|++++|.+++.++ +..++
T Consensus 189 ~~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~l~~n~l~~~~~-~~~~~ 263 (384)
T d2omza2 189 DISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD-I-GTLASLTNLTDLDLANNQISNLAP-LSGLT 263 (384)
T ss_dssp CCGGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCCCGG-GTTCT
T ss_pred CCCCCCCCCCCCEEECCCCCCCCCCC--CCCCCCCCEEECCCCCCCC-C-CHHHCCCCCCHHCCCCCCCCCCCC-CCCCC
T ss_conf 21100223532333035774478786--4445778788887777789-6-134325653410044674478775-35546
Q ss_pred CCCEEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCEECCCCCCCCCCCCCCCC
Q ss_conf 98889875897898888810128988888977478461138945889999878981277242122788763213200034
Q 002774 215 VLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENLLVNLQ 294 (882)
Q Consensus 215 ~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~l~l~ 294 (882)
+|+.|++++|.+.. .+ .+..++.++.+.++.|.+.+ ...+..+++++.|++++|++.+..+ ...+++++.|+++
T Consensus 264 ~L~~L~l~~~~l~~--~~-~~~~~~~l~~l~~~~n~l~~--~~~~~~~~~l~~L~ls~n~l~~l~~-l~~l~~L~~L~L~ 337 (384)
T d2omza2 264 KLTELKLGANQISN--IS-PLAGLTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDISP-VSSLTKLQRLFFA 337 (384)
T ss_dssp TCSEEECCSSCCCC--CG-GGTTCTTCSEEECCSSCCSC--CGGGGGCTTCSEEECCSSCCSCCGG-GGGCTTCCEEECC
T ss_pred CCCEEECCCCCCCC--CC-CCCCCCCCCCCCCCCCCCCC--CCCCCHHCCCCEEECCCCCCCCCCC-CCCCCCCCEEECC
T ss_conf 68775456744578--77-32356522223323233333--2210000246767777887789845-3668988989898
Q ss_pred CCCCCCCCCCCCCCCCCEEEECCC
Q ss_conf 884224567999886435882176
Q 002774 295 NNRISAYTERGGAPAVNLTLIDNP 318 (882)
Q Consensus 295 ~N~l~~~~~~~~~~~~~l~~l~~~ 318 (882)
+|+++.++ .+..+++|+.++..
T Consensus 338 ~n~l~~l~--~l~~l~~L~~L~l~ 359 (384)
T d2omza2 338 NNKVSDVS--SLANLTNINWLSAG 359 (384)
T ss_dssp SSCCCCCG--GGGGCTTCCEEECC
T ss_pred CCCCCCCH--HHCCCCCCCEEECC
T ss_conf 99899974--67089999989897
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-32 Score=191.35 Aligned_cols=252 Identities=20% Similarity=0.209 Sum_probs=168.4
Q ss_pred CEEECCCCCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECC-
Q ss_conf 8985568999866789466677778689830874776665122398888789842785877798676587887576623-
Q 002774 18 HTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLT- 96 (882)
Q Consensus 18 ~~L~l~~n~~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls- 96 (882)
..++.++++ ...+|..+. +.+++|+|++|.|+...+.+|..+++|++|++++|+|....+..+.++..+..++..
T Consensus 14 ~~v~c~~~~--L~~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~ 89 (284)
T d1ozna_ 14 VTTSCPQQG--LQAVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSD 89 (284)
T ss_dssp CEEECCSSC--CSSCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred EEEECCCCC--CCCCCCCCC--CCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 699847999--894497889--9988897748817987977864142130000134454332111212222222222221
Q ss_pred CCEEEEECCCCCCCCCHHHHHHCCCCEECCCCEEEECCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCEEECCC
Q ss_conf 86432204899999950354320251120587100037944348853120000369964566882334899998998468
Q 002774 97 DNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDR 176 (882)
Q Consensus 97 ~N~l~~~~p~~~~~l~~l~~L~~L~~L~l~~N~l~g~i~~~~f~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~ 176 (882)
.|.+....+.. +..+++|+.|++++|.+. .++...+....+|+.+++++|.++++.+..|..+++|+.|++++
T Consensus 90 ~~~~~~l~~~~------~~~l~~L~~L~l~~n~~~-~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~ 162 (284)
T d1ozna_ 90 NAQLRSVDPAT------FHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHG 162 (284)
T ss_dssp CTTCCCCCTTT------TTTCTTCCEEECTTSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCCCCCCCCHH------HCCCCCCCEEECCCCCCC-CCCCCCCCHHCCCCHHHHCCCCCCCCCHHHHCCCCCHHHCCCCC
T ss_conf 02235446201------010102778756885443-20135332000121102001431445805740434050223141
Q ss_pred CCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCC-CCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCC
Q ss_conf 988799882587998889898548705446998-7799998889875897898888810128988888977478461138
Q 002774 177 NSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPN-LTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQI 255 (882)
Q Consensus 177 N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~-l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~ls~N~l~~~~ 255 (882)
|.++...+..+.++++|+.+++++|++++..+. +.++++|+.|++++|.+.. ..+..|..+++|+.|++++|.+...-
T Consensus 163 N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~-~~~~~~~~~~~L~~L~l~~N~l~C~C 241 (284)
T d1ozna_ 163 NRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSA-LPTEALAPLRALQYLRLNDNPWVCDC 241 (284)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSC-CCHHHHTTCTTCCEEECCSSCEECSG
T ss_pred CCCCCCCHHHHCCCCCCCHHHHHHCCCCCCCHHHHHHHHHCCCCCCCCCCCCC-CCCCCCCCCCCCCEEEECCCCCCCCC
T ss_conf 76566256665465634131421143466281676653200023333352210-00002355465688981199887875
Q ss_pred CCCCCCCCCCCEEECCCCCCCEECCCC
Q ss_conf 945889999878981277242122788
Q 002774 256 PADLFSIPHLQTVVMKTNELNGTLDLG 282 (882)
Q Consensus 256 p~~~~~l~~L~~L~Ls~N~l~~~~~~~ 282 (882)
.. ..-...++.+....+.+.+..|..
T Consensus 242 ~~-~~l~~~l~~~~~~~~~~~C~~p~~ 267 (284)
T d1ozna_ 242 RA-RPLWAWLQKFRGSSSEVPCSLPQR 267 (284)
T ss_dssp GG-HHHHHHHHHCCSEECCCBEEESGG
T ss_pred CC-HHHHHHHHHCCCCCCCEEECCCHH
T ss_conf 64-699999986738888667479669
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.6e-30 Score=181.55 Aligned_cols=204 Identities=21% Similarity=0.261 Sum_probs=140.1
Q ss_pred CCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCEEEEECCCCCCCCCHHHH
Q ss_conf 67777868983087477666512239888878984278587779867658788757662386432204899999950354
Q 002774 37 GNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDM 116 (882)
Q Consensus 37 ~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~ 116 (882)
.+...+.+++.++++++ .+|..+. ++|++|+|++|+|++..+..|.++++|++|+|++|+|+ .+|.
T Consensus 7 ~~~~~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~~---------- 72 (266)
T d1p9ag_ 7 SKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQV---------- 72 (266)
T ss_dssp ECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEEC----------
T ss_pred CCCCCCEEEECCCCCCC-EECCCCC--CCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCC-CCCC----------
T ss_conf 42689869980699988-6196757--68898988499289859778634565522135665444-4311----------
Q ss_pred HHCCCCEECCCCEEEECCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEE
Q ss_conf 32025112058710003794434885312000036996456688233489999899846898879988258799888989
Q 002774 117 LVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDL 196 (882)
Q Consensus 117 L~~L~~L~l~~N~l~g~i~~~~f~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L 196 (882)
+..+++|+.|+|++|++. ..+..+..+++|+.|++++|.+....+..+..+.+++.|
T Consensus 73 ----------------------~~~l~~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L 129 (266)
T d1p9ag_ 73 ----------------------DGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQEL 129 (266)
T ss_dssp ----------------------CSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEE
T ss_pred ----------------------CCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCC
T ss_conf ----------------------111223211111222221-111121222222222222231101100112222111122
Q ss_pred ECCCCCCCCCCCC-CCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCC
Q ss_conf 8548705446998-779999888987589789888881012898888897747846113894588999987898127724
Q 002774 197 YLSNNKLTGAMPN-LTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNEL 275 (882)
Q Consensus 197 ~Ls~N~l~~~~~~-l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 275 (882)
++++|.++.+++. +..++.|+.|++++|+++. ..+..|..+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|++
T Consensus 130 ~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~-~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~ 207 (266)
T d1p9ag_ 130 YLKGNELKTLPPGLLTPTPKLEKLSLANNNLTE-LPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207 (266)
T ss_dssp ECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSC-CCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCB
T ss_pred CCCCCCCCEECCCCCCCCCCCHHCCCCCCCCCC-CCCCCCCCCCCCCEEECCCCCCC-CCCHHHCCCCCCCEEEECCCCC
T ss_conf 124342102212333221110000000156522-37200134212423430139785-5686677788899998369998
Q ss_pred CEEC
Q ss_conf 2122
Q 002774 276 NGTL 279 (882)
Q Consensus 276 ~~~~ 279 (882)
.+..
T Consensus 208 ~CdC 211 (266)
T d1p9ag_ 208 LCNC 211 (266)
T ss_dssp CCSG
T ss_pred CCCC
T ss_conf 7886
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.2e-29 Score=176.71 Aligned_cols=201 Identities=21% Similarity=0.257 Sum_probs=105.3
Q ss_pred CCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCC
Q ss_conf 58888889855689998667894666777786898308747766651223988887898427858777986765878875
Q 002774 12 TGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLY 91 (882)
Q Consensus 12 ~~l~~L~~L~l~~n~~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~ 91 (882)
.....+.++|.++++ ++ .+|..+. +.|++|+|++|.|+...+.+|.++++|++|+|++|+|+. ++ .++.+++|+
T Consensus 7 ~~~~~~~~v~C~~~~-L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~-l~-~~~~l~~L~ 80 (266)
T d1p9ag_ 7 SKVASHLEVNCDKRN-LT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQ-VDGTLPVLG 80 (266)
T ss_dssp ECSTTCCEEECTTSC-CS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE-EE-CCSCCTTCC
T ss_pred CCCCCCEEEECCCCC-CC-EECCCCC--CCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCC-CC-CCCCCCCCC
T ss_conf 426898699806999-88-6196757--688989884992898597786345655221356654444-31-111122321
Q ss_pred EEECCCCEEEEECCCCCCCCCHHHHHHCCCCEECCCCEEEECCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCE
Q ss_conf 76623864322048999999503543202511205871000379443488531200003699645668823348999989
Q 002774 92 WLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEV 171 (882)
Q Consensus 92 ~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~~L~l~~N~l~g~i~~~~f~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~ 171 (882)
+|+|++|++. ..+.. +..++.|+.|++++|.+. .++...+..+.+++.|++++|.+....+..+..++.|+.
T Consensus 81 ~L~Ls~N~l~-~~~~~------~~~l~~L~~L~l~~~~~~-~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~ 152 (266)
T d1p9ag_ 81 TLDLSHNQLQ-SLPLL------GQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEK 152 (266)
T ss_dssp EEECCSSCCS-SCCCC------TTTCTTCCEEECCSSCCC-CCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCE
T ss_pred CCCCCCCCCC-CCCCC------CCCCCCCCCCCCCCCCCC-EEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCHH
T ss_conf 1111222221-11112------122222222222223110-110011222211112212434210221233322111000
Q ss_pred EECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEECCCCCC
Q ss_conf 9846898879988258799888989854870544699877999988898758978
Q 002774 172 VRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSF 226 (882)
Q Consensus 172 L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l 226 (882)
+++++|++++..+..+..+++|+.|+|++|+|+.+++.+..++.|+.|+|++|++
T Consensus 153 l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~~lp~~~~~~~~L~~L~L~~Np~ 207 (266)
T d1p9ag_ 153 LSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPW 207 (266)
T ss_dssp EECTTSCCSCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCCCSEEECCSCCB
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHCCCCCCCEEEECCCCC
T ss_conf 0000156522372001342124234301397855686677788899998369998
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.95 E-value=9.9e-29 Score=171.71 Aligned_cols=170 Identities=14% Similarity=0.124 Sum_probs=120.1
Q ss_pred CCCCEEECCCCEEEEEEEECCCCEEEEEECCCCCCC------------------CHHHHHHHHHHHHHCCCCCEEEEEEE
Q ss_conf 977802025737999999369958999972469854------------------08999999999971367870139888
Q 002774 558 SDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQ------------------GGQEFKMEIELLSRVHHKNLVSLLGF 619 (882)
Q Consensus 558 ~~~~~lG~G~fg~Vy~a~~~~g~~vavK~~~~~~~~------------------~~~~~~~E~~~l~~l~H~niv~l~~~ 619 (882)
.+.++||+|+||+||+|+..+|+.||||+++..... .......|...+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred HHCCEEEECCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEE
T ss_conf 22778024856599999979999999999860443466655656300088899999977899999998169991449986
Q ss_pred EEECCCEEEEEEEECCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEE
Q ss_conf 97179369999820699856656889886553999999999999987531102799833058888766986899456940
Q 002774 620 CFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVAD 699 (882)
Q Consensus 620 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NIll~~~~~~kl~D 699 (882)
. ..+++|||++++.+.+. +......++.|++.++.|||+.+ |+||||||+|||++++ .++++|
T Consensus 83 ~----~~~lvme~~~~~~~~~l---------~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~liD 145 (191)
T d1zara2 83 E----GNAVLMELIDAKELYRV---------RVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWIID 145 (191)
T ss_dssp E----TTEEEEECCCCEEGGGC---------CCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEECC
T ss_pred C----CCEEEEEEECCCCCCCH---------HHHHHHHHHHHHHHHHHHHHHCC---EEECCCCHHHEEEECC-CEEEEE
T ss_conf 2----88899995045654200---------15789999999999999982688---8983689036114289-899987
Q ss_pred CCCCCCCCCCCCCEEEEEEECCCCCCCHHHHHHCCCCCHHHHHHHHHHHH
Q ss_conf 46651158998850233333068988977773099995567899999999
Q 002774 700 FGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLML 749 (882)
Q Consensus 700 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~il~ 749 (882)
||+|+...++....... ..... -.+. ..+.|+.++|+||..--++
T Consensus 146 FG~a~~~~~~~~~~~l~---rd~~~-~~~~-f~r~y~~~~d~~s~~~~~~ 190 (191)
T d1zara2 146 FPQSVEVGEEGWREILE---RDVRN-IITY-FSRTYRTEKDINSAIDRIL 190 (191)
T ss_dssp CTTCEETTSTTHHHHHH---HHHHH-HHHH-HHHHHCCCCCHHHHHHHHH
T ss_pred CCCCCCCCCCCCHHHHH---HHHHH-HHHH-HCCCCCCCCCHHHHHHHHH
T ss_conf 78843089987099998---77999-9999-7578998446899999874
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.92 E-value=1.3e-22 Score=138.12 Aligned_cols=95 Identities=26% Similarity=0.381 Sum_probs=53.9
Q ss_pred CCCEEECCCCCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEC
Q ss_conf 88898556899986678946667777868983087477666512239888878984278587779867658788757662
Q 002774 16 ELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDL 95 (882)
Q Consensus 16 ~L~~L~l~~n~~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 95 (882)
++++|||++++ ++ .+|+. .++|++|++++|+|+ .+|..+ .+|+.|++++|+++ .++. +. +.|++|++
T Consensus 39 ~l~~LdLs~~~-L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~-lp--~~L~~L~L 105 (353)
T d1jl5a_ 39 QAHELELNNLG-LS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSD-LP--PLLEYLGV 105 (353)
T ss_dssp TCSEEECTTSC-CS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCS-CC--TTCCEEEC
T ss_pred CCCEEEECCCC-CC-CCCCC---CCCCCEEECCCCCCC-CCCCCH---HHHHHHHHHHCCCC-HHHH-HC--CCCCCCCC
T ss_conf 99899937999-88-78898---789888989999796-336203---32033266551432-0321-02--21111133
Q ss_pred CCCEEEEECCCCCCCCCHHHHHHCCCCEECCCCEEE
Q ss_conf 386432204899999950354320251120587100
Q 002774 96 TDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLS 131 (882)
Q Consensus 96 s~N~l~~~~p~~~~~l~~l~~L~~L~~L~l~~N~l~ 131 (882)
++|++. .+|. ...+..|++|++.+|.+.
T Consensus 106 ~~n~l~-~lp~-------~~~l~~L~~L~l~~~~~~ 133 (353)
T d1jl5a_ 106 SNNQLE-KLPE-------LQNSSFLKIIDVDNNSLK 133 (353)
T ss_dssp CSSCCS-SCCC-------CTTCTTCCEEECCSSCCS
T ss_pred CCCCCC-CCCC-------HHHHCCCEEECCCCCCCC
T ss_conf 455432-2210-------011013123113565100
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.91 E-value=2.1e-23 Score=142.45 Aligned_cols=207 Identities=20% Similarity=0.336 Sum_probs=121.8
Q ss_pred CCCEEECCCCCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEC
Q ss_conf 88898556899986678946667777868983087477666512239888878984278587779867658788757662
Q 002774 16 ELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDL 95 (882)
Q Consensus 16 ~L~~L~l~~n~~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 95 (882)
++..+++..++ +.+.+ .+..+.+|+.|++.+|+|+ .++ .+.++++|++|++++|+|.+..+ +..+++|+++++
T Consensus 20 ~~~~~~l~~~~-~~d~~--~~~~l~~L~~L~l~~~~i~-~l~-~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~ 92 (227)
T d1h6ua2 20 NAIKIAAGKSN-VTDTV--TQADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELEL 92 (227)
T ss_dssp HHHHHHTTCSS-TTSEE--CHHHHHTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEEC
T ss_pred HHHHHHHCCCC-CCCCC--CHHHCCCCCEEECCCCCCC-CCH-HHHCCCCCCEEECCCCEEECCCC--CCCCCCCCCCCC
T ss_conf 99999848887-67757--9878488689977799997-664-57448888376357853202543--112334320121
Q ss_pred CCCEEEEECCCCCCCCCHHHHHHCCCCEECCCCEEEECCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCEEECC
Q ss_conf 38643220489999995035432025112058710003794434885312000036996456688233489999899846
Q 002774 96 TDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFD 175 (882)
Q Consensus 96 s~N~l~~~~p~~~~~l~~l~~L~~L~~L~l~~N~l~g~i~~~~f~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~ 175 (882)
++|.++ . +..+..++ +|+.+.++.+...+. ..+...+.+..+.++
T Consensus 93 ~~n~~~-~-------i~~l~~l~-------------------------~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~~ 137 (227)
T d1h6ua2 93 SGNPLK-N-------VSAIAGLQ-------------------------SIKTLDLTSTQITDV--TPLAGLSNLQVLYLD 137 (227)
T ss_dssp CSCCCS-C-------CGGGTTCT-------------------------TCCEEECTTSCCCCC--GGGTTCTTCCEEECC
T ss_pred CCCCCC-C-------CCCCCCCC-------------------------CCCCCCCCCCCCCCC--CHHCCCCCHHHHHCH
T ss_conf 112222-2-------22222222-------------------------221221222443311--000002301222000
Q ss_pred CCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCC
Q ss_conf 89887998825879988898985487054469987799998889875897898888810128988888977478461138
Q 002774 176 RNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQI 255 (882)
Q Consensus 176 ~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~ls~N~l~~~~ 255 (882)
.+.+.... .+..+++|+.|++++|.++... .+..+++|+.|+|++|+++. ++. +..+++|+.|++++|++++ +
T Consensus 138 ~~~~~~~~--~~~~~~~L~~L~l~~n~~~~~~-~l~~l~~L~~L~Ls~n~l~~--l~~-l~~l~~L~~L~Ls~N~lt~-i 210 (227)
T d1h6ua2 138 LNQITNIS--PLAGLTNLQYLSIGNAQVSDLT-PLANLSKLTTLKADDNKISD--ISP-LASLPNLIEVHLKNNQISD-V 210 (227)
T ss_dssp SSCCCCCG--GGGGCTTCCEEECCSSCCCCCG-GGTTCTTCCEEECCSSCCCC--CGG-GGGCTTCCEEECTTSCCCB-C
T ss_pred HHHHCHHH--HHCCCCCCCCCCCCCCCCCCCH-HHCCCCCCEECCCCCCCCCC--CHH-HCCCCCCCEEECCCCCCCC-C
T ss_conf 00000000--0010211100233333333100-10564633564458884177--853-4479999989795996899-8
Q ss_pred CCCCCCCCCCCEEECCC
Q ss_conf 94588999987898127
Q 002774 256 PADLFSIPHLQTVVMKT 272 (882)
Q Consensus 256 p~~~~~l~~L~~L~Ls~ 272 (882)
+ .+..+++|+.|++++
T Consensus 211 ~-~l~~l~~L~~L~lsn 226 (227)
T d1h6ua2 211 S-PLANTSNLFIVTLTN 226 (227)
T ss_dssp G-GGTTCTTCCEEEEEE
T ss_pred C-CCCCCCCCCEEEEEC
T ss_conf 0-203699989897129
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=1.5e-23 Score=143.14 Aligned_cols=199 Identities=14% Similarity=0.127 Sum_probs=77.1
Q ss_pred CEEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCEEEEECCCCCCCCCHHHHHHCCCC
Q ss_conf 68983087477666512239888878984278587779867658788757662386432204899999950354320251
Q 002774 43 SNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKH 122 (882)
Q Consensus 43 ~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~~ 122 (882)
+.++.++.+++ .+|..+. .++++|+|++|+|+.+.+.+|.++++|++|++++|.+...
T Consensus 11 ~~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~------------------- 68 (242)
T d1xwdc1 11 RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEV------------------- 68 (242)
T ss_dssp SEEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCE-------------------
T ss_pred CEEEEECCCCC-CCCCCCC--CCCCEEECCCCCCCCCCHHHHHCCCHHHHHHHCCCCCCCE-------------------
T ss_conf 99998189988-7688889--9889998769918964966861464323211022112420-------------------
Q ss_pred EECCCCEEEECCCCCCCCCCCCCEEEECCC-CCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCC-CCCCCCCCCEEECCC
Q ss_conf 120587100037944348853120000369-964566882334899998998468988799882-587998889898548
Q 002774 123 FHFGKNQLSGSIPEKLFRPDMVLIHVLFDS-NNLTGELPATLGLVKSLEVVRFDRNSLSGPVPS-NLNNLTSVNDLYLSN 200 (882)
Q Consensus 123 L~l~~N~l~g~i~~~~f~~~~~L~~L~L~~-N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~-~l~~l~~L~~L~Ls~ 200 (882)
++...|..++.++.+.+.. |++....+..|..+++|+++++++|.+....+. .+..+..+..+...+
T Consensus 69 -----------i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n 137 (242)
T d1xwdc1 69 -----------IEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDN 137 (242)
T ss_dssp -----------ECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESC
T ss_pred -----------EECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCC
T ss_conf -----------100112222222221111123432222221222222222234211112554333222111122222221
Q ss_pred CCCCCCCCC-CCCCC-CCCEEECCCCCCCCCCCCCCCCCCCCCCEE-ECCCCCCCCCCCCCCCCCCCCCEEECCCCCCC
Q ss_conf 705446998-77999-988898758978988888101289888889-77478461138945889999878981277242
Q 002774 201 NKLTGAMPN-LTGLS-VLSYLDMSNNSFDASEVPSWFSSMQSLTTL-MMENTNLKGQIPADLFSIPHLQTVVMKTNELN 276 (882)
Q Consensus 201 N~l~~~~~~-l~~l~-~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L-~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 276 (882)
+.+..+.+. +.+++ .+..|++++|+++. ..+. .....++..+ ++++|+++...+..+..+++|++|+|++|+++
T Consensus 138 ~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~-i~~~-~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~ 214 (242)
T d1xwdc1 138 INIHTIERNSFVGLSFESVILWLNKNGIQE-IHNC-AFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH 214 (242)
T ss_dssp TTCCEECTTSSTTSBSSCEEEECCSSCCCE-ECTT-TTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCC
T ss_pred CCCCCCCCCCCCCCCCCCEEEECCCCCCCC-CCCC-CCCCHHHHCCCCCCCCCCCCCCHHHHCCCCCCCEEECCCCCCC
T ss_conf 211122222222223310012200123333-2222-2220111012123543246424788668999998989799289
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.90 E-value=6.7e-24 Score=145.11 Aligned_cols=204 Identities=22% Similarity=0.361 Sum_probs=87.0
Q ss_pred CEEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCEEEEECCCCCCCCCHHHHHHCCCC
Q ss_conf 68983087477666512239888878984278587779867658788757662386432204899999950354320251
Q 002774 43 SNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKH 122 (882)
Q Consensus 43 ~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~~ 122 (882)
..+++..+.+++.+ .+..+.+|+.|++.+|.|+. + ..+..+++|++|++++|++.+..|
T Consensus 22 ~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~-l-~~l~~l~~L~~L~ls~n~i~~~~~----------------- 80 (227)
T d1h6ua2 22 IKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTT-I-EGVQYLNNLIGLELKDNQITDLAP----------------- 80 (227)
T ss_dssp HHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG-----------------
T ss_pred HHHHHCCCCCCCCC--CHHHCCCCCEEECCCCCCCC-C-HHHHCCCCCCEEECCCCEEECCCC-----------------
T ss_conf 99984888767757--98784886899777999976-6-457448888376357853202543-----------------
Q ss_pred EECCCCEEEECCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCC
Q ss_conf 12058710003794434885312000036996456688233489999899846898879988258799888989854870
Q 002774 123 FHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNK 202 (882)
Q Consensus 123 L~l~~N~l~g~i~~~~f~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~ 202 (882)
+..++.++.+++++|.++.. ..+..+++|+.++++.+...+. ..+...+.+..+.++.+.
T Consensus 81 ----------------l~~l~~l~~l~~~~n~~~~i--~~l~~l~~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~ 140 (227)
T d1h6ua2 81 ----------------LKNLTKITELELSGNPLKNV--SAIAGLQSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQ 140 (227)
T ss_dssp ----------------GTTCCSCCEEECCSCCCSCC--GGGTTCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECCSSC
T ss_pred ----------------CCCCCCCCCCCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCC--CHHCCCCCHHHHHCHHHH
T ss_conf ----------------11233432012111222222--2222222221221222443311--000002301222000000
Q ss_pred CCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCEECCCC
Q ss_conf 54469987799998889875897898888810128988888977478461138945889999878981277242122788
Q 002774 203 LTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLG 282 (882)
Q Consensus 203 l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~ 282 (882)
+.... .+..+++|+.|++++|.+.. . ..+..+++|+.|++++|.+.+ ++ .+..+++|++|+|++|+++...+ .
T Consensus 141 ~~~~~-~~~~~~~L~~L~l~~n~~~~--~-~~l~~l~~L~~L~Ls~n~l~~-l~-~l~~l~~L~~L~Ls~N~lt~i~~-l 213 (227)
T d1h6ua2 141 ITNIS-PLAGLTNLQYLSIGNAQVSD--L-TPLANLSKLTTLKADDNKISD-IS-PLASLPNLIEVHLKNNQISDVSP-L 213 (227)
T ss_dssp CCCCG-GGGGCTTCCEEECCSSCCCC--C-GGGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECTTSCCCBCGG-G
T ss_pred HCHHH-HHCCCCCCCCCCCCCCCCCC--C-HHHCCCCCCEECCCCCCCCCC-CH-HHCCCCCCCEEECCCCCCCCCCC-C
T ss_conf 00000-00102111002333333331--0-010564633564458884177-85-34479999989795996899802-0
Q ss_pred CCCCCCCCCCCC
Q ss_conf 763213200034
Q 002774 283 TSYSENLLVNLQ 294 (882)
Q Consensus 283 ~~~~~l~~l~l~ 294 (882)
..+.+|+.|+++
T Consensus 214 ~~l~~L~~L~ls 225 (227)
T d1h6ua2 214 ANTSNLFIVTLT 225 (227)
T ss_dssp TTCTTCCEEEEE
T ss_pred CCCCCCCEEEEE
T ss_conf 369998989712
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.89 E-value=2e-22 Score=137.06 Aligned_cols=218 Identities=13% Similarity=0.117 Sum_probs=98.6
Q ss_pred CEEECCCCCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCC-CCCCCCCCCCCEEECC
Q ss_conf 898556899986678946667777868983087477666512239888878984278587779-8676587887576623
Q 002774 18 HTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRV-PPSIGNLSNLYWLDLT 96 (882)
Q Consensus 18 ~~L~l~~n~~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~-p~~l~~l~~L~~L~Ls 96 (882)
+.++.+++. + ..+|..+. +++++|++++|.|+...+.+|.++++|++|+|++|.+...+ +..|.++++++.+.+.
T Consensus 11 ~~i~c~~~~-l-~~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~ 86 (242)
T d1xwdc1 11 RVFLCQESK-V-TEIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE 86 (242)
T ss_dssp SEEEEESCS-C-SSCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEE
T ss_pred CEEEEECCC-C-CCCCCCCC--CCCCEEECCCCCCCCCCHHHHHCCCHHHHHHHCCCCCCCEEECCCCCCCCCCCCCCCC
T ss_conf 999981899-8-87688889--9889998769918964966861464323211022112420100112222222221111
Q ss_pred C-CEEEEECCCCCCCCCHHHHHHCCCCEECCCCEEEECCCC-CCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCEEEC
Q ss_conf 8-643220489999995035432025112058710003794-43488531200003699645668823348999989984
Q 002774 97 D-NKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPE-KLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRF 174 (882)
Q Consensus 97 ~-N~l~~~~p~~~~~l~~l~~L~~L~~L~l~~N~l~g~i~~-~~f~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l 174 (882)
. |.+....+.. +..+++|+.+++.+|++. .++. ..+..+..+..+...++.+....+..+..++
T Consensus 87 ~~n~l~~~~~~~------~~~l~~L~~l~l~~~~l~-~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~------- 152 (242)
T d1xwdc1 87 KANNLLYINPEA------FQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLS------- 152 (242)
T ss_dssp CCTTCCEECTTS------EECCTTCCEEEEESCCCC-SCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSB-------
T ss_pred CCCCCCCCCCCC------CCCCCCCCCCCCCHHHHC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-------
T ss_conf 123432222221------222222222234211112-554333222111122222221211122222222223-------
Q ss_pred CCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEE-ECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCC
Q ss_conf 689887998825879988898985487054469987799998889-8758978988888101289888889774784611
Q 002774 175 DRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYL-DMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKG 253 (882)
Q Consensus 175 ~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L-~Ls~N~l~~~~~p~~~~~l~~L~~L~ls~N~l~~ 253 (882)
..+..|++++|+++.+........++..+ ++++|.++. ..+..|.++++|+.|++++|+++.
T Consensus 153 ----------------~~l~~L~l~~n~l~~i~~~~~~~~~l~~~~~l~~n~l~~-l~~~~f~~l~~L~~L~Ls~N~l~~ 215 (242)
T d1xwdc1 153 ----------------FESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEE-LPNDVFHGASGPVILDISRTRIHS 215 (242)
T ss_dssp ----------------SSCEEEECCSSCCCEECTTTTTTCCEEEEECTTCTTCCC-CCTTTTTTSCCCSEEECTTSCCCC
T ss_pred ----------------CCCEEEECCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCC-CCHHHHCCCCCCCEEECCCCCCCC
T ss_conf ----------------310012200123333222222201110121235432464-247886689999989897992894
Q ss_pred CCCCCCCCCCCCCEEEC
Q ss_conf 38945889999878981
Q 002774 254 QIPADLFSIPHLQTVVM 270 (882)
Q Consensus 254 ~~p~~~~~l~~L~~L~L 270 (882)
..+..+..+++|+.+++
T Consensus 216 l~~~~~~~l~~L~~l~~ 232 (242)
T d1xwdc1 216 LPSYGLENLKKLRARST 232 (242)
T ss_dssp CCSSSCTTCCEEESSSE
T ss_pred CCHHHHCCCCCCCCCCC
T ss_conf 59779737713414767
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.89 E-value=9.3e-21 Score=127.84 Aligned_cols=264 Identities=25% Similarity=0.327 Sum_probs=158.2
Q ss_pred CCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCC
Q ss_conf 97102585655888888985568999866789466677778689830874776665122398888789842785877798
Q 002774 2 GLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVP 81 (882)
Q Consensus 2 ~~~~~l~~~l~~l~~L~~L~l~~n~~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p 81 (882)
+++ .+|+. .++|++|++++|+ +. .+|..+ .+|+.|++++|.++ .++. + .+.|++|++++|.+. .+|
T Consensus 49 ~L~-~lp~~---~~~L~~L~Ls~N~-l~-~lp~~~---~~L~~L~l~~n~l~-~l~~-l--p~~L~~L~L~~n~l~-~lp 114 (353)
T d1jl5a_ 49 GLS-SLPEL---PPHLESLVASCNS-LT-ELPELP---QSLKSLLVDNNNLK-ALSD-L--PPLLEYLGVSNNQLE-KLP 114 (353)
T ss_dssp CCS-CCCSC---CTTCSEEECCSSC-CS-SCCCCC---TTCCEEECCSSCCS-CCCS-C--CTTCCEEECCSSCCS-SCC
T ss_pred CCC-CCCCC---CCCCCEEECCCCC-CC-CCCCCH---HHHHHHHHHHCCCC-HHHH-H--CCCCCCCCCCCCCCC-CCC
T ss_conf 988-78898---7898889899997-96-336203---32033266551432-0321-0--221111133455432-221
Q ss_pred CCCCCCCCCCEEECCCCEEEEECCCCCCC-------------CCHHHHHHCCCCEECCCCEEEECCCCCCCCCCCCCEEE
Q ss_conf 67658788757662386432204899999-------------95035432025112058710003794434885312000
Q 002774 82 PSIGNLSNLYWLDLTDNKLEGEIPVSDGN-------------SPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHV 148 (882)
Q Consensus 82 ~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~-------------l~~l~~L~~L~~L~l~~N~l~g~i~~~~f~~~~~L~~L 148 (882)
. ++.+++|+.|++++|.+. ..+..... ...+..+..++.+.+..|... .++... .....+
T Consensus 115 ~-~~~l~~L~~L~l~~~~~~-~~~~~~~~l~~l~~~~~~~~~~~~l~~l~~l~~L~l~~n~~~-~~~~~~----~~~~~l 187 (353)
T d1jl5a_ 115 E-LQNSSFLKIIDVDNNSLK-KLPDLPPSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSLK-KLPDLP----LSLESI 187 (353)
T ss_dssp C-CTTCTTCCEEECCSSCCS-CCCCCCTTCCEEECCSSCCSSCCCCTTCTTCCEEECCSSCCS-SCCCCC----TTCCEE
T ss_pred C-HHHHCCCEEECCCCCCCC-CCCCCCCCCCCHHHCCCCCCCCCCCCCCCCCEECCCCCCCCC-CCCCCC----CCCCCC
T ss_conf 0-011013123113565100-132233332100001222223332000122200111233443-222212----222223
Q ss_pred ECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCC
Q ss_conf 03699645668823348999989984689887998825879988898985487054469987799998889875897898
Q 002774 149 LFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDA 228 (882)
Q Consensus 149 ~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~ 228 (882)
....+.+. .. ..+..++.|+.+++++|... ..+. ...++..+.+.++.+....... ..+..+++..+.+.+
T Consensus 188 ~~~~~~~~-~~-~~~~~l~~L~~l~l~~n~~~-~~~~---~~~~l~~~~~~~~~~~~~~~~~---~~l~~~~~~~~~~~~ 258 (353)
T d1jl5a_ 188 VAGNNILE-EL-PELQNLPFLTTIYADNNLLK-TLPD---LPPSLEALNVRDNYLTDLPELP---QSLTFLDVSENIFSG 258 (353)
T ss_dssp ECCSSCCS-SC-CCCTTCTTCCEEECCSSCCS-SCCS---CCTTCCEEECCSSCCSCCCCCC---TTCCEEECCSSCCSE
T ss_pred CCCCCCCC-CC-CCCCCCCCCCCCCCCCCCCC-CCCC---CCCCCCCCCCCCCCCCCCCCCC---CCCCCCCCCCCCCCC
T ss_conf 34443222-21-22345553331222542223-4553---2334333222333334443334---432222222233322
Q ss_pred ---------------CCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCEECCCCCCCCCCCCCCC
Q ss_conf ---------------88881012898888897747846113894588999987898127724212278876321320003
Q 002774 229 ---------------SEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENLLVNL 293 (882)
Q Consensus 229 ---------------~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~l~l 293 (882)
..+......+++|+.|++++|.+. .+|. .+++|+.|+|++|+++.... . ..+++.|++
T Consensus 259 l~~l~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~-~lp~---~~~~L~~L~L~~N~L~~l~~-~--~~~L~~L~L 331 (353)
T d1jl5a_ 259 LSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPA---LPPRLERLIASFNHLAEVPE-L--PQNLKQLHV 331 (353)
T ss_dssp ESCCCTTCCEEECCSSCCSEECCCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCSCCCC-C--CTTCCEEEC
T ss_pred CCCCCCHHCCCCCCCCCCCCCCCCCCCCCEEECCCCCCC-CCCC---CCCCCCEEECCCCCCCCCCC-C--CCCCCEEEC
T ss_conf 234530001233335753234566898898979799168-3566---54879989899996875453-2--288898987
Q ss_pred CCCCCCCCC
Q ss_conf 488422456
Q 002774 294 QNNRISAYT 302 (882)
Q Consensus 294 ~~N~l~~~~ 302 (882)
++|+++.++
T Consensus 332 ~~N~L~~lp 340 (353)
T d1jl5a_ 332 EYNPLREFP 340 (353)
T ss_dssp CSSCCSSCC
T ss_pred CCCCCCCCC
T ss_conf 699189777
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.88 E-value=2.4e-22 Score=136.57 Aligned_cols=139 Identities=18% Similarity=0.207 Sum_probs=68.0
Q ss_pred CCCEEECCCCCCCC-CCCCCCCCCCCCCEEECCCCCCCCCCCC-CCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCEEE
Q ss_conf 99899846898879-9882587998889898548705446998-779999888987589789888881012898888897
Q 002774 168 SLEVVRFDRNSLSG-PVPSNLNNLTSVNDLYLSNNKLTGAMPN-LTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLM 245 (882)
Q Consensus 168 ~L~~L~l~~N~l~~-~~p~~l~~l~~L~~L~Ls~N~l~~~~~~-l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~ 245 (882)
++++|+|++|.|+. ..+..|.++++|+.|+|++|.+...++. +..++.|+.|+|++|+++. ..+..|.++++|+.|+
T Consensus 30 ~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~-l~~~~F~~l~~L~~L~ 108 (192)
T d1w8aa_ 30 HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKE-ISNKMFLGLHQLKTLN 108 (192)
T ss_dssp TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCE-ECSSSSTTCTTCCEEE
T ss_pred CCCEEEECCCCCCCCCCCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCC-CCHHHHHCCCCCCCCC
T ss_conf 878898489877553020025787627213013632212121222112222101003553443-4979980797465524
Q ss_pred CCCCCCCCCCCCCCCCCCCCCEEECCCCCCCEECCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 74784611389458899998789812772421227887632132000348842245679998
Q 002774 246 MENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENLLVNLQNNRISAYTERGGA 307 (882)
Q Consensus 246 ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~l~l~~N~l~~~~~~~~~ 307 (882)
|++|+|++..+..|..+++|++|+|++|++.+.....+-...+..+++..|.+.+..+..+.
T Consensus 109 L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~~~~~l~~~~l~~~~~~c~~p~~l~ 170 (192)
T d1w8aa_ 109 LYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPSKVR 170 (192)
T ss_dssp CCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSSTTTT
T ss_pred CCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCEEECCCHHHC
T ss_conf 57745353597785687533420003644343530277764235403568982768984336
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.88 E-value=8.1e-23 Score=139.18 Aligned_cols=83 Identities=22% Similarity=0.398 Sum_probs=34.9
Q ss_pred CEEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCC-CCCCCCCCEEECCC
Q ss_conf 20000369964566882334899998998468988799882587998889898548705446998-77999988898758
Q 002774 145 LIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPN-LTGLSVLSYLDMSN 223 (882)
Q Consensus 145 L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~-l~~l~~L~~L~Ls~ 223 (882)
|+.|++++|.+....+..+..+++|++|++++|+|+...+..|.++++|+.|+|++|+|+++++. |..+++|+.|+|++
T Consensus 56 L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~ 135 (192)
T d1w8aa_ 56 LVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLAS 135 (192)
T ss_dssp CCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTT
T ss_pred EEEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCC
T ss_conf 72130136322121212221122221010035534434979980797465524577453535977856875334200036
Q ss_pred CCCC
Q ss_conf 9789
Q 002774 224 NSFD 227 (882)
Q Consensus 224 N~l~ 227 (882)
|.+.
T Consensus 136 N~~~ 139 (192)
T d1w8aa_ 136 NPFN 139 (192)
T ss_dssp CCBC
T ss_pred CCCC
T ss_conf 4434
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.87 E-value=3.4e-21 Score=130.24 Aligned_cols=102 Identities=23% Similarity=0.434 Sum_probs=54.9
Q ss_pred CCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 34899998998468988799882587998889898548705446998779999888987589789888881012898888
Q 002774 163 LGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLT 242 (882)
Q Consensus 163 l~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~ 242 (882)
+..+++|+.|++++|.+. .+ ..+..+++|+.+++++|.++.. +.+..+++|+.+++++|+++. ++. +..+++|+
T Consensus 108 l~~l~~L~~L~l~~~~~~-~~-~~l~~l~~l~~l~~~~n~l~~~-~~~~~l~~L~~l~l~~n~l~~--i~~-l~~l~~L~ 181 (210)
T d1h6ta2 108 LKDLKKLKSLSLEHNGIS-DI-NGLVHLPQLESLYLGNNKITDI-TVLSRLTKLDTLSLEDNQISD--IVP-LAGLTKLQ 181 (210)
T ss_dssp GTTCTTCCEEECTTSCCC-CC-GGGGGCTTCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCC--CGG-GTTCTTCC
T ss_pred CCCCCCCCCCCCCCCCCC-CC-CCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCC--CCC-CCCCCCCC
T ss_conf 212221112234565322-11-2201111122211222333454-310001332100134643025--645-36789899
Q ss_pred EEECCCCCCCCCCCCCCCCCCCCCEEECCC
Q ss_conf 897747846113894588999987898127
Q 002774 243 TLMMENTNLKGQIPADLFSIPHLQTVVMKT 272 (882)
Q Consensus 243 ~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 272 (882)
.|++++|.++ .++ .+..+++|++|+|++
T Consensus 182 ~L~Ls~N~i~-~l~-~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 182 NLYLSKNHIS-DLR-ALAGLKNLDVLELFS 209 (210)
T ss_dssp EEECCSSCCC-BCG-GGTTCTTCSEEEEEE
T ss_pred EEECCCCCCC-CCH-HHCCCCCCCEEECCC
T ss_conf 9989799899-872-116999989997118
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.86 E-value=4.5e-21 Score=129.57 Aligned_cols=166 Identities=22% Similarity=0.384 Sum_probs=87.8
Q ss_pred CCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCEEEEECCCCCCCCCHHHHH
Q ss_conf 77778689830874776665122398888789842785877798676587887576623864322048999999503543
Q 002774 38 NLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDML 117 (882)
Q Consensus 38 ~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L 117 (882)
.+.+|+.|++++|.+.. ++ .+..+++|++|+|++|+|++ ++ .++.+++|++|++++|+++
T Consensus 44 ~L~~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~L~~n~i~~-l~-~~~~l~~L~~L~l~~n~i~---------------- 103 (210)
T d1h6ta2 44 ELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTD-IK-PLANLKNLGWLFLDENKVK---------------- 103 (210)
T ss_dssp HHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCC----------------
T ss_pred HHCCCCEEECCCCCCCC-CH-HHHHCCCCCEEECCCCCCCC-CC-CCCCCCCCCCCCCCCCCCC----------------
T ss_conf 95484589782798887-44-47648998987698960258-60-1135862120143333321----------------
Q ss_pred HCCCCEECCCCEEEECCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEE
Q ss_conf 20251120587100037944348853120000369964566882334899998998468988799882587998889898
Q 002774 118 VRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLY 197 (882)
Q Consensus 118 ~~L~~L~l~~N~l~g~i~~~~f~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~ 197 (882)
.++. +..+++|+.+++++|.+.. ...+..++.++.+++++|.+++ +..+..+++|+.++
T Consensus 104 ---------------~l~~--l~~l~~L~~L~l~~~~~~~--~~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~ 162 (210)
T d1h6ta2 104 ---------------DLSS--LKDLKKLKSLSLEHNGISD--INGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLS 162 (210)
T ss_dssp ---------------CGGG--GTTCTTCCEEECTTSCCCC--CGGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEE
T ss_pred ---------------CCCC--CCCCCCCCCCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCC--CCCCCCCCCCCCCC
T ss_conf ---------------2221--2122211122345653221--1220111112221122233345--43100013321001
Q ss_pred CCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCEEECCC
Q ss_conf 548705446998779999888987589789888881012898888897747
Q 002774 198 LSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMEN 248 (882)
Q Consensus 198 Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~ls~ 248 (882)
+++|+++++. .+.++++|+.|+|++|+++ .++ .+..+++|+.|++++
T Consensus 163 l~~n~l~~i~-~l~~l~~L~~L~Ls~N~i~--~l~-~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 163 LEDNQISDIV-PLAGLTKLQNLYLSKNHIS--DLR-ALAGLKNLDVLELFS 209 (210)
T ss_dssp CCSSCCCCCG-GGTTCTTCCEEECCSSCCC--BCG-GGTTCTTCSEEEEEE
T ss_pred CCCCCCCCCC-CCCCCCCCCEEECCCCCCC--CCH-HHCCCCCCCEEECCC
T ss_conf 3464302564-5367898999989799899--872-116999989997118
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.86 E-value=1.2e-20 Score=127.14 Aligned_cols=98 Identities=24% Similarity=0.389 Sum_probs=43.6
Q ss_pred CCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 34899998998468988799882587998889898548705446998779999888987589789888881012898888
Q 002774 163 LGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLT 242 (882)
Q Consensus 163 l~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~ 242 (882)
+.+++.|+.|++++|.+... ..+..+++|+.|++++|++... +.+..+++|+.|++++|.++. ++ .+.++++|+
T Consensus 102 l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~~-~~l~~~~~L~~L~l~~n~l~~--l~-~l~~l~~L~ 175 (199)
T d2omxa2 102 LANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTISDI-SALSGLTSLQQLNFSSNQVTD--LK-PLANLTTLE 175 (199)
T ss_dssp GTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCCC-GGGTTCTTCSEEECCSSCCCC--CG-GGTTCTTCC
T ss_pred CCCCCCCCCCCCCCCCCCCC--CCCCHHHHHHHHHHHHHHHCCC-CCCCCCCCCCCCCCCCCCCCC--CC-CCCCCCCCC
T ss_conf 11122322211122222232--1000122367764311110023-433321111112234555567--70-116799899
Q ss_pred EEECCCCCCCCCCCCCCCCCCCCCEE
Q ss_conf 89774784611389458899998789
Q 002774 243 TLMMENTNLKGQIPADLFSIPHLQTV 268 (882)
Q Consensus 243 ~L~ls~N~l~~~~p~~~~~l~~L~~L 268 (882)
.|++++|++++ + ..+..+++|++|
T Consensus 176 ~L~ls~N~i~~-i-~~l~~L~~L~~L 199 (199)
T d2omxa2 176 RLDISSNKVSD-I-SVLAKLTNLESL 199 (199)
T ss_dssp EEECCSSCCCC-C-GGGGGCTTCSEE
T ss_pred EEECCCCCCCC-C-CCCCCCCCCCCC
T ss_conf 99787997998-8-101278998949
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.85 E-value=1.2e-20 Score=127.16 Aligned_cols=162 Identities=22% Similarity=0.355 Sum_probs=77.4
Q ss_pred CCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCEEEEECCCCCCCCCHHHHH
Q ss_conf 77778689830874776665122398888789842785877798676587887576623864322048999999503543
Q 002774 38 NLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDML 117 (882)
Q Consensus 38 ~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L 117 (882)
.+.+++.|++++|++.. +. .+..+++|++|++++|+|++. +. ++++++|++|++++|.+.
T Consensus 38 ~l~~l~~L~l~~~~i~~-l~-~l~~l~nL~~L~Ls~N~l~~~-~~-l~~l~~L~~L~l~~n~~~---------------- 97 (199)
T d2omxa2 38 DLDQVTTLQADRLGIKS-ID-GVEYLNNLTQINFSNNQLTDI-TP-LKNLTKLVDILMNNNQIA---------------- 97 (199)
T ss_dssp HHTTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCC----------------
T ss_pred HHCCCCEEECCCCCCCC-CC-CCCCCCCCCCCCCCCCCCCCC-CC-CCCCCCCCCCCCCCCCCC----------------
T ss_conf 94687899899999977-52-021378867575456556676-40-167752231111222222----------------
Q ss_pred HCCCCEECCCCEEEECCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEE
Q ss_conf 20251120587100037944348853120000369964566882334899998998468988799882587998889898
Q 002774 118 VRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLY 197 (882)
Q Consensus 118 ~~L~~L~l~~N~l~g~i~~~~f~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~ 197 (882)
.++. +..++.|+.+++++|.+... ..+..+++|+.|++++|.+. .++ .+..+++|+.|+
T Consensus 98 ---------------~~~~--l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~-~~~-~l~~~~~L~~L~ 156 (199)
T d2omxa2 98 ---------------DITP--LANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTIS-DIS-ALSGLTSLQQLN 156 (199)
T ss_dssp ---------------CCGG--GTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCC-CCG-GGTTCTTCSEEE
T ss_pred ---------------CCCC--CCCCCCCCCCCCCCCCCCCC--CCCCHHHHHHHHHHHHHHHC-CCC-CCCCCCCCCCCC
T ss_conf ---------------2211--11122322211122222232--10001223677643111100-234-333211111122
Q ss_pred CCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCEE
Q ss_conf 54870544699877999988898758978988888101289888889
Q 002774 198 LSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTL 244 (882)
Q Consensus 198 Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L 244 (882)
+++|+++++. .+.++++|+.|++++|+++. ++ .+..+++|+.|
T Consensus 157 l~~n~l~~l~-~l~~l~~L~~L~ls~N~i~~--i~-~l~~L~~L~~L 199 (199)
T d2omxa2 157 FSSNQVTDLK-PLANLTTLERLDISSNKVSD--IS-VLAKLTNLESL 199 (199)
T ss_dssp CCSSCCCCCG-GGTTCTTCCEEECCSSCCCC--CG-GGGGCTTCSEE
T ss_pred CCCCCCCCCC-CCCCCCCCCEEECCCCCCCC--CC-CCCCCCCCCCC
T ss_conf 3455556770-11679989999787997998--81-01278998949
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.84 E-value=3.3e-25 Score=152.32 Aligned_cols=113 Identities=20% Similarity=0.248 Sum_probs=49.8
Q ss_pred CCCEEECCCCCCCCCC-CCCCCCCCCCCCEEEEECCCCCC----CCCCCCCCCCCCCEEECCCCCCCCC----CCCCCC-
Q ss_conf 8889855689998667-89466677778689830874776----6651223988887898427858777----986765-
Q 002774 16 ELHTLDLSNNKDLRGP-LPTTIGNLKKLSNLMLVGCSFSG----PIPDSIGSLQELVLLSLNSNGFSGR----VPPSIG- 85 (882)
Q Consensus 16 ~L~~L~l~~n~~i~~~-~p~~l~~l~~L~~L~L~~n~l~~----~~p~~l~~l~~L~~L~Ls~N~l~~~----~p~~l~- 85 (882)
+|+.||+++++ +.+. +..-+..++++++|+|++|+++. .+...+..+++|+.|+|++|+|+.. +...+.
T Consensus 3 ~l~~ld~~~~~-i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~ 81 (460)
T d1z7xw1 3 DIQSLDIQCEE-LSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT 81 (460)
T ss_dssp EEEEEEEESCC-CCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred CCCEEEEECCC-CCHHHHHHHHHHCCCCCEEEECCCCCCHHHHHHHHHHHHCCCCCCEEECCCCCCCHHHHHHHHHHHHC
T ss_conf 87779820895-88689999997677999998289999889999999998539998889795985972899999999843
Q ss_pred CCCCCCEEECCCCEEEEECCCCCCCCCHHHHHHCCCCEECCCCEEE
Q ss_conf 8788757662386432204899999950354320251120587100
Q 002774 86 NLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLS 131 (882)
Q Consensus 86 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~~L~l~~N~l~ 131 (882)
...+|++|+|++|+++...-..+ ...+..++.|+.|++++|+++
T Consensus 82 ~~~~L~~L~L~~n~it~~~~~~l--~~~l~~~~~L~~L~L~~N~i~ 125 (460)
T d1z7xw1 82 PSCKIQKLSLQNCCLTGAGCGVL--SSTLRTLPTLQELHLSDNLLG 125 (460)
T ss_dssp TTCCCCEEECTTSCCBGGGHHHH--HHHTTSCTTCCEEECCSSBCH
T ss_pred CCCCCCEEECCCCCCCCCCCCCC--CCHHHCCCCCCCCCCCCCCCH
T ss_conf 78877887788877543221012--110000343200244433202
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.77 E-value=4e-22 Score=135.33 Aligned_cols=90 Identities=19% Similarity=0.254 Sum_probs=67.0
Q ss_pred CCCCCCCCEEECCCCCCCCC----CCCCCCCCCCCCCEEEEECCCCCCC----CCCCCC-CCCCCCEEECCCCCCCCC--
Q ss_conf 55888888985568999866----7894666777786898308747766----651223-988887898427858777--
Q 002774 11 ITGLTELHTLDLSNNKDLRG----PLPTTIGNLKKLSNLMLVGCSFSGP----IPDSIG-SLQELVLLSLNSNGFSGR-- 79 (882)
Q Consensus 11 l~~l~~L~~L~l~~n~~i~~----~~p~~l~~l~~L~~L~L~~n~l~~~----~p~~l~-~l~~L~~L~Ls~N~l~~~-- 79 (882)
+..++++++|+|++|+ +.. .+...+...++|+.|+|++|.|+.. +...+. ...+|++|+|++|+|+..
T Consensus 23 ~~~l~~l~~L~L~~~~-i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~it~~~~ 101 (460)
T d1z7xw1 23 LPLLQQCQVVRLDDCG-LTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGC 101 (460)
T ss_dssp HHHHTTCSEEEEESSC-CCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGH
T ss_pred HHHCCCCCEEEECCCC-CCHHHHHHHHHHHHCCCCCCEEECCCCCCCHHHHHHHHHHHHCCCCCCCEEECCCCCCCCCCC
T ss_conf 9767799999828999-988999999999853999888979598597289999999984378877887788877543221
Q ss_pred --CCCCCCCCCCCCEEECCCCEEE
Q ss_conf --9867658788757662386432
Q 002774 80 --VPPSIGNLSNLYWLDLTDNKLE 101 (882)
Q Consensus 80 --~p~~l~~l~~L~~L~Ls~N~l~ 101 (882)
++..+..+++|++|++++|++.
T Consensus 102 ~~l~~~l~~~~~L~~L~L~~N~i~ 125 (460)
T d1z7xw1 102 GVLSSTLRTLPTLQELHLSDNLLG 125 (460)
T ss_dssp HHHHHHTTSCTTCCEEECCSSBCH
T ss_pred CCCCCHHHCCCCCCCCCCCCCCCH
T ss_conf 012110000343200244433202
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.77 E-value=2.8e-21 Score=130.69 Aligned_cols=252 Identities=17% Similarity=0.156 Sum_probs=119.7
Q ss_pred CCCCCCCCCCCCEEECCCCCCCCC----CCCCCCCCCCCCCEEEEECCCCCCC----------CCCCCCCCCCCCEEECC
Q ss_conf 585655888888985568999866----7894666777786898308747766----------65122398888789842
Q 002774 7 LSGDITGLTELHTLDLSNNKDLRG----PLPTTIGNLKKLSNLMLVGCSFSGP----------IPDSIGSLQELVLLSLN 72 (882)
Q Consensus 7 l~~~l~~l~~L~~L~l~~n~~i~~----~~p~~l~~l~~L~~L~L~~n~l~~~----------~p~~l~~l~~L~~L~Ls 72 (882)
+...+.+...|++|+|++|. +.. .+...+...++|+.|+++++..... +...+..+++|+.|+|+
T Consensus 23 l~~~L~~~~~l~~L~Ls~n~-i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~ 101 (344)
T d2ca6a1 23 VFAVLLEDDSVKEIVLSGNT-IGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLS 101 (344)
T ss_dssp TSHHHHHCSCCCEEECTTSE-ECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECC
T ss_pred HHHHHHHCCCCCEEECCCCC-CCHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCC
T ss_conf 99999638997889784983-77899999999998589988888877754334542106787999887547775633000
Q ss_pred CCCCCCCCC----CCCCCCCCCCEEECCCCEEEEECCCCCCCCCHHHHHHCCCCEECCCCEEEECCCCCCCCCCCCCEEE
Q ss_conf 785877798----6765878875766238643220489999995035432025112058710003794434885312000
Q 002774 73 SNGFSGRVP----PSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHV 148 (882)
Q Consensus 73 ~N~l~~~~p----~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~~L~l~~N~l~g~i~~~~f~~~~~L~~L 148 (882)
+|.++.... ..+...++|+.|++++|.+.......+. ..+..+ ... ......+.|+.+
T Consensus 102 ~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~--~~l~~~------~~~----------~~~~~~~~L~~l 163 (344)
T d2ca6a1 102 DNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIA--RALQEL------AVN----------KKAKNAPPLRSI 163 (344)
T ss_dssp SCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHH--HHHHHH------HHH----------HHHHTCCCCCEE
T ss_pred CCCCCCCCCCCHHHHHCCCCCCHHEECCCCCCCCCCCCCCC--CCCCCC------CCC----------CCCCCCCCCCEE
T ss_conf 01345543331011100234321000002466665431111--212222------110----------001467642111
Q ss_pred ECCCCCCCCC----CCCCCCCCCCCCEEECCCCCCCCC-----CCCCCCCCCCCCEEECCCCCCCCC-----CCCCCCCC
Q ss_conf 0369964566----882334899998998468988799-----882587998889898548705446-----99877999
Q 002774 149 LFDSNNLTGE----LPATLGLVKSLEVVRFDRNSLSGP-----VPSNLNNLTSVNDLYLSNNKLTGA-----MPNLTGLS 214 (882)
Q Consensus 149 ~L~~N~l~~~----~p~~l~~l~~L~~L~l~~N~l~~~-----~p~~l~~l~~L~~L~Ls~N~l~~~-----~~~l~~l~ 214 (882)
.++.|.+... +...+...+.|+.|++++|.+... +...+..+++|+.|+|++|.++.. ...+..++
T Consensus 164 ~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~ 243 (344)
T d2ca6a1 164 ICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWP 243 (344)
T ss_dssp ECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCT
T ss_pred ECCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 01365013554332211112333213354333222222232002433211012112223333222222223444332322
Q ss_pred CCCEEECCCCCCCCCC---CCCCCCC--CCCCCEEECCCCCCCCCC----CCCCC-CCCCCCEEECCCCCCCE
Q ss_conf 9888987589789888---8810128--988888977478461138----94588-99998789812772421
Q 002774 215 VLSYLDMSNNSFDASE---VPSWFSS--MQSLTTLMMENTNLKGQI----PADLF-SIPHLQTVVMKTNELNG 277 (882)
Q Consensus 215 ~L~~L~Ls~N~l~~~~---~p~~~~~--l~~L~~L~ls~N~l~~~~----p~~~~-~l~~L~~L~Ls~N~l~~ 277 (882)
+|+.|+|++|.++... +...+.. .+.|+.|++++|.+.... ...+. ..+.|+.|+|++|++..
T Consensus 244 ~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~ 316 (344)
T d2ca6a1 244 NLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE 316 (344)
T ss_dssp TCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred CCHHHHHHCCCCCCHHHHHHHHHHHHCCCCCCCEEECCCCCCCHHHHHHHHHHHHCCCCCCCEEECCCCCCCC
T ss_conf 1111030047567156678887763156888898989898698089999999997038999989787980898
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.72 E-value=6.2e-20 Score=123.30 Aligned_cols=257 Identities=16% Similarity=0.148 Sum_probs=158.4
Q ss_pred CCCCCCCCCCCCCEEEEECCCCCCC----CCCCCCCCCCCCEEECCCCCCCCCC----------CCCCCCCCCCCEEECC
Q ss_conf 7894666777786898308747766----6512239888878984278587779----------8676587887576623
Q 002774 31 PLPTTIGNLKKLSNLMLVGCSFSGP----IPDSIGSLQELVLLSLNSNGFSGRV----------PPSIGNLSNLYWLDLT 96 (882)
Q Consensus 31 ~~p~~l~~l~~L~~L~L~~n~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~~~----------p~~l~~l~~L~~L~Ls 96 (882)
.+...+.+...|+.|+|++|.+... +...+...++|+.|+++++.+.... ...+...++|+.|+|+
T Consensus 22 ~l~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~ 101 (344)
T d2ca6a1 22 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLS 101 (344)
T ss_dssp TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECC
T ss_pred HHHHHHHHCCCCCEEECCCCCCCHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCC
T ss_conf 99999963899788978498377899999999998589988888877754334542106787999887547775633000
Q ss_pred CCEEEEECCCCCCCCCHHHHHHCCCCEECCCCEEEECCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCEEECCC
Q ss_conf 86432204899999950354320251120587100037944348853120000369964566882334899998998468
Q 002774 97 DNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDR 176 (882)
Q Consensus 97 ~N~l~~~~p~~~~~l~~l~~L~~L~~L~l~~N~l~g~i~~~~f~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~ 176 (882)
+|.+.......+ ...+...+.|++|++++|.++ ......+ ...+..+ .........+.|+.+.+++
T Consensus 102 ~n~i~~~~~~~l--~~~l~~~~~L~~L~l~~n~l~-~~~~~~l--~~~l~~~---------~~~~~~~~~~~L~~l~l~~ 167 (344)
T d2ca6a1 102 DNAFGPTAQEPL--IDFLSKHTPLEHLYLHNNGLG-PQAGAKI--ARALQEL---------AVNKKAKNAPPLRSIICGR 167 (344)
T ss_dssp SCCCCTTTHHHH--HHHHHHCTTCCEEECCSSCCH-HHHHHHH--HHHHHHH---------HHHHHHHTCCCCCEEECCS
T ss_pred CCCCCCCCCCCH--HHHHCCCCCCHHEECCCCCCC-CCCCCCC--CCCCCCC---------CCCCCCCCCCCCCEEECCC
T ss_conf 013455433310--111002343210000024666-6543111--1212222---------1100014676421110136
Q ss_pred CCCCCCC----CCCCCCCCCCCEEECCCCCCCCC------CCCCCCCCCCCEEECCCCCCCCC---CCCCCCCCCCCCCE
Q ss_conf 9887998----82587998889898548705446------99877999988898758978988---88810128988888
Q 002774 177 NSLSGPV----PSNLNNLTSVNDLYLSNNKLTGA------MPNLTGLSVLSYLDMSNNSFDAS---EVPSWFSSMQSLTT 243 (882)
Q Consensus 177 N~l~~~~----p~~l~~l~~L~~L~Ls~N~l~~~------~~~l~~l~~L~~L~Ls~N~l~~~---~~p~~~~~l~~L~~ 243 (882)
|.+.... ...+...+.|+.|+|++|.++.. ...+...++|+.|+|++|.++.. .+...+..+++|+.
T Consensus 168 n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~ 247 (344)
T d2ca6a1 168 NRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRE 247 (344)
T ss_dssp SCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCE
T ss_pred CCCCCCCCCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCHH
T ss_conf 50135543322111123332133543332222222320024332110121122233332222222234443323221111
Q ss_pred EECCCCCCCCCCCCCC----C--CCCCCCEEECCCCCCCEEC----CCCC--CCCCCCCCCCCCCCCCCC
Q ss_conf 9774784611389458----8--9999878981277242122----7887--632132000348842245
Q 002774 244 LMMENTNLKGQIPADL----F--SIPHLQTVVMKTNELNGTL----DLGT--SYSENLLVNLQNNRISAY 301 (882)
Q Consensus 244 L~ls~N~l~~~~p~~~----~--~l~~L~~L~Ls~N~l~~~~----~~~~--~~~~l~~l~l~~N~l~~~ 301 (882)
|++++|.|.+.....+ . ..+.|+.|++++|++.... .... ..+.++.|++++|++...
T Consensus 248 L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~~ 317 (344)
T d2ca6a1 248 LGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEE 317 (344)
T ss_dssp EECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTT
T ss_pred HHHHCCCCCCHHHHHHHHHHHHCCCCCCCEEECCCCCCCHHHHHHHHHHHHCCCCCCCEEECCCCCCCCC
T ss_conf 0300475671566788877631568888989898986980899999999970389999897879808986
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.71 E-value=9.6e-19 Score=116.76 Aligned_cols=221 Identities=16% Similarity=0.179 Sum_probs=107.0
Q ss_pred CEEECCCCCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCC-CCCCCCCCCCCCEEECC
Q ss_conf 89855689998667894666777786898308747766651223988887898427858777-98676587887576623
Q 002774 18 HTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGR-VPPSIGNLSNLYWLDLT 96 (882)
Q Consensus 18 ~~L~l~~n~~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~-~p~~l~~l~~L~~L~Ls 96 (882)
+++|++++. +.......+-. ..+..+.+.+..+..... ......+|++|||+++.+... +...+..+++|++|+|+
T Consensus 3 ~~lDLs~~~-l~~~~l~~l~~-~~~~~lrl~~~~~~~~~~-~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~ 79 (284)
T d2astb2 3 QTLDLTGKN-LHPDVTGRLLS-QGVIAFRCPRSFMDQPLA-EHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLE 79 (284)
T ss_dssp SEEECTTCB-CCHHHHHHHHH-TTCSEEECTTCEECSCCC-SCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECT
T ss_pred CEEECCCCC-CCCHHHHHHHH-CCCEEEECCCCCCCCCHH-HHCCCCCCCEEECCCCCCCHHHHHHHHHHCCCCCCCCCC
T ss_conf 779789997-88147999874-554274652333455224-425678788788989845777999999748776514523
Q ss_pred CCEEEEECCCCCCCCCHHHHHHCCCCEECCCCEEEECCCCCCCCCCCCCEEEECCCC-CCCCC-CCCCCCCCCCCCEEEC
Q ss_conf 864322048999999503543202511205871000379443488531200003699-64566-8823348999989984
Q 002774 97 DNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSN-NLTGE-LPATLGLVKSLEVVRF 174 (882)
Q Consensus 97 ~N~l~~~~p~~~~~l~~l~~L~~L~~L~l~~N~l~g~i~~~~f~~~~~L~~L~L~~N-~l~~~-~p~~l~~l~~L~~L~l 174 (882)
+|.+....+. .+. ..++|+.|+++++ .++.. +...+..+++|++|++
T Consensus 80 ~~~l~~~~~~------~l~-------------------------~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~l 128 (284)
T d2astb2 80 GLRLSDPIVN------TLA-------------------------KNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNL 128 (284)
T ss_dssp TCBCCHHHHH------HHT-------------------------TCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEEC
T ss_pred CCCCCCHHHH------HHH-------------------------CCCCCCCCCCCCCCCCCCCCCCHHHHHHHHCCCCCC
T ss_conf 4679867899------985-------------------------189975715100134123554036578874356522
Q ss_pred CCC-CCCCC-CCCCCC-CCCCCCEEECCCC--CCCCC-CCC-CCCCCCCCEEECCCCC-CCCCCCCCCCCCCCCCCEEEC
Q ss_conf 689-88799-882587-9988898985487--05446-998-7799998889875897-898888810128988888977
Q 002774 175 DRN-SLSGP-VPSNLN-NLTSVNDLYLSNN--KLTGA-MPN-LTGLSVLSYLDMSNNS-FDASEVPSWFSSMQSLTTLMM 246 (882)
Q Consensus 175 ~~N-~l~~~-~p~~l~-~l~~L~~L~Ls~N--~l~~~-~~~-l~~l~~L~~L~Ls~N~-l~~~~~p~~~~~l~~L~~L~l 246 (882)
+++ .++.. +...+. ..++|+.|+++++ .++.. ... ...+++|+.|++++|. ++. .....+..+++|+.|++
T Consensus 129 s~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd-~~~~~l~~~~~L~~L~L 207 (284)
T d2astb2 129 SWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKN-DCFQEFFQLNYLQHLSL 207 (284)
T ss_dssp CCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCG-GGGGGGGGCTTCCEEEC
T ss_pred CCCCCCCCCCCHHHHCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-HHHHHHCCCCCCCEEEC
T ss_conf 45332333220001000111110122135542444443434232322212355322347783-03333213576877989
Q ss_pred CCC-CCCCCCCCCCCCCCCCCEEECCCC
Q ss_conf 478-461138945889999878981277
Q 002774 247 ENT-NLKGQIPADLFSIPHLQTVVMKTN 273 (882)
Q Consensus 247 s~N-~l~~~~p~~~~~l~~L~~L~Ls~N 273 (882)
++| .+++.....+..+|+|+.|+++++
T Consensus 208 ~~C~~i~~~~l~~L~~~~~L~~L~l~~~ 235 (284)
T d2astb2 208 SRCYDIIPETLLELGEIPTLKTLQVFGI 235 (284)
T ss_dssp TTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred CCCCCCCHHHHHHHHCCCCCCEEEEECC
T ss_conf 9999787378999726999898964488
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.71 E-value=4.4e-19 Score=118.60 Aligned_cols=60 Identities=18% Similarity=0.211 Sum_probs=25.5
Q ss_pred CCCCCCEEEEECCCCCCC-CCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCC
Q ss_conf 777786898308747766-651223988887898427858777986765878875766238
Q 002774 38 NLKKLSNLMLVGCSFSGP-IPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTD 97 (882)
Q Consensus 38 ~l~~L~~L~L~~n~l~~~-~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~ 97 (882)
...+|++|++++|.+... +...+.++++|++|+|+++.+....+..+..+++|++|++++
T Consensus 44 ~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~ 104 (284)
T d2astb2 44 SPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSG 104 (284)
T ss_dssp CCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTT
T ss_pred CCCCCCEEECCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCCCC
T ss_conf 6787887889898457779999997487765145234679867899985189975715100
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.70 E-value=8.8e-18 Score=111.45 Aligned_cols=87 Identities=20% Similarity=0.254 Sum_probs=32.2
Q ss_pred CCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCC-CCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 4899998998468988799882587998889898548705446998-779999888987589789888881012898888
Q 002774 164 GLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPN-LTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLT 242 (882)
Q Consensus 164 ~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~-l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~ 242 (882)
..+++|+.|++++|.|+ .+ ..+..+++|+.|++++|+++.+++. +..+++|+.|++++|+++....-..+..+++|+
T Consensus 38 ~~l~~L~~L~Ls~N~i~-~l-~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L~~N~i~~~~~l~~l~~l~~L~ 115 (162)
T d1a9na_ 38 ATLDQFDAIDFSDNEIR-KL-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLT 115 (162)
T ss_dssp GGTTCCSEEECCSSCCC-EE-CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCCCGGGGGGGGGCTTCC
T ss_pred CCCCCCCEEECCCCCCC-CC-CCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCC
T ss_conf 04145998989799787-64-77445761306431021345777632233453443420300016654211001365320
Q ss_pred EEECCCCCCC
Q ss_conf 8977478461
Q 002774 243 TLMMENTNLK 252 (882)
Q Consensus 243 ~L~ls~N~l~ 252 (882)
.|++++|.+.
T Consensus 116 ~L~l~~N~i~ 125 (162)
T d1a9na_ 116 YLCILRNPVT 125 (162)
T ss_dssp EEECCSSGGG
T ss_pred HHHCCCCCCC
T ss_conf 6640799634
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.70 E-value=2e-17 Score=109.49 Aligned_cols=108 Identities=16% Similarity=0.118 Sum_probs=38.1
Q ss_pred CCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCEE
Q ss_conf 89999899846898879988258799888989854870544699877999988898758978988888101289888889
Q 002774 165 LVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTL 244 (882)
Q Consensus 165 ~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L 244 (882)
++..|++|+|++|+|+ .++..+..+++|+.|+|++|.++.+ +.+..+++|+.|++++|+++. ..+..+..+++|+.|
T Consensus 16 n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~l-~~~~~l~~L~~L~ls~N~i~~-l~~~~~~~l~~L~~L 92 (162)
T d1a9na_ 16 NAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL-DGFPLLRRLKTLLVNNNRICR-IGEGLDQALPDLTEL 92 (162)
T ss_dssp CTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCEE-CCCCCCSSCCEEECCSSCCCE-ECSCHHHHCTTCCEE
T ss_pred CCCCCCEEECCCCCCC-CCCCCCCCCCCCCEEECCCCCCCCC-CCCCCCCCHHHHHCCCCCCCC-CCCCCCCCCCCCCCC
T ss_conf 8574848978899788-6576200414599898979978764-774457613064310213457-776322334534434
Q ss_pred ECCCCCCCCCCC-CCCCCCCCCCEEECCCCCC
Q ss_conf 774784611389-4588999987898127724
Q 002774 245 MMENTNLKGQIP-ADLFSIPHLQTVVMKTNEL 275 (882)
Q Consensus 245 ~ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l 275 (882)
++++|.+..... ..+..+++|++|++++|++
T Consensus 93 ~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i 124 (162)
T d1a9na_ 93 ILTNNSLVELGDLDPLASLKSLTYLCILRNPV 124 (162)
T ss_dssp ECCSCCCCCGGGGGGGGGCTTCCEEECCSSGG
T ss_pred EECCCCCCCCCCCCCCCCCCCCCHHHCCCCCC
T ss_conf 20300016654211001365320664079963
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.65 E-value=4.4e-16 Score=102.09 Aligned_cols=60 Identities=23% Similarity=0.316 Sum_probs=19.3
Q ss_pred CCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEECCCCCC
Q ss_conf 89999899846898879988258799888989854870544699877999988898758978
Q 002774 165 LVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSF 226 (882)
Q Consensus 165 ~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l 226 (882)
.+++|++|++++|.|+ .+|..+..+++|+.|++++|.++.. +.+..+++|+.|++++|++
T Consensus 18 ~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~l-~~~~~l~~L~~L~l~~N~i 77 (124)
T d1dcea3 18 QLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENV-DGVANLPRLQELLLCNNRL 77 (124)
T ss_dssp GGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCC-GGGTTCSSCCEEECCSSCC
T ss_pred CCCCCCEEECCCCCCC-CCHHHHHHHHCCCCCCCCCCCCCCC-CCCCCCCCCCEEECCCCCC
T ss_conf 5898898979787168-6521565543135453243211235-7412335557688889865
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.62 E-value=2.2e-15 Score=98.22 Aligned_cols=109 Identities=20% Similarity=0.256 Sum_probs=77.9
Q ss_pred CCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCC-CCCCCCC-CCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCEE
Q ss_conf 999899846898879988258799888989854870-5446998-77999988898758978988888101289888889
Q 002774 167 KSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNK-LTGAMPN-LTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTL 244 (882)
Q Consensus 167 ~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~-l~~~~~~-l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L 244 (882)
...+.++++++.+. ..|..+..+++|+.|++++|+ ++.+.+. |.++++|+.|+|++|+|+. ..+..|..+++|+.|
T Consensus 8 ~~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~-i~~~~f~~l~~L~~L 85 (156)
T d2ifga3 8 HGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRF-VAPDAFHFTPRLSRL 85 (156)
T ss_dssp SSSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCE-ECTTGGGSCSCCCEE
T ss_pred CCCCEEEECCCCCC-CCCCCCCCCCCCCEEECCCCCCCCCCCCHHHCCCCCCCCCEEECCCCCC-CCCCCCCCCCCCCCE
T ss_conf 99996985289976-5860025765657431689866443692122566666721620212477-420111245543333
Q ss_pred ECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCEE
Q ss_conf 7747846113894588999987898127724212
Q 002774 245 MMENTNLKGQIPADLFSIPHLQTVVMKTNELNGT 278 (882)
Q Consensus 245 ~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 278 (882)
+|++|+|. .++.......+|+.|+|++|++.+.
T Consensus 86 ~Ls~N~l~-~l~~~~~~~~~l~~L~L~~Np~~C~ 118 (156)
T d2ifga3 86 NLSFNALE-SLSWKTVQGLSLQELVLSGNPLHCS 118 (156)
T ss_dssp ECCSSCCS-CCCSTTTCSCCCCEEECCSSCCCCC
T ss_pred ECCCCCCC-CCCHHHHCCCCCCCCCCCCCCCCCC
T ss_conf 22678785-1574563353212433579863388
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.61 E-value=5.9e-18 Score=112.43 Aligned_cols=111 Identities=19% Similarity=0.230 Sum_probs=43.6
Q ss_pred CCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCC
Q ss_conf 33489999899846898879988258799888989854870544699877999988898758978988888101289888
Q 002774 162 TLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSL 241 (882)
Q Consensus 162 ~l~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L 241 (882)
.+..+++|++|++++|.|+ .++ .+..+++|+.|+|++|.++.+++....++.|+.|++++|.++. + ..+..+++|
T Consensus 43 sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~~i~~~~~~~~~L~~L~l~~N~i~~--l-~~~~~l~~L 117 (198)
T d1m9la_ 43 TLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIKKIENLDAVADTLEELWISYNQIAS--L-SGIEKLVNL 117 (198)
T ss_dssp HHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEECSCSSHHHHHHHCCEEECSEEECCC--H-HHHHHHHHS
T ss_pred HHHCCCCCCEEECCCCCCC-CCC-CCCCCCCCCCHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC--C-CCCCCCCCC
T ss_conf 7762604615199446899-864-4247825357341353432100003322123333333322222--2-222222234
Q ss_pred CEEECCCCCCCCCCC-CCCCCCCCCCEEECCCCCCCE
Q ss_conf 889774784611389-458899998789812772421
Q 002774 242 TTLMMENTNLKGQIP-ADLFSIPHLQTVVMKTNELNG 277 (882)
Q Consensus 242 ~~L~ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~ 277 (882)
+.|++++|++..... ..+..+++|+.|+|++|++..
T Consensus 118 ~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~ 154 (198)
T d1m9la_ 118 RVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYN 154 (198)
T ss_dssp SEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHH
T ss_pred CCCCCCCCHHCCCCCCCCCCCCCCCCEEECCCCCCCC
T ss_conf 1112341021255422123677763023427984346
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.56 E-value=2.1e-17 Score=109.41 Aligned_cols=44 Identities=23% Similarity=0.433 Sum_probs=21.1
Q ss_pred CCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCEEE
Q ss_conf 6512239888878984278587779867658788757662386432
Q 002774 56 IPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLE 101 (882)
Q Consensus 56 ~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 101 (882)
++.++..+++|++|+|++|+|+ .++ .+..+++|+.|+|++|+++
T Consensus 40 l~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~ 83 (198)
T d1m9la_ 40 MDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK 83 (198)
T ss_dssp CHHHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC
T ss_pred HHHHHHCCCCCCEEECCCCCCC-CCC-CCCCCCCCCCHHHCCCCCC
T ss_conf 2467762604615199446899-864-4247825357341353432
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.54 E-value=1e-14 Score=94.53 Aligned_cols=103 Identities=16% Similarity=0.135 Sum_probs=36.0
Q ss_pred EEECCCCCCCCCCCCCCCCCCCCEEECCCCC-CCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCC
Q ss_conf 8985487054469987799998889875897-898888810128988888977478461138945889999878981277
Q 002774 195 DLYLSNNKLTGAMPNLTGLSVLSYLDMSNNS-FDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTN 273 (882)
Q Consensus 195 ~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~-l~~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 273 (882)
.++.+++.++..+..+.++++|+.|++++|+ ++ ...+..|.++++|+.|++++|+|+...+..|..+++|++|+|++|
T Consensus 12 ~l~c~~~~~~~~p~~l~~l~~l~~L~l~~n~~l~-~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N 90 (156)
T d2ifga3 12 GLRCTRDGALDSLHHLPGAENLTELYIENQQHLQ-HLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN 90 (156)
T ss_dssp CEECCSSCCCTTTTTSCSCSCCSEEECCSCSSCC-EECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSS
T ss_pred EEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCC-CCCCHHHCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEECCCC
T ss_conf 6985289976586002576565743168986644-369212256666672162021247742011124554333322678
Q ss_pred CCCEECCCCCCCCCCCCCCCCCCCC
Q ss_conf 2421227887632132000348842
Q 002774 274 ELNGTLDLGTSYSENLLVNLQNNRI 298 (882)
Q Consensus 274 ~l~~~~~~~~~~~~l~~l~l~~N~l 298 (882)
++....+..+....++.|++++|++
T Consensus 91 ~l~~l~~~~~~~~~l~~L~L~~Np~ 115 (156)
T d2ifga3 91 ALESLSWKTVQGLSLQELVLSGNPL 115 (156)
T ss_dssp CCSCCCSTTTCSCCCCEEECCSSCC
T ss_pred CCCCCCHHHHCCCCCCCCCCCCCCC
T ss_conf 7851574563353212433579863
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=99.19 E-value=1.2e-10 Score=72.27 Aligned_cols=149 Identities=17% Similarity=0.166 Sum_probs=97.7
Q ss_pred HHHHHHHCCCCCCCEEECCCCEEEEEEEECCCCEEEEEECCCCCCCCHHHHHHHHHHHHHCC-CCCEEEEEEEEEECCCE
Q ss_conf 99999971999778020257379999993699589999724698540899999999997136-78701398889717936
Q 002774 548 EEVKKYTNNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVH-HKNLVSLLGFCFDRGEQ 626 (882)
Q Consensus 548 ~e~~~~~~~~~~~~~lG~G~fg~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~ 626 (882)
.+++..-+.|...+..+-++...||+... ++..+++|+...........+.+|...++.+. +--+.+++++...++..
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHHHHHCEEEEECCCCCCCCCEEEEEE-CCCEEEEEECCCCCCCCHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCE
T ss_conf 99997513527997678998771899990-89869999848876532556999999999876069987289997508964
Q ss_pred EEEEEEECCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---------------------------------
Q ss_conf 99998206998566568898865539999999999999875311027---------------------------------
Q 002774 627 MLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELA--------------------------------- 673 (882)
Q Consensus 627 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--------------------------------- 673 (882)
++||+++++.++.+...... ....++.++++.+..||+..
T Consensus 86 ~lv~~~l~G~~~~~~~~~~~-------~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYEDEQ-------SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEEEECCSSEEHHHHTTTCS-------CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGG
T ss_pred EEEEEECCCCCCCCCCCCCC-------CHHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHCC
T ss_conf 99998604334354334402-------69999998999999985568421435764465655577899877655554303
Q ss_pred -----------------------CCCEEECCCCCCCEEECCCCCEEEEECCCCC
Q ss_conf -----------------------9983305888876698689945694046651
Q 002774 674 -----------------------NPPIIHRDIKSSNILLDERLNAKVADFGLSK 704 (882)
Q Consensus 674 -----------------------~~~ivHrDik~~NIll~~~~~~kl~DfGla~ 704 (882)
...++|+|+.+.||+++++....+.||+.+.
T Consensus 159 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp STTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred CCCCCCHHHHHHHHHHHHCCCCCCCEEEEEECCCCCEEECCCCEEEEEECHHCC
T ss_conf 323200579999999984498678178986004764236499659996023144
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.86 E-value=2.5e-08 Score=59.43 Aligned_cols=130 Identities=18% Similarity=0.176 Sum_probs=86.0
Q ss_pred EEECCCC-EEEEEEEECCCCEEEEEECCCCCCCCHHHHHHHHHHHHHCC--CCCEEEEEEEEEECCCEEEEEEEECCCCC
Q ss_conf 0202573-79999993699589999724698540899999999997136--78701398889717936999982069985
Q 002774 562 DVGSGGY-GKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVH--HKNLVSLLGFCFDRGEQMLIYEFVPNGSL 638 (882)
Q Consensus 562 ~lG~G~f-g~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--H~niv~l~~~~~~~~~~~lV~e~~~~gsL 638 (882)
.+..|.. ..||+....++..+++|....... ..+..|...++.+. .-.+.++++++.+++..++||+++++.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred ECCCCCCCCEEEEEEECCCCEEEEEECCCCCH---HHHHHHHHHHHHHHHCCCCCCCEEEECCCCCCEEEEEEEEECCCC
T ss_conf 76786547758999938987899995896677---689999999999986599988613222456615999874413554
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH-----------------------------------------------
Q ss_conf 665688988655399999999999998753110-----------------------------------------------
Q 002774 639 GDSLSGKNGIRLDWIRRLKIALGAARGLSYLHE----------------------------------------------- 671 (882)
Q Consensus 639 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~----------------------------------------------- 671 (882)
.+.... .. ..+.+++..|.-||.
T Consensus 94 ~~~~~~-------~~---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (255)
T d1nd4a_ 94 LSSHLA-------PA---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA 163 (255)
T ss_dssp TTSCCC-------HH---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred CCCCCC-------HH---HHHHHHHHHHHHHCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHHH
T ss_conf 322126-------89---99999999999873688544887554124688999999875411011340112137999999
Q ss_pred --------CCCCCEEECCCCCCCEEECCCCCEEEEECCCCC
Q ss_conf --------279983305888876698689945694046651
Q 002774 672 --------LANPPIIHRDIKSSNILLDERLNAKVADFGLSK 704 (882)
Q Consensus 672 --------~~~~~ivHrDik~~NIll~~~~~~kl~DfGla~ 704 (882)
...+.++|+|+.+.||+++++..+.|+||+.+.
T Consensus 164 ~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 164 RLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHCCCCCCCEEEECCCCCCCEEEECCCEEEEEECHHCC
T ss_conf 99871876579567867888763577379658999853326
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.82 E-value=6e-11 Score=73.84 Aligned_cols=15 Identities=20% Similarity=0.301 Sum_probs=5.6
Q ss_pred CCCCCEEECCCCCCC
Q ss_conf 999989984689887
Q 002774 166 VKSLEVVRFDRNSLS 180 (882)
Q Consensus 166 l~~L~~L~l~~N~l~ 180 (882)
+++|++|++++|+|+
T Consensus 64 ~~~L~~L~Ls~N~i~ 78 (162)
T d1koha1 64 IPELLSLNLSNNRLY 78 (162)
T ss_dssp CTTCCCCCCCSSCCC
T ss_pred CCCCCEEECCCCCCC
T ss_conf 878788637776666
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.67 E-value=1.4e-10 Score=71.74 Aligned_cols=14 Identities=43% Similarity=0.496 Sum_probs=4.7
Q ss_pred CCCCEEECCCCCCC
Q ss_conf 88898985487054
Q 002774 191 TSVNDLYLSNNKLT 204 (882)
Q Consensus 191 ~~L~~L~Ls~N~l~ 204 (882)
++|+.|+|++|+|+
T Consensus 65 ~~L~~L~Ls~N~i~ 78 (162)
T d1koha1 65 PELLSLNLSNNRLY 78 (162)
T ss_dssp TTCCCCCCCSSCCC
T ss_pred CCCCEEECCCCCCC
T ss_conf 78788637776666
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.49 E-value=4.5e-07 Score=52.53 Aligned_cols=77 Identities=17% Similarity=0.151 Sum_probs=49.9
Q ss_pred CCEEECCCCEEEEEEEECC-CCEEEEEECCCC------C-CCCHHHHHHHHHHHHHCC-C--CCEEEEEEEEEECCCEEE
Q ss_conf 7802025737999999369-958999972469------8-540899999999997136-7--870139888971793699
Q 002774 560 ANDVGSGGYGKVYKGTLPN-GQLIAIKRAQQG------S-MQGGQEFKMEIELLSRVH-H--KNLVSLLGFCFDRGEQML 628 (882)
Q Consensus 560 ~~~lG~G~fg~Vy~a~~~~-g~~vavK~~~~~------~-~~~~~~~~~E~~~l~~l~-H--~niv~l~~~~~~~~~~~l 628 (882)
.+.||.|....||+....+ ++.++||..... . .....+...|.+.++.+. + ..+.+++.+ +++..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEECCCCEEEEEEEEECCCCEEEEEECCCCHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCEEEEE--CCCCCEE
T ss_conf 99807985276899995799848999617713034677788877899999999998650579885528998--5988779
Q ss_pred EEEEECCCCC
Q ss_conf 9982069985
Q 002774 629 IYEFVPNGSL 638 (882)
Q Consensus 629 V~e~~~~gsL 638 (882)
|||++++..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEECCCCCCC
T ss_conf 8713577653
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=98.06 E-value=2.1e-05 Score=43.34 Aligned_cols=74 Identities=11% Similarity=0.139 Sum_probs=48.1
Q ss_pred CCEEECCCCEEEEEEEECC--------CCEEEEEECCCCCCCCHHHHHHHHHHHHHCC-CCCEEEEEEEEEECCCEEEEE
Q ss_conf 7802025737999999369--------9589999724698540899999999997136-787013988897179369999
Q 002774 560 ANDVGSGGYGKVYKGTLPN--------GQLIAIKRAQQGSMQGGQEFKMEIELLSRVH-HKNLVSLLGFCFDRGEQMLIY 630 (882)
Q Consensus 560 ~~~lG~G~fg~Vy~a~~~~--------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~ 630 (882)
.+.|+.|-.-.+|++...+ ...|.+++.-. ........+|..+++.+. +.-..++++++.+ .+|+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~--~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ 120 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN--PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 120 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS--CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEECCCCCCCCEEEEEECCCCCCCCCCCCCEEEEECCC--CCHHHHHHHHHHHHHHHHHCCCCCEEEEECCC----CEEE
T ss_conf 99917853343489996887754457898179996599--61165899999999999757999808998189----5699
Q ss_pred EEECCCCCC
Q ss_conf 820699856
Q 002774 631 EFVPNGSLG 639 (882)
Q Consensus 631 e~~~~gsL~ 639 (882)
||+++..+.
T Consensus 121 efi~g~~l~ 129 (395)
T d1nw1a_ 121 EYIPSRPLS 129 (395)
T ss_dssp CCCCEEECC
T ss_pred EEECCCCCC
T ss_conf 973455488
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=98.01 E-value=1e-05 Score=45.02 Aligned_cols=133 Identities=11% Similarity=0.082 Sum_probs=76.2
Q ss_pred EEEEEEEECCCCEEEEEECCCCCCCCHHHHHHHHHHHHHCCCCCE--EEEEE-----EEEECCCEEEEEEEECCCCCCCC
Q ss_conf 799999936995899997246985408999999999971367870--13988-----89717936999982069985665
Q 002774 569 GKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNL--VSLLG-----FCFDRGEQMLIYEFVPNGSLGDS 641 (882)
Q Consensus 569 g~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni--v~l~~-----~~~~~~~~~lV~e~~~~gsL~~~ 641 (882)
-.||++...+|..+++|..+.... ..+++..|.+.+..|....+ +..+. .....+..+.++++++|..+...
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~~-s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred CEEEEEECCCCCEEEEEEECCCCC-CHHHHHHHHHHHHHHHHCCCCCCCCEECCCCEEEEEEEEEEEEEEECCCCCCCCC
T ss_conf 026999838999799998478778-8999999999999998559987875206898056653479999865277688999
Q ss_pred CC------------------C---CCCCCCCHH----------------------HHHHHHHHHHHHHHHH-HHCCCCCE
Q ss_conf 68------------------8---988655399----------------------9999999999987531-10279983
Q 002774 642 LS------------------G---KNGIRLDWI----------------------RRLKIALGAARGLSYL-HELANPPI 677 (882)
Q Consensus 642 l~------------------~---~~~~~l~~~----------------------~~~~i~~~ia~gL~yL-H~~~~~~i 677 (882)
-. . ......++. .....+..+...+.-. .......+
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l 194 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR 194 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred CHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCCEE
T ss_conf 99999998999999886303578655677897887665689998747699889899999999999999984545687120
Q ss_pred EECCCCCCCEEECCCCCEEEEECCCCC
Q ss_conf 305888876698689945694046651
Q 002774 678 IHRDIKSSNILLDERLNAKVADFGLSK 704 (882)
Q Consensus 678 vHrDik~~NIll~~~~~~kl~DfGla~ 704 (882)
+|+|+.+.|||++++ ..+.||+-+.
T Consensus 195 iHgDlh~~NvL~~~~--~~~IDFdd~~ 219 (325)
T d1zyla1 195 LHGDCHAGNILWRDG--PMFVDLDDAR 219 (325)
T ss_dssp CCSSCSGGGEEESSS--EEECCCTTCC
T ss_pred ECCCCCCCCEEEECC--CEEEECHHCC
T ss_conf 247888042878389--3588652014
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=98.00 E-value=1.1e-06 Score=50.38 Aligned_cols=111 Identities=14% Similarity=0.084 Sum_probs=0.0
Q ss_pred CCCCCCEEEECCC-CCCCCC----CCCCCCCCCCCCEEECCCCCCC----CCCCCCCCCCCCCCEEECCCCCCCCCCC--
Q ss_conf 8853120000369-964566----8823348999989984689887----9988258799888989854870544699--
Q 002774 140 RPDMVLIHVLFDS-NNLTGE----LPATLGLVKSLEVVRFDRNSLS----GPVPSNLNNLTSVNDLYLSNNKLTGAMP-- 208 (882)
Q Consensus 140 ~~~~~L~~L~L~~-N~l~~~----~p~~l~~l~~L~~L~l~~N~l~----~~~p~~l~~l~~L~~L~Ls~N~l~~~~~-- 208 (882)
...+.|++|+|++ +.+... +...+...+.|++|++++|.+. ..+...+...+.|+.|+|++|.++....
T Consensus 12 ~n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~ 91 (167)
T d1pgva_ 12 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLAR 91 (167)
T ss_dssp TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHH
T ss_pred HCCCCCCEEEECCCCCCCHHHHHHHHHHHHHCCCCCEEECCCCCCCHHHHHHHHHHHHHCCCCCCEEEEHHHCCHHHHHH
T ss_conf 28999819782799998989999999997637764540120156215679887531000234330033010214599999
Q ss_pred ---CCCCCCCCCEEECCCCCCCCCC------CCCCCCCCCCCCEEECCCCC
Q ss_conf ---8779999888987589789888------88101289888889774784
Q 002774 209 ---NLTGLSVLSYLDMSNNSFDASE------VPSWFSSMQSLTTLMMENTN 250 (882)
Q Consensus 209 ---~l~~l~~L~~L~Ls~N~l~~~~------~p~~~~~l~~L~~L~ls~N~ 250 (882)
.+...+.|+.|++++|.+.... +...+...+.|+.|+++++.
T Consensus 92 l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~ 142 (167)
T d1pgva_ 92 LLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFAS 142 (167)
T ss_dssp HHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCC
T ss_pred HHHHHHHCCCCCEEECCCCCCCCCCHHHHHHHHHHHHHCCCCCEEECCCCC
T ss_conf 999998489389877887768886579999999999729985386486888
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.97 E-value=3.9e-05 Score=41.85 Aligned_cols=157 Identities=10% Similarity=0.058 Sum_probs=83.4
Q ss_pred CCHHHHHHHHCCCCCCCEE-----ECCCCEEEEEEEECCCCEEEEEECCCCCCCCHHHHHHHHHHHHHCCCCC-----EE
Q ss_conf 2899999997199977802-----0257379999993699589999724698540899999999997136787-----01
Q 002774 545 FSFEEVKKYTNNFSDANDV-----GSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKN-----LV 614 (882)
Q Consensus 545 ~~~~e~~~~~~~~~~~~~l-----G~G~fg~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n-----iv 614 (882)
.+-++++....+|...+.. ..|.--+.|+....+| .+++|++.... ..++...|++++..+...+ .+
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHHCCCCCCEEEECCCCCCCCCEEEEEECCC-CEEEEECCCCC--CHHHHHHHHHHHHHHHHCCCCCCCCC
T ss_conf 8999999999867999856852378885267389997897-28999807899--98899999999875430255545564
Q ss_pred EEEE---EEEECCCEEEEEEEECCCCCCCCCCC----------------------CCCCC-CCHH---------------
Q ss_conf 3988---89717936999982069985665688----------------------98865-5399---------------
Q 002774 615 SLLG---FCFDRGEQMLIYEFVPNGSLGDSLSG----------------------KNGIR-LDWI--------------- 653 (882)
Q Consensus 615 ~l~~---~~~~~~~~~lV~e~~~~gsL~~~l~~----------------------~~~~~-l~~~--------------- 653 (882)
...+ .....+....++.+..+......-.. ..... ..+.
T Consensus 80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (316)
T d2ppqa1 80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 159 (316)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred EECCCCCCEEEECCCCEEEEECCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHCCHHHHHHHHHHHHCC
T ss_conf 10489762134125502453114655333204678888899876454443202453101110120024567777653114
Q ss_pred -HHHHHHHHHHHHHHHHHH-CCCCCEEECCCCCCCEEECCCCCEEEEECCCCC
Q ss_conf -999999999998753110-279983305888876698689945694046651
Q 002774 654 -RRLKIALGAARGLSYLHE-LANPPIIHRDIKSSNILLDERLNAKVADFGLSK 704 (882)
Q Consensus 654 -~~~~i~~~ia~gL~yLH~-~~~~~ivHrDik~~NIll~~~~~~kl~DfGla~ 704 (882)
.....+......+...+. .-+..++|+|+.++||+++++...-+.||+.+.
T Consensus 160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHCCCCCCEEEECCCCCC
T ss_conf 12799999998764204855454503337863656402045412674222123
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.18 E-value=3.1e-06 Score=47.94 Aligned_cols=126 Identities=15% Similarity=0.140 Sum_probs=0.0
Q ss_pred CCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCC----CCCCCCEEEEECCCCC----CCCCCCCCCCCCCCEEECCC
Q ss_conf 971025856558888889855689998667894666----7777868983087477----66651223988887898427
Q 002774 2 GLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIG----NLKKLSNLMLVGCSFS----GPIPDSIGSLQELVLLSLNS 73 (882)
Q Consensus 2 ~~~~~l~~~l~~l~~L~~L~l~~n~~i~~~~p~~l~----~l~~L~~L~L~~n~l~----~~~p~~l~~l~~L~~L~Ls~ 73 (882)
++...+.....+.+.|++|+|+++..+.......|. ..++|++|++++|.+. ..+...+...++++.+++++
T Consensus 4 ~i~~~l~~~~~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~ 83 (166)
T d1io0a_ 4 DVEETLKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVES 83 (166)
T ss_dssp CHHHHHHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCS
T ss_pred CHHHHHHHHHHCCCCCCEEECCCCCCCCHHHHHHHHHHHHCCCCCCEEECCCCCCCHHHHHHHHHHHHHCCCCHHHHHCC
T ss_conf 39999999995599986887689999898999999988841982574301589611778999998775212210121025
Q ss_pred CCCC----CCCCCCCCCCCCCCE--EECCCCEEEEECCCCCCCCCHHHHHHCCCCEECCCCE
Q ss_conf 8587----779867658788757--6623864322048999999503543202511205871
Q 002774 74 NGFS----GRVPPSIGNLSNLYW--LDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQ 129 (882)
Q Consensus 74 N~l~----~~~p~~l~~l~~L~~--L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~~L~l~~N~ 129 (882)
|.++ ..+...+...++|+. |+++.|.+....-..+.. .++..+.|++|++..+.
T Consensus 84 ~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~--~L~~n~~L~~L~l~~~~ 143 (166)
T d1io0a_ 84 NFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIAN--MLEKNTTLLKFGYHFTQ 143 (166)
T ss_dssp SCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHH--HHHHCSSCCEEECCCSS
T ss_pred CCCCCHHHHHHHHHHHHCCCCCEEEECCCCCCCCHHHHHHHHH--HHHHCCCCCEEECCCCC
T ss_conf 4322014788999998486524773216778676799999999--99849984788581898
|